PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Foster, DG				Foster, Diana Greene			Unmet need for abortion and woman-centered contraceptive care	LANCET			English	Editorial Material									[Foster, Diana Greene] Univ Calif San Francisco, Bixby Ctr Global Reprod Hlth, Adv New Stand Reprod Hlth, Oakland, CA 94612 USA	University of California System; University of California San Francisco	Foster, DG (corresponding author), Univ Calif San Francisco, Bixby Ctr Global Reprod Hlth, Adv New Stand Reprod Hlth, Oakland, CA 94612 USA.	fosterd@obgyn.ucsf.edu						Alkema L, 2013, LANCET, V381, P1642, DOI 10.1016/S0140-6736(12)62204-1; Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6; Gunther I, 2016, DEMOGRAPHY, V53, P55, DOI 10.1007/s13524-015-0451-9; Hajri S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145338; Harries J, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0014-y; Horga M, 2013, J FAM PLAN REPROD H, V39, P2, DOI 10.1136/jfprhc-2012-100498; Hussain R, 2016, UNMET NEED IN PRESS; Jones RK, 2007, STUD FAMILY PLANN, V38, P187, DOI 10.1111/j.1728-4465.2007.00130.x; Puri M, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0241-y; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Sedgh G, 2016, LANCET	11	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2016	388	10041					216	217		10.1016/S0140-6736(16)30452-4	http://dx.doi.org/10.1016/S0140-6736(16)30452-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DR2LN	27179753				2022-12-28	WOS:000379736100006
J	Distler, O; Distler, JHW				Distler, Oliver; Distler, Joerg H. W.			Tocilizumab for systemic sclerosis: implications for future trials	LANCET			English	Editorial Material							FIBROSIS; THERAPY; EUSTAR		[Distler, Oliver] Univ Zurich Hosp, Div Rheumatol, CH-8091 Zurich, Switzerland; [Distler, Joerg H. W.] Univ Erlangen Nurnberg, Dept Internal Med, Inst Clin Immunol, Nurnberg, Germany	University of Zurich; University Zurich Hospital; University of Erlangen Nuremberg	Distler, O (corresponding author), Univ Zurich Hosp, Div Rheumatol, CH-8091 Zurich, Switzerland.	oliver.distler@usz.ch	Distler, Oliver/AAE-6225-2019	Distler, Oliver/0000-0002-0546-8310				Braga TT, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00602; Distler O, 2016, SEMIN IMMUNOPATHOL, V38, P87, DOI 10.1007/s00281-015-0551-z; Dobrota R, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0425-8; Khanna D., 2016, LANCET; Kowal-Bielecka O, 2009, ANN RHEUM DIS, V68, P620, DOI 10.1136/ard.2008.096677; Maurer B, 2015, ANN RHEUM DIS, V74, P1124, DOI 10.1136/annrheumdis-2014-205226; Maurer B, 2013, ANN RHEUM DIS, V72, P2039, DOI 10.1136/annrheumdis-2013-203729; Pendergrass SA, 2012, J INVEST DERMATOL, V132, P1363, DOI 10.1038/jid.2011.472; Prasse A, 2007, ARTHRITIS RHEUM-US, V56, P1685, DOI 10.1002/art.22559; Ramming A, 2015, PHARMACOL RES, V100, P93, DOI 10.1016/j.phrs.2015.06.012; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354	12	10	14	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 25	2016	387	10038					2580	2581		10.1016/S0140-6736(16)00622-X	http://dx.doi.org/10.1016/S0140-6736(16)00622-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP3JX	27156931				2022-12-28	WOS:000378390500007
J	Seto, KC; Ramankutty, N				Seto, Karen C.; Ramankutty, Navin			Hidden linkages between urbanization and food systems	SCIENCE			English	Editorial Material							URBAN EXPANSION; IMPACTS; DIETS; HOME	Global societies are becoming increasingly urban. This shift toward urban living is changing our relationship with food, including how we shop and what we buy, as well as ideas about sanitation and freshness. Achieving food security in an era of rapid urbanization will require considerably more understanding about how urban and food systems are intertwined. Here we discuss some potential understudied linkages that are ripe for further examination.	[Seto, Karen C.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Ramankutty, Navin] Univ British Columbia, Liu Inst Global Issues, Vancouver, BC V6T 1Z2, Canada; [Ramankutty, Navin] Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC V6T 1Z2, Canada	Yale University; University of British Columbia; University of British Columbia	Seto, KC (corresponding author), Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA.; Ramankutty, N (corresponding author), Univ British Columbia, Liu Inst Global Issues, Vancouver, BC V6T 1Z2, Canada.; Ramankutty, N (corresponding author), Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC V6T 1Z2, Canada.	karen.seto@yale.edu; navin.ramankutty@ubc.ca	Ramankutty, Navin/AAM-6074-2020; Seto, Karen C./C-2722-2008	Ramankutty, Navin/0000-0002-3737-5717; Seto, Karen C./0000-0002-4928-2446	Directorate For Geosciences [1450657] Funding Source: National Science Foundation; Division Of Behavioral and Cognitive Sci [1229429] Funding Source: National Science Foundation	Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))		Angel S, 2011, PROG PLANN, V75, P53, DOI 10.1016/j.progress.2011.04.001; Aschemann-Witzel J, 2016, SCIENCE, V352, P408, DOI 10.1126/science.aaf2978; Barbier E. B., 2004, American Journal of Agricultural Economics, V86, P1347, DOI 10.1111/j.0002-9092.2004.00688.x; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Garrett RD, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044055; Godfray HCJ, 2010, PHILOS T R SOC B, V365, P2769, DOI 10.1098/rstb.2010.0180; Guthrie JF, 2002, J NUTR EDUC BEHAV, V34, P140, DOI 10.1016/S1499-4046(06)60083-3; HLPE, 2013, INV SMALLH AGR FOOD; Kummu M, 2012, SCI TOTAL ENVIRON, V438, P477, DOI 10.1016/j.scitotenv.2012.08.092; Ma HY, 2006, CAN J AGR ECON, V54, P101, DOI 10.1111/j.1744-7976.2006.00040.x; Marsh K, 2007, J FOOD SCI, V72, pR39, DOI 10.1111/j.1750-3841.2007.00301.x; Martellozzo F, 2015, REG ENVIRON CHANGE, V15, P881, DOI 10.1007/s10113-014-0658-0; McMichael AJ, 2007, LANCET, V370, P1253, DOI 10.1016/S0140-6736(07)61256-2; Pingali P, 2007, FOOD POLICY, V32, P281, DOI 10.1016/j.foodpol.2006.08.001; Popkin BM, 2003, J NUTR, V133, p3898S, DOI 10.1093/jn/133.11.3898S; Popkin BM, 1999, WORLD DEV, V27, P1905, DOI 10.1016/S0305-750X(99)00094-7; Ramankutty N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002952; Reardon T, 2003, AM J AGR ECON, V85, P1140, DOI 10.1111/j.0092-5853.2003.00520.x; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Seto KC, 2012, P NATL ACAD SCI USA, V109, P16083, DOI 10.1073/pnas.1211658109; Tilman D, 2014, NATURE, V515, P518, DOI 10.1038/nature13959; Willer H., 2011, FIBL IFOAM REPORT	22	210	217	23	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2016	352	6288			SI		943	945		10.1126/science.aaf7439	http://dx.doi.org/10.1126/science.aaf7439			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM2AK	27199419				2022-12-28	WOS:000376147800036
J	Morgan, B				Morgan, Branwen			A healthy pipeline	NATURE			English	Editorial Material													Morgan, Branwen/ABG-1328-2021	Morgan, Branwen/0000-0001-5318-1675				Fukudo S, 2016, GASTROENTEROLOGY, V150, P358, DOI 10.1053/j.gastro.2015.10.047	1	3	3	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					S116	S117		10.1038/533S116a	http://dx.doi.org/10.1038/533S116a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0AH	27191492	Bronze			2022-12-28	WOS:000376004300008
J	Drazer, MW; Eggener, SE				Drazer, Michael W.; Eggener, Scott E.			Patient-Initiated Prostate Cancer Screening Among Older US Men	ANNALS OF INTERNAL MEDICINE			English	Letter									[Drazer, Michael W.; Eggener, Scott E.] Univ Chicago, Med Ctr, Chicago, IL 60637 USA	University of Chicago; University of Chicago Medical Center	Drazer, MW (corresponding author), Univ Chicago, Med Ctr, Chicago, IL 60637 USA.							Drazer MW, 2015, J CLIN ONCOL, V33, P2416, DOI 10.1200/JCO.2015.61.6532; Drazer MW, 2014, CANCER-AM CANCER SOC, V120, P1491, DOI 10.1002/cncr.28600; Guo FJ, 2015, ANN INTERN MED, V163, P650, DOI 10.7326/L15-5150; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2016	164	10					702	703		10.7326/L15-0619	http://dx.doi.org/10.7326/L15-0619			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8GF	27182910				2022-12-28	WOS:000375878500027
J	Grace, PM				Grace, Peter M.			Learning the lessons of networking	SCIENCE			English	Editorial Material									[Grace, Peter M.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Grace, PM (corresponding author), Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA.		Grace, Peter/I-5507-2013	Grace, Peter/0000-0002-8999-1220					0	1	1	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2016	352	6286					738	738		10.1126/science.352.6286.738	http://dx.doi.org/10.1126/science.352.6286.738			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL1UC	27151872				2022-12-28	WOS:000375417100043
J	Heneka, MT; Nicotera, P				Heneka, Michael T.; Nicotera, Pierluigi			Thoughts on Obesity and Brain Glucose	CELL			English	Editorial Material							ALZHEIMERS-DISEASE; INSULIN-RESISTANCE; PATHOLOGY; RISK	Homeostatic control of brain metabolism is essential for neuronal activity. Jais et al., (2016) report that reduced brain glucose uptake elicited by a high-fat diet self-corrects by the recruitment of peripheral, VEGF-producing macrophages to the blood-brain barrier. Their findings further suggest that restoring brain glucose availability might help protect from cognitive impairment in Alzheimer's disease.	[Heneka, Michael T.; Nicotera, Pierluigi] DZNE, Ludwig Erhard Alle 2, D-53175 Bonn, Germany; [Heneka, Michael T.; Nicotera, Pierluigi] Univ Bonn, Ludwig Erhard Alle 2, D-53175 Bonn, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn	Nicotera, P (corresponding author), DZNE, Ludwig Erhard Alle 2, D-53175 Bonn, Germany.; Nicotera, P (corresponding author), Univ Bonn, Ludwig Erhard Alle 2, D-53175 Bonn, Germany.	pierluigi.nicotera@dzne.de	Heneka, Michael/AAE-8011-2019; Heneka, Michael/E-8072-2015	Heneka, Michael/0000-0003-4996-1630				Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Jais A, 2016, CELL, V165, P882, DOI 10.1016/j.cell.2016.03.033; Macauley SL, 2015, J CLIN INVEST, V125, P2463, DOI 10.1172/JCI79742; Petrov D, 2015, BBA-MOL BASIS DIS, V1852, P1687, DOI 10.1016/j.bbadis.2015.05.004; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Stranahan AM, 2008, HIPPOCAMPUS, V18, P1085, DOI 10.1002/hipo.20470; Whitmer RA, 2008, NEUROLOGY, V71, P1057, DOI 10.1212/01.wnl.0000306313.89165.ef; Winkler EA, 2015, NAT NEUROSCI, V18, P521, DOI 10.1038/nn.3966	10	4	4	1	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2016	165	4					773	775		10.1016/j.cell.2016.04.057	http://dx.doi.org/10.1016/j.cell.2016.04.057			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DL7DN	27153489	Bronze			2022-12-28	WOS:000375800300005
J	Szewczak, L				Szewczak, Lara			Boundary Issues	CELL			English	Editorial Material																		Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; Ge L, 2016, STRUCTURE, V24, P585, DOI 10.1016/j.str.2016.02.012; Kosinski J, 2016, SCIENCE, V352, P363, DOI 10.1126/science.aaf0643; Lin DH, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1015; Zahn R, 2016, ELIFE, V5, DOI 10.7554/eLife.14119	5	2	2	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2016	165	4					759	761						2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DL7DN	27153485	Bronze			2022-12-28	WOS:000375800300001
J	Vestbo, J; Anderson, JA; Brook, RD; Calverley, PMA; Celli, BR; Crim, C; Martinez, F; Yates, J; Newby, DE				Vestbo, Jorgen; Anderson, Julie A.; Brook, Robert D.; Calverley, Peter M. A.; Celli, Bartolome R.; Crim, Courtney; Martinez, Fernando; Yates, Julie; Newby, David E.		SUMMIT Investigators	Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial	LANCET			English	Article							LUNG-FUNCTION; INHALED BUDESONIDE; COPD; MORTALITY; PROPIONATE; SALMETEROL; MODERATE; OUTCOMES; DECLINE; TORCH	Background Chronic obstructive pulmonary disease (COPD) often coexists with cardiovascular disease. Treatments for airflow limitation might improve survival and both respiratory and cardiovascular outcomes. The aim of this study was to assess whether inhaled treatment with a combined treatment of the corticosteroid, fluticasone furoate, and the long-acting beta agonist, vilanterol could improve survival compared with placebo in patients with moderate COPD and heightened cardiovascular risk. Methods In this double-blind randomised controlled trial (SUMMIT) done in 1368 centres in 43 countries, eligible patients were aged 40-80 years and had a post-bronchodilator forced expiratory volume in 1 s (FEV1) between 50% and 70% of the predicted value, a ratio of post-bronchodilator FEV1 to forced vital capacity (FVC) of 0.70 or less, a smoking history of at least 10 pack-years, and a score of 2 or greater on the modified Medical Research Council dyspnoea scale. Patients had to have a history, or be at increased risk, of cardiovascular disease. Enrolled patients were randomly assigned (1:1:1:1) through a centralised randomisation service in permuted blocks to receive once daily inhaled placebo, fluticasone furoate (100 mu g), vilanterol (25 mu g), or the combination of fluticasone furoate (100 mu g) and vilanterol (25 mu g). The primary outcome was all-cause mortality, and secondary outcomes were on-treatment rate of decline in forced expiratory volume in 1 s (FEV1) and a composite of cardiovascular events. Safety analyses were performed on the safety population (all patients who took at least one dose of study drug) and efficacy analyses were performed on the intention-to-treat population (safety population minus sites excluded with Good Clinical Practice violations). This study is registered with ClinicalTrials.gov, number NCT01313676. Findings Between Jan 24, 2011, and March 12, 2014, 23 835 patients were screened, of whom 16 590 were randomised. 16 485 patients were included in the intention-to-treat efficacy population; 4111 in the placebo group, 4135 in the fluticasone furoate group, 4118 in the vilanterol group, and 4121 in the combination group. Compared with placebo, all-cause mortality was unaffected by combination therapy (hazard ratio [HR] 0.88 [95% CI 0.74-1.04]; 12% relative reduction; p=0.137) or the components (fluticasone furoate, HR 0.91 [0.77-1.08]; p=0.284; vilanterol, 0.96 [0.81-1.14]; p=0.655), and therefore secondary outcomes should be interpreted with caution. Rate of decline in FEV 1 was reduced by combination therapy (38 mL per year [SE 2.4] vs 46 mL per year [2.5] for placebo, difference 8 mL per year [95% CI 1-15]) with similar findings for fluticasone furoate (difference 8 mL per year [95% CI 1-14]), but not vilanterol (difference-2 mL per year [95% CI-8 to 5]). Combination therapy had no effect on composite cardiovascular events (HR 0.93 [95% CI 0.75-1.14]) with similar findings for fluticasone furoate (0.90 [0.72-1.11]) and vilanterol (0.99 [0.80-1.22]). All treatments reduced the rate of moderate and severe exacerbation. No reported excess risks of pneumonia (5% in the placebo group, 6% in the combination group, 5% in the fluticasone furoate group, and 4% in the vilanterol group) or adverse cardiac events (17% in the placebo group, 18% in the combination group, and 17% in the fluticasone furoate group, and 17% in the vilanterol group) were noted in the treatment groups. Interpretation In patients with moderate COPD and heightened cardiovascular risk, treatment with fluticasone furoate and vilanterol did not affect mortality or cardiovascular outcomes, reduced exacerbations, and was well tolerated. Fluticasone furoate, alone or in combination with vilanterol, seemed to reduce FEV1 decline.	[Vestbo, Jorgen] Univ Manchester, Ctr Resp Med & Allergy, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Vestbo, Jorgen] South Manchester Univ Hosp NHS Fdn Trust, Manchester, Lancs, England; [Anderson, Julie A.] GlaxoSmithKline, Res & Dev, Stockley Pk, Middx, England; [Brook, Robert D.; Martinez, Fernando] Univ Michigan Hlth Syst, Ann Arbor, MI USA; [Calverley, Peter M. A.] Univ Liverpool, Dept Med, Ctr Clin Sci, Univ Hosp Aintree, Liverpool L69 3BX, Merseyside, England; [Celli, Bartolome R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Pulm & Crit Care Div, Boston, MA 02115 USA; [Crim, Courtney; Yates, Julie] GlaxoSmithKline, Res & Dev, Res Triangle Pk, NC USA; [Martinez, Fernando] Weill Cornell Med, Div Pulm & Crit Care Med, New York, NY USA; [Newby, David E.] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland	University of Manchester; GlaxoSmithKline; University of Michigan System; University of Michigan; University of Liverpool; Harvard University; Brigham & Women's Hospital; Harvard Medical School; GlaxoSmithKline; Cornell University; University of Edinburgh	Vestbo, J (corresponding author), Univ S Manchester Hosp, Ctr Resp Med & Allergy, Manchester M23 9LT, Lancs, England.	jorgen.vestbo@manchester.ac.uk	Vestbo, Jorgen/Y-2912-2019; Bilokonna, Nataliia/AAC-1436-2021; Newby, David Ernest/AAB-1364-2019	Vestbo, Jorgen/0000-0001-6355-6362	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	GlaxoSmithKline.	Altose MD, 2000, NEW ENGL J MED, V343, P1902; Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Calverley PMA, 2010, THORAX, V65, P719, DOI 10.1136/thx.2010.136077; Celli BR, 2008, AM J RESP CRIT CARE, V178, P332, DOI 10.1164/rccm.200712-1869OC; Crim C, 2009, EUR RESPIR J, V34, P89; Crim C, 2015, ANN AM THORAC SOC, V12, P27, DOI 10.1513/AnnalsATS.201409-413OC; Curkendall SM, 2006, ANN EPIDEMIOL, V16, P63, DOI 10.1016/j.annepidem.2005.04.008; Fabbri LM, 2008, EUR RESPIR J, V31, P204, DOI 10.1183/09031936.00114307; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hole DJ, 1996, BRIT MED J, V313, P711; Kew KM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010115.pub2; Lange P, 2015, NEW ENGL J MED, V373, P111, DOI 10.1056/NEJMoa1411532; Lapperre TS, 2009, ANN INTERN MED, V151, P517, DOI 10.7326/0003-4819-151-8-200910200-00004; Maclay JD, 2009, AM J RESP CRIT CARE, V180, P513, DOI 10.1164/rccm.200903-0414OC; Mannino DM, 2008, EUR RESPIR J, V32, P962, DOI 10.1183/09031936.00012408; McGarvey LP, 2007, THORAX, V62, P411, DOI 10.1136/thx.2006.072348; Pauwels RA, 1999, NEW ENGL J MED, V340, P1948, DOI 10.1056/NEJM199906243402503; Salpeter SR, 2004, CHEST, V125, P2309, DOI 10.1378/chest.125.6.2309; Sin DD, 2006, EUR RESPIR J, V28, P1245, DOI 10.1183/09031936.00133805; Sin DD, 2003, CIRCULATION, V107, P1514, DOI 10.1161/01.CIR.0000056767.69054.B3; TOCKMAN MS, 1995, AM J RESP CRIT CARE, V151, P390, DOI 10.1164/ajrccm.151.2.7842197; Vestbo J, 1999, LANCET, V353, P1819, DOI 10.1016/S0140-6736(98)10019-3; Vestbo J, 2013, EUR RESPIR J, V41, P1017, DOI 10.1183/09031936.00087312; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Watz H, 2009, EUR RESPIR J, V33, P262, DOI 10.1183/09031936.00024608; Zalacain R, 1999, EUR RESPIR J, V13, P343, DOI 10.1034/j.1399-3003.1999.13b21.x	28	275	294	0	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 30	2016	387	10030					1817	1826		10.1016/S0140-6736(16)30069-1	http://dx.doi.org/10.1016/S0140-6736(16)30069-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK6SS	27203508	Green Accepted, Green Submitted			2022-12-28	WOS:000375056100030
J	Ioannidis, JPA				Ioannidis, John P. A.			Stealth Research and Theranos Reflections and Update 1 Year Later	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ioannidis, John P. A.] Stanford Univ, Dept Med, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA	Stanford University; Stanford University	Ioannidis, JPA (corresponding author), 1265 Welch Rd,Med Sch Off Bldg X306, Stanford, CA 94305 USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011					Abelson R, 2016, NY TIMES; Bilton N., 2016, VANITY FAIR; Carreyrou J., 2015, WALL STREET J 1015; Diamandis EP, 2015, CLIN CHEM LAB MED, V53, P989, DOI 10.1515/cclm-2015-0356; Ioannidis JPA, 2015, JAMA-J AM MED ASSOC, V313, P663, DOI 10.1001/jama.2014.17662; Ioannidis JP, 2015, NEW SCI; Kidd BA, 2016, J CLIN INVEST, V126, P1734, DOI 10.1172/JCI86318; US Food and Drug Administration, SUBST EQ DET DEC SUM	8	15	15	1	34	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2016	316	4					389	390		10.1001/jama.2016.6986	http://dx.doi.org/10.1001/jama.2016.6986			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR9MV	27191700				2022-12-28	WOS:000380221700012
J	Gaudry, S; Hajage, D; Schortgen, F; Martin-Lefevre, L; Pons, B; Boulet, E; Boyer, A; Chevrel, G; Lerolle, N; Carpentier, D; de Prost, N; Lautrette, A; Bretagnol, A; Mayaux, J; Nseir, S; Megarbane, B; Thirion, M; Forel, JM; Maizel, J; Yonis, H; Markowicz, P; Thiery, G; Tubach, F; Ricard, JD; Dreyfuss, D				Gaudry, Stephane; Hajage, David; Schortgen, Frederique; Martin-Lefevre, Laurent; Pons, Bertrand; Boulet, Eric; Boyer, Alexandre; Chevrel, Guillaume; Lerolle, Nicolas; Carpentier, Dorothee; de Prost, Nicolas; Lautrette, Alexandre; Bretagnol, Anne; Mayaux, Julien; Nseir, Saad; Megarbane, Bruno; Thirion, Marina; Forel, Jean-Marie; Maizel, Julien; Yonis, Hodane; Markowicz, Philippe; Thiery, Guillaume; Tubach, Florence; Ricard, Jean-Damien; Dreyfuss, Didier		AKIKI Study Grp	Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE KIDNEY INJURY; CRITICALLY-ILL PATIENTS; CONTINUOUS VENOVENOUS HEMOFILTRATION; ACCELERATED INITIATION; ORGAN FAILURE; DIALYSIS; MANAGEMENT; AKI; IMPACT; ICU	BACKGROUND The timing of renal-replacement therapy in critically ill patients who have acute kidney injury but no potentially life-threatening complication directly related to renal failure is a subject of debate. METHODS In this multicenter randomized trial, we assigned patients with severe acute kidney injury (Kidney Disease: Improving Global Outcomes [KDIGO] classification, stage 3 [stages range from 1 to 3, with higher stages indicating more severe kidney injury]) who required mechanical ventilation, catecholamine infusion, or both and did not have a potentially life-threatening complication directly related to renal failure to either an early or a delayed strategy of renal-replacement therapy. With the early strategy, renal-replacement therapy was started immediately after randomization. With the delayed strategy, renal-replacement therapy was initiated if at least one of the following criteria was met: severe hyperkalemia, metabolic acidosis, pulmonary edema, blood urea nitrogen level higher than 112 mg per deciliter, or oliguria for more than 72 hours after randomization. The primary outcome was overall survival at day 60. RESULTS A total of 620 patients underwent randomization. The Kaplan-Meier estimates of mortality at day 60 did not differ significantly between the early and delayed strategies; 150 deaths occurred among 311 patients in the early-strategy group (48.5%; 95% confidence interval [CI], 42.6 to 53.8), and 153 deaths occurred among 308 patients in the delayed-strategy group (49.7%, 95% CI, 43.8 to 55.0; P = 0.79). A total of 151 patients (49%) in the delayed-strategy group did not receive renal-replacement therapy. The rate of catheter-related bloodstream infections was higher in the early-strategy group than in the delayed-strategy group (10% vs. 5%, P = 0.03). Diuresis, a marker of improved kidney function, occurred earlier in the delayed-strategy group (P<0.001). CONCLUSIONS In a trial involving critically ill patients with severe acute kidney injury, we found no significant difference with regard to mortality between an early and a delayed strategy for the initiation of renal-replacement therapy. A delayed strategy averted the need for renal-replacement therapy in an appreciable number of patients.	[Gaudry, Stephane; Ricard, Jean-Damien; Dreyfuss, Didier] Hop Louis Mourier, AP HP, Serv Reanimat Med Chirurg, F-92701 Colombes, France; [Gaudry, Stephane; Hajage, David; Tubach, Florence] Univ Paris Diderot, Sorbonne Paris Cite, Epidemiol Clin Evaluat Econom Appl Populat Vuln, Paris, France; [Gaudry, Stephane; Hajage, David; Tubach, Florence] INSERM, ECEVE, CIC EC 1425, F-75654 Paris 13, France; [Hajage, David] Hop Louis Mourier, AP HP, Dept Epidemiol & Rech Clin, CIC EC 1425, Colombes, France; [Mayaux, Julien; Megarbane, Bruno] Univ Paris Diderot, Serv Pneumol & Reanimat Med, Grp Hosp Pitie SalpetriereMayaux,u1144, APHP,Reanimat Med & Toxicol,Hop Lariboisiere,INSE, Paris, France; [Tubach, Florence] Hop Bichat Claude Bernard, AP HP, Dept Epidemiol & Rech Clin, CIC EC 1425, Paris, France; [Ricard, Jean-Damien; Dreyfuss, Didier] Univ Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cite, Paris, France; [Schortgen, Frederique] Hop Univ Henri Mondor, AP HP, Serv Reanimat Med, Paris, France; [de Prost, Nicolas] Hop Univ Henri Mondor, Dept Hosp Univ Ageing Thorax Vessels, Cardiovasc & Resp Manifestat Acute Lung Injur & S, APHP,Serv Reanima Med, Colombes, France; [de Prost, Nicolas] Univ Paris Est Creteil Val Marne, Creteil, France; [Martin-Lefevre, Laurent] Ctr Hosp Gen, Reanimat Med Chirurg, La Roche Sur Yon, France; [Pons, Bertrand; Thiery, Guillaume] CHU Pointe Pitre Abymes, Serv Reanimat, Pointe A Pitre, Guadeloupe, France; [Boulet, Eric] CH Rene Dubos, Reanimat Polyvalente, Pontoise, France; [Boyer, Alexandre] Hop Pellegrin, Reanimat Med CHU Bordeaux, F-33076 Bordeaux, France; [Chevrel, Guillaume] CH Sud Francilien, Serv Reanimat, Corbeil Essonnes, France; [Lerolle, Nicolas] Univ Angers, CHU Angers, Dept Reanimat Med & Med Hyperbar, Angers, France; [Carpentier, Dorothee] CHU Rouen, Reanimat Med, Rouen, France; [Lautrette, Alexandre] CHU Clermont Ferrand, Hop Gabriel Montpied, Reanimat Med, Clermont Ferrand, France; [Bretagnol, Anne] Hop La Source, Ctr Hosp Reg Orleans, Reanimat Med Chirurg, Orleans, France; [Nseir, Saad] Univ Lille, Fac Med, CHU Lille, Ctr Reanimat, Lille, France; [Thirion, Marina] CH Victor Dupouy, Reanimat Polyvalente, Argenteuil, France; [Forel, Jean-Marie] Hop Nord Marseille, Serv Reanimat Detresses Resp Aigues & Infect Serv, Marseille, France; [Maizel, Julien] CHU Picardie, INSERM, U1088, Serv Reanimat Med, Amiens, France; [Yonis, Hodane] Hop Croix Rousse, Reanimat Med, Lyon, France; [Markowicz, Philippe] CH Cholet, Reanimat, Cholet, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Louis-Mourier - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHD Vendee; CHU Guadeloupe; Centre Hospitalier Rene Dubos, Pontoise; CHU Bordeaux; Centre Hospitalier Sud Francilien; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU de Rouen; CHU Clermont Ferrand; Centre Hospitalier Regional d'Orleans; Universite de Lille - ISITE; CHU Lille; Universite de Lille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; CHU Lyon	Dreyfuss, D (corresponding author), Hop Louis Mourier, Intens Care Unit, 178 Rue Renouillers, F-92110 Colombes, France.	didier.dreyfuss@aphp.fr	Roux, Damien/C-5618-2014; Hoste, Eric/A-6353-2008; Hajage, David/D-5226-2014	Roux, Damien/0000-0002-6103-6416; Hoste, Eric/0000-0001-9301-8055; Hajage, David/0000-0002-8475-4090; de Prost, Nicolas/0000-0002-4833-4320; Darmon, Michael/0000-0003-4198-8038; Schortgen, Frederique/0000-0003-1756-7508; BOYER, Alexandre/0000-0003-4384-8872; Megarbane, Bruno/0000-0002-2522-2764; Nseir, Saad/0000-0002-7618-0357	French Ministry of Health; French Ministry of Health	French Ministry of Health; French Ministry of Health	Funded by the French Ministry of Health; ClinicalTrials.gov number, NCT01932190.	[Anonymous], 2011, KIDNEY INT S, V2, P89; Bagshaw SM, 2009, J CRIT CARE, V24, P129, DOI 10.1016/j.jcrc.2007.12.017; Barbar SD, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-270; Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413; Bonventre JV, 2008, NEW ENGL J MED, V359, P82, DOI 10.1056/NEJMe0803765; Bonventre JV, 2013, CLIN J AM SOC NEPHRO, V8, P1606, DOI 10.2215/CJN.06040613; Bouman CSC, 2002, CRIT CARE MED, V30, P2205, DOI 10.1097/00003246-200210000-00005; Brochard L, 2010, AM J RESP CRIT CARE, V181, P1128, DOI 10.1164/rccm.200711-1664ST; Chou YH, 2011, CRIT CARE, V15, DOI 10.1186/cc10252; Clark E, 2012, NEPHROL DIAL TRANSPL, V27, P2761, DOI 10.1093/ndt/gfr740; Elseviers MM, 2010, CRIT CARE, V14, DOI 10.1186/cc9355; Gaudry S, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0718-x; Gaudry S, 2014, J CRIT CARE, V29, P1022, DOI 10.1016/j.jcrc.2014.07.014; Gibney N, 2008, CLIN J AM SOC NEPHRO, V3, P876, DOI 10.2215/CJN.04871107; Guerin C, 2000, AM J RESP CRIT CARE, V161, P872, DOI 10.1164/ajrccm.161.3.9809066; Hoste E, 2015, INTENS CARE MED, V41, P1411, DOI 10.1007/s00134-015-3934-7; Jamale TE, 2013, AM J KIDNEY DIS, V62, P1116, DOI 10.1053/j.ajkd.2013.06.012; Karrison TG, 2003, CONTROL CLIN TRIALS, V24, P506, DOI 10.1016/S0197-2456(03)00092-8; Karvellas CJ, 2011, CRIT CARE, V15, DOI 10.1186/cc10061; Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group, 2012, KIDNEY INT S, V2, P19, DOI DOI 10.1038/KISUP.2011.32; KLEINKNECHT D, 1972, KIDNEY INT, V1, P190, DOI 10.1038/ki.1972.26; Legrand M, 2013, INTENS CARE MED, V39, P101, DOI 10.1007/s00134-012-2706-x; Mehta RL, 2015, LANCET, V385, P2616, DOI 10.1016/S0140-6736(15)60126-X; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Payen D, 2009, CRIT CARE MED, V37, P803, DOI 10.1097/CCM.0b013e3181962316; Schiffl H, 2002, NEW ENGL J MED, V346, P305, DOI 10.1056/NEJMoa010877; Schneider AG, 2013, INTENS CARE MED, V39, P987, DOI 10.1007/s00134-013-2864-5; Schneider AG, 2012, NEPHROL DIAL TRANSPL, V27, P947, DOI 10.1093/ndt/gfr501; Seabra VF, 2008, AM J KIDNEY DIS, V52, P272, DOI 10.1053/j.ajkd.2008.02.371; Shingarev R, 2011, SEMIN DIALYSIS, V24, P164, DOI 10.1111/j.1525-139X.2011.00828.x; Smith OM, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-320; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Vaara ST, 2014, CLIN J AM SOC NEPHRO, V9, P1577, DOI 10.2215/CJN.12691213; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Vinsonneau C, 2006, LANCET, V368, P379, DOI 10.1016/S0140-6736(06)69111-3; Vinsonneau C, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0093-5; Wald R, 2015, KIDNEY INT, V88, P897, DOI 10.1038/ki.2015.184; Wald R, 2014, CRIT CARE MED, V42, P1933, DOI 10.1097/CCM.0000000000000432; Whitehead J, 1999, STAT MED, V18, P2271	40	574	615	5	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2016	375	2					122	133		10.1056/NEJMoa1603017	http://dx.doi.org/10.1056/NEJMoa1603017			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ9KY	27181456	Bronze			2022-12-28	WOS:000379530000005
J	Aldridge, C; Bion, J; Boyal, A; Chen, YF; Clancy, M; Evans, T; Girling, A; Lord, J; Mannion, R; Rees, P; Roseveare, C; Rudge, G; Sun, JX; Tarrant, C; Temple, M; Watson, S; Lilford, R				Aldridge, Cassie; Bion, Julian; Boyal, Amunpreet; Chen, Yen-Fu; Clancy, Mike; Evans, Tim; Girling, Alan; Lord, Joanne; Mannion, Russell; Rees, Peter; Roseveare, Chris; Rudge, Gavin; Sun, Jianxia; Tarrant, Carolyn; Temple, Mark; Watson, Sam; Lilford, Richard		HiSLAC Collaborative	Weekend specialist intensity and admission mortality in acute hospital trusts in England: a cross-sectional study	LANCET			English	Article							ASSOCIATIONS; SERVICES; DEATH; RISK; CARE	Background Increased mortality rates associated with weekend hospital admission (the so-called weekend eff ect) have been attributed to suboptimum staffi ng levels of specialist consultants. However, evidence for a causal association is elusive, and the magnitude of the weekend specialist defi cit remains unquantifi ed. This uncertainty could hamper eff orts by national health systems to introduce 7 day health services. We aimed to examine preliminary associations between specialist intensity and weekend admission mortality across the English National Health Service. Methods Eligible hospital trusts were those in England receiving unselected emergency admissions. On Sunday June 15 and Wednesday June 18, 2014, we undertook a point prevalence survey of hospital specialists (consultants) to obtain data relating to the care of patients admitted as emergencies. We defi ned specialist intensity at each trust as the selfreported estimated number of specialist hours per ten emergency admissions between 0800 h and 2000 h on Sunday and Wednesday. With use of data for all adult emergency admissions for fi nancial year 2013-14, we compared weekend to weekday admission risk of mortality with the Sunday to Wednesday specialist intensity ratio within each trust. We stratifi ed trusts by size quintile. Findings 127 of 141 eligible acute hospital trusts agreed to participate; 115 (91%) trusts contributed data to the point prevalence survey. Of 34 350 clinicians surveyed, 15 537 (45%) responded. Substantially fewer specialists were present providing care to emergency admissions on Sunday (1667 [11%]) than on Wednesday (6105 [42%]). Specialists present on Sunday spent 40% more time caring for emergency patients than did those present on Wednesday (mean 5 . 74 h [SD 3 . 39] vs 3 . 97 h [3 . 31]); however, the median specialist intensity on Sunday was only 48% (IQR 40-58) of that on Wednesday. The Sunday to Wednesday intensity ratio was less than 0 . 7 in 104 (90%) of the contributing trusts. Mortality risk among patients admitted at weekends was higher than among those admitted on weekdays (adjusted odds ratio 1 . 10, 95% CI 1 . 08-1 . 11; p<0 . 0001). There was no signifi cant association between Sunday to Wednesday specialist intensity ratios and weekend to weekday mortality ratios (r -0 . 042; p= 0 . 654). Interpretation This cross-sectional analysis did not detect a correlation between weekend staffi ng of hospital specialists and mortality risk for emergency admissions. Further investigation is needed to evaluate whole-system secular change during the implementation of 7 day services. Policy makers should exercise caution before attributing the weekend eff ect mainly to diff erences in specialist staffi ng.	[Aldridge, Cassie; Bion, Julian; Girling, Alan; Mannion, Russell; Rudge, Gavin] Univ Birmingham, Birmingham, W Midlands, England; [Boyal, Amunpreet; Sun, Jianxia] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England; [Chen, Yen-Fu; Watson, Sam; Lilford, Richard] Univ Warwick, Coventry CV4 7AL, W Midlands, England; [Clancy, Mike] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England; [Evans, Tim] Royal Brompton & Harefield NHS Fdn Trust, London, England; [Lord, Joanne] Univ Southampton, Southampton, Hants, England; [Rees, Peter] Acad Med Royal Coll Patient Liaison Grp, London, England; [Roseveare, Chris] Southern Hlth NHS Fdn Trust, Southampton, Hants, England; [Tarrant, Carolyn] Univ Leicester, Leicester, Leics, England; [Temple, Mark] Heart England NHS Fdn Trust, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Warwick; University of Southampton; University Hospital Southampton NHS Foundation Trust; Royal Brompton & Harefield NHS Foundation Trust; University of Southampton; University of Leicester; Heart of England NHS Foundation Trust	Bion, J (corresponding author), Queen Elizabeth Hosp, Univ Dept Anaesthesia & Crit Care, Inst Clin Sci, Off 1,Ground Floor East Heritage Bldg, Birmingham B15 2TH, W Midlands, England.	j.f.bion@bham.ac.uk	Hibbert, Peter/T-7981-2019; Lord, Joanne/H-1417-2011; Chen, Yen-Fu/AAD-2825-2019; Grocott, Michael/C-4394-2008	Lord, Joanne/0000-0003-1086-1624; Grocott, Michael/0000-0002-9484-7581; Nolan, Jerry/0000-0003-3141-3812; Wilson, Jane/0000-0002-7736-9151; Mannion, Russell/0000-0002-0680-8049; Evison, Felicity/0000-0002-9378-7548; Girling, Alan/0000-0003-2022-045X; Fulop, Naomi/0000-0001-5306-6140; Chen, Yen-Fu/0000-0002-9446-2761; Aldridge, Cassie/0000-0002-9162-3478; Bion, Julian/0000-0003-0344-5403; Lilford, Richard/0000-0002-0634-984X; Tarrant, Carolyn/0000-0001-7356-5342; Watson, Sam/0000-0002-8972-769X	National Institute for Health Research Health Services and Delivery Research Programme; National Institute for Health Research (NIHR) Health Services and Delivery Research Programme (HSDR) [12/128/07]; NIHR Collaboration for Leadership in Applied Health Research and Care, West Midlands; National Institute for Health Research [12/128/17] Funding Source: researchfish	National Institute for Health Research Health Services and Delivery Research Programme; National Institute for Health Research (NIHR) Health Services and Delivery Research Programme (HSDR); NIHR Collaboration for Leadership in Applied Health Research and Care, West Midlands; National Institute for Health Research(National Institute for Health Research (NIHR))	National Institute for Health Research Health Services and Delivery Research Programme.; The HiSLAC study is funded by the National Institute for Health Research (NIHR) Health Services and Delivery Research Programme (HS & DR; reference 12/128/07). The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the HS&DR Programme, the NIHR, National Health Service (NHS) or the Department of Health. RL, GR, and AG are also funded by the NIHR Collaboration for Leadership in Applied Health Research and Care, West Midlands.	Academy of Medical Royal Colleges, 2012, 7 DAY CONS PRES; Aiken LH, 2014, LANCET, V383, P1824, DOI 10.1016/S0140-6736(13)62631-8; Attenello FJ, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1460; Aylin P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2424; Bell CM, 2001, NEW ENGL J MED, V345, P663, DOI 10.1056/NEJMsa003376; Bell D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061476; Bray BD, 2014, PLOS MED, V19, P11; Bray BD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2827; Buckley D, 2012, CHRONOBIOL INT, V29, P947, DOI 10.3109/07420528.2012.672265; Care Quality Commission, 2016, INSP REP; Department of Health, 2015, 7 DAY NHS SERV FACTS; Freemantle N, 2012, J ROY SOC MED, V105, P74, DOI 10.1258/jrsm.2012.120009; Freemantle N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4596; Ghaferi AA, 2011, MED CARE, V49, P1076, DOI 10.1097/MLR.0b013e3182329b97; Health & Social Care Information Centre, 2015, IND SPEC SUMM HOSP L; Klass P, 2015, NEW ENGL J MED, V372, P402, DOI 10.1056/NEJMp1413363; Lilford RJ, 2015, BMJ QUAL SAF, V24, P480, DOI 10.1136/bmjqs-2015-004360; McKinney JS, 2011, STROKE, V42, P2403, DOI 10.1161/STROKEAHA.110.612317; Meacock R, 2015, HEALTH ECON, V24, P907, DOI 10.1002/hec.3207; Mikulich O, 2011, Acute Med, V10, P182; Mohammed MA, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-87; Morrissey S, 2015, NEW ENGL J MED, V372, P75, DOI 10.1056/NEJMe1415036; Morton B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141361; NHS England, 2016, BED AV OCC; NHS England, 7 DAY HOSP SERV; NHS England, 2014, 5 YEAR FORW VIEW; Ozdemir BA, 2016, BRIT J ANAESTH, V116, P54, DOI 10.1093/bja/aev372; Palmer WL, 2012, ARCH NEUROL-CHICAGO, V69, P1296, DOI 10.1001/archneurol.2012.1030; Ricciardi R, 2016, J SURG RES, V200, P164, DOI 10.1016/j.jss.2015.07.030; Ruiz M, 2015, BMJ QUAL SAF, V24, P492, DOI 10.1136/bmjqs-2014-003467; Shekelle PG, 2013, ANN INTERN MED, V158, P404, DOI 10.7326/0003-4819-158-5-201303051-00007; Turner MR, 2016, J NEUROL NEUROSUR PS, V87, P3, DOI 10.1136/jnnp-2015-311934; Wu TC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/906531	33	76	77	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2016	388	10040					178	186		10.1016/S0140-6736(16)30442-1	http://dx.doi.org/10.1016/S0140-6736(16)30442-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ5TZ	27178476	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000379269200033
J	Blazeby, J				Blazeby, Jane		Bluebelle Study Grp	UNCERTAINTIES Do dressings prevent infection of closed primary wounds after surgery?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SURGICAL-SITE INFECTIONS		[Blazeby, Jane] Univ Bristol, Surg Res Ctr, Sch Social & Community Med, Bristol, Avon, England; Univ Hosp Bristol NHS Fdn Trust, Div Head & Neck Surg, Bristol, Avon, England	University of Bristol; University of Bristol	Blazeby, J (corresponding author), Univ Bristol, Surg Res Ctr, Sch Social & Community Med, Bristol, Avon, England.	j.m.blazeby@bristol.ac.uk	Blazeby, Jane/H-6703-2019; Siassakos, Dimitrios/A-6859-2012; McMullan, Christel/F-4948-2017; Mathers, Jonathan/ABE-1164-2021; Pinkney, Thomas/HGA-4022-2022; Dumville, Jo/O-7867-2014	Blazeby, Jane/0000-0002-3354-3330; Siassakos, Dimitrios/0000-0002-1078-9856; McMullan, Christel/0000-0002-0878-1513; Blencowe, Natalie/0000-0002-6111-2175; Mathers, Jonathan/0000-0001-6651-6286; Calvert, Melanie/0000-0002-1856-837X; Gooberman-Hill, Rachael/0000-0003-3353-2882; Elliott, Daisy/0000-0001-8143-9549; Magill, Laura/0000-0003-2498-8407; Clayton, Gemma/0000-0002-9525-2758; Macefield, Rhiannon/0000-0002-6606-5427; Pinkney, Thomas/0000-0001-7320-6673; Dumville, Jo/0000-0002-6546-3685; Coast, Joanna/0000-0002-3537-5166; Reeves, Barnaby/0000-0002-5101-9487	National Institute for Health Research [NF-SI-0514-10114, 12/200/04] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		[Anonymous], FEASIBILITY STUDY CO; [Anonymous], 2014, JOINT FORM COMM; Dumville JC, 2014, COCHRANE DB SYST REV, V9; Gibbons C, 2011, Health Technol Assess, V15, P1, DOI 10.3310/hta15300; HORAN TC, 1992, AM J INFECT CONTROL, V20, P271, DOI 10.1016/S0196-6553(05)80201-9; Jenks PJ, 2014, J HOSP INFECT, V86, P24, DOI 10.1016/j.jhin.2013.09.012; Parvizi D, 2013, AESTHET PLAST SURG, V37, P529, DOI 10.1007/s00266-013-0123-3; Public Health England, SURV SURG SIT INF NH; Romero P, 2011, EUR J PEDIATR SURG, V21, P159, DOI 10.1055/s-0030-1270458; Tanner J, 2009, J HOSP INFECT, V72, P243, DOI 10.1016/j.jhin.2009.03.021; van Ramshorst GH, 2010, WOUNDS, V22, P38; Walter CJ, 2012, BRIT J SURG, V99, P1185, DOI 10.1002/bjs.8812; WILSON APR, 1986, LANCET, V1, P311	13	6	6	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 24	2016	353								i2270	10.1136/bmj.i2270	http://dx.doi.org/10.1136/bmj.i2270			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3CB	27220592	Green Published			2022-12-28	WOS:000376938800001
J	White, C				White, Caroline			Use mefloquine for UK troops only as "last resort," MPs tell Ministry of Defence	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		House of Commons Defence Committee, ACC RISK US LAR MIL; O'Dowd A, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4868	2	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 24	2016	353								i2946	10.1136/bmj.i2946	http://dx.doi.org/10.1136/bmj.i2946			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3CB	27221087				2022-12-28	WOS:000376938800018
J	Kelly, FJ; Zhu, T				Kelly, Frank J.; Zhu, Tong			Transport solutions for cleaner air	SCIENCE			English	Editorial Material							CHINA	In cities across the globe, road transport remains an important source of air pollutants that are linked with acute and chronic health effects. Decreasing vehicle emissions-while maintaining or increasing commuter journeys-remains a major challenge for city administrators. In London, congestion-charging and a citywide low-emission zone failed to bring nitrogen dioxide concentrations under control. n Beijing, controls on the purchase and use of cars have not decreased transport emissions to a sufficient extent. As cities continue to grow, not even zero-emission vehicles are the solution. Moving increasingly large numbers of people efficiently around a city can only be achieved by expanding mass transit systems.	[Kelly, Frank J.] Kings Coll London, Natl Inst Hlth Res NIHR, Heath Protect Res Unit Hlth Impact Environm Hazar, MRC PHE Ctr Environm & Hlth, London SE1 9NH, England; [Zhu, Tong] Peking Univ, State Key Lab Environm Simulat & Pollut Control, Coll Environm Sci & Engn, Beijing 100871, Peoples R China; [Zhu, Tong] Peking Univ, Beijing Innovat Ctr Engn Sci & Adv Technol BIC ES, Beijing 100871, Peoples R China	University of London; King's College London; Peking University; Peking University	Kelly, FJ (corresponding author), Kings Coll London, Natl Inst Hlth Res NIHR, Heath Protect Res Unit Hlth Impact Environm Hazar, MRC PHE Ctr Environm & Hlth, London SE1 9NH, England.; Zhu, T (corresponding author), Peking Univ, State Key Lab Environm Simulat & Pollut Control, Coll Environm Sci & Engn, Beijing 100871, Peoples R China.; Zhu, T (corresponding author), Peking Univ, Beijing Innovat Ctr Engn Sci & Adv Technol BIC ES, Beijing 100871, Peoples R China.	frank.kelly@kcl.ac.uk; tzhu@pku.edu.cn	ZHU, TONG/H-6501-2011; Kelly, Frank J/C-6125-2009	ZHU, TONG/0000-0002-2752-7924; Kelly, Frank J/0000-0003-2558-8392	Medical Research Council [G0801056, MR/L01341X/1] Funding Source: Medline; Medical Research Council [G0801056B] Funding Source: researchfish; Natural Environment Research Council [NE/N007018/1] Funding Source: researchfish; MRC [MR/L01341X/1, G0801056] Funding Source: UKRI; NERC [NE/N007018/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		[Anonymous], RES REP HLTH EFF I; BBC News, 2013, BBC NEWS; Cames Michel, 2013, Environmental Sciences Europe, V25, P15, DOI 10.1186/2190-4715-25-15; Carslaw DC, 2013, ATMOS ENVIRON, V81, P339, DOI 10.1016/j.atmosenv.2013.09.026; Chen Y, 2016, ENVIRON POLLUT, V212, P269, DOI 10.1016/j.envpol.2016.01.008; Chin R., 2013, BBC; Currie J, 2011, AM ECON J-APPL ECON, V3, P65, DOI 10.1257/app.3.1.65; Davis LW, 2008, J POLIT ECON, V116, P38, DOI 10.1086/529398; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; ExtremeTech, 2014, GOOGL NEW SELF DRIV; Font A., 2015, ROADSIDE AIR QUALI 1; *GLA, 2002, MAYORS AIR QUAL STRA; GLA, 2014, ULTR EM ZON UPD LOND; Hodges P., 2015, FINANCIAL TIMES; Howard R., 2016, AIR SOLVE LONDONS 2; Kelly FJ, 2015, ENVIRON GEOCHEM HLTH, V37, P631, DOI 10.1007/s10653-015-9720-1; RCP/RCPCH, 2016, EV BREATH WE TAK LIF; Transport for London (TfL), 2006, PROP LOND LOW EM ZON; Wang M, 2009, ATMOS CHEM PHYS, V9, P8247, DOI 10.5194/acp-9-8247-2009; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1	20	69	72	10	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2016	352	6288			SI		934	936		10.1126/science.aaf3420	http://dx.doi.org/10.1126/science.aaf3420			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM2AK	27199415	Green Submitted			2022-12-28	WOS:000376147800032
J	Kuo, HH; Chu, JH; Palmstrom, JC; Kivelson, SA; Fisher, IR				Kuo, Hsueh-Hui; Chu, Jiun-Haw; Palmstrom, Johanna C.; Kivelson, Steven A.; Fisher, Ian R.			Ubiquitous signatures of nematic quantum criticality in optimally doped Fe-based superconductors	SCIENCE			English	Article							IRON ARSENIDE SUPERCONDUCTOR; T-C SUPERCONDUCTOR; DETWINNED BA(FE1-XCOX)(2)AS-2; SYMMETRY-BREAKING; STATE; ANISOTROPY; ORDER	A key actor in the conventional theory of superconductivity is the induced interaction between electrons mediated by the exchange of virtual collective fluctuations (phonons in the case of conventional s-wave superconductors). Other collective modes that can play the same role, especially spin fluctuations, have been widely discussed in the context of high-temperature and heavy Fermion superconductors. The strength of such collective fluctuations is measured by the associated susceptibility. Here we use differential elastoresistance measurements from five optimally doped iron-based superconductors to show that divergent nematic susceptibility appears to be a generic feature in the optimal doping regime of these materials. This observation motivates consideration of the effects of nematic fluctuations on the superconducting pairing interaction in this family of compounds and possibly beyond.	[Kuo, Hsueh-Hui; Chu, Jiun-Haw; Palmstrom, Johanna C.; Kivelson, Steven A.; Fisher, Ian R.] Stanford Inst Energy & Mat Sci, SLAC Natl Accelerator Lab, 2575 Sand Hill Rd,Menlo Pk 94025, Stanford, CA 94305 USA; [Kuo, Hsueh-Hui] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA; [Kuo, Hsueh-Hui; Chu, Jiun-Haw; Palmstrom, Johanna C.; Kivelson, Steven A.; Fisher, Ian R.] Stanford Univ, Geballe Lab Adv Mat, Stanford, CA 94305 USA; [Chu, Jiun-Haw; Palmstrom, Johanna C.; Fisher, Ian R.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Kivelson, Steven A.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; Stanford University; Stanford University; Stanford University	Chu, JH; Fisher, IR (corresponding author), Stanford Inst Energy & Mat Sci, SLAC Natl Accelerator Lab, 2575 Sand Hill Rd,Menlo Pk 94025, Stanford, CA 94305 USA.; Chu, JH; Fisher, IR (corresponding author), Stanford Univ, Geballe Lab Adv Mat, Stanford, CA 94305 USA.; Chu, JH; Fisher, IR (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.	arrowchu@gmail.edu; irfisher@stanford.edu	; Chu, Jiun-Haw/B-1613-2012	Fisher, Ian/0000-0002-1278-7862; Chu, Jiun-Haw/0000-0001-6222-1210; Kivelson, Steven/0000-0001-9149-9502	Gabilan Stanford Graduate Fellowship; NSF Graduate Research Fellowship [DGE-114747]; Department of Energy, Office of Basic Energy Sciences [DE-AC02-76SF00515]	Gabilan Stanford Graduate Fellowship; NSF Graduate Research Fellowship(National Science Foundation (NSF)); Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE))	The authors thank S. Raghu, S. Lederer, and E. M. Spanton for helpful discussions. J.C.P. is supported by a Gabilan Stanford Graduate Fellowship and a NSF Graduate Research Fellowship (grant DGE-114747). This work was supported by the Department of Energy, Office of Basic Energy Sciences, under contract no. DE-AC02-76SF00515.	Analytis JG, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.207004; Analytis JG, 2014, NAT PHYS, V10, P194, DOI [10.1038/nphys2869, 10.1038/NPHYS2869]; Ando Y, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.137005; Blackburn E, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.137004; Bohmer AE, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.047001; Chu JH, 2010, SCIENCE, V329, P824, DOI 10.1126/science.1190482; Daou R, 2010, NATURE, V463, P519, DOI 10.1038/nature08716; Dusza A, 2011, EPL-EUROPHYS LETT, V93, DOI 10.1209/0295-5075/93/37002; Fitzpatrick AL, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.125116; Fradkin E, 2010, ANNU REV CONDEN MA P, V1, P153, DOI 10.1146/annurev-conmatphys-070909-103925; Fujita K, 2014, SCIENCE, V344, P612, DOI 10.1126/science.1248783; Gallais Y, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.267001; Ghiringhelli G, 2012, SCIENCE, V337, P821, DOI 10.1126/science.1223532; Hartnoll SA, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.155130; Hinkov V, 2008, SCIENCE, V319, P597, DOI 10.1126/science.1152309; Howald C, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.014533; Kivelson SA, 1998, NATURE, V393, P550, DOI 10.1038/31177; Kretzschmar F., 2016, NAT PHYS; Kuo HH, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.227001; Kuo HH, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.085113; Lederer S, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.097001; Lu XY, 2014, SCIENCE, V345, P657, DOI 10.1126/science.1251853; Metlitski MA, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.115111; Pourret A, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.020504; Shishido H, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.057008; Tamai A, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.097002; Tanatar MA, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.184508; Thorsmolle VK, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.054515; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Wu T, 2011, NATURE, V477, P191, DOI 10.1038/nature10345; Yi M, 2011, P NATL ACAD SCI USA, V108, P6878, DOI 10.1073/pnas.1015572108; Yoshizawa M, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.024604	38	194	196	12	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2016	352	6288			SI		958	962		10.1126/science.aab0103	http://dx.doi.org/10.1126/science.aab0103			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM2AK	27199422	Green Submitted			2022-12-28	WOS:000376147800040
J	Lan, X; Pritchard, JK				Lan, Xun; Pritchard, Jonathan K.			Coregulation of tandem duplicate genes slows evolution of subfunctionalization in mammals	SCIENCE			English	Article							EXPRESSION; TRANSCRIPTOME; PRINCIPLES; REVEALS; DOSAGE; GENOME	Gene duplication is a fundamental process in genome evolution. However, most young duplicates are degraded by loss-of-function mutations, and the factors that allow some duplicate pairs to survive long-term remain controversial. One class of models to explain duplicate retention invokes sub-or neofunctionalization, whereas others focus on sharing of gene dosage. RNA-sequencing data from 46 human and 26 mouse tissues indicate that subfunctionalization of expression evolves slowly and is rare among duplicates that arose within the placental mammals, possibly because tandem duplicates are coregulated by shared genomic elements. Instead, consistent with the dosage-sharing hypothesis, most young duplicates are down-regulated to match expression levels of single-copy genes. Thus, dosage sharing of expression allows for the initial survival of mammalian duplicates, followed by slower functional adaptation enabling long-term preservation.	[Lan, Xun; Pritchard, Jonathan K.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Pritchard, Jonathan K.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Lan, Xun; Pritchard, Jonathan K.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Lan, X; Pritchard, JK (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.; Pritchard, JK (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.; Lan, X; Pritchard, JK (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	xlan@stanford.edu; pritch@stanford.edu		Lan, Xun/0000-0002-6523-046X	NIH [ES025009, MH101825]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES025009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101825, R01MH090951] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by NIH grants ES025009 and MH101825 and by the Howard Hughes Medical Institute. We thank H. Fraser for prepublication access to data (12) and H. Fraser, A. Fu, A. Harpak, Y. I. Li, D. Petrov, P. C. Phillips, M. Przeworski, A. Stoltzfus, and the anonymous reviewers for comments or discussion. J.K.P. is on advisory boards for 23andMe and DNAnexus, with stock options in both.	Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Babak T, 2015, NAT GENET, V47, P544, DOI 10.1038/ng.3274; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Baker CR, 2013, SCIENCE, V342, P104, DOI 10.1126/science.1240810; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Conant GC, 2014, CURR OPIN PLANT BIOL, V19, P91, DOI 10.1016/j.pbi.2014.05.008; Feuerborn A, 2015, TRENDS GENET, V31, P483, DOI 10.1016/j.tig.2015.07.001; Force A, 1999, GENETICS, V151, P1531; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Ganko EW, 2007, MOL BIOL EVOL, V24, P2298, DOI 10.1093/molbev/msm158; Ghanbarian AT, 2015, MOL BIOL EVOL, V32, P1748, DOI 10.1093/molbev/msv053; Gout JF, 2015, MOL BIOL EVOL, V32, P2141, DOI 10.1093/molbev/msv095; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lynch Michael, 2003, Journal of Structural and Functional Genomics, V3, P35, DOI 10.1023/A:1022696612931; Peng K, 2013, NUCLEIC ACIDS RES, V41, pD553, DOI 10.1093/nar/gks1244; Popadin KY, 2014, AM J HUM GENET, V95, P660, DOI 10.1016/j.ajhg.2014.11.003; Qian WF, 2010, TRENDS GENET, V26, P425, DOI 10.1016/j.tig.2010.07.002; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Stoltzfus A, 1999, J MOL EVOL, V49, P169, DOI 10.1007/PL00006540; van de Geijn B, 2015, NAT METHODS, V12, P1061, DOI [10.1038/NMETH.3582, 10.1038/nmeth.3582]; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107	24	85	86	4	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2016	352	6288			SI		1009	1013		10.1126/science.aad8411	http://dx.doi.org/10.1126/science.aad8411			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM2AK	27199432	Green Accepted, Green Submitted			2022-12-28	WOS:000376147800053
J	Thompson, S; English, K; Argyle, R; Beynon, R				Thompson, Sandy; English, Kate; Argyle, Rachel; Beynon, Rhys			George Chalmers Hood Terris Ballard OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2016	353								i2771	10.1136/bmj.i2771	http://dx.doi.org/10.1136/bmj.i2771			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GI	27207716				2022-12-28	WOS:000376448200003
J	Owen, J				Owen, Jonathan			Pay drug companies $1bn for each new antibiotic, says report	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		ONeill J., 2016, TACKLING DRUG RESIST	1	5	5	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2016	353								i2863	10.1136/bmj.i2863	http://dx.doi.org/10.1136/bmj.i2863			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GD	27198868				2022-12-28	WOS:000376447700022
J	Nabhan, C; Smith, SM; Cifu, AS				Nabhan, Chadi; Smith, Sonali M.; Cifu, Adam S.			Surveillance Imaging in Patients in Remission From Hodgkin and Diffuse Large B-Cell Lymphoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CLINICAL-PRACTICE GUIDELINES; POPULATION; DIAGNOSIS; SURVIVAL		[Nabhan, Chadi; Smith, Sonali M.] Univ Chicago, Sect Hematol & Oncol, Chicago, IL 60637 USA; [Cifu, Adam S.] Univ Chicago, Gen Internal Med Sect, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Nabhan, C (corresponding author), Univ Chicago, Ctr Clin Canc, Sect Hematol & Oncol, Dept Med, 5841 S MarylandAve,MC2115, Chicago, IL 60637 USA.	cnabhan@medicine.bsd.uchicago.edu	Smith, Sonali/AAD-9328-2020					Armitage JO, 2015, J CLIN ONCOL, V33, P3983, DOI 10.1200/JCO.2015.63.5946; Cheson BD, 2014, J CLIN ONCOL, V32, P3059, DOI 10.1200/JCO.2013.54.8800; Eichenauer DA, 2014, ANN ONCOL, V25, P70, DOI 10.1093/annonc/mdu181; El-Galaly TC, 2015, J CLIN ONCOL, V33, P3993, DOI 10.1200/JCO.2015.62.0229; Hoppe RT, 2015, J NATL COMPR CANC NE, V13, P554, DOI 10.6004/jnccn.2015.0075; Liedtke M, 2006, ANN ONCOL, V17, P909, DOI 10.1093/annonc/mdl049; Maurer MJ, 2014, J CLIN ONCOL, V32, P1066, DOI 10.1200/JCO.2013.51.5866; Thompson CA, 2014, J CLIN ONCOL, V32, P3506, DOI 10.1200/JCO.2014.55.7561; Tilly H, 2015, ANN ONCOL, V26, pV116, DOI 10.1093/annonc/mdv304; Zelenetz AD, 2016, J NATL COMPR CANC NE, V14, P196, DOI 10.6004/jnccn.2016.0023	10	5	5	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 17	2016	315	19					2115	2116		10.1001/jama.2016.4913	http://dx.doi.org/10.1001/jama.2016.4913			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL9PN	27187305				2022-12-28	WOS:000375975300023
J	[Anonymous]				[Anonymous]			Tests in the Diagnosis of Cancer (Reprinted from JAMA, vol 65, pg 531, 1915)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		Einhorn Kahn, 1911, ARCH VERDAUUNGSKR, Vxvii, P557; Goodridge F. G., 1915, BIOCH B, Viv, P118; Metabolism I, 1913, ARCH INTERN MED, P276; Salomon, 1912, DTSCH MED WCHNSCHR, Vxxxviii, P58; Stadtmuller Norbert, STUDIES ON SULPHUR	5	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 17	2016	315	19					2127	2127		10.1001/jama.2015.17086	http://dx.doi.org/10.1001/jama.2015.17086			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL9PN	27187317				2022-12-28	WOS:000375975300034
J	Edwards, A				Edwards, Aled			Science is still too closed	NATURE			English	Editorial Material									[Edwards, Aled] Univ Toronto, Struct Genom Consortium, Toronto, ON M5S 1A1, Canada	University of Toronto; Structural Genomics Consortium	Edwards, A (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON M5S 1A1, Canada.	aled.edwards@utoronto.ca		Edwards, Aled/0000-0002-4782-6016					0	12	12	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					S70	S70		10.1038/533S70a	http://dx.doi.org/10.1038/533S70a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM0BJ	27167397	Bronze			2022-12-28	WOS:000376007200008
J	Langer, F; Hohenleutner, M; Schmid, CP; Poellmann, C; Nagler, P; Korn, T; Schuller, C; Sherwin, MS; Huttner, U; Steiner, JT; Koch, SW; Kira, M; Huber, R				Langer, F.; Hohenleutner, M.; Schmid, C. P.; Poellmann, C.; Nagler, P.; Korn, T.; Schueller, C.; Sherwin, M. S.; Huttner, U.; Steiner, J. T.; Koch, S. W.; Kira, M.; Huber, R.			Lightwave-driven quasiparticle collisions on a subcycle timescale	NATURE			English	Article							HIGH-HARMONIC GENERATION; SIDE-BAND GENERATION; MANY-BODY; MONOLAYER; ELECTRONS; DYNAMICS; EXCITONS; PULSES; WSE2	Ever since Ernest Rutherford scattered alpha-particles from gold foils(1), collision experiments have revealed insights into atoms, nuclei and elementary particles(2). In solids, many-body correlations lead to characteristic resonances(3)-called quasiparticles-such as excitons, dropletons(4), polarons and Cooper pairs. The structure and dynamics of quasiparticles are important because they define macroscopic phenomena such as Mott insulating states, spontaneous spin-and charge-order, and high-temperature superconductivity(5). However, the extremely short lifetimes of these entities(6) make practical implementations of a suitable collider challenging. Here we exploit lightwave-driven charge transport(7-24), the foundation of attosecond science(9-13), to explore ultrafast quasiparticle collisions directly in the time domain: a femtosecond optical pulse creates excitonic electron-hole pairs in the layered dichalcogenide tungsten diselenide while a strong terahertz field accelerates and collides the electrons with the holes. The underlying dynamics of the wave packets, including collision, pair annihilation, quantum interference and dephasing, are detected as light emission in high-order spectral sidebands(17-19) of the optical excitation. A full quantum theory explains our observations microscopically. This approach enables collision experiments with various complex quasiparticles and suggests a promising new way of generating sub-femtosecond pulses.	[Langer, F.; Hohenleutner, M.; Schmid, C. P.; Poellmann, C.; Nagler, P.; Korn, T.; Schueller, C.; Huber, R.] Univ Regensburg, Dept Phys, D-93040 Regensburg, Germany; [Sherwin, M. S.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Sherwin, M. S.] Univ Calif Santa Barbara, Inst Terahertz Sci & Technol, Santa Barbara, CA 93106 USA; [Huttner, U.; Steiner, J. T.; Koch, S. W.; Kira, M.] Univ Marburg, Dept Phys, D-35032 Marburg, Germany	University of Regensburg; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Philipps University Marburg	Huber, R (corresponding author), Univ Regensburg, Dept Phys, D-93040 Regensburg, Germany.; Kira, M (corresponding author), Univ Marburg, Dept Phys, D-35032 Marburg, Germany.	mackillo.kira@physik.uni-marburg.de; rupert.huber@physik.uni-regensburg.de	Sherwin, Mark S/Q-4762-2017; Korn, Tobias/C-3672-2009; Huber, Rupert/N-4126-2018	Sherwin, Mark S/0000-0002-3869-1893; Korn, Tobias/0000-0003-4808-391X; Huber, Rupert/0000-0001-6617-9283; Kira, Gervais M/0000-0001-6989-7336; Schuller, Christian/0000-0002-6043-5263	European Research Council [305003]; Deutsche Forschungsgemeinschaft [HU 1598/2-1, GRK 1570, SFB 1083, SPP 1840, KI 917/2-2, KI 917/3-1]; National Science Foundation [DMR 1405964]; Division Of Materials Research [1405964] Funding Source: National Science Foundation	European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank H. Banks for critical reading of the manuscript. The work in Regensburg was supported by the European Research Council through grant number 305003 (QUANTUMsubCYCLE) and the Deutsche Forschungsgemeinschaft (through grant number HU 1598/2-1 and GRK 1570), and the work in Marburg by the Deutsche Forschungsgemeinschaft (through SFB 1083, SPP 1840 and grant numbers KI 917/2-2, KI 917/3-1). The work in Santa Barbara was supported by the National Science Foundation (through grant number DMR 1405964).	Almand-Hunter AE, 2014, NATURE, V506, P471, DOI 10.1038/nature12994; Arora A, 2015, NANOSCALE, V7, P10421, DOI 10.1039/c5nr01536g; Banks H, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.267402; Basov DN, 2011, REV MOD PHYS, V83, P471, DOI 10.1103/RevModPhys.83.471; BEAL AR, 1976, J PHYS C SOLID STATE, V9, P2459, DOI 10.1088/0022-3719/9/12/029; Berger C, 2015, AIP ADV, V5, DOI 10.1063/1.4917180; Breuer J, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.134803; Chemla DS, 2001, NATURE, V411, P549, DOI 10.1038/35079000; Corkum PB, 2007, NAT PHYS, V3, P381, DOI 10.1038/nphys620; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Danielson JR, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.237401; Gallot G, 1999, J OPT SOC AM B, V16, P1204, DOI 10.1364/JOSAB.16.001204; Ghimire S, 2011, NAT PHYS, V7, P138, DOI 10.1038/NPHYS1847; Girndt AA, 1997, PHYS STATUS SOLIDI B, V202, P725, DOI 10.1002/1521-3951(199708)202:2<725::AID-PSSB725>3.0.CO;2-K; Golde D, 2011, PHYS STATUS SOLIDI B, V248, P863, DOI 10.1002/pssb.201000840; Higuchi T, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.213901; Hohenleutner M, 2015, NATURE, V523, P572, DOI 10.1038/nature14652; Kira M, 2006, PROG QUANT ELECTRON, V30, P155, DOI 10.1016/j.pquantelec.2006.12.002; Kira M., 2012, SEMICONDUCTOR QUANTU; Kono J, 1997, PHYS REV LETT, V79, P1758, DOI 10.1103/PhysRevLett.79.1758; LEWENSTEIN M, 1994, PHYS REV A, V49, P2117, DOI 10.1103/PhysRevA.49.2117; Li W, 2008, SCIENCE, V322, P1207, DOI 10.1126/science.1163077; Liu RB, 2007, AIP CONF PROC, V893, P1455, DOI 10.1063/1.2730455; Luu TT, 2015, NATURE, V521, P498, DOI 10.1038/nature14456; Mitioglu AA, 2015, NANO LETT, V15, P4387, DOI 10.1021/acs.nanolett.5b00626; Nanni EA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9486; Neppl S, 2015, NATURE, V517, P342, DOI 10.1038/nature14094; Paul PM, 2001, SCIENCE, V292, P1689, DOI 10.1126/science.1059413; PEYGHAMBARIAN N, 1984, PHYS REV LETT, V53, P2433, DOI 10.1103/PhysRevLett.53.2433; Poellmann C, 2015, NAT MATER, V14, P889, DOI [10.1038/nmat4356, 10.1038/NMAT4356]; Ramasubramaniam A, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.115409; Rossi F, 2002, REV MOD PHYS, V74, P895, DOI 10.1103/RevModPhys.74.895; Rutherford E, 1911, PHILOS MAG, V21, P669, DOI 10.1080/14786440508637080; Schubert O, 2014, NAT PHOTONICS, V8, P119, DOI [10.1038/NPHOTON.2013.349, 10.1038/nphoton.2013.349]; Sell A, 2008, OPT LETT, V33, P2767, DOI 10.1364/OL.33.002767; Shah J., 1999, ULTRAFAST SPECTROSCO; Smirnova O, 2009, NATURE, V460, P972, DOI 10.1038/nature08253; Smith RP, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.247401; Vampa G, 2015, NATURE, V522, P462, DOI 10.1038/nature14517; Vampa G, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.073901; Vu QT, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.217403; WANG HL, 1993, PHYS REV LETT, V71, P1261, DOI 10.1103/PhysRevLett.71.1261; Wimmer L, 2014, NAT PHYS, V10, P432, DOI [10.1038/NPHYS2974, 10.1038/nphys2974]; Wyatt T, 2007, NATURE, V448, P274, DOI 10.1038/nature06075; Xu XD, 2014, NAT PHYS, V10, P343, DOI [10.1038/NPHYS2942, 10.1038/nphys2942]; Yan JY, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.075204; Zaks B, 2012, NATURE, V483, P580, DOI 10.1038/nature10864	47	162	162	4	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					225	+		10.1038/nature17958	http://dx.doi.org/10.1038/nature17958			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0BJ	27172045	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000376007200045
J	Yasin, M; Reed, JC				Yasin, Muhammad; Reed, James C.			Diaphragmatic Hernia Causing Lung Collapse	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Yasin, Muhammad; Reed, James C.] Univ Louisville, Louisville, KY 40292 USA	University of Louisville	Yasin, M (corresponding author), Univ Louisville, Louisville, KY 40292 USA.	dr.yasinmd@gmail.com							0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2016	374	19					1874	1874		10.1056/NEJMicm1415660	http://dx.doi.org/10.1056/NEJMicm1415660			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6JS	27168436				2022-12-28	WOS:000375746100010
J	Germann, R; Rabindranath, K; Ninin, D; Sizeland, P				Germann, Richard; Rabindranath, Kannaiyan; Ninin, Daniel; Sizeland, Peter			CASE REVIEW A 65 year old man with macroscopic haematuria and acute kidney injury	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							WARFARIN-RELATED NEPHROPATHY		[Germann, Richard; Rabindranath, Kannaiyan; Sizeland, Peter] Waikato Hosp, Reg Renal Unit, Hamilton 3240, New Zealand; [Ninin, Daniel] Waikato Hosp, Dept Pathol, Hamilton 3240, New Zealand	Waikato Hospital; Waikato Hospital	Germann, R (corresponding author), Waikato Hosp, Reg Renal Unit, Hamilton 3240, New Zealand.	richardgermann@gmail.com						Moreno JA, 2012, NEPHROL DIAL TRANSPL, V27, P28, DOI 10.1093/ndt/gfr749; Moreno JA, 2012, CLIN J AM SOC NEPHRO, V7, P175, DOI 10.2215/CJN.01970211; Brodsky SV, 2011, KIDNEY INT, V80, P182, DOI 10.1038/ki.2011.44; Brodsky SV, 2010, NEPHRON CLIN PRACT, V115, pC142, DOI 10.1159/000312877; Brodsky SV, 2009, AM J KIDNEY DIS, V54, P1121, DOI 10.1053/j.ajkd.2009.04.024; Kadiyala D, 2012, THE AMERICAN SOCIETY; Kidney Disease: Improving Global Outcomes (KDIGO), 2012, KIDNEY INT SUPPL, V2, P1, DOI [10.1038/kisup.2012.1, DOI 10.1038/KISUP.2012.1]; Larpparisuth Nuttasith, 2015, Journal of the Medical Association of Thailand, V98, P212; Moeckel GW, 2013, CLIN KIDNEY J, V6, P507, DOI 10.1093/ckj/sft076; Ryan M, 2014, NEPHROL DIAL TRANSPL, V29, P2228, DOI 10.1093/ndt/gft380; Shafi Salman T, 2013, WMJ, V112, P173; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793	12	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 10	2016	353								i2180	10.1136/bmj.i2180	http://dx.doi.org/10.1136/bmj.i2180			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6FP	27166389				2022-12-28	WOS:000376446300002
J	Storebo, OJ; Simonsen, E; Gluud, C				Storebo, Ole J.; Simonsen, Erik; Gluud, Christian			Methylphenidate for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								CLINICAL QUESTION Is treatment with methylphenidate associated with benefits or harms for children and adolescents with attention-deficit/hyperactivity disorder (ADHD)? BOTTOM LINE Methylphenidate is associated with improvement in ADHD symptoms, general behavior, and quality of life; however, due to the very low quality of the evidence, the magnitude of the associated improvement is uncertain. Methylphenidate was associated with an increased risk of nonserious adverse events. There are too few data to assess the association with serious adverse events.	[Storebo, Ole J.] Region Zealand Psychiat, Child & Adolescent Psychiat Dept, Psychiat Res Unit, Faelledvej 6, DK-4200 Slagelse, Region Zealand, Denmark; [Simonsen, Erik] Region Zealand Psychiat, Psychiat Res Unit, Copenhagen, Region Zealand, Denmark; [Gluud, Christian] Copenhagen Univ Hosp, Rigshosp, Copenhagen Trial Unit, Ctr Clin Intervent Res, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Storebo, OJ (corresponding author), Region Zealand Psychiat, Child & Adolescent Psychiat Dept, Psychiat Res Unit, Faelledvej 6, DK-4200 Slagelse, Region Zealand, Denmark.	ojst@regionsjaelland.dk	Gluud, Christian/AAY-1027-2021; Simonsen, Erik/N-6615-2014; Gluud, Christian/HGB-3191-2022	Gluud, Christian/0000-0002-8861-0799; Simonsen, Erik/0000-0002-6134-2392; Gauci, Dorothy/0000-0002-1524-584X				American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; National Institute for Health Care Excellence, ATTENTION DEFICIT HY; Polanczyk GV, 2015, J CHILD PSYCHOL PSYC, V56, P345, DOI 10.1111/jcpp.12381; Storebo Ole Jakob, 2015, Cochrane Database Syst Rev, pCD009885, DOI 10.1002/14651858.CD009885.pub2; Storebo OJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5203; Wolraich M, 2011, PEDIATRICS, V128, P1007, DOI 10.1542/peds.2011-2654; World Health Organization, 1992, ICD 10 CLASS MENT BE, DOI DOI 10.1002/1520-6505(2000)9:5%3C201::AID-EVAN2%3E3.3.CO;2-P	7	23	23	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 10	2016	315	18					2009	2010		10.1001/jama.2016.3611	http://dx.doi.org/10.1001/jama.2016.3611			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DL2JP	27163989				2022-12-28	WOS:000375461100018
J	Johansson, M; Jorgensen, KJ; Getz, L; Moynihan, R				Johansson, Minna; Jorgensen, Karsten Juhl; Getz, Linn; Moynihan, Ray			"Informed choice" in a time of too much medicine-no panacea for ethical difficulties	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OVERDIAGNOSIS; DISEASE; RISK; NEED		[Johansson, Minna] Univ Gothenburg, Inst Med, Dept Publ Hlth & Community Med, Gothenburg, Sweden; [Johansson, Minna] FoUU Centrum Fyrbodal, Res Unit, Vanersborg, Sweden; [Johansson, Minna] FoUU Centrum Fyrbodal, Sect Gen Practice, Vanersborg, Sweden; [Jorgensen, Karsten Juhl] Rigshosp, Nord Cochrane Ctr, DK-2100 Copenhagen, Denmark; [Getz, Linn] Norwegian Univ Sci & Technol, Gen Practice Res Unit, N-7034 Trondheim, Norway; [Moynihan, Ray] Bond Univ, Ctr Res Evidence Based Practice, Southport, Qld 4229, Australia	University of Gothenburg; Rigshospitalet; University of Copenhagen; Norwegian University of Science & Technology (NTNU); Bond University	Johansson, M (corresponding author), Univ Gothenburg, Inst Med, Dept Publ Hlth & Community Med, Gothenburg, Sweden.; Johansson, M (corresponding author), FoUU Centrum Fyrbodal, Res Unit, Vanersborg, Sweden.; Johansson, M (corresponding author), FoUU Centrum Fyrbodal, Sect Gen Practice, Vanersborg, Sweden.	minna.johansson@vgregion.se	Moynihan, Ray/ABC-3010-2020	Jorgensen, Karsten/0000-0001-8554-0388				ARMSTRONG D, 1995, SOCIOL HEALTH ILL, V17, P393, DOI 10.1111/1467-9566.ep10933329; Barratt A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h867; Cundy T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1567; Dowrick C, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7140; Getz L., 2006, THESIS NTNU TRONDHEI, P63; Getz L, 2010, SCAND J PRIM HEALTH, V28, P1, DOI 10.3109/02813431003625410; Glasziou P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4247; Grady D, 2010, ARCH INTERN MED, V170, P749, DOI 10.1001/archinternmed.2010.90; Hoffmann TC, 2014, MED J AUSTRALIA, V201, P513, DOI 10.5694/mja14.01124; Jarvinen TLN, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2088; Jorgensen P, 2015, FAM PRACT, V32, P492, DOI 10.1093/fampra/cmv065; Kelly MP, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0063-3; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Martin Stephen A, 2014, BMJ, V349, pg5432, DOI 10.1136/bmj.g5432; Meixel A, 2015, J MED ETHICS, V41, P859, DOI 10.1136/medethics-2014-102596; Moynihan R, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4298; National Institute for Health and Care Excellence, 2011, NICE GUIDELINE CG127; Reventlow SD, 2006, SOC SCI MED, V62, P2720, DOI 10.1016/j.socscimed.2005.11.009; ROBERTS MM, 1989, BRIT MED J, V299, P1153, DOI 10.1136/bmj.299.6708.1153; Sackett DL, 2002, CAN MED ASSOC J, V167, P363; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; Slovic P, 2005, HEALTH PSYCHOL, V24, pS35, DOI 10.1037/0278-6133.24.4.S35; Tymstra T, 1989, Int J Technol Assess Health Care, V5, P207; Welch GH, 2011, OVER DIAGNOSED MAKIN; Wiener RS, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f3368	25	18	18	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 9	2016	353								i2230	10.1136/bmj.i2230	http://dx.doi.org/10.1136/bmj.i2230			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6EX	27160274				2022-12-28	WOS:000376444500002
J	Bailey, MJ; Timpe, B				Bailey, Martha J.; Timpe, Brenden			Hope for America's next generation	SCIENCE			English	Editorial Material							HEALTH; MORTALITY		[Bailey, Martha J.] Univ Michigan, Dept Econ, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Populat Studies, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Bailey, MJ (corresponding author), Univ Michigan, Dept Econ, Ann Arbor, MI 48109 USA.	baileymj@umich.edu		Bailey, Martha/0000-0002-7692-6040	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD070950, R24HD041028, P2CHD041028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000221] Funding Source: NIH RePORTER; NIA NIH HHS [T32 AG000221] Funding Source: Medline; NICHD NIH HHS [R24 HD041028, P2C HD041028, R01 HD070950, R01 HD070950-02] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Almond D, 2011, HBK ECON, V4, P1315, DOI 10.1016/S0169-7218(11)02413-0; Bailey MJ, 2015, AM ECON REV, V105, P1067, DOI 10.1257/aer.20120070; Bureau of Labor Statistics, EMPL HOURS EARN CURR; Case A, 2002, AM ECON REV, V92, P1308, DOI 10.1257/000282802762024520; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Currie J, 1996, Q J ECON, V111, P431, DOI 10.2307/2946684; Currie J, 2016, SCIENCE, V352, P708, DOI 10.1126/science.aaf1437; Deaton A, 2013, GREAT ESCAPE: HEALTH, WEALTH, AND THE ORIGINS OF INEQUALITY, P126; Holahan J., 2011, CHANGES HLTH INSURAN; MacDorman M. F., 1993, TRENDS INFANT MORTAL; Miller DL, 2009, AM ECON REV, V99, P122, DOI 10.1257/aer.99.2.122; Wherry LR, 2015, 20929 NBER	13	0	0	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2016	352	6286					661	662		10.1126/science.aaf7270	http://dx.doi.org/10.1126/science.aaf7270			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL1UC	27151853	Green Accepted			2022-12-28	WOS:000375417100018
J	Jacobs, TM; Williams, B; Williams, T; Xu, X; Eletsky, A; Federizon, JF; Szyperski, T; Kuhlman, B				Jacobs, T. M.; Williams, B.; Williams, T.; Xu, X.; Eletsky, A.; Federizon, J. F.; Szyperski, T.; Kuhlman, B.			Design of structurally distinct proteins using strategies inspired by evolution	SCIENCE			English	Article							RATIONAL DESIGN; CONSERVATION; COMBINATION; DOMAIN; FOLD	Natural recombination combines pieces of preexisting proteins to create new tertiary structures and functions. We describe a computational protocol, called SEWING, which is inspired by this process and builds new proteins from connected or disconnected pieces of existing structures. Helical proteins designed with SEWING contain structural features absent from other de novo designed proteins and, in some cases, remain folded at more than 100C. High-resolution structures of the designed proteins CA01 and DA05R1 were solved by x-ray crystallography (2.2 angstrom resolution) and nuclear magnetic resonance, respectively, and there was excellent agreement with the design models. This method provides a new strategy to rapidly create large numbers of diverse and designable protein scaffolds.	[Jacobs, T. M.] Univ N Carolina, Program Bioinformat & Computat Biol, Chapel Hill, NC 27599 USA; [Williams, B.; Williams, T.; Kuhlman, B.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Xu, X.; Eletsky, A.; Federizon, J. F.; Szyperski, T.] SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA; [Xu, X.; Eletsky, A.] Univ N Carolina, Northeast Struct Genom Consortium, Chapel Hill, NC 27599 USA; [Kuhlman, B.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Kuhlman, B (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.; Kuhlman, B (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	bkuhlman@email.unc.edu		Kuhlman, Brian/0000-0003-4907-9699	NIH [R01GM073960, R01GM117968, GM094597]; Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy [W-31-109-Eng-38]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094597, T32GM008570, R01GM117968, R01GM073960] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants R01GM073960 and R01GM117968 (to B.K.) and GM094597 (to T.S.). Use of the Advanced Photon Source was supported by the Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy, under contract no. W-31-109-Eng-38. Coordinates and structure factors have been deposited in the Protein Data Bank with the accession codes 5E6G (CA01), 2N8I (DA05), and 2N8W (DA05R1). Chemical shifts have been deposited in the Biological Magnetic Resonance Bank (BMRB) with the accession codes 25850 (DA05) and 25868 (DA05R1). T.M.J. and B.K. designed the research; T.M.J. wrote the backbone assembly code; T.M.J. and B.W. carried out the backbone assembly and design simulations; T.M.J. conducted the biophysical analysis; T.W. and T.M.J. solved the structure of CA01; and X.X., A.E., and J.F.F., with advice from T.S., solved the NMR structure of DA05 and DA05R1.	ARONSON HEG, 1994, PROTEIN SCI, V3, P1706, DOI 10.1002/pro.5560031009; Bashton M, 2007, STRUCTURE, V15, P85, DOI 10.1016/j.str.2006.11.009; Bharat TAM, 2008, P NATL ACAD SCI USA, V105, P9942, DOI 10.1073/pnas.0802202105; BLAKE CCF, 1978, NATURE, V273, P267, DOI 10.1038/273267a0; Brunette TJ, 2015, NATURE, V528, P580, DOI 10.1038/nature16162; de Bono S, 2005, P NATL ACAD SCI USA, V102, P1396, DOI 10.1073/pnas.0407298102; Doyle L, 2015, NATURE, V528, P585, DOI 10.1038/nature16191; Eisenbeis S, 2012, J AM CHEM SOC, V134, P4019, DOI 10.1021/ja211657k; Fernandez-Fuentes N, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000750; Grishin NV, 2001, J STRUCT BIOL, V134, P167, DOI 10.1006/jsbi.2001.4335; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang PS, 2014, SCIENCE, V346, P481, DOI 10.1126/science.1257481; Hughes AL, 2005, P NATL ACAD SCI USA, V102, P8791, DOI 10.1073/pnas.0503922102; Joh NH, 2014, SCIENCE, V346, P1520, DOI 10.1126/science.1261172; Koga N, 2012, NATURE, V491, P222, DOI 10.1038/nature11600; Koide S, 2009, CURR OPIN BIOTECH, V20, P398, DOI 10.1016/j.copbio.2009.07.007; Kuhlman B, 1998, PROTEIN SCI, V7, P2405, DOI 10.1002/pro.5560071118; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; NUSSINOV R, 1991, P NATL ACAD SCI USA, V88, P10495, DOI 10.1073/pnas.88.23.10495; Reeves GA, 2006, J MOL BIOL, V360, P725, DOI 10.1016/j.jmb.2006.05.035; Richardson JS, 2013, BIOPOLYMERS, V99, P170, DOI 10.1002/bip.22108; Sarai A, 2001, BIOPOLYMERS, V61, P121, DOI 10.1002/1097-0282(2002)61:2<121::AID-BIP10077>3.0.CO;2-1; Schellenberg MJ, 2010, J MOL BIOL, V402, P720, DOI 10.1016/j.jmb.2010.08.020; Sheffler W, 2010, PROTEIN SCI, V19, P1991, DOI 10.1002/pro.458; Soding J, 2003, BIOESSAYS, V25, P837, DOI 10.1002/bies.10321; Tyka MD, 2012, J COMPUT CHEM, V33, P2483, DOI 10.1002/jcc.23069; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224	29	89	92	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2016	352	6286					687	690		10.1126/science.aad8036	http://dx.doi.org/10.1126/science.aad8036			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL1UC	27151863	Green Submitted, Green Accepted			2022-12-28	WOS:000375417100032
J	Medzhitov, R; Belkaid, Y; Davis, MM; Glimcher, L; O'Neill, LAJ; Sallusto, F				Medzhitov, Ruslan; Belkaid, Yasmine; Davis, Mark M.; Glimcher, Laurie; O'Neill, Luke A. J.; Sallusto, Federica			Immunology Gets Out of the Box	CELL			English	Editorial Material														Belkaid, Yasmine/0000-0001-9962-3571					0	1	1	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2016	165	4					763	764						2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DL7DN	27153486	Bronze			2022-12-28	WOS:000375800300002
J	Wang, C; Han, BR; Zhou, RB; Zhuang, XW				Wang, Chong; Han, Boran; Zhou, Ruobo; Zhuang, Xiaowei			Real-Time Imaging of Translation on Single mRNA Transcripts in Live Cells	CELL			English	Article							GENOME-WIDE ANALYSIS; PROTEIN-SYNTHESIS; GENE-EXPRESSION; MAMMALIAN-CELLS; LIVING CELLS; ENDOPLASMIC-RETICULUM; MOLECULAR-MECHANISMS; HIPPOCAMPAL-NEURONS; LOCAL TRANSLATION; IN-VIVO	Translation is under tight spatial and temporal controls to ensure protein production in the right time and place in cells. Methods that allow real-time, high-resolution visualization of translation in live cells are essential for understanding the spatiotemporal dynamics of translation regulation. Based on multivalent fluorescence amplification of the nascent polypeptide signal, we develop a method to image translation on individual mRNA molecules in real time in live cells, allowing direct visualization of translation events at the translation sites. Using this approach, we monitor transient changes of translation dynamics in responses to environmental stresses, capture distinct mobilities of individual polysomes in different subcellular compartments, and detect 3' UTR-dependent local translation and active transport of polysomes in dendrites of primary neurons.	[Wang, Chong; Han, Boran; Zhou, Ruobo; Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Wang, Chong; Han, Boran; Zhou, Ruobo; Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute; Harvard University	Zhuang, XW (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.; Zhuang, XW (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	zhuang@chemistry.harvard.edu		Han, Boran/0000-0001-9567-7062; Zhou, Ruobo/0000-0001-8628-0282	Howard Hughes Medical Institute (HHMI); Jane Coffin Childs fellowship; Life Science Foundation fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096450] Funding Source: NIH RePORTER	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Jane Coffin Childs fellowship; Life Science Foundation fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Siyuan Wang and Jeff Moffitt for assistance with data analysis and Hazen Babcock for technical support on the imaging setup. This work was supported in part by the Howard Hughes Medical Institute (HHMI). C.W. acknowledges support by the Jane Coffin Childs fellowship. R.Z. acknowledges support by the Life Science Foundation fellowship. X.Z. is a HHMI Investigator.	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Andreev DE, 2015, ELIFE, V4, DOI 10.7554/eLife.03971; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; Blanchard SC, 2009, CURR OPIN STRUC BIOL, V19, P103, DOI 10.1016/j.sbi.2009.01.002; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Brar GA, 2015, NAT REV MOL CELL BIO, V16, P651, DOI 10.1038/nrm4069; Bregman A, 2011, CELL, V147, P1473, DOI 10.1016/j.cell.2011.12.005; Bustamante C, 2011, CELL, V144, P480, DOI 10.1016/j.cell.2011.01.033; Buxbaum AR, 2015, NAT REV MOL CELL BIO, V16, P95, DOI 10.1038/nrm3918; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; COLOMBO B, 1965, BIOCHEM BIOPH RES CO, V18, P389, DOI 10.1016/0006-291X(65)90719-9; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Di Prisco GV, 2014, NAT NEUROSCI, V17, P1073, DOI 10.1038/nn.3754; Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580; FRESNO M, 1977, EUR J BIOCHEM, V72, P323, DOI 10.1111/j.1432-1033.1977.tb11256.x; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Halstead JM, 2015, SCIENCE, V347, P1367, DOI 10.1126/science.aaa3380; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Holt CE, 2013, NEURON, V80, P648, DOI 10.1016/j.neuron.2013.10.036; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Ingolia NT, 2014, NAT REV GENET, V15, P205, DOI 10.1038/nrg3645; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; Jung H, 2014, CELL, V157, P26, DOI 10.1016/j.cell.2014.03.005; Katz ZB, 2016, ELIFE, V5, DOI 10.7554/eLife.10415; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Liu N, 2016, NAT STRUCT MOL BIOL, V23, P98, DOI 10.1038/nsmb.3162; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mahamid J, 2016, SCIENCE, V351, P969, DOI 10.1126/science.aad8857; Mitchell SF, 2014, MOL CELL, V54, P547, DOI 10.1016/j.molcel.2014.04.033; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Mor A, 2010, NAT CELL BIOL, V12, P543, DOI 10.1038/ncb2056; Park HY, 2014, SCIENCE, V343, P422, DOI 10.1126/science.1239200; Petrov A, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011551; Reid DW, 2015, NAT REV MOL CELL BIO, V16, P221, DOI 10.1038/nrm3958; Rodriguez AJ, 2006, J CELL BIOL, V175, P67, DOI 10.1083/jcb.200512137; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.07314; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Starck SR, 2004, CHEM BIOL, V11, P999, DOI 10.1016/j.chembiol.2004.05.011; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Tinoco I, 2011, GENE DEV, V25, P1205, DOI 10.1101/gad.2050011; Trcek T, 2011, CELL, V147, P1484, DOI 10.1016/j.cell.2011.11.051; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Wu B, 2015, CELL, V162, P211, DOI 10.1016/j.cell.2015.05.054; Wu B, 2012, BIOPHYS J, V102, P2936, DOI 10.1016/j.bpj.2012.05.017; Yan XW, 2016, CELL, V165, P976, DOI 10.1016/j.cell.2016.04.034; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Zid BM, 2014, NATURE, V514, P117, DOI 10.1038/nature13578	64	190	198	1	122	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2016	165	4					990	1001		10.1016/j.cell.2016.04.040	http://dx.doi.org/10.1016/j.cell.2016.04.040			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DL7DN	27153499	Green Accepted, Bronze			2022-12-28	WOS:000375800300024
J	Schmeler, KM; Sturgis, EM				Schmeler, Kathleen M.; Sturgis, Erich M.			Expanding the benefits of HPV vaccination to boys and men	LANCET			English	Editorial Material							HUMAN-PAPILLOMAVIRUS VACCINATION; COVERAGE		[Schmeler, Kathleen M.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA; [Sturgis, Erich M.] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA; [Sturgis, Erich M.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Schmeler, KM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA.	kschmele@mdanderson.org			NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ali H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2032; Bednarczyk RA, 2012, PEDIATRICS, V130, P798, DOI 10.1542/peds.2012-1516; Binagwaho A, 2011, LANCET, V378, P1916, DOI 10.1016/S0140-6736(11)61837-0; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Gee J, 2011, VACCINE, V29, P8279, DOI 10.1016/j.vaccine.2011.08.106; Jemal A, 2013, JNCI-J NATL CANCER I, V105, P175, DOI 10.1093/jnci/djs491; Joura EA, 2015, NEW ENGL J MED, V372, P711, DOI 10.1056/NEJMoa1405044; Markowitz LE, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1968; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Reagan-Steiner S, 2015, MMWR-MORBID MORTAL W, V64, P784, DOI 10.15585/mmwr.mm6429a3; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F	12	23	24	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 30	2016	387	10030					1798	1799		10.1016/S0140-6736(16)30314-2	http://dx.doi.org/10.1016/S0140-6736(16)30314-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DK6SS	27203488				2022-12-28	WOS:000375056100009
J	Asturias, EJ; Bandyopadhyay, AS; Self, S; Rivera, L; Saez-Llorens, X; Lopez, E; Melgar, M; Gaensbauer, JT; Weldon, WC; Oberste, MS; Borate, BR; Gast, C; Clemens, R; Orenstein, W; O'Ryan, GM; Jimeno, J; Clemens, SAC; Ward, J; Ruttimann, R				Asturias, Edwin J.; Bandyopadhyay, Ananda S.; Self, Steve; Rivera, Luis; Saez-Llorens, Xavier; Lopez, Eduardo; Melgar, Mario; Gaensbauer, James T.; Weldon, William C.; Oberste, M. Steven; Borate, Bhavesh R.; Gast, Chris; Clemens, Ralf; Orenstein, Walter; Miguel O'Ryan, G.; Jimeno, Jose; Costa Clemens, Sue Ann; Ward, Joel; Ruettimann, Ricardo		Latin Amer IPV001BMG Study Grp	Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial	LANCET			English	Article							TRAINED IMMUNITY; NON-INFERIORITY; IMMUNOGENICITY; POLIOMYELITIS	Background Replacement of the trivalent oral poliovirus vaccine (tOPV) with bivalent types 1 and 3 oral poliovirus vaccine (bOPV) and global introduction of inactivated poliovirus vaccine (IPV) are major steps in the polio endgame strategy. In this study, we assessed humoral and intestinal immunity in Latin American infants after three doses of bOPV combined with zero, one, or two doses of IPV. Methods This open-label randomised controlled multicentre trial was part of a larger study. 6-week-old full-term infants due for their first polio vaccinations, who were healthy on physical examination, with no obvious medical conditions and no known chronic medical disorders, were enrolled from four investigational sites in Colombia, Dominican Republic, Guatemala, and Panama. The infants were randomly assigned by permuted block randomisation (through the use of a computer-generated list, block size 36) to nine groups, of which five will be discussed in this report. These five groups were randomly assigned 1: 1: 1: 1 to four permutations of schedule: groups 1 and 2 (control groups) received bOPV at 6, 10, and 14 weeks; group 3 (also a control group, which did not count as a permutation) received tOPV at 6, 10, and 14 weeks; group 4 received bOPV plus one dose of IPV at 14 weeks; and group 5 received bOPV plus two doses of IPV at 14 and 36 weeks. Infants in all groups were challenged with monovalent type 2 vaccine (mOPV2) at 18 weeks (groups 1, 3, and 4) or 40 weeks (groups 2 and 5). The primary objective was to assess the superiority of bOPV-IPV schedules over bOPV alone, as assessed by the primary endpoints of humoral immunity (neutralising antibodies-ie, seroconversion) to all three serotypes and intestinal immunity (faecal viral shedding post-challenge) to serotype 2, analysed in the per-protocol population. Serious and medically important adverse events were monitored for up to 6 months after the study vaccination. This study is registered with ClinicalTrials.gov, number NCT01831050, and has been completed. Findings Between May 20, 2013, and Aug 15, 2013, 940 eligible infants were enrolled and randomly assigned to the five treatment groups (210 to group 1, 210 to group 2, 100 to group 3, 210 to group 4, and 210 to group 5). One infant in group 1 was not vaccinated because their parents withdrew consent after enrolment and randomisation, so 939 infants actually received the vaccinations. Three doses of bOPV or tOPV elicited type 1 and 3 seroconversion rates of at least 97 . 7%. Type 2 seroconversion occurred in 19 of 198 infants (9 . 6%, 95% CI 6 . 2-14 . 5) in the bOPV-only groups, 86 of 88 (97 . 7%, 92 . 1-99 . 4) in the tOPV-only group (p<0 . 0001 vs bOPV-only), and 156 of 194 (80 . 4%, 74 . 3-85 . 4) infants in the bOPV-one dose of IPV group (p<0 . 0001 vs bOPV-only). A further 20 of 193 (10%) infants in the latter group seroconverted 1 week after mOPV2 challenge, resulting in around 98% of infants being seropositive against type 2. After a bOPV-two IPV schedule, all 193 infants (100%, 98 . 0-100; p<0 . 0001 vs bOPV-only) seroconverted to type 2. IPV induced small but signifi cant decreases in a composite serotype 2 viral shedding index after mOPV2 challenge. 21 serious adverse events were reported in 20 patients during the study, including two that were judged to be possibly related to the vaccines. Most of the serious adverse events (18 [86%] of 21) and 24 (80%) of the 30 important medical events reported were infections and infestations. No deaths occurred during the study. Interpretation bOPV provided humoral protection similar to tOPV against polio serotypes 1 and 3. After one or two IPV doses in addition to bOPV, 80% and 100% of infants seroconverted, respectively, and the vaccination induced a degree of intestinal immunity against type 2 poliovirus.	[Asturias, Edwin J.; Gaensbauer, James T.] Univ Colorado, Dept Pediat, Sch Med, Aurora, CO USA; [Asturias, Edwin J.; Gaensbauer, James T.] Childrens Hosp Colorado, Aurora, CO USA; [Asturias, Edwin J.; Gaensbauer, James T.] Colorado Sch Publ Hlth, Ctr Global Hlth, Aurora, CO USA; [Asturias, Edwin J.] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Bandyopadhyay, Ananda S.] Bill & Melinda Gates Fdn, Seattle, WA USA; [Self, Steve; Borate, Bhavesh R.; Gast, Chris] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Rivera, Luis] Ctr Neonatal Res, Santo Domingo, Dominican Rep; [Saez-Llorens, Xavier] Hosp Nino Dr Jose Renan Esquivel, Panama City, Panama; [Lopez, Eduardo] Univ Valle, Dept Pediat, Cali, Colombia; [Lopez, Eduardo] Ctr Estudios Infectol Pediat, Cali, Colombia; [Melgar, Mario] Hosp Roosevelt, Guatemala City, Guatemala; [Melgar, Mario] Univ Francisco, Marroquin Sch Med, Guatemala City, Guatemala; [Weldon, William C.; Oberste, M. Steven] Ctr Dis Control & Prevent, Atlanta, GA USA; [Orenstein, Walter] Emory Vaccine Ctr, Atlanta, GA USA; [Miguel O'Ryan, G.] Univ Chile, Fac Med, Santiago, Chile; [Jimeno, Jose] Vaxtrials, Panama City, Panama; [Clemens, Ralf; Costa Clemens, Sue Ann] Global Res Infect Dis, Rio De Janeiro, Brazil; [Ward, Joel] Univ Calif Los Angeles, Geffin Sch Med, Harbor UCLA Med Ctr, Dept Pediat, Los Angeles, CA USA; [Ruettimann, Ricardo] FIDEC, Miami, FL USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Colorado School of Public Health; Colorado School of Public Health; Bill & Melinda Gates Foundation; Fred Hutchinson Cancer Center; Universidad del Valle; Centers for Disease Control & Prevention - USA; Emory University; Universidad de Chile; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Asturias, EJ (corresponding author), Univ Colorado, Sch Med, Dept Pediat & Infect Dis, 13199 East Montview Blvd,Suite 310, Aurora, CO 80045 USA.; Asturias, EJ (corresponding author), Colorado Sch Publ Hlth, Dept Epidemiol, 13199 East Montview Blvd,Suite 310, Aurora, CO 80045 USA.; Asturias, EJ (corresponding author), Colorado Sch Publ Hlth, Ctr Global Hlth, 13199 East Montview Blvd,Suite 310, Aurora, CO 80045 USA.	edwin.asturias@ucdenver.edu	; Asturias, Edwin/D-9842-2016	SAEZ LLORENS, XAVIER/0000-0002-1149-5905; Asturias, Edwin/0000-0002-1275-0787; Clemens, Ralf/0000-0003-4685-4207; Costa Clemens, Sue Ann/0000-0001-9576-0878; Bandyopadhyay, Ananda/0000-0002-8395-2001	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Bill & Melinda Gates Foundation.	ASHKENAZI A, 1962, NEW ENGL J MED, V267, P1228, DOI 10.1056/NEJM196212132672404; Bandyopadhyay AS, 2015, FUTURE MICROBIOL, V10, P791, DOI [10.2217/FMB.15.19, 10.2217/fmb.15.19]; DEQUADROS CA, 1993, BIOLOGICALS, V21, P335, DOI 10.1006/biol.1993.1093; Estivariz CF, 2015, LANCET INFECT DIS, V15, P898, DOI 10.1016/S1473-3099(15)00094-8; Global Polio Eradication Initiative, POL THIS WEEK 9 DEC; Grassly NC, 2014, J INFECT DIS, V210, pS439, DOI 10.1093/infdis/jit601; Herremans TMPT, 1999, J IMMUNOL, V162, P5011; Hong M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7588; Jafari H, 2014, SCIENCE, V345, P922, DOI 10.1126/science.1255006; John J, 2014, LANCET, V384, P1505, DOI 10.1016/S0140-6736(14)60934-X; Mir F, 2015, LANCET INFECT DIS, V15, P889, DOI 10.1016/S1473-3099(15)00093-6; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; O'Ryan M, 2015, LANCET INFECT DIS, V15, P1273, DOI 10.1016/S1473-3099(15)00219-4; PATRIARCA PA, 1991, REV INFECT DIS, V13, P926; Platt LR, 2014, J INFECT DIS, V210, pS380, DOI 10.1093/infdis/jiu184; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; SABIN AB, 1952, J EXP MED, V96, P99, DOI 10.1084/jem.96.1.99; Saez-Llorens X, 2016, LANCET INFECT DIS, V16, P321, DOI 10.1016/S1473-3099(15)00488-0; Sutter RW, 2015, LANCET, V386, P2413, DOI 10.1016/S0140-6736(15)00237-8; WHO, 2014, VACCINE, V32, P4117, DOI 10.1016/j.vaccine.2014.04.023	20	56	59	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2016	388	10040					158	169		10.1016/S0140-6736(16)00703-0	http://dx.doi.org/10.1016/S0140-6736(16)00703-0			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ5TZ	27212429				2022-12-28	WOS:000379269200031
J	Cui, XL; Chen, KJ; Xing, HB; Yang, QW; Krishna, R; Bao, ZB; Wu, H; Zhou, W; Dong, XL; Han, Y; Li, B; Ren, QL; Zaworotko, MJ; Chen, BL				Cui, Xili; Chen, Kaijie; Xing, Huabin; Yang, Qiwei; Krishna, Rajamani; Bao, Zongbi; Wu, Hui; Zhou, Wei; Dong, Xinglong; Han, Yu; Li, Bin; Ren, Qilong; Zaworotko, Michael J.; Chen, Banglin			Pore chemistry and size control in hybrid porous materials for acetylene capture from ethylene	SCIENCE			English	Article							METAL-ORGANIC FRAMEWORKS; METHANE STORAGE; CARBON-DIOXIDE; CO2; ADSORPTION; FUNCTIONALITIES; SEPARATION; REMOVAL	The trade-off between physical adsorption capacity and selectivity of porous materials is a major barrier for efficient gas separation and purification through physisorption. We report control over pore chemistry and size in metal coordination networks with hexafluorosilicate and organic linkers for the purpose of preferential binding and orderly assembly of acetylene molecules through cooperative host-guest and/or guest-guest interactions. The specific binding sites for acetylene are validated by modeling and neutron powder diffraction studies. The energies associated with these binding interactions afford high adsorption capacity (2.1 millimoles per gram at 0.025 bar) and selectivity (39.7 to 44.8) for acetylene at ambient conditions. Their efficiency for the separation of acetylene/ethylene mixtures is demonstrated by experimental breakthrough curves (0.73 millimoles per gram from a 1/99 mixture).	[Cui, Xili; Xing, Huabin; Yang, Qiwei; Bao, Zongbi; Ren, Qilong] Zhejiang Univ, Coll Chem & Biol Engn, Minist Educ, Key Lab Biomass Chem Engn, Hangzhou 310027, Zhejiang, Peoples R China; [Chen, Kaijie; Zaworotko, Michael J.] Univ Limerick, Dept Chem & Environm Sci, Limerick, Ireland; [Krishna, Rajamani] Univ Amsterdam, Vant Hoff Inst Mol Sci, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands; [Wu, Hui; Zhou, Wei] NIST, Ctr Neutron Res, Gaithersburg, MD 20899 USA; [Dong, Xinglong; Han, Yu] King Abdullah Univ Sci & Technol, Phys Sci & Engn Div, Adv Membranes & Porous Mat Ctr, Thuwal 239556900, Saudi Arabia; [Li, Bin; Chen, Banglin] Univ Texas San Antonio, Dept Chem, One UTSA Circle, San Antonio, TX 78249 USA	Zhejiang University; University of Limerick; University of Amsterdam; National Institute of Standards & Technology (NIST) - USA; King Abdullah University of Science & Technology; University of Texas System; University of Texas at San Antonio (UTSA)	Xing, HB (corresponding author), Zhejiang Univ, Coll Chem & Biol Engn, Minist Educ, Key Lab Biomass Chem Engn, Hangzhou 310027, Zhejiang, Peoples R China.; Zaworotko, MJ (corresponding author), Univ Limerick, Dept Chem & Environm Sci, Limerick, Ireland.; Chen, BL (corresponding author), Univ Texas San Antonio, Dept Chem, One UTSA Circle, San Antonio, TX 78249 USA.	xinghb@zju.edu.cn; michael.zaworotko@ul.ie; banglin.chen@utsa.edu	Xing, Huabin/Q-6750-2017; Han, Yu/GZA-9220-2022; Bao, Zongbi/AAI-2994-2020; Yang, Qiwei/D-9176-2019; Cui, Xili/L-1022-2017; Li, Bin/J-6124-2015; Han, Yu/N-2036-2015; Wu, Hui/C-6505-2008; Dong, Xinglong/AFX-5291-2022; Chen, Banglin/F-5461-2010; Krishna, Rajamani/A-1098-2012; Zhou, Wei/C-6504-2008; Yang, Qiwei/ABE-9241-2020; Zaworotko, Michael/A-7448-2009; Chen, KaiJie/A-1743-2016	Yang, Qiwei/0000-0002-6469-5126; Cui, Xili/0000-0002-5600-8402; Li, Bin/0000-0002-7774-5452; Han, Yu/0000-0003-1462-1118; Wu, Hui/0000-0003-0296-5204; Dong, Xinglong/0000-0001-6478-8819; Chen, Banglin/0000-0001-8707-8115; Krishna, Rajamani/0000-0002-4784-8530; Zhou, Wei/0000-0002-5461-3617; Zaworotko, Michael/0000-0002-1360-540X; Chen, KaiJie/0000-0001-7581-6571	National Natural Science Foundation of China [21222601, 21436010, 21476192]; Zhejiang Provincial Natural Science Foundation of China [LR13B060001]; Ten Thousand Talent Program of China; Welch Foundation [AX-1730]; King Abdullah Science and Technology University Office of Competitive Research Funds [URF/1/1672-01-01]; Science Foundation Ireland [13/RP/B2549]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Ten Thousand Talent Program of China; Welch Foundation(The Welch Foundation); King Abdullah Science and Technology University Office of Competitive Research Funds; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work is supported by the National Natural Science Foundation of China (grants 21222601, 21436010, and 21476192), Zhejiang Provincial Natural Science Foundation of China (grant LR13B060001), Ten Thousand Talent Program of China (to H.X.), the Welch Foundation (grant AX-1730), King Abdullah Science and Technology University Office of Competitive Research Funds (grant URF/1/1672-01-01), and the Science Foundation Ireland (award 13/RP/B2549 to M.Z.). We thank T. L. Hu, Y. F. Zhao, W. D. Shan, and M. D. Jiang for their help and arrangement of the breakthrough experiments; A. Kumar for help with sample characterization; and Z. G. Zhang and B. G. Su for discussions of the experiments. Metrical data for the solid-state structures of SIFSIX-2-Cu-i-C<INF>2</INF>D<INF>2</INF> and SIFSIX-1-Cu-C<INF>2</INF>D<INF>2</INF> are available free of charge from the Cambridge Crystallographic Data Centre under reference numbers CCDC 1471795 and 1471796.	Bloch ED, 2012, SCIENCE, V335, P1606, DOI 10.1126/science.1217544; Das MC, 2012, J AM CHEM SOC, V134, P8703, DOI 10.1021/ja302380x; Datta SJ, 2015, SCIENCE, V350, P302, DOI 10.1126/science.aab1680; Furukawa H, 2013, SCIENCE, V341, P974, DOI 10.1126/science.1230444; Hu TL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8328; Kitagawa S, 2015, ANGEW CHEM INT EDIT, V54, P10686, DOI 10.1002/anie.201503835; Krishna R, 2015, RSC ADV, V5, P52269, DOI 10.1039/c5ra07830j; Kumar A, 2015, ANGEW CHEM INT EDIT, V54, P14372, DOI 10.1002/anie.201506952; Li JR, 2009, CHEM SOC REV, V38, P1477, DOI 10.1039/b802426j; Lin QP, 2012, J AM CHEM SOC, V134, P784, DOI 10.1021/ja2092882; Ma SQ, 2008, J AM CHEM SOC, V130, P1012, DOI 10.1021/ja0771639; Mason JA, 2015, NATURE, V527, P357, DOI 10.1038/nature15732; Matsuda R, 2005, NATURE, V436, P238, DOI 10.1038/nature03852; Nguyen NTT, 2014, ANGEW CHEM INT EDIT, V53, P10645, DOI 10.1002/anie.201403980; Noro S, 2002, J AM CHEM SOC, V124, P2568, DOI 10.1021/ja0113192; Nugent P, 2013, NATURE, V495, P80, DOI 10.1038/nature11893; Peng Y, 2013, J AM CHEM SOC, V135, P11887, DOI 10.1021/ja4045289; Rosi NL, 2003, SCIENCE, V300, P1127, DOI 10.1126/science.1083440; Shekhah O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5228; Studt F, 2008, SCIENCE, V320, P1320, DOI 10.1126/science.1156660; Vaidhyanathan R, 2010, SCIENCE, V330, P650, DOI 10.1126/science.1194237; Walton KS, 2015, AICHE J, V61, P2757, DOI 10.1002/aic.14878; Wu HH, 2012, CHEM REV, V112, P836, DOI 10.1021/cr200216x; Yang SH, 2015, NAT CHEM, V7, P121, DOI 10.1038/nchem.2114; Zhang JP, 2009, J AM CHEM SOC, V131, P5516, DOI 10.1021/ja8089872; Zhang ZJ, 2014, ENERG ENVIRON SCI, V7, P2868, DOI 10.1039/c4ee00143e	26	802	822	72	1383	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2016	353	6295					141	144		10.1126/science.aaf2458	http://dx.doi.org/10.1126/science.aaf2458			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ4XP	27198674				2022-12-28	WOS:000379208400032
J	Kugel, S; Sebastian, C; Fitamant, J; Ross, KN; Saha, SK; Jain, E; Gladden, A; Arora, KS; Kato, Y; Rivera, MN; Ramaswamy, S; Sadreyev, RI; Goren, A; Deshpande, V; Bardeesy, N; Mostoslavsky, R				Kugel, Sita; Sebastian, Carlos; Fitamant, Julien; Ross, Kenneth N.; Saha, Supriya K.; Jain, Esha; Gladden, Adrianne; Arora, Kshitij S.; Kato, Yasutaka; Rivera, Miguel N.; Ramaswamy, Sridhar; Sadreyev, Ruslan I.; Goren, Alon; Deshpande, Vikram; Bardeesy, Nabeel; Mostoslavsky, Raul			SIRT6 Suppresses Pancreatic Cancer through Control of Lin28b	CELL			English	Article							HISTONE DEACETYLASE SIRT6; MESSENGER-RNA; DUCTAL ADENOCARCINOMA; STEM-CELLS; LET-7; EXPRESSION; MICRORNA; PROGRESSION; LIN-28; GENES	Chromatin remodeling proteins are frequently dysregulated in human cancer, yet little is known about how they control tumorigenesis. Here, we uncover an epigenetic program mediated by the NAD(+)-dependent histone deacetylase Sirtuin 6 (SIRT6) that is critical for suppression of pancreatic ductal adenocarcinoma (PDAC), one of the most lethal malignancies. SIRT6 inactivation accelerates PDAC progression and metastasis via upregulation of Lin28b, a negative regulator of the let-7 microRNA. SIRT6 loss results in histone hyperacetylation at the Lin28b promoter, Myc recruitment, and pronounced induction of Lin28b and downstream let-7 target genes, HMGA2, IGF2BP1, and IGF2BP3. This epigenetic program defines a distinct subset with a poor prognosis, representing 30%-40% of human PDAC, characterized by reduced SIRT6 expression and an exquisite dependence on Lin28b for tumor growth. Thus, we identify SIRT6 as an important PDAC tumor suppressor and uncover the Lin28b pathway as a potential therapeutic target in a molecularly defined PDAC subset.	[Kugel, Sita; Sebastian, Carlos; Fitamant, Julien; Ross, Kenneth N.; Saha, Supriya K.; Arora, Kshitij S.; Kato, Yasutaka; Rivera, Miguel N.; Ramaswamy, Sridhar; Deshpande, Vikram; Bardeesy, Nabeel; Mostoslavsky, Raul] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02114 USA; [Kugel, Sita; Sebastian, Carlos; Fitamant, Julien; Ross, Kenneth N.; Saha, Supriya K.; Jain, Esha; Ramaswamy, Sridhar; Bardeesy, Nabeel; Mostoslavsky, Raul] Harvard Univ, Sch Med, MGH Ctr Regenerat Med, Boston, MA 02114 USA; [Gladden, Adrianne; Goren, Alon] Broad Inst Harvard & MIT, BTL, Cambridge, MA 02142 USA; [Sadreyev, Ruslan I.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Sadreyev, Ruslan I.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Mostoslavsky, Raul] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Mostoslavsky, R (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02114 USA.; Mostoslavsky, R (corresponding author), Harvard Univ, Sch Med, MGH Ctr Regenerat Med, Boston, MA 02114 USA.; Mostoslavsky, R (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	rmostoslavsky@mgh.harvard.edu	Saha, Supriya/AAC-5365-2019; Jain, Esha/AAB-9234-2020; Sebastian, Carlos/CAG-6271-2022; Sebastian, Carlos/H-8014-2018	Jain, Esha/0000-0003-1201-2052; Sebastian, Carlos/0000-0001-6623-8028; Goren, Alon/0000-0001-5669-9357	NIH [CA175727-01, R21CA198109-01, P50CA1270003, P01 CA117969-07, R01 CA133557-05]; National Pancreas Foundation; Linda J. Verville Cancer Research Foundation; Canadian Institutes of Health Research; NCI Mentored Clinical Scientist Research Career Development Award [1K08CA194268-01]; DF/HCC GI SPORE Career Development Project Award [P50CA127003]; Department of Defense; Broad Institute SPARC (Scientific Projects to Accelerate Research and Collaboration) program; NATIONAL CANCER INSTITUTE [R21CA198109, P01CA117969, R01CA175727, K08CA194268, P50CA127003, R01CA133557] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Pancreas Foundation; Linda J. Verville Cancer Research Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NCI Mentored Clinical Scientist Research Career Development Award; DF/HCC GI SPORE Career Development Project Award; Department of Defense(United States Department of Defense); Broad Institute SPARC (Scientific Projects to Accelerate Research and Collaboration) program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Richard Gregory for the pBabe let-7g 7S21L mutant construct and members of the R.M. and N.B. labs for invaluable discussions and advise. We also thank Cyril Benes for all the human pancreatic cancer lines. This work was supported in part by NIH grants CA175727-01, R21CA198109-01 (to R.M.), P50CA1270003, P01 CA117969-07, and R01 CA133557-05, the National Pancreas Foundation (to R.M.), and the Linda J. Verville Cancer Research Foundation (to N.B.). R.M. is a Kristine and Bob Higgins MGH Research Scholar, a Warshaw Institute Fellow, a Howard Goodman Awardee, and the recipient of the Glenn Award for Research in Biological Mechanisms of Aging. N.B. holds the Gallagher Endowed Chair in Gastrointestinal Cancer Research. N.B. is a member of the Andrew Warshaw Institute for Pancreatic Cancer Research. S.K. is the recipient of a Canadian Institutes of Health Research postdoctoral fellowship. S.K.S. is supported by a NCI Mentored Clinical Scientist Research Career Development Award (1K08CA194268-01) and a DF/HCC GI SPORE Career Development Project Award (P50CA127003). C.S. is supported by the Visionary Postdoctoral Fellowship from the Department of Defense. A.G. is the recipient of the Broad Institute SPARC (Scientific Projects to Accelerate Research and Collaboration) program.	Badea L, 2008, HEPATO-GASTROENTEROL, V55, P2016; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Boyerinas B, 2008, CANCER RES, V68, P2587, DOI 10.1158/0008-5472.CAN-08-0264; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; de Vries NA, 2015, CELL REP, V10, P383, DOI 10.1016/j.celrep.2014.12.028; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Funato K, 2014, SCIENCE, V346, P1529, DOI 10.1126/science.1253799; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; King CE, 2011, CANCER RES, V71, P4260, DOI 10.1158/0008-5472.CAN-10-4637; Kugel S, 2015, CELL REP, V13, P479, DOI 10.1016/j.celrep.2015.09.022; Lu LG, 2009, EUR J CANCER, V45, P2212, DOI 10.1016/j.ejca.2009.05.003; Marino S, 2000, GENE DEV, V14, P994; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Nguyen LH, 2014, CANCER CELL, V26, P248, DOI 10.1016/j.ccr.2014.06.018; Nielsen J, 2004, NUCLEIC ACIDS RES, V32, P4368, DOI 10.1093/nar/gkh754; Noubissi FK, 2006, NATURE, V441, P898, DOI 10.1038/nature04839; Park SM, 2007, CELL CYCLE, V6, P2585, DOI 10.4161/cc.6.21.4845; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Perez-Mancera PA, 2012, NATURE, V486, P266, DOI 10.1038/nature11114; Piscuoglio S, 2012, HISTOPATHOLOGY, V60, P397, DOI 10.1111/j.1365-2559.2011.04121.x; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Schaeffer DF, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-59; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Taniuchi K, 2014, ONCOTARGET, V5, P6832, DOI 10.18632/oncotarget.2257; Thakur A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-11; Thornton JE, 2012, TRENDS CELL BIOL, V22, P474, DOI 10.1016/j.tcb.2012.06.001; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wagner M, 2003, GASTROENTEROLOGY, V124, P1901, DOI 10.1016/S0016-5085(03)00402-5; Yang DH, 2003, GENE EXPR PATTERNS, V3, P719, DOI 10.1016/S1567-133X(03)00140-6; Yantiss RK, 2005, AM J SURG PATHOL, V29, P188, DOI 10.1097/01.pas.0000149688.98333.54; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zhang G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031507; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	50	174	179	3	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2016	165	6					1401	1415		10.1016/j.cell.2016.04.033	http://dx.doi.org/10.1016/j.cell.2016.04.033			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DN4NV	27180906	Green Accepted, Bronze			2022-12-28	WOS:000377045400014
J	Seo, D; Southard, KM; Kim, JW; Lee, HJ; Farlow, J; Lee, JU; Litt, DB; Haas, T; Alivisatos, AP; Cheon, J; Gartner, ZJ; Jun, YW				Seo, Daeha; Southard, Kaden M.; Kim, Ji-wook; Lee, Hyun Jung; Farlow, Justin; Lee, Jung-uk; Litt, David B.; Haas, Thomas; Alivisatos, A. Paul; Cheon, Jinwoo; Gartner, Zev J.; Jun, Young-wook			A Mechanogenetic Toolkit for Interrogating Cell Signaling in Space and Time	CELL			English	Article							MOLECULE FORCE SPECTROSCOPY; LIVING CELLS; MAGNETIC NANOPARTICLES; SPATIOTEMPORAL CONTROL; NOTCH; ACTIVATION; DNA; NUCLEATION; ADHESION; CATENIN	Tools capable of imaging and perturbing mechanical signaling pathways with fine spatiotemporal resolution have been elusive, despite their importance in diverse cellular processes. The challenge in developing a mechanogenetic toolkit (i.e., selective and quantitative activation of genetically encoded mechanoreceptors) stems from the fact that many mechanically activated processes are localized in space and time yet additionally require mechanical loading to become activated. To address this challenge, we synthesized magnetoplasmonic nanoparticles that can image, localize, and mechanically load targeted proteins with high spatiotemporal resolution. We demonstrate their utility by investigating the cell-surface activation of two mechanoreceptors: Notch and E-cadherin. By measuring cellular responses to a spectrum of spatial, chemical, temporal, and mechanical inputs at the single-molecule and single-cell levels, we reveal how spatial segregation and mechanical force cooperate to direct receptor activation dynamics. This generalizable technique can be used to control and understand diverse mechanosensitive processes in cell signaling.	[Seo, Daeha; Southard, Kaden M.; Lee, Hyun Jung; Haas, Thomas; Jun, Young-wook] Univ Calif San Francisco, Dept Otolaryngol, San Francisco, CA 94115 USA; [Seo, Daeha; Litt, David B.; Alivisatos, A. Paul] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Seo, Daeha; Litt, David B.; Alivisatos, A. Paul] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Seo, Daeha; Litt, David B.; Alivisatos, A. Paul] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Seo, Daeha; Litt, David B.; Alivisatos, A. Paul] Univ Calif Berkeley, Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA; [Seo, Daeha; Litt, David B.; Alivisatos, A. Paul] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Southard, Kaden M.; Farlow, Justin; Gartner, Zev J.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Southard, Kaden M.; Gartner, Zev J.; Jun, Young-wook] Univ Calif San Francisco, Chem & Chem Biol Grad Program, San Francisco, CA 94158 USA; [Kim, Ji-wook; Lee, Jung-uk; Cheon, Jinwoo; Jun, Young-wook] Inst for Basic Sci Korea, Ctr Nanomed, Seoul 03722, South Korea; [Kim, Ji-wook; Lee, Jung-uk; Cheon, Jinwoo; Jun, Young-wook] Yonsei Univ, Yonsei IBS Inst, Seoul 03722, South Korea; [Kim, Ji-wook; Lee, Jung-uk; Cheon, Jinwoo] Yonsei Univ, Dept Chem, Seoul 03722, South Korea; [Farlow, Justin] Univ Calif San Francisco, Tetrad Grad Program, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Institute for Basic Science - Korea (IBS); Institute for Basic Science - Korea (IBS); Yonsei University; Yonsei University; University of California System; University of California San Francisco	Jun, YW (corresponding author), Univ Calif San Francisco, Dept Otolaryngol, San Francisco, CA 94115 USA.; Gartner, ZJ (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA.; Gartner, ZJ; Jun, YW (corresponding author), Univ Calif San Francisco, Chem & Chem Biol Grad Program, San Francisco, CA 94158 USA.; Jun, YW (corresponding author), Inst for Basic Sci Korea, Ctr Nanomed, Seoul 03722, South Korea.; Jun, YW (corresponding author), Yonsei Univ, Yonsei IBS Inst, Seoul 03722, South Korea.	zev.gartner@ucsf.edu; young-wook.jun@ucsf.edu	Alivisatos, Paul/N-8863-2015	Alivisatos, Paul/0000-0001-6895-9048; gartner, zev/0000-0001-7803-1219; Jun, Young-wook/0000-0003-3182-5366; Southard, Kaden/0000-0002-5017-0687; Kim, Ji-wook/0000-0002-3781-5321; Seo, Daeha/0000-0002-0454-1168	National Institute of General Medical Science (NIGMS) [1R01GM112081-01]; UCSF/UCB/LBNL BRAINseed award; National Institute of Biomedical Imaging and Bioengineering [1R21EB015088-01]; National Institute of Child Health and Human Development [DP2 HD080351-01]; NIGMS UCSF Center for Synthetic and Systems Biology [P50 GM081879]; Human Frontier Science Program Fellowship; IBS [IBS-R026-D1]; National Creative Research Initiatives Program [2010-0018286]; Korea Healthcare Technology RD Project [HI08C2149]; King Abdulaziz City for Science and Technology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP2HD080351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB015088, R21EB018044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081879, T32GM066698, T32GM064337, R01GM112081] Funding Source: NIH RePORTER	National Institute of General Medical Science (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); UCSF/UCB/LBNL BRAINseed award; National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS UCSF Center for Synthetic and Systems Biology; Human Frontier Science Program Fellowship(Human Frontier Science Program); IBS; National Creative Research Initiatives Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Healthcare Technology RD Project; King Abdulaziz City for Science and Technology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank S. Blacklow (Harvard University) for the generous gift of Notch plasmids, Y. J. Lim for magnetic nanoparticle synthesis, and the Marvell Nanofabrication Laboratory for use of electron microscope facilities. This work was supported by grant 1R01GM112081-01 from the National Institute of General Medical Science (NIGMS) (Y.J.), a UCSF/UCB/LBNL BRAINseed award (Y.J.), grant 1R21EB015088-01 from the National Institute of Biomedical Imaging and Bioengineering (Z.J.G. and Y.J.), grant DP2 HD080351-01 from the National Institute of Child Health and Human Development (Z.J.G.), grant P50 GM081879 from the NIGMS UCSF Center for Synthetic and Systems Biology (Z.J.G.), a Human Frontier Science Program Fellowship (D.S.), grant IBS-R026-D1 from IBS (J.C. and Y.J.), grant 2010-0018286 from the National Creative Research Initiatives Program (J.C.), grant HI08C2149 from the Korea Healthcare Technology R&D Project (J.C.), and a grant from King Abdulaziz City for Science and Technology (A.P.A.).	Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Bharde AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068879; Biswas KH, 2015, P NATL ACAD SCI USA, V112, P10932, DOI 10.1073/pnas.1513775112; Buckley CD, 2014, SCIENCE, V346, P600, DOI 10.1126/science.1254211; Cho MH, 2012, NAT MATER, V11, P1038, DOI [10.1038/NMAT3430, 10.1038/nmat3430]; Cocco S, 2001, P NATL ACAD SCI USA, V98, P8608, DOI 10.1073/pnas.151257598; Dufrene YF, 2011, NAT METHODS, V8, P123, DOI 10.1038/nmeth0211-123; Engl W, 2014, NAT CELL BIOL, V16, P584, DOI 10.1038/ncb2973; Etoc F, 2013, NAT NANOTECHNOL, V8, P193, DOI [10.1038/NNANO.2013.23, 10.1038/nnano.2013.23]; Farlow J, 2013, NAT METHODS, V10, P1203, DOI [10.1038/NMETH.2682, 10.1038/nmeth.2682]; Gavard J, 2004, J CELL SCI, V117, P257, DOI 10.1242/jcs.00857; Gay G., 2014, SEGMENTING NUCL SKIM; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; Gordon WR, 2015, DEV CELL, V33, P729, DOI 10.1016/j.devcel.2015.05.004; Ho D, 2009, BIOPHYS J, V97, P3158, DOI 10.1016/j.bpj.2009.09.040; Hoffmann C, 2013, NAT NANOTECHNOL, V8, P199, DOI [10.1038/NNANO.2012.246, 10.1038/nnano.2012.246]; Iskratsch T, 2014, NAT REV MOL CELL BIO, V15, P825, DOI 10.1038/nrm3903; Jang JT, 2009, ANGEW CHEM INT EDIT, V48, P1234, DOI 10.1002/anie.200805149; Khait I, 2016, CELL REP, V14, P225, DOI 10.1016/j.celrep.2015.12.040; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Ladoux B, 2010, BIOPHYS J, V98, P534, DOI 10.1016/j.bpj.2009.10.044; Lecuit T, 2015, NAT CELL BIOL, V17, P533, DOI 10.1038/ncb3136; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Liu Z, 2016, NAT METHODS, V13, P143, DOI [10.1038/NMETH.3689, 10.1038/nmeth.3689]; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Mannix RJ, 2008, NAT NANOTECHNOL, V3, P36, DOI 10.1038/nnano.2007.418; Miesenbock G, 2009, SCIENCE, V326, P395, DOI 10.1126/science.1174520; Mosayebi M, 2015, ACS NANO, V9, P11993, DOI 10.1021/acsnano.5b04726; Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218; Peng X, 2010, J CELL SCI, V123, P567, DOI 10.1242/jcs.056432; Rakshit S, 2014, PHYS CHEM CHEM PHYS, V16, P2211, DOI 10.1039/c3cp53963f; Sniadecki NJ, 2007, P NATL ACAD SCI USA, V104, P14553, DOI 10.1073/pnas.0611613104; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Stephenson NL, 2012, P NATL ACAD SCI USA, V109, pE2757, DOI 10.1073/pnas.1205788109; Toettcher JE, 2011, NAT METHODS, V8, P35, DOI [10.1038/nmeth.f.326, 10.1038/NMETH.F.326]; Tseng P, 2012, NAT METHODS, V9, P1113, DOI [10.1038/NMETH.2210, 10.1038/nmeth.2210]; van Roy F, 2014, NAT REV CANCER, V14, P121, DOI 10.1038/nrc3647; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wang H, 2007, ACCOUNTS CHEM RES, V40, P53, DOI 10.1021/ar0401045; Wang XF, 2013, SCIENCE, V340, P991, DOI 10.1126/science.1231041; Weber RJ, 2014, BIOMACROMOLECULES, V15, P4621, DOI 10.1021/bm501467h; Wu SK, 2014, NAT CELL BIOL, V16, P167, DOI 10.1038/ncb2900; Yao MX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5525	43	106	107	8	90	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2016	165	6					1507	1518		10.1016/j.cell.2016.04.045	http://dx.doi.org/10.1016/j.cell.2016.04.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DN4NV	27180907	Green Accepted, Green Published, Green Submitted, Bronze			2022-12-28	WOS:000377045400022
J	Kovac, M				Kovac, Mirko			Learning from nature how to land aerial robots	SCIENCE			English	Editorial Material							MANEUVERS		[Kovac, Mirko] Univ London Imperial Coll Sci Technol & Med, Dept Aeronaut, Aerial Robot Lab, London SW7 2AZ, England	Imperial College London	Kovac, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Aeronaut, Aerial Robot Lab, London SW7 2AZ, England.	m.kovac@imperial.ac.uk	Siddall, Robert/H-7680-2019	Siddall, Robert/0000-0002-2151-2860; Kovac, Mirko/0000-0002-9720-2463	Engineering and Physical Sciences Research Council [EP/N009061/1, 1676886, 1531698, EP/K503733/1, EP/N018494/1] Funding Source: researchfish; EPSRC [EP/N018494/1, EP/N009061/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Aoyama Y, 2012, BIODIVERS CONSERV, V21, P2787, DOI 10.1007/s10531-012-0336-9; Braithwaite A., SPIDER INSPIRED CONS; Carruthers AC, 2010, AERONAUT J, V114, P673, DOI 10.1017/S0001924000004152; Evangelista C, 2010, J EXP BIOL, V213, P262, DOI 10.1242/jeb.037465; Floreano D, 2015, NATURE, V521, P460, DOI 10.1038/nature14542; Graule MA, 2016, SCIENCE, V352, P978, DOI 10.1126/science.aaf1092; HUMPHREY JAC, 1987, OECOLOGIA, V73, P469, DOI 10.1007/BF00385267; HYZER WG, 1962, SCIENCE, V137, P609, DOI 10.1126/science.137.3530.609; Kovac M, 2009, J MICRO-BIO ROBOT, V5, P77, DOI 10.1007/s12213-010-0026-1; LEE DN, 1993, J EXP BIOL, V180, P85; Lussier Desbiens A, 2011, INT J ROBOT RES, V30, P355, DOI 10.1177/0278364910393286; QUINN TH, 1990, ZOOMORPHOLOGY, V109, P281, DOI 10.1007/BF00312195; Schneider JM, 2001, J ARACHNOL, V29, P114, DOI 10.1636/0161-8202(2001)029[0114:DOSDAE]2.0.CO;2	13	38	40	2	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2016	352	6288			SI		895	896		10.1126/science.aaf6605	http://dx.doi.org/10.1126/science.aaf6605			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM2AK	27199404				2022-12-28	WOS:000376147800019
J	McDonnell, MJ; MacGregor-Fors, I				McDonnell, Mark J.; MacGregor-Fors, Ian			The ecological future of cities	SCIENCE			English	Editorial Material							URBAN; DIVERSITY	The discipline of urban ecology arose in the 1990s, primarily motivated by a widespread interest in documenting the distribution and abundance of animals and plants in cities. Today, urban ecologists have greatly expanded their scope of study to include ecological and socioeconomic processes, urban management, planning, and design, with the goal of addressing issues of sustainability, environmental quality, and human well-being within cities and towns. As the global pace of urbanization continues to intensify, urban ecology provides the ecological and social data, as well as the principles, concepts and tools, to create livable cities.	[McDonnell, Mark J.] Univ Melbourne, Australian Res Ctr Urban Ecol, Royal Bot Gardens Victoria, Melbourne, Vic 3010, Australia; [McDonnell, Mark J.] Univ Melbourne, Sch Biosci, Melbourne, Vic 3010, Australia; [MacGregor-Fors, Ian] Inst Ecol AC INECOL, Red Ambiente & Sustentabilidad, Carretera Antigua Coatepec 351, Xalapa 91070, Veracruz, Mexico	University of Melbourne; University of Melbourne; Instituto de Ecologia - Mexico	McDonnell, MJ (corresponding author), Univ Melbourne, Australian Res Ctr Urban Ecol, Royal Bot Gardens Victoria, Melbourne, Vic 3010, Australia.; McDonnell, MJ (corresponding author), Univ Melbourne, Sch Biosci, Melbourne, Vic 3010, Australia.; MacGregor-Fors, I (corresponding author), Inst Ecol AC INECOL, Red Ambiente & Sustentabilidad, Carretera Antigua Coatepec 351, Xalapa 91070, Veracruz, Mexico.	markmc@unimelb.edu.au; ian.macgregor@inecol.mx	MacGregor-Fors, Ian/P-1455-2014	MacGregor-Fors, Ian/0000-0003-3198-7322; McDonnell, Mark J./0000-0002-7937-6566				Aronson MFJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3330; Cheptou PO, 2008, P NATL ACAD SCI USA, V105, P3796, DOI 10.1073/pnas.0708446105; Douglas Ian, 2015, URB EC INTRO; Felson AJ, 2013, FRONT ECOL ENVIRON, V11, P362, DOI 10.1890/130061; Hahs AK, 2009, ECOL LETT, V12, P1165, DOI 10.1111/j.1461-0248.2009.01372.x; Hope D, 2003, P NATL ACAD SCI USA, V100, P8788, DOI 10.1073/pnas.1537557100; MacGregor-Fors I, 2013, ECOLOGIA URBANA EXPE; McDonnell MJ, 2015, ANNU REV ECOL EVOL S, V46, P261, DOI 10.1146/annurev-ecolsys-112414-054258; McDonnell MJ, 2013, URBAN ECOSYST, V16, P397, DOI 10.1007/s11252-013-0315-2; McDonnell MJ, 2011, URBAN ECOLOGY: PATTERNS, PROCESSES, AND APPLICATIONS, P5; Pickett STA, 2011, J ENVIRON MANAGE, V92, P331, DOI 10.1016/j.jenvman.2010.08.022; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; Sol D, 2014, ECOL LETT, V17, P942, DOI 10.1111/ele.12297; UN-Habitat (United Nations Human Settlements Programme), 2008, STAT WORLD CIT 2008; United Nations, 2014, REV WORLD URB PROSP; von der Lippe M, 2005, ERDE, V136, P123	16	123	134	16	235	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2016	352	6288			SI		936	938		10.1126/science.aaf3630	http://dx.doi.org/10.1126/science.aaf3630			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM2AK	27199416				2022-12-28	WOS:000376147800033
J	Feinmann, J				Feinmann, Jane			Clean cut surgery	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jane@janefeinmann.com						Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; de Vries EN, 2010, NEW ENGL J MED, V363, P1928, DOI 10.1056/NEJMsa0911535	2	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 18	2016	353								i2686	10.1136/bmj.i2686	http://dx.doi.org/10.1136/bmj.i2686			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GC	27193459				2022-12-28	WOS:000376447600004
J	Prescott, HC; Osterholzer, JJ; Langa, KM; Angus, DC; Iwashyna, TJ				Prescott, Hallie C.; Osterholzer, John J.; Langa, Kenneth M.; Angus, Derek C.; Iwashyna, Theodore J.			Late mortality after sepsis: propensity matched cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LONG-TERM; COMORBIDITY INDEX; HEALTH; SHOCK; CONSEQUENCES; DEFINITIONS; POPULATION; SURVIVAL; CARE	OBJECTIVES To determine whether late mortality after sepsis is driven predominantly by pre-existing comorbid disease or is the result of sepsis itself. DEIGN Observational cohort study. SETTING US Health and Retirement Study. PARTICIPANTS 960 patients aged = 65 (1998-2010) with fee-for-service Medicare coverage who were admitted to hospital with sepsis. Patients were matched to 777 adults not currently in hospital, 788 patients admitted with non-sepsis infection, and 504 patients admitted with acute sterile inflammatory conditions. MAIN OUTCOME MEASURES Late (31 days to two years) mortality and odds of death at various intervals. RESULTS Sepsis was associated with a 22.1% (95% confidence interval 17.5% to 26.7%) absolute increase in late mortality relative to adults not in hospital, a 10.4% (5.4% to 15.4%) absolute increase relative to patients admitted with non-sepsis infection, and a 16.2% (10.2% to 22.2%) absolute increase relative to patients admitted with sterile inflammatory conditions (P < 0.001 for each comparison). Mortality remained higher for at least two years relative to adults not in hospital. CONCLUSIONS More than one in five patients who survives sepsis has a late death not explained by health status before sepsis.	[Prescott, Hallie C.; Osterholzer, John J.; Langa, Kenneth M.; Iwashyna, Theodore J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Prescott, Hallie C.; Langa, Kenneth M.; Iwashyna, Theodore J.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Prescott, Hallie C.; Langa, Kenneth M.; Iwashyna, Theodore J.] VA Ctr Clin Management Res, Hlth Serv Res & Dev Ctr Innovat, Ann Arbor, MI USA; [Prescott, Hallie C.; Osterholzer, John J.; Iwashyna, Theodore J.] Vet Affairs Ann Arbor Healthcare Syst, Pulm Sect, Med Serv, Ann Arbor, MI USA; [Langa, Kenneth M.; Iwashyna, Theodore J.] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [Angus, Derek C.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Clin Res Invest & Syst Modeling Acute Illness CRI, Pittsburgh, PA USA; [Iwashyna, Theodore J.] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Monash University	Prescott, HC (corresponding author), Univ Michigan, 2800 Plymouth Rd,North Campus Res Ctr,Bldg 16, Ann Arbor, MI 48109 USA.	hprescot@med.umich.edu	Angus, Derek C/E-9671-2012	Prescott, Hallie/0000-0002-8442-6724; Langa, Kenneth/0000-0002-2798-1836	National Institutes of Health [T32 HL007749, L30 GM116118, K08 GM115859]; US Department of Veterans Affairs Health Services Research and Development Service [IIR 11-109]; National Institute on Aging [U01 AG009740]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM115859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG009740] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Veterans Affairs Health Services Research and Development Service(US Department of Veterans Affairs); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants T32 HL007749 (HCP), L30 GM116118 (HCP), and K08 GM115859 (HCP) from the National Institutes of Health and IIR 11-109 (TJI) from the US Department of Veterans Affairs Health Services Research and Development Service. The Health and Retirement Study is sponsored by the National Institute on Aging (U01 AG009740) and performed at the Institute for Social Research, University of Michigan. The funders were not involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the US government.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Benjamim CF, 2003, AM J PATHOL, V163, P2605, DOI 10.1016/S0002-9440(10)63615-2; Benjamin CF, 2004, J LEUKOCYTE BIOL, V75, P408, DOI 10.1189/jlb.0503214; BONE RC, 1992, CHEST, V101, P1481, DOI 10.1378/chest.101.6.1481; Carson WF, 2011, EPIGENETICS-US, V6, P273, DOI 10.4161/epi.6.3.14017; Cavassani KA, 2010, BLOOD, V115, P4403, DOI 10.1182/blood-2009-09-241083; Clermont G, 2002, CHEST, V121, P1963, DOI 10.1378/chest.121.6.1963; Davis JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112224; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Deng JC, 2006, J CLIN INVEST, V116, P2532, DOI 10.1172/JCI28054; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Fiscella K, 1997, BRIT MED J, V314, P1724, DOI 10.1136/bmj.314.7096.1724; Funk MJ, 2011, AM J EPIDEMIOL, V173, P761, DOI 10.1093/aje/kwq439; Garland A, 2014, INTENS CARE MED, V40, P1097, DOI 10.1007/s00134-014-3348-y; Ghelani D, 2009, J EVAL CLIN PRACT, V15, P425, DOI 10.1111/j.1365-2753.2008.01030.x; Iacus SM, 2009, J STAT SOFTW, V30, P1; Inouye SK, 1998, JAMA-J AM MED ASSOC, V279, P1187, DOI 10.1001/jama.279.15.1187; Iwashyna TJ, 2014, MED CARE, V52, pE39, DOI 10.1097/MLR.0b013e318268ac86; Iwashyna TJ, 2012, J AM GERIATR SOC, V60, P1070, DOI 10.1111/j.1532-5415.2012.03989.x; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Kaynar AM, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0469-1; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Leibovici L, 2013, CLIN MICROBIOL INFEC, V19, P510, DOI 10.1111/1469-0691.12160; Levy H, 2009, DOCUMENTATION BENCHM; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Linder A, 2014, CRIT CARE MED, V42, P2211, DOI 10.1097/CCM.0000000000000503; Meijer E, 2013, REPRESENTATIVENESS L; Miilunpalo S, 1997, J CLIN EPIDEMIOL, V50, P517, DOI 10.1016/S0895-4356(97)00045-0; Miller RR, 2013, AM J RESP CRIT CARE, V188, P77, DOI 10.1164/rccm.201212-2199OC; Ofstedal MB, 2011, GERONTOLOGIST, V51, pS8, DOI 10.1093/geront/gnq100; Prescott HC, 2015, AM J RESP CRIT CARE, V192, P581, DOI 10.1164/rccm.201503-0483OC; Prescott HC, 2015, CRIT CARE MED, V43, P1368, DOI 10.1097/CCM.0000000000000970; Quartin AA, 1997, JAMA-J AM MED ASSOC, V277, P1058, DOI 10.1001/jama.277.13.1058; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Shankar-Hari M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1276-7; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sonnega A, 2014, INT J EPIDEMIOL, V43, P576, DOI 10.1093/ije/dyu067; Stevenson EK, 2014, CRIT CARE MED, V42, P625, DOI 10.1097/CCM.0000000000000026; Wang HE, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004283; Yende S, 2008, AM J RESP CRIT CARE, V177, P1242, DOI 10.1164/rccm.200712-1777OC	40	183	187	2	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 17	2016	353								i2375	10.1136/bmj.i2375	http://dx.doi.org/10.1136/bmj.i2375			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GO	27189000	Green Published, hybrid			2022-12-28	WOS:000376448900002
J	Damen, JAAG; Hooft, L; Schuit, E; Debray, TPA; Collins, GS; Tzoulaki, I; Lassale, CM; Siontis, GCM; Chiocchia, V; Roberts, C; Schlussel, MM; Gerry, S; Black, JA; Heus, P; van der Schouw, YT; Peelen, LM; Moons, KGM				Damen, Johanna A. A. G.; Hooft, Lotty; Schuit, Ewoud; Debray, Thomas P. A.; Collins, Gary S.; Tzoulaki, Ioanna; Lassale, Camille M.; Siontis, George C. M.; Chiocchia, Virginia; Roberts, Corran; Schlussel, Michael Maia; Gerry, Stephen; Black, James A.; Heus, Pauline; van der Schouw, Yvonne T.; Peelen, Linda M.; Moons, Karel G. M.			Prediction models for cardiovascular disease risk in the general population: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CORONARY-HEART-DISEASE; INDIVIDUAL PARTICIPANT DATA; EXTERNAL VALIDATION; DYNAMIC PREDICTION; PROGNOSTIC MODELS; DIAGNOSIS TRIPOD; 10-YEAR RISK; SCORE; METAANALYSIS; DERIVATION	OBJECTIVE To provide an overview of prediction models for risk of cardiovascular disease (CVD) in the general population. DESIGN Systematic review. DATA SOURCES Medline and Embase until June 2013. ELIGIBILITY CRITERIA FOR STUDY SELECTION Studies describing the development or external validation of a multivariable model for predicting CVD risk in the general population. RESULTS 9965 references were screened, of which 212 articles were included in the review, describing the development of 363 prediction models and 473 external validations. Most models were developed in Europe (n=167, 46%), predicted risk of fatal or non-fatal coronary heart disease (n=118, 33%) over a 10 year period (n=209, 58%). The most common predictors were smoking (n=325, 90%) and age (n=321, 88%), and most models were sex specific (n=250, 69%). Substantial heterogeneity in predictor and outcome definitions was observed between models, and important clinical and methodological information were often missing. The prediction horizon was not specified for 49 models (13%), and for 92 (25%) crucial information was missing to enable the model to be used for individual risk prediction. Only 132 developed models (36%) were externally validated and only 70 (19%) by independent investigators. Model performance was heterogeneous and measures such as discrimination and calibration were reported for only 65% and 58% of the external validations, respectively. CONCLUSIONS There is an excess of models predicting incident CVD in the general population. The usefulness of most of the models remains unclear owing to methodological shortcomings, incomplete presentation, and lack of external validation and model impact studies. Rather than developing yet another similar CVD risk prediction model, in this era of large datasets, future research should focus on externally validating and comparing head-to-head promising CVD risk models that already exist, on tailoring or even combining these models to local settings, and investigating whether these models can be extended by addition of new predictors.	[Damen, Johanna A. A. G.; Hooft, Lotty; Schuit, Ewoud; Debray, Thomas P. A.; van der Schouw, Yvonne T.; Peelen, Linda M.; Moons, Karel G. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Damen, Johanna A. A. G.; Hooft, Lotty; Schuit, Ewoud; Debray, Thomas P. A.; Heus, Pauline; Moons, Karel G. M.] Univ Med Ctr Utrecht, Cochrane Netherlands, POB 85500,Str 6-131, NL-3508 GA Utrecht, Netherlands; [Schuit, Ewoud] Stanford Univ, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Collins, Gary S.; Chiocchia, Virginia; Roberts, Corran; Schlussel, Michael Maia; Gerry, Stephen] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Oxford, England; [Tzoulaki, Ioanna; Lassale, Camille M.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Siontis, George C. M.] Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland; [Chiocchia, Virginia] Univ Oxford, Surg Intervent Trials Unit, Oxford, England; [Black, James A.] Univ Cambridge, Sch Clin Med, MRC Epidemiol Unit, Cambridge, England	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Stanford University; University of Oxford; Imperial College London; University of Bern; University Hospital of Bern; University of Oxford; University of Cambridge	Damen, JAAG (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.; Damen, JAAG (corresponding author), Univ Med Ctr Utrecht, Cochrane Netherlands, POB 85500,Str 6-131, NL-3508 GA Utrecht, Netherlands.	j.a.a.damen@umcutrecht.nl	Collins, Gary Stephen/A-2258-2014; van der Schouw, Yvonne T./F-8327-2014; Debray, Thomas/J-7413-2012; Tzoulaki, Ioanna/ABE-6269-2020; Black, James A/A-5917-2010; Schuit, Ewoud/N-1869-2014; Lassale, Camille/ABE-7813-2020; Chiocchia, Virginia/H-8885-2019	Collins, Gary Stephen/0000-0002-2772-2316; van der Schouw, Yvonne T./0000-0002-4605-435X; Debray, Thomas/0000-0002-1790-2719; Tzoulaki, Ioanna/0000-0002-4275-9328; Black, James A/0000-0002-2200-3179; Schuit, Ewoud/0000-0002-9548-3214; Lassale, Camille/0000-0002-9340-2708; Chiocchia, Virginia/0000-0002-6196-3308; Gerry, Stephen/0000-0003-4654-7311	Netherlands Organization for Scientific Research [ZONMW 918.10.615, 91208004]; Dutch Heart Foundation; Cochrane Collaboration; MRC grant [G1100513]; European Union [279233]; Cancer Research UK [16895] Funding Source: researchfish; Medical Research Council [MC_UU_12015/4, MC_U106179474] Funding Source: researchfish; MRC [MC_UU_12015/4, MC_U106179474] Funding Source: UKRI	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Heart Foundation(Netherlands Heart Foundation); Cochrane Collaboration; MRC grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	KGMM, JAAGD, LH, ES, and TPAD were supported by various grants from The Netherlands Organization for Scientific Research, Dutch Heart Foundation, and the Cochrane Collaboration. KGMM received a grant from The Netherlands Organization for Scientific Research (ZONMW 918.10.615 and 91208004). GSC was supported by MRC grant G1100513. This project has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no. 279233. None of the funding sources had a role in the design, conduct, analyses, or reporting of the study or in the decision to submit the manuscript for publication.	Abbasi A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5900; Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P9; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; [Anonymous], 2014, LIP MOD CARD RISK AS; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Barzi F, 2007, J EPIDEMIOL COMMUN H, V61, P115, DOI 10.1136/jech.2005.044842; Beswick AD, 2008, SYSTEMATIC REV RIS S; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Chambless LE, 2003, J CLIN EPIDEMIOL, V56, P880, DOI 10.1016/S0895-4356(03)00055-6; Chien KL, 2012, INT J CARDIOL, V157, P263, DOI 10.1016/j.ijcard.2012.03.017; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.1016/j.jclinepi.2014.11.010, 10.7326/M14-0697, 10.1136/bmj.g7594, 10.1186/s12916-014-0241-z, 10.1016/j.eururo.2014.11.025, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Collins GS, 2013, J CLIN EPIDEMIOL, V66, P268, DOI 10.1016/j.jclinepi.2012.06.020; Collins GS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3186; Collins GS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-103; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Debray TPA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001886; Debray TPA, 2015, J CLIN EPIDEMIOL, V68, P280, DOI 10.1016/j.jclinepi.2014.06.018; Debray TPA, 2014, STAT MED, V33, P2341, DOI 10.1002/sim.6080; Debray TPA, 2013, STAT MED, V32, P3158, DOI 10.1002/sim.5732; Debray TPA, 2012, STAT MED, V31, P2697, DOI 10.1002/sim.5412; Eckel R. H., 2014, Journal of the American College of Cardiology, V63, P2960, DOI [10.1161/01.cir.0000437740.48606.d1, 10.1016/j.jacc.2013.11.003]; Ettema RGA, 2010, CIRCULATION, V122, P682, DOI 10.1161/CIRCULATIONAHA.109.926808; Friedland DR, 2009, LARYNGOSCOPE, V119, P473, DOI 10.1002/lary.20130; Gijsberts CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132321; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guo YR, 2016, BMC MED GENOMICS, V9, DOI 10.1186/s12920-016-0165-x; Hajifathalian K, 2015, LANCET DIABETES ENDO, V3, P339, DOI 10.1016/S2213-8587(15)00081-9; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6624; KEYS A, 1972, CIRCULATION, V45, P815, DOI 10.1161/01.CIR.45.4.815; Khan KS, 2014, AM J OBSTET GYNECOL, V211, P575, DOI 10.1016/j.ajog.2014.09.015; LEAVERTON PE, 1987, J CHRON DIS, V40, P775, DOI 10.1016/0021-9681(87)90129-9; LEVY D, 1990, AM HEART J, V119, P712, DOI 10.1016/S0002-8703(05)80050-X; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Matheny M, 2011, SYSTEMATIC REV CARDI; Moons KGM, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001744; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Nicolaie MA, 2013, STAT MED, V32, P2031, DOI 10.1002/sim.5665; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Royston P, 2004, STAT MED, V23, P907, DOI 10.1002/sim.1691; Royston P, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-33; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Sauerbrei W, 2011, STAT MED, V30, P3341, DOI 10.1002/sim.4333; Siontis GCM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3318; Snell KIE, 2016, J CLIN EPIDEMIOL, V69, P40, DOI 10.1016/j.jclinepi.2015.05.009; Steyerberg EW, 2004, STAT MED, V23, P2567, DOI 10.1002/sim.1844; Steyerberg EW, 2014, EUR HEART J, V35, P1925, DOI 10.1093/eurheartj/ehu207; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Steyerberg EW, 2012, EUR J CLIN INVEST, V42, P216, DOI 10.1111/j.1365-2362.2011.02562.x; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Teramukai S, 2016, HYPERTENS RES, V39, P113, DOI 10.1038/hr.2015.120; Usher-Smith Juliet A, 2015, BMJ Open, V5, pe008717, DOI 10.1136/bmjopen-2015-008717; van Dieren S, 2012, HEART, V98, P360, DOI 10.1136/heartjnl-2011-300734; van Klaveren D, 2015, J CLIN EPIDEMIOL, V68, P1366, DOI 10.1016/j.jclinepi.2015.02.012; Wessler BS, 2015, CIRC-CARDIOVASC QUAL, V8, P368, DOI 10.1161/CIRCOUTCOMES.115.001693; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Wolfson J, 2015, STAT MED, V34, P2941, DOI 10.1002/sim.6526; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167; Wu YF, 2006, CIRCULATION, V114, P2217, DOI 10.1161/CIRCULATIONAHA.105.607499	72	374	381	8	60	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 16	2016	353								i2416	10.1136/bmj.i2416	http://dx.doi.org/10.1136/bmj.i2416			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GB	27184143	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000376447500001
J	van der Marel, D				van der Marel, Dirk			Quasiparticles on a collision course	NATURE			English	Editorial Material							2-DIMENSIONAL SYSTEMS; SPIN FLUCTUATIONS; SUPERCONDUCTIVITY; UPT3		[van der Marel, Dirk] Univ Geneva, Dept Quantum Matter Phys, CH-1211 Geneva 4, Switzerland	University of Geneva	van der Marel, D (corresponding author), Univ Geneva, Dept Quantum Matter Phys, CH-1211 Geneva 4, Switzerland.	dirk.vandermarel@unige.ch	van der Marel, Dirk/G-4618-2012	van der Marel, Dirk/0000-0001-5266-9847				BEREZINSKII VL, 1971, SOV PHYS JETP-USSR, V32, P493; DEVISSER A, 1984, PHYSICA B & C, V127, P442, DOI 10.1016/S0378-4363(84)80072-8; Eagles DM, 1996, PHYS REV B, V54, P22, DOI 10.1103/PhysRevB.54.22; Kosterlitz JM, 1973, J PHYS C SOLID STATE, V6, P1181, DOI 10.1088/0022-3719/6/7/010; Langer F, 2016, NATURE, V533, P225, DOI 10.1038/nature17958; Mackenzie AP, 2003, REV MOD PHYS, V75, P657, DOI 10.1103/RevModPhys.75.657; STEWART GR, 1984, PHYS REV LETT, V52, P679, DOI 10.1103/PhysRevLett.52.679; van der Marel D, 2003, NATURE, V425, P271, DOI 10.1038/nature01978; van Mechelen JLM, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.226403	11	0	0	3	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					186	187		10.1038/533186a	http://dx.doi.org/10.1038/533186a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0BJ	27172042				2022-12-28	WOS:000376007200036
J	O'Brien, KL; Binka, F; Marsh, K; Abramson, JS				O'Brien, Katherine L.; Binka, Fred; Marsh, Kevin; Abramson, Jon S.			Mind the gap: jumping from vaccine licensure to routine use	LANCET			English	Editorial Material									[O'Brien, Katherine L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Int Vaccine Access Ctr, Baltimore, MD 21231 USA; [Binka, Fred] Univ Hlth & Allied Sci, Ho, Ghana; [Marsh, Kevin] African Acad Sci, Nairobi, Kenya; [Abramson, Jon S.] Wake Forest Univ, Bowman Gray Sch Med, Dept Paediat, Winston Salem, NC USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Wake Forest University; Wake Forest Baptist Medical Center	O'Brien, KL (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Int Vaccine Access Ctr, Baltimore, MD 21231 USA.	klobrien@jhu.edu		O'Brien, Katherine/0000-0002-0164-4030				Minsoko PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001685; Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P33; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P681; [Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; Christensen H, 2013, VACCINE, V31, P2638, DOI 10.1016/j.vaccine.2013.03.034; European Medicines Agency, 2015, SUMM OP MOSQ PLASM F; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Penny MA, 2016, LANCET, V387, P367, DOI 10.1016/S0140-6736(15)00725-4; Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8; WHO, 2015, GLOB TECHN STRAT MAL; WHO, 2015, WORLD MAL REP 2015	12	14	14	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2016	387	10031					1887	1889						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DL1EE	27203633				2022-12-28	WOS:000375374200008
J	Dreher, D; Pasakarnis, L; Brunner, D				Dreher, David; Pasakarnis, Laurynas; Brunner, Damian			SnapShot: Mechanical Forces in Development II	CELL			English	Editorial Material									[Dreher, David; Pasakarnis, Laurynas; Brunner, Damian] Univ Zurich, Dept Mol Life Sci, CH-8057 Zurich, Switzerland	University of Zurich	Dreher, D (corresponding author), Univ Zurich, Dept Mol Life Sci, CH-8057 Zurich, Switzerland.		Brunner, Damian/F-2024-2011	Brunner, Damian/0000-0001-5250-492X				Chanet S, 2014, PROG MOL BIOL TRANSL, V126, P317, DOI 10.1016/B978-0-12-394624-9.00013-0; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Eltsov M, 2015, NAT CELL BIOL, V17, P605, DOI 10.1038/ncb3159; Ivanovska IL, 2015, TRENDS CELL BIOL, V25, P523, DOI 10.1016/j.tcb.2015.04.003; Kondo T, 2013, NATURE, V494, P125, DOI 10.1038/nature11792; Kotak S, 2013, CURR OPIN CELL BIOL, V25, P741, DOI 10.1016/j.ceb.2013.07.008; LeGoff L, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a019232; Navis A, 2015, CURR OPIN GENET DEV, V32, P24, DOI 10.1016/j.gde.2015.01.010; Saias L, 2015, DEV CELL, V33, P611, DOI 10.1016/j.devcel.2015.03.016; Sirbuly DJ, 2015, REP PROG PHYS, V78, DOI 10.1088/0034-4885/78/2/024101	10	7	7	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2016	165	4					1028	U298		10.1016/j.cell.2016.04.060	http://dx.doi.org/10.1016/j.cell.2016.04.060			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DL7DN	27153501	Bronze			2022-12-28	WOS:000375800300028
J	Sun, LO; Barres, BA				Sun, Lu O.; Barres, Ben A.			Glia Get Neurons in Shape	CELL			English	Editorial Material							ASTROCYTES	Glial cells are essential components of the nervous system. In this issue, Singhvi et al. uncover cellular and molecular mechanisms through which C. elegans glia shape sensory neuron terminals and thus control animal thermosensing behaviors.	[Sun, Lu O.; Barres, Ben A.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Sun, LO (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	lsun2@stanford.edu	Sun, Lu O/P-9339-2015	Sun, Lu O/0000-0002-9293-7241				Chak K, 2014, DEVELOPMENT, V141, P136, DOI 10.1242/dev.095968; Chung WS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020370; Farmer WT, 2016, SCIENCE, V351, P849, DOI 10.1126/science.aab3103; Molofsky AV, 2014, NATURE, V509, P189, DOI 10.1038/nature13161; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Schmidt H, 2007, J CELL BIOL, V179, P331, DOI 10.1083/jcb.200707176; Shaham S, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020578; Singhvi A, 2016, CELL, V165, P936, DOI 10.1016/j.cell.2016.03.026; Stork T, 2014, NEURON, V83, P388, DOI 10.1016/j.neuron.2014.06.026; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013	10	4	4	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2016	165	4					775	776		10.1016/j.cell.2016.04.052	http://dx.doi.org/10.1016/j.cell.2016.04.052			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DL7DN	27153490	Bronze			2022-12-28	WOS:000375800300006
J	Van Cutsem, E; Sagaert, X; Topal, B; Haustermans, K; Prenen, H				Van Cutsem, Eric; Sagaert, Xavier; Topal, Baki; Haustermans, Karin; Prenen, Hans			Gastric cancer	LANCET			English	Review							RANDOMIZED PHASE-III; GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA; EPSTEIN-BARR-VIRUS; HELICOBACTER-PYLORI; DOUBLE-BLIND; OPEN-LABEL; PLUS CISPLATIN; 1ST-LINE THERAPY; SUPPORTIVE CARE; INTESTINAL-TYPE	Gastric cancer is one of the leading causes of cancer-related death worldwide. Many patients have inoperable disease at diagnosis or have recurrent disease after resection with curative intent. Gastric cancer is separated anatomically into true gastric adenocarcinomas and gastro-oesophageal-junction adenocarcinomas, and histologically into diffuse and intestinal types. Gastric cancer should be treated by teams of experts from different disciplines. Surgery is the only curative treatment. For locally advanced disease, adjuvant or neoadjuvant therapy is usually implemented in combination with surgery. In metastatic disease, outcomes are poor, with median survival being around 1 year. Targeted therapies, such as trastuzumab, an antibody against HER2 (also known as ERBB2), and the VEGFR-2 antibody ramucirumab, have been introduced. In this Seminar, we present an update of the causes, classification, diagnosis, and treatment of gastric cancer.	[Van Cutsem, Eric] Univ Hosp Gasthuisberg Leuven, Dept Gastroenterol Digest Oncol, Leuven, Belgium; [Sagaert, Xavier] Univ Hosp Gasthuisberg Leuven, Dept Pathol, Leuven, Belgium; [Topal, Baki] Univ Hosp Gasthuisberg Leuven, Dept Abdominal Surg, Leuven, Belgium; [Haustermans, Karin] Univ Hosp Gasthuisberg Leuven, Dept Radiat Oncol, Leuven, Belgium	KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven	Van Cutsem, E (corresponding author), Univ Hosp Leuven, Dept Gastroenterol Digest Oncol, Herestr 49, B-3000 Leuven, Belgium.	Eric.VanCutsem@uzleuven.be	Haustermans, Karin/AAB-5912-2021; Van+Cutsem, Eric/ABE-1762-2021; Topal, Baki/AAH-9019-2021	Haustermans, Karin/0000-0003-0364-682X; Topal, Baki/0000-0002-2687-7535; Prenen, Hans/0000-0001-8802-7352				Ajani JA, 2010, J CLIN ONCOL, V28, P1547, DOI 10.1200/JCO.2009.25.4706; AKIYAMA T, 1986, SCIENCE, V232, P1644, DOI 10.1126/science.3012781; Al-Batran SE, 2008, J CLIN ONCOL, V26, P1435, DOI 10.1200/JCO.2007.13.9378; Altini C, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000864; An JY, 2007, ANN SURG, V246, P749, DOI 10.1097/SLA.0b013e31811f3fb7; Bang YJ, 2010, LANCET, V376, P1302; Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Beghelli S, 2006, SURGERY, V139, P347, DOI 10.1016/j.surg.2005.08.021; Begnami MD, 2011, J CLIN ONCOL, V29, P3030, DOI 10.1200/JCO.2010.33.6313; Blair V, 2006, CLIN GASTROENTEROL H, V4, P262, DOI 10.1016/j.cgh.2005.12.003; Boku N, 2009, LANCET ONCOL, V10, P1063, DOI 10.1016/S1470-2045(09)70259-1; Bornschein J, 2010, DIGEST DIS SCI, V55, P3124, DOI 10.1007/s10620-010-1351-x; Bouche O, 2004, J CLIN ONCOL, V22, P4319, DOI 10.1200/JCO.2004.01.140; Carneiro F., 1997, CURR DIAGN PATHOL, V4, P51; Choi YY, 2013, J SURG ONCOL, V108, P550, DOI 10.1002/jso.23438; Chu QSC, 2004, CLIN CANCER RES, V10, P4913, DOI 10.1158/1078-0432.CCR-04-0469; Coccolini F, 2014, EJSO-EUR J SURG ONC, V40, P12, DOI 10.1016/j.ejso.2013.10.019; Colquhoun A, 2015, GUT, V64, P1881, DOI 10.1136/gutjnl-2014-308915; CORREA P, 1988, CANCER RES, V48, P3554; CULLINAN SA, 1994, J CLIN ONCOL, V12, P412, DOI 10.1200/JCO.1994.12.2.412; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Dank M, 2008, ANN ONCOL, V19, P1450, DOI 10.1093/annonc/mdn166; Demicco EG, 2011, MODERN PATHOL, V24, P1177, DOI 10.1038/modpathol.2011.77; Deng NT, 2012, GUT, V61, P673, DOI 10.1136/gutjnl-2011-301839; Dinis-Ribeiro M, 2012, ENDOSCOPY, V44, P74, DOI 10.1055/s-0031-1291491; Edge SB, 2010, AJCC CANC STAGING MA; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Enzinger PC, 2009, ANN ONCOL, V20, P475, DOI 10.1093/annonc/mdn658; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Ferro A, 2014, EUR J CANCER, V50, P1330, DOI 10.1016/j.ejca.2014.01.029; Fleisher AS, 1999, CANCER RES, V59, P1090; Ford HER, 2014, LANCET ONCOL, V15, P78, DOI 10.1016/S1470-2045(13)70549-7; Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Glimelius B, 1997, ANN ONCOL, V8, P163, DOI 10.1023/A:1008243606668; Gravalos C, 2008, ANN ONCOL, V19, P1523, DOI 10.1093/annonc/mdn169; Grundei T, 2000, CLIN CANCER RES, V6, P4782; Guimbaud R, 2014, J CLIN ONCOL, V32, P3520, DOI 10.1200/JCO.2013.54.1011; Gylling A, 2007, GUT, V56, P926, DOI 10.1136/gut.2006.114876; Hong YS, 2004, ANN ONCOL, V15, P1344, DOI 10.1093/annonc/mdh343; Ito M, 2009, J GASTROENTEROL, V44, P365, DOI 10.1007/s00535-009-0036-8; Jorgensen JT, 2010, ONCOLOGY-BASEL, V78, P26, DOI 10.1159/000288295; Kang JH, 2012, J CLIN ONCOL, V30, P1513, DOI 10.1200/JCO.2011.39.4585; Kaurah P, 2007, JAMA-J AM MED ASSOC, V297, P2360, DOI 10.1001/jama.297.21.2360; Kohne CH, 2003, BRIT J CANCER, V89, P997, DOI 10.1038/sj.bjc.6601226; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI 10.1016/S1470-2045(08)70035-4; Ladeiras-Lopes R, 2008, CANCER CAUSE CONTROL, V19, P689, DOI 10.1007/s10552-008-9132-y; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lauwers G., 2010, WHO CLASSIFICATION T, P44; Lee J, 2012, J CLIN ONCOL, V30, P268, DOI 10.1200/JCO.2011.39.1953; Lei ZD, 2013, GASTROENTEROLOGY, V145, P554, DOI 10.1053/j.gastro.2013.05.010; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Leung WK, 2004, GUT, V53, P1244, DOI 10.1136/gut.2003.034629; Ley C, 2004, CANCER EPIDEM BIOMAR, V13, P4, DOI 10.1158/1055-9965.EPI-03-0124; Lordick F, 2014, CANCER TREAT REV, V40, P692, DOI 10.1016/j.ctrv.2014.03.002; Lordick F, 2013, LANCET ONCOL, V14, P490, DOI 10.1016/S1470-2045(13)70102-5; Lunet N, 2007, EUR J CANCER PREV, V16, P312, DOI 10.1097/01.cej.0000236255.95769.22; Lutz M, 2007, J CLIN ONCOL, V25, P2850; Lutz MP, 2012, EUR J CANCER, V48, P2941, DOI 10.1016/j.ejca.2012.07.029; MACDONALD JS, 1980, ANN INTERN MED, V93, P533, DOI 10.7326/0003-4819-93-4-533; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Mavroudis D, 2000, AM J CLIN ONCOL-CANC, V23, P341, DOI 10.1097/00000421-200008000-00005; Mera R, 2005, GUT, V54, P1536, DOI 10.1136/gut.2005.072009; Mezhir JJ, 2011, INDIA J SURG ONCOL, V2, P16, DOI 10.1007/s13193-011-0074-6; Mocellin S, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009944.pub2; Moehler M, 2015, GASTRIC CANCER, V18, P550, DOI 10.1007/s10120-014-0403-x; MURAD AM, 1993, CANCER, V72, P37, DOI 10.1002/1097-0142(19930701)72:1<37::AID-CNCR2820720109>3.0.CO;2-P; Muro K, 2014, ANN ONCOL         S4, V25; NAKAMURA K, 1992, CANCER, V70, P1030, DOI 10.1002/1097-0142(19920901)70:5&lt;1030::AID-CNCR2820700504&gt;3.0.CO;2-C; Oba K, 2013, EUR J CANC; Ohtsu A, 2003, J CLIN ONCOL, V21, P54, DOI 10.1200/JCO.2003.04.130; Ohtsu A, 2013, J CLIN ONCOL, V31, P3935, DOI 10.1200/JCO.2012.48.3552; Ohtsu A, 2011, J CLIN ONCOL, V29, P3968, DOI 10.1200/JCO.2011.36.2236; Oliveira C, 2015, LANCET ONCOL, V16, pE60, DOI 10.1016/S1470-2045(14)71016-2; Ott K, 2003, CLIN CANCER RES, V9, P2307; Paoletti X, 2010, JAMA-J AM MED ASSOC, V303, P1729, DOI 10.1001/jama.2010.534; Park DI, 2006, DIGEST DIS SCI, V51, P1371, DOI 10.1007/s10620-005-9057-1; Pharoah PDP, 2001, GASTROENTEROLOGY, V121, P1348, DOI 10.1053/gast.2001.29611; Pohl H, 2010, CANCER EPIDEM BIOMAR, V19, P1468, DOI 10.1158/1055-9965.EPI-10-0012; Ruschoff J, 2010, VIRCHOWS ARCH, V457, P299, DOI 10.1007/s00428-010-0952-2; Sano T, 2004, J CLIN ONCOL, V22, P2767, DOI 10.1200/JCO.2004.10.184; Sasako M, 2006, LANCET ONCOL, V7, P644, DOI 10.1016/S1470-2045(06)70766-5; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Satoh T, 2014, J CLIN ONCOL, V32, P2039, DOI 10.1200/JCO.2013.53.6136; Shaw D, 2005, GUT, V54, P461, DOI 10.1136/gut.2004.049171; Siewert JR, 1998, BRIT J SURG, V85, P1457; Smalley SR, 2012, J CLIN ONCOL, V30, P2327, DOI 10.1200/JCO.2011.36.7136; Sobin L, 2009, TNM CLASSIFICATION M; Soerjomataram I, 2012, LANCET, V380, P1840, DOI 10.1016/S0140-6736(12)60919-2; Songun I, 2010, LANCET ONCOL, V11, P439, DOI 10.1016/S1470-2045(10)70070-X; SULKES A, 1994, BRIT J CANCER, V70, P380, DOI 10.1038/bjc.1994.310; Tan IB, 2011, GASTROENTEROLOGY, V141, P476, DOI 10.1053/j.gastro.2011.04.042; Tanner M, 2005, ANN ONCOL, V16, P273, DOI 10.1093/annonc/mdi064; Thuss-Patience PC, 2011, EUR J CANCER, V47, P2306, DOI 10.1016/j.ejca.2011.06.002; Van Cutsem E, 2015, ANN ONCOL, V26, P149, DOI 10.1093/annonc/mdu496; Van Cutsem E, 2011, ANN ONCOL, V22, pv1, DOI 10.1093/annonc/mdr284; Van Cutsem E, 2008, EUR J CANCER, V44, P182, DOI 10.1016/j.ejca.2007.11.001; Van Cutsem E, 2006, J CLIN ONCOL, V24, P4991, DOI 10.1200/JCO.2006.06.8429; Van Cutsem E, 2015, GASTRIC CANCER, V18, P476, DOI 10.1007/s10120-014-0402-y; Van Cutsem E, 2012, J CLIN ONCOL, V30, P2119, DOI 10.1200/JCO.2011.39.9824; Waddell T, 2013, ANN ONCOL, V24, P57, DOI 10.1093/annonc/mdt344; Waddell T, 2013, LANCET ONCOL, V14, P481, DOI 10.1016/S1470-2045(13)70096-2; Wagner AD, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004064.pub3; Wang F, 2014, CANCER LETT, V345, P196, DOI 10.1016/j.canlet.2013.08.016; Wang HH, 1999, HEPATO-GASTROENTEROL, V46, P1214; Webb A, 1997, J CLIN ONCOL, V15, P261, DOI 10.1200/JCO.1997.15.1.261; Wilke H, 2014, LANCET ONCOL, V15, P1224, DOI 10.1016/S1470-2045(14)70420-6; WILS JA, 1991, J CLIN ONCOL, V9, P827, DOI 10.1200/JCO.1991.9.5.827; Worthley DL, 2012, GUT, V61, P774, DOI 10.1136/gutjnl-2011-300348; Wu MS, 2000, GENE CHROMOSOME CANC, V27, P403, DOI 10.1002/(SICI)1098-2264(200004)27:4<403::AID-GCC10>3.3.CO;2-T; Wu MS, 2000, GASTROENTEROLOGY, V118, P1031, DOI 10.1016/S0016-5085(00)70355-6; Yang P, 2009, EUR J CANCER, V45, P2867, DOI 10.1016/j.ejca.2009.04.019; Ychou M, 2011, J CLIN ONCOL, V29, P1715, DOI 10.1200/JCO.2010.33.0597; Yoon HH, 2012, CLIN CANCER RES, V18, P546, DOI 10.1158/1078-0432.CCR-11-2272; You WC, 2006, JNCI-J NATL CANCER I, V98, P974, DOI 10.1093/jnci/djj264; Youn HG, 2010, ANN SURG ONCOL, V17, P448, DOI 10.1245/s10434-009-0772-2; Zeng YK, 2012, ANN SURG, V256, P39, DOI 10.1097/SLA.0b013e3182583e2e; Zouridis H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004504	120	1266	1274	25	355	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 26	2016	388	10060					2654	2664		10.1016/S0140-6736(16)30354-3	http://dx.doi.org/10.1016/S0140-6736(16)30354-3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ED0EW	27156933				2022-12-28	WOS:000388516800034
J	Temmerman, M				Temmerman, Marleen			Caesarean section surgical techniques: all equally safe	LANCET			English	Editorial Material									[Temmerman, Marleen] Aga Khan Univ, Dept Obstet & Gynaecol, Nairobi, Kenya; [Temmerman, Marleen] Univ Ghent, Fac Med & Hlth Sci, B-9000 Ghent, Belgium	Aga Khan University; Ghent University	Temmerman, M (corresponding author), Aga Khan Univ, Dept Obstet & Gynaecol, Nairobi, Kenya.; Temmerman, M (corresponding author), Univ Ghent, Fac Med & Hlth Sci, B-9000 Ghent, Belgium.	marleen.temmerman@ugent.be						[Anonymous], 2015, BBC NEWS; Arias CA, 2013, LANCET, V382, P234, DOI 10.1016/S0140-6736(13)60441-9; Bauserman M, 2015, REPROD HLTH S2, V12, P55; Betran AP, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0043-6; BETRAN AP, 2016, PLOS ONE, V11, DOI DOI 10.1371/JOURNAL.PONE.0148343; Gibbons L, 2010, GLOBAL NUMBERS COSTS; Signore C, 2008, CLIN PERINATOL, V35, P361, DOI 10.1016/j.clp.2008.03.009; Souza JP, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-71; The CORONIS collaborative group, 2016, LANCET	9	11	11	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 2	2016	388	10039					8	9		10.1016/S0140-6736(16)30355-5	http://dx.doi.org/10.1016/S0140-6736(16)30355-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP9PM	27155904	hybrid, Green Submitted			2022-12-28	WOS:000378828400007
J	Feric, M; Vaidya, N; Harmon, TS; Mitrea, DM; Zhu, L; Richardson, TM; Kriwacki, RW; Pappu, RV; Brangwynne, CP				Feric, Marina; Vaidya, Nilesh; Harmon, Tyler S.; Mitrea, Diana M.; Zhu, Lian; Richardson, Tiffany M.; Kriwacki, Richard W.; Pappu, Rohit V.; Brangwynne, Clifford P.			Coexisting Liquid Phases Underlie Nucleolar Subcompartments	CELL			English	Article							STRESS GRANULES; RIBOSOMAL-RNA; PROTEIN; DROPLETS; SIZE; TRANSITION; DOMAIN; SEPARATION; BODIES; SITES	The nucleolus and other ribonucleoprotein (RNP) bodies are membrane-less organelles that appear to assemble through phase separation of their molecular components. However, many such RNP bodies contain internal subcompartments, and the mechanism of their formation remains unclear. Here, we combine in vivo and in vitro studies, together with computational modeling, to show that subcompartments within the nucleolus represent distinct, coexisting liquid phases. Consistent with their in vivo immiscibility, purified nucleolar proteins phase separate into droplets containing distinct non-coalescing phases that are remarkably similar to nucleoli in vivo. This layered droplet organization is caused by differences in the biophysical properties of the phases-particularly droplet surface tension-which arises from sequence-encoded features of their macromolecular components. These results suggest that phase separation can give rise to multilayered liquids that may facilitate sequential RNA processing reactions in a variety of RNP bodies.	[Feric, Marina; Vaidya, Nilesh; Zhu, Lian; Richardson, Tiffany M.; Brangwynne, Clifford P.] Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA; [Harmon, Tyler S.] Washington Univ, Dept Phys, St Louis, MO 63130 USA; [Harmon, Tyler S.; Pappu, Rohit V.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; [Mitrea, Diana M.; Kriwacki, Richard W.] Washington Univ, Ctr Biol Syst Engn, St Louis, MO 63130 USA; [Mitrea, Diana M.; Kriwacki, Richard W.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38103 USA	Princeton University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); St Jude Children's Research Hospital	Brangwynne, CP (corresponding author), Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA.	cbrangwy@princeton.edu	Kriwacki, Richard/N-8154-2018	Kriwacki, Richard/0000-0002-9798-6018; Feric, Marina/0000-0001-7531-9305; Richardson, Tiffany/0000-0002-0272-6804	Princeton Center for Complex Materials, a MRSEC - NSF [DMR 1420541]; NIH Director's New Innovator Award [1DP2GM105437-01]; NSF CAREER award [1253035]; Helen Hay Whitney Fellowship; NIH [5RO1NS056114, 5R01GM115634]; NCI Cancer Center Support grant (at St. Jude Children's Research Hospital) [P30CA21765]; ALSAC; NSF [MCB 1121867]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP2GM105437, R01GM115634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056114] Funding Source: NIH RePORTER	Princeton Center for Complex Materials, a MRSEC - NSF(National Science Foundation (NSF)); NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF CAREER award(National Science Foundation (NSF)NSF - Office of the Director (OD)); Helen Hay Whitney Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center Support grant (at St. Jude Children's Research Hospital); ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the C.P.B. lab for discussions and Adrienne Fung for preliminary work on surface tension measurements. We acknowledge funding from the Princeton Center for Complex Materials, a MRSEC supported by NSF grant DMR 1420541. This work was also supported by an NIH Director's New Innovator Award (1DP2GM105437-01 to C.P.B.), an NSF CAREER award (1253035 to C.P.B.), a Helen Hay Whitney Fellowship (to N.V.), an NSF grant (MCB 1121867 to R.V.P.), NIH grants (5RO1NS056114 to R.V.P. and 5R01GM115634 to R.W.K.), an NCI Cancer Center Support grant (P30CA21765 at St. Jude Children's Research Hospital to R.W.K.), and ALSAC (R.W.K.).	Aarts DGAL, 2004, SCIENCE, V304, P847, DOI 10.1126/science.1097116; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Berry J, 2015, P NATL ACAD SCI USA, V112, pE5237, DOI 10.1073/pnas.1509317112; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Colby R.H., 2003, POLYM PHYS; Derenzini M, 2000, J PATHOL, V191, P181, DOI 10.1002/(SICI)1096-9896(200006)191:2<181::AID-PATH607>3.0.CO;2-V; Elbaum-Garfinkle S, 2015, P NATL ACAD SCI USA, V112, P7189, DOI 10.1073/pnas.1504822112; Feric M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16607; Feric M, 2013, NAT CELL BIOL, V15, P1253, DOI 10.1038/ncb2830; Foty RA, 1996, DEVELOPMENT, V122, P1611; Frank DJ, 1998, J CELL BIOL, V140, P1321, DOI 10.1083/jcb.140.6.1321; Gall JG, 2000, ANNU REV CELL DEV BI, V16, P273, DOI 10.1146/annurev.cellbio.16.1.273; Gigova A, 2014, RNA, V20, P1632, DOI 10.1261/rna.043398.113; Hennig S, 2015, J CELL BIOL, V210, P529, DOI 10.1083/jcb.201504117; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Hubstenberger A, 2013, DEV CELL, V27, P161, DOI 10.1016/j.devcel.2013.09.024; Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kroschwald S, 2015, ELIFE, V4, DOI 10.7554/eLife.06807; Kruger T, 2007, J CELL BIOL, V177, P573, DOI 10.1083/jcb.200612048; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Mitrea DM, 2016, ELIFE, V5, DOI 10.7554/eLife.13571; Mitrea DM, 2014, P NATL ACAD SCI USA, V111, P4466, DOI 10.1073/pnas.1321007111; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Neeson MJ, 2012, SOFT MATTER, V8, P11042, DOI 10.1039/c2sm26637g; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; OCHS RL, 1985, BIOL CELL, V54, P123, DOI 10.1111/j.1768-322X.1985.tb00387.x; Parry BR, 2014, CELL, V156, P183, DOI 10.1016/j.cell.2013.11.028; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Pederson T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000521; Shav-Tal Y, 2005, MOL BIOL CELL, V16, P2395, DOI 10.1091/mbc.E04-11-0992; Spector DL, 2001, J CELL SCI, V114, P2891; THAN P, 1988, J COLLOID INTERF SCI, V124, P552, DOI 10.1016/0021-9797(88)90191-9; Thiry M, 2005, TRENDS CELL BIOL, V15, P194, DOI 10.1016/j.tcb.2005.02.007; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; WACHTLER F, 1993, MICRON, V24, P473, DOI 10.1016/0968-4328(93)90026-W; Wang JT, 2014, ELIFE, V3, DOI 10.7554/eLife.04591; Weber SC, 2015, CURR BIOL, V25, P641, DOI 10.1016/j.cub.2015.01.012; Weber SC, 2012, CELL, V149, P1188, DOI 10.1016/j.cell.2012.05.022; Wippich F, 2013, CELL, V152, P791, DOI 10.1016/j.cell.2013.01.033; Xiang SH, 2015, CELL, V163, P829, DOI 10.1016/j.cell.2015.10.040; Zhang HY, 2015, MOL CELL, V60, P220, DOI 10.1016/j.molcel.2015.09.017	46	866	877	19	172	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1686	1697		10.1016/j.cell.2016.04.047	http://dx.doi.org/10.1016/j.cell.2016.04.047			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27212236	Bronze, Green Accepted			2022-12-28	WOS:000378062000019
J	Hammond, P				Hammond, Peter			John David Symons Hammond OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2016	353								i2906	10.1136/bmj.i2906	http://dx.doi.org/10.1136/bmj.i2906			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GI	27206443				2022-12-28	WOS:000376448200020
J	Lu, CL; Murakowski, DK; Bournazos, S; Schoofs, T; Sarkar, D; Halper-Stromberg, A; Horwitz, JA; Nogueira, L; Golijanin, J; Gazumyan, A; Ravetch, JV; Caskey, M; Chakraborty, AK; Nussenzweig, MC				Lu, Ching-Lan; Murakowski, Dariusz K.; Bournazos, Stylianos; Schoofs, Till; Sarkar, Debolina; Halper-Stromberg, Ariel; Horwitz, Joshua A.; Nogueira, Lilian; Golijanin, Jovana; Gazumyan, Anna; Ravetch, Jeffrey V.; Caskey, Marina; Chakraborty, Arup K.; Nussenzweig, Michel C.			Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DEPENDENT CELLULAR CYTOTOXICITY; EFFECTOR FUNCTIONS; MOUSE MODEL; THERAPY; VACCINE; PREVENTION; RESPONSES; EFFICACY; IMMUNITY	Antiretroviral drugs and antibodies limit HIV-1 infection by interfering with the viral life cycle. In addition, antibodies also have the potential to guide host immune effector cells to kill HIV-1-infected cells. Examination of the kinetics of HIV-1 suppression in infected individuals by passively administered 3BNC117, a broadly neutralizing antibody, suggested that the effects of the antibody are not limited to free viral clearance and blocking new infection but also include acceleration of infected cell clearance. Consistent with these observations, we find that broadly neutralizing antibodies can target CD4(+) T cells infected with patient viruses and can decrease their in vivo half-lives by a mechanism that requires Fc gamma receptor engagement in a humanized mouse model. The results indicate that passive immunotherapy can accelerate elimination of HIV-1-infected cells.	[Lu, Ching-Lan; Schoofs, Till; Halper-Stromberg, Ariel; Horwitz, Joshua A.; Nogueira, Lilian; Golijanin, Jovana; Gazumyan, Anna; Caskey, Marina; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Lu, Ching-Lan] Weill Cornell Med Coll, New York, NY 10065 USA; [Murakowski, Dariusz K.; Sarkar, Debolina; Chakraborty, Arup K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Bournazos, Stylianos; Ravetch, Jeffrey V.] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10065 USA; [Chakraborty, Arup K.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Nussenzweig, Michel C.] Howard Hughes Med Inst, Chevy Chase, MD USA	Rockefeller University; Cornell University; Massachusetts Institute of Technology (MIT); Rockefeller University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.; Chakraborty, AK (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.; Chakraborty, AK (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.; Chakraborty, AK (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.; Chakraborty, AK (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Chakraborty, AK (corresponding author), MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	arupc@mit.edu; nussen@rockefeller.edu	Bournazos, Stylianos/ABH-1578-2021; Nussenzweig, Michel/AAE-7292-2019; Ravetch, Jeffrey/Z-1596-2019	Ravetch, Jeffrey/0000-0003-2024-9041; Caskey, Marina/0000-0003-1727-8693	Collaboration for AIDS Vaccine Discovery grant [OPP1033115]; National Center for Advancing Translational Sciences (NCATS) [8 UL1 TR000043]; NIH Clinical and Translational Science Award (CTSA) program; NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) [1UM1 AI100663-01]; Bill and Melinda Gates Foundation [OPP1092074, OPP1124068]; Robertson Foundation; German Research Foundation [SCHO 1612/1-1]; NIH [F31 AI118555-01]; American Foundation for AIDS research (amfAR) Mathilde Krim Fellowship in Basic Biomedical Research [108977-57-RKVA]; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard; NSF Graduate Research Fellowship [1122374]; National Institute of Allergy and Infectious Diseases (NIH) [AI100148-02, AI081677-05]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663, P01AI100148, P01AI081677, F31AI118555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	Collaboration for AIDS Vaccine Discovery grant; National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH Clinical and Translational Science Award (CTSA) program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Robertson Foundation; German Research Foundation(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Foundation for AIDS research (amfAR) Mathilde Krim Fellowship in Basic Biomedical Research; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard; NSF Graduate Research Fellowship(National Science Foundation (NSF)); National Institute of Allergy and Infectious Diseases (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all study participants who devoted time to our research. We thank the Rockefeller University Hospital Clinical Research Support Office and nursing staff for patient care and recruitment. We thank T. Eisenreich for help with mouse colony management, K. Yao and S. Hinklein for technical help, P. Smith for Fc gamma R humanized mice, CellDex Therapeutics for providing 3BNC117 and 10-1074, and all members of the Nussenzweig laboratory for helpful discussion and advice. The data reported in this paper are tabulated in the main paper and in the supplementary materials. This work was supported by Collaboration for AIDS Vaccine Discovery grant OPP1033115 (M.C.N. and J.V.R.). This work was also supported, in part, by grant 8 UL1 TR000043 from the National Center for Advancing Translational Sciences (NCATS); NIH Clinical and Translational Science Award (CTSA) program; NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) 1UM1 AI100663-01 (M.C.N); Bill and Melinda Gates Foundation grants OPP1092074 and OPP1124068 (M.C.N); the Robertson Foundation to M.C.N.; German Research Foundation postdoctoral fellowship SCHO 1612/1-1 (T.S.); NIH grant F31 AI118555-01 (J.A.H.); the American Foundation for AIDS research (amfAR) Mathilde Krim Fellowship in Basic Biomedical Research (108977-57-RKVA) (S.B.); the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard (A.K.C.); a NSF Graduate Research Fellowship under grant no. 1122374 (D.K.M.); and National Institute of Allergy and Infectious Diseases (NIH) grants AI100148-02 and AI081677-05 (M.C.N. and J.V.R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. M.C.N. is a Howard Hughes Medical Institute Investigator. There are pending patent applications on the 3BNC117 and 10-1074 antibodies by Rockefeller University on which M.C.N. is an inventor. The patents are not licensed by any companies.	Boesch AW, 2015, IMMUNOL REV, V268, P296, DOI 10.1111/imr.12339; Bournazos S, 2015, J EXP MED, V212, P1361, DOI 10.1084/jem.20151267; Bournazos S, 2014, CELL, V158, P1243, DOI 10.1016/j.cell.2014.08.023; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; De Boer RJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000906; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Euler Z, 2015, AIDS RES HUM RETROV, V31, P13, DOI [10.1089/aid.2014.0235, 10.1089/AID.2014.0235]; Fatkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319; Gibaldi M, 1982, PHARMACOKINETICS; Halper-Stromberg A, 2014, CELL, V158, P989, DOI 10.1016/j.cell.2014.07.043; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Horton HM, 2010, BLOOD, V116, P3004, DOI 10.1182/blood-2010-01-265280; Igarashi T, 1999, NAT MED, V5, P211, DOI 10.1038/5576; Joos B, 2006, ANTIMICROB AGENTS CH, V50, P1773, DOI 10.1128/AAC.50.5.1773-1779.2006; Kramski M, 2015, AIDS, V29, P137, DOI 10.1097/QAD.0000000000000523; Kramski M, 2013, CURR HIV RES, V11, P388, DOI 10.2174/15701; Lewis GK, 2014, IMMUNOLOGY, V142, P46, DOI 10.1111/imm.12232; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mouquet H, 2014, TRENDS IMMUNOL, V35, P549, DOI 10.1016/j.it.2014.08.007; Muller V, 2001, J VIROL, V75, P2597, DOI 10.1128/JVI.75.6.2597-2603.2001; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Pietzsch J, 2012, P NATL ACAD SCI USA, V109, P15859, DOI 10.1073/pnas.1213409109; Pollara J, 2013, CURR HIV RES, V11, P378, DOI 10.2174/1570162X113116660059; Smith P, 2012, P NATL ACAD SCI USA, V109, P6181, DOI 10.1073/pnas.1203954109; Su B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00289; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052	27	232	235	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2016	352	6288			SI		1001	1004		10.1126/science.aaf1279	http://dx.doi.org/10.1126/science.aaf1279			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM2AK	27199430	Green Accepted, Green Submitted			2022-12-28	WOS:000376147800051
J	Quail, DF; Bowman, RL; Akkari, L; Quick, ML; Schuhmacher, AJ; Huse, JT; Holland, EC; Sutton, JC; Joyce, JA				Quail, Daniela F.; Bowman, Robert L.; Akkari, Leila; Quick, Marsha L.; Schuhmacher, Alberto J.; Huse, Jason T.; Holland, Eric C.; Sutton, James C.; Joyce, Johanna A.			The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; IN-VIVO; B-CELLS; MACROPHAGE PLASTICITY; GLIOBLASTOMA; CANCER; GROWTH; RECEPTOR; PROGRESSION; INSULIN	Macrophages accumulate with glioblastoma multiforme (GBM) progression and can be targeted via inhibition of colony-stimulating factor-1 receptor (CSF-1R) to regress high-grade tumors in animal models of this cancer. However, whether and how resistance emerges in response to sustained CSF-1R blockade is unknown. We show that although overall survival is significantly prolonged, tumors recur in >50% of mice. Gliomas reestablish sensitivity to CSF-1R inhibition upon transplantation, indicating that resistance is tumor microenvironment-driven. Phosphatidylinositol 3-kinase (PI3K) pathway activity was elevated in recurrent GBM, driven by macrophage-derived insulin-like growth factor-1 (IGF-1) and tumor cell IGF-1 receptor (IGF-1R). Combining IGF-1R or PI3K blockade with CSF-1R inhibition in recurrent tumors significantly prolonged overall survival. Our findings thus reveal a potential therapeutic approach for treating resistance to CSF-1R inhibitors.	[Quail, Daniela F.; Bowman, Robert L.; Akkari, Leila; Quick, Marsha L.; Schuhmacher, Alberto J.; Joyce, Johanna A.] Mem Sloan Kettering Canc Ctr MSKCC, Canc Biol & Genet Program, New York, NY 10065 USA; [Akkari, Leila; Joyce, Johanna A.] Univ Lausanne, Dept Oncol, CH-1066 Lausanne, Switzerland; [Akkari, Leila; Joyce, Johanna A.] Univ Lausanne, Ludwig Inst Canc Res, CH-1066 Lausanne, Switzerland; [Huse, Jason T.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Holland, Eric C.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Washington, WA 98109 USA; [Sutton, James C.] Novartis Inst Biomed Res, Emeryville, CA 94608 USA	Memorial Sloan Kettering Cancer Center; University of Lausanne; Ludwig Institute for Cancer Research; University of Lausanne; Memorial Sloan Kettering Cancer Center; Fred Hutchinson Cancer Center; Novartis	Joyce, JA (corresponding author), Mem Sloan Kettering Canc Ctr MSKCC, Canc Biol & Genet Program, New York, NY 10065 USA.; Joyce, JA (corresponding author), Univ Lausanne, Dept Oncol, CH-1066 Lausanne, Switzerland.; Joyce, JA (corresponding author), Univ Lausanne, Ludwig Inst Canc Res, CH-1066 Lausanne, Switzerland.	johanna@joycelab.org	Schuhmacher, Alberto J./R-6765-2019; Bowman, Robert/ABF-1007-2021	Schuhmacher, Alberto J./0000-0002-0136-1049; Bowman, Robert/0000-0002-8294-8748; Akkari, Leila/0000-0001-5479-641X	U.S. National Cancer Institute (NCI) [R01CA148967]; Ludwig Institute for Cancer Research; Canadian Institutes of Health Research; NCI [F31CA167863]; American Brain Tumor Association; Obra Social Ibercaja; MSKCC Support Grant from the NCI [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748, U54CA148967, R01CA181355, F31CA167863] Funding Source: NIH RePORTER	U.S. National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ludwig Institute for Cancer Research; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Brain Tumor Association; Obra Social Ibercaja; MSKCC Support Grant from the NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank X. Chen and N. Shah for excellent technical support. We are grateful to C. Brennan for generously providing the TS573 patient tumorsphere line. We thank R. Benezra for critically reading the manuscript and O. Olson, P. Castel, and S. Schwartz for experimental advice. We thank the Animal Imaging Core, the Antitumor Assessment Core, Flow Cytometry Core, and Integrated Genomics Operation at MSKCC for assistance. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. All sequencing data has been deposited to the GEO under accession no. GSE69104, and aCGH data under accession number GSE80399. BLZ945 is available from Novartis under a material transfer agreement with J.C.S., Novartis. D.F.Q., R.L.B., and J.A.J. are inventors on a patent application filed by MSKCC related to the use of combination therapies with CSF-1R inhibitors for gliomas. This research was supported by the U.S. National Cancer Institute (NCI) (R01CA148967, J.A.J.), the Ludwig Institute for Cancer Research (J.A.J.), fellowships from Canadian Institutes of Health Research (D.F.Q.), NCI (F31CA167863, R.L.B.), American Brain Tumor Association (L.A.), Obra Social Ibercaja (A.J.S.), and the MSKCC Support Grant from the NCI (P30 CA008748).	Allred DC, 1998, MODERN PATHOL, V11, P155; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arwert EN, 2012, NAT REV CANCER, V12, P170, DOI 10.1038/nrc3217; Balwierz PJ, 2014, GENOME RES, V24, P869, DOI 10.1101/gr.169508.113; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bowman RL, 2014, IMMUNOTHERAPY-UK, V6, P663, DOI [10.2217/IMT.14.48, 10.2217/imt.14.48]; Brachmann SM, 2012, MOL CANCER THER, V11, P1747, DOI 10.1158/1535-7163.MCT-11-1021; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Butovsky O, 2005, MOL CELL NEUROSCI, V29, P381, DOI 10.1016/j.mcn.2005.03.005; Butowski N, 2016, NEURO-ONCOLOGY, V18, P557, DOI 10.1093/neuonc/nov245; Chiba Y, 2009, AM J RESP CELL MOL, V41, P516, DOI 10.1165/rcmb.2008-0163OC; Coniglio SJ, 2012, MOL MED, V18, P519, DOI 10.2119/molmed.2011.00217; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dupraz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054462; Epskamp S, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i04; Faler Byron J, 2006, Perspect Vasc Surg Endovasc Ther, V18, P55, DOI 10.1177/153100350601800123; Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209; Forbes SJ, 2014, NAT MED, V20, P857, DOI 10.1038/nm.3653; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gabrusiewicz K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023902; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hambardzumyan D, 2009, TRANSL ONCOL, V2, P89, DOI 10.1593/tlo.09100; Harris DP, 2000, NAT IMMUNOL, V1, P475, DOI 10.1038/82717; Hermann-Kleiter N, 2010, BLOOD, V115, P2989, DOI 10.1182/blood-2009-10-233585; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Hu XY, 2005, NEOPLASIA, V7, P356, DOI 10.1593/neo.04595; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Hussain SF, 2006, NEURO-ONCOLOGY, V8, P261, DOI 10.1215/15228517-2006-008; Jensen JB, 2006, MOL NEUROBIOL, V34, P153, DOI 10.1385/MN:34:3:153; Johansson-Lindbom B, 2002, J IMMUNOL, V168, P3165, DOI 10.4049/jimmunol.168.7.3165; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Kratochvill F, 2015, CELL REP, V12, P1902, DOI 10.1016/j.celrep.2015.08.033; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Locatelli G, 2012, NAT NEUROSCI, V15, P543, DOI 10.1038/nn.3062; Loser K, 2006, J INVEST DERMATOL, V126, P1307, DOI 10.1038/sj.jid.5700185; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lund Frances E., 2005, V8, P25; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mulvihill MJ, 2009, FUTURE MED CHEM, V1, P1153, DOI 10.4155/FMC.09.89; Murat A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005947; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Ozawa T, 2014, CANCER CELL, V26, P288, DOI 10.1016/j.ccr.2014.06.005; Pachkov M, 2007, NUCLEIC ACIDS RES, V35, pD127, DOI 10.1093/nar/gkl857; Patel S, 2009, CURR TOP MED CHEM, V9, P599, DOI 10.2174/156802609789007327; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Ponomarev V, 2004, EUR J NUCL MED MOL I, V31, P740, DOI 10.1007/s00259-003-1441-5; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Ries CH, 2014, CANCER CELL, V25, P846, DOI 10.1016/j.ccr.2014.05.016; Roehrl MHA, 2004, P NATL ACAD SCI USA, V101, P7554, DOI 10.1073/pnas.0401835101; Ruffell B, 2015, CANCER CELL, V27, P462, DOI 10.1016/j.ccell.2015.02.015; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Seshan V.E., DNACOPY DNA COPY NUM; Setty M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.37; Shih AH, 2004, CANCER RES, V64, P4783, DOI 10.1158/0008-5472.CAN-03-3831; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Squatrito M, 2010, CANCER CELL, V18, P619, DOI 10.1016/j.ccr.2010.10.034; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szerlip NJ, 2012, P NATL ACAD SCI USA, V109, P3041, DOI 10.1073/pnas.1114033109; Tap WD, 2015, NEW ENGL J MED, V373, P428, DOI 10.1056/NEJMoa1411366; Tchougounova E, 2007, ONCOGENE, V26, P6289, DOI 10.1038/sj.onc.1210455; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wynes MW, 2003, J IMMUNOL, V171, P3550, DOI 10.4049/jimmunol.171.7.3550; Zheng WH, 2000, ADV RES NEURODEGENER, V8, P261; Zhu YT, 2014, NAT METHODS, V11, P599, DOI 10.1038/nmeth.2956	78	356	368	7	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2016	352	6288			SI				aad3018	10.1126/science.aad3018	http://dx.doi.org/10.1126/science.aad3018			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM2AK	27199435	Green Accepted			2022-12-28	WOS:000376147800038
J	Ramaswami, A; Russell, AG; Culligan, PJ; Sharma, KR; Kumar, E				Ramaswami, Anu; Russell, Armistead G.; Culligan, Patricia J.; Sharma, Karnamadakala Rahul; Kumar, Emani			Meta-principles for developing smart, sustainable, and healthy cities	SCIENCE			English	Editorial Material								Policy directives in several nations are focusing on the development of smart cities, linking innovations in the data sciences with the goal of advancing human well-being and sustainability on a highly urbanized planet. To achieve this goal, smart initiatives must move beyond city-level data to a higher-order understanding of cities as transboundary, multisectoral, multiscalar, social-ecological-infrastructural systems with diverse actors, priorities, and solutions. We identify five key dimensions of cities and present eight principles to focus attention on the systems-level decisions that society faces to transition toward a smart, sustainable, and healthy urban future.	[Ramaswami, Anu; Sharma, Karnamadakala Rahul] Univ Minnesota, Hubert H Humphrey Sch Publ Affairs, Minneapolis, MN 55455 USA; [Russell, Armistead G.] Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA; [Culligan, Patricia J.] Columbia Univ, Dept Civil Engn & Engn Mech, New York, NY 10027 USA; [Kumar, Emani] South Asia Secretariat, ICLEI Local Govt Sustainabil, New Delhi 110020, India	University of Minnesota System; University of Minnesota Twin Cities; University System of Georgia; Georgia Institute of Technology; Columbia University	Ramaswami, A (corresponding author), Univ Minnesota, Hubert H Humphrey Sch Publ Affairs, Minneapolis, MN 55455 USA.	anu@umn.edu		Ramaswami, Anu/0000-0002-0476-2315; Sharma, Karnamadakala Rahul/0000-0002-7732-712X				Bettencourt LMA, 2013, SCIENCE, V340, P1438, DOI 10.1126/science.1235823; Bourdic L, 2012, BUILD RES INF, V40, P592, DOI 10.1080/09613218.2012.703488; Building Healthy Cities (BHC) project, 2019, MAK LEV WORKSH BUILD; Bulkeley H, 2005, ENVIRON POLIT, V14, P42, DOI 10.1080/0964401042000310178; Centers for Disease Control and Prevention, 2016, HLTH COMM PROGR 2008; FAO AQUASTAT, 2016, WAT US; Hillman T, 2010, ENVIRON SCI TECHNOL, V44, P1902, DOI 10.1021/es9024194; Hollands Robert, 2008, CITY, V12, P303, DOI [10.1080/1360481080247926, 10.1080/13604810802479126, DOI 10.1080/13604810802479126]; ICLEI-USA, 2016, US COMM PROT ACC REP; Intergovernmental Panel Climate Change Working Grp III, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P1; International Energy Agency, 2016, WAT FOR EN; International Energy Agency and Tsinghua University, 2015, BUILD EN US CHIN TRA; International Standards Organization, 2014, SUST DEV COMM IND CI; Lee T, 2012, POLICY SCI, V45, P199, DOI 10.1007/s11077-012-9159-5; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lund H, 2014, ENERGY, V68, P1, DOI 10.1016/j.energy.2014.02.089; Ramaswami A, 2012, J IND ECOL, V16, P801, DOI 10.1111/j.1530-9290.2012.00566.x; Rydin Y, 2012, LANCET, V379, P2079, DOI 10.1016/S0140-6736(12)60435-8; Seto KC, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P923; Swilling M., 2013, CITY LEVEL DECOUPLIN; Tao T, 2014, NATURE, V511, P527, DOI 10.1038/511527a; World Health Organization, 2013, GLOB STAT REP ROAD S	22	177	184	20	241	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2016	352	6288			SI		940	943		10.1126/science.aaf7160	http://dx.doi.org/10.1126/science.aaf7160			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM2AK	27199418				2022-12-28	WOS:000376147800035
J	Alexander, JH; Smith, PK				Alexander, John H.; Smith, Peter K.			Coronary-Artery Bypass Grafting	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							FRACTIONAL FLOW RESERVE; DRUG-ELUTING STENTS; ADVERSE CEREBRAL OUTCOMES; DUAL ANTIPLATELET THERAPY; ASPIRIN PLUS CLOPIDOGREL; 5-YEAR FOLLOW-UP; OFF-PUMP; ON-PUMP; THORACIC-SURGEONS; CLINICAL-OUTCOMES		[Alexander, John H.] Duke Hlth, Duke Clin Res Inst, DUMC Box 3850, Durham, NC 27710 USA; [Alexander, John H.] Duke Hlth, Div Cardiol, Dept Med, Durham, NC 27710 USA; [Smith, Peter K.] Duke Hlth, Div Cardiothorac Surg, Dept Surg, Durham, NC 27710 USA	Duke University	Alexander, JH (corresponding author), Duke Hlth, Duke Clin Res Inst, DUMC Box 3850, Durham, NC 27710 USA.	john.h.alexander@dm.duke.edu	Alexander, John/GVS-7271-2022	Alexander, John/0000-0002-1444-2462	Regado Biosciences; Moerae Matrix; Sohmalution; Tenax Therapeutics	Regado Biosciences; Moerae Matrix; Sohmalution; Tenax Therapeutics	Dr. Alexander reports receiving consulting fees from Regado Biosciences, Moerae Matrix, and Sohmalution and grant support through his institution from Tenax Therapeutics and Regado Biosciences. No other potential conflict of interest relevant to this article was reported.	Acar C, 1998, J THORAC CARDIOV SUR, V116, P981, DOI 10.1016/S0022-5223(98)70050-9; Afilalo J, 2014, J AM COLL CARDIOL, V63, P747, DOI 10.1016/j.jacc.2013.09.070; Afilalo J, 2012, EUR HEART J, V33, P1257, DOI 10.1093/eurheartj/ehr307; Afilalo J, 2010, J AM COLL CARDIOL, V56, P1668, DOI 10.1016/j.jacc.2010.06.039; Alexander JH, 2005, JAMA-J AM MED ASSOC, V294, P2446; Allen K, 2005, INNOVATIONS, V1, P51, DOI 10.1097/01.gim.0000196315.32179.82; [Anonymous], 2012, P NAT SUMM OV ORG JO, P23; Bangalore S, 2015, NEW ENGL J MED, V372, P1213, DOI 10.1056/NEJMoa1412168; Bari D Study Grp, 2009, NEW ENGL J MED, V360, P2503, DOI 10.1056/NEJMoa0805796; Bonow RO, 2011, NEW ENGL J MED, V364, P1617, DOI 10.1056/NEJMoa1100358; Bradley SM, 2014, JAMA INTERN MED, V174, P1630, DOI 10.1001/jamainternmed.2014.3904; Brener SJ, 2004, CIRCULATION, V109, P2290, DOI 10.1161/01.CIR.0000126826.58526.14; Brooks MM, 2007, J AM COLL CARDIOL, V49, P1600, DOI 10.1016/j.jacc.2006.11.048; Castleberry AW, 2014, CIRCULATION, V129, P2547, DOI 10.1161/CIRCULATIONAHA.113.005223; Chan PS, 2011, JAMA-J AM MED ASSOC, V306, P53, DOI 10.1001/jama.2011.916; Chieffo A, 2012, JACC-CARDIOVASC INTE, V5, P718, DOI 10.1016/j.jcin.2012.03.022; Coylewright M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049827; Cummings SR, 2014, JAMA-J AM MED ASSOC, V311, P2061, DOI 10.1001/jama.2014.3033; De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361; Deo SV, 2013, J CARDIAC SURG, V28, P109, DOI 10.1111/jocs.12074; Desai ND, 2004, NEW ENGL J MED, V351, P2302, DOI 10.1056/NEJMoa040982; DETRE KM, 1984, NEW ENGL J MED, V311, P1333; Diegeler A, 2013, NEW ENGL J MED, V368, P1189, DOI 10.1056/NEJMoa1211666; EDWARDS FH, 1994, ANN THORAC SURG, V57, P12, DOI 10.1016/0003-4975(94)90358-1; ElBardissi AW, 2012, J THORAC CARDIOV SUR, V143, P273, DOI 10.1016/j.jtcvs.2011.10.029; Epstein AJ, 2011, JAMA-J AM MED ASSOC, V305, P1769, DOI 10.1001/jama.2011.551; Farkouh ME, 2008, AM HEART J, V155, P215, DOI 10.1016/j.ahj.2007.10.012; Farkouh ME, 2012, NEW ENGL J MED, V367, P2375, DOI 10.1056/NEJMoa1211585; Ferguson TB, 2002, JAMA-J AM MED ASSOC, V287, P2221, DOI 10.1001/jama.287.17.2221; Fihn SD, 2014, J AM COLL CARDIOL, V64, P1929, DOI 10.1016/j.jacc.2014.07.017; FISHER L, 1983, CIRCULATION, V68, P939, DOI 10.1161/01.CIR.68.5.939; Frutkin AD, 2009, JACC-CARDIOVASC INTE, V2, P614, DOI 10.1016/j.jcin.2009.05.001; Gao G, 2010, J AM COLL CARDIOL, V56, P1639, DOI 10.1016/j.jacc.2010.03.104; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Goff SL, 2014, JAMA INTERN MED, V174, P1614, DOI 10.1001/jamainternmed.2014.3328; Hannan EL, 2008, NEW ENGL J MED, V358, P331, DOI 10.1056/NEJMoa071804; Hannan EL, 2012, J AM COLL CARDIOL, V59, P1870, DOI 10.1016/j.jacc.2012.01.050; Hannan EL, 2010, CIRCULATION, V121, P267, DOI 10.1161/CIRCULATIONAHA.109.887539; Hannan EL, 2005, NEW ENGL J MED, V352, P2174, DOI 10.1056/NEJMoa040316; Harskamp RE, 2014, CIRCULATION, V130, P872, DOI 10.1161/CIRCULATIONAHA.114.009479; Harskamp RE, 2014, AM HEART J, V167, P585, DOI 10.1016/j.ahj.2014.01.006; Head SJ, 2013, EUR HEART J, V34, P2510, DOI 10.1093/eurheartj/eht059; Hess CN, 2014, CIRCULATION, V130, P1445, DOI 10.1161/CIRCULATIONAHA.113.008193; Hillis LD, 2011, J AM COLL CARDIOL, V58, pE123, DOI 10.1016/j.jacc.2011.08.009; Hlatky MA, 1997, CIRCULATION, V96, P11; Hlatky MA, 2014, J AM COLL CARDIOL, V63, P33, DOI 10.1016/j.jacc.2013.08.1632; Hlatky MA, 2013, ANN INTERN MED, V158, P727, DOI 10.7326/0003-4819-158-10-201305210-00639; Hlatky MA, 2009, LANCET, V373, P1190, DOI 10.1016/S0140-6736(09)60552-3; Ibrahim K, 2006, HEART SURG FORUM, V9, pE851, DOI 10.1532/HSF98.20061034; Kappetein AP, 2013, EUR J CARDIO-THORAC, V43, P1006, DOI 10.1093/ejcts/ezt017; Kappetein AP, 2011, EUR HEART J, V32, P2125, DOI 10.1093/eurheartj/ehr213; Kelly R, 2012, J THORAC CARDIOV SUR, V144, P1408, DOI 10.1016/j.jtcvs.2012.01.030; Kouchoukos NT, 1997, NEW ENGL J MED, V336, P1605; Kulik A, 2015, CIRCULATION, V131, P927, DOI 10.1161/CIR.0000000000000182; Lamy A, 2013, NEW ENGL J MED, V368, P1179, DOI 10.1056/NEJMoa1301228; Lamy A, 2012, NEW ENGL J MED, V366, P1489, DOI 10.1056/NEJMoa1200388; Lopes RD, 2012, CIRCULATION, V125, P749, DOI 10.1161/CIRCULATIONAHA.111.040311; Malenka DJ, 2005, CIRCULATION, V112, pI371, DOI 10.1161/CIRCULATIONAHA.104.526392; Mannacio VA, 2012, HEART, V98, P1710, DOI 10.1136/heartjnl-2012-302449; McDonagh DL, 2014, LANCET NEUROL, V13, P490, DOI 10.1016/S1474-4422(14)70004-3; Michler RE, 2016, NEW ENGL J MED, V374, P1932, DOI 10.1056/NEJMoa1602003; Mohr F, 2012, J AM COLL CARDIOL, V60, pB13, DOI 10.1016/j.jacc.2012.08.052; Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5; Nam CW, 2011, J AM COLL CARDIOL, V58, P1211, DOI 10.1016/j.jacc.2011.06.020; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; National Heart Lung and Blood Institute, WHAT EXP COR ART BYP; Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601; Nocerino AG, 2013, AM J CARDIOL, V112, P1576, DOI 10.1016/j.amjcard.2013.07.017; O'Connor GT, 2008, J AM COLL CARDIOL, V51, P2323, DOI 10.1016/j.jacc.2008.01.067; Ong ATL, 2006, AM HEART J, V151, P1194, DOI 10.1016/j.ahj.2005.07.017; Park DW, 2011, J AM COLL CARDIOL, V57, P128, DOI 10.1016/j.jacc.2010.09.022; Park SJ, 2015, NEW ENGL J MED, V372, P1204, DOI 10.1056/NEJMoa1415447; Park SJ, 2011, NEW ENGL J MED, V364, P1718, DOI 10.1056/NEJMoa1100452; Patel Manesh R, 2012, J Am Coll Cardiol, V59, P857, DOI 10.1016/j.jacc.2011.12.001; Pijls NHJ, 2013, EUR HEART J, V34, P1335, DOI 10.1093/eurheartj/ehs436; Roach GW, 1996, NEW ENGL J MED, V335, P1857, DOI 10.1056/NEJM199612193352501; Rothberg MB, 2014, JAMA INTERN MED, V174, P1623, DOI 10.1001/jamainternmed.2014.3331; Selnes OA, 2012, NEW ENGL J MED, V366, P250, DOI 10.1056/NEJMra1100109; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Shroyer AL, 2009, NEW ENGL J MED, V361, P1827, DOI 10.1056/NEJMoa0902905; Shroyer ALW, 2003, ANN THORAC SURG, V75, P1856, DOI 10.1016/S0003-4975(03)00179-6; Sianos Georgios, 2005, EuroIntervention, V1, P219; Sipahi I, 2014, JAMA INTERN MED, V174, P223, DOI 10.1001/jamainternmed.2013.12844; Smith PK, 2014, NEW ENGL J MED, V371, P2178, DOI 10.1056/NEJMoa1410490; Smith PK, 2006, ANN THORAC SURG, V82, P1420, DOI 10.1016/j.athoracsur.2006.04.044; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Suma H, 2007, CIRCULATION, V116, pI188, DOI 10.1161/CIRCULATIONAHA.106.678813; Tabata M, 2009, CIRCULATION, V120, P935, DOI 10.1161/CIRCULATIONAHA.108.832444; Tarakji KG, 2006, CIRCULATION, V113, P230, DOI 10.1161/CIRCULATIONAHA.105.541664; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Van Belle E, 2014, CIRCULATION, V129, P173, DOI 10.1161/CIRCULATIONAHA.113.006646; VARNAUSKAS E, 1988, NEW ENGL J MED, V319, P332, DOI 10.1056/NEJM198808113190603; Velazquez EJ, 2007, J THORAC CARDIOV SUR, V134, P1540, DOI 10.1016/j.jtcvs.2007.05.069; Velazquez EJ, 2016, NEW ENGL J MED, V374, P1511, DOI 10.1056/NEJMoa1602001; Velazquez EJ, 2015, J AM COLL CARDIOL, V65, P615, DOI 10.1016/j.jacc.2014.10.070; Velazquez EJ, 2011, NEW ENGL J MED, V364, P1607, DOI 10.1056/NEJMoa1100356; Wahrborg P, 2004, CIRCULATION, V110, P3411, DOI 10.1161/01.CIR.0000148366.80443.2B; Weintraub WS, 2012, NEW ENGL J MED, V366, P1467, DOI 10.1056/NEJMoa1110717; Williams JB, 2013, J THROMB THROMBOLYS, V36, P384, DOI 10.1007/s11239-013-0904-1; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1	100	121	126	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 19	2016	374	20					1954	1964		10.1056/NEJMra1406944	http://dx.doi.org/10.1056/NEJMra1406944			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM1OX	27192673				2022-12-28	WOS:000376116600008
J	Gulland, A				Gulland, Anne			Libby Wilson OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												annecgulland@yahoo.co.uk						WILSON L, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2016	353								i2854	10.1136/bmj.i2854	http://dx.doi.org/10.1136/bmj.i2854			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GD	27199152				2022-12-28	WOS:000376447700018
J	Woolley, SNC; Tittensor, DP; Dunstan, PK; Guillera-Arroita, G; Lahoz-Monfort, JJ; Wintle, BA; Worm, B; O'Hara, TD				Woolley, Skipton N. C.; Tittensor, Derek P.; Dunstan, Piers K.; Guillera-Arroita, Gurutzeta; Lahoz-Monfort, Jose J.; Wintle, Brendan A.; Worm, Boris; O'Hara, Timothy D.			Deep-sea diversity patterns are shaped by energy availability	NATURE			English	Article							SPECIES-DIVERSITY; GLOBAL PATTERNS; BIODIVERSITY; RICHNESS; COMMUNITIES; PREDICTIONS; HYPOTHESIS; OCCUPANCY; GRADIENTS; CLIMATE	The deep ocean is the largest and least-explored ecosystem on Earth, and a uniquely energy-poor environment. The distribution, drivers and origins of deep-sea biodiversity remain unknown at global scales(1-3). Here we analyse a database of more than 165,000 distribution records of Ophiuroidea (brittle stars), a dominant component of sea-floor fauna, and find patterns of biodiversity unlike known terrestrial or coastal marine realms. Both patterns and environmental predictors of deep-sea (2,000-6,500m) species richness fundamentally differ from those found in coastal (0-20 m), continental shelf (20-200 m), and upper-slope (200-2,000 m) waters. Continental shelf to upper-slope richness consistently peaks in tropical Indo-west Pacific and Caribbean (0-30 degrees) latitudes, and is well explained by variations in water temperature. In contrast, deep-sea species show maximum richness at higher latitudes (30-50 degrees), concentrated in areas of high carbon export flux and regions close to continental margins. We reconcile this structuring of oceanic biodiversity using a species-energy framework, with kinetic energy predicting shallow-water richness, while chemical energy (export productivity) and proximity to slope habitats drive deep-sea diversity. Our findings provide a global baseline for conservation efforts across the sea floor, and demonstrate that deep-sea ecosystems show a biodiversity pattern consistent with ecological theory, despite being different from other planetary-scale habitats.	[Woolley, Skipton N. C.; O'Hara, Timothy D.] Museum Victoria, GPO Box 666, Melbourne, Vic 3001, Australia; [Woolley, Skipton N. C.; Guillera-Arroita, Gurutzeta; Lahoz-Monfort, Jose J.; Wintle, Brendan A.] Univ Melbourne, Quantitat & Appl Ecol Grp, Sch Biol Sci, BioSci Bldg 2, Melbourne, Vic 3010, Australia; [Tittensor, Derek P.; Worm, Boris] Dalhousie Univ, Dept Biol, 1355 Oxford St, Halifax, NS B3H 4J1, Canada; [Tittensor, Derek P.] World Conservat Monitoring Ctr, United Nations Environm Programme, 219 Huntingdon Rd, Cambridge CB3 0DL, England; [Dunstan, Piers K.] CSIRO, Wealth Oceans Flagship, Hobart, Tas 7000, Australia	Museum Victoria; University of Melbourne; Dalhousie University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Woolley, SNC (corresponding author), Museum Victoria, GPO Box 666, Melbourne, Vic 3001, Australia.; Woolley, SNC (corresponding author), Univ Melbourne, Quantitat & Appl Ecol Grp, Sch Biol Sci, BioSci Bldg 2, Melbourne, Vic 3010, Australia.	swoolley@museum.vic.gov.au	Tittensor, Derek P./AAV-1117-2021; Lahoz-Monfort, José J/O-3546-2017; Guillera-Arroita, Gurutzeta/F-7461-2015; Dunstan, Piers K/B-7309-2016	Tittensor, Derek P./0000-0002-9550-3123; Lahoz-Monfort, José J/0000-0002-0845-7035; Guillera-Arroita, Gurutzeta/0000-0002-8387-5739; Dunstan, Piers K/0000-0002-2568-5945; Worm, Boris/0000-0002-5742-8716; O'Hara, Timothy/0000-0003-0885-6578; wintle, brendan/0000-0002-4234-5950	Commonwealth National Environmental Research Program (NERP); Centre of Excellence for Environmental Decisions (CEED)	Commonwealth National Environmental Research Program (NERP); Centre of Excellence for Environmental Decisions (CEED)	We thank all collectors and taxonomists involved for providing biodiversity data. This work is an output of the project 'National maps of biodiversity and connectivity' of the Marine Biodiversity Research Hub and Environmental Decisions Hub, funded through the Commonwealth National Environmental Research Program (NERP) and administered through the Australian Government's Department of Environment. This work is also a product of the International Network for Scientific Investigations of Deep-Sea Ecosystems (INDEEP) working group on biogeography. We also thank the Centre of Excellence for Environmental Decisions (CEED) for travel funding that enabled collaboration between the University of Melbourne, Museum Victoria and Dalhousie University.	Alroy J., 2010, PALEONTOL SOC PAP, V16, P55, DOI [10.1017/S1089332600001819, DOI 10.1017/S1089332600001819]; Amante C., 2009, NOAA TECHNICAL MEMOR, V1, P1, DOI 10.7289/V5C8276M; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Bivand R, 2016, THE SPDEP PACKAGE; Brandt A, 2007, NATURE, V447, P307, DOI 10.1038/nature05827; Chao A., 2016, INEXT ONLINE; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; Clarke A, 2006, P ROY SOC B-BIOL SCI, V273, P2257, DOI 10.1098/rspb.2006.3545; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Currie D.J., 2014, P ROY SOC LOND B BIO, V281, P1776; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; Curtin R., 2014, ARMADILLO C LINEAR A; Dorazio RM, 2006, ECOLOGY, V87, P842, DOI 10.1890/0012-9658(2006)87[842:ESRAAB]2.0.CO;2; Dorazio RM, 2005, J AM STAT ASSOC, V100, P389, DOI 10.1198/016214505000000015; Dunn JR, 2002, DEEP-SEA RES PT I, V49, P591, DOI 10.1016/S0967-0637(01)00069-3; Eddelbuettel D., 2015, RCPP SEAMLESS R C IN; ESRI, 2020, ARCGIS DESKT REL 10; Francois R, 2012, RCPPARMADILLO RCPP I; Fraser RH, 1996, AM NAT, V148, P138, DOI 10.1086/285915; Gelfand AE, 2005, J R STAT SOC C-APPL, V54, P1, DOI 10.1111/j.1467-9876.2005.00466.x; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gillooly JF, 2005, P NATL ACAD SCI USA, V102, P140, DOI 10.1073/pnas.0407735101; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Guisan A, 2006, J APPL ECOL, V43, P386, DOI 10.1111/j.1365-2664.2006.01164.x; Hijmans R.J., 2019, GEOGRAPHIC DATA ANAL; Hijmans R. J., 2012, DISMO SPECIES DISTRI; HOLT RD, 1985, THEOR POPUL BIOL, V28, P181, DOI 10.1016/0040-5809(85)90027-9; Keitt T. H., 2011, RGDAL BINDINGS GEOSP; Kery M, 2008, J APPL ECOL, V45, P589, DOI 10.1111/j.1365-2664.2007.01441.x; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P59, DOI 10.1111/j.1466-8238.2007.00334.x; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Lambshead PJD, 2000, MAR ECOL PROG SER, V194, P159, DOI 10.3354/meps194159; Levin LA, 2003, OCEANOGR MAR BIOL, V41, P1; Lewin-Koh N.J., 2011, MAPTOOLS TOOLS READI; Lutz MJ, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003706; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mannion PD, 2014, TRENDS ECOL EVOL, V29, P42, DOI 10.1016/j.tree.2013.09.012; MAY RM, 1993, NATURE, V361, P598, DOI 10.1038/361598a0; Murray J., 1912, DEPTHS OCEAN GEN ACC; O'Hara TD, 2011, CURR BIOL, V21, P226, DOI 10.1016/j.cub.2011.01.002; Oksanen J., 2008, VEGAN PACKAGE VERSIO; Plummer M., 2003, P 3 INT WORKSH DISTR; Plummer M., 2004, JAGS JUST ANOTHER GI; R Core Team, 2010, R LANG ENV STAT COMP; Ramirez-Llodra E, 2010, BIOGEOSCIENCES, V7, P2851, DOI 10.5194/bg-7-2851-2010; Ramirez-Llodra E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022588; Rex M.A., 2010, BIOSCIENCE; Rex MA, 2005, ECOLOGY, V86, P2288, DOI 10.1890/04-1056; Rex MA, 2005, AM NAT, V165, P163, DOI 10.1086/427226; REX MA, 1993, NATURE, V365, P636, DOI 10.1038/365636a0; Ridgway KR, 2002, J ATMOS OCEAN TECH, V19, P1357, DOI 10.1175/1520-0426(2002)019<1357:OIBFDW>2.0.CO;2; Rogers AD, 2000, DEEP-SEA RES PT II, V47, P119, DOI 10.1016/S0967-0645(99)00107-1; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Smith AG, 2003, J GEOL SOC LONDON, V160, P337, DOI 10.1144/0016-764902-115; Stohr S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031940; Su Y.-S., 2012, R2JAGS PACKAGE RUNNI; Tittensor DP, 2011, BIOL LETTERS, V7, P718, DOI 10.1098/rsbl.2010.1174; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Vallina SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5299; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Vion A., 2009, CONTINENTAL MARGINS; Watling L, 2013, PROG OCEANOGR, V111, P91, DOI 10.1016/j.pocean.2012.11.003; Witman JD, 2004, P NATL ACAD SCI USA, V101, P15664, DOI 10.1073/pnas.0404300101; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109; Yasuhara M, 2016, BIOL REV, V91, P275, DOI 10.1111/brv.12169	66	146	152	5	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					393	+		10.1038/nature17937	http://dx.doi.org/10.1038/nature17937			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0AH	27193685				2022-12-28	WOS:000376004300048
J	Yan, M; Baran, PS				Yan, Ming; Baran, Phil S.			DRUG DISCOVERY Fighting evolution with chemical synthesis	NATURE			English	Editorial Material									[Yan, Ming; Baran, Phil S.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute	Baran, PS (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	pbaran@scripps.edu						Keasling JD, 2012, NATURE, V492, P188, DOI 10.1038/492188a; Kuttruff CA, 2014, NAT PROD REP, V31, P419, DOI 10.1039/c3np70090a; Parenty A, 2013, Chem Rev, V113, pPR1, DOI 10.1021/cr300129n; Seiple IB, 2016, NATURE, V533, P338, DOI 10.1038/nature17967; Seiple IB, 2014, ANGEW CHEM INT EDIT, V53, P4642, DOI 10.1002/anie.201400928; Wright PM, 2014, ANGEW CHEM INT EDIT, V53, P8840, DOI 10.1002/anie.201310843; Zhang ZY, 2016, ANGEW CHEM INT EDIT, V55, P523, DOI 10.1002/anie.201507357	7	7	7	0	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					326	327		10.1038/533326a	http://dx.doi.org/10.1038/533326a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0AH	27193674				2022-12-28	WOS:000376004300032
J	Borgi, L; Rimm, EB; Willett, WC; Forman, JP				Borgi, Lea; Rimm, Eric B.; Willett, Walter C.; Forman, John P.			Potato intake and incidence of hypertension: results from three prospective US cohort studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GLYCEMIC INDEX; REPRODUCIBILITY; VALIDITY; QUESTIONNAIRE; OBESITY; VALIDATION; LIPIDS; YOUNG; RISK; LOAD	OBJECTIVE To determine whether higher intake of baked or boiled potatoes, French fries, or potato chips is associated with incidence of hypertension. DESIGN Prospective longitudinal cohort studies. SETTING Healthcare providers in the United States. PARTICIPANTS 62 175 women in Nurses' Health Study, 88 475 women in Nurses' Health Study II, and 36 803 men in Health Professionals Follow-up Study who were non-hypertensive at baseline. MAIN OUTCOME MEASURE Incident cases of hypertension (self reported diagnosis by healthcare provider). RESULTS Compared with consumption of less than one serving a month, the random effects pooled hazard ratios for four or more servings a week were 1.11 (95% confidence interval 0.96 to 1.28; P for trend=0.05) for baked, boiled, or mashed potatoes, 1.17 (1.07 to 1.27; P for trend=0.001) for French fries, and 0.97 (0.87 to 1.08; P for trend=0.98) for potato chips. In substitution analyses, replacing one serving a day of baked, boiled, or mashed potatoes with one serving a day of non-starchy vegetables was associated with decreased risk of hypertension (hazard ratio 0.93, 0.89 to 0.96). CONCLUSION Higher intake of baked, boiled, or mashed potatoes and French fries was independently and prospectively associated with an increased risk of developing hypertension in three large cohorts of adult men and women.	[Borgi, Lea; Forman, John P.] Brigham & Womens Hosp, Div Renal, 75 Francis St, Boston, MA 02115 USA; [Rimm, Eric B.; Willett, Walter C.; Forman, John P.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Rimm, Eric B.; Willett, Walter C.; Forman, John P.] Harvard Univ, Sch Med, Boston, MA USA; [Rimm, Eric B.; Willett, Walter C.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Rimm, Eric B.; Willett, Walter C.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Borgi, L (corresponding author), Brigham & Womens Hosp, Div Renal, 75 Francis St, Boston, MA 02115 USA.				National Institutes of Health [UM1 CA186107, R01 HL034594, UM1 CA176726, UM1 CA167552, R01 HL35464]; American Heart Association [14POST20380070]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This study was funded by research grants UM1 CA186107, R01 HL034594, UM1 CA176726, UM1 CA167552, and R01 HL35464 from the National Institutes of Health. LB was funded by an American Heart Association fellowship award (14POST20380070). The funding sources did not participate in the design of the study, the analysis or the interpretation of the data, the writing of this manuscript, or the process to submit this article for publication. The authors are not affiliated with the funding sources.	Aburto Nancy J, 2013, BMJ, V346, pf1378, DOI 10.1136/bmj.f1378; Albuquerque TG, 2012, INT J FOOD SCI NUTR, V63, P713, DOI 10.3109/09637486.2011.644768; Appel LJ, 2005, JAMA-J AM MED ASSOC, V294, P2455, DOI 10.1001/jama.294.19.2455; ASCHERIO A, 1992, CIRCULATION, V86, P1475, DOI 10.1161/01.CIR.86.5.1475; Atkinson FS, 2008, DIABETES CARE, V31, P2281, DOI 10.2337/dc08-1239; Ceriello A, 1998, EUR J CLIN INVEST, V28, P329; Choudhury N, 1997, ANN NUTR METAB, V41, P137, DOI 10.1159/000177989; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Food and Nutrition Service (FNS) USDA, 2012, Fed Regist, V77, P4088; Forman JP, 2008, HYPERTENSION, V52, P828, DOI 10.1161/HYPERTENSIONAHA.108.117630; Gagne L, 2008, EXPLORE-NY, V4, P66, DOI 10.1016/j.explore.2007.10.011; Hall JE, 2003, HYPERTENSION, V41, P625, DOI 10.1161/01.HYP.0000052314.95497.78; Hu FB, 1999, AM J CLIN NUTR, V69, P243; *I MED NAT AC, 2006, WIC FOOD PACK TIM CH; Kumanyika S, 2002, INT J OBESITY, V26, P425, DOI 10.1038/sj.ijo.0801938; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Rasmussen KM, 2015, REV WIC FOOD PACKAGE; Report of a Joint WHO/FAO Expert Consultation, 2003, WHO TECHN REP SER, V916, P1; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Title LM, 2000, J AM COLL CARDIOL, V36, P2185, DOI 10.1016/S0735-1097(00)00980-3; WHO, 2003, WHO TECH REP SER, V916, P1; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; WOLEVER TMS, 1991, AM J CLIN NUTR, V54, P846, DOI 10.1093/ajcn/54.5.846; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991	30	55	57	2	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 17	2016	353								i2351	10.1136/bmj.i2351	http://dx.doi.org/10.1136/bmj.i2351			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GO	27189229	Green Published, hybrid			2022-12-28	WOS:000376448900001
J	Natalucci, G; Latal, B; Koller, B; Rugger, C; Sick, B; Held, L; Bucher, HU; Fauchere, JC				Natalucci, Giancarlo; Latal, Beatrice; Koller, Brigitte; Ruegger, Christoph; Sick, Beate; Held, Leonhard; Bucher, Hans Ulrich; Fauchere, Jean-Claude		Swiss EPO Neuroprotection	Effect of Early Prophylactic High-Dose Recombinant Human Erythropoietin in Very Preterm Infants on Neurodevelopmental Outcome at 2 Years A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SWISS NATIONAL COHORT; BIRTH-WEIGHT INFANTS; AGE; NEUROPROTECTION; PREMATURITY; CHILDREN; SYSTEM; INJURY	IMPORTANCE Very preterm infants are at risk of developing encephalopathy of prematurity and long-term neurodevelopmental delay. Erythropoietin treatment is neuroprotective in animal experimental and human clinical studies. OBJECTIVE To determine whether prophylactic early high-dose recombinant human erythropoietin (rhEPO) in preterm infants improves neurodevelopmental outcome at 2 years' corrected age. DESIGN, SETTING, AND PARTICIPANTS Preterm infants born between 26 weeks 0 days' and 31 weeks 6 days' gestation were enrolled in a randomized, double-blind, placebo-controlled, multicenter trial in Switzerland between 2005 and 2012. Neurodevelopmental assessments at age 2 years were completed in 2014. INTERVENTIONS Participants were randomly assigned to receive either rhEPO (3000 IU/kg) or placebo (isotonic saline, 0.9%) intravenously within 3 hours, at 12 to 18 hours, and at 36 to 42 hours after birth. MAIN OUTCOMES AND MEASURES Primary outcome was cognitive development assessed with the Mental Development Index (MDI; norm, 100 [SD, 15]; higher values indicate better function) of the Bayley Scales of Infant Development, second edition (BSID-II) at 2 years corrected age. The minimal clinically important difference between groups was 5 points (0.3 SD). Secondary outcomes were motor development (assessed with the Psychomotor Development Index), cerebral palsy, hearing or visual impairment, and anthropometric growth parameters. RESULTS Among 448 preterm infants randomized (mean gestational age, 29.0 [range, 26.0-30.9] weeks; 264 [59%] female; mean birth weight, 1210 [range, 490-2290] g), 228 were randomized to rhEPO and 220 to placebo. Neurodevelopmental outcome data were available for 365 (81%) at a mean age of 23.6 months. In an intention-to-treat analysis, mean MDI was not statistically significantly different between the rhEPO group (93.5 [SD, 16.0] [95% CI, 91.2 to 95.8]) and the placebo group (94.5 [SD, 17.8] [95% CI, 90.8 to 98.5]) (difference, -1.0 [95% CI, -4.5 to 2.5]; P = .56). No differences were found between groups in the secondary outcomes. CONCLUSIONS AND RELEVANCE Among very preterm infants who received prophylactic early high-dose rhEPO for neuroprotection, compared with infants who received placebo, there were no statistically significant differences in neurodevelopmental outcomes at 2 years. Follow-up for cognitive and physical problems that may not become evident until later in life is required.	[Natalucci, Giancarlo; Koller, Brigitte; Ruegger, Christoph; Bucher, Hans Ulrich; Fauchere, Jean-Claude] Univ Zurich, Univ Zurich Hosp, Dept Neonatol, Zurich, Switzerland; [Natalucci, Giancarlo; Latal, Beatrice] Univ Childrens Hosp Zurich, Child Dev Ctr, Zurich, Switzerland; [Sick, Beate; Held, Leonhard] Univ Zurich, EBPI, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University Children's Hospital Zurich; University of Zurich	Natalucci, G (corresponding author), Univ Zurich Hosp, Dept Neonatol, Frauenklinikstr 10, ZH-8091 Zurich, Switzerland.	giancarlo.natalucci@usz.ch	Wellmann, Sven/A-2771-2017; Held, Leonhard/E-8159-2010; Bucher, Hans Ulrich/AAF-2995-2020; Bucher, Hans/AAL-1739-2020; Bucher, Hans/AAL-1100-2020; Huppi, Petra S./A-4079-2009; Huppi, Petra/A-4079-2009	Held, Leonhard/0000-0002-8686-5325; Bucher, Hans Ulrich/0000-0003-4458-1161; Bucher, Hans/0000-0003-4458-1161; Bucher, Hans/0000-0003-4458-1161; Natalucci, Giancarlo/0000-0003-0225-2431; Ruegger, Christoph/0000-0003-1496-2625; Huppi, Petra S./0000-0002-7383-6648; Huppi, Petra/0000-0002-7063-4215; Schulzke, Sven/0000-0002-5475-6239; Hagmann, Cornelia/0000-0003-2647-9809	Swiss National Science Foundation (SRF) [3200B0-108176/1]; RoFAR Foundation (Roche Foundation for Anemia Research)	Swiss National Science Foundation (SRF); RoFAR Foundation (Roche Foundation for Anemia Research)	This study was supported by a grant from the Swiss National Science Foundation (SRF; No. 3200B0-108176/1), by a research grant to the Faculty of Medicine of the University Zurich ("Matching Fund"), and by the RoFAR Foundation (Roche Foundation for Anemia Research).	[Anonymous], 2014, R LANG ENV STAT COMP; Bayley N, 1993, BAYLEY SCALES INFANT; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Bierer R, 2006, PEDIATRICS, V118, pE635, DOI 10.1542/peds.2005-3186; Brown MS, 2009, PEDIATRICS, V124, pE681, DOI 10.1542/peds.2008-2701; Chateauvieux S, 2011, BIOCHEM PHARMACOL, V82, P1291, DOI 10.1016/j.bcp.2011.06.045; DEVRIES LS, 1992, BEHAV BRAIN RES, V49, P1, DOI 10.1016/S0166-4328(05)80189-5; dos Santos ESL, 2013, EARLY HUM DEV, V89, P487, DOI 10.1016/j.earlhumdev.2013.03.008; Fauchere JC, 2008, PEDIATRICS, V122, P375, DOI 10.1542/peds.2007-2591; Fauchere JC, 2015, J PEDIATR-US, V167, P52, DOI 10.1016/j.jpeds.2015.02.052; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Hack M, 2005, PEDIATRICS, V116, P333, DOI 10.1542/peds.2005-0173; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Juul S, 2012, J MATERN-FETAL NEO M, V25, P105, DOI 10.3109/14767058.2012.715025; Juul SE, 2008, PEDIATRICS, V122, P383, DOI 10.1542/peds.2007-2711; Koulnis M, 2014, ADV EXP MED BIOL, V844, P37, DOI 10.1007/978-1-4939-2095-2_3; Kumral A, 2011, BRAIN DEV-JPN, V33, P632, DOI 10.1016/j.braindev.2010.10.014; LARGO RH, 1989, DEV MED CHILD NEUROL, V31, P440, DOI 10.1111/j.1469-8749.1989.tb04022.x; Leuchter RHV, 2014, JAMA-J AM MED ASSOC, V312, P817, DOI 10.1001/jama.2014.9645; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Marlow N, 2015, ARCH DIS CHILD-FETAL, V100, pF82, DOI 10.1136/archdischild-2014-306191; Neubauer AP, 2010, ANN NEUROL, V67, P657, DOI 10.1002/ana.21977; O'Gorman RL, 2015, BRAIN, V138, P388, DOI 10.1093/brain/awu363; Ohls RK, 2004, PEDIATRICS, V114, P1287, DOI 10.1542/peds.2003-1129-L; Ohls RK, 2014, PEDIATRICS, V133, P1023, DOI 10.1542/peds.2013-4307; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Rangarajan V, 2014, PEDIATR NEUROL, V51, P481, DOI 10.1016/j.pediatrneurol.2014.06.008; Robertson NJ, 2012, J PEDIATR-US, V160, P544, DOI 10.1016/j.jpeds.2011.12.052; Ruegger CM, 2015, NEONATOLOGY, V108, P198, DOI 10.1159/000437248; Schlapbach LJ, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-198; Schlapbach LJ, 2011, PEDIATRICS, V128, pE348, DOI 10.1542/peds.2010-3338; Suk KK, 2008, J AAPOS, V12, P233, DOI 10.1016/j.jaapos.2007.08.009; Toet MC, 1999, ARCH DIS CHILD-FETAL, V81, pF19, DOI 10.1136/fn.81.1.F19; Voigt M, 2006, GEBURTSH FRAUENHEILK, V66, P956, DOI 10.1055/s-2006-924458; Volpe JJ., 2008, NEUROLOGY NEWBORN, P517; Volpe JJ, 2009, SEMIN PEDIATR NEUROL, V16, P167, DOI 10.1016/j.spen.2009.09.005; Wu YW, 2015, DEV MED CHILD NEUROL, V57, P34, DOI 10.1111/dmcn.12730	37	72	76	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 17	2016	315	19					2079	2085		10.1001/jama.2016.5504	http://dx.doi.org/10.1001/jama.2016.5504			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL9PN	27187300	Green Accepted, Bronze			2022-12-28	WOS:000375975300018
J	Schmitt, BP				Schmitt, Brian P.			Review: After lower-extremity DVT, compression stockings do not reduce postthrombotic syndrome or recurrence	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CONTROLLED-TRIAL; PREVENT		[Schmitt, Brian P.] Edward Hines Jr VA Hosp, Hines, IL USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital	Schmitt, BP (corresponding author), Edward Hines Jr VA Hosp, Hines, IL USA.							Amin E, 2016, PHLEBOLOGY, V31, P41, DOI 10.1177/0268355516632986; Bouman AC, 2016, J THROMB HAEMOST, V14, P510, DOI 10.1111/jth.13228; Kahn SR, 2014, LANCET, V383, P880, DOI 10.1016/S0140-6736(13)61902-9; Prandoni P, 2004, ANN INTERN MED, V141, P249, DOI 10.7326/0003-4819-141-4-200408170-00004; ten Cate-Hoek AJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005265	5	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2016	164	10					JC53	JC53		10.7326/ACPJC-2016-164-10-053	http://dx.doi.org/10.7326/ACPJC-2016-164-10-053			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8GF	27182919				2022-12-28	WOS:000375878500004
J	Kocsis, B				Kocsis, Bernat			REMembering what you learned	SCIENCE			English	Editorial Material							MEDIAL SEPTUM; THETA RHYTHM; SLEEP; MEMORY		[Kocsis, Bernat] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Psychiat, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kocsis, B (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Psychiat, Boston, MA 02215 USA.	bernat_kocsis@hms.harvard.edu	Kocsis, Bernat/A-8377-2008; Kocsis, Bernat/V-8120-2019	Kocsis, Bernat/0000-0003-4371-3249; 	NIMH NIH HHS [R01 MH100820] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100820] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Boyce R, 2016, SCIENCE, V352, P812, DOI 10.1126/science.aad5252; Buzsaki G, 2015, HIPPOCAMPUS, V25, P1073, DOI 10.1002/hipo.22488; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; CRICK F, 1983, NATURE, V304, P111, DOI 10.1038/304111a0; Datta S, 2004, J NEUROSCI, V24, P1416, DOI 10.1523/JNEUROSCI.4111-03.2004; Grosmark AD, 2012, NEURON, V75, P1001, DOI 10.1016/j.neuron.2012.08.015; Kang D, 2015, J NEUROPHYSIOL, V114, P2797, DOI 10.1152/jn.00542.2015; Manseau F, 2008, J NEUROSCI, V28, P4096, DOI 10.1523/JNEUROSCI.0247-08.2008; Montgomery SM, 2008, J NEUROSCI, V28, P6731, DOI 10.1523/JNEUROSCI.1227-08.2008; Pace-Schott EF, 2015, PSYCHOL BULL, V141, P835, DOI 10.1037/bul0000014; Rasch B, 2013, PHYSIOL REV, V93, P681, DOI 10.1152/physrev.00032.2012; Ribeiro S, 2004, LEARN MEMORY, V11, P686, DOI 10.1101/lm.75604; Stickgold R, 2013, CURR OPIN NEUROBIOL, V23, P847, DOI 10.1016/j.conb.2013.04.002; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Young JW, 2009, PHARMACOL THERAPEUT, V122, P150, DOI 10.1016/j.pharmthera.2009.02.004	15	3	4	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2016	352	6287					770	771		10.1126/science.aaf9117	http://dx.doi.org/10.1126/science.aaf9117			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5FP	27174973	Green Accepted			2022-12-28	WOS:000375663000019
J	Bender, E				Bender, Eric			Crowdsourced solutions	NATURE			English	Editorial Material																			0	17	17	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					S62	S64		10.1038/533S62a	http://dx.doi.org/10.1038/533S62a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0BJ	27167394	Bronze			2022-12-28	WOS:000376007200005
J	Boyken, SE; Chen, ZB; Groves, B; Langan, RA; Oberdorfer, G; Ford, A; Gilmore, JM; Xu, CF; DiMaio, F; Pereira, JH; Sankaran, B; Seelig, G; Zwart, PH; Baker, D				Boyken, Scott E.; Chen, Zibo; Groves, Benjamin; Langan, Robert A.; Oberdorfer, Gustav; Ford, Alex; Gilmore, Jason M.; Xu, Chunfu; DiMaio, Frank; Pereira, Jose Henrique; Sankaran, Banumathi; Seelig, Georg; Zwart, Peter H.; Baker, David			De novo design of protein homo-oligomers with modular hydrogen-bond network-mediated specificity	SCIENCE			English	Article							BURIED POLAR RESIDUES; TRIMERIC COILED-COIL; COMPUTATIONAL DESIGN; ELECTROSTATIC INTERACTIONS; STRUCTURAL SPECIFICITY; DNA NANOTECHNOLOGY; CRYSTAL-STRUCTURE; DESIGNABILITY; PREDICTION; STABILITY	In nature, structural specificity in DNA and proteins is encoded differently: In DNA, specificity arises from modular hydrogen bonds in the core of the double helix, whereas in proteins, specificity arises largely from buried hydrophobic packing complemented by irregular peripheral polar interactions. Here, we describe a general approach for designing a wide range of protein homo-oligomers with specificity determined by modular arrays of central hydrogen-bond networks. We use the approach to design dimers, trimers, and tetramers consisting of two concentric rings of helices, including previously not seen triangular, square, and supercoiled topologies. X-ray crystallography confirms that the structures overall, and the hydrogen-bond networks in particular, are nearly identical to the design models, and the networks confer interaction specificity in vivo. The ability to design extensive hydrogen-bond networks with atomic accuracy enables the programming of protein interaction specificity for a broad range of synthetic biology applications; more generally, our results demonstrate that, even with the tremendous diversity observed in nature, there are fundamentally new modes of interaction to be discovered in proteins.	[Boyken, Scott E.; Chen, Zibo; Langan, Robert A.; Oberdorfer, Gustav; Ford, Alex; Gilmore, Jason M.; Xu, Chunfu; DiMaio, Frank; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Boyken, Scott E.; Chen, Zibo; Langan, Robert A.; Oberdorfer, Gustav; Ford, Alex; Gilmore, Jason M.; Xu, Chunfu; DiMaio, Frank; Baker, David] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [Boyken, Scott E.; Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Chen, Zibo] Univ Washington, Grad Program Biol Phys Struct & Design, Seattle, WA 98195 USA; [Groves, Benjamin; Seelig, Georg] Univ Washington, Dept Elect Engn, Seattle, WA 98195 USA; [Oberdorfer, Gustav] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Pereira, Jose Henrique] Graz Univ, Inst Mol Biosci, Humboldtstr 50-3, A-8010 Graz, Austria; [Pereira, Jose Henrique] Joint BioEnergy Inst, Emeryville, CA 94608 USA; [Sankaran, Banumathi; Zwart, Peter H.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging, Berkeley, CA 94720 USA; [Seelig, Georg] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley Ctr Struct Biol, Mol Biophys & Integrated Bioimaging, 1 Cyclotron Rd, Berkeley, CA 94720 USA; [Zwart, Peter H.] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Ctr Adv Math Energy Res Applicat, 1 Cyclotron Rd, Berkeley, CA 94720 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Graz; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Washington; University of Washington Seattle; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dabaker@u.washington.edu	Baker, David/K-8941-2012; Xu, Chunfu/B-5963-2012	Baker, David/0000-0001-7896-6217; Xu, Chunfu/0000-0002-8668-0566; Oberdorfer, Gustav/0000-0002-6144-9114; Chen, Zibo/0000-0003-2990-2895	Howard Hughes Medical Institute; U.S. Department of Energy; European Research Area (ERA)-NET BioOrigami consortium; NSF [MCB-1445201]; Lawrence Berkeley National Laboratory, Berkeley, California Department of Energy [DE-AC02-05CH11231]; National Institute of General Medical Sciences (NIH); Marie Curie International Outgoing Fellowship [332094]; Washington Research Foundation Innovation Postdoctoral Fellowships; Direct For Biological Sciences [1445201] Funding Source: National Science Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); U.S. Department of Energy(United States Department of Energy (DOE)); European Research Area (ERA)-NET BioOrigami consortium; NSF(National Science Foundation (NSF)); Lawrence Berkeley National Laboratory, Berkeley, California Department of Energy; National Institute of General Medical Sciences (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Marie Curie International Outgoing Fellowship(European Commission); Washington Research Foundation Innovation Postdoctoral Fellowships; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank L. Carter for assistance with SEC-MALS and protein production and Rosetta@Home volunteers for contributing computing resources to enable rigorous testing of designs by ab initio structure prediction, F. Seeger for guidance with SAXS data analysis, and M. Bick and P. Lu for assistance with crystallographic refinement. This work was supported by the Howard Hughes Medical Institute, the U.S. Department of Energy, the European Research Area (ERA)-NET BioOrigami consortium, and NSF (MCB-1445201). Design calculations were facilitated though the use of advanced computational, storage, and networking infrastructure provided by the Hyak supercomputer system at the University of Washington. X-ray crystallography and SAXS data were collected at the Advanced Light Source (Lawrence Berkeley National Laboratory, Berkeley, California Department of Energy, contract no. DE-AC02-05CH11231); SAXS data were collected through the SIBYLS mail-in SAXS program under the aforementioned contract number, and we thank K. Burnett and G. Hura. The Berkeley Center for Structural Biology is supported in part by the National Institute of General Medical Sciences (NIH), and the Howard Hughes Medical Institute. G.O. is a Marie Curie International Outgoing Fellowship fellow (332094 ASR-CompEnzDes FP7-People-2012-IOF). B.G and J.M.G. are supported by Washington Research Foundation Innovation Postdoctoral Fellowships. Coordinates and structure files have been deposited to the Protein Data Bank with accession codes: 5J0J (2L6HC3_6), 5J0I (2L6HC3_12), 5J0H (2L6HC3_13), 5IZS (5L6HC3_1), 5J73 (2L4HC2_9), 5J2L (2L4HC2_11), 5J0L (3L6HC2_2), 5J0K (2L4HC2_23), 5J10 (2L4HC2_24). S.E.B., Z.C., and D.B. designed the research and S.E.B. and D.B. wrote the manuscript S.E.B. developed the HBNet method and wrote the program code. D.B. wrote the parametric backbone generation code with help from C.X. and G.O. A.F. wrote the loop closure program code. S.E.B., Z.C., R.A.L., and D.B. carried out design calculations. S.E.B. and Z.C. purified and biophysically characterized the designed proteins. B.G. performed yeast two-hybrid assays. J.M.G. performed mass spectrometry. J.H.P. crystallized the designed proteins. B.S.	Acharya A, 2002, BIOCHEMISTRY-US, V41, P14122, DOI 10.1021/bi020486r; Acharya A, 2006, BIOCHEMISTRY-US, V45, P11324, DOI 10.1021/bi060822u; Akey DL, 2001, BIOCHEMISTRY-US, V40, P6352, DOI 10.1021/bi002829w; Baker EG, 2015, NAT CHEM BIOL, V11, P221, DOI 10.1038/nchembio.1739; Betz SF, 1997, BIOCHEMISTRY-US, V36, P2450, DOI 10.1021/bi961704h; Boyle AL, 2011, CHEM SOC REV, V40, P4295, DOI 10.1039/c0cs00152j; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Chakrabarti R, 2005, P NATL ACAD SCI USA, V102, P12035, DOI 10.1073/pnas.0505397102; Chen YJ, 2015, NAT NANOTECHNOL, V10, P748, DOI [10.1038/NNANO.2015.195, 10.1038/nnano.2015.195]; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Dahiyat BI, 1996, PROTEIN SCI, V5, P895, DOI 10.1002/pro.5560050511; Das R, 2009, P NATL ACAD SCI USA, V106, P18978, DOI 10.1073/pnas.0904407106; Eckert DM, 1998, J MOL BIOL, V284, P859, DOI 10.1006/jmbi.1998.2214; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Fleming PJ, 2005, PROTEIN SCI, V14, P1911, DOI 10.1110/ps.051454805; Fletcher JM, 2012, ACS SYNTH BIOL, V1, P240, DOI 10.1021/sb300028q; Gonzalez L, 1996, NAT STRUCT BIOL, V3, P1011, DOI 10.1038/nsb1296-1011; Gradisar H, 2011, J PEPT SCI, V17, P100, DOI 10.1002/psc.1331; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; Grigoryan G, 2011, J MOL BIOL, V405, P1079, DOI 10.1016/j.jmb.2010.08.058; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Gruber M, 2003, TRENDS BIOCHEM SCI, V28, P679, DOI 10.1016/j.tibs.2003.10.008; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Harbury PB, 1998, SCIENCE, V282, P1462, DOI 10.1126/science.282.5393.1462; Huang PS, 2007, PROTEIN SCI, V16, P2770, DOI 10.1110/ps.073125207; Huang PS, 2014, SCIENCE, V346, P481, DOI 10.1126/science.1257481; Jacak R, 2012, PROTEINS, V80, P825, DOI 10.1002/prot.23241; Joachimiak LA, 2006, J MOL BIOL, V361, P195, DOI 10.1016/j.jmb.2006.05.022; Joh NH, 2014, SCIENCE, V346, P1520, DOI 10.1126/science.1261172; Judd ET, 2014, BIOCHEMISTRY-US, V53, P5638, DOI 10.1021/bi500854p; Kaplan JB, 2014, PROTEIN SCI, V23, P940, DOI 10.1002/pro.2477; Karanicolas J, 2011, MOL CELL, V42, P250, DOI 10.1016/j.molcel.2011.03.010; King NP, 2012, SCIENCE, V336, P1171, DOI 10.1126/science.1219364; Koga N, 2012, NATURE, V491, P222, DOI 10.1038/nature11600; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; LUMB KJ, 1995, BIOCHEMISTRY-US, V34, P8642, DOI 10.1021/bi00027a013; O'Meara MJ, 2015, J CHEM THEORY COMPUT, V11, P609, DOI 10.1021/ct500864r; Ogihara NL, 1997, PROTEIN SCI, V6, P80; Procko E, 2013, J MOL BIOL, V425, P3563, DOI 10.1016/j.jmb.2013.06.035; Reinke AW, 2013, SCIENCE, V340, P730, DOI 10.1126/science.1233465; Reinke AW, 2010, J AM CHEM SOC, V132, P6025, DOI 10.1021/ja907617a; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Sanchez-Azqueta M, 2014, BBA-BIOENERGETICS, V1837, P251, DOI 10.1016/j.bbabio.2013.10.010; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Sheinerman FB, 2002, J MOL BIOL, V318, P161, DOI 10.1016/S0022-2836(02)00030-X; Stranges PB, 2013, PROTEIN SCI, V22, P74, DOI 10.1002/pro.2187; Street AG, 1999, STRUCTURE, V7, pR105, DOI 10.1016/S0969-2126(99)80062-8; Tatko CD, 2006, J AM CHEM SOC, V128, P4170, DOI 10.1021/ja055561a; Thomas F, 2013, J AM CHEM SOC, V135, P5161, DOI 10.1021/ja312310g; Thomson AR, 2014, SCIENCE, V346, P485, DOI 10.1126/science.1257452; Wei B, 2012, NATURE, V485, P623, DOI 10.1038/nature11075; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; WOOLFSON DN, 1995, PROTEIN SCI, V4, P1596, DOI 10.1002/pro.5560040818; Xu D, 1997, PROTEIN ENG, V10, P999, DOI 10.1093/protein/10.9.999; Zhang F, 2014, J AM CHEM SOC, V136, P11198, DOI 10.1021/ja505101a	60	188	207	9	166	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2016	352	6286					680	687		10.1126/science.aad8865	http://dx.doi.org/10.1126/science.aad8865			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL1UC	27151862	Green Submitted, Green Accepted			2022-12-28	WOS:000375417100031
J	Garattini, S				Garattini, Silvio			The European Medicines Agency is still too close to industry	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DRUGS		[Garattini, Silvio] IRCCS Ist Ric Farmacol Mario Negri, Via Giuseppe La Masa 19, I-20156 Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Garattini, S (corresponding author), IRCCS Ist Ric Farmacol Mario Negri, Via Giuseppe La Masa 19, I-20156 Milan, Italy.	silvio.garattini@marionegri.it	Garattini, Silvio/AAA-6390-2020	Garattini, Silvio/0000-0003-0647-9297				Banzi R, 2015, EUR J INTERN MED, V26, P572, DOI 10.1016/j.ejim.2015.08.008; Banzi R, 2014, LANCET, V384, P1847, DOI 10.1016/S0140-6736(14)62241-8; Banzi R, 2014, EUR J INTERN MED, V25, P681, DOI 10.1016/j.ejim.2014.07.012; Eichler HG, 2015, CLIN PHARMACOL THER, V97, P234, DOI 10.1002/cpt.59; European Agency for the Evaluation of Medical Products (European Medicines Agency), 2001, 6 EUR MED AG; European Medicines Agency, 2014, BUDG 2015; European Medicines Agency, 2014, EUR MED AG POL PUBL; Garattini S, 2001, LANCET, V358, P64, DOI 10.1016/S0140-6736(00)05258-2; Health Action International International Society of Drug Bulletins Medicines in Europe Forum Mario Negri Institute for Pharmacological Research Nordic Cochrane Centre Wemos, 2015, AD LIC AD PATHW DER	9	12	12	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 6	2016	353								i2412	10.1136/bmj.i2412	http://dx.doi.org/10.1136/bmj.i2412			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL4AT	27154140				2022-12-28	WOS:000375575700002
J	Kim, H; Min, KI; Inoue, K; Im, DJ; Kim, DP; Yoshida, J				Kim, Heejin; Min, Kyoung-Ik; Inoue, Keita; Im, Do Jin; Kim, Dong-Pyo; Yoshida, Jun-ichi			Submillisecond organic synthesis: Outpacing Fries rearrangement through microfluidic rapid mixing	SCIENCE			English	Article							FILM MICROREACTORS; CHEMICAL-SYNTHESIS; FLOW-MICROREACTOR; MICROCHANNEL	In chemical synthesis, rapid intramolecular rearrangements often foil attempts at site-selective bimolecular functionalization. We developed a microfluidic technique that outpaces the very rapid anionic Fries rearrangement to chemoselectively functionalize iodophenyl carbamates at the ortho position. Central to the technique is a chip microreactor of our design, which can deliver a reaction time in the submillisecond range even at cryogenic temperatures. The microreactor was applied to the synthesis of afesal, a bioactive molecule exhibiting anthelmintic activity, to demonstrate its potential for practical synthesis and production.	[Kim, Heejin; Inoue, Keita; Yoshida, Jun-ichi] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan; [Min, Kyoung-Ik; Kim, Dong-Pyo] POSTECH, Dept Chem Engn, Pohang 790784, South Korea; [Im, Do Jin] Pukyong Natl Univ, Dept Chem Engn, Busan 608739, South Korea	Kyoto University; Pohang University of Science & Technology (POSTECH); Pukyong National University	Yoshida, J (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan.; Kim, DP (corresponding author), POSTECH, Dept Chem Engn, Pohang 790784, South Korea.	dpkim@postech.ac.kr; yoshida@sbchem.kyoto-u.ac.jp	Kim, Heejin/HII-8568-2022; Kim, Heejin/E-9054-2010; Yoshida, Jun-ichi/E-8786-2010	Kim, Heejin/0000-0002-6095-1794; Yoshida, Jun-ichi/0000-0001-8439-2272; Min, Kyoung-Ik/0000-0003-2426-5196; Im, Do Jin/0000-0001-8328-1079	National Research Foundation of Korea [2008-0061983, NRF-2015R1D1A3A01019112, NRF-2014M1A8A1074940]; Japan Society for the Promotion of Science [26220804]; Grants-in-Aid for Scientific Research [16K17898] Funding Source: KAKEN	National Research Foundation of Korea(National Research Foundation of Korea); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Supported by National Research Foundation of Korea grants 2008-0061983, NRF-2015R1D1A3A01019112, and NRF-2014M1A8A1074940 and by Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (S) 26220804. Author contributions: H.K. and K.-I.M. conceived the concept at POSTECH; K.-I.M. fabricated the device; H.K. conducted synthetic experiments at POSETCH and Kyoto University with K.I.; D.J.I. conducted CFD simulation and analysis with K.-I.M.; and D.-P.K. and J.Y. directed the project.	Aref H, 2002, PHYS FLUIDS, V14, P1315, DOI 10.1063/1.1458932; Bokenkamp D, 1998, ANAL CHEM, V70, P232, DOI 10.1021/ac9708250; Bringmann G, 2002, J ORG CHEM, V67, P5595, DOI 10.1021/jo020189s; Elvira KS, 2013, NAT CHEM, V5, P905, DOI [10.1038/NCHEM.1753, 10.1038/nchem.1753]; Fries K, 1908, BER DTSCH CHEM GES, V41, P4271, DOI 10.1002/cber.190804103146; Geyer K, 2009, SYNLETT, P2382, DOI 10.1055/s-0029-1217828; Hessel V, 2014, CHEMBIOENG REV, V1, P244, DOI 10.1002/cben.201400022; Illg T, 2010, BIOORGAN MED CHEM, V18, P3707, DOI 10.1016/j.bmc.2010.03.073; Jensen KF, 2014, LAB CHIP, V14, P3206, DOI 10.1039/c4lc00330f; Kim H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1264; Ley SV, 2015, ANGEW CHEM INT EDIT, V54, P10122, DOI 10.1002/anie.201501618; Liu RH, 2000, J MICROELECTROMECH S, V9, P190, DOI 10.1109/84.846699; Liu YZ, 2004, INT J HEAT FLUID FL, V25, P986, DOI 10.1016/j.ijheatfluidflow.2004.03.006; MARTIN R, 1992, ORG PREP PROCED INT, V24, P369, DOI 10.1080/00304949209356226; Min KI, 2016, LAB CHIP, V16, P977, DOI 10.1039/c5lc01585e; Min KI, 2014, LAB CHIP, V14, P3987, DOI 10.1039/c4lc00700j; Min KI, 2010, ANGEW CHEM INT EDIT, V49, P7063, DOI 10.1002/anie.201002004; Seeton CJ, 2006, TRIBOL LETT, V22, P67, DOI 10.1007/s11249-006-9071-2; Semple J. E., 2012, PCT Int. Appl., Patent No. [WO 2012058378, 2012058378]; Sims IR, 2013, NAT CHEM, V5, P734, DOI 10.1038/nchem.1736; Tsubogo T, 2015, NATURE, V520, P329, DOI 10.1038/nature14343; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Yoshida JI, 2008, CHEM-EUR J, V14, P7450, DOI 10.1002/chem.200800582; Yoshida JI, 2011, CHEMSUSCHEM, V4, P331, DOI 10.1002/cssc.201000271	24	156	157	15	241	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2016	352	6286					691	694		10.1126/science.aaf1389	http://dx.doi.org/10.1126/science.aaf1389			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL1UC	27151864				2022-12-28	WOS:000375417100033
J	Shema, E; Jones, D; Shoresh, N; Donohue, L; Ram, O; Bernstein, BE				Shema, Efrat; Jones, Daniel; Shoresh, Noam; Donohue, Laura; Ram, Oren; Bernstein, Bradley E.			Single-molecule decoding of combinatorially modified nucleosomes	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; HISTONE MODIFICATIONS; CHROMATIN SIGNATURES; MUTATIONS; GENOME; EZH2; PROMOTERS; CODE	Different combinations of histone modifications have been proposed to signal distinct gene regulatory functions, but this area is poorly addressed by existing technologies. We applied high-throughput single-molecule imaging to decode combinatorial modifications on millions of individual nucleosomes from pluripotent stem cells and lineage-committed cells. We identified definitively bivalent nucleosomes with concomitant repressive and activating marks, as well as other combinatorial modification states whose prevalence varies with developmental potency. We showed that genetic and chemical perturbations of chromatin enzymes preferentially affect nucleosomes harboring specific modification states. Last, we combined this proteomic platform with single-molecule DNA sequencing technology to simultaneously determine the modification states and genomic positions of individual nucleosomes. This single-molecule technology has the potential to address fundamental questions in chromatin biology and epigenetic regulation.	[Shema, Efrat; Donohue, Laura; Ram, Oren; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Shema, Efrat; Donohue, Laura; Ram, Oren; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Shema, Efrat; Donohue, Laura; Ram, Oren; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Shema, Efrat; Shoresh, Noam; Donohue, Laura; Ram, Oren; Bernstein, Bradley E.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Jones, Daniel] SeqLL, Woburn, MA 01801 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Bernstein, BE (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.; Bernstein, BE (corresponding author), Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA.; Bernstein, BE (corresponding author), Harvard Univ, Sch Med, Boston, MA 02114 USA.; Bernstein, BE (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	bernstein.bradley@mgh.harvard.edu	Shema, Efrat/AHC-5041-2022	Shema, Efrat/0000-0002-3718-593X; Jones, Daniel/0000-0001-8108-0169	Jane Coffin Childs Memorial Fund for Medical Research; National Human Genome Research Institute-Small Business Innovation Research [R44HG005279]; National Human Genome Research Institute; Klarman Cell Observatory; Howard Hughes Medical Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006991, R44HG005279] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund for Medical Research; National Human Genome Research Institute-Small Business Innovation Research; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Klarman Cell Observatory; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank I. Tirosh, P. Blainey, K. Xiong, and S. Elledge for constructive discussions; J. Reifenberger for help with imaging technology; M. Bray for help with image analysis; I.-S. Kim, K. Bouazoune, C. Epstein, and J. Kaur for their experimental contributions; and S. Deindl, B. Liau, and R. Ryan for valuable experimental advice. E.S. is supported by the Jane Coffin Childs Memorial Fund for Medical Research. D.J. is partially supported by National Human Genome Research Institute-Small Business Innovation Research grant R44HG005279. This research was supported by funds from the National Human Genome Research Institute, the Klarman Cell Observatory, and the Howard Hughes Medical Institute. Sequencing data are available in the supplementary materials (database S1). D.J. is a founder and the president of SeqLL, which contributed to the technologies described in this study. E.S., D.J., and B.E.B. have filed a provisional patent covering single-molecule methodologies described in the paper.	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Ferrari KJ, 2014, MOL CELL, V53, P49, DOI 10.1016/j.molcel.2013.10.030; Gomez D, 2013, NAT METHODS, V10, P171, DOI [10.1038/NMETH.2332, 10.1038/nmeth.2332]; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Murphy PJ, 2013, P NATL ACAD SCI USA, V110, P7772, DOI 10.1073/pnas.1218495110; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; Rivera CM, 2013, CELL, V155, P39, DOI 10.1016/j.cell.2013.09.011; Sidoli S, 2015, PROTEOMICS, V15, P2901, DOI 10.1002/pmic.201500298; Turinetto V, 2015, NUCLEIC ACIDS RES, V43, P2489, DOI 10.1093/nar/gkv061; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Voigt P, 2012, CELL, V151, P181, DOI 10.1016/j.cell.2012.09.002; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208	22	71	74	7	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2016	352	6286					717	721		10.1126/science.aad7701	http://dx.doi.org/10.1126/science.aad7701			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL1UC	27151869	Green Accepted			2022-12-28	WOS:000375417100040
J	Appleby, J				Appleby, John			DATA BRIEFING Healthcare and the EU: Brexit, Bremain ... or Brundecided?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Appleby, John] Kings Fund Inst, London NW1 7NF, England		Appleby, J (corresponding author), Kings Fund Inst, London NW1 7NF, England.	j.appleby@kingsfund.org.uk						Curtice J., 2016, DEEPLY DOES BRITAINS; European Commission, 2016, EUR PROF CARD; European Union, 2015, EU BUDG 2014 FIN REP; Health and Social Care Information Centre, 2014, NHS HOSP COMM HLTH S; Health and Social Care Information Centre, 2015, NHS WORKF STAT ENGL; *HLTH SOC CAR INF, 2007, NHS STAFF 1996 2006; House of Commons Library, 2016, 07213 HOUS COMM LIB; Independent Working Time Regulations Taskforce, 2014, IMPL WORK TIM DIR IT; Migration Advisory Committee, 2016, PART REV SHORT OCC L; National Centre for Social Research, 2016, SHOULD UK REM MEMB E; Taylor A., 2016, WHEN COMPETITIVE TEN	11	1	1	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 5	2016	353								i2328	10.1136/bmj.i2328	http://dx.doi.org/10.1136/bmj.i2328			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL4AS	27150451				2022-12-28	WOS:000375575600002
J	Moyer, P				Moyer, Polly			WHAT YOUR PATIENT IS THINKING Healthy approaches to rare conditions	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 5	2016	353								i2042	10.1136/bmj.i2042	http://dx.doi.org/10.1136/bmj.i2042			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL4AS	27151168	Bronze, Green Published			2022-12-28	WOS:000375575600001
J	Weinberger, SE				Weinberger, Steven E.			Curbing Firearm Violence: Identifying a Specific Target for Physician Action	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ASSOCIATION		[Weinberger, Steven E.] Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA	American College of Physicians	Weinberger, SE (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	sweinberger@acponline.org						Butkus R, 2014, ANN INTERN MED, V160, P858, DOI 10.7326/M14-0216; Gardner HG, 2012, PEDIATRICS, V130, pE1416, DOI 10.1542/peds.2012-2481; Lewiecki EM, 2013, AM J PUBLIC HEALTH, V103, P27, DOI 10.2105/AJPH.2012.300964; Parmet W., 2016, HLTH AFFAIRS BLOG; Pinals DA, 2015, BEHAV SCI LAW, V33, P195, DOI 10.1002/bsl.2180; Weinberger SE., 2016, UPDATED LIST ENDORSE; Weinberger SE, 2015, ANN INTERN MED, V162, P513, DOI 10.7326/M15-0337; Weinberger SE, 2012, NEW ENGL J MED, V367, P1557, DOI 10.1056/NEJMsb1209858; Wintemute GJ, 2016, ANN INTERN MED, V165, P205, DOI 10.7326/M15-2905	9	4	4	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 2	2016	165	3					221	222		10.7326/M16-0968	http://dx.doi.org/10.7326/M16-0968			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS2HA	27183475				2022-12-28	WOS:000380583300012
J	Mente, A; O'Donnell, M; Rangarajan, S; Dagenais, G; Lear, S; McQueen, M; Diaz, R; Avezum, A; Lopez-Jaramillo, P; Lanas, F; Wei, L; Yin, L; Sun, Y; Lei, R; Iqbal, RS; Mony, P; Yusuf, R; Yusoff, K; Szuba, A; Oguz, A; Rosengren, A; Bahonar, A; Yusufali, A; Schutte, AE; Chifamba, J; Mann, JFE; Anand, SS; Teo, K; Yusuf, S				Mente, Andrew; O'Donnell, Martin; Rangarajan, Sumathy; Dagenais, Gilles; Lear, Scott; McQueen, Matthew; Diaz, Rafael; Avezum, Alvaro; Lopez-Jaramillo, Patricia; Lanas, Fernando; Wei Li; Yin Lu; Sun Yi; Lei Rensheng; Iqbal, Romaina; Mony, Prem; Yusuf, Rita; Yusoff, Khalid; Szuba, Andrzej; Oguz, Aytekin; Rosengren, Annika; Bahonar, Ahmad; Yusufali, Afzalhussein; Schutte, Aletta Elisabeth; Chifamba, Jephat; Mann, Johannes F. E.; Anand, Sonia S.; Teo, Kuun; Yusuf, S.		PURE Investigator; EPIDREAM Investigator; TARGET TRANSCEND Investigator	Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies	LANCET			English	Article							PLASMA-RENIN ACTIVITY; LOW-INCOME COUNTRIES; BLOOD-PRESSURE; POTASSIUM EXCRETION; HIGH-RISK; HEART-FAILURE; SALT INTAKE; SPOT URINE; DISEASE; MORTALITY	Background Several studies reported a U-shaped association between urinary sodium excretion and cardiovascular disease events and mortality. Whether these associations vary between those individuals with and without hypertension is uncertain. We aimed to explore whether the association between sodium intake and cardiovascular disease events and all-cause mortality is modified by hypertension status. Methods In this pooled analysis, we studied 133 118 individuals (63 559 with hypertension and 69 559 without hypertension), median age of 55 years (IQR 45-63), from 49 countries in four large prospective studies and estimated 24-h urinary sodium excretion (as group-level measure of intake). We related this to the composite outcome of death and major cardiovascular disease events over a median of 4.2 years (IQR 3.0-5.0) and blood pressure. Findings Increased sodium intake was associated with greater increases in systolic blood pressure in individuals with hypertension (2.08 mm Hg change per g sodium increase) compared with individuals without hypertension (1.22 mm Hg change per g; p(interaction) < 0.0001). In those individuals with hypertension (6835 events), sodium excretion of 7 g/day or more (7060 [11%] of population with hypertension: hazard ratio [HR] 1.23 [95% CI 1.11-1.37]; p < 0.0001) and less than 3 g/day (7006 [11%] of population with hypertension: 1.34 [1.23-1.47]; p < 0.0001) were both associated with increased risk compared with sodium excretion of 4-5 g/day (reference 25% of the population with hypertension). In those individuals without hypertension (3021 events), compared with 4-5 g/day (18 508 [27%] of the population without hypertension), higher sodium excretion was not associated with risk of the primary composite outcome (>= 7 g/day in 6271 [9%] of the population without hypertension; HR 0.90 [95% CI 0.76-1.08]; p = 0.2547), whereas an excretion of less than 3 g/day was associated with a significantly increased risk (7547 [11%] of the population without hypertension; HR 1.26 [95% CI 1.10-1.45]; p = 0.0009). Interpretation Compared with moderate sodium intake, high sodium intake is associated with an increased risk of cardiovascular events and death in hypertensive populations (no association in normotensive population), while the association of low sodium intake with increased risk of cardiovascular events and death is observed in those with or without hypertension. These data suggest that lowering sodium intake is best targeted at populations with hypertension who consume high sodium diets.	[Mente, Andrew; O'Donnell, Martin; Rangarajan, Sumathy; Mann, Johannes F. E.; Anand, Sonia S.; Teo, Kuun; Yusuf, S.] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Mente, Andrew; Anand, Sonia S.; Yusuf, S.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [O'Donnell, Martin; Anand, Sonia S.; Yusuf, S.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [McQueen, Matthew] McMaster Univ, Dept Lab Med, Hamilton, ON, Canada; [O'Donnell, Martin] NUI Galway, HRB Clin Res Facil, Galway, Ireland; [Dagenais, Gilles] Univ Laval, Heart & Lungs Inst, Quebec City, PQ, Canada; [Lear, Scott] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Lear, Scott] Providence Hlth Care, Div Cardiol, Vancouver, BC, Canada; [Diaz, Rafael] Estudios Clin Latinoamer, Rosario, Santa Fe, Argentina; [Avezum, Alvaro] Dante Pazzanese Inst Cardiol, Sao Paulo, SP, Brazil; [Lopez-Jaramillo, Patricia] Univ Santander, Sch Med, Fdn Oftalmol Santander FOSCAL, Floridablanca Santander, Colombia; [Lanas, Fernando] Univ La Frontera, Temuco, Chile; [Wei Li] Chinese Acad Med Sci, Cardiovasc Inst, Natl Ctr Cardiovasc Dis, Beijing, Peoples R China; [Wei Li] Chinese Acad Med Sci, Fuwai Hosp, Beijing, Peoples R China; [Yin Lu] FuWai Hosp, Med Res & Biometr Ctr, Natl Ctr Cardiovasc Dis, Beijing, Peoples R China; [Sun Yi] FuWai Hosp, Natl Ctr Cardiovasc Dis, Med Res & Biometr Ctr, Beijing, Peoples R China; [Lei Rensheng] Ctr Dis Control & Prevent Nanchang Cty, Nanchang City, Jiangxi, Peoples R China; [Iqbal, Romaina] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; [Iqbal, Romaina] Aga Khan Univ, Dept Med, Karachi, Pakistan; [Mony, Prem] St Johns Res Inst, Community Hlth & Epidemiol, Bangalore, Karnataka, India; [Yusuf, Rita] Independent Univ, Sch Life Sci, Dhaka, Bangladesh; [Yusuf, Rita] Independent Univ, Ctr Hlth Populat & Dev, Dhaka, Bangladesh; [Yusoff, Khalid] Univ Teknol MARA, Fac Med, Sungai Buloh, Selangor, Malaysia; [Szuba, Andrzej] Wroclaw Med Univ, Div Angiol, Wroclaw, Poland; [Szuba, Andrzej] 4th Mil Hosp, Dept Internal Med, Wroclaw, Poland; [Oguz, Aytekin] Istanbul Medeniyet Univ, Fac Med, Dept Internal Med, Istanbul, Turkey; [Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [Bahonar, Ahmad] Isfahan Univ Med Sci, Cardiovasc Res Inst, Hypertens Res Ctr, Esfahan, Iran; [Yusufali, Afzalhussein] Dubai Hlth Author, Hatta Hosp, Dubai, U Arab Emirates; [Schutte, Aletta Elisabeth] North West Univ, MRC Unit Hypertens & CVD Hypertens Africa Res Tea, Potchefstroom, North West Prov, South Africa; [Chifamba, Jephat] Univ Zimbabwe, Coll Hlth Sci, Dept Physiol, Harare, Zimbabwe; [Mann, Johannes F. E.] Univ Erlangen Nurnberg, Dept Nephrol, Munich, Germany; [Mann, Johannes F. E.] Munich Gen Hosp, Munich, Germany	McMaster University; Population Health Research Institute; McMaster University; McMaster University; McMaster University; Health Research Board - Ireland; Ollscoil na Gaillimhe-University of Galway; Laval University; Simon Fraser University; Instituto Dante Pazzanese de Cardiologia; Universidad Industrial de Santander; Universidad de La Frontera; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Aga Khan University; Aga Khan University; St. John's National Academy of Health Sciences; St. John's Research Institute; Independent University Bangladesh (IUB); Independent University Bangladesh (IUB); Universiti Teknologi MARA; Wroclaw Medical University; Istanbul Medeniyet University; University of Gothenburg; Isfahan University Medical Science; North West University - South Africa; University of Zimbabwe; University of Erlangen Nuremberg	Mente, A (corresponding author), McMaster Univ, Clin Epidemiol & Biostat, Hamilton, ON L8L 2X2, Canada.	andrew.mente@phri.ca	Yusoff, Khalid/I-7029-2019; Sun, Yi/AIB-4900-2022; Bahonar, Ahmad/Q-7698-2019; Lanas, Fernando/AAE-8842-2022; Mony, Prem K./GRF-4752-2022; Mann, Johannes/AAI-8803-2020; Szuba, Andrzej/AAY-1162-2020; O'Donnell, Martin/ABE-7459-2020; Chifamba, Jephat/AHE-4535-2022; Schutte, Aletta E/E-5126-2018; Avezum, Alvaro/AAP-7687-2020; Oguz, Aytekin/AAJ-2732-2021	Yusoff, Khalid/0000-0001-5669-5188; Sun, Yi/0000-0003-0474-822X; Mony, Prem K./0000-0002-1399-0520; O'Donnell, Martin/0000-0002-7347-7761; Chifamba, Jephat/0000-0001-8166-1182; Schutte, Aletta E/0000-0001-9217-4937; Oguz, Aytekin/0000-0002-2595-5167; Lanas, Fernando/0000-0003-3595-9759; Lopez-Jaramillo, Patricio/0000-0002-9122-8742; Yusufali, Afzalhussein/0000-0003-3378-2646; Yusuf, Rita/0000-0002-0151-9571; Yusuf, Salim/0000-0003-4776-5601; AVEZUM, ALVARO/0000-0002-3073-6890; Szuba, Andrzej/0000-0002-7555-6201; Teo, Koon/0000-0002-3731-0956; Iqbal, Romaina/0000-0002-5364-4366	Population Health Research Institute; Canadian Institutes of Health Research; Heart and Stroke Foundation of Ontario, Canada; AstraZeneca (Sweden, Canada, Turkey); Sanofi-Aventis (France, Canada, Turkey); Boehringer Ingelheim (Germany); Boehringer Ingelheim (Canada); Servier; GlaxoSmithKline; Novartis; King Pharma; Bangladesh Independent University and Mitra and Associates, Bangladesh; Unilever Health Institute, Brazil; Public Health Agency of Canada; Champlain Cardiovascular Disease Prevention Network, Canada; Universidad de la Frontera, Chile; National Center for Cardiovascular Diseases, China; Colciencias, Colombia [6566-04-18062]; Indian Council of Medical Research, India; Ministry of Science, Technology and Innovation, Malaysia [07-05-IFN-MEB010]; Ministry of Higher Education, Malaysia [600-RMI/LRGS/5/3]; Universiti Kebangsaan Malaysia, Malaysia [UKM-Hejim-Komuniti-15-2010]; Ministry of Science and Higher Education, Poland [290/W-PURE/2008/0]; Wroclaw Medical University, Poland; North-West University, South Africa; South Africa Netherlands Research Programme on Alternatives in Development (SANPAD); National Research Foundation; Medical Research Council of South Africa; South Africa Sugar Association (SASA), South Africa; Faculty of Community and Health Sciences (UWC), South Africa; Council for Working Life and Social Research, Sweden; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, Sweden; Swedish Heart and Lung Foundation, Sweden; Swedish Research Council; Swedish State under LUA (LakarUtbildningsAvtalet); Vastra Gotaland Region (FOUU), Sweden; Metabolic Syndrome Society; Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences; Dubai Health Authority, Dubai, the United Arab Emirates; Sanofi-Aventis Global; Sanofi Aventis Canada; Genome Quebec Innovation Centre; Heart and Stroke Foundation of Canada; Boehringer Ingelheim	Population Health Research Institute; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario, Canada(Heart & Stroke Foundation of Ontario); AstraZeneca (Sweden, Canada, Turkey)(AstraZeneca); Sanofi-Aventis (France, Canada, Turkey); Boehringer Ingelheim (Germany)(Boehringer Ingelheim); Boehringer Ingelheim (Canada)(Boehringer Ingelheim); Servier(Servier); GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); King Pharma; Bangladesh Independent University and Mitra and Associates, Bangladesh; Unilever Health Institute, Brazil(Unilever); Public Health Agency of Canada; Champlain Cardiovascular Disease Prevention Network, Canada; Universidad de la Frontera, Chile; National Center for Cardiovascular Diseases, China; Colciencias, Colombia(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR)); Ministry of Science, Technology and Innovation, Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia); Universiti Kebangsaan Malaysia, Malaysia; Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland); Wroclaw Medical University, Poland; North-West University, South Africa; South Africa Netherlands Research Programme on Alternatives in Development (SANPAD); National Research Foundation; Medical Research Council of South Africa(South African Medical Research Council); South Africa Sugar Association (SASA), South Africa; Faculty of Community and Health Sciences (UWC), South Africa; Council for Working Life and Social Research, Sweden; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, Sweden; Swedish Heart and Lung Foundation, Sweden; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish State under LUA (LakarUtbildningsAvtalet); Vastra Gotaland Region (FOUU), Sweden; Metabolic Syndrome Society; Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences; Dubai Health Authority, Dubai, the United Arab Emirates; Sanofi-Aventis Global; Sanofi Aventis Canada(Sanofi-Aventis); Genome Quebec Innovation Centre; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Boehringer Ingelheim(Boehringer Ingelheim)	The main PURE study and its components are funded by the Population Health Research Institute, the Canadian Institutes of Health Research, the Heart and Stroke Foundation of Ontario, Canada, and by unrestricted grants from AstraZeneca (Sweden, Canada, Turkey), Sanofi-Aventis (France, Canada, Turkey), Boehringer Ingelheim (Germany and Canada), Servier, GlaxoSmithKline, Novartis, King Pharma; by the Bangladesh Independent University and Mitra and Associates, Bangladesh, Unilever Health Institute, Brazil, Public Health Agency of Canada, Champlain Cardiovascular Disease Prevention Network, Canada, Universidad de la Frontera, Chile, National Center for Cardiovascular Diseases, China, Colciencias, Colombia (grant number 6566-04-18062), Indian Council of Medical Research, India, Ministry of Science, Technology and Innovation (grant number 07-05-IFN-MEB010), Malaysia, Ministry of Higher Education (grant number 600-RMI/LRGS/5/3), Malaysia, Universiti Kebangsaan Malaysia (UKM-Hejim-Komuniti-15-2010), Malaysia, Ministry of Science and Higher Education (grant number 290/W-PURE/2008/0), Poland, Wroclaw Medical University, Poland, The North-West University, South Africa, South Africa Netherlands Research Programme on Alternatives in Development (SANPAD), National Research Foundation, Medical Research Council of South Africa, The South Africa Sugar Association (SASA), South Africa, Faculty of Community and Health Sciences (UWC), South Africa, Council for Working Life and Social Research, Sweden, Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, Sweden, Swedish Heart and Lung Foundation, Sweden, Swedish Research Council, grant from the Swedish State under LUA (LakarUtbildningsAvtalet) agreement, and grant from the Vastra Gotaland Region (FOUU), Sweden, Metabolic Syndrome Society, and the Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences, Dubai Health Authority, Dubai, the United Arab Emirates. EPIDREAM was funded by a grant from the Canadian Institutes of Health Research University Industry competition with partner funding from the GlaxoSmithKline and Sanofi-Aventis Global, Sanofi Aventis Canada, Genome Quebec Innovation Centre, Heart and Stroke Foundation of Canada. The ONTARGET and TRANSCEND trials were funded by Boehringer Ingelheim.	ALDERMAN MH, 1991, NEW ENGL J MED, V324, P1098, DOI 10.1056/NEJM199104183241605; Anand SS, 2012, EUR J PREV CARDIOL, V19, P755, DOI 10.1177/1741826711409327; Benavente OR, 2013, LANCET, V382, P507, DOI 10.1016/S0140-6736(13)60852-1; Benedict CR, 1996, CIRCULATION, V94, P690, DOI 10.1161/01.CIR.94.4.690; BRUNNER HR, 1972, NEW ENGL J MED, V286, P441, DOI 10.1056/NEJM197203022860901; Brunstrom M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i717; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; Corsi DJ, 2013, AM HEART J, V166, P636, DOI 10.1016/j.ahj.2013.04.019; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Czernichow S, 2011, J HYPERTENS, V29, P4, DOI 10.1097/HJH.0b013e32834000be; Dienert HC, 2008, LANCET NEUROL, V7, P875, DOI 10.1016/S1474-4422(08)70198-4; Ekinci EI, 2011, DIABETES CARE, V34, P703, DOI 10.2337/dc10-1723; Emdin CA, 2015, JAMA-J AM MED ASSOC, V313, P603, DOI 10.1001/jama.2014.18574; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Geerling JC, 2008, EXP PHYSIOL, V93, P177, DOI 10.1113/expphysiol.2007.039891; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Graudal N, 2014, AM J HYPERTENS, V27, P1129, DOI 10.1093/ajh/hpu028; Graudal NA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004022.pub3; Han WZ, 2015, AM J HYPERTENS, V28, P1368, DOI 10.1093/ajh/hpv037; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; He FJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004937.pub2; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; Jantsch J, 2015, CELL METAB, V21, P493, DOI 10.1016/j.cmet.2015.02.003; Joosten MM, 2014, CIRCULATION, V129, P1121, DOI 10.1161/CIRCULATIONAHA.113.004290; Kawamura M, 2006, HYPERTENS RES, V29, P397, DOI 10.1291/hypres.29.397; Kawamura M, 2015, CLIN EXP HYPERTENS, V37, P89, DOI 10.3109/10641963.2014.913601; KAWASAKI T, 1993, CLIN EXP PHARMACOL P, V20, P7, DOI 10.1111/j.1440-1681.1993.tb01496.x; Kotchen TA, 2013, NEW ENGL J MED, V368, P1229, DOI 10.1056/NEJMra1212606; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lonn EM, 2016, NEW ENGL J MED, V374, P2009, DOI 10.1056/NEJMoa1600175; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; McCarron DA, 2013, AM J HYPERTENS, V26, P1218, DOI 10.1093/ajh/hpt139; Mente A, 2014, NEW ENGL J MED, V371, P601, DOI 10.1056/NEJMoa1311989; Mente A, 2014, J HYPERTENS, V32, P1005, DOI 10.1097/HJH.0000000000000122; Mozaffarian D, 2014, NEW ENGL J MED, V371, P624, DOI 10.1056/NEJMoa1304127; O'Donnell M, 2014, NEW ENGL J MED, V371, P2137, DOI 10.1056/NEJMc1412113; O'Donnell M, 2014, NEW ENGL J MED, V371, P612, DOI 10.1056/NEJMoa1311889; O'Donnell MJ, 2011, JAMA-J AM MED ASSOC, V306, P2229, DOI 10.1001/jama.2011.1729; OLIVER WJ, 1975, CIRCULATION, V52, P146, DOI 10.1161/01.CIR.52.1.146; Oparil S, 2014, NEW ENGL J MED, V371, P677, DOI 10.1056/NEJMe1407695; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; Pfister R, 2014, EUR J HEART FAIL, V16, P394, DOI 10.1002/ejhf.56; Rakova N, 2013, CELL METAB, V17, P125, DOI 10.1016/j.cmet.2012.11.013; Sim JJ, 2014, J CLIN HYPERTENS, V16, P805, DOI 10.1111/jch.12419; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Stolarz-Skrzypek K, 2011, JAMA-J AM MED ASSOC, V305, P1777, DOI 10.1001/jama.2011.574; Sundstrom J, 2014, LANCET, V384, P591, DOI 10.1016/S0140-6736(14)61212-5; Teo K, 2013, JAMA-J AM MED ASSOC, V309, P1613, DOI 10.1001/jama.2013.3519; Thomas MC, 2011, DIABETES CARE, V34, P861, DOI 10.2337/dc10-1722; Titze J, 2014, CAN J CARDIOL, V30, P473, DOI 10.1016/j.cjca.2014.02.006; Verma S, 2011, EUR HEART J, V32, P2135, DOI 10.1093/eurheartj/ehr066; WEINBERGER MH, 1991, AM J HYPERTENS, V4, pS615, DOI 10.1093/ajh/4.11S.615S; Yusuf S, 2008, LANCET, V372, P1174, DOI 10.1016/S0140-6736(08)61242-8; Yusuf S, 2014, NEW ENGL J MED, V371, P818, DOI 10.1056/NEJMoa1311890; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4; Zoccali C, 2002, CIRCULATION, V105, P1354, DOI 10.1161/hc1102.105261	59	291	305	8	107	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 30	2016	388	10043					465	475		10.1016/S0140-6736(16)30467-6	http://dx.doi.org/10.1016/S0140-6736(16)30467-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS2EK	27216139	Green Submitted			2022-12-28	WOS:000380559400026
J	Bretthauer, M; Kalager, M; Adami, HO; Hoff, G				Bretthauer, Michael; Kalager, Mette; Adami, Hans-Olov; Hoff, Geir			Who Is for CO2? Slow Adoption of Carbon Dioxide Insufflation in Colonoscopy	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Bretthauer, Michael; Kalager, Mette; Adami, Hans-Olov] Univ Oslo, Oslo Univ Hosp, Dept Hlth Management & Hlth Econ, Forskningsveien 2b, N-0318 Oslo, Norway; Canc Registry Norway, Oslo, Norway; Harvard Sch Publ Hlth, Boston, MA USA; [Hoff, Geir] Telemark Hosp, Ulefossveien 10, N-3710 Skien, Norway	University of Oslo; University of Oslo; Harvard University; Harvard T.H. Chan School of Public Health; Telemark Hospital Trust	Bretthauer, M (corresponding author), Univ Oslo, Dept Hlth Management & Hlth Econ, Forskningsveien 2b, N-0318 Oslo, Norway.	michael.bretthauer@medisin.uio.no						Hoff G, 2012, ENDOSCOPY, V44, P349, DOI 10.1055/s-0031-1291657; HUSSEIN AMJ, 1984, GASTROINTEST ENDOSC, V30, P68, DOI 10.1016/S0016-5107(84)72319-4; Janssens F, 2009, WORLD J GASTROENTERO, V15, P1475, DOI 10.3748/wjg.15.1475; Lynch I, 2015, GASTROENTEROL NURS, V38, P211, DOI 10.1097/SGA.0000000000000109; Maple JT, 2013, GASTROINTEST ENDOSC, V77, P519, DOI DOI 10.1016/J.GIE.2012.09.025; SALTZMAN HA, 1968, ANN NY ACAD SCI, V150, P31, DOI 10.1111/j.1749-6632.1968.tb19028.x; Sumanac K, 2002, GASTROINTEST ENDOSC, V56, P190, DOI 10.1067/mge.2002.126391; WILLIAMS CB, 1986, GASTROINTEST ENDOSC, V32, P365, DOI 10.1016/S0016-5107(86)71891-9; Wu J, 2012, ENDOSCOPY, V44, P128, DOI 10.1055/s-0031-1291487; Yamano H, 2010, J GASTROENTEROL, V45, P1235, DOI 10.1007/s00535-010-0286-5	10	3	3	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2016	165	2					145	+		10.7326/M16-0209	http://dx.doi.org/10.7326/M16-0209			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS2GY	27159139				2022-12-28	WOS:000380583100023
J	Gardiner, JR				Gardiner, Jennifer R.			EVOLUTION The bigger, the better	NATURE			English	Editorial Material																		Lupold S, 2016, NATURE, V533, P535, DOI 10.1038/nature18005	1	1	1	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2016	533	7604					476	476		10.1038/533476a	http://dx.doi.org/10.1038/533476a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6EJ	27225117				2022-12-28	WOS:000376443100027
J	Shapiro, MF				Shapiro, Martin F.			Considering the Common Good - The View from Seven Miles Up	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Shapiro, Martin F.] Univ Calif Los Angeles, David Geffen Sch Med, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA 90095 USA; [Shapiro, Martin F.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Hlth Policy & Management, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Shapiro, MF (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA 90095 USA.; Shapiro, MF (corresponding author), Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Hlth Policy & Management, Los Angeles, CA USA.							American Medical Association, PRINC MED ETH; [Anonymous], 2009, CAN OV SUPP PUBL HLT; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Huynh TN, 2014, CRIT CARE MED, V42, P1977, DOI 10.1097/CCM.0000000000000402; Nanos N., 2009, CANADIANS OVERWHELMI	5	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 26	2016	374	21					2006	2007		10.1056/NEJMp1601144	http://dx.doi.org/10.1056/NEJMp1601144			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DM6EN	27223145				2022-12-28	WOS:000376443500003
J	Wigginton, NS; Fahrenkamp-Uppenbrink, J; Wible, B; Malakoff, D				Wigginton, Nicholas S.; Fahrenkamp-Uppenbrink, Julia; Wible, Brad; Malakoff, David			CITIES ARE THE FUTURE	SCIENCE			English	Editorial Material													Wigginton, Nicholas/F-1747-2011	Wigginton, Nicholas/0000-0001-9161-6131					0	80	89	3	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2016	352	6288			SI		904	905		10.1126/science.352.6288.904	http://dx.doi.org/10.1126/science.352.6288.904			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM2AK	27199407				2022-12-28	WOS:000376147800024
J	Dorn, GW				Dorn, Gerald W., II			Tension-Time Integrals and Genetic Cardiomyopathy: The Force Is with You	CELL			English	Editorial Material							DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY	Hundreds of different mutations in genes encoding a few dozen sarcomeric proteins cause two reciprocal human disease phenotypes, hypertrophic or dilated cardiomyopathy. How molecular dysfunction evokes different patterns of cardiac remodeling is unclear. Davis et al. describe a biophysical metric of cardiomyocyte function, the force-time integral, which predicts disease phenotype.	[Dorn, Gerald W., II] Washington Univ, Sch Med, Dept Internal Med, Ctr Pharmacogen, St Louis, MO 63110 USA	Washington University (WUSTL)	Dorn, GW (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Ctr Pharmacogen, St Louis, MO 63110 USA.	gdorn@wustl.edu						Davis J, 2016, CELL, V165, P1147, DOI 10.1016/j.cell.2016.04.002; Debold EP, 2007, AM J PHYSIOL-HEART C, V293, pH284, DOI 10.1152/ajpheart.00128.2007; Green EM, 2016, SCIENCE, V351, P617, DOI 10.1126/science.aad3456; Hershberger RE, 2013, NAT REV CARDIOL, V10, P531, DOI 10.1038/nrcardio.2013.105; Liggett SB, 2000, CIRCULATION, V101, P1707; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Morita H, 2005, J CLIN INVEST, V115, P518, DOI 10.1172/JCI200524351; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Spirito P, 1997, NEW ENGL J MED, V336, P775, DOI 10.1056/NEJM199703133361107	9	1	1	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2016	165	5					1049	1050		10.1016/j.cell.2016.04.036	http://dx.doi.org/10.1016/j.cell.2016.04.036			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DM6QT	27203107	Bronze			2022-12-28	WOS:000376478200005
J	Mutsaerts, MAQ; van Oers, AM; Groen, H; Burggraaff, JM; Kuchenbecker, WKH; Perquin, DAM; Koks, CAM; van Golde, R; Kaaijk, EM; Schierbeek, JM; Oosterhuis, GJE; Broekmans, FJ; Bemelmans, WJE; Lambalk, CB; Verberg, MFG; van der Veen, F; Klijn, NF; Mercelina, PEAM; van Kasteren, YM; Nap, AW; Brinkhuis, EA; Vogel, NEA; Mulder, RJAB; Gondrie, ETCM; de Bruin, JP; Sikkema, JM; de Greef, MHG; ter Bogt, NCW; Land, JA; Mol, BWJ; Hoek, A				Mutsaerts, Meike A. Q.; van Oers, Anne M.; Groen, Henk; Burggraaff, Jan M.; Kuchenbecker, Walter K. H.; Perquin, Denise A. M.; Koks, Carolien A. M.; van Golde, Ron; Kaaijk, Eugenie M.; Schierbeek, Jaap M.; Oosterhuis, Gerrit J. E.; Broekmans, Frank J.; Bemelmans, Wanda J. E.; Lambalk, Cornelis B.; Verberg, Marieke F. G.; van der Veen, Fulco; Klijn, Nicole F.; Mercelina, Patricia E. A. M.; van Kasteren, Yvonne M.; Nap, Annemiek W.; Brinkhuis, Egbert A.; Vogel, Niels E. A.; Mulder, Robert J. A. B.; Gondrie, Ed T. C. M.; de Bruin, Jan P.; Sikkema, J. Marko; de Greef, Mathieu H. G.; ter Bogt, Nancy C. W.; Land, Jolande A.; Mol, Ben W. J.; Hoek, Annemieke			Randomized Trial of a Lifestyle Program in Obese Infertile Women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BODY-MASS INDEX; POLYCYSTIC-OVARY-SYNDROME; WEIGHT-LOSS; OVERWEIGHT; PREGNANCY; RISK; SUBFERTILE; IMPROVEMENT; MANAGEMENT; ENDOCRINE	BACKGROUND Small lifestyle-intervention studies suggest that modest weight loss increases the chance of conception and may improve perinatal outcomes, but large randomized, controlled trials are lacking. METHODS We randomly assigned infertile women with a body-mass index (the weight in kilograms divided by the square of the height in meters) of 29 or higher to a 6-month lifestyle intervention preceding treatment for infertility or to prompt treatment for infertility. The primary outcome was the vaginal birth of a healthy singleton at term within 24 months after randomization. RESULTS We assigned women who did not conceive naturally to one of two treatment strategies: 290 women were assigned to a 6-month lifestyle-intervention program preceding 18 months of infertility treatment (intervention group) and 287 were assigned to prompt infertility treatment for 24 months (control group). A total of 3 women withdrew consent, so 289 women in the intervention group and 285 women in the control group were included in the analysis. The discontinuation rate in the intervention group was 21.8%. In intention-to-treat analyses, the mean weight loss was 4.4 kg in the intervention group and 1.1 kg in the control group (P< 0.001). The primary outcome occurred in 27.1% of the women in the intervention group and 35.2% of those in the control group (rate ratio in the intervention group, 0.77; 95% confidence interval, 0.60 to 0.99). CONCLUSIONS In obese infertile women, a lifestyle intervention preceding infertility treatment, as compared with prompt infertility treatment, did not result in higher rates of a vaginal birth of a healthy singleton at term within 24 months after randomization. (Funded by the Netherlands Organization for Health Research and Development; Netherlands Trial Register number, NTR1530.)	[Mutsaerts, Meike A. Q.; van Oers, Anne M.; Land, Jolande A.; Hoek, Annemieke] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, POB 30001, NL-9400 RB Groningen, Netherlands; [Mutsaerts, Meike A. Q.] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, NL-9400 RB Groningen, Netherlands; [Groen, Henk] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9400 RB Groningen, Netherlands; [de Greef, Mathieu H. G.] Univ Groningen, Univ Med Ctr Groningen, Inst Human Movement Sci, NL-9400 RB Groningen, Netherlands; [Vogel, Niels E. A.] Martini Hosp, Dept Obstet & Gynecol, Groningen, Netherlands; [de Greef, Mathieu H. G.] Hanze Univ Appl Sci, Res & Innovat Grp Hlth Care & Nursing, Groningen, Netherlands; [Burggraaff, Jan M.] Scheper Hosp, Dept Obstet & Gynecol, Emmen, Netherlands; [Kuchenbecker, Walter K. H.] Isala Clin, Dept Obstet & Gynecol, Zwolle, Netherlands; [Perquin, Denise A. M.] Med Ctr Leeuwarden, Dept Obstet & Gynecol, Leeuwarden, Netherlands; [Koks, Carolien A. M.] Maxima Med Ctr, Dept Obstet & Gynecol, Veldhoven, Netherlands; [van Golde, Ron] Maastricht Univ, Med Ctr, Dept Obstet & Gynecol, NL-6200 MD Maastricht, Netherlands; [Kaaijk, Eugenie M.] Onze Lieve Vrouw Hosp, Dept Obstet & Gynecol, Amsterdam, Netherlands; [Lambalk, Cornelis B.] Vrije Univ Amsterdam, Dept Obstet & Gynecol, Med Ctr, Amsterdam, Netherlands; [van der Veen, Fulco] Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Schierbeek, Jaap M.] Deventer Hosp, Dept Obstet & Gynecol, Deventer, Netherlands; [Oosterhuis, Gerrit J. E.] St Antonius Hosp, Dept Obstet & Gynecol, Nieuwegein, Netherlands; [Broekmans, Frank J.] Univ Utrecht, Dept Reprod Med, Div Female & Baby, Univ Med Ctr Utrecht, Utrecht, Netherlands; [Bemelmans, Wanda J. E.] Natl Inst Publ Hlth & Environm, Ctr Prevent & Hlth Serv Res, NL-3720 BA Bilthoven, Netherlands; [Verberg, Marieke F. G.] Med Spectrum Twente, Dept Obstet & Gynecol, Enschede, Netherlands; [Klijn, Nicole F.] Leiden Univ, Med Ctr, Dept Gynecol & Reprod Med, Leiden, Netherlands; [Mercelina, Patricia E. A. M.] Atrium Med Ctr, Dept Obstet & Gynecol, Heerlen, Netherlands; [van Kasteren, Yvonne M.] Med Ctr Alkmaar, Dept Obstet & Gynecol, Alkmaar, Netherlands; [Nap, Annemiek W.] Rijnstate Hosp, Dept Obstet & Gynecol, Arnhem, Netherlands; [Brinkhuis, Egbert A.] Meander Med Ctr, Dept Obstet & Gynecol, Amersfoort, Netherlands; [Mulder, Robert J. A. B.] Laurentius Hosp, Dept Obstet & Gynecol, Roermond, Netherlands; [Gondrie, Ed T. C. M.] Orbis Med Ctr, Dept Obstet & Gynecol, Sittard, Netherlands; [de Bruin, Jan P.] Jeroen Bosch Hosp, Dept Obstet & Gynecol, Shertogenbosch, Netherlands; [Sikkema, J. Marko] Zorggroep Twente Hosp, Dept Obstet & Gynecol, Almelo, Netherlands; [ter Bogt, Nancy C. W.] Acute Zorg Euregio, Enschede, Netherlands; [Mol, Ben W. J.] Univ Adelaide, Sch Paediat & Reprod Hlth, Robinson Res Inst, Adelaide, SA, Australia; [Mol, Ben W. J.] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia	University of Groningen; University of Groningen; University of Groningen; University of Groningen; Martini Hospital; Isala Clinics; Medical Center Leeuwarden; Maxima Medical Center; Maastricht University; Onze Lieve Vrouwe Gasthuis Hospital; Vrije Universiteit Amsterdam; University of Amsterdam; Deventer Hospital; St. Antonius Hospital Utrecht; Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Medical Spectrum Twente; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Atrium Medical Center; Medical Center Of Alkmaar; Rijnstate Hospital; Meander Medisch Centrum; Orbis Medical Center; Jeroen Bosch Ziekenhuis; Robinson Research Institute; University of Adelaide; South Australian Health & Medical Research Institute (SAHMRI)	Hoek, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, POB 30001, NL-9400 RB Groningen, Netherlands.	a.hoek@umcg.nl	Groen, Henk/B-2163-2013; NAP, Annemiek/ABE-1897-2021	Groen, Henk/0000-0002-6629-318X; Lambalk, Cornelis/0000-0003-3947-5129	Netherlands Organization for Health Research and Development	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development)	Funded by the Netherlands Organization for Health Research and Development; Netherlands Trial Register number, NTR1530.	[Anonymous], 1995, HUM REPROD, V10, P1549; [Anonymous], 2008, CBO GUID DIAGN BEH O; Aune D, 2014, JAMA-J AM MED ASSOC, V311, P1536, DOI 10.1001/jama.2014.2269; Bayram N, 2004, BMJ-BRIT MED J, V328, P192, DOI 10.1136/bmj.328.7433.192; Clark AM, 1998, HUM REPROD, V13, P1502, DOI 10.1093/humrep/13.6.1502; Cnattingius S, 2013, JAMA-J AM MED ASSOC, V309, P2362, DOI 10.1001/jama.2013.6295; Correa A, 2013, NUTR REV, V71, pS68, DOI 10.1111/nure.12058; Custers IM, 2012, HUM REPROD, V27, P444, DOI 10.1093/humrep/der389; Dutch Society of Obstetrics and Gynaecology ( NVOG), DAT SHEET; EUROCAT, MINOR ANOMALIES FOR; GUZICK DS, 1994, FERTIL STERIL, V61, P598; Huber-Buchholz MM, 1999, J CLIN ENDOCR METAB, V84, P1470, DOI 10.1210/jc.84.4.1470; Hunault CC, 2004, HUM REPROD, V19, P2019, DOI 10.1093/humrep/deh365; KIDDY DS, 1992, CLIN ENDOCRINOL, V36, P105, DOI 10.1111/j.1365-2265.1992.tb02909.x; Kiran TSU, 2005, BJOG-INT J OBSTET GY, V112, P768, DOI 10.1111/j.1471-0528.2004.00546.x; Kuchenbecker WKH, 2014, OBESITY, V22, P537, DOI 10.1002/oby.20452; Kuchenbecker WKH, 2010, J CLIN ENDOCR METAB, V95, P2107, DOI 10.1210/jc.2009-1915; Legro RS, 2007, NEW ENGL J MED, V356, P551, DOI 10.1056/NEJMoa063971; Legro RS, 2014, HUM REPROD, V29, P2075, DOI 10.1093/humrep/deu218; Metwally M, 2008, FERTIL STERIL, V90, P714, DOI 10.1016/j.fertnstert.2007.07.1290; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Mutsaerts MAQ, 2013, HUM REPROD, V28, P979, DOI 10.1093/humrep/det026; Mutsaerts MAQ, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-22; National Institute for Clinical Excellence, 2004, FERTILITY ASSESSMENT; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Ovesen P, 2011, OBSTET GYNECOL, V118, P305, DOI 10.1097/AOG.0b013e3182245d49; Pfeifer S, 2015, FERTIL STERIL, V104, P1116, DOI 10.1016/j.fertnstert.2015.08.018; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Ramlau-Hansen CH, 2007, HUM REPROD, V22, P1634, DOI 10.1093/humrep/dem035; RICHEDWARDS JW, 1994, AM J OBSTET GYNECOL, V171, P171, DOI 10.1016/0002-9378(94)90465-0; Rittenberg V, 2011, REPROD BIOMED ONLINE, V23, P421, DOI 10.1016/j.rbmo.2011.06.018; Tarlatzis BC, 2008, HUM REPROD, V23, P462, DOI 10.1093/humrep/dem426; ter Bogt NCW, 2009, AM J PREV MED, V37, P270, DOI 10.1016/j.amepre.2009.06.011; Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.02.001, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.04.017]; Tsagareli V, 2006, FERTIL STERIL, V86, P227, DOI 10.1016/j.fertnstert.2005.12.041; van der Steeg JW, 2008, HUM REPROD, V23, P324, DOI 10.1093/humrep/dem371; Visser GHA, 2009, EARLY HUM DEV, V85, P737, DOI 10.1016/j.earlhumdev.2009.09.008; Voedingscentrum, MIJN EETM SCAN JE DA; Vrebosch L, 2012, OBES SURG, V22, P1568, DOI 10.1007/s11695-012-0740-y	39	142	145	1	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 19	2016	374	20					1942	1953		10.1056/NEJMoa1505297	http://dx.doi.org/10.1056/NEJMoa1505297			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM1OX	27192672	Green Published, Bronze			2022-12-28	WOS:000376116600007
J	Sauter, NK; Echols, N; Adams, PD; Zwart, PH; Kern, J; Brewster, AS; Koroidov, S; Alonso-Mori, R; Zouni, A; Messinger, J; Bergmann, U; Yano, J; Yachandra, VK				Sauter, Nicholas K.; Echols, Nathaniel; Adams, Paul D.; Zwart, Petrus H.; Kern, Jan; Brewster, Aaron S.; Koroidov, Sergey; Alonso-Mori, Roberto; Zouni, Athina; Messinger, Johannes; Bergmann, Uwe; Yano, Junko; Yachandra, Vittal K.			No observable conformational changes in PSII	NATURE			English	Letter							PHOTOSYSTEM-II		[Sauter, Nicholas K.; Echols, Nathaniel; Adams, Paul D.; Zwart, Petrus H.; Kern, Jan; Brewster, Aaron S.; Yano, Junko; Yachandra, Vittal K.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA; [Kern, Jan; Alonso-Mori, Roberto; Bergmann, Uwe] SLAC Natl Accelerator Lab, LCLS, Menlo Pk, CA 94025 USA; [Koroidov, Sergey; Messinger, Johannes] Umea Univ, Kemiskt Biol Ctr, Inst Kemi, S-90187 Umea, Sweden; [Zouni, Athina] Humboldt Univ, Inst Biol, D-10099 Berlin, Germany; [Koroidov, Sergey; Bergmann, Uwe] SLAC Natl Accelerator Lab, Stanford PULSE Inst, Menlo Pk, CA 94025 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Umea University; Humboldt University of Berlin; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Sauter, NK; Yachandra, VK (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA.	NKSauter@lbl.gov; VKYachandra@lbl.gov	Messinger, Johannes/AAC-4221-2019; Sauter, Nicholas K/K-3430-2012; Koroidov, Sergey/U-1115-2018; Adams, Paul David/A-1977-2013; alonso mori, roberto/G-2638-2013; Kern, Jan/G-2586-2013	Messinger, Johannes/0000-0003-2790-7721; Koroidov, Sergey/0000-0003-4823-2188; Adams, Paul David/0000-0001-9333-8219; alonso mori, roberto/0000-0002-5357-0934; Kern, Jan/0000-0002-7272-1603	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055302, R01GM117126] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM055302, R01 GM117126] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; de Wijn R, 2001, BIOCHEMISTRY-US, V40, P11912, DOI 10.1021/bi010852r; Grosse-Kunstleve RW, 2003, ACTA CRYSTALLOGR D, V59, P1974, DOI 10.1107/S0907444903021206; HODEL A, 1992, ACTA CRYSTALLOGR A, V48, P851, DOI 10.1107/S0108767392006044; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Krivanek R, 2007, BBA-BIOENERGETICS, V1767, P520, DOI 10.1016/j.bbabio.2007.02.013; Kupitz C, 2014, NATURE, V513, P261, DOI 10.1038/nature13453; Noguchi T, 2012, BIOCHEMISTRY-US, V51, P3205, DOI 10.1021/bi300294n; Oeffner R., 2012, COMPUT CRYSTALLOGR N, V3, P5; Zimmermann K, 2006, BBA-BIOENERGETICS, V1757, P106, DOI 10.1016/j.bbabio.2005.12.002	11	23	23	0	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					E1	E2		10.1038/nature17983	http://dx.doi.org/10.1038/nature17983			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0AH	27193689	Green Accepted, Green Submitted			2022-12-28	WOS:000376004300001
J	Glasziou, P				Glasziou, Paul			Delayed antibiotics reduced antibiotic use in acute respiratory infection without increasing symptom duration	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Glasziou, Paul] Bond Univ, Robina, Qld, Australia	Bond University	Glasziou, P (corresponding author), Bond Univ, Robina, Qld, Australia.		Glasziou, Paul/A-7832-2008	Glasziou, Paul/0000-0001-7564-073X				McCullough AR, 2016, JAMA INTERN MED, V176, P29, DOI 10.1001/jamainternmed.2015.7095; Spurling GKP, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004417.pub3	2	0	1	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2016	164	10					JC50	JC50		10.7326/ACPJC-2016-164-10-050	http://dx.doi.org/10.7326/ACPJC-2016-164-10-050			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8GF	27182916				2022-12-28	WOS:000375878500001
J	White, DB; Ernecoff, N; Buddadhumaruk, P; Hong, S; Weissfeld, L; Curtis, JR; Luce, JM; Lo, B				White, Douglas B.; Ernecoff, Natalie; Buddadhumaruk, Praewpannarai; Hong, Seoyeon; Weissfeld, Lisa; Curtis, J. Randall; Luce, John M.; Lo, Bernard			Prevalence of and Factors Related to Discordance About Prognosis Between Physicians and Surrogate Decision Makers of Critically Ill Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SERIOUSLY ILL; CARE; OUTCOMES; CANCER; FAMILIES; CHILDREN; PARENTS; GOALS	IMPORTANCE Misperceptions about prognosis by individuals making decisions for incapacitated critically ill patients (surrogates) are common and often attributed to poor comprehension of medical information. OBJECTIVE To determine the prevalence of and factors related to physician-surrogate discordance about prognosis in intensive care units (ICUs). DESIGN, SETTING, AND PARTICIPANTS Mixed-methods study comprising quantitative surveys and qualitative interviews conducted in 4 ICUs at a major US medical center involving surrogate decision makers and physicians caring for patients at high risk of death from January 4, 2005, to July 10, 2009. MAIN OUTCOMES AND MEASURES Discordance about prognosis, defined as a difference between a physician's and a surrogate's prognostic estimates of at least 20%; misunderstandings by surrogates (defined as any difference between a physician's prognostic estimate and a surrogate's best guess of that estimate); differences in belief (any difference between a surrogate's actual estimate and their best guess of the physician's estimate). RESULTS Two hundred twenty-nine surrogate decision makers (median age, 47 [interquartile range {IQR}, 35-56] years; 68% women) and 99 physicians were involved in the care of 174 critically ill patients (median age, 60 [IQR, 47-74] years; 44% women). Physician-surrogate discordance about prognosis occurred in 122 of 229 instances (53%; 95% CI, 46.8%-59.7%). In 65 instances (28%), discordance was related to both misunderstandings by surrogates and differences in belief about the patient's prognosis; 38 (17%) were related to misunderstandings by surrogates only; 7 (3%) were related to differences in belief only; and data were missing for 12. Seventy-five patients (43%) died. Surrogates' prognostic estimates were much more accurate than chance alone, but physicians' prognostic estimates were statistically significantly more accurate than surrogates' (C statistic, 0.83 vs 0.74; absolute difference, 0.094; 95% CI, 0.024-0.163; P = .008). Among 71 surrogates interviewed who had beliefs about the prognosis that were more optimistic than that of the physician, the most common reasons for optimism were a need to maintain hope to benefit the patient (n = 34), a belief that the patient had unique strengths unknown to the physician (n = 24), and religious belief (n = 19). CONCLUSIONS AND RELEVANCE Among critically ill patients, discordant expectations about prognosis were common between patients' physicians and surrogate decision makers and were related to misunderstandings by surrogates about physicians' assessments of patients' prognoses and differences in beliefs about patients' prognoses.	[White, Douglas B.; Ernecoff, Natalie; Buddadhumaruk, Praewpannarai; Hong, Seoyeon] Univ Pittsburgh, Clin Res Invest & Syst Modeling Acute Illness Ctr, Dept Crit Care Med, Sch Med, Pittsburgh, PA 15261 USA; [Weissfeld, Lisa] Stat Collaborat, Washington, DC USA; [Curtis, J. Randall] Univ Washington, Sch Med, Div Pulm & Crit Care Med, Seattle, WA USA; [Luce, John M.] Univ Calif San Francisco, Dept Med, Pulm Crit Care Allergy & Sleep Med Program, San Francisco, CA USA; [Lo, Bernard] Univ Calif San Francisco, Dept Med, Program Med Eth, San Francisco, CA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of California System; University of California San Francisco	White, DB (corresponding author), Univ Pittsburgh, Program Eth & Decis Making Crit Illness, Dept Crit Care Med, Med Ctr, 3550 Terrace St,Scaife Hall,Room 608,HPU010604, Pittsburgh, PA 15261 USA.	whitedb@upmc.edu		Curtis, J. Randall/0000-0001-9529-845X	National Institutes of Health [KL2 RR024130, R01 HL094553]; Greenwall Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094553] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Greenwall Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was supported by National Institutes of Health grants KL2 RR024130 and R01 HL094553 and by the Greenwall Foundation (Dr White).	Agresti A, 2013, CATEGORICAL DATA ANA; ALICKE MD, 1995, J PERS SOC PSYCHOL, V68, P804, DOI 10.1037/0022-3514.68.5.804; Azoulay E, 2000, CRIT CARE MED, V28, P3044, DOI 10.1097/00003246-200008000-00061; Burt R.S., 2005, BROKERAGE CLOSURE IN; Char SJL, 2010, AM J RESP CRIT CARE, V182, P905, DOI 10.1164/rccm.201002-0262OC; Cox CE, 2009, CRIT CARE MED, V37, P2888, DOI 10.1097/CCM.0b013e3181ab86ed; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Donnino MW, 2013, RESUSCITATION, V84, P651, DOI 10.1016/j.resuscitation.2012.10.024; Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; Giacomini MK, 2000, JAMA-J AM MED ASSOC, V284, P357, DOI 10.1001/jama.284.3.357; Gigerenzer G, 2003, BMJ-BRIT MED J, V327, P741, DOI 10.1136/bmj.327.7417.741; Glaser B.G., 1965, AWARENESS DYING; HOLLAND JC, 1989, J CLIN ONCOL, V7, P557, DOI 10.1200/JCO.1989.7.5.557; HUSKISSON EC, 1974, LANCET, V2, P1127, DOI 10.1016/S0140-6736(74)90884-8; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Kon AA, 2016, CRIT CARE MED, V44, P188, DOI 10.1097/CCM.0000000000001396; Lloyd CB, 2004, CRIT CARE MED, V32, P649, DOI 10.1097/01.CCM.0000115636.29294.2F; Mack JW, 2007, J CLIN ONCOL, V25, P1357, DOI 10.1200/JCO.2006.08.3170; Mitchell SL, 2009, NEW ENGL J MED, V361, P1529, DOI 10.1056/NEJMoa0902234; Patton MQ, 1999, HEALTH SERV RES, V34, P1189; Sackett DL, 1991, CLIN EPIDEMIOLOGY BA, V2nd; Schenker Y, 2013, J PALLIAT MED, V16, P243, DOI 10.1089/jpm.2012.0331; Silveira MJ, 2010, NEW ENGL J MED, V362, P1211, DOI 10.1056/NEJMsa0907901; Strauss A., 1998, BASICS QUALITATIVE R; Sulmasy DP, 2010, CANCER-AM CANCER SOC, V116, P3702, DOI 10.1002/cncr.25201; Teno JM, 2000, J AM GERIATR SOC, V48, pS70, DOI 10.1111/j.1532-5415.2000.tb03144.x; Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709; Wolfe J, 2000, JAMA-J AM MED ASSOC, V284, P2469, DOI 10.1001/jama.284.19.2469; You JJ, 2015, JAMA INTERN MED, V175, P549, DOI 10.1001/jamainternmed.2014.7732; Zier LS, 2008, CRIT CARE MED, V36, P2341, DOI 10.1097/CCM.0b013e318180ddf9; Zier LS, 2012, ANN INTERN MED, V156, P360, DOI 10.7326/0003-4819-156-5-201203060-00008	31	111	114	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 17	2016	315	19					2086	2094		10.1001/jama.2016.5351	http://dx.doi.org/10.1001/jama.2016.5351			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL9PN	27187301	Bronze			2022-12-28	WOS:000375975300019
J	[Anonymous]				[Anonymous]			Which Oral Anticoagulant for Atrial Fibrillation? (Reprinted from The Medical Letter on Drugs and Therapeutics, vol 58, pg 45, 2016)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint							WARFARIN											[Anonymous], 2015, MED LETT DRUGS THER, V57, P157; [Anonymous], 2013, MED LETT DRUGS THER, V55, P53; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Kalus JS, 2013, AM J HEALTH-SYST PH, V70, pS12, DOI 10.2146/ajhp130041; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Siegal DM, 2015, NEW ENGL J MED, V373, P2413, DOI 10.1056/NEJMoa1510991; US Food and Drug Administration, FDA DRAFT BRIEF DOC	10	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 17	2016	315	19					2117	2118		10.1001/jama.2016.4917	http://dx.doi.org/10.1001/jama.2016.4917			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL9PN	27187306				2022-12-28	WOS:000375975300024
J	Kong, R; Xu, K; Zhou, TQ; Acharya, P; Lemmin, T; Liu, K; Ozorowski, G; Soto, C; Taft, JD; Bailer, RT; Cale, EM; Chen, L; Choi, CW; Chuang, GY; Doria-Rose, NA; Druz, A; Georgiev, IS; Gorman, J; Huang, JH; Joyce, MG; Louder, MK; Ma, XC; Mckee, K; O'Dell, S; Pancera, M; Yang, YP; Blanchard, SC; Mothes, W; Burton, DR; Koff, WC; Connors, M; Ward, AB; Kwong, PD; Mascola, JR				Kong, Rui; Xu, Kai; Zhou, Tongqing; Acharya, Priyamvada; Lemmin, Thomas; Liu, Kevin; Ozorowski, Gabriel; Soto, Cinque; Taft, Justin D.; Bailer, Robert T.; Cale, Evan M.; Chen, Lei; Choi, Chang W.; Chuang, Gwo-Yu; Doria-Rose, Nicole A.; Druz, Aliaksandr; Georgiev, Ivelin S.; Gorman, Jason; Huang, Jinghe; Joyce, M. Gordon; Louder, Mark K.; Ma, Xiaochu; Mckee, Krisha; O'Dell, Sijy; Pancera, Marie; Yang, Yongping; Blanchard, Scott C.; Mothes, Walther; Burton, Dennis R.; Koff, Wayne C.; Connors, Mark; Ward, Andrew B.; Kwong, Peter D.; Mascola, John R.			Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody	SCIENCE			English	Article							VIRAL MEMBRANE-FUSION; CRYO-EM STRUCTURE; ENVELOPE TRIMER; GP41-GP120 INTERFACE; DEPENDENT EPITOPE; CRYSTAL-STRUCTURE; ENV; RECOGNITION; QUATERNARY; DYNAMICS	The HIV-1 fusion peptide, comprising 15 to 20 hydrophobic residues at the N terminus of the Env-gp41 subunit, is a critical component of the virus-cell entry machinery. Here, we report the identification of a neutralizing antibody, N123-VRC34.01, which targets the fusion peptide and blocks viral entry by inhibiting conformational changes in gp120 and gp41 subunits of Env required for entry. Crystal structures of N123-VRC34.01 liganded to the fusion peptide, and to the full Env trimer, revealed an epitope consisting of the N-terminal eight residues of the gp41 fusion peptide and glycan N88 of gp120, and molecular dynamics showed that the N-terminal portion of the fusion peptide can be solvent-exposed. These results reveal the fusion peptide to be a neutralizing antibody epitope and thus a target for vaccine design.	[Kong, Rui; Xu, Kai; Zhou, Tongqing; Acharya, Priyamvada; Liu, Kevin; Soto, Cinque; Taft, Justin D.; Bailer, Robert T.; Cale, Evan M.; Chen, Lei; Choi, Chang W.; Chuang, Gwo-Yu; Doria-Rose, Nicole A.; Druz, Aliaksandr; Georgiev, Ivelin S.; Gorman, Jason; Joyce, M. Gordon; Louder, Mark K.; Mckee, Krisha; O'Dell, Sijy; Pancera, Marie; Yang, Yongping; Kwong, Peter D.; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Lemmin, Thomas] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Ozorowski, Gabriel; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Ozorowski, Gabriel; Ward, Andrew B.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Disc, La Jolla, CA 92037 USA; [Ozorowski, Gabriel; Ward, Andrew B.] Scripps Res Inst, Int AIDS Vaccine Initiat, Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Huang, Jinghe; Connors, Mark] NIAID, HIV Specif Immun Sect, Immunoregulat Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Ma, Xiaochu; Mothes, Walther] Yale Univ, Sch Med, Dept Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06536 USA; [Blanchard, Scott C.] Cornell Univ, Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Burton, Dennis R.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Boston, MA 02142 USA; [Koff, Wayne C.] Int AIDS Vaccine Initiat, New York, NY 10038 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California San Francisco; Scripps Research Institute; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Yale University; Cornell University; International AIDS Vaccine Initiative; Scripps Research Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; International AIDS Vaccine Initiative	Kwong, PD; Mascola, JR (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	pdkwong@nih.gov; jmascola@nih.gov	Ozorowski, Gabriel/HCH-0634-2022; Gorman, Jason/AGG-9417-2022; Huang, Jinghe/P-8068-2019; Blanchard, Scott C./A-5804-2009; Mascola, John/AAI-7193-2021; Lemmin, Thomas/AAO-7849-2021; Ward, Andrew/ABD-7728-2021; Zhou, Tongqing/A-6880-2010; Ward, Andrew B/F-9203-2014	Blanchard, Scott C./0000-0003-2717-9365; Ward, Andrew/0000-0001-7153-3769; Zhou, Tongqing/0000-0002-3935-4637; Ward, Andrew B/0000-0001-7153-3769; Huang, Jinghe/0000-0002-1968-871X; Gorman, Jason/0000-0002-3775-6560; Lemmin, Thomas/0000-0001-5705-4964; Acharya, Priyamvada/0000-0002-0089-277X	Intramural Research Programs of the Vaccine Research Center and Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health; International AIDS Vaccine Initiative's (IAVI's) Neutralizing Antibody Consortium; Bill & Melinda Gates Foundation; Ministry of Foreign Affairs of Denmark, Irish Aid; Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD); UK Department for International Development (DFID); U.S. Agency for International Development (USAID); NIH [R01GM079238, P01GM56550, R01GM116654]; U.S. Department of Energy, Basic Energy Sciences, Office of Science, [W-31-109-Eng-38]; NATIONAL CANCER INSTITUTE [R01CA098727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001090, ZICAI005114, ZIAAI005022, UM1AI100663, ZICAI005112, ZICAI005113, ZICAI005111, ZIAAI005095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079238, R01GM116654, R01GM098859, P01GM056550] Funding Source: NIH RePORTER	Intramural Research Programs of the Vaccine Research Center and Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health; International AIDS Vaccine Initiative's (IAVI's) Neutralizing Antibody Consortium; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Ministry of Foreign Affairs of Denmark, Irish Aid; Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD); UK Department for International Development (DFID); U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Basic Energy Sciences, Office of Science,(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the Flow Cytometry Core, Vaccine Research Center, and especially R. Nguyen for his assistance in cell sorting. We thank members of the Structural Biology Section, Structural Bioinformatics Core Section, and Human Immunology Section, Vaccine Research Center, for discussions and comments on the manuscript. We thank J. Baalwa, D. Ellenberger, F. Gao, B. Hahn, K. Hong, J. Kim, F. McCutchan, D. Montefiori, L. Morris, J. Overbaugh, E. Sanders-Buell, G. Shaw, R. Swanstrom, M. Thomson, S. Tovanabutra, C. Williamson, and L. Zhang for contributing the HIV-1 Envelope plasmids used in our neutralization panel. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. Nucleotide sequences of VRC34.01-VRC34.07 variable regions are available under GenBank accession numbers KU711816 to KU711829. Atomic coordinates and structure factors of the reported crystal structures have been deposited with the Protein Data Bank (PDB) under accession codes 5I8C, 5I8E, and 5I8H. EM data have been deposited with the Electron Microscopy Data Bank under accession code EMD-8125. Support for this work was provided by the Intramural Research Programs of the Vaccine Research Center and Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, and from the International AIDS Vaccine Initiative's (IAVI's) Neutralizing Antibody Consortium. IAVI's work is made possible by support from many donors, including the Bill & Melinda Gates Foundation, the Ministry of Foreign Affairs of Denmark, Irish Aid, the Ministry of Finance of Japan, the Ministry of Foreign Affairs of the Netherlands, the Norwegian Agency for Development Cooperation (NORAD), the UK Department for International Development (DFID), and the U.S. Agency for International Development (USAID). The full list of IAVI donors is available at www.iavi.org. S.C.B. was supported by NIH grants R01GM079238 and P01GM56550. W.M. was supported by NIH grants R01GM116654 and P01GM56550. Use of sector 22 (Southeast Region Collaborative Access team) at the Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract number W-31-109-Eng-38. The following patent applications are pending: U.S. Patent Application 13/202,351, Methods and Compositions for Altering Photopysical Properties of Fluorophores via Proximal Quenching (S.C.B.); U.S. Patent Application 14/373,402 Dye Compositions, Methods of Preparation, Conjugates Thereof, and Methods of Use (S.C.B.); and International and U.S. Patent Application PCT/US13/42249 Reagents and Methods for Identifying Anti-HIV Compounds (S.C.B. and W.M.). S.C.B. holds an equity interest in Lumidyne Technologies Corporation.	Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Do Kwon Y, 2015, NAT STRUCT MOL BIOL, V22, P522, DOI 10.1038/nsmb.3051; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Doria-Rose NA, 2009, J VIROL, V83, P188, DOI 10.1128/JVI.01583-08; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Harvey MJ, 2009, J CHEM THEORY COMPUT, V5, P1632, DOI 10.1021/ct9000685; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Lee JH, 2016, SCIENCE, V351, P1043, DOI 10.1126/science.aad2450; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Munro JB, 2014, SCIENCE, V346, P759, DOI 10.1126/science.1254426; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pancera M, 2013, NAT STRUCT MOL BIOL, V20, P804, DOI 10.1038/nsmb.2600; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373	24	215	222	1	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2016	352	6287					828	833		10.1126/science.aae0474	http://dx.doi.org/10.1126/science.aae0474			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5FP	27174988	Green Submitted, Green Accepted			2022-12-28	WOS:000375663000042
J	Eichler, HG; Hurts, H; Broich, K; Rasi, G				Eichler, Hans-Georg; Hurts, Hugo; Broich, Karl; Rasi, Guido			Drug Regulation and Pricing - Can Regulators Influence Affordability?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Eichler, Hans-Georg; Rasi, Guido] European Med Agcy, London, England; [Hurts, Hugo; Broich, Karl] European Med Agcy, Management Board, London, England; [Eichler, Hans-Georg] Med Univ Vienna, Vienna, Austria; [Hurts, Hugo] Coll Beoordeling Geneesmiddelen, Utrecht, Netherlands; [Broich, Karl] Bundesinst Arzneimittel & Med Prod, Bonn, Germany; [Rasi, Guido] Univ Roma Tor Vergata, Rome, Italy	Medical University of Vienna; University of Rome Tor Vergata	Eichler, HG (corresponding author), European Med Agcy, London, England.; Eichler, HG (corresponding author), Med Univ Vienna, Vienna, Austria.		Rasi, Guido/AAC-8172-2021	Rasi, Guido/0000-0002-2191-1386				Eichler HG, 2015, CLIN PHARMACOL THER, V97, P234, DOI 10.1002/cpt.59; European Medicines Agency, 2011, REFL PAP RISK BAS QU; Fein AJ., 2015, DRUG CHANNELS   0205; Loftus P., 2015, WALL STREET J; Senior M, 2015, NAT REV DRUG DISCOV, V14, P665, DOI 10.1038/nrd4741	5	37	37	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2016	374	19					1807	1809		10.1056/NEJMp1601294	http://dx.doi.org/10.1056/NEJMp1601294			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DL6JS	27168431				2022-12-28	WOS:000375746100003
J	Prodan, CI				Prodan, Calin I.			Platelets after intracerebral haemorrhage: more is not better	LANCET			English	Editorial Material							TRANSFUSION; THERAPY; STROKE; GROWTH		[Prodan, Calin I.] Univ Oklahoma, Dept Neurol, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; [Prodan, Calin I.] Vet Adm Med Ctr, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Prodan, CI (corresponding author), Univ Oklahoma, Dept Neurol, Hlth Sci Ctr, Oklahoma City, OK 73104 USA.; Prodan, CI (corresponding author), Vet Adm Med Ctr, Oklahoma City, OK 73104 USA.	calin-prodan@ouhsc.edu						Baharoglu MI, 2016, LANCET; Borissoff JI, 2011, NEW ENGL J MED, V364, P1746, DOI 10.1056/NEJMra1011670; Charania R, 2011, TRANSFUSION, V51, P2690, DOI 10.1111/j.1537-2995.2011.03179.x; Davis SM, 2006, NEUROLOGY, V66, P1175, DOI 10.1212/01.wnl.0000208408.98482.99; Feigin VL, 2015, NEUROEPIDEMIOLOGY, V45, P161, DOI 10.1159/000441085; Folman CC, 2001, TRANSFUSION, V41, P517, DOI 10.1046/j.1537-2995.2001.41040517.x; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; KAUSHANSKY K, 1995, BLOOD, V86, P419, DOI 10.1182/blood.V86.2.419.bloodjournal862419; Naidech AM, 2012, NEUROCRIT CARE, V16, P82, DOI 10.1007/s12028-011-9619-3; Naidech AM, 2009, STROKE, V40, P2398, DOI 10.1161/STROKEAHA.109.550939; Stolla M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00028; Thompson BB, 2010, NEUROLOGY, V75, P1333, DOI 10.1212/WNL.0b013e3181f735e5	12	7	7	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 25	2016	387	10038					2577	2578		10.1016/S0140-6736(16)30478-0	http://dx.doi.org/10.1016/S0140-6736(16)30478-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP3JX	27178480				2022-12-28	WOS:000378390500005
J	Ameratunga, S; Denny, S				Ameratunga, Shanthi; Denny, Simon			GBD 2013: a window into the world of young people	LANCET			English	Editorial Material							PARTNER VIOLENCE		[Ameratunga, Shanthi] Univ Auckland, Fac Med & Hlth Sci, Sch Populat Hlth, Sect Epidemiol & Biostat, Auckland 1141, New Zealand; [Denny, Simon] Univ Auckland, Fac Med & Hlth Sci, Sch Med, Dept Paediat Child & Youth Hlth, Auckland 1141, New Zealand	University of Auckland; University of Auckland	Ameratunga, S (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Sch Populat Hlth, Sect Epidemiol & Biostat, Auckland 1141, New Zealand.	s.ameratunga@auckland.ac.nz		Ameratunga, Shanthi/0000-0001-8042-2251				Ameratunga S, 2006, LANCET, V367, P1533, DOI 10.1016/S0140-6736(06)68654-6; [Anonymous], 2008, CLOS GAP GEN HLTH EQ; Cukier W., 2002, BROWN J WORLD AFFAIR, V9, P261; Devries KM, 2013, SCIENCE, V340, P1527, DOI 10.1126/science.1240937; Heise LL, 2015, LANCET GLOB HEALTH, V3, pE332, DOI 10.1016/S2214-109X(15)00013-3; Khanna T, 2016, GLOB PUBLIC HEALTH, V11, P1185, DOI 10.1080/17441692.2015.1062905; Krieger N, 1992, J Public Health Policy, V13, P412; Marmot M, 2016, SCI AM, V314, P23, DOI 10.1038/scientificamerican0316-23; Mokdad AH, 2016, LANCET; Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3; Patton GC, 2016, LANCET; UNICEF, 2012, PROGR CHILDR REP CAR	12	3	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 11	2016	387	10036					2353	2354		10.1016/S0140-6736(16)30296-3	http://dx.doi.org/10.1016/S0140-6736(16)30296-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DO1ST	27174309				2022-12-28	WOS:000377560100005
J	Hartig, T; Kahn, PH				Hartig, Terry; Kahn, Peter H., Jr.			Living in cities, naturally	SCIENCE			English	Editorial Material							URBAN; HEALTH; PREVALENCE; DISORDERS	Natural features, settings, and processes in urban areas can help to reduce stress associated with urban life. In this and other ways, public health benefits from, street trees, green roofs, community gardens, parks and open spaces, and extensive connective pathways for walking and biking. Such urban design provisions can also yield ecological benefits, not only directly but also through the role they play in shaping attitudes toward the environment and environmental protection. Knowledge of the psychological benefits of nature experience supports efforts to better integrate nature into the architecture, infrastructure, and public spaces of urban areas.	[Hartig, Terry] Uppsala Univ, Inst Housing & Urban Res, Uppsala, Sweden; [Hartig, Terry] Uppsala Univ, Dept Psychol, Uppsala, Sweden; [Kahn, Peter H., Jr.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA; [Kahn, Peter H., Jr.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA	Uppsala University; Uppsala University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hartig, T (corresponding author), Uppsala Univ, Inst Housing & Urban Res, Uppsala, Sweden.; Hartig, T (corresponding author), Uppsala Univ, Dept Psychol, Uppsala, Sweden.		Hartig, Terry/AAC-5676-2021					Alcock I, 2014, ENVIRON SCI TECHNOL, V48, P1247, DOI 10.1021/es403688w; *AM PSYCH ASS TASK, 2005, URB PSYCH RES ACT PO; Eisenman TS, 2013, J PLAN HIST, V12, P287, DOI 10.1177/1538513212474227; European Commission Directorate General for Research and Innovation, 2015, EU RES INN POL AG NA; Ferrari AJ, 2013, PSYCHOL MED, V43, P471, DOI 10.1017/S0033291712001511; Hartig T, 2014, ANNU REV PUBL HEALTH, V35, P207, DOI 10.1146/annurev-publhealth-032013-182443; Hartig T, 2011, FORESTS, TREES AND HUMAN HEALTH, P127, DOI 10.1007/978-90-481-9806-1_5; Judd FK, 2002, AUST NZ J PSYCHIAT, V36, P104, DOI 10.1046/j.1440-1614.2002.00986.x; Kahn P.H., 2011, TECHNOLOGICAL NATURE; Kahn PH, 2013, REDISCOVERY OF THE WILD, P1; Kaiser FG, 2013, ENVIRON BEHAV, V45, P369, DOI 10.1177/0013916511422444; MILGRAM S, 1970, SCIENCE, V167, P1461, DOI 10.1126/science.167.3924.1461; Peen J, 2010, ACTA PSYCHIAT SCAND, V121, P84, DOI 10.1111/j.1600-0447.2009.01438.x; Rouse D. C., 2013, 571 AM PLANN ASS PLA; van Dillen SME, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2009.104695	15	177	179	20	240	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2016	352	6288			SI		938	940		10.1126/science.aaf3759	http://dx.doi.org/10.1126/science.aaf3759			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM2AK	27199417				2022-12-28	WOS:000376147800034
J	Becker, S; Thoma, I; Deutsch, A; Gehrke, T; Mayer, P; Zipse, H; Carell, T				Becker, Sidney; Thoma, Ines; Deutsch, Amrei; Gehrke, Tim; Mayer, Peter; Zipse, Hendrik; Carell, Thomas			A high-yielding, strictly regioselective prebiotic purine nucleoside formation pathway	SCIENCE			English	Article							ADENINE; ORIGIN; CHEMISTRY; FORMAMIDE; CYANIDE; STATE; BASES; DNA	The origin of life is believed to have started with prebiotic molecules reacting along unidentified pathways to produce key molecules such as nucleosides. To date, a single prebiotic pathway to purine nucleosides had been proposed. It is considered to be inefficient due to missing regioselectivity and low yields. We report that the condensation of formamidopyrimidines (FaPys) with sugars provides the natural N-9 nucleosides with extreme regioselectivity and in good yields (60%). The FaPys are available from formic acid and aminopyrimidines, which are in turn available from prebiotic molecules that were also detected during the Rosetta comet mission. This nucleoside formation pathway can be fused to sugar-forming reactions to produce pentosides, providing a plausible scenario of how purine nucleosides may have formed under prebiotic conditions.	[Becker, Sidney; Thoma, Ines; Deutsch, Amrei; Gehrke, Tim; Mayer, Peter; Zipse, Hendrik; Carell, Thomas] Univ Munich, Dept Chem, D-81377 Munich, Germany	University of Munich	Carell, T (corresponding author), Univ Munich, Dept Chem, D-81377 Munich, Germany.	thomas.carell@cup.uni-muenchen.de	Carell, Thomas/G-4799-2012; Zipse, Hendrik/D-2141-2014; Mayer, Peter/HHS-1373-2022	Carell, Thomas/0000-0001-7898-2831; Becker, Sidney/0000-0002-4746-2822	Deutsche Forschungsgemeinschaft [SFB749, SFB646, SFB1032]; Excellence cluster (Center for Integrated Protein Science) [EXC114]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence cluster (Center for Integrated Protein Science)	We thank the Deutsche Forschungsgemeinschaft (SFB749, SFB646, and SFB1032) and the Excellence cluster EXC114 (Center for Integrated Protein Science) for financial support. Additional figures and synthetic procedures can be found in the supplementary materials. The crystallographic data (CCDC 1416691) can be obtained from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk.	Clark J., 1968, J CHEM SOC C, V1968, P1122; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; FULLER WD, 1972, J MOL EVOL, V1, P249, DOI 10.1007/BF01660244; FULLER WD, 1972, J MOL BIOL, V67, P25, DOI 10.1016/0022-2836(72)90383-X; Goesmann F, 2015, SCIENCE, V349, DOI 10.1126/science.aab0689; Harsch G., 1984, LIEBIGS ANN CHEM, V1984, P623; KASTING JF, 1993, SCIENCE, V259, P920, DOI 10.1126/science.11536547; Kim HJ, 2011, J AM CHEM SOC, V133, P9457, DOI 10.1021/ja201769f; KIRNOS MD, 1977, NATURE, V270, P369, DOI 10.1038/270369a0; Koch K. E., 1992, THESIS ETH ZURICH; Lambert JB, 2010, SCIENCE, V327, P984, DOI 10.1126/science.1182669; Lob W, 1913, BER DTSCH CHEM GES, V46, P684, DOI 10.1002/cber.19130460193; Mori T, 1998, BIOCHEM BIOPH RES CO, V242, P98, DOI 10.1006/bbrc.1997.7916; Orgel LE, 2004, CRIT REV BIOCHEM MOL, V39, P99, DOI 10.1080/10409230490460765; ORO J, 1960, BIOCHEM BIOPH RES CO, V2, P407, DOI 10.1016/0006-291X(60)90138-8; ORO J, 1961, ARCH BIOCHEM BIOPHYS, V94, P217, DOI 10.1016/0003-9861(61)90033-9; Powner MW, 2009, NATURE, V459, P239, DOI 10.1038/nature08013; Ricardo A, 2004, SCIENCE, V303, P196, DOI 10.1126/science.1092464; Ritson DJ, 2013, ANGEW CHEM INT EDIT, V52, P5845, DOI 10.1002/anie.201300321; Robertson MP, 1996, J MOL EVOL, V43, P543, DOI 10.1007/BF02202102; Saladino R, 2003, CHEMBIOCHEM, V4, P514, DOI 10.1002/cbic.200300567; TRATTNER RB, 1964, J ORG CHEM, V29, P2674, DOI 10.1021/jo01032a047; Traube W, 1904, LIEBIGS ANN CHEM, V331, P64; Trinks U. P., 1987, THESIS ETH ZURICH; WHITE HB, 1976, J MOL EVOL, V7, P101, DOI 10.1007/BF01732468	25	130	133	2	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2016	352	6287					833	836		10.1126/science.aad2808	http://dx.doi.org/10.1126/science.aad2808			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5FP	27174989				2022-12-28	WOS:000375663000043
J	Cilliers, J; Dube, O; Siddiqi, B				Cilliers, Jacobus; Dube, Oeindrila; Siddiqi, Bilal			Reconciling after civil conflict increases social capital but decreases individual well-being	SCIENCE			English	Article							FIELD EXPERIMENT; POSTTRAUMATIC-STRESS; FORGIVENESS THERAPY; FOLLOW-UP; INTERVENTION; TRAUMA; TRUTH; PTSD; STATISTICS; INSTRUMENT	Civil wars divide nations along social, economic, and political cleavages, often pitting one neighbor against another. To restore social cohesion, many countries undertake truth and reconciliation efforts. We examined the consequences of one such effort in Sierra Leone, designed and implemented by a Sierra Leonean nongovernmental organization called Fambul Tok. As a part of this effort, community-level forums are set up in which victims detail war atrocities, and perpetrators confess to war crimes. We used random assignment to study its impact across 200 villages, drawing on data from 2383 individuals. We found that reconciliation had both positive and negative consequences. It led to greater forgiveness of perpetrators and strengthened social capital: Social networks were larger, and people contributed more to public goods in treated villages. However, these benefits came at a substantial cost: The reconciliation treatment also worsened psychological health, increasing depression, anxiety, and posttraumatic stress disorder in these same villages. For a subset of villages, we measured outcomes both 9 months and 31 months after the intervention. These results show that the effects, both positive and negative, persisted into the longer time horizon. Our findings suggest that policy-makers need to restructure reconciliation processes in ways that reduce their negative psychological costs while retaining their positive societal benefits.	[Cilliers, Jacobus] Georgetown Univ, McCourt Sch Publ Policy, 3700 O St, Washington, DC 20057 USA; [Dube, Oeindrila] NYU, Dept Polit, 19 West 4th St, New York, NY 10012 USA; [Siddiqi, Bilal] World Bank, Dev Res Grp, 1818 H St NW, Washington, DC 20433 USA	Georgetown University; New York University; The World Bank	Dube, O (corresponding author), NYU, Dept Polit, 19 West 4th St, New York, NY 10012 USA.	odube@nyu.edu			3ie [OW2.253]; J-PAL Governance Initiative [5710003563]	3ie; J-PAL Governance Initiative	We thank J. Caulker from Fambul Tok and L. Hoffman from Catalyst for Peace for enabling us to study Fambul Tok's initiative. We are grateful to E. Dixon, Q.-A. Do, M. Gilligan, S. Mullainathan, and D. Stasavage for providing detailed comments and suggestions on the manuscript and to T. Betancourt for providing valuable input on the psychometric survey measures used in the study. We additionally thank A. Mansaray, A. Ahmed, J. Creighton, and N. Hasham (in chronological order of involvement) for outstanding research assistance in the field. This project was funded by 3ie (grant code OW2.253) and the J-PAL Governance Initiative (subaward 5710003563) and received extensive implementation support from Innovations for Poverty Action. We thank them, without implicating them, for making this project possible. This research also received institutional review board (IRB) approval from Oxford University (ref. SSD/CUREC1/11-028), New York University (HS# 11-8528; IRB#: 14-9936), and Innovations for Poverty Action (Protocol 534.11February002). All errors and omissions are our own. Upon publication, the replication data and code from this study will be made publicly available through the Interuniversity Consortium for Political and Social Research (ICPSR) data depository. The Pre-Analysis Plan, which is already posted publicly in the EGAP depository, will also be made available as a part of the ICPSR replication package.	ALMABUK RH, 1995, J MORAL EDUC, V24, P427, DOI 10.1080/0305724950240405; Anderson ML, 2008, J AM STAT ASSOC, V103, P1481, DOI 10.1198/016214508000000841; [Anonymous], 2013, POLICY RES REPORT; Arvay MJ., 2001, INT J ADV COUNS, V23, P283, DOI DOI 10.1023/A:1014496419410; Asmal K., 1994, RECONCILIATION TRUTH; Backer D., 2007, SECURITY RECONSTRUCT, P165; Backer D.A., 2004, THESIS U MICHIGAN; Baskin TW, 2004, J COUNS DEV, V82, P79, DOI 10.1002/j.1556-6678.2004.tb00288.x; Bayer CP, 2007, JAMA-J AM MED ASSOC, V298, P555, DOI 10.1001/jama.298.5.555; Beath A, 2013, AM POLIT SCI REV, V107, P540, DOI 10.1017/S0003055413000270; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Betancourt TS, 2011, J ADOLESCENT HEALTH, V49, P21, DOI 10.1016/j.jadohealth.2010.09.021; Betancourt TS, 2010, CHILD DEV, V81, P1077, DOI 10.1111/j.1467-8624.2010.01455.x; Biggar Nigel, 2003, BURYING MAKING PEACE; Bisson J., 2009, COCHRANE LIB, V2009, P1; Blattman C, 2014, AM POLIT SCI REV, V108, P100, DOI 10.1017/S0003055413000543; Brahm E., 2005, ANN M INT STUD ASS H; Brouneus K, 2008, SECUR DIALOGUE, V39, P55, DOI 10.1177/0967010607086823; Brouneus K, 2010, J CONFLICT RESOLUT, V54, P408, DOI 10.1177/0022002709360322; Bruhn M, 2009, AM ECON J-APPL ECON, V1, P200, DOI 10.1257/app.1.4.200; Casey K, 2012, Q J ECON, V127, P1755, DOI 10.1093/qje/qje027; Cobban H., 2003, BOSTON REV, V27, P2; Conibere R., 2004, STAT APPENDIX REPORT, P1; Coyle CT, 1997, J CONSULT CLIN PSYCH, V65, P1042, DOI 10.1037/0022-006X.65.6.1042; Cunningham M, 2003, SOC WORK, V48, P451, DOI 10.1093/sw/48.4.451; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; Curran-Everett D, 2004, AM J PHYSIOL-LUNG C, V287, pL259, DOI 10.1152/ajplung.00190.2004; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Enright R.D., 2007, J RES ED, V17, P63; Enright R.D., 2000, HELPING CLIENTS FORG; Fearon JD, 2015, AM POLIT SCI REV, V109, P450, DOI 10.1017/S0003055415000283; Fearon JD, 2009, AM ECON REV, V99, P287, DOI 10.1257/aer.99.2.287; Foa EB, 2006, J CLIN PSYCHIAT, V67, P40; Foa EB, 2000, J TRAUMA STRESS, V13, P181, DOI 10.1023/A:1007781909213; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1007/BF00974317; Freedman SR, 1996, J CONSULT CLIN PSYCH, V64, P983, DOI 10.1037/0022-006X.64.5.983; Fried G., 2010, BEING AND TRUTH, P101; FRISON L, 1992, STAT MED, V11, P1685, DOI 10.1002/sim.4780111304; Gibson JL, 2004, AM J POLIT SCI, V48, P201, DOI 10.1111/j.0092-5853.2004.00065.x; Hamber B., 2003, RECONCILIATION VIOLE; Hawkins SS, 2006, J PEDIATR PSYCHOL, V31, P420, DOI 10.1093/jpepsy/jsj039; Humphreys M, 2013, POLIT ANAL, V21, P1, DOI 10.1093/pan/mps021; Joseph J. S., 2008, J BEHAV ANAL OFFENDE, V1, P69, DOI DOI 10.1037/H0100457; Kaldor Mary, 2006, EVALUATION UNDP ASSI; Kaminer D, 2001, BRIT J PSYCHIAT, V178, P373, DOI 10.1192/bjp.178.4.373; Kling JR, 2007, ECONOMETRICA, V75, P83, DOI 10.1111/j.1468-0262.2007.00733.x; Kritz N., 1999, WAR CRIMES LEGACY NU; Lederarch J., 1999, JOURNEY RECONCILIATI; Lin WF, 2004, J CONSULT CLIN PSYCH, V72, P1114, DOI 10.1037/0022-006X.72.6.1114; McCann I. L., 1990, J TRAUMA STRESS, V3, P131, DOI [DOI 10.1007/BF00975140, 10.1007/BF00975140]; McKenzie D, 2012, J DEV ECON, V99, P210, DOI 10.1016/j.jdeveco.2012.01.002; Mendeloff D., 2004, INT STUDIES REV, V6, P355, DOI DOI 10.1111/J.1521-9488.2004.00421.X; Mendeloff D, 2009, HUM RIGHTS QUART, V31, P592, DOI 10.1353/hrq.0.0100; MURPHY WP, 1980, AFRICA, V50, P193, DOI 10.2307/1159011; Paluck EL, 2009, J PERS SOC PSYCHOL, V96, P574, DOI 10.1037/a0011989; Pearlman L. A., 1995, PSYCNET; Pettersson T, 2015, J PEACE RES, V52, P536, DOI 10.1177/0022343315595927; PUTNAM RD, 1995, J DEMOCRACY, V0006; Reed GL, 2006, J CONSULT CLIN PSYCH, V74, P920, DOI 10.1037/0022-006X.74.5.920; Rose S, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000560; Rye M. S., 1998, THESIS BOWLING GREEN; Rye MS, 2005, J CONSULT CLIN PSYCH, V73, P880, DOI 10.1037/0022-006X.73.5.880; Shaw Rosalind, 2005, 130 US I PEAC; Smith L. A., 2004, CONFLICT MAPPING SIE; Staub E, 2005, J SOC CLIN PSYCHOL, V24, P297, DOI 10.1521/jscp.24.3.297.65617; Steinberg Alan M, 2004, Curr Psychiatry Rep, V6, P96, DOI 10.1007/s11920-004-0048-2; Subkoviak MJ, 1995, J ADOLESCENCE, V18, P641, DOI 10.1006/jado.1995.1045; Sullivan Gail M, 2013, J Grad Med Educ, V5, P541, DOI 10.4300/JGME-5-4-18; Theresa S., 2010, INTEGR PSYCHIAT, V7, P60; Truth and Reconciliation Commission, 1998, TRUTH REC COMM S AFR; van Emmerik AAP, 2002, LANCET, V360, P766, DOI 10.1016/S0140-6736(02)09897-5; Weathers FW, 1991, PCL M FOR DSM IV; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V13, P508, DOI 10.1001/archpsyc.1965.01730060026004	75	49	51	3	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2016	352	6287					787	794		10.1126/science.aad9682	http://dx.doi.org/10.1126/science.aad9682			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5FP	27174981				2022-12-28	WOS:000375663000031
J	Hassan, R; Muller, RD; Gurnis, M; Williams, SE; Flament, N				Hassan, Rakib; Mueller, R. Dietmar; Gurnis, Michael; Williams, Simon E.; Flament, Nicolas			A rapid burst in hotspot motion through the interaction of tectonics and deep mantle flow	NATURE			English	Article							BOUNDARY-LAYER; PLATE MOTIONS; EARTH MODELS; PLUMES; DYNAMICS; TEMPERATURE; CONVECTION; TOMOGRAPHY; EVOLUTION; PACIFIC	Volcanic hotspot tracks featuring linear progressions in the age of volcanism are typical surface expressions of plate tectonic movement on top of narrow plumes of hot material within Earth's mantle(1). Seismic imaging reveals that these plumes can be of deep origin(2)-probably rooted on thermochemical structures in the lower mantle(3-6). Although palaeomagnetic and radiometric age data suggest that mantle flow can advect plume conduits laterally(7,8), the flow dynamics underlying the formation of the sharp bend occurring only in the Hawaiian-Emperor hotspot track in the Pacific Ocean remains enigmatic. Here we present palaeogeographically constrained numerical models of thermochemical convection and demonstrate that flow in the deep lower mantle under the north Pacific was anomalously vigorous between 100 million years ago and 50 million years ago as a consequence of long-lasting subduction systems, unlike those in the south Pacific. These models show a sharp bend in the Hawaiian-Emperor hotspot track arising from the interplay of plume tilt and the lateral advection of plume sources. The different trajectories of the Hawaiian and Louisville hotspot tracks arise from asymmetric deformation of thermochemical structures under the Pacific between 100 million years ago and 50 million years ago. This asymmetric deformation waned just before the Hawaiian-Emperor bend developed, owing to flow in the deepest lower mantle associated with slab descent in the north and south Pacific.	[Hassan, Rakib; Mueller, R. Dietmar; Williams, Simon E.; Flament, Nicolas] Univ Sydney, Sch Geosci, EarthByte Grp, Sydney, NSW 2006, Australia; [Gurnis, Michael] CALTECH, Seismol Lab, Pasadena, CA 91125 USA	University of Sydney; California Institute of Technology	Hassan, R (corresponding author), Univ Sydney, Sch Geosci, EarthByte Grp, Sydney, NSW 2006, Australia.	rakib.hassan@sydney.edu.au	Flament, Nicolas/N-8344-2013; Müller, Dietmar/L-1200-2019; Flament, Nicolas/I-5904-2019	Flament, Nicolas/0000-0002-3237-0757; Müller, Dietmar/0000-0002-3334-5764; Flament, Nicolas/0000-0002-3237-0757; Hassan, Rakib/0000-0002-9100-4191; Williams, Simon/0000-0003-4670-8883	NSF [EAR-1161046, EAR-1247022]; ARC [IH130200012]; Australian Government; Directorate For Geosciences [1247022, 1600956] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); ARC(Australian Research Council); Australian Government(Australian GovernmentCGIAR); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	M.G. was supported by the NSF (awards EAR-1161046 and EAR-1247022). R.D.M. and N.F. were supported by an ARC grant (IH130200012). This research was undertaken with the assistance of resources from the National Computational Infrastructure (NCI), which is supported by the Australian Government.	Auer L, 2014, J GEOPHYS RES-SOL EA, V119, P3006, DOI 10.1002/2013JB010773; BACKUS G, 1986, REV GEOPHYS, V24, P75, DOI 10.1029/RG024i001p00075; Bower DJ, 2015, PHYS EARTH PLANET IN, V238, P8, DOI 10.1016/j.pepi.2014.10.013; Bower DJ, 2013, GEOCHEM GEOPHY GEOSY, V14, P44, DOI 10.1029/2012GC004267; Burke K, 2008, EARTH PLANET SC LETT, V265, P49, DOI 10.1016/j.epsl.2007.09.042; Christensen U.R., 1985, GEOPHYS RES, V90, P10291, DOI DOI 10.1029/JB090IB12P10291; Farnetani CG, 1997, GEOPHYS RES LETT, V24, P1583, DOI 10.1029/97GL01548; French SW, 2015, NATURE, V525, P95, DOI 10.1038/nature14876; Garnero EJ, 2008, SCIENCE, V320, P626, DOI 10.1126/science.1148028; Hassan R, 2015, GEOCHEM GEOPHY GEOSY, V16, P1465, DOI 10.1002/2015GC005751; Jellinek AM, 2002, NATURE, V418, P760, DOI 10.1038/nature00979; KARATO S, 1993, SCIENCE, V260, P771, DOI 10.1126/science.260.5109.771; Koppers A. A., 2004, GEOCHEM GEOPHYS GEOS, V5; Koppers AAP, 2012, NAT GEOSCI, V5, P911, DOI [10.1038/NGEO1638, 10.1038/ngeo1638]; Lay T, 1998, NATURE, V392, P461, DOI 10.1038/33083; Lekic V, 2012, EARTH PLANET SC LETT, V357, P68, DOI 10.1016/j.epsl.2012.09.014; Lin SC, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001072; McNamara AK, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002847; McNamara AK, 2005, NATURE, V437, P1136, DOI 10.1038/nature04066; Montelli R, 2004, SCIENCE, V303, P338, DOI 10.1126/science.1092485; MORGAN WJ, 1971, NATURE, V230, P42, DOI 10.1038/230042a0; OLSON P, 1987, NATURE, V327, P409, DOI 10.1038/327409a0; Portnyagin M, 2008, GEOLOGY, V36, P903, DOI 10.1130/G25171A.1; Seton M, 2012, EARTH-SCI REV, V113, P212, DOI 10.1016/j.earscirev.2012.03.002; Shephard GE, 2013, EARTH-SCI REV, V124, P148, DOI 10.1016/j.earscirev.2013.05.012; Steinberger B, 2000, J GEOPHYS RES-SOL EA, V105, P11127, DOI 10.1029/1999JB900398; Steinberger B, 2004, NATURE, V430, P167, DOI 10.1038/nature02660; Steinberger B, 2008, NATURE, V452, P620, DOI 10.1038/nature06824; Steinberger B, 2006, GEOPHYS J INT, V167, P1461, DOI 10.1111/j.1365-246X.2006.03131.x; Tackley PJ, 1996, J GEOPHYS RES-SOL EA, V101, P3311, DOI 10.1029/95JB03211; Tarduno JA, 2003, SCIENCE, V301, P1064, DOI 10.1126/science.1086442; Tarduno J, 2009, SCIENCE, V324, P50, DOI 10.1126/science.1161256; Tarduno JA, 2007, CHEM GEOL, V241, P234, DOI 10.1016/j.chemgeo.2007.01.021; Thorne MS, 2004, PHYS EARTH PLANET IN, V146, P47, DOI 10.1016/j.pepi.2003.09.026; Torsvik TH, 2014, P NATL ACAD SCI USA, V111, P8735, DOI 10.1073/pnas.1318135111; Torsvik TH, 2008, EARTH PLANET SC LETT, V276, P273, DOI 10.1016/j.epsl.2008.09.026; Tosi N, 2013, PHYS EARTH PLANET IN, V217, P48, DOI 10.1016/j.pepi.2013.02.004; van der Meer DG, 2010, NAT GEOSCI, V3, P36, DOI 10.1038/NGEO708; VANKEKEN PE, 1994, SCIENCE, V264, P1437, DOI 10.1126/science.264.5164.1437; Wright NM, 2015, GEOLOGY, V43, P455, DOI 10.1130/G36303.1; Zhong SJ, 2015, GEOCHEM GEOPHY GEOSY, V16, P1599, DOI 10.1002/2015GC005782; Zhong SJ, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002048	42	49	51	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					239	+		10.1038/nature17422	http://dx.doi.org/10.1038/nature17422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0BJ	27172048	Green Submitted			2022-12-28	WOS:000376007200048
J	Laursen, L				Laursen, Lucas			A neglected cause	NATURE			English	Editorial Material																			0	4	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					S68	S69		10.1038/533S68a	http://dx.doi.org/10.1038/533S68a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0BJ	27167396	Bronze			2022-12-28	WOS:000376007200007
J	Zahnle, K; Buick, R				Zahnle, Kevin; Buick, Roger			Atmospheric science Ancient air caught by shooting stars	NATURE			English	Editorial Material							MASS-INDEPENDENT FRACTIONATION; SULFUR		[Zahnle, Kevin] NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA; [Buick, Roger] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Buick, Roger] Univ Washington, Astrobiol Program, Seattle, WA 98195 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Zahnle, K (corresponding author), NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA.; Buick, R (corresponding author), Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA.; Buick, R (corresponding author), Univ Washington, Astrobiol Program, Seattle, WA 98195 USA.	kevin.j.zahnle@nasa.gov; buick@ess.washington.edu		Buick, Roger/0000-0003-0139-1659				[Anonymous], 2006, GEOBIOLOGY, DOI [DOI 10.1111/J.1472-4669.2006.00085.X, DOI 10.1111/j.1472-4669.2006.00085.x]; Awramik SM, 2009, PRECAMBRIAN RES, V174, P215, DOI 10.1016/j.precamres.2009.07.005; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Genge MJ, 2008, METEORIT PLANET SCI, V43, P497, DOI 10.1111/j.1945-5100.2008.tb00668.x; Holland HD., 1999, GEOCHEM NEWS, V100, P20; Jang JH, 2009, ENVIRON SCI TECHNOL, V43, P1086, DOI 10.1021/es8010139; Krull-Davatzes AE, 2010, EARTH PLANET SC LETT, V296, P319, DOI 10.1016/j.epsl.2010.05.014; Ohmoto H., 1997, GEOCHEM NEWS, V93, P26; OHMOTO H, 1997, GEOCHEM NEWS, V93, P12; Pavlov AA, 2002, ASTROBIOLOGY, V2, P27, DOI 10.1089/153110702753621321; Som S.M., 2016, NATURE GEOSCI; Stueken EE, 2015, EARTH PLANET SC LETT, V411, P1, DOI 10.1016/j.epsl.2014.11.037; Tomkins AG, 2016, NATURE, V533, P235, DOI 10.1038/nature17678; Wordsworth R, 2014, ASTROPHYS J LETT, V785, DOI 10.1088/2041-8205/785/2/L20	14	9	9	0	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					184	186		10.1038/533184a	http://dx.doi.org/10.1038/533184a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0BJ	27172041	Green Submitted			2022-12-28	WOS:000376007200035
J	Butt, CA				Butt, Carrie A.			Susanna Fourment and Her Daughter Anthony van Dyck	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 10	2016	315	18					1932	1934		10.1001/jama.2015.14255	http://dx.doi.org/10.1001/jama.2015.14255			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2JP	27163972				2022-12-28	WOS:000375461100001
J	Haddad, A; Davis, AM				Haddad, Ashley; Davis, Andrew M.			Tobacco Smoking Cessation in Adults and Pregnant Women Behavioral and Pharmacotherapy Interventions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES	GUIDELINE TITLE Tobacco Smoking Cessation in Adults and Pregnant Women: Behavioral and Pharmacotherapy Interventions DEVELOPER US Preventive Services Task Force (USPSTF) RELEASE DATE October 20, 2015 PRIOR VERSIONS April 21, 2009; November 13, 2003 FUNDING SOURCE US Agency for Healthcare Research and Quality (AHRQ) TARGET POPULATION All adults aged 18 years or older, including pregnant women MAJOR RECOMMENDATIONS Ask all adults about tobacco use; if using, advise patients to quit. Provide behavioral interventions to all adults who use tobacco regardless of pregnancy status. Prescribe Food and Drug Administration (FDA)-approved cessation pharmacotherapy to all nonpregnant adults who use tobacco (grade A recommendations). There is insufficient evidence to recommend pharmacologic interventions for tobacco cessation in pregnant adults (I statement). There is also insufficient evidence to recommend use of electronic nicotine delivery systems for tobacco cessation in any adults ( I statement).	[Haddad, Ashley; Davis, Andrew M.] Univ Chicago, Gen Internal Med Sect, 5841 S Maryland Ave,MC2007,Room B221, Chicago, IL 60637 USA	University of Chicago	Haddad, A (corresponding author), Univ Chicago, Gen Internal Med Sect, 5841 S Maryland Ave,MC2007,Room B221, Chicago, IL 60637 USA.	ashley.haddad@uchospitals.edu			US Agency for Healthcare Research and Quality (AHRQ)	US Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	US Agency for Healthcare Research and Quality (AHRQ)	Agaku IT, 2014, MMWR-MORBID MORTAL W, V63, P542; Centers for Disease Control and Prevention, PRAMSTAT SYST; Fiore MC, 2008, CLIN PRACTICE GUIDEL; Jamal A, 2014, MMWR-MORBID MORTAL W, V63, P1108; Leventhal AM, 2015, JAMA-J AM MED ASSOC, V314, P700, DOI 10.1001/jama.2015.8950; Luquis RR, 2015, HEALTH PROMOT PRACT, V16, P745, DOI 10.1177/1524839914561516; Patnode CD, 2015, BEHAV COUNSELING PHA; Siu AL, 2015, ANN INTERN MED, V163, P622, DOI 10.7326/M15-2023; US Department of Health and Human Services, HLTH CONS SMOK 50 YE; US Preventive Serv Task Force, 2009, ANN INTERN MED, V150, P551, DOI 10.7326/0003-4819-150-8-200904210-00009	10	12	12	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 10	2016	315	18					2011	2012		10.1001/jama.2016.2535	http://dx.doi.org/10.1001/jama.2016.2535			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2JP	27163990				2022-12-28	WOS:000375461100019
J	Bustin, M; Misteli, T				Bustin, Michael; Misteli, Tom			Nongenetic functions of the genome	SCIENCE			English	Review							XENOPUS EGG EXTRACTS; EMBRYONIC STEM-CELLS; NUCLEAR-ENVELOPE; INTERPHASE CHROMOSOMES; CHROMATIN CONDENSATION; HISTONE MODIFICATIONS; LINKER HISTONES; IN-VIVO; DNA; MIGRATION	The primary function of the genome is to store, propagate, and express the genetic information that gives rise to a cell's architectural and functional machinery. However, the genome is also a major structural component of the cell. Besides its genetic roles, the genome affects cellular functions by nongenetic means through its physical and structural properties, particularly by exerting mechanical forces and by serving as a scaffold for binding of cellular components. Major cellular processes affected by nongenetic functions of the genome include establishment of nuclear structure, signal transduction, mechanoresponses, cell migration, and vision in nocturnal animals. We discuss the concept, mechanisms, and implications of nongenetic functions of the genome.	[Bustin, Michael; Misteli, Tom] NCI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bustin, M; Misteli, T (corresponding author), NCI, Bethesda, MD 20892 USA.	bustinm@mail.nih.gov; mistelit@mail.nih.gov	Bustin, Michael/G-6155-2015	Bustin, Michael/0000-0002-5147-7242	NIH Intramural Research Program, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010309, ZIABC011154] Funding Source: NIH RePORTER	NIH Intramural Research Program, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Misteli lab and P. Oberdoerffer for comments on the manuscript; G. Gerlitz (Ariel University, Israel) and members of the Bustin laboratory for informative discussions on various topics of this review; and T. Ried and R. Lefcoe for illustrations. Work in the authors' laboratories is supported by the NIH Intramural Research Program, National Cancer Institute, Center for Cancer Research.	Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Ayrapetov MK, 2014, P NATL ACAD SCI USA, V111, P9169, DOI 10.1073/pnas.1403565111; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bell JC, 2015, NAT CELL BIOL, V17, P964, DOI 10.1038/ncb3212; Bermejo R, 2011, CELL, V146, P233, DOI 10.1016/j.cell.2011.06.033; Bianchi ME, 2004, BBA-GENE STRUCT EXPR, V1677, P181, DOI 10.1016/j.bbaexp.2003.10.017; Bickmore WA, 2013, ANNU REV GENOM HUM G, V14, P67, DOI 10.1146/annurev-genom-091212-153515; Bickmore WA, 2013, CELL, V152, P1270, DOI 10.1016/j.cell.2013.02.001; Burgess RC, 2014, CELL REP, V9, P1703, DOI 10.1016/j.celrep.2014.10.060; BURKE B, 1986, CELL, V44, P639, DOI 10.1016/0092-8674(86)90273-4; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Catez F, 2006, NAT STRUCT MOL BIOL, V13, P305, DOI 10.1038/nsmb1077; Cavalli G, 2013, NAT STRUCT MOL BIOL, V20, P290, DOI 10.1038/nsmb.2474; Cui Y, 2000, P NATL ACAD SCI USA, V97, P127, DOI 10.1073/pnas.97.1.127; Deng LF, 2014, IMMUNITY, V41, P843, DOI 10.1016/j.immuni.2014.10.019; Doucet CM, 2010, CELL, V141, P1030, DOI 10.1016/j.cell.2010.04.036; Fazzio TG, 2010, J CELL BIOL, V188, P491, DOI 10.1083/jcb.200908026; FORBES DJ, 1983, CELL, V34, P13, DOI 10.1016/0092-8674(83)90132-0; Friedl P, 2011, CURR OPIN CELL BIOL, V23, P55, DOI 10.1016/j.ceb.2010.10.015; FUNABIKI H, 1993, J CELL BIOL, V121, P961, DOI 10.1083/jcb.121.5.961; Furusawa T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7138; George Carolyn M, 2014, Cells, V3, P865, DOI 10.3390/cells3030865; Gerlitz G, 2013, CELL MOL LIFE SCI, V70, P1255, DOI 10.1007/s00018-012-1200-5; Gerlitz G, 2011, TRENDS CELL BIOL, V21, P6, DOI 10.1016/j.tcb.2010.09.002; Gerlitz G, 2010, J CELL SCI, V123, P2207, DOI 10.1242/jcs.058271; Gorjanacz M, 2007, EMBO J, V26, P132, DOI 10.1038/sj.emboj.7601470; Gorski SA, 2006, CURR OPIN CELL BIOL, V18, P284, DOI 10.1016/j.ceb.2006.03.002; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Gruenbaum Y, 2015, ANNU REV BIOCHEM, V84, P131, DOI 10.1146/annurev-biochem-060614-034115; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; Harada T, 2014, J CELL BIOL, V204, P669, DOI 10.1083/jcb.201308029; HARTL P, 1994, J CELL BIOL, V124, P235, DOI 10.1083/jcb.124.3.235; Hergeth SP, 2015, EMBO REP, V16, P1439, DOI 10.15252/embr.201540749; Hieda M, 2015, METHODS MOL BIOL, V1238, P301, DOI 10.1007/978-1-4939-1804-1_16; Hu N, 2014, DEV BIOL, V396, P159, DOI 10.1016/j.ydbio.2014.09.034; Inoue A, 2014, NAT STRUCT MOL BIOL, V21, P609, DOI 10.1038/nsmb.2839; Jevtic P, 2014, CURR OPIN CELL BIOL, V28, P16, DOI 10.1016/j.ceb.2014.01.003; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Khurana S, 2014, CELL REP, V8, P1049, DOI 10.1016/j.celrep.2014.07.024; King MC, 2008, CELL, V134, P427, DOI 10.1016/j.cell.2008.06.022; Kiyomitsu T, 2012, NAT CELL BIOL, V14, P311, DOI 10.1038/ncb2440; Kumar A, 2014, CELL, V158, P633, DOI 10.1016/j.cell.2014.05.046; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Li HN, 2003, J CELL BIOL, V160, P635, DOI 10.1083/jcb.200211004; London N, 2014, NAT REV MOL CELL BIO, V15, P735, DOI 10.1038/nrm3888; Maizels Y, 2015, FEBS J, V282, P3500, DOI 10.1111/febs.13334; Nikolova V, 2004, J CLIN INVEST, V113, P357, DOI 10.1172/JCI200419448; Ozer G, 2015, CURR OPIN STRUC BIOL, V31, P124, DOI 10.1016/j.sbi.2015.04.002; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Pederson T, 2015, MOL BIOL CELL, V26, P3915, DOI 10.1091/mbc.E15-06-0357; Pinheiro I, 2012, CELL, V150, P948, DOI 10.1016/j.cell.2012.06.048; Podolska MJ, 2015, J INFLAMM RES, V8, P161, DOI 10.2147/JIR.S70325; Rawlings JS, 2011, EMBO J, V30, P263, DOI 10.1038/emboj.2010.314; Rochman M, 2009, MOL CELL, V35, P642, DOI 10.1016/j.molcel.2009.07.002; Rodrigues NTL, 2015, NATURE, V524, P489, DOI 10.1038/nature14496; Rosa A, 2013, BIOCHEM SOC T, V41, P612, DOI 10.1042/BST20120330; Schooley A, 2015, J CELL SCI, V128, P3466, DOI 10.1242/jcs.173013; Schreiner SM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8159; Segura-Totten M, 2002, J CELL BIOL, V158, P475, DOI 10.1083/jcb.200202019; SHEN XT, 1995, CELL, V82, P47, DOI 10.1016/0092-8674(95)90051-9; Solovei I, 2013, CELL, V152, P584, DOI 10.1016/j.cell.2013.01.009; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Swift J, 2014, J CELL SCI, V127, P3005, DOI 10.1242/jcs.149203; Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104; Tanno Y, 2015, SCIENCE, V349, P1237, DOI 10.1126/science.aaa2655; Tapley EC, 2013, CURR OPIN CELL BIOL, V25, P57, DOI 10.1016/j.ceb.2012.10.014; Vlcek S, 2002, J BIOL CHEM, V277, P18898, DOI 10.1074/jbc.M200048200; Voss TC, 2014, NAT REV GENET, V15, P69, DOI 10.1038/nrg3623; Wandke C, 2013, CELL, V152, P1222, DOI 10.1016/j.cell.2013.02.046; WEINTRAUB H, 1976, SCIENCE, V193, P848, DOI 10.1126/science.948749; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152; Woo SR, 2015, TRENDS IMMUNOL, V36, P250, DOI 10.1016/j.it.2015.02.003; Xu ZH, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/205054; Yang D, 2012, J EXP MED, V209, P157, DOI 10.1084/jem.20101354; Yazdani M, 2012, STEM CELLS, V30, P2128, DOI 10.1002/stem.1180; Zhang X, 2015, NUCL ACIDS RES; Zierhut C, 2014, NAT STRUCT MOL BIOL, V21, P617, DOI 10.1038/nsmb.2845	78	59	60	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2016	352	6286							aad6933	10.1126/science.aad6933	http://dx.doi.org/10.1126/science.aad6933			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL1UC	27151873	Green Accepted			2022-12-28	WOS:000375417100027
J	Wallace, LM; Webb, SC; Ito, Y; Mochizuki, K; Hino, R; Henrys, S; Schwartz, SY; Sheehan, AF				Wallace, Laura M.; Webb, Spahr C.; Ito, Yoshihiro; Mochizuki, Kimihiro; Hino, Ryota; Henrys, Stuart; Schwartz, Susan Y.; Sheehan, Anne F.			Slow slip near the trench at the Hikurangi subduction zone, New Zealand	SCIENCE			English	Article							ASEISMIC SLIP; EVENTS; EARTHQUAKES; JAPAN; DEFORMATION; SEAMOUNTS; PENINSULA; FORECASTS; FAULT	The range of fault slip behaviors near the trench at subduction plate boundaries is critical to know, as this is where the world's largest, most damaging tsunamis are generated. Our knowledge of these behaviors has remained largely incomplete, partially due to the challenging nature of crustal deformation measurements at offshore plate boundaries. Here we present detailed seafloor deformation observations made during an offshore slow-slip event (SSE) in September and October 2014, using a network of absolute pressure gauges deployed at the Hikurangi subduction margin offshore New Zealand. These data show the distribution of vertical seafloor deformation during the SSE and reveal direct evidence for SSEs occurring close to the trench (within 2 kilometers of the seafloor), where very low temperatures and pressures exist.	[Wallace, Laura M.] Univ Texas Inst Geophys UTIG, Austin, TX 78758 USA; [Webb, Spahr C.] Columbia Univ, Lamont Doherty Earth Observ LDEO, Palisades, NY 10964 USA; [Ito, Yoshihiro] Kyoto Univ, Disaster Prevent Res Inst, Kyoto, Japan; [Mochizuki, Kimihiro] Univ Tokyo, Earthquake Res Inst, 7-3-1 Hongo, Tokyo 113, Japan; [Hino, Ryota] Tohoku Univ, Dept Geophys, Sendai, Miyagi 980, Japan; [Henrys, Stuart] GNS Sci, Lower Hutt, New Zealand; [Schwartz, Susan Y.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Sheehan, Anne F.] Univ Colorado Boulder, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA	Columbia University; Kyoto University; University of Tokyo; Tohoku University; GNS Science - New Zealand; University of California System; University of California Santa Cruz; University of Colorado System; University of Colorado Boulder	Wallace, LM (corresponding author), Univ Texas Inst Geophys UTIG, Austin, TX 78758 USA.	lwallace@utexas.edu	Henrys, Stuart/ABD-7378-2020; Ito, Yoshihiro/M-2319-2017; Sheehan, Anne F/B-3954-2014; Wallace, Laura/AAR-1862-2021	Henrys, Stuart/0000-0002-7164-5274; Ito, Yoshihiro/0000-0001-9484-9539; Sheehan, Anne F/0000-0002-9629-1687; Wallace, Laura/0000-0003-2070-0891; Webb, Spahr/0000-0002-7277-174X	U.S. NSF [OCE-1334654, 1333311, 1332875, 1333025]; Japan Society for the Promotion of Science [KAKENHI-26257206]; Japan's Ministry of Education, Culture, Sports, Science and Technology; University of Tokyo Earthquake Research Institute; International Research Institute of Disaster Science at Tohoku University; Directorate For Geosciences [1334654] Funding Source: National Science Foundation; Division Of Ocean Sciences [1333311, 1333025] Funding Source: National Science Foundation	U.S. NSF(National Science Foundation (NSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan's Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); University of Tokyo Earthquake Research Institute; International Research Institute of Disaster Science at Tohoku University; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We acknowledge support from U.S. NSF grants OCE-1334654, 1333311, 1332875, and 1333025 to L.M.W., S.C.W., S.Y.S., and A.F.S. and Japan Society for the Promotion of Science grant KAKENHI-26257206 to Y.I. Raw data from the experiment are archived at the Incorporated Research Institutions for Seismology Data Management Center. Additional funding support came from Japan's Ministry of Education, Culture, Sports, Science and Technology; the University of Tokyo Earthquake Research Institute; and the International Research Institute of Disaster Science at Tohoku University. Support for ship time was provided by NSF, GNS Science, and Land Information New Zealand's Oceans 2020 program. We greatly appreciate the immense contribution to the success of this project from ocean bottom instrument engineering teams at LDEO, UTIG, University of Tokyo, and Tohoku University, as well as the captain and crew of the U.S. R/V Roger Revelle and New Zealand R/V Tangaroa.	Bartlow NM, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048714; Bell R, 2014, EARTH PLANET SC LETT, V397, P1, DOI 10.1016/j.epsl.2014.04.005; Bilek SL, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015215; Burgmann R, 2014, ANNU REV EARTH PL SC, V42, P509, DOI 10.1146/annurev-earth-060313-054953; Chadwick WW, 2012, NAT GEOSCI, V5, P474, DOI 10.1038/ngeo1464; Chiswell SM, 2005, NEW ZEAL J MAR FRESH, V39, P121, DOI 10.1080/00288330.2005.9517295; Davis E, 2011, EARTH PLANET SC LETT, V306, P299, DOI 10.1016/j.epsl.2011.04.017; Davis EE, 2015, EARTH PLANET SC LETT, V410, P117, DOI 10.1016/j.epsl.2014.11.015; Dixon TH, 2014, P NATL ACAD SCI USA, V111, P17039, DOI 10.1073/pnas.1412299111; Doser DI, 2003, GEOPHYS J INT, V152, P795, DOI 10.1046/j.1365-246X.2003.01895.x; Douglas A, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023607; Dragert H, 2001, SCIENCE, V292, P1525, DOI 10.1126/science.1060152; Graham SE, 2014, GEOPHYS J INT, V197, P1593, DOI 10.1093/gji/ggu019; Ide S, 2007, NATURE, V447, P76, DOI 10.1038/nature05780; Iinuma T, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009186; Ito Y, 2013, TECTONOPHYSICS, V600, P14, DOI 10.1016/j.tecto.2012.08.022; Jolivet R, 2013, EARTH PLANET SC LETT, V377, P23, DOI 10.1016/j.epsl.2013.07.020; Kato A, 2012, SCIENCE, V335, P705, DOI 10.1126/science.1215141; Kodaira S, 2012, NAT GEOSCI, V5, P646, DOI [10.1038/ngeo1547, 10.1038/NGEO1547]; Mochizuki K, 2008, SCIENCE, V321, P1194, DOI 10.1126/science.1160250; Murray JR, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2005JB003651; Nishimura T, 2014, PROG EARTH PLANET SC, V1, DOI 10.1186/s40645-014-0022-5; Obara K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020848; Ozawa S, 2007, EARTH PLANETS SPACE, V59, P1241, DOI 10.1186/BF03352072; Polster A, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002532; Radiguet M, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008801; Ruiz S, 2014, SCIENCE, V345, P1165, DOI 10.1126/science.1256074; Saffer DM, 2015, NAT GEOSCI, V8, P594, DOI [10.1038/ngeo2490, 10.1038/NGEO2490]; Scholz CH, 1997, GEOLOGY, V25, P487, DOI 10.1130/0091-7613(1997)025<0487:TEOSSO>2.3.CO;2; Schwartz SY, 2007, REV GEOPHYS, V45, DOI 10.1029/2006RG000208; Uchida N, 2016, SCIENCE, V351, P488, DOI 10.1126/science.aad3108; Vallee M, 2013, J GEOPHYS RES-SOL EA, V118, P2965, DOI 10.1002/jgrb.50216; Wallace LM, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009489; Wallace LM, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB007717; Wallace LM, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003241; Wang KL, 2011, GEOLOGY, V39, P819, DOI 10.1130/G31856.1; Yamashita Y, 2015, SCIENCE, V348, P676, DOI 10.1126/science.aaa4242	37	187	194	5	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2016	352	6286					701	704		10.1126/science.aaf2349	http://dx.doi.org/10.1126/science.aaf2349			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL1UC	27151867	Green Published			2022-12-28	WOS:000375417100036
J	Brusselle, G				Brusselle, Guy			Vilanterol fluticasone and mortality in comorbid COPD GOLD B	LANCET			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE; INHALED CORTICOSTEROIDS		[Brusselle, Guy] Ghent Univ Hosp, Dept Resp Med, B-9000 Ghent, Belgium; [Brusselle, Guy] Erasmus MC, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands; [Brusselle, Guy] Erasmus MC, Dept Resp Med, NL-3000 CA Rotterdam, Netherlands	Ghent University; Ghent University Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Brusselle, G (corresponding author), Ghent Univ Hosp, Dept Resp Med, B-9000 Ghent, Belgium.; Brusselle, G (corresponding author), Erasmus MC, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands.; Brusselle, G (corresponding author), Erasmus MC, Dept Resp Med, NL-3000 CA Rotterdam, Netherlands.	guy.brusselle@ugent.be		Brusselle, Guy/0000-0001-7021-8505				Brusselle GG, 2015, LANCET RESP MED, V3, P416, DOI 10.1016/S2213-2600(15)00145-9; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Calverley PMA, 2010, THORAX, V65, P719, DOI 10.1136/thx.2010.136077; Du QX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113048; Lahousse L, 2016, LANCET RESP MED, V4, P149, DOI 10.1016/S2213-2600(15)00518-4; Lahousse L, 2015, EUR HEART J, V36, P1754, DOI 10.1093/eurheartj/ehv121; Price D, 2013, PRIM CARE RESP J, V22, P92, DOI 10.4104/pcrj.2012.00092; Roche N, 2013, LANCET RESP MED, V1, pE29, DOI 10.1016/S2213-2600(13)70199-1; Vestbo J, 2016, LANCET, V387, P1817, DOI 10.1016/S0140-6736(16)30069-1; Vestbo J, 2013, EUR RESPIR J, V41, P1017, DOI 10.1183/09031936.00087312; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP	11	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 30	2016	387	10030					1791	1792		10.1016/S0140-6736(16)30372-5	http://dx.doi.org/10.1016/S0140-6736(16)30372-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK6SS	27203487				2022-12-28	WOS:000375056100005
J	Wintemute, GJ; Betz, ME; Ranney, ML				Wintemute, Garen J.; Betz, Marian E.; Ranney, Megan L.			Yes, You Can: Physicians, Patients, and Firearms	ANNALS OF INTERNAL MEDICINE			English	Article							EMERGENCY-DEPARTMENT; UNITED-STATES; ANTICIPATORY GUIDANCE; VIOLENCE PREVENTION; SUICIDE-PREVENTION; MEANS RESTRICTION; CONTROLLED-TRIAL; NATIONAL COMORBIDITY; MENTAL-DISORDER; RISK BEHAVIORS	Physicians have unique opportunities to help prevent firearm violence. Concern has developed that federal and state laws or regulations prohibit physicians from asking or counseling patients about firearms and disclosing patient information about firearms to others, even when threats to health and safety may be involved. This is not the case. In this article, the authors explain the statutes in question, emphasizing that physicians may ask about firearms (with rare exceptions), may counsel about firearms as they do about other health matters, and may disclose information to third parties when necessary. The authors then review circumstances under which questions about firearms might be most appropriate if they are not asked routinely. Such circumstances include instances when the patient provides information or exhibits behavior suggesting an acutely increased risk for violence, whether to himself or others, or when the patient possesses other individual-level risk factors for violence, such as alcohol abuse. The article summarizes the literature on current physician practices in asking and counseling about firearms, which are done far less commonly than recommended. Barriers to engaging in those practices, the effectiveness of clinical efforts to prevent firearm-related injuries, and what patients think about such efforts and physicians who engage in them are discussed. Proceeding from the limited available evidence, the authors make specific recommendations on how physicians might counsel their patients to reduce their risk for firearm-related death or serious injury. Finally, the authors review the circumstances under which disclosure of patient information about firearms to third parties is supported by regulations implementing the Health Insurance Portability and Accountability Act.	Univ Calif Davis, Sch Med, Sacramento, CA USA; [Betz, Marian E.] Univ Colorado, Sch Med, 12401 East 17th Ave,B-215, Denver, CO 80045 USA; [Ranney, Megan L.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, 593 Eddy St,Claverick 2, Providence, RI 02903 USA; [Wintemute, Garen J.] Univ Calif Davis, Med Ctr, Violence Prevent Res Program, 2315 Stockton Blvd, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; University of California System; University of California Davis	Wintemute, GJ (corresponding author), Univ Calif Davis, Med Ctr, Violence Prevent Res Program, 2315 Stockton Blvd, Sacramento, CA 95817 USA.	vprp@ucdavis.edu	Betz, Marian/H-3303-2017	Betz, Marian/0000-0003-1643-6565	California Wellness Foundation [2014-255]	California Wellness Foundation	Dr. Wintemute's work on this project was supported in part by grant 2014-255 from The California Wellness Foundation.	Albright TL, 2003, J AM BOARD FAM PRACT, V16, P40, DOI 10.3122/jabfm.16.1.40; American Medical Association, 2006, OP 8 082 WITHH INF P; Anglemyer A, 2014, ANN INTERN MED, V160, P101, DOI 10.7326/M13-1301; [Anonymous], 2014, INJ PREV CONTR DAT S; Barkin SL, 2008, PEDIATRICS, V122, pE15, DOI 10.1542/peds.2007-2611; Betz ME, 2016, DEPRESS ANXIETY, V33, P502, DOI 10.1002/da.22486; Betz ME, 2015, J AM GERIATR SOC, V63, P2214, DOI 10.1111/jgs.13695; Betz ME, 2015, JAMA-J AM MED ASSOC, V314, P449, DOI 10.1001/jama.2015.7055; Betz ME, 2013, DEPRESS ANXIETY, V30, P1013, DOI 10.1002/da.22075; Brent DA, 2000, J AM ACAD CHILD PSY, V39, P1220, DOI 10.1097/00004583-200010000-00007; Butkus R, 2014, ANN INTERN MED, V160, P821, DOI 10.7326/M13-1960; Carbone PS, 2005, ARCH PEDIAT ADOL MED, V159, P1049, DOI 10.1001/archpedi.159.11.1049; Cassel CK, 1998, ANN INTERN MED, V128, P224, DOI 10.7326/0003-4819-128-3-199802010-00009; Cook PJ, 2005, JAMA-J AM MED ASSOC, V294, P598, DOI 10.1001/jama.294.5.598; Cunningham RM, 2015, JAMA PEDIATR, V169, P63, DOI 10.1001/jamapediatrics.2014.1900; Dobscha SK, 2014, GEN HOSP PSYCHIAT, V36, P310, DOI 10.1016/j.genhosppsych.2013.11.007; Elbogen EB, 2009, ARCH GEN PSYCHIAT, V66, P152, DOI 10.1001/archgenpsychiatry.2008.537; Everett SA, 1997, J COMMUN HEALTH, V22, P313, DOI 10.1023/A:1025172903135; Gardner HG, 2012, PEDIATRICS, V130, pE1416, DOI 10.1542/peds.2012-2481; Grossman DC, 2000, PEDIATRICS, V106, P22, DOI 10.1542/peds.106.1.22; Hsieh JK, 2015, ANN INTERN MED, V163, P485, DOI 10.7326/L15-5138; Ilgen MA, 2008, PSYCHIAT SERV, V59, P198, DOI 10.1176/ps.2008.59.2.198; Johnson KL, 2016, PSYCHIAT SERV; Johnston BD, 2002, PEDIATRICS, V110, P267, DOI 10.1542/peds.110.2.267; Krouse WJ, 2015, R44126 CONGR RES SER; Kruesi MJP, 1999, J AM ACAD CHILD PSY, V38, P250, DOI 10.1097/00004583-199903000-00010; Liljegren M, 2015, JAMA NEUROL, V72, P295, DOI 10.1001/jamaneurol.2014.3781; Lum Hillary D, 2016, Curr Gerontol Geriatr Res, V2016, P2980416, DOI 10.1155/2016/2980416; McGee KS, 2003, INJURY PREV, V9, P108, DOI 10.1136/ip.9.2.108; McGinty EE, 2016, EPIDEMIOL REV, V38, P5, DOI 10.1093/epirev/mxv008; Miller M, 2009, INJURY PREV, V15, P183, DOI 10.1136/ip.2008.021352; Paola FA, 1998, ANN INTERN MED, V129, P336, DOI 10.7326/0003-4819-129-4-199808150-00020; Pierson J, 2014, NEW ENGL J MED, V370, P2453, DOI 10.1056/NEJMc1401815; Pinholt EM, 2014, J AM GERIATR SOC, V62, P1142, DOI 10.1111/jgs.12836; Price JH, 2007, AM J PREV MED, V33, P370, DOI 10.1016/j.amepre.2007.07.021; Price JH, 2013, J EMERG MED, V44, P1007, DOI 10.1016/j.jemermed.2012.11.010; Pulay AJ, 2008, J CLIN PSYCHIAT, V69, P12, DOI 10.4088/JCP.v69n0103; Purtle J, 2015, ANN INTERN MED, V163, P715, DOI 10.7326/M15-0586; Purtle J, 2013, J TRAUMA ACUTE CARE, V75, P331, DOI 10.1097/TA.0b013e318294f518; Puttagunta R, 2016, ACAD PSYCHIAT; Rodriguez, 2013, COMMUNICATION; Roszko PJD, 2016, EPIDEMIOL REV, V38, P87, DOI 10.1093/epirev/mxv005; Rowhani-Rahbar A, 2016, EPIDEMIOL REV, V38, P111, DOI 10.1093/epirev/mxv006; Rowhani-Rahbar A, 2015, ANN INTERN MED, V162, P492, DOI 10.7326/M14-2362; Runyan CW, 2016, WEST J EMERG MED, V17, P8, DOI 10.5811/westjem.2015.11.28590; Sege RD, 2006, PEDIATRICS, V117, P455, DOI 10.1542/peds.2005-0377; Shaughnessy A F, 1999, J Am Board Fam Pract, V12, P354; Sherman ME, 2001, PSYCHIATR SERV, V52, P1057, DOI 10.1176/appi.ps.52.8.1057; Simon RI, 2006, U CINCI LAW REV, V75, P631; Slovak K, 2008, SOC WORK, V53, P358, DOI 10.1093/sw/53.4.358; Slovak K, 2010, SUICIDE LIFE-THREAT, V40, P63, DOI 10.1521/suli.2010.40.1.63; Snyder L, 2012, ANN INTERN MED, V156, DOI 10.7326/0003-4819-156-1-201201031-00001; Sorenson SB, 2008, EVALUATION REV, V32, P239, DOI 10.1177/0193841X08315871; Spangenberg KB, 1999, J AM GERIATR SOC, V47, P1183, DOI 10.1111/j.1532-5415.1999.tb05197.x; Stevens MM, 2002, PEDIATRICS, V109, P490, DOI 10.1542/peds.109.3.490; Swanson JW, 2015, BEHAV SCI LAW, V33, P199, DOI 10.1002/bsl.2172; Swanson JW, 2015, ANN EPIDEMIOL, V25, P366, DOI 10.1016/j.annepidem.2014.03.004; The Henry J. Kaiser Family Foundation, 2013, KAISER HLTH TRACKING; The Joint Commission, 2018, NAT PAT SAF GOALS EF; The White House, 2013, NOW IS TIM PRES PLAN; Traylor A, 2010, J COMMUN HEALTH, V35, P60, DOI 10.1007/s10900-009-9200-6; U. S. Department of Labor, 2013, FAQS AFF CAR ACT 11; U.S. Preventive Services Task Force. Guide to Clinical Preventive Services, 2014, GUID CLIN PREV SERV; Van Dorn R, 2012, SOC PSYCH PSYCH EPID, V47, P487, DOI 10.1007/s00127-011-0356-x; Vriniotis M, 2015, SUICIDE LIFE-THREAT, V45, P157, DOI 10.1111/sltb.12123; Walters H, 2012, GEN HOSP PSYCHIAT, V34, P692, DOI 10.1016/j.genhosppsych.2012.07.012; Weinberger SE, 2015, ANN INTERN MED, V162, P513, DOI 10.7326/M15-0337; Weinberger SE, 2012, NEW ENGL J MED, V367, P1557, DOI 10.1056/NEJMsb1209858; Wintemute GJ, 2015, ANNU REV PUBL HEALTH, V36, P5, DOI 10.1146/annurev-publhealth-031914-122535; Wintemute GJ, 2011, INJURY PREV, V17, P422, DOI 10.1136/ip.2010.031443; Wintemute GJ, 1998, JAMA-J AM MED ASSOC, V280, P2083, DOI 10.1001/jama.280.24.2083; Wintemute GJ, 1999, NEW ENGL J MED, V341, P1583, DOI 10.1056/NEJM199911183412106; Winternute GJ, 2015, PREV MED, V79, P15, DOI 10.1016/j.ypmed.2015.04.015; Yip PSF, 2012, LANCET, V379, P2393, DOI 10.1016/S0140-6736(12)60521-2; Zatzick D, 2014, JAMA PEDIATR, V168, P532, DOI 10.1001/jamapediatrics.2013.4784	75	92	92	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 2	2016	165	3					205	+		10.7326/M15-2905	http://dx.doi.org/10.7326/M15-2905			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS2HA	27183181				2022-12-28	WOS:000380583300009
J	Boseley, S				Boseley, Sarah			Pauline Cafferkey: dedicated nurse and reluctant Ebola hero	LANCET			English	Biographical-Item																		CAFFERKEY P, PUBLICATION LIST	1	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 30	2016	388	10043					455	455		10.1016/S0140-6736(16)30369-5	http://dx.doi.org/10.1016/S0140-6736(16)30369-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS2EK	27209147	Bronze			2022-12-28	WOS:000380559400013
J	Parker, EPK; Grassly, NC				Parker, Edward P. K.; Grassly, Nicholas C.			Polio vaccination: preparing for a change of routine	LANCET			English	Editorial Material							CONTROLLED-TRIAL; OPEN-LABEL; POLIOMYELITIS; IMMUNOGENICITY; IMMUNITY; TRACT		[Parker, Edward P. K.; Grassly, Nicholas C.] Imperial Coll London, Dept Infect Dis Epidemiol, St Marys Campus, London, England	Imperial College London	Parker, EPK (corresponding author), Imperial Coll London, Dept Infect Dis Epidemiol, St Marys Campus, London, England.	e.parker12@imperial.ac.uk	Grassly, Nicholas C/C-6381-2008	Grassly, Nicholas C/0000-0001-6067-4507; Parker, Edward/0000-0001-5847-109X	MRC [MR/K010174/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1] Funding Source: Medline; Medical Research Council [MR/K010174/1B, 1246243] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Anis E, 2013, EUROSURVEILLANCE, V18, P2, DOI 10.2807/1560-7917.ES2013.18.38.20586; Asturias EJ, 2016, LANCET; Burns CC, 2014, J INFECT DIS, V210, pS283, DOI 10.1093/infdis/jiu295; Estivariz CF, 2015, LANCET INFECT DIS, V15, P898, DOI 10.1016/S1473-3099(15)00094-8; GHENDON YZ, 1961, ACTA VIROL, V5, P265; O'Ryan M, 2015, LANCET INFECT DIS, V15, P1273, DOI 10.1016/S1473-3099(15)00219-4; OGRA PL, 1969, J IMMUNOL, V102, P1423; Parker EPK, 2015, EXPERT REV VACCINES, V14, P1113, DOI 10.1586/14760584.2015.1052800; Platt LR, 2014, J INFECT DIS, V210, pS380, DOI 10.1093/infdis/jiu184; Sutter RW, 2015, LANCET, V386, P2413, DOI 10.1016/S0140-6736(15)00237-8; WHO, 2016, COUNTR US PLANN INTR	11	4	4	1	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2016	388	10040					107	108		10.1016/S0140-6736(16)30593-1	http://dx.doi.org/10.1016/S0140-6736(16)30593-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ5TZ	27212428	Green Submitted			2022-12-28	WOS:000379269200009
J	Jumbe, NL; Murray, JC; Kern, S				Jumbe, N. L'ntshotshole; Murray, Jeffrey C.; Kern, Steven			Data Sharing and Inductive Learning - Toward Healthy Birth, Growth, and Development	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Jumbe, N. L'ntshotshole; Murray, Jeffrey C.; Kern, Steven] Bill & Melinda Gates Fdn, Hlth Birth Growth & Dev Core Team, Seattle, WA 98109 USA	Bill & Melinda Gates Foundation	Jumbe, NL (corresponding author), Bill & Melinda Gates Fdn, Hlth Birth Growth & Dev Core Team, Seattle, WA 98109 USA.			Kern, Steven/0000-0002-2849-0836				Longo DL, 2016, NEW ENGL J MED, V374, P276, DOI 10.1056/NEJMe1516564; Taichman DB, 2016, NEW ENGL J MED, V374, P384, DOI 10.1056/NEJMe1515172; van Panhuis WG, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1144	3	14	14	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2016	374	25					2415	2417		10.1056/NEJMp1605441	http://dx.doi.org/10.1056/NEJMp1605441			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DP1TG	27168111	Bronze			2022-12-28	WOS:000378271700005
J	Anderson, CS; Robinson, T; Lindley, RI; Arima, H; Lavados, PM; Lee, TH; Broderick, JP; Chen, X; Chen, G; Sharma, VK; Kim, JS; Thang, NH; Cao, Y; Parsons, MW; Levi, C; Huang, Y; Olavarria, VV; Demchuk, AM; Bath, PM; Donnan, GA; Martins, S; Pontes-Neto, OM; Silva, F; Ricci, S; Roffe, C; Pandian, J; Billot, L; Woodward, M; Li, Q; Wang, X; Wang, J; Chalmers, J				Anderson, C. S.; Robinson, T.; Lindley, R. I.; Arima, H.; Lavados, P. M.; Lee, T. -H.; Broderick, J. P.; Chen, X.; Chen, G.; Sharma, V. K.; Kim, J. S.; Thang, N. H.; Cao, Y.; Parsons, M. W.; Levi, C.; Huang, Y.; Olavarria, V. V.; Demchuk, A. M.; Bath, P. M.; Donnan, G. A.; Martins, S.; Pontes-Neto, O. M.; Silva, F.; Ricci, S.; Roffe, C.; Pandian, J.; Billot, L.; Woodward, M.; Li, Q.; Wang, X.; Wang, J.; Chalmers, J.		ENCHANTED Investigators	Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; RANDOMIZED CONTROLLED-TRIAL; INTRACRANIAL HEMORRHAGE; STATISTICAL-ANALYSIS; THROMBOLYSIS STROKE; ENHANCED CONTROL; 0.6 MG/KG; OUTCOMES; HYPERTENSION; METAANALYSIS	BACKGROUND Thrombolytic therapy for acute ischemic stroke with a lower-than-standard dose of intravenous alteplase may improve recovery along with a reduced risk of intracerebral hemorrhage. METHODS Using a 2-by-2 quasi-factorial open-label design, we randomly assigned 3310 patients who were eligible for thrombolytic therapy (median age, 67 years; 63% Asian) to low-dose intravenous alteplase (0.6 mg per kilogram of body weight) or the standard dose (0.9 mg per kilogram); patients underwent randomization within 4.5 hours after the onset of stroke. The primary objective was to determine whether the low dose would be noninferior to the standard dose with respect to the primary outcome of death or disability at 90 days, which was defined by scores of 2 to 6 on the modified Rankin scale (range, 0 [no symptoms] to 6 [death]). Secondary objectives were to determine whether the low dose would be superior to the standard dose with respect to centrally adjudicated symptomatic intracerebral hemorrhage and whether the low dose would be noninferior in an ordinal analysis of modified Rankin scale scores (testing for an improvement in the distribution of scores). The trial included 935 patients who were also randomly assigned to intensive or guideline-recommended blood-pressure control. RESULTS The primary outcome occurred in 855 of 1607 participants (53.2%) in the low-dose group and in 817 of 1599 participants (51.1%) in the standard-dose group (odds ratio, 1.09; 95% confidence interval [CI], 0.95 to 1.25; the upper boundary exceeded the noninferiority margin of 1.14; P=0.51 for noninferiority). Low-dose alteplase was noninferior in the ordinal analysis of modified Rankin scale scores (unadjusted common odds ratio, 1.00; 95% CI, 0.89 to 1.13; P=0.04 for noninferiority). Major symptomatic intracerebral hemorrhage occurred in 1.00% of the participants in the low-dose group and in 2.1% of the participants in the standard-dose group (P=0.01); fatal events occurred within 7 days in 0.5% and 1.5%, respectively (P=0.01). Mortality at 90 days did not differ significantly between the two groups (8.5% and 10.3%, respectively; P=0.07). CONCLUSIONS This trial involving predominantly Asian patients with acute ischemic stroke did not show the noninferiority of low-dose alteplase to standard-dose alteplase with respect to death and disability at 90 days. There were significantly fewer symptomatic intracerebral hemorrhages with low-dose alteplase.	[Anderson, C. S.; Lindley, R. I.; Arima, H.; Chen, X.; Billot, L.; Woodward, M.; Li, Q.; Wang, X.; Chalmers, J.] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Anderson, C. S.; Lindley, R. I.; Arima, H.; Chen, X.; Billot, L.; Woodward, M.; Li, Q.; Chalmers, J.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Anderson, C. S.] Sydney Hlth Partners, Royal Prince Alfred Hosp, Dept Neurol, Sydney, NSW, Australia; [Parsons, M. W.; Levi, C.] Univ Newcastle, John Hunter Hosp, Dept Neurol, Newcastle, NSW 2300, Australia; [Parsons, M. W.; Levi, C.] Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW 2300, Australia; [Donnan, G. A.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Anderson, C. S.] Peking Univ, George Inst China, Beijing 100871, Peoples R China; [Huang, Y.] Peking Univ, Hosp 1, Dept Neurol, Beijing 100871, Peoples R China; [Chen, G.] Xuzhou Cent Hosp, Dept Neurol, Xuzhou, Peoples R China; [Cao, Y.] Soochow Univ, Affiliated Hosp 2, Dept Neurol, Suzhou, Peoples R China; [Wang, J.] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Shanghai Inst Hypertens, Shanghai 200030, Peoples R China; [Robinson, T.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Robinson, T.] Natl Inst Hlth Res, Biomed Res Unit, Leicester, Leics, England; [Bath, P. M.] Univ Nottingham, Stroke Trials Unit, Div Clin Neurosci, Nottingham NG7 2RD, England; [Roffe, C.] Royal Stoke Univ Hosp, Dept Neurosci, Stoke On Trent, Staffs, England; [Woodward, M.] Univ Oxford, George Inst Global Hlth, Oxford, England; [Arima, H.] Fukuoka Univ, Fac Med, Dept Prevent Med & Publ Hlth, Fukuoka 81401, Japan; [Lavados, P. M.; Olavarria, V. V.] Clin Alemana Univ Desarrollo, Fac Med, Clin Alemana Santiago, Santiago, Chile; [Lavados, P. M.] Univ Chile, Fac Med, Dept Ciencias Neurol, Santiago, Chile; [Lee, T. -H.] Linkou Chang Gung Mem Hosp, Dept Neurol, Taoyuan, Taiwan; [Broderick, J. P.] Univ Cincinnati, Acad Hlth Ctr, Neurosci Inst, Dept Neurol & Rehabil Med, Cincinnati, OH USA; [Broderick, J. P.] Univ Cincinnati, Acad Hlth Ctr, Neurosci Inst, Dept Radiol, Cincinnati, OH USA; [Sharma, V. K.] Natl Univ Singapore Hosp, Dept Med, Div Neurol, Singapore 117548, Singapore; [Sharma, V. K.] Natl Univ Singapore, Sch Med, Singapore 117548, Singapore; [Kim, J. S.] Univ Ulsan, Asan Med Ctr, Dept Neurol, Seoul, South Korea; [Thang, N. H.] Peoples 115 Hosp, Dept Cerebrovasc Dis, Ho Chi Minh City, Vietnam; [Demchuk, A. M.] Univ Calgary, Dept Clin Neurosci & Radiol, Hotchkiss Brain Inst, Calgary Stroke Program, Calgary, AB, Canada; [Martins, S.] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Stroke Div Neurol Serv, Porto Alegre, RS, Brazil; [Pontes-Neto, O. M.] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Neurosci & Behav, Stroke Serv,Neurol Div, Sao Paulo, Brazil; [Silva, F.] Neurovasc Sci Grp, Neurosci Dept, Bucaramanga, Colombia; [Ricci, S.] USL Umbria 1, Unita Operat Neurol, Sedi Citta Castello Bran, Italy; [Pandian, J.] Christian Med Coll & Hosp, Dept Neurol, Ludhiana, Punjab, India; [Woodward, M.] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA	George Institute for Global Health; University of Sydney; University of Sydney; University of Sydney; John Hunter Hospital; University of Newcastle; Hunter Medical Research Institute; University of Newcastle; Florey Institute of Neuroscience & Mental Health; Peking University; Peking University; Soochow University - China; Shanghai Jiao Tong University; University of Leicester; University of Nottingham; Royal Stoke University Hospital; University of Oxford; Fukuoka University; Clinica Alemana; Universidad del Desarrollo; Universidad de Chile; Chang Gung Memorial Hospital; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; National University of Singapore; National University of Singapore; University of Ulsan; Asan Medical Center; University of Calgary; Universidade Federal do Rio Grande do Sul; Universidade de Sao Paulo; Johns Hopkins University	Anderson, CS (corresponding author), Sydney Hlth Partners, Royal Prince Alfred Hosp, George Inst Global Hlth, POB M201,Missenden Rd, Sydney, NSW, Australia.; Anderson, CS (corresponding author), Univ Sydney, POB M201,Missenden Rd, Sydney, NSW 2006, Australia.	canderson@georgeinstitute.org.au	Bazan, Rodrigo/D-4185-2012; Spratt, Neil J/K-4208-2012; Woodward, Mark/L-6817-2017; Billot, Laurent/Y-1241-2019; Luvizutto, Gustavo/F-3709-2019; FRACP, Tissa Wijeratne MD PhD/I-2086-2019; Lindley, Richard/B-8148-2013; Pontes-Neto, Octavio Marques/G-4294-2012; Wang, Xia/C-3298-2018; Roffe, Christine/AAT-5611-2020; sharma, Vijay/T-5286-2019; sharma, Vijay K/A-6733-2009; Martins, Sheila Cristina Ouriques/L-1616-2016; Leung, Thomas W/AAU-6475-2021; Demchuk, Andrew M/E-1103-2012; Bath, Philip/F-9020-2011	Bazan, Rodrigo/0000-0003-3872-308X; Spratt, Neil J/0000-0002-9023-6177; Billot, Laurent/0000-0002-4975-9793; Luvizutto, Gustavo/0000-0002-6914-7225; FRACP, Tissa Wijeratne MD PhD/0000-0002-1701-7111; Lindley, Richard/0000-0002-0104-5679; Pontes-Neto, Octavio Marques/0000-0003-0317-843X; Wang, Xia/0000-0002-1684-7076; Roffe, Christine/0000-0002-5259-6649; sharma, Vijay/0000-0002-8976-5696; sharma, Vijay K/0000-0002-8976-5696; Leung, Thomas W/0000-0001-8193-0709; Demchuk, Andrew M/0000-0002-4930-7789; Chalmers, John/0000-0002-9931-0580; Li, Qiang/0000-0002-4384-8226; Woodward, Mark/0000-0001-9800-5296; Anderson, Craig/0000-0002-7248-4863; SEAK, CHEN-JUNE/0000-0003-0984-8385; Robinson, Thompson/0000-0003-2144-2468; Bath, Philip/0000-0003-2734-5132; Carcel, Cheryl/0000-0001-8942-953X; corea, francesco/0000-0002-5864-9991; Pandian, Jeyaraj/0000-0003-0028-1968; Matamala, Jose Manuel/0000-0001-9062-5642; Levi, Christopher/0000-0002-9474-796X	National Health and Medical Research Council of Australia; Grants-in-Aid for Scientific Research [15H04773] Funding Source: KAKEN; National Institute for Health Research [NF-SI-0515-10044, NF-SI-0515-10054, NF-SI-0611-10003] Funding Source: researchfish; Alberta Innovates [201300690] Funding Source: researchfish; Stroke Association [TSA2012/01] Funding Source: researchfish	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Institute for Health Research(National Institute for Health Research (NIHR)); Alberta Innovates; Stroke Association	Funded by the National Health and Medical Research Council of Australia and others; ENCHANTED ClinicalTrials.gov number, NCT01422616.	Anderson CS, 2015, INT J STROKE, V10, P1313, DOI 10.1111/ijs.12602; Bath PMW, 2012, STROKE, V43, P1171, DOI 10.1161/STROKEAHA.111.641456; Chaisinanunkul N, 2015, STROKE, V46, P2238, DOI 10.1161/STROKEAHA.114.008547; Chao AC, 2010, STROKE, V41, P885, DOI 10.1161/STROKEAHA.109.575605; Diener HC, 2013, LANCET NEUROL, V12, P677, DOI 10.1016/S1474-4422(13)70101-7; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Howard G, 2012, STROKE, V43, P664, DOI 10.1161/STROKEAHA.111.632935; Huang YN, 2015, INT J STROKE, V10, P778, DOI 10.1111/ijs.12486; Kim BJ, 2015, STROKE, V46, P2541, DOI 10.1161/STROKEAHA.115.010180; Liao XL, 2014, STROKE, V45, P2354, DOI 10.1161/STROKEAHA.114.005989; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Menon BK, 2012, STROKE, V43, P2293, DOI 10.1161/STROKEAHA.112.660415; Nakagawara J, 2010, STROKE, V41, P1984, DOI 10.1161/STROKEAHA.110.589606; Quinn TJ, 2009, INT J STROKE, V4, P200, DOI 10.1111/j.1747-4949.2009.00271.x; Quinn TJ, 2009, STROKE, V40, P3393, DOI [10.1161/STROKEAHA.109.557256, 10.1161/STROKEAHA.108.522516]; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Sandercock P, 2013, LANCET NEUROL, V12, P768, DOI 10.1016/S1474-4422(13)70130-3; Saver JL, 2013, JAMA-J AM MED ASSOC, V309, P2480, DOI 10.1001/jama.2013.6959; Sharma VK, 2011, INT J STROKE, V6, P523, DOI 10.1111/j.1747-4949.2011.00671.x; Toyoda K, 2009, STROKE, V40, P3591, DOI 10.1161/STROKEAHA.109.562991; von Kummer R, 2015, STROKE, V46, P2981, DOI 10.1161/STROKEAHA.115.010049; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Wang YL, 2011, STROKE, V42, P1658, DOI 10.1161/STROKEAHA.110.604249; Wardlaw JM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub3; Wardlaw JM, 2012, LANCET, V379, P2364, DOI 10.1016/S0140-6736(12)60738-7; Wardlaw JM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub2; Whiteley WN, 2012, STROKE, V43, P2904, DOI 10.1161/STROKEAHA.112.665331; Yamaguchi T, 2006, STROKE, V37, P1810, DOI 10.1161/01.STR.0000227191.01792.e3	28	261	280	4	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2016	374	24					2313	2323		10.1056/NEJMoa1515510	http://dx.doi.org/10.1056/NEJMoa1515510			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO5WW	27161018	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000377854600005
J	Wedzicha, JA; Banerji, D; Chapman, KR; Vestbo, J; Roche, N; Ayers, T; Thach, C; Fogel, R; Patalano, F; Vogelmeier, CF				Wedzicha, Jadwiga A.; Banerji, Donald; Chapman, Kenneth R.; Vestbo, Jorgen; Roche, Nicolas; Ayers, Timothy; Thach, Chau; Fogel, Robert; Patalano, Francesco; Vogelmeier, Claus F.		FLAME Investigators	Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; TO-SEVERE COPD; INHALED CORTICOSTEROIDS; BLOOD EOSINOPHILS; PARALLEL-GROUP; LUNG-FUNCTION; DOUBLE-BLIND; EXACERBATIONS; EFFICACY; SAFETY	BACKGROUND Most guidelines recommend either a long-acting beta-agonist (LABA) plus an inhaled glucocorticoid or a long-acting muscarinic antagonist (LAMA) as the first-choice treatment for patients with chronic obstructive pulmonary disease (COPD) who have a high risk of exacerbations. The role of treatment with a LABA-LAMA regimen in these patients is unclear. METHODS We conducted a 52-week, randomized, double-blind, double-dummy, noninferiority trial. Patients who had COPD with a history of at least one exacerbation during the previous year were randomly assigned to receive, by inhalation, either the LABA indacaterol (110 mu g) plus the LAMA glycopyrronium (50 mu g) once daily or the LABA salmeterol (50 mu g) plus the inhaled glucocorticoid fluticasone (500 mu g) twice daily. The primary outcome was the annual rate of all COPD exacerbations. RESULTS A total of 1680 patients were assigned to the indacaterol-glycopyrronium group, and 1682 to the salmeterol-fluticasone group. Indacaterol-glycopyrronium showed not only noninferiority but also superiority to salmeterol-fluticasone in reducing the annual rate of all COPD exacerbations; the rate was 11% lower in the indacaterol-glycopyrronium group than in the salmeterol-fluticasone group (3.59 vs. 4.03; rate ratio, 0.89; 95% confidence interval [CI], 0.83 to 0.96; P = 0.003). The indacaterol-glycopyrronium group had a longer time to the first exacerbation than did the salmeterol-fluticasone group (71 days [95% CI, 60 to 82] vs. 51 days [95% CI, 46 to 57]; hazard ratio, 0.84 [95% CI, 0.78 to 0.91], representing a 16% lower risk; P < 0.001). The annual rate of moderate or severe exacerbations was lower in the indacaterol-glycopyrronium group than in the salmeterol-fluticasone group (0.98 vs. 1.19; rate ratio, 0.83; 95% CI, 0.75 to 0.91; P < 0.001), and the time to the first moderate or severe exacerbation was longer in the indacaterol-glycopyrronium group than in the salmeterol-fluticasone group (hazard ratio, 0.78; 95% CI, 0.70 to 0.86; P < 0.001), as was the time to the first severe exacerbation (hazard ratio, 0.81; 95% CI, 0.66 to 1.00; P = 0.046). The effect of indacaterol-glycopyrronium versus salmeterol-fluticasone on the rate of COPD exacerbations was independent of the baseline blood eosinophil count. The incidence of adverse events and deaths was similar in the two groups. The incidence of pneumonia was 3.2% in the indacaterol-glycopyrronium group and 4.8% in the salmeterol-fluticasone group (P = 0.02). CONCLUSIONS Indacaterol-glycopyrronium was more effective than salmeterol-fluticasone in preventing COPD exacerbations in patients with a history of exacerbation during the previous year. (Funded by Novartis; FLAME ClinicalTrials.gov number, NCT01782326.)	[Wedzicha, Jadwiga A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Vestbo, Jorgen] Univ Manchester, Ctr Resp Med & Allergy, Manchester, Lancs, England; [Vestbo, Jorgen] Univ Hosp South Manchester NHS Fdn Trust, Manchester, Lancs, England; [Banerji, Donald; Thach, Chau; Fogel, Robert] Novartis Pharmaceut, E Hanover, NJ USA; [Chapman, Kenneth R.] Univ Hlth Network, Asthma & Airway Ctr, Toronto, ON, Canada; [Chapman, Kenneth R.] Univ Toronto, Toronto, ON, Canada; [Roche, Nicolas] Univ Paris 05, Serv Pneumol, AP HP, EA2511, Paris, France; [Patalano, Francesco] Novartis Pharma AG, Basel, Switzerland; [Vogelmeier, Claus F.] Univ Marburg, Univ Med Ctr Giessen & Marburg, Dept Med Pulm & Crit Care Med, Marburg, Germany	Imperial College London; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Novartis; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Novartis; Philipps University Marburg; University Hospital of Giessen & Marburg	Wedzicha, JA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, COPD Res Grp, Airways Dis Sect, Dovehouse St, London SW3 6LY, England.	j.wedzicha@imperial.ac.uk	Roche, Nicolas/AAP-4445-2021; Roche, Nicolas/AAE-9206-2021; Patalano, Francesco/AAE-6510-2021; Saryal, Sevgi/AAP-7879-2020; Ambrosino, Nicolino/AAC-2005-2020; Vestbo, Jorgen/Y-2912-2019; Nayci, Sibel/A-6015-2016; DESLEE, Gaetan/G-2625-2013	Saryal, Sevgi/0000-0001-5062-5226; Ambrosino, Nicolino/0000-0002-5331-1393; Nayci, Sibel/0000-0002-8415-5717; Pothirat, Chaicharn/0000-0003-0616-7066; roche, nicolas/0000-0002-3162-5033; Janssens, Wim/0000-0003-1830-2982; DESLEE, Gaetan/0000-0002-4919-5916; Vukcevic, Miodrag/0000-0002-6218-3848; Vestbo, Jorgen/0000-0001-6355-6362; Field, Stephen/0000-0002-6682-4155; Bodtger, Uffe/0000-0002-1231-9209; Antczak, Adam/0000-0003-3430-3088	Novartis; National Institute for Health Research [NF-SI-0513-10077, NF-SI-0510-10270] Funding Source: researchfish	Novartis(Novartis); National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by Novartis; FLAME ClinicalTrials.gov number, NCT01782326.	[Anonymous], 2000, POINTS CONS SWITCH S; ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196; Bateman ED, 2013, EUR RESPIR J, V42, P1484, DOI 10.1183/09031936.00200212; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Calverley PMA, 2011, CHEST, V139, P505, DOI 10.1378/chest.09-2992; Calverley PM, 2003, EUR RESPIR J, V22, P912, DOI 10.1183/09031936.03.00027003; Crim C, 2009, EUR RESPIR J, V34, P641, DOI 10.1183/09031936.00193908; de Torres JP, 2002, CHEST, V121, P1092, DOI 10.1378/chest.121.4.1092; Donaldson GC, 2015, AM J RESP CRIT CARE, V192, P943, DOI 10.1164/rccm.201412-2269OC; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Donohue JF, 2015, RESP MED, V109, P870, DOI 10.1016/j.rmed.2015.04.018; Dransfield MT, 2014, RESP MED, V108, P1171, DOI 10.1016/j.rmed.2014.05.008; FDA, 2010, GUID IND NON CLIN TR; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2015, GLOB STRAT DIAGN MAN; Jones Paul W, 2005, COPD, V2, P75; Jones PW, 2014, EUR RESPIR J, V44, P1156, DOI 10.1183/09031936.00038814; Kerwin E, 2012, EUR RESPIR J, V40, P1106, DOI 10.1183/09031936.00040712; Langsetmo L, 2008, AM J RESP CRIT CARE, V177, P396, DOI 10.1164/rccm.200708-1290OC; Magnussen H, 2014, NEW ENGL J MED, V371, P1285, DOI 10.1056/NEJMoa1407154; Mahler DA, 2015, AM J RESP CRIT CARE, V192, P1068, DOI 10.1164/rccm.201505-1048OC; Muellerova H, 2015, CHEST, V147, P999, DOI 10.1378/chest.14-0655; NICE, 2010, CHRON OBSTR PULM DIS; Pascoe S, 2015, LANCET RESP MED, V3, P435, DOI 10.1016/S2213-2600(15)00106-X; Pavord ID, 2016, THORAX, V71, P118, DOI 10.1136/thoraxjnl-2015-207021; Price D, 2013, PRIM CARE RESP J, V22, P92, DOI 10.4104/pcrj.2012.00092; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Siddiqui SH, 2015, AM J RESP CRIT CARE, V192, P523, DOI 10.1164/rccm.201502-0235LE; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Szafranski W, 2003, EUR RESPIR J, V21, P74, DOI 10.1183/09031936.03.00031402; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Toy EL, 2010, COPD, V7, P214, DOI 10.3109/15412555.2010.481697; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482; Vogelmeier CF, 2013, LANCET RESP MED, V1, P51, DOI 10.1016/S2213-2600(12)70052-8; Wedzicha JA, 2008, AM J RESP CRIT CARE, V177, P19, DOI 10.1164/rccm.200707-973OC; Wedzicha JA, 2015, RESP MED, V109, P105, DOI 10.1016/j.rmed.2014.10.011; Wedzicha JA, 2013, LANCET RESP MED, V1, P199, DOI 10.1016/S2213-2600(13)70052-3; Wilkinson TMA, 2004, AM J RESP CRIT CARE, V169, P1298, DOI 10.1164/rccm.200310-1443OC; Zhong NS, 2015, INT J CHRONIC OBSTR, V10, P1015, DOI 10.2147/COPD.S84436	38	561	602	1	90	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2016	374	23					2222	2234		10.1056/NEJMoa1516385	http://dx.doi.org/10.1056/NEJMoa1516385			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO6VB	27181606	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000377920500006
J	Robb, ML; Eller, LA; Kibuuka, H; Rono, K; Maganga, L; Nitayaphan, S; Kroon, E; Sawe, FK; Sinei, S; Sriplienchan, S; Jagodzinski, LL; Malia, J; Manak, M; de Souza, MS; Tovanabutra, S; Sanders-Buell, E; Rolland, M; Dorsey-Spitz, J; Eller, MA; Milazzo, M; Li, Q; Lewandowski, A; Wu, H; Swann, E; O'Connell, RJ; Peel, S; Dawson, P; Kim, JH; Michael, NL				Robb, Merlin L.; Eller, Leigh A.; Kibuuka, Hannah; Rono, Kathleen; Maganga, Lucas; Nitayaphan, Sorachai; Kroon, Eugene; Sawe, Fred K.; Sinei, Samuel; Sriplienchan, Somchai; Jagodzinski, Linda L.; Malia, Jennifer; Manak, Mark; de Souza, Mark S.; Tovanabutra, Sodsai; Sanders-Buell, Eric; Rolland, Morgane; Dorsey-Spitz, Julie; Eller, Michael A.; Milazzo, Mark; Li, Qun; Lewandowski, Andrew; Wu, Hao; Swann, Edith; O'Connell, Robert J.; Peel, Sheila; Dawson, Peter; Kim, Jerome H.; Michael, Nelson L.		RV 217 Study Team	Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							T-CELL-ACTIVATION; VIRAL LOAD; SET-POINT; RNA LEVELS; 1ST YEAR; TRANSMISSION; DYNAMICS; SYMPTOMS; SEROCONVERSION; PROGRESSION	BACKGROUND Acute human immunodeficiency virus type 1 (HIV-1) infection is a major contributor to transmission of HIV-1. An understanding of acute HIV-1 infection may be important in the development of treatment strategies to eradicate HIV-1 or achieve a functional cure. METHODS We performed twice-weekly qualitative plasma HIV-1 RNA nucleic acid testing in 2276 volunteers who were at high risk for HIV-1 infection. For participants in whom acute HIV-1 infection was detected, clinical observations, quantitative measurements of plasma HIV-1 RNA levels (to assess viremia) and HIV antibodies, and results of immuno-phenotyping of lymphocytes were obtained twice weekly. RESULTS Fifty of 112 volunteers with acute HIV-1 infection had two or more blood samples collected before HIV-1 antibodies were detected. The median peak viremia (6.7 log 10 copies per milliliter) occurred 13 days after the first sample showed reactivity on nucleic acid testing. Reactivity on an enzyme immunoassay occurred at a median of 14 days. The nadir of viremia (4.3 log 10 copies per milliliter) occurred at a median of 31 days and was nearly equivalent to the viral-load set point, the steady-state viremia that persists durably after resolution of acute viremia (median plasma HIV-1 RNA level, 4.4 log 10 copies per milliliter). The peak viremia and downslope were correlated with the viralload set point. Clinical manifestations of acute HIV-1 infection were most common just before and at the time of peak viremia. A median of one symptom of acute HIV-1 infection was recorded at a median of two study visits, and a median of one sign of acute HIV-1 infection was recorded at a median of three visits. CONCLUSIONS The viral-load set point occurred at a median of 31 days after the first detection of plasma viremia and correlated with peak viremia. Few symptoms and signs were observed during acute HIV-1 infection, and they were most common before peak viremia. (Funded by the Department of Defense and the National Institute of Allergy and Infectious Diseases.)	[Robb, Merlin L.; Eller, Leigh A.; Jagodzinski, Linda L.; Malia, Jennifer; Manak, Mark; Tovanabutra, Sodsai; Sanders-Buell, Eric; Rolland, Morgane; Dorsey-Spitz, Julie; Eller, Michael A.; Milazzo, Mark; Li, Qun; Peel, Sheila; Kim, Jerome H.; Michael, Nelson L.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA; [Robb, Merlin L.; Eller, Leigh A.; Manak, Mark; Tovanabutra, Sodsai; Sanders-Buell, Eric; Rolland, Morgane; Dorsey-Spitz, Julie; Eller, Michael A.; Milazzo, Mark] Henry M Jackson Fdn Adv Mil Med, Rockville, MD USA; [Swann, Edith] NIAID, Div Aids, NIH, Rockville, MD USA; [Lewandowski, Andrew; Wu, Hao; Dawson, Peter] Emmes, Rockville, MD USA; [Kibuuka, Hannah] Makerere Univ, Walter Reed Project, Kampala, Uganda; [Rono, Kathleen; Sawe, Fred K.; Sinei, Samuel] Walter Reed Project, Kericho, Kenya; [Maganga, Lucas] Mbeya Med Res Ctr, Mbeya, Tanzania; [Nitayaphan, Sorachai; Kroon, Eugene; Sriplienchan, Somchai; de Souza, Mark S.; O'Connell, Robert J.] Armed Forces Res Inst Med Sci, Bangkok, Thailand; [Kroon, Eugene; de Souza, Mark S.] SEARCH, Thai Red Cross AIDS Res Ctr, Bangkok, Thailand; [Kim, Jerome H.] Int Vaccine Inst, Seoul, South Korea	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Makerere University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Thai Red Cross Society; International Vaccine Institute	Robb, ML (corresponding author), US Mil HIV Res Program, 6720A Rockledge Dr, Bethesda, MD 20817 USA.	mrobb@hivresearch.org	Manak, Mark/Q-6553-2019; Eller, Michael A./I-2156-2019	Manak, Mark/0000-0002-9217-9129; Eller, Michael A./0000-0003-3905-4877	Department of Defense; National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI002642] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the Department of Defense and the National Institute of Allergy and Infectious Diseases.	Ananworanich J, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-56; Ananworanich J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033948; Bebell LM, 2010, AIDS, V24, P1945, DOI 10.1097/QAD.0b013e32833bb732; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Cohen MS, 2013, LANCET, V382, P1515, DOI 10.1016/S0140-6736(13)61998-4; Cohen MS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001232; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Dykhuizen M, 1998, J GEN VIROL, V79, P2461, DOI 10.1099/0022-1317-79-10-2461; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Gay C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019617; Goodreau SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050522; Hecht FM, 2002, AIDS, V16, P1119, DOI 10.1097/00002030-200205240-00005; HENRARD DR, 1995, J ACQ IMMUN DEF SYND, V9, P305; Hill AL, 2014, P NATL ACAD SCI USA, V111, P13475, DOI 10.1073/pnas.1406663111; Hollingsworth TD, 2015, J INFECT DIS, V211, P1757, DOI 10.1093/infdis/jiu831; Jain V, 2013, J INFECT DIS, V208, P1202, DOI 10.1093/infdis/jit311; Kaufmann GR, 1998, J INFECT DIS, V178, P1812, DOI 10.1086/314480; Kaufmann GR, 1999, J ACQ IMMUN DEF SYND, V22, P437; Kelley CF, 2007, JAIDS-J ACQ IMM DEF, V45, P445, DOI 10.1097/QAI.0b013e318074ef6e; Kuhrt D, 2010, J VIROL, V84, P2466, DOI 10.1128/JVI.01966-09; Lavreys L, 2006, CLIN INFECT DIS, V42, P1333, DOI 10.1086/503258; Lefrere JJ, 1998, J INFECT DIS, V177, P1541, DOI 10.1086/515308; Levesque MC, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000107; Lindback S, 2000, AIDS, V14, P2283, DOI 10.1097/00002030-200010200-00009; Mattapallil JJ, 2004, AIDS, V18, P13, DOI 10.1097/00002030-200401020-00002; Ndhlovu ZM, 2015, IMMUNITY, V43, P591, DOI 10.1016/j.immuni.2015.08.012; Novitsky V, 2009, JAIDS-J ACQ IMM DEF, V50, P65, DOI 10.1097/QAI.0b013e3181900141; Parrish NF, 2013, P NATL ACAD SCI USA, V110, P6626, DOI 10.1073/pnas.1304288110; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Pilcher CD, 2007, AIDS, V21, P1723, DOI 10.1097/QAD.0b013e3281532c82; Powers KA, 2011, LANCET, V378, P256, DOI 10.1016/S0140-6736(11)60842-8; Richardson BA, 2003, J VIROL, V77, P7120, DOI 10.1128/JVI.77.12.7120-7123.2003; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Sanders EJ, 2014, AIDS, V28, P1357, DOI 10.1097/QAD.0000000000000245; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; Sterling TR, 2001, NEW ENGL J MED, V344, P720, DOI 10.1056/NEJM200103083441003; Sullivan PS, 2012, AIDS, V26, P175, DOI 10.1097/QAD.0b013e32834ed8c8; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411	39	153	163	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 2	2016	374	22					2120	2130		10.1056/NEJMoa1508952	http://dx.doi.org/10.1056/NEJMoa1508952			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB2RP	27192360	Green Accepted, Bronze			2022-12-28	WOS:000387209900005
J	Heath, JR; Curl, RF				Heath, James R.; Curl, Robert F.			Harry Kroto (1939-2016) OBITUARY	NATURE			English	Biographical-Item									[Heath, James R.] CALTECH, Chem, Pasadena, CA 91125 USA; [Curl, Robert F.] Rice Univ, Chem, Houston, TX USA	California Institute of Technology; Rice University	Heath, JR (corresponding author), CALTECH, Chem, Pasadena, CA 91125 USA.; Curl, RF (corresponding author), Rice Univ, Chem, Houston, TX USA.	heath@caltech.edu; rfcurl@rice.edu	Curl, Robert/R-7252-2019					KROTO H, PUBLICATION LIST	1	1	1	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2016	533	7604					470	470		10.1038/533470a	http://dx.doi.org/10.1038/533470a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6EJ	27225112	Bronze			2022-12-28	WOS:000376443100023
J	Ott, M				Ott, Martin			CELL BIOLOGY Choreography of protein synthesis	NATURE			English	Editorial Material							SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL; TRANSLATION; EXPRESSION	Both nuclear genes and genes in organelles called mitochondria are involved in the assembly of the cellular energy-producing machinery. RNA-translation programs that coordinate the two systems have now been identified. SEE ARTICLE p.499	[Ott, Martin] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden	Stockholm University	Ott, M (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden.	martin.ott@dbb.su.se		Ott, Martin/0000-0001-6367-3091				Archibald JM, 2015, CURR BIOL, V25, pR911, DOI 10.1016/j.cub.2015.07.055; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; COSTANZO MC, 1990, ANNU REV GENET, V24, P91; Couvillion MT, 2016, NATURE, V533, P499, DOI 10.1038/nature18015; Greber B. J., 2016, ANN REV BIOCH; Gruschke S, 2012, J CELL BIOL, V199, P137, DOI 10.1083/jcb.201206040; Neupert W, 2015, J MOL BIOL, V427, P1135, DOI 10.1016/j.jmb.2015.02.001; Ott M., 2016, ANN REV BIOCH; Rak M, 2009, P NATL ACAD SCI USA, V106, P18509, DOI 10.1073/pnas.0910351106; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042	10	3	3	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2016	533	7604					472	473		10.1038/nature18436	http://dx.doi.org/10.1038/nature18436			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6EJ	27225113				2022-12-28	WOS:000376443100024
J	Saloner, B; Sharfstein, J				Saloner, Brendan; Sharfstein, Joshua			A Stronger Treatment System for Opioid Use Disorders	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Saloner, Brendan] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, 624 N Broadway, Baltimore, MD 21205 USA; [Sharfstein, Joshua] Johns Hopkins Bloomberg Sch Publ Hlth, Publ Hlth Practice & Training, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Saloner, B (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, 624 N Broadway, Baltimore, MD 21205 USA.	bsaloner@jhu.edu						Centers for Medicare & Medicaid Services, RED SUBST US DIS; National Institute on Drug Abuse, OV DEATH RAT; Olsen Y, 2014, JAMA-J AM MED ASSOC, V311, P1393, DOI 10.1001/jama.2014.2147; Substance Abuse and Mental Health Services Administration, NAT BEH HLTH QUAL FR; Volkow ND, 2014, NEW ENGL J MED, V370, P2063, DOI 10.1056/NEJMp1402780; Wachino V, AVAILABILITY HITECH; White House Office of the Press Secretary, WHIT HOUS OFF PRESS	7	9	9	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 24	2016	315	20					2165	2166		10.1001/jama.2016.3674	http://dx.doi.org/10.1001/jama.2016.3674			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM4US	27218625				2022-12-28	WOS:000376343000008
J	Bergeron-Sandoval, LP; Safaee, N; Michnick, SW				Bergeron-Sandoval, Louis-Philippe; Safaee, Nozhat; Michnick, Stephen W.			Mechanisms and Consequences of Macromolecular Phase Separation	CELL			English	Review							INTRINSICALLY DISORDERED PROTEINS; CELL-FREE FORMATION; NEURONAL ISOFORM; POLYMER PHYSICS; LIQUID DROPLETS; P GRANULES; RNA; PRION; POLYGLUTAMINE; AGGREGATION	Over a century ago, colloidal phase separation of matter into non-membranous bodies was recognized as a fundamental organizing principal of cell ''protoplasm.'' Recent insights into the molecular properties of such phase-separated bodies present challenges to our understanding of cellular protein interaction networks, as well as opportunities for interpreting and understanding of native and pathological genetic and molecular interactions. Here, we briefly review examples of and discuss physical principles of phase-separated cellular bodies and then reflect on how knowledge of these principles may direct future research on their functions.	[Bergeron-Sandoval, Louis-Philippe; Safaee, Nozhat; Michnick, Stephen W.] Univ Montreal, Dept Biochim, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Michnick, Stephen W.] Univ Montreal, Ctr Robert Cedergren, Bioinformat & Genom, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Michnick, SW (corresponding author), Univ Montreal, Dept Biochim, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.; Michnick, SW (corresponding author), Univ Montreal, Ctr Robert Cedergren, Bioinformat & Genom, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	stephen.michnick@umontreal.ca		Louis-Philippe, Bergeron-Sandoval/0000-0002-2280-4742				Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Alberts B, 2010, MOL BIOL CELL, V21, P3785, DOI 10.1091/mbc.E10-04-0334; Alexandrov AI, 2013, PRION, V7, P209, DOI 10.4161/pri.24628; Altmeyer M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9088; Banjade S, 2014, ELIFE, V3, DOI 10.7554/eLife.04123; Banjade S, 2015, P NATL ACAD SCI USA, V112, pE6426, DOI 10.1073/pnas.1508778112; Brangwynne CP, 2015, NAT PHYS, V11, P899, DOI [10.1038/NPHYS3532, 10.1038/nphys3532]; Brangwynne CP, 2013, J CELL BIOL, V203, P875, DOI 10.1083/jcb.201308087; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Brangwynne CP, 2011, SOFT MATTER, V7, P3052, DOI 10.1039/c0sm00981d; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Brown JCS, 2009, GENE DEV, V23, P2320, DOI 10.1101/gad.1839109; Burke KA, 2015, MOL CELL, V60, P231, DOI 10.1016/j.molcel.2015.09.006; Buxbaum AR, 2014, SCIENCE, V343, P419, DOI 10.1126/science.1242939; Caudron F, 2013, CELL, V155, P1244, DOI 10.1016/j.cell.2013.10.046; Chandler D, 2002, NATURE, V417, P491, DOI 10.1038/417491a; Chung CY, 2013, SCIENCE, V342, P983, DOI 10.1126/science.1245296; Cira NJ, 2015, NATURE, V519, P446, DOI 10.1038/nature14272; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cougot N, 2012, J MOL BIOL, V420, P17, DOI 10.1016/j.jmb.2012.03.027; Cougot N, 2008, J NEUROSCI, V28, P13793, DOI 10.1523/JNEUROSCI.4155-08.2008; Crick SL, 2013, P NATL ACAD SCI USA, V110, P20075, DOI 10.1073/pnas.1320626110; Das RK, 2013, P NATL ACAD SCI USA, V110, P13392, DOI 10.1073/pnas.1304749110; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Drisaldi B, 2015, CELL REP, V11, P1694, DOI 10.1016/j.celrep.2015.04.061; Duennwald Martin L, 2012, PLoS Biol, V10, pe1001346, DOI 10.1371/journal.pbio.1001346; Duim WC, 2011, CHEMPHYSCHEM, V12, P2386, DOI 10.1002/cphc.201100392; Dunker AK, 2015, SEMIN CELL DEV BIOL, V37, P44, DOI 10.1016/j.semcdb.2014.09.025; Falkenberg CV, 2013, BIOPHYS J, V105, P2451, DOI 10.1016/j.bpj.2013.10.016; Feric M, 2016, CELL; Feric M, 2013, NAT CELL BIOL, V15, P1253, DOI 10.1038/ncb2830; Fioriti L, 2015, NEURON, V86, P1433, DOI 10.1016/j.neuron.2015.05.021; Fiumara F, 2010, CELL, V143, P1121, DOI 10.1016/j.cell.2010.11.042; Fondon JW, 2004, P NATL ACAD SCI USA, V101, P18058, DOI 10.1073/pnas.0408118101; Fromm SA, 2014, ANGEW CHEM INT EDIT, V53, P7354, DOI 10.1002/anie.201402885; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gemayel R, 2015, MOL CELL, V59, P615, DOI 10.1016/j.molcel.2015.07.003; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Heinrich SU, 2011, P NATL ACAD SCI USA, V108, P2999, DOI 10.1073/pnas.1019368108; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Holmes DL, 2013, CELL, V153, P153, DOI 10.1016/j.cell.2013.02.026; Hubstenberger A, 2015, J CELL BIOL, V211, P703, DOI 10.1083/jcb.201504044; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Hyman AA, 2012, SCIENCE, V337, P1047, DOI 10.1126/science.1223728; Hyman AA, 2011, DEV CELL, V21, P14, DOI 10.1016/j.devcel.2011.06.013; Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038; Jayaraman M, 2012, J MOL BIOL, V415, P881, DOI 10.1016/j.jmb.2011.12.010; Jiang H, 2015, CELL, V163, P108, DOI 10.1016/j.cell.2015.08.010; Kanshin E, 2015, CELL REP, V10, P1202, DOI 10.1016/j.celrep.2015.01.052; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Keleman K, 2007, NAT NEUROSCI, V10, P1587, DOI 10.1038/nn1996; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kroschwald S, 2015, ELIFE, V4, DOI 10.7554/eLife.06807; La Spada AR, 2010, NAT REV GENET, V11, P247, DOI 10.1038/nrg2748; Landry CR, 2013, CELL, V155, P983, DOI 10.1016/j.cell.2013.11.003; Landry CR, 2009, TRENDS GENET, V25, P193, DOI 10.1016/j.tig.2009.03.003; Lee C, 2013, DEV CELL, V25, P572, DOI 10.1016/j.devcel.2013.05.007; Lee CF, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.088101; Levy ED, 2012, PHILOS T R SOC B, V367, P2594, DOI 10.1098/rstb.2012.0078; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Li ZW, 2012, SOFT MATTER, V8, P6693, DOI 10.1039/c2sm25397f; Liebman SW, 2010, NAT CHEM BIOL, V6, P7, DOI 10.1038/nchembio.279; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Malinovska L., 2015, P NATL ACAD SCI US; Malinovska L, 2013, BBA-PROTEINS PROTEOM, V1834, P918, DOI 10.1016/j.bbapap.2013.01.003; Mishra R, 2012, J MOL BIOL, V415, P900, DOI 10.1016/j.jmb.2011.12.011; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Needleman D, 2015, TRENDS CELL BIOL, V25, P713, DOI 10.1016/j.tcb.2015.08.011; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Padrick SB, 2002, BIOCHEMISTRY-US, V41, P4694, DOI 10.1021/bi0160462; Pappu RV, 2008, ARCH BIOCHEM BIOPHYS, V469, P132, DOI 10.1016/j.abb.2007.08.033; Park HY, 2014, SCIENCE, V343, P422, DOI 10.1126/science.1239200; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Patel BK, 2009, NAT CELL BIOL, V11, P344, DOI 10.1038/ncb1843; Pennisi E, 2013, SCIENCE, V340, P910; Quiroz FG, 2015, NAT MATER, V14, P1164, DOI [10.1038/nmat4418, 10.1038/NMAT4418]; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; Raveendra BL, 2013, NAT STRUCT MOL BIOL, V20, P495, DOI 10.1038/nsmb.2503; Sabate R, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004013; Sassano MF, 2013, J MED CHEM, V56, P2406, DOI 10.1021/jm301749y; Scaramuzzino C, 2015, NEURON, V85, P88, DOI 10.1016/j.neuron.2014.12.031; Sear RP, 2007, SOFT MATTER, V3, P680, DOI 10.1039/b618126k; Sear RP, 2015, BMC BIOPHYS, V8, DOI 10.1186/s13628-015-0018-6; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Sim KL, 2002, MOL CELL PROTEOMICS, V1, P983, DOI 10.1074/mcp.M200032-MCP200; Stephan JS, 2015, CELL REP, V11, P1772, DOI 10.1016/j.celrep.2015.04.060; Strzelecka M, 2010, NAT STRUCT MOL BIOL, V17, P403, DOI 10.1038/nsmb.1783; Su XL, 2016, SCIENCE, V352, P595, DOI 10.1126/science.aad9964; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Tarassov K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r115; Teixeira D, 2007, MOL BIOL CELL, V18, P2274, DOI 10.1091/mbc.E07-03-0199; Toombs JA, 2010, MOL CELL BIOL, V30, P319, DOI 10.1128/MCB.01140-09; Toretsky JA, 2014, J CELL BIOL, V206, P579, DOI 10.1083/jcb.201404124; Tran HT, 2006, BIOPHYS J, V91, P1868, DOI 10.1529/biophysj.106.086264; Uematsu T, 2005, MACROMOLECULES, V38, P6227, DOI 10.1021/ma050478t; Updike DL, 2011, J CELL BIOL, V192, P939, DOI 10.1083/jcb.201010104; van der Lee R, 2014, CELL REP, V8, P1832, DOI 10.1016/j.celrep.2014.07.055; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Vitalis A, 2008, J MOL BIOL, V384, P279, DOI 10.1016/j.jmb.2008.09.026; Vitalis A, 2007, BIOPHYS J, V93, P1923, DOI 10.1529/biophysj.107.110080; Vitalis A, 2011, BIOPHYS CHEM, V159, P14, DOI 10.1016/j.bpc.2011.04.006; Vitalis A, 2009, BIOPHYS J, V97, P303, DOI 10.1016/j.bpj.2009.05.003; Wang JT, 2014, ELIFE, V3, DOI 10.7554/eLife.04591; Webb S, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r8; Weber S. C., 2015, RNA TRANSCRIPTION MO; Weber SC, 2015, CURR BIOL, V25, P641, DOI 10.1016/j.cub.2015.01.012; Weber SC, 2012, CELL, V149, P1188, DOI 10.1016/j.cell.2012.05.022; Williamson TE, 2010, J MOL BIOL, V396, P1295, DOI 10.1016/j.jmb.2009.12.017; Wilson E. B., 1899, Science, Vx, P33; Wippich F, 2013, CELL, V152, P791, DOI 10.1016/j.cell.2013.01.033; Zhang FJ, 2012, SOFT MATTER, V8, P1313, DOI 10.1039/c2sm07008a; Zhang HY, 2015, MOL CELL, V60, P220, DOI 10.1016/j.molcel.2015.09.017; Zhu L, 2015, CURR OPIN CELL BIOL, V34, P23, DOI 10.1016/j.ceb.2015.04.003; Zorn JA, 2011, J AM CHEM SOC, V133, P19630, DOI 10.1021/ja208350u; Zwicker D., 2014, P NATL ACAD SCI US; Zwicker D, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.012317	124	194	196	8	137	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2016	165	5					1067	1079		10.1016/j.cell.2016.05.026	http://dx.doi.org/10.1016/j.cell.2016.05.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DM6QT	27203111	Bronze			2022-12-28	WOS:000376478200009
J	Pardee, K; Green, AA; Takahashi, MK; Braff, D; Lambert, G; Lee, JW; Ferrante, T; Ma, D; Donghia, N; Fan, M; Daringer, NM; Bosch, I; Dudley, DM; O'Connor, DH; Gehrke, L; Collins, JJ				Pardee, Keith; Green, Alexander A.; Takahashi, Melissa K.; Braff, Dana; Lambert, Guillaume; Lee, Jeong Wook; Ferrante, Tom; Ma, Duo; Donghia, Nina; Fan, Melina; Daringer, Nichole M.; Bosch, Irene; Dudley, Dawn M.; O'Connor, David H.; Gehrke, Lee; Collins, James J.			Rapid, Low-Cost Detection of Zika Virus Using Programmable Biomolecular Components	CELL			English	Article							EPIDEMIC; DENGUE; QUANTIFICATION; DIAGNOSTICS	The recent Zika virus outbreak highlights the need for low-cost diagnostics that can be rapidly developed for distribution and use in pandemic regions. Here, we report a pipeline for the rapid design, assembly, and validation of cell-free, paper-based sensors for the detection of the Zika virus RNA genome. By linking isothermal RNA amplification to toehold switch RNA sensors, we detect clinically relevant concentrations of Zika virus sequences and demonstrate specificity against closely related Dengue virus sequences. When coupled with a novel CRISPR/Cas9-based module, our sensors can discriminate between viral strains with single-base resolution. We successfully demonstrate a simple, field-ready sample-processing workflow and detect Zika virus from the plasma of a viremic macaque. Our freeze-dried biomolecular platform resolves important practical limitations to the deployment of molecular diagnostics in the field and demonstrates how synthetic biology can be used to develop diagnostic tools for confronting global health crises.	[Pardee, Keith] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON M5S 3M2, Canada; [Green, Alexander A.; Ma, Duo] Arizona State Univ, Biodesign Ctr Mol Design & Biomimet, Tempe, AZ 85287 USA; [Green, Alexander A.; Ma, Duo] Arizona State Univ, Sch Mol Sci, Tempe, AZ 85287 USA; [Takahashi, Melissa K.; Braff, Dana; Daringer, Nichole M.; Bosch, Irene; Gehrke, Lee; Collins, James J.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Braff, Dana] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Braff, Dana; Lambert, Guillaume; Lee, Jeong Wook; Ferrante, Tom; Donghia, Nina; Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Lambert, Guillaume] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Fan, Melina] Addgene, Cambridge, MA 02139 USA; [Dudley, Dawn M.; O'Connor, David H.] UW Madison, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA; [Dudley, Dawn M.; O'Connor, David H.] UW Madison, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Gehrke, Lee] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Gehrke, Lee; Collins, James J.] Harvard MIT Program Hlth Sci & Technol, Cambridge, MA 02139 USA; [Collins, James J.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Collins, James J.] MIT, Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Collins, James J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	University of Toronto; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Massachusetts Institute of Technology (MIT); Boston University; Harvard University; Cornell University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Collins, JJ (corresponding author), MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Collins, JJ (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.; Collins, JJ (corresponding author), Harvard MIT Program Hlth Sci & Technol, Cambridge, MA 02139 USA.; Collins, JJ (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Collins, JJ (corresponding author), MIT, Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Collins, JJ (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	jimjc@mit.edu	Green, Alexander A./X-7025-2019	Green, Alexander A./0000-0003-2058-1204; Lee, Jeong Wook/0000-0003-0705-0177; Fan, Melina/0000-0002-6196-8408	Wyss Institute for Biologically Inspired Engineering; MIT's Center for Microbiome Informatics and Therapeutics; Defense Threat Reduction Agency [HDTRA1-14-1-0006]; Arizona State University; NIH [AI100190]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI100190] Funding Source: NIH RePORTER	Wyss Institute for Biologically Inspired Engineering; MIT's Center for Microbiome Informatics and Therapeutics; Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Arizona State University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank Marcelle Tuttle from the Church Lab (Wyss Institute) for the vectors used to produce the lentivirus. We would also like to thank Xiao Tan and Shimyn Slomovic for helpful comments on the manuscript, as well as Ewen Cameron, Andres Cubillos, James Niemi and Dionna Williams for assistance with project logistics. The work was supported by the Wyss Institute for Biologically Inspired Engineering, MIT's Center for Microbiome Informatics and Therapeutics, and the Defense Threat Reduction Agency grant HDTRA1-14-1-0006. A.A.G acknowledges startup funds provided by Arizona State University. L.G. acknowledges support from NIH AI100190.	Antunes P, 2015, SCI REP-UK, V5, DOI 10.1038/srep16145; Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159; Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5; Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009; Casper ET, 2007, HARMFUL ALGAE, V6, P112, DOI 10.1016/j.hal.2006.11.001; Cordray MS, 2012, AM J TROP MED HYG, V87, P223, DOI 10.4269/ajtmh.2012.11-0685; Crannell ZA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112146; Galindo-Fraga A, 2015, REV INVEST CLIN, V67, P329; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894; Green AA, 2014, CELL, V159, P925, DOI 10.1016/j.cell.2014.10.002; GUATELLI JC, 1990, P NATL ACAD SCI USA, V87, P1874, DOI 10.1073/pnas.87.5.1874; Kotula JW, 2014, P NATL ACAD SCI USA, V111, P4838, DOI 10.1073/pnas.1321321111; Lambeth CR, 2005, J CLIN MICROBIOL, V43, P3267, DOI 10.1128/JCM.43.7.3267-3272.2005; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Lu TK, 2013, TRENDS BIOTECHNOL, V31, P325, DOI 10.1016/j.tibtech.2013.03.009; Oehler E, 2013, EUROSURVEILLANCE, V19, P20720, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720; Pardee K, 2014, CELL, V159, P940, DOI 10.1016/j.cell.2014.10.004; Rohrman BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045611; Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x; Slomovic S, 2015, P NATL ACAD SCI USA, V112, P14429, DOI 10.1073/pnas.1508521112; Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X; Stefan CP, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0509-3; Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685; Ulrich RM, 2010, HARMFUL ALGAE, V9, P116, DOI 10.1016/j.hal.2009.08.010; Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7; WHO, 2016, WHO FAST TRACK AV DI; Yen CW, 2015, LAB CHIP, V15, P1638, DOI 10.1039/c5lc00055f; Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005; Zika Experimental Science Team, 2016, ZIKV 001 INF 3 RHES	31	677	718	53	489	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2016	165	5					1255	1266		10.1016/j.cell.2016.04.059	http://dx.doi.org/10.1016/j.cell.2016.04.059			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DM6QT	27160350	Green Published, Bronze			2022-12-28	WOS:000376478200023
J	Townsley, DM; Dumitriu, B; Liu, DL; Biancotto, A; Weinstein, B; Chen, C; Hardy, N; Mihalek, AD; Lingala, S; Kim, YJ; Yao, JH; Jones, E; Gochuico, BR; Heller, T; Wu, CO; Calado, RT; Scheinberg, P; Young, NS				Townsley, Danielle M.; Dumitriu, Bogdan; Liu, Delong; Biancotto, Angelique; Weinstein, Barbara; Chen, Christina; Hardy, Nathan; Mihalek, Andrew D.; Lingala, Shilpa; Kim, Yun Ju; Yao, Jianhua; Jones, Elizabeth; Gochuico, Bernadette R.; Heller, Theo; Wu, Colin O.; Calado, Rodrigo T.; Scheinberg, Phillip; Young, Neal S.			Danazol Treatment for Telomere Diseases	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEVERE APLASTIC-ANEMIA; BONE-MARROW FAILURE; DYSKERATOSIS-CONGENITA; PULMONARY-FIBROSIS; ANDROGEN THERAPY; MUTATIONS; LENGTH; TRANSPLANTATION; CANCER; GENE	BACKGROUND Genetic defects in telomere maintenance and repair cause bone marrow failure, liver cirrhosis, and pulmonary fibrosis, and they increase susceptibility to cancer. Historically, androgens have been useful as treatment for marrow failure syndromes. In tissue culture and animal models, sex hormones regulate expression of the telomerase gene. METHODS In a phase 1-2 prospective study involving patients with telomere diseases, we administered the synthetic sex hormone danazol orally at a dose of 800 mg per day for a total of 24 months. The goal of treatment was the attenuation of accelerated telomere attrition, and the primary efficacy end point was a 20% reduction in the annual rate of telomere attrition measured at 24 months. The occurrence of toxic effects of treatment was the primary safety end point. Hematologic response to treatment at various time points was the secondary efficacy end point. RESULTS After 27 patients were enrolled, the study was halted early, because telomere attrition was reduced in all 12 patients who could be evaluated for the primary end point; in the intention-to-treat analysis, 12 of 27 patients (44%; 95% confidence interval [CI], 26 to 64) met the primary efficacy end point. Unexpectedly, almost all the patients (11 of 12, 92%) had a gain in telomere length at 24 months as compared with baseline (mean increase, 386 bp [95% CI, 178 to 593]); in exploratory analyses, similar increases were observed at 6 months (16 of 21 patients; mean increase, 175 bp [95% CI, 79 to 271]) and 12 months (16 of 18 patients; mean increase, 360 bp [95% CI, 209 to 512]). Hematologic responses occurred in 19 of 24 patients (79%) who could be evaluated at 3 months and in 10 of 12 patients (83%) who could be evaluated at 24 months. Known adverse effects of danazol - elevated liver-enzyme levels and muscle cramps - of grade 2 or less occurred in 41% and 33% of the patients, respectively. CONCLUSIONS In our study, treatment with danazol led to telomere elongation in patients with telomere diseases. (Funded by the National Institutes of Health; ClinicalTrials.gov number, NCT01441037.)	[Townsley, Danielle M.; Dumitriu, Bogdan; Liu, Delong; Weinstein, Barbara; Chen, Christina; Hardy, Nathan; Young, Neal S.] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA; [Mihalek, Andrew D.] NHLBI, Cardiopulm Branch, NIH, Bldg 10, Bethesda, MD 20892 USA; [Wu, Colin O.] NHLBI, Off Biostat Res, NIH, Bldg 10, Bethesda, MD 20892 USA; [Biancotto, Angelique] NIH, Ctr Human Immunol Autoimmun & Inflammat, Bldg 10, Bethesda, MD 20892 USA; [Lingala, Shilpa; Kim, Yun Ju; Heller, Theo] NIDDK, Liver Dis Branch, NIH, Bethesda, MD 20892 USA; [Yao, Jianhua; Jones, Elizabeth] NIH, Radiol & Imaging Sci, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA; [Gochuico, Bernadette R.] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; [Calado, Rodrigo T.] Univ Sao Paulo, Dept Internal Med, Ribeirao Preto Medi Sch, BR-14049 Ribeirao Preto, Brazil; [Scheinberg, Phillip] Hosp Sao Jose & Beneficencia Portuguesa, Antonio Ermirio de Moraes Canc Ctr, Clin Hematol, Sao Paulo, Brazil	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Universidade de Sao Paulo	Townsley, DM (corresponding author), NIH, Ctr Clin, Bldg 10 CRC,Rm 3-5216,10 Ctr Dr, Bethesda, MD 20892 USA.	townsleydm@nhlbi.nih.gov	Jouneau, Stephane/K-9956-2015; Scheinberg, Phillip/H-5251-2012; biancotto, angelique/C-4632-2011; Calado, Rodrigo T./G-2619-2011; CTC USP, CEPID 13 18/J-8951-2014	Scheinberg, Phillip/0000-0002-9047-4538; biancotto, angelique/0000-0003-2271-009X; Calado, Rodrigo T./0000-0002-7966-6029; Heller, Theo/0000-0002-2643-6289; Hardy, Nathan/0000-0002-3833-6461; CTC USP, CEPID 13 18/0000-0002-7123-9524; Yao, Jianhua/0000-0001-9157-9596	National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075008] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the National Institutes of Health; ClinicalTrials.gov number, NCT01441037.	Alter BP, 2012, HAEMATOL-HEMATOL J, V97, P353, DOI 10.3324/haematol.2011.055269; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Bar C, 2015, HAEMATOLOGICA, V100, P1267, DOI 10.3324/haematol.2015.129239; Bayne S, 2005, MOL CELL ENDOCRINOL, V240, P11, DOI 10.1016/j.mce.2005.05.009; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Calado RT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007926; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Calado RT, 2009, BLOOD, V114, P2236, DOI 10.1182/blood-2008-09-178871; CAMITTA BM, 1979, BLOOD, V53, P504; de Latour RP, 2012, BLOOD, V120, P3353, DOI 10.1182/blood-2012-01-403337; Diker-Cohen T, 2013, LEUKEMIA LYMPHOMA, V54, P2023, DOI 10.3109/10428194.2012.757765; Dumitriu B, 2015, BLOOD, V125, P706, DOI 10.1182/blood-2014-10-607572; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Guo CH, 2003, J UROLOGY, V170, P615, DOI 10.1097/01.ju.0000074653.22766.c8; Gutierrez-Rodrigues F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113747; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Islam A, 2013, BRIT J HAEMATOL, V162, P854, DOI 10.1111/bjh.12432; Ju ZY, 2007, NAT MED, V13, P742, DOI 10.1038/nm1578; Khincha PP, 2014, BRIT J HAEMATOL, V165, P349, DOI 10.1111/bjh.12748; Lee DC, 2005, YONSEI MED J, V46, P471, DOI 10.3349/ymj.2005.46.4.471; NAJEAN Y, 1981, AM J MED, V71, P543, DOI 10.1016/0002-9343(81)90204-7; Robertson JD, 2001, BONE MARROW TRANSPL, V27, P1283, DOI 10.1038/sj.bmt.1703069; Rosas IO, 2011, CHEST, V140, P1590, DOI 10.1378/chest.10-2545; SANCHEZMEDAL L, 1969, BLOOD-J HEMATOL, V34, P283, DOI 10.1182/blood.V34.3.283.283; Savage SA, 2008, MECH AGEING DEV, V129, P35, DOI 10.1016/j.mad.2007.11.002; Savage SA, 2009, HEMATOL ONCOL CLIN N, V23, P215, DOI 10.1016/j.hoc.2009.01.003; Scheinberg P, 2010, JAMA-J AM MED ASSOC, V304, P1358, DOI 10.1001/jama.2010.1376; Svenson U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021485; Townsley DM, 2014, BLOOD, V124, P2775, DOI 10.1182/blood-2014-05-526285; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Vera E, 2012, CELL REP, V2, P732, DOI 10.1016/j.celrep.2012.08.023; Vergniol J, 2011, GASTROENTEROLOGY, V140, P1970, DOI 10.1053/j.gastro.2011.02.058; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy TJ, 2001, BLOOD CELL MOL DIS, V27, P353, DOI 10.1006/bcmd.2001.0389; Vulliamy TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024383; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; Winkler T, 2013, J CLIN INVEST, V123, P1952, DOI 10.1172/JCI67146; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Yeap BB, 2016, J CLIN ENDOCR METAB, V101, P1299, DOI 10.1210/jc.2015-4139; Ziegler P, 2012, ANN HEMATOL, V91, P1115, DOI 10.1007/s00277-012-1454-x	40	195	203	2	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 19	2016	374	20					1922	1931		10.1056/NEJMoa1515319	http://dx.doi.org/10.1056/NEJMoa1515319			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM1OX	27192671	Green Accepted, Bronze			2022-12-28	WOS:000376116600005
J	Ibrahim, AM; Hughes, TG; Thumma, JR; Dimick, JB				Ibrahim, Andrew M.; Hughes, Tyler G.; Thumma, Jyothi R.; Dimick, Justin B.			Association of Hospital Critical Access Status With Surgical Outcomes and Expenditures Among Medicare Beneficiaries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADMINISTRATIVE DATA; RURAL HOSPITALS; UNITED-STATES; CARE; QUALITY; SURGERY; COMPLICATIONS; PAYMENTS; PROGRAM; RATES	IMPORTANCE Critical access hospitals are a predominant source of care for many rural populations. Previous reports suggest these centers provide lower quality of care for common medical admissions. Little is known about the outcomes and costs of patients admitted for surgical procedures. OBJECTIVE To compare the surgical outcomes and associated Medicare payments at critical access hospitals vs non-critical access hospitals. DESIGN, SETTING, AND PARTICIPANTS Cross-sectional retrospective review of 1 631 904 Medicare beneficiary admissions to critical access hospitals (n = 828) and non-critical access hospitals (n = 3676) for 1 of 4 common types of surgical procedures-appendectomy, 3467 for critical access and 151 867 for non-critical access; cholecystectomy, 10 556 for critical access and 573 435 for non-critical access; colectomy, 10 198 for critical access and 577 680 for non-critical access; hernia repair, 4291 for critical access and 300 410 for non-critical access-between 2009 and 2013. We compared risk-adjusted outcomes using a multivariable logistical regression that adjusted for patient factors (age, sex, race, Elixhauser comorbidities), admission type (elective, urgent, emergency), and type of operation. EXPOSURES Undergoing surgical procedures at critical access vs non-critical access hospitals. MAIN OUTCOMES AND MEASURES Thirty-day mortality, postoperative serious complications (eg, myocardial infarction, pneumonia, or acute renal failure and a length of stay > 75th percentile). Hospital costs were assessed using price-standardized Medicare payments during hospitalization. RESULTS Patients (mean age, 76.5 years; 56.2% women) undergoing surgery at critical access hospitals were less likely to have chronic medical problems, and they had lower rates of heart failure (7.7% vs 10.7%, P <.0001), diabetes (20.2% vs 21.7%, P <.001), obesity (6.5% vs 10.6%, P <.001), or multiple comorbid diseases (% of patients with >= 2 comorbidities; 60.4% vs 70.2%, P <.001). After adjustment for patient factors, critical access and non-critical access hospitals had no statistically significant differences in 30-day mortality rates (5.4% vs 5.6%; adjusted odds ratio [OR], 0.96; 95% confidence interval [CI], 0.89-1.03; P = .28). However, critical access vs non-critical access hospitals had significantly lower rates of serious complications (6.4% vs 13.9%; OR, 0.35; 95% CI, 0.32-0.39; P <.001). Medicare expenditures adjusted for patient factors and procedure type were lower at critical access hospitals than non-critical access hospitals ($ 14 450 vs $ 15 845; difference, -$ 1395, P <.001). CONCLUSIONS AND RELEVANCE Among Medicare beneficiaries undergoing common surgical procedures, patients admitted to critical access hospitals compared with non-critical access hospitals had no significant difference in 30-day mortality rates, decreased risk-adjusted serious complication rates, and lower-adjusted Medicare expenditures, but were less medically complex.	[Ibrahim, Andrew M.; Thumma, Jyothi R.; Dimick, Justin B.] Univ Michigan, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA; [Hughes, Tyler G.] McPherson Hosp, Mcpherson, KS USA	University of Michigan System; University of Michigan	Ibrahim, AM (corresponding author), Univ Michigan, Inst Healthcare Policy & Innovat, 2800 Plymouth Ave,Bldg 10-G016, Ann Arbor, MI 48109 USA.	iandrew@umich.edu			Robert Wood Johnson Foundation; US Department of Veterans Affairs; National Institute on Aging [R01AG039434-04]; NATIONAL INSTITUTE ON AGING [R01AG039434] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); US Department of Veterans Affairs(US Department of Veterans Affairs); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr Ibrahim receives funding from the Robert Wood Johnson Foundation and the US Department of Veterans Affairs supporting his role as a Robert Wood Johnson Clinical Scholar. Dr Dimick has received grant R01AG039434-04 from the National Institute on Aging.	American Hospital Association, AHA ANN SURV DAT; Birkmeyer JD, 2010, HEALTH SERV RES, V45, P1783, DOI 10.1111/j.1475-6773.2010.01150.x; Brooke BS, 2015, LANCET, V386, P884, DOI 10.1016/S0140-6736(15)60087-3; Casey MM, 2015, HEALTH AFFAIR, V34, P627, DOI 10.1377/hlthaff.2014.0788; Centers for Medicare & Medicaid Services, MED PROV AN REV MEDP; Congressional Budget Office, 2011, RED DEF SPEND REV OP; Critical Access Hospital Locations, COMPL LIST 1333 CAHS; Department of Health and Human Services Office of the Inspector General, 2013, MOST CRIT ACC HOSP W; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Finlayson SRG, 2009, SURG CLIN N AM, V89, P1373, DOI 10.1016/j.suc.2009.09.013; Finlayson SRG, 1999, MED CARE, V37, P204, DOI 10.1097/00005650-199902000-00010; Gadzinski AJ, 2013, JAMA SURG, V148, P589, DOI 10.1001/jamasurg.2013.1224; Gottlieb D, 2010, TECHNICAL REPORT STA; Gottlieb DJ, 2010, HEALTH AFFAIR, V29, P537, DOI 10.1377/hlthaff.2009.0609; Holmes GM, 2013, J RURAL HEALTH, V29, P140, DOI 10.1111/j.1748-0361.2012.00425.x; Iezzoni LI, 1997, ANN INTERN MED, V127, P666, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00048; IEZZONI LI, 1994, MED CARE, V32, P700, DOI 10.1097/00005650-199407000-00004; Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P1379, DOI 10.1001/jama.2013.2366; Joynt KE, 2011, JAMA-J AM MED ASSOC, V306, P45, DOI 10.1001/jama.2011.902; Lawthers AG, 2000, MED CARE, V38, P785, DOI 10.1097/00005650-200008000-00003; Livingston EH, 2004, AM J SURG, V188, P105, DOI 10.1016/j.amjsurg.2004.03.001; McAuley WJ, 2008, J RURAL HEALTH, V24, P12, DOI 10.1111/j.1748-0361.2008.00132.x; Miller DC, 2011, HEALTH AFFAIR, V30, P2107, DOI 10.1377/hlthaff.2011.0783; Morris AM, 2007, ANN SURG, V245, P73, DOI 10.1097/01.sla.0000231797.37743.9f; Office of Budget and Management, 2015, FISC YEAR 2015 BUDG; Osborne NH, 2015, JAMA-J AM MED ASSOC, V313, P496, DOI 10.1001/jama.2015.25; Regenbogen SE, 2012, J SURG RES, V172, P212; Research Data Assistance Center (RESDAC), MEDPAR DAT DOC; Scally CP, 2015, ANN SURG, V262, P249, DOI 10.1097/SLA.0000000000001069; Southern DA, 2004, MED CARE, V42, P355, DOI 10.1097/01.mlr.0000118861.56848.ee; Tsai TC, 2013, NEW ENGL J MED, V369, P1134, DOI 10.1056/NEJMsa1303118; US Census Bureau, 2010 CENS URB RUR CL; Weingart SN, 2000, MED CARE, V38, P796, DOI 10.1097/00005650-200008000-00004	33	67	67	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 17	2016	315	19					2095	2103		10.1001/jama.2016.5618	http://dx.doi.org/10.1001/jama.2016.5618			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL9PN	27187302	Bronze			2022-12-28	WOS:000375975300020
J	Jagsi, R; Griffith, KA; Jones, R; Perumalswami, CR; Ubel, P; Stewart, A				Jagsi, Reshma; Griffith, Kent A.; Jones, Rochelle; Perumalswami, Chithra R.; Ubel, Peter; Stewart, Abigail			Sexual Harassment and Discrimination Experiences of Academic Medical Faculty	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Jagsi, Reshma; Jones, Rochelle] Univ Michigan, Dept Radiat Oncol, 1500 E Med Ctr Dr,UHB2C490-SPC 5010, Ann Arbor, MI 48109 USA; [Griffith, Kent A.] Univ Michigan, Ctr Canc Biostat, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Perumalswami, Chithra R.] Univ Michigan, US Dept Vet Affairs, Ann Arbor, MI 48109 USA; [Ubel, Peter] Duke Univ, Fuqua Sch Business, Durham, NC 27706 USA; [Stewart, Abigail] Univ Michigan, Dept Psychol, 580 Union Dr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Duke University; University of Michigan System; University of Michigan	Jagsi, R (corresponding author), Univ Michigan, Dept Radiat Oncol, 1500 E Med Ctr Dr,UHB2C490-SPC 5010, Ann Arbor, MI 48109 USA.	rjagsi@med.umich.edu		Perumalswami, Chithra/0000-0002-6679-1090; Jones, Rochelle/0000-0001-7757-5396; Jagsi, Reshma/0000-0001-6562-1228	NCATS NIH HHS [UL1 TR000433, UL1TR000433, UL1 TR002240] Funding Source: Medline; NHLBI NIH HHS [5 R01 HL101997-04, R01 HL101997] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002240, UL1TR000433] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101997] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Carr PL, 2000, ANN INTERN MED, V132, P889, DOI 10.7326/0003-4819-132-11-200006060-00007; Fnais N, 2014, ACAD MED, V89, P817, DOI 10.1097/ACM.0000000000000200; Jagsi R, 2009, ANN INTERN MED, V151, P804, DOI 10.7326/0003-4819-151-11-200912010-00009; Lewin T., YALE MED SCH REMOVES; Till Frank J., 1980, SEXUAL HARASSMENT RE	5	227	228	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 17	2016	315	19					2120	2121		10.1001/jama.2016.2188	http://dx.doi.org/10.1001/jama.2016.2188			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL9PN	27187307	Green Accepted, Bronze			2022-12-28	WOS:000375975300025
J	Leas, BF; Umscheid, CA				Leas, Brian F.; Umscheid, Craig A.			Principles for Disclosure of Interests and Management of Conflicts in Guidelines: Desirable and Undesirable Action and Consequences	ANNALS OF INTERNAL MEDICINE			English	Letter									[Leas, Brian F.; Umscheid, Craig A.] Univ Penn Hlth Syst, Ctr Evidence Based Practice, Philadelphia, PA USA	University of Pennsylvania	Leas, BF (corresponding author), Univ Penn Hlth Syst, Ctr Evidence Based Practice, Philadelphia, PA USA.							Blank S, 2012, PEDIATRICS, V130, pE756, DOI 10.1542/peds.2012-1990; Burling S., 2014, PHILADELPHIA INQUIRE; Leas BF, 2015, J PEDIAT INF DIS SOC, V4, P126, DOI 10.1093/jpids/piu075; Schunemann HJ, 2015, ANN INTERN MED, V163, P548, DOI 10.7326/M14-1885	4	0	0	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2016	164	10					701	702		10.7326/L15-0622	http://dx.doi.org/10.7326/L15-0622			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8GF	27182909				2022-12-28	WOS:000375878500025
J	Yang, AD; Bilimoria, KY				Yang, Anthony D.; Bilimoria, Karl Y.			Accurately Measuring Hospital Venous Thromboembolism Prevention Efforts	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SURVEILLANCE; ASSOCIATION; COMPOSITE; RATES		[Yang, Anthony D.; Bilimoria, Karl Y.] Northwestern Univ, Feinberg Sch Med, Dept Surg, SOQIC, 633 N St Clair,20th Floor, Chicago, IL 60611 USA; [Yang, Anthony D.; Bilimoria, Karl Y.] Northwestern Univ, Feinberg Sch Med, Ctr Healthcare Studies, Chicago, IL 60611 USA; [Yang, Anthony D.; Bilimoria, Karl Y.] NW Mem Hosp, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern Memorial Hospital	Yang, AD (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Surg, SOQIC, 633 N St Clair,20th Floor, Chicago, IL 60611 USA.	anthony.yang@northwestern.edu						Bates SM, 2012, CHEST, V141, pE351S, DOI 10.1378/chest.11-2299; Bilimoria KY, 2013, JAMA-J AM MED ASSOC, V310, P1482, DOI 10.1001/jama.2013.280048; Gould MK, 2012, CHEST, V141, pE227S, DOI 10.1378/chest.11-2297; Holcomb CN, 2015, JAMA SURG, V150, P520, DOI 10.1001/jamasurg.2015.35; Ju MH, 2014, ANN SURG, V260, P558, DOI 10.1097/SLA.0000000000000897; Kinnier CV, 2016, MED CARE, V54, P210, DOI 10.1097/MLR.0000000000000474; Kinnier CV, 2014, JAMA-J AM MED ASSOC, V312, P286, DOI 10.1001/jama.2014.1841; Rajaram R, 2015, JAMA-J AM MED ASSOC, V313, P897, DOI 10.1001/jama.2015.52	8	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 17	2016	315	19					2113	+		10.1001/jama.2016.5422	http://dx.doi.org/10.1001/jama.2016.5422			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL9PN	27187304				2022-12-28	WOS:000375975300022
J	Molina-Terriza, G				Molina-Terriza, Gabriel			Nanophotonics gets twisted	SCIENCE			English	Editorial Material							ANGULAR-MOMENTUM; FIELDS		[Molina-Terriza, Gabriel] Macquarie Univ, Dept Phys & Astron, N Ryde, NSW 2109, Australia; [Molina-Terriza, Gabriel] Macquarie Univ, Ctr Excellence Engn Quantum Syst, N Ryde, NSW 2109, Australia	Macquarie University; Macquarie University	Molina-Terriza, G (corresponding author), Macquarie Univ, Dept Phys & Astron, N Ryde, NSW 2109, Australia.; Molina-Terriza, G (corresponding author), Macquarie Univ, Ctr Excellence Engn Quantum Syst, N Ryde, NSW 2109, Australia.	gabriel.molina-terriza@mq.edu.au	Molina-Terriza, Gabriel/L-5687-2017	Molina-Terriza, Gabriel/0000-0002-7905-4938				Aeschlimann M, 2007, NATURE, V446, P301, DOI 10.1038/nature05595; Chong KE, 2016, ACS PHOTONICS, V3, P514, DOI 10.1021/acsphotonics.5b00678; Feynman RP, 1960, CALTECH ENG SCI, V23, P22; HE H, 1995, PHYS REV LETT, V75, P826, DOI 10.1103/PhysRevLett.75.826; Jackson J. D., 1999, CLASSICAL ELECTRODYN; Karimi E, 2014, LIGHT-SCI APPL, V3, DOI 10.1038/lsa.2014.48; Ren HR, 2016, SCIENCE, V352, P805, DOI 10.1126/science.aaf1112; Torres J. P., 2011, TWISTED PHOTONS APPL; Volpe G, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.216802; Wozniak P, 2015, LASER PHOTONICS REV, V9, P231, DOI 10.1002/lpor.201400188; Zambrana-Puyalto X, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5922; Zambrana-Puyalto X, 2012, OPT EXPRESS, V20, P24536, DOI 10.1364/OE.20.024536	12	0	0	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2016	352	6287					774	774		10.1126/science.aaf6388	http://dx.doi.org/10.1126/science.aaf6388			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5FP	27174975				2022-12-28	WOS:000375663000021
J	Netzer, R; Fleishman, SJ				Netzer, Ravit; Fleishman, Sarel J.			Inspired by nature	SCIENCE			English	Editorial Material							DESIGN; PROTEINS		[Netzer, Ravit; Fleishman, Sarel J.] Weizmann Inst Sci, Dept Biomol Sci, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Fleishman, SJ (corresponding author), Weizmann Inst Sci, Dept Biomol Sci, IL-76100 Rehovot, Israel.	sarel@weizmann.ac.il		Fleishman, Sarel/0000-0003-3177-7560	European Research Council [335439] Funding Source: Medline	European Research Council(European Research Council (ERC)European Commission)		Boyken SE, 2016, SCIENCE, V352, P680, DOI 10.1126/science.aad8865; Brunette TJ, 2015, NATURE, V528, P580, DOI 10.1038/nature16162; Doyle L, 2015, NATURE, V528, P585, DOI 10.1038/nature16191; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Huang PS, 2014, SCIENCE, V346, P481, DOI 10.1126/science.1257481; Jacobs TM, 2016, SCIENCE, V352, P687, DOI 10.1126/science.aad8036; Khersonsky O, 2016, PROTEIN SCI, V25, P1179, DOI 10.1002/pro.2892; Koga N, 2012, NATURE, V491, P222, DOI 10.1038/nature11600; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Warszawski S, 2014, J MOL BIOL, V426, P4125, DOI 10.1016/j.jmb.2014.10.002	10	7	8	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2016	352	6286					657	658		10.1126/science.aaf7599	http://dx.doi.org/10.1126/science.aaf7599			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL1UC	27151851	Green Accepted			2022-12-28	WOS:000375417100016
J	Stepanek, L; Pigino, G				Stepanek, Ludek; Pigino, Gaia			Microtubule doublets are double-track railways for intraflagellar transport trains	SCIENCE			English	Article							ELECTRON-MICROSCOPY; FUNCTIONAL-ANALYSIS; TUBULIN TRANSPORT; CHLAMYDOMONAS; IFT; FLAGELLUM; MOTILITY; NEURONS; PROTEIN; CILIUM	The cilium is a large macromolecular machine that is vital for motility, signaling, and sensing in most eukaryotic cells. Its conserved core structure, the axoneme, contains nine microtubule doublets, each comprising a full A-microtubule and an incomplete B-microtubule. However, thus far, the function of this doublet geometry has not been understood. We developed a time-resolved correlative fluorescence and three-dimensional electron microscopy approach to investigate the dynamics of intraflagellar transport (IFT) trains, which carry ciliary building blocks along microtubules during the assembly and disassembly of the cilium. Using this method, we showed that each microtubule doublet is used as a bidirectional double-track railway: Anterograde IFT trains move along B-microtubules, and retrograde trains move along A-microtubules. Thus, the microtubule doublet geometry provides direction-specific rails to coordinate bidirectional transport of ciliary components.	[Stepanek, Ludek; Pigino, Gaia] Max Planck Inst Mol Cell Biol & Genet MPI CBG, Pfotenhauerstr 108, D-01307 Dresden, Germany	Max Planck Society	Pigino, G (corresponding author), Max Planck Inst Mol Cell Biol & Genet MPI CBG, Pfotenhauerstr 108, D-01307 Dresden, Germany.	pigino@mpi-cbg.de	Pigino, Gaia/C-7928-2017	Pigino, Gaia/0000-0002-2295-9568	Max Planck Society; Dresden International Graduate School for Biomedicine and Bioengineering - German Research Foundation [GS97]	Max Planck Society(Max Planck Society); Dresden International Graduate School for Biomedicine and Bioengineering - German Research Foundation	We thank J. Rosenbaum and D. Diener for providing the Chlamydomonas IFT27-GFP strain; P. Kiesel, the MPI-CBG EM facility, J. Meissner, the MPI-CBG LM facility, V. Geyer, and A. Kopach for technical support; I. Patten for comments and corrections to the manuscript; and J. Howard, S. Diez, J. Brugues, T. Hyman, M. Zerial, P. Tomancak, F. Jug, and I. Sbalzarini for fruitful discussion and comments. This work was supported by the Max Planck Society and a fellowship of the Dresden International Graduate School for Biomedicine and Bioengineering (GS97), granted by the German Research Foundation to L.S. Supporting data are provided in the supplementary materials.	Absalon S, 2008, MOL BIOL CELL, V19, P929, DOI 10.1091/mbc.E07-08-0749; Bhogaraju S, 2013, SCIENCE, V341, P1009, DOI 10.1126/science.1240985; Buisson J, 2013, J CELL SCI, V126, P327, DOI 10.1242/jcs.117069; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Craft JM, 2015, J CELL BIOL, V208, P223, DOI 10.1083/jcb.201409036; HOOPS HJ, 1983, J CELL BIOL, V97, P902, DOI 10.1083/jcb.97.3.902; Hou YQ, 2007, J CELL BIOL, V176, P653, DOI 10.1083/jcb.200608041; Johnson KA, 1998, J CELL SCI, V111, P313; Konishi Y, 2009, NAT NEUROSCI, V12, P559, DOI 10.1038/nn.2314; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Maheshwari A, 2015, STRUCTURE, V23, P1584, DOI 10.1016/j.str.2015.06.017; Pazour GJ, 1998, J CELL BIOL, V141, P979, DOI 10.1083/jcb.141.4.979; Pigino G, 2009, J CELL BIOL, V187, P135, DOI 10.1083/jcb.200905103; Porter ME, 1999, MOL BIOL CELL, V10, P693, DOI 10.1091/mbc.10.3.693; Qin HM, 2004, J CELL BIOL, V164, P255, DOI 10.1083/jcb.200308132; RINGO DL, 1967, J CELL BIOL, V33, P543, DOI 10.1083/jcb.33.3.543; Rizzo R, 2014, HISTOCHEM CELL BIOL, V142, P133, DOI 10.1007/s00418-014-1249-3; Rogowski M, 2013, METHOD ENZYMOL, V524, P243, DOI 10.1016/B978-0-12-397945-2.00014-7; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Snow JJ, 2004, NAT CELL BIOL, V6, P1109, DOI 10.1038/ncb1186	22	135	139	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2016	352	6286					721	724		10.1126/science.aaf4594	http://dx.doi.org/10.1126/science.aaf4594			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL1UC	27151870				2022-12-28	WOS:000375417100041
J	Alvarez, RD; Straus, JF				Alvarez, Ronald D.; Straus, Jerome F., III			Surveying the Landscape of Ovarian Cancer Research and Care	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																		Bristow RE, 2014, GYNECOL ONCOL, V134, P60, DOI 10.1016/j.ygyno.2014.03.561; Daly MB, 2015, CANCER PREV RES, V8, P342, DOI 10.1158/1940-6207.CAPR-14-0293; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; George R, 2015, J GENET COUNS, V24, P388, DOI 10.1007/s10897-014-9805-5; Jacobs IJ, 2016, LANCET, V387, P945, DOI 10.1016/S0140-6736(15)01224-6; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; National Academies of Sciences Engineering and Medicine, 2016, OV CANC EV PAR RES C	7	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2016	165	6					439	+		10.7326/M16-0604	http://dx.doi.org/10.7326/M16-0604			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW9FR	27183518				2022-12-28	WOS:000383962000019
J	Mark, DB; Federspiel, JJ; Cowper, PA; Anstrom, KJ; Hoffmann, U; Patel, MR; Davidson-Ray, L; Daniels, MR; Cooper, LS; Knight, JD; Lee, KL; Douglas, PS				Mark, Daniel B.; Federspiel, Jerome J.; Cowper, Patricia A.; Anstrom, Kevin J.; Hoffmann, Udo; Patel, Manesh R.; Davidson-Ray, Linda; Daniels, Melanie R.; Cooper, Lawton S.; Knight, J. David; Lee, Kerry L.; Douglas, Pamela S.		PROMISE Investigators	Economic Outcomes With Anatomical Versus Functional Diagnostic Testing for Coronary Artery Disease	ANNALS OF INTERNAL MEDICINE			English	Article							ANGIOGRAPHY; METAANALYSIS; ACCURACY; ECHOCARDIOGRAPHY; MANAGEMENT; ANGINA	Background: PROMISE (PROspective Multicenter Imaging Study for Evaluation of Chest Pain) found that initial use of at least 64-slice multidetector computed tomography angiography (CTA) versus functional diagnostic testing strategies did not improve clinical outcomes in stable symptomatic patients with suspected coronary artery disease (CAD) requiring noninvasive testing. Objective: To conduct an economic analysis for PROMISE (a major secondary aim of the study). Design: Prospective economic study from the U.S. perspective. Comparisons were made according to the intention-to-treat principle, and CIs were calculated using bootstrap methods. (ClinicalTrials.gov: NCT01174550) Setting: 190 U.S. centers. Patients: 9649 U.S. patients enrolled in PROMISE between July 2010 and September 2013. Median follow-up was 25 months. Measurements: Technical costs of the initial (outpatient) testing strategy were estimated from Premier Research Database data. Hospital-based costs were estimated using hospital bills and Medicare cost-charge ratios. Physician fees were taken from the Medicare Physician Fee Schedule. Costs were expressed in 2014 U.S. dollars, discounted at 3% annually, and estimated out to 3 years using inverse probability weighting methods. Results: The mean initial testing costs were $174 for exercise electrocardiography; $404 for CTA; $501 to $514 for pharmacologic and exercise stress echocardiography, respectively; and $946 to $1132 for exercise and pharmacologic stress nuclear testing, respectively. Mean costs at 90 days were $2494 for the CTA strategy versus $2240 for the functional strategy (mean difference, $254 [95% CI, -$634 to $906]). The difference was associated with more revascularizations and catheterizations (4.25 per 100 patients) with CTA use. After 90 days, the mean cost difference between the groups out to 3 years remained small. Limitation: Cost weights for test strategies were obtained from sources outside PROMISE. Conclusion: Computed tomography angiography and functional diagnostic testing strategies in patients with suspected CAD have similar costs through 3 years of follow-up.	Duke Univ, Med Ctr, Duke Clin Res Inst, Outcomes Res Grp, Durham, NC USA; Duke Univ, Durham, NC USA; Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA USA; [Cooper, Lawton S.] NHLBI, RKL2 BG RM 10108,6701 Rockledge Dr, Bethesda, MD 20817 USA; [Mark, Daniel B.; Federspiel, Jerome J.; Cowper, Patricia A.; Anstrom, Kevin J.; Patel, Manesh R.; Davidson-Ray, Linda; Daniels, Melanie R.; Knight, J. David; Lee, Kerry L.; Douglas, Pamela S.] Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA; [Hoffmann, Udo] Radiol Associates, 55 Fruit St, Boston, MA 02114 USA	Duke University; Duke University; Harvard University; Harvard Medical School; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Duke University	Mark, DB (corresponding author), Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.		Carr, John Jeffrey/A-1938-2012; Rubin, Geoffrey D/O-7317-2018; Patel, Manesh/AAC-5385-2019; Picard, Michael/F-1567-2013; Federspiel, Jerome/C-7519-2009; Shapiro, Michael D./S-9851-2018; Ghoshhajra, Brian/J-2114-2016	Carr, John Jeffrey/0000-0002-4398-8237; Rubin, Geoffrey D/0000-0002-3820-2500; Picard, Michael/0000-0002-9264-3243; Federspiel, Jerome/0000-0003-0321-6280; Dolor, Rowena/0000-0001-7317-9468; Bertoni, Alain/0000-0002-7503-6273; Budoff, Matthew/0000-0002-9616-1946; Daniels, Melanie/0000-0003-4360-5635; Shapiro, Michael D./0000-0002-9071-3287; Chow, Benjamin/0000-0001-8631-0234; Ghoshhajra, Brian/0000-0002-3865-3432; Pellikka, Patricia/0000-0001-6800-3521; Douglas, Pamela/0000-0001-9876-4049; Bayley, Erin/0000-0003-4715-0244	National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098236, R01HL098235, R01HL098237, R01HL098305] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Heart, Lung, and Blood Institute.	Bang H, 2000, BIOMETRIKA, V87, P329, DOI 10.1093/biomet/87.2.329; Chow BJW, 2009, CIRC-CARDIOVASC IMAG, V2, P16, DOI 10.1161/CIRCIMAGING.108.792572; Douglas PS, 2015, NEW ENGL J MED, V372, P1291, DOI 10.1056/NEJMoa1415516; Douglas PS, 2014, AM HEART J, V167, P796, DOI 10.1016/j.ahj.2014.03.003; Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013; Hlatky MA, 2015, J AM COLL CARDIOL, V66, P2315, DOI 10.1016/j.jacc.2015.09.051; Hlatky MA, 2014, J AM COLL CARDIOL, V63, P1003, DOI 10.1016/j.jacc.2013.11.038; Mahajan N, 2010, HEART, V96, P956, DOI 10.1136/hrt.2009.182295; Mark DB, 2002, CIRCULATION, V106, P516, DOI 10.1161/01.CIR.0000021407.93752.7B; Metz LD, 2007, J AM COLL CARDIOL, V49, P227, DOI 10.1016/j.jacc.2006.08.048; Mowatt G, 2004, HEALTH TECHNOL ASSES, V8, P1; Nielsen LH, 2014, EUR HEART J-CARD IMG, V15, P961, DOI 10.1093/ehjci/jeu027; Shreibati JB, 2011, JAMA-J AM MED ASSOC, V306, P2128, DOI 10.1001/jama.2011.1652	13	43	43	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2016	165	2					94	+		10.7326/M15-2639	http://dx.doi.org/10.7326/M15-2639			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS2GY	27214597	Green Accepted			2022-12-28	WOS:000380583100016
J	Abalos, E; Addo, V; Brocklehurst, P; El Sheikh, M; Mathews, JE; Masood, SN; Oyarzun, E; Oyieke, J; Sharma, JB; Ashworth, F; Brocklehurst, P; Derrick, DC; Cousens, S; Farrell, B; Juszczak, E; Neilson, J; Purwar, M; Roberts, M; Waddington, C; Abalos, E; Addo, V; Brocklehurst, P; El Sheikh, M; Farrell, B; Gray, S; Hardy, P; Juszczak, E; Mathews, JE; Masood, SN; Oyarzun, E; Oyieke, J; Sharma, JB; Spark, P; Brocklehurst, P; Farrell, B; Gray, S; Hardy, P; Howard, S; Jamieson, N; Juszczak, E; Spark, P; Roberts, T				Abalos, E.; Addo, V.; Brocklehurst, P.; El Sheikh, M.; Mathews, J. E.; Masood, S. Naz; Oyarzun, E.; Oyieke, J.; Sharma, J. B.; Ashworth, F.; Brocklehurst, P.; Derrick, D. Chippington; Cousens, S.; Farrell, B.; Juszczak, E.; Neilson, J.; Purwar, M.; Roberts, M.; Waddington, C.; Abalos, E.; Addo, V.; Brocklehurst, P.; El Sheikh, M.; Farrell, B.; Gray, S.; Hardy, P.; Juszczak, E.; Mathews, J. E.; Masood, S. Naz; Oyarzun, E.; Oyieke, J.; Sharma, J. B.; Spark, P.; Brocklehurst, P.; Farrell, B.; Gray, S.; Hardy, P.; Howard, S.; Jamieson, N.; Juszczak, E.; Spark, P.; Roberts, T.		CORONIS Collaborative Grp	Caesarean section surgical techniques: 3 year follow-up of the CORONIS fractional, factorial, unmasked, randomised controlled trial	LANCET			English	Article							DOUBLE-LAYER CLOSURE; UTERINE RUPTURE; SINGLE-LAYER; DELIVERY; IMPACT	Background The CORONIS trial reported differences in short-term maternal morbidity when comparing five pairs of alternative surgical techniques for caesarean section. Here we report outcomes at 3 years follow-up. Methods The CORONIS trial was a pragmatic international 2 x 2 x 2 x 2x 2 non-regular fractional, factorial, unmasked, randomised controlled trial done at 19 sites in Argentina, Chile, Ghana, India, Kenya, Pakistan, and Sudan. Pregnant women were eligible if they were to undergo their first or second caesarean section through a planned transverse abdominal incision. Women were randomly assigned by a secure web-based allocation system to one intervention from each of the three assigned pairs. All investigators, surgeons, and participants were unmasked to treatment allocation. In this follow-up study, we compared outcomes at 3 years following blunt versus sharp abdominal entry, exteriorisation of the uterus for repair versus intra-abdominal repair, single versus double layer closure of the uterus, closure versus nonclosure of the peritoneum, and chromic catgut versus polyglactin-910 for uterine repair. Outcomes included pelvic pain; deep dyspareunia; hysterectomy and outcomes of subsequent pregnancies. Outcomes were assessed masked to the original trial allocation. This trial is registered with the Current Controlled Trials registry, number ISRCTN31089967. Findings Between Sept 1, 2011, and Sept 30, 2014, 13 153 (84%) women were followed-up for a mean duration of 3.8 years (SD 0.86). For blunt versus sharp abdominal entry there was no evidence of a difference in risk of abdominal hernias (adjusted RR 0.66; 95% CI 0.39-1.11). We also recorded no evidence of a difference in risk of death or serious morbidity of the children born at the time of trial entry (0.99, 0.83-1.17). For exteriorisation of the uterus versus intra-abdominal repair there was no evidence of a difference in risk of infertility (0.91, 0.71-1.18) or of ectopic pregnancy (0.50, 0.15-1.66). For single versus double layer closure of the uterus there was no evidence of a difference in maternal death (0.78, 0.46-1.32) or a composite of pregnancy complications (1.20, 0.75-1.90). For closure versus non-closure of the peritoneum there was no evidence of a difference in any outcomes relating to symptoms associated with pelvic adhesions such as infertility (0.80, 0.61-1.06). For chromic catgut versus polyglactin-910 sutures there was no evidence of a difference in the main comparisons for adverse pregnancy outcomes in a subsequent pregnancy, such as uterine rupture (3.05, 0.32-29.29). Overall, severe adverse outcomes were uncommon in these settings. Interpretation Although our study was not powered to detect modest differences in rare but serious events, there was no evidence to favour one technique over another. Other considerations will probably affect clinical practice, such as the time and cost saving of different approaches.				p.brocklehurst@ucl.ac.uk		Gray, Shan/0000-0002-2551-2112; Jamieson, Nina/0000-0002-8776-5000	MRC [G1000469] Funding Source: UKRI; Medical Research Council [G1000469] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aabakke AJM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108829; Arias CA, 2013, LANCET, V382, P234, DOI 10.1016/S0140-6736(13)60441-9; Bamigboye AA, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000163.pub2; Berghella V, 2005, AM J OBSTET GYNECOL, V193, P1607, DOI 10.1016/j.ajog.2005.03.063; Brocklehurst P, 2010, BJOG-INT J OBSTET GY, V117, P1366, DOI 10.1111/j.1471-0528.2010.02686.x; Bujold E, 2002, AM J OBSTET GYNECOL, V186, P1326, DOI 10.1067/mob.2002.122416; Chapman SJ, 1997, OBSTET GYNECOL, V89, P16, DOI 10.1016/S0029-7844(97)84257-3; Chauhan SP, 2003, AM J OBSTET GYNECOL, V189, P408, DOI 10.1067/S0002-9378(03)00675-6; Cheong YC, 2009, EUR J OBSTET GYN R B, V147, P3, DOI 10.1016/j.ejogrb.2009.06.003; CORONIS Collaborative Grp, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-215; Dodd JM, 2014, COCHRANE DB SYST REV, V7, DOI DOI 10.1002/14651858.CD004732.PUB3; Durnwald C, 2003, AM J OBSTET GYNECOL, V189, P925, DOI 10.1067/S0002-9378(03)01056-1; Fitzpatrick KE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001184; Gates S, 2004, BJOG-INT J OBSTET GY, V111, P213, DOI 10.1111/j.1471-0528.2004.00059.x; Hofmeyr GJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004662.pub2; NICE, 2011, CAES SECT NICE CLIN; Roberge S, 2014, AM J OBSTET GYNECOL, V211, P453, DOI 10.1016/j.ajog.2014.06.014; Roberge S, 2011, INT J GYNECOL OBSTET, V115, P5, DOI 10.1016/j.ijgo.2011.04.013; Roset E, 2003, EUR J OBSTET GYN R B, V108, P40, DOI 10.1016/S0301-2115(02)00366-4; Shi Z, 2011, BJOG-INT J OBSTET GY, V118, P410, DOI 10.1111/j.1471-0528.2010.02808.x; The CORONIS Collaborative Group, HLTH ASS QUEST; Walsh CA, 2010, CURR OPIN OBSTET GYN, V22, P110, DOI 10.1097/GCO.0b013e3283372327	22	35	37	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 2	2016	388	10039					62	72		10.1016/S0140-6736(16)00204-X	http://dx.doi.org/10.1016/S0140-6736(16)00204-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP9PM	27155903	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000378828400029
J	Patel, BK; Wolfe, KS; Pohlman, AS; Hall, JB; Kress, JP				Patel, Bhakti K.; Wolfe, Krysta S.; Pohlman, Anne S.; Hall, Jesse B.; Kress, John P.			Effect of Noninvasive Ventilation Delivered by Helmet vs Face Mask on the Rate of Endotracheal Intubation in Patients With Acute Respiratory Distress Syndrome A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSITIVE AIRWAY PRESSURE; ACQUIRED WEAKNESS; CARE; MORTALITY; FAILURE; HYPOXEMIA; EFFICACY; OXYGEN	IMPORTANCE Noninvasive ventilation (NIV) with a face mask is relatively ineffective at preventing endotracheal intubation in patients with acute respiratory distress syndrome (ARDS). Delivery of NIV with a helmet may be a superior strategy for these patients. OBJECTIVE To determine whether NIV delivered by helmet improves intubation rate among patients with ARDS. DESIGN, SETTING, AND PARTICIPANTS Single-center randomized clinical trial of 83 patients with ARDS requiring NIV delivered by face mask for at least 8 hours while in the medical intensive care unit at the University of Chicago between October 3, 2012, through September 21, 2015. INTERVENTIONS Patients were randomly assigned to continue face mask NIV or switch to a helmet for NIV support for a planned enrollment of 206 patients (103 patients per group). The helmet is a transparent hood that covers the entire head of the patient and has a rubber collar neck seal. Early trial termination resulted in 44 patients randomized to the helmet group and 39 to the face mask group. MAIN OUTCOMES AND MEASURES The primary outcome was the proportion of patients who required endotracheal intubation. Secondary outcomes included 28-day invasive ventilator-free days (ie, days alive without mechanical ventilation), duration of ICU and hospital length of stay, and hospital and 90-day mortality. RESULTS Eighty-three patients (45% women; median age, 59 years; median Acute Physiology and Chronic Health Evaluation [APACHE] II score, 26) were included in the analysis after the trial was stopped early based on predefined criteria for efficacy. The intubation rate was 61.5%(n = 24) for the face mask group and 18.2%(n = 8) for the helmet group (absolute difference, -43.3%; 95% CI, -62.4% to -24.3%; P < .001). The number of ventilator-free days was significantly higher in the helmet group (28 vs 12.5, P < .001). At 90 days, 15 patients (34.1%) in the helmet group died compared with 22 patients (56.4%) in the face mask group (absolute difference, -22.3%; 95% CI, -43.3 to -1.4; P = .02). Adverse events included 3 interface-related skin ulcers for each group (ie, 7.6% in the face mask group had nose ulcers and 6.8% in the helmet group had neck ulcers). CONCLUSIONS AND RELEVANCE Among patients with ARDS, treatment with helmet NIV resulted in a significant reduction of intubation rates. There was also a statistically significant reduction in 90-day mortality with helmet NIV. Multicenter studies are needed to replicate these findings.	[Patel, Bhakti K.; Wolfe, Krysta S.; Pohlman, Anne S.; Hall, Jesse B.; Kress, John P.] Univ Chicago, Dept Med, Sect Pulm & Crit Care, Chicago, IL 60637 USA	University of Chicago	Kress, JP (corresponding author), Univ Chicago, Sect Pulm & Crit Care, 5841 S Maryland Ave,MC6026, Chicago, IL 60637 USA.	jkress@medicine.bsd.uchicago.edu	Wolfe, Krysta/Y-9775-2019		Daniel J. Edelman family; NIH/NHLBI [T32 HL007605]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007605, K12HL119995] Funding Source: NIH RePORTER	Daniel J. Edelman family; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The helmets were purchased using funds from an unrestricted internal grant from the Daniel J. Edelman family. Fellow salary and support for Drs Patel and Wolfe was provided by grant T32 HL007605 from the NIH/NHLBI. All helmet devices were obtained commercially from Sea Long.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Antonelli M, 2001, INTENS CARE MED, V27, P1718, DOI 10.1007/s00134-001-1114-4; Antonelli M, 1998, NEW ENGL J MED, V339, P429, DOI 10.1056/NEJM199808133390703; Antonelli M, 2000, JAMA-J AM MED ASSOC, V283, P235, DOI 10.1001/jama.283.2.235; Antonelli M, 2007, CRIT CARE MED, V35, P18, DOI 10.1097/01.CCM.0000251821.44259.F3; Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; BROCHARD L, 1995, NEW ENGL J MED, V333, P817, DOI 10.1056/NEJM199509283331301; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Dignam JJ, 2012, CLIN CANCER RES, V18, P2301, DOI 10.1158/1078-0432.CCR-11-2097; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Frat JP, 2015, NEW ENGL J MED, V372, P2185, DOI 10.1056/NEJMoa1503326; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Hermans G, 2014, AM J RESP CRIT CARE, V190, P410, DOI 10.1164/rccm.201312-2257OC; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Hilbert G, 2001, NEW ENGL J MED, V344, P481, DOI 10.1056/NEJM200102153440703; Hill NS, 2004, CRIT CARE MED, V32, P2162, DOI 10.1097/01.CCM.0000142945.20310.E4; Kacmarek RM, 2013, MINERVA ANESTESIOL, V79, P1173; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kress JP, 2014, NEW ENGL J MED, V370, P1626, DOI 10.1056/NEJMra1209390; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lemiale V, 2015, JAMA-J AM MED ASSOC, V314, P1711, DOI 10.1001/jama.2015.12402; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Nava S, 2009, CRIT CARE MED, V37, P2111, DOI 10.1097/CCM.0b013e3181a5e6b5; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Principi T, 2004, INTENS CARE MED, V30, P147, DOI 10.1007/s00134-003-2056-9; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Schoenfeld DA, 2002, CRIT CARE MED, V30, P1772, DOI 10.1097/00003246-200208000-00016; Schwartz Andrew R, 2004, Respir Care, V49, P270; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Slutsky AS, 2010, NEW ENGL J MED, V363, P1176, DOI 10.1056/NEJMe1007136; Squadrone V, 2005, JAMA-J AM MED ASSOC, V293, P589, DOI 10.1001/jama.293.5.589; Taccone P, 2004, CRIT CARE MED, V32, P2090, DOI 10.1097/01.CCM.0000142577.63316.C0; Thille AW, 2013, CRIT CARE, V17, DOI 10.1186/cc13103; Vargas F, 2009, CRIT CARE MED, V37, P1921, DOI 10.1097/CCM.0b013e31819fff93; Vital FM, 2013, COCHRANE DB SYST REV, V5, DOI DOI 10.1002/14651858.CD005351	36	280	296	1	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2016	315	22					2435	2441		10.1001/jama.2016.6338	http://dx.doi.org/10.1001/jama.2016.6338			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO3CE	27179847	Green Accepted, Bronze			2022-12-28	WOS:000377656900021
J	Takagi, M; Kato, M				Takagi, Masao; Kato, Mikiro			Salmonella enterica Aortitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Takagi, Masao; Kato, Mikiro] Mito Kyodo Gen Hosp, Mito, Ibaraki, Japan		Kato, M (corresponding author), Mito Kyodo Gen Hosp, Mito, Ibaraki, Japan.	k.mikiro@gmail.com							0	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 26	2016	374	21					E26	E26		10.1056/NEJMicm1508258	http://dx.doi.org/10.1056/NEJMicm1508258			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6EN	27223163				2022-12-28	WOS:000376443500011
J	[Anonymous]				[Anonymous]			Science and Practical Common Sense (Reprinted from JAMA, vol 66, pg 1705, 1916)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		[Anonymous], 1916, EXPT STA REC, Vxxxiv, P401; Pearson Karl, 1900, GRAMMAR SCI, P10	2	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 24	2016	315	20					2239	2239		10.1001/jama.2015.17087	http://dx.doi.org/10.1001/jama.2015.17087			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM4US	27218647				2022-12-28	WOS:000376343000033
J	Wongnate, T; Sliwa, D; Ginovska, B; Smith, D; Wolf, MW; Lehnert, N; Raugei, S; Ragsdale, SW				Wongnate, Thanyaporn; Sliwa, Dariusz; Ginovska, Bojana; Smith, Dayle; Wolf, Matthew W.; Lehnert, Nicolai; Raugei, Simone; Ragsdale, Stephen W.			The radical mechanism of biological methane synthesis by methyl-coenzyme M reductase	SCIENCE			English	Article							ANAEROBIC OXIDATION; ALKYL-NICKEL; CATALYTIC CYCLE; LIQUID FUELS; METHANOGENESIS; ENZYME; ARCHAEA; F430; BOND; ACTIVATION	Methyl-coenzyme M reductase, the rate-limiting enzyme in methanogenesis and anaerobic methane oxidation, is responsible for the biological production of more than 1 billion tons of methane per year. The mechanism of methane synthesis is thought to involve either methyl-nickel(III) or methyl radical/Ni(II)-thiolate intermediates. We employed transient kinetic, spectroscopic, and computational approaches to study the reaction between the active Ni(I) enzyme and substrates. Consistent with the methyl radical-based mechanism, there was no evidence for a methyl-Ni(III) species; furthermore, magnetic circular dichroism spectroscopy identified the Ni(II)-thiolate intermediate. Temperature-dependent transient kinetics also closely matched density functional theory predictions of the methyl radical mechanism. Identifying the key intermediate in methanogenesis provides fundamental insights to develop better catalysts for producing and activating an important fuel and potent greenhouse gas.	[Wongnate, Thanyaporn; Sliwa, Dariusz; Ragsdale, Stephen W.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Ginovska, Bojana; Smith, Dayle; Raugei, Simone] Pacific NW Natl Lab, Phys Sci Div, POB 999,K1-83, Richland, WA 99352 USA; [Wolf, Matthew W.; Lehnert, Nicolai] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Wolf, Matthew W.; Lehnert, Nicolai] Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA; [Sliwa, Dariusz] Appl Photophys Inc, Cummings Ctr 100, Suite 440C, Beverly, MA 01915 USA; [Smith, Dayle] Intel Corp, 2111 NW 25th Ave,JF5-202, Hillsboro, OR 97124 USA	University of Michigan System; University of Michigan; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Intel Corporation	Ragsdale, SW (corresponding author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.	sragsdal@umich.edu		Smith, Dayle/0000-0002-3075-9320	U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences [DE-FG02-08ER15931]; U.S. DOE, Advanced Research Projects Agency - Energy [DE-AR0000426]; DOE's Office of Biological and Environmental Research	U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); U.S. DOE, Advanced Research Projects Agency - Energy; DOE's Office of Biological and Environmental Research(United States Department of Energy (DOE))	Data presented here are available through the Ragsdale LabGuru portal (https://my.labguru.com/knowledge/projects/361/milestones/711). This work was supported by U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences, under award DE-FG02-08ER15931 and by U.S. DOE, Advanced Research Projects Agency - Energy, under award number DE-AR0000426. Computer resources were provided by the W. R. Wiley Environmental Molecular Sciences Laboratory, a DOE Office of Science User Facility located at Pacific Northwest National Laboratory and sponsored by DOE's Office of Biological and Environmental Research. Computer resources were also provided by the National Energy Research Computing Center at the Lawrence Berkeley National Laboratory. Author contributions: T.W. generated the data, performed the data analysis, and prepared Figs. 2, A and B, and 4, and Table 1; and performed the data analysis and generated Fig. 2, C and D, and figs. S1, S4, and S6. D. Sliwa prepared CoBSH substrates and enzyme; generated the data and performed preliminary data analysis for Fig. 2, C and D, and fig. S1; and prepared the samples for the MCD measurements described in Fig. 3 and fig. S2. B.G. and S.R. performed and interpreted the computational studies described in Fig. 5; figs. S5, S7, S8, and S9; and tables S1 to S3. D. Smith performed initial computational experiments on the MCR mechanisms. M.W. and N.L. performed, analyzed, and interpreted the MCD spectroscopic experiments and prepared Fig. 3 and fig. S2. S.W.R. conceptualized and refined the research idea; prepared Figs. 1 and 6 and fig. S3; and coordinated the various collaborations and guided analysis and interpretation of the biochemical experiments. All authors were involved to varying degrees in writing and/or editing the manuscript.	ALBRACHT SPJ, 1988, BIOCHIM BIOPHYS ACTA, V955, P86, DOI 10.1016/0167-4838(88)90182-3; Atreya SK, 2007, PLANET SPACE SCI, V55, P358, DOI 10.1016/j.pss.2006.02.005; Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; Becker DF, 1998, BIOCHEMISTRY-US, V37, P2639, DOI 10.1021/bi972145x; Chen SL, 2014, PHYS CHEM CHEM PHYS, V16, P14029, DOI 10.1039/c4cp01483a; Chen SL, 2012, CHEM-EUR J, V18, P6309, DOI 10.1002/chem.201200274; Chen SL, 2009, J AM CHEM SOC, V131, P9912, DOI 10.1021/ja904301f; Craft JL, 2004, J AM CHEM SOC, V126, P4068, DOI 10.1021/ja038082p; DEDERICHS PH, 1984, PHYS REV LETT, V53, P2512, DOI 10.1103/PhysRevLett.53.2512; Dey M, 2007, BIOCHEMISTRY-US, V46, P11969, DOI 10.1021/bi700925n; Dey M, 2007, J AM CHEM SOC, V129, P11030, DOI 10.1021/ja074556z; Dey M, 2010, BIOCHEMISTRY-US, V49, P10902, DOI 10.1021/bi101562m; DIMARCO AA, 1990, ANNU REV BIOCHEM, V59, P355, DOI 10.1146/annurev.biochem.59.1.355; Duin EC, 2004, J BIOL INORG CHEM, V9, P563, DOI 10.1007/s00775-004-0549-9; Duin EC, 2008, J PHYS CHEM B, V112, P2466, DOI 10.1021/jp709860c; ELLERMANN J, 1987, FEBS LETT, V220, P358, DOI 10.1016/0014-5793(87)80846-3; Ermler U, 1997, SCIENCE, V278, P1457, DOI 10.1126/science.278.5342.1457; Goubeaud M, 1997, EUR J BIOCHEM, V243, P110, DOI 10.1111/j.1432-1033.1997.00110.x; Grabarse W, 2001, J MOL BIOL, V309, P315, DOI 10.1006/jmbi.2001.4647; Hallam SJ, 2004, SCIENCE, V305, P1457, DOI 10.1126/science.1100025; Harmer J, 2005, J AM CHEM SOC, V127, P17744, DOI 10.1021/ja053794w; Harmer J, 2008, J AM CHEM SOC, V130, P10907, DOI 10.1021/ja710949e; Haynes CA, 2014, NAT CHEM BIOL, V10, P331, DOI 10.1038/nchembio.1509; Hinderberger D, 2006, ANGEW CHEM INT EDIT, V45, P3602, DOI 10.1002/anie.200600366; Horng YC, 2001, BIOCHEMISTRY-US, V40, P12875, DOI 10.1021/bi011196y; Kruger M, 2003, NATURE, V426, P878, DOI 10.1038/nature02207; Kunz RC, 2008, BIOCHEMISTRY-US, V47, P2661, DOI 10.1021/bi701942w; Kunz RC, 2006, J BIOL CHEM, V281, P34663, DOI 10.1074/jbc.M606715200; LAHIRI GK, 1993, INORG CHEM, V32, P4409, DOI 10.1021/ic00072a041; LIN SK, 1991, HELV CHIM ACTA, V74, P1725, DOI 10.1002/hlca.19910740814; Michaelis W, 2002, SCIENCE, V297, P1013, DOI 10.1126/science.1072502; Mueller TJ, 2015, J IND MICROBIOL BIOT, V42, P391, DOI 10.1007/s10295-014-1548-7; Nauhaus K, 2002, ENVIRON MICROBIOL, V4, P296, DOI 10.1046/j.1462-2920.2002.00299.x; Pelmenschikov V, 2003, J BIOL INORG CHEM, V8, P653, DOI 10.1007/s00775-003-0461-8; Pelmenschikov V, 2002, J AM CHEM SOC, V124, P4039, DOI 10.1021/ja011664r; Scheller S, 2013, J AM CHEM SOC, V135, P14985, DOI 10.1021/ja4064876; Scheller S, 2013, J AM CHEM SOC, V135, P14975, DOI 10.1021/ja406485z; Scheller S, 2010, ANGEW CHEM INT EDIT, V49, P8112, DOI 10.1002/anie.201003214; Scheller S, 2010, NATURE, V465, P606, DOI 10.1038/nature09015; Shima S, 2005, CURR OPIN MICROBIOL, V8, P643, DOI 10.1016/j.mib.2005.10.002; Shima S, 2012, NATURE, V481, P98, DOI 10.1038/nature10663; Signor L, 2000, CHEM-EUR J, V6, P3508, DOI 10.1002/1521-3765(20001002)6:19<3508::AID-CHEM3508>3.3.CO;2-N; SYMONS MCR, 1974, J CHEM SOC PERK T 2, P1618, DOI 10.1039/p29740001618; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377; U. S. E. I. Administration, 2015, ANN EN OULT 2015 PRO; U.S. Environmental Protection Agency, 2012, SUMM REP GLOB ANT NO; Wongnate T, 2015, J BIOL CHEM, V290, P9322, DOI 10.1074/jbc.M115.636761; Yang N, 2007, J AM CHEM SOC, V129, P11028, DOI 10.1021/ja0734501	48	83	91	3	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2016	352	6288			SI		953	958		10.1126/science.aaf0616	http://dx.doi.org/10.1126/science.aaf0616			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM2AK	27199421				2022-12-28	WOS:000376147800039
J	Grayson, M				Grayson, Michelle			IRRITABLE BOWEL SYNDROME	NATURE			English	Editorial Material																			0	7	7	2	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					S101	S101		10.1038/533S101a	http://dx.doi.org/10.1038/533S101a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0AH	27191484	Bronze			2022-12-28	WOS:000376004300060
J	Levine, A; Baker, M				Levine, Alaina; Baker, Monya			RELATIONSHIPS Doctor's advice	NATURE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					429	430		10.1038/nj7603-429a	http://dx.doi.org/10.1038/nj7603-429a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM0AH	27200448	Bronze			2022-12-28	WOS:000376004300056
J	Linker, B				Linker, Beth			History of Medicine The Great War and Modern Health Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Linker, Beth] Univ Penn, Dept Hist & Sociol Sci, Philadelphia, PA 19104 USA	University of Pennsylvania	Linker, B (corresponding author), Univ Penn, Dept Hist & Sociol Sci, Philadelphia, PA 19104 USA.							Linker B, 2011, WARS WASTE REHABILIT; Rogers Naomi, 2014, POLIO WARS SISTER KE; Roth EJ, 2012, JAMA-J AM MED ASSOC, V308, P719; Schlich T, 2009, ISIS, V100, P758, DOI 10.1086/652018; Stevens Rosemary, 1989, SICKNESS WEALTH AM H	5	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 19	2016	374	20					1907	1909		10.1056/NEJMp1509034	http://dx.doi.org/10.1056/NEJMp1509034			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DM1OX	27192670				2022-12-28	WOS:000376116600003
J	Whitaker, P				Whitaker, Phil			GPs are much more than gatekeepers	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												whitaker.phil@btopenworld.com							0	0	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 18	2016	353								i2751	10.1136/bmj.i2751	http://dx.doi.org/10.1136/bmj.i2751			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GC	27193762				2022-12-28	WOS:000376447600007
J	Bower, H; Smout, E; Bangura, MS; Kamara, O; Turay, C; Johnson, S; Oza, S; Checchi, F; Glynn, JR				Bower, Hilary; Smout, Elizabeth; Bangura, Mohamed S.; Kamara, Osman; Turay, Cecilia; Johnson, Sembia; Oza, Shefali; Checchi, Francesco; Glynn, Judith R.			Deaths, late deaths, and role of infecting dose in Ebola virus disease in Sierra Leone: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EPIDEMIOLOGY; TRANSMISSION; OUTBREAKS; SURVIVORS; SEQUELAE	OBJECTIVES To assess the frequency of fatal recrudescence from Ebola virus disease after discharge from treatment centres, and explore the influence of infecting dose on case fatality rates. DESIGN Retrospective cohort study. SETTING Western Area, Sierra Leone. PARTICIPANTS 151 survivors treated for Ebola virus disease at the Kerry Town treatment centre and discharged. Survivors were followed up for a vital status check at four to nine months after discharge, and again at six to 13 months after discharge. Verbal autopsies were conducted for four survivors who had died since discharge (that is, late deaths). Survivors still living in Western Area were interviewed together with their household members. Exposure level to Ebola virus disease was ascertained as a proxy of infecting dose, including for those who died. MAIN OUTCOME MEASURES Risks and causes of late death; case fatality rates; odds ratios of death from Ebola virus disease by age, sex, exposure level, date, occupation, and household risk factors. RESULTS Follow-up information was obtained on all 151 survivors of Ebola virus disease, a mean of 10 months after discharge. Four deaths occurred after discharge, all within six weeks: two probably due to late complications, one to prior tuberculosis, and only one after apparent full recovery, giving a maximum estimate of recrudescence leading to death of 0.7%. In these households, 395 people were reported to have had Ebola virus disease, of whom 227 died. A further 53 people fulfilled the case definition for probable disease, of whom 11 died. Therefore, the case fatality rate was 57.5% (227/395) for reported Ebola virus disease, or 53.1% (238/448) including probable disease. Case fatality rates were higher in children aged under 2 years and adults older than 30 years, in larger households, and in infections occurring earlier in the epidemic in Sierra Leone. There was no consistent trend of case fatality rate with exposure level, although increasing exposure increased the risk of Ebola virus disease. CONCLUSIONS In this study of survivors in Western Area, Sierra Leone, late recrudescence of severe Ebola virus disease appears to be rare. There was no evidence for an effect of infecting dose (as measured by exposure level) on the severity of disease.	[Bower, Hilary; Smout, Elizabeth; Oza, Shefali] Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England; [Bangura, Mohamed S.; Kamara, Osman; Turay, Cecilia; Johnson, Sembia] Save Children, Freetown, Sierra Leone; [Checchi, Francesco] Save Children, Humanitarian Dept, London, England; [Glynn, Judith R.] Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine; Save the Children; Save the Children; University of London; London School of Hygiene & Tropical Medicine	Glynn, JR (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	judith.glynn@lshtm.ac.uk	Bower, Hilary/AFY-1063-2022	Bower, Hilary/0000-0002-1541-6637; Oza, Shefali/0000-0001-5872-486X; Checchi, Francesco/0000-0001-9030-5382	Save the Children internal funds; Wellcome Trust's Enhancing Research Activity in Epidemic Situations programme [ER1502]	Save the Children internal funds; Wellcome Trust's Enhancing Research Activity in Epidemic Situations programme	The study was funded by Save the Children internal funds and the Wellcome Trust's Enhancing Research Activity in Epidemic Situations programme (grant no ER1502). The study funders had no role in the collection, analysis, and interpretation of data, the writing of the article or the decision to submit it for publication.	AABY P, 1984, AM J EPIDEMIOL, V120, P49, DOI 10.1093/oxfordjournals.aje.a113874; Agua-Agum J, 2016, NEW ENGL J MED, V374, P96, DOI 10.1056/NEJMc1510305; Ajelli M, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0524-z; Alfson KJ, 2015, J VIROL, V89, P6773, DOI 10.1128/JVI.00649-15; Ansumana R, 2015, NEW ENGL J MED, V372, P587, DOI 10.1056/NEJMc1413685; Baize S, 1999, NAT MED, V5, P423, DOI 10.1038/7422; Crowe SJ, 2016, EMERG INFECT DIS, V22, P217, DOI 10.3201/eid2202.151250; Deen GF, 2015, N ENGL J MED, DOI 10.1056/NEJMoa1511410; Dhillon Paul, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2015-211062; Emmett KJ, 2015, PLOS CURR, DOI [10.1371/currents.outbreaks.c7fd7946ba606c982668a96bcba43c9, DOI 10.1371/CURRENTS.OUTBREAKS.C7FD7946BA606C982668A96BCBA43C9]; Fallah MP, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004260; Geisbert TW, 2015, J INFECT DIS, V212, pS91, DOI 10.1093/infdis/jiv284; Lanini S, 2015, J CLIN INVEST, V125, P4692, DOI 10.1172/JCI83111; Laupland KB, 2014, CAN J INFECT DIS MED, V25, P128, DOI 10.1155/2014/527378; Lefebvre A, 2014, MED MALADIES INFECT, V44, P412, DOI 10.1016/j.medmal.2014.08.005; Lindblade KA, 2015, EMERG INFECT DIS, V21, P1800, DOI 10.3201/eid2110.150912; Mattia JG, 2016, LANCET INFECT DIS, V16, P331, DOI 10.1016/S1473-3099(15)00489-2; MEYNELL GG, 1957, J GEN MICROBIOL, V16, P396, DOI 10.1099/00221287-16-2-396; Nanyonga M, 2016, CLIN INFECT DIS, V62, P125, DOI 10.1093/cid/civ795; Olu O, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1166-7; Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007; Pattyn SR, 1977, EBOLA VIRUS HAEMORRH; Qureshi AI, 2015, CLIN INFECT DIS, V61, P1035, DOI 10.1093/cid/civ453; Rosello A, 2015, ELIFE, V4, DOI 10.7554/eLife.09015; Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680; Smither SJ, 2015, J INFECT DIS, V212, pS336, DOI 10.1093/infdis/jiv371; Van Kerkhove MD, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.19; WHO, 2014, CLIN MAN PAT EB TREA; World Health Organization, 2015, TEL EB SURV LAT COMP; Zhang X, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004113	30	16	17	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 17	2016	353								i2403	10.1136/bmj.i2403	http://dx.doi.org/10.1136/bmj.i2403			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GO	27188404	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000376448900003
J	Pakala, AV; Mathew, ST				Pakala, Aneesh V.; Mathew, Sunil T.			In patients >= 80 years of age with NSTEMI or unstable angina, an invasive strategy reduced CV outcomes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Pakala, Aneesh V.; Mathew, Sunil T.] Univ Oklahoma, HSC, Vet Affairs Med Ctr, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Pakala, AV (corresponding author), Univ Oklahoma, HSC, Vet Affairs Med Ctr, Oklahoma City, OK USA.								0	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2016	164	10					JC58	JC58		10.7326/ACPJC-2016-164-10-058	http://dx.doi.org/10.7326/ACPJC-2016-164-10-058			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8GF	27182924				2022-12-28	WOS:000375878500009
J	Van Spall, HGC				Van Spall, Harriette G. C.			Transitional care with telemonitoring did not reduce readmission after hospitalization for heart failure	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Van Spall, Harriette G. C.] McMaster Univ, Hamilton, ON, Canada	McMaster University	Van Spall, HGC (corresponding author), McMaster Univ, Hamilton, ON, Canada.			Van Spall, Harriette Gillian Christine/0000-0002-8370-4569				Chaudhry SI, 2010, NEW ENGL J MED, V363, P2301, DOI 10.1056/NEJMoa1010029; Koehler F, 2011, CIRCULATION, V123, P1873, DOI 10.1161/CIRCULATIONAHA.111.018473; O'Connor CM, 2010, AM HEART J, V159, P841, DOI 10.1016/j.ahj.2010.02.023	3	2	2	5	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2016	164	10					JC59	JC59		10.7326/ACPJC-2016-164-10-059	http://dx.doi.org/10.7326/ACPJC-2016-164-10-059			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8GF	27182925				2022-12-28	WOS:000375878500010
J	Hodson, R				Hodson, Richard			OPEN INNOVATION	NATURE			English	Editorial Material																			0	6	6	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					S53	S53		10.1038/533S53a	http://dx.doi.org/10.1038/533S53a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0BJ	27167389				2022-12-28	WOS:000376007200062
J	Hyun, I; Wilkerson, A; Johnston, J				Hyun, Insoo; Wilkerson, Amy; Johnston, Josephine			Revisit the 14-day rule	NATURE			English	Editorial Material							IMPLANTATION		[Hyun, Insoo] Case Western Reserve Univ, Bioeth & Philosophy, Sch Med, Cleveland, OH USA; [Wilkerson, Amy] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA; [Johnston, Josephine] Hastings Ctr, Garrison, NY USA	Case Western Reserve University; Rockefeller University	Johnston, J (corresponding author), Hastings Ctr, Garrison, NY USA.	insoo.hyun@case.edu		Johnston, Josephine/0000-0002-7411-6992				Ad Hoc Group of Consultants to the Advisory Committee to the Director,NIH, 1994, REP HUM EMBR RES PAN; Carver J, 2003, HUM REPROD, V18, P283, DOI 10.1093/humrep/deg072; Deglincerti A., 2016, NATURE; Ethics Advisory Board, 1979, HEW SUPP RES INV HUM; Pera MF, 2015, NAT METHODS, V12, P917, DOI 10.1038/nmeth.3586; Rossant J, 2016, NATURE, V533, P182, DOI 10.1038/nature17894; Shahbazi M. N., 2016, NATURE CELL BIOL; Taniguchi K, 2015, STEM CELL REP, V5, P954, DOI 10.1016/j.stemcr.2015.10.015; UK Department of Health and Social Security, 1984, REP COMM INQ HUM FER; Warmflash A, 2014, NAT METHODS, V11, P847, DOI [10.1038/NMETH.3016, 10.1038/nmeth.3016]	10	102	105	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					169	171		10.1038/533169a	http://dx.doi.org/10.1038/533169a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0BJ	27172031				2022-12-28	WOS:000376007200024
J	Pal, K				Pal, Kingshuk			Could you wait a second?	LANCET			English	Editorial Material									[Pal, Kingshuk] UCL, Res Dept Primary Care & Populat Hlth, EHlth Unit, London NW3 2PF, England	University of London; University College London	Pal, K (corresponding author), UCL, Res Dept Primary Care & Populat Hlth, EHlth Unit, London NW3 2PF, England.	k.pal@ucl.ac.uk		Pal, Kingshuk/0000-0001-6630-6684					0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2016	387	10031					1900	1901						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DL1EE	27203643				2022-12-28	WOS:000375374200017
J	Veiga-Fernandes, H; Mucida, D				Veiga-Fernandes, Henrique; Mucida, Daniel			Neuro-Immune Interactions at Barrier Surfaces	CELL			English	Review							ENTERIC NERVOUS-SYSTEM; NITRIC-OXIDE PRODUCTION; RAPID MICROGLIAL RESPONSE; HEMATOPOIETIC STEM-CELLS; CD103(+) DENDRITIC CELLS; KINASE RECEPTOR RET; BONE-MARROW NICHE; CROHNS-DISEASE; SUBSTANCE-P; GLIAL-CELLS	Multidirectional interactions between the nervous and immune systems have been documented in homeostasis and pathologies ranging from multiple sclerosis to autism, and from leukemia to acute and chronic inflammation. Recent studies have addressed this crosstalk using cell-specific targeting, novel sequencing, imaging, and analytical tools, shedding light on unappreciated mechanisms of neuro-immune regulation. This Review focuses on neuro-immune interactions at barrier surfaces-mostly the gut, but also including the skin and the airways, areas densely populated by neurons and immune cells that constantly sense and adapt to tissue-specific environmental challenges.	[Veiga-Fernandes, Henrique] Fac Med Lisbon, Inst Med Mol, Ave Prof Egas Moniz,Edificio Egas Moniz, P-1649028 Lisbon, Portugal; [Mucida, Daniel] Rockefeller Univ, Lab Mucosal Immunol, 1230 York Ave, New York, NY 10065 USA	Instituto Superior de Ciencias da Saude Egas Moniz; Universidade de Lisboa; Rockefeller University	Veiga-Fernandes, H (corresponding author), Fac Med Lisbon, Inst Med Mol, Ave Prof Egas Moniz,Edificio Egas Moniz, P-1649028 Lisbon, Portugal.; Mucida, D (corresponding author), Rockefeller Univ, Lab Mucosal Immunol, 1230 York Ave, New York, NY 10065 USA.	jhfernandes@medicina.ulisboa.pt; mucida@rockefeller.edu		Veiga-Fernandes, Henrique/0000-0001-6216-1836	Kenneth Rainin Foundation; Crohn's and Colitis Foundation of America Award; EMBO [1648]; ERC, EU [647274]; FCT, Portugal; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI105047] Funding Source: NIH RePORTER	Kenneth Rainin Foundation; Crohn's and Colitis Foundation of America Award; EMBO(European Molecular Biology Organization (EMBO)); ERC, EU; FCT, Portugal(Portuguese Foundation for Science and Technology); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are indebted to members of our laboratories, particularly D. Esterhazy, D. Hoytema, and P. Muller (Mucida lab) and S. Ibiza and B. Garcia-Cassani (Veiga-Fernandes lab) for discussions, help with the figures, and critical reading and editing of the manuscript. We thank Rui M. Costa for helpful discussions. D. M. and H.V.-F. are supported by the Kenneth Rainin Foundation and by a Crohn's and Colitis Foundation of America Award. H.V.-F. is also supported by EMBO (1648); ERC (647274), EU; and FCT, Portugal.	Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Anitha M, 2012, GASTROENTEROLOGY, V143, P1006, DOI 10.1053/j.gastro.2012.06.034; Arendt D, 2008, NAT REV GENET, V9, P868, DOI 10.1038/nrg2416; Arranz L, 2014, NATURE, V512, P78, DOI 10.1038/nature13383; Balmer ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008618; Barajon I, 2009, J HISTOCHEM CYTOCHEM, V57, P1013, DOI 10.1369/jhc.2009.953539; Basso AS, 2003, J NEUROIMMUNOL, V140, P69, DOI 10.1016/S0165-5728(03)00166-8; BESEDOVSKY H, 1983, SCIENCE, V221, P564, DOI 10.1126/science.6867729; Boesmans W, 2015, GLIA, V63, P229, DOI 10.1002/glia.22746; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Bohorquez DV, 2015, J CLIN INVEST, V125, P782, DOI 10.1172/JCI78361; Branchfield K, 2016, SCIENCE, V351, P707, DOI 10.1126/science.aad7969; Brandt JP, 2015, CURR BIOL, V25, P2228, DOI 10.1016/j.cub.2015.07.037; Brun P, 2015, MOL CELL NEUROSCI, V68, P24, DOI 10.1016/j.mcn.2015.03.018; Brun P, 2013, GASTROENTEROLOGY, V145, P1323, DOI 10.1053/j.gastro.2013.08.047; BULBRING E, 1959, J PHYSIOL-LONDON, V146, P29; Bush TG, 1998, CELL, V93, P189, DOI 10.1016/S0092-8674(00)81571-8; Caceres AI, 2009, P NATL ACAD SCI USA, V106, P9099, DOI 10.1073/pnas.0900591106; CARA DC, 1994, BRAZ J MED BIOL RES, V27, P1331; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Choi GB, 2016, SCIENCE, V351, P933, DOI 10.1126/science.aad0314; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Cirillo C, 2011, NEUROGASTROENT MOTIL, V23, pE372, DOI 10.1111/j.1365-2982.2011.01748.x; Cirillo C, 2009, NEUROGASTROENT MOTIL, V21, P1209, DOI 10.1111/j.1365-2982.2009.01346.x; Cornet A, 2001, P NATL ACAD SCI USA, V98, P13306, DOI 10.1073/pnas.231474098; Costa-Pinto FA, 2005, BRAIN BEHAV IMMUN, V19, P52, DOI 10.1016/j.bbi.2004.02.005; Costello RW, 1997, AM J PHYSIOL-LUNG C, V273, pL93, DOI 10.1152/ajplung.1997.273.1.L93; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Dey N, 2015, CELL, V163, P95, DOI 10.1016/j.cell.2015.08.059; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Emiliani V, 2015, J NEUROSCI, V35, P13917, DOI 10.1523/JNEUROSCI.2916-15.2015; Engel MA, 2011, GASTROENTEROLOGY, V141, P1346, DOI 10.1053/j.gastro.2011.07.002; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Esposito G, 2007, GASTROENTEROLOGY, V133, P918, DOI 10.1053/j.gastro.2007.06.009; Farache J, 2013, IMMUNITY, V38, P581, DOI 10.1016/j.immuni.2013.01.009; Fattahi F, 2016, NATURE, V531, P105, DOI 10.1038/nature16951; Fonseca-Pereira D, 2014, NATURE, V514, P98, DOI 10.1038/nature13498; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; Fryer AD, 2006, J CLIN INVEST, V116, P228, DOI 10.1172/JCI25423; Furness JB, 2008, NEUROGASTROENT MOTIL, V20, P32, DOI 10.1111/j.1365-2982.2008.01094.x; Furness JB, 1999, AM J PHYSIOL-GASTR L, V277, pG922, DOI 10.1152/ajpgi.1999.277.5.G922; Furness JB, 2013, NAT REV GASTRO HEPAT, V10, P729, DOI 10.1038/nrgastro.2013.180; GEBOES K, 1992, GASTROENTEROLOGY, V103, P439, DOI 10.1016/0016-5085(92)90832-J; Gershon MD, 2010, TRENDS NEUROSCI, V33, P446, DOI 10.1016/j.tins.2010.06.002; Grundmann D, 2015, SCI REP-UK, V5, DOI 10.1038/srep09226; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Heidt T, 2014, NAT MED, V20, P754, DOI 10.1038/nm.3589; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Isern J, 2014, ELIFE, V3, DOI 10.7554/eLife.03696; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Joseph NM, 2011, J CLIN INVEST, V121, P3398, DOI 10.1172/JCI58186; Kabouridis PS, 2015, NEURON, V85, P289, DOI 10.1016/j.neuron.2014.12.037; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kioussis D, 2009, IMMUNITY, V31, P705, DOI 10.1016/j.immuni.2009.09.009; Koenigsknecht-Talboo J, 2008, J NEUROSCI, V28, P14156, DOI 10.1523/JNEUROSCI.4147-08.2008; Kong LJ, 2015, NAT METHODS, V12, P759, DOI [10.1038/nmeth.3476, 10.1038/NMETH.3476]; KORETZ K, 1987, AM J PATHOL, V129, P493; Kuo CS, 2015, CELL, V163, P394, DOI 10.1016/j.cell.2015.09.021; Lee LY, 2001, J APPL PHYSIOL, V91, P1318, DOI 10.1152/jappl.2001.91.3.1318; LEVINE JD, 1984, SCIENCE, V226, P547, DOI 10.1126/science.6208609; Liu T, 2010, NAT NEUROSCI, V13, P1460, DOI 10.1038/nn.2683; Liu YA, 2013, NEUROGASTROENT MOTIL, V25, pe324, DOI 10.1111/nmo.12115; Matsunaga H, 2011, AM J PHYSIOL-GASTR L, V301, pG555, DOI 10.1152/ajpgi.00482.2010; Mayer EA, 2011, NAT REV NEUROSCI, V12, P453, DOI 10.1038/nrn3071; Mazzini E, 2014, IMMUNITY, V40, P248, DOI 10.1016/j.immuni.2013.12.012; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Meisel JD, 2014, CELL, V159, P267, DOI 10.1016/j.cell.2014.09.011; Melo JA, 2012, CELL, V149, P452, DOI 10.1016/j.cell.2012.02.050; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Meseguer V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4125; Muller PA, 2014, CELL, V158, P300, DOI 10.1016/j.cell.2014.04.050; Neunlist M, 2013, NAT REV GASTRO HEPAT, V10, P90, DOI 10.1038/nrgastro.2012.221; Nijhuis LEJ, 2010, BIOCHEM PHARMACOL, V80, P2002, DOI 10.1016/j.bcp.2010.06.034; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; NUMAO T, 1992, J IMMUNOL, V149, P3309; Ordovas-Montanes J, 2015, TRENDS IMMUNOL, V36, P578, DOI 10.1016/j.it.2015.08.007; Ostrowski SM, 2011, J INVEST DERMATOL, V131, P1530, DOI 10.1038/jid.2011.60; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; Park CK, 2014, NEURON, V82, P47, DOI 10.1016/j.neuron.2014.02.011; Patel A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002734; Prakash R, 2012, NAT METHODS, V9, P1171, DOI 10.1038/NMETH.2215; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010; Richardson DS, 2015, CELL, V162, P246, DOI 10.1016/j.cell.2015.06.067; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Royer D. J., 2015, MUCOSAL IMMUNOL; Rumio C, 2006, J CELL PHYSIOL, V208, P47, DOI 10.1002/jcp.20632; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schemann M, 2013, GASTROENTEROLOGY, V144, P698, DOI 10.1053/j.gastro.2013.01.040; Schmidt E. F., 2013, COLD SPRING HARB PRO, V2013; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Serrats J, 2010, NEURON, V65, P94, DOI 10.1016/j.neuron.2009.11.032; Sharkey KA, 2015, J CLIN INVEST, V125, P918, DOI 10.1172/JCI76303; Shepherd AJ, 2005, J NEUROIMMUNOL, V164, P115, DOI 10.1016/j.jneuroim.2005.04.008; Shin HN, 2013, TRENDS IMMUNOL, V34, P487, DOI 10.1016/j.it.2013.08.001; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Spiegel A, 2007, NAT IMMUNOL, V8, P1123, DOI 10.1038/ni1509; STEAD RH, 1989, GASTROENTEROLOGY, V97, P575, DOI 10.1016/0016-5085(89)90627-6; STEAD RH, 1987, P NATL ACAD SCI USA, V84, P2975, DOI 10.1073/pnas.84.9.2975; Tainaka K, 2014, CELL, V159, P911, DOI 10.1016/j.cell.2014.10.034; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Talbot S, 2015, NEURON, V87, P341, DOI 10.1016/j.neuron.2015.06.007; Tomer R, 2015, CELL, V163, P1796, DOI 10.1016/j.cell.2015.11.061; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; van de Pavert SA, 2009, NAT IMMUNOL, V10, P1193, DOI 10.1038/ni.1789; van Diest SA, 2012, BBA-MOL BASIS DIS, V1822, P74, DOI 10.1016/j.bbadis.2011.03.019; Van Landeghem L, 2011, AM J PHYSIOL-GASTR L, V300, pG976, DOI 10.1152/ajpgi.00427.2010; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wedel T, 1999, ANN ANAT, V181, P327, DOI 10.1016/S0940-9602(99)80122-8; Willemze RA, 2015, NAT REV GASTRO HEPAT, V12, P353, DOI 10.1038/nrgastro.2015.56; Wilson SR, 2013, CELL, V155, P285, DOI 10.1016/j.cell.2013.08.057; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301; Xiao WD, 2011, MOL CELL NEUROSCI, V46, P527, DOI 10.1016/j.mcn.2010.12.007; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Zariwala HA, 2012, J NEUROSCI, V32, P3131, DOI 10.1523/JNEUROSCI.4469-11.2012; Zhang MD, 2014, P NATL ACAD SCI USA, V111, pE1149, DOI 10.1073/pnas.1402318111	120	143	149	2	51	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2016	165	4					801	811		10.1016/j.cell.2016.04.041	http://dx.doi.org/10.1016/j.cell.2016.04.041			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DL7DN	27153494	Green Accepted, Bronze			2022-12-28	WOS:000375800300010
J	Claes, AS; Hoton, D; Galant, C; Ghaye, B				Claes, Anne-Sophie; Hoton, Delphine; Galant, Christine; Ghaye, Benoit			Intravascular tumour embolism from chondrosarcoma	LANCET			English	Editorial Material									[Claes, Anne-Sophie; Ghaye, Benoit] Univ Catholic Louvain, Clin Univ St Luc, Dept Radiol, Brussels, Belgium; [Hoton, Delphine; Galant, Christine] Univ Catholic Louvain, Clin Univ St Luc, Dept Pathol, Brussels, Belgium	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Claes, AS (corresponding author), Clin Univ St Luc, Dept Radiol, B-1200 Brussels, Belgium.	anso.claes@gmail.com							0	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2022	399	10332					E29	E29		10.1016/S0140-6736(16)30382-8	http://dx.doi.org/10.1016/S0140-6736(16)30382-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	2F3QY	27212430				2022-12-28	WOS:000812828300004
J	Jadhav, U; Nalapareddy, K; Saxena, M; O'Neill, NK; Pinello, L; Yuan, GC; Orkin, SH; Shivdasani, RA				Jadhav, Unmesh; Nalapareddy, Kodandaramireddy; Saxena, Madhurima; O'Neill, Nicholas K.; Pinello, Luca; Yuan, Guo-Cheng; Orkin, Stuart H.; Shivdasani, Ramesh A.			Acquired Tissue-Specific Promoter Bivalency Is a Basis for PRC2 Necessity in Adult Cells	CELL			English	Article							GENOME-WIDE MAPS; CHROMATIN SIGNATURES; EPIGENOMIC LANDSCAPES; GROUND-STATE; STEM-CELLS; GENE; DISTINCT; COMPLEX; EZH2; PLURIPOTENT	Bivalent promoters in embryonic stem cells (ESCs) carry methylation marks on two lysine residues, K4 and K27, in histone3 (H3). K4me2/3 is generally considered to promote transcription, and Polycomb Repressive Complex 2 (PRC2) places K27me3, which is erased at lineage-restricted genes when ESCs differentiate in culture. Molecular defects in various PRC2 null adult tissues lack a unifying explanation. We found that epigenomes in adult mouse intestine and other self-renewing tissues show fewer and distinct bivalent promoters compared to ESCs. Groups of tissue-specific genes that carry bivalent marks are repressed, despite the presence of promoter H3K4me2/3. These are the predominant genes de-repressed in PRC2-deficient adult cells, where aberrant expression is proportional to the H3K4me2/3 levels observed at their promoters in wild-type cells. Thus, in adult animals, PRC2 specifically represses genes with acquired, tissue-restricted promoter bivalency. These findings provide new insights into specificity in chromatin-based gene regulation.	[Jadhav, Unmesh; Nalapareddy, Kodandaramireddy; Saxena, Madhurima; O'Neill, Nicholas K.; Shivdasani, Ramesh A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Jadhav, Unmesh; Nalapareddy, Kodandaramireddy; Saxena, Madhurima; O'Neill, Nicholas K.; Shivdasani, Ramesh A.] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02215 USA; [Jadhav, Unmesh; Nalapareddy, Kodandaramireddy; Saxena, Madhurima; Shivdasani, Ramesh A.] Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA; [Jadhav, Unmesh; Nalapareddy, Kodandaramireddy; Saxena, Madhurima; Shivdasani, Ramesh A.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; [Pinello, Luca; Yuan, Guo-Cheng] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Pinello, Luca; Yuan, Guo-Cheng] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Yuan, Guo-Cheng; Orkin, Stuart H.; Shivdasani, Ramesh A.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Orkin, Stuart H.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA; [Orkin, Stuart H.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Orkin, Stuart H.] Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Shivdasani, RA (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.; Shivdasani, RA (corresponding author), Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02215 USA.; Shivdasani, RA (corresponding author), Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA.; Shivdasani, RA (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA.; Shivdasani, RA (corresponding author), Harvard Stem Cell Inst, Cambridge, MA 02138 USA.	ramesh_shivdasani@dfci.harvard.edu		Pinello, Luca/0000-0003-1109-3823; Nalapareddy, Kodandaramireddy/0000-0003-3290-5114	Intestinal Stem Cell Consortium of the NIDDK [U01DK103152]; NIAID; DFCI-Novartis Drug Discovery Program; NIH [R01DK081113, R01HG005085, F32DK103453, K99HG008399, P50CA127003]; NATIONAL CANCER INSTITUTE [P50CA127003] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K99HG008399, R01HG005085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK103152, F32DK103453, R01DK081113] Funding Source: NIH RePORTER	Intestinal Stem Cell Consortium of the NIDDK; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DFCI-Novartis Drug Discovery Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intestinal Stem Cell Consortium (U01DK103152) of the NIDDK and NIAID; the DFCI-Novartis Drug Discovery Program; NIH awards R01DK081113 (R.A.S.), R01HG005085 (G.-C.Y.), F32DK103453 (U.J.), K99HG008399 (L.P.), and P50CA127003; and gifts from the Lind family. We thank Sylvie Robine for Villin-Cre<SUP>ER-T2</SUP> mice; and Gary Struhl, Jian Xu, Myles Brown, HoMan Chan, Veronica Saenz-Vash, and Huili Zhai for valuable discussions.	Abraham BJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-193; Alder O, 2010, DEVELOPMENT, V137, P2483, DOI 10.1242/dev.048363; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bettess MD, 2005, MOL CELL BIOL, V25, P7868, DOI 10.1128/MCB.25.17.7868-7878.2005; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Das PP, 2014, MOL CELL, V53, P32, DOI 10.1016/j.molcel.2013.11.011; Delgado-Olguin P, 2012, NAT GENET, V44, P343, DOI 10.1038/ng.1068; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Ezhkova E, 2011, GENE DEV, V25, P485, DOI 10.1101/gad.2019811; Faust C, 1998, DEVELOPMENT, V125, P4495; Hasemann MS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004079; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hidalgo I, 2012, CELL STEM CELL, V11, P649, DOI 10.1016/j.stem.2012.08.001; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Juan AH, 2011, GENE DEV, V25, P789, DOI 10.1101/gad.2027911; Kim TH, 2014, NATURE, V506, P511, DOI 10.1038/nature12903; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Li QY, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat057; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Riising EM, 2014, MOL CELL, V55, P347, DOI 10.1016/j.molcel.2014.06.005; Schwarz D, 2014, DEVELOPMENT, V141, P867, DOI 10.1242/dev.094342; Shen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065598; Shpargel KB, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004507; Subramanian V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003725; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Voigt P, 2012, CELL, V151, P181, DOI 10.1016/j.cell.2012.09.002; Xie HF, 2014, CELL STEM CELL, V14, P68, DOI 10.1016/j.stem.2013.10.001; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-537; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	49	74	75	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2016	165	6					1389	1400		10.1016/j.cell.2016.04.031	http://dx.doi.org/10.1016/j.cell.2016.04.031			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DN4NV	27212235	Green Accepted, Bronze			2022-12-28	WOS:000377045400013
J	Couvillion, MT; Soto, IC; Shipkovenska, G; Churchman, LS				Couvillion, Mary T.; Soto, Iliana C.; Shipkovenska, Gergana; Churchman, L. Stirling			Synchronized mitochondrial and cytosolic translation programs	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; IN-VIVO; PROTEIN-SYNTHESIS; GENE-EXPRESSION; YEAST; RNA; POLYMERASE; INITIATION; ADAPTATION; ALIGNMENT	Oxidative phosphorylation (OXPHOS) is a vital process for energy generation, and is carried out by complexes within the mitochondria. OXPHOS complexes pose a unique challenge for cells because their subunits are encoded on both the nuclear and the mitochondrial genomes. Genomic approaches designed to study nuclear/cytosolic and bacterial gene expression have not been broadly applied to mitochondria, so the co-regulation of OXPHOS genes remains largely unexplored. Here we monitor mitochondrial and nuclear gene expression in Saccharomyces cerevisiae during mitochondrial biogenesis, when OXPHOS complexes are synthesized. We show that nuclear-and mitochondrial-encoded OXPHOS transcript levels do not increase concordantly. Instead, mitochondrial and cytosolic translation are rapidly, dynamically and synchronously regulated. Furthermore, cytosolic translation processes control mitochondrial translation unidirectionally. Thus, the nuclear genome coordinates mitochondrial and cytosolic translation to orchestrate the timely synthesis of OXPHOS complexes, representing an unappreciated regulatory layer shaping the mitochondrial proteome. Our whole-cell genomic profiling approach establishes a foundation for studies of global gene regulation in mitochondria.	[Couvillion, Mary T.; Soto, Iliana C.; Shipkovenska, Gergana; Churchman, L. Stirling] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Churchman, LS (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	churchman@genetics.med.harvard.edu		Soto, Iliana/0000-0002-8499-6081; Shipkovenska, Gergana/0000-0001-6288-4401	Damon Runyon Cancer Research Foundation; Burroughs Wellcome Fund Career Award at the Scientific Interface; Ellison Medical Foundation; National Institutes of Health; Boehringer Ingelheim; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM106531] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; Burroughs Wellcome Fund Career Award at the Scientific Interface(Burroughs Wellcome Fund); Ellison Medical Foundation(Lawrence Ellison Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim(Boehringer Ingelheim); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Winston, T. Fox, G. Brar and members of the Churchman lab for advice and discussions; members of the O'Shea, Novina, and Springer labs for use of equipment and advice; and M. Hickman and D. Botstein for sharing the HAP1<SUP>+</SUP> strain. Research supported by a Damon Runyon Cancer Research Foundation Frey Award (to L.S.C.), a Burroughs Wellcome Fund Career Award at the Scientific Interface (to L.S.C.), an Ellison Medical Foundation New Scholar in Aging Award (to L.S.C.), the National Institutes of Health F32 (to M.T.C.), and a Boehringer Ingelheim Fonds PhD Fellowship (to G.S.).	ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test; Amiott EA, 2006, MOL CELL, V22, P329, DOI 10.1016/j.molcel.2006.03.031; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Baruffini E, 2007, GENETICS, V177, P1227, DOI 10.1534/genetics.107.079293; BONITZ SG, 1980, P NATL ACAD SCI-BIOL, V77, P3167, DOI 10.1073/pnas.77.6.3167; Brar GA, 2012, SCIENCE, V335, P552, DOI 10.1126/science.1215110; COSTANZO MC, 1990, ANNU REV GENET, V24, P91; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dimitrov LN, 2009, GENETICS, V183, P365, DOI 10.1534/genetics.109.104497; Ehrenreich IM, 2010, NATURE, V464, P1039, DOI 10.1038/nature08923; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FAYE G, 1977, MOL GEN GENET, V155, P27, DOI 10.1007/BF00268557; FOX TD, 1991, METHOD ENZYMOL, V194, P149; Fraenkel D. G., 2011, YEAST INTERMEDIARY M; Gaisne M, 1999, CURR GENET, V36, P195, DOI 10.1007/s002940050490; Gouget Karine, 2008, V457, P113, DOI 10.1007/978-1-59745-261-8_8; Green-Willms NS, 2001, J BIOL CHEM, V276, P6392, DOI 10.1074/jbc.M009856200; Gruschke S, 2012, J CELL BIOL, V199, P137, DOI 10.1083/jcb.201206040; Herrmann JM, 2013, BBA-MOL CELL RES, V1833, P286, DOI 10.1016/j.bbamcr.2012.03.007; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2010, METHOD ENZYMOL, V470, P119, DOI 10.1016/S0076-6879(10)70006-9; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kehrein K, 2013, ANTIOXID REDOX SIGN, V19, P1928, DOI 10.1089/ars.2012.4896; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kuhn KM, 2001, MOL CELL BIOL, V21, P916, DOI 10.1128/MCB.21.3.916-927.2001; LAMB AJ, 1968, BIOCHIM BIOPHYS ACTA, V161, P415, DOI 10.1016/0005-2787(68)90119-6; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Liu BT, 2014, WIRES RNA, V5, P301, DOI 10.1002/wrna.1212; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; Moqtaderi Z, 2008, YEAST, V25, P287, DOI 10.1002/yea.1581; MUELLER DM, 1986, J BIOL CHEM, V261, P1816; MULLER PP, 1984, J MOL BIOL, V175, P431, DOI 10.1016/0022-2836(84)90178-5; Pavlov MY, 2013, P NATL ACAD SCI USA, V110, P20527, DOI 10.1073/pnas.1309356110; Perez-Martinez X, 2009, MOL BIOL CELL, V20, P4371, DOI 10.1091/mbc.E09-06-0522; POUTRE CG, 1987, GENETICS, V115, P637; Poyton R O, 1996, Methods Enzymol, V264, P36, DOI 10.1016/S0076-6879(96)64006-3; Rak M., 2016, MOL BIOL CELL; Roberts GG, 2006, MOL GENET GENOMICS, V276, P170, DOI 10.1007/s00438-006-0133-9; Rooijers K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3886; Simpson CE, 2012, BIOCHEM SOC T, V40, P794, DOI 10.1042/BST20120078; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Sun T, 2008, NUCLEIC ACIDS RES, V36, P1654, DOI 10.1093/nar/gkm1180; VIGNAIS PV, 1972, J CELL BIOL, V54, P468, DOI 10.1083/jcb.54.3.468; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x; Young MJ, 2008, YEAST, V25, P903, DOI 10.1002/yea.1644; Zhang Y, 2000, RNA, V6, P937, DOI 10.1017/S1355838200991726	49	176	178	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2016	533	7604					499	+		10.1038/nature18015	http://dx.doi.org/10.1038/nature18015			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6EJ	27225121	Green Accepted, Green Submitted			2022-12-28	WOS:000376443100033
J	Showman, AP				Showman, Adam P.			ASTROPHYSICS Illuminating brown dwarfs	NATURE			English	Editorial Material							PLANETS		[Showman, Adam P.] Univ Arizona, Dept Planetary Sci, Tucson, AZ 85721 USA; [Showman, Adam P.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA	University of Arizona; University of Arizona	Showman, AP (corresponding author), Univ Arizona, Dept Planetary Sci, Tucson, AZ 85721 USA.; Showman, AP (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.	showman@lpl.arizona.edu						Artigau E, 2009, ASTROPHYS J, V701, P1534, DOI 10.1088/0004-637X/701/2/1534; Baraffe I, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/1/016901; Casewell SL, 2015, MON NOT R ASTRON SOC, V447, P3218, DOI 10.1093/mnras/stu2721; DAVEY S, 1992, MON NOT R ASTRON SOC, V257, P476, DOI 10.1093/mnras/257.3.476; INGERSOLL AP, 1990, SCIENCE, V248, P308, DOI 10.1126/science.248.4953.308; Komacek TD, 2016, ASTROPHYS J, V821, DOI 10.3847/0004-637X/821/1/16; Santisteban JVH, 2016, NATURE, V533, P366, DOI 10.1038/nature17952; Steele PR, 2013, MON NOT R ASTRON SOC, V429, P3492, DOI 10.1093/mnras/sts620; Stevenson KB, 2014, SCIENCE, V346, P838, DOI 10.1126/science.1256758	10	4	4	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					330	331		10.1038/533330a	http://dx.doi.org/10.1038/533330a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0AH	27193676				2022-12-28	WOS:000376004300035
J	Buckley, NA; Dawson, AH; Isbister, GK				Buckley, Nicholas A.; Dawson, Andrew H.; Isbister, Geoffrey K.			Treatments for paracetamol poisoning	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACTIVATED-CHARCOAL; INTRAVENOUS ACETYLCYSTEINE; N-ACETYLCYSTEINE; MULTICENTER; TRIAL		[Buckley, Nicholas A.; Dawson, Andrew H.; Isbister, Geoffrey K.] NSW Poisons Informat Ctr, Sydney, NSW, Australia; [Buckley, Nicholas A.; Dawson, Andrew H.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Buckley, Nicholas A.; Dawson, Andrew H.] Royal Prince Alfred Hosp, Dept Clin Toxicol, Sydney, NSW, Australia; [Isbister, Geoffrey K.] Univ Newcastle, Clin Toxicol Res Grp, Newcastle, NSW 2300, Australia	University of Sydney; University of Sydney; University of Newcastle	Buckley, NA (corresponding author), NSW Poisons Informat Ctr, Sydney, NSW, Australia.; Buckley, NA (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.; Buckley, NA (corresponding author), Royal Prince Alfred Hosp, Dept Clin Toxicol, Sydney, NSW, Australia.	Nicholas.buckley@sydney.edu.au	Isbister, Geoffrey K/G-8052-2015; Dawson, Andrew H/U-8041-2019; Buckley, Nicholas A/D-4030-2012	Isbister, Geoffrey K/0000-0003-1519-7419; Dawson, Andrew H/0000-0002-8047-397X; Buckley, Nicholas A/0000-0002-6326-4711				18th Expert Committee on the Selection and Use of Essential Medicines, 2011, 18 EXP COMM SEL US E; Bateman DN, 2014, BRIT J CLIN PHARMACO, V78, P610, DOI 10.1111/bcp.12362; Bateman DN, 2014, LANCET, V383, P697, DOI 10.1016/S0140-6736(13)62062-0; Brok J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003328.pub2; Buckley NA, 1999, J TOXICOL-CLIN TOXIC, V37, P753, DOI 10.1081/CLT-100102452; CLARK R, 1973, LANCET, V1, P66; Cooper GM, 2005, QJM-INT J MED, V98, P655, DOI 10.1093/qjmed/hci102; Eddleston M, 2008, LANCET, V371, P579, DOI 10.1016/S0140-6736(08)60270-6; Ferner RE, 2001, BRIT J CLIN PHARMACO, V52, P573, DOI 10.1046/j.0306-5251.2001.01490.x; Gosselin S, 2014, CLIN TOXICOL, V52, P856, DOI 10.3109/15563650.2014.946994; Humphreys RA, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2043; KEAYS R, 1991, BRIT MED J, V303, P1026, DOI 10.1136/bmj.303.6809.1026; Kerr F, 2005, ANN EMERG MED, V45, P402, DOI 10.1016/j.annemergmed.2004.08.040; Medicines and Healthcare Products Regulatory Agency, 2016, TREAT PAR OV INTR AC; Pakravan N, 2008, CLIN TOXICOL, V46, P697, DOI 10.1080/15563650802245497; Park B Kevin, 2015, BMJ Clin Evid, V2015; PRESCOTT LF, 1979, BRIT MED J, V2, P1097, DOI 10.1136/bmj.2.6198.1097; Sandilands EA, 2009, CLIN TOXICOL, V47, P81, DOI 10.1080/15563650802665587; Senarathna S M D K Ganga, 2012, BMC Clin Pharmacol, V12, P6, DOI 10.1186/1472-6904-12-6; SMILKSTEIN MJ, 1988, NEW ENGL J MED, V319, P1557, DOI 10.1056/NEJM198812153192401; Spiller HA, 2007, J EMERG MED, V33, P141, DOI 10.1016/j.jemermed.2007.02.016; Thanacoody HKR, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-20; VALE JA, 1981, ARCH INTERN MED, V141, P394, DOI 10.1001/archinte.141.3.394; Wong A, 2016, CLIN TOXICOL, V54, P115, DOI 10.3109/15563650.2015.1115055	24	9	9	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 18	2016	353								i2579	10.1136/bmj.i2579	http://dx.doi.org/10.1136/bmj.i2579			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GC	27193197				2022-12-28	WOS:000376447600001
J	Gulland, A				Gulland, Anne			How Brexit might affect public health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												agulland@bmj.com						Department for Environment Food and Rural Affairs, 2015, IMPR AIR QUAL UK TAC; European Commission, TOB PROD DIR; European Environment Agency, 2015, EUR BATH WAT QUAL 20; Tobacco Manufacturers' Association, 2015, RU CIG PRIC; Turnock ST, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/2/024010	5	1	1	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 16	2016	353								i2747	10.1136/bmj.i2747	http://dx.doi.org/10.1136/bmj.i2747			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GB	27185784				2022-12-28	WOS:000376447500009
J	Reboldi, A; Arnon, TI; Rodda, LB; Atakilit, A; Sheppard, D; Cyster, JG				Reboldi, Andrea; Arnon, Tal I.; Rodda, Lauren B.; Atakilit, Amha; Sheppard, Dean; Cyster, Jason G.			IgA production requires B cell interaction with subepithelial dendritic cells in Peyer's patches	SCIENCE			English	Article							INNATE LYMPHOID-CELLS; CCR6 EXPRESSION; T-CELLS; HOMEOSTASIS; DEFICIENCY; CHEMOKINE; RESPONSES; DIFFERENTIATION; LOCALIZATION; CD8-ALPHA(+)	Immunoglobulin A (IgA) induction primarily occurs in intestinal Peyer's patches (PPs). However, the cellular interactions necessary for IgA class switching are poorly defined. Here we show that in mice, activated B cells use the chemokine receptor CCR6 to access the subepithelial dome (SED) of PPs. There, B cells undergo prolonged interactions with SED dendritic cells (DCs). PP IgA class switching requires innate lymphoid cells, which promote lymphotoxin-beta receptor (LT beta R)-dependent maintenance of DCs. PP DCs augment IgA production by integrin alpha nu beta 8-mediated activation of transforming growth factor-beta (TGF beta). In mice where B cells cannot access the SED, IgA responses against oral antigen and gut commensals are impaired. These studies establish the PP SED as a niche supporting DC-B cell interactions needed for TGF beta activation and induction of mucosal IgA responses.	[Reboldi, Andrea; Arnon, Tal I.; Rodda, Lauren B.; Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, 513 Parnassus Ave, San Francisco, CA 94143 USA; [Reboldi, Andrea; Arnon, Tal I.; Rodda, Lauren B.; Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, 513 Parnassus Ave, San Francisco, CA 94143 USA; [Atakilit, Amha; Sheppard, Dean] Univ Calif San Francisco, Dept Med, Lung Biol Ctr, 1550 4th St, San Francisco, CA 94158 USA; [Arnon, Tal I.] Univ Oxford, Kennedy Inst Rheumatol, Roosevelt Dr, Oxford OX3 7FY, England	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Oxford	Reboldi, A; Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 513 Parnassus Ave, San Francisco, CA 94143 USA.; Reboldi, A; Cyster, JG (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, 513 Parnassus Ave, San Francisco, CA 94143 USA.	andrea.reboldi@ucsf.edu; jason.cyster@ucsf.edu		Arnon, Tal/0000-0003-4629-5820	Cancer Research Institute; National Institute of Allergy and Infectious Diseases [AI077439, AI045073, AI074847]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007334, U19AI077439, R01AI045073, R01AI074847] Funding Source: NIH RePORTER	Cancer Research Institute; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Matloubian for help with the B16-Flt3L, J. Bluestone for RORgt-GFP mice, M. Krummel for Zbtb46-GFP mice, M. Rosenblum for Baft3<SUP>-/-</SUP> mice, R. Locksley for KN2 mice and Il4ra<SUP>-/-</SUP> mice, F. Kroese for HISM2 hybridoma, M. Miller for advice regarding intravital microscopy, Y. Xu and J. An for expert technical assistance, and O. Bannard for comments on the manuscript. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. UCSF has filed a patent (U.S. patent application 14/778,997) describing the alpha v beta 8 blocking antibody used in this manuscript. D.S. and A. A. are listed as inventors. A. R. was a recipient of the Irvington postdoctoral fellowship from the Cancer Research Institute. J.G.C. is an investigator of the Howard Hughes Medical Institute. The work was supported in part by National Institute of Allergy and Infectious Diseases U19 grant AI077439 (to D.S.) and RO1 grants AI045073 and AI074847 (to J.G.C).	Arnon TI, 2013, NATURE, V493, P684, DOI 10.1038/nature11738; Bergqvist P, 2013, MUCOSAL IMMUNOL, V6, P122, DOI 10.1038/mi.2012.56; Bunker JJ, 2015, IMMUNITY, V43, P541, DOI 10.1016/j.immuni.2015.08.007; Castigli E, 2004, P NATL ACAD SCI USA, V101, P3903, DOI 10.1073/pnas.0307348101; Cazac BB, 2000, IMMUNITY, V13, P443, DOI 10.1016/S1074-7613(00)00044-3; Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; CRAIG SW, 1971, J EXP MED, V134, P188, DOI 10.1084/jem.134.1.188; Ebisawa M, 2011, INT IMMUNOL, V23, P261, DOI 10.1093/intimm/dxq478; Edelson BT, 2011, IMMUNITY, V35, P236, DOI 10.1016/j.immuni.2011.06.012; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Fayette J, 1997, J EXP MED, V185, P1909, DOI 10.1084/jem.185.11.1909; Gommerman JL, 2003, NAT REV IMMUNOL, V3, P642, DOI 10.1038/nri1151; Gros MJ, 2008, J IMMUNOL, V180, P8153, DOI 10.4049/jimmunol.180.12.8153; Hammarstrom L, 2000, CLIN EXP IMMUNOL, V120, P225, DOI 10.1046/j.1365-2249.2000.01131.x; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Iwasaki A, 2001, J IMMUNOL, V166, P4884, DOI 10.4049/jimmunol.166.8.4884; Kabashima K, 2005, IMMUNITY, V22, P439, DOI 10.1016/j.immuni.2005.02.007; Kawamoto S, 2012, SCIENCE, V336, P485, DOI 10.1126/science.1217718; Kelsall BL, 1996, J EXP MED, V183, P237, DOI 10.1084/jem.183.1.237; Kruglov AA, 2013, SCIENCE, V342, P1243, DOI 10.1126/science.1243364; Kucharzik T, 2002, EUR J IMMUNOL, V32, P104, DOI 10.1002/1521-4141(200201)32:1<104::AID-IMMU104>3.0.CO;2-C; Liao F, 2002, J IMMUNOL, V168, P4871, DOI 10.4049/jimmunol.168.10.4871; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; McDonald KG, 2007, AM J PATHOL, V170, P1229, DOI 10.2353/ajpath.2007.060817; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Ngo VN, 2001, J EXP MED, V194, P1649, DOI 10.1084/jem.194.11.1649; Ngo VN, 1998, J EXP MED, V188, P181, DOI 10.1084/jem.188.1.181; Parekh VV, 2003, J IMMUNOL, V170, P5897, DOI 10.4049/jimmunol.170.12.5897; Pereira JP, 2009, NAT IMMUNOL, V10, P403, DOI 10.1038/ni.1710; Ruane D, 2016, J EXP MED, V213, P53, DOI 10.1084/jem.20150567; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Schwickert TA, 2009, J EXP MED, V206, P2907, DOI 10.1084/jem.20091225; Slack E, 2014, IMMUNOL REV, V260, P50, DOI 10.1111/imr.12179; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; Tezuka H, 2007, NATURE, V448, P929, DOI 10.1038/nature06033; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; van Ginkel FW, 1999, J IMMUNOL, V163, P1951; Varona R, 2001, J CLIN INVEST, V107, pR37, DOI 10.1172/JCI11297; Villablanca EJ, 2011, GASTROENTEROLOGY, V141, P176, DOI 10.1053/j.gastro.2011.04.010; Yeap LS, 2015, CELL, V163, P1124, DOI 10.1016/j.cell.2015.10.042; Zhao XY, 2003, J IMMUNOL, V171, P2797, DOI 10.4049/jimmunol.171.6.2797	48	174	180	5	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2016	352	6287							aaf4822	10.1126/science.aaf4822	http://dx.doi.org/10.1126/science.aaf4822			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5FP	27174992	Green Accepted			2022-12-28	WOS:000375663000030
J	Soliman, M; Jalal, H				Soliman, Mohamed; Jalal, Hamza			Strolling With Recovering Addicts	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SUBSTANCE USE DISORDERS; PHYSICIANS; DEPENDENCE; PREVALENCE; PROGRAMS; OPIOIDS		[Soliman, Mohamed] Weill Cornell Med Coll, New York, NY USA; [Jalal, Hamza] Univ Toronto, Dept Neurol, Toronto, ON, Canada	Cornell University; University of Toronto	Soliman, M (corresponding author), Weill Cornell Med Coll, New York, NY USA.	mos2028@med.cornell.edu						Chen JH, 2016, JAMA INTERN MED, V176, P259, DOI 10.1001/jamainternmed.2015.6662; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; DuPont RL, 2009, J SUBST ABUSE TREAT, V37, P1, DOI 10.1016/j.jsat.2009.03.010; Ferri M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005032.pub2; Hooten WM, 2015, MAYO CLIN PROC, V90, P850, DOI 10.1016/j.mayocp.2015.04.012; McLellan AT, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2038; Merlo LJ, 2010, AM J ADDICTION, V19, P529, DOI 10.1111/j.1521-0391.2010.00088.x; Oreskovich MR, 2015, AM J ADDICTION, V24, P30, DOI 10.1111/ajad.12173; Oreskovich MR, 2012, ARCH SURG-CHICAGO, V147, P168, DOI 10.1001/archsurg.2011.1481; Tsui JI, 2010, J SUBST ABUSE TREAT, V39, P378, DOI 10.1016/j.jsat.2010.06.012	10	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 10	2016	315	18					1949	1950		10.1001/jama.2016.0659	http://dx.doi.org/10.1001/jama.2016.0659			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DL2JP	27163982				2022-12-28	WOS:000375461100010
J	Bayoumi, AM; Strike, CJ				Bayoumi, Ahmed M.; Strike, Carol J.			Making the case for supervised injection services	LANCET			English	Editorial Material							FACILITIES; IMPLEMENTATION; HEALTH		[Bayoumi, Ahmed M.] St Michaels Hosp, Div Gen Internal Med, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Bayoumi, Ahmed M.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Res Inner City Hlth, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Bayoumi, Ahmed M.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Bayoumi, Ahmed M.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Strike, Carol J.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Strike, Carol J.] Ctr Addict & Mental Hlth, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Bayoumi, AM (corresponding author), St Michaels Hosp, Div Gen Internal Med, 30 Bond St, Toronto, ON M5B 1W8, Canada.; Bayoumi, AM (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Res Inner City Hlth, 30 Bond St, Toronto, ON M5B 1W8, Canada.; Bayoumi, AM (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.; Bayoumi, AM (corresponding author), Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.	ahmed.bayoumi@utoronto.ca	Strike, Carol/U-8317-2018	Strike, Carol/0000-0002-2716-3681				Agnew D, 2016, STATEMENT SUPPORTERS; Bayoumi A.M., 2012, REPORT TORONTO OTTAW; Csete J, 2016, LANCET, V387, P1427, DOI 10.1016/S0140-6736(16)00619-X; Downing M, 2005, AIDS EDUC PREV, V17, P68, DOI 10.1521/aeap.17.1.68.58688; Enns EA, 2016, ADDICTION, V111, P475, DOI 10.1111/add.13195; European Monitoring Centre for Drugs and Drug Addiction, 2015, DRUG CONS ROOMS OV P; Foderaro L.W., 2016, NY TIMES; Freiler A, 2013, J EPIDEMIOL COMMUN H, V67, P1068, DOI 10.1136/jech-2013-202731; Holland K, 2015, IRISH TIMES; Jauffret-Roustide M, 2013, INT J DRUG POLICY, V24, P628, DOI 10.1016/j.drugpo.2013.05.008; Loxton R, 2016, HERALD SCOTLAND 0208; Morgan-Trimmer S, 2014, J EPIDEMIOL COMMUN H, V68, P1010, DOI 10.1136/jech-2014-203820; NEVIUS C. W., 2016, SAN FRANCISCO CHRONI; Strike C, 2016, CATIE BLOG      0304; Strike C, 2016, SUBST ABUSE TREAT PR, V11, DOI 10.1186/s13011-016-0052-7; Watson TM, 2013, INT J DRUG POLICY, V24, P156, DOI [10.1016/j.drugpo.2012.09.003, 10.1016/j.drugpo.2013.05.005]; Wood E, 2006, CAN MED ASSOC J, V175, P1399, DOI 10.1503/cmaj.060863	17	11	11	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2016	387	10031					1890	1891						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DL1EE	27203635				2022-12-28	WOS:000375374200010
J	Ford, T; Rees, D				Ford, Tom; Rees, David			Patent ductus arteriosus illuminating an old eponym	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PULMONARY-EMBOLISM		[Ford, Tom; Rees, David] St George Hosp, Dept Cardiol, Sydney, NSW, Australia; [Ford, Tom; Rees, David] Univ New S Wales, Sch Med, Sydney, NSW, Australia	St George Hospital; University of New South Wales Sydney	Ford, T (corresponding author), St George Hosp, Dept Cardiol, Sydney, NSW, Australia.; Ford, T (corresponding author), Univ New S Wales, Sch Med, Sydney, NSW, Australia.	thomasjford@gmail.com	Ford, Tom/J-2419-2018	Ford, Tom/0000-0003-4009-6652				Bruun NE, 2014, EUR HEART J, V35, P624, DOI 10.1093/eurheartj/eht274; CAMPBELL M, 1968, BRIT HEART J, V30, P4; Hampton AO, 1940, AM J ROENTGENOL RADI, V43, P305; Hoen B, 2013, NEW ENGL J MED, V368, P1425, DOI 10.1056/NEJMcp1206782; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; LLOYD TR, 1994, AM HEART J, V127, P1664, DOI 10.1016/0002-8703(94)90415-4; Loricera J, 2015, CLIN EXP RHEUMATOL, V33, pS36; Lucassen W, 2011, ANN INTERN MED, V155, P448, DOI 10.7326/0003-4819-155-7-201110040-00007; Schneider DJ, 2006, CIRCULATION, V114, P1873, DOI 10.1161/CIRCULATIONAHA.105.592063; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367	10	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 6	2016	353								i2182	10.1136/bmj.i2182	http://dx.doi.org/10.1136/bmj.i2182			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL4AT	27154278				2022-12-28	WOS:000375575700001
J	Pande, K; Hutchison, CDM; Groenhof, G; Aquila, A; Robinson, JS; Tenboer, J; Basu, S; Boutet, S; DePonte, DP; Liang, MN; White, TA; Zatsepin, NA; Yefanov, O; Morozov, D; Oberthuer, D; Gati, C; Subramanian, G; James, D; Zhao, Y; Koralek, J; Brayshaw, J; Kupitz, C; Conrad, C; Roy-Chowdhury, S; Coe, JD; Metz, M; Xavier, PL; Grant, TD; Koglin, JE; Ketawala, G; Fromme, R; Srajer, V; Henning, R; Spence, JCH; Ourmazd, A; Schwander, P; Weierstall, U; Frank, M; Fromme, P; Barty, A; Chapman, HN; Moffat, K; van Thor, JJ; Schmidt, M				Pande, Kanupriya; Hutchison, Christopher D. M.; Groenhof, Gerrit; Aquila, Andy; Robinson, Josef S.; Tenboer, Jason; Basu, Shibom; Boutet, Sebastien; DePonte, Daniel P.; Liang, Mengning; White, Thomas A.; Zatsepin, Nadia A.; Yefanov, Oleksandr; Morozov, Dmitry; Oberthuer, Dominik; Gati, Cornelius; Subramanian, Ganesh; James, Daniel; Zhao, Yun; Koralek, Jake; Brayshaw, Jennifer; Kupitz, Christopher; Conrad, Chelsie; Roy-Chowdhury, Shatabdi; Coe, Jesse D.; Metz, Markus; Xavier, Paulraj Lourdu; Grant, Thomas D.; Koglin, Jason E.; Ketawala, Gihan; Fromme, Raimund; Srajer, Vukica; Henning, Robert; Spence, John C. H.; Ourmazd, Abbas; Schwander, Peter; Weierstall, Uwe; Frank, Matthias; Fromme, Petra; Barty, Anton; Chapman, Henry N.; Moffat, Keith; van Thor, Jasper J.; Schmidt, Marius			Femtosecond structural dynamics drives the trans/cis isomerization in photoactive yellow protein	SCIENCE			English	Article							X-RAY-DIFFRACTION; TIME; CHROMOPHORE; PHOTOCYCLE; MYOGLOBIN; PHOTOISOMERIZATION; SPECTROSCOPY; EXCITATION; PATHWAYS; MOTIONS	A variety of organisms have evolved mechanisms to detect and respond to light, in which the response is mediated by protein structural changes after photon absorption. The initial step is often the photoisomerization of a conjugated chromophore. Isomerization occurs on ultrafast time scales and is substantially influenced by the chromophore environment. Here we identify structural changes associated with the earliest steps in the trans-to-cis isomerization of the chromophore in photoactive yellow protein. Femtosecond hard x-ray pulses emitted by the Linac Coherent Light Source were used to conduct time-resolved serial femtosecond crystallography on photoactive yellow protein microcrystals over a time range from 100 femtoseconds to 3 picoseconds to determine the structural dynamics of the photoisomerization reaction.	[Pande, Kanupriya; Tenboer, Jason; Brayshaw, Jennifer; Kupitz, Christopher; Ourmazd, Abbas; Schwander, Peter; Schmidt, Marius] Univ Wisconsin, Dept Phys, Milwaukee, WI 53211 USA; [Pande, Kanupriya; Yefanov, Oleksandr; Oberthuer, Dominik; Gati, Cornelius; Metz, Markus; Xavier, Paulraj Lourdu; Barty, Anton; Chapman, Henry N.] DESY, Ctr Free Electron Laser Sci, Notkestr 85, D-22607 Hamburg, Germany; [Hutchison, Christopher D. M.; van Thor, Jasper J.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Fac Nat Sci, London SW7 2AZ, England; [Groenhof, Gerrit] Univ Jyvaskyla, Nanosci Ctr, POB 35, Jyvaskyla 40014, Finland; [Groenhof, Gerrit] Univ Jyvaskyla, Dept Chem, POB 35, Jyvaskyla 40014, Finland; [Aquila, Andy; Robinson, Josef S.; Boutet, Sebastien; DePonte, Daniel P.; Liang, Mengning; Koralek, Jake] SLAC Natl Accelerator Lab, Linac Coherent Light Source, Sand Hill Rd, Menlo Pk, CA 94025 USA; [Basu, Shibom; Conrad, Chelsie; Roy-Chowdhury, Shatabdi; Coe, Jesse D.; Ketawala, Gihan; Fromme, Raimund; Fromme, Petra] Arizona State Univ, Sch Mol Sci, Tempe, AZ 85287 USA; [Basu, Shibom; Conrad, Chelsie; Roy-Chowdhury, Shatabdi; Coe, Jesse D.; Ketawala, Gihan; Fromme, Raimund; Fromme, Petra] Arizona State Univ, Biodesign Ctr Appl Struct Discovery, Tempe, AZ 85287 USA; [Zatsepin, Nadia A.; Subramanian, Ganesh; James, Daniel; Zhao, Yun; Spence, John C. H.; Weierstall, Uwe] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Xavier, Paulraj Lourdu] Max Planck Inst Struct & Dynam Matter, IMPRS UFAST, Luruper Chaussee 149, D-22761 Hamburg, Germany; [Grant, Thomas D.] SUNY Buffalo, Hauptman Woodward Inst, 700 Ellicott St, Buffalo, NY 14203 USA; [Srajer, Vukica; Henning, Robert; Moffat, Keith] Univ Chicago, Ctr Adv Radiat Sources, Chicago, IL 60637 USA; [Frank, Matthias] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Chapman, Henry N.] Univ Hamburg, Ctr Ultrafast Imaging, Luruper Chaussee 149, D-22761 Hamburg, Germany; [Moffat, Keith] Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA; [Moffat, Keith] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA	University of Wisconsin System; University of Wisconsin Milwaukee; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Imperial College London; University of Jyvaskyla; University of Jyvaskyla; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Max Planck Society; Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Chicago; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Hamburg; University of Chicago; University of Chicago	Schmidt, M (corresponding author), Univ Wisconsin, Dept Phys, Milwaukee, WI 53211 USA.	m-schmidt@uwm.edu	Fromme, Raimund/C-8885-2012; FRS, Henry N Chapman/G-2153-2010; Grant, Thomas/T-2921-2019; Oberthuer, Dominik/AAG-5059-2021; Fromme, Raimund/W-5838-2019; Morozov, Dmitry/Q-2433-2017; Zatsepin, Nadia/AAF-2451-2019; Xavier, P. Lourdu/T-8283-2017; Schmidt, Marius/A-1537-2014; Basu, Shibom/GLU-3308-2022; Fromme, Raimund/AAG-6578-2019; Grant, Thomas/GXH-9990-2022; Barty, Anton/K-5137-2014	Fromme, Raimund/0000-0003-4835-1080; FRS, Henry N Chapman/0000-0002-4655-1743; Grant, Thomas/0000-0002-8583-3700; Oberthuer, Dominik/0000-0002-0894-9590; Fromme, Raimund/0000-0003-4835-1080; Morozov, Dmitry/0000-0001-9524-948X; Xavier, P. Lourdu/0000-0001-5132-2999; Schmidt, Marius/0000-0002-0962-9468; Basu, Shibom/0000-0001-6484-8236; Grant, Thomas/0000-0002-8583-3700; Barty, Anton/0000-0003-4751-2727; James, Daniel/0000-0002-8348-6661; Zatsepin, Nadia/0000-0003-1757-0205; Yefanov, Oleksandr/0000-0001-8676-0091; Koralek, Jake/0000-0001-8289-0497; Groenhof, Gerrit/0000-0001-8148-5334; White, Thomas/0000-0002-8407-0270; Fromme, Petra/0000-0003-0953-4909; Frank, Matthias/0000-0002-5244-0791	NSF Science and Technology Center BioXFEL [NSF-1231306]; NIH [R01GM095583, R01EY024363, R24GM111072, P41GM103393, P41RR001209]; Helmholtz Association Virtual Institute Dynamic Pathways; Federal Ministry of Education and Research, Germany (BMBF) [05K14CHA]; Engineering and Physical Sciences Research Council [EP/M000192/1]; Academy of Finland; BMBF project [05K13GUK]; European Union [FP7-PEOPLE-2011-ITN NanoMem]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; U.S. Department of Energy by Lawrence Livermore National Laboratory (LLNL) [DE-AC52-07NA27344]; LLNL Lab-Directed Research and Development Project [012-ERD-031]; PIER Helmholtz Graduate School;  [NSF-0952643];  [NSF-1158138]; EPSRC [EP/M000192/1] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR007707, P41RR001209] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY024363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM111072, P41GM103393, R01GM095583] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1330809] Funding Source: National Science Foundation	NSF Science and Technology Center BioXFEL; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helmholtz Association Virtual Institute Dynamic Pathways; Federal Ministry of Education and Research, Germany (BMBF)(Federal Ministry of Education & Research (BMBF)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Academy of Finland(Academy of Finland); BMBF project(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); U.S. Department of Energy by Lawrence Livermore National Laboratory (LLNL)(United States Department of Energy (DOE)); LLNL Lab-Directed Research and Development Project; PIER Helmholtz Graduate School; ; ; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work is supported by the NSF Science and Technology Center BioXFEL (grant NSF-1231306); by NIH grants R01GM095583 (P.F.), R01EY024363 (K.M.), and R24GM111072 (V.S., R.H., and K.M.); Helmholtz Association Virtual Institute Dynamic Pathways (H.C.); and grant NSF-0952643 (M.S.). K.P. is partly supported by grant NSF-1158138 (to D. Saldin and M.S.) and Federal Ministry of Education and Research, Germany (BMBF) grant 05K14CHA (to H.C.). J.J.v.T. acknowledges support from the Engineering and Physical Sciences Research Council via grant agreement EP/M000192/1. G.G. and D.M. are supported by the Academy of Finland, D.O. by BMBF project 05K13GUK, and M.M. by the European Union through grant FP7-PEOPLE-2011-ITN NanoMem. Use of the LCLS, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-76SF00515. Part of this work was performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory (LLNL) under contract DE-AC52-07NA27344, and M.F. was supported by LLNL Lab-Directed Research and Development Project 012-ERD-031. C.G. thanks the PIER Helmholtz Graduate School for financial support. Parts of the sample injector used at LCLS for this research were funded by NIH grant P41GM103393, formerly P41RR001209. We thank the Moscow State University supercomputing center and the Finnish IT Center for Science (CSC-IT) Center for Science, Finland, for computing resources. We thank M. Hunter for valuable discussions, T. Graen for help with the computer simulations, and C. Li for assistance with injectors. The PYP<INF>ref</INF>, PYP<INF>fast</INF>, PYP<INF>slow</INF>, PYP<INF>3ps</INF>, and PYP<INF>200ns</INF> structures are deposited in the Protein Data Bank together with their respective weighted difference structure factor amplitudes under accession codes 5HD3, 5HDC, 5HDD, 5HDS, and 5HD5, respectively. M.S. prepared the proposal with input from J.J.vT., K.M., V.S., J.C.H.S., H.N.C., A.O., and P.F.; A.A., S.B., M.L., J.S.R., and J.E.K. operated the CXI instrument, including the time tool and the femtosecond laser; and K.P., A.B., J.T., S.B., T.A.W., N.Z., O.Y., and T.D.G. analyzed the SFX data. C.D.M.H and J.J.vT. set up the FROG at the CXI instrument; G.G. and D.M. performed QM/MM calculations; J.T., J.B., D.O., P.L.X., C.G., C.K., and M.S. prepared protein and grew nano-and microcrystals; D.DeP., C.K., C.C., S.R.-C., J.D.C., M.M., G.K., and U.W. provided and operated the injector system; M.F., R.F., M.S., J.T., P.F., D.O., and C.G. wrote the electronic log; M.F., M.S, J.T., J.S.R., J.J.vT., and K.M. discussed femtosecond laser excitation; J.T., M.S, V.S, R.H, C. D.M.H., and J.J.vT. performed preliminary ultrafast experiments on crystals; M.S. calculated and analyzed the difference maps; and M.S., K.P., K.M., G.G., P.F., and J.J.vT. wrote the manuscript, with improvements from all authors.	Anderson S, 2004, ACTA CRYSTALLOGR D, V60, P1008, DOI 10.1107/S090744490400616X; Arnlund D, 2014, NAT METHODS, V11, P923, DOI [10.1038/nmeth.3067, 10.1038/NMETH.3067]; BARDEEN CJ, 1995, PHYS REV LETT, V75, P3410, DOI 10.1103/PhysRevLett.75.3410; Barends TRM, 2015, SCIENCE, V350, P445, DOI 10.1126/science.aac5492; Benedict JB, 2011, CHEM COMMUN, V47, P1704, DOI 10.1039/c0cc04997b; Bionta MR, 2011, OPT EXPRESS, V19, P21855, DOI 10.1364/OE.19.021855; Champion PM, 2005, SCIENCE, V310, P980, DOI 10.1126/science.1120280; Coppens P., 2015, STRUCT DYN, V2; Creelman M, 2014, J PHYS CHEM B, V118, P659, DOI 10.1021/jp408584v; Devanathan S, 1999, BIOPHYS J, V77, P1017, DOI 10.1016/S0006-3495(99)76952-3; Gao M, 2013, NATURE, V496, P343, DOI 10.1038/nature12044; GENBERG L, 1991, SCIENCE, V251, P1051, DOI 10.1126/science.1998121; Glownia JM, 2010, OPT EXPRESS, V18, P17620, DOI 10.1364/OE.18.017620; Groenhof G, 2004, J AM CHEM SOC, V126, P4228, DOI 10.1021/ja039557f; Groenhof G., 2012, METHOD MOL BIOL, V924, P43; Groot ML, 2003, BIOCHEMISTRY-US, V42, P10054, DOI 10.1021/bi034878p; Hartmann N, 2014, NAT PHOTONICS, V8, P706, DOI [10.1038/nphoton.2014.164, 10.1038/NPHOTON.2014.164]; Heyne K, 2005, J AM CHEM SOC, V127, P18100, DOI 10.1021/ja051210k; Ihee H, 2005, P NATL ACAD SCI USA, V102, P7145, DOI 10.1073/pnas.0409035102; Ihee H, 2005, SCIENCE, V309, P1223, DOI [10.1126/science.1114782, 10.1126/scheme.1114782]; Jung YO, 2013, NAT CHEM, V5, P212, DOI [10.1038/NCHEM.1565, 10.1038/nchem.1565]; Kim CD, 2002, ACTA CRYSTALLOGR A, V58, P133, DOI 10.1107/S0108767301017986; Kumar ATN, 2001, J CHEM PHYS, V114, P6795, DOI 10.1063/1.1356011; Larsen DS, 2004, BIOPHYS J, V86, P2538, DOI 10.1016/S0006-3495(04)74309-X; Larsen DS, 2004, BIOPHYS J, V87, P1858, DOI 10.1529/biophysj.104.043794; Levantino M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7772; Liang MN, 2015, J SYNCHROTRON RADIAT, V22, P514, DOI 10.1107/S160057751500449X; Lincoln CN, 2012, PHYS CHEM CHEM PHYS, V14, P15752, DOI 10.1039/c2cp41718a; Mataga N, 2002, CHEM PHYS LETT, V352, P220, DOI 10.1016/S0009-2614(01)01448-8; Minitti MP, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.255501; Mizutani Y, 1997, SCIENCE, V278, P443, DOI 10.1126/science.278.5337.443; Nakamura R, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2802297; Neutze R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.195508; PATRON F, 1991, CHEM PHYS, V152, P121, DOI 10.1016/0301-0104(91)80039-K; Rector KD, 1999, LASER CHEM, V19, P19, DOI 10.1155/1999/83895; Rief M, 2002, CHEMPHYSCHEM, V3, P255, DOI 10.1002/1439-7641(20020315)3:3<255::AID-CPHC255>3.0.CO;2-M; Schmidt M, 2003, BIOPHYS J, V84, P2112, DOI 10.1016/S0006-3495(03)75018-8; Schmidt M, 2013, ACTA CRYSTALLOGR D, V69, P2534, DOI 10.1107/S0907444913025997; Schotte F, 2012, P NATL ACAD SCI USA, V109, P19256, DOI 10.1073/pnas.1210938109; Techert S, 2001, PHYS REV LETT, V86, P2030, DOI 10.1103/PhysRevLett.86.2030; Tenboer J, 2014, SCIENCE, V346, P1242, DOI 10.1126/science.1259357; Trebino R, 1997, REV SCI INSTRUM, V68, P3277, DOI 10.1063/1.1148286; van Wilderen LJGW, 2006, P NATL ACAD SCI USA, V103, P15050, DOI 10.1073/pnas.0603476103; Vengris M, 2004, BIOPHYS J, V87, P1848, DOI 10.1529/biophysj.104.043224; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230; WARSHEL A, 1976, NATURE, V260, P679, DOI 10.1038/260679a0; Zewail AH, 2000, ANGEW CHEM INT EDIT, V39, P2587	47	275	277	4	215	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2016	352	6286					725	729		10.1126/science.aad5081	http://dx.doi.org/10.1126/science.aad5081			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL1UC	27151871	Green Accepted, Green Submitted			2022-12-28	WOS:000375417100042
J	Rimmer, A				Rimmer, Abi			Government will pause introduction of junior doctor contract for five days	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 5	2016	353								i2572	10.1136/bmj.i2572	http://dx.doi.org/10.1136/bmj.i2572			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL4AS	27150357				2022-12-28	WOS:000375575600015
J	Roland, M				Roland, Martin			Does pay-for-performance in primary care save lives?	LANCET			English	Editorial Material							CORONARY-HEART-DISEASE; UNITED-KINGDOM; QUALITY; INCENTIVES; MORTALITY; TRENDS		[Roland, Martin] Univ Cambridge, Inst Publ Hlth, Publ Hlth & Primary Care, Cambridge CB2 8PN, England	University of Cambridge	Roland, M (corresponding author), Univ Cambridge, Inst Publ Hlth, Publ Hlth & Primary Care, Cambridge CB2 8PN, England.	mr108@cam.ac.uk		Roland, Martin/0000-0002-8533-3060				Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; Doran T, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3590; Eijkenaar F, 2013, HEALTH POLICY, V110, P115, DOI 10.1016/j.healthpol.2013.01.008; Gray DP, 2003, MED EDUC, V37, P754, DOI 10.1046/j.1365-2923.2003.01602.x; Guzman-Castillo M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006070; Hotchkiss JW, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1088; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; Roland M, 2015, HEALTH SERV RES, V50, P2090, DOI 10.1111/1475-6773.12419; Roland M, 2014, NEW ENGL J MED, V370, P1944, DOI 10.1056/NEJMhpr1316051; Ryan AM, 2016, LANCET	11	7	7	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2016	388	10041					217	+		10.1016/S0140-6736(16)00550-X	http://dx.doi.org/10.1016/S0140-6736(16)00550-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DR2LN	27207745				2022-12-28	WOS:000379736100007
J	Greenwood, JP; Herzog, BA; Brown, JM; Everett, CC; Nixon, J; Bijsterveld, P; Maredia, N; Motwani, M; Dickinson, CJ; Ball, SG; Plein, S				Greenwood, John P.; Herzog, Bernhard A.; Brown, Julia M.; Everett, Colin C.; Nixon, Jane; Bijsterveld, Petra; Maredia, Neil; Motwani, Manish; Dickinson, Catherine J.; Ball, Stephen G.; Plein, Sven			Prognostic Value of Cardiovascular Magnetic Resonance and Single-Photon Emission Computed Tomography in Suspected Coronary Heart Disease: Long-Term Follow-up of a Prospective, Diagnostic Accuracy Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							MYOCARDIAL-PERFUSION ASSESSMENT; ARTERY-DISEASE; MR-IMPACT; TC-99M-TETROFOSMIN SPECT; STRESS PERFUSION; NORMAL EXERCISE; CE-MARC; RISK; TRIAL; MULTICENTER	Background: There are no prospective, prognostic data comparing cardiovascular magnetic resonance (CMR) and single-photon emission computed tomography (SPECT) in the same population of patients with suspected coronary heart disease (CHD). Objective: To establish the ability of CMR and SPECT to predict major adverse cardiovascular events (MACEs). Design: Annual follow-up of the CE-MARC (Clinical Evaluation of MAgnetic Resonance imaging in Coronary heart disease) study for a minimum of 5 years for MACEs (cardiovascular death, acute coronary syndrome, unscheduled revascularization or hospital admission for cardiovascular cause). (Current Controlled Trials registration: ISRCTN77246133) Setting: Secondary and tertiary care cardiology services. Participants: 752 patients from the CE-MARC study who were being investigated for suspected CHD. Measurements: Prediction of time to MACE was assessed by using univariable (log-rank test) and multivariable (Cox proportional hazards regression) analysis. Results: 744 (99%) of the 752 recruited patients had complete follow-up. Of 628 who underwent CMR, SPECT, and the reference standard test of X-ray angiography, 104 (16.6%) had at least 1 MACE. Abnormal findings on CMR (hazard ratio, 2.77 [95% CI, 1.85 to 4.16]; P < 0.001) and SPECT (hazard ratio, 1.62 [CI, 1.11 to 2.38; P = 0.014) were both strong and independent predictors of MACE. Only CMR remained a significant predictor after adjustment for other cardiovascular risk factors, angiography result, or stratification for initial patient treatment. Limitation: Data are from a single-center observational study (albeit conducted in a high-volume institution for both CMR and SPECT). Conclusion: Five-year follow-up of the CE-MARC study indicates that compared with SPECT, CMR is a stronger predictor of risk for MACEs, independent of cardiovascular risk factors, angiography result, or initial patient treatment. This further supports the role of CMR as an alternative to SPECT for the diagnosis and management of patients with suspected CHD.	[Greenwood, John P.; Motwani, Manish; Ball, Stephen G.; Plein, Sven] Univ Leeds, Multidisciplinary Cardiovasc Res Ctr, LIGHT Bldg,Clarendon Way, Leeds LS2 9JT, W Yorkshire, England; [Greenwood, John P.; Motwani, Manish; Ball, Stephen G.; Plein, Sven] Univ Leeds, Leeds Inst Cardiovasc & Metab Med, LIGHT Bldg,Clarendon Way, Leeds LS2 9JT, W Yorkshire, England; [Herzog, Bernhard A.] Heart Clin Lucerne, St Anna Str 32, CH-6006 Luzern, Switzerland; [Brown, Julia M.; Everett, Colin C.; Nixon, Jane] Univ Leeds, Clin Trials Res Unit, Leeds Inst Clin Trials Res, Clarendon Rd, Leeds LS2 9JT, W Yorkshire, England; [Bijsterveld, Petra; Dickinson, Catherine J.] Leeds Gen Infirm, Dept Cardiol, Old X39,Main Site,Great George St, Leeds LS1 3EX, W Yorkshire, England; [Maredia, Neil] James Cook Univ Hosp, Marton Rd, Middlesbrough TS4 3BW, Cleveland, England	University of Leeds; University of Leeds; University of Leeds; Leeds General Infirmary; University of Leeds; James Cook University Hospital	Greenwood, JP (corresponding author), Univ Leeds, Multidisciplinary Cardiovasc Res Ctr, LIGHT Bldg,Clarendon Way, Leeds LS2 9JT, W Yorkshire, England.; Greenwood, JP (corresponding author), Univ Leeds, Leeds Inst Cardiovasc & Metab Med, LIGHT Bldg,Clarendon Way, Leeds LS2 9JT, W Yorkshire, England.	j.greenwood@leeds.ac.uk		brown, julia/0000-0002-2719-7064; Bijsterveld, Petra/0000-0002-9257-5850; Plein, Sven/0000-0002-0997-4384	British Heart Foundation; British Heart Foundation [FS/10/62/28409] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	British Heart Foundation.	Berman DS, 2003, J AM COLL CARDIOL, V41, P1125, DOI 10.1016/S0735-1097(03)00085-8; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cuocolo A, 2011, EUR J NUCL MED MOL I, V38, P1887, DOI 10.1007/s00259-011-1898-6; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Elhendy A, 2003, J NUCL CARDIOL, V10, P261, DOI 10.1016/S1071-3581(02)43219-9; Fleischmann S, 2004, J NUCL MED, V45, P754; Genders TSS, 2011, EUR HEART J, V32, P1316, DOI 10.1093/eurheartj/ehr014; Germano G, 2007, J NUCL CARDIOL, V14, P25, DOI 10.1016/j.nuclcard.2006.12.317; Gibbons RJ, 1999, CIRCULATION, V100, P2140, DOI 10.1161/01.CIR.100.21.2140; Greenwood JP, 2014, CIRCULATION, V129, P1129, DOI 10.1161/CIRCULATIONAHA.112.000071; Greenwood JP, 2012, LANCET, V379, P453, DOI 10.1016/S0140-6736(11)61335-4; Greenwood JP, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-62; Hachamovitch R, 1998, CIRCULATION, V97, P535; Hachamovitch R, 1996, J AM COLL CARDIOL, V28, P34, DOI 10.1016/0735-1097(96)00095-2; Hachamovitch R, 2011, EUR HEART J, V32, P1012, DOI 10.1093/eurheartj/ehq500; Hansen CL, 2007, J NUCL CARDIOL, V14, P134, DOI 10.1016/j.nuclcard.2006.11.009; HELLER GV, 1995, J AM COLL CARDIOL, V26, P1202, DOI 10.1016/0735-1097(95)00329-0; Hesse B, 2005, EUR J NUCL MED MOL I, V32, P855, DOI 10.1007/s00259-005-1779-y; Holly TA, 2010, J NUCL CARDIOL, V17, P941, DOI 10.1007/s12350-010-9246-y; Hundley WG, 2002, CIRCULATION, V106, P2328, DOI 10.1161/01.CIR.0000036017.46437.02; Iskander S, 1998, J AM COLL CARDIOL, V32, P57, DOI 10.1016/S0735-1097(98)00177-6; Jaarsma C, 2012, J AM COLL CARDIOL, V59, P1719, DOI 10.1016/j.jacc.2011.12.040; Jahnke C, 2007, CIRCULATION, V115, P1769, DOI 10.1161/CIRCULATIONAHA.106.652016; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; Kim WY, 2001, NEW ENGL J MED, V345, P1863, DOI 10.1056/NEJMoa010866; Klem I, 2006, J AM COLL CARDIOL, V47, P1630, DOI 10.1016/j.jacc.2005.10.074; Kwong RY, 2006, CIRCULATION, V113, P2733, DOI 10.1161/CIRCULATIONAHA.105.570648; Lipinski MJ, 2013, J AM COLL CARDIOL, V62, P826, DOI 10.1016/j.jacc.2013.03.080; Schwitter J, 2008, EUR HEART J, V29, P480, DOI 10.1093/eurheartj/ehm617; Schwitter J, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-61; Schwitter J, 2013, EUR HEART J, V34, P775, DOI 10.1093/eurheartj/ehs022; Shaw LJ, 2000, AM J CARDIOL, V86, P1, DOI 10.1016/S0002-9149(00)00819-5; Shaw LJ, 2004, J NUCL CARDIOL, V11, P171, DOI 10.1016/j.nuclcard.2003.12.004; Shaw LJ, 2003, J NUCL MED, V44, P134; Steel K, 2009, CIRCULATION, V120, P1390, DOI 10.1161/CIRCULATIONAHA.108.812503; Travin MI, 2004, J NUCL CARDIOL, V11, P253, DOI 10.1016/j.nuclcard.2004.02.005; Wagner A, 2003, LANCET, V361, P374, DOI 10.1016/S0140-6736(03)12389-6	37	62	63	1	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2016	165	1					1	+		10.7326/M15-1801	http://dx.doi.org/10.7326/M15-1801			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ5AD	27158921	Green Accepted			2022-12-28	WOS:000379215800002
J	Gates, M				Gates, Melinda			Advancing the adolescent health agenda	LANCET			English	Editorial Material									[Gates, Melinda] Bill & Melinda Gates Fdn, Seattle, WA 98109 USA	Bill & Melinda Gates Foundation	Gates, M (corresponding author), Bill & Melinda Gates Fdn, Seattle, WA 98109 USA.	clarissa.brundage@gatesfoundation.org						Buvinic M., 2014, MAPPING GENDER DATA; Every Woman Every Child, 2015, GLOBAL STRATEGY WOME; Gates MF, 2014, SCIENCE, V345, P1273, DOI 10.1126/science.1258882; Hendriks S, 2016, WORLD REALY CAN ELIM; Patton GC, 2016, LANCET; UN, 2015, SUSTAINABLE DEV GOAL; UNAIDS, 2014, THE GAP REP; UNFPA, 2014, STATE WORLD POPULATI, DOI DOI 10.18356/281344F5-EN	8	16	16	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 11	2016	387	10036					2358	2359		10.1016/S0140-6736(16)30298-7	http://dx.doi.org/10.1016/S0140-6736(16)30298-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DO1ST	27174308				2022-12-28	WOS:000377560100008
J	Torjesen, I				Torjesen, Ingrid			"Corrupt" dietary guidelines must be rewritten to tackle obesity and diabetes, report warns	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Public Health Collaboration National Obesity Forum], 2016, EAT FAT CUT CARBS AV	1	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 23	2016	353								i2898	10.1136/bmj.i2898	http://dx.doi.org/10.1136/bmj.i2898			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3BM	27216313				2022-12-28	WOS:000376937200005
J	Rogge, P; Regier, E				Rogge, Paul; Regier, Emily			A problem by any other name	SCIENCE			English	Editorial Material												SciCareerEditor@aaas.org							0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2016	352	6288			SI		1022	1022		10.1126/science.352.6288.1022	http://dx.doi.org/10.1126/science.352.6288.1022			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM2AK	27199433				2022-12-28	WOS:000376147800054
J	Wise, J				Wise, Jacqui			24/7 NHS The weekend effect-how strong is the evidence?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MORTALITY					jacquiyoung1@gmail.com						*AC MED ROY COLL, 2012, 7 DAY CONS PRES CAR; Academy of Medical Royal Colleges, 2012, BEN CONS DEL CAR; Aiken LH, 2014, LANCET, V383, P1824, DOI 10.1016/S0140-6736(13)62631-8; ALDRIDGE, 2016, LANCET, DOI DOI 10.1016/S0140-6736(16)30442-1; [Anonymous], COMMUNICATION; AYLIN, 2010, BMJ QUAL SAF, V19, P182, DOI DOI 10.1136/QSHC.2008.028639; AYLIN, 2013, BMJ-BRIT MED J, V346; Ding Ding, LANCET, V388, P1311, DOI [10.1016/S0140-6736(16)30383-X, DOI 10.1016/S0140-6736(16)30383-X]; *E MIDL CLIN SEN, 2014, 7 DAY SERV PROJ AC C; FREEMANTLE, 2012, JOURNAL OF ROYAL SOC, V105, P74, DOI DOI 10.1258/JRSM.2012.120009; Freemantle N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4596; Li Linxin, 2016, BMJ, V353, pi2648, DOI 10.1136/bmj.i2648; MEACOCK, 2016, JOURNAL OF HEALTH SE, DOI DOI 10.1177/1355819616649630; MICKULICH, 2011, ACUTE MED, V10, P182; *NHS ENGL, 2013, NHS SERV 7 DAYS WEEK; OZDEMIR, 2015, BRIT J ANAESTH, V116, P54, DOI DOI 10.1093/BJA/AEV372; PALMER, 2012, ARCH NEUROL-CHICAGO, V69, P1296; Palmer William L, 2015, BMJ, V351, ph5774, DOI 10.1136/bmj.h5774; RUIS M, 2016, BMJ QUALITY AND SAFE, V25, P337, DOI DOI 10.1136/BMJQS-2015-004105; Ruiz M, 2015, BMJ QUAL SAF, V24, P492, DOI 10.1136/bmjqs-2014-003467; Temple J., 2010, TIME FOR TRAINING	21	12	12	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2016	353								i2781	10.1136/bmj.i2781	http://dx.doi.org/10.1136/bmj.i2781			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GD	27199275				2022-12-28	WOS:000376447700004
J	[Anonymous]				[Anonymous]			Transit time	NATURE			English	Editorial Material																			0	1	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					S120	S103		10.1038/533S102a	http://dx.doi.org/10.1038/533S102a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VH2UC	27191485	Bronze			2022-12-28	WOS:000452214700001
J	Manaker, S				Manaker, Scott			The Reality of ICD-10 in the Office RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter							INTERNATIONAL CLASSIFICATION		[Manaker, Scott] Hosp Univ Penn, 3400 Spruce St, Philadelphia, PA 19104 USA; [Manaker, Scott] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Manaker, S (corresponding author), Hosp Univ Penn, 3400 Spruce St, Philadelphia, PA 19104 USA.; Manaker, S (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.							Centers for Disease Control and Prevention, 2015, ICD 10 COORD MAINT C; Ghofrani HA, 2013, NEW ENGL J MED, V369, P319, DOI 10.1056/NEJMoa1209657; Manaker S, 2015, ANN INTERN MED, V163, P557, DOI 10.7326/M15-1773; National Asthma Education and Prevention Program National Heart Lung and Blood Institute, 2007, NIH PUBL; Outland B, 2015, ANN INTERN MED, V163, P554, DOI 10.7326/M15-1933	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2016	164	10					700	701		10.7326/L15-0585	http://dx.doi.org/10.7326/L15-0585			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8GF	27182907				2022-12-28	WOS:000375878500023
J	Khanna, D; Denton, CP; Merkel, PA; Krieg, T; Le Brun, FO; Marr, A; Papadakis, K; Pope, J; Matucci-Cerinic, M; Furst, DE				Khanna, Dinesh; Denton, Christopher P.; Merkel, Peter A.; Krieg, Thomas; Le Brun, Franck-Olivier; Marr, Angelina; Papadakis, Kelly; Pope, Janet; Matucci-Cerinic, Marco; Furst, Daniel E.		Dual-1 Dual-2 Investigators	Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis DUAL-1 and DUAL-2 Randomized Clinical Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLASMA ENDOTHELIN-1 LEVELS; EULAR SCLERODERMA TRIALS; HEALTH-ASSESSMENT QUESTIONNAIRE; FIBROSIS; BOSENTAN; RECOMMENDATIONS; PREVENTION; SUBSETS; HISTORY	IMPORTANCE Digital ulcers in patients with systemic sclerosis are associated with pain and poor quality of life. Endothelin-1 promotes vasculopathy in systemic sclerosis after macitentan, an endothelin-1 blocker. OBJECTIVE To evaluate the efficacy of macitentan in reducing the number of new digital ulcers in patients with systemic sclerosis. DESIGN, SETTING, AND PARTICIPANTS Two international, randomized, double-blind, placebo-controlled trials (DUAL-1, DUAL-2) were conducted between January 2012 and February 2014. Participants were patients with systemic sclerosis and active digital ulcers at baseline. Target enrollment for each study was 285 patients. INTERVENTIONS Patients were randomized (1: 1: 1) to receive oral doses of 3 mg of macitentan, 10mg of macitentan, or placebo once daily and stratified according to number of digital ulcers at baseline (<= 3 or >3). MAIN OUTCOMES AND MEASURES The primary outcome for each trial was the cumulative number of new digital ulcers from baseline to week 16. Treatment effect was expressed as the ratio between treatment groups. RESULTS In DUAL-1, among 289 randomized patients (mean age 51.2 years; 85.8% women), 226 completed the study. The adjusted mean number of new digital ulcers per patient over 16 weeks was 0.94 in the 3-mg macitentan group (n = 95) and 1.08 in the 10-mg macitentan group (n = 97) compared with 0.85 in the placebo group (n = 97) (absolute difference, 0.09 [95% CI, -0.37 to 0.54] for 3mg of macitentan vs placebo and 0.23 [-0.27 to 0.72] for 10mg of macitentan vs placebo). Among 265 patients randomized in DUAL-2 (mean age 49.6 years; 81.9% women), 216 completed the study. In DUAL-2, the adjusted mean number of new digital ulcers was 1.44 in the 3-mg macitentan group (n = 88) and 1.46 in the 10-mg macitentan group (n = 88) compared with 1.21 in the placebo group (n = 89) (absolute difference, 0.23 [95% CI, -0.35 to 0.82] for 3mg of macitentan vs placebo and 0.25 [95% CI, -0.34 to 0.84] for 10mg of macitentan vs placebo). Adverse events more frequently associated with macitentan than with placebo were headache, peripheral edema, skin ulcer, anemia, upper respiratory tract infection, diarrhea, and nasopharyngitis. CONCLUSIONS AND RELEVANCE Among patients with systemic sclerosis and active ischemic digital ulcers, treatment with macitentan did not reduce new digital ulcers over 16 weeks. These results do not support the use of macitentan for the treatment of digital ulcers in this patient population.	[Khanna, Dinesh] Univ Michigan, Dept Internal Med, Scleroderma Program, Ann Arbor, MI 48109 USA; [Denton, Christopher P.] Royal Free Hosp, Ctr Rheumatol & Connect Tissue Dis, Pond St, London NW3 2QG, England; [Merkel, Peter A.] Univ Penn, Div Rheumatol, Philadelphia, PA 19104 USA; [Krieg, Thomas] Univ Cologne, Dept Dermatol, Cologne, Germany; [Le Brun, Franck-Olivier; Marr, Angelina; Papadakis, Kelly] Actel Pharmaceut Ltd, Allschwil, Switzerland; [Pope, Janet] Univ Western Ontario, Dept Med, Div Rheumatol, London, ON, Canada; [Matucci-Cerinic, Marco] Univ Florence, AOUC, Div Rheumatol, Dept Expt & Clin Med, Florence, Italy; [Furst, Daniel E.] Univ Calif Los Angeles, Div Rheumatol, Los Angeles, CA USA	University of Michigan System; University of Michigan; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Pennsylvania; University of Cologne; Actelion Pharmaceuticals Ltd; Western University (University of Western Ontario); University of Florence; Azienda Ospedaliero Universitaria Careggi; University of California System; University of California Los Angeles	Khanna, D (corresponding author), Univ Michigan, Scleroderma Program, Div Rheumatol, Dept Internal Med, Ste 7C27,300 N Ingalls St,SPC 5422, Ann Arbor, MI 48109 USA.	khannad@med.umich.edu	Lesnyak, Olga M/J-5512-2013; CERINIC, marco MATUCCI/AAO-2769-2020; Batalov, Anastas/J-4921-2019; Belch, Jill/AAE-9189-2019; Vonk, M.C./L-4726-2015; Mikhailova, Elena/AAC-5722-2021; Riemekasten, Gabriela/B-5019-2017; Pope, Janet/G-3342-2011; Petrov, Andriy/P-5280-2015; Oleynikov, V/Q-3648-2017; Chopyak, Valentyna/I-7863-2018; Kaidashev, Igor/L-2606-2019; danda, debashish/AAH-1775-2020; Grunina, Elena/C-8694-2018; Stanislavchuk, Mykola/C-6966-2017; Becvar, Radim/N-6582-2017	Lesnyak, Olga M/0000-0002-0143-0614; Batalov, Anastas/0000-0001-8857-0574; Belch, Jill/0000-0001-8280-6689; Vonk, M.C./0000-0002-2266-9907; Mikhailova, Elena/0000-0001-9716-4009; Pope, Janet/0000-0003-1479-5302; Petrov, Andriy/0000-0002-6398-2545; Oleynikov, V/0000-0002-7463-9259; Chopyak, Valentyna/0000-0003-3127-2028; Kaidashev, Igor/0000-0002-4708-0859; danda, debashish/0000-0002-2121-0942; Birlik, Merih/0000-0001-5118-9307; Novak, Srdan/0000-0001-8870-4704; Ferraccioli, Gianfranco/0000-0002-6884-4301; Grunina, Elena/0000-0002-2196-4592; Veale, Douglas/0000-0003-2802-4971; Szepietowski, Jacek/0000-0003-0766-6342; Zwolak, Robert/0000-0002-5160-6390; Wiland, Piotr/0000-0001-9999-0267; Pacheco-Tena, Cesar/0000-0002-0793-8988; Kovalenko, Volodymyr/0000-0003-3802-9207; Anic, Branimir/0000-0003-4940-0577; Martin, Richard/0000-0002-0411-7519; Stanislavchuk, Mykola/0000-0001-8160-8189; Becvar, Radim/0000-0003-0022-3135				Amanzi L, 2010, RHEUMATOLOGY, V49, P1374, DOI 10.1093/rheumatology/keq097; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Bruce B, 2003, J RHEUMATOL, V30, P167; Denton CP, 2012, ANN RHEUM DIS, V71, P718, DOI 10.1136/annrheumdis-2011-200631; Distler JHW, 2009, ANN RHEUM DIS, V68, P163, DOI 10.1136/ard.2008.091918; Gatfield J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047662; Guillevin L, 2013, CLIN EXP RHEUMATOL, V31, pS71; Hachulla E, 2007, J RHEUMATOL, V34, P2423; Hachulla E, 2016, ANN RHEUM DIS, V75, P1009, DOI 10.1136/annrheumdis-2014-207001; Herrick AL, 2009, ARTHRITIS RHEUM, V60, P878, DOI 10.1002/art.24333; Hilbe J., 2011, NEGATIVE BINOMIAL RE; Iglarz M, 2008, J PHARMACOL EXP THER, V327, P736, DOI 10.1124/jpet.108.142976; Iglarz M, 2015, J CARDIOVASC PHARM, V66, P457, DOI 10.1097/FJC.0000000000000296; Kim HS, 2010, CLIN RHEUMATOL, V29, P247, DOI 10.1007/s10067-009-1288-7; KNOCK GA, 1993, J INVEST DERMATOL, V101, P73, DOI 10.1111/1523-1747.ep12360103; Korn JH, 2004, ARTHRITIS RHEUM-US, V50, P3985, DOI 10.1002/art.20676; Kowal-Bielecka O, 2009, ANN RHEUM DIS, V68, P620, DOI 10.1136/ard.2008.096677; LEROY EC, 1988, J RHEUMATOL, V15, P202; Matucci-Cerinic M, 2008, RHEUMATOLOGY, V47, pV46, DOI 10.1093/rheumatology/ken310; Matucci-Cerinic M, 2013, ARTHRITIS RHEUM-US, V65, P1953, DOI 10.1002/art.37988; Matucci-Cerinic M, 2011, ANN RHEUM DIS, V70, P32, DOI 10.1136/ard.2010.130658; MORELLI S, 1995, AM J MED, V99, P255, DOI 10.1016/S0002-9343(99)80157-0; Pulido T, 2013, NEW ENGL J MED, V369, P809, DOI 10.1056/NEJMoa1213917; Raghu G, 2013, EUR RESPIR J, V42, P1622, DOI 10.1183/09031936.00104612; Steen V, 2009, RHEUMATOLOGY, V48, P19, DOI 10.1093/rheumatology/kep105; Steen VD, 1997, ARTHRITIS RHEUM, V40, P1984, DOI 10.1002/art.1780401110; Tingey T, 2013, ARTHRIT CARE RES, V65, P1460, DOI 10.1002/acr.22018; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; VANCHEESWARAN R, 1994, J RHEUMATOL, V21, P1838; Walker KM, 2012, SEMIN ARTHRITIS RHEU, V42, P42, DOI 10.1016/j.semarthrit.2012.01.003; Walker UA, 2007, ANN RHEUM DIS, V66, P754, DOI 10.1136/ard.2006.062901; YAMANE K, 1992, J RHEUMATOL, V19, P1566	32	70	72	2	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 10	2016	315	18					1975	1988		10.1001/jama.2016.5258	http://dx.doi.org/10.1001/jama.2016.5258			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2JP	27163986	Bronze, Green Published			2022-12-28	WOS:000375461100015
J	Weavers, H; Evans, IR; Martin, P; Wood, W				Weavers, Helen; Evans, Iwan R.; Martin, Paul; Wood, Will			Corpse Engulfment Generates a Molecular Memory that Primes the Macrophage Inflammatory Response	CELL			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; PROGRAMMED CELL-DEATH; CANDIDA-ALBICANS INFECTION; INNATE IMMUNE MEMORY; DROSOPHILA-MELANOGASTER; APOPTOTIC CELLS; LOW-VIRULENCE; HOST-DEFENSE; IN-VIVO; CALCIUM	Macrophages are multifunctional cells that perform diverse roles in health and disease. Emerging evidence has suggested that these innate immune cells might also be capable of developing immunological memory, a trait previously associated with the adaptive system alone. While recent studies have focused on the dramatic macrophage reprogramming that follows infection and protects against secondary microbial attack, can macrophages also develop memory in response to other cues? Here, we show that apoptotic corpse engulfment by Drosophila macrophages is an essential primer for their inflammatory response to tissue damage and infection in vivo. Priming is triggered via calcium-induced JNK signaling, which leads to upregulation of the damage receptor Draper, thus providing a molecular memory that allows the cell to rapidly respond to subsequent injury or infection. This remarkable plasticity and capacity for memory places macrophages as key therapeutic targets for treatment of inflammatory disorders.	[Weavers, Helen; Martin, Paul] Univ Bristol, Dept Biochem Biomed Sci, Bristol BS8 1TD, Avon, England; [Weavers, Helen; Wood, Will] Univ Bristol, Dept Cellular & Mol Med Biomed Sci, Bristol BS8 1TD, Avon, England; [Evans, Iwan R.] Univ Sheffield, Dept Infect Immun & Cardiovasc Dis, Sheffield S10 2TN, S Yorkshire, England; [Evans, Iwan R.] Univ Sheffield, Bateson Ctr, Sheffield S10 2TN, S Yorkshire, England; [Martin, Paul] Univ Bristol, Dept Physiol Pharmacol & Neurosci Biomed Sci, Bristol BS8 1TD, Avon, England; [Martin, Paul] Cardiff Univ, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Martin, Paul] Nanyang Technol Univ, Lee Kong Chiang Sch Med, Singapore 636921, Singapore	University of Bristol; University of Bristol; University of Sheffield; University of Sheffield; University of Bristol; Cardiff University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Martin, P (corresponding author), Univ Bristol, Dept Biochem Biomed Sci, Bristol BS8 1TD, Avon, England.; Wood, W (corresponding author), Univ Bristol, Dept Cellular & Mol Med Biomed Sci, Bristol BS8 1TD, Avon, England.; Martin, P (corresponding author), Univ Bristol, Dept Physiol Pharmacol & Neurosci Biomed Sci, Bristol BS8 1TD, Avon, England.; Martin, P (corresponding author), Cardiff Univ, Sch Med, Cardiff CF14 4XN, S Glam, Wales.; Martin, P (corresponding author), Nanyang Technol Univ, Lee Kong Chiang Sch Med, Singapore 636921, Singapore.	paul.martin@bristol.ac.uk; w.wood@bristol.ac.uk	Weavers, Helen/AGX-6323-2022; Wood, William/A-4939-2012	Wood, William/0000-0001-5485-0236; Weavers, Helen/0000-0002-5383-6085; Evans, Iwan/0000-0002-3485-4456; Martin, Paul/0000-0002-2665-5086	MRC Programme Grant [MR/J002577/1]; Wellcome Trust Investigator and Fellowship Award; MRC [MR/J002577/1] Funding Source: UKRI; Medical Research Council [MR/J002577/1] Funding Source: researchfish; Wellcome Trust [097791/Z/11/Z] Funding Source: researchfish	MRC Programme Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Investigator and Fellowship Award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	We would like to thank J.-P. Vincent (NIMR, UK), Marc Freeman (HHMI, UMass), and Joaquin de Navascues (Cardiff, UK) for reagents and members of P.M.'s/Nobes and W.W.'s labs for helpful discussion. We also thank the Wolfson Bioimaging Facility (University of Bristol, UK), the Bloomington Stock Centre (University of Indiana, USA), and Flybase. This work is funded by an MRC Programme Grant to P.M. and W.W. (MR/J002577/1) and Wellcome Trust Investigator and Fellowship Awards to P.M., W.W., and I.E.	Adachi-Yamada T, 1999, MOL CELL BIOL, V19, P2322; Bardet PL, 2008, P NATL ACAD SCI USA, V105, P13901, DOI 10.1073/pnas.0806983105; BISTONI F, 1986, INFECT IMMUN, V51, P668, DOI 10.1128/IAI.51.2.668-674.1986; BISTONI F, 1988, J MED VET MYCOL, V26, P285; Blok BA, 2015, J LEUKOCYTE BIOL, V98, P347, DOI 10.1189/jlb.5RI0315-096R; Bowdish DME, 2007, MICROBES INFECT, V9, P1680, DOI 10.1016/j.micinf.2007.09.002; BUMP NJ, 1995, SCIENCE, V269, P1885, DOI 10.1126/science.7569933; Chatterjee N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034063; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; Cho NK, 2002, CELL, V108, P865, DOI 10.1016/S0092-8674(02)00676-1; Cuttell L, 2008, CELL, V135, P524, DOI 10.1016/j.cell.2008.08.033; Davis JR, 2012, DEVELOPMENT, V139, P4555, DOI 10.1242/dev.082248; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Evans IR, 2010, DEVELOPMENT, V137, P1625, DOI 10.1242/dev.046797; Evans IR, 2015, CURR BIOL, V25, P1606, DOI 10.1016/j.cub.2015.04.037; Feng Y, 2015, NAT REV CANCER, V15, P556, DOI 10.1038/nrc3979; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Fu ZQ, 2013, ANNU REV PLANT BIOL, V64, P839, DOI 10.1146/annurev-arplant-042811-105606; Gao K, 2013, GLIA, V61, P2063, DOI 10.1002/glia.22577; Geisbrecht ER, 2004, CELL, V118, P111, DOI 10.1016/j.cell.2004.06.020; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Gronski MA, 2009, CELL DEATH DIFFER, V16, P1323, DOI 10.1038/cdd.2009.55; Hafen E., 1997, NATURE, V389, P559; Harrisingh MC, 2007, J NEUROSCI, V27, P12489, DOI 10.1523/JNEUROSCI.3680-07.2007; Hashimoto Y, 2009, J IMMUNOL, V183, P7451, DOI 10.4049/jimmunol.0901032; HAY BA, 1994, DEVELOPMENT, V120, P2121; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; Luna E, 2012, PLANT PHYSIOL, V158, P844, DOI 10.1104/pp.111.187468; MacDonald JM, 2013, CELL DEATH DIFFER, V20, P1140, DOI 10.1038/cdd.2013.30; Manaka J, 2004, J BIOL CHEM, V279, P48466, DOI 10.1074/jbc.M408597200; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; MEAGHER LC, 1992, J LEUKOCYTE BIOL, V52, P269, DOI 10.1002/jlb.52.3.269; Moreira S, 2010, CURR BIOL, V20, P464, DOI 10.1016/j.cub.2010.01.047; Mortimer NT, 2013, P NATL ACAD SCI USA, V110, P9427, DOI 10.1073/pnas.1222351110; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nagaso H, 2001, J HISTOCHEM CYTOCHEM, V49, P1177, DOI 10.1177/002215540104900911; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Quintin J, 2014, CURR OPIN IMMUNOL, V29, P1, DOI 10.1016/j.coi.2014.02.006; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Razzell W, 2013, CURR BIOL, V23, P424, DOI 10.1016/j.cub.2013.01.058; Rodrigues J, 2010, SCIENCE, V329, P1353, DOI 10.1126/science.1190689; Roitt I., 2006, ROITTS ESSENTIAL IMM; Rubartelli A, 1997, EUR J IMMUNOL, V27, P1893, DOI 10.1002/eji.1830270812; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Slaughter A, 2012, PLANT PHYSIOL, V158, P835, DOI 10.1104/pp.111.191593; Stern M, 1996, AM J PATHOL, V149, P911; Suzanne M, 2013, CELL DEATH DIFFER, V20, P669, DOI 10.1038/cdd.2013.11; Tan KL, 2014, CURR BIOL, V24, P1145, DOI 10.1016/j.cub.2014.03.062; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; TEPASS U, 1994, DEVELOPMENT, V120, P1829; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; VECCHIARELLI A, 1989, CELL IMMUNOL, V124, P334, DOI 10.1016/0008-8749(89)90135-4; Vlisidou I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000518; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; Wood W, 2006, J CELL BIOL, V173, P405, DOI 10.1083/jcb.200508161; Wood W, 2000, DEVELOPMENT, V127, P5245; Wood W, 2007, NAT REV MOL CELL BIO, V8, P542, DOI 10.1038/nrm2202	65	112	116	2	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1658	1671		10.1016/j.cell.2016.04.049	http://dx.doi.org/10.1016/j.cell.2016.04.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27212238	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000378062000017
J	Kleinert, S; Horton, R				Kleinert, Sabine; Horton, Richard			Adolescent health and wellbeing: a key to a sustainable future	LANCET			English	Editorial Material									[Kleinert, Sabine; Horton, Richard] The Lancet, London EC2Y 5AS, England		Kleinert, S (corresponding author), The Lancet, London EC2Y 5AS, England.							Ahmed SP, 2015, DEV COGN NEUROS-NETH, V15, P11, DOI 10.1016/j.dcn.2015.07.006; [Anonymous], 2015, LANCET, V386, P2227; Every Woman Every Child, 2015, GLOBAL STRATEGY WOME; Kleinert S, 2007, LANCET, V369, P1057, DOI 10.1016/S0140-6736(07)60374-2; Patton GC, 2016, LANCET; Peper JS, 2013, CURR DIR PSYCHOL SCI, V22, P134, DOI 10.1177/0963721412473755; Resnick MD, 2012, LANCET, V379, P1564, DOI 10.1016/S0140-6736(12)60472-3; UN, 2015, SUSTAINABLE DEV GOAL; UN, 2015, 3RANSF OUR WORLD 203; UNFPA, 2013, STRAT AD YOUTH REAL; UNICEF, 2011, STAT WORLDS CHILDR 2; Whitmee S, 2015, LANCET, V386, P1973, DOI 10.1016/S0140-6736(15)60901-1; WHO, 2014, HLTH WORLDS AD 2 CHA; You DZ, 2015, LANCET, V386, P2275, DOI 10.1016/S0140-6736(15)00120-8	14	24	24	2	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 11	2016	387	10036					2355	2356		10.1016/S0140-6736(16)30297-5	http://dx.doi.org/10.1016/S0140-6736(16)30297-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DO1ST	27174303				2022-12-28	WOS:000377560100006
J	Peyvandi, F; Mannucci, PM; Garagiola, I; El-Beshlawy, A; Elalfy, M; Ramanan, V; Eshghi, P; Hanagavadi, S; Varadarajan, R; Karimi, M; Manglani, MV; Ross, C; Young, G; Seth, T; Apte, S; Nayak, DM; Santagostino, E; Mancuso, ME; Gonzalez, ACS; Mahlangu, JN; Boix, SB; Cerqueira, M; Ewing, NP; Male, C; Owaidah, T; Arellano, VS; Kobrinsky, NL; Majumdar, S; Garrido, RP; Sachdeva, A; Simpson, M; Thomas, M; Zanon, E; Antmen, B; Kavakli, K; Manco-Johnson, MJ; Martinez, M; Marzouka, E; Mazzucconi, MG; Neme, D; Bravo, AP; Aguilera, RP; Prezotti, A; Schmitt, K; Wicklund, BM; Zulfikar, B; Rosendaal, FR				Peyvandi, F.; Mannucci, P. M.; Garagiola, I.; El-Beshlawy, A.; Elalfy, M.; Ramanan, V.; Eshghi, P.; Hanagavadi, S.; Varadarajan, R.; Karimi, M.; Manglani, M. V.; Ross, C.; Young, G.; Seth, T.; Apte, S.; Nayak, D. M.; Santagostino, E.; Mancuso, M. E.; Sandoval Gonzalez, A. C.; Mahlangu, J. N.; Bonanad Boix, S.; Cerqueira, M.; Ewing, N. P.; Male, C.; Owaidah, T.; Soto Arellano, V.; Kobrinsky, N. L.; Majumdar, S.; Perez Garrido, R.; Sachdeva, A.; Simpson, M.; Thomas, M.; Zanon, E.; Antmen, B.; Kavakli, K.; Manco-Johnson, M. J.; Martinez, M.; Marzouka, E.; Mazzucconi, M. G.; Neme, D.; Palomo Bravo, A.; Paredes Aguilera, R.; Prezotti, A.; Schmitt, K.; Wicklund, B. M.; Zulfikar, B.; Rosendaal, F. R.			A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PREVIOUSLY UNTREATED PATIENTS; INHIBITOR DEVELOPMENT; UNITED-STATES; PLASMA; PRODUCTS; FVIII; RECOMBINANT; CONCENTRATE; MORTALITY; CHILDREN	BACKGROUND The development of neutralizing anti-factor VIII alloantibodies (inhibitors) in patients with severe hemophilia A may depend on the concentrate used for replacement therapy. METHODS We conducted a randomized trial to assess the incidence of factor VIII inhibitors among patients treated with plasma-derived factor VIII containing von Willebrand factor or recombinant factor VIII. Patients who met the eligibility criteria (male sex, age <6 years, severe hemophilia A, and no previous treatment with any factor VIII concentrate or only minimal treatment with blood components) were included from 42 sites. RESULTS Of 303 patients screened, 264 underwent randomization and 251 were analyzed. Inhibitors developed in 76 patients, 50 of whom had high-titer inhibitors (>= 5 Bethesda units). Inhibitors developed in 29 of the 125 patients treated with plasma-derived factor VIII (20 patients had high-titer inhibitors) and in 47 of the 126 patients treated with recombinant factor VIII (30 patients had high-titer inhibitors). The cumulative incidence of all inhibitors was 26.8% (95% confidence interval [CI], 18.4 to 35.2) with plasma-derived factor VIII and 44.5% (95% CI, 34.7 to 54.3) with recombinant factor VIII; the cumulative incidence of high-titer inhibitors was 18.6% (95% CI, 11.2 to 26.0) and 28.4% (95% CI, 19.6 to 37.2), respectively. In Cox regression models for the primary end point of all inhibitors, recombinant factor VIII was associated with an 87% higher incidence than plasma-derived factor VIII (hazard ratio, 1.87; 95% CI, 1.17 to 2.96). This association did not change in multivariable analysis. For high-titer inhibitors, the hazard ratio was 1.69 (95% CI, 0.96 to 2.98). When the analysis was restricted to recombinant factor VIII products other than second-generation full-length recombinant factor VIII, effect estimates remained similar for all inhibitors (hazard ratio, 1.98; 95% CI, 0.99 to 3.97) and high-titer inhibitors (hazard ratio, 2.59; 95% CI, 1.11 to 6.00). CONCLUSIONS Patients treated with plasma-derived factor VIII containing von Willebrand factor had a lower incidence of inhibitors than those treated with recombinant factor VIII. (Funded by the Angelo Bianchi Bonomi Foundation and others; ClinicalTrials.gov number, NCT01064284; EudraCT number, 2009-011186-88.)	[Peyvandi, F.; Mannucci, P. M.; Santagostino, E.; Mancuso, M. E.] Ca Granda Osped Maggiore Policlin, Fdn Ist Ricovero & Cura Carattere Sci IRCCS, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy; [Peyvandi, F.; Mannucci, P. M.; Garagiola, I.] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy; [Zanon, E.] Azienda Osped Padova, Med Clin 2, Ctr Emofilia, Padua, Italy; [Mazzucconi, M. G.] Univ Roma La Sapienza, Policlin Umberto I, Unita Operat Diagnost Speciale & Terapia Malattie, Ematol, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [El-Beshlawy, A.] Cairo Univ Pediat Hosp, Dept Pediat Hematol, Cairo, Egypt; [Elalfy, M.] Ain Shams Univ, Fac Med, Dept Pediat, Cairo, Egypt; [Ramanan, V.] Jehangir Hosp Premises, Dept Hematol, Jehangir Clin Dev Ctr, Pune, Maharashtra, India; [Apte, S.] Sahyadri Special Hosp, Pune, Maharashtra, India; [Hanagavadi, S.] Jagadguru Jayadeva Murugarajendra Med Coll, Davangere, India; [Varadarajan, R.] Ctr Blood Disorders, Madras, Tamil Nadu, India; [Manglani, M. V.] Lokmanya Tilak Municipal Gen Hosp & Med Coll, Bombay, Maharashtra, India; [Manglani, M. V.] Gen Hosp, Bombay, Maharashtra, India; [Ross, C.] St Johns Med Coll Hosp, Bangalore, Karnataka, India; [Seth, T.] All India Inst Med Sci, Dept Hematol, New Delhi, India; [Sachdeva, A.] Sir Ganga Ram Hosp, Inst Child Hlth, Pediat Hematol Oncol & Bone Marrow Transplantat, New Delhi, India; [Nayak, D. M.] Manipal Univ, Melaka Manipal Med Coll, Manipal, India; [Thomas, M.] Kerala Inst Med Sci, Trivandrum, Kerala, India; [Eshghi, P.] Shahid Beheshti Univ Med Sci, Congenital Pediat Hematol Disorders Res Ctr, Tehran, Iran; [Karimi, M.] Shiraz Univ Med Sci, Hematol Res Ctr, Shiraz, Iran; [Young, G.] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Ewing, N. P.] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA; [Sandoval Gonzalez, A. C.] Hosp Especialidades Ctr Med La Raza, Unidad Med Alta Especialidad, Inst Mexicano Seguro Social, Monterrey, Mexico; [Paredes Aguilera, R.] Inst Nacl Pediat, Mexico City, DF, Mexico; [Mahlangu, J. N.] Univ Witwatersrand, Natl Hlth Lab Serv, Sch Pathol, Johannesburg, South Africa; [Mahlangu, J. N.] Charlotte Maxeke Johannesburg Acad Hosp, Johannesburg, South Africa; [Bonanad Boix, S.] Hosp Univ La Fe, Unidad Coagulopatias Congenitas, Valencia, Spain; [Perez Garrido, R.] Hosp Univ Virgen Rocio, Unidad Hemofilia, Seville, Spain; [Palomo Bravo, A.] Hosp Reg Univ Carlos Haya, Malaga, Spain; [Cerqueira, M.] Inst Estadual Hematol Arthur Siqueira Cavalcanti, Ctr Pesquisa Clin Hemorio, Rio De Janeiro, Brazil; [Prezotti, A.] Ctr Hematol & Hemoterapia Espirito Santo, Vitoria, Spain; [Male, C.] Med Univ Wien, Dept Pediat, Vienna, Austria; [Schmitt, K.] Kepler Univ Clin, Dept Pediat & Adolescent Med, Linz, Austria; [Owaidah, T.] King Faisal Specialist Hosp & Res Ctr, Riyadh, Saudi Arabia; [Soto Arellano, V.] Hosp Ninos Dr Roberto del Rio, Ctr Hemofil, Santiago, Chile; [Marzouka, E.] Hosp Ninos Dr Luis Calvo Mackenna, Ctr Hemofil, Santiago, Chile; [Kobrinsky, N. L.] Sanford Roger Maris Canc Ctr, Fargo, ND USA; [Majumdar, S.] Univ Mississippi, Med Ctr, Div Pediat Hematol Oncol, Jackson, MS USA; [Simpson, M.] Rush Univ, Med Ctr, Rush Hemophilia & Thrombophilia Ctr, Chicago, IL 60612 USA; [Antmen, B.] Cukurova Univ, Tip Fak Pediat Hematoloji Bilim Dali, Adana, Turkey; [Kavakli, K.] Ege Univ, Tip Fak, Cocuk Sagligi & Hastalikari Anabilim Dali, Pediat Hematoloji Bilim Dali, Izmir, Turkey; [Zulfikar, B.] Istanbul Univ, Cerrahpasa Tip Fak, Pediat Hematoloji Bilim Dali, Istanbul, Turkey; [Manco-Johnson, M. J.] Univ Colorado Denver, Hemophilia & Thrombosis Ctr, Aurora, CO USA; [Martinez, M.] Hosp Ninos Sor Maria Ludov La Plata, Serv Hematol, Buenos Aires, DF, Argentina; [Neme, D.] Fdn Hemofilia, Buenos Aires, DF, Argentina; [Wicklund, B. M.] Childrens Mercy Hosp, Kansas City, MO 64108 USA; [Rosendaal, F. R.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Padua; Azienda Ospedaliera - Universita di Padova; Sapienza University Rome; University Hospital Sapienza Rome; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Ain Shams University; St. John's National Academy of Health Sciences; St. John's Medical College; All India Institute of Medical Sciences (AIIMS) New Delhi; Manipal Academy of Higher Education (MAHE); Shahid Beheshti University Medical Sciences; Shiraz University of Medical Science; Children's Hospital Los Angeles; City of Hope; Instituto Mexicano del Seguro Social; National Health Laboratory Service; University of Witwatersrand; University of Witwatersrand; Hospital Universitari i Politecnic La Fe; Virgen del Rocio University Hospital; Hospital Carlos Haya; Medical University of Vienna; Kepler University Hospital; King Faisal Specialist Hospital & Research Center; Sanford Health; University of Mississippi; University of Mississippi Medical Center; Rush University; Cukurova University; Ege University; Istanbul University; Istanbul University - Cerrahpasa; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Mercy Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Peyvandi, F (corresponding author), IRCCS Ca Granda Maggiore Policlin Hosp Fdn, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Via Pace 9, I-20122 Milan, Italy.; Peyvandi, F (corresponding author), Univ Milan, Dept Pathophysiol & Transplantat, Via Pace 9, I-20122 Milan, Italy.	flora.peyvandi@unimi.it	Bonanad, Santiago/O-6683-2018; Mahlangu, Johnny Ndoni/H-7558-2019; Mancuso, Maria Elisa/L-1552-2019; Rosendaal, Frits/Q-3842-2017; Karimi, Mehran/P-3530-2017; Mancuso, Maria Elisa/AAT-4785-2020; Bulent Zulfikar, zulfikar b/AAD-8080-2020; eshghi, peyman/R-4485-2019; Peyvandi, Flora/AAK-7437-2020	Bonanad, Santiago/0000-0002-8390-8211; Mahlangu, Johnny Ndoni/0000-0001-5781-7669; Rosendaal, Frits/0000-0003-2558-7496; Karimi, Mehran/0000-0001-8555-1001; Mancuso, Maria Elisa/0000-0002-7113-4028; eshghi, peyman/0000-0002-3503-1363; Peyvandi, Flora/0000-0001-7423-9864; Male, Christoph/0000-0002-4989-6421; Elalfy, Mohsen/0000-0002-2809-1552; Nayak, Dinesh M/0000-0001-7384-8916	Angelo Bianchi Bonomi Foundation	Angelo Bianchi Bonomi Foundation	Funded by the Angelo Bianchi Bonomi Foundation and others	Aledort LM, 1998, HAEMOPHILIA, V4, P68; Bagnall RD, 2002, BLOOD, V99, P168, DOI 10.1182/blood.V99.1.168; Barrowcliffe TW, 2013, HAEMOPHILIA, V19, P799, DOI 10.1111/hae.12282; Calvez T, 2014, BLOOD, V124, P3398, DOI 10.1182/blood-2014-07-586347; Chalmers EA, 2007, HAEMOPHILIA, V13, P149, DOI 10.1111/j.1365-2516.2006.01418.x; Collins PW, 2014, BLOOD, V124, P3389, DOI 10.1182/blood-2014-07-580498; Darby SC, 2004, J THROMB HAEMOST, V2, P1047, DOI 10.1046/j.1538-7836.2004.00710.x; Dasgupta S, 2007, BLOOD, V109, P610, DOI 10.1182/blood-2006-05-022756; Franchini M, 2013, SEMIN THROMB HEMOST, V39, P752, DOI 10.1055/s-0033-1356715; Goudemand J, 2006, BLOOD, V107, P46, DOI 10.1182/blood-2005-04-1371; Goudemand J, 2015, J THROMB HAEMOST, V13, P148; Gouw SC, 2007, BLOOD, V109, P4648, DOI 10.1182/blood-2006-11-056291; Gouw SC, 2013, BLOOD, V121, P4046, DOI 10.1182/blood-2012-09-457036; Gouw SC, 2013, NEW ENGL J MED, V368, P231, DOI 10.1056/NEJMoa1208024; Gringeri A, 2003, BLOOD, V102, P2358, DOI 10.1182/blood-2003-03-0941; Guh S, 2012, HAEMOPHILIA, V18, P268, DOI 10.1111/j.1365-2516.2011.02692.x; Hernandez-Navarro F, 2008, HAEMOPHILIA, V14, P963, DOI 10.1111/j.1365-2516.2008.01784.x; Iorio A, 2010, J THROMB HAEMOST, V8, P1256, DOI 10.1111/j.1538-7836.2010.03823.x; Leissinger C, 2011, HAEMOPHILIA, V17, P884, DOI 10.1111/j.1365-2516.2011.02509.x; Liu Q, 1998, BLOOD, V92, P1458, DOI 10.1182/blood.V92.4.1458.splL4_1458_1459; Logan LJ, 2009, HAEMOPHILIA, V15, P369, DOI 10.1111/j.1365-2516.2008.01859.x; Mannucci PM, 2007, HAEMOPHILIA, V13, P65, DOI 10.1111/j.1365-2516.2007.01580.x; Mannucci PM, 2001, NEW ENGL J MED, V344, P1773, DOI 10.1056/NEJM200106073442307; Marcucci M, 2015, THROMB HAEMOSTASIS, V113, P958, DOI 10.1160/TH14-07-0621; Peyvandi F, 2013, AM J HEMATOL, V88, P895, DOI 10.1002/ajh.23527; Plug I, 2006, J THROMB HAEMOST, V4, P510, DOI 10.1111/j.1538-7836.2006.01808.x; Qadura M, 2009, BLOOD, V114, P871, DOI 10.1182/blood-2008-09-174649; Samor B, 2012, VOX SANG, V103, P35, DOI 10.1111/j.1423-0410.2011.01576.x; Santacroce R, 2008, J HUM GENET, V53, P275, DOI 10.1007/s10038-007-0238-y; Schwaab R, 1995, THROMB HAEMOSTASIS, V74, P1402; Verbruggen B, 2002, THROMB HAEMOSTASIS, V88, P362; Walsh CE, 2015, AM J HEMATOL, V90, P400, DOI 10.1002/ajh.23957; Wight J, 2003, HAEMOPHILIA, V9, P418, DOI 10.1046/j.1365-2516.2003.00780.x	33	313	332	0	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 26	2016	374	21					2054	2064		10.1056/NEJMoa1516437	http://dx.doi.org/10.1056/NEJMoa1516437			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6EN	27223147	Green Published, Bronze			2022-12-28	WOS:000376443500008
J	Kammen, DM; Sunter, DA				Kammen, Daniel M.; Sunter, Deborah A.			City-integrated renewable energy for urban sustainability	SCIENCE			English	Review							GREENHOUSE-GAS EMISSIONS; WIND TURBINES; CITIES; SYSTEMS; INFRASTRUCTURE; OPPORTUNITIES; PERFORMANCE; ENVIRONMENT; HOUSEHOLDS; FOOTPRINT	To prepare for an urban influx of 2.5 billion people by 2050, it is critical to create cities that are low-carbon, resilient, and livable. Cities not only contribute to global climate change by emitting the majority of anthropogenic greenhouse gases but also are particularly vulnerable to the effects of climate change and extreme weather. We explore options for establishing sustainable energy systems by reducing energy consumption, particularly in the buildings and transportation sectors, and providing robust, decentralized, and renewable energy sources. Through technical advancements in power density, city-integrated renewable energy will be better suited to satisfy the high-energy demands of growing urban areas. Several economic, technical, behavioral, and political challenges need to be overcome for innovation to improve urban sustainability.	[Kammen, Daniel M.; Sunter, Deborah A.] Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA; [Kammen, Daniel M.] Univ Calif Berkeley, Goldman Sch Publ Policy, Berkeley, CA 94720 USA; [Kammen, Daniel M.; Sunter, Deborah A.] Univ Calif Berkeley, Renewable & Appropriate Energy Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Kammen, DM (corresponding author), Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA.; Kammen, DM (corresponding author), Univ Calif Berkeley, Goldman Sch Publ Policy, Berkeley, CA 94720 USA.; Kammen, DM (corresponding author), Univ Calif Berkeley, Renewable & Appropriate Energy Lab, Berkeley, CA 94720 USA.	kammen@berkeley.edu			Karsten Family Foundation; Zaffaroni Foundation; Energy Efficiency and Renewable Energy Postdoctoral Research Award from the U.S. Department of Energy	Karsten Family Foundation; Zaffaroni Foundation; Energy Efficiency and Renewable Energy Postdoctoral Research Award from the U.S. Department of Energy	We thank F. Creutzig, C. Jones, B. Gould, J. Sager, J. Apte, and D. Lemoine for useful discussions. This research was supported by the Karsten Family Foundation and the Zaffaroni Foundation through their support of the Renewable and Appropriate Energy Laboratory (to D.M.K.) and by an Energy Efficiency and Renewable Energy Postdoctoral Research Award from the U.S. Department of Energy (to D.A.S.).	Ackerman K, 2014, ECON SOC REV, V45, P189; Adil AM, 2016, RENEW SUST ENERG REV, V57, P1025, DOI 10.1016/j.rser.2015.12.079; Aguilera A., 2014, INT J AUTOMOTIVE TEC, V14, P203, DOI 10.1504/IJATM.2014.065290; AlZaharani AA, 2013, INT J HYDROGEN ENERG, V38, P14505, DOI 10.1016/j.ijhydene.2013.09.002; Amado M, 2014, ENRGY PROCED, V48, P1539, DOI 10.1016/j.egypro.2014.02.174; Amini HR, 2011, WASTE MANAGE, V31, P2020, DOI 10.1016/j.wasman.2011.05.010; [Anonymous], 2009, BUILD CLIM CHANG SUM; Baker N., 2000, ENERGY ENV ARCHITECT; Benz SA, 2015, SCI TOTAL ENVIRON, V524, P427, DOI 10.1016/j.scitotenv.2015.04.003; Castellon C, 2009, J SOL ENERG-T ASME, V131, DOI 10.1115/1.3197843; Chavez A, 2013, ENERG POLICY, V54, P376, DOI 10.1016/j.enpol.2012.10.037; Dabiri JO, 2011, J RENEW SUSTAIN ENER, V3, DOI 10.1063/1.3608170; Demographia, 2015, DEM WORLD URB AR, Veleventh; Dincer I, 2012, INT J HYDROGEN ENERG, V37, P1954, DOI 10.1016/j.ijhydene.2011.03.173; Fagnant DJ, 2014, TRANSPORT RES C-EMER, V40, P1, DOI 10.1016/j.trc.2013.12.001; Fath K, 2015, SOL ENERGY, V116, P357, DOI 10.1016/j.solener.2015.03.023; Fong WK., 2014, GLOBAL PROTOCOL COMM; Frankfurt School-United Nations Environment Programme Centre, 2014, GLOB TRENDS REN EN I; Freitas S, 2015, RENEW SUST ENERG REV, V41, P915, DOI 10.1016/j.rser.2014.08.060; Gagliano A, 2013, INT J ENERGY ENVIR E, V4, DOI 10.1186/2251-6832-4-43; Georgeson L, 2016, NAT CLIM CHANGE, V6, P584, DOI [10.1038/NCLIMATE2944, 10.1038/nclimate2944]; Global Energy Assessment, 2012, GLOB EN ASS SUST FUT; Gonder J, 2012, SAE INT J PASSENG CA, V5, P450, DOI 10.4271/2012-01-0494; Grubler A., 2013, ENERGIZING SUSTAINAB; Halu A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500700; Hanson S, 2011, CLIMATIC CHANGE, V104, P89, DOI 10.1007/s10584-010-9977-4; Hofierka J, 2009, RENEW ENERG, V34, P2206, DOI 10.1016/j.renene.2009.02.021; Hoornweg D., 2012, WHAT WASTE GLOBAL RE; International Energy Agency, 2012, EN TECHN PERSP 2012; Ishugah TF, 2014, RENEW SUST ENERG REV, V37, P613, DOI 10.1016/j.rser.2014.05.053; Jones C, 2014, ENVIRON SCI TECHNOL, V48, P895, DOI 10.1021/es4034364; Jones CM, 2011, ENVIRON SCI TECHNOL, V45, P4088, DOI 10.1021/es102221h; Joost WJ, 2012, JOM-US, V64, P1032, DOI 10.1007/s11837-012-0424-z; Sarralde JJ, 2015, RENEW ENERG, V73, P10, DOI 10.1016/j.renene.2014.06.028; Kagel A, 2007, GUIDE GEOTHERMAL ENE; Kamal M. A., 2014, CIV ENG ARCHIT, V2, P116; Kaygusuz K, 2012, RENEW SUST ENERG REV, V16, P1116, DOI 10.1016/j.rser.2011.11.013; Kennedy C, 2013, ENERG POLICY, V59, P773, DOI 10.1016/j.enpol.2013.04.031; Killien C., 2011, DEEP GREEN RENOVATIO; Ko YK, 2013, J PLAN LIT, V28, P327, DOI 10.1177/0885412213491499; Kulak M, 2013, LANDSCAPE URBAN PLAN, V111, P68, DOI 10.1016/j.landurbplan.2012.11.007; Li DHW, 2013, ENERGY, V54, P1, DOI 10.1016/j.energy.2013.01.070; Lopez A., 2012, US RENEWABLE ENERGY, DOI [10.2172/1219777, DOI 10.2172/1219777]; Lund H, 2014, ENERGY, V68, P1, DOI 10.1016/j.energy.2014.02.089; Lund P, 2012, ENERG CONVERS MANAGE, V63, P162, DOI 10.1016/j.enconman.2012.01.037; MacKay David J.C., 2009, SUSTAINABLE ENERGY H; McKinsey & Company, 2009, ENV EN SUST APPR IND; Mithraratne N, 2009, ENERG BUILDINGS, V41, P1013, DOI 10.1016/j.enbuild.2009.05.003; Monsere C., 2014, NITC44583; Mussche C., 2014, 2014 ENERGY EC VALUE; Mwasilu F, 2014, RENEW SUST ENERG REV, V34, P501, DOI 10.1016/j.rser.2014.03.031; NASA, 2014, SURF MET SOL EN DAT; National Renewable Energy Laboratory, 2015, BEST RES CELL EFF; Neumann HM, 2012, PROG PHOTOVOLTAICS, V20, P639, DOI 10.1002/pip.1199; Olgyay V, 2010, ASHRAE TRAN, V116, P244; Reber TJ, 2014, ENERG POLICY, V70, P30, DOI 10.1016/j.enpol.2014.03.004; Sager J, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/2/024018; Saha M, 2015, APPL ENERG, V159, P540, DOI 10.1016/j.apenergy.2015.09.021; Scott A., 2016, CHEM ENG NEWS, V94, P18; Searchinger TD, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/2/024007; Simon J., 2015, SUSTAINABLE CITIES G; Singh R, 2015, SOL ENERGY, V115, P589, DOI 10.1016/j.solener.2015.03.016; Smil V., 2015, POWER DENSITY KEY UN; Sovacool B., 2007, ELECT J, V20, P48, DOI DOI 10.1016/J.TEJ.2007.03.006; Sovacool BK, 2009, ENERG POLICY, V37, P4500, DOI 10.1016/j.enpol.2009.05.073; Stephens T. S., 2014, VEHICLE TECHNOLOGIES; Tatsidjodoung P, 2013, RENEW SUST ENERG REV, V18, P327, DOI 10.1016/j.rser.2012.10.025; Terziotti LT, 2012, ENERG BUILDINGS, V45, P28, DOI 10.1016/j.enbuild.2011.10.023; U.S. Department of Energy, 2015, QUADR TECHN REV 2015; U.S. Department of Energy, 2011, WORKSH ID RES NEEDS; UITP, 2018, WORLD METR FIG 2018; United Nations, 2014, REV WORLD URB PROSP; United Nations Human Settlements Programme, 2011, CIT CLIM CHANG POL D; Wang ZY, 2015, RENEW SUST ENERG REV, V41, P68, DOI 10.1016/j.rser.2014.08.026; Wei HK, 2014, APPL ENERG, V126, P47, DOI 10.1016/j.apenergy.2014.04.003; Zhang Y, 2014, GEOTECH LETT, V4, P125, DOI 10.1680/geolett.13.00061; Zhu JL, 2015, ENERGY, V93, P466, DOI 10.1016/j.energy.2015.08.098; Zhu K, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/4/044002	79	259	270	78	516	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2016	352	6288			SI		922	928		10.1126/science.aad9302	http://dx.doi.org/10.1126/science.aad9302			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM2AK	27199413	Green Submitted			2022-12-28	WOS:000376147800030
J	Eisenstein, M				Eisenstein, Michael			Bacterial broadband	NATURE			English	Editorial Material							IRRITABLE-BOWEL-SYNDROME; GUT MICROBIOTA											Asano Y, 2012, AM J PHYSIOL-GASTR L, V303, pG1288, DOI 10.1152/ajpgi.00341.2012; Bercik P, 2011, NEUROGASTROENT MOTIL, V23, P1132, DOI 10.1111/j.1365-2982.2011.01796.x; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Jalanka-Tuovinen J, 2014, GUT, V63, P1737, DOI 10.1136/gutjnl-2013-305994; Jeffery IB, 2012, GUT, V61, P997, DOI 10.1136/gutjnl-2011-301501; Labus JS, 2014, PAIN, V155, P137, DOI 10.1016/j.pain.2013.09.020; O'Mahony SM, 2014, NEUROSCIENCE, V277, P885, DOI 10.1016/j.neuroscience.2014.07.054; Rajilic-Stojanovic M, 2011, GASTROENTEROLOGY, V141, P1792, DOI 10.1053/j.gastro.2011.07.043; Tillisch K, 2013, GASTROENTEROLOGY, V144, P1394, DOI 10.1053/j.gastro.2013.02.043; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047	11	48	56	5	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					S104	S106		10.1038/533S104a	http://dx.doi.org/10.1038/533S104a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0AH	27191486	Bronze			2022-12-28	WOS:000376004300002
J	Minderer, M; Harvey, CD				Minderer, Matthias; Harvey, Christopher D.			FORUM Neuroscience Virtual reality explored	NATURE			English	Editorial Material									[Minderer, Matthias; Harvey, Christopher D.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Harvey, CD (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	harvey@hms.harvard.edu		Donato, Flavio/0000-0002-0732-1654					0	49	49	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					324	324		10.1038/nature17899	http://dx.doi.org/10.1038/nature17899			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0AH	27193673	Bronze			2022-12-28	WOS:000376004300030
J	White, RH				White, Richard H.			Evidence-Based Guideline: CHEST made 20 strong recommendations about antithrombotic therapy for VTE	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[White, Richard H.] Univ Calif Davis, Sacramento, CA 95817 USA	University of California System; University of California Davis	White, RH (corresponding author), Univ Calif Davis, Sacramento, CA 95817 USA.								0	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2016	164	10					JC52	JC52		10.7326/ACPJC-2016-164-10-052	http://dx.doi.org/10.7326/ACPJC-2016-164-10-052			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8GF	27182918				2022-12-28	WOS:000375878500003
J	Mayor, S				Mayor, Susan			Father's age and lifestyle link to birth defects in offspring, review finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Day J, 2016, AM J STEM CELLS, V5, P11	1	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 16	2016	353								i2739	10.1136/bmj.i2739	http://dx.doi.org/10.1136/bmj.i2739			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GB	27185321				2022-12-28	WOS:000376447500007
J	Viswanathan, V; Pande, V; Abraham, KM; Luntz, AC; McCloskey, BD; Addison, D				Viswanathan, Venkatasubramanian; Pande, Vikram; Abraham, K. M.; Luntz, Alan C.; McCloskey, Bryan D.; Addison, Dan			Comment on "Cycling Li-O-2 batteries via LiOH formation and decomposition"	SCIENCE			English	Editorial Material								Based on a simple thermodynamic analysis, we show that iodide-mediated electrochemical decomposition of lithium hydroxide (LiOH) likely occurs through a different mechanism than that proposed by Liu et al. (Research Article, 30 October 2015, p. 530). The mismatch in thermodynamic potentials for iodide/triiodide (I-/I-3(-)) redox and O-2 evolution from LiOH implies a different active iodine/oxygen electrochemistry on battery charge. It is therefore possible that the system described in Liu et al. may not form the basis for a rechargeable lithium-oxygen (Li-O-2) battery.	[Viswanathan, Venkatasubramanian; Pande, Vikram] Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA; [Abraham, K. M.] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Luntz, Alan C.] SLAC Natl Accelerator Lab, SUNCAT, Menlo Pk, CA 94025 USA; [McCloskey, Bryan D.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [McCloskey, Bryan D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Energy Storage & Distributed Resources Div, Berkeley, CA 94720 USA; [Addison, Dan] Liox Power Inc, 129 North Hill Ave,Suite 103, Pasadena, CA 91106 USA	Carnegie Mellon University; Northeastern University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Viswanathan, V (corresponding author), Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA.	venkvis@cmu.edu	McCloskey, Bryan D/A-6556-2015; Dou, Shi Xue/D-5179-2012; Chou, Shulei/D-9895-2011; Pande, Vikram/AAN-4217-2021	McCloskey, Bryan D/0000-0001-6599-2336; Dou, Shi Xue/0000-0003-3824-7693; Chou, Shulei/0000-0003-1155-6082; 				Aetukuri NB, 2015, NAT CHEM, V7, P50, DOI [10.1038/NCHEM.2132, 10.1038/nchem.2132]; Boschloo G, 2009, ACCOUNTS CHEM RES, V42, P1819, DOI 10.1021/ar900138m; Kwak WJ, 2015, J MATER CHEM A, V3, P8855, DOI 10.1039/c5ta01399b; Landa-Medrano I, 2015, ELECTROCHEM COMMUN, V59, P24, DOI 10.1016/j.elecom.2015.06.019; Laoire CO, 2011, J ELECTROCHEM SOC, V158, pA302, DOI 10.1149/1.3531981; Lide DR, 2004, CRC HDB CHEM PHYS; Liu T, 2015, SCIENCE, V350, P530, DOI 10.1126/science.aac7730	7	31	32	7	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2016	352	6286								10.1126/science.aad8689	http://dx.doi.org/10.1126/science.aad8689			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL1UC	27151860				2022-12-28	WOS:000375417100026
J	Macaulay, T				Macaulay, Thomas			MEDICINE AND THE MEDIA How the papers covered the strike	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Macaulay, Thomas] City Univ London, London EC1V 0HB, England	City University London	Macaulay, T (corresponding author), City Univ London, London EC1V 0HB, England.	thommacaulay@gmail.com						[Anonymous], 2016, INDEPENDENT; [Anonymous], 2016, DAILY MAIL; [Anonymous], 2016, JUNIOR DOCTORS STRIK; Campbell D, 2016, GUARDIAN; Grice A., 2016, INDEPENDENT; Hopkins R., 2016, DAILY MAIL; Ipsos MORI, 2016, MAJ SUPP JUN DOCT 1; Jones O, 2016, GUARDIAN; Khomani N, 2016, GUARDIAN; Kirkup M., 2016, TELEGRAPH; Routledge P., 2016, MIRROR          0426; Spencer B., 2016, DAILY MAIL; Toynbee P., 2016, GUARDIAN; White M., 2016, GUARDIAN; YouGov, 2016, PUBL INCR BLAM GOV J; Younger R., 2016, ITV NEWS        0426	16	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 5	2016	353								i2506	10.1136/bmj.i2506	http://dx.doi.org/10.1136/bmj.i2506			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL4AS	27150737				2022-12-28	WOS:000375575600007
J	Williamson, JD; Supiano, MA; Applegate, WB; Berlowitz, DR; Campbell, RC; Chertow, GM; Fine, LJ; Haley, WE; Hawfield, AT; Ix, JH; Kitzman, D; Kostis, JB; Krousel-Wood, MA; Launer, LJ; Oparil, S; Rodriguez, CJ; Roumie, CL; Shorr, RI; Sink, KM; Wadley, VG; Whelton, PK; Whittle, J; Woolard, NF; Wright, JT; Pajewski, NM				Williamson, Jeff D.; Supiano, Mark A.; Applegate, William B.; Berlowitz, Dan R.; Campbell, Ruth C.; Chertow, Glenn M.; Fine, Larry J.; Haley, William E.; Hawfield, Amret T.; Ix, Joachim H.; Kitzman, DalaneW.; Kostis, John B.; Krousel-Wood, Marie A.; Launer, Lenore J.; Oparil, Suzanne; Rodriguez, Carlos J.; Roumie, Christianne L.; Shorr, Ronald I.; Sink, Kaycee M.; Wadley, Virginia G.; Whelton, Paul K.; Whittle, Jeffrey; Woolard, Nancy F.; Wright, Jackson T., Jr.; Pajewski, Nicholas M.		SPRINT Res Grp	Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged >= 75 Years A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANTIHYPERTENSIVE TREATMENT; OLDER-PEOPLE; HYPERTENSION; FRAILTY; GUIDELINES; EVENTS; STROKE; FALLS; INDEX; RISK	IMPORTANCE The appropriate treatment target for systolic blood pressure (SBP) in older patients with hypertension remains uncertain. OBJECTIVE To evaluate the effects of intensive (<120mmHg) compared with standard (<140mmHg) SBP targets in persons aged 75 years or older with hypertension but without diabetes. DESIGN, SETTING, AND PARTICIPANTS A multicenter, randomized clinical trial of patients aged 75 years or older who participated in the Systolic Blood Pressure Intervention Trial (SPRINT). Recruitment began on October 20, 2010, and follow-up ended on August 20, 2015. INTERVENTIONS Participants were randomized to an SBP target of less than 120mmHg (intensive treatment group, n = 1317) or an SBP target of less than 140mmHg (standard treatment group, n = 1319). MAIN OUTCOMES AND MEASURES The primary cardiovascular disease outcomewas a composite of nonfatalmyocardial infarction, acute coronary syndrome not resulting in a myocardial infarction, nonfatal stroke, nonfatal acute decompensated heart failure, and death from cardiovascular causes. All-cause mortality was a secondary outcome. RESULTS Among 2636 participants (mean age, 79.9 years; 37.9% women), 2510 (95.2%) provided complete follow-up data. At a median follow-up of 3.14 years, there was a significantly lower rate of the primary composite outcome (102 events in the intensive treatment group vs 148 events in the standard treatment group; hazard ratio [HR], 0.66 [95% CI, 0.51-0.85]) and all-cause mortality (73 deaths vs 107 deaths, respectively; HR, 0.67 [95% CI, 0.49-0.91]). The overall rate of serious adverse events was not different between treatment groups (48.4% in the intensive treatment group vs 48.3% in the standard treatment group; HR, 0.99 [95% CI, 0.89-1.11]). Absolute rates of hypotension were 2.4% in the intensive treatment group vs 1.4% in the standard treatment group (HR, 1.71 [95% CI, 0.97-3.09]), 3.0% vs 2.4%, respectively, for syncope (HR, 1.23 [95% CI, 0.76-2.00]), 4.0% vs 2.7% for electrolyte abnormalities (HR, 1.51 [95% CI, 0.99-2.33]), 5.5% vs 4.0% for acute kidney injury (HR, 1.41 [95% CI, 0.98-2.04]), and 4.9% vs 5.5% for injurious falls (HR, 0.91 [95% CI, 0.65-1.29]). CONCLUSIONS AND RELEVANCE Among ambulatory adults aged 75 years or older, treating to an SBP target of less than 120mmHg compared with an SBP target of less than 140mmHg resulted in significantly lower rates of fatal and nonfatal major cardiovascular events and death from any cause.	[Williamson, Jeff D.; Applegate, William B.; Sink, Kaycee M.; Woolard, Nancy F.] Wake Forest Sch Med, Med Ctr Blvd, Sect Gerontol & Geriatr Med, Winston Salem, NC 27157 USA; [Supiano, Mark A.] Univ Utah, Sch Med, Div Geriatr, Salt Lake City, UT USA; [Supiano, Mark A.] Vet Affairs Salt Lake City, Geriatr Res Educ & Clin Ctr, Salt Lake City, UT USA; [Berlowitz, Dan R.] Bedford Vet Affairs Hosp, Bedford, MA USA; [Berlowitz, Dan R.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Campbell, Ruth C.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Chertow, Glenn M.] Stanford Univ, Sch Med, Dept Med, Palo Alto, CA 94304 USA; [Fine, Larry J.] NHLBI, Div Cardiovasc Sci, Clin Applicat & Prevent Branch, Bldg 10, Bethesda, MD 20892 USA; [Haley, William E.] Mayo Clin, Dept Hypertens & Nephrol, Jacksonville, FL 32224 USA; [Hawfield, Amret T.] Wake Forest Sch Med, Nephrol Sect, Winston Salem, NC USA; [Ix, Joachim H.] Univ Calif San Diego, Dept Med, Div Nephrol & Hypertens, San Diego, CA 92103 USA; [Ix, Joachim H.] Univ Calif San Diego, Dept Family Med & Publ Hlth, Div Prevent Med, San Diego, CA 92103 USA; [Ix, Joachim H.] Vet Affairs San Diego Healthcare Syst, Dept Med, Nephrol Sect, San Diego, CA USA; [Kitzman, DalaneW.] Wake Forest Sch Med, Sect Cardiovasc Med, Winston Salem, NC USA; [Kostis, John B.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Cardiovasc Inst Rutgers, New Brunswick, NJ USA; [Krousel-Wood, Marie A.] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA; [Krousel-Wood, Marie A.] Tulane Univ, Dept Epidemiol, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA; [Krousel-Wood, Marie A.] Ochsner Clin Fdn, Ctr Appl Hlth Res, New Orleans, LA USA; [Launer, Lenore J.] NIA, Intramural Res Program, Bethesda, MD 20892 USA; [Oparil, Suzanne] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35294 USA; [Rodriguez, Carlos J.] Wake Forest Sch Med, Dept Epidemiol & Prevent, Div Publ Hlth Sci, Winston Salem, NC USA; [Roumie, Christianne L.] HSR&D Ctr, Vet Hlth Adm Tennessee Valley Healthcare Syst Ger, Nashville, TN USA; [Roumie, Christianne L.] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Shorr, Ronald I.] Univ Florida, Dept Epidemiol, Gainesville, FL USA; [Shorr, Ronald I.] Malcom Randall Vet Adm Med Ctr, Geriatr Res Educ & Clin Ctr, Gainesville, FL USA; [Wadley, Virginia G.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Whelton, Paul K.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; [Whittle, Jeffrey] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; [Whittle, Jeffrey] Clement J Zablocki Vet Affairs Med Ctr, Primary Care Div, Milwaukee, WI USA; [Wright, Jackson T., Jr.] Case Western Reserve Univ, Dept Med, Div Nephrol & Hypertens, Cleveland, OH 44106 USA; Wake Forest Sch Med, Dept Biostat Sci, Div Publ Hlth Sci, Winston Salem, NC USA	Wake Forest University; Utah System of Higher Education; University of Utah; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Boston University; Medical University of South Carolina; Stanford University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Mayo Clinic; Wake Forest University; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Wake Forest University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Tulane University; Tulane University; Ochsner Health System; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Alabama System; University of Alabama Birmingham; Wake Forest University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; State University System of Florida; University of Florida; Geriatric Research Education & Clinical Center; University of Alabama System; University of Alabama Birmingham; Tulane University; Medical College of Wisconsin; Case Western Reserve University; Wake Forest University	Williamson, JD (corresponding author), Wake Forest Sch Med, Med Ctr Blvd, Dept Internal Med, Sect Gerontol & Geriatr Med,Sticht Ctr Aging, Winston Salem, NC 27157 USA.; Williamson, JD (corresponding author), Wake Forest Sch Med, Med Ctr Blvd, Sect Gerontol & Geriatr Med, Winston Salem, NC 27157 USA.	jwilliam@wakehealth.edu	Sink, Kaycee/AAY-5920-2020; Pajewski, Nicholas/J-1096-2019	Sink, Kaycee/0000-0001-9608-3856; Chertow, Glenn/0000-0002-7599-0534; Supiano, Mark/0000-0002-5438-5087; Berlowitz, Dan/0000-0002-8783-5611; Whittle, Jeff/0000-0002-9544-838X	National Institutes of Health (National Heart, Lung, and Blood Institute) [HHSN268200900040C, HHSN268200900046C, HHSN268200900047C, HHSN268200900048C, HHSN268200900049C, A-HL-13-002-001]; National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases) [HHSN268200900040C, HHSN268200900046C, HHSN268200900047C, HHSN268200900048C, HHSN268200900049C, A-HL-13-002-001]; National Institutes of Health (National Institute on Aging) [HHSN268200900040C, HHSN268200900046C, HHSN268200900047C, HHSN268200900048C, HHSN268200900049C, A-HL-13-002-001]; National Institutes of Health (National Institute of Neurological Disorders and Stroke) [HHSN268200900040C, HHSN268200900046C, HHSN268200900047C, HHSN268200900048C, HHSN268200900049C, A-HL-13-002-001]; Department of Veterans Affairs; Wake Forest Claude Pepper Older Americans Independence Center [P30-AG21332, R01-HL10741]; National Center for Advancing Translational Sciences [UL1TR000439, UL1RR025755, UL1RR024134, UL1TR000003, UL1RR025771, UL1TR000093, UL1RR025752, UL1TR000073, UL1TR001064, UL1TR000050, UL1TR000005, 9U54TR000017-06, UL1TR000105-05, UL1 TR000064, UL1TR000433]; National Institute of General Medical Sciences, Centers of Biomedical Research Excellence [NIGMS P30GM103337]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000073, UL1TR000075, UL1TR000064, UL1TR001085, UL1TR001064, UL1TR000105, UL1TR000445, UL1TR000005, UL1TR000433, UL1TR000002, UL1TR000093, UL1TR000003, UL1TR000050, UL1TR001070, UL1TR001427, UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755, UL1RR024134, UL1RR025752, UL1RR025771] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107257, R01HL107241, R01HL130500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021332] Funding Source: NIH RePORTER	National Institutes of Health (National Heart, Lung, and Blood Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health (National Institute on Aging)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health (National Institute of Neurological Disorders and Stroke)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Department of Veterans Affairs(US Department of Veterans Affairs); Wake Forest Claude Pepper Older Americans Independence Center; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of General Medical Sciences, Centers of Biomedical Research Excellence; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The SPRINT study was funded by the National Institutes of Health (including the National Heart, Lung, and Blood Institute, the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute on Aging, and the National Institute of Neurological Disorders and Stroke) under contracts HHSN268200900040C, HHSN268200900046C, HHSN268200900047C, HHSN268200900048C, and HHSN268200900049C and interagency agreement A-HL-13-002-001. It was also supported in part with resources and use of facilities through the Department of Veterans Affairs. Azilsartan and chlorthalidone (combined with azilsartan) were provided by Takeda Pharmaceuticals International Inc. Additional support was provided by grants P30-AG21332 and R01-HL10741 from the Wake Forest Claude Pepper Older Americans Independence Center; through the following National Center for Advancing Translational Sciences clinical and translational science awards: UL1TR000439 (awarded to Case Western Reserve University); UL1RR025755 (Ohio State University); UL1RR024134 and UL1TR000003 (University of Pennsylvania); UL1RR025771 (Boston University); UL1TR000093 (Stanford University); UL1RR025752, UL1TR000073, and UL1TR001064 (Tufts University); UL1TR000050 (University of Illinois); UL1TR000005 (University of Pittsburgh); 9U54TR000017-06 (University of Texas Southwestern Medical Center); UL1TR000105-05 (University of Utah); UL1 TR000445 (Vanderbilt University); UL1TR000075 (George Washington University); UL1 TR000002 (University of California, Davis); UL1 TR000064 (University of Florida); and UL1TR000433 (University of Michigan); and by National Institute of General Medical Sciences, Centers of Biomedical Research Excellence award NIGMS P30GM103337 (awarded to Tulane University).	Altman DG, 1998, BRIT MED J, V317, P1309, DOI 10.1136/bmj.317.7168.1309; Ambrosius WT, 2014, CLIN TRIALS, V11, P532, DOI 10.1177/1740774514537404; [Anonymous], 2015, CIRCULATION, DOI DOI 10.1161/CIR.0000000000000152; Apperloo AJ, 1997, KIDNEY INT, V51, P793, DOI 10.1038/ki.1997.111; Bakris GL, 2000, ARCH INTERN MED, V160, P685, DOI 10.1001/archinte.160.5.685; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Benavente OR, 2013, LANCET, V382, P507, DOI 10.1016/S0140-6736(13)60852-1; Blodgett J, 2015, ARCH GERONTOL GERIAT, V60, P464, DOI 10.1016/j.archger.2015.01.016; Bress AP, 2016, J AM COLL CARDIOL, V67, P463, DOI 10.1016/j.jacc.2015.10.037; Charlesworth CJ, 2016, AM J HYPERTENS, V29, P690, DOI 10.1093/ajh/hpv177; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; den Ouden MEM, 2014, EXP GERONTOL, V58, P1, DOI 10.1016/j.exger.2014.06.002; Dong HR, 2015, AM J EPIDEMIOL, V181, P532, DOI 10.1093/aje/kwu289; ETTINGER WH, 1994, J AM GERIATR SOC, V42, P1035, DOI 10.1111/j.1532-5415.1994.tb06206.x; Ferrucci L, 1997, JAMA-J AM MED ASSOC, V277, P728; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gangavati A, 2011, J AM GERIATR SOC, V59, P383, DOI 10.1111/j.1532-5415.2011.03317.x; Hoover M, 2013, HEALTH REP, V24, P10; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kjeldsen S, 2014, DRUGS, V74, P2033, DOI 10.1007/s40265-014-0306-5; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Margolis KL, 2014, J GEN INTERN MED, V29, P1599, DOI 10.1007/s11606-014-2961-3; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Ooi WL, 1997, JAMA-J AM MED ASSOC, V277, P1299, DOI 10.1001/jama.277.16.1299; Pajewski NM, 2016, J GERONTOL A-BIOL, V71, P649, DOI 10.1093/gerona/glv228; Peralta CA, 2014, HYPERTENSION, V64, P472, DOI 10.1161/HYPERTENSIONAHA.114.03831; PRENTICE RL, 1981, BIOMETRIKA, V68, P373, DOI 10.1093/biomet/68.2.373; Sabayan B, 2013, STROKE, V44, P15, DOI 10.1161/STROKEAHA.112.663062; Sussman J, 2013, CIRCULATION, V128, P2309, DOI 10.1161/CIRCULATIONAHA.113.002290; van Kan GA, 2009, J NUTR HEALTH AGING, V13, P881; Warwick J, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0328-1; Wright JT, 2015, NEW ENGL J MED, V373, P2103, DOI 10.1056/NEJMoa1511939; Wright JT, 2014, ANN INTERN MED, V160, P499, DOI 10.7326/M13-2981; [No title captured]	34	754	779	3	92	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 28	2016	315	24					2673	2682		10.1001/jama.2016.7050	http://dx.doi.org/10.1001/jama.2016.7050			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP7WG	27195814	Bronze, Green Accepted			2022-12-28	WOS:000378709300018
J	Lane, R				Lane, Richard			George Patton: global leader in adolescent health	LANCET			English	Biographical-Item																		PATTON G, PUBLICATION LIST	1	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 11	2016	387	10036					2373	2373		10.1016/S0140-6736(16)30465-2	http://dx.doi.org/10.1016/S0140-6736(16)30465-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO1ST	27174306				2022-12-28	WOS:000377560100017
J	El Abiad, Y; Qarro, A				El Abiad, Yassine; Qarro, Abdelmounaim			Acute Varicocele Revealing Renal Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[El Abiad, Yassine; Qarro, Abdelmounaim] My Ismail Mil Hosp, Meknes, Morocco	Moulay Ismail University of Meknes	El Abiad, Y (corresponding author), My Ismail Mil Hosp, Meknes, Morocco.	yassineelabiad@gmail.com							0	7	7	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 26	2016	374	21					2075	2075		10.1056/NEJMicm1506668	http://dx.doi.org/10.1056/NEJMicm1506668			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6EN	27223149				2022-12-28	WOS:000376443500010
J	Mills, KT; Chen, J; Yang, W; Appel, LJ; Kusek, JW; Alper, A; Delafontaine, P; Keane, MG; Mohler, E; Ojo, A; Rahman, M; Ricardo, AC; Soliman, EZ; Steigerwalt, S; Townsend, R; He, J				Mills, Katherine T.; Chen, Jing; Yang, Wei; Appel, Lawrence J.; Kusek, John W.; Alper, Arnold; Delafontaine, Patrice; Keane, Martin G.; Mohler, Emile; Ojo, Akinlolu; Rahman, Mahboob; Ricardo, Ana C.; Soliman, Elsayed Z.; Steigerwalt, Susan; Townsend, Raymond; He, Jiang		CRIC Study Investigators	Sodium Excretion and the Risk of Cardiovascular Disease in Patients With Chronic Kidney Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC RENAL-INSUFFICIENCY; BLOOD-PRESSURE; URINARY SODIUM; REGRESSION-MODELS; POTASSIUM INTAKE; SALT INTAKE; ASSOCIATION; ADULTS; HYPERTENSION; REDUCTION	IMPORTANCE Patients with chronic kidney disease (CKD) are at an increased risk of cardiovascular disease (CVD) compared with the general population. Prior studies have produced contradictory results on the association of dietary sodium intake with risk of CVD, and this relationship has not been investigated in patients with CKD. OBJECTIVE To evaluate the association between urinary sodium excretion and clinical CVD events among patients with CKD. DESIGN, SETTING, AND PARTICIPANTS A prospective cohort study of patients with CKD from 7 locations in the United States enrolled in the Chronic Renal Insufficiency Cohort Study and followed up from May 2003 to March 2013. EXPOSURES The cumulative mean of urinary sodium excretion from three 24-hour urinary measurements and calibrated to sex-specific mean 24-hour urinary creatinine excretion. MAIN OUTCOMES AND MEASURES A composite of CVD events defined as congestive heart failure, stroke, or myocardial infarction. Events were reported every 6 months and confirmed by medical record adjudication. RESULTS Among 3757 participants (mean age, 58 years; 45% women), 804 composite CVD events (575 heart failure, 305 myocardial infarction, and 148 stroke) occurred during a median 6.8 years of follow-up. From lowest (<2894 mg/24 hours) to highest (>= 4548 mg/24 hours) quartile of calibrated sodium excretion, 174, 159, 198, and 273 composite CVD events occurred, and the cumulative incidence was 18.4%, 16.5%, 20.6%, and 29.8% at median follow-up. In addition, the cumulative incidence of CVD events in the highest quartile of calibrated sodium excretion compared with the lowest was 23.2% vs 13.3% for heart failure, 10.9% vs 7.8% for myocardial infarction, and 6.4% vs 2.7% for stroke at median follow-up. Hazard ratios of the highest quartile compared with the lowest quartile were 1.36 (95% CI, 1.09-1.70; P = .007) for composite CVD events, 1.34 (95% CI, 1.03-1.74; P = .03) for heart failure, and 1.81 (95% CI, 1.08-3.02; P = .02) for stroke after multivariable adjustment. Restricted cubic spline analyses of the association between sodium excretion and composite CVD provided no evidence of a nonlinear association (P = .11) and indicated a significant linear association (P < .001). CONCLUSIONS AND RELEVANCE Among patients with CKD, higher urinary sodium excretion was associated with increased risk of CVD.	[Mills, Katherine T.; Chen, Jing; He, Jiang] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, 1440 Canal St,Ste 2000, New Orleans, LA 70112 USA; [Chen, Jing; Alper, Arnold; Delafontaine, Patrice; He, Jiang] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA; [Yang, Wei] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Appel, Lawrence J.] Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Kusek, John W.; Townsend, Raymond] NIDDK, Div Kidney Urol & Hematol Dis, NIH, Bethesda, MD 20892 USA; [Keane, Martin G.] Temple Univ, Sch Med, Dept Med, Philadelphia, PA 19122 USA; [Mohler, Emile] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ojo, Akinlolu] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; [Rahman, Mahboob] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Div Nephrol & Hypertens, Cleveland, OH 44106 USA; [Rahman, Mahboob] Louis Stokes Cleveland VA Med Ctr, Cleveland, OH USA; [Ricardo, Ana C.] Univ Illinois, Dept Med, Chicago, IL USA; [Soliman, Elsayed Z.] Wake Forest Sch Med, Dept Internal Med Cardiol, Winston Salem, NC USA; [Steigerwalt, Susan] St Johns Hlth Syst, Dept Med, Detroit, MI USA	Tulane University; Tulane University; University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; Pennsylvania Medicine; University of Michigan System; University of Michigan; Case Western Reserve University; Case Western Reserve University Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Wake Forest University	He, J (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, 1440 Canal St,Ste 2000, New Orleans, LA 70112 USA.	jhe@tulane.edu	Appel, Larry/GLT-2608-2022; Ricardo, Ana/AAN-6583-2021; Soliman, Elsayed Z/AAD-7135-2020; He, Jiang/AAF-5303-2020; Keane, Martin/A-1072-2007	Ricardo, Ana/0000-0001-8670-3644; Soliman, Elsayed Z/0000-0001-5632-8150; He, Jiang/0000-0002-8286-9652; Delafontaine, Patrice/0000-0003-3744-3617; Keane, Martin/0000-0002-6567-3826	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK074615]; NIDDK [U01DK060990, U01DK060984, U01DK061022, U01DK061021, U01DK061028, U01DK060980, U01DK060963, U01DK060902]; University of Pennsylvania Clinical and Translational Science Award [NIH/NCATS UL1TR000003]; Johns Hopkins University [UL1 TR-000424]; University of Maryland [GCRC M01 RR-16500]; Clinical and Translational Science Collaborative of Cleveland [UL1TR000439]; Michigan Institute for Clinical and Health Research [UL1TR000433]; University of Illinois at Chicago [CTSA UL1RR029879]; Tulane COBRE for Clinical and Translational Research in Cardiometabolic Diseases [P20 GM109036]; Kaiser [NIH/NCRR UCSF-CTSI UL1 RR-024131]; National Heart, Lung, and Blood Institute [T32HL007024]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000003, UL1TR000439, UL1TR000433, UL1TR000424] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131, UL1RR029879, M01RR016500] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK060963, K23DK094829, U01DK060902, R01DK074615, U01DK061022, U01DK060980, U01DK060984, U01DK060990, U01DK061021, U01DK061028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109036] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Pennsylvania Clinical and Translational Science Award; Johns Hopkins University(Johns Hopkins University); University of Maryland; Clinical and Translational Science Collaborative of Cleveland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Michigan Institute for Clinical and Health Research; University of Illinois at Chicago; Tulane COBRE for Clinical and Translational Research in Cardiometabolic Diseases; Kaiser; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by a research grant (R01DK074615) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Funding for the CRIC Study was obtained under a cooperative agreement from the NIDDK (U01DK060990, U01DK060984, U01DK061022, U01DK061021, U01DK061028, U01DK060980, U01DK060963, and U01DK060902). In addition, this work was supported in part by the University of Pennsylvania Clinical and Translational Science Award (NIH/NCATS UL1TR000003), Johns Hopkins University (UL1 TR-000424), University of Maryland (GCRC M01 RR-16500), Clinical and Translational Science Collaborative of Cleveland (UL1TR000439), Michigan Institute for Clinical and Health Research (UL1TR000433), University of Illinois at Chicago (CTSA UL1RR029879), Tulane COBRE for Clinical and Translational Research in Cardiometabolic Diseases (P20 GM109036), and Kaiser (NIH/NCRR UCSF-CTSI UL1 RR-024131). Dr Mills is supported in part by the National Heart, Lung, and Blood Institute Cardiovascular Epidemiology training grant (T32HL007024, principal investigator: Coresh).	ALDERMAN MH, 1995, HYPERTENSION, V25, P1144, DOI 10.1161/01.HYP.25.6.1144; [Anonymous], 2007, DIET HIST QUEST VERS; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; Cook NR, 2014, CIRCULATION, V129, P981, DOI 10.1161/CIRCULATIONAHA.113.006032; COX DR, 1972, J R STAT SOC B, V34, P187; Currie G, 2014, INT J NEPHROL RENOV, V7, P13, DOI 10.2147/IJNRD.S40522; Denny SD, 2006, AM J MED, V119, P327, DOI [10.1016/j.amjmed.2005.08.027, 10.1016/j.amjmed.2005.10.042]; Dobrian AD, 2003, AM J PHYSIOL-RENAL, V285, pF619, DOI 10.1152/ajprenal.00388.2002; Dong J, 2010, CLIN J AM SOC NEPHRO, V5, P240, DOI 10.2215/CJN.05410709; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Ekinci EI, 2011, DIABETES CARE, V34, P703, DOI 10.2337/dc10-1723; Frohlich ED, 2007, HYPERTENSION, V50, P161, DOI 10.1161/HYPERTENSIONAHA.107.088328; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; He F. J., 2013, BMJ, V346; He J, 2002, ARCH INTERN MED, V162, P1619, DOI 10.1001/archinte.162.14.1619; He JA, 1999, JAMA-J AM MED ASSOC, V282, P2027, DOI 10.1001/jama.282.21.2027; HOLBROOK JT, 1984, AM J CLIN NUTR, V40, P786, DOI 10.1093/ajcn/40.4.786; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; IOM (Institute of Medicine), 2013, SOD INT POP ASS EV; Johnson RJ, 2002, NEW ENGL J MED, V346, P913, DOI 10.1056/NEJMra011078; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Lambers Heerspink HJ, 2012, KIDNEY INT, V82, P330, DOI 10.1038/ki.2012.74; Lash JP, 2009, CLIN J AM SOC NEPHRO, V4, P1302, DOI 10.2215/CJN.00070109; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2007, AM J KIDNEY DIS, V49, pS10, DOI 10.1053/j.ajkd.2006.12.004; LIU K, 1979, AM J EPIDEMIOL, V110, P219, DOI 10.1093/oxfordjournals.aje.a112806; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Musso Carlos G., 2004, International Urology and Nephrology, V36, P465, DOI 10.1007/s11255-004-6193-z; Nagata C, 2004, STROKE, V35, P1543, DOI 10.1161/01.STR.0000130425.50441.b0; O'Donnell MJ, 2011, JAMA-J AM MED ASSOC, V306, P2229, DOI 10.1001/jama.2011.1729; Ogihara T, 2003, LIFE SCI, V73, P509, DOI 10.1016/S0024-3205(03)00315-1; PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460; SANDLE GI, 1986, CLIN SCI, V71, P393, DOI 10.1042/cs0710393; Stolarz-Skrzypek K, 2011, JAMA-J AM MED ASSOC, V305, P1777, DOI 10.1001/jama.2011.574; Subar AF, 2003, AM J EPIDEMIOL, V158, P1, DOI 10.1093/aje/kwg092; Weir MR, 2010, CLIN J AM SOC NEPHRO, V5, P531, DOI 10.2215/CJN.07821109; Whelton PK, 2012, CIRCULATION, V126, P2880, DOI 10.1161/CIR.0b013e318279acbf; Yang QH, 2011, ARCH INTERN MED, V171, P1183, DOI 10.1001/archinternmed.2011.257	39	142	149	0	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 24	2016	315	20					2200	2210		10.1001/jama.2016.4447	http://dx.doi.org/10.1001/jama.2016.4447			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM4US	27218629	Green Accepted, Bronze			2022-12-28	WOS:000376343000016
J	O'Connor, J				O'Connor, Jeremy			Black Lives	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COLORECTAL-CANCER		[O'Connor, Jeremy] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA	University of Chicago	O'Connor, J (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	jeremy.o'connor@uchospitals.edu		O'Connor, Jeremy/0000-0002-7907-6432				Clemans-Cope L, 2014, RACIAL ETHNIC DIFFER; Ferrante JM, 2013, ANN INTERN MED, V159, P437, DOI 10.7326/0003-4819-159-7-201310010-00003; Grubbs SS, 2013, J CLIN ONCOL, V31, P1928, DOI 10.1200/JCO.2012.47.8412; Jemal A, 2015, J CLIN ONCOL, V33, P829, DOI 10.1200/JCO.2014.58.7519	4	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 24	2016	315	20					2169	2170		10.1001/jama.2016.1689	http://dx.doi.org/10.1001/jama.2016.1689			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM4US	27218626				2022-12-28	WOS:000376343000010
J	Howie, J				Howie, John			John Sanford Berkeley OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		BERKELEY JS, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2016	353								i2792	10.1136/bmj.i2792	http://dx.doi.org/10.1136/bmj.i2792			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GI	27206978				2022-12-28	WOS:000376448200007
J	Kamarthapu, V; Epshtein, V; Benjamin, B; Proshkin, S; Mironov, A; Cashel, M; Nudler, E				Kamarthapu, Venu; Epshtein, Vitaly; Benjamin, Bradley; Proshkin, Sergey; Mironov, Alexander; Cashel, Michael; Nudler, Evgeny			ppGpp couples transcription to DNA repair in E. coli	SCIENCE			English	Article							NUCLEOTIDE EXCISION-REPAIR; ESCHERICHIA-COLI; RNA-POLYMERASE; UVRD GENE; IN-VITRO; REPLICATION; MECHANISM; DAMAGE; INITIATION; HELICASE	The small molecule alarmone (p) ppGpp mediates bacterial adaptation to nutrient deprivation by altering the initiation properties of RNA polymerase (RNAP). ppGpp is generated in Escherichia coli by two related enzymes, RelA and SpoT. We show that ppGpp is robustly, but transiently, induced in response to DNA damage and is required for efficient nucleotide excision DNA repair (NER). This explains why relA-spoT-deficient cells are sensitive to diverse genotoxic agents and ultraviolet radiation, whereas ppGpp induction renders them more resistant to such challenges. The mechanism of DNA protection by ppGpp involves promotion of UvrD-mediated RNAP backtracking. By rendering RNAP backtracking-prone, ppGpp couples transcription to DNA repair and prompts transitions between repair and recovery states.	[Kamarthapu, Venu; Epshtein, Vitaly; Benjamin, Bradley; Nudler, Evgeny] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Kamarthapu, Venu; Nudler, Evgeny] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Proshkin, Sergey; Mironov, Alexander] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow 119991, Russia; [Cashel, Michael] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Dev Biol, Intramural Res Program, NIH, Bethesda, MD 20892 USA	New York University; Howard Hughes Medical Institute; New York University; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Nudler, E (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA.; Nudler, E (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA.	evgeny.nudler@nyumc.org	Proshkin, Sergey/G-2733-2017; Mironov, Alexander/G-8531-2013	Proshkin, Sergey/0000-0002-6116-4637; Mironov, Alexander/0000-0003-3914-1380; Nudler, Evgeny/0000-0002-8811-3071	Russian Science Foundation [14-50-00060]; Ministry of Education and Science of the Russian Federation [14.Z50.31.0014]; National Institute of Child Health and Human Development, NIH; NIH [R01 GM107329]; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107329] Funding Source: NIH RePORTER	Russian Science Foundation(Russian Science Foundation (RSF)); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Lloyd for N4849 and N4235 strains and T. Artemyev for his contribution. This work was supported by the Russian Science Foundation grant 14-50-00060 and the Ministry of Education and Science of the Russian Federation grant 14.Z50.31.0014 (S.P. and A.M.), the National Institute of Child Health and Human Development, NIH Intramural Program (M.C.), NIH grant R01 GM107329, and by the Howard Hughes Medical Institute (E.N.).	ARTHUR HM, 1983, GENE, V25, P309, DOI 10.1016/0378-1119(83)90235-4; Barker MM, 2001, J MOL BIOL, V305, P673, DOI 10.1006/jmbi.2000.4327; Batty DP, 2000, GENE, V241, P193, DOI 10.1016/S0378-1119(99)00489-8; DeNapoli J, 2013, MOL MICROBIOL, V88, P93, DOI 10.1111/mmi.12172; Dutta D, 2011, CELL, V146, P533, DOI 10.1016/j.cell.2011.07.034; Epshtein V, 2003, EMBO J, V22, P4719, DOI 10.1093/emboj/cdg452; Epshtein V, 2014, NATURE, V505, P372, DOI 10.1038/nature12928; Kamarthapu V, 2015, CURR OPIN MICROBIOL, V24, P15, DOI 10.1016/j.mib.2014.12.005; Madison KE, 2014, MOL MICROBIOL, V92, P28, DOI 10.1111/mmi.12538; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; Maluf NK, 2003, J MOL BIOL, V325, P889, DOI 10.1016/S0022-2836(02)01276-7; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; McGlynn P, 2000, CELL, V101, P35, DOI 10.1016/S0092-8674(00)80621-2; MELLON I, 1989, NATURE, V342, P95, DOI 10.1038/342095a0; Park JS, 2002, CELL, V109, P757, DOI 10.1016/S0092-8674(02)00769-9; Parshin A, 2015, P NATL ACAD SCI USA, V112, pE6862, DOI 10.1073/pnas.1521365112; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Potrykus K, 2011, ENVIRON MICROBIOL, V13, P563, DOI 10.1111/j.1462-2920.2010.02357.x; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; Reardon JT, 2005, PROG NUCLEIC ACID RE, V79, P183, DOI 10.1016/S0079-6603(04)79004-2; SARUBBI E, 1988, MOL GEN GENET, V213, P214, DOI 10.1007/BF00339584; Schalow BJ, 2012, J BACTERIOL, V194, P2637, DOI 10.1128/JB.06725-11; SCHREIBER G, 1995, CURR MICROBIOL, V30, P27, DOI 10.1007/BF00294520; Sekine S, 2015, MOL CELL, V57, P408, DOI 10.1016/j.molcel.2014.12.014; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SIEGEL EC, 1983, MOL GEN GENET, V191, P397, DOI 10.1007/BF00425753; Trautinger BW, 2005, MOL CELL, V19, P247, DOI 10.1016/j.molcel.2005.06.004; Westblade LF, 2010, NUCLEIC ACIDS RES, V38, P8357, DOI 10.1093/nar/gkq692; Zuo YH, 2013, MOL CELL, V50, P430, DOI 10.1016/j.molcel.2013.03.020	29	85	86	4	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2016	352	6288			SI		993	996		10.1126/science.aad6945	http://dx.doi.org/10.1126/science.aad6945			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM2AK	27199428	Green Accepted			2022-12-28	WOS:000376147800049
J	Kimmelman, J; Hyun, I; Benvenisty, N; Caulfield, T; Heslop, HE; Murry, CE; Sipp, D; Studer, L; Sugarman, J; Daley, GQ				Kimmelman, Jonathan; Hyun, Insoo; Benvenisty, Nissim; Caulfield, Timothy; Heslop, Helen E.; Murry, Charles E.; Sipp, Douglas; Studer, Lorenz; Sugarman, Jeremy; Daley, George Q.			Global standards for stem-cell research	NATURE			English	Editorial Material							ISSCR GUIDELINES		[Kimmelman, Jonathan] McGill Univ, Biomed Eth, Montreal, PQ, Canada; [Hyun, Insoo; Benvenisty, Nissim; Caulfield, Timothy; Heslop, Helen E.; Murry, Charles E.; Sipp, Douglas; Studer, Lorenz; Sugarman, Jeremy; Daley, George Q.] Int Soc Stem Cell Res Guidelines Task Force, Steering Comm, Skokie, IL 60077 USA	McGill University	Kimmelman, J (corresponding author), McGill Univ, Biomed Eth, Montreal, PQ, Canada.; Daley, GQ (corresponding author), Int Soc Stem Cell Res Guidelines Task Force, Steering Comm, Skokie, IL 60077 USA.	jonathan.kimmelman@mcgill.ca; george.daley@childrens.harvard.edu	Studer, Lorenz/ABH-1491-2021; Heslop, Helen/AAC-9500-2020; Sipp, Doug/C-9218-2017	Studer, Lorenz/0000-0003-0741-7987; Sipp, Doug/0000-0002-5979-0938; Sugarman, Jeremy/0000-0001-7022-8332				[Anonymous], 2016, GUID STEM CELL SCI C; Campbell A, 2001, McGill Law J, V46, P473; Daley GQ, 2007, SCIENCE, V315, P603, DOI 10.1126/science.1139337; De Los Angeles A, 2015, NATURE, V525, P469, DOI 10.1038/nature15515; Haimes E, 2013, CELL STEM CELL, V12, P285, DOI 10.1016/j.stem.2013.02.002; Hyun I, 2007, CELL STEM CELL, V1, P367, DOI 10.1016/j.stem.2007.09.006; Hyun I, 2016, NATURE, V533, P169, DOI 10.1038/533169a; Hyun I, 2008, CELL STEM CELL, V3, P607, DOI 10.1016/j.stem.2008.11.009; Taylor PL, 2010, CELL STEM CELL, V7, P43, DOI 10.1016/j.stem.2010.06.001; United States National Institutes of Health, 2015, NIH RES INV INTR HUM	10	36	36	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					311	313		10.1038/533311a	http://dx.doi.org/10.1038/533311a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM0AH	27193661	Bronze			2022-12-28	WOS:000376004300020
J	Lemieux, B; Laterreur, N; Perederina, A; Noel, JF; Dubois, ML; Krasilnikov, AS; Wellinger, RJ				Lemieux, Bruno; Laterreur, Nancy; Perederina, Anna; Noel, Jean-Francois; Dubois, Marie-Line; Krasilnikov, Andrey S.; Wellinger, Raymund J.			Active Yeast Telomerase Shares Subunits with Ribonucleoproteins RNase P and RNase MRP	CELL			English	Article							SACCHAROMYCES-CEREVISIAE TELOMERASE; TERMINAL TRANSFERASE; FLEXIBLE SCAFFOLD; RIBONUCLEASE P; IN-VITRO; IDENTIFICATION; P/MRP; TETRAHYMENA; BIOGENESIS; SENESCENCE	Telomerase is the ribonucleoprotein enzyme that replenishes telomeric DNA and maintains genome integrity. Minimally, telomerase activity requires a templating RNA and a catalytic protein. Additional proteins are required for activity on telomeres in vivo. Here, we report that the Pop1, Pop6, and Pop7 proteins, known components of RNase P and RNase MRP, bind to yeast telomerase RNA and are essential constituents of the telomerase holoenzyme. Pop1/Pop6/Pop7 binding is specific and involves an RNA domain highly similar to a protein-binding domain in the RNAs of RNase P/MRP. The results also show that Pop1/Pop6/Pop7 function to maintain the essential components Est1 and Est2 on the RNA in vivo. Consistently, addition of Pop1 allows for telomerase activity reconstitution with wild-type telomerase RNA in vitro. Thus, the same chaperoning module has allowed the evolution of functionally and, remarkably, structurally distinct RNPs, telomerase, and RNases P/MRP from unrelated progenitor RNAs.	[Lemieux, Bruno; Laterreur, Nancy; Noel, Jean-Francois; Wellinger, Raymund J.] Univ Sherbrooke, Dept Microbiol & Infect Dis, Ctr Excellence RNA Biol, Sherbrooke, PQ J1E 4K8, Canada; [Perederina, Anna; Krasilnikov, Andrey S.] Penn State Univ, Ctr RNA Mol Biol, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Dubois, Marie-Line] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Anat & Cellular Biol, Sherbrooke, PQ J1E 4K8, Canada	University of Sherbrooke; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Sherbrooke	Wellinger, RJ (corresponding author), Univ Sherbrooke, Dept Microbiol & Infect Dis, Ctr Excellence RNA Biol, Sherbrooke, PQ J1E 4K8, Canada.	raymund.wellinger@usherbrooke.ca	Wellinger, Raymund/K-3207-2019	Wellinger, Raymund/0000-0001-6670-2759	Canadian Institutes of Health Research [CIHR 97874]; Canadian Research Chair in Telomere Biology; CRCHUS; NIH [GM085149]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085149] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Research Chair in Telomere Biology; CRCHUS; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Benjira for help during project setup, D. Engelke, V. Lundblad, M. Schmitt, and D. Zappulla for valuable tools such as numerous yeast strains and plasmids, I. Berezin for help with protein purification, and members of the R.J.W. lab for input. We also thank F.-M. Boisvert for use of his MS facility. This work was supported by a grant from the Canadian Institutes of Health Research (CIHR 97874) (to R.J.W.) and the Canadian Research Chair in Telomere Biology and support by the CRCHUS (to R.J.W.). A.S.K. was supported by an NIH grant (GM085149).	Bajon E, 2015, CELL REP, V12, P441, DOI 10.1016/j.celrep.2015.06.045; Chang M, 2007, GENE DEV, V21, P2485, DOI 10.1101/gad.1588807; Chappell AS, 2004, MOL CELL BIOL, V24, P7720, DOI 10.1128/MCB.24.17.7720-7736.2004; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dandjinou AT, 2004, CURR BIOL, V14, P1148, DOI 10.1016/j.cub.2004.05.054; Drissi R, 2015, MOL CELL PROTEOMICS, V14, P2002, DOI 10.1074/mcp.M115.048991; Egan ED, 2012, RNA, V18, P1747, DOI 10.1261/rna.034629.112; Esakova O, 2010, RNA, V16, P1725, DOI 10.1261/rna.2214510; Fagerlund RD, 2015, RNA, V21, P1591, DOI 10.1261/rna.049007.114; Friedman KL, 1999, GENE DEV, V13, P2863, DOI 10.1101/gad.13.21.2863; Gallardo F, 2011, MOL CELL, V44, P819, DOI 10.1016/j.molcel.2011.09.020; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Gunisova S, 2009, RNA, V15, P546, DOI 10.1261/rna.1194009; Hipp K, 2012, NUCLEIC ACIDS RES, V40, P3275, DOI 10.1093/nar/gkr1217; Hockemeyer D, 2015, NAT STRUCT MOL BIOL, V22, P848, DOI 10.1038/nsmb.3083; Khanova E, 2012, RNA, V18, P720, DOI 10.1261/rna.030874.111; Laterreur N, 2013, NUCLEIC ACIDS RES, V41, P7713, DOI 10.1093/nar/gkt514; Lebo KJ, 2015, RNA, V21, P862, DOI 10.1261/rna.049379.114; Lebo KJ, 2012, RNA, V18, P1666, DOI 10.1261/rna.033555.112; Lendvay TS, 1996, GENETICS, V144, P1399; Lin KW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9290; Lindahl L, 2000, RNA, V6, P653, DOI 10.1017/S1355838200992574; Lingner J, 1997, P NATL ACAD SCI USA, V94, P11190, DOI 10.1073/pnas.94.21.11190; Livengood AJ, 2002, MOL CELL BIOL, V22, P2366, DOI 10.1128/MCB.22.7.2366-2374.2002; Lubin JW, 2012, RNA, V18, P1597, DOI 10.1261/rna.034447.112; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; Mozdy AD, 2006, RNA, V12, P1721, DOI 10.1261/rna.134706; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Perederina A, 2007, RNA, V13, P1648, DOI 10.1261/rna.654407; Perederina A, 2010, EMBO J, V29, P761, DOI 10.1038/emboj.2009.396; Piccinelli P, 2005, NUCLEIC ACIDS RES, V33, P4485, DOI 10.1093/nar/gki756; Podlevsky JD, 2012, MUTAT RES-FUND MOL M, V730, P3, DOI 10.1016/j.mrfmmm.2011.11.002; Qi XD, 2013, NUCLEIC ACIDS RES, V41, P450, DOI 10.1093/nar/gks980; Reiter NJ, 2010, NATURE, V468, P784, DOI 10.1038/nature09516; Sarek G, 2015, NAT STRUCT MOL BIOL, V22, P867, DOI 10.1038/nsmb.3093; Schmidt JC, 2015, GENE DEV, V29, P1095, DOI 10.1101/gad.263863.115; Seto AG, 2003, RNA, V9, P1323, DOI 10.1261/rna.5570803; Seto AG, 2002, GENE DEV, V16, P2800, DOI 10.1101/gad.1029302; Seto AG, 1999, NATURE, V401, P177, DOI 10.1038/43694; Shadel GS, 2000, GENE, V245, P175, DOI 10.1016/S0378-1119(00)00013-5; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Stellwagen AE, 2003, GENE DEV, V17, P2384, DOI 10.1101/gad.1125903; Tucey TM, 2014, GENE DEV, V28, P2077, DOI 10.1101/gad.246256.114; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Zappulla DC, 2006, COLD SPRING HARB SYM, V71, P217, DOI 10.1101/sqb.2006.71.011; Zappulla DC, 2005, NAT STRUCT MOL BIOL, V12, P1072, DOI 10.1038/nsmb1019; Zappulla DC, 2004, P NATL ACAD SCI USA, V101, P10024, DOI 10.1073/pnas.0403641101; Ziehler WA, 2001, RNA, V7, P565, DOI 10.1017/S1355838201001996	51	57	57	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2016	165	5					1171	1181		10.1016/j.cell.2016.04.018	http://dx.doi.org/10.1016/j.cell.2016.04.018			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DM6QT	27156450	Bronze, Green Accepted			2022-12-28	WOS:000376478200017
J	Lu, ZP; Zhang, QC; Lee, B; Flynn, RA; Smith, MA; Robinson, JT; Davidovich, C; Gooding, AR; Goodrich, KJ; Mattick, JS; Mesirov, JP; Cech, TR; Chang, HY				Lu, Zhipeng; Zhang, Qiangfeng Cliff; Lee, Byron; Flynn, Ryan A.; Smith, Martin A.; Robinson, James T.; Davidovich, Chen; Gooding, Anne R.; Goodrich, Karen J.; Mattick, John S.; Mesirov, Jill P.; Cech, Thomas R.; Chang, Howard Y.			RNA Duplex Map in Living Cells Reveals Higher-Order Transcriptome Structure	CELL			English	Article							SMALL NUCLEOLAR RNA; SECONDARY STRUCTURE; X-CHROMOSOME; XIST RNA; PROMOTER DIRECTIONALITY; PROTEINS; DNA; INACTIVATION; SEQUENCE; ELEMENTS	RNA has the intrinsic property to base pair, forming complex structures fundamental to its diverse functions. Here, we develop PARIS, a method based on reversible psoralen crosslinking for global mapping of RNA duplexes with near base-pair resolution in living cells. PARIS analysis in three human and mouse cell types reveals frequent long-range structures, higher-order architectures, and RNA-RNA interactions in trans across the transcriptome. PARIS determines base-pairing interactions on an individual-molecule level, revealing pervasive alternative conformations. We used PARIS-determined helices to guide phylogenetic analysis of RNA structures and discovered conserved long-range and alternative structures. XIST, a long noncoding RNA (lncRNA) essential for X chromosome inactivation, folds into evolutionarily conserved RNA structural domains that span many kilobases. XIST A-repeat forms complex inter-repeat duplexes that nucleate higher-order assembly of the key epigenetic silencing protein SPEN. PARIS is a generally applicable and versatile method that provides novel insights into the RNA structurome and interactome.	[Lu, Zhipeng; Zhang, Qiangfeng Cliff; Lee, Byron; Flynn, Ryan A.; Chang, Howard Y.] Stanford Univ, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA; [Zhang, Qiangfeng Cliff] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Tsinghua Peking Joint Ctr Life Sci, MOE Key Lab Bioinformat,Ctr Synthet & Syst Biol,S, Beijing 100084, Peoples R China; [Smith, Martin A.; Mattick, John S.] St Vincents Hosp, Garvan Inst Med Res, RNA Biol & Plast Grp, Darlinghurst, NSW 2010, Australia; [Smith, Martin A.; Mattick, John S.] UNSW Med, St Vincents Clin Sch, Sydney, NSW 2052, Australia; [Robinson, James T.; Mesirov, Jill P.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Robinson, James T.; Mesirov, Jill P.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Davidovich, Chen; Gooding, Anne R.; Goodrich, Karen J.; Cech, Thomas R.] Univ Colorado, HHMI, Boulder, CO 80303 USA; [Davidovich, Chen; Gooding, Anne R.; Goodrich, Karen J.; Cech, Thomas R.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80303 USA; [Davidovich, Chen] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Davidovich, Chen] EMBL Australia, Clayton, Vic 3800, Australia; [Davidovich, Chen] ARC Ctr Excellence Adv Mol Imaging, Clayton, Vic 3800, Australia	Stanford University; Tsinghua University; Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Monash University; European Molecular Biology Laboratory (EMBL)	Chang, HY (corresponding author), Stanford Univ, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA.	howchang@stanford.edu	Lu, Zhipeng/E-1736-2017; Mattick, John/ABH-6130-2020; Mesirov, Jill/AGF-7626-2022; Zhang, Qiangfeng/C-2902-2011; Smith, Martin A./L-5265-2019; Mattick, John S/I-7789-2012	Lu, Zhipeng/0000-0001-5124-7546; Mattick, John/0000-0002-7680-7527; Smith, Martin A./0000-0003-2259-1713; Mattick, John S/0000-0002-7680-7527; Flynn, Ryan/0000-0001-5013-0442; Lee, Byron/0000-0001-7132-2662; Davidovich, Chen/0000-0002-1085-6094	NIH [R01-HG004361, P50-HG007735]; Damon Runyon-Sohn Foundation Pediatric Cancer Fellowship Award [DRSG-14-15]; Cancer Council NSW project [RG 14-18]; NATIONAL CANCER INSTITUTE [R01CA157304, U24CA194107, T32CA009302, P30CA124435] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG007517, P50HG007735, R01HG004361] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon-Sohn Foundation Pediatric Cancer Fellowship Award; Cancer Council NSW project(Cancer Council New South Wales); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Anton Petrov (Georgia Tech) for the compiled rRNA structures, Alexey Amunts (Stockholm University) for the mitochondrial rRNA structure, and Sebastian Will (MIT) for help with LocARNA software. We also want to thank Yoon-Jae Cho, Sekyung Oh, Y. Grace Chen for reagents. H.Y.C. is supported by NIH R01-HG004361 and P50-HG007735. Z.L. is a Layton Family Fellow of the Damon Runyon-Sohn Foundation Pediatric Cancer Fellowship Award (DRSG-14-15). M.A.S. and J.S.M. are supported by a Cancer Council NSW project grant (RG 14-18). T.R.C. is an investigator of the Howard Hughes Medical Institute.	Almada AE, 2013, NATURE, V499, P360, DOI 10.1038/nature12349; Arieti F, 2014, NUCLEIC ACIDS RES, V42, P6742, DOI 10.1093/nar/gku277; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; CALVET JP, 1979, P NATL ACAD SCI USA, V76, P755, DOI 10.1073/pnas.76.2.755; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; CECH TR, 1976, P NATL ACAD SCI USA, V73, P2644, DOI 10.1073/pnas.73.8.2644; Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025; CIMINO GD, 1985, ANNU REV BIOCHEM, V54, P1151, DOI 10.1146/annurev.bi.54.070185.005443; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Elisaphenko EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002521; Engreitz JM, 2014, CELL, V159, P188, DOI 10.1016/j.cell.2014.08.018; Fang R, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005668; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gesell T, 2006, BIOINFORMATICS, V22, P716, DOI 10.1093/bioinformatics/bti812; Ilik IA, 2013, MOL CELL, V51, P156, DOI 10.1016/j.molcel.2013.07.001; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; Kiss T, 2001, EMBO J, V20, P3617, DOI 10.1093/emboj/20.14.3617; Kutchko KM, 2015, RNA, V21, P1274, DOI 10.1261/rna.049221.114; Lee N, 2015, CELL, V160, P607, DOI 10.1016/j.cell.2015.01.015; Lu ZP, 2016, CURR OPIN STRUC BIOL, V36, P142, DOI 10.1016/j.sbi.2016.01.007; Lu ZP, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r7; Maenner S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000276; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; McHugh CA, 2015, NATURE, V521, P232, DOI 10.1038/nature14443; Moindrot B, 2015, CELL REP, V12, P562, DOI 10.1016/j.celrep.2015.06.053; Monfort A, 2015, CELL REP, V12, P554, DOI 10.1016/j.celrep.2015.06.067; Ntini E, 2013, NAT STRUCT MOL BIOL, V20, P923, DOI 10.1038/nsmb.2640; PECULIS BA, 1993, CELL, V73, P1233, DOI 10.1016/0092-8674(93)90651-6; Peculis BA, 1997, MOL CELL BIOL, V17, P3702, DOI 10.1128/MCB.17.7.3702; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Ramani V, 2015, NAT BIOTECHNOL, V33, P980, DOI 10.1038/nbt.3289; Ritz J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003152; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894; SHEN CKJ, 1976, P NATL ACAD SCI USA, V73, P2649, DOI 10.1073/pnas.73.8.2649; Smola MJ, 2015, BIOCHEMISTRY-US, V54, P6867, DOI 10.1021/acs.biochem.5b00977; Spitale RC, 2015, NATURE, V519, P486, DOI 10.1038/nature14263; Sugimoto Y, 2015, NATURE, V519, P491, DOI 10.1038/nature14280; Sunwoo H, 2015, P NATL ACAD SCI USA, V112, pE4216, DOI 10.1073/pnas.1503690112; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820	41	339	347	8	91	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2016	165	5					1267	1279		10.1016/j.cell.2016.04.028	http://dx.doi.org/10.1016/j.cell.2016.04.028			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DM6QT	27180905	Bronze, Green Accepted			2022-12-28	WOS:000376478200024
J	Hawkes, N				Hawkes, Nigel			Sixty seconds on ... psilocybin	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Carhart-Harris RL, 2016, LANCET PSYCHIAT, V3, P619, DOI 10.1016/S2215-0366(16)30065-7	1	1	1	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 18	2016	353								i2775	10.1136/bmj.i2775	http://dx.doi.org/10.1136/bmj.i2775			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GC	27194646				2022-12-28	WOS:000376447600008
J	Swanton, C; Govindan, R				Swanton, Charles; Govindan, Ramaswamy			Clinical Implications of Genomic Discoveries in Lung Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CIRCULATING TUMOR DNA; INTRATUMOR HETEROGENEITY; MUTATIONAL LANDSCAPE; CELL; FUSIONS; GENES; ADENOCARCINOMAS; PROGENITOR; PLASMA; IMPACT		[Swanton, Charles] Univ Coll London Hosp & Canc Inst, Translat Canc Therapeut Lab, Francis Crick Inst, London, England; [Swanton, Charles] Univ Coll London Hosp & Canc Inst, Canc Res UK CRUK Lung Canc Ctr Excellence, London, England; [Govindan, Ramaswamy] Washington Univ, Sch Med, Div Oncol, Dept Med, St Louis, MO 63110 USA; [Govindan, Ramaswamy] Washington Univ, Sch Med, Alvin J Siteman Canc Ctr, St Louis, MO 63110 USA	Francis Crick Institute; University College London Hospitals NHS Foundation Trust; University College London Hospitals NHS Foundation Trust; Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	Govindan, R (corresponding author), Washington Univ, Sch Med, Div Oncol, 660 S Euclid,Box 8056, St Louis, MO 63110 USA.	rgovinda@dom.wustl.edu		Swanton, Charles/0000-0002-4299-3018	Cancer Research UK [20466] Funding Source: researchfish; Novo Nordisk Fonden [NNF15OC0016584] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Novo Nordisk Fonden(Novo Nordisk Foundation)		Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Calbo J, 2011, CANCER CELL, V19, P244, DOI 10.1016/j.ccr.2010.12.021; Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chan KCA, 2013, CLIN CHEM, V59, P211, DOI 10.1373/clinchem.2012.196014; Cheung WKC, 2015, ONCOGENE, V34, P5771, DOI 10.1038/onc.2015.85; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; Downward J, 2015, CLIN CANCER RES, V21, P1802, DOI 10.1158/1078-0432.CCR-14-2180; Fernandez-Cuesta L, 2014, CANCER DISCOV, V4, P415, DOI 10.1158/2159-8290.CD-13-0633; Fernandez-Cuesta L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4518; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; George J, 2015, NATURE, V524, P47, DOI 10.1038/nature14664; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Hagemann IS, 2015, CANCER-AM CANCER SOC, V121, P631, DOI 10.1002/cncr.29089; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hodgkinson CL, 2014, NAT MED, V20, P897, DOI 10.1038/nm.3600; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Iwakawa R, 2015, CARCINOGENESIS, V36, P616, DOI 10.1093/carcin/bgv026; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Katayama R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003316; Kim Y, 2014, J CLIN ONCOL, V32, P121, DOI 10.1200/JCO.2013.50.8556; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; Larsen JE, 2011, CLIN CHEST MED, V32, P703, DOI 10.1016/j.ccm.2011.08.003; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lebofsky R, 2015, MOL ONCOL, V9, P783, DOI 10.1016/j.molonc.2014.12.003; McFadden DG, 2014, CELL, V156, P1298, DOI 10.1016/j.cell.2014.02.031; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; Nakaoku T, 2014, CLIN CANCER RES, V20, P3087, DOI 10.1158/1078-0432.CCR-14-0107; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Niederst MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7377; Oxnard GR, 2013, J CLIN ONCOL, V31, P1097, DOI 10.1200/JCO.2012.42.9829; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sutherland KD, 2011, CANCER CELL, V19, P754, DOI 10.1016/j.ccr.2011.04.019; Szpechcinski A, 2015, BRIT J CANCER, V113, P476, DOI 10.1038/bjc.2015.225; Travis WD, 2015, J THORAC ONCOL, V10, P1243, DOI 10.1097/JTO.0000000000000630; Vaishnavi A, 2013, NAT MED, V19, P1469, DOI 10.1038/nm.3352; Wu YM, 2013, CANCER DISCOV, V3, P636, DOI 10.1158/2159-8290.CD-13-0050; Yates LR, 2012, NAT REV GENET, V13, P795, DOI 10.1038/nrg3317; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930; Zhao L, 2013, AM J PHYSIOL-LUNG C, V305, pL409, DOI 10.1152/ajplung.00032.2013	47	173	183	3	67	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2016	374	19					1864	1873		10.1056/NEJMra1504688	http://dx.doi.org/10.1056/NEJMra1504688			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6JS	27168435	Green Published			2022-12-28	WOS:000375746100009
J	Dam, MK; Hvidtfeldt, UA; Tjonneland, A; Overvad, K; Gronbaek, M; Tolstrup, JS				Dam, Marie K.; Hvidtfeldt, Ulla A.; Tjonneland, Anne; Overvad, Kim; Gronbaek, Morten; Tolstrup, Janne S.			Five year change in alcohol intake and risk of breast cancer and coronary heart disease among postmenopausal women: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FOOD FREQUENCY QUESTIONNAIRE; ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; MIDDLE-AGE; DRINKING PATTERN; CONSUMPTION; ASSOCIATION; EPIDEMIOLOGY; VALIDITY; REGISTRY	OBJECTIVE To test the hypothesis that postmenopausal women who increase their alcohol intake over a five year period have a higher risk of breast cancer and a lower risk of coronary heart disease compared with stable alcohol intake. DESIGN Prospective cohort study. SETTING Denmark, 1993-2012. PARTICIPANTS 21 523 postmenopausal women who participated in the Diet, Cancer, and Health Study in two consecutive examinations in 1993-98 and 1999-2003. Information on alcohol intake was obtained from questionnaires completed by participants. MAIN OUTCOME MEASURES Incidence of breast cancer, coronary heart disease, and all cause mortality during 11 years of follow-up. Information was obtained from the Danish Cancer Register, Danish Hospital Discharge Register, Danish Register of Causes of Death, and National Central Person Register. We estimated hazard ratios according to five year change in alcohol intake using Cox proportional hazards models. RESULTS During the study, 1054, 1750, and 2080 cases of breast cancer, coronary heart disease, and mortality occurred, respectively. Analyses modelling five year change in alcohol intake with cubic splines showed that women who increased their alcohol intake over the five year period had a higher risk of breast cancer and a lower risk of coronary heart disease than women with a stable alcohol intake. For instance, women who increased their alcohol intake by seven or 14 drinks per week (corresponding to one or two drinks more per day) had hazard ratios of breast cancer of 1.13 (95% confidence interval 1.03 to 1.23) and 1.29 (1.07 to 1.55), respectively, compared to women with stable intake, and adjusted for age, education, body mass index, smoking, Mediterranean diet score, parity, number of births, and hormone replacement therapy. For coronary heart disease, corresponding hazard ratios were 0.89 (0.81 to 0.97) and 0.78 (0.64 to 0.95), respectively, adjusted for age, education, body mass index, Mediterranean diet score, smoking, physical activity, hypertension, elevated cholesterol, and diabetes. Results among women who reduced their alcohol intake over the five year period were not significantly associated with risk of breast cancer or coronary heart disease. Analyses of all cause mortality showed that women who increased their alcohol intake from a high intake (>= 14 drinks per week) to an even higher intake had a higher mortality risk that women with a stable high intake. CONCLUSION In this study of postmenopausal women over a five year period, results support the hypotheses that alcohol intake is associated with increased risk of breast cancer and decreased risk of coronary heart disease.	[Dam, Marie K.; Gronbaek, Morten; Tolstrup, Janne S.] Univ Southern Denmark, Natl Inst Publ Hlth, DK-1353 Copenhagen K, Denmark; [Hvidtfeldt, Ulla A.] Univ Copenhagen, Dept Publ Hlth, Social Med Sect, Copenhagen, Denmark; [Tjonneland, Anne] Danish Canc Soc, Res Ctr, Copenhagen, Denmark; [Overvad, Kim] Aarhus Univ, Dept Epidemiol, Dept Publ Hlth, Aarhus, Denmark; [Overvad, Kim] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark	University of Southern Denmark; University of Copenhagen; Danish Cancer Society; Aarhus University; Aalborg University; Aalborg University Hospital	Tolstrup, JS (corresponding author), Univ Southern Denmark, Natl Inst Publ Hlth, DK-1353 Copenhagen K, Denmark.	jst@niph.dk		Gronbaek, Morten Klocker/0000-0002-8473-6474; Hvidtfeldt, Ulla Arthur/0000-0002-0335-4838; Tjonneland, Anne/0000-0003-4385-2097; Tolstrup, Janne/0000-0002-9796-3967; Overvad, Kim/0000-0001-6429-7921				Allen NE, 2009, JNCI-J NATL CANCER I, V101, P296, DOI 10.1093/jnci/djn514; Anderson KN, 2014, BREAST CANCER RES TR, V144, P1, DOI 10.1007/s10549-014-2852-7; Anderson P, 2012, MLGG ALCOHOL IN THE; Bagnardi V, 2008, J EPIDEMIOL COMMUN H, V62, P615, DOI 10.1136/jech.2007.065607; Beral V, 2002, BRIT J CANCER, V87, P1234, DOI 10.1038/sj.bjc.6600596; Brien SE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d636; Britton A, 2010, ADDICTION, V105, P639, DOI 10.1111/j.1360-0443.2009.02832.x; Brooks PJ, 2013, ALCOHOL CLIN EXP RES, V37, P23, DOI 10.1111/j.1530-0277.2012.01888.x; Chen WY, 2011, JAMA-J AM MED ASSOC, V306, P1884, DOI 10.1001/jama.2011.1590; Chikritzhs T, 2015, ADDICTION, V110, P726, DOI 10.1111/add.12828; Christensen AI, 2015, ADDICTION, V110, P1505, DOI 10.1111/add.12939; Di Castelnuovo A, 2006, ARCH INTERN MED, V166, P2437, DOI 10.1001/archinte.166.22.2437; Dorgan JF, 2001, JNCI-J NATL CANCER I, V93, P710, DOI 10.1093/jnci/93.9.710; Emberson JR, 2006, VASC HEALTH RISK MAN, V2, P239, DOI 10.2147/vhrm.2006.2.3.239; Emberson JR, 2005, AM J EPIDEMIOL, V161, P856, DOI 10.1093/aje/kwi111; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; Gronbaek M, 1996, EUR J CLIN NUTR, V50, P487; Gronbaek M, 2004, EPIDEMIOLOGY, V15, P222, DOI 10.1097/01.ede.0000112219.01955.56; Hanf V, 2014, BREAST CARE, V9, P398, DOI 10.1159/000369570; Harrell J, 2001, RELAXING LINEARITY A; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Holmes MV, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4164; Jensen AR, 2002, EUR J CANCER PREV, V11, P359, DOI 10.1097/00008469-200208000-00007; Joensen AM, 2009, J CLIN EPIDEMIOL, V62, P188, DOI 10.1016/j.jclinepi.2008.03.005; Juel K, 1999, DAN MED BULL, V46, P354; JURGENSEN HJ, 1986, METHOD INFORM MED, V25, P158; Kaplan NM, 2005, AM J MED SCI, V329, P124, DOI 10.1097/00000441-200503000-00003; King DE, 2008, AM J MED, V121, P201, DOI 10.1016/j.amjmed.2007.12.004; LAZARUS NB, 1991, BRIT MED J, V303, P553, DOI 10.1136/bmj.303.6802.553; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Mosbech J, 1995, Ugeskr Laeger, V157, P3741; Mukamal KJ, 2003, NEW ENGL J MED, V348, P109, DOI 10.1056/NEJMoa022095; Okwuosa TM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002944; OVERVAD K, 1991, INT J EPIDEMIOL, V20, P900, DOI 10.1093/ije/20.4.900; Rehm J, 2013, ALCOHOL ALCOHOLISM, V48, P509, DOI 10.1093/alcalc/agt021; Rehm J, 2010, ADDICTION, V105, P817, DOI 10.1111/j.1360-0443.2010.02899.x; Roerecke M, 2012, ADDICTION, V107, P1246, DOI 10.1111/j.1360-0443.2012.03780.x; Roerecke M, 2010, AM J EPIDEMIOL, V171, P633, DOI 10.1093/aje/kwp451; Ronksley Paul E, 2011, BMJ, V342, pd671, DOI 10.1136/bmj.d671; Rubin DB, 1987, MULTIPLE IMPUTATION; Scoccianti C, 2014, AM J PREV MED, V46, pS16, DOI 10.1016/j.amepre.2013.10.031; Seitz HK, 2012, ALCOHOL ALCOHOLISM, V47, P204, DOI 10.1093/alcalc/ags011; Sesso HD, 2000, ARCH INTERN MED, V160, P2605, DOI 10.1001/archinte.160.17.2605; Shekelle Paul, 2007, ACP J Club, V146, P48; Spratt M, 2010, AM J EPIDEMIOL, V172, P478, DOI 10.1093/aje/kwq137; STORM HH, 1988, INT J EPIDEMIOL, V17, P44, DOI 10.1093/ije/17.1.44; Storm HH, 1997, DAN MED BULL, V44, P535; Thygesen LC, 2008, INT J EPIDEMIOL, V37, P669, DOI 10.1093/ije/dyn060; TJONNELAND A, 1991, INT J EPIDEMIOL, V20, P906, DOI 10.1093/ije/20.4.906; Tjonneland A, 2004, J NUTR, V134, P173, DOI 10.1093/jn/134.1.173; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; Trichopoulou A, 2005, BMJ-BRIT MED J, V330, P991, DOI 10.1136/bmj.38415.644155.8F; Vatsalya V, 2012, ALCOHOL CLIN EXP RES, V36, P207, DOI 10.1111/j.1530-0277.2011.01600.x; Wang C, 2014, J WOMENS HEALTH, V23, P373, DOI 10.1089/jwh.2013.4414; Wannamethee SG, 2002, HEART, V87, P32, DOI 10.1136/heart.87.1.32; Wellmann J, 2004, EUR J CARDIOV PREV R, V11, P48, DOI 10.1097/01.hjr.0000118174.70522.20	57	26	26	2	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 11	2016	353								i2314	10.1136/bmj.i2314	http://dx.doi.org/10.1136/bmj.i2314			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6FR	27169583	Green Published, hybrid			2022-12-28	WOS:000376446500005
J	Liu, T; Kim, G; Carretero-Gonzalez, J; Castillo-Martinez, E; Grey, CP				Liu, Tao; Kim, Gunwoo; Carretero-Gonzalez, Javier; Castillo-Martinez, Elizabeth; Grey, Clare P.			Response to Comment on "Cycling Li-O-2 batteries via LiOH formation and decomposition"	SCIENCE			English	Editorial Material								We described a lithium-oxygen (Li-O-2) battery comprising a graphene electrode, a dimethoxyethane-based electrolyte, and H2O and lithium iodide (LiI) additives, lithium hydroxide (LiOH) being the predominant discharge product. We demonstrate, in contrast to the work of Shen et al., that the chemical reactivity between LiOH and the triiodide ion (I-3(-)) to form IO3- indicates that LiOH can be removed on charging; the electrodes do not clog, even after multiple cycles, confirming that solid products are reversibly removed.	[Liu, Tao; Kim, Gunwoo; Carretero-Gonzalez, Javier; Castillo-Martinez, Elizabeth; Grey, Clare P.] Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England; [Kim, Gunwoo; Grey, Clare P.] Univ Cambridge, Cambridge Graphene Ctr, Cambridge CB3 0FA, England	University of Cambridge; University of Cambridge	Grey, CP (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.; Grey, CP (corresponding author), Univ Cambridge, Cambridge Graphene Ctr, Cambridge CB3 0FA, England.	cpg27@cam.ac.uk	Liu, Tao/K-3098-2017; Castillo-Martinez, Elizabeth/D-1776-2013; Gonzalez, Javier Carretero/H-3105-2017; Grey, Clare P/Q-8860-2017	Liu, Tao/0000-0002-6515-0427; Castillo-Martinez, Elizabeth/0000-0002-8577-9572; Gonzalez, Javier Carretero/0000-0002-6265-9746; Grey, Clare P/0000-0001-5572-192X; Carretero Gonzalez, Javier/0000-0002-8008-5715	EPSRC [EP/K01711X/1, EP/K017144/1] Funding Source: UKRI	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Burgot JL, 2012, IONIC EQUILIBRIA IN ANALYTICAL CHEMISTRY, P1, DOI 10.1007/978-1-4419-8382-4; Liu T, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1652; Liu T, 2015, SCIENCE, V350, P530, DOI 10.1126/science.aac7730; PAQUETTE J, 1985, CAN J CHEM, V63, P2444, DOI 10.1139/v85-404; Shen Y, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1399; Wu SC, 2015, CHEM COMMUN, V51, P16860, DOI 10.1039/c5cc06370a; Zhang T, 2016, ENERG ENVIRON SCI, V9, P1024, DOI 10.1039/c5ee02803e	7	18	18	6	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2016	352	6286								10.1126/science.aaf1652	http://dx.doi.org/10.1126/science.aaf1652			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL1UC	27151859				2022-12-28	WOS:000375417100024
J	Phillips, CB; Jerolmack, DJ				Phillips, Colin B.; Jerolmack, Douglas J.			Self-organization of river channels as a critical filter on climate signals	SCIENCE			English	Article							BED; INCISION; EROSION; GEOMORPHOLOGY; FREQUENCY; SEDIMENT	Spatial and temporal variations in rainfall are hypothesized to influence landscape evolution through erosion and sediment transport by rivers. However, determining the relation between rainfall and river dynamics requires a greater understanding of the feedbacks between flooding and a river's capacity to transport sediment. We analyzed channel geometry and stream-flow records from 186 coarse-grained rivers across the United States. We found that channels adjust their shape so that floods slightly exceed the critical shear velocity needed to transport bed sediment, independently of climatic, tectonic, and bedrock controls. The distribution of fluid shear velocity associated with floods is universal, indicating that self-organization of near-critical channels filters the climate signal evident in discharge. This effect blunts the impact of extreme rainfall events on landscape evolution.	[Phillips, Colin B.] Univ Minnesota, St Anthony Falls Lab, Minneapolis, MN 55414 USA; [Jerolmack, Douglas J.] Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Pennsylvania	Phillips, CB (corresponding author), Univ Minnesota, St Anthony Falls Lab, Minneapolis, MN 55414 USA.	colinbphillips@gmail.com	Phillips, Colin/E-9522-2013	Phillips, Colin/0000-0001-9950-2497	NSF Luquillo Critical Zone Observatory (LCZO) [EAR-1331841]; NSF INSPIRE program (Integrated NSF Support Promoting Interdisciplinary Research and Education) [EAR-1344280]; NSF Postdoctoral Fellowship [EAR-1349776]; Directorate For Geosciences [1331841, 1344280, 1349776] Funding Source: National Science Foundation	NSF Luquillo Critical Zone Observatory (LCZO); NSF INSPIRE program (Integrated NSF Support Promoting Interdisciplinary Research and Education); NSF Postdoctoral Fellowship(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Research was supported by the NSF Luquillo Critical Zone Observatory (LCZO) (grant EAR-1331841 to D.J.J.), the NSF INSPIRE program (Integrated NSF Support Promoting Interdisciplinary Research and Education; grant EAR-1344280 to D.J.J.), and an NSF Postdoctoral Fellowship (grant EAR-1349776 to C.B.P.). We thank M. Brandon for encouraging this study; J. Willenbring, P. Wilcock, C. Paola, J. Kirchner, D. Furbish, and three anonymous reviewers for comments that improved this manuscript; and J. Buffington, W. Dietrich, G. Grant, J. O'Connor, A. Pike, J. Scheingross, M. Singer, L. Sklar, and J. Warrick for assistance in acquiring additional stream data. The authors declare that they have no competing financial interests. The data in this study are available from multiple sources: Field site data are compiled in table S1; all unprocessed stream gage data are freely available from the USGS National Water Information System; and lidar data are available from the LCZO. The Mameyes stream morphology and derived hydrograph data are available at https://figshare.com/authors/Colin_Phillips/644773.	Attal M, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000893; Barbour JR, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL035786; Burbank DW, 2003, NATURE, V426, P652, DOI 10.1038/nature02187; DiBiase RA, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2011JF002095; Egholm DL, 2013, NATURE, V498, P475, DOI 10.1038/nature12218; Ferrier KL, 2013, NATURE, V496, P206, DOI 10.1038/nature11982; Finnegan NJ, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000569; Furbish DJ, 2013, WATER RESOUR RES, V49, P1537, DOI 10.1002/wrcr.20074; Hartshorn K, 2002, SCIENCE, V297, P2036, DOI 10.1126/science.1075078; Jerolmack DJ, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044638; Johnson JPL, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001335; Johnson JPL, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2007JF000862; Kirchner JW, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR006912; Lague D, 2005, J GEOPHYS RES-EARTH, V110, DOI 10.1029/2004JF000259; Lague D, 2014, EARTH SURF PROC LAND, V39, P38, DOI 10.1002/esp.3462; Leopold L.B., 1992, FLUVIAL PROCESSES GE; Molnar P, 2006, J GEOPHYS RES-EARTH, V111, DOI 10.1029/2005JF000310; Molnar P, 2004, ANNU REV EARTH PL SC, V32, P67, DOI 10.1146/annurev.earth.32.091003.143456; Montgomery DR, 2001, WATER RESOUR RES, V37, P1841, DOI 10.1029/2000WR900393; Paola C., 1992, BASIN RES, V4, P73, DOI [10.1111/j.1365-2117.1992.tb00145.x, DOI 10.1111/J.1365-2117.1992.TB00145.X]; PARKER G, 1978, J FLUID MECH, V89, P127, DOI 10.1017/S0022112078002505; Parker G, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000549; Phillips CB, 2014, EARTH SURF DYNAM, V2, P513, DOI 10.5194/esurf-2-513-2014; Phillips CB, 2013, GEOPHYS RES LETT, V40, DOI 10.1002/grl.50323; Pike AS, 2010, EARTH SURF PROC LAND, V35, P1402, DOI 10.1002/esp.1978; Sklar LS, 2001, GEOLOGY, V29, P1087, DOI 10.1130/0091-7613(2001)029<1087:SARSCO>2.0.CO;2; Slater LJ, 2013, GEOLOGY, V41, P595, DOI 10.1130/G34070.1; Sornette D, 2006, CRITICAL PHENOMENA N; Tucker GE, 2010, EARTH SURF PROC LAND, V35, P28, DOI 10.1002/esp.1952; TURCOTTE DL, 1993, STOCH HYDROL HYDRAUL, V7, P33, DOI 10.1007/BF01581565; Van De Wiel MJ, 2010, GEOLOGY, V38, P87, DOI 10.1130/G30490.1; Whipple KX, 2009, NAT GEOSCI, V2, P97, DOI 10.1038/ngeo413; Whipple KX, 2004, ANNU REV EARTH PL SC, V32, P151, DOI 10.1146/annurev.earth.32.101802.120356; WOLMAN MG, 1960, J GEOL, V68, P54, DOI 10.1086/626637; Yanites BJ, 2015, NAT GEOSCI, V8, P462, DOI 10.1038/NGEO2429; Yanites BJ, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001601; Zhang PZ, 2001, NATURE, V410, P891, DOI 10.1038/35073504	37	91	93	6	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2016	352	6286					694	697		10.1126/science.aad3348	http://dx.doi.org/10.1126/science.aad3348			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL1UC	27151865				2022-12-28	WOS:000375417100034
J	Gehr, S; Garner, CC				Gehr, Sinje; Garner, Craig C.			Rescuing the Lost in Translation	CELL			English	Editorial Material								The translation of medically relevant academic inventions that could transform public health has been notoriously difficult, stemming largely from cultural differences been academia and industry. New initiatives to kindle academic entrepreneurship and establish stronger public/private partnerships are helping to align these differences and accelerating the translation of promising new therapies.	[Gehr, Sinje] Charite, D-10117 Berlin, Germany; [Garner, Craig C.] German Ctr Neurodegenerat Dis DZNE, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Garner, CC (corresponding author), German Ctr Neurodegenerat Dis DZNE, D-10117 Berlin, Germany.	craig-curtis.garner@dzne.de		Gehr, Sinje/0000-0001-7589-9119; Garner, Craig/0000-0003-1970-5417				Butler D, 2008, NATURE, V453, P840, DOI 10.1038/453840a; Duda GN, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.aaa0599; Ehrismann D, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14086; Fang FC, 2010, INFECT IMMUN, V78, P563, DOI 10.1128/IAI.01318-09; Fischer D., 2015, PHARMAINDUSTRIE EINB; Kirkpatrick L, 2015, NAT BIOTECHNOL, V33, P129, DOI 10.1038/nbt.3137; Ledford H, 2015, NATURE, V519, P402, DOI 10.1038/519402a; Luijten PR, 2012, J CONTROL RELEASE, V161, P416, DOI 10.1016/j.jconrel.2012.03.012; MochlyRosen D, 2014, SPRBRIEF PHARM SCI, P1, DOI 10.1007/978-3-319-02201-7	9	16	16	1	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2016	165	4					765	770		10.1016/j.cell.2016.04.043	http://dx.doi.org/10.1016/j.cell.2016.04.043			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DL7DN	27153487	Bronze			2022-12-28	WOS:000375800300003
J	Gulland, A				Gulland, Anne			EU REFERENDUM AND HEALTH What Brexit would mean for employment of doctors	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												agulland@bmj.com						Confederation of British Industry, 2012, ENS AG WORK SUPP JOB; Royal College of Surgeons of England, 2014, IMPL WORK TIM DIR IT; Society of Pension Professionals, 2016, WOULD BREX BEN BE DE	3	0	0	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 24	2016	353								i2928	10.1136/bmj.i2928	http://dx.doi.org/10.1136/bmj.i2928			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3CB	27221385				2022-12-28	WOS:000376938800014
J	[Anonymous]				[Anonymous]			Lessons from the fatal French study BIA-10-2474 (vol 353, i2727, 2016)	BMJ-BRITISH MEDICAL JOURNAL			English	Correction																		Moore N, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2727	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 24	2016	353								i2956	10.1136/bmj.i2956	http://dx.doi.org/10.1136/bmj.i2956			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3CB	27221545	Bronze, Green Published			2022-12-28	WOS:000376938800020
J	Guillebaud, J				Guillebaud, John			Voluntary family planning to minimise and mitigate climate change	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ENVIRONMENT		[Guillebaud, John] UCL, Inst Womens Hlth, Family Planning & Reprod Hlth, Mortimer St, London WC1E 6BT, England	University of London; University College London	Guillebaud, J (corresponding author), UCL, Inst Womens Hlth, Family Planning & Reprod Hlth, Mortimer St, London WC1E 6BT, England.	j.guillebaud@lineone.net						Bellamy D, COMMUNICATION; Bellizzi S, 2015, HUM REPROD, V30, P973, DOI 10.1093/humrep/deu348; Bradshaw CJA, 2014, P NATL ACAD SCI USA, V111, P16610, DOI 10.1073/pnas.1410465111; Butler CD, 2010, J PUBLIC HEALTH-UK, V32, P157, DOI 10.1093/pubmed/fdq039; Campbell MM, 2013, J FAM PLAN REPROD H, V39, P44, DOI 10.1136/jfprhc-2012-100405; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Cleland J, 2009, BEST PRACT RES CL OB, V23, P165, DOI 10.1016/j.bpobgyn.2008.11.002; EHRLICH PR, 1972, SCI PUBLIC AFF, V28, P16; Feng Y., REDUCING CO2 EMISSIO; Graham-Smith F, 1994, POPULATION COMPLEX R, P17; GUILLEBAUD J, 1994, BRIT MED J, V308, P1377, DOI 10.1136/bmj.308.6940.1377a; Guillebaud J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.39575.691343.80; Hempel M, 1992, FACING POPULATION CH, P127; Keyfitz N, 1994, POPULATION COMPLEX R, P21; Mayhew SH, 2015, THINKING SECTORS SUS, P37, DOI [DOI 10.5334/BAO.E, 10.5334/bao.e]; Maynard R., 2012, WHY POPULATION MATTE; McMichael AJ, 1999, AM J EPIDEMIOL, V149, P887; Murtaugh PA, 2009, GLOBAL ENVIRON CHANG, V19, P14, DOI 10.1016/j.gloenvcha.2008.10.007; National Priorities Project, MIL SPEND US; O'Neill BC, 2010, P NATL ACAD SCI USA, V107, P17521, DOI 10.1073/pnas.1004581107; O'Sullivan J., 2013, 27 INT POP C IUSSP B; O'Sullivan JN, 2015, P NATL ACAD SCI USA, V112, pE507, DOI 10.1073/pnas.1422507112; Population Reference Bureau, WORLD POP DAT SHEETS; Rawe K, 2012, SAVE CHILDREN EVERY; Rosling H., 2013, DONT PANIC FACTS POP; Rovin Kimberly, 2013, Afr J Reprod Health, V17, P15; Royal Society, 2012, PEOPL PLAN, P63; Ryerson W., 2015, OVERDEVLOPMENT OVERP; Singh S., 2014, ADDING IT COSTS BENE; Smith KR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P709; Speidel J, 2015, UCSF BIXBY CTR GLOBA; United Nations, 2015, ESAPWP241 UN, DOI DOI 10.1007/S13398-014-0173-7.2; United Nations, 2015, TRANSF OUR WORLD 203, DOI DOI 10.1163/157180910X12665776638740; Watts J, 2016, GUARDIAN; Worldwide Fund for Nature, 2014, LIV PLAN REP; Wu Y., 2013, MORE AID MORE PEOPLE	36	10	10	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2016	353								i2102	10.1136/bmj.i2102	http://dx.doi.org/10.1136/bmj.i2102			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GI	27207903	Green Submitted, Bronze			2022-12-28	WOS:000376448200001
J	Ehlers, MD				Ehlers, Michael D.			Lessons from a Recovering Academic	CELL			English	Editorial Material								The conversion of basic biology into new therapeutics requires scientific activities in both academia and industry. Successful drug discovery projects span disciplines, sectors, and institutions and tightly couple laboratory and clinical experiments. Here, Ehlers describes conceptions and misconceptions about how science is conducted in industry versus academia.	[Ehlers, Michael D.] Biogen Inc, 225 Binney St, Cambridge, MA 02142 USA	Biogen	Ehlers, MD (corresponding author), Biogen Inc, 225 Binney St, Cambridge, MA 02142 USA.	michael.ehlers@biogen.com							0	3	3	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2016	165	5					1043	1048		10.1016/j.cell.2016.05.005	http://dx.doi.org/10.1016/j.cell.2016.05.005			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DM6QT	27203106	Bronze			2022-12-28	WOS:000376478200004
J	Rickaby, REM				Rickaby, Rosalind E. M.			Harry Elderfield (1943-2016) OBITUARY	NATURE			English	Biographical-Item									[Rickaby, Rosalind E. M.] Univ Oxford, Biogeochem, Oxford OX1 2JD, England	University of Oxford	Rickaby, REM (corresponding author), Univ Oxford, Biogeochem, Oxford OX1 2JD, England.	rosalind.rickaby@earth.ox.ac.uk		Rickaby, Rosalind/0000-0002-6095-8419					0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					322	322		10.1038/533322a	http://dx.doi.org/10.1038/533322a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0AH	27193672	Bronze			2022-12-28	WOS:000376004300029
J	Guo, FJ				Guo, Fangjian			Patient-Initiated Prostate Cancer Screening Among Older US Men RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter									[Guo, Fangjian] Univ Texas Med Branch, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Guo, FJ (corresponding author), Univ Texas Med Branch, Galveston, TX 77555 USA.		Guo, Fangjian/B-7705-2015	Guo, Fangjian/0000-0003-3729-2724				Drazer MW, 2015, J CLIN ONCOL, V33, P2416, DOI 10.1200/JCO.2015.61.6532; Guo FJ, 2015, PREV MED, V81, P427, DOI 10.1016/j.ypmed.2015.10.005; Jemal A, 2015, JAMA-J AM MED ASSOC, V314, P2054, DOI 10.1001/jama.2015.14905; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459	4	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2016	164	10					703	703		10.7326/L15-0620	http://dx.doi.org/10.7326/L15-0620			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8GF	27182912				2022-12-28	WOS:000375878500028
J	Mayor, S				Mayor, Susan			Five minutes with ... David Field, coauthor of perinatal mortality report	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mayor S, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2778	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 17	2016	353								i2790	10.1136/bmj.i2790	http://dx.doi.org/10.1136/bmj.i2790			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GO	27189176				2022-12-28	WOS:000376448900017
J	Stafford, N				Stafford, Ned			Albert L Rhoton Jr OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												ns@europefn.de						RHOTON AL, PUBLICATION LIST	1	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 17	2016	353								i2762	10.1136/bmj.i2762	http://dx.doi.org/10.1136/bmj.i2762			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GO	27188187				2022-12-28	WOS:000376448900012
J	Liu, PX; Zhao, Y; Qin, RX; Mo, SG; Chen, GX; Gu, L; Chevrier, DM; Zhang, P; Guo, Q; Zang, DD; Wu, BH; Fu, G; Zheng, NF				Liu, Pengxin; Zhao, Yun; Qin, Ruixuan; Mo, Shiguang; Chen, Guangxu; Gu, Lin; Chevrier, Daniel M.; Zhang, Peng; Guo, Qing; Zang, Dandan; Wu, Binghui; Fu, Gang; Zheng, Nanfeng			Photochemical route for synthesizing atomically dispersed palladium catalysts	SCIENCE			English	Article							WATER-GAS SHIFT; SINGLE-ATOM CATALYSIS; HETEROGENEOUS CATALYSTS; CO OXIDATION; ACTIVE-SITES; HYDROGENATION; CLUSTERS; SURFACE; TIO2; SIZE	Atomically dispersed noble metal catalysts often exhibit high catalytic performances, but the metal loading density must be kept low (usually below 0.5%) to avoid the formation of metal nanoparticles through sintering. We report a photochemical strategy to fabricate a stable atomically dispersed palladium-titanium oxide catalyst (Pd-1/TiO2) on ethylene glycolate (EG)-stabilized ultrathin TiO2 nanosheets containing Pd up to 1.5%. The Pd-1/TiO2 catalyst exhibited high catalytic activity in hydrogenation of C=C bonds, exceeding that of surface Pd atoms on commercial Pd catalysts by a factor of 9. No decay in the activity was observed for 20 cycles. More important, the Pd-1/TiO2-EG system could activate H-2 in a heterolytic pathway, leading to a catalytic enhancement in hydrogenation of aldehydes by a factor of more than 55.	[Liu, Pengxin; Zhao, Yun; Qin, Ruixuan; Mo, Shiguang; Chen, Guangxu; Guo, Qing; Zang, Dandan; Wu, Binghui; Fu, Gang; Zheng, Nanfeng] Xiamen Univ, Collaborat Innovat Ctr Chem Energy Mat, Engn Res Ctr Nano Preparat Technol Fujian Prov, Natl Engn Lab Green Chem Prod Alcohols Ethers & E, Xiamen 361005, Peoples R China; [Liu, Pengxin; Zhao, Yun; Qin, Ruixuan; Mo, Shiguang; Chen, Guangxu; Guo, Qing; Zang, Dandan; Wu, Binghui; Fu, Gang; Zheng, Nanfeng] Xiamen Univ, Coll Chem & Chem Engn, Dept Chem, Xiamen 361005, Peoples R China; [Gu, Lin] Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China; [Chevrier, Daniel M.; Zhang, Peng] Dalhousie Univ, Dept Chem, Halifax, NS B3H 4R2, Canada	Xiamen University; Xiamen University; Chinese Academy of Sciences; Institute of Physics, CAS; Dalhousie University	Zheng, NF (corresponding author), Xiamen Univ, Collaborat Innovat Ctr Chem Energy Mat, Engn Res Ctr Nano Preparat Technol Fujian Prov, Natl Engn Lab Green Chem Prod Alcohols Ethers & E, Xiamen 361005, Peoples R China.; Zheng, NF (corresponding author), Xiamen Univ, Coll Chem & Chem Engn, Dept Chem, Xiamen 361005, Peoples R China.	nfzheng@xmu.edu.cn	Gu, Lin/D-9631-2011; Zhang, Peng/K-5174-2012; Liu, Pengxin/H-5216-2018; Wu, Binghui/C-5799-2008; Qin, Ruixuan/M-5845-2019; Zheng, Nanfeng/G-4613-2010; Liu, Pengxin/K-8363-2019; Chevrier, Daniel/AAI-7027-2021	Gu, Lin/0000-0002-7504-031X; Zhang, Peng/0000-0003-3603-0175; Liu, Pengxin/0000-0002-2332-4652; Wu, Binghui/0000-0003-4015-9991; Qin, Ruixuan/0000-0003-0074-1901; Zheng, Nanfeng/0000-0001-9879-4790; Liu, Pengxin/0000-0002-2332-4652; Chevrier, Daniel/0000-0002-0914-6714	Ministry of Science and Technology of China [2015CB932303]; National Natural Science Foundation of China [21420102001, 21131005, 21390390, 21133004, 21373167, 21573178, 21333008]; NSERC CGS Alexander Graham Bell scholarship; NSERC Discovery grant	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSERC CGS Alexander Graham Bell scholarship; NSERC Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	Supported by Ministry of Science and Technology of China grant 2015CB932303; National Natural Science Foundation of China grants 21420102001, 21131005, 21390390, 21133004, 21373167, 21573178, and 21333008; a NSERC CGS Alexander Graham Bell scholarship (D.M.C.); and a NSERC Discovery grant (P.Z.). We thank the XAFS station (BL14W1) of the Shanghai Synchrotron Radiation Facility.	Abbet S, 2000, J AM CHEM SOC, V122, P3453, DOI 10.1021/ja9922476; Chen YX, 2005, J PHOTOCH PHOTOBIO A, V172, P47, DOI 10.1016/j.jphotochem.2004.11.006; Comas-Vives A, 2006, J AM CHEM SOC, V128, P4756, DOI 10.1021/ja057998o; Dedieu A, 2004, THEOR CHEM ACC, V112, P305, DOI 10.1007/s00214-004-0588-x; Ding K, 2015, SCIENCE, V350, P189, DOI 10.1126/science.aac6368; Ehresmann JO, 2006, ANGEW CHEM INT EDIT, V45, P574, DOI 10.1002/anie.200502864; Flytzani-Stephanopoulos M, 2012, ANNU REV CHEM BIOMOL, V3, P545, DOI 10.1146/annurev-chembioeng-062011-080939; Fu Q, 2003, SCIENCE, V301, P935, DOI 10.1126/science.1085721; Gong XQ, 2008, J AM CHEM SOC, V130, P370, DOI 10.1021/ja0773148; HOFFMANN MR, 1995, CHEM REV, V95, P69, DOI 10.1021/cr00033a004; HOWE RF, 1985, J PHYS CHEM-US, V89, P4495, DOI 10.1021/j100267a018; Kaden WE, 2009, SCIENCE, V326, P826, DOI 10.1126/science.1180297; Kaichev VV, 2003, J PHYS CHEM B, V107, P3522, DOI 10.1021/jp021992t; Kiraly Z, 2004, CATAL LETT, V95, P57, DOI 10.1023/B:CATL.0000023722.50580.e8; Kluwer AM, 2005, J AM CHEM SOC, V127, P15470, DOI 10.1021/ja052729j; Kwak JH, 2009, SCIENCE, V325, P1670, DOI 10.1126/science.1176745; Kyriakou G, 2012, SCIENCE, V335, P1209, DOI 10.1126/science.1215864; Lin J, 2013, J AM CHEM SOC, V135, P15314, DOI 10.1021/ja408574m; Matthey D, 2007, SCIENCE, V315, P1692, DOI 10.1126/science.1135752; Ortalan V, 2010, NAT NANOTECHNOL, V5, P506, DOI [10.1038/nnano.2010.92, 10.1038/NNANO.2010.92]; Peterson EJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5885; Qiao BT, 2011, NAT CHEM, V3, P634, DOI [10.1038/nchem.1095, 10.1038/NCHEM.1095]; SHIGA T, 1965, J PHYS CHEM-US, V69, P3805, DOI 10.1021/j100895a028; Sun SH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01775; Syrenova S, 2015, NAT MATER, V14, P1236, DOI [10.1038/NMAT4409, 10.1038/nmat4409]; Thomas JM, 2006, TOP CATAL, V40, P3, DOI 10.1007/s11244-006-0105-7; Thomas JM, 2015, NATURE, V525, P325, DOI 10.1038/525325a; Thomas JM, 2011, TOP CATAL, V54, P588, DOI 10.1007/s11244-011-9677-y; Uzun A, 2009, J AM CHEM SOC, V131, P15887, DOI 10.1021/ja906553n; Veisz B, 2002, CHEM MATER, V14, P2882, DOI 10.1021/cm0112542; Vile G, 2015, ANGEW CHEM INT EDIT, V54, P11265, DOI 10.1002/anie.201505073; Wei HS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6634; Xiang GL, 2010, CHEM COMMUN, V46, P6801, DOI 10.1039/c0cc02327b; Yan H, 2015, J AM CHEM SOC, V137, P10484, DOI 10.1021/jacs.5b06485; Yang M, 2015, J AM CHEM SOC, V137, P3470, DOI 10.1021/ja513292k; Yang M, 2014, SCIENCE, V346, P1498, DOI 10.1126/science.1260526; Yang M, 2013, J AM CHEM SOC, V135, P3768, DOI 10.1021/ja312646d; Yu LH, 2012, PHYS CHEM CHEM PHYS, V14, P3589, DOI 10.1039/c2cp23226j; Zhai YP, 2010, SCIENCE, V329, P1633, DOI 10.1126/science.1192449; Zhang X, 2005, ANGEW CHEM INT EDIT, V44, P7132, DOI 10.1002/anie.200502101	40	1166	1192	185	3355	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2016	352	6287					797	801		10.1126/science.aaf5251	http://dx.doi.org/10.1126/science.aaf5251			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5FP	27174982				2022-12-28	WOS:000375663000033
J	Mohtadi, M; Prange, M; Steinke, S				Mohtadi, Mahyar; Prange, Matthias; Steinke, Stephan			Palaeoclimatic insights into forcing and response of monsoon rainfall	NATURE			English	Review							INTERTROPICAL CONVERGENCE ZONE; INDIAN-SUMMER MONSOON; ASIAN MONSOON; GLOBAL MONSOON; CLIMATE-CHANGE; ISOTOPIC COMPOSITION; VOLCANIC-ERUPTIONS; EL-NINO; HOLOCENE; PRECIPITATION	Monsoons are the dominant seasonal mode of climate variability in the tropics and are critically important conveyors of atmospheric moisture and energy at a global scale. Predicting monsoons, which have profound impacts on regions that are collectively home to more than 70 per cent of Earth's population, is a challenge that is difficult to overcome by relying on instrumental data from only the past few decades. Palaeoclimatic evidence of monsoon rainfall dynamics across different regions and timescales could help us to understand and predict the sensitivity and response of monsoons to various forcing mechanisms. This evidence suggests that monsoon systems exhibit substantial regional character.	[Mohtadi, Mahyar; Prange, Matthias; Steinke, Stephan] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany	University of Bremen	Mohtadi, M (corresponding author), Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany.	mmohtadi@marum.de	Mohtadi, Mahyar/N-2106-2014	Mohtadi, Mahyar/0000-0003-3306-0969	DFG Research Centre/Cluster of Excellence 'The Ocean in the Earth System'; German Ministry of Education and Research (BMBF) [03G0228A, 03G0828A, 03G0484A]	DFG Research Centre/Cluster of Excellence 'The Ocean in the Earth System'; German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	We are grateful to J. H. C. Bosmans for providing Fig. 3. We thank F. He, Z. Liu and B. Otto-Bliesner for making the TraCE-21k model output available via the Earth System Grid (National Center for Atmospheric Research). This study is supported by the DFG Research Centre/Cluster of Excellence 'The Ocean in the Earth System' and the German Ministry of Education and Research (BMBF) grants 03G0228A (EISPAC), 03G0828A (TransGeoBiOc) and 03G0484A (INVERS).	An ZS, 2015, ANNU REV EARTH PL SC, V43, P29, DOI 10.1146/annurev-earth-060313-054623; Anchukaitis KJ, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044843; Asharaf S, 2015, J CLIMATE, V28, P5414, DOI 10.1175/JCLI-D-14-00233.1; Asmerom Y, 2013, P NATL ACAD SCI USA, V110, P9651, DOI 10.1073/pnas.1214870110; Baker PA, 2015, QUATERNARY SCI REV, V124, P31, DOI 10.1016/j.quascirev.2015.06.011; Battisti DS, 2014, J GEOPHYS RES-ATMOS, V119, P11997, DOI 10.1002/2014JD021960; Berkelhammer M, 2010, EARTH PLANET SC LETT, V290, P166, DOI 10.1016/j.epsl.2009.12.017; Bollasina MA, 2011, SCIENCE, V334, P502, DOI 10.1126/science.1204994; Bordoni S, 2008, NAT GEOSCI, V1, P515, DOI 10.1038/ngeo248; Bosmans JHC, 2015, CLIM PAST, V11, P1335, DOI 10.5194/cp-11-1335-2015; Bosmans JHC, 2015, CLIM DYNAM, V44, P279, DOI 10.1007/s00382-014-2260-z; Braconnot P, 2008, CLIM PAST, V4, P281, DOI 10.5194/cp-4-281-2008; Cai YJ, 2015, P NATL ACAD SCI USA, V112, P2954, DOI 10.1073/pnas.1424035112; Caley T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6371; Caley T, 2011, QUATERNARY SCI REV, V30, P3705, DOI 10.1016/j.quascirev.2011.09.015; CHARNEY JG, 1975, Q J ROY METEOR SOC, V101, P193, DOI 10.1002/qj.49710142802; Chen XL, 2015, GEOPHYS RES LETT, V42, P9433, DOI 10.1002/2015GL066384; Cheng H, 2012, CLIM DYNAM, V39, P1045, DOI 10.1007/s00382-012-1363-7; Chiang JCH, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000916; Chiang JCH, 2005, CLIM DYNAM, V25, P477, DOI 10.1007/s00382-005-0040-5; Chiang JCH, 2015, QUATERNARY SCI REV, V108, P111, DOI 10.1016/j.quascirev.2014.11.009; Christensen JH, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1217; Claussen M, 1997, GLOBAL ECOL BIOGEOGR, V6, P369, DOI 10.2307/2997337; Clemens SC, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2010PA001926; Collins JA, 2013, QUATERNARY SCI REV, V65, P88, DOI 10.1016/j.quascirev.2013.01.007; Cook BI, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052565; Cook ER, 2010, SCIENCE, V328, P486, DOI 10.1126/science.1185188; Dallmeyer A, 2015, CLIM PAST, V11, P305, DOI 10.5194/cp-11-305-2015; Dallmeyer A, 2010, CLIM PAST, V6, P195, DOI 10.5194/cp-6-195-2010; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; Devaraju N, 2015, P NATL ACAD SCI USA, V112, P3257, DOI 10.1073/pnas.1423439112; Donohoe A, 2013, J CLIMATE, V26, P3597, DOI 10.1175/JCLI-D-12-00467.1; Douglas PMJ, 2015, P NATL ACAD SCI USA, V112, P5607, DOI 10.1073/pnas.1419133112; Flato G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P741; Fleitmann D, 2003, SCIENCE, V300, P1737, DOI 10.1126/science.1083130; Fu CB, 2003, GLOBAL PLANET CHANGE, V37, P219, DOI 10.1016/S0921-8181(02)00207-2; Gadgil S, 2003, ANNU REV EARTH PL SC, V31, P429, DOI 10.1146/annurev.earth.31.100901.141251; Goswami BN, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024803; Gottschalk J, 2015, NAT GEOSCI, V8, P950, DOI [10.1038/ngeo2558, 10.1038/NGEO2558]; Gray LJ, 2010, REV GEOPHYS, V48, DOI 10.1029/2009RG000282; Kropelin S, 2008, SCIENCE, V320, P765, DOI 10.1126/science.1154913; Kumar KK, 2006, SCIENCE, V314, P115, DOI 10.1126/science.1131152; KUTZBACH JE, 1981, SCIENCE, V214, P606; Lachniet MS, 2012, GEOLOGY, V40, P259, DOI 10.1130/G32471.1; Lee JW, 2014, CLIM DYNAM, V42, P733, DOI 10.1007/s00382-013-1841-6; Liu XJ, 2015, J CLIMATE, V28, P4841, DOI 10.1175/JCLI-D-14-00639.1; Liu Z, 2007, QUATERNARY SCI REV, V26, P1818, DOI 10.1016/j.quascirev.2007.03.002; Liu Z, 2009, SCIENCE, V325, P310, DOI 10.1126/science.1171041; Man WM, 2014, J CLIMATE, V27, P7394, DOI 10.1175/JCLI-D-13-00739.1; Mantsis DF, 2014, J CLIMATE, V27, P5504, DOI 10.1175/JCLI-D-13-00526.1; Marzin C, 2013, CLIM PAST, V9, P2135, DOI 10.5194/cp-9-2135-2013; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Meehl GA, 2003, J CLIMATE, V16, P426, DOI [10.1175/1520-0442(2003)016<0426:SAGGFA>2.0.CO;2, 10.1175/1520-0442(2003)016&lt;0426:SAGGFA&gt;2.0.CO;2]; Merlis TM, 2013, J CLIMATE, V26, P2010, DOI 10.1175/JCLI-D-12-00186.1; Metcalfe SE, 2015, QUATERNARY SCI REV, V120, P1, DOI 10.1016/j.quascirev.2015.04.004; Mohtadi M, 2014, NATURE, V509, P76, DOI 10.1038/nature13196; Mohtadi M, 2011, NAT GEOSCI, V4, P540, DOI [10.1038/ngeo1209, 10.1038/NGEO1209]; Molnar P, 2010, ANNU REV EARTH PL SC, V38, P77, DOI 10.1146/annurev-earth-040809-152456; Muri H, 2013, J CLIMATE, V26, P9696, DOI 10.1175/JCLI-D-12-00520.1; Myers CG, 2015, GEOPHYS RES LETT, V42, P4124, DOI 10.1002/2015GL063826; Niyogi D, 2010, WATER RESOUR RES, V46, DOI 10.1029/2008WR007082; Otto-Bliesner BL, 2014, SCIENCE, V346, P1223, DOI 10.1126/science.1259531; Bernal JP, 2011, QUATERNARY RES, V75, P104, DOI 10.1016/j.yqres.2010.09.002; Park JY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6985; Polissar PJ, 2013, P NATL ACAD SCI USA, V110, P14551, DOI 10.1073/pnas.1219681110; Rachmayani R, 2015, CLIM PAST, V11, P175, DOI 10.5194/cp-11-175-2015; Rachmayani R, 2016, CLIM PAST, V12, P677, DOI 10.5194/cp-12-677-2016; Rahmstorf S, 2002, NATURE, V419, P207, DOI 10.1038/nature01090; Rahmstorf S, 2015, NAT CLIM CHANGE, V5, P475, DOI [10.1038/nclimate2554, 10.1038/NCLIMATE2554]; Ridley HE, 2015, NAT GEOSCI, V8, P195, DOI [10.1038/ngeo2353, 10.1038/NGEO2353]; Russell JM, 2014, P NATL ACAD SCI USA, V111, P5100, DOI 10.1073/pnas.1402373111; Schmidt GA, 2014, CLIM PAST, V10, P221, DOI 10.5194/cp-10-221-2014; Schneider T, 2014, NATURE, V513, P45, DOI 10.1038/nature13636; Shanahan TM, 2009, SCIENCE, V324, P377, DOI 10.1126/science.1166352; Shanahan TM, 2015, NAT GEOSCI, V8, P140, DOI [10.1038/ngeo2329, 10.1038/NGEO2329]; Shen MG, 2015, P NATL ACAD SCI USA, V112, P9299, DOI 10.1073/pnas.1504418112; Sigl M, 2015, NATURE, V523, P543, DOI 10.1038/nature14565; Sperber K, 2013, CLIM DYNAM, V41, P2711, DOI 10.1007/s00382-012-1607-6; Steinke S, 2014, QUATERNARY SCI REV, V93, P142, DOI 10.1016/j.quascirev.2014.04.006; Swann ALS, 2014, J CLIMATE, V27, P4857, DOI 10.1175/JCLI-D-13-00690.1; Ting MF, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048712; Trenberth KE, 2000, J CLIMATE, V13, P3969, DOI 10.1175/1520-0442(2000)013<3969:TGMAST>2.0.CO;2; Valle F, 2014, PALAEOGEOGR PALAEOCL, V414, P403, DOI 10.1016/j.palaeo.2014.09.023; van Loon H, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051977; Vuille M, 2012, CLIM PAST, V8, P1309, DOI 10.5194/cp-8-1309-2012; Wang B, 2008, DYNAM ATMOS OCEANS, V44, P165, DOI 10.1016/j.dynatmoce.2007.05.002; Wang B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8154; Wang B, 2013, P NATL ACAD SCI USA, V110, P5347, DOI 10.1073/pnas.1219405110; Wang PX, 2014, CLIM PAST, V10, P2007, DOI 10.5194/cp-10-2007-2014; Wang YJ, 2005, SCIENCE, V308, P854, DOI 10.1126/science.1106296; Winter A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8627; Yamashima R, 2015, INT J CLIMATOL, V35, P2419, DOI 10.1002/joc.4132; Yeh SW, 2009, NATURE, V461, P511, DOI 10.1038/nature08316; Yuan Y, 2012, J CLIMATE, V25, P7702, DOI 10.1175/JCLI-D-11-00576.1; Zhang LP, 2013, J GEOPHYS RES-OCEANS, V118, P5772, DOI 10.1002/jgrc.20390; Zhang R, 2005, J CLIMATE, V18, P1853, DOI 10.1175/JCLI3460.1; Zhang R, 2013, CLIM PAST, V9, P2085, DOI 10.5194/cp-9-2085-2013; Zhang X, 2015, GEOPHYS RES LETT, V42, P1903, DOI 10.1002/2014GL063003; Zhao L, 2014, J CLIMATE, V27, P3043, DOI 10.1175/JCLI-D-13-00482.1	100	140	148	11	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					191	199		10.1038/nature17450	http://dx.doi.org/10.1038/nature17450			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0BJ	27172043				2022-12-28	WOS:000376007200039
J	Levy, SD; Alladina, JW; Hibbert, KA; Harris, RS; Bajwa, EK; Hess, DR				Levy, Sean D.; Alladina, Jehan W.; Hibbert, Kathryn A.; Harris, R. Scott; Bajwa, Ednan K.; Hess, Dean R.			High-flow oxygen therapy and other inhaled therapies in intensive care units	LANCET			English	Article							ACUTE RESPIRATORY-DISTRESS; NASAL CANNULA OXYGEN; ACUTE LUNG INJURY; VENTILATOR-ASSOCIATED PNEUMONIA; NITRIC-OXIDE; PULMONARY-HYPERTENSION; NONINVASIVE VENTILATION; HELIUM-OXYGEN; REFRACTORY HYPOXEMIA; RANDOMIZED-TRIAL	In this Series paper, we review the current evidence for the use of high-flow oxygen therapy, inhaled gases, and aerosols in the care of critically ill patients. The available evidence supports the use of high-flow nasal cannulae for selected patients with acute hypoxaemic respiratory failure. Heliox might prevent intubation or improve gas flow in mechanically ventilated patients with severe asthma. Additionally, it might improve the delivery of aerosolised bronchodilators in obstructive lung disease in general. Inhaled nitric oxide might improve outcomes in a subset of patients with postoperative pulmonary hypertension who had cardiac surgery; however, it has not been shown to provide long-term benefit in patients with acute respiratory distress syndrome (ARDS). Inhaled prostacyclins, similar to inhaled nitric oxide, are not recommended for routine use in patients with ARDS, but can be used to improve oxygenation in patients who are not adequately stabilised with traditional therapies. Aerosolised bronchodilators are useful in mechanically ventilated patients with asthma and chronic obstructive pulmonary disease, but are not recommended for those with ARDS. Use of aerosolised antibiotics for ventilator-associated pneumonia and ventilator-associated tracheobronchitis shows promise, but the delivered dose can be highly variable if proper attention is not paid to the delivery method.	[Levy, Sean D.; Alladina, Jehan W.; Hibbert, Kathryn A.; Harris, R. Scott; Bajwa, Ednan K.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Pulm Crit Care & Sleep Med, Boston, MA USA; [Hess, Dean R.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Resp Care, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Hess, DR (corresponding author), Massachusetts Gen Hosp, Resp Care, Boston, MA 02114 USA.	dhess@mgh.harvard.edu	Hess, Dean/AAL-3017-2020	Bajwa, Ednan/0000-0001-9026-1009	Merck; Philips Respironics; Medtronic Covidien; Bayer; McGraw-Hill; UpToDate; American Board of Internal Medicine	Merck(Merck & Company); Philips Respironics; Medtronic Covidien; Bayer(Bayer AG); McGraw-Hill; UpToDate; American Board of Internal Medicine	RSH receives consulting fees from Merck for service on a clinical adjudication committee for pneumonia events in a clinical trial. DRH reports personal fees from Philips Respironics, Medtronic Covidien, Bayer, McGraw-Hill, Jones and Bartlett, UpToDate, and the American Board of Internal Medicine. SDL, JWA, KAH, and EKB declare no competing interests.	Adhikari NKJ, 2014, CRIT CARE MED, V42, P404, DOI 10.1097/CCM.0b013e3182a27909; Afshari A, 2011, ANESTH ANALG, V112, P1411, DOI 10.1213/ANE.0b013e31820bd185; Ammar MA, 2015, ANN PHARMACOTHER, V49, P1105, DOI 10.1177/1060028015595642; Ardehali A, 2001, TRANSPLANTATION, V72, P112, DOI 10.1097/00007890-200107150-00022; Argenziano M, 1998, ANN THORAC SURG, V65, P340, DOI 10.1016/S0003-4975(97)01307-6; Ari A, 2012, J AEROSOL MED PULM D, V25, P319, DOI 10.1089/jamp.2011.0936; BEATY CD, 1989, CHEST, V96, P1360, DOI 10.1378/chest.96.6.1360; Beghetti M, 1998, ANN THORAC SURG, V66, P532, DOI 10.1016/S0003-4975(98)00447-0; Beurskens CJ, 2014, CRIT CARE RES PRACT, V2014, DOI 10.1155/2014/954814; Beurskens CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078159; Black SM, 1999, AM J PHYSIOL-HEART C, V277, pH1849, DOI 10.1152/ajpheart.1999.277.5.H1849; Brandao DC, 2009, J ASTHMA, V46, P356, DOI 10.1080/02770900902718829; Chanques G, 2013, MINERVA ANESTESIOL, V79, P1344; Christenson J, 2000, AM J RESP CRIT CARE, V161, P1443, DOI 10.1164/ajrccm.161.5.9806138; Corley A, 2011, BRIT J ANAESTH, V107, P998, DOI 10.1093/bja/aer265; CRAVEN DE, 1984, AM J MED, V77, P834, DOI 10.1016/0002-9343(84)90520-5; Cuthbertson BH, 1997, BRIT J ANAESTH, V78, P696, DOI 10.1093/bja/78.6.696; De Wet CJ, 2004, J THORAC CARDIOV SUR, V127, P1058, DOI 10.1016/j.jtcvs.2003.11.035; Dellinger RP, 1998, CRIT CARE MED, V26, P619, DOI 10.1097/00003246-199803000-00043; Diehl JL, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-24; Dzierba AL, 2014, PHARMACOTHERAPY, V34, P279, DOI 10.1002/phar.1365; Ehrmann S, 2016, INTENS CARE MED, V42, P192, DOI 10.1007/s00134-015-4114-5; El-Khatib MF, 2014, LUNG, V192, P377, DOI 10.1007/s00408-014-9570-0; FERNANDEZ A, 1994, INTENS CARE MED, V20, P199, DOI 10.1007/BF01704700; Foubert L, 1993, J Cardiothorac Vasc Anesth, V7, P506, DOI 10.1016/1053-0770(93)90200-5; Frat JP, 2015, NEW ENGL J MED, V372, P2185, DOI 10.1056/NEJMoa1503326; Frat JP, 2015, RESP CARE, V60, P170, DOI 10.4187/respcare.03075; FROSTELL C, 1991, CIRCULATION, V83, P2038, DOI 10.1161/01.CIR.83.6.2038; Fuller BM, 2015, CHEST, V147, P1510, DOI 10.1378/chest.14-3161; Fullerton DA, 1996, ANN THORAC SURG, V61, P1856, DOI 10.1016/0003-4975(96)00046-X; Galindo VC, 2013, RESP CARE, V58, P241, DOI 10.4187/respcare.01371; Gerbeaux P, 2001, CRIT CARE MED, V29, P2322, DOI 10.1097/00003246-200112000-00015; GLUCK EH, 1990, CHEST, V98, P693, DOI 10.1378/chest.98.3.693; Guerin C, 1999, AM J RESP CRIT CARE, V159, P1036, DOI 10.1164/ajrccm.159.4.9710081; Hanhan U, 1993, RESP CARE, V38, P474; Harris KW, 2007, RESP CARE, V52, P1507; Hernandez G, 2016, JAMA-J AM MED ASSOC, V315, P1354, DOI 10.1001/jama.2016.2711; Hess DR, 2015, RESP CARE, V60, P880, DOI 10.4187/respcare.04042; Hess DR, 2006, RESPIR CARE, V51, P608; Holland A, 2013, COCHRANE DB SYST REV, V6; Inglessis I, 2004, J AM COLL CARDIOL, V44, P793, DOI 10.1016/j.jacc.2004.05.047; Jaber S, 2001, AM J RESP CRIT CARE, V164, P633, DOI 10.1164/ajrccm.164.4.2008027; Jolliet P, 2003, CRIT CARE MED, V31, P878, DOI 10.1097/01.CCM.0000055369.37620.EE; Jolliet P, 2015, INTENSIVE CARE ME S1, V3, pA422; Jones PG, 2016, RESP CARE, V61, P291, DOI 10.4187/respcare.04252; Kang BJ, 2015, INTENS CARE MED, V41, P623, DOI 10.1007/s00134-015-3693-5; Khan TA, 2009, J THORAC CARDIOV SUR, V138, P1417, DOI 10.1016/j.jtcvs.2009.04.063; Kollef MH, 1997, CHEST, V112, P765, DOI 10.1378/chest.112.3.765; Kress JP, 2002, AM J RESP CRIT CARE, V165, P1317, DOI 10.1164/rccm.9907035; Leatherman J, 2015, CHEST, V147, P1671, DOI 10.1378/chest.14-1733; Longest PW, 2013, J AEROSOL MED PULM D, V26, P266, DOI 10.1089/jamp.2012.1006; Lu Q, 2012, ANESTHESIOLOGY, V117, P1335, DOI 10.1097/ALN.0b013e31827515de; Lu Q, 2011, AM J RESP CRIT CARE, V184, P106, DOI 10.1164/rccm.201011-1894OC; Lu Q, 2010, INTENS CARE MED, V36, P1147, DOI 10.1007/s00134-010-1879-4; Lundin S, 1999, INTENS CARE MED, V25, P911, DOI 10.1007/s001340050982; Maggiore SM, 2014, AM J RESP CRIT CARE, V190, P282, DOI 10.1164/rccm.201402-0364OC; Maggiore SM, 2010, CRIT CARE MED, V38, P145, DOI 10.1097/CCM.0b013e3181b78abe; Matthay MA, 2011, AM J RESP CRIT CARE, V184, P561, DOI 10.1164/rccm.201012-2090OC; McGinn K, 2016, ANN PHARMACOTHER, V50, P22, DOI 10.1177/1060028015608865; Meade MO, 2003, AM J RESP CRIT CARE, V167, P1483, DOI 10.1164/rccm.2203034; Miguel-Montanes R, 2015, CRIT CARE MED, V43, P574, DOI 10.1097/CCM.0000000000000743; Moller W, 2015, J APPL PHYSIOL, V118, P1525, DOI 10.1152/japplphysiol.00934.2014; Mundel T, 2013, J APPL PHYSIOL, V114, P1058, DOI 10.1152/japplphysiol.01308.2012; Napolitano LM, 2010, CRIT CARE MED, V38, pE74, DOI 10.1097/CCM.0b013e3181cc5373; Nishimura M, 2016, RESP CARE, V61, P529, DOI 10.4187/respcare.04577; Nishimura M, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-015-0084-5; Oishi P, 2011, RESP CARE, V56, P1314, DOI 10.4187/respcare.01297; Olschewski H, 1998, INTENS CARE MED, V24, P631, DOI 10.1007/s001340050628; Palmer LB, 2008, CRIT CARE MED, V36, P2008, DOI 10.1097/CCM.0b013e31817c0f9e; Palmer Lucy B, 2015, Curr Opin Pulm Med, V21, P239, DOI 10.1097/MCP.0000000000000160; Palmer LB, 2014, AM J RESP CRIT CARE, V189, P1225, DOI 10.1164/rccm.201312-2161OC; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Parke RL, 2015, RESP CARE, V60, P1397, DOI 10.4187/respcare.04028; Parke RL, 2013, RESP CARE, V58, P1621, DOI 10.4187/respcare.02358; PEPKEZABA J, 1991, LANCET, V338, P1173, DOI 10.1016/0140-6736(91)92033-X; Restrepo MI, 2015, RESP CARE, V60, P762, DOI 10.4187/respcare.04208; Rittayamai N, 2015, RESP CARE, V60, P1377, DOI 10.4187/respcare.03837; Rittayamai N, 2014, RESP CARE, V59, P485, DOI 10.4187/respcare.02397; Roberts JD, 1997, NEW ENGL J MED, V336, P605, DOI 10.1056/NEJM199702273360902; Rodrigo G, 1998, AM J RESP CRIT CARE, V157, P698, DOI 10.1164/ajrccm.157.3.9704022; Rodrigo GJ, 2014, ANN ALLERG ASTHMA IM, V112, P29, DOI 10.1016/j.anai.2013.09.024; Searcy RJ, 2015, THER ADV RESPIR DIS, V9, P302, DOI 10.1177/1753465815599345; SEMIGRAN MJ, 1994, J AM COLL CARDIOL, V24, P982, DOI 10.1016/0735-1097(94)90859-1; Semler MW, 2016, AM J RESP CRIT CARE, V193, P273, DOI 10.1164/rccm.201507-1294OC; Senturk E, 2012, MINERVA ANESTESIOL, V78, P1005; Smith FG, 2012, LANCET, V379, P229, DOI 10.1016/S0140-6736(11)61623-1; Sokol GM, 1999, CLIN CHEM, V45, P382; Sokol J, 2003, ANESTH ANALG, V97, P989, DOI [10.1213/01.ANE.0000078819.48523.26, 10.1213/01.ANE.0000078819.45523.26]; Sole-Lleonart C, 2016, RESP CARE, V61, P1008, DOI 10.4187/respcare.04519; Spoletini G, 2015, CHEST, V148, P253, DOI 10.1378/chest.14-2871; Stephan F, 2015, JAMA-J AM MED ASSOC, V313, P2331, DOI 10.1001/jama.2015.5213; Stork E, 1997, NEW ENGL J MED, V336, P597; Taylor RW, 2004, JAMA-J AM MED ASSOC, V291, P1603, DOI 10.1001/jama.291.13.1603; Torbic H, 2016, ANN PHARMACOTHER, V50, P106, DOI 10.1177/1060028015621308; Torbic H, 2013, J CRIT CARE, V28, P844, DOI 10.1016/j.jcrc.2013.03.006; Valachis A, 2015, CRIT CARE MED, V43, P527, DOI 10.1097/CCM.0000000000000771; van Heerden PV, 2000, CHEST, V117, P819, DOI 10.1378/chest.117.3.819; Venegas J, 2013, J AEROSOL MED PULM D, V26, P1, DOI 10.1089/jamp.2011.0944; Vourc'h M, 2015, INTENS CARE MED, V41, P1538, DOI 10.1007/s00134-015-3796-z; Weinberger B, 2001, TOXICOL SCI, V59, P5, DOI 10.1093/toxsci/59.1.5; YAHAGI N, 1995, ARTIF ORGANS, V19, P557, DOI 10.1111/j.1525-1594.1995.tb02378.x; Yu B, 2015, SCI TRANSL MED, V7; Zampieri FG, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0868-y	103	28	31	1	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 30	2016	387	10030					1867	1878		10.1016/S0140-6736(16)30245-8	http://dx.doi.org/10.1016/S0140-6736(16)30245-8			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK6SS	27203510				2022-12-28	WOS:000375056100035
J	Huizinga, TWJ; Grondal, G				Huizinga, Tom W. J.; Grondal, Gerdur			Drivers of costly treatment strategies in rheumatoid arthritis	LANCET			English	Editorial Material							PSORIATIC-ARTHRITIS; METHOTREXATE; RITUXIMAB		[Huizinga, Tom W. J.] Leiden Univ, Med Ctr, Dept Rheumatol, NL-2300 RC Leiden, Netherlands; [Grondal, Gerdur] Natl Univ Hosp Reykjavik, Landspitali, Ctr Rheumatol Res, Dept Rheumatol, Reykjavik, Iceland	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Landspitali National University Hospital	Huizinga, TWJ (corresponding author), Leiden Univ, Med Ctr, Dept Rheumatol, NL-2300 RC Leiden, Netherlands.	T.W.J.Huizinga@lumc.nl						Clifford DB, 2011, ARCH NEUROL-CHICAGO, V68, P1156, DOI 10.1001/archneurol.2011.103; Dougados M, 2012, RHEUMATOLOGY, V51, P1343, DOI 10.1093/rheumatology/kes059; Kingsley GH, 2012, RHEUMATOLOGY, V51, P1368, DOI 10.1093/rheumatology/kes001; Porter D, 2016, LANCET; Sebastiani M, 2014, JOINT BONE SPINE, V81, P508, DOI 10.1016/j.jbspin.2014.06.011	5	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2016	388	10041					213	214		10.1016/S0140-6736(16)30548-7	http://dx.doi.org/10.1016/S0140-6736(16)30548-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR2LN	27197691				2022-12-28	WOS:000379736100004
J	Bray, BD; Cloud, GC; James, MA; Hemingway, H; Paley, L; Stewart, K; Tyrrell, PJ; Wolfe, CDA; Rudd, AG				Bray, Benjamin D.; Cloud, Geoffrey C.; James, Martin A.; Hemingway, Harry; Paley, Lizz; Stewart, Kevin; Tyrrell, Pippa J.; Wolfe, Charles D. A.; Rudd, Anthony G.		SSNAP Collaboration	Weekly variation in health-care quality by day and time of admission: a nationwide, registry-based, prospective cohort study of acute stroke care	LANCET			English	Article							IN-HOSPITAL MORTALITY; WEEKEND; WEEKDAY; ADJUSTMENT; CENTERS; DEATH; RISK	Background Studies in many health systems have shown evidence of poorer quality health care for patients admitted on weekends or overnight than for those admitted during the week (the so-called weekend effect). We postulated that variation in quality was dependent on not only day, but also time, of admission, and aimed to describe the pattern and magnitude of variation in the quality of acute stroke care across the entire week. Methods We did this nationwide, registry-based, prospective cohort study using data from the Sentinel Stroke National Audit Programme. We included all adult patients (aged > 16 years) admitted to hospital with acute stroke (ischaemic or primary intracerebral haemorrhage) in England and Wales between April 1, 2013, and March 31, 2014. Our outcome measure was 30 day post-admission survival. We estimated adjusted odds ratios for 13 indicators of acute stroke-care quality by fitting multilevel multivariable regression models across 42 4-h time periods per week. Findings The study cohort comprised 74 307 patients with acute stroke admitted to 199 hospitals. Care quality varied across the entire week, not only between weekends and weekdays, with different quality measures showing different patterns and magnitudes of temporal variation. We identified four patterns of variation: a diurnal pattern (thrombolysis, brain scan within 12 h, brain scan within 1 h, dysphagia screening), a day of the week pattern (stroke physician assessment, nurse assessment, physiotherapy, occupational therapy, and assessment of communication and swallowing by a speech and language therapist), an off - hours pattern (door-to-needle time for thrombolysis), and a flow pattern whereby quality changed sequentially across days (stroke-unit admission within 4 h). The largest magnitude of variation was for door-to-needle time within 60 min (range in quality 35-66% [16/46-232/350]; coefficient of variation 18 . 2). There was no difference in 30 day survival between weekends and weekdays (adjusted odds ratio 1 . 03, 95% CI 0 . 95-1 . 13), but patients admitted overnight on weekdays had lower odds of survival (0 . 90, 0 . 82-0 . 99). Interpretation The weekend effect is a simplification, and just one of several patterns of weekly variation occurring in the quality of stroke care. Weekly variation should be further investigated in other health-care settings, and quality improvement should focus on reducing temporal variation in quality and not only the weekend effect.	[Bray, Benjamin D.; Hemingway, Harry] UCL, Farr Inst Hlth Informat Res, London NW1 2DA, England; [Cloud, Geoffrey C.] St Georges NHS Fdn Trust, London, England; [James, Martin A.] Royal Devon & Exeter NHS Fdn Trust, Exeter, Devon, England; [Stewart, Kevin] Royal Coll Physicians, Clin Effectiveness & Evaluat Unit, London NW1 4LE, England; [Paley, Lizz] Royal Coll Physicians, London NW1 4LE, England; [Tyrrell, Pippa J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Wolfe, Charles D. A.; Rudd, Anthony G.] Kings Coll London, Div Hlth & Social Care Res, London WC2R 2LS, England	University of London; University College London; University of Exeter; Royal College of Physicians; Royal College of Physicians; University of Manchester; University of London; King's College London	Bray, BD (corresponding author), UCL, Farr Inst Hlth Informat Res, London NW1 2DA, England.	benjamin.bray@kcl.ac.uk	; Hemingway, Harry/C-1219-2009	James, Martin/0000-0001-6065-6018; Paley, Lizz/0000-0002-3879-5377; Hemingway, Harry/0000-0003-2279-0624; Cloud, Geoffrey/0000-0002-8365-6907; Tyrrell, Pippa/0000-0001-9609-1231	Healthcare Quality Improvement Partnership on behalf of National Health Service (NHS) England; National Institute for Health Research (NIHR); NIHR Collaboration for Leadership in Applied Health Research and Care for the South West Peninsula; NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; Stanley Thomas Johnson Foundation; Stroke Association; NIHR; Medical Research Council [MR/K006584/1]; Arthritis Research UK; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Engineering and Physical Sciences Research Council; National Institute for Social Care and Health Research (Welsh Assembly Government); Chief Scientific Office (Scottish Government Health Directorates); Wellcome Trust; National Institute for Health Research [ACF-2015-18-019, RP-PG-0407-10184, NF-SI-0510-10060] Funding Source: researchfish	Healthcare Quality Improvement Partnership on behalf of National Health Service (NHS) England; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR Collaboration for Leadership in Applied Health Research and Care for the South West Peninsula; NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; Stanley Thomas Johnson Foundation; Stroke Association; NIHR(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Social Care and Health Research (Welsh Assembly Government); Chief Scientific Office (Scottish Government Health Directorates); Wellcome Trust(Wellcome Trust); National Institute for Health Research(National Institute for Health Research (NIHR))	The Sentinel Stroke National Audit Programme (SSNAP) is funded by the Healthcare Quality Improvement Partnership on behalf of National Health Service (NHS) England. The study received no specific funding, but some of the authors are funded either fully or partly. BDB is supported by the National Institute for Health Research (NIHR) as an academic clinical fellow. MAJ is supported by the NIHR Collaboration for Leadership in Applied Health Research and Care for the South West Peninsula. CDAW acknowledges financial support from the NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London, the Stanley Thomas Johnson Foundation, the Stroke Association, and NIHR Programme Grant funding. HH is supported by awards establishing the Farr Institute of Health Informatics Research from the Medical Research Council (reference MR/K006584/1), in partnership with Arthritis Research UK, the British Heart Foundation, Cancer Research UK, the Economic and Social Research Council, the Engineering and Physical Sciences Research Council, NIHR, the National Institute for Social Care and Health Research (Welsh Assembly Government), the Chief Scientific Office (Scottish Government Health Directorates), and the Wellcome Trust. We thank the many hundreds of individuals and organisations participating in the SSNAP, without whose efforts this study would not be possible. On behalf of everyone who has contributed to the project, we thank the clinical leads at each participating site and the individuals in the Royal College of Physicians Stroke Programme involved in coordinating data collection, whose names are available online (www.rcplondon.ac.uk/projects/outputs/ssnap-collaboration).	Albright KC, 2012, CEREBROVASC DIS, V34, P424, DOI 10.1159/000345077; Aylin P, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4652; Bell CM, 2001, NEW ENGL J MED, V345, P663, DOI 10.1056/NEJMsa003376; Bray BD, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001705; Coiera E, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-226; Concha OP, 2014, BMJ QUAL SAF, V23, P215, DOI 10.1136/bmjqs-2013-002218; Coumbe A, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-63; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Fang JM, 2010, NEUROLOGY, V75, P1589, DOI 10.1212/WNL.0b013e3181fb84bc; Fonarow GC, 2012, JAMA-J AM MED ASSOC, V308, P257, DOI 10.1001/jama.2012.7870; Guo G, 2000, ANNU REV SOCIOL, V26, P441, DOI 10.1146/annurev.soc.26.1.441; Intercollegiate Stroke Working Party, 2012, NAT CLIN GUID STROK, V4th ed; Kostis WJ, 2007, NEW ENGL J MED, V356, P1099, DOI 10.1056/NEJMoa063355; Langhorne P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000197.pub3; Lilford RJ, 2015, BMJ QUAL SAF, V24, P480, DOI 10.1136/bmjqs-2015-004360; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lyndon A, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.07.018; Magid DJ, 2005, JAMA-J AM MED ASSOC, V294, P803, DOI 10.1001/jama.294.7.803; McKinney JS, 2011, STROKE, V42, P2403, DOI 10.1161/STROKEAHA.110.612317; Meacock R, 2015, HEALTH ECON, V24, P907, DOI 10.1002/hec.3207; Muller CJ, 2014, INT J EPIDEMIOL, V43, P962, DOI 10.1093/ije/dyu029; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; NHS England, 2013, EV COUNTS PLANN PAT; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Ruiz M, 2015, BMJ QUAL SAF, V24, P492, DOI 10.1136/bmjqs-2014-003467; Sorita A, 2014, BMJ-BRIT MED J, V348, pf7393; Turner M, 2016, J NEUROL NEUROSUR PS, V87, P138, DOI 10.1136/jnnp-2015-311273; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Vest-Hansen B, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006731	29	94	96	1	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2016	388	10040					170	177		10.1016/S0140-6736(16)30443-3	http://dx.doi.org/10.1016/S0140-6736(16)30443-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ5TZ	27178477	Green Submitted, Green Published			2022-12-28	WOS:000379269200032
J	Johnston, SC; Amarenco, P; Albers, GW; Denison, H; Easton, JD; Evans, SR; Held, P; Jonasson, J; Minematsu, K; Molina, CA; Wang, YJ; Wong, KSL				Johnston, S. Claiborne; Amarenco, Pierre; Albers, Gregory W.; Denison, Hans; Easton, J. Donald; Evans, Scott R.; Held, Peter; Jonasson, Jenny; Minematsu, Kazuo; Molina, Carlos A.; Wang, Yongjun; Wong, K. S. Lawrence		SOCRATES Steering Comm Investigato	Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MINOR STROKE; EARLY RISK; CLOPIDOGREL; ANTAGONIST; AZD6140	BACKGROUND Ticagrelor may be a more effective antiplatelet therapy than aspirin for the prevention of recurrent stroke and cardiovascular events in patients with acute cerebral ischemia. METHODS We conducted an international double-blind, controlled trial in 674 centers in 33 countries, in which 13,199 patients with a nonsevere ischemic stroke or high-risk transient ischemic attack who had not received intravenous or intraarterial thrombolysis and were not considered to have had a cardioembolic stroke were randomly assigned within 24 hours after symptom onset, in a 1: 1 ratio, to receive either ticagrelor (180 mg loading dose on day 1 followed by 90 mg twice daily for days 2 through 90) or aspirin (300 mg on day 1 followed by 100 mg daily for days 2 through 90). The primary end point was the time to the occurrence of stroke, myocardial infarction, or death within 90 days. RESULTS During the 90 days of treatment, a primary end-point event occurred in 442 of the 6589 patients (6.7%) treated with ticagrelor, versus 497 of the 6610 patients (7.5%) treated with aspirin (hazard ratio, 0.89; 95% confidence interval [CI], 0.78 to 1.01; P = 0.07). Ischemic stroke occurred in 385 patients (5.8%) treated with ticagrelor and in 441 patients (6.7%) treated with aspirin (hazard ratio, 0.87; 95% CI, 0.76 to 1.00). Major bleeding occurred in 0.5% of patients treated with ticagrelor and in 0.6% of patients treated with aspirin, intracranial hemorrhage in 0.2% and 0.3%, respectively, and fatal bleeding in 0.1% and 0.1%. CONCLUSIONS In our trial involving patients with acute ischemic stroke or transient ischemic attack, ticagrelor was not found to be superior to aspirin in reducing the rate of stroke, myocardial infarction, or death at 90 days.	[Johnston, S. Claiborne] Univ Texas Austin, Dell Med Sch, Deans Off, 1912 Speedway,Suite 564, Austin, TX 78712 USA; [Amarenco, Pierre] Hop Xavier Bichat, Dept Neurol, Paris, France; [Amarenco, Pierre] Hop Xavier Bichat, Stroke Ctr, Paris, France; [Amarenco, Pierre] Sch Med, Paris, France; [Albers, Gregory W.] Stanford Univ, Med Ctr, Stanford Stroke Ctr, Palo Alto, CA 94304 USA; [Easton, J. Donald] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Denison, Hans; Held, Peter; Jonasson, Jenny] AstraZeneca, Gothenburg, Sweden; [Evans, Scott R.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Minematsu, Kazuo] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan; [Molina, Carlos A.] Hosp Valle De Hebron, Stroke Unit, Barcelona, Spain; [Wang, Yongjun] Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Wong, K. S. Lawrence] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China	University of Texas System; University of Texas Austin; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; Stanford University; University of California System; University of California San Francisco; AstraZeneca; Harvard University; Harvard T.H. Chan School of Public Health; National Cerebral & Cardiovascular Center - Japan; Hospital Universitari Vall d'Hebron; Chinese University of Hong Kong	Johnston, SC (corresponding author), Univ Texas Austin, Dell Med Sch, Deans Off, 1912 Speedway,Suite 564, Austin, TX 78712 USA.	clay.johnston@utexas.edu	LEYS, Didier/G-2955-2016; UZUNER, NEVZAT/B-3367-2018; FRACP, Tissa Wijeratne MD PhD/I-2086-2019; Zini, Andrea/K-1136-2014; Arsava, Ethem Murat/AAY-5260-2020; ince, birsen/AAI-1704-2019; Hill, Michael D/C-9073-2012; Muengtaweepongsa, Sombat/C-1402-2010; Uzuner, Nevzat/ABB-5971-2020; Androulakis, X. Michelle/I-6072-2019; Brola, Waldemar/D-8813-2014; Di Lazzaro, Vincenzo/L-3731-2018; Koziolkin, Oleksandr/AAA-5382-2019; Titianova, Ekaterina/Q-1102-2018; Wong, Ka Sing Lawrence/N-3434-2015; Michel, Patrik/Q-2275-2016	LEYS, Didier/0000-0003-4408-4392; UZUNER, NEVZAT/0000-0002-4961-4332; FRACP, Tissa Wijeratne MD PhD/0000-0002-1701-7111; Zini, Andrea/0000-0003-1486-4507; Arsava, Ethem Murat/0000-0002-6527-4139; Hill, Michael D/0000-0002-6269-1543; Muengtaweepongsa, Sombat/0000-0003-3715-4428; Uzuner, Nevzat/0000-0002-4961-4332; Androulakis, X. Michelle/0000-0002-1833-3474; Brola, Waldemar/0000-0002-7955-3454; Di Lazzaro, Vincenzo/0000-0002-9113-5925; Koziolkin, Oleksandr/0000-0001-9878-5798; Titianova, Ekaterina/0000-0001-9186-5613; Wong, Ka Sing Lawrence/0000-0002-2031-9866; Michel, Patrik/0000-0003-4954-7579; Albers, Gregory/0000-0003-0263-4632; corea, francesco/0000-0002-5864-9991; Hemelsoet, Dimitri/0000-0001-5403-3092; Burgin, William/0000-0001-5376-8302; Touze, Emmanuel/0000-0002-7254-2162; Oh, Kyungmi/0000-0002-7304-0308; Lemmens, Robin/0000-0002-4948-5956; Carrera, Emmanuel/0000-0003-0045-5382; Timsit, Serge/0000-0003-0346-8576; Fiszer, Urszula/0000-0002-9286-2454; Vanacker, Peter/0000-0003-2169-5123; Lasek-Bal, Anetta/0000-0003-2481-7528; Smolanka, Volodymyr/0000-0001-7296-8297; , Dorothea/0000-0001-9893-989X; Nikonov, Vadim/0000-0002-0078-9991	AstraZeneca	AstraZeneca(AstraZeneca)	Funded by AstraZeneca; ClinicalTrials.gov number, NCT01994720.	Amarenco P, 2016, NEW ENGL J MED, V374, P1533, DOI 10.1056/NEJMoa1412981; Bonaca MP, 2015, NEW ENGL J MED, V372, P1791, DOI 10.1056/NEJMoa1500857; CAST (Chinese Acute Stroke Trial) Collaborative Group, 2013, GASTROENTEROLOGY, V27, P159; Chen ZM, 1997, LANCET, V349, P1641, DOI 10.1016/S0140-6736(97)04010-5; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Coull AJ, 2004, BMJ-BRIT MED J, V328, P326, DOI 10.1136/bmj.37991.635266.44; Giles MF, 2007, LANCET NEUROL, V6, P1063, DOI 10.1016/S1474-4422(07)70274-0; Halkes PHA, 2006, LANCET, V367, P1665; Husted S, 2006, EUR HEART J, V27, P1038, DOI 10.1093/eurheartj/ehi754; Johnston SC, 2015, INT J STROKE, V10, P1304, DOI 10.1111/ijs.12610; Johnston SC, 2000, JAMA-J AM MED ASSOC, V284, P2901, DOI 10.1001/jama.284.22.2901; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Sandercock P, 1997, LANCET, V349, P1569; Storey RF, 2007, J AM COLL CARDIOL, V50, P1852, DOI 10.1016/j.jacc.2007.07.058; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wang YJ, 2013, NEW ENGL J MED, V369, P11, DOI 10.1056/NEJMoa1215340; Wu CM, 2007, ARCH INTERN MED, V167, P2417, DOI 10.1001/archinte.167.22.2417	17	310	321	2	62	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 7	2016	375	1					35	43		10.1056/NEJMoa1603060	http://dx.doi.org/10.1056/NEJMoa1603060			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ1ZP	27160892	Bronze, Green Published			2022-12-28	WOS:000379000200003
J	Katki, HA; Kovalchik, SA; Berg, CD; Cheung, LC; Chaturvedi, AK				Katki, Hormuzd A.; Kovalchik, Stephanie A.; Berg, Christine D.; Cheung, Li C.; Chaturvedi, Anil K.			Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DECISION AID; PREDICTION; PROSTATE; MANAGEMENT; MORTALITY; BENEFITS; OUTCOMES; BREAST	IMPORTANCE The US Preventive Services Task Force (USPSTF) recommends computed tomography (CT) lung cancer screening for ever-smokers aged 55 to 80 years who have smoked at least 30 pack-years with no more than 15 years since quitting. However, selecting ever-smokers for screening using individualized lung cancer risk calculations may be more effective and efficient than current USPSTF recommendations. OBJECTIVE Comparison of modeled outcomes from risk-based CT lung-screening strategies vs USPSTF recommendations. DESIGN, SETTING, AND PARTICIPANTS Empirical risk models for lung cancer incidence and death in the absence of CT screening using data on ever-smokers from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO; 1993-2009) control group. Covariates included age; education; sex; race; smoking intensity, duration, and quit-years; body mass index; family history of lung cancer; and self-reported emphysema. Model validation in the chest radiography groups of the PLCO and the National Lung Screening Trial (NLST; 2002-2009), with additional validation of the death model in the National Health Interview Survey (NHIS; 1997-2001), a representative sample of the United States. Models were applied to US ever-smokers aged 50 to 80 years (NHIS 2010-2012) to estimate outcomes of risk-based selection for CT lung screening, assuming screening for all ever-smokers, yield the percent changes in lung cancer detection and death observed in the NLST. EXPOSURES Annual CT lung screening for 3 years beginning at age 50 years. MAIN OUTCOMES AND MEASURES For model validity: calibration (number of model-predicted cases divided by number of observed cases [estimated/observed]) and discrimination (area under curve [AUC]). For modeled screening outcomes: estimated number of screen-avertable lung cancer deaths and estimated screening effectiveness (number needed to screen [NNS] to prevent 1 lung cancer death). RESULTS Lung cancer incidence and death risk models were well calibrated in PLCO and NLST. The lung cancer death model calibrated and discriminated well for US ever-smokers aged 50 to 80 years (NHIS 1997-2001: estimated/observed = 0.94 [95% CI, 0.84-1.05]; AUC, 0.78 [95% CI, 0.76-0.80]). Under USPSTF recommendations, the models estimated 9.0 million US ever-smokers would qualify for lung cancer screening and 46 488 (95% CI, 43 924-49 053) lung cancer deaths were estimated as screen-avertable over 5 years (estimated NNS, 194 [95% CI, 187-201]). In contrast, risk-based selection screening of the same number of ever-smokers (9.0 million) at highest 5-year lung cancer risk (>= 1.9%) was estimated to avert 20% more deaths (55 717 [95% CI, 53 033-58 400]) and was estimated to reduce the estimated NNS by 17%(NNS, 162 [95% CI, 157-166]). CONCLUSIONS AND RELEVANCE Among a cohort of US ever-smokers aged 50 to 80 years, application of a risk-based model for CT screening for lung cancer compared with a model based on USPSTF recommendations was estimated to be associated with a greater number of lung cancer deaths prevented over 5 years, along with a lower NNS to prevent 1 lung cancer death.	[Katki, Hormuzd A.; Berg, Christine D.; Chaturvedi, Anil K.] NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, 9609 Med Ctr Dr,Room 7E606, Bethesda, MD 20892 USA; [Kovalchik, Stephanie A.] Victoria Univ, Inst Sport Exercise & Act Living, Melbourne, Vic 8001, Australia; [Berg, Christine D.] Johns Hopkins Med, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD USA; [Cheung, Li C.] Informat Management Serv Inc, Calverton, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Victoria University; Johns Hopkins University; Johns Hopkins Medicine; Information Management Services, Inc.	Katki, HA (corresponding author), NCI, Div Canc Epidemiol & Genet, 9609 Med Ctr Dr,Room 7E606, Bethesda, MD 20892 USA.; Chaturvedi, AK (corresponding author), NCI, Div Canc Epidemiol & Genet, 9609 Med Ctr Dr,Room 6E238, Bethesda, MD 20892 USA.	katkih@mail.nih.gov; chaturva@mail.nih.gov	Cheung, Li/AAY-3594-2020	Cheung, Li/0000-0003-1625-4331	Intramural Research Program of the US National Institutes of Health (NIH)/National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIACP010188] Funding Source: NIH RePORTER	Intramural Research Program of the US National Institutes of Health (NIH)/National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Intramural Research Program of the US National Institutes of Health (NIH)/National Cancer Institute.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Agency for Healthcare Research and Quality (AHRQ), LUNG CANC SCREEN TOO; American Society for Colposcopy and Cervical Pathology (ASCCP), 2015, ASCCP MOB ALG APP; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2013, NAT HLTH INT SURV 19; Bach PB, 2003, JNCI-J NATL CANCER I, V95, P470, DOI 10.1093/jnci/95.6.470; Bach PB, 2014, LUNG CANC SCREEN DEC; Bach PB, 2014, ANN INTERN MED, V160, P365, DOI 10.7326/M13-2926; Bach PB, 2012, ANN INTERN MED, V157, P571, DOI 10.7326/0003-4819-157-8-201210160-00524; BENICHOU J, 1990, BIOMETRICS, V46, P813, DOI 10.2307/2532098; Beral V, 2011, J MED SCREEN, V18, P210, DOI 10.1258/jms.2011.011134; Black WC, 2014, NEW ENGL J MED, V371, P1793, DOI 10.1056/NEJMoa1312547; Centers for Disease Control and Prevention (CDC), 2013, NAT HLTH INT SURV; Chin J, 2015, DECISION MEMO SCREEN; de Koning HJ, 2014, ANN INTERN MED, V160, P311, DOI 10.7326/M13-2316; Edwards BK, 2014, CANCER-AM CANCER SOC, V120, P1290, DOI 10.1002/cncr.28509; Gould MK, 2014, NEW ENGL J MED, V371, P1813, DOI 10.1056/NEJMcp1404071; Hoggart C, 2012, CANCER PREV RES, V5, P834, DOI 10.1158/1940-6207.CAPR-11-0237; Katki HA, 2013, J LOW GENIT TRACT DI, V17, pS28, DOI 10.1097/LGT.0b013e318285423c; Katki HA, 2009, LANCET ONCOL, V10, P1022, DOI 10.1016/S1470-2045(09)70253-0; Kovalchik SA, 2013, NEW ENGL J MED, V369, P245, DOI 10.1056/NEJMoa1301851; Lau YK, 2014, JMIR RES PROTOC, V3, DOI 10.2196/resprot.4039; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Marcus MW, 2015, CANCER PREV RES, V8, P570, DOI 10.1158/1940-6207.CAPR-14-0438; Massad LS, 2013, OBSTET GYNECOL, V121, P829, DOI 10.1097/AOG.0b013e3182883a34; McMahon PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099978; Meza R, 2014, CANCER-AM CANCER SOC, V120, P1713, DOI 10.1002/cncr.28623; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; Oken MM, 2011, JAMA-J AM MED ASSOC, V306, P1865, DOI 10.1001/jama.2011.1591; Pinsky PF, 2007, AM J EPIDEMIOL, V165, P874, DOI 10.1093/aje/kwk075; Pinsky PF, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv226; Pinsky PF, 2015, ANN INTERN MED, V162, P485, DOI 10.7326/M14-2086; Pinsky PF, 2013, CANCER-AM CANCER SOC, V119, P593, DOI 10.1002/cncr.27774; Spitz MR, 2007, JNCI-J NATL CANCER I, V99, P715, DOI 10.1093/jnci/djk153; Tammemagi MC, 2015, J THORAC IMAG, V30, P88, DOI 10.1097/RTI.0000000000000142; Tammemagi MC, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001764; Tammemagi MC, 2013, NEW ENGL J MED, V368, P728, DOI 10.1056/NEJMoa1211776; Terry N, 2013, NEW ASCCP GUIDELINES; Trevena LJ, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-S2-S7; Vehmas T, 2015, EUR J CANCER PREV, V24, P454, DOI 10.1097/CEJ.0000000000000110	40	173	179	8	180	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2016	315	21					2300	2311		10.1001/jama.2016.6255	http://dx.doi.org/10.1001/jama.2016.6255			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN6KO	27179989	Green Accepted, Bronze			2022-12-28	WOS:000377183100019
J	Bayry, J				Bayry, Jagadeesh			Repressing Immunity in Autoimmune Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bayry, Jagadeesh] INSERM, Ctr Rech Cordeliers, Unite 1138, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Bayry, J (corresponding author), INSERM, Ctr Rech Cordeliers, Unite 1138, Paris, France.		Bayry, Jagadeesh/A-6589-2011	Bayry, Jagadeesh/0000-0003-0498-9808				Bacchetta R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00016; Bluestone JA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad4134; Clemente-Casares X, 2016, NATURE, V530, P434, DOI 10.1038/nature16962; Jin RR, 2014, CURR OPIN PHARMACOL, V18, P18, DOI 10.1016/j.coph.2014.08.002; Saadoun D, 2011, NEW ENGL J MED, V365, P2067, DOI 10.1056/NEJMoa1105143	5	8	9	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 26	2016	374	21					2090	2092		10.1056/NEJMcibr1602864	http://dx.doi.org/10.1056/NEJMcibr1602864			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6EN	27223152				2022-12-28	WOS:000376443500015
J	Shima, M; Hanabusa, H; Taki, M; Matsushita, T; Sato, T; Fukutake, K; Fukazawa, N; Yoneyama, K; Yoshida, H; Nogami, K				Shima, Midori; Hanabusa, Hideji; Taki, Masashi; Matsushita, Tadashi; Sato, Tetsuji; Fukutake, Katsuyuki; Fukazawa, Naoki; Yoneyama, Koichiro; Yoshida, Hiroki; Nogami, Keiji			Factor VIII-Mimetic Function of Humanized Bispecific Antibody in Hemophilia A	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; IMMUNE TOLERANCE; JOINT BLEEDS; FACTORS IXA; PROPHYLAXIS; ACE910; INHIBITORS; MODEL; DEFINITIONS; HEMOSTASIS	BACKGROUND In patients with severe hemophilia A, standard treatment is regular prophylactic and episodic intravenous infusions of factor VIII. However, these treatments are burdensome, especially for children, and may lead to the formation of anti-factor VIII alloantibodies (factor VIII inhibitors). Emicizumab (ACE910), a humanized bispecific antibody mimicking the cofactor function of factor VIII, was developed to abate these problems. METHODS We enrolled 18 Japanese patients with severe hemophilia A (with or without factor VIII inhibitors) in an open-label, nonrandomized, interindividual dose-escalation study of emicizumab. The patients received subcutaneous emicizumab weekly for 12 weeks at a dose of 0.3, 1.0, or 3.0 mg per kilogram of body weight (cohorts 1, 2, and 3, respectively). The end points were safety and pharmacokinetic and pharmacodynamic profiles. An additional, exploratory end point was the annualized bleeding rate, calculated as 365.25 times the number of bleeding episodes, divided by the number of days in the treatment period as compared with the 6 months before enrollment. RESULTS Emicizumab was associated with neither serious adverse events nor clinically relevant coagulation abnormalities. Plasma concentrations of emicizumab increased in a dose-dependent manner. Activated partial-thromboplastin times remained short throughout the study. The median annualized bleeding rates in cohorts 1, 2, and 3 decreased from 32.5 to 4.4, 18.3 to 0.0, and 15.2 to 0.0, respectively. There was no bleeding in 8 of 11 patients with factor VIII inhibitors (73%) and in 5 of 7 patients without factor VIII inhibitors (71%). Episodic use of clotting factors to control bleeding was reduced. Antibodies to emicizumab did not develop. CONCLUSIONS Once-weekly subcutaneous administration of emicizumab markedly decreased the bleeding rate in patients who had hemophilia A with or without factor VIII inhibitors. (Funded by Chugai Pharmaceutical; JapicCTI number, 121934.)	[Shima, Midori; Nogami, Keiji] Nara Med Univ, Kashihara, Nara 634, Japan; [Hanabusa, Hideji] Ogikubo Hosp, Tokyo, Japan; [Fukutake, Katsuyuki] Tokyo Med Univ, Tokyo 1608402, Japan; [Fukazawa, Naoki; Yoneyama, Koichiro; Yoshida, Hiroki] Chugai Pharmaceut, Tokyo, Japan; [Taki, Masashi] St Marianna Univ, Sch Med, Kawasaki, Kanagawa, Japan; [Matsushita, Tadashi] Nagoya Univ, Nagoya, Aichi 4648601, Japan; [Sato, Tetsuji] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka 807, Japan	Nara Medical University; Tokyo Medical University; Chugai Pharmaceutical Co., Ltd.; Roche Holding; Saint Marianna University; Nagoya University; University of Occupational & Environmental Health - Japan	Shima, M (corresponding author), Nara Med Univ, Dept Pediat, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	mshima@naramed-u.ac.jp		Yoneyama, Koichiro/0000-0001-8166-6522	Chugai Pharmaceutical	Chugai Pharmaceutical	Funded by Chugai Pharmaceutical	Aznar JA, 2012, HAEMOPHILIA, V18, P738, DOI 10.1111/j.1365-2516.2012.02806.x; Baker Matthew P, 2010, Self Nonself, V1, P314, DOI 10.4161/self.1.4.13904; Beeton K, 2007, HAEMOPHILIA, V13, P570, DOI 10.1111/j.1365-2516.2007.01494.x; Berntorp E, 2003, HAEMOPHILIA, V9, P1, DOI 10.1046/j.1365-2516.9.s1.17.x; Blanchette VS, 2014, J THROMB HAEMOST, V12, P1935, DOI 10.1111/jth.12672; Caram C, 2011, THROMB HAEMOSTASIS, V105, P59, DOI 10.1160/TH10-04-0231; De Moerloose P, 2008, HAEMOPHILIA, V14, P931, DOI 10.1111/j.1365-2516.2008.01843.x; den Uijl IEM, 2011, HAEMOPHILIA, V17, P41, DOI 10.1111/j.1365-2516.2010.02383.x; DiMichele DM, 2014, TEXTBOOK OF HEMOPHILIA, 3RD EDITION, P64; Du Treil S, 2007, HAEMOPHILIA, V13, P493, DOI 10.1111/j.1365-2516.2007.01526.x; Fischer K, 2012, HAEMOPHILIA, V18, pe241, DOI 10.1111/j.1365-2516.2011.02687.x; Giordano P, 2014, PEDIATR HEMAT ONCOL, V31, P687, DOI 10.3109/08880018.2014.930768; Hay CRM, 2012, BLOOD, V119, P1335, DOI 10.1182/blood-2011-08-369132; Holstein K, 2014, THROMB RES, V134, pS53, DOI 10.1016/j.thromres.2013.10.012; Kitazawa T, 2012, NAT MED, V18, P1570, DOI 10.1038/nm.2942; Konkle BA, 2007, J THROMB HAEMOST, V5, P1904, DOI 10.1111/j.1538-7836.2007.02663.x; Leissinger C, 2011, NEW ENGL J MED, V365, P1684, DOI 10.1056/NEJMoa1104435; Manco-Johnson MJ, 2007, NEW ENGL J MED, V357, P535, DOI 10.1056/NEJMoa067659; Muto A, 2014, J THROMB HAEMOST, V12, P206, DOI 10.1111/jth.12474; Muto A, 2014, BLOOD, V124, P3165, DOI 10.1182/blood-2014-07-585737; NILSSON IM, 1976, ACTA PAEDIATR SCAND, V65, P129, DOI 10.1111/j.1651-2227.1976.tb16525.x; Oldenburg J, 2014, HAEMOPHILIA, V20, P23, DOI 10.1111/hae.12428; Sampei Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057479; Soeda T, 2014, HAEMOPHILIA, V20, P77; Srivastava A, 2013, HAEMOPHILIA, V19, pE1, DOI 10.1111/j.1365-2516.2012.02909.x; SRIVASTAVA A, 2014, HAEMOPHILIA S4, V20, P4, DOI DOI 10.1111/HAE.12429; Uchida N, 2016, BLOOD, V127, P1633, DOI 10.1182/blood-2015-06-650226; White II G. C., 2001, THROMB HAEMOST, V85, P560	28	274	293	5	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 26	2016	374	21					2044	2053		10.1056/NEJMoa1511769	http://dx.doi.org/10.1056/NEJMoa1511769			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6EN	27223146	Bronze			2022-12-28	WOS:000376443500007
J	Soni, SM; Giboney, P; Yee, HF				Soni, S. Monica; Giboney, Paul; Yee, Hal F., Jr.			Development and Implementation of Expected Practices to Reduce Inappropriate Variations in Clinical Practice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Soni, S. Monica; Giboney, Paul; Yee, Hal F., Jr.] Los Angeles Cty Dept Hlth Serv, Los Angeles, CA USA		Soni, SM (corresponding author), Los Angeles Dept Hlth Serv, Martin Luther King Jr Outpatient Ctr, Med Adm, 1670 120th St,NSB 2C, Los Angeles, CA 90059 USA.	ssoni2@dhs.lacounty.gov						Fisher ES, 2009, NEW ENGL J MED, V360, P849, DOI 10.1056/NEJMp0809794; GREENFIELD S, 1992, JAMA-J AM MED ASSOC, V267, P1624, DOI 10.1001/jama.267.12.1624; Kaiser Permanente, 2011, CEL OUR NEW COMP CLI; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615	4	23	23	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 24	2016	315	20					2163	2164		10.1001/jama.2016.4255	http://dx.doi.org/10.1001/jama.2016.4255			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM4US	27218624				2022-12-28	WOS:000376343000007
J	Ha, SH; Ferrell, JE				Ha, S. H.; Ferrell, J. E., Jr.			Thresholds and ultrasensitivity from negative cooperativity	SCIENCE			English	Article							BASE-STACKING; BINDING; PHOSPHORYLATION; STABILITY; PROTEINS; SYSTEMS; KSR	Negative cooperativity is a phenomenon in which the binding of one or more molecules of a ligand to a multimeric receptor makes it more difficult for subsequent ligand molecules to bind. Negative cooperativity can make a multimeric receptor's response more graded than it would otherwise be. However, through theory and experimental results, we show that if the ligand binds the receptor with high affinity and can be appreciably depleted by receptor binding, then negative cooperativity produces a qualitatively different type of response: a highly ultrasensitive response with a pronounced threshold. Because ultrasensitivity and thresholds are important for generating various complex systems-level behaviors, including bistability and oscillations, negative cooperativity may be an important ingredient in many types of biological responses.	[Ha, S. H.; Ferrell, J. E., Jr.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Ferrell, J. E., Jr.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA	Stanford University; Stanford University	Ferrell, JE (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.; Ferrell, JE (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.	james.ferrell@stanford.edu			U.S. NIH [R01 GM046383, P50 GM107615]; National Research Foundation of Korea [NRF-2011-357-C00151, 2012M3A9B9036680]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046383, P50GM107615] Funding Source: NIH RePORTER	U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Herschlag and R. Owczarzy for helpful discussions and G. Anderson, B. Beltran, X. Cheng, and T. H. Lee for comments on the paper. This work was supported in part by grants from the U.S. NIH (R01 GM046383 and P50 GM107615) and from the National Research Foundation of Korea (NRF-2011-357-C00151 and 2012M3A9B9036680). S.H.H. and J.E.F. jointly designed the studies, made the figures, and wrote the paper. S.H.H. carried out the experiments and J.E.F. did the theoretical work.	Bray D, 1997, P NATL ACAD SCI USA, V94, P13493, DOI 10.1073/pnas.94.25.13493; Buchler NE, 2008, J MOL BIOL, V384, P1106, DOI 10.1016/j.jmb.2008.09.079; Cacace AM, 1999, MOL CELL BIOL, V19, P229; CAHILL MA, 1994, FEBS LETT, V344, P105, DOI 10.1016/0014-5793(94)00320-3; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Ferrell JE, 2014, TRENDS BIOCHEM SCI, V39, P612, DOI 10.1016/j.tibs.2014.10.002; Ferrell JE, 2014, TRENDS BIOCHEM SCI, V39, P556, DOI 10.1016/j.tibs.2014.09.003; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Ha SH, 2016, CELL REP, V14, P1408, DOI 10.1016/j.celrep.2016.01.033; Heidelberger M, 1929, J EXP MED, V50, P809, DOI 10.1084/jem.50.6.809; IDT-Biophysics, 2015, DNA THERM HYBR; Jullien N, 2011, BIOTECHNIQUES, V51, P267, DOI 10.2144/000113751; Kool ET, 2001, ANNU REV BIOPH BIOM, V30, P1, DOI 10.1146/annurev.biophys.30.1.1; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; LEVITZKI A, 1969, P NATL ACAD SCI USA, V62, P1121, DOI 10.1073/pnas.62.4.1121; Michaud NR, 1997, P NATL ACAD SCI USA, V94, P12792, DOI 10.1073/pnas.94.24.12792; Natesan S, 1997, NATURE, V390, P349, DOI 10.1038/37019; Owczarzy R, 2011, BIOCHEMISTRY-US, V50, P9352, DOI 10.1021/bi200904e; PRYWES R, 1992, NUCLEIC ACIDS RES, V20, P513, DOI 10.1093/nar/20.3.513; SAVAGEAU M. A., 1972, CURR TOP CELL REGUL, V6, P63, DOI DOI 10.1016/B978-0-12-152806-5.50010-2; Yakovchuk P, 2006, NUCLEIC ACIDS RES, V34, P564, DOI 10.1093/nar/gkj454	24	39	39	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2016	352	6288			SI		990	993		10.1126/science.aad5937	http://dx.doi.org/10.1126/science.aad5937			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM2AK	27174675	Green Accepted			2022-12-28	WOS:000376147800048
J	Henderson, JV; Venables, AJ; Regan, T; Samsonov, I				Henderson, J. Vernon; Venables, Anthony J.; Regan, Tanner; Samsonov, Ilia			Building functional cities	SCIENCE			English	Editorial Material								The literature views many African cities as dysfunctional with a hodgepodge of land uses and poor "connectivity." One driver of inefficient land uses is construction decisions for highly durable buildings made under weak institutions. In a novel approach, we model the dynamics of urban land use with both formal and slum dwellings and ongoing urban redevelopment to higher building heights in the formal sector as a city grows. We analyze the evolution of Nairobi using a unique high-spatial resolution data set. The analysis suggests insufficient building volume through most of the city and large slum areas with low housing volumes near the center, where corrupted institutions deter conversion to formal sector usage.	[Henderson, J. Vernon; Venables, Anthony J.; Regan, Tanner; Samsonov, Ilia] Univ London London Sch Econ & Polit Sci, Houghton St, London WC2A 2AE, England; [Venables, Anthony J.] Univ Oxford, Dept Econ, Oxford OX1 3UQ, England	University of London; London School Economics & Political Science; University of Oxford	Henderson, JV (corresponding author), Univ London London Sch Econ & Polit Sci, Houghton St, London WC2A 2AE, England.	j.v.henderson@lse.ac.uk		venables, anthony/0000-0003-0251-7479	ESRC [ES/M010341/1] Funding Source: UKRI; Economic and Social Research Council [ES/M010341/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Coulibaly S., 2008, 43738 WORLD BANK GRO; Duranton G., 2015, HDB REGIONAL URBAN E, P467; Fay M., 2010, POLICY RES WORKING P, V2412; Henderson J., 2016, 11211 CTR EC POL RES; Marx B, 2013, J ECON PERSPECT, V27, P187, DOI 10.1257/jep.27.4.187; SOLOW RM, 1971, J ECON THEORY, V3, P430, DOI 10.1016/0022-0531(71)90040-8; Southall R., 2005, REV AFR POLITICAL EC, V32, P142; Trans-Africa Consortium, 2010, PUBL TRANSP SUBS AFR; United Nations Human Settlements Program, 2012, STAT WORLDS CIT 2012; Williams S, 2014, ANN ASSOC AM GEOGR, V104, P114, DOI 10.1080/00045608.2013.846157; World Bank, 2014, RP1059 WORLD BANK GR; World Bank Group, 2005, 34855 WORLD BANK GRO; Zinnes C., 2012, KENYA URBAN PROGRAM	13	34	35	5	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2016	352	6288			SI		946	947		10.1126/science.aaf7150	http://dx.doi.org/10.1126/science.aaf7150			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM2AK	27199420	Green Submitted, Green Published			2022-12-28	WOS:000376147800037
J	Rottner, K				Rottner, Klemens			Formin' filaments at a faster CLIP	SCIENCE			English	Editorial Material							CAPPING PROTEIN; ACTIN-FILAMENT; IN-VIVO; DYNAMICS; PROFILIN; ENDS		[Rottner, Klemens] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Spielmannstr 7, D-38106 Braunschweig, Germany; [Rottner, Klemens] Helmholtz Ctr Infect Res, Inhoffenstr 7, D-38124 Braunschweig, Germany	Braunschweig University of Technology; Helmholtz Association; Helmholtz-Center for Infection Research	Rottner, K (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Spielmannstr 7, D-38106 Braunschweig, Germany.; Rottner, K (corresponding author), Helmholtz Ctr Infect Res, Inhoffenstr 7, D-38124 Braunschweig, Germany.	k.rottner@tu-braunschweig.de		Rottner, Klemens/0000-0003-4244-4198				Akhmanova A, 2015, NAT REV MOL CELL BIO, V16, P711, DOI 10.1038/nrm4084; Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Bombardier JP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9707; Breitsprecher D, 2012, SCIENCE, V336, P1164, DOI 10.1126/science.1218062; Brouhard GJ, 2015, MOL BIOL CELL, V26, P1207, DOI 10.1091/mbc.E13-10-0594; Eskin JA, 2016, MOL BIOL CELL, V27, P828, DOI 10.1091/mbc.E15-09-0639; Etienne-Manneville S, 2013, ANNU REV CELL DEV BI, V29, P471, DOI 10.1146/annurev-cellbio-101011-155711; Firat-Karalar EN, 2011, CURR OPIN CELL BIOL, V23, P4, DOI 10.1016/j.ceb.2010.10.007; Henty-Ridilla JL, 2016, SCIENCE, V352, P1004, DOI 10.1126/science.aaf1709; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Okada K, 2010, J CELL BIOL, V189, P1087, DOI 10.1083/jcb.201001016; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Shekhar S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9730; Swiech L, 2011, J NEUROSCI, V31, P4555, DOI 10.1523/JNEUROSCI.6582-10.2011	15	0	0	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2016	352	6288			SI		894	895		10.1126/science.aaf9624	http://dx.doi.org/10.1126/science.aaf9624			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM2AK	27199403				2022-12-28	WOS:000376147800018
J	Al-Qurainy, R; Collis, E				Al-Qurainy, Rasha; Collis, Emily			Metastatic spinal cord compression: diagnosis and management	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HIGH-DOSE DEXAMETHASONE; CANCER		[Al-Qurainy, Rasha] St Charles Ctr Hlth & Wellbeing, Pembridge Palliat Care Ctr, Community Serv, London W10 6DZ, England; [Collis, Emily] Islington ELiPSe, London NW1 2PG, England; [Collis, Emily] UCLH, London NW1 2PG, England; [Collis, Emily] HCA Palliat Care Serv, London NW1 2PG, England	University College London Hospitals NHS Foundation Trust; University of London; University College London	Al-Qurainy, R (corresponding author), St Charles Ctr Hlth & Wellbeing, Pembridge Palliat Care Ctr, Community Serv, London W10 6DZ, England.	rasha.al-qurainy@nhs.net						Abrahm Janet L, 2004, J Support Oncol, V2, P377; Abrahm JL, 2004, J SUPPORT ONCOL, V2, P391; Abrahm JL, 2004, J SUPPORT ONCOL, V2, P398; Abrahm JL, 2004, J SUPPORT ONCOL, V2, P401; Aoude A, 2014, CAN J SURG, V57, P188, DOI 10.1503/cjs.012013; Bucholtz J D, 1999, Semin Oncol Nurs, V15, P150, DOI 10.1016/S0749-2081(99)80002-3; Fan Y, 2016, EUR SPINE J, V25, P4060, DOI 10.1007/s00586-016-4406-7; Fourney DR, 2011, J CLIN ONCOL, V29, P3072, DOI 10.1200/JCO.2010.34.3897; GREENBERG HS, 1980, ANN NEUROL, V8, P361, DOI 10.1002/ana.410080404; Harris M, 2016, INT J PALLIAT NURS, V22, P37, DOI 10.12968/ijpn.2016.22.1.37; HEIMDAL K, 1992, J NEURO-ONCOL, V12, P141; Klimo Paul Jr, 2003, Neurosurg Focus, V15, pE1; L'Esperance S, 2012, CURR ONCOL, V19, pE478, DOI 10.3747/co.19.1128; Levack P, 2002, CLIN ONCOL-UK, V14, P472, DOI 10.1053/clon.2002.0098; Levack P, 2001, PROSPECTIVE AUDIT DI; LI KC, 1988, MAGN RESON IMAGING, V6, P547, DOI 10.1016/0730-725X(88)90129-4; Loblaw DA, 2012, INT J RADIAT ONCOL, V84, P312, DOI 10.1016/j.ijrobp.2012.01.014; Loblaw DA, 2005, J CLIN ONCOL, V23, P2028, DOI 10.1200/JCO.2005.00.067; Loblaw DA, 2003, CLIN ONCOL-UK, V15, P211, DOI 10.1016/S0936-6555(02)00400-4; Maranzano E, 1996, AM J CLIN ONCOL-CANC, V19, P179, DOI 10.1097/00000421-199604000-00018; McCurdy MT, 2012, CRIT CARE MED, V40, P2212, DOI 10.1097/CCM.0b013e31824e1865; Murray-Brown F, 2015, CLIN MED, V15, P108, DOI 10.7861/clinmedicine.15-1-106c; National Institute for Health and Care Excellence, 2008, MET SPIN CORD COMPR; Patchell RA, 2005, LANCET, V366, P643, DOI 10.1016/S0140-6736(05)66954-1; Prasad D, 2005, LANCET ONCOL, V6, P15, DOI 10.1016/S1470-2045(04)01709-7; Rades D, 1999, STRAHLENTHER ONKOL, V175, P378, DOI 10.1007/s000660050024; Ribas ESC, 2012, CURR TREAT OPTION NE, V14, P391, DOI 10.1007/s11940-012-0176-7; Royal College of Radiologists, 2006, RADIOTHERAPY DOSE FR; Savage P, 2014, QJM-INT J MED, V107, P277, DOI 10.1093/qjmed/hct244; SORENSEN PS, 1994, EUR J CANCER, V30A, P22, DOI 10.1016/S0959-8049(05)80011-5; VECHT CJ, 1989, NEUROLOGY, V39, P1255, DOI 10.1212/WNL.39.9.1255	31	32	36	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2016	353								i2539	10.1136/bmj.i2539	http://dx.doi.org/10.1136/bmj.i2539			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GD	27199232				2022-12-28	WOS:000376447700001
J	Koues, OI; Collins, PL; Cella, M; Robinette, ML; Porter, SI; Pyfrom, SC; Payton, JE; Colonna, M; Oltz, EM				Koues, Olivia I.; Collins, Patrick L.; Cella, Marina; Robinette, Michelle L.; Porter, Sofia I.; Pyfrom, Sarah C.; Payton, Jacqueline E.; Colonna, Marco; Oltz, Eugene M.			Distinct Gene Regulatory Pathways for Human Innate versus Adaptive Lymphoid Cells	CELL			English	Article							TRANSCRIPTIONAL REGULATION; SUPER-ENHANCERS; IFN-GAMMA; LINEAGE; DIFFERENTIATION; COMMITMENT; EXPRESSION; SUBSET; SPECIFICATION; DEREGULATION	Innate lymphoid cells (ILCs) serve as sentinels in mucosal tissues, sensing release of soluble inflammatory mediators, rapidly communicating danger via cytokine secretion, and functioning as guardians of tissue homeostasis. Although ILCs have been extensively studied in model organisms, little is known about these "first responders'' in humans, especially their lineage and functional kinships to cytokine-secreting T helper (Th) cell counterparts. Here, we report gene regulatory circuitries for four human ILC-Th counterparts derived from mucosal environments, revealing that each ILC subset diverges as a distinct lineage from Th and circulating natural killer cells but shares circuitry devoted to functional polarization with their Th counterparts. Super-enhancers demarcate cohorts of cell-identity genes in each lineage, uncovering new modes of regulation for signature cytokines, new molecules that likely impart important functions to ILCs, and potential mechanisms for autoimmune disease SNP associations within ILC-Th subsets.	[Koues, Olivia I.; Collins, Patrick L.; Cella, Marina; Robinette, Michelle L.; Porter, Sofia I.; Pyfrom, Sarah C.; Payton, Jacqueline E.; Colonna, Marco; Oltz, Eugene M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Koues, Olivia I.] Vanderbilt Univ, Vanderbilt Technol Adv Genom, Nashville, TN 37232 USA	Washington University (WUSTL); Vanderbilt University	Colonna, M; Oltz, EM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	mcolonna@pathology.wustl.edu; eoltz@wustl.edu	Collins, Patrick/AAN-7599-2020; Cella, Marina/ABA-8564-2020	Collins, Patrick/0000-0003-4550-4272; Colonna, Marco/0000-0001-5222-4987; Cella, Marina/0000-0003-1230-1313	NIH [AI120606, AI115734, AI118852, AI095542, DE021255, CA188286, CA176695]; WU-ICTS grant [TR000448]; Siteman Cancer Center [CA91842]; NATIONAL CANCER INSTITUTE [P30CA091842, R01CA188286, R01CA176695] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI120606, R01AI118852, U01AI095542, R21AI115734, R56AI134035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WU-ICTS grant; Siteman Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants (AI120606 to E.M.O. and M. Colonna; AI115734 and AI118852 to E.M.O.; AI095542 and DE021255 to M. Colonna; CA188286 to J.E.P. and E.M.O.; CA176695 to M. Cella), a WU-ICTS grant (TR000448), and a Siteman Cancer Center grant (CA91842). We thank the Genome Technology Access Center for help with "omics" analyses.	Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Balasubramani A, 2010, IMMUNITY, V33, P35, DOI 10.1016/j.immuni.2010.07.004; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Braga FAV, 2015, EUR J IMMUNOL, V45, P2945, DOI 10.1002/eji.201545650; Brind'Amour J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7033; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Choi SC, 2011, J IMMUNOL, V187, P3483, DOI 10.4049/jimmunol.1101549; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Collins PL, 2012, J IMMUNOL, V188, P1726, DOI 10.4049/jimmunol.1102879; Constantinides MG, 2015, P NATL ACAD SCI USA, V112, P5123, DOI 10.1073/pnas.1423244112; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Daussy C, 2014, J EXP MED, V211, P563, DOI 10.1084/jem.20131560; De Obaldia ME, 2015, ANNU REV IMMUNOL, V33, P607, DOI 10.1146/annurev-immunol-032414-112032; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Ebihara T, 2015, NAT IMMUNOL, V16, P1124, DOI 10.1038/ni.3272; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hughes T, 2014, CELL REP, V8, P150, DOI 10.1016/j.celrep.2014.05.042; Ishizuka IE, 2016, NAT IMMUNOL, V17, P269, DOI 10.1038/ni.3344; Kanno Y, 2012, ANNU REV IMMUNOL, V30, P707, DOI 10.1146/annurev-immunol-020711-075058; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Koues OI, 2015, IMMUNITY, V42, P186, DOI 10.1016/j.immuni.2014.12.021; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Majumder K, 2015, J EXP MED, V212, P107, DOI 10.1084/jem.20141479; Marson A, 2015, J CLIN INVEST, V125, P2234, DOI 10.1172/JCI78086; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mercer EM, 2011, IMMUNITY, V35, P413, DOI 10.1016/j.immuni.2011.06.013; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Montaldo E, 2014, IMMUNITY, V41, P988, DOI 10.1016/j.immuni.2014.11.010; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; MUNFORD RS, 1992, J BIOL CHEM, V267, P10116; Quintana FJ, 2013, SEMIN IMMUNOPATHOL, V35, P627, DOI 10.1007/s00281-013-0397-1; Ramesh R, 2014, J EXP MED, V211, P89, DOI 10.1084/jem.20130301; Ramirez K, 2012, IMMUNITY, V36, P921, DOI 10.1016/j.immuni.2012.04.006; Rankin L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00022; Rankin LC, 2016, NAT IMMUNOL, V17, P179, DOI 10.1038/ni.3332; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Stappenbeck TS, 2011, AUTOPHAGY, V7, P355, DOI 10.4161/auto.7.2.13074; Stockinger B, 2011, SEMIN IMMUNOL, V23, P99, DOI 10.1016/j.smim.2011.01.008; Tindemans I, 2014, IMMUNITY, V41, P191, DOI 10.1016/j.immuni.2014.06.006; Wang C, 2015, CURR OPIN IMMUNOL, V37, P6, DOI 10.1016/j.coi.2015.08.001; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Xu W, 2015, CELL REP, V10, P2043, DOI 10.1016/j.celrep.2015.02.057; Yu XF, 2014, ELIFE, V3, DOI 10.7554/eLife.04406; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	56	116	119	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2016	165	5					1134	1146		10.1016/j.cell.2016.04.014	http://dx.doi.org/10.1016/j.cell.2016.04.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DM6QT	27156452	Bronze, Green Accepted			2022-12-28	WOS:000376478200014
J	Hamidi, O; Montori, VM				Hamidi, Oksana; Montori, Victor M.			Testosterone gel improved sexual function, but not walk distance or fatigue, in older men with low testosterone	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Hamidi, Oksana; Montori, Victor M.] Mayo Clin, Rochester, MN USA	Mayo Clinic	Hamidi, O (corresponding author), Mayo Clin, Rochester, MN USA.			Montori, Victor/0000-0003-0595-2898; Hamidi, Oksana/0000-0002-7367-3885				Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; Bolona ER, 2007, MAYO CLIN PROC, V82, P20, DOI 10.4065/82.1.20	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2016	164	10					JC56	JC56		10.7326/ACPJC-2016-164-10-056	http://dx.doi.org/10.7326/ACPJC-2016-164-10-056			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8GF	27182922				2022-12-28	WOS:000375878500007
J	Savage, N				Savage, Neil			Unlikely partnerships	NATURE			English	Editorial Material																			0	7	7	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					S56	S58		10.1038/533S56a	http://dx.doi.org/10.1038/533S56a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM0BJ	27167391	Bronze			2022-12-28	WOS:000376007200002
J	Tomkins, AG; Bowlt, L; Genge, M; Wilson, SA; Brand, HEA; Wykes, JL				Tomkins, Andrew G.; Bowlt, Lara; Genge, Matthew; Wilson, Siobhan A.; Brand, Helen E. A.; Wykes, Jeremy L.			Ancient micrometeorites suggestive of an oxygen-rich Archaean upper atmosphere	NATURE			English	Article							MASS-INDEPENDENT FRACTIONATION; SULFUR ISOTOPES; PILBARA CRATON; IRON; EVOLUTION; OXIDATION; RISE	It is widely accepted that Earth's early atmosphere contained less than 0.001 per cent of the present-day atmospheric oxygen (O-2) level, until the Great Oxidation Event resulted in a major rise in O-2 concentration about 2.4 billion years ago(1). There are multiple lines of evidence for low O-2 concentrations on early Earth, but all previous observations relate to the composition of the lower atmosphere(2) in the Archaean era; to date no method has been developed to sample the Archaean upper atmosphere. We have extracted fossil micrometeorites from limestone sedimentary rock that had accumulated slowly 2.7 billion years ago before being preserved in Australia's Pilbara region. We propose that these micrometeorites formed when sand-sized particles entered Earth's atmosphere and melted at altitudes of about 75 to 90 kilometres (given an atmospheric density similar to that of today(3)). Here we show that the FeNi metal in the resulting cosmic spherules was oxidized while molten, and quench-crystallized to form spheres of interlocking dendritic crystals primarily of magnetite (Fe3O4), with wstit(FeO)+metal preserved in a few particles. Our model of atmospheric micrometeorite oxidation suggests that Archaean upper-atmosphere oxygen concentrations may have been close to those of the present-day Earth, and that the ratio of oxygen to carbon monoxide was sufficiently high to prevent noticeable inhibition of oxidation by carbon monoxide. The anomalous sulfur isotope (Delta S-33) signature of pyrite (FeS2) in seafloor sediments from this period, which requires an anoxic surface environment(4), implies that there may have been minimal mixing between the upper and lower atmosphere during the Archaean.	[Tomkins, Andrew G.; Bowlt, Lara; Wilson, Siobhan A.; Wykes, Jeremy L.] Monash Univ, Sch Earth Atmosphere & Environm, Melbourne, Vic 3800, Australia; [Genge, Matthew] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, Impact & Astromat Res Ctr, Exhibit Rd, London SW7 2AZ, England; [Genge, Matthew] Nat Hist Museum, Dept Mineral, Cromwell Rd, London SW7 2BT, England; [Brand, Helen E. A.; Wykes, Jeremy L.] Australian Synchrotron, 800 Blackburn Rd, Clayton, Vic 3168, Australia; [Wykes, Jeremy L.] Macquarie Univ, Dept Earth & Planetary Sci, N Ryde, NSW 2113, Australia	Monash University; Imperial College London; Natural History Museum London; Macquarie University	Tomkins, AG (corresponding author), Monash Univ, Sch Earth Atmosphere & Environm, Melbourne, Vic 3800, Australia.	andrew.tomkins@monash.edu		Wykes, Jeremy/0000-0003-1626-0803; Tomkins, Andrew/0000-0003-2788-331X; Wilson, Siobhan/0000-0002-0858-6902	STFC [ST/J001260/1]; STFC [ST/N000803/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/J001260/1, ST/N000803/1] Funding Source: researchfish; UK Space Agency [ST/M003167/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency	We thank N. Wilson and A. Langendam for assistance with electron microprobe work and electron microscopy, respectively. The authors acknowledge use of the Monash Centre for Electron Microscopy, and use of the CSIRO Microbeam Laboratory. Part of this research was undertaken on the powder diffraction beamline at the Australian Synchrotron, Victoria, Australia. M.G. acknowledges STFC grant number ST/J001260/1.	Abuluwefa HT, 1997, METALL MATER TRANS A, V28, P1633, DOI 10.1007/s11661-997-0255-7; [Anonymous], 2006, GEOBIOLOGY, DOI [DOI 10.1111/J.1472-4669.2006.00085.X, DOI 10.1111/j.1472-4669.2006.00085.x]; Awramik SM, 2009, PRECAMBRIAN RES, V174, P215, DOI 10.1016/j.precamres.2009.07.005; Bekker A, 2010, ECON GEOL, V105, P467, DOI 10.2113/gsecongeo.105.3.467; Blake TS, 2004, PRECAMBRIAN RES, V133, P143, DOI 10.1016/j.precamres.2004.03.012; BREDESEN R, 1991, OXID MET, V36, P27, DOI 10.1007/BF00938455; BUICK R, 1992, SCIENCE, V255, P74, DOI 10.1126/science.11536492; Chevrier V, 2004, GEOLOGY, V32, P1033, DOI 10.1130/G21078.1; Cioni R., 2015, ENCY VOLCANOES, V2, P519, DOI [10.1016/B978-0-12-385938-9.00029-8, DOI 10.1016/B978-0-12-385938-9.00029-8]; deFaria DLA, 1997, J RAMAN SPECTROSC, V28, P873, DOI 10.1002/(SICI)1097-4555(199711)28:11<873::AID-JRS177>3.0.CO;2-B; Eigenbrode JL, 2006, P NATL ACAD SCI USA, V103, P15759, DOI 10.1073/pnas.0607540103; Farquhar J, 2003, EARTH PLANET SC LETT, V213, P1, DOI 10.1016/S0012-821X(03)00296-6; Farquhar J., 2014, TREATISE GEOCHEMISTR, P91; Finlayson-Pitts B.J., 1999, CHEM UPPER LOWER ATM; Fulchignoni M, 2005, NATURE, V438, P785, DOI 10.1038/nature04314; Genge M, METEORIT PL IN PRESS; Genge MJ, 2008, METEORIT PLANET SCI, V43, P497, DOI 10.1111/j.1945-5100.2008.tb00668.x; Goldin TJ, 2009, GEOLOGY, V37, P1135, DOI 10.1130/G30433A.1; Kasting J. F., 2014, TREATISE GEOCHEMISTR, V6, P157; Konhauser KO, 2009, NATURE, V458, P750, DOI 10.1038/nature07858; Krull-Davatzes AE, 2010, EARTH PLANET SC LETT, V296, P319, DOI 10.1016/j.epsl.2010.05.014; Legras B, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003045; LOVE SG, 1991, ICARUS, V89, P26, DOI 10.1016/0019-1035(91)90085-8; Lyons TW, 2014, NATURE, V506, P307, DOI 10.1038/nature13068; Pavlov AA, 2002, ASTROBIOLOGY, V2, P27, DOI 10.1089/153110702753621321; Rasmussen B, 1999, GEOLOGY, V27, P115, DOI 10.1130/0091-7613(1999)027<0115:RSOTAA>2.3.CO;2; Rietmeijer FJM, 2000, EARTH MOON PLANETS, V88, P35, DOI 10.1023/A:1013862627781; Rudraswami NG, 2014, GEOCHIM COSMOCHIM AC, V131, P247, DOI 10.1016/j.gca.2014.01.026; Rye R, 1998, AM J SCI, V298, P621, DOI 10.2475/ajs.298.8.621; Song TR, 2007, ACTA GEOL SIN-ENGL, V81, P649; Trendall AF, 2004, AUST J EARTH SCI, V51, P621, DOI 10.1111/j.1400-0952.2004.01082.x; Wang J., 1994, LUNAR PLANETARY SCI, P1459	33	39	39	2	54	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					235	+		10.1038/nature17678	http://dx.doi.org/10.1038/nature17678			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0BJ	27172047	Green Submitted			2022-12-28	WOS:000376007200047
J	Taylor-Phillips, S; Wallis, MG; Jenkinson, D; Adekanmbi, V; Parsons, H; Dunn, J; Stallard, N; Szczepura, A; Gates, S; Kearins, O; Duncan, A; Hudson, S; Clarke, A				Taylor-Phillips, Sian; Wallis, Matthew G.; Jenkinson, David; Adekanmbi, Victor; Parsons, Helen; Dunn, Janet; Stallard, Nigel; Szczepura, Ala; Gates, Simon; Kearins, Olive; Duncan, Alison; Hudson, Sue; Clarke, Aileen			Effect of Using the Same vs Different Order for Second Readings of Screening Mammograms on Rates of Breast Cancer Detection A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VIGILANCE DECREMENT; PERFORMANCE; TIME; WORK; TASK	IMPORTANCE Interpreting screening mammograms is a difficult repetitive task that can result in missed cancers and false-positive recalls. In the United Kingdom, 2 film readers independently evaluate each mammogram to search for signs of cancer and examine digital mammograms in batches. However, a vigilance decrement (reduced detection rate with time on task) has been observed in similar settings. OBJECTIVE To determine the effect of changing the order for the second film reader of batches of screening mammograms on rates of breast cancer detection. DESIGN, SETTING, AND PARTICIPANTS A multicenter, double-blind, cluster randomized clinical trial conducted at 46 specialized breast screening centers from the National Health Service Breast Screening Program in England for 1 year (all between December 20, 2012, and November 3, 2014). Three hundred sixty readers participated (mean, 7.8 readers per center)-186 radiologists, 143 radiography advanced practitioners, and 31 breast clinicians, all fully qualified to report mammograms in the NHS breast screening program. INTERVENTIONS The 2 readers examined each batch of digital mammograms in the same order in the control group and in the opposite order to one another in the intervention group. MAIN OUTCOMES AND MEASURES The primary outcome was cancer detection rate; secondary outcomes were rates of recall and disagreements between readers. RESULTS Among 1 194 147 women (mean age, 59.3; SD, 7.49) who had screening mammograms (596 642 in the intervention group; 597 505 in the control group), the images were interpreted in 37 688 batches (median batch size, 35; interquartile range [IQR]; 16-46), with each reader interpreting a median of 176 batches (IQR, 96-278). After completion of all subsequent diagnostic tests, a total of 10 484 cases (0.88%) of breast cancer were detected. There was no significant difference in cancer detection rate with 5272 cancers (0.88%) detected in the intervention group vs 5212 cancers (0.87%) detected in the control group (difference, 0.01% points; 95% CI, -0.02% to 0.04% points; recall rate, 24 681 [4.14%] vs 24 894 [4.17%]; difference, -0.03% points; 95% CI, -0.10% to 0.04% points; or rate of reader disagreements, 20 471 [3.43%] vs 20 793 [3.48%]; difference, -0.05% points; 95% CI, -0.11% to 0.02% points). CONCLUSIONS AND RELEVANCE Interpretation of batches of mammograms by qualified screening mammography readers using a different order vs the same order for the second reading resulted in no significant difference in rates of detection of breast cancer.	[Taylor-Phillips, Sian; Jenkinson, David; Adekanmbi, Victor; Parsons, Helen; Dunn, Janet; Stallard, Nigel; Szczepura, Ala; Gates, Simon; Clarke, Aileen] Univ Warwick, Warwick Med Sch, Gibbett Hill Rd, Coventry CV4 7AL, W Midlands, England; [Wallis, Matthew G.] Cambridge Univ NHS Fdn Trust, Cambridge Breast Unit, Cambridge, England; [Wallis, Matthew G.] NIHR Cambridge Biomed Res Ctr, Cambridge, England; [Kearins, Olive] City Link, Screening QA Serv Midland & East, Seaton House, Nottingham, England; [Duncan, Alison] Univ Hosp Coventry, Warwickshire Solihull & Coventry Breast Screening, Coventry, W Midlands, England; [Duncan, Alison] Univ Hosp Warwickshire, Warwickshire Solihull & Coventry Breast Screening, Coventry, W Midlands, England; [Hudson, Sue] Peel & Schriek Consulting Ltd, London, England	University of Warwick; University of Cambridge; University of Warwick; University of Warwick	Taylor-Phillips, S (corresponding author), Univ Warwick, Warwick Med Sch, Gibbett Hill Rd, Coventry CV4 7AL, W Midlands, England.	s.taylor-phillips@warwick.ac.uk	Clarke, Aileen/I-5679-2012; Taylor-Phillips, Sian/AAW-8544-2021	Clarke, Aileen/0000-0001-8299-3146; Taylor-Phillips, Sian/0000-0002-1841-4346; Adekanmbi, Victor/0000-0002-7394-1640; Parsons, Helen/0000-0002-2765-3728; Szczepura, Ala/0000-0001-6244-9872; Kearins, Olive/0000-0002-4135-3035; Stallard, Nigel/0000-0001-7781-1512	NIHR; NIHR CLAHRC West Midlands initiative; University of Warwick; National Institute for Health Research [NF-SI-0507-10244, 11/25/03, PDF-2011-04-073] Funding Source: researchfish	NIHR(National Institute for Health Research (NIHR)); NIHR CLAHRC West Midlands initiative; University of Warwick; National Institute for Health Research(National Institute for Health Research (NIHR))	This study presents independent research that was impart funded by the NIHR through a postdoctoral fellowship for Dr Taylor-Phillips. The research is also supported by the NIHR CLAHRC West Midlands initiative and sponsored by the University of Warwick.	[Anonymous], 2015, STAT STAT SOFTW COMP; [Anonymous], 2014, POL MAMM SCREEN BREA; BADALAME.RV, 1969, HUM FACTORS, V11, P339, DOI 10.1177/001872086901100405; Basner M, 2008, SLEEP, V31, P1251; Baxter G, 2014, GUIDANCE NOTES EQUIP; Bennett RL, 2011, BRIT J CANCER, V104, P571, DOI 10.1038/bjc.2011.3; BROADBENT DE, 1965, HUM FACTORS, V7, P155, DOI 10.1177/001872086500700207; Burnside ES, 2005, AM J ROENTGENOL, V185, P790, DOI 10.2214/ajr.185.3.01850790; Donald F, 2015, APPL ERGON, V47, P220, DOI 10.1016/j.apergo.2014.10.001; Gale A. G., 1989, Contemporary Ergonomics 1989. Proceedings of the Ergonomics Society's Annual Conference. Ergonomics - Designing Progress', P461; Goldstein H, 1995, MULTILEVEL STAT MODE, V2nd; Gunn DV, 2005, HUM FACTORS, V47, P488, DOI 10.1518/001872005774859971; Gur D, 2008, RADIOLOGY, V249, P47, DOI 10.1148/radiol.2491072025; Hancock PA, 2013, AM PSYCHOL, V68, P97, DOI 10.1037/a0030214; Larsen K, 2005, AM J EPIDEMIOL, V161, P81, DOI 10.1093/aje/kwi017; Mackworth NH, 1948, Q J EXP PSYCHOL, V1, P6, DOI 10.1080/17470214808416738; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; National Institutes of Health, BREAST CANC SURV CON; NHS Digital, 2021, CHILDH VACC COV STAT; Perry N, 2008, ANN ONCOL, V19, P614, DOI 10.1093/annonc/mdm481; Rasbash J, 2015, USERS GUIDE MLWIN; Rayat P., BREAST SCREENING PRO; SEE JE, 1995, PSYCHOL BULL, V117, P230, DOI 10.1037/0033-2909.117.2.230; Snijders T.A., 1999, INTRO BASIC ADV MULT; Taylor P, 2008, EUR J CANCER, V44, P798, DOI 10.1016/j.ejca.2008.02.016; Taylor-Phillips S, 2009, EUR RADIOL, V19, P1890, DOI 10.1007/s00330-009-1366-x; Taylor-Phillips S, 2015, J DIGIT IMAGING, V28, P32, DOI 10.1007/s10278-014-9717-9; Taylor-Phillips S, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-17; Verster JC, 2013, ACCIDENT ANAL PREV, V58, P244, DOI 10.1016/j.aap.2012.10.005; Wiggins MW, 2011, APPL COGNITIVE PSYCH, V25, P229, DOI 10.1002/acp.1668; Wilson R, 2011, QUALITY ASSURANCE GU, V59	31	19	19	2	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 10	2016	315	18					1956	1965		10.1001/jama.2016.5257	http://dx.doi.org/10.1001/jama.2016.5257			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DL2JP	27163985	Bronze, Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000375461100013
J	Weill, A; Dalichampt, M; Raguideau, F; Ricordeau, P; Blotiere, PO; Rudant, J; Alla, F; Zureik, M				Weill, Alain; Dalichampt, Marie; Raguideau, Fanny; Ricordeau, Philippe; Blotiere, Pierre-Olivier; Rudant, Jeremie; Alla, Francois; Zureik, Mahmoud			Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							VENOUS THROMBOEMBOLISM; YOUNG-WOMEN; DROSPIRENONE; THROMBOSIS; HEALTH; USERS	OBJECTIVE To assess the risk of pulmonary embolism, ischaemic stroke, and myocardial infarction associated with combined oral contraceptives according to dose of oestrogen (ethinylestradiol) and progestogen. DESIGN Observational cohort study. SETTING Data from the French national health insurance database linked with data from the French national hospital discharge database. PARTICIPANTS 4 945 088 women aged 15-49 years, living in France, with at least one reimbursement for oral contraceptives and no previous hospital admission for cancer, pulmonary embolism, ischaemic stroke, or myocardial infarction, between July 2010 and September 2012. MAIN OUTCOME MEASURES Relative and absolute risks of first pulmonary embolism, ischaemic stroke, and myocardial infarction. RESULTS The cohort generated 5 443 916 women years of oral contraceptive use, and 3253 events were observed: 1800 pulmonary embolisms (33 per 100 000 women years), 1046 ischaemic strokes (19 per 100 000 women years), and 407 myocardial infarctions (7 per 100 000 women years). After adjustment for progestogen and risk factors, the relative risks for women using low dose oestrogen (20 mu g v 30-40 mu g) were 0.75 (95% confidence interval 0.67 to 0.85) for pulmonary embolism, 0.82 (0.70 to 0.96) for ischaemic stroke, and 0.56 (0.39 to 0.79) for myocardial infarction. After adjustment for oestrogen dose and risk factors, desogestrel and gestodene were associated with statistically significantly higher relative risks for pulmonary embolism (2.16, 1.93 to 2.41 and 1.63, 1.34 to 1.97, respectively) compared with levonorgestrel. Levonorgestrel combined with 20 mu g oestrogen was associated with a statistically significantly lower risk than levonorgestrel with 30-40 mu g oestrogen for each of the three serious adverse events. CONCLUSIONS For the same dose of oestrogen, desogestrel and gestodene were associated with statistically significantly higher risks of pulmonary embolism but not arterial thromboembolism compared with levonorgestrel. For the same type of progestogen, an oestrogen dose of 20 mu g versus 30-40 mu g was associated with lower risks of pulmonary embolism, ischaemic stroke, and myocardial infarction.	[Weill, Alain; Dalichampt, Marie; Ricordeau, Philippe; Blotiere, Pierre-Olivier; Rudant, Jeremie; Alla, Francois] French Natl Hlth Insurance, Dept Studies Publ Hlth, F-75986 Paris 20, France; [Raguideau, Fanny; Zureik, Mahmoud] French Natl Agcy Med & Hlth Prod Safety, St Denis, Reunion, France		Weill, A (corresponding author), French Natl Hlth Insurance, Dept Studies Publ Hlth, F-75986 Paris 20, France.	alain.weill@cnamts.fr	Blotière, Pierre-Olivier/AAH-2024-2021; alla, francois/D-2295-2014; Zureik, Mahmoud/F-7855-2018	Zureik, Mahmoud/0000-0002-8393-4217; Weill, Alain/0000-0001-8687-9092; alla, francois/0000-0002-5793-7190	French National Health Insurance Fund (CNAMTS); French National Agency for Medicines and Health Products Safety (ANSM)	French National Health Insurance Fund (CNAMTS); French National Agency for Medicines and Health Products Safety (ANSM)	This research was funded by the French National Health Insurance Fund (CNAMTS) and the French National Agency for Medicines and Health Products Safety (ANSM). AW, MD, PB, JR, PR, and FA are employees of the French National Health Insurance Fund, MZ and FR of the French National Agency for Medicines and Health Products Safety. The present paper represents the opinions of the authors and does not necessarily reflect the position of their employers.	Aboa-Eboule C, 2013, J NEUROL, V260, P605, DOI 10.1007/s00415-012-6686-0; Bajos N, 2012, POPUL SOC PARIS, P492; Bitzer J, 2013, J FAM PLAN REPROD H, V39, P156, DOI 10.1136/jfprhc-2013-100624; BLOEMENKAMP KWM, 1995, LANCET, V346, P1593, DOI 10.1016/S0140-6736(95)91929-5; Casez P, 2010, J CLIN EPIDEMIOL, V63, P790, DOI 10.1016/j.jclinepi.2009.09.002; Dinger J, 2010, J FAM PLAN REPROD H, V36, P123, DOI 10.1783/147118910791749416; Dinger JC, 2007, CONTRACEPTION, V75, P344, DOI 10.1016/j.contraception.2006.12.019; Dunn N, 1999, BRIT MED J, V318, P1579, DOI 10.1136/bmj.318.7198.1579; Dunn N, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3164; Dunn NR, 2001, CONTRACEPTION, V63, P65, DOI 10.1016/S0010-7824(01)00172-X; Earth Policy Institute from U.N. Population Division, 2011, WORLD CONTRACEPTIVE; Farmer RDT, 1997, LANCET, V349, P83, DOI 10.1016/S0140-6736(96)07496-X; Food and Drug Administration Office of Surveillance and Epidemiology, COMBINED HORMONAL CO; French Ministry of Labour. Employment and Health, 2011, OFFICIAL BULLETIN; GERSTMAN BB, 1991, AM J EPIDEMIOL, V133, P32, DOI 10.1093/oxfordjournals.aje.a115799; Gronich N, 2011, CAN MED ASSOC J, V183, pE1319, DOI 10.1503/cmaj.110463; Haute Autorite de Sante, 2012, CORRECT USE OF MEDIC; Heinemann LAJ, 1998, CONTRACEPTION, V57, P29, DOI 10.1016/S0010-7824(97)00204-7; Jick SS, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2151; Lewis MA, 1997, CONTRACEPTION, V56, P129, DOI 10.1016/S0010-7824(97)00118-2; Lidegaard O, 2002, CONTRACEPTION, V65, P197, DOI 10.1016/S0010-7824(01)00306-7; Lidegaard Ojvind, 2011, BMJ, V343, pd6423, DOI 10.1136/bmj.d6423; Lidegaard O, 2012, NEW ENGL J MED, V366, P2257, DOI 10.1056/NEJMoa1111840; Lidegaard Ojvind, 2009, BMJ, V339, pb2890, DOI 10.1136/bmj.b2890; Margolis KL, 2007, FERTIL STERIL, V88, P310, DOI 10.1016/j.fertnstert.2006.11.206; Moulis G, 2015, REV MED INTERNE, V36, P411, DOI 10.1016/j.revmed.2014.11.009; Parkin L, 2000, LANCET, V355, P2133, DOI 10.1016/S0140-6736(00)02382-5; Parkin L, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2139; Poulter NR, 1999, LANCET, V354, P301, DOI 10.1016/S0140-6736(99)01013-2; POULTER NR, 1995, LANCET, V346, P1575; Poulter NR, 1997, LANCET, V349, P1202, DOI 10.1016/S0140-6736(97)02358-1; Rey G, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-33; Rosenberg L, 2001, ARCH INTERN MED, V161, P1065, DOI 10.1001/archinte.161.8.1065; Sidney S, 1998, CIRCULATION, V98, P1058, DOI 10.1161/01.CIR.98.11.1058; STAMPFER MJ, 1988, NEW ENGL J MED, V319, P267, DOI 10.1056/NEJM198808043190503; Stegeman BH, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5298; Suissa S, 2000, HUM REPROD, V15, P817, DOI 10.1093/humrep/15.4.817; Tanis BC, 2001, NEW ENGL J MED, V345, P1787, DOI 10.1056/NEJMoa003216; THOROGOOD M, 1992, INT J EPIDEMIOL, V21, P48, DOI 10.1093/ije/21.1.48; Tricotel A, 2015, J THROMB HAEMOST, V13, P1576, DOI 10.1111/jth.13053; Tuppin P, 2010, REV EPIDEMIOL SANTE, V58, P286, DOI 10.1016/j.respe.2010.04.005; van Hylckama Vlieg A, 2009, BMJ, V339, pb2921, DOI 10.1136/bmj.b2921; VANDENBROUCKE JP, 1994, LANCET, V344, P1453, DOI 10.1016/S0140-6736(94)90286-0; VESSEY M, 1986, BRIT MED J, V292, P526, DOI 10.1136/bmj.292.6519.526; Vinogradova Y, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2135; Zhang G, 2014, SE ASIAN J TROP MED, V45, P736	46	97	98	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 10	2016	353								i2002	10.1136/bmj.i2002	http://dx.doi.org/10.1136/bmj.i2002			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6FP	27164970	Green Published, hybrid			2022-12-28	WOS:000376446300001
J	Xie, JX; Shaw, LJ				Xie, Joe X.; Shaw, Leslee J.			Measuring Diagnostic Health Care Costs in Stable Coronary Artery Disease: Should We Follow the Money?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MYOCARDIAL-PERFUSION; HEART-DISEASE; ANGIOGRAPHY; MANAGEMENT; TRIAL		[Xie, Joe X.; Shaw, Leslee J.] Emory Univ, Sch Med, Emory Clin Cardiovasc Clin Res Inst, 1462 Clifton Rd NE,Room 529, Atlanta, GA 30324 USA	Emory University	Shaw, LJ (corresponding author), Emory Univ, Sch Med, Emory Clin Cardiovasc Clin Res Inst, 1462 Clifton Rd NE,Room 529, Atlanta, GA 30324 USA.							Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013; Genders TSS, 2015, ANN INTERN MED, V162, P474, DOI 10.7326/M14-0027; Hachamovitch R, 2012, J AM COLL CARDIOL, V59, P462, DOI 10.1016/j.jacc.2011.09.066; Mark DB, 2016, ANN INTERN MED, V165, P94, DOI 10.7326/M15-2639; Mark DB, 2014, J AM COLL CARDIOL, V63, P698, DOI 10.1016/j.jacc.2013.02.002; Martin WH, 2015, NEW ENGL J MED, V373, P89, DOI 10.1056/NEJMc1505594; Newby D, 2015, LANCET, V385, P2383, DOI 10.1016/S0140-6736(15)60291-4; Shaw LJ, 2011, CIRCULATION, V124, P1239, DOI 10.1161/CIRCULATIONAHA.111.029660; Shreibati JB, 2011, JAMA-J AM MED ASSOC, V306, P2128, DOI 10.1001/jama.2011.1652; Williams MC, 2016, J AM COLL CARDIOL, V67, P1759, DOI 10.1016/j.jacc.2016.02.026	10	5	5	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2016	165	2					147	+		10.7326/M16-1048	http://dx.doi.org/10.7326/M16-1048			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS2GY	27214118				2022-12-28	WOS:000380583100024
J	Gurevich, DB; Nguyen, PD; Siegel, AL; Ehrlich, OV; Sonntag, C; Phan, JMN; Berger, S; Ratnayake, D; Hersey, L; Berger, J; Verkade, H; Hall, TE; Currie, PD				Gurevich, David B.; Phong Dang Nguyen; Siegel, Ashley L.; Ehrlich, Ophelia V.; Sonntag, Carmen; Phan, Jennifer M. N.; Berger, Silke; Ratnayake, Dhanushika; Hersey, Lucy; Berger, Joachim; Verkade, Heather; Hall, Thomas E.; Currie, Peter D.			Asymmetric division of clonal muscle stem cells coordinates muscle regeneration in vivo	SCIENCE			English	Article							TEMPLATE DNA STRANDS; SKELETAL-MUSCLE; SELF-RENEWAL; HEAVY-CHAINS; ZEBRAFISH; EXPRESSION; MYOSIN; ACTIVATION; FILOPODIA; PAX7	Skeletal muscle is an example of a tissue that deploys a self-renewing stem cell, the satellite cell, to effect regeneration. Recent in vitro studies have highlighted a role for asymmetric divisions in renewing rare "immortal" stem cells and generating a clonal population of differentiation-competent myoblasts. However, this model currently lacks in vivo validation. We define a zebrafish muscle stem cell population analogous to the mammalian satellite cell and image the entire process of muscle regeneration from injury to fiber replacement in vivo. This analysis reveals complex interactions between satellite cells and both injured and uninjured fibers and provides in vivo evidence for the asymmetric division of satellite cells driving both self-renewal and regeneration via a clonally restricted progenitor pool.	[Gurevich, David B.; Phong Dang Nguyen; Siegel, Ashley L.; Ehrlich, Ophelia V.; Sonntag, Carmen; Phan, Jennifer M. N.; Berger, Silke; Ratnayake, Dhanushika; Hersey, Lucy; Berger, Joachim; Hall, Thomas E.; Currie, Peter D.] Monash Univ, Australian Regenerat Med Inst, Level 1,15 Innovat Walk, Clayton, Vic 3800, Australia; [Verkade, Heather] Monash Univ, Sch Biol Sci, Bldg 18, Clayton, Vic 3800, Australia; [Currie, Peter D.] Monash Univ, European Mol Biol Lab, Australia Melbourne Node, Level 1,Bldg 75,Wellington Rd, Clayton, Vic 3800, Australia	Australian Regenerative Medicine Institute; Monash University; Monash University; European Molecular Biology Laboratory (EMBL); Monash University	Currie, PD (corresponding author), Monash Univ, Australian Regenerat Med Inst, Level 1,15 Innovat Walk, Clayton, Vic 3800, Australia.; Currie, PD (corresponding author), Monash Univ, European Mol Biol Lab, Australia Melbourne Node, Level 1,Bldg 75,Wellington Rd, Clayton, Vic 3800, Australia.	peter.currie@monash.edu	Berger, Joachim/N-2979-2019; Hall, Thomas/J-2125-2014	Berger, Joachim/0000-0002-7859-545X; Currie, Peter/0000-0001-8874-8862; Hall, Thomas/0000-0002-7718-7614; Sonntag, Carmen/0000-0003-2560-1710; Ratnayake, Dhanushika/0000-0003-2476-127X; Gurevich, David/0000-0002-7194-7520; Nguyen, Phong Dang/0000-0003-1889-3276; Verkade, Heather/0000-0002-2817-0509	National Health and Medical Research Council of Australia; state government of Victoria; Australian federal government	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); state government of Victoria; Australian federal government(Australian Government)	We thank P. Ingham, A. Schier, G. Lieschke, L. Bally-Cuif, and the Zebrafish International Resource Center for the supply of fish strains and reagents; R. Cheney for technical advice; N. Cole for technical assistance; and C. Marcelle and T. Rando for comments on the manuscript. This work was supported by a National Health and Medical Research Council of Australia grant to P.D.C. The Australian Regenerative Medicine Institute is supported by funds from the state government of Victoria and the Australian federal government. cmet transgenic lines are available from P.D.C. under a material transfer agreement with Monash University.	Berger J, 2014, DIS MODEL MECH, V7, P1407, DOI 10.1242/dmm.017376; Berger J, 2012, BIOCHEM BIOPH RES CO, V423, P785, DOI 10.1016/j.bbrc.2012.06.040; Bryson-Richardson R, 2005, DEV DYNAM, V233, P1018, DOI 10.1002/dvdy.20380; Burnette DT, 2007, NAT CELL BIOL, V9, P1360, DOI 10.1038/ncb1655; Busch-Nentwich E., 2010, SANGER INSTITUTE ZEB; CARRARO U, 1983, EXP NEUROL, V79, P106, DOI 10.1016/0014-4886(83)90382-5; Chapouton P, 2010, J NEUROSCI, V30, P7961, DOI 10.1523/JNEUROSCI.6170-09.2010; Chen YH, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-1; Cole NJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001168; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Delous M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002754; Dent EW, 2007, NAT CELL BIOL, V9, P1347, DOI 10.1038/ncb1654; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Dumont NA, 2015, NAT MED, V21, P1455, DOI 10.1038/nm.3990; Elworthy S, 2008, DEVELOPMENT, V135, P2115, DOI 10.1242/dev.015719; Fierro-Gonzalez JC, 2013, NAT CELL BIOL, V15, P1424, DOI 10.1038/ncb2875; Gayraud-Morel B, 2007, DEV BIOL, V312, P13, DOI 10.1016/j.ydbio.2007.08.059; Groves JA, 2005, DEVELOPMENT, V132, P4211, DOI 10.1242/dev.01958; Haines L, 2004, DEVELOPMENT, V131, P4857, DOI 10.1242/dev.01374; Hall TE, 2007, P NATL ACAD SCI USA, V104, P7092, DOI 10.1073/pnas.0700942104; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hinits Y, 2007, GENE EXPR PATTERNS, V7, P738, DOI 10.1016/j.modgep.2007.06.003; Hinits Y, 2011, DEV BIOL, V358, P102, DOI 10.1016/j.ydbio.2011.07.015; Hinits Y, 2009, DEVELOPMENT, V136, P403, DOI 10.1242/dev.028019; Hollway GE, 2007, DEV CELL, V12, P207, DOI 10.1016/j.devcel.2007.01.001; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Kikuta Hiroshi, 2009, V546, P69, DOI 10.1007/978-1-60327-977-2_5; Knappe S, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00161; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; MATSUDA R, 1983, DEV BIOL, V100, P478, DOI 10.1016/0012-1606(83)90240-3; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Montarras D, 2013, FEBS J, V280, P4036, DOI 10.1111/febs.12372; Otten C, 2013, JOVE-J VIS EXP, DOI 10.3791/4351; Pan YA, 2013, DEVELOPMENT, V140, P2835, DOI 10.1242/dev.094631; Nguyen PD, 2014, NATURE, V512, P314, DOI 10.1038/nature13678; Pisharath H, 2007, MECH DEVELOP, V124, P218, DOI 10.1016/j.mod.2006.11.005; Pisharath Harshan, 2009, V546, P133, DOI 10.1007/978-1-60327-977-2_9; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; Rowlerson A, 1997, CELL TISSUE RES, V289, P311, DOI 10.1007/s004410050878; Ruf-Zamojski F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128944; SARTORE S, 1982, NATURE, V298, P294, DOI 10.1038/298294a0; Schiaffino S, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0046-6; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Seger C, 2011, DEV DYNAM, V240, P2440, DOI 10.1002/dvdy.22745; Seo HC, 1998, MECH DEVELOP, V70, P49, DOI 10.1016/S0925-4773(97)00175-5; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Siegel AL, 2009, STEM CELLS, V27, P2527, DOI 10.1002/stem.178; Stanganello E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6846; Stellabotte F, 2007, DEVELOPMENT, V134, P1253, DOI 10.1242/dev.000067; Troy A, 2012, CELL STEM CELL, V11, P541, DOI 10.1016/j.stem.2012.05.025; Webster MT, 2016, CELL STEM CELL, V18, P243, DOI 10.1016/j.stem.2015.11.005; Webster MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081757; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Westerfield M., 1995, THE ZEBRAFISH BOOK A; Zhang HL, 2014, J EXP BIOL, V217, P1910, DOI 10.1242/jeb.102210	59	86	89	2	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2016	353	6295							aad9969	10.1126/science.aad9969	http://dx.doi.org/10.1126/science.aad9969			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ4XP	27198673				2022-12-28	WOS:000379208400030
J	Bonham, VL; Callier, SL; Royal, CD				Bonham, Vence L.; Callier, Shawneequa L.; Royal, Charmaine D.			Will Precision Medicine Move Us beyond Race?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bonham, Vence L.] NHGRI, Social & Behav Res Branch, Bethesda, MD 20892 USA; [Callier, Shawneequa L.] George Washington Univ, Dept Clin Res & Leadership, Washington, DC USA; [Royal, Charmaine D.] Duke Univ, Dept African & African Amer Studies, Durham, NC 27706 USA; [Royal, Charmaine D.] Duke Univ, Ctr Genom, Race, Ident,Difference, Durham, NC 27706 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); George Washington University; Duke University; Duke University	Bonham, VL (corresponding author), NHGRI, Social & Behav Res Branch, Bethesda, MD 20892 USA.			Royal, Charmaine/0000-0003-3593-851X; Callier, Shawneequa/0000-0002-1007-333X	Intramural NIH HHS [ZIA HG200324-12] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200324] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Precision Medicine Initiative (PMI) Working Group, 2015, PREC MED IN COH PROG; Ramamoorthy A, 2015, CLIN PHARMACOL THER, V97, P263, DOI 10.1002/cpt.61; Temple R, 2007, ANN INTERN MED, V146, P57, DOI 10.7326/0003-4819-146-1-200701020-00010; Wu AHB, 2015, PERS MED, V12, P179, DOI [10.2217/PME.15.4, 10.2217/pme.15.4]	5	68	68	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 26	2016	374	21					2003	2005		10.1056/NEJMp1511294	http://dx.doi.org/10.1056/NEJMp1511294			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6EN	27223144	Green Accepted			2022-12-28	WOS:000376443500002
J	Cappa, C				Cappa, Chris			ATMOSPHERIC SCIENCE Unexpected player in particle formation	NATURE			English	Editorial Material							SECONDARY ORGANIC AEROSOL; VOLATILITY; NUCLEATION; OXIDATION; PRODUCTS; GROWTH; CARBON	Three studies find that a family of organic compounds affects the formation and initial growth of atmospheric aerosol particles in clean air - with implications for our knowledge of the climate effects of aerosols. SEE LETTERS P.521 & 527	[Cappa, Chris] Univ Calif Davis, Dept Civil & Environm Engn, Davis, CA 95616 USA	University of California System; University of California Davis	Cappa, C (corresponding author), Univ Calif Davis, Dept Civil & Environm Engn, Davis, CA 95616 USA.	cdcappa@ucdavis.edu						Ball SM, 1999, J GEOPHYS RES-ATMOS, V104, P23709, DOI 10.1029/1999JD900411; Bianchi F., 2016, SCIENCE; Carslaw KS, 2013, NATURE, V503, P67, DOI 10.1038/nature12674; D'Andrea SD, 2013, ATMOS CHEM PHYS, V13, P11519, DOI 10.5194/acp-13-11519-2013; Ehn M, 2014, NATURE, V506, P476, DOI 10.1038/nature13032; Farmer DK, 2015, CHEM REV, V115, P4199, DOI 10.1021/cr5006292; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Jokinen T, 2015, P NATL ACAD SCI USA, V112, P7123, DOI 10.1073/pnas.1423977112; Kirkby J, 2016, NATURE, V533, P521, DOI 10.1038/nature17953; Kolesar KR, 2015, ATMOS CHEM PHYS, V15, P9327, DOI 10.5194/acp-15-9327-2015; Kroll JH, 2008, ATMOS ENVIRON, V42, P3593, DOI 10.1016/j.atmosenv.2008.01.003; Kroll JH, 2015, J PHYS CHEM A, V119, P10767, DOI 10.1021/acs.jpca.5b06946; Kulmala M, 2013, SCIENCE, V339, P943, DOI 10.1126/science.1227385; Lopez-Hilfiker FD, 2015, ATMOS CHEM PHYS, V15, P7765, DOI 10.5194/acp-15-7765-2015; McConnell JR, 2007, SCIENCE, V317, P1381, DOI 10.1126/science.1144856; Riccobono F, 2014, SCIENCE, V344, P717, DOI 10.1126/science.1243527; Riipinen I, 2012, NAT GEOSCI, V5, P453, DOI 10.1038/ngeo1499; Ruehl CR, 2016, SCIENCE, V351, P1447, DOI 10.1126/science.aad4889; Trostl J, 2016, NATURE, V533, P527, DOI 10.1038/nature18271; Zhang RY, 2004, SCIENCE, V304, P1487, DOI 10.1126/science.1095139	20	12	13	6	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2016	533	7604					478	479		10.1038/533478a	http://dx.doi.org/10.1038/533478a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6EJ	27225118				2022-12-28	WOS:000376443100029
J	Creatore, MI; Glazier, RH; Moineddin, R; Fazli, GS; Johns, A; Gozdyra, P; Matheson, FI; Kaufman-Shriqui, V; Rosella, LC; Manuel, DG; Booth, GL				Creatore, Maria I.; Glazier, Richard H.; Moineddin, Rahim; Fazli, Ghazal S.; Johns, Ashley; Gozdyra, Peter; Matheson, Flora I.; Kaufman-Shriqui, Vered; Rosella, Laura C.; Manuel, Doug G.; Booth, Gillian L.			Association of Neighborhood Walkability With Change in Overweight, Obesity, and Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICAL-ACTIVITY; UNITED-STATES; RISK-FACTORS; POPULATION; PREVALENCE; TRENDS; ADULTS; INTERVENTION; IMMIGRANTS; MORTALITY	IMPORTANCE Rates of obesity and diabetes have increased substantially in recent decades; however, the potential role of the built environment in mitigating these trends is unclear. OBJECTIVE To examine whether walkable urban neighborhoods are associated with a slower increase in overweight, obesity, and diabetes than less walkable ones. DESIGN, SETTING, AND PARTICIPANTS Time-series analysis (2001-2012) using annual provincial health care (N approximate to 3 million per year) and biennial Canadian Community Health Survey (N approximate to 5500 per cycle) data for adults (30-64 years) living in Southern Ontario cities. EXPOSURES Neighborhood walkability derived from a validated index, with standardized scores ranging from 0 to 100, with higher scores indicating more walkability. Neighborhoods were ranked and classified into quintiles from lowest (quintile 1) to highest (quintile 5) walkability. MAIN OUTCOMES AND MEASURES Annual prevalence of overweight, obesity, and diabetes incidence, adjusted for age, sex, area income, and ethnicity. RESULTS Among the 8777 neighborhoods included in this study, the median walkability index was 16.8, ranging from 10.1 in quintile 1 to 35.2 in quintile 5. Resident characteristics were generally similar across neighborhoods; however, poverty rates were higher in high- vs low-walkability areas. In 2001, the adjusted prevalence of overweight and obesity was lower in quintile 5 vs quintile 1 (43.3% vs 53.5%; P < .001). Between 2001 and 2012, the prevalence increased in less walkable neighborhoods (absolute change, 5.4%[95% CI, 2.1%-8.8%] in quintile 1, 6.7%[95% CI, 2.3%-11.1%] in quintile 2, and 9.2%[95% CI, 6.2%-12.1%] in quintile 3). The prevalence of overweight and obesity did not significantly change in areas of higher walkability (2.8%[95% CI, -1.4% to 7.0%] in quintile 4 and 2.1% [95% CI, -1.4% to 5.5%] in quintile 5). In 2001, the adjusted diabetes incidence was lower in quintile 5 than other quintiles and declined by 2012 from 7.7 to 6.2 per 1000 persons in quintile 5 (absolute change, -1.5 [95% CI, -2.6 to -0.4]) and 8.7 to 7.6 in quintile 4 (absolute change, -1.1 [95% CI, -2.2 to -0.05]). In contrast, diabetes incidence did not change significantly in less walkable areas (change, -0.65 in quintile 1 [95% CI, -1.65 to 0.39], -0.5 in quintile 2 [95% CI, -1.5 to 0.5], and -0.9 in quintile 3 [95% CI, -1.9 to 0.02]). Rates of walking or cycling and public transit use were significantly higher and that of car use lower in quintile 5 vs quintile 1 at each time point, although daily walking and cycling frequencies increased only modestly from 2001 to 2011 in highly walkable areas. Leisure-time physical activity, diet, and smoking patterns did not vary by walkability (P > .05 for quintile 1 vs quintile 5 for each outcome) and were relatively stable over time. CONCLUSIONS AND RELEVANCE In Ontario, Canada, higher neighborhood walkability was associated with decreased prevalence of overweight and obesity and decreased incidence of diabetes between 2001 and 2012. However, the ecologic nature of these findings and the lack of evidence that more walkable urban neighborhood design was associated with increased physical activity suggest that further research is necessary to assess whether the observed associations are causal.	[Creatore, Maria I.; Glazier, Richard H.; Moineddin, Rahim; Fazli, Ghazal S.; Johns, Ashley; Gozdyra, Peter; Booth, Gillian L.] St Michaels Hosp, Li Ka Shing Knowledge Inst, 61 Queen St E,Sixth Floor, Toronto, ON M5C 2T2, Canada; [Creatore, Maria I.; Glazier, Richard H.; Moineddin, Rahim; Gozdyra, Peter; Matheson, Flora I.; Rosella, Laura C.; Manuel, Doug G.; Booth, Gillian L.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Creatore, Maria I.; Glazier, Richard H.; Matheson, Flora I.; Rosella, Laura C.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Glazier, Richard H.; Moineddin, Rahim; Fazli, Ghazal S.; Rosella, Laura C.; Booth, Gillian L.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Glazier, Richard H.; Fazli, Ghazal S.; Johns, Ashley; Gozdyra, Peter; Matheson, Flora I.; Kaufman-Shriqui, Vered] St Michaels Hosp, Ctr Res Inner City Hlth, Toronto, ON M5C 2T2, Canada; [Glazier, Richard H.; Moineddin, Rahim] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Manuel, Doug G.] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Booth, Gillian L.] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute; University of Toronto	Booth, GL (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, 61 Queen St E,Sixth Floor, Toronto, ON M5C 2T2, Canada.	boothg@smh.ca	Shriqui, Vered Kaufman/R-8657-2019; Manuel, Doug/D-7100-2014	Shriqui, Vered Kaufman/0000-0003-3190-4187; Manuel, Doug/0000-0003-0912-0845	Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Ontario; Department of Medicine at the University of Toronto; Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Department of Medicine at the University of Toronto; Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario)	This study was funded through an open operating grant from the Canadian Institutes of Health Research (CIHR). Dr Glazier is supported as a clinician-scientist in the Department of Family and Community Medicine at the University of Toronto and at St Michael's Hospital. Dr Manuel holds a Chair in Applied Public Health Sciences from CIHR/Public Health Agency of Canada. Dr Booth is supported by Mid-Career Investigator Awards from the Heart and Stroke Foundation of Ontario and the Department of Medicine at the University of Toronto. This study was supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC).	Auchincloss AH, 2008, EPIDEMIOLOGY, V19, P146, DOI 10.1097/EDE.0b013e31815c480; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Berry TR, 2010, INT J OBESITY, V34, P1275, DOI 10.1038/ijo.2010.36; Booth GL, 2013, DIABETES CARE, V36, P302, DOI 10.2337/dc12-0777; Chiu M, 2011, DIABETES CARE, V34, P1741, DOI 10.2337/dc10-2300; Christine PJ, 2015, JAMA INTERN MED, V175, P1311, DOI 10.1001/jamainternmed.2015.2691; Creatore MI, 2012, DIABETES CARE, V35, P754, DOI 10.2337/dc11-1393; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Data Management Group, TRANSP TOM SURV 2006; Data Management Group, TRANSP TOM SURV 2011; Eriksson M, 2011, J INTERN MED, V269, P219, DOI 10.1111/j.1365-2796.2010.02312.x; Faeh D, 2010, SWISS MED WKLY, V140, DOI 10.4414/smw.2010.13090; Frank LD, 2004, AM J PREV MED, V27, P87, DOI 10.1016/j.amepre.2004.04.011; Fryar CD, NCHS HLTH ESTAT PREV; Garcia-Alvarez A, 2007, PUBLIC HEALTH NUTR, V10, P1368, DOI 10.1017/S1368980007000973; Geiss LS, 2014, JAMA-J AM MED ASSOC, V312, P1218, DOI 10.1001/jama.2014.11494; Glazier RH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085295; Health and Social Care Information Centre, HLTH SURV ENGL 2011; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Huynh M, 2014, J URBAN HEALTH, V91, P211, DOI 10.1007/s11524-013-9823-x; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Ludwig J, 2011, NEW ENGL J MED, V365, P1509, DOI 10.1056/NEJMsa1103216; Lysy Z, 2013, DIABETES RES CLIN PR, V99, P372, DOI 10.1016/j.diabres.2012.12.005; Muller-Riemenschneider F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-755; Nichols GA, 2015, AM J EPIDEMIOL, V181, P32, DOI 10.1093/aje/kwu255; Norberg M., 2010, GLOB HLTH ACTION, V3; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Polsky JY, 2016, PREV MED, V82, P28, DOI 10.1016/j.ypmed.2015.11.008; Public Health Agency of Canada, 2005, 2005 INT PAN CAN HLT; Rosella LC, 2016, DIABETIC MED, V33, P395, DOI 10.1111/dme.12858; Saelens BE, 2008, MED SCI SPORT EXER, V40, pS550, DOI 10.1249/MSS.0b013e31817c67a4; Sallis JF, LANCET, DOI [10.1016/S0140-6736(15), DOI 10.1016/S0140-6736(15)]; Shields Margot, 2008, Health Rep, V19, P61; Statistics Canada, OTH REF PER CAN COMM; U.S. Department of Health and Human Services, 2001, SURG GEN CALL ACT PR; Walks A, NEIGHBOURHOOD GENTRI; Wen CP, 2009, PUBLIC HEALTH NUTR, V12, P497, DOI 10.1017/S1368980008002802	39	182	182	3	79	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 24	2016	315	20					2211	2220		10.1001/jama.2016.5898	http://dx.doi.org/10.1001/jama.2016.5898			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM4US	27218630	Bronze			2022-12-28	WOS:000376343000017
J	Walker, DD; Cifu, AS; Gluth, MB				Walker, David D.; Cifu, Adam S.; Gluth, Michael B.			Tinnitus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Walker, David D.; Gluth, Michael B.] Univ Chicago, Div Surg, Sect Otolaryngol Head & Neck Surg, Chicago, IL 60637 USA; [Cifu, Adam S.] Univ Chicago, Sect Gen Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Cifu, AS (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu						Henry James A, 2008, Trends Amplif, V12, P170, DOI 10.1177/1084713808319941; Homer CJ, 2004, PEDIATRICS, V114, P874, DOI 10.1542/peds.2004-1260; Knipper L, 2013, PROG NEUROBIOL, V111, P17, DOI 10.1016/j.pneurobio.2013.08.002; OCEBM Levels of Evidence Working Group, OCEBM LEV EV; Rosenfeld RM, 2009, OTOLARYNG HEAD NECK, V140, P1, DOI 10.1016/j.otohns.2008.11.024; Sajisevi M, 2014, LARYNGOSCOPE, V124, P583, DOI 10.1002/lary.24147; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Tunkel DE, 2014, OTOLARYNG HEAD NECK, V151, pS1, DOI 10.1177/0194599814545325	8	10	10	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 24	2016	315	20					2221	2222		10.1001/jama.2016.5209	http://dx.doi.org/10.1001/jama.2016.5209			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM4US	27218631				2022-12-28	WOS:000376343000018
J	Bill, A; Schmitz, A; Albertoni, B; Song, JN; Heukamp, LC; Walrafen, D; Thorwirth, F; Verveer, PJ; Zimmer, S; Meffert, L; Schreiber, A; Chatterjee, S; Thomas, RK; Ullrich, RT; Lang, T; Famulok, M				Bill, Anke; Schmitz, Anton; Albertoni, Barbara; Song, Jin-Na; Heukamp, Lukas C.; Walrafen, David; Thorwirth, Franziska; Verveer, Peter J.; Zimmer, Sebastian; Meffert, Lisa; Schreiber, Arne; Chatterjee, Sampurna; Thomas, Roman K.; Ullrich, Roland T.; Lang, Thorsten; Famulok, Michael			RETRACTION: Cytohesins Are Cytoplasmic ErbB Receptor Activators (Retraction of vol 143, pg 201, 2010)	CELL			English	Retraction												m.famulok@uni-bonn.de	Chatterjee, SAMPURNA/AAA-8398-2019; Heukamp, Lukas/G-9967-2012	Chatterjee, SAMPURNA/0000-0003-0850-0328; Bill, Anke/0000-0003-1244-7574; Heukamp, Lukas/0000-0002-3388-3482				Bill A, 2010, CELL, V143, P201, DOI 10.1016/j.cell.2010.09.011	1	0	0	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2016	165	5					1293	1293		10.1016/j.cell.2016.05.013	http://dx.doi.org/10.1016/j.cell.2016.05.013			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DM6QT	27203114	Bronze			2022-12-28	WOS:000376478200026
J	Dyer, O				Dyer, Owen			Oncologist pays $300 000 to settle US claims of billing for fake cancer drug	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2016	353								i2861	10.1136/bmj.i2861	http://dx.doi.org/10.1136/bmj.i2861			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GD	27198575				2022-12-28	WOS:000376447700021
J	Hawkes, N				Hawkes, Nigel			Improved health outcomes are linked to higher social spending	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Bradley E., 2013, AM HLTH CARE PARADOX; Rubin J, 2016, ARE BETTER HLTH OUTC	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2016	353								i2707	10.1136/bmj.i2707	http://dx.doi.org/10.1136/bmj.i2707			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6FU	27172979				2022-12-28	WOS:000376446800009
J	Blank, CU; Haanen, JB; Ribas, A; Schumacher, TN				Blank, Christian U.; Haanen, John B.; Ribas, Antoni; Schumacher, Ton N.			The "cancer immunogram"	SCIENCE			English	Editorial Material									[Blank, Christian U.; Haanen, John B.] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands; [Blank, Christian U.; Haanen, John B.; Schumacher, Ton N.] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands; [Ribas, Antoni] Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90024 USA	Netherlands Cancer Institute; Netherlands Cancer Institute; University of California System; University of California Los Angeles	Blank, CU (corresponding author), Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands.; Blank, CU; Schumacher, TN (corresponding author), Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands.	c.blank@nki.nl; t.schumacher@nki.nl	Haanen, John/AAD-8534-2022; Schumacher, Ton/Y-2432-2019; Haanen, John/AAD-8578-2022	Haanen, John/0000-0001-5884-7704; Schumacher, Ton/0000-0003-0517-8804; 					0	468	489	3	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2016	352	6286					658	660		10.1126/science.aaf2834	http://dx.doi.org/10.1126/science.aaf2834			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL1UC	27151852				2022-12-28	WOS:000375417100017
J	Shen, Y; Zhang, W; Chou, SL; Dou, SX				Shen, Yue; Zhang, Wang; Chou, Shu-Lei; Dou, Shi-Xue			Comment on "Cycling Li-O-2 batteries via LiOH formation and decomposition"	SCIENCE			English	Editorial Material								Liu et al. (Research Article, 30 October 2015, p. 530) described a lithium-oxygen (Li-O-2) battery based on lithium iodide (LiI)-assisted lithium hydroxide (LiOH) formation and decomposition. We argue that LiOH cannot be oxidized by triiodide (I-3(-)). The charge capacity is from the oxidation of I-instead of LiOH. The limited-capacity cycling test is misleading when the electrolyte contributes considerable parasitic reaction capacity.	[Shen, Yue; Zhang, Wang] Huazhong Univ Sci & Technol, Sch Mat Sci & Engn, State Key Lab Mat Proc & Die & Mould Technol, Wuhan 430074, Hunan, Peoples R China; [Chou, Shu-Lei; Dou, Shi-Xue] Univ Wollongong, Australian Inst Innovat Mat, Inst Superconducting & Elect Mat, Innovation Campus, North Wollongong, NSW 2522, Australia	Huazhong University of Science & Technology; University of Wollongong	Shen, Y (corresponding author), Huazhong Univ Sci & Technol, Sch Mat Sci & Engn, State Key Lab Mat Proc & Die & Mould Technol, Wuhan 430074, Hunan, Peoples R China.; Chou, SL (corresponding author), Univ Wollongong, Australian Inst Innovat Mat, Inst Superconducting & Elect Mat, Innovation Campus, North Wollongong, NSW 2522, Australia.	shenyue1213@hust.edu.cn; shulei@uow.edu.au	Dou, Shi Xue/D-5179-2012; Chou, Shulei/D-9895-2011	Dou, Shi Xue/0000-0003-3824-7693; Chou, Shulei/0000-0003-1155-6082				Bruce PG, 2012, NAT MATER, V11, P19, DOI [10.1038/nmat3191, 10.1038/NMAT3191]; Cho MH, 2014, J POWER SOURCES, V268, P565, DOI 10.1016/j.jpowsour.2014.05.148; Liu T, 2015, SCIENCE, V350, P530, DOI 10.1126/science.aac7730; Lu J, 2014, CHEM REV, V114, P5611, DOI 10.1021/cr400573b; Peng ZQ, 2012, SCIENCE, V337, P563, DOI 10.1126/science.1223985; Thotiyl MMO, 2013, NAT MATER, V12, P1049, DOI [10.1038/nmat3737, 10.1038/NMAT3737]; Zhang T, 2011, CHEM LETT, V40, P668, DOI 10.1246/cl.2011.668	7	35	35	11	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2016	352	6286								10.1126/science.aaf1399	http://dx.doi.org/10.1126/science.aaf1399			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL1UC	27151858	Green Published			2022-12-28	WOS:000375417100023
J	Simon, R				Simon, Richard			Genomic Alteration-Driven Clinical Trial Designs in Oncology	ANNALS OF INTERNAL MEDICINE			English	Article							PHASE-II TRIALS; LUNG-CANCER; VEMURAFENIB; THERAPY; PARADIGM; MEDICINE	The established molecular heterogeneity of human cancers necessitates the development of new paradigms to serve as a reliable basis for precision medicine. The assumptions underlying some of the conventional approaches to clinical trial design and analysis are no longer appropriate because of the molecular heterogeneity of tumors of a given primary site. This article reviews some clinical trial designs that have been actively applied in the codevelopment of therapeutics and predictive biomarkers to inform their use in oncology. These include the enrichment design, the basket design, and the umbrella design. Oncology leads most other therapeutic areas in development of personalized or precision medicine. Personalized or precision medicine is practiced daily in oncology on the basis of tumor genomics and may evolve in other therapeutic areas as it has in oncology, rather than according to inherited polymorphisms as so often imagined. Consequently, some of the clinical trial designs described here may serve as a possible blueprint for therapeutic development in fields other than oncology.	[Simon, Richard] NCI, Rockville, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Simon, R (corresponding author), NCI, Div Canc Treatment & Diag, Biometr Res Program, 9609 Med Ctr Dr, Rockville, MD 20892 USA.	rsimon@nih.gov						Bollag G, 2012, NAT REV DRUG DISCOV, V11, P873, DOI 10.1038/nrd3847; Chakradhar S, 2016, NAT MED, V22, P222, DOI 10.1038/nm0316-222; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Conley BA, 2014, SEMIN ONCOL, V41, P297, DOI 10.1053/j.seminoncol.2014.05.002; Freidlin B, 2013, CLIN CANCER RES, V19, P1326, DOI 10.1158/1078-0432.CCR-12-1223; Gerber DE, 2015, CLIN PHARMACOL THER, V97, P447, DOI 10.1002/cpt.91; Herbst RS, 2015, CLIN CANCER RES, V21, P1514, DOI 10.1158/1078-0432.CCR-13-3473; Hyman DM, 2015, NEW ENGL J MED, V373, P726, DOI 10.1056/NEJMoa1502309; Katayama R, 2015, CLIN CANCER RES, V21, P2227, DOI 10.1158/1078-0432.CCR-14-2791; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; Korn EL, 2011, J CLIN ONCOL, V29, P771, DOI 10.1200/JCO.2010.31.1423; Kummar S, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv003; Lawler M, 2015, ONCOLOGIST, V20, P849, DOI 10.1634/theoncologist.2015-0014; Le Tourneau C, 2015, LANCET ONCOL, V16, P1324, DOI 10.1016/S1470-2045(15)00188-6; LeBlanc M, 2009, CLIN CANCER RES, V15, P4256, DOI 10.1158/1078-0432.CCR-08-2069; Mandrekar Sumithra J, 2015, Am Soc Clin Oncol Educ Book, pe141, DOI 10.14694/EdBook_AM.2015.35.e141; Peto R, 1998, BMJ-BRIT MED J, V317, P1170, DOI 10.1136/bmj.317.7167.1170; SCHOENFELD DA, 1983, BIOMETRICS, V39, P499, DOI 10.2307/2531021; Shak S, 1999, SEMIN ONCOL, V26, P71; Simon R, 2004, CLIN CANCER RES, V10, P6759, DOI 10.1158/1078-0432.CCR-04-0496; SIMON R, 1989, CONTROL CLIN TRIALS, V10, P1, DOI 10.1016/0197-2456(89)90015-9; Simon R.M., 2013, GENOMIC CLIN TRIALS; Simon R, 2016, SEMIN ONCOL, V43, P13, DOI 10.1053/j.seminoncol.2016.01.002; Simon R, 2013, PERS MED, V10, P485, DOI 10.2217/pme.13.36; Simon R, 2013, NAT REV DRUG DISCOV, V12, P359, DOI 10.1038/nrd3979; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMoa1408440, 10.1056/NEJMx150034]; Thall PF, 2003, STAT MED, V22, P763, DOI 10.1002/sim.1399	27	31	32	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2016	165	4					270	U114		10.7326/M15-2413	http://dx.doi.org/10.7326/M15-2413			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT1UI	27214515				2022-12-28	WOS:000381267200016
J	Saver, JL				Saver, Jeffrey L.			Cryptogenic Stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PATENT FORAMEN OVALE; TRANSIENT ISCHEMIC ATTACK; ATRIAL-FIBRILLATION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; CAUSATIVE CLASSIFICATION; MEDICAL THERAPY; YOUNG-PATIENTS; RISK-FACTORS; CLOSURE; PREVENTION	After a gym workout, a 48-year-old man had sudden ataxia, nausea, and diplopia, followed by persistent inability to see the upper left quadrant of space with either the left or right eye. He did not have neck pain. His medical history included hypertension and migraines with aura. Magnetic resonance imaging (MRI) showed a right occipitotemporal and thalamic infarct. Magnetic resonance angiography showed an abrupt cutoff of a distal segment of the right posterior cerebral artery. The complete blood count, prothrombin time, and partial-thromboplastin time were normal. Transthoracic echocardiographic results suggested a possible right-to-left shunt. Cardiac telemetry during the first 2 inpatient days revealed no dysrhythmias. How should this case be further evaluated?	[Saver, Jeffrey L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Saver, Jeffrey L.] Univ Calif Los Angeles, David Geffen Sch Med, Comprehens Stroke Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Saver, JL (corresponding author), Univ Calif Los Angeles, Stroke Ctr, 710 Westwood Plaza, Los Angeles, CA 90095 USA.	jsaver@mednet.ucla.edu			St. Jude Medical; Boehringer Ingelheim	St. Jude Medical(St. Jude Medical); Boehringer Ingelheim(Boehringer Ingelheim)	Dr. Saver reports receiving consulting fees and travel support for serving on clinical-trial steering committees from St. Jude Medical and Boehringer Ingelheim, and serving as an unpaid site investigator in a trial sponsored by St. Jude Medical, for which his institution receives contracted payments. No other potential conflict of interest relevant to this article was reported.	Acampa M, 2015, INT J CARDIOL, V190, P202, DOI 10.1016/j.ijcard.2015.04.185; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Alsheikh-Ali AA, 2009, STROKE, V40, P2349, DOI 10.1161/STROKEAHA.109.547828; Amarenco P, 2013, CEREBROVASC DIS, V36, P1, DOI 10.1159/000352050; Arsava EM, 2010, NEUROLOGY, V75, P1277, DOI 10.1212/WNL.0b013e3181f612ce; Bang OY, 2003, ANN NEUROL, V54, P227, DOI 10.1002/ana.10644; Boriani G, 2014, EUR HEART J, V35, P508, DOI 10.1093/eurheartj/eht491; Caplan LR, 2008, UNCOMMON CAUSES OF STROKE, 2ND EDITION, P1, DOI 10.1017/CBO9780511544897; Carroll JD, 2013, NEW ENGL J MED, V368, P1092, DOI 10.1056/NEJMoa1301440; Chatzikonstantinou A, 2012, J NEUROL, V259, P653, DOI 10.1007/s00415-011-6234-3; Chiti A, 2015, J STROKE CEREBROVASC, V24, P1287, DOI 10.1016/j.jstrokecerebrovasdis.2015.01.033; Cramer SC, 2004, STROKE, V35, P46, DOI 10.1161/01.STR.0000106137.42649.AB; Culebras A, 2014, NEUROLOGY, V82, P716, DOI 10.1212/WNL.0000000000000145; Favilla CG, 2015, STROKE, V46, P1210, DOI 10.1161/STROKEAHA.114.007763; Freilinger TM, 2012, JACC-CARDIOVASC IMAG, V5, P397, DOI 10.1016/j.jcmg.2012.01.012; Furlan AJ, 2012, NEW ENGL J MED, V366, P991, DOI 10.1056/NEJMoa1009639; Gladstone DJ, 2014, NEW ENGL J MED, V370, P2467, DOI 10.1056/NEJMoa1311376; Hart RG, 2014, LANCET NEUROL, V13, P429, DOI 10.1016/S1474-4422(13)70310-7; Healey JS, 2012, NEW ENGL J MED, V366, P120, DOI 10.1056/NEJMoa1105575; Homma S, 2002, CIRCULATION, V105, P2625, DOI 10.1161/01.CIR.0000017498.88393.44; Hornung M, 2013, EUR HEART J, V34, P3362, DOI 10.1093/eurheartj/eht283; Huang YY, 2014, J STROKE CEREBROVASC, V23, P1690, DOI 10.1016/j.jstrokecerebrovasdis.2014.01.017; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Ji RJ, 2013, JAMA NEUROL, V70, P51, DOI 10.1001/jamaneurol.2013.575; Kamel H, 2015, FUTUR CARDIOL, V11, P323, DOI [10.2217/fca.15.22, 10.2217/FCA.15.22]; Kent DM, 2016, J AM COLL CARDIOL, V67, P907, DOI 10.1016/j.jacc.2015.12.023; Kent DM, 2015, EUR HEART J, V36, P2381, DOI 10.1093/eurheartj/ehv252; Kent DM, 2013, NEUROLOGY, V81, P619, DOI 10.1212/WNL.0b013e3182a08d59; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Kitsios GD, 2012, STROKE, V43, P422, DOI 10.1161/STROKEAHA.111.631648; Knebel F, 2009, CARDIOVASC ULTRASOUN, V7, DOI 10.1186/1476-7120-7-15; Korhonen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118822; Lazzaro MA, 2012, J STROKE CEREBROVASC, V21, P89, DOI 10.1016/j.jstrokecerebrovasdis.2010.05.006; Lee LJ, 2000, STROKE, V31, P1081, DOI 10.1161/01.STR.31.5.1081; Li LX, 2015, LANCET NEUROL, V14, P903, DOI 10.1016/S1474-4422(15)00132-5; Marnane M, 2010, STROKE, V41, P1579, DOI 10.1161/STROKEAHA.109.575373; Martin DT, 2015, EUR HEART J, V36, P1660, DOI 10.1093/eurheartj/ehv115; Mas JL, 2001, NEW ENGL J MED, V345, P1740, DOI 10.1056/NEJMoa011503; Meier B, 2013, NEW ENGL J MED, V368, P1083, DOI 10.1056/NEJMoa1211716; Ozdemir AO, 2008, J NEUROL SCI, V275, P121, DOI 10.1016/j.jns.2008.08.018; Paciaroni M, 2005, J THROMB HAEMOST, V3, P1218, DOI 10.1111/j.1538-7836.2005.01344.x; Mansilla CR, 2008, MED CLIN-BARCELONA, V130, P241, DOI 10.1157/13116547; SACCO RL, 1989, ANN NEUROL, V25, P382, DOI 10.1002/ana.410250410; Sanna T, 2014, NEW ENGL J MED, V370, P2478, DOI 10.1056/NEJMoa1313600; Saver Jeffrey L, 2007, Curr Atheroscler Rep, V9, P319, DOI 10.1007/s11883-007-0039-y; Saver JL, 1999, NEUROGENETICS, P403; Scullen TA, 2015, J STROKE CEREBROVASC, V24, P993, DOI 10.1016/j.jstrokecerebrovasdis.2014.12.024; Singhal AB, 2013, NEUROLOGY, V81, P1089, DOI 10.1212/WNL.0b013e3182a4a451; Sposato LA, 2015, LANCET NEUROL, V14, P377, DOI 10.1016/S1474-4422(15)70027-X; Suzuki S, 2013, AM J CARDIOL, V111, P1602, DOI 10.1016/j.amjcard.2013.01.335; Taina M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079519; Thaler DE, 2013, STROKE, V44, P675, DOI 10.1161/STROKEAHA.112.677039; Wolf ME, 2015, CEREBROVASC DIS, V40, P129, DOI 10.1159/000434760; Yaghi S, 2015, STROKE, V46, P1488, DOI 10.1161/STROKEAHA.115.008711	54	142	154	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 26	2016	374	21					2065	2074		10.1056/NEJMcp1503946	http://dx.doi.org/10.1056/NEJMcp1503946			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6EN	27223148				2022-12-28	WOS:000376443500009
J	McClure, E				McClure, Elizabeth			Ronald Henry McClure OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2016	353								i2777	10.1136/bmj.i2777	http://dx.doi.org/10.1136/bmj.i2777			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GI	27206772				2022-12-28	WOS:000376448200005
J	Beggs, S; Salter, MW				Beggs, Simon; Salter, Michael W.			SnapShot: Microglia in Disease	CELL			English	Editorial Material							BRAIN; SCHIZOPHRENIA; PATHOLOGY; RISK; CNS		[Beggs, Simon; Salter, Michael W.] Hosp Sick Children, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Beggs, Simon] UCL Inst Child Hlth, Dev Neurosci Programme, London WC1N 1EH, England	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of London; University College London	Beggs, S (corresponding author), Hosp Sick Children, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.; Beggs, S (corresponding author), UCL Inst Child Hlth, Dev Neurosci Programme, London WC1N 1EH, England.		Beggs, Simon/AAI-4438-2021	Beggs, Simon/0000-0002-1582-8391	Medical Research Council [MR/K022636/1] Funding Source: Medline; MRC [MR/K022636/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bloomfield PS, 2016, AM J PSYCHIAT, V173, P44, DOI 10.1176/appi.ajp.2015.14101358; Estes ML, 2015, NAT REV NEUROSCI, V16, P469, DOI 10.1038/nrn3978; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Mapplebeck JCS, 2016, PAIN, V157, pS2, DOI 10.1097/j.pain.0000000000000389; Salter MW, 2014, CELL, V158, P15, DOI 10.1016/j.cell.2014.06.008; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Spangenberg EE, 2016, BRAIN, V139, P1265, DOI 10.1093/brain/aww016; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110	10	33	35	4	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2016	165	5					1294	+		10.1016/j.cell.2016.05.036	http://dx.doi.org/10.1016/j.cell.2016.05.036			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DM6QT	27203115	Bronze			2022-12-28	WOS:000376478200027
J	Wu, H; Fuxreiter, M				Wu, Hao; Fuxreiter, Monika			The Structure and Dynamics of Higher-Order Assemblies: Amyloids, Signalosomes, and Granules	CELL			English	Review							INTRINSICALLY DISORDERED PROTEINS; LOW-COMPLEXITY DOMAINS; RNA-POLYMERASE-II; PHASE-SEPARATION; SIGNALING COMPLEXES; LIQUID DROPLETS; CRYSTAL-STRUCTURE; FUZZY COMPLEXES; INNATE IMMUNITY; PRION FORMATION	We here attempt to achieve an integrated understanding of the structure and dynamics of a number of higher-order assemblies, including amyloids, various kinds of signalosomes, and cellular granules. We propose that the synergy between folded domains, linear motifs, and intrinsically disordered regions regulates the formation and intrinsic fuzziness of all higher-order assemblies, creating a structural and dynamic continuum. We describe how such regulatory mechanisms could be influenced under pathological conditions.	[Wu, Hao] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Wu, Hao] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Fuxreiter, Monika] Univ Debrecen, Dept Biochem & Mol Biol, Lab Prot Dynam, MTA DE Momentum, H-4010 Debrecen, Hungary	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); University of Debrecen	Wu, H (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Wu, H (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.; Fuxreiter, M (corresponding author), Univ Debrecen, Dept Biochem & Mol Biol, Lab Prot Dynam, MTA DE Momentum, H-4010 Debrecen, Hungary.	wu@crystal.harvard.edu; fmoni@med.unideb.hu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP1HD087988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050872, R01AI124491, R01AI045937] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI050872, R01 AI124491, R01 AI045937] Funding Source: Medline; NICHD NIH HHS [DP1 HD087988] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ader C, 2010, P NATL ACAD SCI USA, V107, P6281, DOI 10.1073/pnas.0910163107; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Altmeyer M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9088; Anderson P, 2015, BBA-GENE REGUL MECH, V1849, P861, DOI 10.1016/j.bbagrm.2014.11.009; Balagopalan L, 2015, J BIOL CHEM, V290, P26422, DOI 10.1074/jbc.R115.665869; Banjade S, 2015, P NATL ACAD SCI USA, V112, pE6426, DOI 10.1073/pnas.1508778112; Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919; Bergeron-Sandoval LP, 2016, CELL, V165, P1067, DOI 10.1016/j.cell.2016.05.026; Bienz M, 2014, TRENDS BIOCHEM SCI, V39, P487, DOI 10.1016/j.tibs.2014.08.006; Brangwynne CP, 2015, NAT PHYS, V11, P899, DOI [10.1038/NPHYS3532, 10.1038/nphys3532]; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Burke KA, 2015, MOL CELL, V60, P231, DOI 10.1016/j.molcel.2015.09.006; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; Chen T, 2015, CURR OPIN STRUC BIOL, V30, P32, DOI 10.1016/j.sbi.2014.12.002; Ciuffa R, 2015, CELL REP, V11, P748, DOI 10.1016/j.celrep.2015.03.062; Coussens NP, 2013, MOL CELL BIOL, V33, P4140, DOI 10.1128/MCB.00410-13; Crick SL, 2013, P NATL ACAD SCI USA, V110, P20075, DOI 10.1073/pnas.1320626110; CUNNINGHAM BC, 1993, J MOL BIOL, V234, P554, DOI 10.1006/jmbi.1993.1611; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Elbaum-Garfinkle S, 2015, P NATL ACAD SCI USA, V112, P7189, DOI 10.1073/pnas.1504822112; Ferrao R, 2014, MOL CELL, V55, P891, DOI 10.1016/j.molcel.2014.08.006; Fiedler M, 2011, P NATL ACAD SCI USA, V108, P1937, DOI 10.1073/pnas.1017063108; Flory PJ, 1941, J AM CHEM SOC, V63, P3083, DOI 10.1021/ja01856a061; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913; Frederick KK, 2014, CHEM BIOL, V21, P295, DOI 10.1016/j.chembiol.2013.12.013; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Fuxreiter M, 2012, MOL BIOSYST, V8, P168, DOI 10.1039/c1mb05234a; Gallivan JP, 2000, J AM CHEM SOC, V122, P870, DOI 10.1021/ja991755c; Greenwald J, 2010, MOL CELL, V38, P889, DOI 10.1016/j.molcel.2010.05.019; Halfmann R, 2012, PRION, V6, P391, DOI 10.4161/pri.20199; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Hough LE, 2015, ELIFE, V4, DOI 10.7554/eLife.10027; Huntley MA, 2002, PROTEINS, V48, P134, DOI 10.1002/prot.10150; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Isono K, 2013, DEV CELL, V26, P565, DOI 10.1016/j.devcel.2013.08.016; Jain S, 2013, ADV EXP MED BIOL, V768, P23, DOI 10.1007/978-1-4614-5107-5_3; Jin TC, 2013, J BIOL CHEM, V288, P13225, DOI 10.1074/jbc.M113.468033; Jin TC, 2012, IMMUNITY, V36, P561, DOI 10.1016/j.immuni.2012.02.014; Kagan JC, 2014, NAT REV IMMUNOL, V14, P821, DOI 10.1038/nri3757; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Kwon I, 2013, CELL, V155, P1049, DOI 10.1016/j.cell.2013.10.033; Labokha AA, 2013, EMBO J, V32, P204, DOI 10.1038/emboj.2012.302; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Lu A, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.13; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Lu A, 2014, J MOL BIOL, V426, P1420, DOI 10.1016/j.jmb.2013.12.029; Malinovska L, 2013, BBA-PROTEINS PROTEOM, V1834, P918, DOI 10.1016/j.bbapap.2013.01.003; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Milles S, 2015, CELL, V163, P734, DOI 10.1016/j.cell.2015.09.047; Mitchell SF, 2014, MOL CELL, V54, P547, DOI 10.1016/j.molcel.2014.04.033; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Murakami T, 2015, NEURON, V88, P678, DOI 10.1016/j.neuron.2015.10.030; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Oldfield CJ, 2014, ANNU REV BIOCHEM, V83, P553, DOI 10.1146/annurev-biochem-072711-164947; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Qiao Q, 2013, MOL CELL, V51, P766, DOI 10.1016/j.molcel.2013.08.032; Reymer A, 2014, P NATL ACAD SCI USA, V111, P17158, DOI 10.1073/pnas.1415663111; Ross ED, 2005, P NATL ACAD SCI USA, V102, P12825, DOI 10.1073/pnas.0506136102; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schmidt HB, 2015, ELIFE, V4, DOI 10.7554/eLife.04251; Schwartz JC, 2013, CELL REP, V5, P918, DOI 10.1016/j.celrep.2013.11.017; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Selenko P, 2003, MOL CELL, V11, P965, DOI 10.1016/S1097-2765(03)00115-1; Semenov AN, 1998, MACROMOLECULES, V31, P1373, DOI 10.1021/ma970616h; Sharma R, 2015, FEBS LETT, V589, P2533, DOI 10.1016/j.febslet.2015.07.022; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; tenWolde PR, 1997, SCIENCE, V277, P1975, DOI 10.1126/science.277.5334.1975; Thanos CD, 1999, SCIENCE, V283, P833, DOI 10.1126/science.283.5403.833; Tompa P, 2009, FEBS J, V276, P5406, DOI 10.1111/j.1742-4658.2009.07250.x; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Tradewell ML, 2012, HUM MOL GENET, V21, P136, DOI 10.1093/hmg/ddr448; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Wasmer C, 2009, J MOL BIOL, V394, P119, DOI 10.1016/j.jmb.2009.09.015; Wickner RB, 2007, NAT REV MICROBIOL, V5, P611, DOI 10.1038/nrmicro1708; Wilson MI, 2003, MOL CELL, V12, P39, DOI 10.1016/S1097-2765(03)00246-6; Wippich F, 2013, CELL, V152, P791, DOI 10.1016/j.cell.2013.01.033; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Wu B, 2014, MOL CELL, V55, P511, DOI 10.1016/j.molcel.2014.06.010; Wu H, 2013, CELL, V153, P287, DOI 10.1016/j.cell.2013.03.013; Wu JH, 2010, J CLIN IMMUNOL, V30, P693, DOI 10.1007/s10875-010-9425-2; Xiang SH, 2015, CELL, V163, P829, DOI 10.1016/j.cell.2015.10.040; Yin Q, 2015, ANNU REV IMMUNOL, V33, P393, DOI 10.1146/annurev-immunol-032414-112258; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; Zhang HY, 2015, MOL CELL, V60, P220, DOI 10.1016/j.molcel.2015.09.017	97	229	229	3	91	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2016	165	5					1055	1066		10.1016/j.cell.2016.05.004	http://dx.doi.org/10.1016/j.cell.2016.05.004			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DM6QT	27203110	Green Accepted, Bronze			2022-12-28	WOS:000376478200008
J	Maki, DG				Maki, Dennis G.			In large-vessel ischemic stroke, adding endovascular thrombectomy to usual care reduced 90-day disability	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							EARLY MANAGEMENT; PROFESSIONALS; GUIDELINES		[Maki, Dennis G.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison	Maki, DG (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA.							Goyal M, 2016, RADIOLOGY, V278, P642, DOI 10.1148/radiol.2015151965; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Powers WJ, 2015, STROKE, V46, P3020, DOI 10.1161/STR.0000000000000074	4	0	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2016	164	10					JC57	JC57		10.7326/ACPJC-2016-164-10-057	http://dx.doi.org/10.7326/ACPJC-2016-164-10-057			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8GF	27182923				2022-12-28	WOS:000375878500008
J	He, XL; Liu, L				He, Xionglei; Liu, Li			Toward a prospective molecular evolution	SCIENCE			English	Editorial Material							FITNESS LANDSCAPES; CONSTRAINT		[He, Xionglei; Liu, Li] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	He, XL; Liu, L (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	hexiongl@mail.sysu.edu.cn; liul47@mail.sysu.edu.cn		Liu, Li/0000-0003-4588-4906				Bank C, 2015, MOL BIOL EVOL, V32, P229, DOI 10.1093/molbev/msu301; Cooper VS, 2000, NATURE, V407, P736, DOI 10.1038/35037572; de Visser JAGM, 2014, NAT REV GENET, V15, P480, DOI 10.1038/nrg3744; de Vos MGJ, 2015, P NATL ACAD SCI USA, V112, P14906, DOI 10.1073/pnas.1510282112; Li C, 2016, SCIENCE, V352, P837, DOI 10.1126/science.aae0568; Pal C, 2001, GENETICS, V158, P927; Pitt JN, 2010, SCIENCE, V330, P376, DOI 10.1126/science.1192001; Puchta O, 2016, SCIENCE, V352, P840, DOI 10.1126/science.aaf0965; Steinberg B, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500921; Weinreich DM, 2005, EVOLUTION, V59, P1165; Zhang JZ, 2015, NAT REV GENET, V16, P409, DOI 10.1038/nrg3950	11	8	9	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2016	352	6287					769	770		10.1126/science.aaf7543	http://dx.doi.org/10.1126/science.aaf7543			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5FP	27174972				2022-12-28	WOS:000375663000018
J	Scott, AR				Scott, Andrew R.			A shared toolbox	NATURE			English	Editorial Material																			0	7	7	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					S60	S61		10.1038/533S60a	http://dx.doi.org/10.1038/533S60a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM0BJ	27167393	Bronze			2022-12-28	WOS:000376007200004
J	Yang, KS; Engle, KM				Yang, Kin S.; Engle, Keary M.			Precision pruning of molecules	NATURE			English	Editorial Material							BOND ACTIVATION; FUNCTIONALIZATION		[Yang, Kin S.; Engle, Keary M.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute	Engle, KM (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	keary@scripps.edu	Engle, Keary/A-9223-2015	Engle, Keary/0000-0003-2767-6556				ARNDTSEN BA, 1995, ACCOUNTS CHEM RES, V28, P154, DOI 10.1021/ar00051a009; Bruckl T, 2012, ACCOUNTS CHEM RES, V45, P826, DOI 10.1021/ar200194b; Davies HML, 2003, CHEM REV, V103, P2861, DOI 10.1021/cr0200217; Davies HML, 2011, CHEM SOC REV, V40, P1857, DOI 10.1039/c0cs00217h; Labinger JA, 2002, NATURE, V417, P507, DOI 10.1038/417507a; Liao KB, 2016, NATURE, V533, P230, DOI 10.1038/nature17651; Neufeldt SR, 2012, ACCOUNTS CHEM RES, V45, P936, DOI 10.1021/ar300014f	7	1	1	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					183	184		10.1038/533183a	http://dx.doi.org/10.1038/533183a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0BJ	27172040				2022-12-28	WOS:000376007200034
J	Pophali, P; Halland, M				Pophali, Prachi; Halland, Magnus			Barrett's oesophagus: diagnosis and management	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HIGH-GRADE DYSPLASIA; ENDOSCOPIC MUCOSAL RESECTION; RADIOFREQUENCY ABLATION; INTRAMUCOSAL CARCINOMA; STRICTURE FORMATION; SPRAY CRYOTHERAPY; EARLY NEOPLASIA; RISK; ADENOCARCINOMA; ASSOCIATION		[Pophali, Prachi; Halland, Magnus] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA	Mayo Clinic	Halland, M (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA.	halland.magnus@mayo.edu						Anaparthy R, 2013, CLIN GASTROENTEROL H, V11, P1430, DOI 10.1016/j.cgh.2013.05.007; Anders M, 2014, GUT, V63, P1535, DOI 10.1136/gutjnl-2013-305538; Bennett C, 2015, AM J GASTROENTEROL, V110, P662, DOI 10.1038/ajg.2015.55; Bennett C, 2012, GASTROENTEROLOGY, V143, P336, DOI 10.1053/j.gastro.2012.04.032; Bollschweiler E, 2006, ENDOSCOPY, V38, P149, DOI 10.1055/s-2006-924993; Corley DA, 2013, GASTROENTEROLOGY, V145, P312, DOI 10.1053/j.gastro.2013.05.004; Desai TK, 2012, GUT, V61, P970, DOI 10.1136/gutjnl-2011-300730; DeVault KR, 2005, AM J GASTROENTEROL, V100, P190, DOI 10.1111/j.1572-0241.2005.41217.x; Dunbar KB, 2012, AM J GASTROENTEROL, V107, P850, DOI 10.1038/ajg.2012.78; El-Serag HB, 2016, GUT, V65, P1252, DOI 10.1136/gutjnl-2014-308865; Evans JA, 2012, GASTROINTEST ENDOSC, V76, P1087, DOI 10.1016/j.gie.2012.08.004; Fitzgerald RC, 2014, GUT, V63, P7, DOI 10.1136/gutjnl-2013-305372; Gaddam S, 2013, GASTROENTEROLOGY, V145, P548, DOI 10.1053/j.gastro.2013.05.040; Ghorbani S, 2016, DIS ESOPHAGUS, V29, P241, DOI 10.1111/dote.12330; Giacchino M, 2013, GASTROINTEST ENDOSC, V77, P711, DOI 10.1016/j.gie.2013.01.029; Gosain S, 2013, GASTROINTEST ENDOSC, V78, P260, DOI 10.1016/j.gie.2013.03.002; Gupta M, 2013, GASTROENTEROLOGY, V145, P79, DOI 10.1053/j.gastro.2013.03.008; Haidry RJ, 2015, GUT, V64, P1192, DOI 10.1136/gutjnl-2014-308501; Hvid-Jensen F, 2011, NEW ENGL J MED, V365, P1375, DOI 10.1056/NEJMoa1103042; Kastelein F, 2011, GASTROENTEROLOGY, V141, P2000, DOI 10.1053/j.gastro.2011.08.036; Katz PO, 2013, AM J GASTROENTEROL, V108, P308, DOI 10.1038/ajg.2012.444; Khalaf N, 2014, CLIN GASTROENTEROL H, V12, P1832, DOI 10.1016/j.cgh.2014.04.027; Krishnamoorthi R, 2016, GASTROINTEST ENDOSC; Levine DM, 2013, NAT GENET, V45, P1487, DOI 10.1038/ng.2796; LEVINE DS, 1993, GASTROENTEROLOGY, V105, P40, DOI 10.1016/0016-5085(93)90008-Z; Lim CH, 2006, GASTROINTEST ENDOSC, V64, P195, DOI 10.1016/j.gie.2005.07.025; Menon D, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-111; Okoro NI, 2012, CLIN GASTROENTEROL H, V10, P150, DOI 10.1016/j.cgh.2011.10.030; Orman ES, 2013, CLIN GASTROENTEROL H, V11, P1245, DOI 10.1016/j.cgh.2013.03.039; Park WG, 2015, AM J GASTROENTEROL, V110, P60, DOI 10.1038/ajg.2014.384; Phoa KN, 2013, GASTROENTEROLOGY, V145, P96, DOI 10.1053/j.gastro.2013.03.046; Prasad GA, 2007, GASTROINTEST ENDOSC, V65, P60, DOI 10.1016/j.gie.2006.04.028; Qumseya B, 2014, CLIN ENDOSC, V47, P155, DOI 10.5946/ce.2014.47.2.155; Ronkainen J, 2005, GASTROENTEROLOGY, V129, P1825, DOI 10.1053/j.gastro.2005.08.053; Shaheen NJ, 2010, GASTROINTEST ENDOSC, V71, P680, DOI 10.1016/j.gie.2010.01.018; Sikkema M, 2010, CLIN GASTROENTEROL H, V8, P235, DOI 10.1016/j.cgh.2009.10.010; Singh S, 2013, CLIN GASTROENTEROL H, V11, P1399, DOI 10.1016/j.cgh.2013.05.009; Small AJ, 2015, GASTROINTEST ENDOSC, V81, P1158, DOI 10.1016/j.gie.2014.10.029; Spechler SJ, 2011, GASTROENTEROLOGY, V140, pE18, DOI 10.1053/j.gastro.2011.01.031; Thrift AP, 2011, AM J GASTROENTEROL, V106, P1220, DOI 10.1038/ajg.2011.89; Ward EM, 2006, AM J GASTROENTEROL, V101, P12, DOI 10.1111/j.1572-0241.2006.00379.x; Westhoff B, 2005, GASTROINTEST ENDOSC, V61, P226, DOI 10.1016/S0016-5107(04)02589-1; Wu J, 2014, GASTROINTEST ENDOSC, V79, P233, DOI 10.1016/j.gie.2013.08.005	43	6	7	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 11	2016	353								i2373	10.1136/bmj.i2373	http://dx.doi.org/10.1136/bmj.i2373			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6FR	27169585				2022-12-28	WOS:000376446500007
J	Mayor, S				Mayor, Susan			NICE recommends PCSK9 inhibitors for patients not responding to statins	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 9	2016	353								i2609	10.1136/bmj.i2609	http://dx.doi.org/10.1136/bmj.i2609			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6EX	27159996				2022-12-28	WOS:000376444500005
J	Amor, M; Busigny, V; Louvat, P; Gelabert, A; Cartigny, P; Durand-Dubief, M; Ona-Nguema, G; Alphandery, E; Chebbi, I; Guyot, F				Amor, Matthieu; Busigny, Vincent; Louvat, Pascale; Gelabert, Alexandre; Cartigny, Pierre; Durand-Dubief, Mickael; Ona-Nguema, Georges; Alphandery, Edouard; Chebbi, Imene; Guyot, Francois			Mass-dependent and -independent signature of Fe isotopes in magnetotactic bacteria	SCIENCE			English	Article							BANDED IRON-FORMATION; OXIDE REDUCTION; SPIN-STATE; FRACTIONATION; MAGNETITE; BIOMINERALIZATION; MAGNETOSOMES; CONSTRAINTS; OXYGEN	Magnetotactic bacteria perform biomineralization of intracellular magnetite (Fe3O4) nanoparticles. Although they may be among the earliest microorganisms capable of biomineralization on Earth, identifying their activity in ancient sedimentary rocks remains challenging because of the lack of a reliable biosignature. We determined Fe isotope fractionations by the magnetotactic bacterium Magnetospirillum magneticum AMB-1. The AMB-1 strain produced magnetite strongly depleted in heavy Fe isotopes, by 1.5 to 2.5 per mil relative to the initial growth medium. Moreover, we observed mass-independent isotope fractionations in Fe-57 during magnetite biomineralization but not in even Fe isotopes (Fe-54, Fe-56, and Fe-58), highlighting a magnetic isotope effect. This Fe isotope anomaly provides a potential biosignature for the identification of magnetite produced by magnetotactic bacteria in the geological record.	[Amor, Matthieu; Busigny, Vincent; Louvat, Pascale; Gelabert, Alexandre; Cartigny, Pierre] Univ Paris Diderot, UMR CNRS 7154, Inst Phys Globe Paris, Sorbonne Paris Cite, F-75238 Paris, France; [Amor, Matthieu; Ona-Nguema, Georges; Alphandery, Edouard; Guyot, Francois] Univ Paris 06, Univ Sorbonne, Inst Mineral Phys Mat & Cosmochim, Inst Rech Dev,Museum Natl Hist Nat,UMR 206,UMR CN, F-75252 Paris 05, France; [Durand-Dubief, Mickael; Alphandery, Edouard; Chebbi, Imene] Nanobacterie SARL, 36 Blvd Flandrin, F-75016 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Amor, M; Busigny, V (corresponding author), Univ Paris Diderot, UMR CNRS 7154, Inst Phys Globe Paris, Sorbonne Paris Cite, F-75238 Paris, France.; Amor, M (corresponding author), Univ Paris 06, Univ Sorbonne, Inst Mineral Phys Mat & Cosmochim, Inst Rech Dev,Museum Natl Hist Nat,UMR 206,UMR CN, F-75252 Paris 05, France.	amor@ipgp.fr; busigny@ipgp.fr	Amor, Matthieu/C-3849-2016; GUYOT, François J/C-3824-2016; gelabert, alexandre/A-5684-2011; BUSIGNY, Vincent/A-5615-2011; Durand-Dubief, Mickael/O-2315-2019; Cartigny, Pierre/A-6251-2011; Louvat, Pascale/E-8907-2017; IMPMC, MINENV GROUP/AGQ-3988-2022; alphandéry, edouard/AAB-2871-2019; Alphandery, Edouard/AAH-1374-2021	Amor, Matthieu/0000-0002-4299-1493; GUYOT, François J/0000-0003-4622-2218; BUSIGNY, Vincent/0000-0001-7556-0772; Durand-Dubief, Mickael/0000-0002-8556-4459; Louvat, Pascale/0000-0003-1972-0633; IMPMC, MINENV GROUP/0000-0002-8100-936X; alphandéry, edouard/0000-0002-2952-2270; 	Institut National des Sciences de l'Univers; UnivEarths Labex program at Sorbonne Paris Cite [ANR-10-LABX-0023, ANR-11-IDEX-0005-02]; Institut de Physique du Globe de Paris multidisciplinary program PARI; Region Ile-de-France SESAME [12015908]	Institut National des Sciences de l'Univers; UnivEarths Labex program at Sorbonne Paris Cite; Institut de Physique du Globe de Paris multidisciplinary program PARI; Region Ile-de-France SESAME(Region Ile-de-France)	We thank J. Moureau for analytical assistance on multi-collection-inductively coupled plasma-mass spectrometry measurements. This work was funded by the programs InterrVie 2013 (V. B.) and 2015 (F. G.) of the Institut National des Sciences de l'Univers and the UnivEarths Labex program at Sorbonne Paris Cite (grants ANR-10-LABX-0023 and ANR-11-IDEX-0005-02). This is Institut de Physique du Globe de Paris contribution 3615. Parts of this work were supported by the Institut de Physique du Globe de Paris multidisciplinary program PARI, and by Region Ile-de-France SESAME grant no. 12015908. We thank reviewers for their contributions to improvements of the manuscript. All data are available in the supplementary materials.	Amor M, 2015, P NATL ACAD SCI USA, V112, P1699, DOI 10.1073/pnas.1414112112; Baumgartner J, 2013, P NATL ACAD SCI USA, V110, P14883, DOI 10.1073/pnas.1307119110; Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; Bengtson A, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.155141; Bergquist BA, 2007, SCIENCE, V318, P417, DOI 10.1126/science.1148050; Buchachenko AL, 2013, J PHYS CHEM B, V117, P2231, DOI 10.1021/jp308727w; Craddock PR, 2011, EARTH PLANET SC LETT, V303, P121, DOI 10.1016/j.epsl.2010.12.045; Crosby HA, 2005, ENVIRON SCI TECHNOL, V39, P6698, DOI 10.1021/es0505346; Czaja AD, 2013, EARTH PLANET SC LETT, V363, P192, DOI 10.1016/j.epsl.2012.12.025; Estevam ML, 2004, J BIOL CHEM, V279, P39214, DOI 10.1074/jbc.M402093200; Faivre D, 2008, CHEM REV, V108, P4875, DOI 10.1021/cr078258w; Farquhar J, 2007, GEOCHIM COSMOCHIM AC, V71, P5862, DOI 10.1016/j.gca.2007.08.028; Frierdich AJ, 2014, EARTH PLANET SC LETT, V391, P77, DOI 10.1016/j.epsl.2014.01.032; Guilbaud R, 2011, SCIENCE, V332, P1548, DOI 10.1126/science.1202924; Icopini GA, 2004, GEOLOGY, V32, P205, DOI 10.1130/G20184.1; Jimenez-Lopez C, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001152; Johnson CM, 2008, GEOCHIM COSMOCHIM AC, V72, P151, DOI 10.1016/j.gca.2007.10.013; Johnson CM, 2005, GEOCHIM COSMOCHIM AC, V69, P963, DOI 10.1016/j.gca.2004.06.043; Jones SR, 2015, P NATL ACAD SCI USA, V112, P3904, DOI 10.1073/pnas.1417614112; Komeili A, 2012, FEMS MICROBIOL REV, V36, P232, DOI 10.1111/j.1574-6976.2011.00315.x; Kopp RE, 2008, EARTH-SCI REV, V86, P42, DOI 10.1016/j.earscirev.2007.08.001; Lefevre CT, 2013, MICROBIOL MOL BIOL R, V77, P497, DOI 10.1128/MMBR.00021-13; Lefevre CT, 2013, ENVIRON MICROBIOL, V15, P2267, DOI 10.1111/1462-2920.12097; Li JH, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004384; Mandernack KW, 1999, SCIENCE, V285, P1892, DOI 10.1126/science.285.5435.1892; Rouxel OJ, 2005, SCIENCE, V307, P1088, DOI 10.1126/science.1105692; Schuler D, 1996, ARCH MICROBIOL, V166, P301, DOI 10.1007/s002030050387; Siponen MI, 2013, NATURE, V502, P681, DOI 10.1038/nature12573; Steinhoefel G, 2010, GEOCHIM COSMOCHIM AC, V74, P2677, DOI 10.1016/j.gca.2010.01.028; TSAI R, 1970, P NATL ACAD SCI USA, V66, P1157, DOI 10.1073/pnas.66.4.1157; VALI H, 1989, NATURE, V339, P203, DOI 10.1038/339203a0	31	40	41	8	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2016	352	6286					705	708		10.1126/science.aad7632	http://dx.doi.org/10.1126/science.aad7632			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL1UC	27151868				2022-12-28	WOS:000375417100037
J	Ballauff, M				Ballauff, Matthias			Self-assembly creates 2D materials	SCIENCE			English	Editorial Material							MICELLES		[Ballauff, Matthias] Humboldt Univ, Helmholtz Zentrum Berlin, D-10099 Berlin, Germany; [Ballauff, Matthias] Humboldt Univ, Inst Phys, D-10099 Berlin, Germany	Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); Humboldt University of Berlin; Humboldt University of Berlin	Ballauff, M (corresponding author), Humboldt Univ, Helmholtz Zentrum Berlin, D-10099 Berlin, Germany.; Ballauff, M (corresponding author), Humboldt Univ, Inst Phys, D-10099 Berlin, Germany.	matthias.ballauff@helmholtz-berlin.de	Ballauff, Matthias/AAZ-8185-2020; Ballauff, Matthias M/O-4593-2016	Ballauff, Matthias M/0000-0003-0872-1438				Crassous JJ, 2015, POLYMER, V62, pA1, DOI 10.1016/j.polymer.2015.02.030; Cui HG, 2007, SCIENCE, V317, P647, DOI 10.1126/science.1141768; Gilroy JB, 2010, NAT CHEM, V2, P566, DOI [10.1038/NCHEM.664, 10.1038/nchem.664]; Groschel AH, 2013, NATURE, V503, P247, DOI 10.1038/nature12610; Hudson ZM, 2014, NAT CHEM, V6, P893, DOI [10.1038/NCHEM.2038, 10.1038/nchem.2038]; Qui H., 2016, SCIENCE, V352, P697; Schacher FH, 2012, ANGEW CHEM INT EDIT, V51, P7898, DOI 10.1002/anie.201200310; Wang XS, 2007, SCIENCE, V317, P644, DOI 10.1126/science.1141382; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821	9	10	10	2	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2016	352	6286					656	657		10.1126/science.aaf4930	http://dx.doi.org/10.1126/science.aaf4930			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL1UC	27151850				2022-12-28	WOS:000375417100015
J	Rathinam, VAK; Fitzgerald, KA				Rathinam, Vijay A. K.; Fitzgerald, Katherine A.			Inflammasome Complexes: Emerging Mechanisms and Effector Functions	CELL			English	Review							UNCONVENTIONAL PROTEIN SECRETION; INNATE IMMUNE RECOGNITION; NF-KAPPA-B; IL-1-BETA PRODUCTION; AUTOINFLAMMATORY DISEASE; FRANCISELLA INFECTION; SALMONELLA INFECTION; NLRP3 INFLAMMASOMES; COLON INFLAMMATION; INTRACELLULAR LPS	Canonical activation of the inflammasome is critical to promote caspase-1-dependent maturation of the proinflammatory cytokines IL-1 beta and IL-18, as well as to induce pyroptotic cell death in response to pathogens and endogenous danger signals. Recent discoveries, however, are beginning to unveil new components of the inflammasome machinery as well as the full spectrum of inflammasome functions, extending their influence beyond canonical functions to regulation of eicosanoid storm, autophagy, and metabolism. In addition, the receptor components of the inflammasome can also regulate diverse biological processes, such as cellular proliferation, gene transcription, and tumorigenesis, all of which are independent of their inflammasome complex-forming capabilities. Here, we review these recent advances that are shaping our understanding of the complex biology of the inflammasome and its constituents.	[Rathinam, Vijay A. K.] Univ Connecticut, Ctr Hlth, Dept Immunol, 263 Farmington Ave, Farmington, CT 06030 USA; [Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Med, Program Innate Immun,Div Infect Dis & Immunol, Worcester, MA 01605 USA	University of Connecticut; University of Massachusetts System; University of Massachusetts Worcester	Fitzgerald, KA (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Program Innate Immun,Div Infect Dis & Immunol, Worcester, MA 01605 USA.	kate.fitzgerald@umassmed.edu	Fitzgerald, Katherine/ABE-6317-2020; Rathinam, Vijay/ABE-7544-2020	Rathinam, Vijay/0000-0002-8009-3977; Fitzgerald, Kate/0000-0003-3175-609X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079293, R01AI067497, R01AI083713] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI067497, R01 AI079293, R01 AI083713] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akhter A, 2012, IMMUNITY, V37, P35, DOI 10.1016/j.immuni.2012.05.001; Allen IC, 2012, IMMUNITY, V36, P742, DOI 10.1016/j.immuni.2012.03.012; Anand PK, 2012, NATURE, V488, P389, DOI 10.1038/nature11250; Becker CE, 2009, J BIOL CHEM, V284, P34531, DOI 10.1074/jbc.M109.046102; Bossaller L, 2012, J IMMUNOL, V189, P5508, DOI 10.4049/jimmunol.1202121; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Bruchard M, 2015, NAT IMMUNOL, V16, P859, DOI 10.1038/ni.3202; Casson CN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003400; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; Ding ZF, 2014, CARDIOVASC RES, V103, P619, DOI 10.1093/cvr/cvu114; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Ganesan S, 2014, J IMMUNOL, V193, P2519, DOI 10.4049/jimmunol.1400276; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; Gurung P, 2012, J BIOL CHEM, V287, P34474, DOI 10.1074/jbc.M112.401406; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; He Y, 2016, NATURE, V530, P354, DOI 10.1038/nature16959; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Jabir MS, 2014, CELL HOST MICROBE, V15, P214, DOI 10.1016/j.chom.2014.01.010; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Karki R, 2015, CELL HOST MICROBE, V17, P357, DOI 10.1016/j.chom.2015.01.006; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kerur N, 2011, CELL HOST MICROBE, V9, P363, DOI 10.1016/j.chom.2011.04.008; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Kotas ME, 2013, P NATL ACAD SCI USA, V110, P4810, DOI 10.1073/pnas.1301996110; Krauss JL, 2015, P NATL ACAD SCI USA, V112, P10455, DOI 10.1073/pnas.1500196112; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Levy M, 2015, CELL, V163, P1428, DOI 10.1016/j.cell.2015.10.048; Lukens JR, 2015, IMMUNITY, V42, P654, DOI 10.1016/j.immuni.2015.03.006; Lukens JR, 2014, NATURE, V516, P246, DOI 10.1038/nature13788; Lupfer C, 2013, NAT IMMUNOL, V14, P480, DOI 10.1038/ni.2563; Man SM, 2015, CELL, V162, P45, DOI 10.1016/j.cell.2015.06.001; Man SM, 2015, NAT IMMUNOL, V16, P467, DOI 10.1038/ni.3118; Man SM, 2013, J IMMUNOL, V191, P5239, DOI 10.4049/jimmunol.1301581; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Meunier E, 2015, NAT IMMUNOL, V16, P476, DOI 10.1038/ni.3119; Meunier E, 2014, NATURE, V509, P366, DOI 10.1038/nature13157; Monroe KM, 2014, SCIENCE, V343, P428, DOI 10.1126/science.1243640; Monteleone M, 2015, CYTOKINE, V74, P213, DOI 10.1016/j.cyto.2015.03.022; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Pilla DM, 2014, P NATL ACAD SCI USA, V111, P6046, DOI 10.1073/pnas.1321700111; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Schmid-Burgk JL, 2016, J BIOL CHEM, V291, P103, DOI 10.1074/jbc.C115.700492; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Sokolovska A, 2013, NAT IMMUNOL, V14, P543, DOI 10.1038/ni.2595; Suzuki T, 2007, PLOS PATHOG, V3, P1082, DOI 10.1371/journal.ppat.0030111; van Diepen JA, 2013, J LIPID RES, V54, P448, DOI 10.1194/jlr.M031963; von Moltke J, 2013, ANNU REV IMMUNOL, V31, P73, DOI 10.1146/annurev-immunol-032712-095944; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Wang PH, 2015, SCIENCE, V350, P826, DOI 10.1126/science.aab3145; Wilson JE, 2015, NAT MED, V21, P906, DOI 10.1038/nm.3908; Wlodarska M, 2014, CELL, V156, P1045, DOI 10.1016/j.cell.2014.01.026; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449; Yu JJ, 2014, P NATL ACAD SCI USA, V111, P15514, DOI 10.1073/pnas.1414859111; Zaki MH, 2011, CANCER CELL, V20, P649, DOI 10.1016/j.ccr.2011.10.022; Zamoshnikova A, 2016, IMMUNOBIOLOGY, V221, P341, DOI 10.1016/j.imbio.2015.10.001; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	74	511	543	3	121	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2016	165	4					792	800		10.1016/j.cell.2016.03.046	http://dx.doi.org/10.1016/j.cell.2016.03.046			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DL7DN	27153493	Bronze, Green Accepted			2022-12-28	WOS:000375800300009
J	Yan, XW; Hoek, TA; Vale, RD; Tanenbaum, ME				Yan, Xiaowei; Hoek, Tim A.; Vale, Ronald D.; Tanenbaum, Marvin E.			Dynamics of Translation of Single mRNA Molecules In Vivo	CELL			English	Article							PROTEIN-SYNTHESIS; GENE-EXPRESSION; RIBOSOME; CELLS; VISUALIZATION; REVEALS	Regulation of mRNA translation, the process by which ribosomes decode mRNAs into polypeptides, is used to tune cellular protein levels. Currently, methods for observing the complete process of translation from single mRNAs in vivo are unavailable. Here, we report the long-term (>1 hr) imaging of single mRNAs undergoing hundreds of rounds of translation in live cells, enabling quantitative measurements of ribosome initiation, elongation, and stalling. This approach reveals a surprising heterogeneity in the translation of individual mRNAs within the same cell, including rapid and reversible transitions between a translating and non-translating state. Applying this method to the cell-cycle gene Emi1, we find strong overall repression of translation initiation by specific 5' UTR sequences, but individual mRNA molecules in the same cell can exhibit dramatically different translational efficiencies. The ability to observe translation of single mRNA molecules in live cells provides a powerful tool to study translation regulation.	[Hoek, Tim A.; Tanenbaum, Marvin E.] Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Hoek, Tim A.; Tanenbaum, Marvin E.] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Yan, Xiaowei; Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Tanenbaum, ME (corresponding author), Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands.; Tanenbaum, ME (corresponding author), Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands.	m.tanenbaum@hubrecht.eu		Yan, Xiaowei/0000-0002-4846-8812	European Research Council (ERC) [ERC-STG 677936-RNAREG]; Dutch Cancer Society (KWF); Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038499] Funding Source: NIH RePORTER	European Research Council (ERC)(European Research Council (ERC)); Dutch Cancer Society (KWF)(KWF Kankerbestrijding); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Nico Stuurman for developing the spot_counter plugin for imageJ and for general help with microscopy, Dr. J. Tanaka for providing hippuristanol, and S. Ruijtenberg and L. Krenning for helpful discussions. This work was supported by a European Research Council (ERC) starting grant (ERC-STG 677936-RNAREG). M.E.T. was supported by a fellowship of the Dutch Cancer Society (KWF), and R.D.V. was supported by the Howard Hughes Medical Institute. A patent has been filed for the SunTag technology (M.E.T. and R.D.V.).	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Babendure JR, 2006, RNA, V12, P851, DOI 10.1261/rna.2309906; Blanchard SC, 2009, CURR OPIN STRUC BIOL, V19, P103, DOI 10.1016/j.sbi.2009.01.002; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; Brar GA, 2012, SCIENCE, V335, P552, DOI 10.1126/science.1215110; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Chao JA, 2008, NAT STRUCT MOL BIOL, V15, P103, DOI 10.1038/nsmb1327; Chen J, 2012, CURR OPIN STRUC BIOL, V22, P804, DOI 10.1016/j.sbi.2012.09.004; Cornish PV, 2008, MOL CELL, V30, P578, DOI 10.1016/j.molcel.2008.05.004; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482; Fei J, 2008, MOL CELL, V30, P348, DOI 10.1016/j.molcel.2008.03.012; Gupta I, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.135068; Halstead JM, 2015, SCIENCE, V347, P1367, DOI 10.1126/science.aaa3380; Han K, 2014, NAT METHODS, V11, P86, DOI [10.1038/NMETH.2729, 10.1038/nmeth.2729]; Holt CE, 2013, NEURON, V80, P648, DOI 10.1016/j.neuron.2013.10.036; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; Jovanovic M, 2015, SCIENCE, V347, DOI 10.1126/science.1259038; Katz ZB, 2016, ELIFE, V5, DOI 10.7554/eLife.10415; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Le Hir H, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.7; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Mukherjee C, 2012, CELL REP, V2, P674, DOI 10.1016/j.celrep.2012.07.011; Peshkin L, 2015, DEV CELL, V35, P383, DOI 10.1016/j.devcel.2015.10.010; Raab-Graham KF, 2006, SCIENCE, V314, P144, DOI 10.1126/science.1131693; Rodriguez AJ, 2006, J CELL BIOL, V175, P67, DOI 10.1083/jcb.200512137; Rojas-Duran MF, 2012, RNA, V18, P2299, DOI 10.1261/rna.035865.112; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Simms CL, 2014, CELL REP, V9, P1256, DOI 10.1016/j.celrep.2014.10.042; Stumpf CR, 2013, MOL CELL, V52, P574, DOI 10.1016/j.molcel.2013.09.018; Tanenbaum ME, 2015, ELIFE, V4, DOI 10.7554/eLife.07957; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Tanenbaum ME, 2011, CURR BIOL, V21, P1356, DOI 10.1016/j.cub.2011.07.017; Tatavarty V, 2012, MOL BIOL CELL, V23, P918, DOI 10.1091/mbc.E11-07-0622; Tholstrup J, 2012, NUCLEIC ACIDS RES, V40, P303, DOI 10.1093/nar/gkr686; WALTER P, 1981, J CELL BIOL, V91, P557, DOI 10.1083/jcb.91.2.557; Wang C, 2016, CELL, V165, P990, DOI 10.1016/j.cell.2016.04.040; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; Wu B, 2015, CELL, V162, P211, DOI 10.1016/j.cell.2015.05.054; Yanagitani K, 2011, SCIENCE, V331, P586, DOI 10.1126/science.1197142; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Zaher HS, 2009, NATURE, V457, P161, DOI 10.1038/nature07582	46	232	242	1	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2016	165	4					976	989		10.1016/j.cell.2016.04.034	http://dx.doi.org/10.1016/j.cell.2016.04.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DL7DN	27153498	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000375800300023
J	Haug, CJ				Haug, Charlotte J.			From Patient to Patient - Sharing the Data from Clinical Trials	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Bierer BE, 2016, NEW ENGL J MED, V374, P2411, DOI 10.1056/NEJMp1605348; Merson L, 2016, NEW ENGL J MED, V374, P2414, DOI 10.1056/NEJMp1605148; Taichman DB, 2016, NEW ENGL J MED, V374, P384, DOI 10.1056/NEJMe1515172	3	16	16	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2016	374	25					2409	2411		10.1056/NEJMp1605378	http://dx.doi.org/10.1056/NEJMp1605378			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DP1TG	27168009	Bronze			2022-12-28	WOS:000378271700002
J	Chen, Q; Boire, A; Jin, X; Valiente, M; Er, EE; Lopez-Soto, A; Jacob, LS; Patwa, R; Shah, H; Xu, K; Cross, JR; Massague, J				Chen, Qing; Boire, Adrienne; Jin, Xin; Valiente, Manuel; Er, Ekrem Emrah; Lopez-Soto, Alejandro; Jacob, Leni S.; Patwa, Ruzeen; Shah, Hardik; Xu, Ke; Cross, Justin R.; Massague, Joan			Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer	NATURE			English	Article							BREAST-CANCER METASTASIS; CADHERIN SUPERFAMILY; EXPRESSION ANALYSIS; TUMOR-CELLS; GENES; CONNEXIN; CLASSIFICATION; RECOGNITION; SURVIVAL; PATHWAY	Brain metastasis represents a substantial source of morbidity and mortality in various cancers, and is characterized by high resistance to chemotherapy. Here we define the role of the most abundant cell type in the brain, the astrocyte, in promoting brain metastasis. We show that human and mouse breast and lung cancer cells express protocadherin 7 (PCDH7), which promotes the assembly of carcinoma-astrocyte gap junctions composed of connexin 43 (Cx43). Once engaged with the astrocyte gap-junctional network, brain metastatic cancer cells use these channels to transfer the second messenger cGAMP to astrocytes, activating the STING pathway and production of inflammatory cytokines such as interferon-alpha (IFN alpha) and tumour necrosis factor (TNF). As paracrine signals, these factors activate the STAT1 and NF-kappa B pathways in brain metastatic cells, thereby supporting tumour growth and chemoresistance. The orally bioavailable modulators of gap junctions meclofenamate and tonabersat break this paracrine loop, and we provide proof-of-principle that these drugs could be used to treat established brain metastasis.	[Chen, Qing; Boire, Adrienne; Jin, Xin; Valiente, Manuel; Er, Ekrem Emrah; Lopez-Soto, Alejandro; Jacob, Leni S.; Patwa, Ruzeen; Massague, Joan] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Boire, Adrienne] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10065 USA; [Shah, Hardik; Cross, Justin R.] Mem Sloan Kettering Canc Ctr, Donald B & Catherine C Marron Canc Metab Ctr, New York, NY 10065 USA; [Xu, Ke] Mem Sloan Kettering Canc Ctr, Mol Cytol Core Facil, New York, NY 10065 USA; [Chen, Qing] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA; [Jin, Xin] Eli & Edythe L Broad Inst, Canc Program, Cambridge, MA 02142 USA; [Valiente, Manuel] Spanish Natl Canc Res Ctr CNIO, Brain Metastasis Grp, E-28029 Madrid, Spain; [Lopez-Soto, Alejandro] Univ Oviedo, Fac Med, Dept Funct Biol IUOPA, Oriedo 33006, Spain; [Jacob, Leni S.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Genet, 3 Blackfan Circle,CLS 417, Boston, MA 02115 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; The Wistar Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Centro Nacional de Investigaciones Oncologicas (CNIO); University of Oviedo; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA.	j-massague@ski.mskcc.org	Boire, Adrienne/AAA-3578-2022; Valiente, Manuel/J-9523-2014; Boire, Adrienne/AAJ-9352-2021; López-Soto, Alejandro/A-9779-2018	Boire, Adrienne/0000-0002-9029-1248; Valiente, Manuel/0000-0002-0647-7542; Boire, Adrienne/0000-0002-9029-1248; López-Soto, Alejandro/0000-0002-6360-5205; Xu, Ke/0000-0003-2628-2061; Cross, Justin/0000-0002-6356-057X; Shah, Hardik/0000-0001-8408-5686; Massague, Joan/0000-0001-9324-8408	NIH [P01-CA129243, U54-163167, P30 CA008748]; DOD [W81XWH-12-0074]; Alan and Sandra Gerry Metastasis Research Initiative; MSKCC Clinical Scholars Training Program; Solomon R. and Rebecca D. Baker Foundation; Susan G. Komen Organization; NATIONAL CANCER INSTITUTE [K22CA181470, U54CA163167, P30CA008748, P01CA094060, P01CA129243] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); Alan and Sandra Gerry Metastasis Research Initiative; MSKCC Clinical Scholars Training Program; Solomon R. and Rebecca D. Baker Foundation; Susan G. Komen Organization; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. Macalinao and other members of the Massague laboratory for discussions. This work was supported by NIH grants P01-CA129243, U54-163167 and P30 CA008748, DOD Innovator award W81XWH-12-0074, the Alan and Sandra Gerry Metastasis Research Initiative (J.M.), the MSKCC Clinical Scholars Training Program (A.B.), the Solomon R. and Rebecca D. Baker Foundation (A.B), and by the Susan G. Komen Organization (X.J.).	Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Beahm DL, 2006, J BIOL CHEM, V281, P7994, DOI 10.1074/jbc.M506533200; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Chan WN, 1999, BIOORG MED CHEM LETT, V9, P285, DOI 10.1016/S0960-894X(98)00728-8; Damodaram S, 2009, HEADACHE, V49, P5, DOI 10.1111/j.1526-4610.2008.01262.x; Deeken JF, 2007, CLIN CANCER RES, V13, P1663, DOI 10.1158/1078-0432.CCR-06-2854; Demaria O, 2015, P NATL ACAD SCI USA, V112, P15408, DOI 10.1073/pnas.1512832112; Eichler AF, 2011, NAT REV CLIN ONCOL, V8, P344, DOI 10.1038/nrclinonc.2011.58; Gaspar LE, 2000, INT J RADIAT ONCOL, V47, P1001, DOI 10.1016/S0360-3016(00)00547-2; Gaspar LE, 2005, J CLIN ONCOL, V23, P2955, DOI 10.1200/JCO.2005.08.026; Gatza ML, 2010, P NATL ACAD SCI USA, V107, P6994, DOI 10.1073/pnas.0912708107; Gavrilovic IT, 2005, J NEURO-ONCOL, V75, P5, DOI 10.1007/s11060-004-8093-6; Giaume C, 2010, NAT REV NEUROSCI, V11, P87, DOI 10.1038/nrn2757; Harks EGA, 2001, J PHARMACOL EXP THER, V298, P1033; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Herdon HJ, 1997, BRIT J PHARMACOL, V121, P1687, DOI 10.1038/sj.bjp.0701331; Hirano S, 2003, FRONT BIOSCI-LANDMRK, V8, pD306, DOI 10.2741/972; Jin MM, 2013, NEUROSCI LETT, V543, P110, DOI 10.1016/j.neulet.2013.03.029; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim SY, 2007, NEUROSCIENCE, V147, P996, DOI 10.1016/j.neuroscience.2007.03.052; Kim SJ, 2011, NEOPLASIA, V13, P286, DOI 10.1593/neo.11112; Lim E, 2014, ONCOLOGY-NY, V28, P572; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Oshima A, 2014, FEBS LETT, V588, P1230, DOI 10.1016/j.febslet.2014.01.042; Osswald M, 2015, NATURE, V528, P93, DOI 10.1038/nature16071; Patel SJ, 2009, P NATL ACAD SCI USA, V106, P12867, DOI 10.1073/pnas.0809292106; Pitz MW, 2011, J NEURO-ONCOL, V104, P629, DOI 10.1007/s11060-011-0564-y; Read S. J., 2000, CEPHALALGIA, V20, P92; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Sin WC, 2016, ONCOGENE, V35, P1504, DOI 10.1038/onc.2015.210; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stelzer Keith J, 2013, Surg Neurol Int, V4, pS192, DOI 10.4103/2152-7806.111296; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Taimur Sadaf, 2003, Curr Oncol Rep, V5, P342, DOI 10.1007/s11912-003-0077-8; Theis M, 2012, BRAIN RES, V1487, P88, DOI 10.1016/j.brainres.2012.06.045; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Wilson AA, 2013, MOL THER, V21, P825, DOI 10.1038/mt.2013.19; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yagi T, 2000, GENE DEV, V14, P1169; Yoshida K, 1998, GENOMICS, V49, P458, DOI 10.1006/geno.1998.5271; Zhang XHF, 2013, CELL, V154, P1060, DOI 10.1016/j.cell.2013.07.036	51	449	474	7	157	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 26	2016	533	7604					493	+		10.1038/nature18268	http://dx.doi.org/10.1038/nature18268			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6EJ	27225120	Green Accepted			2022-12-28	WOS:000376443100032
J	Klein, S				Klein, Spencer			Invest in neutrino astronomy	NATURE			English	Editorial Material									[Klein, Spencer] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Nucl Sci, 1 Cyclotron Rd, Berkeley, CA 94720 USA; [Klein, Spencer] Univ Calif Berkeley, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Klein, S (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Nucl Sci, 1 Cyclotron Rd, Berkeley, CA 94720 USA.; Klein, S (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	srklein@lbl.gov		Klein, Spencer/0000-0003-2841-6553	Division Of Physics [1307472] Funding Source: National Science Foundation	Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Aartsen MG, 2015, ASTROPHYS J LETT, V805, DOI 10.1088/2041-8205/805/1/L5; Aartsen MG, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.021103; Avrorin A. D., 2015, PREPRINT; Bahcall J, 2001, PHYS REV D, V64, DOI 10.1103/PhysRevD.64.023002; Bechtol K., 2015, PREPRINT; Chakraborty S, 2015, PHYS LETT B, V745, P35, DOI 10.1016/j.physletb.2015.04.032; DeYoung T, 2016, EPJ WEB CONF, V116, DOI 10.1051/epjconf/201611611004; Halzen F, 2008, PHYS TODAY, V61, P29, DOI 10.1063/1.2930733; The IceCube Collaboration et al, 2015, PREPRINT	9	1	1	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2016	533	7604					462	464		10.1038/533462a	http://dx.doi.org/10.1038/533462a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6EJ	27225103	Bronze			2022-12-28	WOS:000376443100015
J	Nagata, S				Nagata, Shigekazu			CELL BIOLOGY Killer enzymes tethered	NATURE			English	Editorial Material								Caspase enzymes promote cell death, but are also involved in sperm development in fruit flies. The discovery that, in sperm, caspase activation is restricted to the surface of organelles called mitochondria sheds light on this unusual role.					Nagata, Shigekazu/AAG-3203-2019	Nagata, Shigekazu/0000-0001-9758-8426					0	1	1	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2016	533	7604					474	475		10.1038/nature18439	http://dx.doi.org/10.1038/nature18439			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6EJ	27225115				2022-12-28	WOS:000376443100026
J	Mayor, S				Mayor, Susan			Sixty seconds on ... gardening	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 24	2016	353								i2925	10.1136/bmj.i2925	http://dx.doi.org/10.1136/bmj.i2925			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3CB	27222263				2022-12-28	WOS:000376938800012
J	Lloyd, D; Thomas, D; Cuckow, P				Lloyd, David; Thomas, David; Cuckow, Peter			Anthony Michael Kent Rickwood OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		RICKWOOD AMK, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2016	353								i2789	10.1136/bmj.i2789	http://dx.doi.org/10.1136/bmj.i2789			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GI	27207153				2022-12-28	WOS:000376448200006
J	Mason, N				Mason, Nadya			Superconductivity on the edge	SCIENCE			English	Editorial Material									[Mason, Nadya] Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Mason, N (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	nadya@illinois.edu						Amet F, 2016, SCIENCE, V352, P966, DOI 10.1126/science.aad6203; Andreev A. F., 1964, ZH EKSP TEOR FIZ, V46, P1823; Clarke DJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2340; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Hoppe H, 2000, PHYS REV LETT, V84, P1804, DOI 10.1103/PhysRevLett.84.1804; Katnelson M. I, 2012, GRAPHENE CARBON 2 DI; MA M, 1993, EUROPHYS LETT, V21, P941, DOI 10.1209/0295-5075/21/9/011; Mong RSK, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.011036; Ostaay J. A. M., 2011, PHYS REV B, V83; Prange R. E., 1990, QUANTUM HALL EFFECT; San-Jose P, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.041042	11	3	3	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2016	352	6288			SI		891	892		10.1126/science.aaf6604	http://dx.doi.org/10.1126/science.aaf6604			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM2AK	27199401				2022-12-28	WOS:000376147800016
J	Alpern, JD; Song, J; Stauffer, WM				Alpern, Jonathan D.; Song, John; Stauffer, William M.			Essential Medicines in the United States - Why Access Is Diminishing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Alpern, Jonathan D.; Stauffer, William M.] Univ Minnesota, Div Infect Dis, Minneapolis, MN USA; [Song, John] Univ Minnesota, Ctr Bioeth, Minneapolis, MN USA; [Song, John] Univ Minnesota, Div Gen Internal Med, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Alpern, JD (corresponding author), Univ Minnesota, Div Infect Dis, Minneapolis, MN USA.							Alpern JD, 2014, NEW ENGL J MED, V371, P1859, DOI 10.1056/NEJMp1408376; Greene JA, 2016, JAMA-J AM MED ASSOC, V315, P461, DOI 10.1001/jama.2015.18720; World Health Organization, 2016, ESS MED HLTH PROD IN	3	24	25	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 19	2016	374	20					1904	1907		10.1056/NEJMp1601559	http://dx.doi.org/10.1056/NEJMp1601559			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DM1OX	27192669				2022-12-28	WOS:000376116600002
J	Howlett, DC; Sinnott, JD				Howlett, David C.; Sinnott, Joseph Dalby			SPOT DIAGNOSIS Plain radiography of the skull after investigation for raised calcium	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Howlett, David C.] East Sussex Hosp NHS Trust, Dept Radiol, Eastbourne, E Sussex, England; [Sinnott, Joseph Dalby] East Sussex Hosp NHS Trust, Eastbourne, E Sussex, England		Howlett, DC (corresponding author), East Sussex Hosp NHS Trust, Dept Radiol, Eastbourne, E Sussex, England.	david.howlett@nhs.net							0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2016	353								i2759	10.1136/bmj.i2759	http://dx.doi.org/10.1136/bmj.i2759			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GD	27197983				2022-12-28	WOS:000376447700003
J	Khonsari, RH; Ruhin, B				Khonsari, Roman H.; Ruhin, Blandine			Loose Teeth and Excessive Thirst	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Khonsari, Roman H.; Ruhin, Blandine] CHU Pitie Salpetriere, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Khonsari, RH (corresponding author), CHU Pitie Salpetriere, Paris, France.	roman.khonsari@aphp.fr	Khonsari, Roman Hossein/H-7460-2017	Khonsari, Roman Hossein/0000-0002-0649-1432					0	0	0	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 19	2016	374	20					E25	E25		10.1056/NEJMicm1512541	http://dx.doi.org/10.1056/NEJMicm1512541			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM1OX	27192691				2022-12-28	WOS:000376116600010
J	Schunemann, H				Schunemann, Holger			Principles for Disclosure of Interests and Management of Conflicts in Guidelines: Desirable and Undesirable Action and Consequences RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter									[Schunemann, Holger] McMaster Univ, Hamilton, ON, Canada	McMaster University	Schunemann, H (corresponding author), McMaster Univ, Hamilton, ON, Canada.			Schunemann, Holger/0000-0003-3211-8479				[Anonymous], 2014, US DEL TREATM MULT R; Schunemann HJ, 2014, CAN MED ASSOC J, V186, pE123, DOI 10.1503/cmaj.131237; World Health Organization, 2013, US BED TREATM MULT R	3	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2016	164	10					702	702		10.7326/L15-0623	http://dx.doi.org/10.7326/L15-0623			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8GF	27182911				2022-12-28	WOS:000375878500026
J	Dunn, EC				Dunn, Elizabeth Cullen			Refugee protection and resettlement problems	SCIENCE			English	Editorial Material									[Dunn, Elizabeth Cullen] Indiana Univ, Dept Geog, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Dunn, EC (corresponding author), Indiana Univ, Dept Geog, Bloomington, IN 47405 USA.	elcdunn@indiana.edu						Ali D, 2012, GLOB FOOD SECUR-AGR, V1, P57, DOI 10.1016/j.gfs.2012.07.008; [Anonymous], CASH BASED RESPONSES; Bennett Christina, 2016, TIME LET GO REMAKING; Capps R., 2015, INTERGRATION OUTCOME; Crawford N., 2015, PROTRACTED DISPLACEM; Dunn EC, 2012, HUMANITY, V3, P1, DOI 10.1353/hum.2012.0005; O'Brien S., 2015, UNDER SECRETARY GEN; Thomson MJ, 2014, ARCHIT THEORY REV, V19, P376, DOI 10.1080/13264826.2014.1041633; UNHCR, 2015, JORD INT UPD; van der Zee B., 2015, GUARDIAN	10	5	5	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2016	352	6287					772	773		10.1126/science.aaf8962	http://dx.doi.org/10.1126/science.aaf8962			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5FP	27174974				2022-12-28	WOS:000375663000020
J	Scadden, DT				Scadden, David T.			Blood and Bone	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEMATOPOIETIC STEM-CELLS; MARROW NICHE		[Scadden, David T.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Scadden, David T.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University	Scadden, DT (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.; Scadden, DT (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA.; Scadden, DT (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.							Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Chen JY, 2016, NATURE, V530, P223, DOI 10.1038/nature16943; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703	6	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2016	374	19					1891	1893		10.1056/NEJMcibr1601737	http://dx.doi.org/10.1056/NEJMcibr1601737			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6JS	27168440				2022-12-28	WOS:000375746100017
J	Woodruff, PG; Barr, RG; Bleecker, E; Christenson, SA; Couper, D; Curtis, JL; Gouskova, NA; Hansel, NN; Hoffman, EA; Kanner, RE; Kleerup, E; Lazarus, SC; Martinez, FJ; Paine, R; Rennard, S; Tashkin, DP; Han, MK				Woodruff, Prescott G.; Barr, R. Graham; Bleecker, Eugene; Christenson, Stephanie A.; Couper, David; Curtis, Jeffrey L.; Gouskova, Natalia A.; Hansel, Nadia N.; Hoffman, Eric A.; Kanner, Richard E.; Kleerup, Eric; Lazarus, Stephen C.; Martinez, Fernando J.; Paine, Robert, III; Rennard, Stephen; Tashkin, Donald P.; Han, MeiLan K.		SPIROMICS Res Grp	Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESPIRATORY SYMPTOMS; COPD; DISEASE; LUNG; EXACERBATIONS; OUTCOMES; DYSPNEA; OBESITY	BACKGROUND Currently, the diagnosis of chronic obstructive pulmonary disease (COPD) requires a ratio of forced expiratory volume in 1 second (FEV 1) to forced vital capacity (FVC) of less than 0.70 as assessed by spirometry after bronchodilator use. However, many smokers who do not meet this definition have respiratory symptoms. METHODS We conducted an observational study involving 2736 current or former smokers and controls who had never smoked and measured their respiratory symptoms using the COPD Assessment Test (CAT; scores range from 0 to 40, with higher scores indicating greater severity of symptoms). We examined whether current or former smokers who had preserved pulmonary function as assessed by spirometry (FEV1 : FVC >= 0.70 and an FVC above the lower limit of the normal range after bronchodilator use) and had symptoms (CAT score, >= 10) had a higher risk of respiratory exacerbations than current or former smokers with preserved pulmonary function who were asymptomatic (CAT score, <10) and whether those with symptoms had different findings from the asymptomatic group with respect to the 6-minute walk distance, lung function, or high-resolution computed tomographic (HRCT) scan of the chest. RESULTS Respiratory symptoms were present in 50% of current or former smokers with preserved pulmonary function. The mean (+/- SD) rate of respiratory exacerbations among symptomatic current or former smokers was significantly higher than the rates among asymptomatic current or former smokers and among controls who never smoked (0.27 +/- 0.67 vs. 0.08 +/- 0.31 and 0.03 +/- 0.21 events, respectively, per year; P<0.001 for both comparisons). Symptomatic current or former smokers, regardless of history of asthma, also had greater limitation of activity, slightly lower FEV 1, FVC, and inspiratory capacity, and greater airway-wall thickening without emphysema according to HRCT than did asymptomatic current or former smokers. Among symptomatic current or former smokers, 42% used bronchodilators and 23% used inhaled glucocorticoids. CONCLUSIONS Although they do not meet the current criteria for COPD, symptomatic current or former smokers with preserved pulmonary function have exacerbations, activity limitation, and evidence of airway disease. They currently use a range of respiratory medications without any evidence base.	[Woodruff, Prescott G.; Lazarus, Stephen C.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Woodruff, Prescott G.; Christenson, Stephanie A.; Lazarus, Stephen C.] Univ Calif San Francisco, Dept Med, Div Pulm Crit Care Sleep & Allergy, San Francisco, CA 94143 USA; [Barr, R. Graham] Columbia Univ, Dept Med, Med Ctr, New York, NY USA; [Barr, R. Graham] Columbia Univ, Med Ctr, Dept Epidemiol, New York, NY USA; [Martinez, Fernando J.] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Bleecker, Eugene] Wake Forest Univ, Dept Med, Ctr Genom & Personalized Med Res, Winston Salem, NC 27109 USA; [Couper, David; Gouskova, Natalia A.] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Curtis, Jeffrey L.] Vet Affairs Ann Arbor Healthcare Syst, Med Serv, Pulm & Crit Care Med Sect, Ann Arbor, MI USA; [Curtis, Jeffrey L.; Han, MeiLan K.] Univ Michigan, Dept Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Hansel, Nadia N.] Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA; [Hoffman, Eric A.] Univ Iowa, Dept Radiol, Carver Coll Med, Iowa City, IA 52242 USA; [Kanner, Richard E.; Paine, Robert, III] Univ Utah, Dept Med, Hosp & Clin, Salt Lake City, UT 84112 USA; [Kleerup, Eric; Tashkin, Donald P.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Rennard, Stephen] Univ Nebraska, Med Ctr, Dept Med, Omaha, NE 68105 USA; [Rennard, Stephen] AstraZeneca, Clin Discovery Unit, Cambridge, England	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Columbia University; Columbia University; Cornell University; Wake Forest University; University of North Carolina; University of North Carolina Chapel Hill; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; Johns Hopkins University; University of Iowa; Utah System of Higher Education; University of Utah; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Nebraska System; University of Nebraska Medical Center; AstraZeneca	Woodruff, PG (corresponding author), Univ Calif San Francisco, Box 0130,Rm HSE 1305,513 Parnassus Ave, San Francisco, CA 94143 USA.	prescott.woodruff@ucsf.edu	Facility, Biospecimen Processing/AAC-7837-2022	Couper, David/0000-0002-4313-9235; Comellas, Alejandro/0000-0003-1521-7520	National Heart, Lung, and Blood Institute; Foundation for the National Institutes of Health; SPIROMICS; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095372, R01HL110906, K12HL119997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018526] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000911] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SPIROMICS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	Funded by the National Heart, Lung, and Blood Institute and the Foundation for the National Institutes of Health; SPIROMICS	Agusti A, 2013, EUR RESPIR J, V42, P636, DOI 10.1183/09031936.00195212; [Anonymous], 1965, Lancet, V1, P775; Beghe B, 2013, EUR RESPIR J, V41, P993, DOI 10.1183/09031936.00180812; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; Bowler RP, 2014, CHEST, V146, P941, DOI 10.1378/chest.13-2946; Celli BR, 2015, EUR RESPIR REV, V24, P159, DOI 10.1183/16000617.00000315; Couper D, 2014, THORAX, V69, P491, DOI 10.1136/thoraxjnl-2013-203897; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Global Initiative for Chronic Obstructive Lung Disease, GLOB STRAT DIAGN MAN; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Johns DP, 2014, J THORAC DIS, V6, P1557, DOI 10.3978/j.issn.2072-1439.2014.08.18; Jones PW, 2009, EUR RESPIR J, V34, P648, DOI 10.1183/09031936.00102509; Lin DY, 2000, J ROY STAT SOC B, V62, P711, DOI 10.1111/1467-9868.00259; Lopez-Campos JL, 2015, LANCET RESP MED, V3, P729, DOI 10.1016/S2213-2600(15)00242-8; Martinez CH, 2014, RESP MED, V108, P491, DOI 10.1016/j.rmed.2013.11.003; Oelsner EC, 2014, ANN INTERN MED, V161, P863, DOI 10.7326/M13-2570; Patel BD, 2008, AM J RESP CRIT CARE, V178, P500, DOI 10.1164/rccm.200801-059OC; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Pinto LM, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-68; Regan EA, 2015, JAMA INTERN MED, V175, P1539, DOI 10.1001/jamainternmed.2015.2735; Salome CM, 2010, J APPL PHYSIOL, V108, P206, DOI 10.1152/japplphysiol.00694.2009; Sin DD, 2002, ARCH INTERN MED, V162, P1477, DOI 10.1001/archinte.162.13.1477; Tan WC, 2014, THORAX, V69, P709, DOI 10.1136/thoraxjnl-2013-205048; van der Molen Thys, 2003, Health Qual Life Outcomes, V1, P13, DOI 10.1186/1477-7525-1-13; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP	25	397	403	1	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2016	374	19					1811	1821		10.1056/NEJMoa1505971	http://dx.doi.org/10.1056/NEJMoa1505971			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6JS	27168432	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000375746100004
J	Qiu, HB; Gao, Y; Boott, CE; Gould, OEC; Harniman, RL; Miles, MJ; Webb, SED; Winnik, MA; Manners, I				Qiu, Huibin; Gao, Yang; Boott, Charlotte E.; Gould, Oliver E. C.; Harniman, Robert L.; Miles, Mervyn J.; Webb, Stephen E. D.; Winnik, Mitchell A.; Manners, Ian			Uniform patchy and hollow rectangular platelet micelles from crystallizable polymer blends	SCIENCE			English	Article							BLOCK-COPOLYMER MICELLES; CYLINDRICAL MICELLES; NANOSTRUCTURED MATERIALS; DIBLOCK COPOLYMERS; CO-MICELLES; NANOPARTICLES; ARCHITECTURES; CONSTRUCTION; GROWTH; LENGTH	The preparation of colloidally stable, self-assembled materials with tailorable solid or hollow two-dimensional (2D) structures represents a major challenge. We describe the formation of uniform, monodisperse rectangular platelet micelles of controlled size by means of seeded-growth methods that involve the addition of blends of crystalline-coil block copolymers and the corresponding crystalline homopolymer to cylindrical micelle seeds. Sequential addition of different blends yields solid platelet block comicelles with concentric rectangular patches with distinct coronal chemistries. These complex nano-objects can be subject to spatially selective processing that allows their disassembly to form perforated platelets, such as well-defined hollow rectangular rings. The solid and hollow 2D micelles provide a tunable platform for further functionalization and potential for a variety of applications.	[Qiu, Huibin; Gao, Yang; Boott, Charlotte E.; Gould, Oliver E. C.; Harniman, Robert L.; Manners, Ian] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England; [Miles, Mervyn J.] Univ Bristol, Sch Phys, Bristol BS8 1TL, Avon, England; [Webb, Stephen E. D.] Rutherford Appleton Lab, Cent Laser Facil Sci & Technol Facil Council, Res Complex Harwell, Didcot OX11 0QX, Oxon, England; [Winnik, Mitchell A.] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; [Qiu, Huibin] ShanghaiTech Univ, Sch Phys Sci & Technol, Shanghai, Peoples R China	University of Bristol; University of Bristol; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Toronto; ShanghaiTech University	Manners, I (corresponding author), Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England.	ian.manners@bristol.ac.uk	Harniman, Robert/A-6355-2012; Qiu, Huibin/AAB-1319-2019; Winnik, Mitchell A/R-8621-2018; Qiu, Huibin/B-1663-2013; Gao, Yang/B-1345-2019; Webb, Stephen E D/G-5682-2010	Harniman, Robert/0000-0002-3452-1213; Qiu, Huibin/0000-0002-4699-6558; Qiu, Huibin/0000-0002-4699-6558; Gao, Yang/0000-0001-7945-4811; Webb, Stephen E D/0000-0002-6304-1702; Boott, Charlotte/0000-0003-0902-030X	European Union Marie Curie Postdoctoral Fellowship; European Research Council; Engineering and Physical Sciences Research Council (EPSRC); Medical Research Council; BBSRC [BB/L014181/1] Funding Source: UKRI; EPSRC [EP/K035746/1, EP/K03927X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L014181/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/K035746/1, EP/K03927X/1, 1245296] Funding Source: researchfish	European Union Marie Curie Postdoctoral Fellowship; European Research Council(European Research Council (ERC)European Commission); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	H.Q. acknowledges a European Union Marie Curie Postdoctoral Fellowship. H.Q and Y.G. thank the European Research Council for support, and I.M. acknowledges an Advanced Investigator Grant. C.E.B. thanks the Engineering and Physical Sciences Research Council (EPSRC)-funded Bristol Chemical Synthesis Centre for Doctoral Training, O.E.C.G. thanks the EPSRC-funded Bristol Center for Functional Nanomaterials, and M.A.W. thanks the Natural Sciences and Engineering Research Council of Canada. For assistance, the authors thank V. A. Du (polymer synthesis) and J. A. Jones of the Electron Microscopy Unit (School of Chemistry, TEM) and Wolfson Bioimaging Facility (CLSM) at Bristol. PeakForce AFM was carried out in the Chemical Imaging Facility at Bristol, and SIM imaging was performed at Harwell, using equipment funded by EPSRC and the Medical Research Council, respectively. H.Q. and I.M. conceived the project. H.Q. and Y.G. performed the self-assembly experiments. C.E.B. synthesized the fluorescent polymers. H.Q., C.E.B., and S.E.D.W. performed the CLSM and SIM imaging, and H.Q. and R.L.H. performed the AFM analysis. O.E.C.G. performed the manipulation experiments using optical tweezers and the corresponding analyses. H.Q. and I. M. prepared the manuscript with input from all the other authors. The project was supervised by I.M.	Baek K, 2015, ACCOUNTS CHEM RES, V48, P2221, DOI 10.1021/acs.accounts.5b00067; Boott CE, 2015, ANGEW CHEM INT EDIT, V54, P13876, DOI 10.1002/anie.201502009; Chen WY, 2004, MACROMOLECULES, V37, P5292, DOI 10.1021/ma0493325; Cui HG, 2007, SCIENCE, V317, P647, DOI 10.1126/science.1141768; Dong B, 2013, ACS NANO, V7, P5192, DOI 10.1021/nn400925q; Gadt T, 2009, NAT MATER, V8, P144, DOI [10.1038/NMAT2356, 10.1038/nmat2356]; Gilroy JB, 2010, NAT CHEM, V2, P566, DOI [10.1038/NCHEM.664, 10.1038/nchem.664]; Groschel AH, 2013, NATURE, V503, P247, DOI 10.1038/nature12610; Hill JP, 2004, SCIENCE, V304, P1481, DOI 10.1126/science.1097789; Huang Z, 2012, SCIENCE, V337, P1521, DOI 10.1126/science.1224741; Hudson ZM, 2014, NAT CHEM, V6, P893, DOI [10.1038/NCHEM.2038, 10.1038/nchem.2038]; Jia L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4882; Li B, 2007, J AM CHEM SOC, V129, P12, DOI 10.1021/ja0668318; Mai YY, 2012, CHEM SOC REV, V41, P5969, DOI 10.1039/c2cs35115c; O'Reilly RK, 2006, CHEM SOC REV, V35, P1068, DOI 10.1039/b514858h; Pochan DJ, 2004, SCIENCE, V306, P94, DOI 10.1126/science.1102866; Qian JS, 2014, J AM CHEM SOC, V136, P4121, DOI 10.1021/ja500661k; Qiu HB, 2015, SCIENCE, V347, P1329, DOI 10.1126/science.1261816; Qiu HB, 2013, J AM CHEM SOC, V135, P17739, DOI 10.1021/ja410176n; Rizis G, 2014, ANGEW CHEM INT EDIT, V53, P9000, DOI 10.1002/anie.201404089; Rupar PA, 2012, SCIENCE, V337, P559, DOI 10.1126/science.1221206; Schacher FH, 2012, ANGEW CHEM INT EDIT, V51, P7898, DOI 10.1002/anie.201200310; Schmelz J, 2012, J AM CHEM SOC, V134, P14217, DOI 10.1021/ja306264d; Sun L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6746; Wang XS, 2007, SCIENCE, V317, P644, DOI 10.1126/science.1141382; Wright DB, 2015, MACROMOLECULES, V48, P6516, DOI 10.1021/acs.macromol.5b01426; Yu B, 2014, MACROMOLECULES, V47, P4761, DOI 10.1021/ma500845e; Zheng JX, 2006, MACROMOLECULES, V39, P641, DOI 10.1021/ma052166w; Zhu JH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3297; Zhuang XD, 2015, ADV MATER, V27, P403, DOI 10.1002/adma.201401857	31	230	233	26	475	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2016	352	6286					697	701		10.1126/science.aad9521	http://dx.doi.org/10.1126/science.aad9521			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL1UC	27151866	Green Submitted			2022-12-28	WOS:000375417100035
J	Merson, L; Gaye, O; Guerin, PJ				Merson, Laura; Gaye, Oumar; Guerin, Philippe J.			Avoiding Data Dumpsters - Toward Equitable and Useful Data Sharing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Merson, Laura; Guerin, Philippe J.] Univ Oxford, Ctr Trop Med & Global Hlth, Infect Dis Data Observ, WorldWide Antimalarial Resistance Network, Oxford, England; [Gaye, Oumar] Univ Cheikh Anta Diop, Fac Med, Lab Parasitol Mycol, Dakar, Senegal	University of Oxford; Worldwide Antimalarial Resistance Network (WWARN); University Cheikh Anta Diop Dakar	Merson, L (corresponding author), Univ Oxford, Ctr Trop Med & Global Hlth, Infect Dis Data Observ, WorldWide Antimalarial Resistance Network, Oxford, England.		Guerin, Philippe/AAH-8873-2021	Merson, Laura/0000-0002-4168-1960; Guerin, Philippe/0000-0002-6008-2963					0	43	45	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2016	374	25					2414	2415		10.1056/NEJMp1605148	http://dx.doi.org/10.1056/NEJMp1605148			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DP1TG	27168351	Bronze, Green Published			2022-12-28	WOS:000378271700004
J	Mokdad, AH; Forouzanfar, MH; Daoud, F; Mokdad, AA; El Bcheraoui, C; Moradi-Lakeh, M; Kyu, HH; Barber, RM; Wagner, J; Cercy, K; Kravitz, H; Coggeshall, M; Chew, A; O'Rourke, KF; Steiner, C; Tuffaha, M; Charara, R; Al-Ghamdi, EA; Adi, Y; Afifi, RA; Alahmadi, H; AlBuhairan, F; Allen, N; AlMazroa, M; Al-Nehmi, AA; AlRayess, Z; Arora, M; Azzopardi, P; Barroso, C; Basulaiman, M; Bhutta, ZA; Bonell, C; Breinbauer, C; Degenhardt, L; Denno, D; Fang, J; Fatusi, A; Feigl, AB; Kakuma, R; Karam, N; Kennedy, E; Khoja, TKAM; Maalouf, F; Obermeyer, CM; Mattoo, A; McGovern, T; Memish, ZA; Mensah, GA; Patel, V; Petroni, S; Reavley, N; Zertuche, DR; Saeedi, M; Santelli, J; Sawyer, SM; Ssewamala, F; Taiwo, K; Tantawy, M; Viner, RM; Waldfogel, J; Zuniga, MP; Naghavi, M; Wang, HD; Vos, T; Lopez, AD; Al Rabeeah, AA; Patton, GC; Murray, CJL				Mokdad, Ali H.; Forouzanfar, Mohammad Hossein; Daoud, Farah; Mokdad, Arwa A.; El Bcheraoui, Charbel; Moradi-Lakeh, Maziar; Kyu, Hmwe Hmwe; Barber, Ryan M.; Wagner, Joseph; Cercy, Kelly; Kravitz, Hannah; Coggeshall, Megan; Chew, Adrienne; O'Rourke, Kevin F.; Steiner, Caitlyn; Tuffaha, Marwa; Charara, Raghid; Al-Ghamdi, Essam Abdullah; Adi, Yaser; Afifi, Rima A.; Alahmadi, Hanan; AlBuhairan, Fadia; Allen, Nicholas; AlMazroa, Mohammad; Al-Nehmi, Abdulwahab A.; AlRayess, Zulfa; Arora, Monika; Azzopardi, Peter; Barroso, Carmen; Basulaiman, Mohammed; Bhutta, Zulfiqar A.; Bonell, Chris; Breinbauer, Cecilia; Degenhardt, Louisa; Denno, Donna; Fang, Jing; Fatusi, Adesegun; Feigl, Andrea B.; Kakuma, Ritsuko; Karam, Nadim; Kennedy, Elissa; Khoja, Tawfi K. A. M.; Maalouf, Fadi; Obermeyer, Carla Makhlouf; Mattoo, Amitabh; McGovern, Terry; Memish, Ziad A.; Mensah, George A.; Patel, Vikram; Petroni, Suzanne; Reavley, Nicola; Zertuche, Diego Rios; Saeedi, Mohammad; Santelli, John; Sawyer, Susan M.; Ssewamala, Fred; Taiwo, Kikelomo; Tantawy, Muhammad; Viner, Russell M.; Waldfogel, Jane; Zuniga, Maria Paola; Naghavi, Mohsen; Wang, Haidong; Vos, Theo; Lopez, Alan D.; Al Rabeeah, Abdullah A.; Patton, George C.; Murray, Christopher J. L.			Global burden of diseases, injuries, and risk factors for young people's health during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013	LANCET			English	Article							LIFE YEARS DALYS; ADOLESCENT HEALTH; 188 COUNTRIES; 21 REGIONS; DISABILITY; MORTALITY; AGE; ADULTHOOD; CHINA	Background Young people's health has emerged as a neglected yet pressing issue in global development. Changing patterns of young people's health have the potential to undermine future population health as well as global economic development unless timely and effective strategies are put into place. We report the past, present, and anticipated burden of disease in young people aged 10-24 years from 1990 to 2013 using data on mortality, disability, injuries, and health risk factors. Methods The Global Burden of Disease Study 2013 (GBD 2013) includes annual assessments for 188 countries from 1990 to 2013, covering 306 diseases and injuries, 1233 sequelae, and 79 risk factors. We used the comparative risk assessment approach to assess how much of the burden of disease reported in a given year can be attributed to past exposure to a risk. We estimated attributable burden by comparing observed health outcomes with those that would have been observed if an alternative or counterfactual level of exposure had occurred in the past. We applied the same method to previous years to allow comparisons from 1990 to 2013. We cross-tabulated the quantiles of disability-adjusted life-years (DALYs) by quintiles of DALYs annual increase from 1990 to 2013 to show rates of DALYs increase by burden. We used the GBD 2013 hierarchy of causes that organises 306 diseases and injuries into four levels of classification. Level one distinguishes three broad categories: first, communicable, maternal, neonatal, and nutritional disorders; second, non-communicable diseases; and third, injuries. Level two has 21 mutually exclusive and collectively exhaustive categories, level three has 163 categories, and level four has 254 categories. Findings The leading causes of death in 2013 for young people aged 10-14 years were HIV/AIDS, road injuries, and drowning (25.2%), whereas transport injuries were the leading cause of death for ages 15-19 years (14.2%) and 20-24 years (15.6%). Maternal disorders were the highest cause of death for young women aged 20-24 years (17.1%) and the fourth highest for girls aged 15-19 years (11.5%) in 2013. Unsafe sex as a risk factor for DALYs increased from the 13th rank to the second for both sexes aged 15-19 years from 1990 to 2013. Alcohol misuse was the highest risk factor for DALYs (7.0% overall, 10.5% for males, and 2.7% for females) for young people aged 20-24 years, whereas drug use accounted for 2.7% (3.3% for males and 2.0% for females). The contribution of risk factors varied between and within countries. For example, for ages 20-24 years, drug use was highest in Qatar and accounted for 4.9% of DALYs, followed by 4.8% in the United Arab Emirates, whereas alcohol use was highest in Russia and accounted for 21.4%, followed by 21.0% in Belarus. Alcohol accounted for 9.0% (ranging from 4.2% in Hong Kong to 11.3% in Shandong) in China and 11.6% (ranging from 10.1% in Aguascalientes to 14.9% in Chihuahua) of DALYs in Mexico for young people aged 20-24 years. Alcohol and drug use in those aged 10-24 years had an annual rate of change of >1.0% from 1990 to 2013 and accounted for more than 3.1% of DALYs. Interpretation Our findings call for increased efforts to improve health and reduce the burden of disease and risks for diseases in later life in young people. Moreover, because of the large variations between countries in risks and burden, a global approach to improve health during this important period of life will fail unless the particularities of each country are taken into account. Finally, our results call for a strategy to overcome the financial and technical barriers to adequately capture young people's health risk factors and their determinants in health information systems.	[Mokdad, Ali H.; Forouzanfar, Mohammad Hossein; Daoud, Farah; Mokdad, Arwa A.; El Bcheraoui, Charbel; Moradi-Lakeh, Maziar; Kyu, Hmwe Hmwe; Barber, Ryan M.; Wagner, Joseph; Cercy, Kelly; Kravitz, Hannah; Coggeshall, Megan; Chew, Adrienne; O'Rourke, Kevin F.; Steiner, Caitlyn; Naghavi, Mohsen; Wang, Haidong; Vos, Theo; Lopez, Alan D.; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Breinbauer, Cecilia] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Denno, Donna] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Moradi-Lakeh, Maziar] Iran Univ Med Sci, Dept Community Med, Gastrointestinal & Liver Dis Res Ctr, Tehran, Iran; [Al-Ghamdi, Essam Abdullah; Adi, Yaser; AlMazroa, Mohammad; AlRayess, Zulfa; Basulaiman, Mohammed; Memish, Ziad A.; Saeedi, Mohammad; Tantawy, Muhammad; Al Rabeeah, Abdullah A.] Saudi Minist Hlth, Riyadh, Saudi Arabia; [Memish, Ziad A.] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia; [Obermeyer, Carla Makhlouf] Amer Univ Beirut, Fac Med & Med Ctr, Ctr Res Populat & Hlth, Beirut, Lebanon; [Afifi, Rima A.] Amer Univ Beirut, Fac Med & Med Ctr, Dept Hlth Promot & Community Hlth, Beirut, Lebanon; [Maalouf, Fadi] Amer Univ Beirut, Fac Med & Med Ctr, Fac Hlth Sci, Dept Psychiat, Beirut, Lebanon; [Alahmadi, Hanan] Inst Publ Adm, Riyadh, Saudi Arabia; [AlBuhairan, Fadia] King Saud bin Abdulaziz Univ Hlth Sci, King Abdullah Specialized Childrens Hosp, Riyadh, Saudi Arabia; [AlBuhairan, Fadia] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [Allen, Nicholas] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA; [Al-Nehmi, Abdulwahab A.] Minist Hlth, Sanaa, Yemen; [Arora, Monika; Patel, Vikram] Publ Hlth Fdn India, Delhi, India; [Patel, Vikram] London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1, England; [Azzopardi, Peter; Sawyer, Susan M.; Patton, George C.] Royal Childrens Hosp, Ctr Adolescent Hlth, Flemington Rd, Parkville, Vic 3052, Australia; [Azzopardi, Peter; Sawyer, Susan M.; Patton, George C.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia; [Azzopardi, Peter] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Kakuma, Ritsuko] Univ Melbourne, Global & Cultural Mental Hlth Unit, Melbourne, Vic, Australia; [Mattoo, Amitabh] Univ Melbourne, Melbourne Sch Govt, Melbourne, Vic, Australia; [Reavley, Nicola] Univ Melbourne, Ctr Mental Hlth, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Lopez, Alan D.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Azzopardi, Peter; Sawyer, Susan M.; Patton, George C.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Mattoo, Amitabh] Australia India Inst, Carlton, Vic, Australia; [Mattoo, Amitabh] Jawaharlal Nehru Univ, Sch Int Studies, Delhi, India; [Barroso, Carmen] Int Planned Parenthood Federat, New York, NY USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Iran University of Medical Sciences; Alfaisal University; American University of Beirut; American University of Beirut; American University of Beirut; Institute of Public Administration - Saudi Arabia; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah Specialist Childrens Hospital (KASCH); King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); University of Oregon; Public Health Foundation of India; University of London; London School of Hygiene & Tropical Medicine; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; South Australian Health & Medical Research Institute (SAHMRI); University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Jawaharlal Nehru University, New Delhi	Mokdad, AH (corresponding author), Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.		Viner, Russell M/A-1441-2009; Memish, Ziad Ahmed/AEJ-9424-2022; Lopez, Alan/AAA-2734-2022; Ribeiro, Ana Cristina/HHN-7466-2022; Patton, George C/B-5246-2013; Afifi, Rima A/M-5615-2016; Degenhardt, Louisa J/D-4515-2012; Adi, Yaser A/S-5100-2016; Moradi-Lakeh, Maziar/ABC-9793-2021; Reavley, Nicola/ABE-6510-2020; Lopez, Alan D/F-1487-2010; Mokdad, Ali H./AAD-1232-2022; Santelli, John/AAG-3046-2021; Bhutta, Zulfiqar/L-7822-2015	Viner, Russell M/0000-0003-3047-2247; Memish, Ziad Ahmed/0000-0002-5099-0714; Ribeiro, Ana Cristina/0000-0002-0493-8376; Patton, George C/0000-0001-5039-8326; Afifi, Rima A/0000-0003-3154-3617; Degenhardt, Louisa J/0000-0002-8513-2218; Adi, Yaser A/0000-0002-3989-2873; Moradi-Lakeh, Maziar/0000-0001-7381-5305; Reavley, Nicola/0000-0001-5513-8291; Lopez, Alan D/0000-0001-5818-6512; Mokdad, Ali H./0000-0002-4994-3339; azzopardi, peter/0000-0002-9280-6997; Bhutta, Zulfiqar/0000-0003-0637-599X; Barroso, Carmen/0000-0002-9452-7086; Kakuma, Ritsuko/0000-0002-0196-2100; Allen, Nicholas/0000-0002-1086-6639; Kravitz, Hannah/0000-0003-2998-8043; Maalouf, Fadi/0000-0001-8727-3084; AlBuhairan, Fadia/0000-0002-7377-503X; Ssewamala, Fred/0000-0002-4849-5650	Australian National Health and Medical Research Council Principal Research Fellowship [1041742]; National Health and Medical Research Council, Australia	Australian National Health and Medical Research Council Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	LD is supported by an Australian National Health and Medical Research Council Principal Research Fellowship (1041742). EK gratefully acknowledges the contribution of the Victorian Operational Infrastructure Support Program received by the Burnet Institute to this work. NR receives salary support from the National Health and Medical Research Council, Australia. The views expressed in this article are those of the authors and do not necessarily represent the views of the National Heart, Lung, and Blood Institute, National Institutes of Health, or Department of Health and Human Services. We would like to thank Wendy Baldwin for her important contributions to this manuscript.	[Anonymous], 2005, MENT HLTH POL SERV G; Azevedo JP, TEENAGE PREGNANCY OP; Bardone AM, 1996, DEV PSYCHOPATHOL, V8, P811, DOI 10.1017/S0954579400007446; Blum RW, 2004, J ADOLESCENT HEALTH, V35, P402, DOI [10.1016/j.jadohealth.2003.10.007, 10.1016/S1054-139X(03)00537-8]; Carter JS, 2015, J YOUTH ADOLESCENCE, V44, P2122, DOI 10.1007/s10964-015-0301-5; CHRISTIE KA, 1988, AM J PSYCHIAT, V145, P971; Costa BM, 2015, AGGRESS VIOLENT BEH, V24, P261, DOI 10.1016/j.avb.2015.06.001; Currie C, HLTH POLICY CHILDREN; Dehne KL, 2001, REPROD HEALTH MATTER, V9, P170, DOI 10.1016/S0968-8080(01)90021-7; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; GORTMAKER SL, 1993, NEW ENGL J MED, V329, P1008, DOI 10.1056/NEJM199309303291406; Institute for Health Metrics and Evaluation, GBD COMP VIZ HUB; International Labour Office Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ) GmbH WHO, EXT SOC PROT HLTH DE; Jenkins Rachel, 2011, Ment Health Fam Med, V8, P87; Lassi ZS, 2015, SEMIN PERINATOL, V39, P353, DOI 10.1053/j.semperi.2015.06.005; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lloyd Cynthia B., 2005, GROWING GLOBAL CHANG; Moran P, 2012, LANCET, V379, P236, DOI 10.1016/S0140-6736(11)61141-0; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Newton JN, 2015, LANCET, V386, P2257, DOI 10.1016/S0140-6736(15)00195-6; Patton GC, 2012, LANCET, V379, P1665, DOI 10.1016/S0140-6736(12)60203-7; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Shah IH, 2012, REPROD HEALTH MATTER, V20, P169, DOI 10.1016/S0968-8080(12)39598-0; Torsheim T, 2001, J ADOLESCENCE, V24, P701, DOI 10.1006/jado.2001.0440; UN, 2015, TRANSF OUR WORLD 203; UNDESA, 2009, WORLD POP PROSP 2008; United Nations Department of Economic and Social Affairs, WORLD POP PROSP 2015; United Nations Department of Economic and Social Affairs, CHILDR YOUTH SUST DE; University of Bristol, AV LONG STUD PAR CHI; Viner RM, 2011, LANCET, V377, P1162, DOI 10.1016/S0140-6736(11)60106-2; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; Wang SY, 2008, LANCET, V372, P1765, DOI 10.1016/S0140-6736(08)61367-7; Warren CW, 2006, LANCET, V367, P749, DOI 10.1016/S0140-6736(06)68192-0; World Bank, 2006, WORLD DEV REP 2007 D; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Yusoff M.S.B., 2011, INT J STUD, V1, P23, DOI [10.5549/IJSR.1.1.23-2810.5549/IJSR.1.1.23-28, DOI 10.5549/IJSR.1.1.23-2810.5549/IJSR.1.1.23-28, 10.5549/IJSR.1.1.23-28, DOI 10.5549/IJSR.1.1.23-28]; Zhou MG, 2016, LANCET, V387, P251, DOI 10.1016/S0140-6736(15)00551-6	43	495	525	7	142	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 11	2016	387	10036					2383	2401		10.1016/S0140-6736(16)00648-6	http://dx.doi.org/10.1016/S0140-6736(16)00648-6			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DO1ST	27174305				2022-12-28	WOS:000377560100032
J	Nioi, P; Sigurdsson, A; Thorleifsson, G; Helgason, H; Agustsdottir, AB; Norddahl, GL; Helgadottir, A; Magnusdottir, A; Jonasdottir, A; Gretarsdottir, S; Jonsdottir, I; Steinthorsdottir, V; Rafnar, T; Swinkels, DW; Galesloot, TE; Grarup, N; Jorgensen, T; Vestergaard, H; Hansen, T; Lauritzen, T; Linneberg, A; Friedrich, N; Krarup, NT; Fenger, M; Abildgaard, U; Hansen, PR; Galloe, AM; Braund, PS; Nelson, CP; Hall, AS; Williams, MJA; van Rij, AM; Jones, GT; Patel, RS; Levey, AI; Hayek, S; Shah, SH; Reilly, M; Eyjolfsson, GI; Sigurdardottir, O; Olafsson, I; Kiemeney, LA; Quyyumi, AA; Rader, DJ; Kraus, WE; Samani, NJ; Pedersen, O; Thorgeirsson, G; Masson, G; Holm, H; Gudbjartsson, D; Sulem, P; Thorsteinsdottir, U; Stefansson, K				Nioi, P.; Sigurdsson, A.; Thorleifsson, G.; Helgason, H.; Agustsdottir, A. B.; Norddahl, G. L.; Helgadottir, A.; Magnusdottir, A.; Jonasdottir, A.; Gretarsdottir, S.; Jonsdottir, I.; Steinthorsdottir, V.; Rafnar, T.; Swinkels, D. W.; Galesloot, T. E.; Grarup, N.; Jorgensen, T.; Vestergaard, H.; Hansen, T.; Lauritzen, T.; Linneberg, A.; Friedrich, N.; Krarup, N. T.; Fenger, M.; Abildgaard, U.; Hansen, P. R.; Galloe, A. M.; Braund, P. S.; Nelson, C. P.; Hall, A. S.; Williams, M. J. A.; van Rij, A. M.; Jones, G. T.; Patel, R. S.; Levey, A. I.; Hayek, S.; Shah, S. H.; Reilly, M.; Eyjolfsson, G. I.; Sigurdardottir, O.; Olafsson, I.; Kiemeney, L. A.; Quyyumi, A. A.; Rader, D. J.; Kraus, W. E.; Samani, N. J.; Pedersen, O.; Thorgeirsson, G.; Masson, G.; Holm, H.; Gudbjartsson, D.; Sulem, P.; Thorsteinsdottir, U.; Stefansson, K.			Variant ASGR1 Associated with a Reduced Risk of Coronary Artery Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; FAMILIAL HYPERCHOLESTEROLEMIA; SIALIC-ACID; ASIALOGLYCOPROTEIN; LOCUS; GLYCOPROTEINS; CHOLESTEROL; GALACTOSYL; MUTATIONS; PROTEINS	BACKGROUND Several sequence variants are known to have effects on serum levels of non-high-density lipoprotein (HDL) cholesterol that alter the risk of coronary artery disease. METHODS We sequenced the genomes of 2636 Icelanders and found variants that we then imputed into the genomes of approximately 398,000 Icelanders. We tested for association between these imputed variants and non-HDL cholesterol levels in 119,146 samples. We then performed replication testing in two populations of European descent. We assessed the effects of an implicated loss-of-function variant on the risk of coronary artery disease in 42,524 case patients and 249,414 controls from five European ancestry populations. An augmented set of genomes was screened for additional loss-of-function variants in a target gene. We evaluated the effect of an implicated variant on protein stability. RESULTS We found a rare noncoding 12-base-pair (bp) deletion (del12) in intron 4 of ASGR1, which encodes a subunit of the asialoglycoprotein receptor, a lectin that plays a role in the homeostasis of circulating glycoproteins. The del12 mutation activates a cryptic splice site, leading to a frameshift mutation and a premature stop codon that renders a truncated protein prone to degradation. Heterozygous carriers of the mutation (1 in 120 persons in our study population) had a lower level of non-HDL cholesterol than noncarriers, a difference of 15.3 mg per deciliter (0.40 mmol per liter) (P = 1.0x10(-16)), and a lower risk of coronary artery disease (by 34%; 95% confidence interval, 21 to 45; P = 4.0x10(-6)). In a larger set of sequenced samples from Icelanders, we found another loss-of-function ASGR1 variant (p.W158X, carried by 1 in 1850 persons) that was also associated with lower levels of non-HDL cholesterol (P = 1.8x10(-3)). CONCLUSIONS ASGR1 haploinsufficiency was associated with reduced levels of non-HDL cholesterol and a reduced risk of coronary artery disease. (Funded by the National Institutes of Health and others.)	[Nioi, P.; Sigurdsson, A.; Thorleifsson, G.; Helgason, H.; Agustsdottir, A. B.; Norddahl, G. L.; Helgadottir, A.; Magnusdottir, A.; Jonasdottir, A.; Gretarsdottir, S.; Jonsdottir, I.; Steinthorsdottir, V.; Rafnar, T.; Masson, G.; Holm, H.; Gudbjartsson, D.; Sulem, P.; Thorsteinsdottir, U.; Stefansson, K.] DeCODE Genet Amgen, Sturlugata 8, IS-101 Reykjavik, Iceland; [Helgadottir, A.; Jonsdottir, I.; Thorgeirsson, G.; Thorsteinsdottir, U.; Stefansson, K.] Univ Iceland, Fac Med, Reykjavik, Iceland; [Helgason, H.; Gudbjartsson, D.] Univ Iceland, Sch Engn & Nat Sci, Reykjavik, Iceland; [Eyjolfsson, G. I.] Natl Univ Hosp Iceland, Lab Mjodd, Landspitali, Reykjavik, Iceland; [Olafsson, I.] Natl Univ Hosp Iceland, Dept Clin Biochem, Landspitali, Reykjavik, Iceland; [Thorleifsson, G.; Holm, H.] Natl Univ Hosp Iceland, Dept Internal Med, Div Cardiol, Landspitali, Reykjavik, Iceland; [Sigurdardottir, O.] Akureyri Hosp, Dept Clin Biochem, Akureyri, Iceland; [Swinkels, D. W.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Nijmegen, Netherlands; [Galesloot, T. E.; Kiemeney, L. A.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Nijmegen, Netherlands; [Kiemeney, L. A.] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, Nijmegen, Netherlands; [Grarup, N.; Vestergaard, H.; Hansen, T.; Krarup, N. T.; Pedersen, O.] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Genet, Copenhagen, Denmark; [Jorgensen, T.; Linneberg, A.] Univ Copenhagen, Fac Hlth & Med Sci, Inst Publ Hlth, Copenhagen, Denmark; [Jorgensen, T.; Linneberg, A.] Capital Reg Denmark, Res Ctr Prevent & Hlth, Copenhagen, Denmark; [Jorgensen, T.] Aalborg Univ, Fac Med, Aalborg, Denmark; [Hansen, T.] Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark; [Lauritzen, T.] Univ Aarhus, Dept Publ Hlth, Sect Gen Practice, Aarhus, Denmark; [Linneberg, A.] Rigshosp, Dept Clin Expt Res, Glostrup, Denmark; [Fenger, M.] Univ Hosp Copenhagen Hvidovre, Dept Clin Biochem, Hvidovre, Denmark; [Abildgaard, U.; Hansen, P. R.; Galloe, A. M.] Gentofte Univ Hosp, Dept Cardiol, Hellerup, Denmark; [Galloe, A. M.] Roskilde Hosp, Dept Cardiol, Roskilde, Denmark; [Friedrich, N.] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Braund, P. S.; Nelson, C. P.; Samani, N. J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Braund, P. S.; Nelson, C. P.; Samani, N. J.] Glenfield Hosp, NIHR Leicester Cardiovasc Biomed Res Unit, Leicester, Leics, England; [Hall, A. S.] Univ Leeds, Leeds Inst Genet Hlth & Therapeut, Leeds, W Yorkshire, England; [Patel, R. S.] UCL, Inst Cardiovasc Sci, London, England; [Williams, M. J. A.] Univ Otago, Dept Med, Dunedin Sch Med, Dunedin, New Zealand; [van Rij, A. M.; Jones, G. T.] Univ Otago, Dept Surg, Dunedin Sch Med, Dunedin, New Zealand; [Patel, R. S.; Levey, A. I.; Hayek, S.; Quyyumi, A. A.] Emory Univ, Sch Med, Atlanta, GA USA; [Shah, S. H.; Kraus, W. E.] Duke Univ, Sch Med, Durham, NC USA; [Reilly, M.; Rader, D. J.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Iceland; University of Iceland; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Aalborg University; University of Southern Denmark; Aarhus University; Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Greifswald Medical School; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Leeds; University of London; University College London; University of Otago; University of Otago; Emory University; Duke University; University of Pennsylvania; Pennsylvania Medicine	Thorsteinsdottir, U; Stefansson, K (corresponding author), DeCODE Genet Amgen, Sturlugata 8, IS-101 Reykjavik, Iceland.	unnur.thorsteinsdottir@decode.is; kstefans@decode.is	Grarup, Niels/K-2807-2015; Pedersen, Oluf/AAG-8015-2020; Hall, Alistair/K-1953-2019; Levey, Allan/F-2104-2011; Swinkels, Dorine W./H-8098-2014; Pedersen, Oluf/Z-1731-2019; Stefansson, Kari/AAE-7187-2019; Jørgensen, Torben/Z-1335-2018; Girelli, Domenico/B-1183-2008; Hansen, Peter Riis/AAR-7659-2020; Galesloot, Tessel/P-6667-2015; Kiemeney, Lambertus A./D-3357-2009; Michael, Williams J A/C-1759-2008; Hayek, Salim S./E-6932-2013	Grarup, Niels/0000-0001-5526-1070; Levey, Allan/0000-0002-3153-502X; Swinkels, Dorine W./0000-0002-1040-9446; Pedersen, Oluf/0000-0002-3321-3972; Girelli, Domenico/0000-0001-9684-1899; Galesloot, Tessel/0000-0002-2717-3679; Kiemeney, Lambertus A./0000-0002-2368-1326; Michael, Williams J A/0000-0003-4822-4962; Hayek, Salim S./0000-0003-0180-349X; Jones, Gregory T/0000-0002-6950-4210; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Reilly, Muredach/0000-0002-3035-9386; Krarup, Nikolaj Thure/0000-0001-6526-8663; Hansen, Peter Riis/0000-0002-9056-535X; Jorgensen, Torben/0000-0001-9453-2830; Hall, Alistair/0000-0003-0306-7887; Masson, Gisli/0000-0003-0493-8242; Vestergaard, Henrik/0000-0003-3090-269X; Linneberg, Allan/0000-0002-0994-0184; Nelson, Christopher/0000-0001-8025-2897; Hansen, Torben/0000-0001-8748-3831	National Institutes of Health; MRC [MR/L01629X/1] Funding Source: UKRI; British Heart Foundation [FS/14/76/30933] Funding Source: researchfish; Medical Research Council [MR/L01629X/1] Funding Source: researchfish; National Institute for Health Research [CL-2011-11-003, NF-SI-0611-10170] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by the National Institutes of Health and others.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; BURGER RL, 1975, J BIOL CHEM, V250, P7707; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; Ciechanover A, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.117; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Do R, 2013, NAT GENET, V45, P1345, DOI 10.1038/ng.2795; Doring Y, 2014, CIRC RES, V114, P976, DOI 10.1161/CIRCRESAHA.114.302426; Frommhold D, 2008, J EXP MED, V205, P1435, DOI 10.1084/jem.20070846; Furger E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037421; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gretarsdottir S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005379; Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247; Haddad L, 1999, J LIPID RES, V40, P1113; Helgadottir A, 2016, NAT GENET; Hirayama S, 2008, MOL BIOL CELL, V19, P899, DOI 10.1091/mbc.E07-07-0631; Hoogendoorn EH, 2006, CLIN CHEM, V52, P104, DOI 10.1373/clinchem.2005.055194; Hunt SC, 2000, ARTERIOSCL THROM VAS, V20, P1089, DOI 10.1161/01.ATV.20.4.1089; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Miller JN, 2014, MUTAT RES-REV MUTAT, V762, P52, DOI 10.1016/j.mrrev.2014.05.001; MORELL AG, 1971, J BIOL CHEM, V246, P1461; Rana JS, 2012, CURR ATHEROSCLER REP, V14, P130, DOI 10.1007/s11883-011-0224-x; Sperandio M, 2012, ANN NY ACAD SCI, V1253, P201, DOI 10.1111/j.1749-6632.2011.06271.x; Steinthorsdottir V, 2014, NAT GENET, V46, P294, DOI 10.1038/ng.2882; Steirer LM, 2009, J BIOL CHEM, V284, P3777, DOI 10.1074/jbc.M808689200; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; Tuin A, 2006, AM J PHYSIOL-GASTR L, V290, pG377, DOI 10.1152/ajpgi.00147.2005; van den Donk M, 2011, DIABETIC MED, V28, P1416, DOI 10.1111/j.1464-5491.2011.03365.x; VANDENHA.CJ, 1970, J BIOL CHEM, V245, P4397; Varret M, 1999, AM J HUM GENET, V64, P1378, DOI 10.1086/302370; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; WEIGEL PH, 1994, BIOESSAYS, V16, P519, DOI 10.1002/bies.950160713; Weigel PH, 2002, BBA-GEN SUBJECTS, V1572, P341, DOI 10.1016/S0304-4165(02)00318-5; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Yang A, 2012, J LIPID RES, V53, P2573, DOI 10.1194/jlr.M027300	38	79	85	5	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 2	2016	374	22					2131	2141		10.1056/NEJMoa1508419	http://dx.doi.org/10.1056/NEJMoa1508419			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB2RP	27192541	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000387209900006
J	Wong, J; Motulsky, A; Eguale, T; Buckeridge, DL; Abrahamowicz, M; Tamblyn, R				Wong, Jenna; Motulsky, Aude; Eguale, Tewodros; Buckeridge, David L.; Abrahamowicz, Michal; Tamblyn, Robyn			Treatment Indications for Antidepressants Prescribed in Primary Care in Quebec, Canada, 2006-2015	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Wong, Jenna; Motulsky, Aude; Buckeridge, David L.; Abrahamowicz, Michal; Tamblyn, Robyn] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Eguale, Tewodros] Massachusetts Coll Pharm & Hlth Sci, Sch Pharm, Boston, MA USA	McGill University	Wong, J (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Fac Med, Clin & Hlth Informat Res Grp, 1140 Pine Ave W, Montreal, PQ H3A 1A3, Canada.	jenna.wong@mail.mcgill.ca	Tamblyn, Robyn/L-6010-2016					Bartlett Gillian, 2005, Acta bioeth., V11, P145, DOI 10.4067/S1726-569X2005000200005; CAREY V, 1993, BIOMETRIKA, V80, P517, DOI 10.2307/2337173; Eguale T, 2010, DRUG SAFETY, V33, P559, DOI 10.2165/11534580-000000000-00000; Gardarsdottir H, 2007, J AFFECT DISORDERS, V98, P109, DOI 10.1016/j.jad.2006.07.003; National Center for Health Statistics, HLTH US 2010 SPEC FE; Tamblyn R, 2006, J AM MED INFORM ASSN, V13, P148, DOI 10.1197/jamia.M1887	6	98	100	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 24	2016	315	20					2230	2232		10.1001/jama.2016.3445	http://dx.doi.org/10.1001/jama.2016.3445			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM4US	27218634	Green Published, Bronze			2022-12-28	WOS:000376343000021
J	Henty-Ridilla, JL; Rankova, A; Eskin, JA; Kenny, K; Goode, BL				Henty-Ridilla, Jessica L.; Rankova, Aneliya; Eskin, Julian A.; Kenny, Katelyn; Goode, Bruce L.			Accelerated actin filament polymerization from microtubule plus ends	SCIENCE			English	Article							CAPPING PROTEIN; GROWTH CONE; FORMIN FOR3P; BARBED END; CLIP-170; MECHANISM; DYNAMICS; REORGANIZATION; ORGANIZATION; ELONGATION	Microtubules (MTs) govern actin network remodeling in a wide range of biological processes, yet the mechanisms underlying this cytoskeletal cross-talk have remained obscure. We used single-molecule fluorescence microscopy to show that the MT plus-end-associated protein CLIP-170 binds tightly to formins to accelerate actin filament elongation. Furthermore, we observed mDia1 dimers and CLIP-170 dimers cotracking growing filament ends for several minutes. CLIP-170-mDia1 complexes promoted actin polymerization similar to 18 times faster than free-barbed-end growth while simultaneously enhancing protection from capping proteins. We used a MT-actin dynamics co-reconstitution system to observe CLIP-170-mDia1 complexes being recruited to growing MT ends by EB1. The complexes triggered rapid growth of actin filaments that remained attached to the MT surface. These activities of CLIP-170 were required in primary neurons for normal dendritic morphology. Thus, our results reveal a cellular mechanism whereby growing MT plus ends direct rapid actin assembly.	[Henty-Ridilla, Jessica L.; Rankova, Aneliya; Eskin, Julian A.; Kenny, Katelyn; Goode, Bruce L.] Brandeis Univ, Dept Biol, 415 South St, Waltham, MA 02454 USA	Brandeis University	Goode, BL (corresponding author), Brandeis Univ, Dept Biol, 415 South St, Waltham, MA 02454 USA.	goode@brandeis.edu			NIH [GM083137, T32NS007292]; Brandeis NSF Materials Research Science and Engineering Center [142038]; Leukemia and Lymphoma Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083137, R01GM098143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007292] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brandeis NSF Materials Research Science and Engineering Center; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Paradis for guidance on experiments using neurons, D. Breitsprecher for pioneering the MT-actin co-reconstitution system, J. Gelles for guidance on single-molecule analysis, S. Jansen for guidance with cell culture, H. Higgs for providing INF1 and INF2 proteins, and L. Cassimeris for providing pGFP-EB1. This research was supported by NIH grant GM083137 to B.L.G. and Brandeis NSF Materials Research Science and Engineering Center grant 142038. J.L.H.-R. was supported in part by a fellowship from the Leukemia and Lymphoma Society and in part by NIH training grant T32NS007292. J.L.H.-R. and B.L.G. designed the experiments and wrote the manuscript, J.L.H.-R. performed the experiments and data analysis, J.A.E. performed data analysis, A.R. built reagents and performed preliminary experiments, and K.K. performed overexpression analysis in neurons and assisted in other neuronal work. We declare no conflicts of interest. The supplementary materials contain additional data.	Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Applegate KT, 2011, J STRUCT BIOL, V176, P168, DOI 10.1016/j.jsb.2011.07.009; Bartolini F, 2008, J CELL BIOL, V181, P523, DOI 10.1083/jcb.200709029; Beaven R, 2015, MOL BIOL CELL, V26, P1491, DOI 10.1091/mbc.E14-06-1083; Bombardier JP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9707; Breitsprecher D, 2012, SCIENCE, V336, P1164, DOI 10.1126/science.1218062; Chesarone M, 2009, DEV CELL, V16, P292, DOI 10.1016/j.devcel.2008.12.001; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Chesarone-Cataldo M, 2011, DEV CELL, V21, P217, DOI 10.1016/j.devcel.2011.07.004; Coles CH, 2015, CURR BIOL, V25, pR677, DOI 10.1016/j.cub.2015.06.020; Dixit R, 2009, P NATL ACAD SCI USA, V106, P492, DOI 10.1073/pnas.0807614106; Erck C, 2005, P NATL ACAD SCI USA, V102, P7853, DOI 10.1073/pnas.0409626102; Eskin JA, 2016, MOL BIOL CELL, V27, P828, DOI 10.1091/mbc.E15-09-0639; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Gaillard J, 2011, MOL BIOL CELL, V22, P4575, DOI 10.1091/mbc.E11-07-0616; Gould CJ, 2011, CURR BIOL, V21, P384, DOI 10.1016/j.cub.2011.01.047; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Lewkowicz E, 2008, J CELL BIOL, V183, P1287, DOI 10.1083/jcb.200807023; Martin SG, 2005, DEV CELL, V8, P479, DOI 10.1016/j.devcel.2005.02.008; Martin SG, 2007, MOL BIOL CELL, V18, P4155, DOI 10.1091/mbc.E07-02-0094; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Neukirchen D, 2011, J NEUROSCI, V31, P1528, DOI 10.1523/JNEUROSCI.3983-10.2011; PIERRE P, 1992, CELL, V70, P887, DOI 10.1016/0092-8674(92)90240-D; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Salmon WC, 2002, J CELL BIOL, V158, P31, DOI 10.1083/jcb.200203022; Sampathkumar A, 2011, PLANT CELL, V23, P2302, DOI 10.1105/tpc.111.087940; Shekhar S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9730; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Suter DM, 2000, J NEUROBIOL, V44, P97, DOI 10.1002/1097-4695(200008)44:2<97::AID-NEU2>3.0.CO;2-U; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Swiech L, 2011, J NEUROSCI, V31, P4555, DOI 10.1523/JNEUROSCI.6582-10.2011; Wear MA, 2004, TRENDS BIOCHEM SCI, V29, P418, DOI 10.1016/j.tibs.2004.06.003; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Weng JH, 2013, NAT CHEM BIOL, V9, P636, DOI [10.1038/NCHEMBIO.1321, 10.1038/nchembio.1321]; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057	37	103	104	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2016	352	6288			SI		1004	1009		10.1126/science.aaf1709	http://dx.doi.org/10.1126/science.aaf1709			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM2AK	27199431	Green Accepted			2022-12-28	WOS:000376147800052
J	Schoofs, T; Klein, F; Braunschweig, M; Kreider, EF; Feldmann, A; Nogueira, L; Oliveira, T; Lorenzi, JCC; Parrish, EH; Learn, GH; West, AP; Bjorkman, PJ; Schlesinger, SJ; Seaman, MS; Czartoski, J; McElrath, MJ; Pfeifer, N; Hahn, BH; Caskey, M; Nussenzweig, MC				Schoofs, Till; Klein, Florian; Braunschweig, Malte; Kreider, Edward F.; Feldmann, Anna; Nogueira, Lilian; Oliveira, Thiago; Lorenzi, Julio C. C.; Parrish, Erica H.; Learn, Gerald H.; West, Anthony P., Jr.; Bjorkman, Pamela J.; Schlesinger, Sarah J.; Seaman, Michael S.; Czartoski, Julie; McElrath, M. Juliana; Pfeifer, Nico; Hahn, Beatrice H.; Caskey, Marina; Nussenzweig, Michel C.			HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1	SCIENCE			English	Article							BROADLY NEUTRALIZING ANTIBODIES; GENETIC SEQUENCE DIVERSITY; 2-SAMPLE TESTS; HUMANIZED MICE; CD4 BINDING; VACCINE; MACAQUES; VIREMIA; IMMUNOTHERAPY; POPULATIONS	3BNC117 is a broad and potent neutralizing antibody to HIV-1 that targets the CD4 binding site on the viral envelope spike. When administered passively, this antibody can prevent infection in animal models and suppress viremia in HIV-1-infected individuals. Here we report that HIV-1 immunotherapy with a single injection of 3BNC117 affects host antibody responses in viremic individuals. In comparison to untreated controls that showed little change in their neutralizing activity over a 6-month period, 3BNC117 infusion significantly improved neutralizing responses to heterologous tier 2 viruses in nearly all study participants. We conclude that 3BNC117-mediated immunotherapy enhances host humoral immunity to HIV-1.	[Schoofs, Till; Klein, Florian; Braunschweig, Malte; Nogueira, Lilian; Oliveira, Thiago; Lorenzi, Julio C. C.; Schlesinger, Sarah J.; Caskey, Marina; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Klein, Florian] Univ Cologne, Ctr Mol Med Cologne, Lab Expt Immunol, D-50931 Cologne, Germany; [Klein, Florian] Univ Hosp Cologne, Ctr Integrated Oncol Cologne Bonn, Dept Internal Med, D-50937 Cologne, Germany; [Braunschweig, Malte] Univ Freiburg, Hugstetter Str 55, D-79106 Freiburg, Germany; [Kreider, Edward F.; Parrish, Erica H.; Learn, Gerald H.; Hahn, Beatrice H.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kreider, Edward F.; Parrish, Erica H.; Learn, Gerald H.; Hahn, Beatrice H.] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Feldmann, Anna; Pfeifer, Nico] Max Planck Inst Informat, Dept Computat Biol & Appl Algorithm, Campus E14, D-66123 Saarbrucken, Germany; [West, Anthony P., Jr.; Bjorkman, Pamela J.] CALTECH, Dept Biol, Pasadena, CA 91125 USA; [Seaman, Michael S.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Czartoski, Julie; McElrath, M. Juliana] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; University of Cologne; University of Cologne; University of Freiburg; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Max Planck Society; California Institute of Technology; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute; Rockefeller University	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.; Nussenzweig, MC (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.	nussen@rockefeller.edu	Lorenzi, Julio Cesar C.C. Cetrulo/B-5264-2008; Pfeifer, Nico/G-1559-2016; Kreider, Edward/GSD-5998-2022; Learn, Jerry/E-3356-2012; Oliveira, Thiago Y/ABF-5186-2020; Nussenzweig, Michel/AAE-7292-2019; Lorenzi, Julio/S-2394-2019; Oliveira, Thiago Y/HGA-3848-2022	Lorenzi, Julio Cesar C.C. Cetrulo/0000-0003-2492-3961; Oliveira, Thiago Y/0000-0002-2654-0879; Lorenzi, Julio/0000-0003-2492-3961; Oliveira, Thiago Y/0000-0002-2654-0879; Kreider, Edward/0000-0003-2330-8430; Pfeifer, Nico/0000-0002-4647-8566; Hahn, Beatrice/0000-0002-9400-9887; Caskey, Marina/0000-0003-1727-8693	Bill and Melinda Gates Foundation [OPP1032144, OPP1092074, OPP1124068]; Robertson Foundation; NIH Center for HIV/AIDS Vaccine Immunology and Immunogen [1UM1 AI100663-01, 1UM1 AI00645]; University of Pennsylvania Center for AIDS Research Single Genome Amplification Service Center P30 [AI045008]; NIH [UM1AI068618, UM1AI069481, F30 AI112426, HIVRAD P01 AI100148]; Deutsche Forschungsgemeinschaft [SCHO 1612/1-1]; Heisenberg-Program of the Deutsche Forschungsgemeinschaft [KL 2389/2-1]; European Research Council [ERC-StG639961]; German Center for Infection Research; German National Academic Foundation; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico "Ciencia sem Fronteiras" [248676/2013-0]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI100148, UM1AI100663, Z01AI000645, F30AI112426, UM1AI100645, UM1AI069481, P30AI045008, UM1AI068618] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Robertson Foundation; NIH Center for HIV/AIDS Vaccine Immunology and Immunogen; University of Pennsylvania Center for AIDS Research Single Genome Amplification Service Center P30; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Heisenberg-Program of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); German Center for Infection Research; German National Academic Foundation; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico "Ciencia sem Fronteiras"; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all study participants, who devoted time to our research. We thank the Rockefeller University Hospital Clinical Research Support Office, the nursing staff for patient care and recruitment, the clinical study group of the Infectious Disease Division at the University Hospital Cologne, and all members of the Nussenzweig lab for helpful discussions. We thank M. Schechter and C. Baro for technical assistance, P. Fast and H. Park for clinical monitoring, E. Gotschlich and B. Coller for input on study design, and P. Hraber for helping with LASSIE analyses. The data reported in this study are tabulated in the main paper and in the supplementary materials. Envelope single-genome sequencing data can be downloaded from GenBank (accession numbers KX027737 to KX028736). This work was supported in part by the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery, grants OPP1032144 (M.S.S.) and OPP1092074 and OPP1124068 (M.C.N); the Robertson Foundation to M.C.N.; the NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, grants 1UM1 AI100663-01 (M.C.N) and 1UM1 AI00645 (B.H.H.); the University of Pennsylvania Center for AIDS Research Single Genome Amplification Service Center P30, grant AI045008 (B.H.H.); and NIH grants UM1AI068618 (M.J.M.), UM1AI069481 (M.J.M.), F30 AI112426 (E.F.K), and HIVRAD P01 AI100148 (P.J.B.). T.S. is supported by a Deutsche Forschungsgemeinschaft postdoctoral fellowship (grant SCHO 1612/1-1). F.K. is supported by the Heisenberg-Program of the Deutsche Forschungsgemeinschaft (grant KL 2389/2-1); the European Research Council (grant ERC-StG639961); and the German Center for Infection Research, partner site Bonn-Cologne, Cologne, Germany. M. B. is supported by the German National Academic Foundation. J.C.C.L. is supported by an award from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico "Ciencia sem Fronteiras" (grant 248676/2013-0). M.C.N. is a Howard Hughes Medical Investigator and an inventor on U.S Patent Application no. 14/118,496, filed by Rockefeller University related to 3BNC117.	Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Bhiman JN, 2015, NAT MED, V21, P1332, DOI 10.1038/nm.3963; Bonsignori M, 2012, J VIROL, V86, P4688, DOI 10.1128/JVI.07163-11; Bournazos S, 2015, J EXP MED, V212, P1361, DOI 10.1084/jem.20151267; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; deCamp A, 2014, J VIROL, V88, P2489, DOI 10.1128/JVI.02853-13; Decks SG, 2006, J VIROL, V80, P6155, DOI 10.1128/JVI.00093-06; Deng WJ, 2010, BIOTECHNIQUES, V48, P405, DOI 10.2144/000113370; DiLillo DJ, 2015, CELL, V161, P1035, DOI 10.1016/j.cell.2015.04.016; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Gao F, 2014, CELL, V158, P481, DOI 10.1016/j.cell.2014.06.022; Gilbert PB, 2005, BIOMETRICS, V61, P106, DOI 10.1111/j.0006-341X.2005.020719.x; Giorgi EE, 2012, BIOMETRICS, V68, P1323, DOI 10.1111/j.1541-0420.2012.01775.x; Goo L, 2014, NAT MED, V20, P655, DOI 10.1038/nm.3565; Haigwood NL, 2004, J VIROL, V78, P5983, DOI 10.1128/JVI.78.11.5983-5995.2004; Horwitz JA, 2013, P NATL ACAD SCI USA, V110, P16538, DOI 10.1073/pnas.1315295110; Hraber P, 2015, VIRUSES-BASEL, V7, P5443, DOI 10.3390/v7102881; Hraber P, 2014, AIDS, V28, P163, DOI 10.1097/QAD.0000000000000106; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lu CL, 2016, SCIENCE, V352, P1001, DOI 10.1126/science.aaf1279; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Moore PL, 2015, TRENDS MICROBIOL, V23, P204, DOI 10.1016/j.tim.2014.12.007; Moore PL, 2012, NAT MED, V18, P1688, DOI 10.1038/nm.2985; Ng CT, 2010, NAT MED, V16, P1117, DOI 10.1038/nm.2233; Pietzsch J, 2012, P NATL ACAD SCI USA, V109, P15859, DOI 10.1073/pnas.1213409109; Ratcliffe SJ, 2008, J STAT SOFTW, V25, P1; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Wang TT, 2015, CELL, V162, P160, DOI 10.1016/j.cell.2015.06.026; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	40	208	212	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2016	352	6288			SI		997	1001		10.1126/science.aaf0972	http://dx.doi.org/10.1126/science.aaf0972			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM2AK	27199429	Green Accepted, Bronze			2022-12-28	WOS:000376147800050
J	Gupta, S				Gupta, Sujata			Something in the water	NATURE			English	Editorial Material																		Spiller RC, 2000, GUT, V47, P804, DOI 10.1136/gut.47.6.804; Wensaas KA, 2012, GUT, V61, P214, DOI 10.1136/gutjnl-2011-300220	2	5	5	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					S114	S115		10.1038/533S114a	http://dx.doi.org/10.1038/533S114a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0AH	27191491	Bronze			2022-12-28	WOS:000376004300007
J	Hahn, S; Buratowski, S				Hahn, Steven; Buratowski, Stephen			STRUCTURAL BIOLOGY Snapshots of transcription initiation	NATURE			English	Editorial Material							RNA-POLYMERASE-II; PREINITIATION COMPLEX; MECHANISM		[Hahn, Steven] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Buratowski, Stephen] Harvard Univ, Sch Med, Dept Biochem Chem & Mol Pharmacol, Boston, MA 02115 USA	Fred Hutchinson Cancer Center; Harvard University; Harvard Medical School	Hahn, S (corresponding author), Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA.; Buratowski, S (corresponding author), Harvard Univ, Sch Med, Dept Biochem Chem & Mol Pharmacol, Boston, MA 02115 USA.	shahn@fredhutch.org; steve_buratowski@hms.harvard.edu		Hahn, Steven/0000-0001-7240-2533	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046498] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM046498] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bae B, 2015, ELIFE, V4, DOI 10.7554/eLife.08504; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Cramer P, 2008, ANNU REV BIOPHYS, V37, P337, DOI 10.1146/annurev.biophys.37.032807.130008; Fazal FM, 2015, NATURE, V525, P274, DOI 10.1038/nature14882; Fishburn J, 2015, P NATL ACAD SCI USA, V112, P3961, DOI 10.1073/pnas.1417709112; Grunberg S, 2012, NAT STRUCT MOL BIOL, V19, P788, DOI 10.1038/nsmb.2334; He Y, 2016, NATURE, V533, P359, DOI 10.1038/nature17970; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Louder RK, 2016, NATURE, V531, P604, DOI 10.1038/nature17394; Murakami K, 2015, P NATL ACAD SCI USA, V112, P13543, DOI 10.1073/pnas.1518255112; Plaschka C, 2016, NATURE, V533, P353, DOI 10.1038/nature17990; Poss ZC, 2013, CRIT REV BIOCHEM MOL, V48, P575, DOI 10.3109/10409238.2013.840259; Saecker RM, 2011, J MOL BIOL, V412, P754, DOI 10.1016/j.jmb.2011.01.018; Sainsbury S, 2015, NAT REV MOL CELL BIO, V16, P129, DOI 10.1038/nrm3952; Sainsbury S, 2013, NATURE, V493, P437, DOI 10.1038/nature11715; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023; Werner F, 2011, NAT REV MICROBIOL, V9, P85, DOI 10.1038/nrmicro2507; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786	20	3	3	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					331	332		10.1038/nature18437	http://dx.doi.org/10.1038/nature18437			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0AH	27193677	Green Accepted			2022-12-28	WOS:000376004300036
J	Montenegro, RE				Montenegro, Roberto E.			My Name Is Not "Interpreter"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Montenegro, Roberto E.] Yale Univ, Sch Med, Dept Psychiat, ERIC, New Haven, CT USA	Yale University	Montenegro, RE (corresponding author), Univ Washington, Sch Med, Seattle, WA USA.	roberto.montenegro@yale.edu			CMHS SAMHSA HHS [SM060562-04] Funding Source: Medline	CMHS SAMHSA HHS		MONTENEGRO RE, 2016, AM J PSYCHIAT RESIDE, V11, P2; Nadal KL, 2013, THATS SO GAY MICROAG, P108; PIERCE CM, 1977, EDUC URBAN SOC, V10, P61, DOI 10.1177/001312457701000105; Sue DW, 2007, AM PSYCHOL, V62, P271, DOI 10.1037/0003-066X.62.4.271; Sue DW, 2013, MICROAGGRESSIONS MAR	5	29	29	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 17	2016	315	19					2071	2072		10.1001/jama.2016.1249	http://dx.doi.org/10.1001/jama.2016.1249			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DL9PN	27187296				2022-12-28	WOS:000375975300014
J	Winawer, SJ; Fischer, SE; Levin, B				Winawer, Sidney J.; Fischer, Sara E.; Levin, Bernard			Evidence-Based, Reality-Driven Colorectal Cancer Screening Guidelines The Critical Relationship of Adherence to Effectiveness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FECAL IMMUNOCHEMICAL TEST; UNITED-STATES; TASK-FORCE; 4 ROUNDS		[Winawer, Sidney J.; Fischer, Sara E.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Levin, Bernard] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Memorial Sloan Kettering Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Winawer, SJ (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.	winawers@mskcc.org	Fischer, Sara/ABC-5123-2020	Fischer, Sara/0000-0001-5960-1896				Crotta S, 2012, CLIN GASTROENTEROL H, V10, P633, DOI 10.1016/j.cgh.2012.02.030; Gellad ZF, 2011, AM J GASTROENTEROL, V106, P1125, DOI 10.1038/ajg.2011.11; Jensen CD, 2016, ANN INTERN MED, V164, P456, DOI 10.7326/M15-0983; Klabunde CN, 2013, MMWR-MORBID MORTAL W, V62, P881; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Meester RGS, 2015, CANCER-AM CANCER SOC, V121, P2281, DOI 10.1002/cncr.29336; Winawer SJ, 2015, DIGEST DIS SCI, V60, P596, DOI 10.1007/s10620-014-3466-y; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370	9	10	11	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 17	2016	315	19					2065	2066		10.1001/jama.2016.3377	http://dx.doi.org/10.1001/jama.2016.3377			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL9PN	27187294				2022-12-28	WOS:000375975300011
J	McCartney, M; Treadwell, J; Maskrey, N; Lehman, R				McCartney, Margaret; Treadwell, Julian; Maskrey, Neal; Lehman, Richard			Making evidence based medicine work for individual patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GUIDELINES; CARE		[McCartney, Margaret] Fulton St Med Ctr, Glasgow G13 1NG, Lanark, Scotland; [Treadwell, Julian] Hindon Surg, Salisbury, Wilts, England; [Maskrey, Neal] Keele Univ, Sch Pharm, Keele, Staffs, England; [Lehman, Richard] Cochrane UK, Oxford, England	Keele University; Cochrane Centre	McCartney, M (corresponding author), Fulton St Med Ctr, Glasgow G13 1NG, Lanark, Scotland.	margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Audit Commission, 2011, PAYING GPS; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Coulter A, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-S2-S2; Dumbreck S, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h949; Freeman G, 2010, CONTINUITY OF CARE A; Gawande A, 2014, METROPOLITAN; Goldacre BM, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5081; Greenhalgh T, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0437-x; Greenhalgh T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3725; Harrison S, 2000, Policy Stud Rev, V17, P25, DOI 10.1111/j.1541-1338.2000.tb00955.x; Health Foundation, WHY DO SHAR DEC MAK; Heath I, 1995, MYST GEN PRACT; Hegarty K, 2009, BRIT J GEN PRACT, V59, P322, DOI 10.3399/bjgp09X420581; Huntley A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004746; Irving G, 2013, INT J CARDIOL, V168, P2304, DOI 10.1016/j.ijcard.2013.01.189; National Voices, SUPP SHAR DEC MAK; NHS, 2012, SHAR DEC MAK; NICE, 2014, PAT DEC AID ATR FIBR; NICE, 2014, PAT DEC AID TAK STAT; Snow R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003583; Steel N, 2014, J CLIN EPIDEMIOL, V67, P1251, DOI 10.1016/j.jclinepi.2014.05.020; Towards Optimized Practice, 2015, OPTIMIZED PRACTICE C; Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205	23	47	48	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 16	2016	353								i2452	10.1136/bmj.i2452	http://dx.doi.org/10.1136/bmj.i2452			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GB	27185764	Green Submitted			2022-12-28	WOS:000376447500002
J	Dahl, TW				Dahl, Tais W.			Identifying remnants of early Earth	SCIENCE			English	Editorial Material							TUNGSTEN ISOTOPIC COMPOSITION; ACCRETION; MANTLE; DIFFERENTIATION; PRESERVATION		[Dahl, Tais W.] Univ Copenhagen, Nat Hist Museum Denmark, DK-1350 Copenhagen K, Denmark	University of Copenhagen	Dahl, TW (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, DK-1350 Copenhagen K, Denmark.	tais.dahl@snm.ku.dk	Dahl, Tais/AAS-4634-2020	Dahl, Tais/0000-0003-4629-8036				Burke K, 2011, ANNU REV EARTH PL SC, V39, P1, DOI 10.1146/annurev-earth-040809-152521; Chambers JE, 2004, EARTH PLANET SC LETT, V223, P241, DOI 10.1016/j.epsl.2004.04.031; Dahl TW, 2010, EARTH PLANET SC LETT, V295, P177, DOI 10.1016/j.epsl.2010.03.038; Halliday A, 1996, EARTH PLANET SC LETT, V142, P75, DOI 10.1016/0012-821X(96)00096-9; Lee DC, 1996, SCIENCE, V274, P1876, DOI 10.1126/science.274.5294.1876; Rizo H, 2016, SCIENCE, V352, P809, DOI 10.1126/science.aad8563; Touboul M, 2012, SCIENCE, V335, P1065, DOI 10.1126/science.1216351; Tronnes RG, 2010, MINER PETROL, V99, P243, DOI 10.1007/s00710-009-0068-z; Willbold M, 2015, EARTH PLANET SC LETT, V419, P168, DOI 10.1016/j.epsl.2015.02.040; Willbold M, 2011, NATURE, V477, P195, DOI 10.1038/nature10399	11	0	3	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2016	352	6287					768	769		10.1126/science.aaf2482	http://dx.doi.org/10.1126/science.aaf2482			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5FP	27174971				2022-12-28	WOS:000375663000017
J	Liao, KB; Negretti, S; Musaev, DG; Bacsa, J; Davies, HML				Liao, Kuangbiao; Negretti, Solymar; Musaev, Djamaladdin G.; Bacsa, John; Davies, Huw M. L.			Site-selective and stereoselective functionalization of unactivated C-H bonds	NATURE			English	Article							INSERTION; ACTIVATION; CATALYSTS; ALKANES	The laboratory synthesis of complex organic molecules relies heavily on the introduction and manipulation of functional groups, such as carbon-oxygen or carbon-halogen bonds; carbon-hydrogen bonds are far less reactive and harder to functionalize selectively. The idea of C-H functionalization, in which C-H bonds are modified at will instead of the functional groups, represents a paradigm shift in the standard logic of organic synthesis(1-3). For this approach to be generally useful, effective strategies for site-selective C-H functionalization need to be developed. The most practical solutions to the site-selectivity problem rely on either intramolecular reactions(4) or the use of directing groups within the substrate(5-8). A challenging, but potentially more flexible approach, would be to use catalyst control to determine which site in a particular substrate would be functionalized(9-11). Here we describe the use of dirhodium catalysts to achieve highly site-selective, diastereoselective and enantioselective C-H functionalization of n-alkanes and terminally substituted n-alkyl compounds. The reactions proceed in high yield, and functional groups such as halides, silanes and esters are compatible with this chemistry. These studies demonstrate that high site selectivity is possible in C-H functionalization reactions without the need for a directing or anchoring group present in the molecule.	[Liao, Kuangbiao; Negretti, Solymar; Bacsa, John; Davies, Huw M. L.] Emory Univ, Dept Chem, 1515 Dickey Dr, Atlanta, GA 30322 USA; [Musaev, Djamaladdin G.] Emory Univ, Cherry L Emerson Ctr Sci Computat, 1521 Dickey Dr, Atlanta, GA 30322 USA	Emory University; Emory University	Davies, HML (corresponding author), Emory Univ, Dept Chem, 1515 Dickey Dr, Atlanta, GA 30322 USA.	hmdavie@emory.edu	BACSA, JOHN/L-8501-2016	Liao, Kuangbiao/0000-0001-9089-0569	National Science Foundation (NSF) through the CCI Center for Selective C-H Functionalization [CHE-1205646]; Novartis; AbbVie; NSF MRI-R2 grant [CHE-0958205]; Division Of Chemistry [1205646] Funding Source: National Science Foundation	National Science Foundation (NSF) through the CCI Center for Selective C-H Functionalization(National Science Foundation (NSF)); Novartis(Novartis); AbbVie(AbbVie); NSF MRI-R2 grant(National Science Foundation (NSF)NSF - Office of the Director (OD)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Financial support was provided by the National Science Foundation (NSF) through the CCI Center for Selective C-H Functionalization (CHE-1205646). We thank Novartis and AbbVie for supporting our research in C-H functionalization. We thank D. Guptill for conducting some preliminary studies on this project. D.G.M. gratefully acknowledges an NSF MRI-R2 grant (CHE-0958205) and the use of the resources of the Cherry Emerson Center for Scientific Computation.	Caballero A, 2015, DALTON T, V44, P20295, DOI 10.1039/c5dt03450g; Colby DA, 2010, CHEM REV, V110, P624, DOI 10.1021/cr900005n; Davies HML, 2000, J AM CHEM SOC, V122, P3063, DOI 10.1021/ja994136c; Davies HML, 1996, J AM CHEM SOC, V118, P6897, DOI 10.1021/ja9604931; Davies HML, 2011, CHEM SOC REV, V40, P1857, DOI 10.1039/c0cs00217h; DeAngelis A, 2009, J AM CHEM SOC, V131, P7230, DOI 10.1021/ja9026852; DEMONCEAU A, 1981, J CHEM SOC CHEM COMM, P688, DOI 10.1039/c39810000688; Doyle MP, 2010, CHEM REV, V110, P704, DOI 10.1021/cr900239n; Engle KM, 2012, ACCOUNTS CHEM RES, V45, P788, DOI 10.1021/ar200185g; Guptill DM, 2014, J AM CHEM SOC, V136, P17718, DOI 10.1021/ja5107404; Gutekunst WR, 2011, CHEM SOC REV, V40, P1976, DOI 10.1039/c0cs00182a; Hansen J, 2008, COORDIN CHEM REV, V252, P545, DOI 10.1016/j.ccr.2007.08.019; Hansen J, 2009, J ORG CHEM, V74, P6555, DOI 10.1021/jo9009968; Hartwig JF, 2016, J AM CHEM SOC, V138, P2, DOI 10.1021/jacs.5b08707; Kuhl N, 2012, ANGEW CHEM INT EDIT, V51, P10236, DOI 10.1002/anie.201203269; Lindsay VNG, 2009, J AM CHEM SOC, V131, P16383, DOI 10.1021/ja9044955; Mkhalid IAI, 2010, CHEM REV, V110, P890, DOI 10.1021/cr900206p; Qin CM, 2014, J AM CHEM SOC, V136, P9792, DOI 10.1021/ja504797x; Qin CM, 2011, J AM CHEM SOC, V133, P19198, DOI 10.1021/ja2074104; Thu HY, 2008, ANGEW CHEM INT EDIT, V47, P9747, DOI 10.1002/anie.200803157; Topczewski JJ, 2015, CHEM SCI, V6, P70, DOI 10.1039/c4sc02591a; Yamaguchi J, 2012, ANGEW CHEM INT EDIT, V51, P8960, DOI 10.1002/anie.201201666; Zhang FZ, 2014, CHEM SOC REV, V43, P6906, DOI 10.1039/c4cs00137k	23	224	228	12	273	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					230	234		10.1038/nature17651	http://dx.doi.org/10.1038/nature17651			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0BJ	27172046				2022-12-28	WOS:000376007200046
J	Snyder, A				Snyder, Alison			Holbrook Kohrt Obituary	LANCET			English	Biographical-Item												amsnyder@alum.mit.edu							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 30	2016	387	10030					1810	1810		10.1016/S0140-6736(16)30329-4	http://dx.doi.org/10.1016/S0140-6736(16)30329-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK6SS	27203496	Bronze			2022-12-28	WOS:000375056100015
J	Porter, D; van Melckebeke, J; Dale, J; Messow, CM; McConnachie, A; Walker, A; Munro, R; McLaren, J; McRorie, E; Packham, J; Buckley, CD; Harvie, J; Taylor, P; Choy, E; Pitzalis, C; McInnes, IB				Porter, Duncan; van Melckebeke, Jurgen; Dale, James; Messow, C. Martina; McConnachie, Alexander; Walker, Andrew; Munro, Robin; McLaren, John; McRorie, Euan; Packham, Jon; Buckley, Christopher D.; Harvie, John; Taylor, Peter; Choy, Ernest; Pitzalis, Costantino; McInnes, Iain B.			Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trial	LANCET			English	Article							DOUBLE-BLIND; METHOTREXATE; ETANERCEPT; ADALIMUMAB; EFFICACY; THERAPY; SAFETY; MULTICENTER; COMBINATION; MONOTHERAPY	Background Tumour necrosis factor (TNF) inhibition and B-cell depletion are highly effective treatments for active rheumatoid arthritis, but so far no randomised controlled trials have directly compared their safety, efficacy, and cost-effectiveness. This study was done to test the hypothesis that using rituximab would be clinically non-inferior and cheaper compared with TNF inhibitor treatment in biological-treatment naive patients with rheumatoid arthritis. Methods This open-label, randomised controlled, non-inferiority trial enrolled patients with active, seropositive rheumatoid arthritis and an inadequate response to synthetic disease modifying anti-rheumatic drugs (DMARDs) from 35 rheumatology departments in the UK. Patients were randomly assigned 1: 1 to the rituximab or TNF inhibitor groups with minimisation to account for methotrexate intolerance using a web-based randomisation system. Patients were given intravenous rituximab 1 g on days 1 and 15, and after 26 weeks if they responded to treatment but had persistent disease activity (28 joint count disease activity score [DAS28-ESR] >3.2; rituximab group) or a TNF inhibitor-adalimumab (40 mg subcutaneously every other week) or etanercept (50 mg per week subcutaneously) according to the patient's and rheumatologist's choice (TNF inhibitor group). Patients could switch treatment in the case of drug-related toxic effects or absence or loss of response. The primary outcome measure was the change in DAS28-ESR between 0 and 12 months in the per-protocol population of patients who were assigned to treatment and remained in follow-up to 1 year. We assessed safety in all patients who received at least one dose of study drug. We also assessed the cost-effectiveness of each strategy. The non-inferiority margin was specified as 0.6 DAS28-ESR units. This study is registered with ClinicalTrials.gov, number NCT01021735. Findings Between April 6, 2009, and Nov 11, 2013, 295 patients were randomly assigned and given either rituximab (n=144) or TNF inhibitor (n=151) treatment. After 12 months, the change in DAS28-ESR for patients assigned to rituximab was -2.6 (SD 1.4) and TNF inhibitor was -2.4 (SD 1.5), with a difference within the prespecified noninferiority margin of -0.19 (95% CI -0.51 to 0.13; p=0.24). The health-related costs associated with the rituximab strategy were lower than the TNF inhibitor strategy (9405 pound vs 11 pound 523 per patient, p<0.0001). 137 (95%) of 144 patients in the rituximab group and 143 (95%) of 151 patients in the TNF inhibitor group had adverse events. 37 serious adverse events occurred in patients receiving rituximab compared with 26 in patients receiving TNF inhibitors, of which 27 were deemed to be possibly, probably, or definitely related to the treatment (15 vs 12, p=0.5462). One patient in each group died during the study. Interpretation Initial treatment with rituximab is non-inferior to initial TNF inhibitor treatment in patients seropositive for rheumatoid arthritis and naive to treatment with biologicals, and is cost saving over 12 months.	[Messow, C. Martina; McConnachie, Alexander] Robertson Ctr Biostat, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Porter, Duncan; van Melckebeke, Jurgen; Walker, Andrew; McInnes, Iain B.] Univ Glasgow, Glasgow, Lanark, Scotland; [Dale, James; Munro, Robin] Wishaw Gen Hosp, Wishaw, Scotland; [McLaren, John] Whytemans Brae Hosp, Kirkcaldy, Fife, Scotland; [McRorie, Euan] Western Gen Hosp, Edinburgh, Midlothian, Scotland; [Packham, Jon] Haywood Hosp, Stoke On Trent, Staffs, England; [Buckley, Christopher D.] Univ Birmingham, Birmingham, W Midlands, England; [Harvie, John] Raigmore Hosp, Inverness, Scotland; [Taylor, Peter] Univ Oxford, Oxford, England; [Choy, Ernest] Cardiff Univ, Cardiff, S Glam, Wales; [Pitzalis, Costantino] Queen Mary Univ, London, England	University of Glasgow; University of Glasgow; University of Edinburgh; University of Birmingham; University of Oxford; Cardiff University; University of London; Queen Mary University London	Porter, D (corresponding author), Gartnavel Royal Hosp, Glasgow G12 0YN, Lanark, Scotland.	duncan.porter@glasgow.ac.uk	Buckley, Christopher/AAN-6378-2021	Buckley, Christopher/0000-0001-6924-6402; Pitzalis, Costantino/0000-0003-1326-5051; Gomez-Reino, Juan/0000-0001-5229-6294; Packham, Jon/0000-0001-5531-1680; Porter, Duncan/0000-0001-8481-5204	Arthritis Research UK; Roche; MRC [MR/N005813/1] Funding Source: UKRI; Medical Research Council [MR/N005813/1] Funding Source: researchfish; Versus Arthritis [19791, 18824] Funding Source: researchfish; Chief Scientist Office [ETM/293] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Roche(Roche Holding); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); Chief Scientist Office	Arthritis Research UK, Roche.	Bredemeier M, 2014, ARTHRIT CARE RES, V66, P228, DOI 10.1002/acr.22116; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Buch MH, 2011, ANN RHEUM DIS, V70, P909, DOI 10.1136/ard.2010.144998; Cohen SB, 2006, ARTHRITIS RHEUM-US, V54, P2793, DOI 10.1002/art.22025; De Filippis L, 2006, PANMINERVA MED, V48, P129; Emery P, 2006, ARTHRITIS RHEUM, V54, P1390, DOI 10.1002/art.21778; Emery P, 2008, LANCET, V372, P375, DOI 10.1016/S0140-6736(08)61000-4; Gabay C, 2013, LANCET, V381, P1541, DOI 10.1016/S0140-6736(13)60250-0; Genovese MC, 2002, ARTHRITIS RHEUM, V46, P1443, DOI 10.1002/art.10308; Gomberg-Maitland M, 2003, AM HEART J, V146, P398, DOI 10.1016/S0002-8703(03)00324-7; Isaacs JD, 2013, ANN RHEUM DIS, V72, P329, DOI 10.1136/annrheumdis-2011-201117; Jobanputra P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001395; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P1400, DOI 10.1002/art.20217; Keystone EC, 2012, J RHEUMATOL, V39, P2238, DOI 10.3899/jrheum.120573; Moreland LW, 1999, ANN INTERN MED, V130, P478, DOI 10.7326/0003-4819-130-6-199903160-00004; Scott DL, 2014, BMJ-BRIT MED J, V307, P425; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Weinblatt ME, 2013, ARTHRITIS RHEUM-US, V65, P28, DOI 10.1002/art.37711	19	70	75	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2016	388	10041					239	247		10.1016/S0140-6736(16)00380-9	http://dx.doi.org/10.1016/S0140-6736(16)00380-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR2LN	27197690	Green Submitted, Green Accepted			2022-12-28	WOS:000379736100027
J	Baharoglu, MI; Cordonnier, C; Salman, RAS; de Gans, K; Koopman, MM; Brand, A; Majoie, CB; Beenen, LF; Marquering, HA; Vermeulen, M; Nederkoorn, PJ; de Haan, RJ; Roos, YB				Baharoglu, M. Irem; Cordonnier, Charlotte; Salman, Rustam Al-Shahi; de Gans, Koen; Koopman, Maria M.; Brand, Anneke; Majoie, Charles B.; Beenen, Ludo F.; Marquering, Henk A.; Vermeulen, Marinus; Nederkoorn, Paul J.; de Haan, Rob J.; Roos, Yvo B.		PATCH Investigators	Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial	LANCET			English	Article							INTRACEREBRAL HEMORRHAGE; OXFORDSHIRE; COMMUNITY; GROWTH; AGENTS	Background Platelet transfusion after acute spontaneous primary intracerebral haemorrhage in people taking antiplatelet therapy might reduce death or dependence by reducing the extent of the haemorrhage. We aimed to investigate whether platelet transfusion with standard care, compared with standard care alone, reduced death or dependence after intracerebral haemorrhage associated with antiplatelet therapy use. Methods We did this multicentre, open-label, masked-endpoint, randomised trial at 60 hospitals in the Netherlands, UK, and France. We enrolled adults within 6 h of supratentorial intracerebral haemorrhage symptom onset if they had used antiplatelet therapy for at least 7 days beforehand and had a Glasgow Coma Scale score of at least 8. With use of a secure web-based system that concealed allocation and used biased coin randomisation, study collaborators randomly assigned participants (1: 1; stratified by hospital and type of antiplatelet therapy) to receive either standard care or standard care with platelet transfusion within 90 min of diagnostic brain imaging. Participants and local investigators giving interventions were not masked to treatment allocation, but allocation was concealed from outcome assessors and investigators analysing data. The primary outcome was shift towards death or dependence rated on the modified Rankin Scale (mRS) at 3 months, and analysed by ordinal logistic regression, adjusted for stratification variables and the Intracerebral Haemorrhage Score. The primary analysis was done in the intention-to-treat population and safety analyses were done in the intention-to-treat and as-treated populations. This trial is registered with the Netherlands Trial Register, number NTR1303, and is now closed. Findings Between Feb 4, 2009, and Oct 8, 2015, 41 sites enrolled 190 participants. 97 participants were randomly assigned to platelet transfusion and 93 to standard care. The odds of death or dependence at 3 months were higher in the platelet transfusion group than in the standard care group (adjusted common odds ratio 2.05, 95% CI 1.18-3.56; p = 0.0114). 40 (42%) participants who received platelet transfusion had a serious adverse event during their hospital stay, as did 28 (29%) who received standard care. 23 (24%) participants assigned to platelet transfusion and 16 (17%) assigned to standard care died during hospital stay. Interpretation Platelet transfusion seems inferior to standard care for people taking antiplatelet therapy before intracerebral haemorrhage. Platelet transfusion cannot be recommended for this indication in clinical practice.	[Baharoglu, M. Irem; Vermeulen, Marinus; Nederkoorn, Paul J.; Roos, Yvo B.] Acad Med Ctr, Dept Neurol, NL-1100 DD Amsterdam, Netherlands; [Majoie, Charles B.; Beenen, Ludo F.; Marquering, Henk A.] Acad Med Ctr, Dept Radiol, NL-1100 DD Amsterdam, Netherlands; [Marquering, Henk A.] Acad Med Ctr, Dept Biomed Engn & Phys, NL-1100 DD Amsterdam, Netherlands; [de Haan, Rob J.] Acad Med Ctr, Clin Res Unit, NL-1100 DD Amsterdam, Netherlands; [Cordonnier, Charlotte] Univ Lille, Degenerat & Vasc Cognit Disorders, CHU Lille, Inserm,U1171,Dept Neurol, Lille, France; [Salman, Rustam Al-Shahi] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [de Gans, Koen] Groene Hart Ziekenhuis, Dept Neurol, Gouda, Netherlands; [Koopman, Maria M.; Brand, Anneke] Sanquin Bloodbank, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; University of Edinburgh	Roos, YB (corresponding author), Acad Med Ctr, Dept Neurol, NL-1100 DD Amsterdam, Netherlands.	y.b.roos@amc.uva.nl	Cordonnier, Charlotte/O-3258-2017; Roos, Yvo BWEM/B-9843-2013; Klijn, C.J.M./E-1700-2016; Beenen, Ludo F/AAA-3114-2021	Cordonnier, Charlotte/0000-0002-5697-6892; Klijn, C.J.M./0000-0002-8495-4578; Beenen, Ludo F/0000-0001-9204-1026; Marquering, Henk/0000-0002-1414-6313; Al-Shahi Salman, Rustam/0000-0002-2108-9222; Touze, Emmanuel/0000-0002-7254-2162; El Tawil, Salwa/0000-0002-0473-8091; Timsit, Serge/0000-0003-0346-8576; Mazighi, Mikael/0000-0003-0911-8999; Bejot, Yannick/0000-0001-7848-7072	Netherlands Organisation for Health Research and Development (ZonMw) [170881002]; Sanquin Blood Bank in the Netherlands; French Ministry of Health (PHRC-N) [19-15]; Chest Heart and Stroke Scotland [Res10]; MRC [G108/613]; Academic Medical Centre, University of Amsterdam, in the Netherlands; Inserm, CHU Lille, Lille, in France [U1171]; University of Edinburgh, NHS Lothian Academic and Clinical Central Office for Research and Development (ACCORD) in Scotland;  [G1002605]; MRC [G1002605, G0900428] Funding Source: UKRI; Medical Research Council [G0900428, G1002605, G108/613] Funding Source: researchfish; Chest Heart and Stroke Scotland [Res10/A127] Funding Source: researchfish	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Sanquin Blood Bank in the Netherlands; French Ministry of Health (PHRC-N); Chest Heart and Stroke Scotland; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academic Medical Centre, University of Amsterdam, in the Netherlands; Inserm, CHU Lille, Lille, in France; University of Edinburgh, NHS Lothian Academic and Clinical Central Office for Research and Development (ACCORD) in Scotland; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chest Heart and Stroke Scotland	PATCH was funded by The Netherlands Organisation for Health Research and Development (ZonMw, 170881002) and Sanquin Blood Bank in the Netherlands; French Ministry of Health (PHRC-N, 2011, 19-15; to CC); and a Chest Heart and Stroke Scotland project grant (Reference Res10; to RA-SS)) and MRC clinician scientist (G108/613 to RA-SS) and senior clinical fellowships (G1002605 to RA-SS) in Scotland. PATCH was sponsored by Academic Medical Centre, University of Amsterdam, in the Netherlands; Inserm U1171, CHU Lille, Lille, in France; and The University of Edinburgh, NHS Lothian Academic and Clinical Central Office for Research and Development (ACCORD) in Scotland. PATCH received non-financial support from Strokavenir network and Etablissement Francais du Sang in France; and the UK National Institute for Health Research (NIHR) stroke research network, the Scottish Stroke Research Network, and the Scottish National Blood Transfusion Service clinical governance and safety committee in the UK. CC is a member of the Institut Universitaire de France. We are very grateful for the tireless dedication of the PATCH trial managers and research staff : Nadine Fleitour (Netherlands); Fanny Ben Oune, Thavarak Ouk, and Dominique Deplanque (France); and Bridget Colam, Robin Flaig, Katrina McCormick, Neshika Samarasekera, Aidan Hutchison, and Christine Lerpiniere (Scotland). We are grateful to all principal investigators and delegated physicians who included participants in all participating centres. We are indebted to the participants and their carers and families who consented to participate in PATCH.	BAMFORD J, 1990, J NEUROL NEUROSUR PS, V53, P16, DOI 10.1136/jnnp.53.1.16; Batchelor JS, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000588; Bath PMW, 2012, STROKE, V43, P1171, DOI 10.1161/STROKEAHA.111.641456; Beshay JE, 2010, J NEUROSURG, V112, P307, DOI 10.3171/2009.7.JNS0982; Boers AM, 2014, AM J NEURORADIOL, V35, P2279, DOI 10.3174/ajnr.A4042; Charlton A, 2014, TRANSFUSION MED, V24, P213, DOI 10.1111/tme.12126; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Creutzfeldt CJ, 2009, J STROKE CEREBROVASC, V18, P221, DOI 10.1016/j.jstrokecerebrovasdis.2008.10.007; Davis SM, 2006, NEUROLOGY, V66, P1175, DOI 10.1212/01.wnl.0000208408.98482.99; de Gans K, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-19; Ducruet AF, 2010, NEUROL RES, V32, P706, DOI 10.1179/174313209X459129; Feigin VL, 2015, NEUROEPIDEMIOLOGY, V45, P161, DOI 10.1159/000441085; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Fonville AF, 2013, STROKE, V44, P2729, DOI 10.1161/STROKEAHA.113.001493; Goel R, 2015, BLOOD, V125, P1470, DOI 10.1182/blood-2014-10-605493; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Kaufman RM, 2015, ANN INTERN MED, V162, P205, DOI 10.7326/M14-1589; Kelsey P, 2003, BRIT J HAEMATOL, V122, P10; Kumar A, 2015, TRANSFUSION, V55, P1116, DOI 10.1111/trf.12943; Leong LB, 2015, J EMERG MED, V49, P561, DOI 10.1016/j.jemermed.2015.02.023; Lovelock CE, 2007, LANCET NEUROL, V6, P487, DOI 10.1016/S1474-4422(07)70107-2; Mendelow AD, 2013, LANCET, V382, P397, DOI 10.1016/S0140-6736(13)60986-1; Naidech AM, 2012, NEUROCRIT CARE, V16, P82, DOI 10.1007/s12028-011-9619-3; Naidech AM, 2009, STROKE, V40, P2398, DOI 10.1161/STROKEAHA.109.550939; Salman RAS, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2586; Steiner T, 2006, CEREBROVASC DIS, V22, P294, DOI 10.1159/000094831; Stolla M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00028; Suzuki Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097328; Thompson BB, 2010, NEUROLOGY, V75, P1333, DOI 10.1212/WNL.0b013e3181f735e5; Vilahur G, 2007, J THROMB HAEMOST, V5, P82, DOI 10.1111/j.1538-7836.2006.02245.x	30	371	386	1	47	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 25	2016	387	10038					2605	2613		10.1016/S0140-6736(16)30392-0	http://dx.doi.org/10.1016/S0140-6736(16)30392-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP3JX	27178479	Green Accepted			2022-12-28	WOS:000378390500028
J	Khanna, D; Denton, CP; Jahreis, A; van Laar, JM; Frech, TM; Anderson, ME; Baron, M; Chung, L; Fierlbeck, G; Lakshminarayanan, S; Allanore, Y; Pope, JE; Riemekasten, G; Steen, V; Muller-Ladner, U; Lafyatis, R; Stifano, G; Spotswood, H; Chen-Harris, H; Dziadek, S; Morimoto, A; Sornasse, T; Siegel, J; Furst, DE				Khanna, Dinesh; Denton, Christopher P.; Jahreis, Angelika; van Laar, Jacob M.; Frech, Tracy M.; Anderson, Marina E.; Baron, Murray; Chung, Lorinda; Fierlbeck, Gerhard; Lakshminarayanan, Santhanam; Allanore, Yannick; Pope, Janet E.; Riemekasten, Gabriela; Steen, Virginia; Mueller-Ladner, Ulf; Lafyatis, Robert; Stifano, Giuseppina; Spotswood, Helen; Chen-Harris, Haiyin; Dziadek, Sebastian; Morimoto, Alyssa; Sornasse, Thierry; Siegel, Jeffrey; Furst, Daniel E.			Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial	LANCET			English	Article							INTERSTITIAL LUNG-DISEASE; LYSOPHOSPHATIDIC ACID; DIFFUSE SCLERODERMA; SKIN FIBROSIS; SSC SKIN; INTERLEUKIN-6; EXPRESSION; MORTALITY; SURVIVAL; PLACEBO	Background Systemic sclerosis is a rare disabling autoimmune disease with few treatment options. The efficacy and safety of tocilizumab, an interleukin 6 receptor-a inhibitor, was assessed in the faSScinate phase 2 trial in patients with systemic sclerosis. Methods We did this double-blind, placebo-controlled study at 35 hospitals in Canada, France, Germany, the UK, and the USA. We enrolled adults with progressive systemic sclerosis of 5 or fewer years' duration from first non-Raynaud's sign or symptom. Patients were randomly assigned (1: 1) to weekly subcutaneous tocilizumab 162 mg or placebo. The primary endpoint was the difference in mean change from baseline in modified Rodnan skin score at 24 weeks. This study is registered with ClinicalTrials.gov, number NCT01532869. Findings We enrolled 87 patients: 43 assigned to tocilizumab and 44 assigned to placebo. The least squares mean change in modified Rodnan skin score at 24 weeks was -3.92 in the tocilizumab group and -1.22 in the placebo group (difference -2.70, 95% CI -5.85 to 0.45; p = 0.0915). The least squares mean change at 48 weeks was -6.33 in the tocilizumab group and -2.77 in the placebo group (treatment difference -3.55, 95% CI -7.23 to 0.12; p = 0.0579). In one of several exploratory analyses, fewer patients in the tocilizumab group than in the placebo group had a decline in percent predicted forced vital capacity at 48 weeks (p = 0.0373). However, we detected no significant difference in disability, fatigue, itching, or patient or clinician global disease severity. 42 (98%) of 43 patients in the tocilizumab group versus 40 (91%) of 44 in the placebo group had adverse events. 14 (33%) versus 15 (34%) had serious adverse events. Serious infections were more common in the tocilizumab group (seven [16%] of 43 patients) than in the placebo group (two [5%] of 44). One patient died in relation to tocilizumab treatment. Interpretation Tocilizumab was not associated with a significant reduction in skin thickening. However, the difference was greater in the tocilizumab group than in the placebo group and we found some evidence of less decline in forced vital capacity. The efficacy and safety of tocilizumab should be investigated in a phase 3 trial before definitive conclusions can be made about its risks and benefits.	[Khanna, Dinesh] Univ Michigan, Scleroderma Program, Ann Arbor, MI 48109 USA; [Denton, Christopher P.] UCL, London, England; [Jahreis, Angelika; Chen-Harris, Haiyin; Morimoto, Alyssa; Sornasse, Thierry; Siegel, Jeffrey] Genentech Inc, San Francisco, CA 94080 USA; [van Laar, Jacob M.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Frech, Tracy M.] Univ Utah, Vet Affairs Med Ctr, Salt Lake City, UT USA; [Anderson, Marina E.] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Anderson, Marina E.] Aintree Univ Hosp NHS Fdn Trust, Liverpool L9 7AL, Merseyside, England; [Baron, Murray] McGill Univ, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada; [Chung, Lorinda] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; [Chung, Lorinda] Palo Alto VA Hlth Care Syst, Palo Alto, CA USA; [Fierlbeck, Gerhard] Univ Tubingen, Tubingen, Germany; [Lakshminarayanan, Santhanam] Univ Connecticut, Ctr Hlth, Farmington, CT USA; [Allanore, Yannick] Paris Descartes Univ, Paris, France; [Allanore, Yannick] Cochin Hosp, Paris, France; [Pope, Janet E.] Univ Western Ontario, Schulich Sch Med & Dent, London, ON, Canada; [Riemekasten, Gabriela] Charite, German Rheumatism Res Ctr, Berlin, Germany; [Steen, Virginia] Georgetown Univ, Washington, DC USA; [Mueller-Ladner, Ulf] Univ Giessen, Kerckhoff Clin, Bad Nauheim, Germany; [Lafyatis, Robert; Stifano, Giuseppina] Boston Univ, Sch Med, Boston, MA 02118 USA; [Spotswood, Helen] Roche Prod, Welwyn Garden City, Herts, England; [Dziadek, Sebastian] Roche, Basel, Switzerland; [Furst, Daniel E.] Univ Calif Los Angeles, Los Angeles, CA USA	University of Michigan System; University of Michigan; University of London; University College London; Roche Holding; Genentech; Utrecht University; Utrecht University Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Utah System of Higher Education; University of Utah; University of Liverpool; Aintree University Hospitals NHS Foundation Trust; McGill University; Stanford University; Eberhard Karls University of Tubingen; University of Connecticut; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Western University (University of Western Ontario); Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Georgetown University; Justus Liebig University Giessen; Kerckhoff Clinic; Boston University; Roche Holding; Roche Holding; University of California System; University of California Los Angeles	Khanna, D (corresponding author), Univ Michigan, Dept Internal Med, Div Rheumatol, Scleroderma Program, Ann Arbor, MI 48109 USA.	khannad@med.umich.edu	Riemekasten, Gabriela/B-5019-2017; Sornasse, Thierry/AAO-5793-2021; Baron, Murray/AAF-9486-2019; Pope, Janet/G-3342-2011	Pope, Janet/0000-0003-1479-5302; Chung, Lorinda/0000-0003-0072-6939	Bristol-Myers Squibb; Genentech/Roche; National Institute of Allergy and Infectious Diseases; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Patient-Centered Outcomes Research Institute; Scleroderma Foundation; Actelion; Bayer; Cytori; EMD Serono (Merck); Genkyotex; Gilead; GlaxoSmithKline; Sanofi-Aventis; Seattle Genetics; CSL Behring; Roche; Merck-Serono; Roche/Genentech; Inventiva; Pfizer; Sanofi; Servier; Medac; UCB; Biogen; Celgene; Genentech; Chugai; Shire; Regeneron; Human Genome Sciences; Precision Dermatology; Inception; Stromedix; Boston University; PRISM; Lycera; Novartis; Amira; Celdara; Celltex; Dart Therapeutics; Idera; Intermune; Medimmune; Promedior; Zwitter; EMD Serono; Akros; Extera; Reneo; Scholar Rock; Merck; National Institutes of Health	Bristol-Myers Squibb(Bristol-Myers Squibb); Genentech/Roche(Roche HoldingGenentech); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Patient-Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI); Scleroderma Foundation; Actelion; Bayer(Bayer AG); Cytori; EMD Serono (Merck); Genkyotex; Gilead(Gilead Sciences); GlaxoSmithKline(GlaxoSmithKline); Sanofi-Aventis(Sanofi-Aventis); Seattle Genetics; CSL Behring; Roche(Roche Holding); Merck-Serono(Merck & Company); Roche/Genentech(Roche HoldingGenentech); Inventiva; Pfizer(Pfizer); Sanofi; Servier(Servier); Medac; UCB(UCB Pharma SA); Biogen(Biogen); Celgene(Bristol-Myers SquibbCelgene Corporation); Genentech(Roche HoldingGenentech); Chugai; Shire; Regeneron(Regeneron); Human Genome Sciences(GlaxoSmithKline); Precision Dermatology; Inception; Stromedix; Boston University; PRISM; Lycera; Novartis(Novartis); Amira; Celdara; Celltex; Dart Therapeutics; Idera; Intermune; Medimmune(AstraZenecaMedimmune); Promedior; Zwitter; EMD Serono; Akros; Extera; Reneo; Scholar Rock; Merck(Merck & Company); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	DK has received grants from Bristol-Myers Squibb, Genentech/Roche, National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Patient-Centered Outcomes Research Institute, and the Scleroderma Foundation; and consultancy fees from Actelion, Bayer, Cytori, EMD Serono (Merck), Genkyotex, Gilead, GlaxoSmithKline, Genentech/Roche, Sanofi-Aventis, and Seattle Genetics. CPD has received grants from CSL Behring and GlaxoSmithKline (paid to his institution); consultancy fees from GlaxoSmithKline and Roche (paid to his institution); consultancy fees from Merck-Serono; and speaker fees from Actelion and Bayer. AJ is an employee of and owns stock options in Genentech and has been issued a patent for subcutaneously administered tocilizumab (US 8580264 B2). JMvL has received honoraria from Merck Sharp & Dohme, Pfizer, Roche, and Eli Lilly. MEA has received advisory board and related fees from Actelion and honoraria from Actelion and Bristol-Myers Squibb and has served as principal investigator of clinical trials for Actelion and Roche. LC has served on an advisory board for Gilead and a data monitoring committee for Cytori. YA has received grants from Bristol-Myers Squibb, Roche/Genentech, Inventiva, Pfizer, Sanofi, and Servier; and personal fees from Actelion, Bayer, Roche/Genentech, Inventiva, Medac, Pfizer, Sanofi, Servier, and UCB. JEP has received research and consulting fees from Roche and consulting fees from Actelion, Bayer, Biogen, Celgene, and Genentech. GR has received honoraria for lectures and advisory boards from Actelion, Bayer, GlaxoSmithKline, Pfizer, and Roche. VS has received a grant and advisory board fees from Roche. UM-L has received grants and speaker or advisory board fees from Roche and Chugai. RL has received grants from Shire, Sanofi, Regeneron, Genentech, UCB, Human Genome Sciences, Precision Dermatology, Biogen, Bristol-Myers Squibb, Inception, Stromedix, Pfizer, Boston University, Bristol-Myers Squibb, and PRISM; and consultancy fees from Shire, Sanofi, Regeneron, Roche/Genentech, Biogen, Lycera, Novartis, Celgene, Bristol-Myers Squibb, Amira, Celdara, Celltex, Dart Therapeutics, Idera, Inception, Intermune, Medimmune, Precision Dermatology, Promedior, Zwitter, PRISM, UCB, Actelion, EMD Serono, Akros, Extera, Reneo, Scholar Rock, and Merck. HS is an employee of Roche Products and owns stock in Roche. HC-H is an employee of Genentech. SD is an employee of Roche Diagnostics/F Hoffmann-La Roche. AM and JS are employees of Genentech. TS is an employee of Genentech, and holds stocks, stock options, or bond holdings in Genentech. DEF has received grants from AbbVie, Actelion, Amgen, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, National Institutes of Health, Novartis, Pfizer, Roche/Genentech, UCB; consultancy fees from AbbVie, Actelion, Amgen, Bristol-Myers Squibb, Cytori, Janssen, Gilead, GlaxoSmith Kline, National Institutes of Health, Novartis, Pfizer, and Roche/Genentech, UCB; and speaker fees from AbbVie, Actelion, and UCB. The remaining authors declare no competing interests.	[Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Castelino FV, 2014, ANN RHEUM DIS, V73, P153, DOI 10.1136/annrheumdis-2014-eular.2979; Christmann RB, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3167; Clements PJ, 2000, ARTHRITIS RHEUM-US, V43, P2445, DOI 10.1002/1529-0131(200011)43:11<2445::AID-ANR11>3.0.CO;2-Q; De Lauretis A, 2013, J RHEUMATOL, V40, P435, DOI 10.3899/jrheum.120725; Desallais L, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4672; Elhai M, 2013, ANN RHEUM DIS, V72, P1217, DOI 10.1136/annrheumdis-2012-202657; Hesselstrand R, 2012, RHEUMATOLOGY, V51, P915, DOI 10.1093/rheumatology/ker442; Higashi-Kuwata N, 2009, EXP DERMATOL, V18, P727, DOI 10.1111/j.1600-0625.2008.00828.x; Kadono T, 1998, J RHEUMATOL, V25, P296, DOI 10.1016/S0923-1811(98)84143-1; Khan K, 2012, ANN RHEUM DIS, V71, P1235, DOI 10.1136/annrheumdis-2011-200955; Khanna D, 2006, ANN RHEUM DIS, V65, P1325, DOI 10.1136/ard.2005.050187; Khanna D, 2009, ARTHRITIS RHEUM-US, V60, P1102, DOI 10.1002/art.24380; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Kitaba S, 2012, AM J PATHOL, V180, P165, DOI 10.1016/j.ajpath.2011.09.013; Kowal-Bielecka O, 2009, ANN RHEUM DIS, V68, P620, DOI 10.1136/ard.2008.096677; Liu XC, 2013, ARTHRIT CARE RES, V65, P1375, DOI 10.1002/acr.21968; Mathes AL, 2014, ANN RHEUM DIS, V73, P1864, DOI 10.1136/annrheumdis-2012-202814; Maurer B, 2015, ANN RHEUM DIS, V74, P1124, DOI 10.1136/annrheumdis-2014-205226; Nagaraja V, 2015, RHEUMATOLOGY, V54, P1944, DOI 10.1093/rheumatology/keu285; Nikpour M, 2010, BEST PRACT RES CL RH, V24, P857, DOI 10.1016/j.berh.2010.10.007; O'Reilly S, 2013, CLIN TRANSL IMMUNOL, V2, DOI 10.1038/cti.2013.2; Okudaira S, 2010, BIOCHIMIE, V92, P698, DOI 10.1016/j.biochi.2010.04.015; Pattanaik D, 2010, DISCOV MED, V10, P161; Pope JE, 2001, ARTHRITIS RHEUM-US, V44, P1351, DOI 10.1002/1529-0131(200106)44:6<1351::AID-ART227>3.0.CO;2-I; Prasse A, 2007, ARTHRITIS RHEUM-US, V56, P1685, DOI 10.1002/art.22559; Rice LM, 2015, ARTHRITIS RHEUMATOL, V67, P3004, DOI 10.1002/art.39287; Rice LM, 2015, J CLIN INVEST, V125, P2795, DOI 10.1172/JCI77958; Rubio-Rivas M, 2014, SEMIN ARTHRITIS RHEU, V44, P208, DOI 10.1016/j.semarthrit.2014.05.010; Shima Y, 2010, RHEUMATOLOGY, V49, P2408, DOI 10.1093/rheumatology/keq275; Steen VD, 2000, ARTHRITIS RHEUM-US, V43, P2437, DOI 10.1002/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U; Steen VD, 2001, ARTHRITIS RHEUM, V44, P2828, DOI 10.1002/1529-0131(200112)44:12<2828::AID-ART470>3.0.CO;2-U; Stifano G, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4598; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tashkin DP, 2006, NEW ENGL J MED, V354, P2655, DOI 10.1056/NEJMoa055120; Tiev KP, 2011, EUR RESPIR J, V38, P1355, DOI 10.1183/09031936.00004711; Tokumura A, 2009, INT J MED SCI, V6, P168; van Laar JM, 2014, JAMA-J AM MED ASSOC, V311, P2490, DOI 10.1001/jama.2014.6368; van Lieshout AWT, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-23; Yamaguchi Y, 2013, BRIT J DERMATOL, V168, P717, DOI 10.1111/bjd.12117	40	380	400	1	24	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 25	2016	387	10038					2630	2640		10.1016/S0140-6736(16)00232-4	http://dx.doi.org/10.1016/S0140-6736(16)00232-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP3JX	27156934	Green Submitted			2022-12-28	WOS:000378390500031
J	Mikuni, T; Nishiyama, J; Sun, Y; Kamasawa, N; Yasuda, R				Mikuni, Takayasu; Nishiyama, Jun; Sun, Ye; Kamasawa, Naomi; Yasuda, Ryohei			High-Throughput, High-Resolution Mapping of Protein Localization in Mammalian Brain by In Vivo Genome Editing	CELL			English	Article							LONG-TERM POTENTIATION; ONE-STEP GENERATION; UTERO ELECTROPORATION; DENDRITIC SPINES; MOUSE-BRAIN; SYNAPTIC PLASTICITY; CALCIUM-CHANNEL; GENE-TRANSFER; HUMAN-CELLS; CRISPR-CAS9	A scalable and high-throughput method to identify precise subcellular localization of endogenous proteins is essential for integrative understanding of a cell at the molecular level. Here, we developed a simple and generalizable technique to image endogenous proteins with high specificity, resolution, and contrast in single cells in mammalian brain tissue. The technique, single-cell labeling of endogenous proteins by clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9-mediated homology-directed repair (SLENDR), uses in vivo genome editing to insert a sequence encoding an epitope tag or a fluorescent protein to a gene of interest by CRISPR-Cas9-mediated homology-directed repair (HDR). Single-cell, HDR-mediated genome editing was achieved by delivering the editing machinery to dividing neuronal progenitors through in utero electroporation. We demonstrate that SLENDR allows rapid determination of the localization and dynamics of many endogenous proteins in various cell types, regions, and ages in the brain. Thus, SLENDR provides a high-throughput platform to map the subcellular localization of endogenous proteins with the resolution of micro-to nanometers in the brain.	[Mikuni, Takayasu; Nishiyama, Jun; Sun, Ye; Yasuda, Ryohei] Max Planck Florida Inst Neurosci, Neuronal Signal Transduct Grp, Jupiter, FL 33458 USA; [Sun, Ye] Florida Atlantic Univ, Integrat Program Biol & Neurosci, Jupiter, FL 33458 USA; [Kamasawa, Naomi] Max Planck Florida Inst Neurosci, Electron Microscopy Core Facil, Jupiter, FL 33458 USA	Max Planck Society; State University System of Florida; Florida Atlantic University; Max Planck Society	Nishiyama, J; Yasuda, R (corresponding author), Max Planck Florida Inst Neurosci, Neuronal Signal Transduct Grp, Jupiter, FL 33458 USA.	jun.nishiyama@mpfi.org; ryohei.yasuda@mpfi.org	Sun, Ye/AAN-4214-2021	Sun, Ye/0000-0002-3464-4600; Nishiyama, Jun/0000-0002-3627-8114; Yasuda, Ryohei/0000-0001-6263-9297; Mikuni, Takayasu/0000-0002-9769-9369	NIH [R01MH080047, DP1NS096787]; Human Frontier Science Program; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [DP1NS096787] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Sanger Institute for the gift of the piggyBac transposon vector plasmids (pPB-CAG. EBNXN and pCMV-hyPBase) and Y. Hayashi for CaMKII alpha and CaMKII beta cDNA; L. Colgan, M. Yuzaki, S. Soderling, and M. Kano for critical reading of the manuscript; the R.Y. lab members for discussion; J. Richards, K. Liu, and J. Chen for technical assistance; and D. Kloetzer for laboratory management. This work was supported by the NIH (R01MH080047 and DP1NS096787 to R.Y.) and the Human Frontier Science Program (long-term fellowship to T.M.).	Borrell V, 2005, J NEUROSCI METH, V143, P151, DOI 10.1016/j.jneumeth.2004.09.027; Bosch M, 2014, NEURON, V82, P444, DOI 10.1016/j.neuron.2014.03.021; Chen FY, 2012, J NEUROSCI METH, V207, P172, DOI 10.1016/j.jneumeth.2012.03.016; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Contractor A, 2015, NEURON, V87, P699, DOI 10.1016/j.neuron.2015.06.017; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fortin DA, 2014, J NEUROSCI, V34, P16698, DOI 10.1523/JNEUROSCI.3888-14.2014; Fukaya M, 2000, J COMP NEUROL, V426, P572; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Gross GG, 2013, NEURON, V78, P971, DOI 10.1016/j.neuron.2013.04.017; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Heidenreich M, 2016, NAT REV NEUROSCI, V17, P36, DOI 10.1038/nrn.2015.2; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Imamura F, 2015, EUR J NEUROSCI, V41, P147, DOI 10.1111/ejn.12784; Incontro S, 2014, NEURON, V83, P1051, DOI 10.1016/j.neuron.2014.07.043; Kasthuri N, 2015, CELL, V162, P648, DOI 10.1016/j.cell.2015.06.054; Kim K, 2015, NEURON, V87, P813, DOI 10.1016/j.neuron.2015.07.023; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Korb E, 2013, NAT NEUROSCI, V16, P874, DOI 10.1038/nn.3429; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Nishiyama J, 2015, NEURON, V87, P63, DOI 10.1016/j.neuron.2015.05.043; Nishiyama J, 2012, EUR J NEUROSCI, V36, P2867, DOI 10.1111/j.1460-9568.2012.08203.x; Parajuli LK, 2012, J NEUROSCI, V32, P13555, DOI 10.1523/JNEUROSCI.1142-12.2012; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Saleh-Gohari N, 2004, NUCLEIC ACIDS RES, V32, P3683, DOI 10.1093/nar/gkh703; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schalek R., 2011, MICROSC MICROANAL, V17, P966, DOI [10.1017/S1431927611005708, DOI 10.1017/S1431927611005708]; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Soma M, 2009, J COMP NEUROL, V513, P113, DOI 10.1002/cne.21945; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Straub C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105584; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Toyo-oka K, 2014, J NEUROSCI, V34, P12168, DOI 10.1523/JNEUROSCI.2513-13.2014; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Viswanathan S, 2015, NAT METHODS, V12, P568, DOI 10.1038/nmeth.3365; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; YAMAMOTO N, 1989, SCIENCE, V245, P192, DOI 10.1126/science.2749258; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yang JM, 2009, NAT NEUROSCI, V12, P113, DOI 10.1038/nn.2244; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	58	121	125	0	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1803	1817		10.1016/j.cell.2016.04.044	http://dx.doi.org/10.1016/j.cell.2016.04.044			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27180908	Green Accepted, Bronze			2022-12-28	WOS:000378062000028
J	Kor, DJ; Carter, RE; Park, PK; Festic, E; Banner-Goodspeed, VM; Hinds, R; Talmor, D; Gajic, O; Ware, LB; Gong, MN				Kor, Daryl J.; Carter, Rickey E.; Park, Pauline K.; Festic, Emir; Banner-Goodspeed, Valerie M.; Hinds, Richard; Talmor, Daniel; Gajic, Ognjen; Ware, Lorraine B.; Gong, Michelle Ng		US Critical Illness Injury Trials	Effect of Aspirin on Development of ARDS in At-Risk Patients Presenting to the Emergency Department The LIPS-A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; INTENSIVE-CARE-UNIT; 15-EPI-LIPOXIN A(4); THERAPY; MORTALITY; PREVENTION; RESOLUTION; PLATELETS	IMPORTANCE Management of acute respiratory distress syndrome (ARDS) remains largely supportive. Whether early intervention can prevent development of ARDS remains unclear. OBJECTIVE To evaluate the efficacy and safety of early aspirin administration for the prevention of ARDS. DESIGN, SETTING, AND PARTICIPANTS A multicenter, double-blind, placebo-controlled, randomized clinical trial conducted at 16 US academic hospitals. Between January 2, 2012, and November 17, 2014, 7673 patients at risk for ARDS (Lung Injury Prediction Score >= 4) in the emergency department were screened and 400 were randomized. Ten patients were excluded, leaving 390 in the final modified intention-to-treat analysis cohort. INTERVENTIONS Administration of aspirin, 325-mg loading dose followed by 81 mg/d (n = 195) or placebo (n = 195) within 24 hours of emergency department presentation and continued to hospital day 7, discharge, or death. MAIN OUTCOMES AND MEASURES The primary outcome was the development of ARDS by study day 7. Secondary measures included ventilator-free days, hospital and intensive care unit length of stay, 28-day and 1-year survival, and change in serum biomarkers associated with ARDS. A final a level of.0737 (a = .10 overall) was required for statistical significance of the primary outcome. RESULTS Among 390 analyzed patients (median age, 57 years; 187 [48%] women), median (IQR) hospital length of stay was 6 (3-10) days. Administration of aspirin, compared with placebo, did not significantly reduce the incidence of ARDS at 7 days (OR, 1.24; 92.6% CI, 0.67-2.31). No significant differences were seen in secondary outcomes or adverse events. [GRAPHICS] CONCLUSIONS AND RELEVANCE Among at-risk patients presenting to the ED, the use of aspirin compared with placebo did not reduce the risk of ARDS at 7 days. The findings of this phase 2b trial do not support continuation to a larger phase 3 trial.	[Kor, Daryl J.; Hinds, Richard] Mayo Clin, Coll Med, Dept Anesthesiol, Rochester, MN 55905 USA; [Carter, Rickey E.] Mayo Clin, Coll Med, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Park, Pauline K.] Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI USA; [Festic, Emir] Mayo Clin, Coll Med, Dept Med, Jacksonville, FL 32224 USA; [Banner-Goodspeed, Valerie M.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Talmor, Daniel] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Anaesthesia, Sch Med, Boston, MA 02215 USA; [Gajic, Ognjen] Mayo Clin, Coll Med, Dept Med, Rochester, MN 55905 USA; [Ware, Lorraine B.] Vanderbilt Univ, Sch Med, Dept Pathol & Med, Nashville, TN 37212 USA; [Ware, Lorraine B.] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37212 USA; [Gong, Michelle Ng] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA	Mayo Clinic; Mayo Clinic; University of Michigan System; University of Michigan; Mayo Clinic; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Mayo Clinic; Vanderbilt University; Vanderbilt University; Yeshiva University; Albert Einstein College of Medicine	Kor, DJ (corresponding author), Mayo Clin, Coll Med, 200 First St SW, Rochester, MN 55905 USA.	kor.daryl@mayo.edu	Akca, Ozan/I-8856-2019; Frendl, Gyorgy/AAE-5345-2020; Ware, Lorraine/AAJ-9307-2021; Bansal, Vikas/I-9938-2014	Akca, Ozan/0000-0002-7275-1060; Frendl, Gyorgy/0000-0001-8918-8553; Ware, Lorraine/0000-0002-9429-4702; Bansal, Vikas/0000-0001-6047-5559; Banner-Goodspeed, Valerie/0000-0002-7644-2521; Bajwa, Ednan/0000-0001-9026-1009	NIH [U01-HL108712-01, KL2 RR024151, K23HL112855, UL1TR000433]; Mayo Clinic Critical Care Research Committee; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000433] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024151] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL112855, U01HL108712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U24AI118656] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Critical Care Research Committee; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study is supported by NIH grants U01-HL108712-01, KL2 RR024151, K23HL112855, UL1TR000433 and the Mayo Clinic Critical Care Research Committee.	Antithrombotic Trialists' Collaboration, 2002, BMJ-BRIT MED J, V324, P141, DOI DOI 10.1136/BMJ.324.7330.141; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Bates JJ, 2004, SHOCK, V21, P495, DOI 10.1097/01.shk.0000126146.94237.92; Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; Bellomo R, 2004, CRIT CARE; Bernard GR, 1997, NEW ENGL J MED, V336, P912, DOI 10.1056/NEJM199703273361303; Boyle AJ, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0846-4; Chen W, 2015, CRIT CARE MED, V43, P801, DOI 10.1097/CCM.0000000000000789; Chiang N, 2004, P NATL ACAD SCI USA, V101, P15178, DOI 10.1073/pnas.0405445101; El Kebir D, 2009, AM J RESP CRIT CARE, V180, P311, DOI 10.1164/rccm.200810-1601OC; Erickson SE, 2009, CRIT CARE MED, V37, P1574, DOI 10.1097/CCM.0b013e31819fefdf; Erlich JM, 2011, CHEST, V139, P289, DOI 10.1378/chest.10-0891; Ferguson ND, 2007, CRIT CARE, V11, DOI 10.1186/cc6113; Festic E, 2015, CURR OPIN CRIT CARE, V21, P82, DOI 10.1097/MCC.0000000000000174; Fukunaga K, 2005, J IMMUNOL, V174, P5033, DOI 10.4049/jimmunol.174.8.5033; Gajic O, 2011, AM J RESP CRIT CARE, V183, P462, DOI 10.1164/rccm.201004-0549OC; HSIA J, 1989, IMMUNOPHARMACOLOGY, V17, P167, DOI 10.1016/0162-3109(89)90045-3; Jin SW, 2007, ANESTH ANALG, V104, P369, DOI 10.1213/01.ane.0000252414.00363.c4; Kor DJ, 2011, CRIT CARE MED, V39, P2393, DOI 10.1097/CCM.0b013e318225757f; Kor DJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001606; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Litell JM, 2012, CRIT CARE S1, V504; Looney MR, 2009, J CLIN INVEST, V119, P3450, DOI 10.1172/JCI38432; Maderna P, 2009, BRIT J PHARMACOL, V158, P947, DOI 10.1111/j.1476-5381.2009.00386.x; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; Phua J, 2009, AM J RESP CRIT CARE, V179, P220, DOI 10.1164/rccm.200805-722OC; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rice TW, 2007, CHEST, V132, P410, DOI 10.1378/chest.07-0617; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Spragg RG, 2010, AM J RESP CRIT CARE, V181, P1121, DOI 10.1164/rccm.201001-0024WS; Yadav H, 2015, AM J PHYSIOL-LUNG C, V309, pL915, DOI 10.1152/ajplung.00266.2015; Zarbock A, 2007, BLOOD REV, V21, P99, DOI 10.1016/j.blre.2006.06.001; Zarbock A, 2009, FRONT BIOSCI-LANDMRK, V14, P150, DOI 10.2741/3236	35	140	145	1	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2016	315	22					2406	2414		10.1001/jama.2016.6330	http://dx.doi.org/10.1001/jama.2016.6330			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO3CE	27179988	Green Accepted, Bronze			2022-12-28	WOS:000377656900018
J	Cheung, E; Bundy, K; Cappellari, M; Peirani, S; Rujopakarn, W; Westfall, K; Yan, RB; Bershady, M; Greene, JE; Heckman, TM; Drory, N; Law, DR; Masters, KL; Thomas, D; Wake, DA; Weijmans, AM; Rubin, K; Belfiore, F; Vulcani, B; Chen, YM; Zhang, K; Gelfand, JD; Bizyaev, D; Roman-Lopes, A; Schneider, DP				Cheung, Edmond; Bundy, Kevin; Cappellari, Michele; Peirani, Sebastien; Rujopakarn, Wiphu; Westfall, Kyle; Yan, Renbin; Bershady, Matthew; Greene, Jenny E.; Heckman, Timothy M.; Drory, Niv; Law, David R.; Masters, Karen L.; Thomas, Daniel; Wake, David A.; Weijmans, Anne-Marie; Rubin, Kate; Belfiore, Francesco; Vulcani, Benedetta; Chen, Yan-mei; Zhang, Kai; Gelfand, Joseph D.; Bizyaev, Dmitry; Roman-Lopes, A.; Schneider, Donald P.			Suppressing star formation in quiescent galaxies with supermassive black hole winds	NATURE			English	Article							MULTI-GAUSSIAN EXPANSION; ACTIVE GALACTIC NUCLEI; FORMATION HISTORIES; STELLAR MASSES; COOLING FLOWS; RED-SEQUENCE; MODELS; GAS; EVOLUTION; EMISSION	Quiescent galaxies with little or no ongoing star formation dominate the population of galaxies with masses above 2 x 10(10) times that of the Sun; the number of quiescent galaxies has increased by a factor of about 25 over the past ten billion years (refs 1-4). Once star formation has been shut down, perhaps during the quasar phase of rapid accretion onto a supermassive black hole(5-7), an unknown mechanism must remove or heat the gas that is subsequently accreted from either stellar mass loss(8) or mergers and that would otherwise cool to form stars(9,10). Energy output from a black hole accreting at a low rate has been proposed(11-13), but observational evidence for this in the form of expanding hot gas shells is indirect and limited to radio galaxies at the centres of clusters(14,15), which are too rare to explain the vast majority of the quiescent population(16). Here we report bisymmetric emission features co-aligned with strong ionized-gas velocity gradients from which we infer the presence of centrally driven winds in typical quiescent galaxies that host low-luminosity active nuclei. These galaxies are surprisingly common, accounting for as much as ten per cent of the quiescent population with masses around 2 x 10(10) times that of the Sun. In a prototypical example, we calculate that the energy input from the galaxy's low-level active supermassive black hole is capable of driving the observed wind, which contains sufficient mechanical energy to heat ambient, cooler gas (also detected) and thereby suppress star formation.	[Cheung, Edmond; Bundy, Kevin; Peirani, Sebastien; Rujopakarn, Wiphu; Vulcani, Benedetta] Univ Tokyo, World Premier Int Res Ctr Initiative, Kavli Inst Phys & Math Universe, Inst Adv Study, Kashiwa, Chiba 2778583, Japan; [Cappellari, Michele] Univ Oxford, Subdept Astrophys, Dept Phys, Denys Wilkinson Bldg,Keble Rd, Oxford OX1 3RH, England; [Peirani, Sebastien] CNRS, UMR 7095, Inst Astrophys Paris, 98 Bis Blvd Arago, F-75014 Paris, France; [Peirani, Sebastien] UPMC, 98 Bis Blvd Arago, F-75014 Paris, France; [Rujopakarn, Wiphu] Chulalongkorn Univ, Dept Phys, Fac Sci, 254 Phayathai Rd, Bangkok 10330, Thailand; [Westfall, Kyle; Masters, Karen L.; Thomas, Daniel] Univ Portsmouth, Inst Cosmol & Gravitat, Dennis Sciama Bldg,Burnaby Rd, Portsmouth PO1 3FX, Hants, England; [Yan, Renbin; Zhang, Kai] Univ Kentucky, Dept Phys & Astron, 505 Rose St, Lexington, KY 40506 USA; [Bershady, Matthew; Wake, David A.] Univ Wisconsin, Dept Astron, 475 North Charter St, Madison, WI 53706 USA; [Greene, Jenny E.] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA; [Heckman, Timothy M.] Johns Hopkins Univ, Dept Phys & Astron, Ctr Astrophys Sci, Baltimore, MD 21218 USA; [Drory, Niv] Univ Texas Austin, Dept Astron, McDonald Observ, 1 Univ Stn, Austin, TX 78712 USA; [Law, David R.] Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA; [Wake, David A.] Open Univ, Dept Phys Sci, Milton Keynes MK7 6AA, Bucks, England; [Weijmans, Anne-Marie] Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland; [Rubin, Kate] Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA; [Belfiore, Francesco] Univ Cambridge, Cavendish Lab, 19 JJ Thomson Ave, Cambridge CB3 0HE, England; [Belfiore, Francesco] Univ Cambridge, Kavli Inst Cosmol, Cambridge CB3 0HE, England; [Chen, Yan-mei] Nanjing Univ, Dept Astron, Nanjing 210093, Jiangsu, Peoples R China; [Gelfand, Joseph D.] New York Univ Abu Dhabi, POB 129188, Abu Dhabi, U Arab Emirates; [Gelfand, Joseph D.] NYU, Ctr Cosmol & Particle Phys, Meyer Hall Phys,4 Washington Pl, New York, NY 10003 USA; [Bizyaev, Dmitry] Apache Point Observ, POB 59, Sunspot, NM 88349 USA; [Bizyaev, Dmitry] New Mexico State Univ, POB 59, Sunspot, NM 88349 USA; [Bizyaev, Dmitry] Moscow MV Lomonosov State Univ, Sternberg Astron Inst, Moscow, Russia; [Roman-Lopes, A.] Univ La Serena, Fac Ciencias, Dept Fis & Astron, Cisternas 1200, La Serena, Chile; [Schneider, Donald P.] Penn State Univ, Dept Astron & Astrophys, 525 Davey Lab, University Pk, PA 16802 USA; [Schneider, Donald P.] Penn State Univ, Inst Gravitat & Cosmos, University Pk, PA 16802 USA	University of Tokyo; University of Oxford; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Chulalongkorn University; University of Portsmouth; University of Kentucky; University of Wisconsin System; University of Wisconsin Madison; Princeton University; Johns Hopkins University; University of Texas System; University of Texas Austin; Space Telescope Science Institute; Open University - UK; University of St Andrews; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Cambridge; University of Cambridge; Nanjing University; New York University; New Mexico State University; Lomonosov Moscow State University; Universidad de La Serena; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Cheung, E (corresponding author), Univ Tokyo, World Premier Int Res Ctr Initiative, Kavli Inst Phys & Math Universe, Inst Adv Study, Kashiwa, Chiba 2778583, Japan.	ec2250@gmail.com	Bundy, Kevin/ABE-6356-2021; Roman-Lopes, Alexandre/M-2274-2015; Thomas, Daniel/ABA-8218-2020; Cappellari, Michele/AAB-5062-2019; Rujopakarn, Wiphu/AAV-2176-2021; Zhang, Kai/S-7652-2019; Masters, Karen/AAJ-8228-2021; Vulcani, Benedetta/ABB-4847-2020; Gelfand, Joseph/F-1110-2015	Roman-Lopes, Alexandre/0000-0002-1379-4204; Thomas, Daniel/0000-0002-6325-5671; Cappellari, Michele/0000-0002-1283-8420; Zhang, Kai/0000-0002-9808-3646; Masters, Karen/0000-0003-0846-9578; Vulcani, Benedetta/0000-0003-0980-1499; Weijmans, Anne-Marie/0000-0002-5908-6852; Gelfand, Joseph/0000-0003-4679-1058; Law, David/0000-0002-9402-186X; Rujopakarn, Wiphu/0000-0002-0303-499X; Belfiore, Francesco/0000-0002-2545-5752; , Kyle/0000-0003-1809-6920; Cheung, Edmond/0000-0001-8546-1428	World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan; JSPS KAKENHI [15K17603]; Leverhulme Trust; Japan Society for the Promotion of Science (JSPS); Royal Society; Chulalongkorn University; Alfred P. Sloan Foundation; US Department of Energy Office of Science; Center for High-Performance Computing at the University of Utah; Brazilian Participation Group; Carnegie Institution for Science; Carnegie Mellon University; Chilean Participation Group; French Participation Group; Harvard-Smithsonian Center for Astrophysics; Instituto de Astrofisica de Canarias; Johns Hopkins University; Kavli Institute for the Physics and Mathematics of the Universe (IPMU)/University of Tokyo; Lawrence Berkeley National Laboratory; Leibniz Institut fur Astrophysik Potsdam (AIP); Max-Planck-Institut fur Astronomie (MPIA Heidelberg); Max-Planck-Institut fur Astrophysik (MPA Garching); Max-Planck-Institut fur Extraterrestrische Physik (MPE); National Astronomical Observatory of China; New Mexico State University; New York University; University of Notre Dame; Observatorio Nacional/MCTI; Ohio State University; Pennsylvania State University; Shanghai Astronomical Observatory; UK Participation Group; Universidad Nacional Autonoma de Mexico; University of Arizona; University of Colorado Boulder; University of Oxford; University of Portsmouth; University of Utah; University of Virginia; University of Washington; University of Wisconsin; Vanderbilt University; Yale University; Science and Technology Facilities Council [ST/K00090X/1, 1363788, ST/N000668/1] Funding Source: researchfish; Russian Science Foundation [14-50-00043] Funding Source: Russian Science Foundation; STFC [ST/N000668/1, ST/K00090X/1] Funding Source: UKRI	World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Leverhulme Trust(Leverhulme Trust); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Royal Society(Royal Society of London); Chulalongkorn University(Chulalongkorn University); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); US Department of Energy Office of Science(United States Department of Energy (DOE)); Center for High-Performance Computing at the University of Utah; Brazilian Participation Group; Carnegie Institution for Science; Carnegie Mellon University; Chilean Participation Group; French Participation Group; Harvard-Smithsonian Center for Astrophysics(Smithsonian InstitutionHarvard-Smithsonian Center for Astrophysics); Instituto de Astrofisica de Canarias; Johns Hopkins University(Johns Hopkins University); Kavli Institute for the Physics and Mathematics of the Universe (IPMU)/University of Tokyo; Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Leibniz Institut fur Astrophysik Potsdam (AIP); Max-Planck-Institut fur Astronomie (MPIA Heidelberg); Max-Planck-Institut fur Astrophysik (MPA Garching); Max-Planck-Institut fur Extraterrestrische Physik (MPE); National Astronomical Observatory of China; New Mexico State University; New York University; University of Notre Dame; Observatorio Nacional/MCTI; Ohio State University(Ohio State University); Pennsylvania State University; Shanghai Astronomical Observatory; UK Participation Group; Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); University of Arizona; University of Colorado Boulder; University of Oxford; University of Portsmouth; University of Utah; University of Virginia; University of Washington(University of Washington); University of Wisconsin; Vanderbilt University; Yale University; Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Russian Science Foundation(Russian Science Foundation (RSF)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We are grateful to Y.-Y. Chang for checks on the SED fitting and implied SFR. We thank S. Juneau, J. Newman, H. Fu, K. Nyland, and S. F. Sanchez for discussions and comments. This work was supported by the World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan, and JSPS KAKENHI grant no. 15K17603. A.W. acknowledges support of a Leverhulme Trust Early Career Fellowship. S.P. acknowledges support from the Japan Society for the Promotion of Science (JSPS long-term invitation fellowship). M.C. acknowledges support from a Royal Society University Research Fellowship. W.R. is supported by a CUniverse Grant (CUAASC) from Chulalongkorn University. Funding for the Sloan Digital Sky Survey IV (SDSS-VI) has been provided by the Alfred P. Sloan Foundation, the US Department of Energy Office of Science, and the Participating Institutions. SDSS-IV acknowledges support and resources from the Center for High-Performance Computing at the University of Utah. The SDSS website is www.sdss.org. SDSS-IV is managed by the Astrophysical Research Consortium for the Participating Institutions of the SDSS Collaboration, including the Brazilian Participation Group, the Carnegie Institution for Science, Carnegie Mellon University, the Chilean Participation Group, the French Participation Group, Harvard-Smithsonian Center for Astrophysics, Instituto de Astrofisica de Canarias, The Johns Hopkins University, Kavli Institute for the Physics and Mathematics of the Universe (IPMU)/University of Tokyo, Lawrence Berkeley National Laboratory, Leibniz Institut fur Astrophysik Potsdam (AIP), Max-Planck-Institut fur Astronomie (MPIA Heidelberg), Max-Planck-Institut fur Astrophysik (MPA Garching), Max-Planck-Institut fur Extraterrestrische Physik (MPE), National Astronomical Observatory of China, New Mexico State University, New York University, University of Notre Dame, Observatorio Nacional/MCTI, The Ohio State University, Pennsylvania State University, Shanghai Astronomical Observatory, UK Participation Group, Universidad Nacional Autonoma de Mexico, University of Arizona, University of Colorado Boulder, University of Oxford, University of Portsmouth, University of Utah, University of Virginia, University of Washington, University of Wisconsin, Vanderbilt University and Yale University.	Allen JT, 2015, MON NOT R ASTRON SOC, V451, P2780, DOI 10.1093/mnras/stv1121; Allen MG, 2008, ASTROPHYS J SUPPL S, V178, P20, DOI 10.1086/589652; Andersen DR, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/1/41; [Anonymous], 2010, MPA JHU DR7 RELEASE; BECKER RH, 1995, ASTROPHYS J, V450, P559, DOI 10.1086/176166; Belfiore F, 2015, MON NOT R ASTRON SOC, V449, P867, DOI 10.1093/mnras/stv296; Bell EF, 2004, ASTROPHYS J, V608, P752, DOI 10.1086/420778; Bershady MA, 2011, ASTROPHYS J LETT, V739, DOI 10.1088/2041-8205/739/2/L47; Bershady MA, 2010, ASTROPHYS J, V716, P198, DOI 10.1088/0004-637X/716/1/198; Best PN, 2012, MON NOT R ASTRON SOC, V421, P1569, DOI 10.1111/j.1365-2966.2012.20414.x; BOHLIN RC, 1978, ASTROPHYS J, V224, P132, DOI 10.1086/156357; Booth CM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01738; Bouche N, 2012, MON NOT R ASTRON SOC, V426, P801, DOI 10.1111/j.1365-2966.2012.21114.x; Bower RG, 2006, MON NOT R ASTRON SOC, V370, P645, DOI 10.1111/j.1365-2966.2006.10519.x; Bundy K, 2006, ASTROPHYS J, V651, P120, DOI 10.1086/507456; Bundy K, 2015, ASTROPHYS J, V798, DOI 10.1088/0004-637X/798/1/7; Cappellari M, 2004, PUBL ASTRON SOC PAC, V116, P138, DOI 10.1086/381875; Cappellari M, 2002, MON NOT R ASTRON SOC, V333, P400, DOI 10.1046/j.1365-8711.2002.05412.x; Cappellari M, 2008, MON NOT R ASTRON SOC, V390, P71, DOI 10.1111/j.1365-2966.2008.13754.x; Cavagnolo KW, 2010, ASTROPHYS J, V720, P1066, DOI 10.1088/0004-637X/720/2/1066; Chang YY, 2015, ASTROPHYS J SUPPL S, V219, DOI 10.1088/0067-0049/219/1/8; Ciotti L, 1997, ASTROPHYS J, V487, pL105, DOI 10.1086/310902; Ciotti L, 2010, ASTROPHYS J, V717, P708, DOI 10.1088/0004-637X/717/2/708; Croton DJ, 2006, MON NOT R ASTRON SOC, V365, P11, DOI 10.1111/j.1365-2966.2005.09675.x; DEHNEN W, 1994, MON NOT R ASTRON SOC, V268, P1019, DOI 10.1093/mnras/268.4.1019; Di Matteo T, 2005, NATURE, V433, P604, DOI 10.1038/nature03335; Drory N, 2015, ASTRON J, V149, DOI 10.1088/0004-6256/149/2/77; EMSELLEM E, 1994, ASTRON ASTROPHYS, V285, P723; Faber SM, 2007, ASTROPHYS J, V665, P265, DOI 10.1086/519294; Fabian AC, 2012, ANNU REV ASTRON ASTR, V50, P455, DOI 10.1146/annurev-astro-081811-125521; Fabian AC, 2006, MON NOT R ASTRON SOC, V366, P417, DOI 10.1111/j.1365-2966.2005.09896.x; Fritz J, 2014, ASTRON ASTROPHYS, V566, DOI 10.1051/0004-6361/201323138; Fritz J, 2011, ASTRON ASTROPHYS, V526, DOI 10.1051/0004-6361/201015214; Genzel R, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/2/101; Gomes JM, 2016, ASTRON ASTROPHYS, V588, DOI 10.1051/0004-6361/201525976; Gunn JE, 2006, ASTRON J, V131, P2332, DOI 10.1086/500975; Harrison CM, 2014, MON NOT R ASTRON SOC, V441, P3306, DOI 10.1093/mnras/stu515; Heckman TM, 2014, ANNU REV ASTRON ASTR, V52, P589, DOI 10.1146/annurev-astro-081913-035722; Heckman TM, 2004, ASTROPHYS J, V613, P109, DOI 10.1086/422872; Hopkins PF, 2006, ASTROPHYS J SUPPL S, V163, P1, DOI 10.1086/499298; Hopkins PF, 2010, ASTROPHYS J, V715, P202, DOI 10.1088/0004-637X/715/1/202; Ilbert O, 2010, ASTROPHYS J, V709, P644, DOI 10.1088/0004-637X/709/2/644; Kehrig C, 2012, ASTRON ASTROPHYS, V540, DOI 10.1051/0004-6361/201118357; Kennicutt RC, 2007, ASTROPHYS J, V671, P333, DOI 10.1086/522300; Kennicutt RC, 2012, ANNU REV ASTRON ASTR, V50, P531, DOI 10.1146/annurev-astro-081811-125610; Lagos CD, 2015, MON NOT R ASTRON SOC, V448, P1271, DOI 10.1093/mnras/stu2763; Law DR, 2015, ASTRON J, V150, DOI 10.1088/0004-6256/150/1/19; Li HY, 2016, MON NOT R ASTRON SOC, V455, P3680, DOI 10.1093/mnras/stv2565; Lin YT, 2007, ASTROPHYS J SUPPL S, V170, P71, DOI 10.1086/513565; McConnell NJ, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/2/184; Navarro JF, 1996, ASTROPHYS J, V462, P563, DOI 10.1086/177173; OKE JB, 1983, ASTROPHYS J, V266, P713, DOI 10.1086/160817; Osterbrock D. E., 2006, ASTROPHYSICS GASEOUS; Ostriker JP, 2010, ASTROPHYS J, V722, P642, DOI 10.1088/0004-637X/722/1/642; Peirani S, 2010, MON NOT R ASTRON SOC, V405, P2327, DOI 10.1111/j.1365-2966.2010.16666.x; Peng CY, 2002, ASTRON J, V124, P266, DOI 10.1086/340952; Sarzi M, 2010, MON NOT R ASTRON SOC, V402, P2187, DOI 10.1111/j.1365-2966.2009.16039.x; Springel V, 2005, MON NOT R ASTRON SOC, V364, P1105, DOI 10.1111/j.1365-2966.2005.09655.x; SUTHERLAND RS, 1993, ASTROPHYS J SUPPL S, V88, P253, DOI 10.1086/191823; TOHLINE JE, 1982, ASTROPHYS J, V252, P92, DOI 10.1086/159537; van de Voort F, 2015, MON NOT R ASTRON SOC, V451, P3269, DOI 10.1093/mnras/stv1217; Vazdekis A, 2012, MON NOT R ASTRON SOC, V424, P157, DOI 10.1111/j.1365-2966.2012.21179.x; Yang XH, 2007, ASTROPHYS J, V671, P153, DOI 10.1086/522027; Yan RB, 2006, ASTROPHYS J, V648, P281, DOI 10.1086/505629; Yan RB, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/1/61; Yuan F, 2014, ANNU REV ASTRON ASTR, V52, P529, DOI 10.1146/annurev-astro-082812-141003	69	130	131	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2016	533	7604					504	+		10.1038/nature18006	http://dx.doi.org/10.1038/nature18006			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6EJ	27225122	Green Submitted, Green Accepted			2022-12-28	WOS:000376443100034
J	Mills, SM; Fabrycky, DC; Migaszewski, C; Ford, EB; Petigura, E; Isaacson, H				Mills, Sean M.; Fabrycky, Daniel C.; Migaszewski, Cezary; Ford, Eric B.; Petigura, Erik; Isaacson, Howard			A resonant chain of four transiting, sub-Neptune planets	NATURE			English	Article							MEAN MOTION RESONANCES; HOT SUPER-EARTHS; LOW-MASS; SYSTEM; KEPLER; CANDIDATES; MIGRATION; DYNAMICS; II.; PLANETESIMALS	Surveys have revealed many multi-planet systems containing super-Earths and Neptunes in orbits of a few days to a few months(1). There is debate whether in situ assembly(2) or inward migration is the dominant mechanism of the formation of such planetary systems. Simulations suggest that migration creates tightly packed systems with planets whose orbital periods may be expressed as ratios of small integers (resonances)(3-5), often in a many-planet series (chain)(6). In the hundreds of multi-planet systems of sub-Neptunes, more planet pairs are observed near resonances than would generally be expected(7), but no individual system has hitherto been identified that must have been formed by migration. Proximity to resonance enables the detection of planets perturbing each other(8). Here we report transit timing variations of the four planets in the Kepler-223 system, model these variations as resonant-angle librations, and compute the long-term stability of the resonant chain. The architecture of Kepler-223 is too finely tuned to have been formed by scattering, and our numerical simulations demonstrate that its properties are natural outcomes of the migration hypothesis. Similar systems could be destabilized by any of several mechanisms(5,9-11), contributing to the observed orbital-period distribution, where many planets are not in resonances. Planetesimal interactions in particular are thought to be responsible for establishing the current orbits of the four giant planets in the Solar System by disrupting a theoretical initial resonant chain(12) similar to that observed in Kepler-223.	[Mills, Sean M.; Fabrycky, Daniel C.] Univ Chicago, Dept Astron & Astrophys, 5640 S Ellis Ave, Chicago, IL 60637 USA; [Migaszewski, Cezary] Univ Szczecin, Inst Phys, Wielkopolska 15, PL-70451 Szczecin, Poland; [Migaszewski, Cezary] Univ Szczecin, CASA, Wielkopolska 15, PL-70451 Szczecin, Poland; [Migaszewski, Cezary] Nicolaus Copernicus Univ, Torun Ctr Astron, Gagarina 11, PL-87100 Torun, Poland; [Ford, Eric B.] Penn State Univ, Ctr Exoplanets & Habitable Worlds, University Pk, PA 16802 USA; [Ford, Eric B.] Penn State Univ, Dept Astron & Astrophys, 525 Davey Lab, University Pk, PA 16802 USA; [Ford, Eric B.] Penn State Univ, Ctr Astrostat, University Pk, PA 16802 USA; [Petigura, Erik; Isaacson, Howard] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Petigura, Erik] CALTECH, Pasadena, CA 91125 USA	University of Chicago; University of Szczecin; University of Szczecin; Nicolaus Copernicus University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California Berkeley; California Institute of Technology	Mills, SM (corresponding author), Univ Chicago, Dept Astron & Astrophys, 5640 S Ellis Ave, Chicago, IL 60637 USA.	sean.martin.mills@gmail.com	Petigura, Erik/GZL-2909-2022; Ford, Eric B./AAB-5479-2019; Migaszewski, Cezary/E-3060-2017	Petigura, Erik/0000-0003-0967-2893; Ford, Eric B./0000-0001-6545-639X; Migaszewski, Cezary/0000-0003-2546-6328; Fabrycky, Daniel/0000-0003-3750-0183	NASA issued through the Kepler Participating Scientist Program [NNX14AB87G, NNX12AF73G, NNX14AN76G]; NASA [NNX15AE21G]; Alfred P. Sloan Foundation; Polish National Science Centre [DEC-2012/06/A/ST9/00276]	NASA issued through the Kepler Participating Scientist Program; NASA(National Aeronautics & Space Administration (NASA)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Polish National Science Centre	We thank A. Howard and G. Marcy for their role in obtaining spectra, and E. Agol, J. Lissauer, and J. Bean for comments on the manuscript. This material is based on work supported by NASA under grant numbers NNX14AB87G (D.C.F.), NNX12AF73G (E.B.F.) and NNX14AN76G (E.B.F.) issued through the Kepler Participating Scientist Program. E.B.F. received support from NASA Exoplanet Research Program award NNX15AE21G. D.C.F. received support from the Alfred P. Sloan Foundation. C.M. was supported by the Polish National Science Centre MAESTRO grant DEC-2012/06/A/ST9/00276.	Adams FC, 2008, ASTROPHYS J, V683, P1117, DOI 10.1086/589986; Agol E, 2005, MON NOT R ASTRON SOC, V359, P567, DOI 10.1111/j.1365-2966.2005.08922.x; Batalha NM, 2013, ASTROPHYS J SUPPL S, V204, DOI 10.1088/0067-0049/204/2/24; Borucki WJ, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/19; Brown TM, 2013, PUBL ASTRON SOC PAC, V125, P1031, DOI 10.1086/673168; Brown TM, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/4/112; Carter JA, 2011, SCIENCE, V331, P562, DOI 10.1126/science.1201274; Chambers J.E., 2012, ASCL1201008; Chatterjee S, 2015, ASTROPHYS J, V803, DOI 10.1088/0004-637X/803/1/33; Coelho P, 2005, ASTRON ASTROPHYS, V443, P735, DOI 10.1051/0004-6361:20053511; Cossou C, 2014, ASTRON ASTROPHYS, V569, DOI 10.1051/0004-6361/201424157; Cresswell P, 2006, ASTRON ASTROPHYS, V450, P833, DOI 10.1051/0004-6361:20054551; Delisle JB, 2014, ASTRON ASTROPHYS, V570, DOI 10.1051/0004-6361/201424227; Demarque P, 2004, ASTROPHYS J SUPPL S, V155, P667, DOI 10.1086/424966; Fabrycky DC, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/2/146; Girardi L, 2005, ASTRON ASTROPHYS, V436, P895, DOI 10.1051/0004-6361:20042352; Gozdziewski K, 2016, MON NOT R ASTRON SOC, V455, pL104, DOI 10.1093/mnrasl/slv156; Hansen BMS, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/53; Howell SB, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/2/123; Howell SB, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/1/19; Huber D, 2013, SCIENCE, V342, P331, DOI 10.1126/science.1242066; Lee EJ, 2016, ASTROPHYS J, V817, DOI 10.3847/0004-637X/817/2/90; Lee MH, 2002, ASTROPHYS J, V567, P596, DOI 10.1086/338504; Lissauer JJ, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/44; Lissauer JJ, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/1/8; Lissauer JJ, 2011, NATURE, V470, P53, DOI 10.1038/nature09760; Lopez ED, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/1; Masset FS, 2006, ASTROPHYS J, V642, P478, DOI 10.1086/500967; Masuda K, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/185; Melita MD, 1996, MON NOT R ASTRON SOC, V280, P854, DOI 10.1093/mnras/280.3.854; Minton DA, 2014, ICARUS, V232, P118, DOI 10.1016/j.icarus.2014.01.001; Moore A, 2013, MON NOT R ASTRON SOC, V432, P1196, DOI 10.1093/mnras/stt535; Morton T. D., 2015, ASCL1503010; Mullally F, 2015, ASTROPHYS J SUPPL S, V217, DOI 10.1088/0067-0049/217/2/31; Ormel CW, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/2/80; Pu BN, 2015, ASTROPHYS J, V807, DOI 10.1088/0004-637X/807/1/44; Quillen AC, 2011, MON NOT R ASTRON SOC, V418, P1043, DOI 10.1111/j.1365-2966.2011.19555.x; Sing DK, 2010, ASTRON ASTROPHYS, V510, DOI 10.1051/0004-6361/200913675; Southworth J, 2007, ASTRON ASTROPHYS, V467, P1215, DOI 10.1051/0004-6361:20077184; Southworth J, 2008, MON NOT R ASTRON SOC, V386, P1644, DOI 10.1111/j.1365-2966.2008.13145.x; ter Braak C. J. F, 2005, GENETIC ALGORITHMS M; Terquem C, 2007, ASTROPHYS J, V654, P1110, DOI 10.1086/509497; Veras D, 2004, ICARUS, V172, P349, DOI 10.1016/j.icarus.2004.06.012; VOGT S, 1994, P SOC PHOTO-OPT INS, V2198, P362, DOI 10.1117/12.176725; Williams JP, 2011, ANNU REV ASTRON ASTR, V49, P67, DOI 10.1146/annurev-astro-081710-102548	51	106	106	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2016	533	7604					509	+		10.1038/nature17445	http://dx.doi.org/10.1038/nature17445			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6EJ	27225123	Green Accepted, Green Submitted			2022-12-28	WOS:000376443100035
J	Sciurba, FC; Criner, GJ; Strange, C; Shah, PL; Michaud, G; Connolly, TA; Deslee, G; Tillis, WP; Delage, A; Marquette, CH; Krishna, G; Kalhan, R; Ferguson, JS; Jantz, M; Maldonado, F; McKenna, R; Majid, A; Rai, N; Gay, S; Dransfield, MT; Angel, L; Maxfield, R; Herth, FJF; Wahidi, MM; Mehta, A; Slebos, DJ				Sciurba, Frank C.; Criner, Gerard J.; Strange, Charlie; Shah, Pallav L.; Michaud, Gaetane; Connolly, Timothy A.; Deslee, Gaetan; Tillis, William P.; Delage, Antoine; Marquette, Charles-Hugo; Krishna, Ganesh; Kalhan, Ravi; Ferguson, J. Scott; Jantz, Michael; Maldonado, Fabien; McKenna, Robert; Majid, Adnan; Rai, Navdeep; Gay, Steven; Dransfield, Mark T.; Angel, Luis; Maxfield, Roger; Herth, Felix J. F.; Wahidi, Momen M.; Mehta, Atul; Slebos, Dirk-Jan		RENEW Study Res Grp	Effect of Endobronchial Coils vs Usual Care on Exercise Tolerance in Patients With Severe Emphysema The RENEW Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LUNG-VOLUME-REDUCTION; OBSTRUCTIVE PULMONARY-DISEASE; MINIMAL IMPORTANT DIFFERENCE; HOMOGENEOUS EMPHYSEMA; COPD; SURGERY; TESTS; CAPACITY; SOCIETY; VALVES	IMPORTANCE Preliminary clinical trials have demonstrated that endobronchial coils compress emphysematous lung tissue and may improve lung function, exercise tolerance, and symptoms in patients with emphysema and severe lung hyperinflation. OBJECTIVE To determine the effectiveness and safety of endobronchial coil treatment. DESIGN, SETTING, AND PARTICIPANTS Randomized clinical trial conducted among 315 patients with emphysema and severe air trapping recruited from 21 North American and 5 European sites from December 2012 through November 2015. INTERVENTIONS Participants were randomly assigned to continue usual care alone (guideline based, including pulmonary rehabilitation and bronchodilators; n = 157) vs usual care plus bilateral coil treatment (n = 158) involving 2 sequential procedures 4 months apart in which 10 to 14 coils were bronchoscopically placed in a single lobe of each lung. MAIN OUTCOMES AND MEASURES The primary effectiveness outcome was difference in absolute change in 6-minute-walk distance between baseline and 12 months (minimal clinically important difference [MCID], 25 m). Secondary end points included the difference between groups in 6-minute walk distance responder rate, absolute change in quality of life using the St George's Respiratory Questionnaire (MCID, 4) and change in forced expiratory volume in the first second (FEV1; MCID, 10%). The primary safety analysis compared the proportion of participants experiencing at least 1 of 7 prespecified major complications. RESULTS Among 315 participants (mean age, 64 years; 52% women), 90% completed the 12-month follow-up. Median change in 6-minute walk distance at 12 months was 10.3 m with coil treatment vs -7.6 m with usual care, with a between-group difference of 14.6 m (Hodges-Lehmann 97.5% CI, 0.4 mto infinity; 1-sided P = .02). Improvement of at least 25 m occurred in 40.0% of patients in the coil group vs 26.9% with usual care (odds ratio, 1.8 [97.5% CI, 1.1 to infinity]; unadjusted between-group difference, 11.8%[97.5% CI, 1.0% to infinity]; 1-sided P = .01). The between-group difference in median change in FEV1 was 7.0%(97.5% CI, 3.4% to infinity; 1-sided P < .001), and the between-group St George's Respiratory Questionnaire score improved -8.9 points (97.5% CI, -infinity to -6.3 points; 1-sided P < .001), each favoring the coil group. Major complications (including pneumonia requiring hospitalization and other potentially life-threatening or fatal events) occurred in 34.8% of coil participants vs 19.1% of usual care (P = .002). Other serious adverse events including pneumonia (20% coil vs 4.5% usual care) and pneumothorax (9.7% vs 0.6%, respectively) occurred more frequently in the coil group. CONCLUSIONS AND RELEVANCE Among patients with emphysema and severe hyperinflation treated for 12 months, the use of endobronchial coils compared with usual care resulted in an improvement in median exercise tolerance that was modest and of uncertain clinical importance, with a higher likelihood of major complications. Further follow-up is needed to assess long-term effects on health outcomes.	[Sciurba, Frank C.] Univ Pittsburgh, Sch Med, 3471 Fifth Ave,Ste 1211,Kaufmann Bldg, Pittsburgh, PA 15213 USA; [Criner, Gerard J.] Temple Univ, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [Strange, Charlie] Med Univ S Carolina, Charleston, SC 29425 USA; [Shah, Pallav L.] Univ London Imperial Coll Sci Technol & Med, Royal Brompton & Harefield NHS Fdn Trust, Natl Inst Hlth Res Unit, London, England; [Shah, Pallav L.] Chelsea & Westminster Hosp, London, England; [Michaud, Gaetane] NYU, Sch Med, New York, NY USA; [Deslee, Gaetan] Univ Hosp Reims, INSERM, U903, Reims, France; [Tillis, William P.] OSF HealthCare Illinois Lung & Crit Care Inst, Peoria, IL USA; [Delage, Antoine] Quebec Heart & Lung Inst, Quebec City, PQ, Canada; [Marquette, Charles-Hugo] Univ Nice Sophia Antipolis, IRCAN, ONCOAGE, F-06189 Nice, France; [Krishna, Ganesh] El Camino Hosp, Palo Alto Med Fdn, Mountain View, CA USA; [Kalhan, Ravi] Northwestern Univ, Chicago, IL 60611 USA; [Jantz, Michael] Univ Wisconsin, Sch Med, Madison, WI USA; [Maldonado, Fabien] Mayo Clin, Rochester, MN USA; [McKenna, Robert] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Majid, Adnan] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Rai, Navdeep] Franciscan Res Ctr, Tacoma, WA USA; [Gay, Steven] Univ Michigan, Ann Arbor, MI 48109 USA; [Dransfield, Mark T.] Univ Alabama Birmingham, Birmingham, AL USA; [Angel, Luis] Univ Texas San Antonio, San Antonio, TX USA; [Maxfield, Roger] Columbia Univ, New York Presbyterian Hosp, New York, NY USA; [Herth, Felix J. F.] Heidelberg Univ, Thoraxklin, Heidelberg, Germany; [Wahidi, Momen M.] Duke Univ, Med Ctr, Durham, NC USA; [Mehta, Atul] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Slebos, Dirk-Jan] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Medical University of South Carolina; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Imperial College London; New York University; CHU de Reims; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Reims Champagne-Ardenne; Quebec Heart & Lung Institute; UDICE-French Research Universities; Universite Cote d'Azur; Palo Alto Medical Foundation Research Institute; Northwestern University; University of Wisconsin System; University of Wisconsin Madison; Mayo Clinic; Cedars Sinai Medical Center; Harvard University; Beth Israel Deaconess Medical Center; University of Michigan System; University of Michigan; University of Alabama System; University of Alabama Birmingham; University of Texas System; University of Texas at San Antonio (UTSA); Columbia University; NewYork-Presbyterian Hospital; Ruprecht Karls University Heidelberg; Duke University; Cleveland Clinic Foundation; University of Groningen	Sciurba, FC (corresponding author), Univ Pittsburgh, 3471 Fifth Ave,Ste 1211,Kaufmann Bldg, Pittsburgh, PA 15213 USA.	sciurbafc@upmc.edu	Marquette, Charles Hugo/O-4084-2016; Sciurba, Frank/AAZ-9339-2021; Shah, Pallav L/AAB-2758-2019; DESLEE, Gaëtan/G-2625-2013	Marquette, Charles Hugo/0000-0002-0846-9941; Shah, Pallav L/0000-0002-9052-4638; DESLEE, Gaëtan/0000-0002-4919-5916; sciurba, frank/0000-0001-7468-2225; Kalhan, Ravi/0000-0003-2443-0876; McNulty, William/0000-0002-1315-7942; Gompelmann, Daniela/0000-0002-4857-9854; Michaud, Gaetane/0000-0002-2623-1021	PneumRx Inc, a BTG International group company	PneumRx Inc, a BTG International group company	This study was supported by PneumRx Inc, a BTG International group company. Drs Sciurba, Criner, and Slebos receive institutional support from Pulmonx.	Carlucci A, 2012, EUR RESPIR REV, V21, P347, DOI 10.1183/09059180.00001512; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Chandra D, 2012, CHEST, V142, P1545, DOI 10.1378/chest.11-2702; CONOVER WJ, 1982, BIOMETRICS, V38, P715, DOI 10.2307/2530051; Decker MR, 2014, J THORAC CARDIOV SUR, V148, P2651, DOI 10.1016/j.jtcvs.2014.02.005; Deslee G, 2016, JAMA-J AM MED ASSOC, V315, P175, DOI 10.1001/jama.2015.17821; Deslee G, 2014, THORAX, V69, P980, DOI 10.1136/thoraxjnl-2014-205221; Donohue James F, 2005, COPD, V2, P111; Fishman A, 2003, NEW ENGL J MED, V348, P2059; Ginsburg ME, 2016, J THORAC CARDIOV SUR, V151, P717, DOI 10.1016/j.jtcvs.2015.10.095; Global Initiative for Chronic Obstructive Lung Disease, GLOB STRAT DIAGN MAN; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hartman JE, 2015, RESPIROLOGY, V20, P319, DOI 10.1111/resp.12435; Hartman JE, 2012, EUR RESPIR J, V40, P1137, DOI 10.1183/09031936.00219111; HODGES JL, 1962, ANN MATH STAT, V33, P482, DOI 10.1214/aoms/1177704575; Holland AE, 2014, EUR RESPIR J, V44, P1428, DOI 10.1183/09031936.00150314; Jones PW, 2002, EUR RESPIR J, V19, P398, DOI 10.1183/09031936.02.00063702; Klooster K, 2015, NEW ENGL J MED, V373, P2325, DOI 10.1056/NEJMoa1507807; Klooster K, 2014, RESPIRATION, V88, P116, DOI 10.1159/000362522; Kontogianni K, 2014, RESPIRATION, V88, P52, DOI 10.1159/000358441; Kreider Maryl, 2009, Proc Am Thorac Soc, V6, P20, DOI 10.1513/pats.200808-097GO; LaVange LM, 2006, CIRCULATION, V114, P2528, DOI 10.1161/CIRCULATIONAHA.106.613638; Little R. J. A., 1987, STAT ANAL MISSING DA; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Puhan MA, 2011, EUR RESPIR J, V37, P784, DOI 10.1183/09031936.00063810; Sciurba FC, 2016, JAMA-J AM MED ASSOC, V315, P139, DOI 10.1001/jama.2015.17714; Sciurba FC, 2010, NEW ENGL J MED, V363, P1233, DOI 10.1056/NEJMoa0900928; Shah PL, 2013, LANCET RESP MED, V1, P233, DOI 10.1016/S2213-2600(13)70047-X; Slebos DJ, 2015, RESPIRATION, V90, P136, DOI 10.1159/000431384; Slebos DJ, 2012, CHEST, V142, P574, DOI 10.1378/chest.11-0730; Valipour A, 2015, RESPIRATION, V90, P402, DOI 10.1159/000439544; Valipour A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00387	32	165	167	0	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 24	2016	315	20					2178	2189		10.1001/jama.2016.6261	http://dx.doi.org/10.1001/jama.2016.6261			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM4US	27179849	Bronze, Green Published			2022-12-28	WOS:000376343000014
J	Berg, JM; Bhalla, N; Bourne, PE; Chalfie, M; Drubin, DG; Fraser, JS; Greider, CW; Hendricks, M; Jones, C; Kiley, R; King, S; Kirschner, MW; Krumholz, HM; Lehmann, R; Leptin, M; Pulverer, B; Rosenzweig, B; Spiro, JE; Stebbins, M; Strasser, C; Swaminathan, S; Turner, P; Vale, RD; VijayRaghavan, K; Wolberger, C				Berg, Jeremy M.; Bhalla, Needhi; Bourne, Philip E.; Chalfie, Martin; Drubin, David G.; Fraser, James S.; Greider, Carol W.; Hendricks, Michael; Jones, Chonnettia; Kiley, Robert; King, Susan; Kirschner, Marc W.; Krumholz, Harlan M.; Lehmann, Ruth; Leptin, Maria; Pulverer, Bernd; Rosenzweig, Brooke; Spiro, John E.; Stebbins, Michael; Strasser, Carly; Swaminathan, Sowmya; Turner, Paul; Vale, Ronald D.; VijayRaghavan, K.; Wolberger, Cynthia			Preprints for the life sciences	SCIENCE			English	Editorial Material									[Berg, Jeremy M.] Univ Pittsburgh, Sch Med, Inst Personalized Med, Pittsburgh, PA 15260 USA; [Bhalla, Needhi] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Bourne, Philip E.] NIH, Off Director, Bethesda, MD USA; [Chalfie, Martin] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Drubin, David G.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Fraser, James S.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Greider, Carol W.] Johns Hopkins Univ, Dept Mol Biol & Genet, Sch Med, Baltimore, MD 21218 USA; [Hendricks, Michael] McGill Univ, Dept Biol, Montreal, PQ H3A 2T5, Canada; [Jones, Chonnettia; Kiley, Robert] Wellcome Trust Res Labs, London, England; [King, Susan] Rockefeller Univ Press, New York, NY 10065 USA; [Kirschner, Marc W.] Harvard Univ, Dept Syst Biol, Sch Med, Cambridge, MA 02138 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Lehmann, Ruth] NYU, Sch Med, Dept Cell Biol, Kimmel Ctr Biol & Med,Skirball Inst, New York, NY 10003 USA; [Leptin, Maria; Pulverer, Bernd] European Mol Biol Org, Heidelberg, Germany; [Rosenzweig, Brooke] Leona M & Harry B Helmsley Charitable Trust, New York, NY USA; [Spiro, John E.] Simons Fdn, New York, NY USA; [Stebbins, Michael] Laura & John Arnold Fdn, Houston, TX USA; [Strasser, Carly] Gordon & Betty Moore Fdn, Palo Alto, CA USA; [Swaminathan, Sowmya] Nat Res Grp, Banchory, Kincardine, Scotland; [Turner, Paul] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA; [Vale, Ronald D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA USA; [VijayRaghavan, K.] Govt India, New Delhi, India; [Wolberger, Cynthia] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21218 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Santa Cruz; National Institutes of Health (NIH) - USA; Columbia University; University of California System; University of California Berkeley; University of California System; University of California San Francisco; Johns Hopkins University; McGill University; Rockefeller University; Harvard University; Yale University; New York University; Yale University; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Johns Hopkins University	Vale, RD (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA.; Vale, RD (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA USA.	ron.vale@ucsf.edu	, Harlan/AAI-2875-2020; Berg, Jeremy/GRY-6706-2022; Bourne, Philip/ABG-8967-2021	Berg, Jeremy/0000-0002-2444-8139; Bourne, Philip/0000-0002-7618-7292; Spiro, John/0000-0003-2820-5844; Jones, Chonnettia/0000-0003-3430-8110; Hendricks, Michael/0000-0002-3408-3858; Fraser, James/0000-0002-5080-2859; Kiley, Robert/0000-0003-4733-2558; Wolberger, Cynthia/0000-0001-8578-2969; Lehmann, Ruth/0000-0002-8454-5651; Strasser, Carly/0000-0001-9592-2339; Stebbins, Michael/0000-0003-0941-2805; Berg, Jeremy/0000-0003-3022-0963	Howard Hughes Medical Institute Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030997] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM000928] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		[Anonymous], 2016, WHAT AR PREPR; Arns M, 2014, NATURE, V515, P467, DOI 10.1038/515467a; ASAPbio, 2016, DOC IN PRESS; ASAPbio, 2016, 2016 M; Powell K, 2016, NATURE, V530, P148, DOI 10.1038/530148a; Sense About Science, 2009, PEER REV REP 2009 FI; Vale RD, 2015, P NATL ACAD SCI USA, V112, P13439, DOI 10.1073/pnas.1511912112	7	74	80	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2016	352	6288			SI		899	901		10.1126/science.aaf9133	http://dx.doi.org/10.1126/science.aaf9133			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM2AK	27199406				2022-12-28	WOS:000376147800021
J	Kuld, S; Thorhauge, M; Falsig, H; Elkjaer, CF; Helveg, S; Chorkendorff, I; Sehested, J				Kuld, Sebastian; Thorhauge, Max; Falsig, Hanne; Elkjaer, Christian F.; Helveg, Stig; Chorkendorff, Ib; Sehested, Jens			Quantifying the promotion of Cu catalysts by ZnO for methanol synthesis	SCIENCE			English	Article							METAL-SUPPORT INTERACTIONS; ZINC OXIDE CATALYSTS; CU/ZNO CATALYSTS; COPPER-CATALYSTS; SURFACE ALLOY; ACTIVE-SITE; ALPHA-BRASS; CO2; WATER; DEACTIVATION	Promoter elements enhance the activity and selectivity of heterogeneous catalysts. Here, we show how methanol synthesis from synthesis gas over copper (Cu) nanoparticles is boosted by zinc oxide (ZnO) nanoparticles. By combining surface area titration, electron microscopy, activity measurement, density functional theory calculations, and modeling, we show that the promotion is related to Zn atoms migrating in the Cu surface. The Zn coverage is quantitatively described as a function of the methanol synthesis conditions and of the size-dependent thermodynamic activities of the Cu and ZnO nanoparticles. Moreover, experimental data reveal a strong interdependency of the methanol synthesis activity and the Zn coverage. These results demonstrate the size-dependent activities of nanoparticles as a general means to design synergetic functionality in binary nanoparticle systems.	[Kuld, Sebastian; Thorhauge, Max; Falsig, Hanne; Elkjaer, Christian F.; Helveg, Stig; Sehested, Jens] Haldor Topsoe Res Labs, Haldor Topsoes Alle 1, DK-2800 Lyngby, Denmark; [Elkjaer, Christian F.; Chorkendorff, Ib] Tech Univ Denmark, Dept Phys, CINF, Bldg 312, DK-2800 Lyngby, Denmark	Haldor Topsoe; Technical University of Denmark	Sehested, J (corresponding author), Haldor Topsoe Res Labs, Haldor Topsoes Alle 1, DK-2800 Lyngby, Denmark.	jss@topsoe.dk	Helveg, Stig/AAD-8603-2021; Helveg, Stig/O-7513-2018; Chorkendorff, Ib/C-7282-2008	Helveg, Stig/0000-0002-0328-8295; Chorkendorff, Ib/0000-0003-2738-0325; Falsig, Hanne/0000-0002-2474-4093	Danish National Research Foundation [DNRF54]	Danish National Research Foundation(Danmarks Grundforskningsfond)	We thank P. G. Moses for fruitful discussions and commenting on the work at an early stage. The Center for Individual Nanoparticle Funtionality is sponsored by the Danish National Research Foundation (DNRF54).	Barin I., 1989, THERMODYNAMIC DATA P; Batyrev EB, 2005, J CATAL, V229, P136, DOI 10.1016/j.jcat.2004.10.012; Behrens M, 2012, SCIENCE, V336, P893, DOI [10.1126/science.12198331, 10.1126/science.1219831]; CHINCHEN GC, 1986, APPL CATAL, V25, P101, DOI 10.1016/S0166-9834(00)81226-9; d'Alnoncourt RN, 2006, PHYS CHEM CHEM PHYS, V8, P1525, DOI 10.1039/b515487a; Fichtl MB, 2015, APPL CATAL A-GEN, V502, P262, DOI 10.1016/j.apcata.2015.06.014; Fisher IA, 1999, J CATAL, V184, P357, DOI 10.1006/jcat.1999.2420; Grabow LC, 2011, ACS CATAL, V1, P365, DOI 10.1021/cs200055d; Graciani J, 2014, SCIENCE, V345, P546, DOI 10.1126/science.1253057; Grunwaldt JD, 2000, J CATAL, V194, P452, DOI 10.1006/jcat.2000.2930; Hansen J.B., 2008, HDB HETEROGENEOUS CA; Hansen PL, 2002, SCIENCE, V295, P2053, DOI 10.1126/science.1069325; Honkala K, 2005, SCIENCE, V307, P555, DOI 10.1126/science.1106435; Jansen WPA, 2002, J CATAL, V210, P229, DOI 10.1006/jcat.2002.3679; Kasatkin I., 2007, ANGEW CHEM, V119, P7465, DOI DOI 10.1002/ANGE.200702600; Kuld S, 2014, ANGEW CHEM INT EDIT, V53, P5941, DOI 10.1002/anie.201311073; Kurtz M, 2004, CATAL LETT, V92, P49, DOI 10.1023/B:CATL.0000011085.88267.a6; Kurtz M, 2003, CATAL LETT, V86, P77, DOI 10.1023/A:1022663125977; Liao FL, 2011, ANGEW CHEM INT EDIT, V50, P2162, DOI 10.1002/anie.201007108; Lunkenbein T, 2015, ANGEW CHEM INT EDIT, V54, P4544, DOI 10.1002/anie.201411581; Martin O, 2013, CATAL SCI TECHNOL, V3, P3343, DOI 10.1039/c3cy00573a; MUHLER M, 1994, CATAL LETT, V25, P1, DOI 10.1007/BF00815409; Nakamura J, 2003, TOP CATAL, V22, P277, DOI 10.1023/A:1023588322846; Nakamura J, 1996, STUD SURF SCI CATAL, V101, P1389; Olah GA, 2013, ANGEW CHEM INT EDIT, V52, P104, DOI 10.1002/anie.201204995; Ouyang RH, 2013, J AM CHEM SOC, V135, P1760, DOI 10.1021/ja3087054; RAPPERPORT EJ, 1972, METALL TRANS, V3, P827, DOI 10.1007/BF02647656; Rasmussen DB, 2012, J CATAL, V293, P205, DOI 10.1016/j.jcat.2012.07.001; Sano M, 2002, J PHYS CHEM B, V106, P7627, DOI 10.1021/jp012810i; Schlogl R, 2015, ANGEW CHEM INT EDIT, V54, P3465, DOI 10.1002/anie.201410738; Schumann J, 2015, ACS CATAL, V5, P3260, DOI 10.1021/acscatal.5b00188; SPENCER MS, 1987, SURF SCI, V192, P336, DOI 10.1016/S0039-6028(87)81129-9; SPENCER MS, 1987, SURF SCI, V192, P329, DOI 10.1016/S0039-6028(87)81128-7; Studt F, 2015, CHEMCATCHEM, V7, P1105, DOI 10.1002/cctc.201500123; van Rensburg WJ, 2015, CATAL LETT, V145, P559, DOI 10.1007/s10562-014-1407-1; VANHARDE.R, 1969, SURF SCI, V15, P189, DOI 10.1016/0039-6028(69)90148-4; Vesborg PCK, 2009, J CATAL, V262, P65, DOI 10.1016/j.jcat.2008.11.028; Vitos L, 1998, SURF SCI, V411, P186, DOI 10.1016/S0039-6028(98)00363-X; Yang Y, 2013, J CATAL, V298, P10, DOI 10.1016/j.jcat.2012.10.028; Yang Y, 2015, ACS CATAL, V5, P7328, DOI 10.1021/acscatal.5b02060; Yoshihara J, 1996, J CATAL, V161, P776, DOI 10.1006/jcat.1996.0240	41	409	426	50	834	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2016	352	6288			SI		969	974		10.1126/science.aaf0718	http://dx.doi.org/10.1126/science.aaf0718			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM2AK	27199425				2022-12-28	WOS:000376147800043
J	Haverty, PM; Lin, E; Tan, J; Yu, YH; Lam, B; Lianoglou, S; Neve, RM; Artin, SM; Ettleman, JS; Yauch, RL; Bourgon, R				Haverty, Peter M.; Lin, Eva; Tan, Jenille; Yu, Yihong; Lam, Billy; Lianoglou, Steve; Neve, Richard M.; Artin, Scott M.; Ettleman, Jeff S.; Yauch, Robert L.; Bourgon, Richard			Reproducible pharmacogenomic profiling of cancer cell line panels	NATURE			English	Article							DRUG-SENSITIVITY; BREAST-CANCER; IDENTIFICATION; ANNOTATION; VARIANTS; QUALITY; GENES	The use of large-scale genomic and drug response screening of cancer cell lines depends crucially on the reproducibility of results. Here we consider two previously published screens, plus a later critique of these studies. Using independent data, we show that consistency is achievable, and provide a systematic description of the best laboratory and analysis practices for future studies.	[Haverty, Peter M.; Lianoglou, Steve; Bourgon, Richard] Genentech Inc, Dept Bioinformat & Computat Biol, 1 DNA Way, San Francisco, CA 94080 USA; [Lin, Eva; Tan, Jenille; Yu, Yihong; Lam, Billy; Neve, Richard M.; Artin, Scott M.; Ettleman, Jeff S.; Yauch, Robert L.] Genentech Inc, Dept Discovery Oncol, 1 DNA Way, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Bourgon, R (corresponding author), Genentech Inc, Dept Bioinformat & Computat Biol, 1 DNA Way, San Francisco, CA 94080 USA.	bourgon.richard@gene.com		Lianoglou, Steve/0000-0002-0924-1754; Bourgon, Richard/0000-0002-5890-4374				Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barretina J, 2012, NATURE, V492, P290, DOI 10.1038/nature11735; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Cancer Cell Line Encyclopedia Consortium & Genomics of Drug Sensitivity in Cancer Consortium, 2015, NATURE, V528, P84; Chan GKY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063583; Dawes TD, 2016, JALA-J LAB AUTOM, V21, P64, DOI 10.1177/2211068215590588; Duan ZF, 2005, CANCER CHEMOTH PHARM, V55, P277, DOI 10.1007/s00280-004-0878-y; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; Greshock J, 2010, CANCER RES, V70, P3677, DOI 10.1158/0008-5472.CAN-09-3788; Haibe-Kains B, 2013, NATURE, V504, P389, DOI 10.1038/nature12831; Jiang YT, 2015, J CHROMATOGR A, V1411, P63, DOI 10.1016/j.chroma.2015.07.112; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Sigoillot FD, 2011, ACS CHEM BIOL, V6, P47, DOI 10.1021/cb100358f; Tibshirani R, 2008, BIOSTATISTICS, V9, P18, DOI 10.1093/biostatistics/kxm013; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yourshaw M, 2015, BRIEF BIOINFORM, V16, P255, DOI 10.1093/bib/bbu008; Yu M, 2015, NATURE, V520, P307, DOI 10.1038/nature14397; Zoppoli G, 2012, P NATL ACAD SCI USA, V109, P15030, DOI 10.1073/pnas.1205943109	26	164	165	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					333	+		10.1038/nature17987	http://dx.doi.org/10.1038/nature17987			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0AH	27193678				2022-12-28	WOS:000376004300037
J	Lacy, BE				Lacy, Brian E.			An easier diagnosis	NATURE			English	Editorial Material									[Lacy, Brian E.] Dartmouth Hitchcock Med Ctr, Div Gastroenterol & Hepatol, Lebanon, NH 03756 USA	Dartmouth College	Lacy, BE (corresponding author), Dartmouth Hitchcock Med Ctr, Div Gastroenterol & Hepatol, Lebanon, NH 03756 USA.	brian.e.lacy@hitchcock.org						Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Lovell RM, 2012, CLIN GASTROENTEROL H, V10, P712, DOI 10.1016/j.cgh.2012.02.029; Mearin F., 2016, GASTROENTER IN PRESS; Thompson WG., 1989, GASTROENTEROL INT, V2, P92	4	6	6	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					S107	S107		10.1038/533S107a	http://dx.doi.org/10.1038/533S107a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0AH	27191487				2022-12-28	WOS:000376004300003
J	Ronthal, M; Venna, N; Hunter, GJ; Frosch, MP				Ronthal, Michael; Venna, Nagagopal; Hunter, George J.; Frosch, Matthew P.			Case 15-2016: A 32-Year-Old Man with Olfactory Hallucinations and Paresthesias	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PRIMARY SJOGREN-SYNDROME; BRAIN-TUMORS; SARCOIDOSIS; NEUROSARCOIDOSIS; MANIFESTATIONS; INFLIXIMAB; PROGRESS; LESIONS; MASS		[Ronthal, Michael] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; [Venna, Nagagopal] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Hunter, George J.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Frosch, Matthew P.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Ronthal, Michael; Venna, Nagagopal] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Hunter, George J.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Frosch, Matthew P.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Ronthal, M (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA.; Ronthal, M (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA.		Frosch, Matthew P/ABD-7456-2021	Frosch, Matthew P/0000-0002-3940-9861				Butzen J, 2000, AM J NEURORADIOL, V21, P1213; Chen ES, 2015, CLIN REV ALLERG IMMU, V49, P6, DOI 10.1007/s12016-015-8481-z; Chen ES, 2011, NAT REV RHEUMATOL, V7, P457, DOI 10.1038/nrrheum.2011.93; Chen W, 2008, SEMIN NUCL MED, V38, P240, DOI 10.1053/j.semnuclmed.2008.02.005; Cunliffe CH, 2009, ARCH PATHOL LAB MED, V133, P101, DOI 10.1043/1543-2165-133.1.101; Delalande S, 2004, MEDICINE, V83, P280, DOI 10.1097/01.md.0000141099.53742.16; Drosos AA, 1999, RHEUMATOL INT, V18, P177, DOI 10.1007/s002960050081; Goenka N, 2013, NEUROLOGY, V81, pE61, DOI 10.1212/WNL.0b013e3182a2cc03; Gupta D, 2007, EUR RESPIR J, V30, P508, DOI 10.1183/09031936.00002607; HOCHBERG FH, 1994, CANCER, V74, P3080, DOI 10.1002/1097-0142(19941215)74:12<3080::AID-CNCR2820741203>3.0.CO;2-J; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Jordan HT, 2011, J OCCUP ENVIRON MED, V53, P966, DOI 10.1097/JOM.0b013e31822a3596; Kiroglu Y, 2010, DIAGN INTERV RADIOL, V16, P263, DOI 10.4261/1305-3825.DIR.2626-09.1; Krumholz Allan, 2014, Handb Clin Neurol, V119, P305, DOI 10.1016/B978-0-7020-4086-3.00021-7; LAX F, 1979, NEUROSURGERY, V5, P604, DOI 10.1227/00006123-197911000-00011; Lazow SK, 2011, ORAL MAXIL SURG CLIN, V23, P569, DOI 10.1016/j.coms.2011.08.001; Omuro AMP, 2006, LANCET NEUROL, V5, P937, DOI 10.1016/S1474-4422(06)70597-X; Pereira J, 2011, INTERN MED J, V41, P354, DOI 10.1111/j.1445-5994.2011.02457.x; Sanahuja J, 2008, AM J NEURORADIOL, V29, P1878, DOI 10.3174/ajnr.A1204; Segal BM, 2013, CURR OPIN NEUROL, V26, P307, DOI 10.1097/WCO.0b013e3283608459; Smith JK, 2004, AM J ROENTGENOL, V182, P289, DOI 10.2214/ajr.182.2.1820289; Tavee JO, 2015, CLIN CHEST MED, V36, P643, DOI 10.1016/j.ccm.2015.08.007; Urbach H, 1997, NEURORADIOLOGY, V39, P516, DOI 10.1007/s002340050457; Vecht CJ, 1997, HDB CLIN NEUROLOGY 1, P139; Young GS, 2007, NEUROL CLIN, V25, P947, DOI 10.1016/j.ncl.2007.07.010	25	2	2	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 19	2016	374	20					1966	1975		10.1056/NEJMcpc1516449	http://dx.doi.org/10.1056/NEJMcpc1516449			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM1OX	27192675				2022-12-28	WOS:000376116600011
J	Sarkisyan, KS; Bolotin, DA; Meer, MV; Usmanova, DR; Mishin, AS; Sharonov, GV; Ivankov, DN; Bozhanova, NG; Baranov, MS; Soylemez, O; Bogatyreva, NS; Vlasov, PK; Egorov, ES; Logacheva, MD; Kondrashov, AS; Chudakov, DM; Putintseva, EV; Mamedov, IZ; Tawfik, DS; Lukyanov, KA; Kondrashov, FA				Sarkisyan, Karen S.; Bolotin, Dmitry A.; Meer, Margarita V.; Usmanova, Dinara R.; Mishin, Alexander S.; Sharonov, George V.; Ivankov, Dmitry N.; Bozhanova, Nina G.; Baranov, Mikhail S.; Soylemez, Onuralp; Bogatyreva, Natalya S.; Vlasov, Peter K.; Egorov, Evgeny S.; Logacheva, Maria D.; Kondrashov, Alexey S.; Chudakov, Dmitry M.; Putintseva, Ekaterina V.; Mamedov, Ilgar Z.; Tawfik, Dan S.; Lukyanov, Konstantin A.; Kondrashov, Fyodor A.			Local fitness landscape of the green fluorescent protein	NATURE			English	Article							SEQUENCE SPACE; EVOLUTION; SELECTION; EPISTASIS; MUTATIONS; DOMAIN	Fitness landscapes(1,2) depict how genotypes manifest at the phenotypic level and form the basis of our understanding of many areas of biology(2-7), yet their properties remain elusive. Previous studies have analysed specific genes, often using their function as a proxy for fitness(2,4), experimentally assessing the effect on function of single mutations and their combinations in a specific sequence(2,5,8-15) or in different sequences(2,3,5,16-18). However, systematic high-throughput studies of the local fitness landscape of an entire protein have not yet been reported. Here we visualize an extensive region of the local fitness landscape of the green fluorescent protein from Aequorea victoria (avGFP) by measuring the native function (fluorescence) of tens of thousands of derivative genotypes of avGFP. We show that the fitness landscape of avGFP is narrow, with 3/4 of the derivatives with a single mutation showing reduced fluorescence and half of the derivatives with four mutations being completely non-fluorescent. The narrowness is enhanced by epistasis, which was detected in up to 30% of genotypes with multiple mutations and mostly occurred through the cumulative effect of slightly deleterious mutations causing a threshold-like decrease in protein stability and a concomitant loss of fluorescence. A model of orthologous sequence divergence spanning hundreds of millions of years predicted the extent of epistasis in our data, indicating congruence between the fitness landscape properties at the local and global scales. The characterization of the local fitness landscape of avGFP has important implications for several fields including molecular evolution, population genetics and protein design.	[Sarkisyan, Karen S.; Bolotin, Dmitry A.; Mishin, Alexander S.; Sharonov, George V.; Bozhanova, Nina G.; Baranov, Mikhail S.; Egorov, Evgeny S.; Chudakov, Dmitry M.; Putintseva, Ekaterina V.; Mamedov, Ilgar Z.; Lukyanov, Konstantin A.] Shemyakin Ovchinnikov Inst Bioorgan Chem, Miklukho Maklaya 16-10, Moscow 117997, Russia; [Sarkisyan, Karen S.; Mishin, Alexander S.; Lukyanov, Konstantin A.] Nizhny Novgorod State Med Acad, Minin Sq 10-1, Nizhnii Novgorod 603005, Russia; [Sarkisyan, Karen S.; Bolotin, Dmitry A.; Chudakov, Dmitry M.; Putintseva, Ekaterina V.; Mamedov, Ilgar Z.] Masaryk Univ, Cent European Inst Technol, Brno 62500, Czech Republic; [Sarkisyan, Karen S.; Meer, Margarita V.; Usmanova, Dinara R.; Ivankov, Dmitry N.; Soylemez, Onuralp; Bogatyreva, Natalya S.; Vlasov, Peter K.; Kondrashov, Fyodor A.] Barcelona Inst Sci & Technol, CRG, Bioinformat & Genom Programme, 88 Dr Aiguader, Barcelona 08003, Spain; [Sarkisyan, Karen S.; Meer, Margarita V.; Usmanova, Dinara R.; Ivankov, Dmitry N.; Soylemez, Onuralp; Bogatyreva, Natalya S.; Vlasov, Peter K.; Kondrashov, Fyodor A.] UPF, Barcelona 08003, Spain; [Usmanova, Dinara R.] Moscow Inst Phys & Technol, Inst Pereulok 9, G Dolgoprudny 141700, Russia; [Sharonov, George V.] Moscow MV Lomonosov State Univ, Fac Med, Lomonosov Ave 31-5, Moscow 119192, Russia; [Ivankov, Dmitry N.; Bogatyreva, Natalya S.] Russian Acad Sci, Inst Prot Res, Lab Prot Phys, 4 Inst Skaya Str, Pushchino 142290, Moscow Region, Russia; [Baranov, Mikhail S.; Logacheva, Maria D.] Pirogov Russian Natl Res Med Univ, Ostrovitianov 1, Moscow 117997, Russia; [Logacheva, Maria D.] Russian Acad Sci, AA Kharkevich Inst Informat Transmiss Problems, Moscow 127051, Russia; [Logacheva, Maria D.; Kondrashov, Alexey S.] Moscow MV Lomonosov State Univ, Dept Bioinformat & Bioengn, Moscow 119234, Russia; [Kondrashov, Alexey S.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Tawfik, Dan S.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Kondrashov, Fyodor A.] ICREA, 23 Pg Lluis Companys, Barcelona 08010, Spain	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Privolzhsky Research Medical University; Masaryk University Brno; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Moscow Institute of Physics & Technology; Lomonosov Moscow State University; Russian Academy of Sciences; Pirogov Russian National Research Medical University; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Lomonosov Moscow State University; University of Michigan System; University of Michigan; Weizmann Institute of Science; ICREA	Kondrashov, FA (corresponding author), Barcelona Inst Sci & Technol, CRG, Bioinformat & Genom Programme, 88 Dr Aiguader, Barcelona 08003, Spain.; Kondrashov, FA (corresponding author), UPF, Barcelona 08003, Spain.; Kondrashov, FA (corresponding author), ICREA, 23 Pg Lluis Companys, Barcelona 08010, Spain.	fyodor.kondrashov@crg.es	Sarkisyan, Karen S/M-6821-2015; Mishin, Alexander/L-9420-2014; Lukyanov, Konstantin A/D-4030-2013; Usmanova, Dinara Ravilevna/I-9370-2014; Baranov, Mikhail S/L-5014-2016; Logacheva, Maria/K-5217-2012; Ivankov, Dmitry/AAD-8104-2019; Mamedov, Ilgar Z/H-9559-2014; Sharonov, George V/B-1323-2014; Chudakov, Dmitriy M/G-7741-2014; Sarkisyan, Karen/AAA-5784-2021; Bogatyreva, Natalya S/B-9598-2017; Bolotin, Dmitry A/D-3245-2014; Bolotin, Dmitry/AAN-7763-2020; Putintseva, Ekaterina/M-6818-2015	Sarkisyan, Karen S/0000-0002-5375-6341; Mishin, Alexander/0000-0002-4935-7030; Lukyanov, Konstantin A/0000-0001-9845-2088; Baranov, Mikhail S/0000-0002-9339-7603; Ivankov, Dmitry/0000-0002-8224-4118; Mamedov, Ilgar Z/0000-0002-3992-9285; Sharonov, George V/0000-0001-8610-5054; Chudakov, Dmitriy M/0000-0003-0430-790X; Sarkisyan, Karen/0000-0002-5375-6341; Bolotin, Dmitry A/0000-0002-8484-6067; Bolotin, Dmitry/0000-0002-8484-6067; Bogatyreva, Natalya/0000-0002-1719-1136; Bozhanova, Nina/0000-0002-2164-5698; Putintseva, Ekaterina/0000-0003-4421-3844	Russian Science Foundation [14-50-00150, 14-25-00129]; HHMI International Early Career Scientist Program [55007424]; EMBO Young Investigator Programme; MINECO [BFU2012-31329]; Spanish Ministry of Economy and Competitiveness Centro de Excelencia Severo Ochoa [SEV-2012-0208]; Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat's AGAUR program [2014 SGR 0974]; European Research Council under the European Union's Seventh Framework Programme (ERC) [335980_EinME]; ICREA Funding Source: Custom	Russian Science Foundation(Russian Science Foundation (RSF)); HHMI International Early Career Scientist Program; EMBO Young Investigator Programme(European Molecular Biology Organization (EMBO)); MINECO(Spanish Government); Spanish Ministry of Economy and Competitiveness Centro de Excelencia Severo Ochoa(Spanish Government); Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat's AGAUR program; European Research Council under the European Union's Seventh Framework Programme (ERC)(European Research Council (ERC)); ICREA(ICREA)	We thank Y. Kulikova and G. Filion for discussion on statistical analysis and I. Osterman, R. Moretti and J. Meiler for technical assistance and M. Friesen for a critical reading of the manuscript. We thank H. Himmelbauer, CRG Genomic Unit and the Russian Science Foundation project (14-50-00150) for sequencing. Experiments were partially carried out using the equipment provided by the IBCH core facility (CKP IBCH). The work was supported by HHMI International Early Career Scientist Program (55007424), the EMBO Young Investigator Programme, MINECO (BFU2012-31329), Spanish Ministry of Economy and Competitiveness Centro de Excelencia Severo Ochoa 2013-2017 grant (SEV-2012-0208), Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat's AGAUR program (2014 SGR 0974), Russian Science Foundation (14-25-00129) and the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013, ERC grant agreement, 335980_EinME).	AKASHI H, 1995, GENETICS, V139, P1067; Bank C, 2015, MOL BIOL EVOL, V32, P229, DOI 10.1093/molbev/msu301; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Coates MM, 2006, J EXP BIOL, V209, P3758, DOI 10.1242/jeb.02431; CROW JF, 1979, P NATL ACAD SCI USA, V76, P396, DOI 10.1073/pnas.76.1.396; de Visser JAGM, 2014, NAT REV GENET, V15, P480, DOI 10.1038/nrg3744; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Eyre-Walker A, 2007, NAT REV GENET, V8, P610, DOI 10.1038/nrg2146; Firnberg E, 2014, MOL BIOL EVOL, V31, P1581, DOI 10.1093/molbev/msu081; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Jacquier H, 2013, P NATL ACAD SCI USA, V110, P13067, DOI 10.1073/pnas.1215206110; KIMURA M, 1978, P NATL ACAD SCI USA, V75, P6168, DOI 10.1073/pnas.75.12.6168; Kondrashov AS, 2002, P NATL ACAD SCI USA, V99, P14878, DOI 10.1073/pnas.232565499; LI WH, 1987, J MOL EVOL, V24, P337, DOI 10.1007/BF02134132; Mackay TFC, 2014, NAT REV GENET, V15, P22, DOI 10.1038/nrg3627; Meini MR, 2015, MOL BIOL EVOL, V32, P1774, DOI 10.1093/molbev/msv059; Melamed D, 2013, RNA, V19, P1537, DOI 10.1261/rna.040709.113; MILKMAN R, 1978, GENETICS, V88, P391; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; Olson CA, 2014, CURR BIOL, V24, P2643, DOI 10.1016/j.cub.2014.09.072; Parera M, 2014, MOL BIOL EVOL, V31, P1546, DOI 10.1093/molbev/msu113; Povolotskaya IS, 2010, NATURE, V465, P922, DOI 10.1038/nature09105; Rockah-Shmuel L, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004421; Roscoe BP, 2013, J MOL BIOL, V425, P1363, DOI 10.1016/j.jmb.2013.01.032; Soskine M, 2010, NAT REV GENET, V11, P572, DOI 10.1038/nrg2808; Taylor MB, 2015, TRENDS GENET, V31, P34, DOI 10.1016/j.tig.2014.09.001; Usmanova DR, 2015, MOL BIOL EVOL, V32, P542, DOI 10.1093/molbev/msu318; Weinreich DM, 2013, CURR OPIN GENET DEV, V23, P700, DOI 10.1016/j.gde.2013.10.007; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356	30	203	205	3	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					397	+		10.1038/nature17995	http://dx.doi.org/10.1038/nature17995			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0AH	27193686	Green Accepted			2022-12-28	WOS:000376004300049
J	Taylor, NMI; Prokhorov, NS; Guerrero-Ferreira, RC; Shneider, MM; Browning, C; Goldie, KN; Stahlberg, H; Leiman, PG				Taylor, Nicholas M. I.; Prokhorov, Nikolai S.; Guerrero-Ferreira, Ricardo C.; Shneider, Mikhail M.; Browning, Christopher; Goldie, Kenneth N.; Stahlberg, Henning; Leiman, Petr G.			Structure of the T4 baseplate and its function in triggering sheath contraction	NATURE			English	Article							VI SECRETION SYSTEM; PROTEIN HOMOLOGY DETECTION; BACTERIOPHAGE-T4 BASEPLATE; 3-DIMENSIONAL STRUCTURE; GENETIC-CONTROL; PSEUDOMONAS-AERUGINOSA; TAIL; PHAGE; MORPHOGENESIS; IMPLEMENTATION	Several systems, including contractile tail bacteriophages, the type VI secretion system and R-type pyocins, use a multiprotein tubular apparatus to attach to and penetrate host cell membranes. This macromolecular machine resembles a stretched, coiled spring (or sheath) wound around a rigid tube with a spike-shaped protein at its tip. A baseplate structure, which is arguably the most complex part of this assembly, relays the contraction signal to the sheath. Here we present the atomic structure of the approximately 6-megadalton bacteriophage T4 baseplate in its pre- and post-host attachment states and explain the events that lead to sheath contraction in atomic detail. We establish the identity and function of a minimal set of components that is conserved in all contractile injection systems and show that the triggering mechanism is universally conserved.	[Taylor, Nicholas M. I.; Prokhorov, Nikolai S.; Guerrero-Ferreira, Ricardo C.; Shneider, Mikhail M.; Browning, Christopher; Leiman, Petr G.] Ecole Polytech Fed Lausanne, BSP 415, CH-1015 Lausanne, Switzerland; [Prokhorov, Nikolai S.] Russian Acad Sci, Winogradsky Inst Microbiol, Biotechnol Res Ctr, Pr 60 Letiya Oktyabrya,7 Bldg 2, Moscow 117312, Russia; [Shneider, Mikhail M.] Shemyakin Ovchinnikov Inst Bioorgan Chem, Lab Mol Bioengn, 16-10 Miklukho Maklaya St, Moscow 117997, Russia; [Goldie, Kenneth N.; Stahlberg, Henning] Univ Basel, Ctr Cellular Imaging & NanoAnalyt C CINA, Biozentrum, Mattenstr 26, CH-4058 Basel, Switzerland; [Browning, Christopher] Vertex Pharmaceut Europe Ltd, 86-88 Jubilee Ave,Milton Pk, Abingdon OX14 4RW, Oxon, England	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Research Center of Biotechnology RAS; Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; University of Basel; Vertex Pharmaceuticals	Leiman, PG (corresponding author), Ecole Polytech Fed Lausanne, BSP 415, CH-1015 Lausanne, Switzerland.	petr.leiman@epfl.ch	Shneider, Mikhail/AAL-6817-2020; Leiman, Petr G/E-5120-2010; Taylor, Nicholas/O-6477-2016; Prokhorov, Nikolai/W-9043-2019; Stahlberg, Henning/H-1868-2011	Shneider, Mikhail/0000-0002-3768-3541; Leiman, Petr G/0000-0002-9091-0918; Taylor, Nicholas/0000-0003-0761-4921; Prokhorov, Nikolai/0000-0001-9621-0245; Stahlberg, Henning/0000-0002-1185-4592; Guerrero-Ferreira, Ricardo/0000-0002-3664-8277	EPFL SCITAS (high performance computing); EPFL Centre for Interdisciplinary Electron Microscopy; EPFL Proteomics Core Facility; Swiss National Science Foundation [310030_144243]	EPFL SCITAS (high performance computing); EPFL Centre for Interdisciplinary Electron Microscopy; EPFL Proteomics Core Facility; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank V. Mesyanshinov for developing the initial baseplate-tail tube complex purification protocol; C. Maillard for technical support; A. Brown for advice on structure refinement involving cryo-EM data; D. Demurtas for sample screening by negative stain EM; R. McLeod for help with data transfer; S. Nazarov, M. Plattner, and V. Kostyuchenko for discussions; and M. Basler for reading the manuscript. We acknowledge support from the EPFL SCITAS (high performance computing), the EPFL Centre for Interdisciplinary Electron Microscopy and the EPFL Proteomics Core Facility. The work was supported by the Swiss National Science Foundation grant 310030_144243.	ABULADZE NK, 1994, VIROLOGY, V199, P301, DOI 10.1006/viro.1994.1128; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AFONINE PV, 2013, COMPUT CRYSTALLOGR N, V0004; Aksyuk AA, 2009, STRUCTURE, V17, P800, DOI 10.1016/j.str.2009.04.005; Aksyuk AA, 2009, EMBO J, V28, P821, DOI 10.1038/emboj.2009.36; AMOS LA, 1975, J MOL BIOL, V99, P51, DOI 10.1016/S0022-2836(75)80158-6; Amunts A, 2015, SCIENCE, V348, P95, DOI 10.1126/science.aaa1193; APPLEYARD RK, 1956, VIROLOGY, V2, P565, DOI 10.1016/0042-6822(56)90012-5; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Basler M, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0021; Bonemann G, 2010, MOL MICROBIOL, V76, P815, DOI 10.1111/j.1365-2958.2010.07171.x; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; Browning C, 2012, STRUCTURE, V20, P326, DOI 10.1016/j.str.2011.12.009; Brunet YR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005545; Clemens DL, 2015, CELL, V160, P940, DOI 10.1016/j.cell.2015.02.005; Clokie M.R.J., 2009, BACTERIOPHAGES METHO; Coombs D, 1994, MOL BIOL BACTERIOPHA, P259; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; CROWTHER RA, 1977, J MOL BIOL, V116, P489, DOI 10.1016/0022-2836(77)90081-X; DEROSIER DJ, 1968, NATURE, V217, P130, DOI 10.1038/217130a0; DOERMANN AH, 1948, J BACTERIOL, V55, P257, DOI 10.1128/JB.55.2.257-276.1948; Effantin G, 2013, STRUCTURE, V21, P298, DOI 10.1016/j.str.2012.12.017; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fokine A, 2013, J MOL BIOL, V425, P1731, DOI 10.1016/j.jmb.2013.02.012; Ge P, 2015, NAT STRUCT MOL BIOL, V22, P377, DOI 10.1038/nsmb.2995; Han KY, 2007, PROTEIN ENG DES SEL, V20, P543, DOI 10.1093/protein/gzm055; Heymann JB, 2013, J BIOL CHEM, V288, P25276, DOI 10.1074/jbc.M113.456145; Hu B, 2015, P NATL ACAD SCI USA, V112, pE4919, DOI 10.1073/pnas.1501064112; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; KIKUCHI Y, 1975, J MOL BIOL, V99, P695, DOI 10.1016/S0022-2836(75)80180-X; KIKUCHI Y, 1975, J SUPRAMOL STR CELL, V3, P24, DOI 10.1002/jss.400030104; KIKUCHI Y, 1975, J MOL BIOL, V99, P645, DOI 10.1016/S0022-2836(75)80178-1; KIKUCHI Y, 1975, J MOL BIOL, V99, P673, DOI 10.1016/S0022-2836(75)80179-3; Kostyuchenko VA, 1999, STRUCTURE, V7, P1213, DOI 10.1016/S0969-2126(00)80055-6; Kostyuchenko VA, 2003, NAT STRUCT BIOL, V10, P688, DOI 10.1038/nsb970; Kostyuchenko VA, 2005, NAT STRUCT MOL BIOL, V12, P810, DOI 10.1038/nsmb975; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kudryashev M, 2015, CELL, V160, P952, DOI 10.1016/j.cell.2015.01.037; Leiman PG, 2012, ADV EXP MED BIOL, V726, P93, DOI 10.1007/978-1-4614-0980-9_5; Leiman PG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-355; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Leiman PG, 2004, CELL, V118, P419, DOI 10.1016/j.cell.2004.07.022; Leiman PG, 2000, J MOL BIOL, V301, P975, DOI 10.1006/jmbi.2000.3989; Leiman PG, 2003, J MOL BIOL, V328, P821, DOI 10.1016/S0022-2836(03)00366-8; Leiman PG, 2006, J MOL BIOL, V358, P912, DOI 10.1016/j.jmb.2006.02.058; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liu J, 2011, VIROLOGY, V417, P304, DOI 10.1016/j.virol.2011.06.005; Lossi NS, 2011, MICROBIOL-SGM, V157, P3292, DOI 10.1099/mic.0.051987-0; Maxwell KL, 2014, J BACTERIOL, V196, P2122, DOI 10.1128/JB.01699-14; Nakayama K, 2000, MOL MICROBIOL, V38, P213, DOI 10.1046/j.1365-2958.2000.02135.x; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Sambrook J., 2001, MOL CLONING LAB MANU; Scherer S, 2014, J STRUCT BIOL, V186, P302, DOI 10.1016/j.jsb.2014.03.016; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shikuma NJ, 2014, SCIENCE, V343, P529, DOI 10.1126/science.1246794; Shneider MM, 2013, NATURE, V500, P350, DOI 10.1038/nature12453; Silverman JM, 2013, MOL CELL, V51, P584, DOI 10.1016/j.molcel.2013.07.025; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tao YZ, 1997, STRUCTURE, V5, P789, DOI 10.1016/S0969-2126(97)00233-5; Thomassen E, 2003, J MOL BIOL, V331, P361, DOI 10.1016/s0022-2836(03)00755-1; van Raaij MJ, 2001, J MOL BIOL, V314, P1137, DOI 10.1006/jmbi.2000.5204; Veesler D, 2012, ANNU REV BIOPHYS, V41, P473, DOI 10.1146/annurev-biophys-042910-155407; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; YAMAMOTO T, 1967, J BACTERIOL, V94, P1746, DOI 10.1128/JB.94.5.1746-1756.1967; Yan CY, 2015, SCIENCE, V349, P1182, DOI 10.1126/science.aac7629; Yang G, 2006, J BACTERIOL, V188, P2254, DOI 10.1128/JB.188.6.2254-2261.2006; Yap ML, 2016, P NATL ACAD SCI USA, V113, P2654, DOI 10.1073/pnas.1601654113; Zhao L, 2000, BBA-PROTEIN STRUCT M, V1479, P286, DOI 10.1016/S0167-4838(00)00015-7; Zoued A, 2013, J BIOL CHEM, V288, P27031, DOI 10.1074/jbc.M113.499772	85	155	166	7	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					346	+		10.1038/nature17971	http://dx.doi.org/10.1038/nature17971			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0AH	27193680				2022-12-28	WOS:000376004300039
J	Colloff, E				Colloff, Edwin			The Reality of ICD-10 in the Office	ANNALS OF INTERNAL MEDICINE			English	Letter							INTERNATIONAL CLASSIFICATION; 10TH REVISION		[Colloff, Edwin] Stanford Univ, Vaden Hlth Ctr, Palo Alto, CA 94304 USA	Stanford University	Colloff, E (corresponding author), Stanford Univ, Vaden Hlth Ctr, Palo Alto, CA 94304 USA.							Manaker S, 2015, ANN INTERN MED, V163, P557, DOI 10.7326/M15-1773; Mathews AW, 2011, WALL STREET J; Outland B, 2015, ANN INTERN MED, V163, P554, DOI 10.7326/M15-1933	3	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2016	164	10					700	700		10.7326/L15-0584	http://dx.doi.org/10.7326/L15-0584			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8GF	27182906				2022-12-28	WOS:000375878500022
J	Kimmelman, J; Heslop, HE; Sugarman, J; Studer, L; Benvenisty, N; Caulfield, T; Hyun, I; Murry, CE; Sipp, D; Daley, GQ				Kimmelman, Jonathan; Heslop, Helen E.; Sugarman, Jeremy; Studer, Lorenz; Benvenisty, Nissim; Caulfield, Timothy; Hyun, Insoo; Murry, Charles E.; Sipp, Douglas; Daley, George Q.			New ISSCR guidelines: clinical translation of stem cell research	LANCET			English	Editorial Material									[Kimmelman, Jonathan] McGill Univ, Biomed Eth Unit, Montreal, PQ H3A 1X, Canada; [Heslop, Helen E.] Baylor Coll Med, Houston, TX 77030 USA; [Sugarman, Jeremy] Johns Hopkins Univ, Baltimore, MD USA; [Studer, Lorenz] Sloan Kettering Inst Canc Res, New York, NY USA; [Benvenisty, Nissim] Hebrew Univ Jerusalem, Jerusalem, Israel; [Caulfield, Timothy] Univ Alberta, Edmonton, AB, Canada; [Hyun, Insoo] Case Western Reserve Univ, Sch Med, Cleveland, OH USA; [Murry, Charles E.] Univ Washington, Seattle, WA 98195 USA; [Sipp, Douglas] RIKEN, Ctr Dev Biol, Kobe, Hyogo, Japan; [Sipp, Douglas] Keio Univ, Sch Med, Tokyo, Japan; [Daley, George Q.] Boston Childrens Hosp, Boston, MA USA	McGill University; Baylor College of Medicine; Johns Hopkins University; Memorial Sloan Kettering Cancer Center; Hebrew University of Jerusalem; University of Alberta; Case Western Reserve University; University of Washington; University of Washington Seattle; RIKEN; Keio University; Harvard University; Boston Children's Hospital	Kimmelman, J (corresponding author), McGill Univ, Biomed Eth Unit, Montreal, PQ H3A 1X, Canada.	jonathan.kimmelman@mcgill.ca	Studer, Lorenz/ABH-1491-2021; Heslop, Helen/AAC-9500-2020; Sipp, Douglas/C-9218-2017	Studer, Lorenz/0000-0003-0741-7987; Sugarman, Jeremy/0000-0001-7022-8332; Sipp, Douglas/0000-0002-5979-0938				Antonic A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001738; Brison DR, 2013, REPROD BIOMED ONLINE, V27, P710, DOI 10.1016/j.rbmo.2013.09.006; Couzin-Frankel J, 2014, SCIENCE, V345, P252, DOI 10.1126/science.345.6194.252; Cyranoski D, 2013, NAT MED, V19, P510, DOI 10.1038/nm0513-510; Daley GQ, 2016, STEM CELL REP, V6, P787, DOI 10.1016/j.stemcr.2016.05.001; FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; International Society for Stem Cell Research, 2016, PHYT ROADM RES TRANS; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; London AJ, 2010, SCIENCE, V328, P829, DOI 10.1126/science.1189369; Magnus D, 2010, J LAW MED ETHICS, V38, P267, DOI 10.1111/j.1748-720X.2010.00487.x; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Turner LG, 2015, REGEN MED, V10, P397, DOI [10.2217/RME.15.10, 10.2217/rme.15.10]	13	27	29	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 14	2016	387	10032					1979	1981		10.1016/S0140-6736(16)30390-7	http://dx.doi.org/10.1016/S0140-6736(16)30390-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DL8HJ	27179752				2022-12-28	WOS:000375881500009
J	Cameron, JI; Chu, LM; Matte, A; Tomlinson, G; Chan, L; Thomas, C; Friedrich, JO; Mehta, S; Lamontagne, F; Levasseur, M; Ferguson, ND; Adhikari, NKJ; Rudkowski, JC; Meggison, H; Skrobik, Y; Flannery, J; Bayley, M; Batt, J; dos Santos, C; Abbey, SE; Tan, A; Lo, V; Mathur, S; Parotto, M; Morris, D; Flockhart, L; Fan, E; Lee, CM; Wilcox, ME; Ayas, N; Choong, K; Fowler, R; Scales, DC; Sinuff, T; Cuthbertson, BH; Rose, L; Robles, P; Burns, S; Cypel, M; Singer, L; Chaparro, C; Chow, CW; Keshavjee, S; Brochard, L; Hebert, P; Slutsky, AS; Marshall, JC; Cook, D; Herridge, MS				Cameron, Jill I.; Chu, Leslie M.; Matte, Andrea; Tomlinson, George; Chan, Linda; Thomas, Claire; Friedrich, Jan O.; Mehta, Sangeeta; Lamontagne, Francois; Levasseur, Melanie; Ferguson, Niall D.; Adhikari, Neill K. J.; Rudkowski, Jill C.; Meggison, Hilary; Skrobik, Yoanna; Flannery, John; Bayley, Mark; Batt, Jane; dos Santos, Claudia; Abbey, Susan E.; Tan, Adrienne; Lo, Vincent; Mathur, Sunita; Parotto, Matteo; Morris, Denise; Flockhart, Linda; Fan, Eddy; Lee, Christie M.; Wilcox, M. Elizabeth; Ayas, Najib; Choong, Karen; Fowler, Robert; Scales, Damon C.; Sinuff, Tasnim; Cuthbertson, Brian H.; Rose, Louise; Robles, Priscila; Burns, Stacey; Cypel, Marcelo; Singer, Lianne; Chaparro, Cecilia; Chow, Chung-Wai; Keshavjee, Shaf; Brochard, Laurent; Hebert, Paul; Slutsky, Arthur S.; Marshall, John C.; Cook, Deborah; Herridge, Margaret S.		RECOVER Program Investigators Phas	One-Year Outcomes in Caregivers of Critically Ill Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFORMAL CAREGIVERS; FAMILY CAREGIVERS; STROKE SURVIVORS; NEGATIVE AFFECT; CARE; DEPRESSION; DISTRESS; SYMPTOMS; BURDEN; PREDICTORS	BACKGROUND Few resources are available to support caregivers of patients who have survived critical illness; consequently, the caregivers' own health may suffer. We studied caregiver and patient characteristics to determine which characteristics were associated with caregivers' health outcomes during the first year after patient discharge from an intensive care unit (ICU). METHODS We prospectively enrolled 280 caregivers of patients who had received 7 or more days of mechanical ventilation in an ICU. Using hospital data and self-administered questionnaires, we collected information on caregiver and patient characteristics, including caregiver depressive symptoms, psychological well-being, health-related quality of life, sense of control over life, and effect of providing care on other activities. Assessments occurred 7 days and 3, 6, and 12 months after ICU discharge. RESULTS The caregivers' mean age was 53 years, 70% were women, and 61% were caring for a spouse. A large percentage of caregivers (67% initially and 43% at 1 year) reported high levels of depressive symptoms. Depressive symptoms decreased at least partially with time in 84% of the caregivers but did not in 16%. Variables that were significantly associated with worse mental health outcomes in caregivers were younger age, greater effect of patient care on other activities, less social support, less sense of control over life, and less personal growth. No patient variables were consistently associated with caregiver outcomes over time. CONCLUSIONS In this study, most caregivers of critically ill patients reported high levels of depressive symptoms, which commonly persisted up to 1 year and did not decrease in some caregivers.	[Cameron, Jill I.; Chan, Linda] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Cameron, Jill I.; Mathur, Sunita; Robles, Priscila] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Cameron, Jill I.; Flannery, John; Bayley, Mark] Univ Toronto, Toronto Rehabil Inst, Univ Hlth Network, Toronto, ON, Canada; [Chu, Leslie M.; Matte, Andrea; Tomlinson, George; Thomas, Claire; Ferguson, Niall D.; Flannery, John; Bayley, Mark; Lo, Vincent; Parotto, Matteo; Morris, Denise; Flockhart, Linda; Fan, Eddy; Wilcox, M. Elizabeth; Robles, Priscila; Burns, Stacey; Cypel, Marcelo; Singer, Lianne; Chaparro, Cecilia; Chow, Chung-Wai; Keshavjee, Shaf; Herridge, Margaret S.] Univ Toronto, Inst Med Sci, Dept Med, Toronto Gen Res Inst,Univ Hlth Network, Toronto, ON, Canada; [Friedrich, Jan O.; Mehta, Sangeeta; Ferguson, Niall D.; Adhikari, Neill K. J.; Batt, Jane; dos Santos, Claudia; Parotto, Matteo; Lee, Christie M.; Fowler, Robert; Scales, Damon C.; Sinuff, Tasnim; Cuthbertson, Brian H.; Chaparro, Cecilia; Chow, Chung-Wai; Brochard, Laurent; Slutsky, Arthur S.; Herridge, Margaret S.] Univ Toronto, Interdept Div Crit Care, Toronto, ON, Canada; [Friedrich, Jan O.; Batt, Jane; dos Santos, Claudia; Rose, Louise; Brochard, Laurent; Marshall, John C.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Friedrich, Jan O.; Batt, Jane; dos Santos, Claudia; Rose, Louise; Brochard, Laurent; Marshall, John C.] Univ Toronto, Dept Crit Care, Toronto, ON, Canada; [Brochard, Laurent; Slutsky, Arthur S.; Marshall, John C.] Univ Toronto, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON, Canada; [Mehta, Sangeeta; Lee, Christie M.; Rose, Louise; Singer, Lianne] Univ Toronto, Mt Sinai Hosp, Dept Med & Anesthesia, St Michaels Hosp, Toronto, ON M5G 1X5, Canada; [Adhikari, Neill K. J.; Fowler, Robert; Scales, Damon C.; Sinuff, Tasnim; Cuthbertson, Brian H.; Rose, Louise] Univ Toronto, Dept Crit Care Med, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Flannery, John; Bayley, Mark] Univ Toronto, Interdept Div Physiatry, Toronto, ON, Canada; [Abbey, Susan E.; Tan, Adrienne] Univ Toronto, Univ Hlth Network, Dept Psychiat, Toronto, ON, Canada; [Mathur, Sunita] Univ Toronto, Dept Phys Therapy, Toronto, ON, Canada; [Rudkowski, Jill C.] St Josephs Healthcare, Dept Gen Internal Med, Hamilton, New Zealand; [Rudkowski, Jill C.] St Josephs Healthcare, Dept Crit Care, Hamilton, New Zealand; [Choong, Karen] McMaster Univ, Div Crit Care & Clin Epidemiol & Biostat, Dept Pediat, Hamilton, ON, Canada; [Cook, Deborah] McMaster Univ, Div Crit Care & Clin Epidemiol & Biostat, Dept Med, Hamilton, ON, Canada; [Lamontagne, Francois; Hebert, Paul] Ctr Hosp Univ Sherbrooke, Ctr Rech, Sherbrooke, PQ, Canada; [Levasseur, Melanie] Univ Sherbrooke, Sch Rehabil, Sherbrooke, PQ J1K 2R1, Canada; [Levasseur, Melanie] Univ Sherbrooke, Res Ctr Aging, Hlth & Social Serv Ctr, Sherbrooke, PQ J1K 2R1, Canada; [Meggison, Hilary] Univ Ottawa, Dept Crit Care, Ottawa, ON, Canada; [Skrobik, Yoanna] Univ Montreal, Dept Med, Div Crit Care, Maisonneuve Rosemont Hosp, Montreal, PQ H3C 3J7, Canada; [Ayas, Najib] Univ British Columbia, St Pauls Hosp, Dept Med, Vancouver, BC V5Z 1M9, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Sinai Health System Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; McMaster University; McMaster University; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; University of Ottawa; Universite de Montreal; St. Paul's Hospital; University of British Columbia; University of Saskatchewan	Cameron, JI (corresponding author), Univ Toronto, Rehabil Sci Inst, Fac Med, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5G 1V7, Canada.	jill.cameron@utoronto.ca	Chow, Chung-Wai/AAP-5533-2020; Tomlinson, George A/L-5432-2016; Robles, Priscila G./O-1678-2019; Mehta, Sangeeta/C-4623-2015; Skrobik, Yoanna/K-8165-2014; Ferguson, Niall/D-7619-2019; Rose, Louise/F-4723-2011; Singer, Lianne/E-9962-2019; Slutsky, Arthur/M-3325-2019; Skrobik, Yoanna/J-6393-2013; Choong, Karen/ABB-7867-2021	Chow, Chung-Wai/0000-0001-9344-8522; Tomlinson, George A/0000-0002-9328-6399; Robles, Priscila G./0000-0003-2240-3401; Skrobik, Yoanna/0000-0002-5315-6020; Ferguson, Niall/0000-0002-6213-5264; Singer, Lianne/0000-0002-2693-8676; Choong, Karen/0000-0002-4608-4508; Mathur, Sunita/0000-0001-5564-9796; dos Santos, Claudia/0000-0002-6446-8791; Friedrich, Jan/0000-0001-7248-2350; Levasseur, Melanie/0000-0002-5914-0708; Cameron, Jill/0000-0003-4161-1572; Herridge, Margaret/0000-0002-2903-1631; Parotto, Matteo/0000-0003-1165-4264; Bayley, Mark/0000-0001-7860-9463; Keshavjee, Shaf/0000-0003-4547-8094; Cypel, Marcelo/0000-0001-5652-1938; Lamontagne, Francois/0000-0002-0360-3427; Flannery, John F/0000-0003-3924-4283; Rose, Louise/0000-0003-1700-3972	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funded by the Canadian Institutes of Health Research and others;	Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Cameron JI, 2006, ARCH PHYS MED REHAB, V87, P177, DOI 10.1016/j.apmr.2005.10.012; Cameron JI, 2006, CRIT CARE MED, V34, P81, DOI 10.1097/01.CCM.0000190428.71765.31; Cameron JI, 2002, CANCER-AM CANCER SOC, V94, P521, DOI 10.1002/cncr.10212; Cameron JI, 2008, PATIENT EDUC COUNS, V70, P305, DOI 10.1016/j.pec.2007.10.020; Chari AV, 2015, HEALTH SERV RES, V50, P871, DOI 10.1111/1475-6773.12238; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chelluri L, 2004, CRIT CARE MED, V32, P61, DOI 10.1097/01.CCM.0000098029.65347.F9; Cheung AM, 2006, AM J RESP CRIT CARE, V174, P538, DOI 10.1164/rccm.200505-693OC; Choi J, 2012, CRIT CARE MED, V40, P1546, DOI 10.1097/CCM.0b013e3182451c58; Covinsky KE, 2003, J GEN INTERN MED, V18, P1006, DOI 10.1111/j.1525-1497.2003.30103.x; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; Dos Santos C, 2016, AM J RESP CRIT CARE; Douglas SL, 2005, CHEST, V128, P3925, DOI 10.1378/chest.128.6.3925; Drame M, 2011, J NUTR HEALTH AGING, V15, P399, DOI 10.1007/s12603-011-0004-x; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Enright PL, 1998, AM J RESP CRIT CARE, V158, P1384, DOI 10.1164/ajrccm.158.5.9710086; EVANS RL, 1991, ARCH PHYS MED REHAB, V72, P144; Foster M, 2003, SCAND J CARING SCI, V17, P205, DOI 10.1046/j.1471-6712.2003.00230.x; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Herridge MS, 2016, AM J RESP CRIT CARE; Hollander Marcus J, 2009, Healthc Q, V12, P42; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Im KA, 2004, CHEST, V125, P597, DOI 10.1378/chest.125.2.597; Johnson P, 2001, Intensive Crit Care Nurs, V17, P219, DOI 10.1054/iccn.2001.1577; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lyness JM, 1997, ARCH INTERN MED, V157, P449, DOI 10.1001/archinte.157.4.449; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Muthen B, 1999, BIOMETRICS, V55, P463, DOI 10.1111/j.0006-341X.1999.00463.x; OCZKOWSKI WJ, 1993, ARCH PHYS MED REHAB, V74, P1291, DOI 10.1016/0003-9993(93)90081-K; Patten SB, 2006, CAN J PSYCHIAT, V51, P84, DOI 10.1177/070674370605100204; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; Pochard F, 2005, J CRIT CARE, V20, P90, DOI 10.1016/j.jcrc.2004.11.004; Proust C, 2005, COMPUT METH PROG BIO, V78, P165, DOI 10.1016/j.cmpb.2004.12.004; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Richter P, 1998, PSYCHOPATHOLOGY, V31, P160, DOI 10.1159/000066239; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Singer J.D., 2003, APPL LONGITUDINAL DA; van Buuren S, 2011, J STAT SOFTW, V45, P1; Van Pelt DC, 2007, AM J RESP CRIT CARE, V175, P167, DOI 10.1164/rccm.200604-493OC; Van Pelt DC, 2010, CHEST, V137, P88, DOI 10.1378/chest.09-0795; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P1159, DOI 10.1016/S0895-4356(98)00107-3; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	46	207	212	6	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2016	374	19					1831	1841		10.1056/NEJMoa1511160	http://dx.doi.org/10.1056/NEJMoa1511160			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DL6JS	27168433	Bronze			2022-12-28	WOS:000375746100006
J	Wittenberg, E; Prosser, LA				Wittenberg, Eve; Prosser, Lisa A.			Health as a Family Affair	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SPILLOVER		[Wittenberg, Eve] Harvard Univ, TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA 02115 USA; [Prosser, Lisa A.] Univ Michigan, Dept Pediat & Communicable Dis, Child Hlth Evaluat & Res Unit, Ann Arbor, MI 48109 USA; [Prosser, Lisa A.] Univ Michigan, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Wittenberg, E (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA 02115 USA.							Bobinac A, 2011, MED DECIS MAKING, V31, P292, DOI 10.1177/0272989X10374212; National Alliance for Caregiving & AARP, 2015, CAR US 2015 REP; Perkins M, 2013, J GERONTOL B-PSYCHOL, V68, P504, DOI 10.1093/geronb/gbs084; Prosser LA, 2015, MED DECIS MAKING, V35, P81, DOI 10.1177/0272989X14541328; Wittenberg E, 2013, MED DECIS MAKING, V33, P235, DOI 10.1177/0272989X12464434	5	39	39	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2016	374	19					1804	1806		10.1056/NEJMp1604456	http://dx.doi.org/10.1056/NEJMp1604456			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6JS	27168430				2022-12-28	WOS:000375746100002
J	Figueroa, JF; Tsugawa, Y; Zheng, J; Orav, EJ; Jha, AK				Figueroa, Jose F.; Tsugawa, Yusuke; Zheng, Jie; Orav, E. John; Jha, Ashish K.			Association between the Value-Based Purchasing pay for performance program and patient mortality in US hospitals: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FOR-PERFORMANCE; UNINTENDED CONSEQUENCES; QUALITY; MEDICARE; CARE; OUTCOMES; ENGLAND; IMPACT	OBJECTIVE To determine the impact of the Hospital Value-Based Purchasing (HVBP) program-the US pay for performance program introduced by Medicare to incentivize higher quality care-on 30 day mortality for three incentivized conditions: acute myocardial infarction, heart failure, and pneumonia. DESIGN Observational study. SETTING 4267 acute care hospitals in the United States: 2919 participated in the HVBP program and 1348 were ineligible and used as controls (44 in general hospitals in Maryland and 1304 critical access hospitals across the United States). PARTICIPANTS 2 430 618 patients admitted to US hospitals from 2008 through 2013. MAIN OUTCOME MEASURES 30 day risk adjusted mortality for acute myocardial infarction, heart failure, and pneumonia using a patient level linear spline analysis to examine the association between the introduction of the HVBP program and 30 day mortality. Non-incentivized, medical conditions were the comparators. A secondary outcome measure was to determine whether the introduction of the HVBP program was particularly beneficial for a subgroup of hospital-poor performers at baseline-that may benefit the most. RESULTS Mortality rates of incentivized conditions in hospitals participating in the HVBP program declined at -0.13% for each quarter during the preintervention period and -0.03% point difference for each quarter during the post-intervention period. For non-HVBP hospitals, mortality rates declined at -0.14% point difference for each quarter during the preintervention period and -0.01% point difference for each quarter during the post-intervention period. The difference in the mortality trends between the two groups was small and non-significant (difference in difference in trends -0.03% point difference for each quarter, 95% confidence interval -0.08% to 0.13% point difference, P=0.35). In no subgroups of hospitals was HVBP associated with better outcomes, including poor performers at baseline. CONCLUSIONS Evidence that HVBP has led to lower mortality rates is lacking. Nations considering similar pay for performance programs may want to consider alternative models to achieve improved patient outcomes.	[Figueroa, Jose F.; Tsugawa, Yusuke; Zheng, Jie; Jha, Ashish K.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Orav, E. John] Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Figueroa, Jose F.; Orav, E. John] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Jha, Ashish K.] VA Boston Healthcare Syst, Gen Internal Med Sect, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Jha, AK (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.; Jha, AK (corresponding author), VA Boston Healthcare Syst, Gen Internal Med Sect, Boston, MA USA.	ajha@hsph.harvard.edu		Tsugawa, Yusuke/0000-0002-1937-4833				Bardach NS, 2009, CURR OPIN PEDIATR, V21, P777, DOI 10.1097/MOP.0b013e3283329937; Bratzler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017401; Burwell SM, 2015, NEW ENGL J MED, V372, P897, DOI 10.1056/NEJMp1500445; Casalino LP, 2016, HEALTH AFFAIR, V35, P401, DOI 10.1377/hlthaff.2015.1258; Cashin C, 2014, PAYING PERFORMANCE H; Centers for Medicare Medicaid Services, 2014, HOSP VAL BAS PURCH; Centers of Medicare and Medicaid Services, 2015, BETT CAR SMART SPEND; Chen TT, 2011, HEALTH SERV RES, V46, P47, DOI 10.1111/j.1475-6773.2010.01182.x; Conrad DA, 2010, PERFORMANCE MEASUREM, P582, DOI [10.1017/CBO9780511711800.021, DOI 10.1017/CBO9780511711800.021]; Cutler DM, 2015, JAMA-J AM MED ASSOC, V313, P1606, DOI 10.1001/jama.2015.1926; Eappen S, 2013, JAMA-J AM MED ASSOC, V309, P1599, DOI 10.1001/jama.2013.2773; Eijkenaar F, 2013, HEALTH POLICY, V110, P115, DOI 10.1016/j.healthpol.2013.01.008; Glickman SW, 2007, JAMA-J AM MED ASSOC, V297, P2373, DOI 10.1001/jama.297.21.2373; Government of Greenland, 2015, GAO REPORT, P1; Jha AK, 2013, JAMA-J AM MED ASSOC, V309, P347, DOI 10.1001/jama.2012.196646; Jha AK, 2012, NEW ENGL J MED, V366, P1606, DOI 10.1056/NEJMsa1112351; Joynt KE, 2012, JAMA-J AM MED ASSOC, V308, P1460, DOI 10.1001/jama.2012.12922; Kontopantelis E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h904; Kristensen SR, 2015, HEALTH POLICY, V119, P264, DOI 10.1016/j.healthpol.2014.12.009; Kristensen SR, 2014, NEW ENGL J MED, V371, P540, DOI 10.1056/NEJMoa1400962; Lester HE, 2011, BMJ QUAL SAF, V20, P1057, DOI 10.1136/bmjqs.2010.048371; Li PX, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-245; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Lindenauer PK, 2012, JAMA-J AM MED ASSOC, V307, P1405, DOI 10.1001/jama.2012.384; QualityNet, 2016, HOSP VAL BAS PURCH O; Rau J., 2015, KAISER HLTH NEWS; Rosenthal MB, 2006, MED CARE RES REV, V63, P135, DOI 10.1177/1077558705285291; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Rosenthal MB, 2004, HEALTH AFFAIR, V23, P127, DOI 10.1377/hlthaff.23.2.127; Ryan AM, 2015, HEALTH SERV RES, V50, P81, DOI 10.1111/1475-6773.12206; Ryan AM, 2012, HEALTH AFFAIR, V31, P585, DOI 10.1377/hlthaff.2011.0719; TVERSKY A, 1986, J BUS, V59, pS251, DOI 10.1086/296365; VanLare JM, 2012, NEW ENGL J MED, V367, P292, DOI 10.1056/NEJMp1204939; Werner RM, 2012, HEALTH AFFAIR, V31, P1932, DOI 10.1377/hlthaff.2011.0990; Werner RM, 2011, HEALTH AFFAIR, V30, P690, DOI 10.1377/hlthaff.2010.1277	35	74	75	0	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 9	2016	353								i2214	10.1136/bmj.i2214	http://dx.doi.org/10.1136/bmj.i2214			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DM6EX	27160187	hybrid, Green Published			2022-12-28	WOS:000376444500001
J	Hauer, KE; Clauser, J; Lipner, RS; Holmboe, ES; Caverzagie, K; Hamstra, SJ; Hood, S; Iobst, W; Warm, E; McDonald, FS				Hauer, Karen E.; Clauser, Jerome; Lipner, Rebecca S.; Holmboe, Eric S.; Caverzagie, Kelly; Hamstra, Stanley J.; Hood, Sarah; Iobst, William; Warm, Eric; McDonald, Furman S.			The Internal Medicine Reporting Milestones: Cross-sectional Description of Initial Implementation in US Residency Programs	ANNALS OF INTERNAL MEDICINE			English	Article							ACCREDITATION SYSTEM; CLINICAL COMPETENCE; EDUCATION	Background: High-quality assessment of resident performance is needed to guide individual residents' development and ensure their preparedness to provide patient care. To facilitate this aim, reporting milestones are now required across all internal medicine (IM) residency programs. Objective: To describe initial milestone ratings for the population of IM residents by IM residency programs. Design: Cross-sectional study. Setting: IM residency programs. Participants: All IM residents whose residency program directors submitted milestone data at the end of the 2013-2014 academic year. Measurements: Ratings addressed 6 competencies and 22 subcompetencies. A rating of "not assessable" indicated insufficient information to evaluate the given subcompetency. Descriptive statistics were calculated to describe ratings across competencies and training years. Results: Data were available for all 21 774 U.S. IM residents from all 383 programs. Overall, 2889 residents (1621 in postgraduate year 1 [PGY-1], 902 in PGY-2, and 366 in PGY-3) had at least 1 subcompetency rated as not assessable. Summaries of average ratings by competency and training year showed higher ratings for PGY-3 residents in all competencies. Overall ratings for each of the 6 individual competencies showed that fewer than 1% of third-year residents were rated as "unsatisfactory" or "conditional on improvement." However, when subcompetency milestone ratings were used, 861 residents (12.8%) who successfully completed training had at least 1 competency with all corresponding subcompetencies graded below the threshold of "readiness for unsupervised practice." Limitation: Data were derived from a point in time in the first reporting period in which milestones were used. Conclusion: The initial milestone-based evaluations of IM residents nationally suggest that documenting developmental progression of competency is possible over training years. Subcompetencies may identify areas in which residents might benefit from additional feedback and experience. Future work is needed to explore how milestones are used to support residents' development and enhance residency curricula.	[Hauer, Karen E.] Univ Calif San Francisco, Med, 533 Parnassus Ave,U80,Box 0710, San Francisco, CA 94143 USA; [Clauser, Jerome] Amer Board Internal Med, 510 Walnut St,Suite 1700, Philadelphia, PA 19106 USA; [Lipner, Rebecca S.] Amer Board Internal Med, Assessment & Res, 510 Walnut St,Suite 1700, Philadelphia, PA 19106 USA; [Hood, Sarah] Amer Board Internal Med, Initial Certificat, 510 Walnut St,Suite 1700, Philadelphia, PA 19106 USA; [McDonald, Furman S.] Amer Board Internal Med, Acad & Med Affairs, 510 Walnut St,Suite 1700, Philadelphia, PA 19106 USA; [McDonald, Furman S.] Amer Board Internal Med, Med, 510 Walnut St,Suite 1700, Philadelphia, PA 19106 USA; [Holmboe, Eric S.] Accreditat Council Grad Med Educ, Milestones Dev & Evaluat, 515 North State St, Chicago, IL 60654 USA; [Caverzagie, Kelly] Univ Nebraska, Coll Med, Internal Med, 986430 Nebraska Med Ctr, Omaha, NE 68198 USA; [Iobst, William] Commonwealth Med Coll, Acad & Clin Affairs, 525 Pine St, Scranton, PA 18509 USA; Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Warm, Eric] Univ Cincinnati, Med, 234 Albert Sabin Way,ML 0557, Cincinnati, OH 45267 USA	University of California System; University of California San Francisco; American Board of Internal Medicine; American Board of Internal Medicine; American Board of Internal Medicine; American Board of Internal Medicine; American Board of Internal Medicine; University of Nebraska System; Geisinger Commonwealth School of Medicine; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Hauer, KE (corresponding author), Univ Calif San Francisco, 533 Parnassus Ave,U80,Box 0710, San Francisco, CA 94143 USA.	karen.hauer@ucsf.edu	Hamstra, Stanley/A-3808-2016; Hamstra, Stanley/N-1310-2019	Hamstra, Stanley/0000-0002-0680-366X; Hamstra, Stanley/0000-0002-0680-366X	ABIM	ABIM	Dr. Hauer reports that she received consulting fees to work with the ABIM on the preparation of this analysis and manuscript. Dr. Lipner reports employment at the ABIM. Dr. Holmboe reports royalties from Mosby-Elsevier and employment with the ACGME outside the submitted work and membership on the board of the National Board of Medical Examiners. Dr. Iobst reports that he led the milestones writing group that developed the IM milestones while he was employed at the ABIM. Authors not named here have disclosed no conflicts of interest. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M15-2411.	Beeson MS, 2015, ACAD EMERG MED, V22, P838, DOI 10.1111/acem.12697; Boulware DR, 2010, J GEN INTERN MED, V25, P25, DOI 10.1007/s11606-009-1142-2; Carraccio CL, 2013, ACAD MED, V88, P1067, DOI 10.1097/ACM.0b013e318299396f; Caverzagie KJ, 2013, ANN INTERN MED, V158, P557, DOI 10.7326/0003-4819-158-7-201304020-00593; Cook D. A., 2006, AM J MED, V119, DOI [10.1016/j.amjmed.2005.10.036, DOI 10.1016/J.AMJMED.2005.10.036]; Eden J., 2014, GRADUATE MED ED MEET; Englander R, 2013, ACAD MED, V88, P1088, DOI 10.1097/ACM.0b013e31829a3b2b; Frank JR, 2010, MED TEACH, V32, P638, DOI 10.3109/0142159X.2010.501190; Friedman KA, 2014, MED EDUC ONLINE, V19, DOI 10.3402/meo.v19.25185; Guntupalli SR, 2015, OBSTET GYNECOL, V126, P559, DOI 10.1097/AOG.0000000000000999; HABER RJ, 1994, J GEN INTERN MED, V9, P140, DOI 10.1007/BF02600028; Hauer KE, 2015, ACAD MED, V90, P1084, DOI 10.1097/ACM.0000000000000736; Hawkins RE, 2015, MED EDUC, V49, P1086, DOI 10.1111/medu.12831; Malik Mohammad U, 2012, J Grad Med Educ, V4, P425, DOI 10.4300/JGME-D-11-00222.1; Mattar SG, 2013, ANN SURG, V258, P440, DOI 10.1097/SLA.0b013e3182a191ca; Messick S., 1995, EDUC MEAS-ISSUES PRA, V14, P5, DOI [10.1111/j.1745-3992.1995.tb00881.x, DOI 10.1111/J.1745-3992.1995.TB00881.X]; Mourad M, 2010, J GEN INTERN MED, V25, P351, DOI 10.1007/s11606-009-1226-z; Nasca TJ, 2012, NEW ENGL J MED, V366, P1051, DOI 10.1056/NEJMsr1200117; NASCA TJ, 2008, ACGME B, P2; Stillman MD, 2014, ANN INTERN MED, V160, P800, DOI 10.7326/M13-2358; Swing Susan R, 2013, J Grad Med Educ, V5, P98, DOI 10.4300/JGME-05-01-33; Tekian A, 2015, MED TEACH, V37, P399, DOI 10.3109/0142159X.2014.993954; Warm EJ, 2014, J GEN INTERN MED, V29, P1177, DOI 10.1007/s11606-014-2801-5; Weinberger SE, 2010, ANN INTERN MED, V153, P751, DOI 10.7326/0003-4819-153-11-201012070-00009	24	29	29	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 6	2016	165	5					356	+		10.7326/M15-2411	http://dx.doi.org/10.7326/M15-2411			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3BC	27159244				2022-12-28	WOS:000382795000005
J	Rothwell, PM; Algra, A; Chen, ZM; Diener, HC; Norrving, B; Mehta, Z				Rothwell, Peter M.; Algra, Ale; Chen, Zhengming; Diener, Hans-Christoph; Norrving, Bo; Mehta, Ziyah			Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials	LANCET			English	Article							TEST PUBLIC-EDUCATION; CEREBRAL-BLOOD-FLOW; MINOR STROKE; DOUBLE-BLIND; SECONDARY PREVENTION; URGENT TREATMENT; CLOPIDOGREL; TIA; IMPACT; VALIDATION	Background Aspirin is recommended for secondary prevention after transient ischaemic attack (TIA) or ischaemic stroke on the basis of trials showing a 13% reduction in long-term risk of recurrent stroke. However, the risk of major stroke is very high for only the first few days after TIA and minor ischaemic stroke, and observational studies show substantially greater benefits of early medical treatment in the acute phase than do longer-term trials. We hypothesised that the short-term benefits of early aspirin have been underestimated. Methods Pooling the individual patient data from all randomised trials of aspirin versus control in secondary prevention after TIA or ischaemic stroke, we studied the effects of aspirin on the risk and severity of recurrent stroke, stratified by the following time periods: less than 6 weeks, 6-12 weeks, and more than 12 weeks after randomisation. We compared the severity of early recurrent strokes between treatment groups with shift analysis of modified Rankin Scale (mRS) score. To understand possible mechanisms of action, we also studied the time course of the interaction between effects of aspirin and dipyridamole in secondary prevention of stroke. In a further analysis we pooled data from trials of aspirin versus control in which patients were randomised less than 48 h after major acute stroke, stratified by severity of baseline neurological deficit, to establish the very early time course of the effect of aspirin on risk of recurrent ischaemic stroke and how this differs by severity at baseline. Findings We pooled data for 15 778 participants from 12 trials of aspirin versus control in secondary prevention. Aspirin reduced the 6 week risk of recurrent ischaemic stroke by about 60% (84 of 8452 participants in the aspirin group had an ischaemic stroke vs 175 of 7326; hazard ratio [HR] 0.42, 95% CI 0.32-0.55, p<0.0001) and disabling or fatal ischaemic stroke by about 70% (36 of 8452 vs 110 of 7326; 0.29, 0.20-0.42, p<0.0001), with greatest benefit noted in patients presenting with TIA or minor stroke (at 0-2 weeks, two of 6691 participants in the aspirin group with TIA or minor stroke had a disabling or fatal ischaemic stroke vs 23 of 5726 in the control group, HR 0.07, 95% CI 0.02-0.31, p=0.0004; at 0-6 weeks, 14 vs 60 participants, 0.19, 0.11-0.34, p<0.0001). The effect of aspirin on early recurrent ischaemic stroke was due partly to a substantial reduction in severity (mRS shift analysis odds ratio [OR] 0.42, 0.26-0.70, p=0.0007). These effects were independent of dose, patient characteristics, or aetiology of TIA or stroke. Some further reduction in risk of ischaemic stroke accrued for aspirin only versus control from 6-12 weeks, but there was no benefit after 12 weeks (stroke risk OR 0.97, 0.84-1.12, p=0.67; severity mRS shift OR 1.00, 0.77-1.29, p=0.97). By contrast, dipyridamole plus aspirin versus aspirin alone had no effect on risk or severity of recurrent ischaemic stroke within 12 weeks (OR 0.90, 95% CI 0.65-1.25, p=0.53; mRS shift OR 0.90, 0.37-1.72, p=0.99), but dipyridamole did reduce risk thereafter (0.76, 0.63-0.92, p=0.005), particularly of disabling or fatal ischaemic stroke (0.64, 0.49-0.84, p=0.0010). We pooled data for 40 531 participants from three trials of aspirin versus control in major acute stroke. The reduction in risk of recurrent ischaemic stroke at 14 days was most evident in patients with less severe baseline deficits, and was substantial by the second day after starting treatment (2-3 day HR 0.37, 95% CI 0.25-0.57, p<0.0001). Interpretation Our findings confirm that medical treatment substantially reduces the risk of early recurrent stroke after TIA and minor stroke and identify aspirin as the key intervention. The considerable early benefit from aspirin warrants public education about self-administration after possible TIA. The previously unrecognised effect of aspirin on severity of early recurrent stroke, the diminishing benefit with longer-term use, and the contrasting time course of effects of dipyridamole have implications for understanding mechanisms of action. Copyright (C) Rothwell et al. Open Access article distributed under the terms of CC BY.	[Rothwell, Peter M.; Mehta, Ziyah] Univ Oxford, Nuffield Dept Clin Neurosci, Stroke Prevent Res Unit, Oxford, England; [Algra, Ale] Univ Med Ctr Utrecht, Dept Neurol, Rudolph Magnus Inst Neurosci, Utrecht, Netherlands; [Algra, Ale] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Chen, Zhengming] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Diener, Hans-Christoph] Univ Duisburg Essen, Dept Neurol, Essen, Germany; [Norrving, Bo] Lund Univ, Neurol Sect, Dept Clin Sci, S-22100 Lund, Sweden	University of Oxford; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Oxford; University of Duisburg Essen; Lund University	Rothwell, PM (corresponding author), John Radcliffe Hosp, Stroke Prevent Res Unit, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England.	peter.rothwell@clneuro.ox.ac.uk	Rothwell, Peter/ABE-5913-2020; Diener, Hans-Christoph/AAF-7275-2019	Rothwell, Peter/0000-0001-9739-9211; 	Wellcome Trust; National Institute of Health Research (NIHR) Biomedical Research Centre, Oxford; National Institute for Health Research [NF-SI-0514-10168] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Health Research (NIHR) Biomedical Research Centre, Oxford(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	Wellcome Trust, the National Institute of Health Research (NIHR) Biomedical Research Centre, Oxford.	Algra A, 1996, J NEUROL NEUROSUR PS, V60, P197, DOI 10.1136/jnnp.60.2.197; [Anonymous], 1988, LANCET, V2, P349; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Bath PMW, 2010, STROKE, V41, P732, DOI 10.1161/STROKEAHA.109.564906; Bousser MG, 2011, LANCET, V377, P2013, DOI 10.1016/S0140-6736(11)60600-4; British Heart Foundation, HEART ATT; Chandratheva A, 2009, NEUROLOGY, V72, P1941, DOI 10.1212/WNL.0b013e3181a826ad; Chandratheva A, 2010, STROKE, V41, P1108, DOI 10.1161/STROKEAHA.109.576611; Chen ZM, 1997, LANCET, V349, P1641, DOI 10.1016/S0140-6736(97)04010-5; Chen ZM, 2000, STROKE, V31, P1240, DOI 10.1161/01.STR.31.6.1240; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Coull AJ, 2004, BMJ-BRIT MED J, V328, P326, DOI 10.1136/bmj.37991.635266.44; De Schryver EL, 2007, COCHRANE DB SYST REV, V3; Diener HC, 2013, LANCET NEUROL, V12, P677, DOI 10.1016/S1474-4422(13)70101-7; Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Flynn D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104289; FRITH PA, 1988, THROMB RES, V49, P463, DOI 10.1016/S0049-3848(98)90003-2; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Giles MF, 2007, LANCET NEUROL, V6, P1063, DOI 10.1016/S1474-4422(07)70274-0; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Huang YI, 2008, LANCET NEUROL, V7, P494, DOI 10.1016/S1474-4422(08)70094-2; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Johnston SC, 2000, JAMA-J AM MED ASSOC, V284, P2901, DOI 10.1001/jama.284.22.2901; Keir SL, 2002, CEREBROVASC DIS, V14, P197, DOI 10.1159/000065661; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Lasserson DS, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1569; Lavallee PC, 2007, LANCET NEUROL, V6, P953, DOI 10.1016/S1474-4422(07)70248-X; Lovelock CE, 2009, INT J STROKE, V4, P6, DOI 10.1111/j.1747-4949.2009.00238.x; Luengo-Fernandez R, 2009, LANCET NEUROL, V8, P235, DOI 10.1016/S1474-4422(09)70019-5; MARKUS HS, 1994, STROKE, V25, P1760, DOI 10.1161/01.STR.25.9.1760; O'Kane PD, 2003, CARDIOVASC RES, V59, P152, DOI 10.1016/S0008-6363(03)00323-7; Roden-Jullig A, 2003, J INTERN MED, V254, P584, DOI 10.1111/j.1365-2796.2003.01233.x; RODENJULLIG A, 1994, J INTERN MED, V236, P125; Rothwell PM, 2007, LANCET, V370, P1432, DOI 10.1016/S0140-6736(07)61448-2; Rothwell PM, 2011, LANCET, V377, P1681, DOI 10.1016/S0140-6736(11)60516-3; Sacco RL, 2008, NEW ENGL J MED, V359, P1238, DOI 10.1056/NEJMoa0805002; Sandercock P, 1997, LANCET, V349, P1569; Sandercock PAG, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000029.pub3; SATTERFIELD S, 1990, AM J PREV MED, V6, P290, DOI 10.1016/S0749-3797(18)30997-8; Shinohara Y, 2010, LANCET NEUROL, V9, P959, DOI 10.1016/S1474-4422(10)70198-8; Wang XW, 2015, NEUROLOGY, V85, P573, DOI 10.1212/WNL.0000000000001844; Wang YJ, 2013, NEW ENGL J MED, V369, P11, DOI 10.1056/NEJMoa1215340; Wardlaw JM, 2003, J NEUROL NEUROSUR PS, V74, P77, DOI 10.1136/jnnp.74.1.77; Wolters FJ, 2013, CEREBROVASC DIS, V35, P719; Wolters FJ, 2015, INT J STROKE, V10, P1108, DOI 10.1111/ijs.12484; Zhang QH, 2015, CEREBROVASC DIS, V39, P13, DOI 10.1159/000369778; Zinkstok SM, 2012, LANCET, V380, P731, DOI 10.1016/S0140-6736(12)60949-0	48	234	241	2	39	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2016	388	10042					365	375		10.1016/S0140-6736(16)30468-8	http://dx.doi.org/10.1016/S0140-6736(16)30468-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR6MV	27209146	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000380016900040
J	Cummings, KJ; Choi, MJ; Esswein, EJ; de Perio, MA; Harney, JM; Chung, WM; Lakey, DL; Liddell, AM; Rollin, PE				Cummings, Kristin J.; Choi, Mary J.; Esswein, Eric J.; de Perio, Marie A.; Harney, Joshua M.; Chung, Wendy M.; Lakey, David L.; Liddell, Allison M.; Rollin, Pierre E.			Addressing Infection Prevention and Control in the First US Community Hospital to Care for Patients With Ebola Virus Disease: Context for National Recommendations and Future Strategies	ANNALS OF INTERNAL MEDICINE			English	Review							UNITED-STATES; HEMORRHAGIC-FEVER; MANAGEMENT; CLUSTER; EXPERIENCE; EPIDEMIC; OUTBREAK; WORKERS; KIKWIT; CONGO	Health care personnel (HCP) caring for patients with Ebola virus disease (EVD) are at increased risk for infection with the virus. In 2014, a Texas hospital became the first U.S. community hospital to care for a patient with EVD; 2 nurses were infected while providing care. This article describes infection control measures developed to strengthen the hospital's capacity to safely diagnose and treat patients with EVD. After admission of the first patient with EVD, a multidisciplinary team from the Centers for Disease Control and Prevention (CDC) joined the hospital's infection preventionists to implement a system of occupational safety and health controls for direct patient care, handling of clinical specimens, and managing regulated medical waste. Existing engineering and administrative controls were strengthened. The personal protective equipment (PPE) ensemble was standardized, HCP were trained on donning and doffing PPE, and a system of trained observers supervising PPE donning and doffing was implemented. Caring for patients with EVD placed substantial demands on a community hospital. The experiences of the authors and others informed national policies for the care of patients with EVD and protection of HCP, including new guidance for PPE, a rapid system for deploying CDC staff to assist hospitals ("Ebola Response Team"), and a framework for a tiered approach to hospital preparedness. The designation of regional Ebola treatment centers and the establishment of the National Ebola Training and Education Center address the need for HCP to be prepared to safely care for patients with EVD and other high-consequence emerging infectious diseases.	[Cummings, Kristin J.] NIOSH, Ctr Dis Control & Prevent, 1095 Willowdale Rd,MS 2800, Morgantown, WV 26505 USA; [Choi, Mary J.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, 1600 Clifton Rd, Atlanta, GA 30333 USA; [Esswein, Eric J.] NIOSH, Ctr Dis Control & Prevent, Western States Div, Denver Fed Ctr, POB 25226, Denver, CO USA; Univ Witwatersrand, Johannesburg, South Africa; [de Perio, Marie A.; Harney, Joshua M.] NIOSH, Ctr Dis Control & Prevent, 1090 Tusculum Ave,R-10, Cincinnati, OH 45226 USA; [Chung, Wendy M.] Dallas Cty Dept Hlth & Human Serv, 2377 North Stemmons Freeway,502, Dallas, TX 75207 USA; [Liddell, Allison M.] Texas Hlth Presbyterian Hosp Dallas, 8230 Walnut Hill Lane,Suite 308, Dallas, TX 76231 USA; Texas Dept State Hlth Serv, Austin, TX USA; [Lakey, David L.] Dept State Hlth Serv, 601 Colorado St,Suite 201, Austin, TX 78701 USA; [Rollin, Pierre E.] Ctr Dis Control & Prevent, Viral Special Pathogens Branch, MS G-14,1600 Clifton Rd, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); University of Witwatersrand; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Texas Department of State Health Services; Centers for Disease Control & Prevention - USA	Cummings, KJ (corresponding author), NIOSH, Ctr Dis Control & Prevent, 1095 Willowdale Rd,MS 2800, Morgantown, WV 26505 USA.		choi, mary/AAV-9456-2020	Rollin, Pierre/0000-0002-4608-2641	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Financial Support: By the Centers for Disease Control and Prevention.	American Conference of Governmental Industrial Hygienists, 2013, IND VENT MAN REC PRA; [Anonymous], 2015, INT GUID US HOSP PRE; Berdan B, 2014, EBOLA EVENTS TEXAS H; Center for Disease Control, 2014, 2014 EB OUTBR W AFR; Centers for Disease Control and Prevention, 2014, REV HUM TO HUM TRANS; Centers for Disease Control and Prevention, 2015, GUID PERS PROT EQ PP; Centers for Disease Control and Prevention, 2015, CURR EB TREATM CTR; Centers for Disease Control and Prevention, 2014, UPD NEW YORK CIT CDC; Centers for Disease Control and Prevention, 2014, EB VIR DIS TRANSM; Centers for Disease Control and Prevention, 2016, VIR EC GRAPH; Centres for Disease Control and Prevention (CDC), 2015, INF PREV CONTR REC H; Chevalier MS, 2014, MMWR-MORBID MORTAL W, V63, P1087; Chung WM, 2015, ANN INTERN MED, V163, P164, DOI 10.7326/M15-0968; Connor MJ, 2015, J AM SOC NEPHROL, V26, P31, DOI 10.1681/ASN.2014111057; Cortese D, EXPERT PANEL REPORT; Emory Healthcare, 2014, EM HEALTHC LAUNCH EB; Fischer WA, 2014, ANN INTERN MED, V161, P753, DOI 10.7326/M14-1953; Frieden TR, 2015, EMERG INFECT DIS, V21, P1897, DOI 10.3201/eid2111.150949; Guimard Y, 1999, J INFECT DIS, V179, pS268, DOI 10.1086/514315; Hewlett AL, 2015, CURR OPIN INFECT DIS, V28, P343, DOI 10.1097/QCO.0000000000000176; Isakov A, 2014, ANN INTERN MED, V161, P829, DOI 10.7326/M14-2084; Johnson DW, 2015, CRIT CARE MED, V43, P1157, DOI 10.1097/CCM.0000000000000935; Kerstiens B, 1999, J INFECT DIS, V179, pS263, DOI 10.1086/514320; Liddell AM, 2015, ANN INTERN MED, V163, P81, DOI 10.7326/M15-0530; Lowe JJ, 2015, AM J INFECT CONTROL, V43, P747, DOI 10.1016/j.ajic.2015.03.006; Lyon GM, 2014, NEW ENGL J MED, V371, P2402, DOI 10.1056/NEJMoa1409838; *OCC SAF HLTH ADM, PERS PROT EQ; Occupational Safety & Health Administration, 2016, HAZ PREV CONTR; Shigayeva A, 2007, INFECT CONT HOSP EP, V28, P1275, DOI 10.1086/521661; Smith PW, 2015, AM J INFECT CONTROL, V43, P441, DOI 10.1016/j.ajic.2015.01.019; University of Nebraska Medical Center, 2014, PPE DONN DOFF EB PAT; World Health Organization, 2014, FAC GUID INF PREV CO; World Health Organization, 2015, EB SIT REP	33	14	14	1	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2016	165	1					41	+		10.7326/M15-2944	http://dx.doi.org/10.7326/M15-2944			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ5AD	27159355				2022-12-28	WOS:000379215800006
J	Bierer, BE; Li, R; Barnes, M; Sim, I				Bierer, Barbara E.; Li, Rebecca; Barnes, Mark; Sim, Ida			A Global, Neutral Platform for Sharing Trial Data	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bierer, Barbara E.; Li, Rebecca; Barnes, Mark] Brigham & Womens Hosp, Multireg Clin Trials Ctr, 75 Francis St, Boston, MA 02115 USA; [Bierer, Barbara E.; Li, Rebecca; Barnes, Mark] Harvard Univ, Cambridge, MA 02138 USA; [Bierer, Barbara E.; Li, Rebecca] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Bierer, Barbara E.; Li, Rebecca] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Bierer, Barbara E.; Li, Rebecca; Barnes, Mark] Harvard Univ, Sch Med, Ctr Bioeth, Boston, MA 02115 USA; [Barnes, Mark] Yale Univ, Sch Law, Boston, MA USA; [Sim, Ida] Univ Calif San Francisco, San Francisco, CA 94143 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Yale University; University of California System; University of California San Francisco	Bierer, BE (corresponding author), Brigham & Womens Hosp, Multireg Clin Trials Ctr, 75 Francis St, Boston, MA 02115 USA.; Bierer, BE (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.; Bierer, BE (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.; Bierer, BE (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA.; Bierer, BE (corresponding author), Harvard Univ, Sch Med, Ctr Bioeth, Boston, MA 02115 USA.			Bierer, Barbara/0000-0001-6448-8170				Institute of Medicine, 2015, SHAR CLIN TRIAL DAT; Taichman DB, 2016, NEW ENGL J MED, V374, P384, DOI 10.1056/NEJMe1515172	2	68	68	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2016	374	25					2411	2413		10.1056/NEJMp1605348	http://dx.doi.org/10.1056/NEJMp1605348			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DP1TG	27168194	Bronze			2022-12-28	WOS:000378271700003
J	Howorka, S				Howorka, Stefan			Changing of the guard	SCIENCE			English	Editorial Material							DNA NANOSTRUCTURES; MEMBRANE; VESICLES; ARRAYS		[Howorka, Stefan] UCL, Dept Chem, Inst Struct Mol Biol, London WC1H 0AJ, England	University of London; Birkbeck University London; University College London	Howorka, S (corresponding author), UCL, Dept Chem, Inst Struct Mol Biol, London WC1H 0AJ, England.	s.howorka@ucl.ac.uk		Howorka, Stefan/0000-0002-6527-2846	Biotechnology and Biological Sciences Research Council [BB/N017331/1, BB/M025373/1, BB/M012700/1] Funding Source: Medline; Engineering and Physical Sciences Research Council [EP/N009282/1] Funding Source: researchfish; BBSRC [BB/M025373/1, BB/M012700/1, BB/N017331/1] Funding Source: UKRI; EPSRC [EP/N009282/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Bombelli FB, 2009, SOFT MATTER, V5, P1639, DOI 10.1039/b816716h; Burns JR, 2016, NAT NANOTECHNOL, V11, P152, DOI [10.1038/NNANO.2015.279, 10.1038/nnano.2015.279]; Burns JR, 2013, NANO LETT, V13, P2351, DOI 10.1021/nl304147f; Chen YJ, 2015, NAT NANOTECHNOL, V10, P748, DOI [10.1038/NNANO.2015.195, 10.1038/nnano.2015.195]; Czogalla A, 2015, ANGEW CHEM INT EDIT, V54, P6501, DOI 10.1002/anie.201501173; Gopfrich K, 2015, NANO LETT, V15, P3134, DOI 10.1021/acs.nanolett.5b00189; Johnson-Buck A, 2014, ACS NANO, V8, P5641, DOI 10.1021/nn500108k; Kocabey S, 2015, ACS NANO, V9, P3530, DOI 10.1021/acsnano.5b00161; Langecker M, 2012, SCIENCE, V338, P932, DOI 10.1126/science.1225624; Perrault SD, 2014, ACS NANO, V8, P5132, DOI 10.1021/nn5011914; Seifert A, 2015, ACS NANO, V9, P1117, DOI 10.1021/nn5039433; Weitz M, 2014, NAT CHEM, V6, P295, DOI [10.1038/NCHEM.1869, 10.1038/nchem.1869]; Xu WM, 2016, J AM CHEM SOC, V138, P4439, DOI 10.1021/jacs.5b13107; Yang Y, 2016, NAT CHEM, V8, P476, DOI [10.1038/nchem.2472, 10.1038/NCHEM.2472]; Yoshina-Ishii C, 2003, J AM CHEM SOC, V125, P3696, DOI 10.1021/ja029783+	15	43	45	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2016	352	6288			SI		890	891		10.1126/science.aaf5154	http://dx.doi.org/10.1126/science.aaf5154			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM2AK	27199400				2022-12-28	WOS:000376147800015
J	Wang, YL; Xiao, ZL; Snezhko, A; Xu, J; Ocola, LE; Divan, R; Pearson, JE; Crabtree, GW; Kwok, WK				Wang, Yong-Lei; Xiao, Zhi-Li; Snezhko, Alexey; Xu, Jing; Ocola, Leonidas E.; Divan, Ralu; Pearson, John E.; Crabtree, George W.; Kwok, Wai-Kwong			Rewritable artificial magnetic charge ice	SCIENCE			English	Article							DOT CELLULAR-AUTOMATA; SPIN-ICE; LOGIC GATE; FRUSTRATION; ELECTRONS; LATTICE	Artificial ices enable the study of geometrical frustration by design and through direct observation. However, it has proven difficult to achieve tailored long-range ordering of their diverse configurations, limiting both fundamental and applied research directions. We designed an artificial spin structure that produces a magnetic charge ice with tunable long-range ordering of eight different configurations. We also developed a technique to precisely manipulate the local magnetic charge states and demonstrate write-read-erase multifunctionality at room temperature. This globally reconfigurable and locally writable magnetic charge ice could provide a setting for designing magnetic monopole defects, tailoring magnonics, and controlling the properties of other two-dimensional materials.	[Wang, Yong-Lei; Xiao, Zhi-Li; Snezhko, Alexey; Xu, Jing; Pearson, John E.; Crabtree, George W.; Kwok, Wai-Kwong] Argonne Natl Lab, Div Mat Sci, 9700 S Cass Ave, Argonne, IL 60439 USA; [Wang, Yong-Lei] Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA; [Xiao, Zhi-Li; Xu, Jing] No Illinois Univ, Dept Phys, De Kalb, IL 60115 USA; [Ocola, Leonidas E.; Divan, Ralu] Argonne Natl Lab, Ctr Nanoscale Mat, 9700 S Cass Ave, Argonne, IL 60439 USA; [Crabtree, George W.] Univ Illinois, Dept Phys, Chicago, IL 60607 USA; [Crabtree, George W.] Univ Illinois, Dept Elect & Comp Engn, Chicago, IL 60607 USA; [Crabtree, George W.] Univ Illinois, Dept Mech & Ind Engn, Chicago, IL 60607 USA	United States Department of Energy (DOE); Argonne National Laboratory; University of Notre Dame; Northern Illinois University; United States Department of Energy (DOE); Argonne National Laboratory; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Wang, YL; Xiao, ZL (corresponding author), Argonne Natl Lab, Div Mat Sci, 9700 S Cass Ave, Argonne, IL 60439 USA.; Wang, YL (corresponding author), Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA.; Xiao, ZL (corresponding author), No Illinois Univ, Dept Phys, De Kalb, IL 60115 USA.	ylwang@anl.gov; xiao@anl.gov	Pearson, John/R-6356-2018; Wang, Yong-Lei/N-7940-2013; Xu, Jing/B-3798-2019; Snezhko, Alexey/S-3758-2017	Pearson, John/0000-0001-7552-9353; Wang, Yong-Lei/0000-0003-0391-7757; Xu, Jing/0000-0003-0160-7616; Snezhko, Alexey/0000-0001-5634-6228; Kwok, Wai-Kwong/0000-0003-0030-084X	U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division; NSF [DMR-1407175]; DOE, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Division Of Materials Research [1407175] Funding Source: National Science Foundation	U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division; NSF(National Science Foundation (NSF)); DOE, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank W. J. Jiang, S. Zhang, W. Zhang, and M. P. Smylie for critical comments. This work was supported by the U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division. Z.-L.X. and J.X. were supported by NSF grant no. DMR-1407175. Use of the Center for Nanoscale Materials, an Office of Science user facility, was supported by the DOE, Office of Science, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357.	Amlani I, 1999, SCIENCE, V284, P289, DOI 10.1126/science.284.5412.289; Anghinolfi L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9278; Bardea A, 2009, SMALL, V5, P316, DOI 10.1002/smll.200801058; Branford WR, 2012, SCIENCE, V335, P1597, DOI 10.1126/science.1211379; Budrikis Z, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.037203; Budrikis Z, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.017201; Castelnovo C, 2008, NATURE, V451, P42, DOI 10.1038/nature06433; Chern GW, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.177201; Farhan A, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.057204; Gilbert I, 2016, NAT PHYS, V12, P162, DOI [10.1038/nphys3520, 10.1038/NPHYS3520]; Gilbert I, 2014, NAT PHYS, V10, P671, DOI [10.1038/NPHYS3037, 10.1038/nphys3037]; Heyderman LJ, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/36/363201; Heyderman LJ, 2013, NAT NANOTECHNOL, V8, P705, DOI 10.1038/nnano.2013.193; Imre A, 2006, SCIENCE, V311, P205, DOI 10.1126/science.1120506; Kapaklis V, 2014, NAT NANOTECHNOL, V9, P514, DOI [10.1038/NNANO.2014.104, 10.1038/nnano.2014.104]; Ke X, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.037205; Krawczyk M, 2014, J PHYS-CONDENS MAT, V26, DOI 10.1088/0953-8984/26/12/123202; Ladak S, 2010, NAT PHYS, V6, P359, DOI 10.1038/NPHYS1628; Libal A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.228302; Libal A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.237004; Mengotti E, 2011, NAT PHYS, V7, P68, DOI [10.1038/nphys1794, 10.1038/NPHYS1794]; Moller G, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.140409; Morgan JP, 2011, NAT PHYS, V7, P75, DOI 10.1038/NPHYS1853; Nisoli C, 2013, REV MOD PHYS, V85, P1473, DOI 10.1103/RevModPhys.85.1473; Nisoli C, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.047205; Nisoli C, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.217203; Phatak C, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.174431; Remhof A, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.134409; Schumann A, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3463482; Singha A, 2011, SCIENCE, V332, P1176, DOI 10.1126/science.1204333; Taillefumier M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.085427; Trastoy J, 2014, NAT NANOTECHNOL, V9, P710, DOI [10.1038/NNANO.2014.158, 10.1038/nnano.2014.158]; Wang RF, 2006, NATURE, V439, P303, DOI 10.1038/nature04447; YE PD, 1995, PHYS REV LETT, V74, P3013, DOI 10.1103/PhysRevLett.74.3013; Zhang S, 2013, NATURE, V500, P553, DOI 10.1038/nature12399	36	98	98	6	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2016	352	6288			SI		962	966		10.1126/science.aad8037	http://dx.doi.org/10.1126/science.aad8037			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM2AK	27199423	Green Submitted			2022-12-28	WOS:000376147800041
J	Kmietowicz, Z				Kmietowicz, Zosia			Patient care worsens as NHS deficits persist	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Appleby J, 2016, 19 KINGS FUND; Iacobucci G, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6430; O'Dowd A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1444	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2016	353								i2866	10.1136/bmj.i2866	http://dx.doi.org/10.1136/bmj.i2866			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GD	27198695				2022-12-28	WOS:000376447700023
J	Laschke, MW; Menger, MD				Laschke, Matthias W.; Menger, Michael D.			Bioengineered vascular grafts off the shelf	LANCET			English	Editorial Material							HEMODIALYSIS ACCESS		[Laschke, Matthias W.; Menger, Michael D.] Univ Saarland, Inst Clin & Expt Surg, D-66421 Homburg, Germany	Saarland University	Laschke, MW (corresponding author), Univ Saarland, Inst Clin & Expt Surg, D-66421 Homburg, Germany.	matthias.laschke@uks.eu						Dahl SLM, 2011, TRENDS CARDIOVAS MED, V21, P83, DOI 10.1016/j.tcm.2012.03.004; Dahl SLM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001426; Dukkipati R, 2013, SEMIN DIALYSIS, V26, P233, DOI 10.1111/j.1525-139X.2012.01106.x; Lawson JH, 2016, LANCET, V387, P2026, DOI 10.1016/S0140-6736(16)00557-2; Manson RJ, 2012, SEMIN NEPHROL, V32, P582, DOI 10.1016/j.semnephrol.2012.10.010; Palumbo R, 2009, NEPHRON CLIN PRACT, V113, pC76, DOI 10.1159/000228538; Peck MK, 2011, J VASC ACCESS, V12, P185, DOI 10.5301/JVA.2011.6451; Roy-Chaudhury P, 2001, KIDNEY INT, V59, P2325, DOI 10.1046/j.1523-1755.2001.00750.x; Schinstock CA, 2011, CLIN J AM SOC NEPHRO, V6, P1996, DOI 10.2215/CJN.11251210; Shemesh D, 2015, J VASC SURG, V62, P115, DOI 10.1016/j.jvs.2015.01.056; United States Renal Data System, 2015, 2015 USRDS ANN DAT R; Wystrychowski W, 2014, J VASC SURG, V60, P1353, DOI 10.1016/j.jvs.2013.08.018	12	4	4	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 14	2016	387	10032					1976	1978		10.1016/S0140-6736(16)30180-5	http://dx.doi.org/10.1016/S0140-6736(16)30180-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8HJ	27203754				2022-12-28	WOS:000375881500007
J	McGilvray, A				McGilvray, Annabel			Fresh hunting ground	NATURE			English	Editorial Material																			0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					S65	S67		10.1038/533S65a	http://dx.doi.org/10.1038/533S65a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0BJ	27167395	Bronze			2022-12-28	WOS:000376007200006
J	Chan, E; Fogler, JM; Hammerness, PG				Chan, Eugenia; Fogler, Jason M.; Hammerness, Paul G.			Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							DEFICIT HYPERACTIVITY DISORDER; GUANFACINE EXTENDED-RELEASE; SCHOOL-BASED TREATMENT; RANDOMIZED CONTROLLED-TRIALS; STIMULANT MEDICATION; DOUBLE-BLIND; YOUNG ADOLESCENTS; CHILDHOOD ADHD; MENTAL-HEALTH; CHILDREN	IMPORTANCE Although attention-deficit/hyperactivity disorder (ADHD) is highly prevalent in adolescents and often persists into adulthood, most studies about treatment were performed in children. Less is known about ADHD treatment in adolescents. OBJECTIVE To review the evidence for pharmacological and psychosocial treatment of ADHD in adolescents. EVIDENCE REVIEW The databases of CINAHL Plus, MEDLINE, PsycINFO, ERIC, and the Cochrane Database of Systematic Reviews were searched for articles published between January 1, 1999, and January 31, 2016, on ADHD treatment in adolescents. Additional studies were identified by hand-searching reference lists of retrieved articles. Study quality was rated using McMaster University Effective Public Health Practice Project criteria. The evidence level for treatment recommendations was based on Oxford Centre for Evidence-Based Medicine criteria. FINDINGS Sixteen randomized clinical trials and 1meta-analysis, involving 2668 participants, of pharmacological and psychosocial treatments for ADHD in adolescents aged 12 years to 18 years were included. Evidence of efficacy was stronger for the extended-release methylphenidate and amphetamine class stimulant medications (level 1B based on Oxford Centre for Evidence-Based Medicine criteria) and atomoxetine than for the extended-release alpha(2)-adrenergic agonists guanfacine or clonidine (no studies). For the primary efficacy measure of total symptom score on the ADHD Rating Scale (score range, 0 [least symptomatic] to 54 [most symptomatic]), both stimulant and nonstimulant medications led to clinically significant reductions of 14.93 to 24.60 absolute points. The psychosocial treatments combining behavioral, cognitive behavioral, and skills training techniques demonstrated small-to medium-sized improvements (range for mean SD difference in Cohen d, 0.30-0.69) for parent-rated ADHD symptoms, co-occurring emotional or behavioral symptoms, and interpersonal functioning. Psychosocial treatments were associated with more robust (Cohen d range, 0.51-5.15) improvements in academic and organizational skills, such as homework completion and planner use. CONCLUSIONS AND RELEVANCE Evidence supports the use of extended-release methylphenidate and amphetamine formulations, atomoxetine, and extended-release guanfacine to improve symptoms of ADHD in adolescents. Psychosocial treatments incorporating behavior contingency management, motivational enhancement, and academic, organizational, and social skills training techniques were associated with inconsistent effects on ADHD symptoms and greater benefit for academic and organizational skills. Additional treatment studies in adolescents, including combined pharmacological and psychosocial treatments, are needed.	[Chan, Eugenia; Fogler, Jason M.] Boston Childrens Hosp, Div Dev Med, 300 Longwood Ave, Boston, MA 02115 USA; [Fogler, Jason M.; Hammerness, Paul G.] Boston Childrens Hosp, Dept Psychiat, Boston, MA USA; [Chan, Eugenia; Fogler, Jason M.; Hammerness, Paul G.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Chan, E (corresponding author), Boston Childrens Hosp, Div Dev Med, 300 Longwood Ave, Boston, MA 02115 USA.	eugenia.chan@childrens.harvard.edu						Adler L, 2004, PSYCHIAT CLIN N AM, V27, P187, DOI 10.1016/j.psc.2003.12.003; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Barbaresi WJ, 2013, PEDIATRICS, V131, P637, DOI 10.1542/peds.2012-2354; Benson K, 2015, CLIN CHILD FAM PSYCH, V18, P50, DOI 10.1007/s10567-014-0177-z; Biederman J, 2008, PEDIATRICS, V121, pE73, DOI 10.1542/peds.2006-3695; Bloch MH, 2014, J AM ACAD CHILD PSY, V53, P135, DOI 10.1016/j.jaac.2013.12.001; Boyer BE, 2015, EUR CHILD ADOLES PSY, V24, P1075, DOI 10.1007/s00787-014-0661-5; Brook JS, 2013, PEDIATRICS, V131, P5, DOI 10.1542/peds.2012-1725; Chan E, 2002, ARCH PEDIAT ADOL MED, V156, P504, DOI 10.1001/archpedi.156.5.504; Childress AC, 2014, CNS DRUGS, V28, P121, DOI 10.1007/s40263-013-0130-6; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Daley D, 2014, J AM ACAD CHILD ADOL, V53, pe1; Daley D, 2014, J AM ACAD CHILD PSY, V53, P835, DOI 10.1016/j.jaac.2014.05.013; Doshi JA, 2012, J AM ACAD CHILD PSY, V51, P990, DOI 10.1016/j.jaac.2012.07.008; DuPaul G. J., 1998, ADHD RATING SCALE 4; Evans SW, 2007, SCHOOL PSYCHOL REV, V36, P256; Evans SW, 2018, J CLIN CHILD ADOLESC, V47, P157, DOI 10.1080/15374416.2017.1390757; Evans SW, 2016, J CONSULT CLIN PSYCH, V84, P15, DOI 10.1037/ccp0000057; Evans SW, 2014, CHILD ADOL PSYCH CL, V23, P699, DOI 10.1016/j.chc.2014.05.004; Evans SW, 2014, SCHOOL PSYCHOL REV, V43, P185; Evans SW, 2011, BEHAV THER, V42, P462, DOI 10.1016/j.beth.2010.11.008; Fabiano GA, 2015, CLIN CHILD FAM PSYCH, V18, P77, DOI 10.1007/s10567-015-0178-6; Findling RL, 2011, J AM ACAD CHILD PSY, V50, P395, DOI 10.1016/j.jaac.2011.01.007; Findling RL, 2010, CNS SPECTRUMS, V15, P419, DOI 10.1017/S1092852900000353; Freeman G., 2013, SUMMARY HLTH STAT US; Goodman D., 2010, PRIMARY PSYCHIAT, V17, P44; Greenhill L, 2006, J AM ACAD CHILD PSY, V45, P1284, DOI 10.1097/01.chi.0000235077.32661.61; Groenman AP, 2013, BRIT J PSYCHIAT, V203, P112, DOI 10.1192/bjp.bp.112.124784; Harstad E, 2014, PEDIATRICS, V134, pE293, DOI 10.1542/peds.2014-0992; Hinshaw SP, 2007, J PEDIATR PSYCHOL, V32, P664, DOI 10.1093/jpepsy/jsl055; Hirota T, 2014, J AM ACAD CHILD PSY, V53, P153, DOI 10.1016/j.jaac.2013.11.009; Hodgkins P, 2012, CNS DRUGS, V26, P245, DOI 10.2165/11599630-000000000-00000; Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555; Humphreys KL, 2013, JAMA PSYCHIAT, V70, P740, DOI 10.1001/jamapsychiatry.2013.1273; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1073; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Langberg JM, 2012, SCHOOL PSYCHOL REV, V41, P342; Lee SS, 2011, CLIN PSYCHOL REV, V31, P328, DOI 10.1016/j.cpr.2011.01.006; Lundahl B, 2009, J CLIN PSYCHOL, V65, P1232, DOI 10.1002/jclp.20638; Maneeton B, 2015, DRUG DES DEV THER, V9, P1927, DOI 10.2147/DDDT.S79071; Maneeton N, 2015, NEUROPSYCH DIS TREAT, V11, P2943, DOI 10.2147/NDT.S91765; Meyer K, 2007, CHILD FAM BEHAV THER, V29, P25, DOI 10.1300/J019v29n04_02; Mick E, 2004, PSYCHIAT CLIN N AM, V27, P215, DOI 10.1016/j.psc.2004.01.003; Molina BSG, 2008, J ATTEN DISORD, V12, P207, DOI 10.1177/1087054707311666; Nutt DJ, 2007, J PSYCHOPHARMACOL, V21, P10, DOI 10.1177/0269881106073219; Olfson M, 2015, JAMA PSYCHIAT, V72, P867, DOI 10.1001/jamapsychiatry.2015.0500; Owens EB, 2003, J CONSULT CLIN PSYCH, V71, P540, DOI 10.1037/0022-006X.71.3.540; Pliszka S, 2007, J AM ACAD CHILD PSY, V46, P894, DOI 10.1097/chi.0b013e318054e724; Sallee F, 2013, J CHILD ADOL PSYCHOP, V23, P308, DOI 10.1089/cap.2013.0028; Sibley MH, 2014, CLIN PSYCHOL REV, V34, P218, DOI 10.1016/j.cpr.2014.02.001; Sibley MH, 2013, J PSYCHOPATHOL BEHAV, V35, P436, DOI 10.1007/s10862-013-9353-6; Sonuga-Barke EJS, 2013, AM J PSYCHIAT, V170, P275, DOI 10.1176/appi.ajp.2012.12070991; Spencer TJ, 2009, J CHILD ADOL PSYCHOP, V19, P501, DOI 10.1089/cap.2008.0152; Spencer TJ, 2006, CLIN THER, V28, P266, DOI 10.1016/j.clinthera.2006.02.011; Turgay A, 2012, J CLIN PSYCHIAT, V73, P192, DOI 10.4088/JCP.10m06628; Vidal R, 2015, J AM ACAD CHILD PSY, V54, P275, DOI 10.1016/j.jaac.2014.12.016; Visser SN, 2015, J PEDIATR-US, V166, P1423, DOI 10.1016/j.jpeds.2015.02.018; Volkow ND, 2003, AM J PSYCHIAT, V160, P1909, DOI 10.1176/appi.ajp.160.11.1909; Wietecha LA, 2009, J CHILD ADOL PSYCHOP, V19, P719, DOI 10.1089/cap.2008.074; Wilens TE, 2006, J AM ACAD CHILD PSY, V45, P149, DOI 10.1097/01.chi.0000190352.90946.0b; Wilens TE, 2006, ARCH PEDIAT ADOL MED, V160, P82, DOI 10.1001/archpedi.160.1.82; Wilens TE, 2015, J AM ACAD CHILD PSY, V54, P916, DOI 10.1016/j.jaac.2015.08.016; Wolraich M, 2011, PEDIATRICS, V128, P1007, DOI 10.1542/peds.2011-2654; Wolraich ML, 1996, CLASSIFICATION CHILD; Wong ICK, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13490; Wong ICK, 2009, HEALTH TECHNOL ASSES, V13, pix; Yoshimasu K, 2012, J CHILD PSYCHOL PSYC, V53, P1036, DOI 10.1111/j.1469-7610.2012.02567.x; Zhang S, 2005, INT J METH PSYCH RES, V14, P186, DOI 10.1002/mpr.7; Zuvekas SH, 2012, AM J PSYCHIAT, V169, P160, DOI 10.1176/appi.ajp.2011.11030387; Zwi M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003018.pub3	70	154	159	2	98	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 10	2016	315	18					1997	2008		10.1001/jama.2016.5453	http://dx.doi.org/10.1001/jama.2016.5453			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DL2JP	27163988				2022-12-28	WOS:000375461100017
J	Indolfi, G; Mangone, G; Bartolini, E; Moriondo, M; Azzari, C; Resti, M				Indolfi, Giuseppe; Mangone, Giusi; Bartolini, Elisa; Moriondo, Maria; Azzari, Chiara; Resti, Massimo			Hepatitis C viraemia after apparent spontaneous clearance in a vertically infected child	LANCET			English	Editorial Material									[Indolfi, Giuseppe; Bartolini, Elisa; Resti, Massimo] Meyer Childrens Univ Hosp Florence, Paediat & Liver Unit, I-50139 Florence, Italy; [Mangone, Giusi; Moriondo, Maria; Azzari, Chiara] Meyer Childrens Univ Hosp Florence, Immunol Unit & Lab, I-50139 Florence, Italy; [Moriondo, Maria; Azzari, Chiara] Univ Florence, Dept Hlth Sci, Florence, Italy	University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Florence	Indolfi, G (corresponding author), Meyer Childrens Univ Hosp Florence, Paediat & Liver Unit, I-50139 Florence, Italy.	g.indolfi@meyer.it	Moriondo, Maria/AAB-7883-2019; Mangone, Giusi/K-5330-2016; Resti, Massimo/AAB-8756-2019; Indolfi, Giuseppe/AAK-5548-2020; Azzari, Chiara/AAB-8584-2019	Moriondo, Maria/0000-0001-9653-8371; Mangone, Giusi/0000-0002-9322-1069; Resti, Massimo/0000-0001-6350-1361; Indolfi, Giuseppe/0000-0003-3830-9823; Azzari, Chiara/0000-0001-7236-1655				Honegger JR, 2013, NAT MED, V19, P1529, DOI 10.1038/nm.3351; Lin A, 2008, J MED VIROL, V80, P1720, DOI 10.1002/jmv.21257; Maheshwari A, 2008, LANCET, V372, P321, DOI 10.1016/S0140-6736(08)61116-2; Resti M, 2003, DIGEST LIVER DIS, V35, P453, DOI 10.1016/S1590-8658(03)00217-2; Veerapu NS, 2011, GASTROENTEROLOGY, V140, P676, DOI 10.1053/j.gastro.2010.10.048	5	14	15	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2016	387	10031					1967	1968						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DL1EE	27203660	Green Published			2022-12-28	WOS:000375374200041
J	Wang, CC; Schmid, CH; Iversen, MD; Harvey, WF; Fielding, RA; Driban, JB; Price, LL; Wong, JB; Reid, KF; Rones, R; McAlindon, T				Wang, Chenchen; Schmid, Christopher H.; Iversen, Maura D.; Harvey, William F.; Fielding, Roger A.; Driban, Jeffrey B.; Price, Lori Lyn; Wong, John B.; Reid, Kieran F.; Rones, Ramel; McAlindon, Timothy			Comparative Effectiveness of Tai Chi Versus Physical Therapy for Knee Osteoarthritis	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; CLINICAL-TRIALS; PAIN; FIBROMYALGIA; ARTHRITIS; OUTCOMES; HIP; INTERVENTIONS; RELIABILITY; DISABILITY	Background: Few remedies effectively treat long-term pain and disability from knee osteoarthritis. Studies suggest that Tai Chi alleviates symptoms, but no trials have directly compared Tai Chi with standard therapies for osteoarthritis. Objective: To compare Tai Chi with standard physical therapy for patients with knee osteoarthritis. Design: Randomized, 52-week, single-blind comparative effectiveness trial. (ClinicalTrials.gov:NCT01258985) Setting: An urban tertiary care academic hospital. Patients: 204 participants with symptomatic knee osteoarthritis (mean age, 60 years; 70% women; 53% white). Intervention: Tai Chi (2 times per week for 12 weeks) or standard physical therapy (2 times per week for 6 weeks, followed by 6 weeks of monitored home exercise). Measurements: The primary outcome was Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score at 12 weeks. Secondary outcomes included physical function, depression, medication use, and quality of life. Results: At 12 weeks, the WOMAC score was substantially reduced in both groups (Tai Chi, 167 points [ 95% CI, 145 to 190 points]; physical therapy, 143 points [ CI, 119 to 167 points]). The between-group difference was not significant (24 points [ CI, - 10 to 58 points]). Both groups also showed similar clinically significant improvement in most secondary outcomes, and the benefits were maintained up to 52 weeks. Of note, the Tai Chi group had significantly greater improvements in depression and the physical component of quality of life. The benefit of Tai Chi was consistent across instructors. No serious adverse events occurred. Limitation: Patients were aware of their treatment group assignment, and the generalizability of the findings to other settings remains undetermined. Conclusion: Tai Chi produced beneficial effects similar to those of a standard course of physical therapy in the treatment of knee osteoarthritis.	[Wang, Chenchen] Tufts Med Ctr, 800 Washington St,Box 406, Boston, MA 02111 USA; [Wang, Chenchen] Tufts Univ, Sch Med, 800 Washington St,Box 406, Boston, MA 02111 USA; Tufts Univ, Boston, MA 02111 USA; Northeastern Univ, Boston, MA 02115 USA; Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; Harvard Med Sch, Boston, MA USA; Ctr Mind Body Therapies, Boston, MA USA; Brown Univ, Sch Publ Hlth, Providence, RI 02912 USA; [Schmid, Christopher H.] Brown Univ, Sch Publ Hlth, Ctr Evidence Based Med, 121 South Main St,Box G-S121-8, Providence, RI 02912 USA; [Iversen, Maura D.] Northeastern Univ, Dept Phys Therapy Movement & Rehabil Sci, 360 Huntington Ave,Room 301c, Boston, MA 02115 USA; [Harvey, William F.; Driban, Jeffrey B.; McAlindon, Timothy] Tufts Univ, Sch Med, Tufts Med Ctr, Div Rheumatol, Box 406, Boston, MA 02111 USA; [Fielding, Roger A.; Reid, Kieran F.] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Nutr Exercise Physiol & Sarcopenia Lab, 711 Washington St, Boston, MA 02111 USA; [Price, Lori Lyn] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Box 063, Boston, MA 02111 USA; [Wong, John B.] Tufts Med Ctr, Dept Med, Ctr Clin Decis Making, Box 302, Boston, MA 02111 USA; [Rones, Ramel] RR Prod, 17 Parker St, Lexington, MA 02421 USA	Tufts Medical Center; Tufts University; Tufts University; Northeastern University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Brown University; Brown University; Northeastern University; Tufts Medical Center; Tufts University; Tufts University; United States Department of Agriculture (USDA); Tufts Medical Center; Tufts Medical Center	Wang, CC (corresponding author), Tufts Med Ctr, 800 Washington St,Box 406, Boston, MA 02111 USA.; Wang, CC (corresponding author), Tufts Univ, Sch Med, 800 Washington St,Box 406, Boston, MA 02111 USA.	cwang2@tuftsmedicalcenter.org	Driban, Jeffrey/H-3486-2019; Schmid, Christopher H./J-2398-2014	Driban, Jeffrey/0000-0001-6098-4273; Schmid, Christopher H./0000-0002-0855-5313; Wong, John/0000-0003-4203-9010	National Center for Complementary and Integrative Health of the National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD065688] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001064, UL1TR000073] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT005521] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [K24AT007323] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG031679] Funding Source: NIH RePORTER	National Center for Complementary and Integrative Health of the National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Center for Complementary and Integrative Health of the National Institutes of Health.	ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Axford J, 2008, J PSYCHOSOM RES, V64, P461, DOI 10.1016/j.jpsychores.2007.11.009; Baker KR, 2001, J RHEUMATOL, V28, P1655; Beck A.T., 1996, BDI 2 BECK DEPRESSIO, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Bellamy N, 1997, J RHEUMATOL, V24, P799; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Blagojevic M, 2010, OSTEOARTHR CARTILAGE, V18, P24, DOI 10.1016/j.joca.2009.08.010; Fitzmaurice G, 2011, APPL LONGITUDINAL AN, V2nd; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hall MC, 2006, ANN RHEUM DIS, V65, P865, DOI 10.1136/ard.2005.043653; Irwin MR, 2011, NAT REV IMMUNOL, V11, P625, DOI 10.1038/nri3042; Iversen MD, 2012, AM J NURS, V112, pS32, DOI 10.1097/01.NAJ.0000412649.02926.35; Jamtvedt G, 2008, PHYS THER, V88, P123, DOI 10.2522/ptj.20070043; King S, 1999, J RHEUMATOL, V26, P2233; LORIG K, 1989, ARTHRITIS RHEUM, V32, P37, DOI 10.1002/anr.1780320107; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; Morgan N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100903; Motyl JM, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-166; Murphy L, 2008, ARTHRIT RHEUM-ARTHR, V59, P1207, DOI 10.1002/art.24021; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Pham T, 2003, J RHEUMATOL, V30, P1648; Phillips K, 2011, BEST PRACT RES CL RH, V25, P141, DOI 10.1016/j.berh.2011.02.005; R Development Core Team, 2012, R LANG ENV STAT COMP; Resnick B, 2000, J GERONTOL B-PSYCHOL, V55, pS352, DOI 10.1093/geronb/55.6.S352; Slemenda C, 1997, ANN INTERN MED, V127, P97, DOI 10.7326/0003-4819-127-2-199707150-00001; Smalley WE, 1996, GASTROENTEROL CLIN N, V25, P373, DOI 10.1016/S0889-8553(05)70253-3; Sports China, 1983, SIMPL TAIJ; Tubach F, 2005, ANN RHEUM DIS, V64, P34, DOI 10.1136/ard.2004.023028; Wang C, 2005, RHEUMATOLOGY, V44, P685, DOI 10.1093/rheumatology/keh572; Wang CC, 2004, ARCH INTERN MED, V164, P493, DOI 10.1001/archinte.164.5.493; Wang CC, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-333; Wang CC, 2012, CURR RHEUMATOL REP, V14, P598, DOI 10.1007/s11926-012-0294-y; Wang CC, 2011, RHEUM DIS CLIN N AM, V37, P19, DOI 10.1016/j.rdc.2010.11.002; Wang CC, 2010, NEW ENGL J MED, V363, P2266; Wang CC, 2010, NEW ENGL J MED, V363, P743, DOI 10.1056/NEJMoa0912611; Wang CC, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-23; Wang CC, 2009, ARTHRIT RHEUM-ARTHR, V61, P1545, DOI 10.1002/art.24832; Ware J., 2001, SF 36 PHYS MENTAL HL, P1994; Wayne PM, 2008, J ALTERN COMPLEM MED, V14, P95, DOI 10.1089/acm.2007.7170A; Yan JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061672	40	84	90	1	66	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2016	165	2					77	+		10.7326/M15-2143	http://dx.doi.org/10.7326/M15-2143			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS2GY	27183035	Green Accepted			2022-12-28	WOS:000380583100014
J	Johansson, MA; Mier-y-Teran-Romero, L; Reefhuis, J; Gilboa, SM; Hills, SL				Johansson, Michael A.; Mier-y-Teran-Romero, Luis; Reefhuis, Jennita; Gilboa, Suzanne M.; Hills, Susan L.			Zika and the Risk of Microcephaly	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VIRUS		[Johansson, Michael A.; Mier-y-Teran-Romero, Luis; Hills, Susan L.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Atlanta, GA 30333 USA; [Reefhuis, Jennita; Gilboa, Suzanne M.] Ctr Dis Control & Prevent, Div Congenital & Dev Disorders, Atlanta, GA 30333 USA; [Johansson, Michael A.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Harvard University; Harvard T.H. Chan School of Public Health	Johansson, MA (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Atlanta, GA 30333 USA.; Johansson, MA (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.		Mier-y-Teran-Romero, Luis/GWC-8536-2022	Johansson, Michael/0000-0002-5090-7722	NIGMS NIH HHS [U54 GM088558] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Cauchemez S, 2016, LANCET; Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036; Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338	5	310	314	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 7	2016	375	1					1	4		10.1056/NEJMp1605367	http://dx.doi.org/10.1056/NEJMp1605367			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL8VA	27222919	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000394897200001
J	Clough, JD; McClellan, M				Clough, Jeffrey D.; McClellan, Mark			Implementing MACRA Implications for Physicians and for Physician Leadership	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Clough, Jeffrey D.] Duke Univ, Duke Clin Res Inst, Durham, NC USA; [Clough, Jeffrey D.] Duke Univ, Dept Med, Durham, NC USA; [McClellan, Mark] Duke Univ, Duke Margolis Ctr Hlth Policy, Durham, NC USA	Duke University; Duke University; Duke University	Clough, JD (corresponding author), Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	jeffrey.clough@duke.edu						Centers for Medicare & Medicaid Services Department of Health and Human Services, PHYS GROUPS REC UPW; Clough JD, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002594; Cooper Z, PRICE AINT RIGHT HOS; McClellan M, MEDICARE ACOS CONTIN; Nyweide DJ, 2015, JAMA-J AM MED ASSOC, V313, P2152, DOI 10.1001/jama.2015.4930	5	82	82	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2016	315	22					2397	2398		10.1001/jama.2016.7041	http://dx.doi.org/10.1001/jama.2016.7041			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO3CE	27213914				2022-12-28	WOS:000377656900013
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Delirium matters	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PEOPLE					davidoliver372@googlemail.com						Clegg A, 2011, AGE AGEING, V40, P23, DOI 10.1093/ageing/afq140; European Delirium Association, 2011, PAT DEL EXP; Gordon A, 2014, BRIT GERIATRIC  0303; Health Improvement Scotland, 2015, CAR OLD PEOPL AC HOS; Hshieh TT, 2015, JAMA INTERN MED, V175, P512, DOI 10.1001/jamainternmed.2014.7779; MacLullich A, 2014, 4AT RAPID ASSESSMENT; National Institute for Health and Care Excellence, 2010, CLIN GUID 103, P103; National Institute for Health and Care Excellence, 2014, QS63 NICE; NHS Education for Scotland, 2014, THINK DEL; Ninan S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4070; Oliver D, 2008, J ROY SOC MED, V101, P168, DOI 10.1258/jrsm.2008.080017; Royal College of Psychiatrists, 2009, DEL; Ryan DJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001772; Sanders RD, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4331; Young J, 2007, BMJ-BRIT MED J, V334, P842, DOI 10.1136/bmj.39169.706574.AD	15	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 24	2016	353								i2886	10.1136/bmj.i2886	http://dx.doi.org/10.1136/bmj.i2886			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3CB	27220842	Bronze, Green Published			2022-12-28	WOS:000376938800008
J	Lawton, TJ; Rosenzweig, AC				Lawton, Thomas J.; Rosenzweig, Amy C.			Methane-make it or break it	SCIENCE			English	Editorial Material							METHYL-COENZYME-M; M-REDUCTASE; ENZYME; MECHANISM; COFACTOR; CYCLE; F-430		[Lawton, Thomas J.; Rosenzweig, Amy C.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Lawton, TJ; Rosenzweig, AC (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	thomas.j.lawton@gmail.com; amyr@northwestern.edu			NIGMS NIH HHS [R35 GM118035] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118035] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Conrad R, 2009, ENV MICROBIOL REP, V1, P285, DOI 10.1111/j.1758-2229.2009.00038.x; Craft JL, 2004, J AM CHEM SOC, V126, P4068, DOI 10.1021/ja038082p; Dey M, 2010, BIOCHEMISTRY-US, V49, P10902, DOI 10.1021/bi101562m; Duin EC, 2004, J BIOL INORG CHEM, V9, P563, DOI 10.1007/s00775-004-0549-9; Ermler U, 2005, DALTON T, P3451, DOI 10.1039/b506697b; Ermler U, 1997, SCIENCE, V278, P1457, DOI 10.1126/science.278.5342.1457; Goubeaud M, 1997, EUR J BIOCHEM, V243, P110, DOI 10.1111/j.1432-1033.1997.00110.x; Haynes CA, 2014, NAT CHEM BIOL, V10, P331, DOI 10.1038/nchembio.1509; Horng YC, 2001, BIOCHEMISTRY-US, V40, P12875, DOI 10.1021/bi011196y; Ragsdale SW, 2014, METAL IONS LIFE SCI, V14, P125, DOI 10.1007/978-94-017-9269-1_6; Scheller S, 2010, ANGEW CHEM INT EDIT, V49, P8112, DOI 10.1002/anie.201003214; Wongnate T, 2016, SCIENCE, V352, P953, DOI 10.1126/science.aaf0616; Wongnate T, 2015, J BIOL CHEM, V290, P9322, DOI 10.1074/jbc.M115.636761	13	8	8	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2016	352	6288			SI		892	893		10.1126/science.aaf7700	http://dx.doi.org/10.1126/science.aaf7700			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM2AK	27199402	Green Accepted			2022-12-28	WOS:000376147800017
J	Curley, M				Curley, Martin			Twelve principles for open innovation 2.0	NATURE			English	Editorial Material									[Curley, Martin] Intel Corp, Santa Clara, CA 95051 USA; [Curley, Martin] Intel Labs Europe, Dublin, Ireland	Intel Corporation; Intel Corporation	Curley, M (corresponding author), Intel Corp, Santa Clara, CA 95051 USA.; Curley, M (corresponding author), Intel Labs Europe, Dublin, Ireland.	martin.g.curley@intel.com						Chesbrough H., 2003, OPEN INNOVATION NEW; Curley M., 2013, EXPT NATURE NEW VENT; Curley M, 2013, OPEN INNOVATION 2 0; Gawer A., 2011, PLATFORMS MARKETS IN; Keeley L., 2013, 10 TYPES INNOVATION; Porter MichaelE., 2011, HARVARD BUS REV; Roger E.M, 2003, DIFFUSION INNOVATION, V5th; Stahel WR, 2010, PERFORMANCE ECONOMY, 2ND EDITION, P1, DOI 10.1057/9780230274907; von Hippel E., 1988, SOURCES INNOVATION	9	24	25	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					314	316		10.1038/533314a	http://dx.doi.org/10.1038/533314a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM0AH	27193662	Bronze			2022-12-28	WOS:000376004300021
J	Grayson, M				Grayson, Michelle			4 BIG QUESTIONS	NATURE			English	Editorial Material																			0	2	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					S118	S118		10.1038/533S118a	http://dx.doi.org/10.1038/533S118a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VH2UC	27191493	Bronze			2022-12-28	WOS:000452214700002
J	He, Y; Yan, CL; Fang, J; Inouye, C; Tjian, R; Ivanov, I; Nogales, E				He, Yuan; Yan, Chunli; Fang, Jie; Inouye, Carla; Tjian, Robert; Ivanov, Ivaylo; Nogales, Eva			Near-atomic resolution visualization of human transcription promoter opening	NATURE			English	Article							RNA-POLYMERASE-II; STRUCTURAL BASIS; GENERAL TRANSCRIPTION; PREINITIATION COMPLEX; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; ABORTIVE INITIATION; ELONGATION COMPLEX; SWI2/SNF2 ATPASE; BINDING DOMAIN	In eukaryotic transcription initiation, a large multi-subunit pre-initiation complex (PIC) that assembles at the core promoter is required for the opening of the duplex DNA and identification of the start site for transcription by RNA polymerase II. Here we use cryo-electron microscropy (cryo-EM) to determine near-atomic resolution structures of the human PIC in a closed state (engaged with duplex DNA), an open state (engaged with a transcription bubble), and an initially transcribing complex (containing six base pairs of DNA-RNA hybrid). Our studies provide structures for previously uncharacterized components of the PIC, such as TFIIE and TFIIH, and segments of TFIIA, TFIIB and TFIIF. Comparison of the different structures reveals the sequential conformational changes that accompany the transition from each state to the next throughout the transcription initiation process. This analysis illustrates the key role of TFIIB in transcription bubble stabilization and provides strong structural support for a translocase activity of XPB.	[He, Yuan; Nogales, Eva] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Biophys & Integrat Bioimaging Div, Berkeley, CA 94720 USA; [He, Yuan] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Yan, Chunli; Ivanov, Ivaylo] Georgia State Univ, Ctr Diagnost & Therapeut, Dept Chem, Atlanta, GA 30302 USA; [Fang, Jie; Tjian, Robert; Nogales, Eva] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Inouye, Carla; Tjian, Robert] Univ Calif Berkeley, Li Ka Shing Ctr Biomed & Hlth Sci, Berkeley, CA 94720 USA; [Tjian, Robert; Nogales, Eva] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Northwestern University; University System of Georgia; Georgia State University; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Stanford University; Li Ka Shing Center; University of California System; University of California Berkeley; University of California System; University of California Berkeley	He, Y; Nogales, E (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Biophys & Integrat Bioimaging Div, Berkeley, CA 94720 USA.; He, Y (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.; Nogales, E (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Nogales, E (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	yuanhe@northwestern.edu; ENogales@lbl.gov	He, Yuan/GVT-7268-2022; Ivanov, Ivaylo/A-7613-2013	He, Yuan/0000-0002-1455-3963; Ivanov, Ivaylo/0000-0002-5306-1005	NIGMS [GM63072, GM110387]; National Science Foundation [MCB-1149521]; Div Of Molecular and Cellular Bioscience [1149521] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110387, R01GM063072] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Zheng for providing XPB mAb, D. King for providing peptides, P. Grob and T. Houweling for electron microscopy and computer support, respectively; S. Scheres for advice on image processing, S. Kassube for providing TFIIS, and G. Cardone for advice concerning filtering according to local resolution. This work was funded by NIGMS (GM63072 to E.N. and GM110387 to I. I.) and the National Science Foundation (MCB-1149521 to I. I.). Computational resources were provided in part by XSEDE (CHE110042) and the National Energy Research for Scientific Computing Center (DE-AC02-05CH11231). E.N. and R.T are Howard Hughes Medical Institute Investigators.	Adamczak R, 2004, PROTEINS, V56, P753, DOI 10.1002/prot.20176; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Anandapadamanaban M, 2013, NAT STRUCT MOL BIOL, V20, P1008, DOI 10.1038/nsmb.2611; Bernecky C, 2016, NATURE, V529, P551, DOI 10.1038/nature16482; Bleichenbacher M, 2003, J MOL BIOL, V332, P783, DOI 10.1016/S0022-2836(03)00887-8; Boeger H, 2005, FEBS LETT, V579, P899, DOI 10.1016/j.febslet.2004.11.027; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; BURATOWSKI S, 1991, P NATL ACAD SCI USA, V88, P7509, DOI 10.1073/pnas.88.17.7509; BURATOWSKI S, 1992, SCIENCE, V255, P1130, DOI 10.1126/science.1546314; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; Cabart P, 2011, P NATL ACAD SCI USA, V108, P15786, DOI 10.1073/pnas.1104591108; Cardone G, 2013, J STRUCT BIOL, V184, P226, DOI 10.1016/j.jsb.2013.08.002; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Cheung ACM, 2011, EMBO J, V30, P4755, DOI 10.1038/emboj.2011.396; Coin F, 2006, MOL CELL, V21, P215, DOI 10.1016/j.molcel.2005.10.024; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Eichner J, 2010, EMBO J, V29, P706, DOI 10.1038/emboj.2009.386; Fan L, 2006, MOL CELL, V22, P27, DOI 10.1016/j.molcel.2006.02.017; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Gaiser F, 2000, J MOL BIOL, V302, P1119, DOI 10.1006/jmbi.2000.4110; GIARDINA C, 1993, SCIENCE, V261, P759, DOI 10.1126/science.8342041; Gibbons BJ, 2012, P NATL ACAD SCI USA, V109, P1949, DOI 10.1073/pnas.1105266109; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Groft CM, 1998, P NATL ACAD SCI USA, V95, P9117, DOI 10.1073/pnas.95.16.9117; Grunberg S, 2012, NAT STRUCT MOL BIOL, V19, P788, DOI 10.1038/nsmb.2334; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Henderson R, 2012, STRUCTURE, V20, P205, DOI 10.1016/j.str.2011.12.014; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hilario E, 2013, ACTA CRYSTALLOGR D, V69, P237, DOI 10.1107/S0907444912045040; Iyer LM, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-5; Juo ZS, 2003, NATURE, V422, P534, DOI 10.1038/nature01534; Juven-Gershon T, 2006, NAT METHODS, V3, P917, DOI 10.1038/NMETH937; Kainov DE, 2008, NAT STRUCT MOL BIOL, V15, P980, DOI 10.1038/nsmb.1478; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kassube SA, 2013, NAT STRUCT MOL BIOL, V20, P892, DOI 10.1038/nsmb.2596; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kim B, 2007, P NATL ACAD SCI USA, V104, P16068, DOI 10.1073/pnas.0704573104; Kim JS, 2015, J BIOL CHEM, V290, P8321, DOI 10.1074/jbc.M115.636514; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; LEE DK, 1992, MOL CELL BIOL, V12, P5189, DOI 10.1128/MCB.12.11.5189; Lewis R, 2008, NUCLEIC ACIDS RES, V36, P1881, DOI 10.1093/nar/gkn040; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liu X, 2011, SCIENCE, V333, P633, DOI 10.1126/science.1206629; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; Louder RK, 2016, NATURE, V531, P604, DOI 10.1038/nature17394; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Luo J, 2015, MOL CELL, V59, P794, DOI 10.1016/j.molcel.2015.07.016; LUSE DS, 1987, J BIOL CHEM, V262, P14990; Maertens GN, 2014, P NATL ACAD SCI USA, V111, P2728, DOI 10.1073/pnas.1320755111; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Meinhart A, 2003, J BIOL CHEM, V278, P48267, DOI 10.1074/jbc.M307874200; Meka H, 2005, NUCLEIC ACIDS RES, V33, P6435, DOI 10.1093/nar/gki945; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Murakami K, 2015, P NATL ACAD SCI USA, V112, P13543, DOI 10.1073/pnas.1518255112; OHKUMA Y, 1995, MOL CELL BIOL, V15, P4856; Okuda M, 2004, J BIOL CHEM, V279, P51395, DOI 10.1074/jbc.M404722200; Okuda M, 2000, EMBO J, V19, P1346, DOI 10.1093/emboj/19.6.1346; Okuda M, 2008, EMBO J, V27, P1161, DOI 10.1038/emboj.2008.47; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Pei JM, 2007, NUCLEIC ACIDS RES, V35, pW649, DOI 10.1093/nar/gkm227; Plaschka C, 2015, NATURE, V518, P376, DOI 10.1038/nature14229; QIAN XQ, 1993, BIOCHEMISTRY-US, V32, P9944, DOI 10.1021/bi00089a010; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Revyakin A, 2012, GENE DEV, V26, P1691, DOI 10.1101/gad.194936.112; Sainsbury S, 2013, NATURE, V493, P437, DOI 10.1038/nature11715; SALI A, 1995, MOL MED TODAY, V1, P270, DOI 10.1016/s1357-4310(95)91170-7; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schmitt DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102389; Schultz P, 2000, CELL, V102, P599, DOI 10.1016/S0092-8674(00)00082-9; Shinkai A, 2007, J MOL BIOL, V372, P1293, DOI 10.1016/j.jmb.2007.07.051; STRUHL K, 1987, CELL, V49, P295, DOI 10.1016/0092-8674(87)90277-7; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Thoma NH, 2005, NAT STRUCT MOL BIOL, V12, P350, DOI 10.1038/nsmb919; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Tsai FTF, 2000, EMBO J, V19, P25, DOI 10.1093/emboj/19.1.25; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Wind M, 2000, BIOESSAYS, V22, P327, DOI 10.1002/(SICI)1521-1878(200004)22:4<327::AID-BIES3>3.0.CO;2-4; Wollmann P, 2011, NATURE, V475, P403, DOI 10.1038/nature10215; Wolski SC, 2008, PLOS BIOL, V6, P1332, DOI 10.1371/journal.pbio.0060149; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786	92	184	186	1	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					359	+		10.1038/nature17970	http://dx.doi.org/10.1038/nature17970			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0AH	27193682	Green Accepted			2022-12-28	WOS:000376004300041
J	Howlett, DC; Sinnott, JD				Howlett, David C.; Sinnott, Joseph Dalby			SPOT DIAGNOSIS Chest and neck pain in a 22 year old woman	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Howlett, David C.] East Sussex Hosp NHS Trust, Dept Radiol, Eastbourne, E Sussex, England; [Sinnott, Joseph Dalby] East Sussex Hosp NHS Trust, Eastbourne, E Sussex, England		Howlett, DC (corresponding author), East Sussex Hosp NHS Trust, Dept Radiol, Eastbourne, E Sussex, England.	david.howlett@nhs.net							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2016	353								i2757	10.1136/bmj.i2757	http://dx.doi.org/10.1136/bmj.i2757			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GD	27197847				2022-12-28	WOS:000376447700002
J	Chandra, A; Shafrin, J; Dhawan, R				Chandra, Amitabh; Shafrin, Jason; Dhawan, Ravinder			Utility of Cancer Value Frameworks for Patients, Payers, and Physicians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SOCIETY		[Chandra, Amitabh] Harvard Univ, Cambridge, MA 02138 USA; [Shafrin, Jason] Precis Hlth Econ, Los Angeles, CA USA; [Dhawan, Ravinder] Merck, Kenilworth, NJ USA	Harvard University; Merck & Company	Chandra, A (corresponding author), Harvard Univ, John F Kennedy Sch Govt, Mailbox 114,79 John F Kennedy St, Cambridge, MA 02138 USA.	amitabh_chandra@harvard.edu	Shafrin, Jason/AAI-7041-2020	Shafrin, Jason/0000-0001-8444-5979				Cherny NI, 2015, ANN ONCOL, V26, P1547, DOI 10.1093/annonc/mdv249; Durie Brian, 2013, J Med Econ, V16, P614, DOI 10.3111/13696998.2012.760159; FITCH KATE, 2011, BENEFIT DESIGNS HIGH; Institute for Clinical and Economic Review, EV VAL NEW DRUGS DEV; Moriates C, 2013, JAMA-J AM MED ASSOC, V310, P577, DOI 10.1001/jama.2013.7516; Schnipper LE, 2015, J CLIN ONCOL, V33, P2563, DOI 10.1200/JCO.2015.61.6706	6	49	49	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 17	2016	315	19					2069	2070		10.1001/jama.2016.4915	http://dx.doi.org/10.1001/jama.2016.4915			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL9PN	27187295				2022-12-28	WOS:000375975300013
J	Mayor, S				Mayor, Susan			Physical activity increases after bariatric surgery, review finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Herring LY, 2016, OBES REV, V17, P250, DOI 10.1111/obr.12361	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 16	2016	353								i2731	10.1136/bmj.i2731	http://dx.doi.org/10.1136/bmj.i2731			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GB	27185406				2022-12-28	WOS:000376447500006
J	Guglani, S				Guglani, Sam			Feeling	LANCET			English	Editorial Material									[Guglani, Sam] Cheltenham Gen Hosp, Ctr Oncol, Cheltenham GL53 7AN, Glos, England	Gloucestershire Hospitals NHS Foundation Trust; Cheltenham General Hospital	Guglani, S (corresponding author), Cheltenham Gen Hosp, Ctr Oncol, Cheltenham GL53 7AN, Glos, England.	sam@medicineunboxed.org							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 14	2016	387	10032					1991	1991		10.1016/S0140-6736(16)30476-7	http://dx.doi.org/10.1016/S0140-6736(16)30476-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8HJ	27203763				2022-12-28	WOS:000375881500015
J	Lu, C; Jain, SU; Hoelper, D; Bechet, D; Molden, RC; Ran, LL; Murphy, D; Venneti, S; Hameed, M; Pawel, BR; Wunder, JS; Dickson, BC; Lundgren, SM; Jani, KS; De Jay, N; Papillon-Cavanagh, S; Andrulis, IL; Sawyer, SL; Grynspan, D; Turcotte, RE; Nadaf, J; Fahiminiyah, S; Muir, TW; Majewski, J; Thompson, CB; Chi, P; Garcia, BA; Allis, CD; Jabado, N; Lewis, PW				Lu, Chao; Jain, Siddhant U.; Hoelper, Dominik; Bechet, Denise; Molden, Rosalynn C.; Ran, Leili; Murphy, Devan; Venneti, Sriram; Hameed, Meera; Pawel, Bruce R.; Wunder, Jay S.; Dickson, Brendan C.; Lundgren, Stefan M.; Jani, Krupa S.; De Jay, Nicolas; Papillon-Cavanagh, Simon; Andrulis, Irene L.; Sawyer, Sarah L.; Grynspan, David; Turcotte, Robert E.; Nadaf, Javad; Fahiminiyah, Somayyeh; Muir, Tom W.; Majewski, Jacek; Thompson, Craig B.; Chi, Ping; Garcia, Benjamin A.; Allis, C. David; Jabado, Nada; Lewis, Peter W.			Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape	SCIENCE			English	Article							PEDIATRIC GLIOBLASTOMA; GENE-EXPRESSION; DRIVER MUTATIONS; H3; GLIOMAS; CELLS; PRC2	Several types of pediatric cancers reportedly contain high-frequency missense mutations in histone H3, yet the underlying oncogenic mechanism remains poorly characterized. Here we report that the H3 lysine 36-to-methionine (H3K36M) mutation impairs the differentiation of mesenchymal progenitor cells and generates undifferentiated sarcoma in vivo. H3K36M mutant nucleosomes inhibit the enzymatic activities of several H3K36 methyltransferases. Depleting H3K36 methyltransferases, or expressing an H3K36I mutant that similarly inhibits H3K36 methylation, is sufficient to phenocopy the H3K36M mutation. After the loss of H3K36 methylation, a genome-wide gain in H3K27 methylation leads to a redistribution of polycomb repressive complex 1 and de-repression of its target genes known to block mesenchymal differentiation. Our findings are mirrored in human undifferentiated sarcomas in which novel K36M/I mutations in H3.1 are identified.	[Lu, Chao; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA; [Jain, Siddhant U.; Hoelper, Dominik; Lundgren, Stefan M.; Lewis, Peter W.] Univ Wisconsin, Wisconsin Inst Discovery, Epigenet Theme, Madison, WI 53715 USA; [Jain, Siddhant U.; Hoelper, Dominik; Lundgren, Stefan M.; Lewis, Peter W.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53715 USA; [Bechet, Denise; De Jay, Nicolas; Papillon-Cavanagh, Simon; Nadaf, Javad; Fahiminiyah, Somayyeh; Majewski, Jacek; Jabado, Nada] McGill Univ, Dept Human Genet, Montreal, PQ H3Z 2Z3, Canada; [Molden, Rosalynn C.; Garcia, Benjamin A.] Univ Penn, Epigenet Program, Perelman Sch Med, Philadelphia, PA 19104 USA; [Molden, Rosalynn C.; Garcia, Benjamin A.] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Molden, Rosalynn C.; Jani, Krupa S.; Muir, Tom W.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Ran, Leili; Murphy, Devan; Chi, Ping] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Ran, Leili; Murphy, Devan; Chi, Ping] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Venneti, Sriram] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Hameed, Meera] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Pawel, Bruce R.] Univ Penn, Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Pawel, Bruce R.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Wunder, Jay S.] Mt Sinai Hosp, Univ Musculoskeletal Oncol Unit, Toronto, ON M5G 1X5, Canada; [Wunder, Jay S.] Univ Toronto, Princess Margaret Hosp, Dept Surg Oncol, Toronto, ON M5T 2M9, Canada; [Wunder, Jay S.] Univ Toronto, Princess Margaret Hosp, Div Orthoped Surg, Toronto, ON M5T 2M9, Canada; [Dickson, Brendan C.; Andrulis, Irene L.] Univ Toronto, Dept Lab Med & Pathobiol, 100 Coll St, Toronto, ON M5S 1A8, Canada; [Dickson, Brendan C.; Andrulis, Irene L.] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Andrulis, Irene L.] Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada; [Andrulis, Irene L.] Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Sawyer, Sarah L.] Univ Ottawa, Dept Med Genet, Ottawa, ON K1H 8L1, Canada; [Sawyer, Sarah L.; Grynspan, David] Univ Ottawa, Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [Grynspan, David] Univ Ottawa, Dept Pathol & Lab Med, Ottawa, ON K1H 8L1, Canada; [Turcotte, Robert E.] McGill Univ, Montreal Gen Hosp, Ctr Hlth, Div Orthopaed Surg, Montreal, PQ H3G 1A4, Canada; [Thompson, Craig B.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Chi, Ping] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Jabado, Nada] McGill Univ, Dept Pediat, Montreal, PQ H3Z 2Z3, Canada; [Molden, Rosalynn C.] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA	Rockefeller University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; McGill University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Princeton University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Michigan System; University of Michigan; Memorial Sloan Kettering Cancer Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; McGill University; Memorial Sloan Kettering Cancer Center; Cornell University; McGill University; Regeneron	Allis, CD (corresponding author), Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA.; Lewis, PW (corresponding author), Univ Wisconsin, Wisconsin Inst Discovery, Epigenet Theme, Madison, WI 53715 USA.; Lewis, PW (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53715 USA.; Jabado, N (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ H3Z 2Z3, Canada.; Jabado, N (corresponding author), McGill Univ, Dept Pediat, Montreal, PQ H3Z 2Z3, Canada.	alliscd@rockefeller.edu; nada.jabado@mcgill.ca; plewis@discovery.wisc.edu	Papillon-Cavanagh, Simon/AAS-8749-2020; Andrulis, Irene L./E-7267-2013; Jabado, Nada/AAN-4026-2020; Dickson, Brendan C/J-2347-2016; Muir, Tom/AHD-0860-2022	Papillon-Cavanagh, Simon/0000-0002-0372-2266; Dickson, Brendan C/0000-0003-2269-6216; Muir, Tom/0000-0001-9635-0344; Lewis, Peter/0000-0002-9816-7823; Lu, Chao/0000-0003-0982-8122; Hoelper, Dominik/0000-0003-3830-0781; Lundgren, Stefan/0000-0003-4028-4055; Jain, Siddhant/0000-0002-7390-6757; Jani, Krupa/0000-0002-3103-4575	Rockefeller University; Wisconsin Institute for Discovery; Greater Milwaukee Foundation; Starr Cancer Consortium [SCC I6-A614]; Sidney Kimmel Foundation; NIH [P01CA196539, DP2OD007447, R01GM110174, DP2CA174499, K08CA151660, K08CA181475]; NIH (Cancer Center Support grant) [P30CA008748]; Genome Canada; Genome Quebec; Institute for Cancer Research of the Canadian Institutes for Health Research (CIHR); McGill University; Montreal Children's Hospital Foundation; Damon Runyon Cancer Research Foundation [DRG-2195-14]; Chercheur Clinician Senior Award; Boehringer Ingelheim Fonds Predoctoral fellowship; T.D Trust/Montreal Children's Hospital Foundation; NATIONAL CANCER INSTITUTE [DP2CA174499, P30CA008748, K08CA181475, P01CA196539, K08CA151660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107047, R01GM110174] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007447] Funding Source: NIH RePORTER	Rockefeller University; Wisconsin Institute for Discovery; Greater Milwaukee Foundation; Starr Cancer Consortium; Sidney Kimmel Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (Cancer Center Support grant); Genome Canada(Genome Canada); Genome Quebec; Institute for Cancer Research of the Canadian Institutes for Health Research (CIHR); McGill University; Montreal Children's Hospital Foundation; Damon Runyon Cancer Research Foundation; Chercheur Clinician Senior Award; Boehringer Ingelheim Fonds Predoctoral fellowship(Boehringer Ingelheim); T.D Trust/Montreal Children's Hospital Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank D. Weinberg, B. Carey, B. Sabari, and R. Phillips for help in manuscript preparation. This research was supported by funding from Rockefeller University (to C.D.A.), a startup provided by the Wisconsin Institute for Discovery (to P.W.L.), the Greater Milwaukee Foundation (to P.W.L), the Starr Cancer Consortium (grant SCC I6-A614 to C.D.A.), the Sidney Kimmel Foundation (Kimmel Scholar Award to P.C. and P.W.L.), and NIH grants (P01CA196539 to P.W.L., C.D.A., T.W.M., N.J., J.M., and B.A.G.; Innovator grant DP2OD007447 and R01GM110174 to B.A.G.; DP2CA174499 and K08CA151660 to P.C.; K08CA181475 to S.V.; and Cancer Center Support grant P30CA008748 to C.B.T.). This work was performed within the context of the I-CHANGE consortium and supported by funding from Genome Canada, Genome Quebec, The Institute for Cancer Research of the Canadian Institutes for Health Research (CIHR), McGill University, and the Montreal Children's Hospital Foundation. C.L. is the Kandarian Family Fellow supported by the Damon Runyon Cancer Research Foundation (grant DRG-2195-14). N.J. is a member of the Penny Cole lab and the recipient of a Chercheur Clinician Senior Award. J.M. holds a Canada Research Chair (tier 2). D.H. is supported by a Boehringer Ingelheim Fonds Predoctoral fellowship. D. B. is supported by a studentship from the T.D Trust/Montreal Children's Hospital Foundation. C.B.T. is a founder of Agios Pharmaceuticals and a member of its scientific advisory board and also serves on the board of directors of Merck and Charles River Laboratories. R.E.T. is the president of the Quebec Orthopaedic Association. We thank the molecular cytology core facility of Memorial Sloan Kettering Cancer Center for technical help and EMD Millipore for H3.3K36M antibody generation. The sequencing data reported in this paper are deposited at the Gene Expression Omnibus database (accession number GSE69291).	Banaszynski LA, 2010, DEV CELL, V19, P662, DOI 10.1016/j.devcel.2010.10.014; Behjati S, 2013, NAT GENET, V45, P1479, DOI 10.1038/ng.2814; Bender S, 2013, CANCER CELL, V24, P660, DOI 10.1016/j.ccr.2013.10.006; Bjerke L, 2013, CANCER DISCOV, V3, P512, DOI 10.1158/2159-8290.CD-12-0426; Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Fletcher C., 2013, IARC WHO CLASSIFICAT, V5; Funato K, 2014, SCIENCE, V346, P1529, DOI 10.1126/science.1253799; Gaydos LJ, 2012, CELL REP, V2, P1169, DOI 10.1016/j.celrep.2012.09.019; Herz HM, 2014, SCIENCE, V345, P1065, DOI 10.1126/science.1255104; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Orlando DA, 2014, CELL REP, V9, P1163, DOI 10.1016/j.celrep.2014.10.018; Popovic R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004566; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Smits P, 2004, J CELL BIOL, V164, P747, DOI 10.1083/jcb.200312045; Somers GR, 2006, PEDIATR DEVEL PATHOL, V9, P132, DOI 10.2350/08-05-0098.1; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Yao YC, 2013, J CELL BIOCHEM, V114, P1223, DOI 10.1002/jcb.24467; Yuan W, 2011, J BIOL CHEM, V286, P7983, DOI 10.1074/jbc.M110.194027	21	234	242	2	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2016	352	6287					844	849		10.1126/science.aac7272	http://dx.doi.org/10.1126/science.aac7272			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5FP	27174990	Green Accepted			2022-12-28	WOS:000375663000046
J	Tuttle, S; Salvucci, G				Tuttle, Samuel; Salvucci, Guido			Empirical evidence of contrasting soil moisture-precipitation feedbacks across the United States	SCIENCE			English	Article							AFTERNOON PRECIPITATION; COUPLING STRENGTH; RAINFALL; VEGETATION; MODELS; MEMORY	Soil moisture influences fluxes of heat and moisture originating at the land surface, thus altering atmospheric humidity and temperature profiles. However, empirical and modeling studies disagree on how this affects the propensity for precipitation, mainly owing to the difficulty in establishing causality. We use Granger causality to estimate the relationship between soil moisture and occurrence of subsequent precipitation over the contiguous United States using remotely sensed soil moisture and gauge-based precipitation observations. After removing potential confounding effects of daily persistence, and seasonal and interannual variability in precipitation, we find that soil moisture anomalies significantly influence rainfall probabilities over 38% of the area with a median factor of 13%. The feedback is generally positive in the west and negative in the east, suggesting dependence on regional aridity.	[Tuttle, Samuel; Salvucci, Guido] Boston Univ, Boston, MA 02215 USA	Boston University	Tuttle, S (corresponding author), Boston Univ, Boston, MA 02215 USA.	stuttle@bu.edu	Tuttle, Samuel/AAG-3107-2021		NASA [NNX12AP78G]	NASA(National Aeronautics & Space Administration (NASA))	Thanks to P. Dirmeyer and two anonymous reviewers for constructive comments that helped to strengthen this analysis. The data used in this study are freely available online from the NASA Goddard Earth Sciences (GES) Data and Information Services Center (DISC) (http://disc.sci.gsfc.nasa.gov/hydrology), the National Snow and Ice Data Center (NSIDC) Distributed Active Archive Center (DAAC) (http://nsidc.org/data/nsidc-0451), and the Oak Ridge National Laboratory (ORNL) DAAC for biogeochemical dynamics (https://daac.ornl.gov/NACP/guides/NBCD_2000_V2.html). This research was funded by NASA under grant NNX12AP78G (to G.S.).	Alfieri L, 2008, J HYDROMETEOROL, V9, P280, DOI 10.1175/2007JHM863.1; Carbone RE, 2008, J CLIMATE, V21, P4132, DOI 10.1175/2008JCLI2275.1; Dirmeyer PA, 2009, J HYDROMETEOROL, V10, P278, DOI 10.1175/2008JHM1016.1; EDDY JA, 1975, SCIENCE, V188, P279, DOI 10.1126/science.188.4185.279; Ek MB, 2004, J HYDROMETEOROL, V5, P86, DOI 10.1175/1525-7541(2004)005<0086:IOSMOB>2.0.CO;2; Ferguson CR, 2012, J HYDROMETEOROL, V13, P749, DOI 10.1175/JHM-D-11-0119.1; Findell KL, 2011, NAT GEOSCI, V4, P434, DOI [10.1038/NGEO1174, 10.1038/ngeo1174]; Findell KL, 1997, WATER RESOUR RES, V33, P725, DOI 10.1029/96WR03756; Findell KL, 2003, J HYDROMETEOROL, V4, P570, DOI 10.1175/1525-7541(2003)004<0570:ACOSML>2.0.CO;2; Fischer EM, 2007, J CLIMATE, V20, P5081, DOI 10.1175/JCLI4288.1; Froidevaux P, 2014, J ATMOS SCI, V71, P782, DOI 10.1175/JAS-D-13-0180.1; Giorgi F, 1996, J CLIMATE, V9, P1150, DOI 10.1175/1520-0442(1996)009<1150:ARMSOT>2.0.CO;2; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Guillod BP, 2014, ATMOS CHEM PHYS, V14, P8343, DOI 10.5194/acp-14-8343-2014; Guillod BP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7443; Hohenegger C, 2009, J CLIMATE, V22, P5003, DOI 10.1175/2009JCLI2604.1; Jones L. A., 2009, P IEEE GEOSC REM SEN, V3; Koster RD, 2006, J HYDROMETEOROL, V7, P590, DOI 10.1175/JHM510.1; Koster RD, 2004, SCIENCE, V305, P1138, DOI 10.1126/science.1100217; Mei R, 2012, J HYDROMETEOROL, V13, P1010, DOI 10.1175/JHM-D-11-075.1; Mitchell KE, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003823; Orlowsky B, 2010, J CLIMATE, V23, P3918, DOI 10.1175/2010JCLI3366.1; Owe M, 2001, IEEE T GEOSCI REMOTE, V39, P1643, DOI 10.1109/36.942542; Pielke RA, 2001, REV GEOPHYS, V39, P151, DOI 10.1029/1999RG000072; Salvucci GD, 2002, ADV WATER RESOUR, V25, P1305, DOI 10.1016/S0309-1708(02)00057-X; Seneviratne SI, 2012, J HYDROMETEOROL, V13, P404, DOI 10.1175/JHM-D-11-044.1; Seneviratne SI, 2010, EARTH-SCI REV, V99, P125, DOI 10.1016/j.earscirev.2010.02.004; Taylor CM, 2012, NATURE, V489, P423, DOI 10.1038/nature11377; Taylor CM, 2011, NAT GEOSCI, V4, P430, DOI 10.1038/ngeo1173; Wei JF, 2008, J HYDROMETEOROL, V9, P1364, DOI 10.1175/2008JHM955.1; Zeng XB, 2010, J HYDROMETEOROL, V11, P979, DOI 10.1175/2010JHM1226.1	31	126	134	5	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2016	352	6287					825	828		10.1126/science.aaa7185	http://dx.doi.org/10.1126/science.aaa7185			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5FP	27174987				2022-12-28	WOS:000375663000041
J	Martin, L; Rackard, F				Martin, Leslie; Rackard, Forrest			Hair-on-End Sign	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Martin, Leslie] Univ Calif San Diego, San Diego, CA 92103 USA; [Rackard, Forrest] Univ Florida, Gainesville, FL USA	University of California System; University of California San Diego; State University System of Florida; University of Florida	Martin, L (corresponding author), Univ Calif San Diego, San Diego, CA 92103 USA.	lmartin@ucsd.edu							0	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2016	374	19					E23	E23		10.1056/NEJMicm1510045	http://dx.doi.org/10.1056/NEJMicm1510045			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6JS	27168449				2022-12-28	WOS:000375746100011
J	Koch, MA; Reiner, GL; Lugo, KA; Kreuk, LSM; Stanbery, AG; Ansaldo, E; Seher, TD; Ludington, WB; Barton, GM				Koch, Meghan A.; Reiner, Gabrielle L.; Lugo, Kyler A.; Kreuk, Lieselotte S. M.; Stanbery, Alison G.; Ansaldo, Eduard; Seher, Thaddeus D.; Ludington, William B.; Barton, Gregory M.			Maternal IgG and IgA Antibodies Dampen Mucosal T Helper Cell Responses in Early Life	CELL			English	Article							GUT MICROBIOTA; PLASMA-CELLS; BACTERIA; INNATE; IMMUNITY; IMMUNOGLOBULINS; INDUCTION; HOMEOSTASIS; GENERATION; INFECTION	To maintain a symbiotic relationship between the host and its resident intestinal microbiota, appropriate mucosal T cell responses to commensal antigens must be established. Mice acquire both IgG and IgA maternally; the former has primarily been implicated in passive immunity to pathogens while the latter mediates host-commensal mutualism. Here, we report the surprising observation that mice generate T cell-independent and largely Toll-like receptor (TLR)-dependent IgG2b and IgG3 antibody responses against their gut microbiota. We demonstrate that maternal acquisition of these antibodies dampens mucosal T follicular helper responses and subsequent germinal center B cell responses following birth. This work reveals a feedback loop whereby T cell-independent, TLR-dependent antibodies limit mucosal adaptive immune responses to newly acquired commensal antigens and uncovers a broader function for maternal IgG.	[Koch, Meghan A.; Reiner, Gabrielle L.; Lugo, Kyler A.; Kreuk, Lieselotte S. M.; Stanbery, Alison G.; Ansaldo, Eduard; Seher, Thaddeus D.; Ludington, William B.; Barton, Gregory M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA; [Reiner, Gabrielle L.] Aduro Biotech Inc, Berkeley, CA 94710 USA; [Lugo, Kyler A.] Stanford Univ, Stanford Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Seher, Thaddeus D.] Univ Calif Merced, Dept Quantitat & Syst Biol, Merced, CA 95343 USA	University of California System; University of California Berkeley; Stanford University; University of California System; University of California Merced	Barton, GM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA.	barton@berkeley.edu	Lugo, Kyler/P-4774-2016	Lugo, Kyler/0000-0001-9050-6993; Seher, Thaddeus/0000-0002-0872-2855; Barton, Gregory/0000-0002-3793-0100	NIH [AI063302, AI095587, AI104914]; Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease award; Crohn's and Colitis Foundation of America [252507]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095587, P01AI063302, R01AI072429, R56AI095587, R01AI104914] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017851] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease award(Burroughs Wellcome Fund); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank N. Arpaia, A. Rudensky and J. Sonnenberg for providing samples from Tcrb<SUP>-/-</SUP>Tcrd<SUP>-/-</SUP> and GF animals, respectively, H. Nolla and A. Valeros (Berkeley Cancer Research Laboratory Flow Cytometry Facility) for assistance with cell sorting, T. Huynh, J. Yap, A. Lin La, S. Chu, J. Nguyen, C. Purba, A. Ahn, E. Lau, E. Wu, K. Shamardani and the Life Sciences Addition Vivarium Staff for mouse colony maintenance, K. Ching and B. Russell for technical assistance, and Aduro Biotech for use of their ImmunoSpot C.T.L. Analyzer. We thank R. Vance, M. Headley, E. Roberts and members of the Barton and Vance labs for critical reading of the manuscript and helpful discussions. This work was supported by the NIH (AI063302, AI095587, AI104914 to G.M.B.). G.M.B. is a John P. Stock Faculty Fellow and the recipient of a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease award. M. A. K. was supported by postdoctoral fellowship #252507 from the Crohn's and Colitis Foundation of America. William Ludington is a shareholder of uBiome.	Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; BOS NA, 1989, EUR J IMMUNOL, V19, P2335, DOI 10.1002/eji.1830191223; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Bunker JJ, 2015, IMMUNITY, V43, P541, DOI 10.1016/j.immuni.2015.08.007; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; Chassaing B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044328; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Cullender TC, 2013, CELL HOST MICROBE, V14, P571, DOI 10.1016/j.chom.2013.10.009; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; de Stahl TD, 2003, J EXP MED, V197, P1183, DOI 10.1084/jem.20022232; Deenick EK, 1999, J IMMUNOL, V163, P4707; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Fransen F, 2015, IMMUNITY, V43, P527, DOI 10.1016/j.immuni.2015.08.011; GAROFALO R, 1995, PEDIATR RES, V37, P444, DOI 10.1203/00006450-199504000-00010; Ha SA, 2006, J EXP MED, V203, P2541, DOI 10.1084/jem.20061041; Hand TW, 2012, SCIENCE, V337, P1553, DOI 10.1126/science.1220961; Harmsen HJM, 2012, CLIN VACCINE IMMUNOL, V19, P515, DOI 10.1128/CVI.05517-11; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hurley WL, 2011, NUTRIENTS, V3, P442, DOI 10.3390/nu3040442; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kane SV, 2009, AM J GASTROENTEROL, V104, P228, DOI 10.1038/ajg.2008.71; Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75; Lamm ME, 1997, ANNU REV MICROBIOL, V51, P311, DOI 10.1146/annurev.micro.51.1.311; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Laukens D, 2016, FEMS MICROBIOL REV, V40, P117, DOI 10.1093/femsre/fuv036; Lee BL, 2013, ELIFE, V2, DOI [10.7554/eLife.00291, 10.1155/2013/961957]; LETTERIO JJ, 1994, SCIENCE, V264, P1936, DOI 10.1126/science.8009224; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; MARKOWITZ JS, 1993, J IMMUNOL, V150, P1223; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; Moon BG, 2004, J IMMUNOL, V172, P6020, DOI 10.4049/jimmunol.172.10.6020; Moon C, 2015, NATURE, V521, P90, DOI 10.1038/nature14139; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Niewiesk S, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00446; Obata T, 2010, P NATL ACAD SCI USA, V107, P7419, DOI 10.1073/pnas.1001061107; Pabst O, 2012, NAT REV IMMUNOL, V12, P821, DOI 10.1038/nri3322; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Pfeiffer JK, 2016, SCIENCE, V351, DOI 10.1126/science.aad5872; Rogier EW, 2014, P NATL ACAD SCI USA, V111, P3074, DOI 10.1073/pnas.1315792111; Roopenian DC, 2003, J IMMUNOL, V170, P3528, DOI 10.4049/jimmunol.170.7.3528; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Saylor CA, 2010, J IMMUNOL, V184, P336, DOI 10.4049/jimmunol.0902752; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Smith T, 1922, J EXP MED, V36, P181, DOI 10.1084/jem.36.2.181; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Ubeda C, 2012, J EXP MED, V209, P1445, DOI 10.1084/jem.20120504; VANDERWAAIJ LA, 1994, CYTOMETRY, V16, P270, DOI 10.1002/cyto.990160312; Washington K, 1996, AM J SURG PATHOL, V20, P1240, DOI 10.1097/00000478-199610000-00010; WEISZCARRINGTON P, 1977, J IMMUNOL, V119, P1306; Yel L, 2010, J CLIN IMMUNOL, V30, P10, DOI 10.1007/s10875-009-9357-x; Yilmaz B, 2014, CELL, V159, P1277, DOI 10.1016/j.cell.2014.10.053; Zeng MY, 2016, IMMUNITY, V44, P647, DOI 10.1016/j.immuni.2016.02.006	60	162	164	2	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2016	165	4					827	841		10.1016/j.cell.2016.04.055	http://dx.doi.org/10.1016/j.cell.2016.04.055			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DL7DN	27153495	Green Accepted, Bronze			2022-12-28	WOS:000375800300012
J	Patel, V; Xiao, SY; Chen, HH; Hanna, F; Jotheeswaran, AT; Luo, D; Parikh, R; Sharma, E; Usmani, S; Yu, Y; Druss, BG; Saxena, S				Patel, Vikram; Xiao, Shuiyuan; Chen, Hanhui; Hanna, Fahmy; Jotheeswaran, A. T.; Luo, Dan; Parikh, Rachana; Sharma, Eesha; Usmani, Shamaila; Yu, Yu; Druss, Benjamin G.; Saxena, Shekhar			The magnitude of and health system responses to the mental health treatment gap in adults in India and China	LANCET			English	Article							METHADONE-MAINTENANCE TREATMENT; MIDDLE-INCOME COUNTRIES; CROSS-SECTIONAL SURVEY; QUALITY-OF-LIFE; PRIMARY-CARE; METROPOLITAN CHINA; DRUG-USERS; FOLLOW-UP; SCHIZOPHRENIA-PATIENTS; MEDICAL-STUDENTS	This Series paper describes the first systematic effort to review the unmet mental health needs of adults in China and India. The evidence shows that contact coverage for the most common mental and substance use disorders is very low. Effective coverage is even lower, even for severe disorders such as psychotic disorders and epilepsy. There are vast variations across the regions of both countries, with the highest treatment gaps in rural regions because of inequities in the distribution of mental health resources, and variable implementation of mental health policies across states and provinces. Human and financial resources for mental health are grossly inadequate with less than 1% of the national health-care budget allocated to mental health in either country. Although China and India have both shown renewed commitment through national programmes for community-oriented mental health care, progress in achieving coverage is far more substantial in China. Improvement of coverage will need to address both supply-side barriers and demand-side barriers related to stigma and varying explanatory models of mental disorders. Sharing tasks with community-based workers in a collaborative stepped-care framework is an approach that is ripe to be scaled up, in particular through integration within national priority health programmes. India and China need to invest in increasing demand for services through active engagement with the community, to strengthen service user leadership and ensure that the content and delivery of mental health programmes are culturally and contextually appropriate.	[Patel, Vikram; Usmani, Shamaila] London Sch Hyg & Trop Med, London, England; [Patel, Vikram] Ctr Control Chron Condit, Guragon, India; [Patel, Vikram; Parikh, Rachana] Publ Hlth Fdn India, Ctr Chron Condit & Injuries, New Delhi, India; [Xiao, Shuiyuan; Luo, Dan; Yu, Yu] Cent S Univ, Xiangya Sch Publ Hlth, Dept Social Med & Hlth Management, Changsha, Hunan, Peoples R China; [Chen, Hanhui] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai, Peoples R China; [Hanna, Fahmy; Saxena, Shekhar] WHO, Dept Mental Hlth & Substance Abuse, Geneva, Switzerland; [Jotheeswaran, A. T.] WHO, Dept Ageing & Life Course, Geneva, Switzerland; [Sharma, Eesha] King George Med Univ, Dept Psychiat, Lucknow, Uttar Pradesh, India; [Druss, Benjamin G.] Emory Univ, Mental Hlth Sch Publ Hlth, Hlth Policy & Management, Atlanta, GA 30322 USA	University of London; London School of Hygiene & Tropical Medicine; Public Health Foundation of India; Central South University; Shanghai Jiao Tong University; World Health Organization; World Health Organization; King George's Medical University; Emory University	Xiao, SY (corresponding author), Cent S Univ, Xiangya Hosp, Sch Publ Hlth, Mental Hlth Ctr,Dept Social Med & Hlth Management, Changsha, Hunan, Peoples R China.	xiaosy@csu.edu.cn	Sharma, Eesha/O-8770-2019	Parikh, Rachana/0000-0002-0761-5513; Amuthavalli Thiyagarajan, Jotheeswaran/0000-0001-7895-788X	China-India Mental Health Alliance; China Medical Board; Wellcome Trust Principal Research Fellowship in Clinical Science; China Medical Board grant; Vanderbilt-Emory-Cornell-Duke (VECD) Fogarty Global Health Fellowship	China-India Mental Health Alliance; China Medical Board; Wellcome Trust Principal Research Fellowship in Clinical Science; China Medical Board grant; Vanderbilt-Emory-Cornell-Duke (VECD) Fogarty Global Health Fellowship	The China-India Mental Health Alliance, which is jointly coordinated by the Shanghai Jiao Tong University and the Public Health Foundation of India, supported the multinational collaboration that made this paper possible. The activities of the Alliance have been supported by a grant from the China Medical Board and by technical assistance from WHO, Emory University, the London School of Hygiene & Tropical Medicine, and Harvard University. VP is supported by a Wellcome Trust Principal Research Fellowship in Clinical Science. SX is supported by a China Medical Board grant. RP is supported by Vanderbilt-Emory-Cornell-Duke (VECD) Fogarty Global Health Fellowship.	Aaltonen S. Elina, 2010, Pharmacy Pract (Granada), V8, P122; Aggarwal NK, 2014, J AFFECT DISORDERS, V163, P88, DOI 10.1016/j.jad.2014.03.036; Albanese E, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-153; Andrade LH, 2014, PSYCHOL MED, V44, P1303, DOI 10.1017/S0033291713001943; [Anonymous], CHIN MENT HLTH J; Cao X, 2012, J INT AIDS SOC, V15, P90; Central Bureau of Health Intelligence, 2015, NAT HLTH PROF 2015; Central Bureau of Health Intelligence, 2013, NAT HLTH PROF 2013; Chatterjee S, 2014, LANCET, V383, P1385, DOI 10.1016/S0140-6736(13)62629-X; Chatterjee S, 2009, BRIT J PSYCHIAT, V195, P433, DOI 10.1192/bjp.bp.108.057596; Che YH, 2010, DRUG ALCOHOL REV, V29, P263, DOI 10.1111/j.1465-3362.2009.00157.x; Chen Hh, 2012, Shanghai Arch Psychiatry, V24, P305, DOI 10.3969/j.issn.1002-0829.2012.06.001; Chen HT, 2013, AIDS EDUC PREV, V25, P336, DOI 10.1521/aeap.2013.25.4.336; Chen SL, 2012, J AFFECT DISORDERS, V141, P86, DOI 10.1016/j.jad.2012.02.027; Cherian AV, 2014, J AFFECT DISORDERS, V152, P387, DOI 10.1016/j.jad.2013.09.042; Cowan J, 2012, INT J MENT HEALTH SY, V6, DOI 10.1186/1752-4458-6-21; D'Costa G, 2007, ALCOHOL ALCOHOLISM, V42, P131, DOI 10.1093/alcal/agl103; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Dhanasekaran S, 2014, DELHI PSYCHIAT J, V17, P160; Global Burden of Disease Study 2013 (GBD 2013), 2015, INC PREV YEARS LIV D; Goel DS, 2011, NATL MED J INDIA, V24, P94; Gong WJ, 2015, THESIS; Grover S, 2008, GERMAN J PSYCHIAT, V11, P10; Grover S, 2012, ASIAN J PSYCHIATR, V5, P251, DOI 10.1016/j.ajp.2012.07.003; Gu J, 2012, ADDICTION, V107, P1641, DOI 10.1111/j.1360-0443.2012.03859.x; Gwalani P., 2015, COMMONEST MENTAL ILL; Hong Z, 2009, EPILEPSIA, V50, P2192, DOI 10.1111/j.1528-1167.2009.02185.x; [胡宓 Hu Mi], 2012, [中国心理卫生杂志, Chinese Mental Health Journal], V26, P98; ICMR, 2009, EV DISTR MENT HLTH P; Isaac M., 2011, THEMES ISSUES CONT I, P2; Iyer RS, 2011, EPILEPSY BEHAV, V21, P137, DOI 10.1016/j.yebeh.2011.03.023; Jain B, 2014, HARM REDUCT J, V11, DOI 10.1186/1477-7517-11-3; Jain N, 2012, ASIAN J PSYCHIATR, V5, P303, DOI 10.1016/j.ajp.2012.04.003; Jenkins R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009049; Kato TA, 2013, INT REV PSYCHIATR, V25, P378, DOI 10.3109/09540261.2013.812959; Kermode M, 2010, INT J SOC PSYCHIATR, V56, P606, DOI 10.1177/0020764009345058; Kishore Jugal, 2011, Indian J Psychiatry, V53, P324, DOI 10.4103/0019-5545.91906; KLEINMAN A, 1982, CULT MED PSYCHIAT, V6, P117, DOI 10.1007/BF00051427; Lasalvia A, 2013, LANCET, V381, P55, DOI 10.1016/S0140-6736(12)61379-8; Lee S, 2007, ACTA PSYCHIAT SCAND, V116, P10, DOI 10.1111/j.1600-0447.2006.00933.x; Lee S, 2010, PSYCHIAT SERV, V61, P1260, DOI 10.1176/ps.2010.61.12.1260; Li J, 2014, INT J MENT HEALTH SY, V8, DOI 10.1186/1752-4458-8-49; Li M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079955; Li Qingjin, 2012, Shanghai Arch Psychiatry, V24, P131, DOI 10.3969/j.issn.1002-0829.2012.03.002; Li SC, 2010, EPILEPSY BEHAV, V17, P242, DOI 10.1016/j.yebeh.2009.12.015; Li X, 2011, PSYCHOGERIATRICS, V11, P83, DOI 10.1111/j.1479-8301.2010.00349.x; Li XM, 2014, INT J SOC PSYCHIATR, V60, P280, DOI 10.1177/0020764013485364; Liao CC, 2013, ANN SURG, V257, P433, DOI 10.1097/SLA.0b013e31827b9b25; Liu Caiping, 2013, Shanghai Arch Psychiatry, V25, P277, DOI 10.3969/j.issn.1002-0829.2013.05.003; Liu EW, 2009, INT J DRUG POLICY, V20, P304, DOI 10.1016/j.drugpo.2008.09.004; Liu JM, 2013, NEURAL REGEN RES, V8, P3316, DOI 10.3969/j.issn.1673-5374.2013.35.006; Liu Y., 2012, THESIS; Luo T, 2014, DRUG ALCOHOL DEPEN, V134, P285, DOI 10.1016/j.drugalcdep.2013.10.015; Ma N, 2012, ASIA-PAC PSYCHIAT, V4, P181, DOI 10.1111/j.1758-5872.2011.00172.x; Ma X, 2008, PSYCHOL MED, V38, P1723, DOI 10.1017/S0033291708003164; Ma X, 2009, PERSPECT PSYCHIATR C, V45, P119, DOI 10.1111/j.1744-6163.2009.00212.x; Olivares JM, 2013, NEUROPSYCH DIS TREAT, V9, P1163, DOI 10.2147/NDT.S49080; Ministry of Health, CHIN HLTH STAT YB BE; Ministry of Health and Family Welfare, 2014, ANN REP MOHFW 2013 1; Ministry of Health and Family Welfare, 2012, REG WORKSH NAT MENT; Mohamed S, 2014, SOC PSYCH PSYCH EPID, V49, P1063, DOI 10.1007/s00127-014-0824-1; Nadkarni J, 2011, ANN INDIAN ACAD NEUR, V14, P279, DOI 10.4103/0972-2327.91948; National Audit Office, 2010, NORTH IR POL BOARD C; National Health and Family Planning Commission, 2015, NAT PLANS MENT HLTH; NHRC, 2012, CAR TREATM MENT HLTH; Ning M, 2012, CHIN MENT HLTH J, V26, P885; Nizamie SH, 2009, EPILEPSY RES, V84, P146, DOI 10.1016/j.eplepsyres.2009.01.008; Nortje G, 2013, INT REV PSYCHIATR, V25, P385, DOI 10.3109/09540261.2013.813838; Pandey S, 2014, J TROP PEDIATRICS, V60, P118, DOI 10.1093/tropej/fmt091; Patel V, 2001, PSYCHOL MED, V31, P29, DOI 10.1017/S0033291799003098; Patel V, 2007, TROP MED INT HEALTH, V12, P130, DOI 10.1111/j.1365-3156.2006.01756.x; Patel V, 2015, LANCET, V386, P2422, DOI 10.1016/S0140-6736(15)00955-1; Patel V, 2011, BRIT J PSYCHIAT, V199, P459, DOI 10.1192/bjp.bp.111.092155; Patel V, 2011, LANCET, V377, P413, DOI 10.1016/S0140-6736(10)61188-9; Pattanayak RD, 2012, INT J SOC PSYCHIATR, V58, P463, DOI 10.1177/0020764011408543; Pereira B, 2007, J AFFECT DISORDERS, V102, P209, DOI 10.1016/j.jad.2006.09.025; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Pi XR, 2012, EPILEPSY RES, V101, P129, DOI 10.1016/j.eplepsyres.2012.03.012; Qian JW, 2012, J MENT HEALTH POLICY, V15, P179; Qingyue M, 2010, 7 WHO; Raban MZ, 2010, NATL MED J INDIA, V23, P267; Raja S, 2010, INT J MENT HEALTH SY, V4, DOI 10.1186/1752-4458-4-11; Ran MS, 2015, BRIT J PSYCHIAT, V207, P495, DOI 10.1192/bjp.bp.114.157685; Saravanan B, 2008, SOC PSYCH PSYCH EPID, V43, P231, DOI 10.1007/s00127-007-0292-y; Sarin E, 2011, INT J DRUG POLICY, V22, P161, DOI 10.1016/j.drugpo.2010.09.011; Sen A, 2013, NY TIMES; Shaji KS., 2010, DEMENTIA INDIA REPOR; Shen YC, 2006, PSYCHOL MED, V36, P257, DOI 10.1017/S0033291705006367; Shetty C, 2011, MENTAL HLTH NGOS IND; Sinha A, 2011, NEUROL ASIA, V16, P33; Sreevani R, 2012, Nurs J India, V103, P44; Suresh KK, 2012, SOC PSYCH PSYCH EPID, V47, P1865, DOI 10.1007/s00127-012-0495-8; TANAHASHI T, 1978, B WORLD HEALTH ORGAN, V56, P295; Thara R, 2008, INT J SOC PSYCHIATR, V54, P197, DOI 10.1177/0020764008090421; Thara R., 2010, INDIAN J PSYCHIAT, V52, pS389, DOI [DOI 10.4103/0019-5545.69276, 10.4103/0019-5545.69276]; Thara R, 2008, BEHAV SCI LAW, V26, P315, DOI 10.1002/bsl.816; Thara Rangawsamy, 2008, Int J Ment Health Syst, V2, P11, DOI 10.1186/1752-4458-2-11; Thirthalli J, 2009, ACTA PSYCHIAT SCAND, V119, P209, DOI 10.1111/j.1600-0447.2008.01299.x; Thirthalli JZ, LANCET PSYC IN PRESS; Thornicroft G, 2009, LANCET, V373, P408, DOI 10.1016/S0140-6736(08)61817-6; United Nations Department of economic and social affairs population division, 2015, POP DIV WORLD POP PR; Varma NP, 2007, EPILEPSY BEHAV, V10, P250, DOI 10.1016/j.yebeh.2006.11.009; Wang K., 2012, EC OPERATION SPECIAL; Wang PS, 2007, LANCET, V370, P841, DOI 10.1016/S0140-6736(07)61414-7; Wang WZ, 2008, B WORLD HEALTH ORGAN, V86, P964, DOI 10.2471/BLT.07.047050; Wasan AD, 2009, SOC PSYCH PSYCH EPID, V44, P109, DOI 10.1007/s00127-008-0408-z; [位照国 Wei Zhaoguo], 2010, [中国心理卫生杂志, Chinese Mental Health Journal], V24, P597; Wen H, 2012, SICHUAN MENTAL HLTH, V25, P200; WHO, 2015, MENT HLTH ATL 2014 W; WHO, 2006, WHO AIMS REPORT MENT; WHO, 2013, GLOB HLTH EXP DAT NH; WHO, 2014, IMM COV; WHO, 2020, MENT HLTH ATL 2011; World Bank, WORLD DEV IND; World Health Organisation, 2021, MENT HLTH ACT PLAN 2; World Health Organization, 2016, MHGAP INT GUID MENT; Wu S, 2007, J CLIN PSYCHOL MED S, V17, P6; Xiang YT, 2011, SOC PSYCH PSYCH EPID, V46, P1325, DOI 10.1007/s00127-010-0304-1; Yang LH, 2013, BRIT J PSYCHIAT, V203, P272, DOI 10.1192/bjp.bp.112.118927; Zhang DX, 2014, J AFFECT DISORDERS, V169, P212, DOI 10.1016/j.jad.2014.08.015; Zhang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068906; Zhang WJ, 2013, INT J MENT HEALTH SY, V7, DOI 10.1186/1752-4458-7-22; Zhou YL, 2014, J MENT HEALTH POLICY, V17, P25; 姚付新, 2015, [中国心理卫生杂志, Chinese Mental Health Journal], V29, P331	124	139	143	9	76	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 17	2016	388	10063					3074	3084		10.1016/S0140-6736(16)00160-4	http://dx.doi.org/10.1016/S0140-6736(16)00160-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EF1VF	27209149				2022-12-28	WOS:000390112300039
J	Jacobs, M; Rodger, A; Bell, DJ; Bhagani, S; Cropley, I; Filipe, A; Gifford, RJ; Hopkins, S; Hughes, J; Jabeen, F; Johannessen, I; Karageorgopoulos, D; Lackenby, A; Lester, R; Liu, RSN; MacConnachie, A; Mahungu, T; Martin, D; Marshall, N; Mepham, S; Orton, R; Palmarini, M; Patel, M; Perry, C; Peters, SE; Porter, D; Ritchie, D; Ritchie, ND; Seaton, RA; Sreenu, VB; Templeton, K; Warren, S; Wilkie, GS; Zambon, M; Gopal, R; Thomson, EC				Jacobs, Michael; Rodger, Alison; Bell, David J.; Bhagani, Sanjay; Cropley, Ian; Filipe, Ana; Gifford, Robert J.; Hopkins, Susan; Hughes, Joseph; Jabeen, Farrah; Johannessen, Ingolfur; Karageorgopoulos, Drosos; Lackenby, Angie; Lester, Rebecca; Liu, Rebecca S. N.; MacConnachie, Alisdair; Mahungu, Tabitha; Martin, Daniel; Marshall, Neal; Mepham, Stephen; Orton, Richard; Palmarini, Massimo; Patel, Monika; Perry, Colin; Peters, S. Erica; Porter, Duncan; Ritchie, David; Ritchie, Neil D.; Seaton, R. Andrew; Sreenu, Vattipally B.; Templeton, Kate; Warren, Simon; Wilkie, Gavin S.; Zambon, Maria; Gopal, Robin; Thomson, Emma C.			Late Ebola virus relapse causing meningoencephalitis: a case report	LANCET			English	Article							ARGENTINE HEMORRHAGIC-FEVER; SIERRA-LEONE; DISEASE	Background There are thousands of survivors of the 2014 Ebola outbreak in west Africa. Ebola virus can persist in survivors for months in immune-privileged sites; however, viral relapse causing life-threatening and potentially transmissible disease has not been described. We report a case of late relapse in a patient who had been treated for severe Ebola virus disease with high viral load (peak cycle threshold value 13.2). Methods A 39-year-old female nurse from Scotland, who had assisted the humanitarian effort in Sierra Leone, had received intensive supportive treatment and experimental antiviral therapies, and had been discharged with undetectable Ebola virus RNA in peripheral blood. The patient was readmitted to hospital 9 months after discharge with symptoms of acute meningitis, and was found to have Ebola virus in cerebrospinal fluid (CSF). She was treated with supportive therapy and experimental antiviral drug GS-5734 (Gilead Sciences, San Francisco, Foster City, CA, USA). We monitored Ebola virus RNA in CSF and plasma, and sequenced the viral genome using an unbiased metagenomic approach. Findings On admission, reverse transcriptase PCR identified Ebola virus RNA at a higher level in CSF (cycle threshold value 23.7) than plasma (31.3); infectious virus was only recovered from CSF. The patient developed progressive meningoencephalitis with cranial neuropathies and radiculopathy. Clinical recovery was associated with addition of high-dose corticosteroids during GS-5734 treatment. CSF Ebola virus RNA slowly declined and was undetectable following 14 days of treatment with GS-5734. Sequencing of plasma and CSF viral genome revealed only two non-coding changes compared with the original infecting virus. Interpretation Our report shows that previously unanticipated, late, severe relapses of Ebola virus can occur, in this case in the CNS. This finding fundamentally redefines what is known about the natural history of Ebola virus infection. Vigilance should be maintained in the thousands of Ebola survivors for cases of relapsed infection. The potential for these cases to initiate new transmission chains is a serious public health concern.	[Jacobs, Michael; Bhagani, Sanjay; Cropley, Ian; Hopkins, Susan; Karageorgopoulos, Drosos; Lester, Rebecca; Mahungu, Tabitha; Mepham, Stephen; Warren, Simon] Royal Free London NHS Fdn Trust, Dept Infect, London NW3 2QG, England; [Liu, Rebecca S. N.] Royal Free London NHS Fdn Trust, Dept Neurol, London, England; [Jabeen, Farrah] Royal Free London NHS Fdn Trust, Dept Radiol, London, England; [Marshall, Neal] Royal Free London NHS Fdn Trust, Dept Pharm, London, England; [Martin, Daniel] UCL, Div Surg, London, England; [Rodger, Alison] UCL, Res Dept Infect & Populat Hlth, London, England; [Bell, David J.; MacConnachie, Alisdair; Perry, Colin; Peters, S. Erica; Porter, Duncan; Ritchie, David; Ritchie, Neil D.; Seaton, R. Andrew; Thomson, Emma C.] Queen Elizabeth Univ Hosp, Glasgow, Lanark, Scotland; [Johannessen, Ingolfur; Templeton, Kate] Royal Edinburgh Infirm, Reg Virus Lab Specialist Virol Ctr, Edinburgh, Midlothian, Scotland; [Filipe, Ana; Gifford, Robert J.; Hughes, Joseph; Orton, Richard; Palmarini, Massimo; Sreenu, Vattipally B.; Wilkie, Gavin S.; Thomson, Emma C.] Univ Glasgow, MRC, Ctr Virus Res, Glasgow, Lanark, Scotland; [Lackenby, Angie; Zambon, Maria] Publ Hlth England, Natl Infect Serv, Virus Reference Dept, Colindale, England; [Patel, Monika; Gopal, Robin] Publ Hlth England, Natl Infect Serv, High Containment Microbiol Dept, Colindale, England	University of London; University College London; Royal Free London NHS Foundation Trust; University of London; University College London; Royal Free London NHS Foundation Trust; University of London; University College London; Royal Free London NHS Foundation Trust; University of London; University College London; Royal Free London NHS Foundation Trust; University of London; University College London; University of London; University College London; Queen Elizabeth University Hospital (QEUH); Royal Infirmary of Edinburgh; University of Glasgow; Public Health England; Public Health England	Jacobs, M (corresponding author), Royal Free London NHS Fdn Trust, Dept Infect, London NW3 2QG, England.	michael.jacobs@ucl.ac.uk	Karageorgopoulos, Drosos/K-9241-2018; Hughes, Joseph/B-7711-2009; Thomson, Emma C/M-8690-2017	Karageorgopoulos, Drosos/0000-0002-9959-9978; Hughes, Joseph/0000-0003-2556-2563; Thomson, Emma C/0000-0003-1482-0889; Porter, Duncan/0000-0001-8481-5204; Gifford, Robert/0000-0003-4028-9884; Martin, Daniel/0000-0001-6220-8235; Hopkins, Susan/0000-0001-5179-5702; Lackenby, Angie/0000-0002-1557-0415; da Silva Filipe, Ana Cristina/0000-0002-9442-2903; Palmarini, Massimo/0000-0001-7007-4070; Templeton, Kate/0000-0001-7414-1277; Bhagani, Sanjay/0000-0003-2557-4337; Vattipally, Bala Sreenu/0000-0001-6673-4697	Royal Free London NHS Foundation Trust; Medical Research Council [MC_UU_12014/12, G0801822] Funding Source: researchfish; Wellcome Trust [102789/Z/13/Z] Funding Source: researchfish; MRC [G0801822, MC_UU_12014/12, MC_UU_12014/2] Funding Source: UKRI	Royal Free London NHS Foundation Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Royal Free London NHS Foundation Trust.	Bell A, 2015, EUROSURVEILLANCE, V20, P6, DOI 10.2807/1560-7917.ES2015.20.20.21131; Bwaka MA, 1999, J INFECT DIS, V179, pS1, DOI 10.1086/514308; Clark DV, 2015, LANCET INFECT DIS, V15, P905, DOI 10.1016/S1473-3099(15)70152-0; Deen GF, 2017, NEW ENGL J MED, V377, P1428, DOI 10.1056/NEJMoa1511410; ENRIA D, 1986, MED MICROBIOL IMMUN, V175, P173, DOI 10.1007/BF02122443; Faye O, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001908; Howlett P, 2016, EMERG INFECT DIS, V22, P150, DOI 10.3201/eid2201.151212; MAIZTEGUI JI, 1979, LANCET, V2, P1216; Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773; Qui X, 2012, SCI TRANSL MED, V4; Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680; Trombley AR, 2010, AM J TROP MED HYG, V82, P954, DOI 10.4269/ajtmh.2010.09-0636; Varkey JB, 2015, NEW ENGL J MED, V372, P2423, DOI 10.1056/NEJMoa1500306; Warren T, 2015, ID WEEK         1007; Wilson AJ, 2016, CLIN INFECT DIS, V62, P610, DOI 10.1093/cid/civ977; World Health Organisation, 2016, EB SIT REP 30 MARCH	16	215	225	6	60	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 30	2016	388	10043					498	503		10.1016/S0140-6736(16)30386-5	http://dx.doi.org/10.1016/S0140-6736(16)30386-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS2EK	27209148	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000380559400029
J	O'Brien, E				O'Brien, Eoin			Salt-too much or too little?	LANCET			English	Editorial Material							URINARY SODIUM; CARDIOVASCULAR EVENTS; POTASSIUM EXCRETION; RISK; MORTALITY					profeobrien@icloud.com						[Anonymous], 2011, LANCET, V377, P1626, DOI 10.1016/S0140-6736(11)60657-0; Graudal N, 2014, AM J HYPERTENS, V27, P1129, DOI 10.1093/ajh/hpu028; Joosten MM, 2014, CIRCULATION, V129, P1121, DOI 10.1161/CIRCULATIONAHA.113.004290; Mente A, 2016, LANCET; O'Donnell M, 2014, NEW ENGL J MED, V371, P612, DOI 10.1056/NEJMoa1311889; O'Donnell MJ, 2011, JAMA-J AM MED ASSOC, V306, P2229, DOI 10.1001/jama.2011.1729; Oparil S, 2014, NEW ENGL J MED, V371, P677, DOI 10.1056/NEJMe1407695; Stolarz-Skrzypek K, 2011, JAMA-J AM MED ASSOC, V305, P1777, DOI 10.1001/jama.2011.574; Strom BL, 2013, SOD INT POP ASEV	9	8	8	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 30	2016	388	10043					439	440		10.1016/S0140-6736(16)30510-4	http://dx.doi.org/10.1016/S0140-6736(16)30510-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS2EK	27216140				2022-12-28	WOS:000380559400004
J	Liu, SW; Page, A				Liu, Shiwei; Page, Andrew			Reforming mental health in China and India	LANCET			English	Editorial Material							MORTALITY; SYSTEM		[Liu, Shiwei] Chinese Ctr Dis Control & Prevent, Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing 100050, Peoples R China; [Page, Andrew] Univ Western Sydney, Ctr Hlth Res, Penrith, NSW 2571, Australia	Chinese Center for Disease Control & Prevention; National Center for Chronic & Noncommunicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Western Sydney University	Liu, SW (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing 100050, Peoples R China.	liusw@chinacdc.cn						Astell-Burt T, 2015, SCI REP-UK, V5, DOI 10.1038/srep15038; Charlson F. J., 2016, LANCET; Huang C, 2014, LANCET, V384, P783, DOI 10.1016/S0140-6736(14)61214-9; Liu J, 2011, WORLD PSYCHIATRY, V10, P210; Liu S, 2015, PSYCHOL MED, V45, P3259, DOI 10.1017/S0033291715001269; Mathias K, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1778-2; Murthy RS, 2011, NATL MED J INDIA, V24, P98; National Health and Family Planning Commission, 2012, WORK SPEC MAN TREATM; National Health and Family Planning Commission, 2013, REG SEV MENT ILLN RE; Sinha Suman K, 2011, Indian J Psychiatry, V53, P261, DOI 10.4103/0019-5545.86821; The State Council of China, NAT MENT HLTH WORK P; Zhou MG, 2015, DIABETES CARE, V38, P72, DOI 10.2337/dc14-1100	12	17	18	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2016	388	10042					314	316		10.1016/S0140-6736(16)30373-7	http://dx.doi.org/10.1016/S0140-6736(16)30373-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DR6MV	27209145				2022-12-28	WOS:000380016900007
J	Torjesen, I				Torjesen, Ingrid			EU exit would have a detrimental effect on the NHS, academics warn	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Majeed A, 2016, J ROY SOC MED, V109, P216, DOI 10.1177/0141076816652027; Treasury HM, 2016, HM TREAS AN LONG TER	2	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 24	2016	353								i2953	10.1136/bmj.i2953	http://dx.doi.org/10.1136/bmj.i2953			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3CB	27220718				2022-12-28	WOS:000376938800019
J	Enyedi, B; Jelcic, M; Niethammer, P				Enyedi, Balazs; Jelcic, Mark; Niethammer, Philipp			The Cell Nucleus Serves as a Mechanotransducer of Tissue Damage-Induced Inflammation	CELL			English	Article							PHOSPHOLIPASE A(2); OSMOTIC SURVEILLANCE; ARACHIDONIC-ACID; IN-VIVO; ENVELOPE; MECHANICS; PROTEINS; ACTIVATION; DEATH; CYTOSKELETON	Tissue damage activates cytosolic phospholipase A(2) (cPLA(2)), releasing arachidonic acid (AA), which is oxidized to proinflammatory eicosanoids by 5-lipoxygenase (5-LOX) on the nuclear envelope. How tissue damage is sensed to activate cPLA(2) is unknown. We investigated this by live imaging in wounded zebrafish larvae, where damage of the fin tissue causes osmotic cell swelling at the wound margin and the generation of a chemotactic eicosanoid signal. Osmotic swelling of cells and their nuclei activates cPla(2) by translocating it from the nucleoplasm to the nuclear envelope. Elevated cytosolic Ca2+ was necessary but not sufficient for cPla(2) translocation, and nuclear swelling was required in parallel. cPla(2) translocation upon nuclear swelling was reconstituted in isolated nuclei and appears to be a simple physical process mediated by tension in the nuclear envelope. Our data suggest that the nucleus plays a mechanosensory role in inflammation by transducing cell swelling and lysis into proinflammatory eicosanoid signaling.	[Enyedi, Balazs; Jelcic, Mark; Niethammer, Philipp] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Niethammer, P (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA.	niethamp@mskcc.org	Enyedi, Balázs/I-9320-2017	Enyedi, Balázs/0000-0001-5713-3785; Niethammer, Philipp/0000-0003-4175-4012	Lucille Castori Center for Microbes, Inflammation and Cancer Fellowship; NIH [GM099970]; American Asthma Foundation; Louis V. Gerstner, Jr. Young Investigator award; NIH/NCI Cancer Center [P30CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099970] Funding Source: NIH RePORTER	Lucille Castori Center for Microbes, Inflammation and Cancer Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; Louis V. Gerstner, Jr. Young Investigator award; NIH/NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank Tim Mitchison and Michelina Stoddard for their thoughtful comments on the manuscript, and Kris Noel Dahl, Alan Hall (1952-2015), Peter Enyedi, and Andras Kapus for helpful discussions along the way. We thank Emily Foley for granting access to her confocal microscope. B.E. was supported by a Lucille Castori Center for Microbes, Inflammation and Cancer Fellowship. Research was funded by NIH grant GM099970, an American Asthma Foundation Scholar grant, and a Louis V. Gerstner, Jr. Young Investigator award to P.N., and in part through the NIH/NCI Cancer Center Support Grant P30CA008748.	BAZAN NG, 1970, BIOCHIM BIOPHYS ACTA, V218, P1, DOI 10.1016/0005-2760(70)90086-X; BOGUSLAVSKY V, 1994, BIOCHEMISTRY-US, V33, P3032, DOI 10.1021/bi00176a036; Briand S I, 1998, Methods Mol Biol, V105, P161; Brock TG, 2005, J CELL BIOCHEM, V96, P1203, DOI 10.1002/jcb.20662; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Compan V, 2012, IMMUNITY, V37, P487, DOI 10.1016/j.immuni.2012.06.013; Dahl KN, 2004, J CELL SCI, V117, P4779, DOI 10.1242/jcs.01357; Dahl KN, 2008, CIRC RES, V102, P1307, DOI 10.1161/CIRCRESAHA.108.173989; Davidson PM, 2014, TRENDS CELL BIOL, V24, P247, DOI 10.1016/j.tcb.2013.11.004; De Vos WH, 2011, HUM MOL GENET, V20, P4175, DOI 10.1093/hmg/ddr344; Enyedi B., 2016, CELL MOL BIOENG; Enyedi B, 2013, NAT CELL BIOL, V15, P1123, DOI 10.1038/ncb2818; Finan JD, 2010, J CELL BIOCHEM, V109, P460, DOI 10.1002/jcb.22437; Friedl P, 2011, CURR OPIN CELL BIOL, V23, P55, DOI 10.1016/j.ceb.2010.10.015; Gault WJ, 2014, J CELL BIOL, V207, P767, DOI 10.1083/jcb.201408049; Graf C, 2008, MOL PHARMACOL, V74, P925, DOI 10.1124/mol.108.048652; Guilluy C, 2014, NAT CELL BIOL, V16, P376, DOI 10.1038/ncb2927; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Hammond GRV, 2009, J CELL BIOL, V184, P297, DOI 10.1083/jcb.200809073; Itano N, 2003, P NATL ACAD SCI USA, V100, P5181, DOI 10.1073/pnas.0531397100; Izsvak Z, 2009, METHODS, V49, P287, DOI 10.1016/j.ymeth.2009.07.001; Kang M, 2012, TRAFFIC, V13, P1589, DOI 10.1111/tra.12008; Khatau SB, 2009, P NATL ACAD SCI USA, V106, P19017, DOI 10.1073/pnas.0908686106; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; LeBert DC, 2014, SEMIN IMMUNOL, V26, P315, DOI 10.1016/j.smim.2014.04.007; LEHTONEN JYA, 1995, BIOPHYS J, V68, P1888, DOI 10.1016/S0006-3495(95)80366-8; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Lichtenbergova L, 1998, BIOCHEMISTRY-US, V37, P14128, DOI 10.1021/bi980888s; Lombardi ML, 2011, J BIOL CHEM, V286, P26743, DOI 10.1074/jbc.M111.233700; Luxton GWG, 2010, SCIENCE, V329, P956, DOI 10.1126/science.1189072; MAJNO G, 1995, AM J PATHOL, V146, P3; Mateus R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051766; NEEDHAM D, 1988, BIOCHEMISTRY-US, V27, P4668, DOI 10.1021/bi00413a013; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Rock KL, 2011, IMMUNOL REV, V243, P191, DOI 10.1111/j.1600-065X.2011.01040.x; Rowat AC, 2008, BIOESSAYS, V30, P226, DOI 10.1002/bies.20720; SLATER SJ, 1994, J BIOL CHEM, V269, P4866; Starr DA, 2010, ANNU REV CELL DEV BI, V26, P421, DOI 10.1146/annurev-cellbio-100109-104037; Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104; Thoroed SM, 1997, J MEMBRANE BIOL, V160, P47, DOI 10.1007/s002329900294; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Vargas JD, 2012, NUCLEUS-PHILA, V3, P88, DOI 10.4161/nucl.18954; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002	48	110	111	1	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2016	165	5					1160	1170		10.1016/j.cell.2016.04.016	http://dx.doi.org/10.1016/j.cell.2016.04.016			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DM6QT	27203112	Green Accepted, Bronze			2022-12-28	WOS:000376478200016
J	Katsnelson, A				Katsnelson, Alla			Filling in the missing pieces	NATURE			English	Editorial Material																		Drossman DA, 2009, J CLIN GASTROENTEROL, V43, P541, DOI 10.1097/MCG.0b013e318189a7f9; Pike BL, 2015, J TRAVEL MED, V22, P242, DOI 10.1111/jtm.12218; Pimentel M, 2000, AM J GASTROENTEROL, V95, P3503, DOI 10.1111/j.1572-0241.2000.03368.x; Pimentel M, 2008, DIGEST DIS SCI, V53, P982, DOI 10.1007/s10620-007-9977-z; Pimentel M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126438; Pimentel M, 2015, DIGEST DIS SCI, V60, P1195, DOI 10.1007/s10620-014-3435-5	6	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					S110	S111		10.1038/533S110a	http://dx.doi.org/10.1038/533S110a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0AH	27191489				2022-12-28	WOS:000376004300005
J	O'Malley, RC; Huang, SSC; Song, L; Lewsey, MG; Bartlett, A; Nery, JR; Galli, M; Gallavotti, A; Ecker, JR				O'Malley, Ronan C.; Huang, Shao-shan Carol; Song, Liang; Lewsey, Mathew G.; Bartlett, Anna; Nery, Joseph R.; Galli, Mary; Gallavotti, Andrea; Ecker, Joseph R.			Cistrome and Epicistrome Features Shape the Regulatory DNA Landscape	CELL			English	Article							NAC TRANSCRIPTION FACTORS; BINDING SPECIFICITIES; STRUCTURAL BASIS; METHYLATION; CHROMATIN; PLANTS; CHIP; MICROARRAYS; PRINCIPLES; EVOLUTION	The cistrome is the complete set of transcription factor (TF) binding sites (cis-elements) in an organism, while an epicistrome incorporates tissue-specific DNA chemical modifications and TF-specific chemical sensitivities into these binding profiles. Robust methods to construct comprehensive cistrome and epicistrome maps are critical for elucidating complex transcriptional networks that underlie growth, behavior, and disease. Here, we describe DNA affinity purification sequencing (DAP-seq), a high-throughput TF binding site discovery method that interrogates genomic DNA with in-vitro-expressed TFs. Using DAP-seq, we defined the Arabidopsis cistrome by resolving motifs and peaks for 529 TFs. Because genomic DNA used in DAP-seq retains 5-methylcytosines, we determined that >75% (248/327) of Arabidopsis TFs surveyed were methylation sensitive, a property that strongly impacts the epicistrome landscape. DAP-seq datasets also yielded insight into the biology and binding site architecture of numerous TFs, demonstrating the value of DAP-seq for cost-effective cistromic and epicistromic annotation in any organism.	[O'Malley, Ronan C.; Huang, Shao-shan Carol; Bartlett, Anna; Nery, Joseph R.; Galli, Mary; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [O'Malley, Ronan C.; Huang, Shao-shan Carol; Song, Liang; Lewsey, Mathew G.; Ecker, Joseph R.] Salk Inst Biol Studies, Plant Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Ecker, Joseph R.] Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Galli, Mary; Gallavotti, Andrea] Rutgers State Univ, Waksman Inst, POB 759, Piscataway, NJ 08854 USA; [Lewsey, Mathew G.] La Trobe Univ, Dept Anim Plant & Soil Sci, Sch Life Sci, Ctr AgriBiosci, Bundoora, Vic 3086, Australia	Salk Institute; Salk Institute; Howard Hughes Medical Institute; Salk Institute; Rutgers State University New Brunswick; La Trobe University	Ecker, JR (corresponding author), Salk Inst Biol Studies, Genom Anal Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.; Ecker, JR (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.; Ecker, JR (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ecker@salk.edu	Ecker, Joseph R/B-9144-2008; Lewsey, Mathew G/AAE-8530-2019; Nery, Joseph/AAE-8422-2019	Ecker, Joseph R/0000-0001-5799-5895; Nery, Joseph/0000-0003-0153-5659; Lewsey, Mathew/0000-0002-2631-4337; omalley, ronan/0000-0002-4907-0339	NSF [IOS-0820729/IOS-1114484, MCB1024999]; Gordon and Betty Moore Foundation [GBMF3034]; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Andrew Kuruzar for assistance with images (p40design@gmail.com). We thank Chris Benner, Ian Quigley, Debra Fulton, Robert Schmitz, and Yue Zhao for their critical reading of the manuscript. We thank Rosa Castanon for sharing biological materials. A.G. acknowledges funding from NSF (IOS-0820729/IOS-1114484). This work was supported by grants from the NSF (MCB1024999) and the Gordon and Betty Moore Foundation (GBMF3034) (to J.R.E.). J.R.E. is an Investigator of the Howard Hughes Medical Institute.	Berger MF, 2009, NAT PROTOC, V4, P393, DOI 10.1038/nprot.2008.195; Berke L., 2015, BMC Evolutionary Biology, V15; Bu QY, 2008, CELL RES, V18, P756, DOI 10.1038/cr.2008.53; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Chang KN, 2013, ELIFE, V2, DOI 10.7554/eLife.00675; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Domcke S, 2015, NATURE, V528, P575, DOI 10.1038/nature16462; Farcot E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122231; Finet C, 2013, MOL BIOL EVOL, V30, P45, DOI 10.1093/molbev/mss220; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; Franco-Zorrilla JM, 2014, P NATL ACAD SCI USA, V111, P2367, DOI 10.1073/pnas.1316278111; Galli M, 2015, P NATL ACAD SCI USA, V112, P13372, DOI 10.1073/pnas.1516473112; Correa LGG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002944; Guertin MJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002610; Guo YC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002638; Harashima H, 2013, TRENDS CELL BIOL, V23, P345, DOI 10.1016/j.tcb.2013.03.002; Haudry A, 2013, NAT GENET, V45, P891, DOI 10.1038/ng.2684; Hunt RW, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0412-4; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; Kheradpour P, 2014, NUCLEIC ACIDS RES, V42, P2976, DOI 10.1093/nar/gkt1249; Kidder BL, 2011, NAT IMMUNOL, V12, P918, DOI 10.1038/ni.2117; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Levo M, 2014, NAT REV GENET, V15, P453, DOI 10.1038/nrg3684; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Liu X, 2005, GENOME RES, V15, P421, DOI 10.1101/gr.3256505; Mann IK, 2013, GENOME RES, V23, P988, DOI 10.1101/gr.146654.112; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Mouse ENCODE Consortium, 2012, Genome Biol, V13, P418, DOI 10.1186/gb-2012-13-8-418; Nanao MH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4617; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Pruneda-Paz JL, 2014, CELL REP, V8, P621, DOI 10.1016/j.celrep.2014.06.033; Rajeev Lara, 2014, J Vis Exp, DOI 10.3791/51715; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Re DA, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-150; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Boer DR, 2014, CELL, V156, P577, DOI 10.1016/j.cell.2013.12.027; Schmitz RJ, 2013, NATURE, V495, P193, DOI 10.1038/nature11968; Staudt N, 2006, MOL BIOL CELL, V17, P2356, DOI 10.1091/mbc.E05-11-1056; Struhl K, 2013, NAT STRUCT MOL BIOL, V20, P267, DOI 10.1038/nsmb.2506; Sullivan AM, 2014, CELL REP, V8, P2015, DOI 10.1016/j.celrep.2014.08.019; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Ulmasov T, 1997, SCIENCE, V276, P1865, DOI 10.1126/science.276.5320.1865; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Welch D, 2007, GENE DEV, V21, P2196, DOI 10.1101/gad.440307; Xu DQ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004197; Zemach A, 2013, CELL, V153, P193, DOI 10.1016/j.cell.2013.02.033; Zhang WL, 2012, PLANT CELL, V24, P2719, DOI 10.1105/tpc.112.098061; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	52	604	607	12	174	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2016	165	5					1280	1292		10.1016/j.cell.2016.04.038	http://dx.doi.org/10.1016/j.cell.2016.04.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DM6QT	27203113	Green Accepted, Bronze			2022-12-28	WOS:000376478200025
J	Seiple, IB; Zhang, ZY; Jakubec, P; Langlois-Mercier, A; Wright, PM; Hog, DT; Yabu, K; Allu, SR; Fukuzaki, T; Carlsen, PN; Kitamura, Y; Zhou, X; Condakes, ML; Szczypinski, FT; Green, WD; Myers, AG				Seiple, Ian B.; Zhang, Ziyang; Jakubec, Pavol; Langlois-Mercier, Audrey; Wright, Peter M.; Hog, Daniel T.; Yabu, Kazuo; Allu, Senkara Rao; Fukuzaki, Takehiro; Carlsen, Peter N.; Kitamura, Yoshiaki; Zhou, Xiang; Condakes, Matthew L.; Szczypinski, Filip T.; Green, William D.; Myers, Andrew G.			A platform for the discovery of new macrolide antibiotics	NATURE			English	Article							ASYMMETRIC TOTAL-SYNTHESIS; AZITHROMYCIN CP-62,993; ERYTHROMYCIN-B; EFFICIENT; RESISTANCE; TELITHROMYCIN; DERIVATIVES; KETOLIDES; RIBOSOME; BINDING	The chemical modification of structurally complex fermentation products, a process known as semisynthesis, has been an important tool in the discovery and manufacture of antibiotics for the treatment of various infectious diseases. However, many of the therapeutics obtained in this way are no longer effective, because bacterial resistance to these compounds has developed. Here we present a practical, fully synthetic route to macrolide antibiotics by the convergent assembly of simple chemical building blocks, enabling the synthesis of diverse structures not accessible by traditional semisynthetic approaches. More than 300 new macrolide antibiotic candidates, as well as the clinical candidate solithromycin, have been synthesized using our convergent approach. Evaluation of these compounds against a panel of pathogenic bacteria revealed that the majority of these structures had antibiotic activity, some efficacious against strains resistant to macrolides in current use. The chemistry we describe here provides a platform for the discovery of new macrolide antibiotics and may also serve as the basis for their manufacture.	[Seiple, Ian B.; Zhang, Ziyang; Jakubec, Pavol; Langlois-Mercier, Audrey; Wright, Peter M.; Hog, Daniel T.; Yabu, Kazuo; Allu, Senkara Rao; Fukuzaki, Takehiro; Carlsen, Peter N.; Kitamura, Yoshiaki; Zhou, Xiang; Condakes, Matthew L.; Szczypinski, Filip T.; Green, William D.; Myers, Andrew G.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Seiple, Ian B.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Langlois-Mercier, Audrey] Novartis Pharma AG, Chem & Analyt Dev, CH-4002 Basel, Switzerland; [Wright, Peter M.] McKinsey & Co Inc, 55 East 52nd St,21st Floor, New York, NY 10022 USA; [Hog, Daniel T.] Bayer Pharma AG, Med Chem, Mullerstr 178, D-13353 Berlin, Germany; [Yabu, Kazuo] Daiichi Sankyo Co Ltd, Med Chem Res Labs, Shinagawa R&D Ctr, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan; [Kitamura, Yoshiaki] Gifu Univ, Dept Chem & Biomol Sci, 1-1 Yanagido, Gifu 5011193, Japan; [Condakes, Matthew L.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Szczypinski, Filip T.] Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England; [Green, William D.] Univ Cambridge Trinity Coll, Cambridge CB2 1TQ, England	Harvard University; University of California System; University of California San Francisco; Novartis; Bayer AG; Bayer Healthcare Pharmaceuticals; Daiichi Sankyo Company Limited; Gifu University; University of California System; University of California Berkeley; University of Cambridge; University of Cambridge	Myers, AG (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	myers@chemistry.harvard.edu	Kitamura, Yoshiaki/L-5138-2018; Zhang, Ziyang/J-4974-2019; Szczypiński, Filip T./H-6985-2019; Kitamura, Yoshiaki/ABE-4680-2020	Kitamura, Yoshiaki/0000-0002-5785-6892; Szczypiński, Filip T./0000-0003-3174-8532; Kitamura, Yoshiaki/0000-0002-5785-6892; Condakes, Matthew/0000-0002-0614-457X; Jakubec, Pavol/0000-0001-8872-3817; Green, Will/0000-0001-8556-0389; Zhang, Ziyang/0000-0003-0541-7211; Yabu, Kazuo/0000-0003-2825-1955	Gustavus and Louise Pfeiffer Research Foundation; Blavatnik Biomedical Accelerator Program at Harvard University; NERCE (NIH) [U54 AI057159]; National Institutes of Health [F32GM099233]; Swiss National Science Foundation [PBGEPE2-139864]; Novartis Foundation; Deutsche Forschungsgemeinschaft (DFG) [HO 5326/1-1]; Daiichi-Sankyo Co., Ltd; Engineering Promotion Fund of Gifu University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM099233] Funding Source: NIH RePORTER	Gustavus and Louise Pfeiffer Research Foundation; Blavatnik Biomedical Accelerator Program at Harvard University; NERCE (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Foundation(Novartis); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Daiichi-Sankyo Co., Ltd(Daiichi Sankyo Company Limited); Engineering Promotion Fund of Gifu University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge funding from Alistair and Celine Mactaggart, from the Gustavus and Louise Pfeiffer Research Foundation, and from the Blavatnik Biomedical Accelerator Program at Harvard University. We thank NERCE (NIH project number U54 AI057159), W. Weiss (Univ. North Texas), and R. Alm and S. Lahiri (Macrolide Pharmaceuticals) for measuring MIC values, R. Alm and T. Dougherty (Harvard Medical School) for genetic characterization of a microbial resistance gene, and S.-L. Zheng (Harvard University) for conducting X-ray crystallographic analyses. I.B.S. acknowledges postdoctoral fellowship support from the National Institutes of Health (F32GM099233); Z.Z. is a Howard Hughes Medical Institute International Student Research fellow; A.L.-M. acknowledges postdoctoral fellowship support from the Swiss National Science Foundation (PBGEPE2-139864) and the Novartis Foundation; D.T.H. is indebted to the Deutsche Forschungsgemeinschaft (DFG) for a postdoctoral fellowship (HO 5326/1-1); T.F. acknowledges Daiichi-Sankyo Co., Ltd, for financial support; and Y.K. acknowledges support from the Engineering Promotion Fund of Gifu University.	Andrade RB, 2015, SYNLETT, V26, P2199, DOI 10.1055/s-0034-1381047; [Anonymous], 2013, ANTIBIOTIC RESISTANC; Ashley G., 2003, US patent, Patent No. [6,590,083, 6590083]; Berisio R, 2003, J BACTERIOL, V185, P4276, DOI 10.1128/JB.185.14.4276-4279.2003; BOECKMAN RK, 1989, J AM CHEM SOC, V111, P8286, DOI 10.1021/ja00203a044; BOECKMAN RK, 1986, J ORG CHEM, V51, P5486, DOI 10.1021/jo00376a101; BRIGHT GM, 1988, J ANTIBIOT, V41, P1029, DOI 10.7164/antibiotics.41.1029; Bryskier A, 2000, CLIN MICROBIOL INFEC, V6, P661, DOI 10.1046/j.1469-0691.2000.00185.x; Bulkley D, 2010, P NATL ACAD SCI USA, V107, P17158, DOI 10.1073/pnas.1008685107; Cane DE, 1998, SCIENCE, V282, P63, DOI 10.1126/science.282.5386.63; Charest MG, 2005, SCIENCE, V308, P395, DOI 10.1126/science.1109755; Denis A, 1998, BIOORG MED CHEM LETT, V8, P2427, DOI 10.1016/S0960-894X(98)00402-8; Eyal Z, 2015, P NATL ACAD SCI USA, V112, pE5805, DOI 10.1073/pnas.1517952112; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Gaynor M, 2003, CURR TOP MED CHEM, V3, P949, DOI 10.2174/1568026033452159; GIRARD AE, 1987, ANTIMICROB AGENTS CH, V31, P1948, DOI 10.1128/AAC.31.12.1948; Hauske J. R., 1993, WO patent, Patent No. 1993018042; Khosla C, 1997, CHEM REV, V97, P2577, DOI 10.1021/cr960027u; Kim HC, 2009, ANGEW CHEM INT EDIT, V48, P1827, DOI 10.1002/anie.200805334; KURATH P, 1971, EXPERIENTIA, V27, P362, DOI 10.1007/BF02137246; Leclercq R, 2002, CLIN INFECT DIS, V34, P482, DOI 10.1086/324626; Leyes AE, 1999, ORG LETT, V1, P1067, DOI 10.1021/ol990875m; Liu F, 2016, CURR OPIN CHEM BIOL, V32, P48, DOI 10.1016/j.cbpa.2016.03.011; Llano-Sotelo B, 2010, ANTIMICROB AGENTS CH, V54, P4961, DOI 10.1128/AAC.00860-10; Marsden AFA, 1998, SCIENCE, V279, P199, DOI 10.1126/science.279.5348.199; Martin SF, 1997, J AM CHEM SOC, V119, P3193, DOI 10.1021/ja963575y; MCGUIRE JM, 1952, ANTIBIOT CHEMOTHER, V2, P281; Mikami K, 2007, J AM CHEM SOC, V129, P12950, DOI 10.1021/ja076539f; MORIMOTO S, 1984, J ANTIBIOT, V37, P187, DOI 10.7164/antibiotics.37.187; MUKAIYAMA T, 1973, CHEM LETT, P1011, DOI 10.1246/cl.1973.1011; Park SR, 2010, APPL MICROBIOL BIOT, V85, P1227, DOI 10.1007/s00253-009-2326-8; Prabhavathi FB, 2010, Preparation of aminodeoxy glycoside macrolides and ketolides as antibiotics for the treatment of gastrointestinal diseases, Patent No. [WO2010048599A1, 2010048599]; Putnam SD, 2010, DIAGN MICR INFEC DIS, V66, P393, DOI 10.1016/j.diagmicrobio.2009.10.013; RETSEMA J, 1987, ANTIMICROB AGENTS CH, V31, P1939, DOI 10.1128/AAC.31.12.1939; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; SANTANIELLO E, 1990, TETRAHEDRON LETT, V31, P5657, DOI 10.1016/S0040-4039(00)97925-5; SATO F, 1981, J CHEM SOC CHEM COMM, P718, DOI 10.1039/c39810000718; Seiple IB, 2016, SYNLETT, V27, P57, DOI 10.1055/s-0035-1560972; Seiple IB, 2014, ANGEW CHEM INT EDIT, V53, P4642, DOI 10.1002/anie.201400928; Subramanian SL, 2012, ANTIBIOTIC DISCOVERY AND DEVELOPMENT, VOLS 1 AND 2, P455, DOI 10.1007/978-1-4614-1400-1_13; Tan Z, 2004, ANGEW CHEM INT EDIT, V43, P2911, DOI 10.1002/anie.200353429; THOMPSON AS, 1995, TETRAHEDRON LETT, V36, P8937, DOI 10.1016/0040-4039(95)01955-H; Tu D, 2005, CELL, V121, P257, DOI 10.1016/j.cell.2005.02.005; Walsh C., 2003, ANTIBIOTICS ACTIONS; WOODWARD RB, 1981, J AM CHEM SOC, V103, P3215, DOI 10.1021/ja00401a051; WOODWARD RB, 1981, J AM CHEM SOC, V103, P3213, DOI 10.1021/ja00401a050; Wright PM, 2014, ANGEW CHEM INT EDIT, V53, P8840, DOI 10.1002/anie.201310843; Zhanel GG, 2002, DRUGS, V62, P1771, DOI 10.2165/00003495-200262120-00006; Zhang ZY, 2016, ANGEW CHEM INT EDIT, V55, P523, DOI 10.1002/anie.201507357; Zhang ZY, 2015, SYNTHESIS-STUTTGART, V47, P2709, DOI 10.1055/s-0034-1378822	50	191	195	10	226	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					338	+		10.1038/nature17967	http://dx.doi.org/10.1038/nature17967			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0AH	27193679	Green Accepted, Green Submitted			2022-12-28	WOS:000376004300038
J	Schiermeier, Q				Schiermeier, Quirin			PEER REVIEW Close inspection	NATURE			English	Editorial Material																			0	6	6	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					279	281		10.1038/nj7602-279a	http://dx.doi.org/10.1038/nj7602-279a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM0BJ	27200447	Bronze			2022-12-28	WOS:000376007200060
J	Singh, SP; Anderson, B; Liabo, K; Ganeshamoorthy, T				Singh, Swaran P.; Anderson, Beth; Liabo, Kristin; Ganeshamoorthy, Thines		Guideline Committee	Supporting young people in their transition to adults' services: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Singh, Swaran P.] Univ Warwick, Warwick, England; [Singh, Swaran P.] Birmingham & Solihull Mental Hlth Fdn Trust, Birmingham, W Midlands, England; [Singh, Swaran P.] Forward Thinking Birmingham, Birmingham, W Midlands, England; [Anderson, Beth] Social Care Inst Excellence, London SW1Y 5BP, England; [Ganeshamoorthy, Thines] Univ Exeter, Sch Med, Peninsula Collaborat Leadership Appl Hlth Res Pen, Exeter, Devon, England; [Guideline Committee] Royal Coll Paediat & Child Hlth, London, England	University of Warwick; University of Exeter	Anderson, B (corresponding author), Social Care Inst Excellence, London SW1Y 5BP, England.	Beth.Anderson@scie.org.uk	Ganeshamoorthy, Thines/AAV-1333-2021	Ganeshamoorthy, Thines/0000-0003-2558-1502; Anderson, Beth/0000-0001-5613-6722				Beresford B, 2009, TRANS AD SERV DIS YO; Clarke S, 2011, J INTEGR CARE, V19, P30, DOI 10.1108/14769011111176734; Department of Health, 2006, TRANS GETT RIGHT YOU; National Institute for Health and Care Excellence, 2016, TRANS CHILDR AD SERV; National Institute for Health and Care Excellence, 2004, DEV NICE GUID MAN; Singh SP, 2010, BRIT J PSYCHIAT, V197, P305, DOI 10.1192/bjp.bp.109.075135; Watson AR, 2005, PEDIATR NEPHROL, V20, P113, DOI 10.1007/s00467-004-1763-y	7	38	38	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 11	2016	353								i2225	10.1136/bmj.i2225	http://dx.doi.org/10.1136/bmj.i2225			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6FR	27170336				2022-12-28	WOS:000376446500002
J	Kamerow, D				Kamerow, Douglas			Finally the US regulates e-cigarettes as tobacco Treating them as tobacco will outlaw sales to children	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kamerow, Douglas] Robert Graham Ctr policy Studies Primary Care, Washington, DC 20036 USA; [Kamerow, Douglas] Georgetown Univ, Washington, DC 20057 USA	Georgetown University	Kamerow, D (corresponding author), Robert Graham Ctr policy Studies Primary Care, Washington, DC 20036 USA.; Kamerow, D (corresponding author), Georgetown Univ, Washington, DC 20057 USA.	dkamerow@aafp.org		Kamerow, Douglas/0000-0001-7000-9957				McCarthy M, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2594; Singh T, 2016, MMWR-MORBID MORTAL W, V65, P361, DOI 10.15585/mmwr.mm6514a1	2	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 6	2016	353								i2596	10.1136/bmj.i2596	http://dx.doi.org/10.1136/bmj.i2596			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL4AT	27154900				2022-12-28	WOS:000375575700008
J	Dorrestein, PC; Gallo, RL; Knight, R				Dorrestein, Pieter C.; Gallo, Richard L.; Knight, Rob			Microbial Skin Inhabitants: Friends Forever	CELL			English	Editorial Material							DIVERSITY	To gain insight into the stability of the microbial communities that inhabit our skin, Oh et al., in a tour-de-force effort, map the human skin metagenomes over time. Remarkably, their data indicate that the individual, not the environment, primarily drives the composition of skin microbial communities.	[Dorrestein, Pieter C.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Collaborat Mass Spectrometry Innovat Ctr, La Jolla, CA 92093 USA; [Dorrestein, Pieter C.; Gallo, Richard L.; Knight, Rob] Univ Calif San Diego, UC San Diego Ctr Microbiome Innovat, La Jolla, CA 92093 USA; [Gallo, Richard L.] Univ Calif San Diego, Dept Dermatol, La Jolla, CA 92093 USA; [Knight, Rob] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Knight, Rob] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Knight, R (corresponding author), Univ Calif San Diego, UC San Diego Ctr Microbiome Innovat, La Jolla, CA 92093 USA.; Knight, R (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.; Knight, R (corresponding author), Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA.	rknight@ucsd.edu	Gallo, Richard L/A-8931-2009; Dorrestein, Pieter/ABF-2930-2020	Gallo, Richard L/0000-0002-1401-7861; Knight, Rob/0000-0002-0975-9019				Bouslimani A, 2015, P NATL ACAD SCI USA, V112, pE2120, DOI 10.1073/pnas.1424409112; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Clemente JC, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500183; Costello EK, 2013, MBIO, V4, DOI 10.1128/mBio.00782-13; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Nakatsuji T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2441; Oh J, 2016, CELL, V165, P854, DOI 10.1016/j.cell.2016.04.008	10	7	7	5	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2016	165	4					771	772		10.1016/j.cell.2016.04.035	http://dx.doi.org/10.1016/j.cell.2016.04.035			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DL7DN	27153488	Bronze			2022-12-28	WOS:000375800300004
J	Goligher, EC; Ferguson, ND; Brochard, LJ				Goligher, Ewan C.; Ferguson, Niall D.; Brochard, Laurent J.			Clinical challenges in mechanical ventilation	LANCET			English	Article							RESPIRATORY-DISTRESS-SYNDROME; EXTRACORPOREAL MEMBRANE-OXYGENATION; END-EXPIRATORY PRESSURE; ACUTE LUNG INJURY; NONINVASIVE VENTILATION; ACUTE EXACERBATIONS; PULMONARY-EDEMA; RECRUITMENT MANEUVERS; ESOPHAGEAL PRESSURE; DIAPHRAGM THICKNESS	Mechanical ventilation supports gas exchange and alleviates the work of breathing when the respiratory muscles are overwhelmed by an acute pulmonary or systemic insult. Although mechanical ventilation is not generally considered a treatment for acute respiratory failure per se, ventilator management warrants close attention because inappropriate ventilation can result in injury to the lungs or respiratory muscles and worsen morbidity and mortality. Key clinical challenges include averting intubation in patients with respiratory failure with non-invasive techniques for respiratory support; delivering lung-protective ventilation to prevent ventilator-induced lung injury; maintaining adequate gas exchange in severely hypoxaemic patients; avoiding the development of ventilator-induced diaphragm dysfunction; and diagnosing and treating the many pathophysiological mechanisms that impair liberation from mechanical ventilation. Personalisation of mechanical ventilation based on individual physiological characteristics and responses to therapy can further improve outcomes.	[Goligher, Ewan C.; Ferguson, Niall D.; Brochard, Laurent J.] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada; [Goligher, Ewan C.; Ferguson, Niall D.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Ferguson, Niall D.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Goligher, Ewan C.; Ferguson, Niall D.] Univ Hlth Network, Dept Med, Div Respirol, Toronto, ON, Canada; [Goligher, Ewan C.; Ferguson, Niall D.] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Brochard, Laurent J.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1T8, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Brochard, LJ (corresponding author), St Michaels Hosp, Keenan Res Ctr Biomed Sci, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1T8, Canada.	brochardl@smh.ca	Ferguson, Niall/D-7619-2019	Ferguson, Niall/0000-0002-6213-5264; Goligher, Ewan/0000-0002-0990-6701	Covidien; Philips; Fisher-Paykel; Maquet; General Electric	Covidien; Philips; Fisher-Paykel; Maquet; General Electric(General Electric)	LJB reports receiving support in the form of grants and equipment from Covidien, Philips, Fisher-Paykel, Maquet, and General Electric. ECG and NDF declare no competing interests.	Adhikari NKJ, 2007, BMJ-BRIT MED J, V334, P779, DOI 10.1136/bmj.39139.716794.55; Adler D, 2014, AM J RESP CRIT CARE, V190, P347, DOI 10.1164/rccm.201404-0655LE; Akoumianaki E, 2014, AM J RESP CRIT CARE, V189, P520, DOI 10.1164/rccm.201312-2193CI; Akoumianaki E, 2013, CHEST, V143, P927, DOI 10.1378/chest.12-1817; Amato MBP, 2015, NEW ENGL J MED, V372, P747, DOI 10.1056/NEJMsa1410639; Antonelli M, 1998, NEW ENGL J MED, V339, P429, DOI 10.1056/NEJM199808133390703; ASHBAUGH DG, 1967, LANCET, V2, P319; BAKER A B, 1971, Medical History, V15, P336; Barbaro RP, 2015, AM J RESP CRIT CARE, V191, P894, DOI 10.1164/rccm.201409-1634OC; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Beitler JR, 2014, INTENS CARE MED, V40, P332, DOI 10.1007/s00134-013-3194-3; Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; Bellani G, 2014, CURR OPIN CRIT CARE, V20, P352, DOI 10.1097/MCC.0000000000000089; Blanch L, 2015, INTENS CARE MED, V41, P633, DOI 10.1007/s00134-015-3692-6; Briel M, 2010, JAMA-J AM MED ASSOC, V303, P865, DOI 10.1001/jama.2010.218; BROCHARD L, 1995, NEW ENGL J MED, V333, P817, DOI 10.1056/NEJM199509283331301; BROCHARD L, 1990, NEW ENGL J MED, V323, P1523, DOI 10.1056/NEJM199011293232204; Brower RG, 2004, NEW ENGL J MED, V351, P327; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Carteaux G, 2016, CRIT CARE MED, V44, P282, DOI 10.1097/CCM.0000000000001379; Carteaux G, 2013, CRIT CARE MED, V41, P2125, DOI 10.1097/CCM.0b013e31828a42e5; Chandra D, 2012, AM J RESP CRIT CARE, V185, P152, DOI 10.1164/rccm.201106-1094OC; CHENEY FW, 1980, ANESTHESIOLOGY, V52, P496, DOI 10.1097/00000542-198006000-00009; Chiumello D, 2015, AM J RESP CRIT CARE, DOI [10.1164/rccm.201507-1413OC, DOI 10.1164/RCCM.201507-14130C]; Chiumello D, 2008, AM J RESP CRIT CARE, V178, P346, DOI 10.1164/rccm.200710-1589OC; Chiumello D, 2014, CRIT CARE MED, V42, P252, DOI 10.1097/CCM.0b013e3182a6384f; Combes A, 2014, AM J RESP CRIT CARE, V190, P488, DOI 10.1164/rccm.201404-0630CP; DANTZKER DR, 1980, CHEST, V77, P636, DOI 10.1378/chest.77.5.636; Davies A, 2009, JAMA-J AM MED ASSOC, V302, P1888, DOI 10.1001/jama.2009.1535; Del Sorbo L, 2014, LANCET RESP MED, V2, P154, DOI 10.1016/S2213-2600(13)70197-8; Demoule A, 2004, BRIT J ANAESTH, V93, P295, DOI 10.1093/bja/aeh185; Dessap AM, 2016, INTENS CARE MED, V42, P862, DOI 10.1007/s00134-015-4141-2; Dessap AM, 2012, AM J RESP CRIT CARE, V186, P1256, DOI 10.1164/rccm.201205-0939OC; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; Ebihara S, 2002, AM J RESP CRIT CARE, V165, P221, DOI 10.1164/ajrccm.165.2.2108041; Ely EW, 1996, NEW ENGL J MED, V335, P1864, DOI 10.1056/NEJM199612193352502; Esteban A, 2004, NEW ENGL J MED, V350, P2452, DOI 10.1056/NEJMoa032736; Fan E, 2008, AM J RESP CRIT CARE, V178, P1156, DOI 10.1164/rccm.200802-335OC; Ferguson ND, 2013, NEW ENGL J MED, V368, P795, DOI 10.1056/NEJMoa1215554; Frat JP, 2015, NEW ENGL J MED, V372, P2185, DOI 10.1056/NEJMoa1503326; Gattinoni L, 2006, NEW ENGL J MED, V354, P1775, DOI 10.1056/NEJMoa052052; Gattinoni L, 2016, INTENS CARE MED, V42, P663, DOI 10.1007/s00134-015-4200-8; Gea JQ, 2009, ARCH BRONCONEUMOL, V45, P68, DOI 10.1016/j.arbres.2008.04.003; Girou E, 2000, JAMA-J AM MED ASSOC, V284, P2361, DOI 10.1001/jama.284.18.2361; Goligher EC, 2015, AM J RESP CRIT CARE, V192, P1416, DOI 10.1164/rccm.201410-1832CP; Goligher EC, 2015, AM J RESP CRIT CARE, V192, P1080, DOI 10.1164/rccm.201503-0620OC; Goligher EC, 2015, INTENS CARE MED, V41, P642, DOI 10.1007/s00134-015-3687-3; Goligher EC, 2014, AM J RESP CRIT CARE, V190, P70, DOI 10.1164/rccm.201404-0688OC; Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103; Hernandez G, 2016, JAMA-J AM MED ASSOC, V315, P1354, DOI 10.1001/jama.2016.2711; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Hooijman PE, 2015, AM J RESP CRIT CARE, V191, P1126, DOI 10.1164/rccm.201412-2214OC; Ibsen B, 1966, Int Anesthesiol Clin, V4, P277, DOI 10.1097/00004311-196622000-00003; Jaber S, 2016, JAMA-J AM MED ASSOC, V315, P1345, DOI 10.1001/jama.2016.2706; Jiang TX, 1998, AM J RESP CRIT CARE, V157, P736, DOI 10.1164/ajrccm.157.3.9707056; Jubran A, 2013, JAMA-J AM MED ASSOC, V309, P671, DOI 10.1001/jama.2013.159; Jubran A, 2010, INTENS CARE MED, V36, P828, DOI 10.1007/s00134-010-1842-4; Kahn JM, 2006, NEW ENGL J MED, V355, P41, DOI 10.1056/NEJMsa053993; Kavanagh BP, 2005, INTENS CARE MED, V31, P1161, DOI 10.1007/s00134-005-2729-7; LEMAIRE F, 1988, ANESTHESIOLOGY, V69, P171, DOI 10.1097/00000542-198808000-00004; Levine S, 2008, NEW ENGL J MED, V358, P1327, DOI 10.1056/NEJMoa070447; Lorusso R, 2016, ANN THORAC SURG, V101, P919, DOI 10.1016/j.athoracsur.2015.08.014; Maggiore SM, 2014, AM J RESP CRIT CARE, V190, P282, DOI 10.1164/rccm.201402-0364OC; Martin AD, 2011, CRIT CARE, V15, DOI 10.1186/cc10081; Masip J, 2005, JAMA-J AM MED ASSOC, V294, P3124, DOI 10.1001/jama.294.24.3124; Matamis D, 2013, INTENS CARE MED, V39, P801, DOI 10.1007/s00134-013-2823-1; MEAD J, 1970, J APPL PHYSIOL, V28, P596, DOI 10.1152/jappl.1970.28.5.596; Meade MO, 2008, JAMA-J AM MED ASSOC, V299, P637, DOI 10.1001/jama.299.6.637; Mehta S, 2012, JAMA-J AM MED ASSOC, V308, P1985, DOI 10.1001/jama.2012.13872; Mekontso-Dessap A, 2006, INTENS CARE MED, V32, P1529, DOI 10.1007/s00134-006-0339-7; Mercat A, 2008, JAMA-J AM MED ASSOC, V299, P646, DOI 10.1001/jama.299.6.646; Miller DR, 2010, THORAX, V65, P938, DOI 10.1136/thx.2009.134411; NASH G, 1967, NEW ENGL J MED, V276, P368, DOI 10.1056/NEJM196702162760702; Noah MA, 2011, JAMA-J AM MED ASSOC, V306, P1659, DOI 10.1001/jama.2011.1471; Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; Perren A, 2013, INTENS CARE MED, V39, P1885, DOI 10.1007/s00134-013-3014-9; Pham T, 2013, AM J RESP CRIT CARE, V187, P276, DOI 10.1164/rccm.201205-0815OC; Piastra M, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2013.08.006; Poulton EP, 1936, LANCET, V2, P981; Puthucheary ZA, 2013, JAMA-J AM MED ASSOC, V310, P1591, DOI 10.1001/jama.2013.278481; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; RUTLEDGE FS, 1988, J APPL PHYSIOL, V64, P1908, DOI 10.1152/jappl.1988.64.5.1908; Slutsky AS, 2015, AM J RESP CRIT CARE, V191, P1106, DOI 10.1164/rccm.201503-0421PP; Spoletini G, 2015, CHEST, V148, P253, DOI 10.1378/chest.14-2871; Strom T, 2010, LANCET, V375, P475, DOI 10.1016/S0140-6736(09)62072-9; Sud S, 2014, CAN MED ASSOC J, V186, pE381, DOI 10.1503/cmaj.140081; Supinski GS, 2013, CRIT CARE, V17, DOI 10.1186/cc12792; Talmor D, 2008, NEW ENGL J MED, V359, P2095, DOI 10.1056/NEJMoa0708638; Thille AW, 2006, INTENS CARE MED, V32, P1515, DOI 10.1007/s00134-006-0301-8; Thille AW, 2013, AM J RESP CRIT CARE, V187, P1294, DOI 10.1164/rccm.201208-1523CI; Tremblay L, 1997, J CLIN INVEST, V99, P944, DOI 10.1172/JCI119259; Vassilakopoulos T, 1998, AM J RESP CRIT CARE, V158, P378, DOI 10.1164/ajrccm.158.2.9710084; Vassilakopoulos T, 2004, AM J RESP CRIT CARE, V169, P336, DOI 10.1164/rccm.200304-489CP; WEBB HH, 1974, AM REV RESPIR DIS, V110, P556; YANG KL, 1991, NEW ENGL J MED, V324, P1445, DOI 10.1056/NEJM199105233242101; Yoshida T, 2013, AM J RESP CRIT CARE, V188, P1420, DOI 10.1164/rccm.201303-0539OC; Yoshida T, 2013, CRIT CARE MED, V41, P536, DOI 10.1097/CCM.0b013e3182711972; Zanella A, 2015, AM J RESP CRIT CARE, V192, P719, DOI 10.1164/rccm.201502-0289OC; ZAPOL WM, 1979, JAMA-J AM MED ASSOC, V242, P2193, DOI 10.1001/jama.242.20.2193	100	65	80	3	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 30	2016	387	10030					1856	1866		10.1016/S0140-6736(16)30176-3	http://dx.doi.org/10.1016/S0140-6736(16)30176-3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK6SS	27203509				2022-12-28	WOS:000375056100034
J	Smolen, JS; Aletaha, D; McInnes, IB				Smolen, Josef S.; Aletaha, Daniel; McInnes, Iain B.			Rheumatoid arthritis	LANCET			English	Review							MODIFYING ANTIRHEUMATIC DRUGS; ADALIMUMAB PLUS METHOTREXATE; LOW DISEASE-ACTIVITY; DOUBLE-BLIND; EULAR RECOMMENDATIONS; COMBINATION THERAPY; AMERICAN-COLLEGE; INFLAMMATORY ARTHRITIS; CLINICAL-TRIALS; 2013 UPDATE	Rheumatoid arthritis is a chronic inflammatory joint disease, which can cause cartilage and bone damage as well as disability. Early diagnosis is key to optimal therapeutic success, particularly in patients with well-characterised risk factors for poor outcomes such as high disease activity, presence of autoantibodies, and early joint damage. Treatment algorithms involve measuring disease activity with composite indices, applying a treatment-to-target strategy, and use of conventional, biological, and newz non-biological disease-modifying antirheumatic drugs. After the treatment target of stringent remission (or at least low disease activity) is maintained, dose reduction should be attempted. Although the prospects for most patients are now favourable, many still do not respond to current therapies. Accordingly, new therapies are urgently required. In this Seminar, we describe current insights into genetics and aetiology, pathophysiology, epidemiology, assessment, therapeutic agents, and treatment strategies together with unmet needs of patients with rheumatoid arthritis.	[Smolen, Josef S.; Aletaha, Daniel] Med Univ Vienna, Dept Med 3, Div Rheumatol, A-1090 Vienna, Austria; [Smolen, Josef S.] Hietzing Hosp Vienna, Dept Med 2, Vienna, Austria; [McInnes, Iain B.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland	Medical University of Vienna; Hietzing Hospital; University of Glasgow	Smolen, JS (corresponding author), Med Univ Vienna, Dept Med 3, Div Rheumatol, A-1090 Vienna, Austria.	josef.smolen@wienkav.at	Pepe, Guglielmina/K-8013-2016	Pepe, Guglielmina/0000-0001-9825-6618				Alamanos Y, 2006, SEMIN ARTHRITIS RHEU, V36, P182, DOI 10.1016/j.semarthrit.2006.08.006; Aletaha D, 2005, ARTHRITIS RES THER, V7, pR796, DOI 10.1186/ar1740; Aletaha D, 2016, ANN RHEUM DIS, V75, P1479, DOI 10.1136/annrheumdis-2015-208324; Aletaha D, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0736-9; Aletaha D, 2012, ANN RHEUM DIS, V71, P1190, DOI 10.1136/annrheumdis-2012-201491; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Anquetil F, 2015, J IMMUNOL, V194, P3664, DOI 10.4049/jimmunol.1402334; Baecklund E, 2006, ARTHRITIS RHEUM, V54, P692, DOI 10.1002/art.21675; Bakker MF, 2012, ANN INTERN MED, V156, P329, DOI 10.7326/0003-4819-156-5-201203060-00004; Balsa A, 2010, RHEUMATOLOGY, V49, P683, DOI 10.1093/rheumatology/kep442; Barra L, 2011, RHEUMATOLOGY, V50, P311, DOI 10.1093/rheumatology/keq190; Baxter D, 2012, IMMUNOL CELL BIOL, V90, P288, DOI 10.1038/icb.2011.114; Bluml S, 2011, ARTHRITIS RHEUM-US, V63, P1281, DOI 10.1002/art.30281; Bohler C, 2013, ANN RHEUM DIS, V72, P241, DOI 10.1136/annrheumdis-2012-202297; Bonelli M, 2013, ARTHRITIS RHEUM-US, V65, P599, DOI 10.1002/art.37787; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Burmester GR, 2007, ANN RHEUM DIS, V66, P732, DOI 10.1136/ard.2006.066761; Burmester GR, 2016, ANN RHEUM DIS, V75, P1081, DOI 10.1136/annrheumdis-2015-207628; Callahan LF, 1997, ARTHRIT CARE RES, V10, P283, DOI 10.1002/art.1790100502; Capell HA, 2007, ANN RHEUM DIS, V66, P235, DOI 10.1136/ard.2006.057133; Choi HK, 2002, LANCET, V359, P1173, DOI 10.1016/S0140-6736(02)08213-2; Combe B, 2007, ANN RHEUM DIS, V66, P34, DOI 10.1136/ard.2005.044354; Cross M, 2014, ANN RHEUM DIS, V73, P1316, DOI 10.1136/annrheumdis-2013-204627; Dale J, 2013, ARTHRITIS RHEUM-US, V65, pS338; de Hair MJH, 2012, ANN RHEUM DIS, V71, P1911, DOI 10.1136/annrheumdis-2012-201540; de Jong PH, 2014, ANN RHEUM DIS, V73, P1331, DOI 10.1136/annrheumdis-2013-204788; De Nard F, 2015, WORLD J HEPATOL, V7, P344, DOI 10.4254/wjh.v7.i3.344; De Stefano R, 2010, CLIN RHEUMATOL, V29, P517, DOI 10.1007/s10067-009-1349-y; Dougados M, 1999, ANN RHEUM DIS, V58, P220, DOI 10.1136/ard.58.4.220; Dougados M, 2014, ANN RHEUM DIS, V73, P803, DOI 10.1136/annrheumdis-2013-204761; Ducreux J, 2014, ARTHRITIS RHEUMATOL, V66, P15, DOI 10.1002/art.38202; Ebringer A, 2000, J MED MICROBIOL, V49, P305, DOI 10.1099/0022-1317-49-4-305; Emery P, 2015, ANN RHEUM DIS, V74, P19, DOI 10.1136/annrheumdis-2014-206106; Feldmann M, 2008, IMMUNOL REV, V223, P7, DOI 10.1111/j.1600-065X.2008.00626.x; Felson DT, 2011, ANN RHEUM DIS, V70, P404, DOI 10.1002/art.30129; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Fleischmann R, 2015, ANN RHEUM DIS, V74, P1132, DOI 10.1136/annrheumdis-2013-204920; Fleischmann R, 2012, NEW ENGL J MED, V367, P495, DOI 10.1056/NEJMoa1109071; Flint J, 2016, RHEUMATOLOGY; Food and Drug Administration, 2013, GUID IND RHEUM ARTHR; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Frisell T, 2016, ANN RHEUM DIS, V75, P183, DOI 10.1136/annrheumdis-2014-206133; Gabay C, 2013, LANCET, V381, P1541, DOI 10.1016/S0140-6736(13)60250-0; Gaujoux-Viala C, 2014, ANN RHEUM DIS, V73, P510, DOI 10.1136/annrheumdis-2013-204588; Genovese MC, 2016, NEW ENGL J MED, V374, P1243, DOI 10.1056/NEJMoa1507247; Gerlag DM, 2012, ANN RHEUM DIS, V71, P638, DOI 10.1136/annrheumdis-2011-200990; Girbal-Neuhauser E, 1999, J IMMUNOL, V162, P585; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Gonzalez A, 2008, J RHEUMATOL, V35, P1009; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Grigor C, 2004, LANCET, V364, P263, DOI 10.1016/S0140-6736(04)16676-2; Gullick NJ, 2012, RHEUMATOLOGY, V51, P759, DOI 10.1093/rheumatology/ker399; Harre U, 2012, J CLIN INVEST, V122, P1791, DOI 10.1172/JCI60975; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Hayer S, 2007, ARTHRITIS RHEUM-US, V56, P79, DOI 10.1002/art.22313; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Humby F, 2015, ARTHRITIS RHEUMATOL, V67, P2601, DOI 10.1002/art.39235; HURD ER, 1979, SEMIN ARTHRITIS RHEU, V8, P151, DOI 10.1016/S0049-0172(79)80005-0; Jacobsson LTH, 2007, ANN RHEUM DIS, V66, P670, DOI 10.1136/ard.2006.062497; James EA, 2014, ARTHRITIS RHEUMATOL, V66, P1712, DOI 10.1002/art.38637; Jiang X, 2015, ARTHRITIS RHEUMATOL, V67, P352, DOI 10.1002/art.38927; Jimenez-Boj E, 2007, ARTHRITIS RHEUM-US, V56, P1118, DOI 10.1002/art.22496; Jones G, 2010, ANN RHEUM DIS, V69, P88, DOI 10.1136/ard.2008.105197; Kaneko Y, 2016, ANN RHEUM DIS, V75, P1917, DOI 10.1136/annrheumdis-2015-208426; Kavanaugh A, 2013, ANN RHEUM DIS, V72, P64, DOI 10.1136/annrheumdis-2011-201247; Kerkman PF, 2016, ANN RHEUM DIS, V75, P1170, DOI 10.1136/annrheumdis-2014-207182; KIRWAN JR, 1995, NEW ENGL J MED, V333, P142, DOI 10.1056/NEJM199507203330302; Kitas GD, 2011, ANN RHEUM DIS, V70, P8, DOI 10.1136/ard.2010.142133; Klarenbeek PL, 2012, ANN RHEUM DIS, V71, P1088, DOI 10.1136/annrheumdis-2011-200612; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Klareskog L, 2011, SEMIN IMMUNOL, V23, P92, DOI 10.1016/j.smim.2011.01.014; Klein K, 2015, CURR OPIN RHEUMATOL, V27, P76, DOI 10.1097/BOR.0000000000000128; Kraan MC, 1998, ARTHRITIS RHEUM, V41, P1481, DOI 10.1002/1529-0131(199808)41:8<1481::AID-ART19>3.0.CO;2-O; Landewe RBM, 2014, ANN RHEUM DIS, V73, P1755, DOI 10.1136/annrheumdis-2014-205821; Lee EB, 2014, NEW ENGL J MED, V370, P2377, DOI 10.1056/NEJMoa1310476; Lee HH, 2007, BRIT J DERMATOL, V156, P486, DOI 10.1111/j.1365-2133.2007.07682.x; Lenz TL, 2015, NAT GENET, V47, P1085, DOI 10.1038/ng.3379; Listing J, 2005, ARTHRITIS RHEUM-US, V52, P3403, DOI 10.1002/art.21386; Listing J, 2015, ANN RHEUM DIS, V74, P415, DOI 10.1136/annrheumdis-2013-204021; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Makinen H, 2005, ANN RHEUM DIS, V64, P1410, DOI 10.1136/ard.2005.037333; Manders SHM, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0630-5; Mandl P, 2012, ARTHRITIS RHEUM-US, V64, P1272, DOI 10.1002/art.33491; Martel-Pelletier J, 2001, BEST PRACT RES CL RH, V15, P805, DOI 10.1053/berh.2001.0195; Mavers Melissa, 2009, Curr Rheumatol Rep, V11, P378; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Millar K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058256; Mohan N, 2001, ARTHRITIS RHEUM-US, V44, P2862, DOI 10.1002/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W; Nam JL, 2014, ANN RHEUM DIS, V73, P75, DOI 10.1136/annrheumdis-2013-203440; Nam JL, 2014, ANN RHEUM DIS, V73, P516, DOI 10.1136/annrheumdis-2013-204577; Nell-Duxneuner V, 2010, ANN RHEUM DIS, V69, P169, DOI 10.1136/ard.2008.100677; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P380, DOI 10.1002/art.20018; Nordberg Lena B, 2015, ARTHRITIS RHEUMA S10, V67, P162; O'Dell JR, 2013, NEW ENGL J MED, V369, P307, DOI 10.1056/NEJMoa1303006; O'Shea JJ, 2015, ANNU REV MED, V66, P311, DOI 10.1146/annurev-med-051113-024537; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Ortea I, 2012, J PROTEOMICS, V77, P372, DOI 10.1016/j.jprot.2012.09.011; Ostensen M, 2009, NAT REV RHEUMATOL, V5, P382, DOI 10.1038/nrrheum.2009.103; Patakas A, 2016, ARTHRITIS RHEUMATOL, V68, P627, DOI 10.1002/art.39470; Patatanian E, 2002, PHARMACOTHERAPY, V22, P1157, DOI 10.1592/phco.22.13.1157.33525; Pettit AR, 2001, AM J PATHOL, V159, P1689, DOI 10.1016/S0002-9440(10)63016-7; Pincus T, 2008, J RHEUMATOL, V35, P2136, DOI 10.3899/jrheum.080182; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Radner H, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4491; Radner H, 2014, ANN RHEUM DIS, V73, P114, DOI 10.1136/annrheumdis-2013-203284; Raja H, 2012, TRANSL VIS SCI TECHN, V1, DOI 10.1167/tvst.1.2.6; Ramiro S, 2014, ANN RHEUM DIS, V73, P529, DOI 10.1136/annrheumdis-2013-204575; Rau R, 2002, RHEUMATOLOGY, V41, P196, DOI 10.1093/rheumatology/41.2.196; Raza K, 2012, ANN RHEUM DIS, V71, P1921, DOI 10.1136/annrheumdis-2012-201893; Redlich K, 2002, J CLIN INVEST, V110, P1419, DOI 10.1172/JCI200215582; Reynisdottir G, 2016, ANN RHEUM DIS, V75, P1722, DOI 10.1136/annrheumdis-2015-208216; Roberson EDO, 2010, TRENDS GENET, V26, P415, DOI 10.1016/j.tig.2010.06.006; Rombouts Y, 2016, ANN RHEUM DIS, V75, P578, DOI 10.1136/annrheumdis-2014-206598; Rombouts Y, 2015, ANN RHEUM DIS, V74, P234, DOI 10.1136/annrheumdis-2013-203565; SABHARWAL UK, 1982, ARTHRITIS RHEUM-US, V25, P161, DOI 10.1002/art.1780250208; Sakellariou G, 2013, ANN RHEUM DIS, V72, P245, DOI 10.1136/annrheumdis-2012-201817; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; Scher JU, 2016, ARTHRITIS RHEUMATOL, V68, P35, DOI 10.1002/art.39259; Scher JU, 2015, ARTHRITIS RHEUMATOL, V67, P128, DOI 10.1002/art.38892; Schoels M, 2012, ANN RHEUM DIS, V71, P1303, DOI 10.1136/annrheumdis-2011-200490; Semerano L, 2015, ANN RHEUM DIS, V74, P1325, DOI 10.1136/annrheumdis-2014-206618; Shi J, 2014, AUTOIMMUN REV, V13, P225, DOI 10.1016/j.autrev.2013.10.008; Silman AJ, 1996, ARTHRITIS RHEUM, V39, P732, DOI 10.1002/art.1780390504; SILMAN AJ, 1993, BRIT J RHEUMATOL, V32, P903; Silman AJ, 2002, ARTHRITIS RES THER, V4, pS265, DOI 10.1186/ar578; Singh JA, 2016, ARTHRITIS RHEUMATOL, V68, P1, DOI 10.1002/art.39480; Skorpen CG, 2016, ANN RHEUM DIS, V75, P795, DOI 10.1136/annrheumdis-2015-208840; Smolen JS, 2015, ANN RHEUM DIS, V74, P843, DOI 10.1136/annrheumdis-2013-204632; Smolen JS, 2012, ARTHRITIS RHEUM-US, V64, pS334; Smolen JS, 2009, ANN RHEUM DIS, V68, P823, DOI 10.1136/ard.2008.090019; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; Smolen JS, 2016, ANN RHEUM DIS, V75, P3, DOI 10.1136/annrheumdis-2015-207524; Smolen JS, 2016, ANN RHEUM DIS, V75, P1268, DOI 10.1136/annrheumdis-2016-209429; Smolen JS, 2015, NAT REV RHEUMATOL, V11, P276, DOI 10.1038/nrrheum.2015.8; Smolen JS, 2014, ANN RHEUM DIS, V73, P1811, DOI 10.1136/annrheumdis-2013-203435; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Smolen JS, 2014, LANCET, V383, P321, DOI 10.1016/S0140-6736(13)61751-1; Smolen JS, 2014, ANN RHEUM DIS, V73, P3, DOI 10.1136/annrheumdis-2013-204317; Smolen JS, 2013, LANCET, V381, P918, DOI 10.1016/S0140-6736(12)61811-X; Smolen JS, 2013, ANN RHEUM DIS, V72, P3, DOI 10.1136/annrheumdis-2012-202361; Smolen JS, 2011, ARTHRITIS RHEUM-US, V63, P43, DOI 10.1002/art.27740; Smolen JS, 2003, RHEUMATOLOGY, V42, P244, DOI 10.1093/rheumatology/keg072; Smolen JS, 2005, ARTHRITIS RHEUM-US, V52, P2975, DOI 10.1002/art.21293; Smolen JS, 2006, ARTHRITIS RHEUM-US, V54, P702, DOI 10.1002/art.21678; Smolen JS, 2003, NAT REV DRUG DISCOV, V2, P473, DOI 10.1038/nrd1109; Sokka T, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2951; Sokolove J, 2014, ARTHRITIS RHEUMATOL, V66, P813, DOI 10.1002/art.38307; Stoffer MA, 2016, ANN RHEUM DIS, V75, P16, DOI 10.1136/annrheumdis-2015-207526; Strangfeld A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2904; Tak PP, 2011, ANN RHEUM DIS, V70, P39, DOI 10.1136/ard.2010.137703; Taylor PC, 2015, ARTHRITIS RHEUMATOL, V67; Terslev L, 2004, ANN RHEUM DIS, V63, P644, DOI 10.1136/ard.2003.009548; Thiele K, 2013, ANN RHEUM DIS, V72, P1194, DOI 10.1136/annrheumdis-2012-201821; van der Heijde D, 2002, ARTHRIT RHEUM-ARTHR, V47, P215, DOI 10.1002/art.10181; van Gaalen FA, 2004, ARTHRITIS RHEUM, V50, P2113, DOI 10.1002/art.20316; VANDERHEIJDE DM, 1989, LANCET, V1, P1036, DOI 10.1016/S0140-6736(89)92442-2; VANDERHEIJDE DMFM, 1992, ANN RHEUM DIS, V51, P177, DOI 10.1136/ard.51.2.177; Verschueren P, 2015, ANN RHEUM DIS, V74, P27, DOI 10.1136/annrheumdis-2014-205489; Verstappen SMM, 2011, ANN RHEUM DIS, V70, P823, DOI 10.1136/ard.2010.140822; Viatte S, 2015, JAMA-J AM MED ASSOC, V313, P1645, DOI 10.1001/jama.2015.3435; WARD JR, 1983, ARTHRITIS RHEUM, V26, P1303, DOI 10.1002/art.1780261102; Wassenberg S, 2005, ARTHRITIS RHEUM-US, V52, P3371, DOI 10.1002/art.21421; Wegner N, 2010, ARTHRITIS RHEUM-US, V62, P2662, DOI 10.1002/art.27552; Weinblatt ME, 2013, ARTHRITIS RHEUM-US, V65, P28, DOI 10.1002/art.37711; Welsing PMJ, 2001, ARTHRITIS RHEUM, V44, P2009, DOI 10.1002/1529-0131(200109)44:9<2009::AID-ART349>3.0.CO;2-L; Welsing PMJ, 2004, ARTHRITIS RHEUM-US, V50, P2082, DOI 10.1002/art.20350; Winthrop KL, 2005, ARTHRITIS RHEUM-US, V52, P2968, DOI 10.1002/art.21382; Zhao XY, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2478	168	1161	1206	84	459	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 22	2016	388	10055					2023	2038		10.1016/S0140-6736(16)30173-8	http://dx.doi.org/10.1016/S0140-6736(16)30173-8			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ6EQ	27156434	Green Accepted			2022-12-28	WOS:000385954800032
J	Sarzi, M				Sarzi, Marc			ASTROPHYSICS How black holes restrain old galaxies	NATURE			English	Editorial Material							OBSERVATIONAL EVIDENCE; LENTICULAR GALAXIES; SAURON PROJECT; AGN FEEDBACK; GAS; KINEMATICS	Supermassive black holes are thought to keep star formation under control by ejecting or stirring gas in galaxies. Observations of an old galaxy reveal a potential mechanism for how this process occurs. SEE LETTER P.504	[Sarzi, Marc] Univ Hertfordshire, Ctr Astrophys Res, Hatfield AL10 9AB, Herts, England	University of Hertfordshire	Sarzi, M (corresponding author), Univ Hertfordshire, Ctr Astrophys Res, Hatfield AL10 9AB, Herts, England.	m.sarzi@herts.ac.uk	Sarzi, Marc/HGB-2092-2022					BINETTE L, 1994, ASTRON ASTROPHYS, V292, P13; Bundy K, 2015, ASTROPHYS J, V798, DOI 10.1088/0004-637X/798/1/7; Cheung E, 2016, NATURE, V533, P504, DOI 10.1038/nature18006; Davis TA, 2011, MON NOT R ASTRON SOC, V417, P882, DOI 10.1111/j.1365-2966.2011.19355.x; Fabian AC, 2012, ANNU REV ASTRON ASTR, V50, P455, DOI 10.1146/annurev-astro-081811-125521; Sarzi M, 2006, MON NOT R ASTRON SOC, V366, P1151, DOI 10.1111/j.1365-2966.2005.09839.x; Sarzi M, 2010, MON NOT R ASTRON SOC, V402, P2187, DOI 10.1111/j.1365-2966.2009.16039.x; Schawinski K, 2007, MON NOT R ASTRON SOC, V382, P1415, DOI 10.1111/j.1365-2966.2007.12487.x; Stasinska G, 2008, MON NOT R ASTRON SOC, V391, pL29, DOI 10.1111/j.1745-3933.2008.00550.x; Young LM, 2008, ASTROPHYS J, V676, P317, DOI 10.1086/529019; Young LM, 2011, MON NOT R ASTRON SOC, V414, P940, DOI 10.1111/j.1365-2966.2011.18561.x	12	0	0	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2016	533	7604					473	474		10.1038/533473a	http://dx.doi.org/10.1038/533473a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6EJ	27225114				2022-12-28	WOS:000376443100025
J	Amet, F; Ke, CT; Borzenets, IV; Wang, J; Watanabe, K; Taniguchi, T; Deacon, RS; Yamamoto, M; Bomze, Y; Tarucha, S; Finkelstein, G				Amet, F.; Ke, C. T.; Borzenets, I. V.; Wang, J.; Watanabe, K.; Taniguchi, T.; Deacon, R. S.; Yamamoto, M.; Bomze, Y.; Tarucha, S.; Finkelstein, G.			Supercurrent in the quantum Hall regime	SCIENCE			English	Article							MAGNETIC-FIELDS; INDUCED SUPERCONDUCTIVITY; JOSEPHSON-JUNCTIONS; ANDREEV REFLECTION; GRAPHENE; EDGE; ELECTRODES	A promising route for creating topological states and excitations is to combine superconductivity and the quantum Hall (QH) effect. Despite this potential, signatures of superconductivity in the QH regime remain scarce, and a superconducting current through a QH weak link has been challenging to observe. We demonstrate the existence of a distinct supercurrent mechanism in encapsulated graphene samples contacted by superconducting electrodes, in magnetic fields as high as 2 tesla. The observation of a supercurrent in the QH regime marks an important step in the quest for exotic topological excitations, such as Majorana fermions and parafermions, which may find applications in fault-tolerant quantum computing.	[Amet, F.; Ke, C. T.; Wang, J.; Bomze, Y.; Finkelstein, G.] Duke Univ, Dept Phys, Durham, NC 27708 USA; [Amet, F.] Appalachian State Univ, Dept Phys & Astron, Boone, NC 28607 USA; [Borzenets, I. V.; Yamamoto, M.; Tarucha, S.] Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan; [Watanabe, K.; Taniguchi, T.] Natl Inst Mat Sci, Adv Mat Lab, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan; [Deacon, R. S.; Tarucha, S.] RIKEN, CEMS, Wako, Saitama 3510198, Japan; [Yamamoto, M.] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Duke University; University of North Carolina; Appalachian State University; University of Tokyo; National Institute for Materials Science; RIKEN; Japan Science & Technology Agency (JST)	Amet, F; Finkelstein, G (corresponding author), Duke Univ, Dept Phys, Durham, NC 27708 USA.; Amet, F (corresponding author), Appalachian State Univ, Dept Phys & Astron, Boone, NC 28607 USA.	ametf@appstate.edu; gleb@phy.duke.edu	Ke, Chung Ting/AAV-6582-2021; TARUCHA, SEIGO/I-7030-2012; Yamamoto, Michihisa/E-6850-2017; TANIGUCHI, Takashi/H-2718-2011; Borzenets, Ivan/M-9912-2015; Ke, Chung Ting/G-7454-2016; Deacon, Russell/GRI-9503-2022	Ke, Chung Ting/0000-0002-6031-4226; Yamamoto, Michihisa/0000-0001-9113-6461; Borzenets, Ivan/0000-0002-1577-8312; Ke, Chung Ting/0000-0002-6031-4226; Amet, Francois/0000-0001-8910-6765	Division of Materials Sciences and Engineering, Office of Basic Energy Sciences, U.S. Department of Energy [DE-SC0002765]; Fritz London postdoctoral fellowship; Canon foundation; Japan Society for the Promotion of Science [26220710];  [26790008]; Grants-in-Aid for Scientific Research [25107003] Funding Source: KAKEN	Division of Materials Sciences and Engineering, Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE)); Fritz London postdoctoral fellowship; Canon foundation(Canon Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H. Baranger, P. Gallagher, K. Matveev, K. Michaeli, A. Smirnov, J. Williams, and S. Yarmolenko for fruitful discussions and technical help. The work done in the United States was supported by the Division of Materials Sciences and Engineering, Office of Basic Energy Sciences, U.S. Department of Energy, under Award no. DE-SC0002765. F.A. acknowledges support from the Fritz London postdoctoral fellowship. I.V.B. and M.Y. are funded by the Canon foundation and Grants-in-Aid for Scientific Research on Innovative Areas, Science of Atomic Layers. R.S.D. is funded by Grants-in-Aid for Young Scientists B (no. 26790008). S.T. is funded by Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research S (no. 26220710).	Ben Shalom M, 2016, NAT PHYS, V12, P318, DOI 10.1038/NPHYS3592; Bolotin KI, 2009, NATURE, V462, P196, DOI 10.1038/nature08582; Calado VE, 2015, NAT NANOTECHNOL, V10, P761, DOI [10.1038/NNANO.2015.156, 10.1038/nnano.2015.156]; Clarke DJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2340; Du X, 2009, NATURE, V462, P192, DOI 10.1038/nature08522; Hart S, 2014, NAT PHYS, V10, P638, DOI [10.1038/NPHYS3036, 10.1038/nphys3036]; Hoppe H, 2000, PHYS REV LETT, V84, P1804, DOI 10.1103/PhysRevLett.84.1804; Katsnelson M.I., 2012, GRAPHENE CARBON 2 DI; Knez I, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.186603; Komatsu K, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.115412; Kumaravadivel P., PREPRINT; Lee SP, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.197001; Lindner NH, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.041002; MA M, 1993, EUROPHYS LETT, V21, P941, DOI 10.1209/0295-5075/21/9/011; Mong RSK, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.011036; Moore TD, 1999, PHYS REV B, V59, P7308, DOI 10.1103/PhysRevB.59.7308; Pribiag VS, 2015, NAT NANOTECHNOL, V10, P593, DOI [10.1038/NNANO.2015.86, 10.1038/nnano.2015.86]; Rickhaus P, 2012, NANO LETT, V12, P1942, DOI 10.1021/nl204415s; San-Jose P, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.041042; Takagaki Y, 1998, PHYS REV B, V57, P4009, DOI 10.1103/PhysRevB.57.4009; Takayanagi H, 1998, PHYSICA B, V249, P462, DOI 10.1016/S0921-4526(98)00164-1; Tinkham M., 1996, INTRO SUPERCONDUCTIV, V2nd ed.; van Ostaay JAM, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.195441; Wan Z, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8426; Wiedenmann J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10303; Williams JR, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.045408	27	137	137	4	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2016	352	6288			SI		966	969		10.1126/science.aad6203	http://dx.doi.org/10.1126/science.aad6203			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM2AK	27199424	Green Submitted			2022-12-28	WOS:000376147800042
J	Graule, MA; Chirarattananon, P; Fuller, SB; Jafferis, NT; Ma, KY; Spenko, M; Kornbluh, R; Wood, RJ				Graule, M. A.; Chirarattananon, P.; Fuller, S. B.; Jafferis, N. T.; Ma, K. Y.; Spenko, M.; Kornbluh, R.; Wood, R. J.			Perching and takeoff of a robotic insect on overhangs using switchable electrostatic adhesion	SCIENCE			English	Article							MECHANISM	For aerial robots, maintaining a high vantage point for an extended time is crucial in many applications. However, available on-board power and mechanical fatigue constrain their flight time, especially for smaller, battery-powered aircraft. Perching on elevated structures is a biologically inspired approach to overcome these limitations. Previous perching robots have required specific material properties for the landing sites, such as surface asperities for spines, or ferromagnetism. We describe a switchable electroadhesive that enables controlled perching and detachment on nearly any material while requiring approximately three orders of magnitude less power than required to sustain flight. These electroadhesives are designed, characterized, and used to demonstrate a flying robotic insect able to robustly perch on a wide range of materials, including glass, wood, and a natural leaf.	[Graule, M. A.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Graule, M. A.; Chirarattananon, P.; Fuller, S. B.; Jafferis, N. T.; Ma, K. Y.; Wood, R. J.] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Graule, M. A.; Chirarattananon, P.; Fuller, S. B.; Jafferis, N. T.; Ma, K. Y.; Wood, R. J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Chirarattananon, P.] City Univ Hong Kong, Dept Mech & Biomed Engn, Kowloon, Hong Kong, Peoples R China; [Fuller, S. B.] Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA; [Spenko, M.] IIT, Mech Mat & Aerosp Engn Dept, Chicago, IL 60616 USA; [Kornbluh, R.] SRI Int, 333 Ravenswood Ave, Menlo Pk, CA 94025 USA	Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; City University of Hong Kong; University of Washington; University of Washington Seattle; Illinois Institute of Technology; SRI International	Graule, MA (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.; Graule, MA; Wood, RJ (corresponding author), Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA.; Graule, MA; Wood, RJ (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA.	graule@mit.edu; rjwood@seas.harvard.edu	Liu, Fuyou/AAC-4831-2019; Chirarattananon, Pakpong/N-3910-2016	Chirarattananon, Pakpong/0000-0003-0142-8394; Graule, Moritz/0000-0003-1221-9723	National Science Foundation [CMMI-1251729]; Wyss Institute for Biologically Inspired Research; Swiss Study Foundation	National Science Foundation(National Science Foundation (NSF)); Wyss Institute for Biologically Inspired Research; Swiss Study Foundation	This material is based on work supported by the National Science Foundation (award CMMI-1251729), the Wyss Institute for Biologically Inspired Research, and the Swiss Study Foundation.	Anderson B, 2005, NATURE, V435, P41, DOI 10.1038/435041a; Anderson M. L., 2009, 47 AIAA AER SCI M; Baird E, 2013, P NATL ACAD SCI USA, V110, P18686, DOI 10.1073/pnas.1314311110; Chen R, 2013, IEEE INT C INT ROBOT, P2327, DOI 10.1109/IROS.2013.6696682; Cory R, 2008, AIAA GUIDANCE NAVIGA, P1, DOI DOI 10.2514/6.2008-7256; Daler L, 2013, IEEE INT CONF ROBOT, P4433, DOI 10.1109/ICRA.2013.6631206; Doyle CE, 2013, IEEE-ASME T MECH, V18, P506, DOI 10.1109/TMECH.2012.2211081; Floreano D, 2015, NATURE, V521, P460, DOI 10.1038/nature14542; Frank A., 2007, HOVER TRANSITION LEV; Hawkes EW, 2013, IEEE INT C INT ROBOT, P5487, DOI 10.1109/IROS.2013.6697151; Kovac M, 2009, J MICRO-BIO ROBOT, V5, P77, DOI 10.1007/s12213-010-0026-1; Liu R, 2013, INT J ADV ROBOT SYST, V10, DOI 10.5772/54634; Lussier Desbiens A, 2011, INT J ROBOT RES, V30, P355, DOI 10.1177/0278364910393286; Ma KY, 2013, SCIENCE, V340, P603, DOI 10.1126/science.1231806; Mellinger D., 2010, P INT POW LIFT C, P205; Monkman GJ, 1997, INT J ROBOT RES, V16, P1, DOI 10.1177/027836499701600101; Prahlad H, 2008, IEEE INT CONF ROBOT, P3028, DOI 10.1109/ROBOT.2008.4543670; Roberts JF, 2008, 2008 IEEE/RSJ INTERNATIONAL CONFERENCE ON ROBOTS AND INTELLIGENT SYSTEMS, VOLS 1-3, CONFERENCE PROCEEDINGS, P1242, DOI 10.1109/IROS.2008.4650856; Ruffatto D, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1089; Sazima M, 1999, CAN J ZOOL, V77, P47, DOI 10.1139/cjz-77-1-47; Sogard MR, 2007, J VAC SCI TECHNOL B, V25, P2155, DOI 10.1116/1.2798724; Tellez J. P. D., 2011, 2011 IEEE International Conference on Robotics and Biomimetics (ROBIO), P1867, DOI 10.1109/ROBIO.2011.6181562; Tschapka M, 2003, BIOL J LINN SOC, V80, P281, DOI 10.1046/j.1095-8312.2003.00235.x; Wang HQ, 2012, IEEE INT C INT ROBOT, P914, DOI 10.1109/IROS.2012.6385758; Wang LY, 2013, IEEE T ROBOT, V29, P863, DOI 10.1109/TRO.2013.2256312	25	174	184	21	208	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2016	352	6288			SI		978	982		10.1126/science.aaf1092	http://dx.doi.org/10.1126/science.aaf1092			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM2AK	27199427				2022-12-28	WOS:000376147800045
J	Dunbar, KB; Agoston, AT; Odze, RD; Huo, XF; Pham, TH; Cipher, DJ; Castell, DO; Genta, RM; Souza, RF; Spechler, SJ				Dunbar, Kerry B.; Agoston, Agoston T.; Odze, Robert D.; Huo, Xiaofang; Pham, Thai H.; Cipher, Daisha J.; Castell, Donald O.; Genta, Robert M.; Souza, Rhonda F.; Spechler, Stuart J.			Association of Acute Gastroesophageal Reflux Disease With Esophageal Histologic Changes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FACTOR-KAPPA-B; PEPTIC ESOPHAGITIS; ACID; INTERLEUKIN-8; EXPRESSION; PATHOGENESIS; CHEMOKINES; PEPSIN	IMPORTANCE The histologic changes associated with acute gastroesophageal reflux disease (GERD) have not been studied prospectively in humans. Recent studies in animals have challenged the traditional notion that reflux esophagitis develops when esophageal surface epithelial cells are exposed to lethal chemical injury from refluxed acid. OBJECTIVE To evaluate histologic features of esophageal inflammation in acute GERD to study its pathogenesis. DESIGN, SETTING, AND PARTICIPANTS Patients from the Dallas Veterans Affairs Medical Center who had reflux esophagitis successfully treated with proton pump inhibitors (PPIs) began 24-hour esophageal pH and impedance monitoring and esophagoscopy (including confocal laser endomicroscopy [CLE]) with biopsies from noneroded areas of distal esophagus at baseline (taking PPIs) and at 1 week and 2 weeks after stopping the PPI medication. Enrollment began May 2013 and follow-up ended July 2015. INTERVENTIONS PPIs stopped for 2 weeks. MAIN OUTCOMES AND MEASURES Twelve patients (men, 11; mean age, 57.6 year [SD, 13.1]) completed the study. Primary outcome was change in esophageal inflammation 2 weeks after stopping the PPI medication, determined by comparing lymphocyte, eosinophil, and neutrophil infiltrates (each scored on a 0-3 scale) in esophageal biopsies. Also evaluated were changes in epithelial basal cell and papillary hyperplasia, surface erosions, intercellular space width, endoscopic grade of esophagitis, esophageal acid exposure, and mucosal impedance (an index of mucosal integrity). RESULTS At 1 week and 2 weeks after discontinuation of PPIs, biopsies showed significant increases in intraepithelial lymphocytes, which were predominantly T cells (median [range]: 0 (0-2) at baseline vs 1 (1-2) at both 1 week [P = .005] and 2 weeks [P = .002]); neutrophils and eosinophils were few or absent. Biopsies also showed widening of intercellular spaces (confirmed by CLE), and basal cell and papillary hyperplasia developed without surface erosions. Two weeks after stopping the PPI medication, esophageal acid exposure increased (median: 1.2% at baseline to 17.8% at 2 weeks;., 16.2%[95% CI, 4.4%-26.5%], P = .005), mucosal impedance decreased (mean: 2671.3 O at baseline to 1508.4 O at 2 weeks;., 1162.9 O [95% CI, 629.9-1695.9], P = .001), and all patients had evidence of esophagitis. CONCLUSIONS AND RELEVANCE In this preliminary study of 12 patients with severe reflux esophagitis successfully treated with PPI therapy, stopping PPI medication was associated with T lymphocyte-predominant esophageal inflammation and basal cell and papillary hyperplasia without loss of surface cells. If replicated, these findings suggest that the pathogenesis of reflux esophagitis may be cytokine-mediated rather than the result of chemical injury.	[Dunbar, Kerry B.; Huo, Xiaofang; Pham, Thai H.; Genta, Robert M.; Souza, Rhonda F.; Spechler, Stuart J.] Univ Texas SW Med Ctr Dallas, Esophageal Dis Ctr, Vet Affairs North Texas Hlth Care Syst, Dallas, TX 75390 USA; [Dunbar, Kerry B.; Huo, Xiaofang; Souza, Rhonda F.; Spechler, Stuart J.] Univ Texas SW Med Ctr Dallas, Dept Med, Vet Affairs North Texas Hlth Care Syst, Dallas, TX 75390 USA; [Agoston, Agoston T.; Odze, Robert D.] Harvard Univ, Brigham & Womens Hosp, Pathol Hosp, Sch Med, Boston, MA 02115 USA; [Pham, Thai H.] Univ Texas SW Med Ctr Dallas, Dept Surg, Vet Affairs North Texas Hlth Care Syst, Dallas, TX 75390 USA; [Cipher, Daisha J.] Univ Texas Arlington, Coll Nursing & Hlth Innovat, Arlington, TX USA; [Castell, Donald O.] Med Univ S Carolina, Dept Med, Charleston, SC USA; [Genta, Robert M.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Vet Affairs North Texas Hlth Care Syst, Dallas, TX 75390 USA; [Genta, Robert M.] Miraca Life Sci, Irving, TX USA; [Souza, Rhonda F.; Spechler, Stuart J.] Univ Texas SW Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Arlington; Medical University of South Carolina; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas	Souza, RF; Spechler, SJ (corresponding author), Dallas Vet Affairs Med Ctr, Dept Gastroenterol, 4500 S Lancaster Rd,MC 111B1, Dallas, TX 75216 USA.	rhonda.souza@utsouthwestern.edu; sjspechler@aol.com			US Department of Veterans Affairs Biomedical Laboratory Research Program [BX002666]; National Institutes of Health [R01-DK63621]; American Gastroenterological Association June and Donald O. Castell Esophageal Clinical Research Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063621] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002666] Funding Source: NIH RePORTER	US Department of Veterans Affairs Biomedical Laboratory Research Program(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Gastroenterological Association June and Donald O. Castell Esophageal Clinical Research Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Merit Review Award BX002666 from the US Department of Veterans Affairs Biomedical Laboratory Research Program (Dr Spechler), the National Institutes of Health (R01-DK63621 to Drs Souza and Spechler), and the American Gastroenterological Association June and Donald O. Castell Esophageal Clinical Research Award (Dr Dunbar).	Altomare A, 2012, NEUROGASTROENT MOTIL, V24, DOI 10.1111/j.1365-2982.2012.01963.x; Bigildeev AE, 2015, CYTOKINE, V71, P246, DOI 10.1016/j.cyto.2014.10.018; Chiba N., 1997, CAN J GASTROENTEROL, V11, p66B; EASTWOOD GL, 1986, J CLIN GASTROENTEROL, V8, P45, DOI 10.1097/00004836-198606001-00007; Fiocca R, 2010, HUM PATHOL, V41, P223, DOI 10.1016/j.humpath.2009.07.016; Fitzgerald RC, 2002, GUT, V50, P451, DOI 10.1136/gut.50.4.451; FRIERSON HF, 1990, GASTROENTEROL CLIN N, V19, P631; Ganz RA, 2013, NEW ENGL J MED, V368, P719, DOI 10.1056/NEJMoa1205544; GOLDBERG HI, 1969, GASTROENTEROLOGY, V56, P223; Hershcovici Tiberiu, 2010, J Neurogastroenterol Motil, V16, P8, DOI 10.5056/jnm.2010.16.1.8; HETZEL DJ, 1988, GASTROENTEROLOGY, V95, P903, DOI 10.1016/0016-5085(88)90162-X; Huo XF, 2014, GUT, V63, P1042, DOI 10.1136/gutjnl-2013-305533; ISMAIL-BEIGI F, 1970, Gastroenterology, V58, P163; Isomoto H, 2004, AM J GASTROENTEROL, V99, P589, DOI 10.1111/j.1572-0241.2004.04110.x; Isomoto H, 2003, AM J GASTROENTEROL, V98, P551, DOI 10.1016/S0002-9270(02)06025-2; Jovov B, 2011, AM J GASTROENTEROL, V106, P1039, DOI 10.1038/ajg.2011.102; Kandulski A, 2015, CLIN GASTROENTEROL H, V13, P1075, DOI 10.1016/j.cgh.2014.11.033; Kedika RR, 2009, DIGEST DIS SCI, V54, P2312, DOI 10.1007/s10620-009-0951-9; KHALBUSS WE, 1995, GASTROENTEROLOGY, V108, P662, DOI 10.1016/0016-5085(95)90437-9; Leoni G, 2015, MUCOSAL IMMUNOL, V8, P959, DOI 10.1038/mi.2015.63; Locke GR, 1997, GASTROENTEROLOGY, V112, P1448, DOI 10.1016/S0016-5085(97)70025-8; Lundell LR, 1999, GUT, V45, P172, DOI 10.1136/gut.45.2.172; Malfertheiner P, 2012, ALIMENT PHARM THER, V35, P154, DOI 10.1111/j.1365-2036.2011.04901.x; Martinucci I, 2014, NEUROGASTROENT MOTIL, V26, P546, DOI 10.1111/nmo.12299; ODZE R, 1993, AM J SURG PATHOL, V17, P869, DOI 10.1097/00000478-199309000-00002; Oh DS, 2007, ARCH SURG-CHICAGO, V142, P554, DOI 10.1001/archsurg.142.6.554; Orlando RC, 2005, MED CLIN N AM, V89, P219, DOI 10.1016/j.mcna.2004.08.006; Souza RF, 2009, GASTROENTEROLOGY, V137, P1776, DOI 10.1053/j.gastro.2009.07.055; SPECHLER SJ, 1992, DIGESTION, V51, P24, DOI 10.1159/000200911; Tobey NA, 2008, DIS ESOPHAGUS, V21, P757, DOI 10.1111/j.1442-2050.2008.00841.x; Tobey NA, 2001, AM J GASTROENTEROL, V96, P3062; Velanovich V, 2007, DIS ESOPHAGUS, V20, P130, DOI 10.1111/j.1442-2050.2007.00658.x; Winklestein A, 1935, J AMER MED ASSOC, V104, P906, DOI 10.1001/jama.1935.02760110034008; Xu L, 2000, ONCOL RES, V12, P97, DOI 10.3727/096504001108747567; Zhong CJ, 2013, J GASTROENTEROL, V48, P601, DOI 10.1007/s00535-012-0689-6	35	113	114	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 17	2016	315	19					2104	2112		10.1001/jama.2016.5657	http://dx.doi.org/10.1001/jama.2016.5657			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL9PN	27187303	Green Accepted, Bronze			2022-12-28	WOS:000375975300021
J	Humphreys, H; MacLellan, K				Humphreys, Hilary; MacLellan, Kathleen			Principles for Disclosure of Interests and Management of Conflicts in Guidelines: Desirable and Undesirable Action and Consequences	ANNALS OF INTERNAL MEDICINE			English	Letter									[Humphreys, Hilary] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Humphreys, Hilary] Beaumont Hosp, Dublin 9, Ireland; [MacLellan, Kathleen] Dept Hlth, Dublin, Ireland	Royal College of Surgeons - Ireland	Humphreys, H (corresponding author), Royal Coll Surgeons Ireland, Dublin 2, Ireland.; Humphreys, H (corresponding author), Beaumont Hosp, Dublin 9, Ireland.			Humphreys, Hilary/0000-0002-9646-2183				Schunemann HJ, 2015, ANN INTERN MED, V163, P548, DOI 10.7326/M14-1885	1	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2016	164	10					701	701		10.7326/L15-0621	http://dx.doi.org/10.7326/L15-0621			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8GF	27182908				2022-12-28	WOS:000375878500024
J	McGeachie, MJ; Yates, KP; Zhou, X; Guo, F; Sternberg, AL; Van Natta, ML; Wise, RA; Szefler, SJ; Sharma, S; Kho, AT; Cho, MH; Croteau-Chonka, DC; Castaldi, PJ; Jain, G; Sanyal, A; Zhan, Y; Lajoie, BR; Dekker, J; Stamatoyannopoulos, J; Covar, RA; Zeiger, RS; Adkinson, NF; Williams, PV; Kelly, HW; Grasemann, H; Vonk, JM; Koppelman, GH; Postma, DS; Raby, BA; Houston, I; Lu, Q; Fuhlbrigge, AL; Tantisira, KG; Silverman, EK; Tonascia, J; Weiss, ST; Strunk, RC				McGeachie, M. J.; Yates, K. P.; Zhou, X.; Guo, F.; Sternberg, A. L.; Van Natta, M. L.; Wise, R. A.; Szefler, S. J.; Sharma, S.; Kho, A. T.; Cho, M. H.; Croteau-Chonka, D. C.; Castaldi, P. J.; Jain, G.; Sanyal, A.; Zhan, Y.; Lajoie, B. R.; Dekker, J.; Stamatoyannopoulos, J.; Covar, R. A.; Zeiger, R. S.; Adkinson, N. F.; Williams, P. V.; Kelly, H. W.; Grasemann, H.; Vonk, J. M.; Koppelman, G. H.; Postma, D. S.; Raby, B. A.; Houston, I.; Lu, Q.; Fuhlbrigge, A. L.; Tantisira, K. G.; Silverman, E. K.; Tonascia, J.; Weiss, S. T.; Strunk, R. C.		CAMP Res Grp	Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AIR-FLOW LIMITATION; RISK-FACTORS; HYPERRESPONSIVENESS; MORTALITY; CHILDREN; INFANCY; COHORT; HEALTH; COPD	BACKGROUND Tracking longitudinal measurements of growth and decline in lung function in patients with persistent childhood asthma may reveal links between asthma and subsequent chronic airflow obstruction. METHODS We classified children with asthma according to four characteristic patterns of lung-function growth and decline on the basis of graphs showing forced expiratory volume in 1 second (FEV1), representing spirometric measurements performed from childhood into adulthood. Risk factors associated with abnormal patterns were also examined. To define normal values, we used FEV1 values from participants in the National Health and Nutrition Examination Survey who did not have asthma. RESULTS Of the 684 study participants, 170 (25%) had a normal pattern of lung-function growth without early decline, and 514 (75%) had abnormal patterns: 176 (26%) had reduced growth and an early decline, 160 (23%) had reduced growth only, and 178 (26%) had normal growth and an early decline. Lower baseline values for FEV1, smaller bronchodilator response, airway hyperresponsiveness at baseline, and male sex were associated with reduced growth (P<0.001 for all comparisons). At the last spirometric measurement (mean [+/- SD] age, 26.0 +/- 1.8 years), 73 participants (11%) met Global Initiative for Chronic Obstructive Lung Disease spirometric criteria for lung-function impairment that was consistent with chronic obstructive pulmonary disease (COPD); these participants were more likely to have a reduced pattern of growth than a normal pattern (18% vs. 3%, P<0.001). CONCLUSIONS Childhood impairment of lung function and male sex were the most significant predictors of abnormal longitudinal patterns of lung-function growth and decline. Children with persistent asthma and reduced growth of lung function are at increased risk for fixed airflow obstruction and possibly COPD in early adulthood.	[McGeachie, M. J.; Zhou, X.; Guo, F.; Kho, A. T.; Cho, M. H.; Croteau-Chonka, D. C.; Castaldi, P. J.; Lajoie, B. R.; Houston, I.; Fuhlbrigge, A. L.; Tantisira, K. G.; Silverman, E. K.; Weiss, S. T.] Boston Childrens Hosp, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA USA; [McGeachie, M. J.; Guo, F.; Kho, A. T.; Cho, M. H.; Croteau-Chonka, D. C.; Castaldi, P. J.; Lajoie, B. R.; Houston, I.; Fuhlbrigge, A. L.; Tantisira, K. G.; Silverman, E. K.; Weiss, S. T.] Boston Childrens Hosp, Brigham & Womens Hosp, Dept Med, Boston, MA USA; [Fuhlbrigge, A. L.] Boston Childrens Hosp, Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA USA; [Lu, Q.] Harvard Univ, TH Chan Sch Publ Hlth, Program Mol & Integrat Physiol Sci, Dept Environm Hlth, Boston, MA 02115 USA; [Lu, Q.] Harvard Univ, TH Chan Sch Publ Hlth, Program Mol & Integrat Physiol Sci, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Yates, K. P.; Sternberg, A. L.; Van Natta, M. L.; Tonascia, J.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Wise, R. A.; Adkinson, N. F.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Szefler, S. J.; Covar, R. A.] Childrens Hosp Colorado, Natl Jewish Hlth, Denver, CO USA; [Szefler, S. J.; Covar, R. A.] Univ Colorado, Sch Med, Denver, CO 80202 USA; [Sharma, S.] Univ Colorado, Dept Med, Div Pulm Sci & Crit Care Med, Denver, CO 80202 USA; [Covar, R. A.] Univ Colorado, Denver, CO 80202 USA; [Jain, G.; Sanyal, A.; Zhan, Y.; Lajoie, B. R.; Dekker, J.] Univ Massachusetts, Sch Med, Program Syst Biol, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Dekker, J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Sanyal, A.] Nanyang Technol Univ, Sch Biol Sci, Lee Kong Chian Sch Med, Singapore 639798, Singapore; [Stamatoyannopoulos, J.] Univ Washington, Sch Med, Genome Sci, Seattle, WA 98195 USA; [Williams, P. V.] ASTHMA Inc, Clin Res Ctr, Seattle, WA USA; [Williams, P. V.] Northwest Asthma & Allergy Ctr, Seattle, WA USA; [Zeiger, R. S.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Zeiger, R. S.] Kaiser Permanente Southern Calif Reg, San Diego, CA USA; [Kelly, H. W.] Univ New Mexico, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Grasemann, H.] Hosp Sick Children, Dept Pediat, Div Resp Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Grasemann, H.] Univ Toronto, Toronto, ON, Canada; [Vonk, J. M.; Koppelman, G. H.; Postma, D. S.] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma & COPD, Groningen, Netherlands; [Vonk, J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Postma, D. S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands; [Koppelman, G. H.] Beatrix Childrens Hosp, Dept Pediat Pulmonol & Pediat Allergol, Groningen, Netherlands; [Strunk, R. C.] Washington Univ, Sch Med, Div Allergy Immunol & Pulmonary Med, St Louis, MO 63130 USA	Harvard University; Boston Children's Hospital; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Children's Hospital Colorado; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Denver; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; Kaiser Permanente; University of New Mexico; University of New Mexico's Health Sciences Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Groningen; University of Groningen; University of Groningen; University of Groningen; Washington University (WUSTL)	Wise, RA (corresponding author), Channing Labs, 181 Long Wood Ave,Rm 459, Boston, MA 02115 USA.	scott.weiss@channing.harvard.edu	Koppelman, Gerard/AAG-9187-2020; Vonk, Judith M/ABA-3009-2020; Vonk, Judith/K-8477-2019; Raby, Benjamin/AAK-3866-2021; SANYAL, AMARTYA/D-7240-2015	Vonk, Judith M/0000-0001-7531-4547; Vonk, Judith/0000-0001-7531-4547; SANYAL, AMARTYA/0000-0002-2109-4478; Guo, Feng/0000-0002-4506-7618; Zhou, Xiaobo/0000-0002-7127-2869; Koppelman, Gerard/0000-0001-8567-3252; Szefler, Stanley/0000-0002-6911-3199; Wise, Robert/0000-0002-8353-2349; Zeiger, Robert/0000-0001-5788-5063	Parker B. Francis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105569, T32HL007427, K25HL091124, U01HL091075, U01HL075408, P01HL105339, R01HL075478, P01HL083069, K08HL102265, R01HL089856, R33HL120794, R21HL120794, K08HL097029, R01HL124233, R01HL127200, R01HL113264, U01HL065899] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143, U54HG007010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR013391] Funding Source: NIH RePORTER	Parker B. Francis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	Funded by the Parker B. Francis Foundation and others;	Cherniack R, 1999, CONTROL CLIN TRIALS, V20, P91; CLEVELAND WS, 1981, AM STAT, V35, P54, DOI 10.2307/2683591; Fleiss JL., 2003, STAT METHODS RATES P; Flercher C., 1976, NATURAL HIST CHRONIC; Gibson PG, 2009, THORAX, V64, P728, DOI 10.1136/thx.2008.108027; Grol MH, 1999, AM J RESP CRIT CARE, V160, P1830, DOI 10.1164/ajrccm.160.6.9812100; Guerra S, 2008, RESP MED, V102, P1473, DOI 10.1016/j.rmed.2008.04.011; Hallberg J, 2010, PEDIATR PULM, V45, P341, DOI 10.1002/ppul.21190; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Harmsen L, 2014, RESP MED, V108, P752, DOI 10.1016/j.rmed.2014.01.009; Hoesein FAAM, 2011, RESP MED, V105, P907, DOI 10.1016/j.rmed.2011.01.008; Hollams EM, 2014, AM J RESP CRIT CARE, V189, P401, DOI 10.1164/rccm.201302-0323OC; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Hosmer DW, 2008, APPL SURVIVAL ANAL R, V2nd; Hospers JJ, 2000, LANCET, V356, P1313, DOI 10.1016/S0140-6736(00)02815-4; Huang S, 2015, EUR RESPIR J, V45, P338, DOI 10.1183/09031936.00108514; James AL, 2005, AM J RESP CRIT CARE, V171, P109, DOI 10.1164/rccm.200402-230OC; Jamrozik E, 2009, RESPIROLOGY, V14, P814, DOI 10.1111/j.1440-1843.2009.01562.x; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lange P, 1998, NEW ENGL J MED, V339, P1194, DOI 10.1056/NEJM199810223391703; Lange P, 2015, NEW ENGL J MED, V373, P111, DOI 10.1056/NEJMoa1411532; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Speizer F E, 1979, Epidemiol Rev, V1, P124; Stern DA, 2007, LANCET, V370, P758, DOI 10.1016/S0140-6736(07)61379-8; Stocks J, 2013, LANCET RESP MED, V1, P728, DOI 10.1016/S2213-2600(13)70118-8; Strunk RC, 2006, J ALLERGY CLIN IMMUN, V118, P1040, DOI 10.1016/j.jaci.2006.07.053; Svanes C, 2010, THORAX, V65, P14, DOI 10.1136/thx.2008.112136; Swanney MP, 2008, THORAX, V63, P1046, DOI 10.1136/thx.2008.098483; Szefler S, 2000, NEW ENGL J MED, V343, P1054; Tai A, 2014, THORAX, V69, P805, DOI 10.1136/thoraxjnl-2013-204815; Tamimi A, 2012, RESP MED, V106, P319, DOI 10.1016/j.rmed.2011.11.003; Tantisira KG, 2006, J ALLERGY CLIN IMMUN, V117, P1264, DOI 10.1016/j.jaci.2006.01.050; Ulrik CS, 1999, EUR RESPIR J, V13, P904, DOI 10.1034/j.1399-3003.1999.13d35.x; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Vonk JM, 2003, THORAX, V58, P322, DOI 10.1136/thorax.58.4.322; Wang XB, 2004, AM J RESP CRIT CARE, V169, P941, DOI 10.1164/rccm.2201011; Weiss S, 1993, BRONCHIAL ASTHMA MEC, P15	37	324	340	2	50	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2016	374	19					1842	1852		10.1056/NEJMoa1513737	http://dx.doi.org/10.1056/NEJMoa1513737			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6JS	27168434	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000375746100007
J	Guillevin, L; Regent, A				Guillevin, Loic; Regent, Alexis			Treating giant-cell arteritis: is IL-6 the cytokine to target?	LANCET			English	Editorial Material							POLYMYALGIA-RHEUMATICA; PATHOGENESIS; INTERLEUKIN-6		[Guillevin, Loic] Univ Paris 05, Paris, France; Hop Cochin, AP HP, Ctr Reference Malad Autoimmunes & Syst Rares, Serv Med Interne, 27 Rue Faubourg St Jacques, F-75674 Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Guillevin, L (corresponding author), Univ Paris 05, Paris, France.	Loic.guillevin@aphp.fr	REGENT, Alexis/AHA-6753-2022					Fernandez-Fernandez FJ, 2013, ARTHRITIS RHEUM-US, V65, P289, DOI [10.1002/art.37699, 10.1002/art.37700]; Ly KH, 2010, AUTOIMMUN REV, V9, P635, DOI 10.1016/j.autrev.2010.05.002; Mahr AD, 2007, ARTHRITIS RHEUM, V56, P2789, DOI 10.1002/art.22754; Proven A, 2003, ARTHRIT RHEUM-ARTHR, V49, P703, DOI 10.1002/art.11388; Rincon M, 2012, TRENDS IMMUNOL, V33, P571, DOI 10.1016/j.it.2012.07.003; ROCHE NE, 1993, ARTHRITIS RHEUM, V36, P1286, DOI 10.1002/art.1780360913; Samson M, 2013, CLIN EXP RHEUMATOL, V31, pS65; Samson M, 2012, ARTHRITIS RHEUM-US, V64, P3788, DOI 10.1002/art.34647; Terrier B, 2012, ARTHRITIS RHEUM-US, V64, P2001, DOI 10.1002/art.34327; Villiger PM, 2016, LANCET, V387, P1921, DOI 10.1016/S0140-6736(16)00560-2; Weyand CM, 2014, NEW ENGL J MED, V371, P1653, DOI [10.1056/NEJMcp1214825, 10.1056/NEJMc1409206]	11	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2016	387	10031					1882	1883						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL1EE	27203632				2022-12-28	WOS:000375374200005
J	Trehu, AM				Trehu, Anne M.			Measuring slow slip offshore	SCIENCE			English	Editorial Material							EARTHQUAKES; ZONE		[Trehu, Anne M.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA	Oregon State University	Trehu, AM (corresponding author), Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA.	trehu@coas.oregonstate.edu			Directorate For Geosciences [1130013] Funding Source: National Science Foundation	Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Beroza GC, 2011, ANNU REV EARTH PL SC, V39, P271, DOI 10.1146/annurev-earth-040809-152531; Burgmann R, 2014, ANNU REV EARTH PL SC, V42, P509, DOI 10.1146/annurev-earth-060313-054953; Faulkner DR, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048552; Kanamori H., 1972, Physics of the Earth and Planetary Interiors, V6, P346, DOI 10.1016/0031-9201(72)90058-1; Marone C, 2010, GEOLOGY, V38, P767, DOI 10.1130/focus082010.1; Schwartz SY, 2007, REV GEOPHYS, V45, DOI 10.1029/2006RG000208; Spiess F. N., 1983, SEAFLOOR REFERENCED; Wallace LM, 2016, SCIENCE, V352, P701, DOI 10.1126/science.aaf2349; Wallace LM, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB007717; Wallace LM, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002610; Ye LL, 2016, J GEOPHYS RES-SOL EA, V121, P845, DOI 10.1002/2015JB012427	11	4	4	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2016	352	6286					654	655		10.1126/science.aaf6534	http://dx.doi.org/10.1126/science.aaf6534			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL1UC	27151849				2022-12-28	WOS:000375417100014
J	Masri, S; Papagiannakopoulos, T; Kinouchi, K; Liu, Y; Cervantes, M; Baldi, P; Jacks, T; Sassone-Corsi, P				Masri, Selma; Papagiannakopoulos, Thales; Kinouchi, Kenichiro; Liu, Yu; Cervantes, Marlene; Baldi, Pierre; Jacks, Tyler; Sassone-Corsi, Paolo			Lung Adenocarcinoma Distally Rewires Hepatic Circadian Homeostasis	CELL			English	Article							INSULIN-RESISTANCE; STAT3 ACTIVATION; INNATE IMMUNITY; KNOCKOUT MICE; FATTY LIVER; IL-6; METABOLISM; CANCER; CLOCK; TRANSCRIPTION	The circadian clock controls metabolic and physiological processes through finely tuned molecular mechanisms. The clock is remarkably plastic and adapts to exogenous "zeitgebers," such as light and nutrition. How a pathological condition in a given tissue influences systemic circadian homeostasis in other tissues remains an unanswered question of conceptual and biomedical importance. Here, we show that lung adenocarcinoma operates as an endogenous reorganizer of circadian metabolism. High-throughput transcriptomics and metabolomics revealed unique signatures of transcripts and metabolites cycling exclusively in livers of tumor-bearing mice. Remarkably, lung cancer has no effect on the core clock but rather reprograms hepatic metabolism through altered pro-inflammatory response via the STAT3-Socs3 pathway. This results in disruption of AKT, AMPK, and SREBP signaling, leading to altered insulin, glucose, and lipid metabolism. Thus, lung adenocarcinoma functions as a potent endogenous circadian organizer (ECO), which rewires the pathophysiological dimension of a distal tissue such as the liver.	[Masri, Selma; Kinouchi, Kenichiro; Cervantes, Marlene; Sassone-Corsi, Paolo] Univ Calif Irvine, Dept Biol Chem, Ctr Epigenet & Metab, INSERM,Unit 904, Irvine, CA 92697 USA; [Papagiannakopoulos, Thales; Jacks, Tyler] MIT, Div Comparat Med, Cambridge, MA 02139 USA; [Liu, Yu; Baldi, Pierre] Univ Calif Irvine, Dept Comp Sci, Inst Genom & Bioinformat, Irvine, CA 92697 USA; [Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Papagiannakopoulos, Thales] NYU, Sch Med, Dept Pathol, Perlmutter Canc Ctr, New York, NY 10016 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); University of California System; University of California Irvine; Massachusetts Institute of Technology (MIT); University of California System; University of California Irvine; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); New York University	Sassone-Corsi, P (corresponding author), Univ Calif Irvine, Dept Biol Chem, Ctr Epigenet & Metab, INSERM,Unit 904, Irvine, CA 92697 USA.	psc@uci.edu	Liu, Yu/C-3867-2016; Kinouchi, Kenichiro/AAW-8471-2021	Liu, Yu/0000-0003-3698-4892; Kinouchi, Kenichiro/0000-0003-4743-2583; Cervantes, Marlene/0000-0003-4619-6144; Masri, Selma/0000-0002-8619-8331	NIH [GM097899, LM010235, AG043745]; Japan Society for the Promotion of Science (JSPS); Hope Funds for Cancer Research; Ludwig Center for Molecular Oncology at MIT; Koch Institute Frontier Fund; NSF [IIS-1321053]; Merieux Research Grant [53923]; University of California Irvine Chao Family Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM097899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG043745] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010235] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Hope Funds for Cancer Research; Ludwig Center for Molecular Oncology at MIT; Koch Institute Frontier Fund; NSF(National Science Foundation (NSF)); Merieux Research Grant; University of California Irvine Chao Family Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank all members of the Sassone-Corsi laboratory for scientific discussion or technical assistance and T. Leff, G. Servillo, and M. Oakes for discussions. Funding for S.M. was provided by NIH post-doctoral fellowship GM097899. K.K. was supported by a post-doctoral fellowship from the Japan Society for the Promotion of Science (JSPS). T.P. was supported by the Hope Funds for Cancer Research. Financial support for T.J. was provided by the Ludwig Center for Molecular Oncology at MIT and by the Koch Institute Frontier Fund. Grants from the NSF (IIS-1321053) and the NIH (LM010235) to P.B. supported the work of Y.L. and P.B. Financial support for P.S.-C. was provided by NIH (AG043745), Merieux Research Grant (53923), and the University of California Irvine Chao Family Comprehensive Cancer Center.	Adser H, 2011, ACTA PHYSIOL, V202, P165, DOI 10.1111/j.1748-1716.2011.02269.x; Al-Zhoughbi W, 2014, SEMIN ONCOL, V41, P281, DOI 10.1053/j.seminoncol.2014.02.005; Asher G, 2015, CELL, V161, P84, DOI 10.1016/j.cell.2015.03.015; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Bonetto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022538; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fitzgerald JS, 2005, INT J BIOCHEM CELL B, V37, P2284, DOI 10.1016/j.biocel.2005.02.025; Gamble KL, 2014, NAT REV ENDOCRINOL, V10, P466, DOI 10.1038/nrendo.2014.78; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Gilardi F, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004155; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guo DQ, 1998, J IMMUNOL, V160, P2742; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kelly M, 2004, BIOCHEM BIOPH RES CO, V320, P449, DOI 10.1016/j.bbrc.2004.05.188; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Ma KL, 2008, HEPATOLOGY, V48, P770, DOI 10.1002/hep.22423; Masri S, 2015, CURR OPIN ONCOL, V27, P50, DOI 10.1097/CCO.0000000000000153; Masri S, 2014, CELL, V158, P659, DOI 10.1016/j.cell.2014.06.050; Mauer J, 2015, TRENDS IMMUNOL, V36, P92, DOI 10.1016/j.it.2014.12.008; Michalaki V, 2004, BRIT J CANCER, V90, P2312, DOI 10.1038/sj.bjc.6601814; Miller AM, 2011, HEPATOLOGY, V54, P846, DOI 10.1002/hep.24517; Narimatsu M, 2001, MOL CELL BIOL, V21, P6615, DOI 10.1128/MCB.21.19.6615-6625.2001; Narsale AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119888; Okin D, 2016, CELL, V165, P343, DOI 10.1016/j.cell.2016.02.023; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002; Ruderman NB, 2006, DIABETES, V55, pS48, DOI 10.2337/db06-S007; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Sachithanandan N, 2010, HEPATOLOGY, V52, P1632, DOI 10.1002/hep.23861; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Senn JJ, 2003, J BIOL CHEM, V278, P13740, DOI 10.1074/jbc.M210689200; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Torisu T, 2007, GENES CELLS, V12, P143, DOI 10.1111/j.1365-2443.2007.01044.x; Tsoli M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092966; Vavvas D, 1997, J BIOL CHEM, V272, P13255, DOI 10.1074/jbc.272.20.13255; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Yamaguchi K, 2010, LAB INVEST, V90, P1169, DOI 10.1038/labinvest.2010.75; Yeh HH, 2006, ONCOGENE, V25, P4300, DOI 10.1038/sj.onc.1209464; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214; Zhao L, 2011, J GASTROEN HEPATOL, V26, P875, DOI 10.1111/j.1440-1746.2010.06560.x	63	144	149	1	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2016	165	4					896	909		10.1016/j.cell.2016.04.039	http://dx.doi.org/10.1016/j.cell.2016.04.039			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DL7DN	27153497	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000375800300017
J	Watts, G				Watts, Geoff			Maria Neira: no limits to public health	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 30	2016	387	10030					1807	1807		10.1016/S0140-6736(16)30327-0	http://dx.doi.org/10.1016/S0140-6736(16)30327-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DK6SS	27203494				2022-12-28	WOS:000375056100013
J	Sands, P; El Turabi, A; Saynisch, PA; Dzau, VJ				Sands, Peter; El Turabi, Anas; Saynisch, Philip A.; Dzau, Victor J.			Assessment of economic vulnerability to infectious disease crises	LANCET			English	Editorial Material								Infectious disease crises have substantial economic impact. Yet mainstream macroeconomic forecasting rarely takes account of the risk of potential pandemics. This oversight contributes to persistent underestimation of infectious disease risk and consequent underinvestment in preparedness and response to infectious disease crises. One reason why economists fail to include economic vulnerability to infectious disease threats in their assessments is the absence of readily available and digestible input data to inform such analysis. In this Viewpoint we suggest an approach by which the global health community can help to generate such inputs, and a framework to use these inputs to assess the economic vulnerability to infectious disease crises of individual countries and regions. We argue that incorporation of these risks in influential macroeconomic analyses such as the reports from the International Monetary Fund's Article IV consultations, rating agencies and risk consultancies would simultaneously improve the quality of economic risk forecasting and reinforce individual government and donor incentives to mitigate infectious disease risks.	[Sands, Peter] Harvard Kennedy Sch, Cambridge, MA USA; [El Turabi, Anas] Harvard Grad Sch Arts & Sci, Cambridge, MA USA; [Saynisch, Philip A.] Harvard Sch Business, Boston, MA USA; [Dzau, Victor J.] Natl Acad Med, Washington, DC 20001 USA	Harvard University; Harvard University; Harvard University; National Academies of Sciences, Engineering & Medicine	Dzau, VJ (corresponding author), Natl Acad Med, Washington, DC 20001 USA.	VDzau@nas.edu		El Turabi, Anas/0000-0003-3234-6746				AIR Worldwide, 2016, AIR PAND MOD; [Anonymous], 2016, INCLUSIVE COST PANDE; [Anonymous], 2014, EC IMP 2014 EB EP SH, DOI 10.1596/978-1-4648-0438-0; Baumgart C., 2007, INFLUENZA PANDEMICS; Burns A, 2008, EVALUATING EC CONSEQ; Commission on a Global Health Risk Framework for the Future, 2016, J CLIN PSYCHOL, V33, P1125; Jamison DT, 2001, EFFECTS AIDS EPIDEMI; Jonas O., 2014, PANDEMIC RISK; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kahneman D., 2011, THINKING FAST SLOW; Munich Re, 2007, PAND RISK TRAD GEOGR; Risk Management Solutions, 2007, RMS PAND INFL MOD OV; Sands P, 2016, NEW ENGL J MED, V374, P1281, DOI 10.1056/NEJMsr1600236; Taleb N.N., 2010, BLACK SWAN IMPACT HI, DOI DOI 10.1176/PS.2009.60.11.1564; United Nations Development Group-Western and Central Africa (UNDG-WCA), 2015, SOC EC IMP EB VIR DI, DOI [10.13140/RG.2.2.29620.04481, DOI 10.13140/RG.2.2.29620.04481]; WHO, 2015, WHO; Woolnough K, 2007, PANDEMIC INFLUENZA 2; World Bank, 2016, SHORT TERM EC COSTS	18	41	44	1	26	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 12	2016	388	10058					2443	2448		10.1016/S0140-6736(16)30594-3	http://dx.doi.org/10.1016/S0140-6736(16)30594-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EB5RB	27212427	Green Published, Bronze			2022-12-28	WOS:000387436900031
J	Lucey, D; Gostin, LO				Lucey, Daniel; Gostin, Lawrence O.			A Yellow Fever Epidemic A New Global Health Emergency?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lucey, Daniel; Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904; Monath TP, 2016, LANCET, V387, P1599, DOI 10.1016/S0140-6736(16)30195-7; Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0; (PAHO) Pan American Health Organization/Wolrd Health Organization, 2016, EP AL YELL FEV; United Nations, PROT HUM FUT HLTH CR, P25; World Health Organization, SIT REP ZIK VIR YELL	6	24	28	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 28	2016	315	24					2661	2662		10.1001/jama.2016.6606	http://dx.doi.org/10.1001/jama.2016.6606			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP7WG	27158803				2022-12-28	WOS:000378709300012
J	Burch, JL; Torbert, RB; Phan, TD; Chen, LJ; Moore, TE; Ergun, RE; Eastwood, JP; Gershman, DJ; Cassak, PA; Argall, MR; Wang, S; Hesse, M; Pollock, CJ; Giles, BL; Nakamura, R; Mauk, BH; Fuselier, SA; Russell, CT; Strangeway, RJ; Drake, JF; Shay, MA; Khotyaintsev, YV; Lindqvist, PA; Marklund, G; Wilder, FD; Young, DT; Torkar, K; Goldstein, J; Dorelli, JC; Avanov, LA; Oka, M; Baker, DN; Jaynes, AN; Goodrich, KA; Cohen, IJ; Turner, DL; Fennell, JF; Blake, JB; Clemmons, J; Goldman, M; Newman, D; Petrinec, SM; Trattner, KJ; Lavraud, B; Reiff, PH; Baumjohann, W; Magnes, W; Steller, M; Lewis, W; Saito, Y; Coffey, V; Chandler, M				Burch, J. L.; Torbert, R. B.; Phan, T. D.; Chen, L. -J.; Moore, T. E.; Ergun, R. E.; Eastwood, J. P.; Gershman, D. J.; Cassak, P. A.; Argall, M. R.; Wang, S.; Hesse, M.; Pollock, C. J.; Giles, B. L.; Nakamura, R.; Mauk, B. H.; Fuselier, S. A.; Russell, C. T.; Strangeway, R. J.; Drake, J. F.; Shay, M. A.; Khotyaintsev, Yu. V.; Lindqvist, P. -A.; Marklund, G.; Wilder, F. D.; Young, D. T.; Torkar, K.; Goldstein, J.; Dorelli, J. C.; Avanov, L. A.; Oka, M.; Baker, D. N.; Jaynes, A. N.; Goodrich, K. A.; Cohen, I. J.; Turner, D. L.; Fennell, J. F.; Blake, J. B.; Clemmons, J.; Goldman, M.; Newman, D.; Petrinec, S. M.; Trattner, K. J.; Lavraud, B.; Reiff, P. H.; Baumjohann, W.; Magnes, W.; Steller, M.; Lewis, W.; Saito, Y.; Coffey, V.; Chandler, M.			Electron-scale measurements of magnetic reconnection in space	SCIENCE			English	Article							MULTISCALE MMS MISSION; DIFFUSION REGION; MAGNETOSPHERIC MULTISCALE; EARTHS MAGNETOPAUSE; ACCELERATION	Magnetic reconnection is a fundamental physical process in plasmas whereby stored magnetic energy is converted into heat and kinetic energy of charged particles. Reconnection occurs in many astrophysical plasma environments and in laboratory plasmas. Using measurements with very high time resolution, NASA's Magnetospheric Multiscale (MMS) mission has found direct evidence for electron demagnetization and acceleration at sites along the sunward boundary of Earth's magnetosphere where the interplanetary magnetic field reconnects with the terrestrial magnetic field. We have (i) observed the conversion of magnetic energy to particle energy; (ii) measured the electric field and current, which together cause the dissipation of magnetic energy; and (iii) identified the electron population that carries the current as a result of demagnetization and acceleration within the reconnection diffusion/dissipation region.	[Burch, J. L.; Torbert, R. B.; Fuselier, S. A.; Young, D. T.; Goldstein, J.; Lewis, W.] Southwest Res Inst, San Antonio, TX USA; [Torbert, R. B.; Argall, M. R.] Univ New Hampshire, Durham, NH 03824 USA; [Phan, T. D.; Oka, M.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Chen, L. -J.; Wang, S.; Drake, J. F.] Univ Maryland, College Pk, MD 20742 USA; [Moore, T. E.; Gershman, D. J.; Hesse, M.; Pollock, C. J.; Giles, B. L.; Dorelli, J. C.; Avanov, L. A.] NASA, Goddard Space Flight Ctr, Greenbelt, MD USA; [Ergun, R. E.; Wilder, F. D.; Baker, D. N.; Jaynes, A. N.; Goodrich, K. A.; Trattner, K. J.] Univ Colorado, LASP, Boulder, CO 80309 USA; [Eastwood, J. P.] Univ London Imperial Coll Sci Technol & Med, Blackett Lab, London, England; [Cassak, P. A.] W Virginia Univ, Morgantown, WV 26506 USA; [Nakamura, R.; Torkar, K.; Baumjohann, W.; Magnes, W.; Steller, M.] Austrian Acad Sci, Space Res Inst, A-8010 Graz, Austria; [Mauk, B. H.; Cohen, I. J.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD USA; [Russell, C. T.; Strangeway, R. J.] Univ Calif Los Angeles, Los Angeles, CA USA; [Shay, M. A.] Univ Delaware, Newark, DE USA; [Khotyaintsev, Yu. V.] Swedish Inst Space Phys, Uppsala, Sweden; [Lindqvist, P. -A.; Marklund, G.] Royal Inst Technol, Stockholm, Sweden; [Turner, D. L.; Fennell, J. F.; Blake, J. B.; Clemmons, J.] Aerosp Corp, El Segundo, CA 90245 USA; [Goldman, M.; Newman, D.] Univ Colorado, Boulder, CO 80309 USA; [Petrinec, S. M.] Lockheed Martin Adv Technol Ctr, Palo Alto, CA USA; [Lavraud, B.] Inst Rech Astrophys & Planetol, Toulouse, France; [Reiff, P. H.] Rice Univ, Dept Phys & Astron, Houston, TX USA; [Saito, Y.] Inst Space & Astronaut Sci, 3-1-1 Yoshinodai, Sagamihara, Kanagawa 229, Japan; [Coffey, V.; Chandler, M.] NASA, George C Marshall Space Flight Ctr, Huntsville, AL 35812 USA	Southwest Research Institute; University System Of New Hampshire; University of New Hampshire; University of California System; University of California Berkeley; University System of Maryland; University of Maryland College Park; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Colorado System; University of Colorado Boulder; Imperial College London; West Virginia University; Austrian Academy of Sciences; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of California System; University of California Los Angeles; University of Delaware; Royal Institute of Technology; Aerospace Corporation - USA; University of Colorado System; University of Colorado Boulder; Lockheed Martin; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Rice University; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center	Burch, JL (corresponding author), Southwest Res Inst, San Antonio, TX USA.	jburch@swri.edu	Giles, Barbara L/J-7393-2017; Reiff, Patricia H/D-2564-2014; Khotyaintsev, Yuri/AAX-9720-2021; MMS, Science Team NASA/J-5393-2013; Cohen, Ian J/K-3038-2015; Baumjohann, Wolfgang/A-1012-2010; Cohen, Ian/P-1710-2019; Lindqvist, Per-Arne/G-1221-2016; Drake, James/P-9477-2017; Mauk, Barry H/E-8420-2017; Clemmons, James/AAA-6749-2020; Dorelli, John C./C-9488-2012; Moore, Thomas Earle/D-4675-2012; Chen, Li-Jen/C-2106-2012; Turner, Drew L/G-3224-2012; Russell, Christopher T/E-7745-2012; JAYNES, ALLISON N/F-7876-2018; Nakamura, Rumi/I-7712-2013; Wang, Shan/AFS-6135-2022; Shay, Michael A/G-5476-2013	Giles, Barbara L/0000-0001-8054-825X; Reiff, Patricia H/0000-0002-8043-5682; Khotyaintsev, Yuri/0000-0001-5550-3113; Cohen, Ian J/0000-0002-9163-6009; Baumjohann, Wolfgang/0000-0001-6271-0110; Cohen, Ian/0000-0002-9163-6009; Lindqvist, Per-Arne/0000-0001-5617-9765; Drake, James/0000-0002-9150-1841; Mauk, Barry H/0000-0001-9789-3797; Clemmons, James/0000-0002-5298-5222; Moore, Thomas Earle/0000-0002-3150-1137; Chen, Li-Jen/0000-0002-4768-189X; Turner, Drew L/0000-0002-2425-7818; Russell, Christopher T/0000-0003-1639-8298; JAYNES, ALLISON N/0000-0002-1470-4266; Nakamura, Rumi/0000-0002-2620-9211; Wang, Shan/0000-0002-6783-7759; Saito, Yoshifumi/0000-0002-1354-3544; Dorelli, John/0000-0003-0475-6545; Oka, Mitsuo/0000-0003-2191-1025	NASA [NNG04EB99C, NNX16AG76G, NNS16AF75G]; CNES; Austrian Research Promotion Agency FFG; UK Science and Technology Facilities Council [ST/K001051/1, ST/N000692/1]; NASA Solar Terrestrial Probes program; NASA Goddard Planetary Heliophysics Institute [NNG11PL02A]; NASA MMS-IDS grant through the University of California [NNX08A083G]; NASA MMS-IDS Grant through the University of Colorado [NNX08A084G]; Swedish National Space Board; NSF [AGS-0953463, AGS-1460037]; Grants-in-Aid for Scientific Research [26247082] Funding Source: KAKEN; STFC [ST/K001051/1, ST/N000692/1] Funding Source: UKRI; Directorate For Geosciences [1543598] Funding Source: National Science Foundation; Science and Technology Facilities Council [ST/N000692/1, ST/K001051/1] Funding Source: researchfish	NASA(National Aeronautics & Space Administration (NASA)); CNES(Centre National D'etudes Spatiales); Austrian Research Promotion Agency FFG; UK Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); NASA Solar Terrestrial Probes program; NASA Goddard Planetary Heliophysics Institute; NASA MMS-IDS grant through the University of California; NASA MMS-IDS Grant through the University of Colorado; Swedish National Space Board; NSF(National Science Foundation (NSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	The dedicated efforts of the entire MMS team are greatly appreciated. We are especially grateful to the leadership of C. Tooley, B. Robertson, and R. Black. Special thanks are due to C. Pankratz and K. Larsen of the University of Colorado for their leadership of the MMS Science Operations Center. Supported by NASA contract NNG04EB99C at Southwest Research Institute, which funded work at most of the co-author institutions in the United States. The IRAP contribution to MMS was supported by CNES. The Austrian contributions to the MMS mission are supported by grants from the Austrian Research Promotion Agency FFG. The UK work was supported by the UK Science and Technology Facilities Council through grants ST/K001051/1 and ST/N000692/1. The work by NASA GSFC authors was supported by the NASA Solar Terrestrial Probes program. The work of the GSFC-resident University of Maryland co-authors was supported by NASA Goddard Planetary Heliophysics Institute contract NNG11PL02A. Work at U.C. Berkeley was supported by NASA MMS-IDS grant NNX08A083G through the University of California. Work at the University of Colorado by M.G. and D.N. was supported by NASA MMS-IDS Grant NNX08A084G through the University of Colorado. Work at the Swedish Institute for Space Physics and the Royal Institute of Technology was supported by the Swedish National Space Board. Work at West Virginia University was supported by NSF grants AGS-0953463 and AGS-1460037 and by NASA grants NNX16AG76G and NNS16AF75G.	Bessho N, 2016, GEOPHYS RES LETT, V43, P1828, DOI 10.1002/2016GL067886; Bessho N, 2014, GEOPHYS RES LETT, V41, P8688, DOI 10.1002/2014GL062034; Birdsall C. K., 2004, PLASMA PHYS VIA COMP; Blake JB, 2016, SPACE SCI REV, V199, P309, DOI 10.1007/s11214-015-0163-x; Burch JL, 2016, SPACE SCI REV, V199, P5, DOI 10.1007/s11214-015-0164-9; Burch JL, 2009, AM SCI, V97, P392, DOI 10.1511/2009.80.392; Cassak PA, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2795630; Chen LJ, 2016, GEOPHYS RES LETT, V43, P2405, DOI 10.1002/2016GL068243; COATES AJ, 1989, J GEOPHYS RES-SPACE, V94, P9983, DOI 10.1029/JA094iA08p09983; Hesse M, 2014, GEOPHYS RES LETT, V41, P8673, DOI 10.1002/2014GL061586; Mauk BH, 2016, SPACE SCI REV, V199, P471, DOI 10.1007/s11214-014-0055-5; Mozer FS, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.015002; Nagai T, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016283; Oieroset M, 2001, NATURE, V412, P414, DOI 10.1038/35086520; PASCHMANN G, 1979, NATURE, V282, P243, DOI 10.1038/282243a0; Paschmann G., 2005, OUTER MAGNETOSPHERIC; Phan TD, 2000, NATURE, V404, P848, DOI 10.1038/35009050; Pollock C, 2016, SPACE SCI REV, V199, P331, DOI 10.1007/s11214-016-0245-4; Pritchett PL, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2007JA012930; Shay MA, 2016, GEOPHYS RES LETT, V43, P4145, DOI 10.1002/2016GL069034; Shuster JR, 2015, GEOPHYS RES LETT, V42, P2586, DOI 10.1002/2015GL063601; Torbert RB, 2016, SPACE SCI REV, V199, P105, DOI 10.1007/s11214-014-0109-8; Vaivads A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.105001; WILLIS DM, 1971, REV GEOPHYS SPACE GE, V9, P953, DOI 10.1029/RG009i004p00953; Yamada M, 2016, ASTROPHYS SPACE SC L, V427, P143, DOI 10.1007/978-3-319-26432-5_4; Yamada M, 2010, REV MOD PHYS, V82, P603, DOI 10.1103/RevModPhys.82.603; Zeiler A, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA000287; Zenitani S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.195003	28	435	437	10	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2016	352	6290							aaf2939	10.1126/science.aaf2939	http://dx.doi.org/10.1126/science.aaf2939			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN4NY	27174677	Green Submitted			2022-12-28	WOS:000377045700034
J	McCarthy, M				McCarthy, Michael			New US food labels reflect modern serving sizes and added sugar	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2016, FOOD LAB REV NUTR SU; Off. Dis. Prev. Health Promot, 2015, DIET GUID AM 2015 20	2	2	2	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 24	2016	353								i2960	10.1136/bmj.i2960	http://dx.doi.org/10.1136/bmj.i2960			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3CB	27221303				2022-12-28	WOS:000376938800021
J	Willekens, F; Massey, D; Raymer, J; Beauchemin, C				Willekens, Frans; Massey, Douglas; Raymer, James; Beauchemin, Cris			International migration under the microscope	SCIENCE			English	Editorial Material									[Willekens, Frans] Max Planck Inst Demog Res, Rostock, Germany; [Willekens, Frans] Netherlands Interdisciplinary Demog Inst, The Hague, Netherlands; [Massey, Douglas] Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA; [Raymer, James] Australia Natl Univ, Sch Demog, Canberra, ACT, Australia; [Beauchemin, Cris] Inst Natl Etud Demog, F-75675 Paris, France	Max Planck Society; Royal Netherlands Academy of Arts & Sciences; Netherlands Interdisciplinary Demographic Institute (NIDI-KNAW); Princeton University; Australian National University	Willekens, F (corresponding author), Max Planck Inst Demog Res, Rostock, Germany.; Willekens, F (corresponding author), Netherlands Interdisciplinary Demog Inst, The Hague, Netherlands.	willekens@demogr.mpg.de		Raymer, James/0000-0001-6588-8985	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD035643, P2CHD047879] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD035643, P2C HD047879] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abel G. J., 2016, 22016 VIENN I DEM; Abel GJ, 2014, SCIENCE, V343, P1520, DOI 10.1126/science.1248676; Beauchemin C, 2014, INT MIGR REV, V48, P921, DOI 10.1111/imre.12157; Department of Economic and Social Affairs (DESA), 1998, RECOMMENDATIONS STAT; Dumont Jean-Christophe, 2005, OECD EC STUDIES, V2005, DOI [10.1787/eco_studies-v2005-art3-en, DOI 10.1787/ECO_STUDIES-V2005-ART3-EN]; Esipova N., 2011, GALLUP WORLD POLL MA; Gerland P., 2015, MIGRATION MOBILITY B; Raymer J, 2013, J AM STAT ASSOC, V108, P801, DOI 10.1080/01621459.2013.789435; UNHCR, 2016, TOT NUMB SYR REF EXC; UNHCR, 2016, SYR REG REF RESP DAT; UNHCR, 2015, WORLDW DISPL HITS AL	11	61	63	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2016	352	6288			SI		897	899		10.1126/science.aaf6545	http://dx.doi.org/10.1126/science.aaf6545			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM2AK	27199405	Green Accepted			2022-12-28	WOS:000376147800020
J	Gulland, A				Gulland, Anne			Global life expectancy increases by five years	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		WHO, 2016, WORLD HLTH STAT 2016	1	11	11	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2016	353								i2883	10.1136/bmj.i2883	http://dx.doi.org/10.1136/bmj.i2883			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GD	27197748				2022-12-28	WOS:000376447700028
J	Li, J; Song, J; Zaytseva, YY; Liu, YJ; Rychahou, P; Jiang, K; Starr, ME; Kim, JT; Harris, JW; Yiannikouris, FB; Katz, WS; Nilsson, PM; Orho-Melander, M; Chen, J; Zhu, HN; Fahrenholz, T; Higashi, RM; Gao, TY; Morris, AJ; Cassis, LA; Fan, TWM; Weiss, HL; Dobner, PR; Melander, O; Jia, JH; Evers, BM				Li, Jing; Song, Jun; Zaytseva, Yekaterina Y.; Liu, Yajuan; Rychahou, Piotr; Jiang, Kai; Starr, Marlene E.; Kim, Ji Tae; Harris, Jennifer W.; Yiannikouris, Frederique B.; Katz, Wendy S.; Nilsson, Peter M.; Orho-Melander, Marju; Chen, Jing; Zhu, Haining; Fahrenholz, Timothy; Higashi, Richard M.; Gao, Tianyan; Morris, Andrew J.; Cassis, Lisa A.; Fan, Teresa W. -M.; Weiss, Heidi L.; Dobner, Paul R.; Melander, Olle; Jia, Jianhang; Evers, B. Mark			An obligatory role for neurotensin in high-fat-diet-induced obesity	NATURE			English	Article							STRIATAL FOS EXPRESSION; FOOD-INTAKE; ENTEROENDOCRINE CELLS; GENE-EXPRESSION; DROSOPHILA; SECRETION; PATHWAY; HOMEOSTASIS; MIDGUT; CANCER	Obesity and its associated comorbidities (for example, diabetes mellitus and hepatic steatosis) contribute to approximately 2.5 million deaths annually(1) and are among the most prevalent and challenging conditions confronting the medical profession(2,3). Neurotensin (NT; also known as NTS), a 13-amino-acid peptide predominantly localized in specialized enteroendocrine cells of the small intestine(4) and released by fat ingestion(5), facilitates fatty acid translocation in rat intestine(6), and stimulates the growth of various cancers(7). The effects of NT are mediated through three known NT receptors (NTR1, 2 and 3; also known as NTSR1, 2, and NTSR3, respectively)(8). Increased fasting plasma levels of pro-NT (a stable NT precursor fragment produced in equimolar amounts relative to NT) are associated with increased risk of diabetes, cardiovascular disease and mortality(9); however, a role for NT as a causative factor in these diseases is unknown. Here we show that NT-deficient mice demonstrate significantly reduced intestinal fat absorption and are protected from obesity, hepatic steatosis and insulin resistance associated with high fat consumption. We further demonstrate that NT attenuates the activation of AMP-activated protein kinase (AMPK) and stimulates fatty acid absorption in mice and in cultured intestinal cells, and that this occurs through a mechanism involving NTR1 and NTR3 (also known as sortilin). Consistent with the findings in mice, expression of NT in Drosophila midgut enteroendocrine cells results in increased lipid accumulation in the midgut, fat body, and oenocytes (specialized hepatocyte-like cells) and decreased AMPK activation. Remarkably, in humans, we show that both obese and insulin-resistant subjects have elevated plasma concentrations of pro-NT, and in longitudinal studies among non-obese subjects, high levels of pro-NT denote a doubling of the risk of developing obesity later in life. Our findings directly link NT with increased fat absorption and obesity and suggest that NT may provide a prognostic marker of future obesity and a potential target for prevention and treatment.	[Li, Jing; Song, Jun; Rychahou, Piotr; Starr, Marlene E.; Kim, Ji Tae; Harris, Jennifer W.; Evers, B. Mark] Univ Kentucky, Dept Surg, Lexington, KY 40536 USA; [Li, Jing; Song, Jun; Zaytseva, Yekaterina Y.; Liu, Yajuan; Rychahou, Piotr; Jiang, Kai; Kim, Ji Tae; Harris, Jennifer W.; Fahrenholz, Timothy; Higashi, Richard M.; Gao, Tianyan; Fan, Teresa W. -M.; Weiss, Heidi L.; Jia, Jianhang; Evers, B. Mark] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA; [Zaytseva, Yekaterina Y.; Fahrenholz, Timothy; Higashi, Richard M.; Fan, Teresa W. -M.] Univ Kentucky, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA; [Yiannikouris, Frederique B.; Katz, Wendy S.; Cassis, Lisa A.] Univ Kentucky, Dept Pharmacol & Nutr Sci, Lexington, KY 40536 USA; [Nilsson, Peter M.; Orho-Melander, Marju; Melander, Olle] Lund Univ, Dept Clin Sci, S-22100 Lund, Sweden; [Nilsson, Peter M.; Melander, Olle] Skane Univ Hosp, Dept Internal Med, S-20502 Malmo, Sweden; [Chen, Jing; Zhu, Haining; Gao, Tianyan; Jia, Jianhang] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Chen, Jing; Zhu, Haining] Univ Kentucky, Struct Biol Ctr, Lexington, KY 40536 USA; [Fahrenholz, Timothy; Higashi, Richard M.; Fan, Teresa W. -M.] Univ Kentucky, Ctr Environm & Syst Biochem, Lexington, KY 40536 USA; [Morris, Andrew J.] Univ Kentucky, Gill Heart Inst, Div Cardiovasc Med, Lexington, KY 40536 USA; [Morris, Andrew J.] Lexington Vet Affairs Med Ctr, Lexington, KY 40536 USA; [Weiss, Heidi L.] Univ Kentucky, Dept Biostat, Lexington, KY 40536 USA; [Dobner, Paul R.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01655 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; Lund University; Lund University; Skane University Hospital; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center; University of Kentucky; University of Massachusetts System; University of Massachusetts Worcester	Evers, BM (corresponding author), Univ Kentucky, Dept Surg, Lexington, KY 40536 USA.; Evers, BM (corresponding author), Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA.	mark.evers@uky.edu	Zhu, Haining/A-6076-2008	Zhu, Haining/0000-0001-5498-6694; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Melander, Olle/0000-0002-2581-484X; Katz, Wendy/0000-0003-3038-6314; Rychahou, Piotr/0000-0001-7352-9122; Jiang, Kai/0000-0002-8507-1945	National Cancer Institute [P30 CA177558]; National Institutes of Health (NIH) [R37 AG10885, R01 DK048498, R01 GM079684, U24 DK097215, R01 ES022191, P01 CA163223, P20 GM103527, R01 HL120507, RO1 NS077284, R01 HL073085]; Swedish National Research Council; Swedish Heart-Lung Foundation; Novo Nordisk Foundation; Swedish Diabetes Association; Region Skane, ALF; European Research Council [StG-2011-282255]; Markey Cancer Foundation; NIH [T32 CA165990, T32 CA160003]; National Center for Research Resources [S10 RR029127]; Novo Nordisk Fonden [NNF14OC0011049, NNF16OC0021370, NNF15OC0016320] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [T32CA160003, T32CA165990, P01CA163223, P30CA177558] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029127] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073085, R01HL120507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048498, U24DK097215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103527, R01GM079684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG010885] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish National Research Council; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Diabetes Association; Region Skane, ALF; European Research Council(European Research Council (ERC)European Commission); Markey Cancer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank D. A. Gilbreath, C. E. Anthony, H. N. Russell-Simmons and J. F. Rogers for manuscript preparation; D. Napier for tissue sectioning and staining; G. Epperly for intestinal crypt measurements and the use of the Aperio ScanScope; E. Y. Lee for consultation and assessment of histological sections and immunohistochemistry; R. Carraway and P. Forgez for their suggestions and helpful advice; J. Ambati and K. Grzech for their review of the manuscript; J. Young Kwon for the Gr36C-Gal4 line, M. Vidal for the voila-Gal4 line, N. Perrimon and T.Ip for the TKg-Gal4 line, and S. Hou for MyoIA-Gal4 and Esg-Gal4 lines; the Bloomington Stock Center, Vienna Drosophila RNAi Center (VDRC) and TRiP at Harvard Medical School for fly stocks; the Developmental Studies Hybridoma Bank (DSHB) for antibodies; B. Gebelein for the anti-HNF4 antibody; the Biospecimen and Tissue Procurement, Redox Metabolism, and Biostatistics and Bioinformatics Shared Resource Facilities of the University of Kentucky Markey Cancer Center (supported by National Cancer Institute grant P30 CA177558). This study was further supported by National Institutes of Health (NIH) grants R37 AG10885 and R01 DK048498 to B. M. E.; R01 GM079684 to J. J.; U24 DK097215, R01 ES022191, P01 CA163223 and P20 GM103527 to T. W.-M. F. and R. M. H.; R01 HL120507 to A. J. M.; RO1 NS077284 to H.Z.; R01 HL073085 and P20 GM103527 to L.A.C. O.M., P. M. N. and M.O.-M. are funded by the Swedish National Research Council; the Swedish Heart-Lung Foundation; Novo Nordisk Foundation; Swedish Diabetes Association; Region Skane, ALF; and European Research Council grant StG-2011-282255. B. M. E. is also supported by the Markey Cancer Foundation. Y. Y. Z. and J.W.H. are supported by NIH postdoctoral training grants T32 CA165990 and T32 CA160003, respectively. The LC-MS/MS equipment was acquired using a National Center for Research Resources High-End Instrumentation grant (S10 RR029127 to H.Z.).	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Alfa RW, 2015, CELL METAB, V21, P323, DOI 10.1016/j.cmet.2015.01.006; Amcheslavsky A, 2014, CELL REP, V9, P32, DOI 10.1016/j.celrep.2014.08.052; Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; ARMSTRONG MJ, 1986, AM J PHYSIOL, V251, pG823, DOI 10.1152/ajpgi.1986.251.6.G823; BERGLUND G, 1993, J INTERN MED, V233, P39; Birse RT, 2010, CELL METAB, V12, P533, DOI 10.1016/j.cmet.2010.09.014; Boules M, 2000, BRAIN RES, V865, P35, DOI 10.1016/S0006-8993(00)02187-9; Cooke JH, 2009, OBESITY, V17, P1135, DOI 10.1038/oby.2008.652; Dobner PR, 2001, P NATL ACAD SCI USA, V98, P8048, DOI 10.1073/pnas.141042198; Enhorning S, 2010, CIRCULATION, V121, P2102, DOI 10.1161/CIRCULATIONAHA.109.909663; Ernst A, 2006, PEPTIDES, V27, P1787, DOI 10.1016/j.peptides.2006.01.021; Evers BM, 2006, PEPTIDES, V27, P2424, DOI 10.1016/j.peptides.2006.01.028; Fadel J, 2001, NEUROSCI LETT, V303, P17, DOI 10.1016/S0304-3940(01)01708-6; Fadel J, 2006, NEUROSCI LETT, V402, P97, DOI 10.1016/j.neulet.2006.03.043; Fan TWM, 2011, METABOLOMICS, V7, P257, DOI 10.1007/s11306-010-0249-0; FERRIS CF, 1981, PEPTIDES, V2, P263, DOI 10.1016/0196-9781(81)90042-5; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Gutzwiller LM, 2010, DEV BIOL, V348, P231, DOI 10.1016/j.ydbio.2010.09.014; Hardie DG, 2015, CURR OPIN CELL BIOL, V33, P1, DOI 10.1016/j.ceb.2014.09.004; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Hipkiss AR, 2007, MECH AGEING DEV, V128, P412, DOI 10.1016/j.mad.2007.03.002; Jia H, 2009, DEVELOPMENT, V136, P307, DOI 10.1242/dev.030015; Jiang HQ, 2009, DEVELOPMENT, V136, P483, DOI 10.1242/dev.026955; Jiang K, 2014, P NATL ACAD SCI USA, V111, pE4842, DOI 10.1073/pnas.1417147111; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lane AN, 2009, ANAL CHIM ACTA, V651, P201, DOI 10.1016/j.aca.2009.08.032; Li J, 2007, MOL ENDOCRINOL, V21, P159, DOI 10.1210/me.2006-0340; Li J, 2012, MOL ENDOCRINOL, V26, P1380, DOI 10.1210/me.2012-1024; Li J, 2011, AM J PHYSIOL-CELL PH, V301, pC213, DOI 10.1152/ajpcell.00067.2011; Lim CT, 2010, J MOL ENDOCRINOL, V44, P87, DOI 10.1677/JME-09-0063; Liu YJ, 2007, GENE DEV, V21, P1949, DOI 10.1101/gad.1557407; Martin S, 2002, GASTROENTEROLOGY, V123, P1135, DOI 10.1053/gast.2002.36000; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Melander O, 2012, JAMA-J AM MED ASSOC, V308, P1469, DOI 10.1001/jama.2012.12998; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; MOOLENBEEK C, 1981, LAB ANIM, V15, P57, DOI 10.1258/002367781780958577; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Onono F, 2013, J BIOL CHEM, V288, P27444, DOI 10.1074/jbc.M113.482307; OWENS RB, 1976, J NATL CANCER I, V56, P843, DOI 10.1093/jnci/56.4.843; Palanker L, 2009, CELL METAB, V9, P228, DOI 10.1016/j.cmet.2009.01.009; Park JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029022; Park JH, 2011, MOL CELLS, V32, P375, DOI 10.1007/s10059-011-0128-1; Park Y, 2002, P NATL ACAD SCI USA, V99, P11423, DOI 10.1073/pnas.162276199; Persson M, 2008, ATHEROSCLEROSIS, V200, P191, DOI 10.1016/j.atherosclerosis.2007.12.001; Piliponsky AM, 2008, NAT MED, V14, P392, DOI 10.1038/nm1738; POLAK JM, 1977, NATURE, V270, P183, DOI 10.1038/270183a0; Rabinowich L, 2015, J HEPATOL, V62, P175, DOI 10.1016/j.jhep.2014.08.030; Racioppi L, 2012, J BIOL CHEM, V287, P31658, DOI 10.1074/jbc.R112.356485; Reiher W, 2011, J PROTEOME RES, V10, P1881, DOI 10.1021/pr101116g; Sahu A, 2001, BRAIN RES, V888, P343, DOI 10.1016/S0006-8993(00)03107-3; Salous AK, 2013, J LIPID RES, V54, P2775, DOI 10.1194/jlr.M039685; Scopelliti A, 2014, CURR BIOL, V24, P1199, DOI 10.1016/j.cub.2014.04.007; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Song J, 2006, AM J PHYSIOL-CELL PH, V290, pC1469, DOI 10.1152/ajpcell.00486.2005; Song W, 2014, CELL REP, V9, P40, DOI 10.1016/j.celrep.2014.08.060; STEINBERG R, 1994, NEUROSCIENCE, V59, P921, DOI 10.1016/0306-4522(94)90295-X; Stenesen D, 2013, CELL METAB, V17, P101, DOI 10.1016/j.cmet.2012.12.006; Vincent JP, 1999, TRENDS PHARMACOL SCI, V20, P302, DOI 10.1016/S0165-6147(99)01357-7; Wang P, 2010, J CELL PHYSIOL, V222, P33, DOI 10.1002/jcp.21928; Xue BZ, 2006, J PHYSIOL-LONDON, V574, P73, DOI 10.1113/jphysiol.2006.113217; Yang LQ, 2014, P NATL ACAD SCI USA, V111, P17809, DOI 10.1073/pnas.1414004111; Yiannikouris F, 2012, AM J PHYSIOL-REG I, V302, pR244, DOI 10.1152/ajpregu.00323.2011	64	157	160	3	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					411	+		10.1038/nature17662	http://dx.doi.org/10.1038/nature17662			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0AH	27193687	Green Accepted			2022-12-28	WOS:000376004300052
J	Miner, JJ; Cao, B; Govero, J; Smith, AM; Fernandez, E; Cabrera, OH; Garber, C; Noll, M; Klein, RS; Noguchi, KK; Mysorekar, IU; Diamond, MS				Miner, Jonathan J.; Cao, Bin; Govero, Jennifer; Smith, Amber M.; Fernandez, Estefania; Cabrera, Omar H.; Garber, Charise; Noll, Michelle; Klein, Robyn S.; Noguchi, Kevin K.; Mysorekar, Indira U.; Diamond, Michael S.			Zika Virus Infection during Pregnancy in Mice Causes Placental Damage and Fetal Demise	CELL			English	Article							DETERMINANTS; TROPHOBLAST; BRAZIL; BRAIN	Zika virus (ZIKV) infection in pregnant women causes intrauterine growth restriction, spontaneous abortion, and microcephaly. Here, wedescribe two mouse models of placental and fetal disease associated with in utero transmission of ZIKV. Female mice lacking type I interferon signaling (Ifnar1(-/-)) crossed to wild-type (WT) males produced heterozygous fetuses resembling the immune status of human fetuses. Maternal inoculation at embryonic day 6.5 (E6.5) or E7.5 resulted in fetal demise that was associated with ZIKV infection of the placenta and fetal brain. We identified ZIKV within trophoblasts of the maternal and fetal placenta, consistent with a transplacental infection route. Antibody blockade of Ifnar1 signaling in WT pregnant mice enhanced ZIKV trans-placental infection although it did not result in fetal death. These models will facilitate the study of ZIKV pathogenesis, in utero transmission, and testing of therapies and vaccines to prevent congenital malformations.	[Miner, Jonathan J.; Govero, Jennifer; Smith, Amber M.; Fernandez, Estefania; Garber, Charise; Noll, Michelle; Klein, Robyn S.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Klein, Robyn S.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Klein, Robyn S.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Fernandez, Estefania; Klein, Robyn S.; Mysorekar, Indira U.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Cao, Bin; Mysorekar, Indira U.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; [Cabrera, Omar H.; Noguchi, Kevin K.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Mysorekar, IU; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Mysorekar, IU (corresponding author), Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.	mysorekari@wudosis.wustl.edu; diamond@borcim.wustl.edu	Mysorekar, Indira U./GRS-4574-2022; Diamond, Michael/AAH-1733-2019	Mysorekar, Indira U./0000-0003-3917-8677; Diamond, Michael/0000-0002-8791-3165; Cabrera, Omar/0000-0002-9501-6720	NIH [R01 AI073755, R01 AI104972, R01 HD052664, R01 NS052632]; Intellectual and Developmental Disabilities Research Center at Washington University (NIH/NICHD) [U54 HD087011]; Rheumatology Research Foundation Scientist Development Award; NIH Pre-doctoral training grant award [T32 AI007163]; NIH Research Education Program [R25 HG006687]; Preventing Prematurity Initiative grant from the Burroughs Wellcome Fund; Prematurity Research Initiative Investigator award from the March of Dimes; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD087011, R01HD052664] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R25HG006687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083019, R01AI104972, T32AI007163, R01AI073755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052632] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intellectual and Developmental Disabilities Research Center at Washington University (NIH/NICHD); Rheumatology Research Foundation Scientist Development Award; NIH Pre-doctoral training grant award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Research Education Program; Preventing Prematurity Initiative grant from the Burroughs Wellcome Fund; Prematurity Research Initiative Investigator award from the March of Dimes; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the NIH (R01 AI073755 and R01 AI104972 to M.S.D., R01 HD052664 to K.K.N., and R01 NS052632 to R.S.K.) and the Intellectual and Developmental Disabilities Research Center at Washington University (NIH/NICHD U54 HD087011). J.J.M., E.F., and D.J.P. were supported by a Rheumatology Research Foundation Scientist Development Award, NIH Pre-doctoral training grant award (T32 AI007163), and the NIH Research Education Program (R25 HG006687), respectively. The work also was supported by a Preventing Prematurity Initiative grant from the Burroughs Wellcome Fund and a Prematurity Research Initiative Investigator award from the March of Dimes (to I.U.M). We thank Wandy Betty for her TEM assistance, Fredrik Kraus for his expertise in placental pathology, and Justin Richner for advice with establishing the RNA FISH assays. Finally, we acknowledge Xavier de Lamballerie (Emergence des Pathologies Virales, Aix-Marseille Universite, Marseille, France) and the European Virus Archive goes Global (EVAg) for consenting to the use of H/PF/2013 ZIKV strain for this study under a material transfer agreement with the EVAg parter, Aix-Marseille Universite. M.S.D. is a consultant for Inbios, Visterra, and Takeda Pharmaceuticals and on the Scientific Advisory Boards of Moderna and OraGene.	Allison SL, 2003, J VIROL, V77, P11357, DOI 10.1128/JVI.77.21.11357-11366.2003; ANDERSEN AA, 1975, INFECT IMMUN, V12, P1173, DOI 10.1128/IAI.12.5.1173-1183.1975; [Anonymous], 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.18655, 10.1001/jama.2016.19328]; Arechavaleta-Velasco F, 2002, J REPROD IMMUNOL, V55, P113, DOI 10.1016/S0165-0378(01)00143-7; Baronti C, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00500-14; Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Brien James D, 2013, Curr Protoc Microbiol, V31, DOI 10.1002/9780471729259.mc15d03s31; Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5; Cao B, 2014, PLACENTA, V35, P139, DOI 10.1016/j.placenta.2013.12.007; Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964; Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1135; CHATURVEDI UC, 1980, J INFECT DIS, V141, P712, DOI 10.1093/infdis/141.6.712; CHERVENAK FA, 1987, OBSTET GYNECOL, V69, P908; Delorme-Axford E, 2014, ANNU REV VIROL, V1, P133, DOI 10.1146/annurev-virology-031413-085524; Edwards MS, 2015, PEDIATR DEVEL PATHOL, V18, P155, DOI 10.2350/14-09-1548-CR.1; Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010; Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16; Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; Oehler E, 2013, EUROSURVEILLANCE, V19, P20720, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720; Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06; Pinto AK, 2015, MBIO, V6, DOI 10.1128/mBio.01316-15; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006; Rossi SL, 2016, AM J TROP MED HYG, DOI [10.4269/ajtmh.16-0111, DOI 10.4269/AJTMH.16-0111, 10.4269/ajtmh.16-0111.]; Sarathy VV, 2015, J VIROL, V89, P1254, DOI 10.1128/JVI.01320-14; Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804; Sheehan KCF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128636; Simmons DG, 2005, DEV BIOL, V284, P12, DOI 10.1016/j.ydbio.2005.05.010; Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Zeldovich VB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002804	43	587	606	7	195	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2016	165	5					1080	1090		10.1016/j.cell.2016.05.008	http://dx.doi.org/10.1016/j.cell.2016.05.008			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DM6QT	27180225	Bronze, Green Accepted			2022-12-28	WOS:000376478200010
J	Santisteban, JVH; Knigge, C; Littlefair, SP; Breton, RP; Dhillon, VS; Gansicke, BT; Marsh, TR; Pretorius, ML; Southworth, J; Hauschildt, PH				Santisteban, Juan V. Hernandez; Knigge, Christian; Littlefair, Stuart P.; Breton, Rene P.; Dhillon, Vikram S.; Gansicke, Boris T.; Marsh, Thomas R.; Pretorius, Magaretha L.; Southworth, John; Hauschildt, Peter H.			An irradiated brown-dwarf companion to an accreting white dwarf	NATURE			English	Article							CATACLYSMIC VARIABLES; MODEL ATMOSPHERES; THERMAL STRUCTURE; MASS DONOR; STARS; EVOLUTION	Interacting compact binary systems provide a natural laboratory in which to study irradiated substellar objects. As the mass-losing secondary (donor) in these systems makes a transition from the stellar to the substellar regime, it is also irradiated by the primary (compact accretor)(1,2). The internal and external energy fluxes are both expected to be comparable in these objects, providing access to an unexplored irradiation regime. The atmospheric properties of donors are largely unknown(3), but could be modified by the irradiation. To constrain models of donor atmospheres, it is necessary to obtain accurate observational estimates of their physical properties (masses, radii, temperatures and albedos). Here we report the spectroscopic detection and characterization of an irradiated substellar donor in an accreting white-dwarf binary system. Our near-infrared observations allow us to determine a model-independent mass estimate for the donor of 0.055 +/- 0.008 solar masses and an average spectral type of L1 +/- 1, supporting both theoretical predictions and model-dependent observational constraints that suggest that the donor is a brown dwarf. Our time-resolved data also allow us to estimate the average irradiation-induced temperature difference between the dayside and nightside of the substellar donor (57 kelvin) and the maximum difference between the hottest and coolest parts of its surface (200 kelvin). The observations are well described by a simple geometric reprocessing model with a bolometric (Bond) albedo of less than 0.54 at the 2 sigma confidence level, consistent with high reprocessing efficiency, but poor lateral heat redistribution in the atmosphere of the brown-dwarf donor(4,5). These results add to our knowledge of binary evolution, in that the donor has survived the transition from the stellar to the substellar regime, and of substellar atmospheres, in that we have been able to test a regime in which the irradiation and the internal energy of a brown dwarf are comparable.	[Santisteban, Juan V. Hernandez; Knigge, Christian; Breton, Rene P.] Univ Southampton, Dept Phys & Astron, Southampton SO17 1BJ, Hants, England; [Littlefair, Stuart P.; Dhillon, Vikram S.] Univ Sheffield, Dept Phys & Astron, Sheffield S3 7RH, S Yorkshire, England; [Breton, Rene P.] Univ Manchester, Sch Phys & Astron, Jodrell Bank, Ctr Astrophys, Manchester M13 9PL, Lancs, England; [Dhillon, Vikram S.] Inst Astrofis Canarias, E-38205 San Cristobal la Laguna, Santa Cruz De T, Spain; [Gansicke, Boris T.; Marsh, Thomas R.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England; [Pretorius, Magaretha L.] Univ Oxford, Dept Phys, Denys Wilkinson Bldg,Keble Rd, Oxford OX1 3RH, England; [Southworth, John] Keele Univ, Astrophys Grp, Newcastle Upon Tyne ST5 5BG, Tyne & Wear, England; [Hauschildt, Peter H.] Hamburger Sternwarte, Gojenbergsweg 112, D-21029 Hamburg, Germany	University of Southampton; University of Sheffield; University of Manchester; Jodrell Bank Centre for Astrophysics; Instituto de Astrofisica de Canarias; University of Warwick; University of Oxford; Keele University; University of Hamburg	Santisteban, JVH (corresponding author), Univ Southampton, Dept Phys & Astron, Southampton SO17 1BJ, Hants, England.	j.v.hernandez@soton.ac.uk	Santisteban, Juan Venancio Hernandez/M-6218-2019; Breton, Rene P/A-5536-2017; Gaensicke, Boris T/A-9421-2012; Dhillon, Vikram/AAB-5180-2019; Breton, Rene/AAA-7257-2020	Breton, Rene P/0000-0001-8522-4983; Gaensicke, Boris T/0000-0002-2761-3005; Dhillon, Vikram/0000-0003-4236-9642; Breton, Rene/0000-0001-8522-4983; Knigge, Christian/0000-0002-1116-2553; Littlefair, Stuart/0000-0001-7221-855X; Pretorius, Magaretha/0000-0001-6017-9522; Hernandez Santisteban, Juan Venancio/0000-0002-6733-5556	CONACyT (Mexico); University of Southampton; Royal Astronomical Society; European Union [PIIF-GA-2012-332393]; ERC [320964]; Office of Science of the US Department of Energy [DE-AC03-76SF00098]; STFC [ST/L000733/1, ST/H005307/1, ST/M002012/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/L000733/1, ST/M002012/1, ST/H005307/1] Funding Source: researchfish	CONACyT (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of Southampton; Royal Astronomical Society; European Union(European Commission); ERC(European Research Council (ERC)European Commission); Office of Science of the US Department of Energy(United States Department of Energy (DOE)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work is based on observations made with ESO Telescopes at the La Silla Paranal Observatory under programme ID 085.D-0489. J.V.H.S. acknowledges support via studentships from CONACyT (Mexico) and the University of Southampton, as well as research support by the Royal Astronomical Society. R.P.B. has received funding from the European Union Eleventh Framework Programme under grant agreement PIIF-GA-2012-332393. B.T.G. was supported by ERC grant agreement number 320964. P.H.H. acknowledges computing time allocations at the Hochstleistungs Rechenzentrum Nord (HLRN), at the Regionales Rechenzentrum of the University of Hamburg and at the National Energy Research Supercomputer Center (NERSC), which is supported by the Office of Science of the US Department of Energy under contract number DE-AC03-76SF00098.	Arras P, 2006, ASTROPHYS J, V650, P394, DOI 10.1086/506011; Barman TS, 2004, ASTROPHYS J, V614, P338, DOI 10.1086/423661; Breton RP, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/2/115; Burgasser A. J., 2007, PROTOSTARS PLANETS, P427; CHANAN GA, 1976, ASTROPHYS J, V208, P512, DOI 10.1086/154633; Cowan NB, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/54; Cushing MC, 2005, ASTROPHYS J, V623, P1115, DOI 10.1086/428040; Gansicke BT, 2009, MON NOT R ASTRON SOC, V397, P2170, DOI 10.1111/j.1365-2966.2009.15126.x; HUBENY I, 1995, ASTROPHYS J, V439, P875, DOI 10.1086/175226; Knigge C, 2006, MON NOT R ASTRON SOC, V373, P484, DOI 10.1111/j.1365-2966.2006.11096.x; Knigge C, 2011, ASTROPHYS J SUPPL S, V194, DOI 10.1088/0067-0049/194/2/28; Littlefair SP, 2008, MON NOT R ASTRON SOC, V388, P1582, DOI 10.1111/j.1365-2966.2008.13539.x; Littlefair SP, 2006, SCIENCE, V314, P1578, DOI 10.1126/science.1133333; Littlefair SP, 2013, MON NOT R ASTRON SOC, V431, P2820, DOI 10.1093/mnras/stt378; LUCY LB, 1967, Z ASTROPHYS, V65, P89; Nordhaus J, 2013, MON NOT R ASTRON SOC, V432, P500, DOI 10.1093/mnras/stt569; Perez-Becker D, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/2/134; Politano M, 2004, ASTROPHYS J, V604, P817, DOI 10.1086/381958; Ritter H, 2000, ASTRON ASTROPHYS, V360, P969; Rucinski S. M., 1969, ACTA ASTRON, V19, P245; Savoury CDJ, 2011, MON NOT R ASTRON SOC, V415, P2025, DOI 10.1111/j.1365-2966.2011.18707.x; Showman AP, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/2/85; Stevenson KB, 2014, SCIENCE, V346, P838, DOI 10.1126/science.1256758; Szkody P, 2007, ASTRON J, V134, P185, DOI 10.1086/518506; Tulloch SM, 2009, MON NOT R ASTRON SOC, V397, pL82, DOI 10.1111/j.1745-3933.2009.00689.x; Uthas H, 2011, MON NOT R ASTRON SOC, V414, pL85, DOI 10.1111/j.1745-3933.2011.01061.x; Vernet J, 2011, ASTRON ASTROPHYS, V536, DOI 10.1051/0004-6361/201117752; Zorotovic M, 2011, ASTRON ASTROPHYS, V536, DOI 10.1051/0004-6361/201116626	28	31	31	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					366	+		10.1038/nature17952	http://dx.doi.org/10.1038/nature17952			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0AH	27193683	Green Accepted, Green Submitted			2022-12-28	WOS:000376004300042
J	Tatar, M; Sedivy, JM				Tatar, Marc; Sedivy, John M.			Mitochondria: Masters of Epigenetics	CELL			English	Editorial Material							LONGEVITY	Accumulating evidence argues that aging exerts a profound influence on epigenetics, and vice versa. A pair of studies by Merkwirth et al. and Tian et al. now provide insights on how mitochondrial stress experienced by C. elegans larvae propagates a specific and persistent epigenetic response that protects adult cells and extends lifespan.	[Tatar, Marc] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Sedivy, John M.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA	Brown University; Brown University	Sedivy, JM (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA.	john_sedivy@brown.edu		Tatar, Marc/0000-0003-3232-6884	NIA NIH HHS [R37 AG016694, R01 AG016694, R37 AG024360] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R37AG016694, R01AG016694, R37AG024360] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Andreux PA, 2012, CELL, V150, P1287, DOI 10.1016/j.cell.2012.08.012; Brignull HR, 2006, J NEUROSCI, V26, P7597, DOI 10.1523/JNEUROSCI.0990-06.2006; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Merkwirth C, 2016, CELL, V165, P1209, DOI 10.1016/j.cell.2016.04.012; Shore DE, 2013, TRENDS CELL BIOL, V23, P409, DOI 10.1016/j.tcb.2013.04.007; Sun L, 2009, J GERONTOL A-BIOL, V64, P711, DOI 10.1093/gerona/glp051; Tian Y, 2016, CELL, V165, P1197, DOI 10.1016/j.cell.2016.04.011	9	18	20	2	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2016	165	5					1052	1054		10.1016/j.cell.2016.05.021	http://dx.doi.org/10.1016/j.cell.2016.05.021			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DM6QT	27203109	Green Accepted, Bronze			2022-12-28	WOS:000376478200007
J	Bell, J				Bell, John			10 years of the UK's National Institute for Health Research	LANCET			English	Editorial Material									[Bell, John] Univ Oxford, Off Regius Prof Med, Oxford OX3 7DG, England	University of Oxford	Bell, J (corresponding author), Univ Oxford, Off Regius Prof Med, Oxford OX3 7DG, England.	regius@medsci.ox.ac.uk						Academy of Medical Sciences, 2003, STRENGTH CLIN RES RE; Association of the British Pharmaceutical Industry, 2011, ABPI WHIT PAP VIS RE; Canadian Institutes of Health Research, 2006, CIHR YEAR 5 INT REV; Cooksey D., 2006, REV UK HLTH RES FUND; National Institute for Health Research, 2015, GROWTH HLTH RES NIHR; National Institute for Health Research, 2014, NIHR ANN REP 2014 20	6	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 14	2016	387	10032					1978	1979		10.1016/S0140-6736(16)30479-2	http://dx.doi.org/10.1016/S0140-6736(16)30479-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DL8HJ	27203755				2022-12-28	WOS:000375881500008
J	Boseley, S				Boseley, Sarah			Sally Davies: CMO, scientist, and campaigner	LANCET			English	Editorial Material																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 14	2016	387	10032					1987	1987		10.1016/S0140-6736(16)30473-1	http://dx.doi.org/10.1016/S0140-6736(16)30473-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8HJ	27203760				2022-12-28	WOS:000375881500014
J	Watts, G				Watts, Geoff			Charles Sidney Hirsch Obituary	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 14	2016	387	10032					1992	1992		10.1016/S0140-6736(16)30477-9	http://dx.doi.org/10.1016/S0140-6736(16)30477-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8HJ	27203764	Bronze			2022-12-28	WOS:000375881500016
J	Holmes, D				Holmes, David			A NEW CHAPTER IN INNOVATION	NATURE			English	Editorial Material																			0	8	8	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					S54	S55		10.1038/533S54a	http://dx.doi.org/10.1038/533S54a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM0BJ	27167390	Bronze			2022-12-28	WOS:000376007200001
J	Welbourn, R; le Roux, CW; Owen-Smith, A; Wordsworth, S; Blazeby, JM				Welbourn, Richard; le Roux, Carel W.; Owen-Smith, Amanda; Wordsworth, Sarah; Blazeby, Jane M.			Why the NHS should do more bariatric surgery; how much should we do?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TYPE-2 DIABETES-MELLITUS; SWEDISH OBESE SUBJECTS; PUBLIC-HEALTH; WEIGHT; MANAGEMENT; TRIAL; INTERVENTION; GUIDANCE; ENGLAND; COHORT		[Welbourn, Richard] Musgrove Pk Hosp, Dept Upper Gastrointestinal & Bariatr Surg, Taunton TA1 5DA, Somerset, England; [le Roux, Carel W.] Univ Coll Dublin, Conway Inst, Diabet Complicat Res Ctr, Dublin, Ireland; [Owen-Smith, Amanda] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Wordsworth, Sarah] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Blazeby, Jane M.] Univ Bristol, Sch Social & Community Med, Surg Res Ctr, Bristol BS8 1TH, Avon, England	Musgrove Park Hospital; University College Dublin; University of Bristol; University of Oxford; University of Bristol	Welbourn, R (corresponding author), Musgrove Pk Hosp, Dept Upper Gastrointestinal & Bariatr Surg, Taunton TA1 5DA, Somerset, England.	Richard.Welbourn@tst.nhs.uk	Blazeby, Jane/H-6703-2019	Blazeby, Jane/0000-0002-3354-3330; Le Roux, Carel/0000-0001-5521-5445; Wordsworth, Sarah/0000-0002-2361-3040	National Institute for Health Research [NF-SI-0514-10114, 09/127/53] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Ahmad Ahmir, 2014, JRSM Open, V5, p2042533313512479, DOI [10.1177/2042533313517689, 10.1177/2042533313512479]; Angrisani L, 2015, OBES SURG, V25, P1822, DOI 10.1007/s11695-015-1657-z; Colquitt JL, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003641.pub4; Courcoulas AP, 2015, JAMA SURG, V150, P931, DOI 10.1001/jamasurg.2015.1534; Eliasson B, 2015, LANCET DIABETES ENDO, V3, P847, DOI 10.1016/S2213-8587(15)00334-4; Fildes A, 2015, AM J PUBLIC HEALTH, V105, pE54, DOI 10.2105/AJPH.2015.302773; Gatineau M., 2014, ADULT OBESITY TYPE 2; Global Health Observatory Data Repository, TOT EXP HLTH PROP GD; Hawkins SC, 2007, OBES SURG, V17, P434, DOI 10.1007/s11695-007-9073-7; Holman N, 2011, DIABETIC MED, V28, P575, DOI 10.1111/j.1464-5491.2010.03216.x; Jennings A, 2014, CLIN OBES, V4, P254, DOI 10.1111/cob.12066; Keating C, 2015, LANCET DIABETES ENDO, V3, P855, DOI 10.1016/S2213-8587(15)00290-9; Klein S, 2011, OBESITY, V19, P581, DOI 10.1038/oby.2010.199; Lewis E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g6845; Mahawar KK, 2015, OBES SURG, V25, P1527, DOI 10.1007/s11695-015-1738-z; Marsh K, 2013, J PUBLIC HEALTH-UK, V35, P460, DOI 10.1093/pubmed/fds099; Miras AD, 2015, DIABETOLOGIA, V58, P1443, DOI 10.1007/s00125-015-3595-7; National Bariatric Surgery Registry, 2014, PUBL SURG LEV DAT PU; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; NHS England, 2013, CLIN COMM POL COMPL; NICE, 2014, OB ID ASS MAN; OECD, 2014, HLTH GLANC EUR 2014, DOI [10.1787/health_glance_eur-2014-23-en, DOI 10.1787/HEALTH_GLANCE_EUR-2014-23-EN]; Owen-Smith Amanda, 2013, BMJ, V346, pf2453, DOI 10.1136/bmj.f2453; Owen-Smith A, 2014, QUAL HEALTH RES, V24, P1212, DOI 10.1177/1049732314544908; Pi-Sunyer X, 2015, NEW ENGL J MED, V373, P11, DOI 10.1056/NEJMoa1411892; Picot J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13410; Rubino F, 2014, ANN SURG, V259, P117, DOI 10.1097/SLA.0b013e3182759656; Scandinavian Obesity Surgery Registry (SOREG), 2014 REPORT 2015 09; Sjostrom L, 2013, J INTERN MED, V273, P219, DOI 10.1111/joim.12012; Stegenga H, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6608; Teachman BA, 2001, INT J OBESITY, V25, P1525, DOI 10.1038/sj.ijo.0801745; Welbourn R, 2014, NATL BARIATRIC SURG; Welbourn R, 2016, OBES SURG, V26, P649, DOI 10.1007/s11695-015-2041-8; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914	34	44	44	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 11	2016	353								i1472	10.1136/bmj.i1472	http://dx.doi.org/10.1136/bmj.i1472			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6FR	27169605	Green Submitted			2022-12-28	WOS:000376446500001
J	Gulland, A				Gulland, Anne			BRIEFING How "Brexit" might affect the pharmaceutical industry	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												agulland@bmj.com						[Anonymous], 2015, PHARM EXEC      0621; BioIndustry Association, 2016, BIA RESP S T COMM IN; SmithKline Glaxo, 2016, GLAX SMITHKLINE ANN	3	5	5	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 10	2016	353								i2615	10.1136/bmj.i2615	http://dx.doi.org/10.1136/bmj.i2615			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6FP	27164898				2022-12-28	WOS:000376446300004
J	Mehrotra, A; Jena, AB; Busch, AB; Souza, J; Uscher-Pines, L; Landon, BE				Mehrotra, Ateev; Jena, Anupam B.; Busch, Alisa B.; Souza, Jeffrey; Uscher-Pines, Lori; Landon, Bruce E.			Utilization of Telemedicine Among Rural Medicare Beneficiaries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Mehrotra, Ateev; Jena, Anupam B.; Souza, Jeffrey; Landon, Bruce E.] Harvard Univ, Sch Med, Boston, MA USA; [Busch, Alisa B.] McLean Hosp, 115 Mill St, Belmont, MA 02178 USA; [Uscher-Pines, Lori] RAND Corp, Arlington, VA USA	Harvard University; Harvard Medical School; Harvard University; McLean Hospital; RAND Corporation	Mehrotra, A (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	mehrotra@hcp.med.harvard.edu	Busch, Alisa/AAA-4885-2021; Mehrotra, Ateev/AAO-8454-2021; Busch, Alisa/ABE-1524-2021	Mehrotra, Ateev/0000-0003-2223-1582; 	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017897] Funding Source: NIH RePORTER; NIH HHS [DP5 OD017897] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		American Telemedicine Association, STAT TEL GAPS AN COV; American Telemedicine Association, STAT TEL GAPS AN; BASHSHUR RL, 1995, J MED SYST, V19, P81, DOI 10.1007/BF02257059; Neufeld JD, 2016, TELEMED E-HEALTH, V22, P70, DOI 10.1089/tmj.2015.0044; US Department of Veterans Affairs, VA TEL SERV SERV 690	5	94	95	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 10	2016	315	18					2015	2016		10.1001/jama.2016.2186	http://dx.doi.org/10.1001/jama.2016.2186			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2JP	27163991	Green Accepted, Bronze			2022-12-28	WOS:000375461100020
J	Ni, XJ; Li, Q; Li, LZ; Beard, KC				Ni, Xijun; Li, Qiang; Li, Luzhou; Beard, K. Christopher			Oligocene primates from China reveal divergence between African and Asian primate evolution	SCIENCE			English	Article							OLD-WORLD MONKEYS; MIDDLE EOCENE; FOSSIL PRIMATE; BUGTI HILLS; PAKISTAN; MYANMAR; BIOGEOGRAPHY; BOUNDARY; ARABIA; ORIGIN	Profound environmental and faunal changes are associated with climatic deterioration during the Eocene-Oligocene transition (EOT) roughly 34 million years ago. Reconstructing how Asian primates responded to the EOT has been hindered by a sparse record of Oligocene primates on that continent. Here, we report the discovery of a diverse primate fauna from the early Oligocene of southern China. In marked contrast to Afro-Arabian Oligocene primate faunas, this Asian fauna is dominated by strepsirhines. There appears to be a strong break between Paleogene and Neogene Asian anthropoid assemblages. Asian and Afro-Arabian primate faunas responded differently to EOT climatic deterioration, indicating that the EOT functioned as a critical evolutionary filter constraining the subsequent course of primate evolution across the Old World.	[Ni, Xijun; Li, Qiang; Li, Luzhou] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol IVPP, Key Lab Vertebrate Evolut & Human Origins, 142 Xi Zhi Men Wai St, Beijing 100044, Peoples R China; [Ni, Xijun; Li, Qiang] Chinese Acad Sci, Ctr Excellence Tibetan Plateau Earth Sci, Beijing 100101, Peoples R China; [Beard, K. Christopher] Univ Kansas, Biodivers Inst, 1345 Jayhawk Blvd, Lawrence, KS 66045 USA; [Beard, K. Christopher] Univ Kansas, Dept Ecol & Evolutionary Biol, 1345 Jayhawk Blvd, Lawrence, KS 66045 USA	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Chinese Academy of Sciences; University of Kansas; University of Kansas	Ni, XJ (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol IVPP, Key Lab Vertebrate Evolut & Human Origins, 142 Xi Zhi Men Wai St, Beijing 100044, Peoples R China.	nixijun@ivpp.ac.cn	Beard, K. Christopher/AAQ-4438-2021	Beard, K. Christopher/0000-0002-6279-9837; Li, luzhou/0000-0002-9453-6900	Strategic Priority Research Program of CAS [XDB03020501]; National Basic Research Program of China [2012CB821904]; CAS 100-talent Program; National Natural Science Foundation of China [41472025]; U.S. National Science Foundation [BCS 0820602, BCS 1441585, EAR 1543684]; Direct For Social, Behav & Economic Scie [1441585] Funding Source: National Science Foundation; Division Of Earth Sciences [1543684] Funding Source: National Science Foundation	Strategic Priority Research Program of CAS; National Basic Research Program of China(National Basic Research Program of China); CAS 100-talent Program(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Science Foundation(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This project has been supported by the Strategic Priority Research Program of CAS (CAS, XDB03020501), the National Basic Research Program of China (2012CB821904), the CAS 100-talent Program, the National Natural Science Foundation of China (41472025), and the U.S. National Science Foundation (BCS 0820602, BCS 1441585, and EAR 1543684). We thank Z. Yan, G. Wang, R. Li, and G. Li for their assistance in the field. The phylogenetic data used in the paper are archived in the supplementary materials.	Beard KC, 2008, P NATL ACAD SCI USA, V105, P3815, DOI 10.1073/pnas.0710180105; Beard KC, 2009, P ROY SOC B-BIOL SCI, V276, P3285, DOI 10.1098/rspb.2009.0836; Beard KC, 2004, J HUM EVOL, V46, P401, DOI 10.1016/j.jhevol.2004.01.002; BEARD KC, 1994, NATURE, V368, P604, DOI 10.1038/368604a0; Chaimanee Y, 2012, P NATL ACAD SCI USA, V109, P10293, DOI 10.1073/pnas.1200644109; GINGERICH PD, 1979, NATURE, V279, P415, DOI 10.1038/279415a0; Jaeger JJ, 1999, SCIENCE, V286, P528, DOI 10.1126/science.286.5439.528; Kohler M, 1999, P NATL ACAD SCI USA, V96, P14664, DOI 10.1073/pnas.96.25.14664; Licht A, 2014, NATURE, V513, P501, DOI 10.1038/nature13704; Maridet O, 2013, J VERTEBR PALEONTOL, V33, P185, DOI 10.1080/02724634.2012.710283; Marivaux L, 2001, SCIENCE, V294, P587, DOI 10.1126/science.1065257; Marivaux L, 2005, P NATL ACAD SCI USA, V102, P8436, DOI 10.1073/pnas.0503469102; Marivaux L, 2002, J HUM EVOL, V42, P379, DOI 10.1006/jhev.2001.0529; Meng J, 1998, NATURE, V394, P364, DOI 10.1038/28603; Morley RJ, 2011, S-P B ENVIRON SCI, P1; Ni X., 2015, PALAEOVERTEBRATA SIN, VIII, P284; Ni XJ, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)528[1:DOTFEC]2.0.CO;2; Ni XJ, 2010, P ROY SOC B-BIOL SCI, V277, P247, DOI 10.1098/rspb.2009.0173; Ni XJ, 2005, ANTHROPOL SCI, V113, P3, DOI 10.1537/ase.04S001; Samuels JX, 2015, AM J PHYS ANTHROPOL, V158, P43, DOI 10.1002/ajpa.22769; Seiffert ER, 2007, FOLIA PRIMATOL, V78, P314, DOI 10.1159/000105147; Seiffert ER, 2012, EVOL ANTHROPOL, V21, P239, DOI 10.1002/evan.21335; Seiffert ER, 2010, P NATL ACAD SCI USA, V107, P9712, DOI 10.1073/pnas.1001393107; Stevens NJ, 2013, NATURE, V497, P611, DOI 10.1038/nature12161; Sun JM, 2014, SCI REP-UK, V4, DOI 10.1038/srep07463; Wang Ban-Yue, 2008, Vertebrata Palasiatica, V46, P81; Zalmout IS, 2010, NATURE, V466, P360, DOI 10.1038/nature09094	27	46	50	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2016	352	6286					673	677		10.1126/science.aaf2107	http://dx.doi.org/10.1126/science.aaf2107			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL1UC	27151861				2022-12-28	WOS:000375417100029
J	Hankey, GJ				Hankey, Graeme J.			The benefits of aspirin in early secondary stroke prevention	LANCET			English	Editorial Material							TRANSIENT ISCHEMIC ATTACK; ANTIPLATELET THERAPY; HEMORRHAGE		[Hankey, Graeme J.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA, Australia; [Hankey, Graeme J.] Sir Charles Gairdner Hosp, Dept Neurol, Perth, WA, Australia; [Hankey, Graeme J.] WANRI, Perth, WA, Australia	University of Western Australia; University of Western Australia	Hankey, GJ (corresponding author), Univ Western Australia, Sch Med & Pharmacol, Perth, WA, Australia.; Hankey, GJ (corresponding author), Sir Charles Gairdner Hosp, Dept Neurol, Perth, WA, Australia.; Hankey, GJ (corresponding author), WANRI, Perth, WA, Australia.	graeme.hankey@uwa.edu.au	Hankey, Graeme J/H-4968-2014	Hankey, Graeme J/0000-0002-6044-7328				Bath P, 2015, INT J STROKE, V10, P1159, DOI 10.1111/ijs.12538; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Johnston SC, 2016, NEW ENGL J MED, V375, P35, DOI 10.1056/NEJMoa1603060; Johnston SC, 2013, INT J STROKE, V8, P479, DOI 10.1111/ijs.12129; Keir SL, 2002, CEREBROVASC DIS, V14, P197, DOI 10.1159/000065661; Meseguer E, 2015, INT J STROKE, V10, P163, DOI 10.1111/ijs.12421; Rothwell PM, 2007, LANCET, V370, P1432, DOI 10.1016/S0140-6736(07)61448-2; Rothwell PM, 2016, LANCET; Sandercock P. A., 2014, COCHRANE DB SYST REV, V3; Thompson BB, 2010, NEUROLOGY, V75, P1333, DOI 10.1212/WNL.0b013e3181f735e5; Toyoda K, 2015, INT J STROKE, V10, P253, DOI 10.1111/ijs.12420; Wong KSL, 2013, CIRCULATION, V128, P1656, DOI 10.1161/CIRCULATIONAHA.113.003187	12	11	11	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2016	388	10042					312	314		10.1016/S0140-6736(16)30511-6	http://dx.doi.org/10.1016/S0140-6736(16)30511-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR6MV	27209144	hybrid			2022-12-28	WOS:000380016900006
J	Ryan, AM; Krinsky, S; Kontopantelis, E; Doran, T				Ryan, Andrew M.; Krinsky, Sam; Kontopantelis, Evangelos; Doran, Tim			Long-term evidence for the effect of pay-for-performance in primary care on mortality in the UK: a population study	LANCET			English	Article							CORONARY-HEART-DISEASE; QUALITY; HEALTH; PREVENTION; MANAGEMENT; TARGETS	Background Introduced in 2004, the UK's Quality and Outcomes Framework (QOF) is the world's largest primary care pay-for-performance programme. We tested whether the QOF was associated with reduced population mortality. Methods We used population-level mortality statistics between 1994 and 2010 for the UK and other high-income countries that were not exposed to pay-for-performance. The primary outcome was age-adjusted and sex-adjusted mortality per 100 000 people for a composite outcome of chronic disorders that were targeted by the QOF. Secondary outcomes were age-adjusted and sex-adjusted mortality for ischaemic heart disease, cancer, and a composite of all non-targeted conditions. For each study outcome, we created a so-called synthetic UK as a weighted combination of comparison countries. We then estimated difference-in-differences models to test whether mortality fell more in the UK than in the synthetic UK after the QOF. Findings Introduction of the QOF was not significantly associated with changes in population mortality for the composite outcome (-3.68 per 100 000 population [95% CI -8.16 to 0.80]; p=0.107), ischaemic heart disease (-2.21 per 100 000 [-6.86 to 2.44]; p=0.357), cancer (0.28 per 100 000 [-0.99 to 1.55]; p=0.679), or all non-targeted conditions (11.60 per 100 000 [-3.91 to 27.11]; p=0.143). Interpretation Although we noted small mortality reductions for a composite outcome of targeted disorders, the QOF was not associated with significant changes in mortality. Our findings have implications for the probable effects of similar programmes on population health outcomes. The relation between incentives and mortality needs to be assessed in specific disease domains.	[Ryan, Andrew M.; Krinsky, Sam] Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA; [Kontopantelis, Evangelos] Univ Manchester, Ctr Hlth Informat, Manchester, Lancs, England; [Kontopantelis, Evangelos] Radcliffe Observ Quarter, Sch Primary Care Res, Natl Inst Hlth Res, Oxford, England; [Doran, Tim] Univ York, Dept Hlth Sci, York, N Yorkshire, England	University of Michigan System; University of Michigan; University of Manchester; University of York - UK	Ryan, AM (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA.	amryan@umich.edu	Kontopantelis, Evangelos/H-2966-2019	Kontopantelis, Evangelos/0000-0001-6450-5815	MRC [MR/K006665/1] Funding Source: UKRI; Medical Research Council [MR/K006665/1, MC_PC_13042] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Abadie A., SYNTH STATA MODULE I; Abadie A, 2010, J AM STAT ASSOC, V105, P493, DOI 10.1198/jasa.2009.ap08746; Altman DG, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d2090; [Anonymous], STANDARDIZED WORLD I; Bellamy D, 2007, INT J CLIN PRACT, V61, P1380, DOI 10.1111/j.1742-1241.2007.01447.x; Bohm K, 2012, TRANSSTATE WORKING P, V165, P1; Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; Capewell S, 2011, EUR HEART J, V32, P1187, DOI 10.1093/eurheartj/ehr049; Dimick JB, 2014, JAMA-J AM MED ASSOC, V312, P2401, DOI 10.1001/jama.2014.16153; Doran T, 2008, NEW ENGL J MED, V359, P274, DOI 10.1056/NEJMsa0800310; Doran T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1595; Doran T, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3590; Dusheiko M, 2011, J HEALTH ECON, V30, P919, DOI 10.1016/j.jhealeco.2011.08.001; Feenstra RC, 2015, AM ECON REV, V105, P3150, DOI 10.1257/aer.20130954; Flanagan DEH, 1999, QJM-INT J MED, V92, P245, DOI 10.1093/qjmed/92.5.245; Fleetcroft Robert, 2010, Br J Gen Pract, V60, pe345, DOI 10.3399/bjgp10X515359; Flodgren G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009255; Ford ES, 2011, ANNU REV PUBL HEALTH, V32, P5, DOI 10.1146/annurev-publhealth-031210-101211; Gini C., 1997, RIV POLIT ECON, V87, P769; Harrison MJ, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6423; Houle SKD, 2012, ANN INTERN MED, V157, P889, DOI 10.7326/0003-4819-157-12-201212180-00009; ILO, 2015, KEY IND LAB MARK KIL, VNinth; Kontopantelis E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h904; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Leatherman S, 2003, HEALTH AFFAIR, V22, P17, DOI 10.1377/hlthaff.22.2.17; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Nolte E, 2008, HEALTH AFFAIR, V27, P58, DOI 10.1377/hlthaff.27.1.58; Petersen LA, 2006, ANN INTERN MED, V145, P265, DOI 10.7326/0003-4819-145-4-200608150-00006; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; Ryan AM, 2013, HEALTHCARE-J DEL SCI, V1, P42, DOI 10.1016/j.hjdsi.2013.04.006; Singal AG, 2014, CLIN TRANSL GASTROEN, V5, DOI 10.1038/ctg.2013.13; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; United States Census Bureau, 2015, INT DAT BAS; World Health Organization, WHO MORT DAT; Zatonski W, 2008, EUR J EPIDEMIOL, V23, P3, DOI 10.1007/s10654-007-9195-1	37	85	86	1	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2016	388	10041					268	274		10.1016/S0140-6736(16)00276-2	http://dx.doi.org/10.1016/S0140-6736(16)00276-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DR2LN	27207746	Green Accepted			2022-12-28	WOS:000379736100030
J	Stronen, E; Toebes, M; Kelderman, S; van Buuren, MM; Yang, WW; van Rooij, N; Donia, M; Boschen, ML; Lund-Johansen, F; Olweus, J; Schumacher, TN				Stronen, Erlend; Toebes, Mireille; Kelderman, Sander; van Buuren, Marit M.; Yang, Weiwen; van Rooij, Nienke; Donia, Marco; Boschen, Maxi-Lu; Lund-Johansen, Fridtjof; Olweus, Johanna; Schumacher, Ton N.			Targeting of cancer neoantigens with donor-derived T cell receptor repertoires	SCIENCE			English	Article							EXOME ANALYSIS REVEALS; HUMAN-MELANOMA; IMMUNOTHERAPY; IMMUNOGENICITY; BLOCKADE; ANTIGENS; RECOGNITION; MUTATIONS; STABILITY	Accumulating evidence suggests that clinically efficacious cancer immunotherapies are driven by T cell reactivity against DNA mutation -derived neoantigens. However, among the large number of predicted neoantigens, only a minority is recognized by autologous patient T cells, and strategies to broaden neoantigen-specific T cell responses are therefore attractive. We found that naive T cell repertoires of healthy blood donors provide a source of neoantigen-specific T cells, responding to 11 of 57 predicted human leukocyte antigen (HLA)-A*02:01-binding epitopes from three patients. Many of the T cell reactivities involved epitopes that in vivo were neglected by patient autologous tumor -infiltrating lymphocytes. Finally, T cells redirected with T cell receptors identified from donor -derived T cells efficiently recognized patient -derived melanoma cells harboring the relevant mutations, providing a rationale for the use of such "outsourced" immune responses in cancer immunotherapy.	[Stronen, Erlend; Yang, Weiwen; Boschen, Maxi-Lu; Olweus, Johanna] Oslo Univ Hosp, Radiumhosp, Dept Canc Immunol, Oslo, Norway; [Stronen, Erlend; Yang, Weiwen; Boschen, Maxi-Lu; Lund-Johansen, Fridtjof; Olweus, Johanna] Univ Oslo, Inst Clin Med, KG Jebsen Ctr Canc Immunotherapy, Oslo, Norway; [Stronen, Erlend; Yang, Weiwen; Boschen, Maxi-Lu; Lund-Johansen, Fridtjof; Olweus, Johanna] Univ Oslo, Inst Clin Med, KG Jebsen Ctr Inflammat Res, Oslo, Norway; [Toebes, Mireille; Kelderman, Sander; van Buuren, Marit M.; van Rooij, Nienke; Schumacher, Ton N.] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands; [Donia, Marco] Univ Copenhagen, Herlev Hosp, Dept Hematol, Ctr Canc Immune Therapy, DK-2730 Herlev, Denmark; [Lund-Johansen, Fridtjof] Oslo Univ Hosp, Rikshosp, Dept Immunol & Transfus Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; Netherlands Cancer Institute; University of Copenhagen; Herlev & Gentofte Hospital; University of Oslo; National Hospital Norway	Olweus, J (corresponding author), Oslo Univ Hosp, Radiumhosp, Dept Canc Immunol, Oslo, Norway.; Olweus, J (corresponding author), Univ Oslo, Inst Clin Med, KG Jebsen Ctr Canc Immunotherapy, Oslo, Norway.; Olweus, J (corresponding author), Univ Oslo, Inst Clin Med, KG Jebsen Ctr Inflammat Res, Oslo, Norway.; Schumacher, TN (corresponding author), Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands.	johanna.olweus@medisin.uio.no; t.schumacher@nki.nl	Schumacher, Ton/Y-2432-2019; Olweus, Johanna/G-8008-2015	Schumacher, Ton/0000-0003-0517-8804; Olweus, Johanna/0000-0002-1898-3100; Donia, Marco/0000-0003-4966-9752; Lund-Johansen, Fridtjof/0000-0002-2445-1258	Dutch Cancer Society Queen Wilhelmina Award [NKI 2013-6122]; EU H2020 project APERIM; K. G. Jebsen Foundation; Research Council of Norway, Regional Authorities South-Eastern Norway; University of Oslo; Oslo University Hospital; Norwegian Cancer Society	Dutch Cancer Society Queen Wilhelmina Award; EU H2020 project APERIM; K. G. Jebsen Foundation; Research Council of Norway, Regional Authorities South-Eastern Norway; University of Oslo; Oslo University Hospital; Norwegian Cancer Society(Norwegian Cancer Society)	We thank L. Fanchi, R. Mezzadra., and F. Scheeren for advice and support: A. Vefferstad and the OUH flow cytometry use facility for exemplary technical assistance: I. M. Serene for sharing clinical material; and the Norwegian Bone Marrow Donor Registry for HLA typing. The data presented in the manuscript are tabulated in the main paper and in the Supplementary materials. DNA and RNA sequencing data have been deposited in the European Genome-Phenome Archive (accession codes EGAD00001000243 and EGAD00001000325). A patent application (P32649NL00) has been filed that covers the technology of targeting cancer-specific amino acid sequences with donor-derived TCR repertoires (inventors J.O., T.N.S., E.S., and M.T.). All described TCRs are available under an MTA with the Netherlands Cancer Institute and Oslo University Hospital. Supported by Dutch Cancer Society Queen Wilhelmina Award NKI 2013-6122 and EU H2020 project APERIM (T.N.S.); the K. G. Jebsen Foundation (J.O., T.N.S., F.L.-J.); and the Research Council of Norway, Regional Authorities South-Eastern Norway, the University of Oslo and Oslo University Hospital, and the Norwegian Cancer Society (J.O.).	Abrahamsen IW, 2010, LEUKEMIA, V24, P1901, DOI 10.1038/leu.2010.186; Carreno BM, 2015, SCIENCE, V348, P803, DOI 10.1126/science.aaa3828; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Harndahl M, 2012, EUR J IMMUNOL, V42, P1405, DOI 10.1002/eji.201141774; Klebanoff CA, 2016, NAT MED, V22, P26, DOI 10.1038/nm.4015; Kreiter S, 2015, NATURE, V520, P692, DOI 10.1038/nature14426; Linnemann C, 2015, NAT MED, V21, P81, DOI 10.1038/nm.3773; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Mittal D, 2014, CURR OPIN IMMUNOL, V27, P16, DOI 10.1016/j.coi.2014.01.004; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Tran E, 2015, SCIENCE, V350, P1387, DOI 10.1126/science.aad1253; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; vanderBurg SH, 1996, J IMMUNOL, V156, P3308; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577; Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001	20	290	314	0	125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2016	352	6291					1337	1341		10.1126/science.aaf2288	http://dx.doi.org/10.1126/science.aaf2288			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7ON	27198675				2022-12-28	WOS:000377972000046
J	Larsen, TA; Hoffmann, S; Luthi, C; Truffer, B; Maurer, M				Larsen, Tove A.; Hoffmann, Sabine; Luthi, Christoph; Truffer, Bernhard; Maurer, Max			Emerging solutions to the water challenges of an urbanizing world	SCIENCE			English	Review							WASTE-WATER; SUSTAINABILITY TRANSITIONS; SANITATION; MANAGEMENT; PERSPECTIVE; RECOVERY; URINE	The top priorities for urban water sustainability include the provision of safe drinking water, wastewater handling for public health, and protection against flooding. However, rapidly aging infrastructure, population growth, and increasing urbanization call into question current urban water management strategies, especially in the fast-growing urban areas in Asia and Africa. We review innovative approaches in urban water management with the potential to provide locally adapted, resource-efficient alternative solutions. Promising examples include new concepts for stormwater drainage, increased water productivity, distributed or on-site treatment of wastewater, source separation of human waste, and institutional and organizational reforms. We conclude that there is an urgent need for major transdisciplinary efforts in research, policy, and practice to develop alternatives with implications for cities and aquatic ecosystems alike.	[Larsen, Tove A.; Hoffmann, Sabine; Luthi, Christoph; Truffer, Bernhard; Maurer, Max] Eawag, Swiss Fed Inst Aquat Sci & Technol, CH-8600 Dubendorf, Switzerland; [Truffer, Bernhard] Univ Utrecht, Fac Geosci, Heidelberglaan 2, NL-3584 CS Utrecht, Netherlands; [Maurer, Max] ETH, Inst Environm Engn, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Utrecht University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Larsen, TA (corresponding author), Eawag, Swiss Fed Inst Aquat Sci & Technol, CH-8600 Dubendorf, Switzerland.	tove.larsen@eawag.ch	Truffer, Bernhard/K-3366-2016; Hoffmann, Sabine/K-4427-2016; Larsen, Tove A/C-4235-2008; Maurer, Max/B-5579-2009	Truffer, Bernhard/0000-0002-8635-0911; Hoffmann, Sabine/0000-0001-6750-8069; Larsen, Tove A/0000-0002-9978-6191; Maurer, Max/0000-0002-5326-6035				[Anonymous], 2016, COSTS M 2030 SUSTAIN; [Anonymous], 2007, WAT FOOD WAT LIF COM; Araral E, 2009, POLICY SOC, V27, P221, DOI [DOI 10.1016/J.POLSOC.2008.10.006, 10.1016/j.polsoc.2008.10.006, DOI 10.1016/J.P0LS0C.2008.10.006]; Ashley R., 2006, INFRASTRUCTURE 2030; Binz C, 2016, ECON GEOGR, V92, P172, DOI 10.1080/00130095.2015.1103177; Dahlgren E, 2013, ENG ECON, V58, P231, DOI 10.1080/0013791X.2013.825038; Dominguez D, 2009, CALIF MANAGE REV, V51, P30, DOI 10.2307/41166479; Eickhout B, 2006, AGR ECOSYST ENVIRON, V116, P4, DOI 10.1016/j.agee.2006.03.009; Endo T, 2015, WATER POLICY, V17, P332, DOI 10.2166/wp.2014.255; FAO, 2015, AQUASTAT MAIN DAT; Fay M., 2003, POLICY RES WORKING P; Ferguson BC, 2013, LANDSCAPE URBAN PLAN, V117, P32, DOI 10.1016/j.landurbplan.2013.04.016; Ferriman A, 2007, BRIT MED J, V334, P111, DOI 10.1136/bmj.39097.611806.DB; Finger M, 2011, INTERNATIONAL HANDBOOK OF NETWORK INDUSTRIES: THE LIBERALIZATION OF INFRASTRUCTURE, P1; Fletcher TD, 2015, URBAN WATER J, V12, P525, DOI 10.1080/1573062X.2014.916314; Foray D, 2012, RES POLICY, V41, P1697, DOI 10.1016/j.respol.2012.07.011; Garud R, 2003, RES POLICY, V32, P277, DOI 10.1016/S0048-7333(02)00100-2; Grant SB, 2012, SCIENCE, V337, P681, DOI 10.1126/science.1216852; Harris-Lovett SR, 2015, ENVIRON SCI TECHNOL, V49, P7552, DOI 10.1021/acs.est.5b00504; Hiessl H., 2010, ISI SCHRIFTENREIHE I, P145; Jacobsen M., 2012, DIRECTIONS DEV; Jacobsson S, 2012, ENERG POLICY, V44, P374, DOI 10.1016/j.enpol.2012.01.069; Jahn T., 2008, TRANSDISZIPLIN RE FO, P21; Jimenez B., 2008, SCI TECHNICAL REPORT, V20; Kikeri S, 2004, WORLD BANK RES OBSER, V19, P87, DOI 10.1093/wbro/lkh014; Kiparsky M, 2013, ENVIRON ENG SCI, V30, P395, DOI 10.1089/ees.2012.0427; Kunzle R, 2015, J WATER SANIT HYG DE, V5, P448, DOI 10.2166/washdev.2015.116; Kunneke R, 2010, J ECON BEHAV ORGAN, V75, P494, DOI 10.1016/j.jebo.2010.05.009; Larsen TA, 2013, SOURCE SEPARATION AND DECENTRALIZATION FOR WASTEWATER MANAGEMENT, P1; Larsen TA, 1997, WATER SCI TECHNOL, V35, P3, DOI 10.2166/wst.1997.0326; Larsen TA, 2015, WATER RES, V87, P513, DOI 10.1016/j.watres.2015.06.006; Larsen TA, 2015, J WATER SANIT HYG DE, V5, P64, DOI 10.2166/washdev.2014.115; Larsen TA, 2009, ENVIRON SCI TECHNOL, V43, P6121, DOI 10.1021/es803001r; Lerner DN, 2002, HYDROGEOL J, V10, P143, DOI 10.1007/s10040-001-0177-1; Lieberherr E, 2015, ENVIRON INNOV SOC TR, V15, P101, DOI 10.1016/j.eist.2013.12.002; Luthi C, 2013, SOURCE SEPARATION AND DECENTRALIZATION FOR WASTEWATER MANAGEMENT, P455; Luthy RG, 2015, DAEDALUS-US, V144, P72, DOI 10.1162/DAED_a_00343; Marin, 2009, PUBLIC PRIVATE PARTN, V8; Markard J, 2012, RES POLICY, V41, P955, DOI 10.1016/j.respol.2012.02.013; Marlow DR, 2013, WATER RES, V47, P7150, DOI 10.1016/j.watres.2013.07.046; Maurer M, 2005, WA SCI TECHNOL, V5, P145, DOI 10.2166/ws.2005.0059; Maurer M, 2013, SOURCE SEPARATION AND DECENTRALIZATION FOR WASTEWATER MANAGEMENT, P85; McConville JR, 2014, ENVIRON SCI TECHNOL, V48, P12238, DOI 10.1021/es501854x; Meggers F, 2011, ENERG BUILDINGS, V43, P879, DOI 10.1016/j.enbuild.2010.12.008; Mejia A, 2014, WATER RESOUR RES, V50, P1984, DOI 10.1002/2013WR014834; National Academies of Sciences Engineering Medicine, 2016, US GRAYW STORMW ENH; National Development and Reform Commission, 2007, MED LONG TERM DEV PL; Niemeier D, 2014, SCIENCE, V345, P1287, DOI 10.1126/science.1257085; Noyola A., 2012, WATER, V40, P926; O'Keefe M, 2015, ENVIRON URBAN, V27, P421, DOI 10.1177/0956247815581758; OECD Studies on Water, 2015, WAT CIT ENS SUST FUT, DOI 10.1787/9789264230149-en; Pahl-Wostl C, 2013, CURR OPIN ENV SUST, V5, P708, DOI 10.1016/j.cosust.2013.10.012; Pahl-Wostl C, 2011, WATER RESOUR MANAG, V25, P837, DOI 10.1007/s11269-010-9729-2; Peal A, 2014, J WATER SANIT HYG DE, V4, P563, DOI 10.2166/washdev.2014.026; Pierce G, 2015, J PLAN LIT, V30, P119, DOI 10.1177/0885412214562427; Potts J., 2009, POLICY PRACT, V11, P34; Randall DG, 2016, WATER RES, V95, P361, DOI 10.1016/j.watres.2016.03.007; Rockstrom J, 2014, ECOHYDROLOGY, V7, P1249, DOI 10.1002/eco.1562; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Schneider A, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/044003; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Shiklomanov I. A., 1999, WORLD WATER RESOURCE; Singh NK, 2015, WATER SCI TECHNOL, V71, P468, DOI 10.2166/wst.2014.413; Udert KM, 2015, WATER SA, V41, P212, DOI 10.4314/wsa.v41i2.06; UN Habitat, 2006, STAT WORLDS CIT 2006; UN-Habitat, 2003, WORKING PAPER; UN-Habitat, 2013, STAT WORLDS CIT 2012; Van Drecht G, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2009GB003458; Varis O, 2014, INT J WATER RESOUR D, V30, P433, DOI 10.1080/07900627.2014.912130; Wankhade K, 2015, ENVIRON URBAN, V27, P555, DOI 10.1177/0956247814567058; World Bank, 2009, WORLD DEV REP; World Health Organization, 2015, PROGR SAN DRINK WAT; Zeeman G, 2011, WATER SCI TECHNOL, V64, P1987, DOI 10.2166/wst.2011.562	73	344	360	79	967	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2016	352	6288			SI		928	933		10.1126/science.aad8641	http://dx.doi.org/10.1126/science.aad8641			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM2AK	27199414				2022-12-28	WOS:000376147800031
J	Chang, W; Gundersen, GG				Chang, Wakam; Gundersen, Gregg G.			Swollen Nuclei Signal from the Grave	CELL			English	Editorial Material							LINC COMPLEX; INFLAMMATION	Eicosanoid signaling plays key pro-inflammatory roles during tissue damage. Now, Enyedi et al. show that swelling of nuclei in cell corpses activates eicosanoid signaling to recruit leukocytes to sites of tissue damage. The enhanced membrane tension in swollen nuclei directly promotes calcium-dependent translocation and activation of enzymes involved in eicosanoid biosynthesis.	[Chang, Wakam; Gundersen, Gregg G.] Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, 630 W 168th St, New York, NY 10032 USA	Columbia University	Gundersen, GG (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, 630 W 168th St, New York, NY 10032 USA.	ggg1@columbia.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099481] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM099481] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arsenovic PT, 2016, BIOPHYS J, V110, P34, DOI 10.1016/j.bpj.2015.11.014; Chang W, 2015, J CELL BIOL, V208, P11, DOI 10.1083/jcb.201409047; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; Enyedi B, 2016, CELL, V165, P1160, DOI 10.1016/j.cell.2016.04.016; Enyedi B, 2013, NAT CELL BIOL, V15, P1123, DOI 10.1038/ncb2818; Guilluy C, 2014, NAT CELL BIOL, V16, P376, DOI 10.1038/ncb2927; LIN LL, 1992, P NATL ACAD SCI USA, V89, P6147, DOI 10.1073/pnas.89.13.6147; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Pearce MJ, 1996, BIOCHEM BIOPH RES CO, V218, P500, DOI 10.1006/bbrc.1996.0089; SierraHonigmann R, 1996, LAB INVEST, V74, P684	10	3	3	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2016	165	5					1051	1052		10.1016/j.cell.2016.05.015	http://dx.doi.org/10.1016/j.cell.2016.05.015			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DM6QT	27203108	Bronze			2022-12-28	WOS:000376478200006
J	Denman, M				Denman, Michael			Review: Exercise therapy reduces fatigue in chronic fatigue syndrome	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Denman, Michael] Univ London Imperial Coll Sci Technol & Med, London, England	Imperial College London	Denman, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, London, England.							Smith MEB, 2015, ANN INTERN MED, V162, P841, DOI 10.7326/M15-0114	1	3	3	1	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2016	164	10					JC55	JC55		10.7326/ACPJC-2016-164-10-055	http://dx.doi.org/10.7326/ACPJC-2016-164-10-055			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8GF	27182921				2022-12-28	WOS:000375878500006
J	McCartney, M				McCartney, Margaret			Margaret McCartney: We need more openness on GPs' pay	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Health and Social Care Information Centre, 2015, GP EARN EXP 2013 14	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 16	2016	353								i2729	10.1136/bmj.i2729	http://dx.doi.org/10.1136/bmj.i2729			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GB	27183960	Green Published, Bronze			2022-12-28	WOS:000376447500005
J	Boyce, R; Glasgow, SD; Williams, S; Adamantidis, A				Boyce, Richard; Glasgow, Stephen D.; Williams, Sylvain; Adamantidis, Antoine			Causal evidence for the role of REM sleep theta rhythm in contextual memory consolidation	SCIENCE			English	Article							TEMPORALLY STRUCTURED REPLAY; ENTORHINAL CORTEX; SEPTAL AREA; HIPPOCAMPUS; RETROGRADE; BEHAVIOR; CELLS; RATS	Rapid eye movement sleep (REMS) has been linked with spatial and emotional memory consolidation. However, establishing direct causality between neural activity during REMS and memory consolidation has proven difficult because of the transient nature of REMS and significant caveats associated with REMS deprivation techniques. In mice, we optogenetically silenced medial septum gamma-aminobutyric acid-releasing (MSGABA) neurons, allowing for temporally precise attenuation of the memory-associated theta rhythm during REMS without disturbing sleeping behavior. REMS-specific optogenetic silencing of MSGABA neurons selectively during a REMS critical window after learning erased subsequent novel object place recognition and impaired fear-conditioned contextual memory. Silencing MSGABA neurons for similar durations outside REMS episodes had no effect on memory. These results demonstrate that MSGABA neuronal activity specifically during REMS is required for normal memory consolidation.	[Boyce, Richard] McGill Univ, Integrated Program Neurosci, Montreal, PQ, Canada; [Glasgow, Stephen D.; Williams, Sylvain; Adamantidis, Antoine] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Adamantidis, Antoine] Univ Bern, Dept Neurol, Bern, Switzerland; [Adamantidis, Antoine] Univ Bern, Inselspital, Univ Hosp, Dept Clin Res, CH-3010 Bern, Switzerland	McGill University; McGill University; University of Bern; University of Bern; University Hospital of Bern	Williams, S; Adamantidis, A (corresponding author), McGill Univ, Dept Psychiat, Montreal, PQ, Canada.; Adamantidis, A (corresponding author), Univ Bern, Dept Neurol, Bern, Switzerland.; Adamantidis, A (corresponding author), Univ Bern, Inselspital, Univ Hosp, Dept Clin Res, CH-3010 Bern, Switzerland.	sylvain.williams@douglas.mcgill.ca; antoine.adamantidis@dkf.unibe.ch		Adamantidis, Antoine/0000-0003-2531-5175; Glasgow, Stephen/0000-0002-9809-4812	Alexander Graham Bell Canada Graduate Scholarship [Natural Sciences and Engineering Research Council of Canada (NSERC)]; Fonds de la Recherche en Sante du Quebec; Canadian Institutes of Health Research (CIHR); NSERC; Human Frontier Science Program [RGY0076/2012]; Douglas Foundation; McGill University; Canadian Fund for Innovation (CFI); Canadian Research Chair (CRC Tier 2); CIHR; Swiss National Science Foundation; Inselspital; University of Bern	Alexander Graham Bell Canada Graduate Scholarship [Natural Sciences and Engineering Research Council of Canada (NSERC)]; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Human Frontier Science Program(Human Frontier Science Program); Douglas Foundation; McGill University; Canadian Fund for Innovation (CFI)(Canada Foundation for Innovation); Canadian Research Chair (CRC Tier 2); CIHR(Canadian Institutes of Health Research (CIHR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Inselspital; University of Bern	We thank all members of the Williams and Tidis labs for their helpful comments on the manuscript, E. Boyden for viral constructs, and B. Lowell and L. Vong for mice. R.B. was supported by an Alexander Graham Bell Canada Graduate Scholarship [Natural Sciences and Engineering Research Council of Canada (NSERC)] while completing this research. S.D.G. was supported by a postdoctoral fellowship from Fonds de la Recherche en Sante du Quebec. S.W. is supported by the Canadian Institutes of Health Research (CIHR) and NSERC. A. A. is supported by the Human Frontier Science Program (RGY0076/2012), the Douglas Foundation, McGill University, the Canadian Fund for Innovation (CFI), the Canadian Research Chair (CRC Tier 2), CIHR, NSERC, the Swiss National Science Foundation, the Inselspital, and the University of Bern. All data are available in the supplementary materials. We declare no conflicts of interest.	Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Borbely A A, 1982, Hum Neurobiol, V1, P195; Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; GREEN JD, 1954, J NEUROPHYSIOL, V17, P533, DOI 10.1152/jn.1954.17.6.533; Grosmark AD, 2012, NEURON, V75, P1001, DOI 10.1016/j.neuron.2012.08.015; Hasselmo ME, 2008, EUR J NEUROSCI, V28, P1301, DOI 10.1111/j.1460-9568.2008.06437.x; JONES BE, 1991, NEUROSCIENCE, V40, P637, DOI 10.1016/0306-4522(91)90002-6; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; MEIBACH RC, 1977, BRAIN RES, V119, P1, DOI 10.1016/0006-8993(77)90088-9; MITCHELL SJ, 1982, J NEUROSCI, V2, P292; Moser M. B., 2016, COLD SPRING HARBOR P, V7, P1; PETSCHE H, 1962, ELECTROEN CLIN NEURO, V14, P202, DOI 10.1016/0013-4694(62)90030-5; Poe GR, 2000, BRAIN RES, V855, P176, DOI 10.1016/S0006-8993(99)02310-0; ROBINSON TE, 1977, BRAIN RES, V124, P544, DOI 10.1016/0006-8993(77)90954-4; Siegel JM, 2001, SCIENCE, V294, P1058, DOI 10.1126/science.1063049; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; Simon AP, 2006, J NEUROSCI, V26, P9038, DOI 10.1523/JNEUROSCI.1401-06.2006; Stickgold R, 2005, SLEEP, V28, P1225, DOI 10.1093/sleep/28.10.1225; Toth K, 1997, J PHYSIOL-LONDON, V500, P463, DOI 10.1113/jphysiol.1997.sp022033; Vertes RP, 2004, NEURON, V44, P135, DOI 10.1016/j.neuron.2004.08.034	23	318	327	11	181	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2016	352	6287					812	816		10.1126/science.aad5252	http://dx.doi.org/10.1126/science.aad5252			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5FP	27174984				2022-12-28	WOS:000375663000037
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Nurse staffing levels are still not safe	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						[Anonymous], 2015, BBC NEWS; Campbell D, 2016, GUARDIAN; Cummings J, 2015, COMMUNICATION; Department of Health, 2013, FLOR GOV INTH SUNSH; Department of Health, 2014, HARD TRUTHS JOURN PU; Department of Health, 2015, COMMUNICATION; Dowler C., 2016, HLTH SERV J; Dowler C, 2016, NURS TIMES; Ford S., 2013, NURS TIMES; Francis R., 2013, REPORT MID STAFFORDS; Griffiths P, 2014, NICE SAF STAFF NURS; Hughes D, 2016, BBC NEWS; Lintern S, 2016, HLTH SERV J; Lintern S, 2013, NURS TIMES; National Assembly for Wales, 2015, BILL SUMM SAF NURS S; Royal College of Nursing, 2010, GUID SAF NURS STAFF; Royal College of Nursing, 2012, SAF STAFF OLD PEOPL	17	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 13	2016	353								i2665	10.1136/bmj.i2665	http://dx.doi.org/10.1136/bmj.i2665			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6FX	27177770	Green Published, Bronze			2022-12-28	WOS:000376447100001
J	Rizo, H; Walker, RJ; Carlson, RW; Horan, MF; Mukhopadhyay, S; Manthos, V; Francis, D; Jackson, MG				Rizo, Hanika; Walker, Richard J.; Carlson, Richard W.; Horan, Mary F.; Mukhopadhyay, Sujoy; Manthos, Vicky; Francis, Don; Jackson, Matthew G.			Preservation of Earth-forming events in the tungsten isotopic composition of modern flood basalts	SCIENCE			English	Article							SIDEROPHILE ELEMENT ABUNDANCES; MANTLE; DIFFERENTIATION; W-182; HETEROGENEITIES; ND-142	How much of Earth's compositional variation dates to processes that occurred during planet formation remains an unanswered question. High-precision tungsten isotopic data from rocks from two large igneous provinces, the North Atlantic Igneous Province and the Ontong Java Plateau, reveal preservation to the Phanerozoic of tungsten isotopic heterogeneities in the mantle. These heterogeneities, caused by the decay of hafnium-182 in mantle domains with high hafnium/tungsten ratios, were created during the first similar to 50 million years of solar system history, indicating that portions of the mantle that formed during Earth's primary accretionary period have survived to the present.	[Rizo, Hanika] Univ Quebec, Dept Sci Terre & Atmosphere, Geotop, Montreal, PQ H3C 3P8, Canada; [Walker, Richard J.] Univ Maryland, Dept Geol, College Pk, MD 20742 USA; [Carlson, Richard W.; Horan, Mary F.] Carnegie Inst Sci, Washington, DC 20005 USA; [Mukhopadhyay, Sujoy; Manthos, Vicky] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Francis, Don] McGill Univ, Dept Earth & Planetary Sci, Montreal, PQ, Canada; [Jackson, Matthew G.] Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA	University of Quebec; University of Quebec Montreal; University System of Maryland; University of Maryland College Park; Carnegie Institution for Science; University of California System; University of California Davis; McGill University; University of California System; University of California Santa Barbara	Rizo, H (corresponding author), Univ Quebec, Dept Sci Terre & Atmosphere, Geotop, Montreal, PQ H3C 3P8, Canada.	rizo.hanika@uqam.ca	Walker, Richard/K-6869-2016	Walker, Richard/0000-0003-0348-2407	NSF [EAR-1265169, EAR-1250419]	NSF(National Science Foundation (NSF))	We thank T. Mock for assistance with mass spectrometry. This work was improved by helpful discussions with J. O'Neil, S. Shirey, and B. Wood. We thank S. Shirey, who provided sample VE-32. We also appreciate the helpful comments and suggestions from three anonymous reviewers. We thank M. Garcon, who developed the four-step <SUP>142</SUP>Nd acquisition method. This work was supported by NSF grant EAR-1265169 (Cooperative Studies of the Earth's Deep Interior program) to R.J.W. and grant EAR-1250419 to S.M. All data are available in the main manuscript and supplementary materials.	Bennett VC, 2007, SCIENCE, V318, P1907, DOI 10.1126/science.1145928; Boyet M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021873; Brandenburg JP, 2008, EARTH PLANET SC LETT, V276, P1, DOI 10.1016/j.epsl.2008.08.027; Dale CW, 2009, EARTH PLANET SC LETT, V278, P267, DOI 10.1016/j.epsl.2008.12.014; Garnero EJ, 2008, SCIENCE, V320, P626, DOI 10.1126/science.1148028; Hallis LJ, 2015, SCIENCE, V350, P795, DOI 10.1126/science.aac4834; Horan MF, 2003, CHEM GEOL, V196, P5, DOI 10.1016/S0009-2541(02)00405-9; Ireland TJ, 2009, CHEM GEOL, V260, P112, DOI 10.1016/j.chemgeo.2008.12.009; Jackson MG, 2016, GEOCHIM COSMOCHIM AC, V185, P21, DOI 10.1016/j.gca.2016.02.011; Jackson MG, 2011, NATURE, V476, P316, DOI 10.1038/nature10326; Jackson MG, 2010, NATURE, V466, P853, DOI 10.1038/nature09287; Kleine T, 2009, GEOCHIM COSMOCHIM AC, V73, P5150, DOI 10.1016/j.gca.2008.11.047; Neal C.R., 1997, GEOPH MONOG SERIES, V100, P183; ONEILL HSC, 1995, CHEM GEOL, V120, P255, DOI 10.1016/0009-2541(94)00141-T; Peto MK, 2013, EARTH PLANET SC LETT, V369, P13, DOI 10.1016/j.epsl.2013.02.012; Rizo H, 2016, GEOCHIM COSMOCHIM AC, V175, P319, DOI 10.1016/j.gca.2015.12.007; Rizo H, 2013, EARTH PLANET SC LETT, V377, P324, DOI 10.1016/j.epsl.2013.07.012; Rubie D., 2015, TREATISE GEOPHYS, P51; Saunders A.D., 1997, GEOPH MONOG SERIES, V100, P45, DOI [10.1029/GM100p0045, 10.1029/GM100P0045]; Starkey NA, 2009, EARTH PLANET SC LETT, V277, P91, DOI 10.1016/j.epsl.2008.10.007; TONKS WB, 1993, J GEOPHYS RES-PLANET, V98, P5319, DOI 10.1029/92JE02726; Touboul M, 2014, CHEM GEOL, V383, P63, DOI 10.1016/j.chemgeo.2014.05.030; Touboul M, 2012, SCIENCE, V335, P1065, DOI 10.1126/science.1216351; Willbold M, 2015, EARTH PLANET SC LETT, V419, P168, DOI 10.1016/j.epsl.2015.02.040; Willbold M, 2011, NATURE, V477, P195, DOI 10.1038/nature10399	26	110	112	1	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2016	352	6287					809	812		10.1126/science.aad8563	http://dx.doi.org/10.1126/science.aad8563			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5FP	27174983	Green Submitted			2022-12-28	WOS:000375663000036
J	Wikelski, M; Tertitski, G				Wikelski, Martin; Tertitski, Grigori			Living sentinels for climate change effects	SCIENCE			English	Editorial Material							TRACKING; ECOLOGY; HAWKS		[Wikelski, Martin] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Wikelski, Martin] Univ Konstanz, Dept Biol, Constance, Germany; [Wikelski, Martin] Smithsonian Trop Res Inst, Balboa, Panama; [Tertitski, Grigori] Russian Acad Sci, Inst Geog, Moscow V71, Russia	Max Planck Society; University of Konstanz; Smithsonian Institution; Smithsonian Tropical Research Institute; Russian Academy of Sciences	Wikelski, M (corresponding author), Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany.; Wikelski, M (corresponding author), Univ Konstanz, Dept Biol, Constance, Germany.; Wikelski, M (corresponding author), Smithsonian Trop Res Inst, Balboa, Panama.	wikelski@orn.mpg.de	Tertitski, Grigori/J-4834-2018	Tertitski, Grigori/0000-0002-4836-364X				Berdahl A, 2013, SCIENCE, V339, P574, DOI 10.1126/science.1225883; CADE TJ, 1971, SCIENCE, V172, P955, DOI 10.1126/science.172.3986.955; Criscuolo F, 2008, P ROY SOC B-BIOL SCI, V275, P1565, DOI 10.1098/rspb.2008.0148; Fisher MO, 2006, PLOS BIOL, V4, P1462, DOI 10.1371/journal.pbio.0040251; Goldstein MI, 1999, ECOTOXICOLOGY, V8, P201, DOI 10.1023/A:1026496331396; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Inger R, 2015, ECOL LETT, V18, P28, DOI 10.1111/ele.12387; Kays R, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2478; Pennisi E, 2011, SCIENCE, V334, P1042, DOI 10.1126/science.334.6059.1042; Proffitt F, 2004, SCIENCE, V306, P223, DOI 10.1126/science.306.5694.223; van Gils JA, 2016, SCIENCE, V352, P819, DOI 10.1126/science.aad6351; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Wikelski M, 2007, J EXP BIOL, V210, P181, DOI 10.1242/jeb.02629; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188	14	22	23	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2016	352	6287					775	776		10.1126/science.aaf6544	http://dx.doi.org/10.1126/science.aaf6544			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5FP	27174976	Green Submitted			2022-12-28	WOS:000375663000022
J	Chambers, DA; Feero, WG; Khoury, MJ				Chambers, David A.; Feero, W. Gregory; Khoury, Muin J.			Convergence of Implementation Science, Precision Medicine, and the Learning Health Care System A New Model for Biomedical Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Chambers, David A.; Khoury, Muin J.] NCI, Div Canc Control & Populat Sci, 9609 Med Ctr Dr,Room 3E414, Rockville, MD 20850 USA; [Feero, W. Gregory] Maine Dartmouth Family Med Residency, Augusta, GA USA; [Khoury, Muin J.] Ctr Dis Control & Prevent, Off Publ Hlth Gen, Atlanta, GA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centers for Disease Control & Prevention - USA	Chambers, DA (corresponding author), NCI, Div Canc Control & Populat Sci, 9609 Med Ctr Dr,Room 3E414, Rockville, MD 20850 USA.	dchamber@mail.nih.gov			Intramural NIH HHS [Z99 CA999999] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		[Anonymous], NAT CANC MOONSH IN; [Anonymous], BEST CAR LOW COST PA; Eccles MP, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-28; Fisher ES, 2016, JAMA-J AM MED ASSOC, V315, P339, DOI 10.1001/jama.2015.17949; Institute of Medicine, ROUNDT TRANSL GEN BA; Powell BJ, 2012, MED CARE RES REV, V69, P123, DOI 10.1177/1077558711430690; Tabak RG, 2012, AM J PREV MED, V43, P337, DOI 10.1016/j.amepre.2012.05.024	7	189	190	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 10	2016	315	18					1941	1942		10.1001/jama.2016.3867	http://dx.doi.org/10.1001/jama.2016.3867			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2JP	27163980	Green Accepted			2022-12-28	WOS:000375461100006
J	Kelly, D				Kelly, Deirdre			Hepatitis C viraemia after apparent spontaneous clearance	LANCET			English	Editorial Material							CHILDREN		[Kelly, Deirdre] Birmingham Childrens Hosp, Liver Unit, Birmingham B4 6NH, W Midlands, England	University of Birmingham	Kelly, D (corresponding author), Birmingham Childrens Hosp, Liver Unit, Birmingham B4 6NH, W Midlands, England.	deirdre.kelly@bch.nhs.uk						Abdel-Hady M, 2011, J VIRAL HEPATITIS, V18, pE535, DOI 10.1111/j.1365-2893.2011.01456.x; El-Kamary SS, 2013, J PEDIATR-US, V162, P148, DOI 10.1016/j.jpeds.2012.06.057; Farci P, 2006, P NATL ACAD SCI USA, V103, P8475, DOI 10.1073/pnas.0602546103; Gerlach JT, 2003, GASTROENTEROLOGY, V125, P80, DOI 10.1016/S0016-5085(03)00668-1; Indolfi G, 2016, LANCET, V387, P1967, DOI 10.1016/S0140-6736(16)00085-4	5	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2016	387	10031					1968	1968						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL1EE	27203661				2022-12-28	WOS:000375374200042
J	Watts, G				Watts, Geoff			Jim Smith: biologist at the heart of embryonic Francis Crick Institute	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2016	387	10031					1899	1899						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL1EE	27203642				2022-12-28	WOS:000375374200016
J	Nunan, D				Nunan, David			Doctors should be able to prescribe exercise like a drug	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PHYSICAL-ACTIVITY		[Nunan, David] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England	University of Oxford	Nunan, D (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England.	david.nunan@phc.ox.ac.uk		Barrett, Kevin/0000-0002-0785-1815				Abell B, 2015, CIRC-CARDIOVASC QUAL, V8, P187, DOI 10.1161/CIRCOUTCOMES.114.001381; Academy of Medical Royal Colleges, 2015, EX MIR CUR; Bailey V, 2012, NHSS ROLE PUBLICS HL; Bull F, 2003, LANCET, V361, P258, DOI 10.1016/S0140-6736(03)12290-8; Department of Health, 2008, HIGH QUALITY CARE AL; Hebert ET, 2012, BRIT J SPORT MED, V46, P625, DOI 10.1136/bjsports-2011-090734; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Josephson RA, 2016, EXERCISE PRESCRIPTIO; Kohl Harold W 3rd, 2012, Lancet, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; National Institute for Health and Care Excellence, 2014, PHYS ACT EX REF SCHE; Nunan D, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-56; Royal College of Physicians, 2015, EX FOR LIF	12	13	13	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 5	2016	353								i2468	10.1136/bmj.i2468	http://dx.doi.org/10.1136/bmj.i2468			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL4AS	27149982	Green Published			2022-12-28	WOS:000375575600003
J	Oh, J; Byrd, AL; Park, M; Kong, HH; Segre, JA				Oh, Julia; Byrd, Allyson L.; Park, Morgan; Kong, Heidi H.; Segre, Julia A.		NISC Comparative Sequencing	Temporal Stability of the Human Skin Microbiome	CELL			English	Article							DIVERSITY; FRAMEWORK; FUNGAL	Biogeography and individuality shape the structural and functional composition of the human skin microbiome. To explore these factors' contribution to skin microbial community stability, we generated metagenomic sequence data from longitudinal samples collected over months and years. Analyzing these samples using a multi-kingdom, reference-based approach, we found that despite the skin's exposure to the external environment, its bacterial, fungal, and viral communities were largely stable over time. Site, individuality, and phylogeny were all determinants of stability. Foot sites exhibited the most variability; individuals differed in stability; and transience was a particular characteristic of eukaryotic viruses, which showed little site-specificity in colonization. Strain and single-nucleotide variant-level analysis showed that individuals maintain, rather than reacquire, prevalent microbes from the environment. Longitudinal stability of skin microbial communities generates hypotheses about colonization resistance and empowers clinical studies exploring alterations observed in disease states.	[Oh, Julia; Byrd, Allyson L.; Segre, Julia A.] NHGRI, Translat & Funct Genom Branch, NIH, Bethesda, MD 20892 USA; [Byrd, Allyson L.] Boston Univ, Dept Bioinformat, Boston, MA 02215 USA; [Park, Morgan; NISC Comparative Sequencing] NHGRI, NIH, Intramural Sequencing Ctr, Bethesda, MD 20892 USA; [Kong, Heidi H.] NCI, Dermatol Branch, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA; [Oh, Julia] Jackson Lab Genom Med, Farmington, CT 06030 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Boston University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Jackson Laboratory	Segre, JA (corresponding author), NHGRI, Translat & Funct Genom Branch, NIH, Bethesda, MD 20892 USA.; Kong, HH (corresponding author), NCI, Dermatol Branch, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA.	konghe@mail.nih.gov; jsegre@mail.nih.gov	Kong, Heidi H/L-4856-2018	Kong, Heidi H/0000-0003-4424-064X	NHGRI; NCI Intramural Research Programs; Chanel/CE.R.I.E.S. research award; NIH [4UH3AR057504-02]; NATIONAL CANCER INSTITUTE [ZIABC010938, ZIABC011558] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000180, ZIBHG000196] Funding Source: NIH RePORTER	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI Intramural Research Programs; Chanel/CE.R.I.E.S. research award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Amynah Pradhan, Sharon Osgood, Clay Deming, Cynthia Ng, Brian Schmidt, Pamela Thomas, and Sean Conlan provided underlying efforts; the J.A.S. lab and Mark Udey engaged in helpful discussions. Work was supported by NHGRI and NCI Intramural Research Programs and a Chanel/CE.R.I.E.S. research award (to J.A.S.). This study utilized the high-performance computational capabilities of the NIH Biowulf Linux cluster. Sequencing was funded by grants from the NIH (4UH3AR057504-02). IGS Analysis Engine at University of Maryland School of Medicine provided structural and functional annotation of genomes.	Alekseyenko AV, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-31; Belkaid Y, 2014, SCIENCE, V346, P954, DOI 10.1126/science.1260144; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Conlan S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r64; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Franzosa EA, 2015, P NATL ACAD SCI USA, V112, pE2930, DOI 10.1073/pnas.1423854112; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Greenblum S, 2015, CELL, V160, P583, DOI 10.1016/j.cell.2014.12.038; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hannigan GD, 2015, MBIO, V6, DOI 10.1128/mBio.01578-15; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kang DZ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2009; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Lieberman TD, 2014, NAT GENET, V46, P82, DOI 10.1038/ng.2848; Liu J, 2015, ISME J, V9, P2116, DOI 10.1038/ismej.2015.144; Ma ZS, 2015, MOL ECOL, V24, P5428, DOI 10.1111/mec.13394; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Oh J, 2014, NATURE, V514, P59, DOI 10.1038/nature13786; Oh J, 2013, GENOME RES, V23, P2103, DOI 10.1101/gr.159467.113; Peleg AY, 2010, NAT REV MICROBIOL, V8, P340, DOI 10.1038/nrmicro2313; Scharschmidt TC, 2013, DRUG DISCOV TODAY DI, V10, P83; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Tomida S, 2013, MBIO, V4, DOI 10.1128/mBio.00003-13; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418; Zhu A, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0646-9	34	458	475	11	123	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2016	165	4					854	866		10.1016/j.cell.2016.04.008	http://dx.doi.org/10.1016/j.cell.2016.04.008			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DL7DN	27153496	Green Accepted, Bronze			2022-12-28	WOS:000375800300014
J	Shah, A; Keir, M; Ducas, R; Crean, AM				Shah, Ashish; Keir, Michelle; Ducas, Robin; Crean, Andrew M.			Uric acid bladder stones in congenital cyanotic heart disease	LANCET			English	Editorial Material									[Shah, Ashish; Keir, Michelle; Ducas, Robin; Crean, Andrew M.] Toronto Gen Hosp, Div Cardiol, Toronto Congenital Cardiac Ctr Adults, Toronto, ON, Canada	University of Toronto; Toronto Congenital Cardiac Centre for Adults; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Crean, AM (corresponding author), Toronto Gen Hosp, Peter Munk Cardiac Ctr, Toronto Congenital Ctr Adults, Toronto, ON M5G 2N2, Canada.	andrew.crean@uhn.ca							0	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 15	2016	388	10054					1921	1921		10.1016/S0140-6736(16)00347-0	http://dx.doi.org/10.1016/S0140-6736(16)00347-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DZ0AM	27156932				2022-12-28	WOS:000385499000036
J	Mailankody, S; Prasad, V				Mailankody, Sham; Prasad, Vinay			Implications of Proposed Medicare Reforms to Counteract High Cancer Drug Prices	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Mailankody, Sham] Mem Sloan Kettering Canc Ctr, Dept Med, Div Hematol Oncol, Myeloma Serv, 1275 York Ave, New York, NY 10021 USA; [Prasad, Vinay] Oregon Hlth & Sci Univ, Knight Canc Inst, Div Hematol Oncol, Portland, OR 97201 USA; [Prasad, Vinay] Oregon Hlth & Sci Univ, Ctr Hlth Care Eth, Portland, OR 97201 USA	Memorial Sloan Kettering Cancer Center; Oregon Health & Science University; Oregon Health & Science University	Prasad, V (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	prasad@ohsu.edu		Prasad, Vinayak/0000-0002-6110-8221				Bach PB, 2014, JAMA-J AM MED ASSOC, V312, P1629, DOI 10.1001/jama.2014.13235; Dangi-Garimella S. ASCO, COA UNHAPPY PROPOSED; Dusetzina SB, 2014, J CLIN ONCOL, V32, P306, DOI 10.1200/JCO.2013.52.9123; Mailankody S, 2015, JAMA ONCOL, V1, P539, DOI 10.1001/jamaoncol.2015.0373; Neumann PJ, 2011, HEALTH AFFAIR, V30, P2329, DOI 10.1377/hlthaff.2010.1147; Rugo HS, 2015, J CLIN ONCOL, V33, P2361, DOI 10.1200/JCO.2014.59.5298	6	22	22	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 19	2016	316	3					271	272		10.1001/jama.2016.5998	http://dx.doi.org/10.1001/jama.2016.5998			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR3LN	27149663				2022-12-28	WOS:000379804800011
J	Patton, GC; Sawyer, SM; Santelli, JS; Ross, DA; Afifi, R; Allen, NB; Arora, M; Azzopardi, P; Baldwin, W; Bonell, C; Kakuma, R; Kennedy, E; Mahon, J; McGovern, T; Mokdad, AH; Patel, V; Petroni, S; Reavley, N; Taiwo, K; Waldfogel, J; Wickremarathne, D; Barroso, C; Bhutta, Z; Fatusi, AO; Mattoo, A; Diers, J; Fang, J; Ferguson, J; Ssewamala, F; Viner, RM				Patton, George C.; Sawyer, Susan M.; Santelli, John S.; Ross, David A.; Afifi, Rima; Allen, Nicholas B.; Arora, Monika; Azzopardi, Peter; Baldwin, Wendy; Bonell, Christopher; Kakuma, Ritsuko; Kennedy, Elissa; Mahon, Jaqueline; McGovern, Terry; Mokdad, Ali H.; Patel, Vikram; Petroni, Suzanne; Reavley, Nicola; Taiwo, Kikelomo; Waldfogel, Jane; Wickremarathne, Dakshitha; Barroso, Carmen; Bhutta, Zulfiqar; Fatusi, Adesegun O.; Mattoo, Amitabh; Diers, Judith; Fang, Jing; Ferguson, Jane; Ssewamala, Frederick; Viner, Russell M.			Our future: a Lancet commission on adolescent health and wellbeing	LANCET			English	Review							YOUNG-PEOPLE; MENTAL-HEALTH; REPRODUCTIVE HEALTH; PHYSICAL-ACTIVITY; NONCOMMUNICABLE DISEASES; ALCOHOL-CONSUMPTION; YOUTH PARTICIPATION; SECULAR TRENDS; MIDDLE-INCOME; FOLLOW-UP		[Patton, George C.; Sawyer, Susan M.; Azzopardi, Peter] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Kakuma, Ritsuko; Reavley, Nicola] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Allen, Nicholas B.] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Mattoo, Amitabh] Univ Melbourne, Australia India Ctr, Melbourne, Vic, Australia; [Patton, George C.; Sawyer, Susan M.; Azzopardi, Peter] Royal Childrens Hosp, Ctr Adolescent Hlth, Melbourne, Vic, Australia; [Sawyer, Susan M.] Columbia Univ, Murdoch Childrens Res Inst, New York, NY USA; [Santelli, John S.; McGovern, Terry] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Waldfogel, Jane; Ssewamala, Frederick] Columbia Univ, Sch Social Work, New York, NY USA; [Allen, Nicholas B.] Univ Oregon, Eugene, OR 97403 USA; [Ross, David A.] WHO, CH-1211 Geneva, Switzerland; [Ross, David A.; Patel, Vikram; Ferguson, Jane] London Sch Hyg & Trop Med, London WC1, England; [Afifi, Rima] Amer Univ Beirut, Dept Hlth Promot & Community Hlth, Beirut, Lebanon; [Arora, Monika; Patel, Vikram] Publ Hlth Fdn India, New Delhi, India; [Bonell, Christopher] UCL, Inst Educ, London, England; [Viner, Russell M.] UCL, Inst Child Hlth, London, England; [Kennedy, Elissa] Burnet Inst, Melbourne, Vic, Australia; [Mahon, Jaqueline] United Nations Populat Fund, New York, NY USA; [Mokdad, Ali H.] Univ Washinton, Inst Hlth Metr & Evaluat, Seattle, WA USA; [Petroni, Suzanne] Int Ctr Res Women, Washington, DC USA; [Barroso, Carmen] Int Planned Parenthood Fdn, London, England; [Bhutta, Zulfiqar] Univ Toronto, Toronto, ON, Canada; [Bhutta, Zulfiqar] Aga Khan Univ, Karachi, Pakistan; [Fatusi, Adesegun O.] Obafemi Awolowo Univ, Ife, Nigeria; [Wickremarathne, Dakshitha] CARE Int, London, England; [Mattoo, Amitabh] Jawaharlal Nehru Univ, New Delhi 110067, India; [Diers, Judith] UNICEF, New York, NY USA; [Taiwo, Kikelomo] Girls Educ Mentoring Serv, New York, NY USA; [Fang, Jing] Kunming Med Univ, Kunming, Peoples R China	University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; Columbia University; Columbia University; Columbia University; University of Oregon; World Health Organization; University of London; London School of Hygiene & Tropical Medicine; American University of Beirut; Public Health Foundation of India; University of London; University College London; UCL Institute of Education; University of London; University College London; Burnet Institute; United Nations Population Fund; Institute for Health Metrics & Evaluation; University of Toronto; Aga Khan University; Obafemi Awolowo University; Jawaharlal Nehru University, New Delhi; UNICEF; Kunming Medical University	Patton, GC (corresponding author), Royal Childrens Hosp, Ctr Adolescent Hlth, Flemington Rd, Parkville, Vic 3052, Australia.	george.patton@rch.org.au	Patton, George C/B-5246-2013; Santelli, John/AAG-3046-2021; Mokdad, Ali H./AAD-1232-2022; Afifi, Rima A/M-5615-2016; Reavley, Nicola/ABE-6510-2020; Viner, Russell M/A-1441-2009; Ribeiro, Ana Cristina/HHN-7466-2022; Bhutta, Zulfiqar/L-7822-2015	Patton, George C/0000-0001-5039-8326; Mokdad, Ali H./0000-0002-4994-3339; Afifi, Rima A/0000-0003-3154-3617; Reavley, Nicola/0000-0001-5513-8291; Viner, Russell M/0000-0003-3047-2247; Ribeiro, Ana Cristina/0000-0002-0493-8376; Allen, Nicholas/0000-0002-1086-6639; azzopardi, peter/0000-0002-9280-6997; Bhutta, Zulfiqar/0000-0003-0637-599X; Barroso, Carmen/0000-0002-9452-7086; Kakuma, Ritsuko/0000-0002-0196-2100; Ssewamala, Fred/0000-0002-4849-5650	Bill & Melinda Gates Foundation (Seattle, WA, USA); John D and Catherine T MacArthur Foundation; Australia India Institute; Murdoch Childrens Research Institute; University of Melbourne; University College London; London School of Hygiene & Tropical Medicine; Columbia University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R13HD081897] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation (Seattle, WA, USA)(Bill & Melinda Gates Foundation); John D and Catherine T MacArthur Foundation; Australia India Institute; Murdoch Childrens Research Institute; University of Melbourne(University of Melbourne); University College London(General Electric); London School of Hygiene & Tropical Medicine; Columbia University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The Bill & Melinda Gates Foundation (Seattle, WA, USA) provided a grant to assist with the production of the Commission. Additional funding came from the John D and Catherine T MacArthur Foundation, Australia India Institute, and the Murdoch Childrens Research Institute. The University of Melbourne, University College London, the London School of Hygiene & Tropical Medicine, and Columbia University provided financial or logistic support. All Commissioners were supported by their employing organisations to undertake the Commission's work. The findings and recommendations are those of the authors and do not necessarily reflect recommendations or policies of the funders. Overall project Secretariat was provided by Molly O'Sullivan (MCRI), Kristina Bennett (MCRI), and Jennifer Heitel (Columbia). A very special thank you goes to all the research assistants from the five working groups who assisted with the conceptualisation, literature screening, data extraction, and synthesis of evidence. These include Dr Bidyut K Sarkar (UCL/PHFI), Dr Soumyadeep Bhaumik, Dr Kiran Saluja (PHFI), Kate Hinds (UCL), Kelly Dickson (UCL), Dr Farah Jamal (UCL), and Dr Nichola Shackleton (UCL) from Project 1. Sonia Haerizadeh JD (Columbia University), Dr Elia De la Cruz Toledo (Columbia University), and Dr Nathan Hughes (University of Birmingham) from Project 2. Dr Lydia K Murithi (ICRW), Preeti Dhillon (ICRW), Lilian Ghandour (AUB), Chaza Akik (AUB), Dr Elie Akl (AUB), Mariana Yaafar Jaafar (AUB), Noura El Salibi (AUB), Hala Najm (AUB), Tamara Lotfi (AUB), Jillian Grisel, and Caroline Zahm from Project 3. Donna Lorenze (MCRI), Dr Alana Deery (MCRI), Tim Gartland (MCRI), Liz Comrie-Thomson (Burnet Institute), Dr Jo Robinson (Orygen), Eric Howard (Whiting Moyne), Stephen Hearps (MCRI), Annie Haakenstad (Harvard School of Public Health), and Kara Estep (IHME) from Project 4, without whose hard work this report would not have been possible. Additional administrative support provided by Charmaine Sambathkumar, Dr Michelle Tollit (MCRI), Dr Anne-Lise Goddings (UCL) Jenelle Frances, Mary Boyle, Monica Chase, Stephanie Grilo, and Chelsea Kolff (Columbia University). Website and graphic support was provided by Adam Leadoux and Bill Reid (RCH). The authors also thank the peer reviewers who provided important feedback on earlier drafts of the report.	Adelman S, 2012, SCH FEEDING REDUCES; Afukaar Francis K, 2003, Inj Control Saf Promot, V10, P77, DOI 10.1076/icsp.10.1.77.14113; Agwu AL, 2015, J ADOLESCENT HEALTH, V56, P345, DOI 10.1016/j.jadohealth.2014.11.009; Akinfaderin-Agurau F, 2011, WHAT BUSINESS DO YOU; Al-sheyab N, 2012, PEDIATRICS, V129, pE106, DOI 10.1542/peds.2011-0346; Alonso J, 2007, BRIT J PSYCHIAT, V190, P299, DOI 10.1192/bjp.bp.106.022004; Ambresin AE, 2013, J ADOLESCENT HEALTH, V52, P670, DOI 10.1016/j.jadohealth.2012.12.014; Andersen SL, 2008, TRENDS NEUROSCI, V31, P183, DOI 10.1016/j.tins.2008.01.004; Andriessen K, 2014, CRISIS, V35, P338, DOI 10.1027/0227-5910/a000269; [Anonymous], 2008, CLOS GAP GEN HLTH EQ; Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; Asquith S, 1995, CHILDREN YOUNG PERSO; Baggio S, 2015, J ADOLESCENT HEALTH, V56, P238, DOI 10.1016/j.jadohealth.2014.09.006; Bajos N, 2010, AIDS, V24, P1185, DOI 10.1097/QAD.0b013e328336ad52; Baker STE, 2015, J NEUROSCI, V35, P9078, DOI 10.1523/JNEUROSCI.5043-14.2015; Batura N, 2015, HEALTH POLICY PLANN, V30, P813, DOI 10.1093/heapol/czu055; Baxter-Jones ADG, 2011, J BONE MINER RES, V26, P1729, DOI 10.1002/jbmr.412; Beaglehole R, 2014, LANCET, V384, P105, DOI 10.1016/S0140-6736(14)61091-6; Beaglehole R, 2013, LANCET, V381, P602, DOI 10.1016/S0140-6736(13)60101-4; Behrendt S, 2009, DRUG ALCOHOL DEPEN, V99, P68, DOI 10.1016/j.drugalcdep.2008.06.014; Bell J., 2008, REWRITING RULES YOUT; BELL V, 2015, BMJ-BRIT MED J, V351, pH3064, DOI DOI 10.1136/BMJ.H3064; Benjet C, 2012, SALUD PUBLICA MEXICO, V54, P410, DOI 10.1590/S0036-36342012000400011; Bhamra AS, 2015, ROLE NONSTATE ACTORS; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Biddlecom Ann E, 2007, Afr J Reprod Health, V11, P99, DOI 10.2307/25549734; Biegler P, 2011, ETHICAL TREATMENT DE; Binder M, 2015, KYKLOS, V68, P3, DOI 10.1111/kykl.12071; Black WW, 2012, J LGBT YOUTH, V9, P321, DOI 10.1080/19361653.2012.714343; Blakemore SJ, 2014, ANNU REV PSYCHOL, V65, P187, DOI 10.1146/annurev-psych-010213-115202; Blanc AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059864; Blanc AK, 2009, INT PERSPECT SEX R H, V35, P63, DOI 10.1363/ipsrh.35.063.09; Blank L, 2010, MENT HEALTH REV J, V15, P43, DOI 10.5042/mhrj.2010.0371; Blank L, 2010, J PEDIATR ADOL GYNEC, V23, P341, DOI 10.1016/j.jpag.2010.03.007; Bloom, 2012, FINANC DEV, V49, P6; Boampong M, 2011, ADOLESCENTS YOUTH MI; Bonell C, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3078; Bonell C, 2013, HEALTH PLACE, V21, P180, DOI 10.1016/j.healthplace.2012.12.001; Bonell C, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2011.137539; Bonita R, 2013, LANCET, V381, P575, DOI 10.1016/S0140-6736(12)61993-X; Bonomo YA, 2004, ADDICTION, V99, P1520, DOI 10.1111/j.1360-0443.2004.00846.x; Bonomo YA, 2006, ALCOHOL CLIN EXP RES, V30, p117A; Bottino SMB, 2015, CAD SAUDE PUBLICA, V31, P463, DOI [10.1590/0102-311X00036114, 10.1590/0102-311x00036114]; Bouris A, 2010, J PRIM PREV, V31, P273, DOI 10.1007/s10935-010-0229-1; Brandtzaeg PB, 2015, 9 INT AAAI C WEB SOC; Breiner H, 2015, INV HLTH WELL BEING, DOI DOI 10.17226/18869; Brown B., 2004, HDB ADOLESCENT PSYCH, V2nd, P363; Brown JD, 2005, J ADOLESCENT HEALTH, V36, P420, DOI 10.1016/j.jadohealth.2004.06.003; Bruin JE, 2010, TOXICOL SCI, V116, P364, DOI 10.1093/toxsci/kfq103; Bushamuka Victor N., 2005, Food and Nutrition Bulletin, V26, P17; Calhoun LM, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-532; Campbell C, 2009, J YOUTH STUD, V12, P93, DOI 10.1080/13676260802345757; Casanueva E, 2006, J NUTR, V136, P2498, DOI 10.1093/jn/136.10.2498; Catalano RF, 2012, LANCET, V379, P1653, DOI 10.1016/S0140-6736(12)60238-4; Chambers RA, 2014, AM J PSYCHIAT; Chandra-Mouli V, 2015, GLOB HEALTH-SCI PRAC, V3, P333, DOI 10.9745/GHSP-D-15-00126; Chandra-Mouli V, 2015, J ADOLESCENT HEALTH, V56, pS1, DOI 10.1016/j.jadohealth.2014.09.015; Chandra-Mouli V, 2013, J ADOLESCENT HEALTH, V52, P517, DOI 10.1016/j.jadohealth.2013.03.002; Chen LH, 2006, PEDIATRICS, V118, P56, DOI 10.1542/peds.2005-2281; Chesson HW, 2011, VACCINE, V29, P8443, DOI 10.1016/j.vaccine.2011.07.096; Coates D, 2014, CHILD YOUTH SERV REV, V46, P294, DOI 10.1016/j.childyouth.2014.09.012; Coffey C, 2003, BRIT MED J, V326, P1064, DOI 10.1136/bmj.326.7398.1064; Collins C, 2008, AIDS, V22, pS105, DOI 10.1097/01.aids.0000327442.66656.01; Collishaw S, 2015, J CHILD PSYCHOL PSYC, V56, P370, DOI 10.1111/jcpp.12372; Commendador KA, 2010, PEDIAT NURS, V36, P70; Commendador Kathleen A, 2010, Pediatr Nurs, V36, P147; Copeland W, 2011, J AM ACAD CHILD PSY, V50, P252, DOI 10.1016/j.jaac.2010.12.014; Cortes R, 2011, ADOLESCENTS RIGHTS G; Crone EA, 2012, NAT REV NEUROSCI, V13, P636, DOI 10.1038/nrn3313; Cutler DM, 2012, ED HLTH INSIGHTS INT; Dahl RE, 2004, ANN NY ACAD SCI, V1021, P1, DOI 10.1196/annals.1308.001; Dakin EK, 2015, QUAL SOC WORK, V14, P170, DOI 10.1177/1473325014526085; de Azevedo WF, 2015, EINSTEIN-SAO PAULO, V13, P618, DOI 10.1590/S1679-45082015RW3127; Dean AJ, 2010, ARCH DIS CHILD, V95, P717, DOI 10.1136/adc.2009.175125; Demissie Z, 2013, SCH HLTH PROFILES 20; Denno DM, 2015, J ADOLESCENT HEALTH, V56, pS22, DOI 10.1016/j.jadohealth.2014.09.012; DFID, 2012, NEGL CRIS UND EV ACT; Dhillon N, 2009, GENERATION IN WAITING: THE UNFULFILLED PROMISE OF YOUNG PEOPLE IN THE MIDDLE EAST, P1; Dick B, 2015, J ADOLESCENT HEALTH, V56, P3, DOI 10.1016/j.jadohealth.2014.10.260; Dishion TJ, 2004, J ADOLESCENCE, V27, P515, DOI 10.1016/j.adolescence.2004.06.005; DNA India, 2012, CAB APPR BILL COMP M; Draper CE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-S2-S5; DriversEd.com, DRIVERSED; Dumith SC, 2011, INT J EPIDEMIOL, V40, P685, DOI 10.1093/ije/dyq272; Duncan RE, 2014, J ADOLESCENT HEALTH, V55, P59, DOI 10.1016/j.jadohealth.2013.11.024; Dunkel F., 2012, YOUNG ADULT OFFENDER, P11; Eisenberg ME, 2015, EMERG ADULTHOOD, V3, P277, DOI 10.1177/2167696815574639; Ellis SJ, 2002, J COMMUNITY APPL SOC, V12, P167, DOI 10.1002/casp.670; Ellsberg M, 2015, LANCET, V385, P1555, DOI 10.1016/S0140-6736(14)61703-7; Elvik R, 2009, HANDBOOK OF ROAD SAFETY MEASURES, 2ND EDITION, P1; Elzakkers IFFM, 2014, INT J EAT DISORDER, V47, P845, DOI 10.1002/eat.22330; Engstrom L. M., 2008, Physical Education and Sport Pedagogy, V13, P319, DOI 10.1080/17408980802400510; Euromonitor International, 2013, SPEC REP FAM STRUCT; Evans E, 2004, CLIN PSYCHOL REV, V24, P957, DOI 10.1016/j.cpr.2004.04.005; Ewing SWF, 2014, NEUROIMAGE-CLIN, V5, P420, DOI 10.1016/j.nicl.2014.06.011; Fagan AA, 2013, RES SOCIAL WORK PRAC, V23, P141, DOI 10.1177/1049731512465899; Feldman SS, 1990, THRESHOLD DEV ADOLES; Fellmeth GLT, 2013, COCHRANE DB SYST REV, V6; Findholt Nancy E, 2011, Am J Health Promot, V26, pe74, DOI 10.4278/ajhp.100622-QUAL-210; Findholt NE, 2011, PUBLIC HEALTH NURS, V28, P186, DOI 10.1111/j.1525-1446.2010.00895.x; Finer LB, 2012, FERTIL STERIL, V98, P893, DOI 10.1016/j.fertnstert.2012.06.027; Fisher LB, 2007, ARCH PEDIAT ADOL MED, V161, P959, DOI 10.1001/archpedi.161.10.959; Fletcher A, 2008, J ADOLESCENT HEALTH, V42, P209, DOI 10.1016/j.jadohealth.2007.09.020; Ford CA, 1997, JAMA-J AM MED ASSOC, V278, P1029, DOI 10.1001/jama.278.12.1029; Forjuoh Samuel N, 2003, Inj Control Saf Promot, V10, P109, DOI 10.1076/icsp.10.1.109.14115; Forum on Marriage and the Rights of Women and Girls, 2001, EARL MARR WHOS RIGHT; Foxcroft DR, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009113; Francis JM, 2014, TROP MED INT HEALTH, V19, P476, DOI 10.1111/tmi.12267; Furlong A., 1997, YOUNG PEOPLE SOCIAL; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Galati JA, 2015, GUTTMACHER POLICY RE, V18, P77; Garcia AP, 2014, HEALTH PROMOT PRACT, V15, P18, DOI 10.1177/1524839912472904; Garcia-Moreno C, 2012, FEMALE GENITAL MUTIL; Gibbs A, 2010, AJAR-AFR J AIDS RES, V9, P153, DOI 10.2989/16085906.2010.517482; Gibbs CM, 2012, PAEDIATR PERINAT EP, V26, P259, DOI 10.1111/j.1365-3016.2012.01290.x; Giedd JN, 2009, J AM ACAD CHILD PSY, V48, P465, DOI 10.1097/CHI.0b013e31819f2715; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Glewwe P., 2006, HDB EC ED, DOI [10.1016/S1574-0692(06)02016-2, DOI 10.1016/S1574-0692(06)02016-2]; Goddings A., 2015, THESIS U COLL LONDON; Goldie SJ, 2008, VACCINE, V26, pL59, DOI 10.1016/j.vaccine.2008.05.063; Goldie SJ, 2008, VACCINE, V26, pM17, DOI 10.1016/j.vaccine.2008.06.018; Gottfredson LS, 2004, CURR DIR PSYCHOL SCI, V13, P1, DOI 10.1111/j.0963-7214.2004.01301001.x; Gould MS, 2003, J AM ACAD CHILD PSY, V42, P386, DOI 10.1097/01.CHI.0000046821.95464.CF; Graham P., 2004, END ADOLESCENCE; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; GROSSMAN M, 1972, J POLIT ECON, V80, P223, DOI 10.1086/259880; Haddad L, 2015, J NUTR, V145, P663, DOI 10.3945/jn.114.206078; Haider R, 2006, ADOLESCENT NUTR REV; Hale DR, 2015, PEDIATRICS, V136, P128, DOI 10.1542/peds.2014-2105; Hanson MA, 2015, BEST PRACT RES CL OB, V29, P24, DOI 10.1016/j.bpobgyn.2014.06.007; Harden A, 2001, HLTH ED J, V60, P339, DOI DOI 10.1177/001789690106000406; Harden A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4254; Hargreaves DS, 2015, J ADOLESCENT HEALTH, V57, P413, DOI 10.1016/j.jadohealth.2015.05.015; Hargreaves DS, 2011, J CLIN RES PEDIATR E, V3, P43, DOI 10.4274/jcrpe.v3i2.10; Harlen W., 2003, ASSESS EDUC, V10, P169, DOI DOI 10.1080/0969594032000121270; Harris KM, 2010, J FAM ISSUES, V31, P1106, DOI 10.1177/0192513X10365823; Hawton K, 2003, BRIT J PSYCHIAT, V182, P537, DOI 10.1192/bjp.182.6.537; HAZELL P, 1993, AUST NZ J PSYCHIAT, V27, P653, DOI 10.3109/00048679309075828; Hochberg Z, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-113; Hotez PJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001600; Hunter Ernest, 2002, Emerg Med (Fremantle), V14, P14, DOI 10.1046/j.1442-2026.2002.00281.x; ICRW, 2011, DEL MARR GIRLS IND F; ICRW, 2005, DEV IN SUPP HLTH AD; Independent Expert Review Group (iERG), 2013, EV WOM EV CHILD STRE; Institute for Health Metrics and Evaluation (IHME), 2015, GLOB ED ATT 1970 201; Institute of Medicine (IOM) and National Research Council (NRC) of the National Academies, 2011, INT SCI RES FAM WORK; International Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS FAC S; International Institute for Population Sciences (IIPS), 1995, NAT FAM HLTH SURV NF, P199293; International Institute for Population Sciences (IIPS) Macro International, 2007, MACR NAT FAM HLTH SU; International Labour Organization, 2015, WORLD REP CHILD LAB; International Labour Organization, 2013, GLOB EMPL TRENDS YOU; Iwasaki Y, 2014, RELAT CHILD YOUTH CA, V27, P24; Jaccard J, 2005, DEV PSYCHOL, V41, P135, DOI 10.1037/0012-1649.41.1.135; Jacquez F, 2013, AM J COMMUN PSYCHOL, V51, P176, DOI 10.1007/s10464-012-9533-7; Jain S, 2007, NEW INSIGHTS PREVENT; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Jensen LA, 2012, J SOC ISSUES, V68, P473, DOI 10.1111/j.1540-4560.2012.01759.x; Johnson SB, 2011, INJURY PREV, V17, P50, DOI 10.1136/ip.2010.028126; Johnson SL, 2009, J SCHOOL HEALTH, V79, P451, DOI 10.1111/j.1746-1561.2009.00435.x; Jordan Amy B, 2008, Adolesc Med State Art Rev, V19, P431; Jorm AF, 2015, AUST NZ J PSYCHIAT, V49, P861, DOI 10.1177/0004867415608003; Joshi PD, 2013, PSYCHOL SCI, V24, P432, DOI 10.1177/0956797612457950; Julian-Almarcegui C, 2015, NUTR REV, V73, P127, DOI 10.1093/nutrit/nuu065; Kadivar H, 2014, J ADOLESCENT HEALTH, V55, P24, DOI 10.1016/j.jadohealth.2013.12.002; Kahana SY, 2013, AIDS BEHAV, V17, P41, DOI 10.1007/s10461-012-0159-4; Kaplan AM, 2010, BUS HORIZONS, V53, P59, DOI 10.1016/j.bushor.2009.09.003; Kauer SD, 2014, J MED INTERNET RES, V16, P314, DOI 10.2196/jmir.3103; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kesterton AJ, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-25; King JC, 2003, J NUTR, V133, p1732S, DOI 10.1093/jn/133.5.1732S; Kivela Jari, 2013, Cost Eff Resour Alloc, V11, P17, DOI 10.1186/1478-7547-11-17; Klimes-Dougan B, 2013, CRISIS, V34, P82, DOI 10.1027/0227-5910/a000178; Klugman J., 2014, VOICE AGENCY EMPOWER; Kneale D, 2013, J EPIDEMIOL COMMUN H, V67, P48, DOI 10.1136/jech-2011-200867; Kraak VI, 2015, OBES REV, V16, P433, DOI 10.1111/obr.12279; Kraak VI, 2014, PUBLIC HEALTH NUTR, V17, P2467, DOI 10.1017/S1368980014000093; Kretman SE., 2009, ADOLESCENT HLTH UNDE, P213; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; Kwan I, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003201; Labrique AB, 2012, J MOB TECHNOL MED, V1, P26, DOI DOI 10.7309/JMTM.48; Lamy P., 2013, NOW LONG TERM REPORT; Lansdown G, 2005, RIGHTS BASED APPROAC; Lansdown Gerison., 2005, INNOCENTI INSIGHT EV; Larson RW, 2002, J RES ADOLESCENCE, V12, P31, DOI 10.1111/1532-7795.00024; Larson RW, 1996, DEV PSYCHOL, V32, P744, DOI 10.1037/0012-1649.32.4.744; Laska MN, 2012, J ADOLESCENT HEALTH, V50, P324, DOI 10.1016/j.jadohealth.2012.01.016; Lester R, 2008, LANCET INFECT DIS, V8, P738, DOI 10.1016/S1473-3099(08)70265-2; Lesthaeghe R, 2014, P NATL ACAD SCI USA, V111, P18112, DOI 10.1073/pnas.1420441111; Li SC, 2004, PSYCHOL SCI, V15, P155, DOI 10.1111/j.0956-7976.2004.01503003.x; Lloyd CB, 2005, PAN TRANS AD DEV COU; Lou CH, 2012, J ADOLESCENT HEALTH, V50, pS26, DOI 10.1016/j.jadohealth.2011.12.009; Lundgren R, 2015, J ADOLESCENT HEALTH, V56, pS42, DOI 10.1016/j.jadohealth.2014.08.012; Luxford K., 2010, PATIENT CTR CARE IMP; Lyon JD, 2012, J SAFETY RES, V43, P29, DOI 10.1016/j.jsr.2011.10.007; Macleod CI, 2010, S AFR J PSYCHOL, V40, P18, DOI 10.1177/008124631004000103; Madden M, 2014, TEENS TECHNOLOGY 201; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Martins A, 2010, PERS INDIV DIFFER, V49, P554, DOI 10.1016/j.paid.2010.05.029; Mason E, 2014, LANCET, V384, P455, DOI 10.1016/S0140-6736(14)60750-9; Mason-Jones AJ, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-49; Masset E., 2011, SYSTEMATIC REV AGR I; Maticka-Tyndale E, 2010, EVAL PROGRAM PLANN, V33, P98, DOI 10.1016/j.evalprogplan.2009.07.001; McGorry Patrick, 2013, Br J Psychiatry Suppl, V54, ps30, DOI 10.1192/bjp.bp.112.119214; McPherson Kerri E, 2014, BMC Psychol, V2, P7, DOI 10.1186/2050-7283-2-7; McQueston K, 2013, STUD FAMILY PLANN, V44, P369, DOI 10.1111/j.1728-4465.2013.00365.x; Meier MH, 2012, P NATL ACAD SCI USA, V109, pE2657, DOI 10.1073/pnas.1206820109; Meng Y, 2014, ADDICTION, V109, P206, DOI 10.1111/add.12330; Michaud PA, 2015, J ADOLESCENT HEALTH, V57, P361, DOI 10.1016/j.jadohealth.2015.06.012; Milat AJ, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-18; Miyamoto K., 2010, IMPROVING HLTH SOCIA, P111; de Andrade LOM, 2015, LANCET, V385, P1343, DOI 10.1016/S0140-6736(14)61494-X; Morin-Major JK, 2016, PSYCHONEUROENDOCRINO, V63, P238, DOI 10.1016/j.psyneuen.2015.10.005; Moser C., 1999, YOUTH VIOLENCE LATIN; Moyer-Guse E, 2008, COMMUN THEOR, V18, P407, DOI 10.1111/j.1468-2885.2008.00328.x; Muncie J, 2013, INT J CRIME JUSTICE, V2, P43; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Nair M, 2015, J ADOLESCENT HEALTH, V57, P288, DOI 10.1016/j.jadohealth.2015.05.011; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Ngwena C, 2011, SEXUAL HLTH HUMAN RI; Niemeier HM, 2006, J ADOLESCENT HEALTH, V39, P842, DOI 10.1016/j.jadohealth.2006.07.001; Norton R, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P737; Nussbaum M.C., 2011, CREATING CAPABILITIE; O'Neill J, 2014, J CLIN EPIDEMIOL, V67, P56, DOI 10.1016/j.jclinepi.2013.08.005; OECD, 2014, YOUTH NEITH EMPL ED; OECD, 2011, FUT FAM 2030, DOI DOI 10.1787/9789264168367-EN; OECD, 2012, RES FOC WHAT STUD KN; Omer Y, 2014, CONFLICT MANAG PEACE, V33, P25, DOI DOI 10.1177/0738894214544613; Parry CD, 2011, ADDICTION, V106, P1718, DOI 10.1111/j.1360-0443.2011.03605.x; Patel V, 2007, LANCET, V370, P991, DOI 10.1016/S0140-6736(07)61240-9; Patel Vikram, 2007, Lancet, V369, P1302, DOI 10.1016/S0140-6736(07)60368-7; Patel V, 2012, LANCET, V379, P2343, DOI 10.1016/S0140-6736(12)60606-0; Paterson BL, 2008, INT J DRUG POLICY, V19, P24, DOI 10.1016/j.drugpo.2007.11.007; Patton G, 2003, J ADOLESCENT HEALTH, V33, P231, DOI 10.1016/S1054-139X(03)00204-0; Patton GC, 2015, LANCET, V386, P875, DOI 10.1016/S0140-6736(14)62248-0; Patton GC, 2014, LANCET, V383, P1404, DOI [10.1016/s0140-6736(13)62116-9, 10.1016/S0140-6736(13)62116-9]; Patton GC, 2012, LANCET, V379, P1665, DOI 10.1016/S0140-6736(12)60203-7; Patton GC, 2011, J ADOLESCENT HEALTH, V48, P275, DOI 10.1016/j.jadohealth.2010.06.019; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Pearson N, 2015, ACAD PEDIATR, V15, P9, DOI 10.1016/j.acap.2014.08.009; Peden M., 2004, WORLD REPORT ROAD TR; Penman-Aguilar A, 2013, PUBLIC HEALTH REP, V128, P5, DOI 10.1177/00333549131282S102; Pfeifer JH, 2011, NEURON, V69, P1029, DOI 10.1016/j.neuron.2011.02.019; Pilgrim NA, 2012, REV PANAM SALUD PUBL, V32, P62, DOI 10.1590/S1020-49892012000700010; Plan International and Special Representative of the UN Secretary-General on Violence against Children, 2012, PROT CHILDR HARMF PR; Porchia B R, 2014, Ann Ig, V26, P63, DOI 10.7416/ai.2014.1959; Prentice AM, 2013, AM J CLIN NUTR, V97, P911, DOI 10.3945/ajcn.112.052332; Puccio JA, 2006, AIDS PATIENT CARE ST, V20, P438, DOI 10.1089/apc.2006.20.438; Rah JH, 2008, J NUTR, V138, P1505, DOI 10.1093/jn/138.8.1505; Rausch JR, 2012, DIABETES CARE, V35, P1219, DOI 10.2337/dc11-2163; Rees R, 2006, HEALTH EDUC RES, V21, P806, DOI 10.1093/her/cyl120; Rehm J, 2007, INT J EPIDEMIOL, V36, P458, DOI 10.1093/ije/dyl294; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Reinhardt Kristina, 2014, Front Nutr, V1, P13, DOI 10.3389/fnut.2014.00013; Resnick MD, 2012, LANCET, V379, P1564, DOI 10.1016/S0140-6736(12)60472-3; Retting RA, 2003, AM J PUBLIC HEALTH, V93, P1456, DOI 10.2105/AJPH.93.9.1456; Richards M, 2005, ANN NEUROL, V58, P617, DOI 10.1002/ana.20637; Riley EP, 2005, EXP BIOL MED, V230, P357, DOI 10.1177/15353702-0323006-03; Robinson J, 2013, CRISIS, V34, P164, DOI 10.1027/0227-5910/a000168; Robinson J, 2011, AUST NZ J PSYCHIAT, V45, P3, DOI 10.3109/00048674.2010.511147; Rockwood K, 2011, CAN MED ASSOC J, V183, pE487, DOI 10.1503/cmaj.101271; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Rosen DS, 2003, J ADOLESCENT HEALTH, V33, P309, DOI 10.1016/S1054-139X(03)00208-8; Rosenberg M, 2015, INT J EPIDEMIOL, V44, P928, DOI 10.1093/ije/dyv007; Ruager-Martin R, 2010, EARLY HUM DEV, V86, P715, DOI 10.1016/j.earlhumdev.2010.08.007; Ruiz JR, 2009, BRIT J SPORT MED, V43, P909, DOI 10.1136/bjsm.2008.056499; Saavedra M., 2009, SPORT INT DEV, P124, DOI [10.1057/9780230584402_6, DOI 10.1057/9780230584402_6, DOI 10.1057/9780230584402]; Salazar L.F., 2009, ADOLESCENT HLTH UNDE, P274; Salema NEM, 2011, J ADOLESCENT HEALTH, V49, P455, DOI 10.1016/j.jadohealth.2011.02.010; Saltman E.M., 2015, TILL MARTYRDOM DO US, P3; Sanci L, 2011, J ADOLESCENT HEALTH, V49, P450, DOI 10.1016/j.jadohealth.2011.09.002; Santhya KG, 2011, CURR OPIN OBSTET GYN, V23, P334, DOI 10.1097/GCO.0b013e32834a93d2; Sasse RA, 2013, J ADOLESCENT HEALTH, V52, P786, DOI 10.1016/j.jadohealth.2012.11.019; Sawhill I.V., 2014, GENERATION UNBOUND; Sawyer SM, 2013, J PAEDIATR CHILD H, V49, P901, DOI 10.1111/jpc.12429; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Saydah S, 2013, PEDIATRICS, V131, pE679, DOI 10.1542/peds.2012-2583; Schlegel A., 1991, ADOLESCENCE ANTHROPO; Schoen C., 1998, HLTH ADOLESCENT BOYS; Schwalbe CS, 2012, CLIN PSYCHOL REV, V32, P26, DOI 10.1016/j.cpr.2011.10.002; Schwartz OS, 2014, CLIN PSYCHOL SCI, V2, P272, DOI 10.1177/2167702613505531; Sedlander E, 2015, J ADOLESCENT HEALTH, V56, P7, DOI 10.1016/j.jadohealth.2014.10.262; Sen A, 1999, COMMODITIES CAPABILI; Shaw A, 2014, COMMUNITY DEV, V45, P300, DOI 10.1080/15575330.2014.931447; Morris AS, 2007, SOC DEV, V16, P361, DOI 10.1111/j.1467-9507.2007.00389.x; Shochat T, 2014, SLEEP MED REV, V18, P75, DOI 10.1016/j.smrv.2013.03.005; Simpson HM, 2003, J SAFETY RES, V34, P25, DOI 10.1016/S0022-4375(02)00077-4; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; Smith GD, 2012, INT J EPIDEMIOL, V41, P236, DOI 10.1093/ije/dys016; Snoubar Y, EJIS, V1, P129; Somerville LH, 2013, CURR DIR PSYCHOL SCI, V22, P121, DOI 10.1177/0963721413476512; Song Y, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.26929; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Staff J, 2010, DEV PSYCHOPATHOL, V22, P917, DOI 10.1017/S0954579410000544; Starcevic V, 2015, WORLD PSYCHIATRY, V14, P97, DOI 10.1002/wps.20195; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Steinberg L, 2007, DEV PSYCHOL, V43, P1531, DOI 10.1037/0012-1649.43.6.1531; Stice E, 2006, PSYCHOL BULL, V132, P667, DOI 10.1037/0033-2909.132.5.667; Stockings EA, 2016, PSYCHOL MED, V46, P11, DOI 10.1017/S0033291715001725; Strasburger VC, 2010, PEDIATRICS, V125, P756, DOI 10.1542/peds.2009-2563; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001242, 10.1371/journal.pmed.1001235]; Suleiman AB, 2006, J COMMUNITY PRACT, V14, P125, DOI 10.1300/J125v14n01_08; Suris JC, 2015, J ADOLESCENT HEALTH, V56, P612, DOI 10.1016/j.jadohealth.2015.02.007; Taffa N, 2002, INT J STD AIDS, V13, P714, DOI 10.1258/095646202760326480; Tandon U, 2010, FAMILY PLANNING INDI; Tanner J. L., 2011, DEBATING EMERGING AD, P13, DOI DOI 10.1093/ACPROF:OSO/9780199757176.003; Terris-Prestholt F, 2006, SEX TRANSM DIS, V33, pS133, DOI 10.1097/01.olq.0000200606.98181.42; Thow AM, 2015, HEALTH POLICY, V119, P88, DOI 10.1016/j.healthpol.2014.08.002; Tomasik Martin J, 2012, New Dir Youth Dev, V2012, P27, DOI 10.1002/yd.20026; Toroyan T., 2007, YOUTH ROAD SAFETY; Tylee A, 2007, LANCET, V369, P1565, DOI 10.1016/S0140-6736(07)60371-7; U.S. Agency for International Development (USAID), 2015, ROADM HLTH MEAS ACC; Udonwa NE, 2010, AFR J PRIM HEALTH CA, V2, DOI 10.4102/phcfm.v2i1.103; UN, 2014, ROAD DIGN 2030 END P; UN DESA, 2011, WORLD MARR PATT; UN General Assembly, 1989, CONV RIGHTS CHILD; UNESCO, 2015, ED ALL GLOBAL MONITO; UNESCO Institute for Statistics and UNICEF, 2015, FIX BROK PROM ED ALL; UNFPA, STAT WORLDS POP POW; UNICEF, 2008, CHILD MARR LAW; UNICEF, 2002, STAT WORLDS CHILDR R; UNICEF, 2011, STAT WORLDS CHILDR 2; UNICEF, 2013, STATE WORLDS CHILDRE; United Nations, 2015, TRANSF OUR WORLD 203, DOI DOI 10.1163/157180910X12665776638740; United Nations, 2010, WORLD PROGR ACT YOUT; United Nations Children?s Fund (UNICEF), 2015, INV CAS ED EQ; United Nations Children's Fund, 2013, IMPR CHILD NUTR ACH; United Nations (DESA), 2007, WORLD YOUTH REP 2007; United Nations Secretary-General, 2015, GLOB STRAT WOM CHILD; Van Duijvenvoorde ACK, 2013, CURR DIR PSYCHOL SCI, V22, P108, DOI 10.1177/0963721413475446; Vanheusden K, 2008, SOC PSYCH PSYCH EPID, V43, P808, DOI 10.1007/s00127-008-0367-4; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Villa-Torres L, 2015, J ADOLESCENT HEALTH, V56, pS51, DOI 10.1016/j.jadohealth.2014.07.022; Viner RM, 2007, J EPIDEMIOL COMMUN H, V61, DOI 10.1136/jech.2005.038117; Viner RM, 2012, LANCET, V379, P1641, DOI 10.1016/S0140-6736(12)60149-4; Viner RM, 2011, LANCET, V377, P1162, DOI 10.1016/S0140-6736(11)60106-2; Volpe J. S., 1996, EFFECTS DOMESTIC VIO; Waddington C, 2015, B WORLD HEALTH ORGAN, V93, P57, DOI 10.2471/BLT.14.139741; Warren Charles W, 2009, Glob Health Promot, V16, P38, DOI 10.1177/1757975909342192; Whitaker DJ, 2006, AGGRESS VIOLENT BEH, V11, P151, DOI 10.1016/j.avb.2005.07.007; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Whiting SJ, 2004, J NUTR, V134, p696S, DOI 10.1093/jn/134.3.696S; Whitmee S, 2015, LANCET, V386, P1973, DOI 10.1016/S0140-6736(15)60901-1; WHO, 2011, KEEP PROM MEAS RES C; WHO, 2011, GUID INT IR FOL SUPP; WHO, 2015, GLOB REF LIST 100 CO; Williams AF, 2006, INJURY PREV, V12, P4, DOI 10.1136/ip.2006.011783; Winner B, 2012, NEW ENGL J MED, V366, P1998, DOI 10.1056/NEJMoa1110855; Wong NT, 2010, AM J COMMUN PSYCHOL, V46, P100, DOI 10.1007/s10464-010-9330-0; Woog V., 2015, ADOLESCENT WOMENS NE; World Bank, 2013, WORLD DEV REP 2014 R; World Bank, 2007, AGR NUTR PATHW SYN O, DOI 10.1596/28183; World Bank, 2007, WORLD DEV REP 2007 D; World Health Organisation, 2002, AD FRIENDL HLTH SERV; World Health . Organization, 2013, GUID CALC SUPPL PREG; World Health Organization, 2013, GLOB STAT REP ROAD S; World Health Organization, 2001, 2 DEC IMPR AD HLTH D; World Health Organization, 2002, WORLD REPORT VIOLENC; World Health Organization, 2011, GLOB HLTH SECT STRAT; World Health Organization, 2010, VIOLENCE PREVENTION; Yasunaga M, 2014, NONFORMAL ED MEANS M; Ybarra ML, 2014, J ADOLESCENT HEALTH, V55, P757, DOI 10.1016/j.jadohealth.2014.07.012; Yi J, 2016, QUAL HEALTH RES, V26, P1044, DOI 10.1177/1049732315599374; Yu CKH, 2006, BJOG-INT J OBSTET GY, V113, P1117, DOI 10.1111/j.1471-0528.2006.00991.x	366	1378	1402	15	207	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 11	2016	387	10036					2423	2478		10.1016/S0140-6736(16)00579-1	http://dx.doi.org/10.1016/S0140-6736(16)00579-1			56	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DO1ST	27174304	Green Submitted, Bronze, Green Published, Green Accepted			2022-12-28	WOS:000377560100036
J	Miller, MP; Asbury, CL; Biggins, S				Miller, Matthew P.; Asbury, Charles L.; Biggins, Sue			A TOG Protein Confers Tension Sensitivity to Kinetochore-Microtubule Attachments	CELL			English	Article							SISTER-CHROMATID SEPARATION; BUDDING YEAST; CHROMOSOME SEGREGATION; SPINDLE; COMPLEX; MITOSIS; DYNAMICS; XMAP215; POLYMERASE; STU2P	The development and survival of all organisms depends on equal partitioning of their genomes during cell division. Accurate chromosome segregation requires selective stabilization of kinetochore-microtubule attachments that come under tension due to opposing pulling forces exerted on sister kineto-chores by dynamic microtubule tips. Here, we show that the XMAP215 family member, Stu2, makes a major contribution to kinetochore-microtubule coupling. Stu2 and its human ortholog, ch-TOG, exhibit a conserved interaction with the Ndc80 kinetochore complex that strengthens its attachment to microtubule tips. Strikingly, Stu2 can either stabilize or destabilize kinetochore attachments, depending on the level of kinetochore tension and whether the microtubule tip is assembling or disassembling. These dichotomous effects of Stu2 are independent of its previously studied regulation of microtubule dynamics. Altogether, our results demonstrate how a kinetochore-associated factor can confer opposing, tension-dependent effects to selectively stabilize tension-bearing attachments, providing mechanistic insight into the basis for accuracy during chromosome segregation.	[Miller, Matthew P.; Biggins, Sue] Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Div Basic Sci, Seattle, WA 98109 USA; [Asbury, Charles L.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Biggins, S (corresponding author), Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Div Basic Sci, Seattle, WA 98109 USA.; Asbury, CL (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.	casbury@uw.edu; sbiggins@fredhutch.org		Biggins, Susan/0000-0002-4499-6319	Packard Fellowship [2006-30521]; NIH [R01GM079373, R01GM064386]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064386, R01GM079373] Funding Source: NIH RePORTER	Packard Fellowship(The David & Lucile Packard Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Dan Gestaut and Trisha Davis for kindly providing purified Hec1/Ndc80 complex, Shih-Chieh Ti and Tarun Kapoor for generously providing purified ch-TOG, Arshad Desai for providing antibodies, Angelika Amon, Leon Chan, Eris Duro, and Adele Marston for reagents, Geert Kops for generating an spc105-AID allele, and Neil Umbreit and Krishna Sarangapani for technical assistance. We thank Bungo Akiyoshi, Trisha Davis, Geert Kops, Luke Rice, and members of the S.B. lab for their critical reading of this manuscript. M.P.M. is an HHMI Fellow of the Damon Runyon Cancer Research Foundation. This work was supported by a Packard Fellowship 2006-30521 (to C.L.A.) and NIH grants R01GM079373 (to C.L.A) and R01GM064386 (to S.B.). S.B. is also an investigator of the Howard Hughes Medical Institute.	Akiyoshi B, 2010, NATURE, V468, P576, DOI 10.1038/nature09594; Al-Bassam J, 2006, J CELL BIOL, V172, P1009, DOI 10.1083/jcb.200511010; Al-Bassam J, 2012, MOL BIOL CELL, V23, P2878, DOI 10.1091/mbc.E12-03-0205; Al-Bassam J, 2011, TRENDS CELL BIOL, V21, P604, DOI 10.1016/j.tcb.2011.06.007; Alushin GM, 2010, NATURE, V467, P805, DOI 10.1038/nature09423; Aoki K, 2006, CURR BIOL, V16, P1627, DOI 10.1016/j.cub.2006.06.065; Aravamudhan P, 2014, CURR BIOL, V24, P1437, DOI 10.1016/j.cub.2014.05.014; Ayaz P, 2014, ELIFE, V3, DOI 10.7554/eLife.03069; Ayaz P, 2012, SCIENCE, V337, P857, DOI 10.1126/science.1221698; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Charrasse S, 1998, J CELL SCI, V111, P1371; CHARRASSE S, 1995, EUR J BIOCHEM, V234, P406, DOI 10.1111/j.1432-1033.1995.406_b.x; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a015826; Cheeseman IM, 2001, J CELL BIOL, V155, P1137, DOI 10.1083/jcb.200109063; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; DIETZ R, 1958, CHROMOSOMA, V9, P359; Fox JC, 2014, MOL BIOL CELL, V25, P2375, DOI 10.1091/mbc.E13-08-0501; Franck AD, 2007, NAT CELL BIOL, V9, P832, DOI 10.1038/ncb1609; Franck AD, 2010, METHODS, V51, P242, DOI 10.1016/j.ymeth.2010.01.020; Gandhi SR, 2011, DEV CELL, V21, P920, DOI 10.1016/j.devcel.2011.09.006; GARD DL, 1987, J CELL BIOL, V105, P2191, DOI 10.1083/jcb.105.5.2191; Gergely F, 2003, GENE DEV, V17, P336, DOI 10.1101/gad.245603; Gillett ES, 2004, J CELL BIOL, V164, P535, DOI 10.1083/jcb.200308100; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; Hanisch A, 2006, EMBO J, V25, P5504, DOI 10.1038/sj.emboj.7601426; He XW, 2000, CELL, V101, P763, DOI 10.1016/S0092-8674(00)80888-0; He XW, 2001, CELL, V106, P195, DOI 10.1016/S0092-8674(01)00438-X; Kalantzaki M, 2015, NAT CELL BIOL, V17, P421, DOI 10.1038/ncb3128; Kitamura E, 2010, DEV CELL, V18, P248, DOI 10.1016/j.devcel.2009.12.018; Kosco KA, 2001, MOL BIOL CELL, V12, P2870, DOI 10.1091/mbc.12.9.2870; Krenn V, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00225; Ma L, 2007, MOL BIOL CELL, V18, P2805, DOI 10.1091/mbc.E06-09-0882; Marco E, 2013, CELL, V154, P1127, DOI 10.1016/j.cell.2013.08.008; Maure JF, 2011, CURR BIOL, V21, P207, DOI 10.1016/j.cub.2010.12.050; McCleland ML, 2004, CURR BIOL, V14, P131, DOI 10.1016/j.cub.2003.12.058; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; NICKLAS RB, 1969, J CELL BIOL, V43, P40, DOI 10.1083/jcb.43.1.40; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Nogales E, 2009, J CELL SCI, V122, P3831, DOI 10.1242/jcs.004689; OHKURA H, 1988, EMBO J, V7, P1465, DOI 10.1002/j.1460-2075.1988.tb02964.x; Pearson CG, 2003, MOL BIOL CELL, V14, P4181, DOI 10.1091/mbc.e03-03-0180; Pearson CG, 2001, J CELL BIOL, V152, P1255, DOI 10.1083/jcb.152.6.1255; Podolski M, 2014, J BIOL CHEM, V289, P28087, DOI 10.1074/jbc.M114.584300; Powers AF, 2009, CELL, V136, P865, DOI 10.1016/j.cell.2008.12.045; Severin F, 2001, J CELL BIOL, V153, P435, DOI 10.1083/jcb.153.2.435; Sherman F., 1974, METHODS YEAST GENETI; Shirasu-Hiza M, 2003, J CELL BIOL, V161, P349, DOI 10.1083/jcb.200211095; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; Tanaka K, 2005, NATURE, V434, P987, DOI 10.1038/nature03483; Tang NH, 2013, MOL BIOL CELL, V24, P1122, DOI 10.1091/mbc.E12-11-0817; Trushko A, 2013, P NATL ACAD SCI USA, V110, P14670, DOI 10.1073/pnas.1218053110; Umbreit NT, 2012, P NATL ACAD SCI USA, V109, P16113, DOI 10.1073/pnas.1209615109; van Breugel M, 2003, J CELL BIOL, V161, P359, DOI 10.1083/jcb.200211097; Wang PJJ, 1997, J CELL BIOL, V139, P1271, DOI 10.1083/jcb.139.5.1271; Welburn JPI, 2009, DEV CELL, V16, P374, DOI 10.1016/j.devcel.2009.01.011; Widlund PO, 2011, P NATL ACAD SCI USA, V108, P2741, DOI 10.1073/pnas.1016498108; Wigge PA, 2001, J CELL BIOL, V152, P349, DOI 10.1083/jcb.152.2.349	61	94	97	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2016	165	6					1428	1439		10.1016/j.cell.2016.04.030	http://dx.doi.org/10.1016/j.cell.2016.04.030			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DN4NV	27156448	Green Accepted, Bronze			2022-12-28	WOS:000377045400016
J	Katmis, F; Lauter, V; Nogueira, FS; Assaf, BA; Jamer, ME; Wei, P; Satpati, B; Freeland, JW; Eremin, I; Heiman, D; Jarillo-Herrero, P; Moodera, JS				Katmis, Ferhat; Lauter, Valeria; Nogueira, Flavio S.; Assaf, Badih A.; Jamer, Michelle E.; Wei, Peng; Satpati, Biswarup; Freeland, John W.; Eremin, Ilya; Heiman, Don; Jarillo-Herrero, Pablo; Moodera, Jagadeesh S.			A high-temperature ferromagnetic topological insulating phase by proximity coupling	NATURE			English	Article							MAJORANA FERMIONS; SURFACE	Topological insulators are insulating materials that display conducting surface states protected by time-reversal symmetry(1,)2, wherein electron spins are locked to their momentum. This unique property opens up new opportunities for creating next-generation electronic, spintronic and quantum computation devices(3-5). Introducing ferromagnetic order into a topological insulator system without compromising its distinctive quantum coherent features could lead to the realization of several predicted physical phenomena(6,7). In particular, achieving robust long-range magnetic order at the surface of the topological insulator at specific locations without introducing spin-scattering centres could open up new possibilities for devices. Here we use spin-polarized neutron reflectivity experiments to demonstrate topologically enhanced interface magnetism by coupling a ferromagnetic insulator (EuS) to a topological insulator (Bi2Se3) in a bilayer system. This interfacial ferromagnetism persists up to room temperature, even though the ferromagnetic insulator is known to order ferromagnetically only at low temperatures (<17 K). The magnetism induced at the interface resulting from the large spin-orbit interaction and the spin-momentum locking of the topological insulator surface greatly enhances the magnetic ordering (Curie) temperature of this bilayer system. The ferromagnetism extends similar to 2 nm into the Bi2Se3 from the interface. Owing to the short-range nature of the ferromagnetic exchange interaction, the time-reversal symmetry is broken only near the surface of a topological insulator, while leaving its bulk states unaffected. The topological magneto-electric response originating in such an engineered topological insulator(2,8) could allow efficient manipulation of the magnetization dynamics by an electric field, providing an energy-efficient topological control mechanism for future spin-based technologies.	[Katmis, Ferhat; Wei, Peng; Jarillo-Herrero, Pablo; Moodera, Jagadeesh S.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Katmis, Ferhat; Wei, Peng; Moodera, Jagadeesh S.] MIT, Francis Bitter Magnet Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Katmis, Ferhat; Wei, Peng; Moodera, Jagadeesh S.] MIT, Plasma Sci & Fus Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Lauter, Valeria] Oak Ridge Natl Lab, Neutron Sci Directorate, Quantum Condensed Matter Div, Oak Ridge, TN 37831 USA; [Nogueira, Flavio S.; Eremin, Ilya] Ruhr Univ Bochum, Inst Theoret Phys 3, D-44801 Bochum, Germany; [Nogueira, Flavio S.] Inst Festkoerper & Werkstoffforsch Dresden, Inst Theoret Solid State Phys, D-01069 Dresden, Germany; [Assaf, Badih A.; Jamer, Michelle E.; Heiman, Don] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Assaf, Badih A.] Paris Sci & Lettres Res Univ, CNRS, Ecole Normale Super, Dept Phys, F-75005 Paris, France; [Satpati, Biswarup] Saha Inst Nucl Phys, 1-AF Bidhannagar, Kolkata 64, India; [Freeland, John W.] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); United States Department of Energy (DOE); Oak Ridge National Laboratory; Ruhr University Bochum; Northeastern University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Saha Institute of Nuclear Physics; United States Department of Energy (DOE); Argonne National Laboratory	Katmis, F; Moodera, JS (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.; Katmis, F; Moodera, JS (corresponding author), MIT, Francis Bitter Magnet Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Katmis, F; Moodera, JS (corresponding author), MIT, Plasma Sci & Fus Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	katmis@mit.edu; moodera@mit.edu	Wei, Peng/L-5738-2013; Lauter, Valeria/AAP-4805-2021; Satpati, Biswarup/B-5194-2013; Assaf, Badih/AAE-9457-2020; Nogueira, Flavio S/G-1064-2012; Eremin, Ilya/M-2079-2016; Jarillo-Herrero, Pablo/E-3755-2013	Wei, Peng/0000-0003-2289-6007; Lauter, Valeria/0000-0003-0989-6563; Satpati, Biswarup/0000-0003-1175-7562; Nogueira, Flavio S/0000-0001-7296-5096; Eremin, Ilya/0000-0003-0557-8015; Assaf, Badih A./0000-0002-6879-9651; Jamer, Michelle/0000-0001-5316-8817; Jarillo-Herrero, Pablo/0000-0001-8217-8213	Scientific User Facilities Division, Office of Basic Energy Sciences; US Department of Energy; MIT MRSEC through the MRSEC Program of the National Science Foundation [DMR-0819762]; National Science Foundation [DMR-1207469, DMR-0907007, ECCS-1402738]; Office of Naval Research [N00014-13-1-0301]; STC Center for Integrated Quantum Materials under National Science Foundation [DMR-1231319]; US Department of Energy, Basic Energy Sciences Office, Division of Material Sciences and Engineering [DE-SC0006418]; Agence Nationale de la Recherche LabEx grants ENS-ICFP [ANR-10-LABX-0010/ANR-10-IDEX-0001-02 PSL]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; German Research Council (DFG) under the collaborative research centre [SFB TR 12]; German Research Council (DFG) under the priority programme SPP 1666 [ER 463/9]; Direct For Mathematical & Physical Scien [1207469] Funding Source: National Science Foundation; Div Of Electrical, Commun & Cyber Sys [1402738] Funding Source: National Science Foundation	Scientific User Facilities Division, Office of Basic Energy Sciences(United States Department of Energy (DOE)); US Department of Energy(United States Department of Energy (DOE)); MIT MRSEC through the MRSEC Program of the National Science Foundation; National Science Foundation(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); STC Center for Integrated Quantum Materials under National Science Foundation; US Department of Energy, Basic Energy Sciences Office, Division of Material Sciences and Engineering(United States Department of Energy (DOE)); Agence Nationale de la Recherche LabEx grants ENS-ICFP(French National Research Agency (ANR)); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); German Research Council (DFG) under the collaborative research centre(German Research Foundation (DFG)); German Research Council (DFG) under the priority programme SPP 1666(German Research Foundation (DFG)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Div Of Electrical, Commun & Cyber Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	F.K. thanks L. Fu, V. Madhavan, N. Gedik, B. Sinkovic, Y. Wang and H. Lin for discussions. V.L. thanks S. Nagler for discussions, and H. Ambaye, A. Glavic and the Spallation Neutron Source staff for support. The research conducted at ORNL's Spallation Neutron Source was sponsored by the Scientific User Facilities Division, Office of Basic Energy Sciences, and the US Department of Energy. F.K., P.J.-H., and J.S.M. thank the MIT MRSEC through the MRSEC Program of the National Science Foundation under award number DMR-0819762 (upgrade of the molecular beam epitaxy system) for support. J.S.M. thanks the National Science Foundation (DMR-1207469), Office of Naval Research (N00014-13-1-0301) and the STC Center for Integrated Quantum Materials under National Science Foundation grant DMR-1231319 for support, and the thin-film growth and characterization of the materials used. The hetero-structure characterization was supported by the US Department of Energy, Basic Energy Sciences Office, Division of Material Sciences and Engineering under award number DE-SC0006418 (F.K. and P.J.-H.). B.A.A., M.E.J. and D.H. thank the National Science Foundation under award numbers DMR-0907007 and ECCS-1402738 (for SQUID magnetometry characterization) for support. B.A.A. is also supported in part by the Agence Nationale de la Recherche LabEx grants ENS-ICFP (ANR-10-LABX-0010/ANR-10-IDEX-0001-02 PSL). The use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract number DE-AC02-06CH11357. I.E. and F.S.N. acknowledge the German Research Council (DFG) for the financial support under the collaborative research centre SFB TR 12 and the priority programme SPP 1666 (grant number ER 463/9).	Akhmerov AR, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.216404; Arenholz E, 2009, J APPL PHYS, V105, DOI 10.1063/1.3054364; Assaf BA, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3697998; Chang CZ, 2013, SCIENCE, V340, P167, DOI 10.1126/science.1234414; CHAPPERT C, 1988, J APPL PHYS, V64, P5736, DOI 10.1063/1.342243; Checkelsky JG, 2014, NAT PHYS, V10, P731, DOI [10.1038/NPHYS3053, 10.1038/nphys3053]; Chen YL, 2010, SCIENCE, V329, P659, DOI 10.1126/science.1189924; Essin AM, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.146805; Ferreira GJ, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.106802; Fu L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.096407; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Idzuchi H, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.113002; Kinoshita T, 2002, J PHYS SOC JPN, V71, P148, DOI 10.1143/JPSJ.71.148; KORNEEV DA, 1992, NUCL INSTRUM METH B, V63, P328, DOI 10.1016/0168-583X(92)95117-A; Lauter V, 2009, PHYSICA B, V404, P2543, DOI 10.1016/j.physb.2009.06.021; Mellnik AR, 2014, NATURE, V511, P449, DOI 10.1038/nature13534; Miao GX, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3130230; Miyazaki H, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3416911; Nadj-Perge S, 2014, SCIENCE, V346, P602, DOI 10.1126/science.1259327; Nogueira FS, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.237203; Ott H, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.094407; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Qi XL, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195424; Scholz MR, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.256810; Semenov YG, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.161406; Starovoitov S. A., 1987, SOV TECH PHYS LETT, V13, P642; Stoehr J., 2006, MAGNETISM FUNDAMENTA; Tserkovnyak Y, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.187201; Vobornik I, 2011, NANO LETT, V11, P4079, DOI 10.1021/nl201275q; VONMOLNAR S, 1968, PHYS REV LETT, V21, P1757, DOI 10.1103/PhysRevLett.21.1757; Wei P, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.186807; WELLER D, 1985, PHYS REV LETT, V54, P1555, DOI 10.1103/PhysRevLett.54.1555; Xu SY, 2012, NAT PHYS, V8, P616, DOI [10.1038/nphys2351, 10.1038/NPHYS2351]; Yokoyama T, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.241410; Zhu T, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4718423	36	288	293	9	381	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2016	533	7604					513	+		10.1038/nature17635	http://dx.doi.org/10.1038/nature17635			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6EJ	27225124	Green Submitted			2022-12-28	WOS:000376443100036
J	Jensen, K				Jensen, Kimberley			John Mark Hinton OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		HINTON JM, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2016	353								i2773	10.1136/bmj.i2773	http://dx.doi.org/10.1136/bmj.i2773			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GI	27207614				2022-12-28	WOS:000376448200004
J	O'Keeffe, H				O'Keeffe, Helen			NEUTRINO PHYSICS A deliberate mix-up in flavour	NATURE			English	Editorial Material									[O'Keeffe, Helen] Univ Lancaster, Dept Phys, Lancaster LA1 4YB, England	Lancaster University	O'Keeffe, H (corresponding author), Univ Lancaster, Dept Phys, Lancaster LA1 4YB, England.	h.okeeffe@lancaster.ac.uk	O'Keeffe, Helen Mary/AAC-4361-2019	O'Keeffe, Helen Mary/0000-0002-4593-3598	STFC [ST/M00001X/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/M00001X/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Abe K, 2015, PHYS REV D, V91, DOI 10.1103/PhysRevD.91.072010; Abe K, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.061802; Acciarri R., 2016, PREPRINT; Adamson P, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.191801; Adamson P., 2016, PREPRINT; Ahn JK, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.191802; An FP, 2016, PHYS REV D, V93, DOI 10.1103/PhysRevD.93.072011	8	1	1	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					327	328		10.1038/533327a	http://dx.doi.org/10.1038/533327a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0AH	27193675				2022-12-28	WOS:000376004300033
J	Plaschka, C; Hantsche, M; Dienemann, C; Burzinski, C; Plitzko, J; Cramer, P				Plaschka, C.; Hantsche, M.; Dienemann, C.; Burzinski, C.; Plitzko, J.; Cramer, P.			Transcription initiation complex structures elucidate DNA opening	NATURE			English	Article							RNA-POLYMERASE-II; CRYSTAL-STRUCTURE; PREINITIATION COMPLEX; IMMEDIATELY UPSTREAM; PROMOTER DNA; FACTOR TFIIF; ARCHITECTURE; DOMAINS; VISUALIZATION; MECHANISM	Transcription of eukaryotic protein-coding genes begins with assembly of the RNA polymerase (Pol) II initiation complex and promoter DNA opening. Here we report cryo-electron microscopy (cryo-EM) structures of yeast initiation complexes containing closed and open DNA at resolutions of 8.8 angstrom and 3.6 angstrom, respectively. DNA is positioned and retained over the Pol II cleft by a network of interactions between the TATA-box-binding protein TBP and transcription factors TFIIA, TFIIB, TFIIE, and TFIIF. DNA opening occurs around the tip of the Pol II clamp and the TFIIE 'extended winged helix' domain, and can occur in the absence of TFIIH. Loading of the DNA template strand into the active centre may be facilitated by movements of obstructing protein elements triggered by allosteric binding of the TFIIE 'E-ribbon' domain. The results suggest a unified model for transcription initiation with a key event, the trapping of open promoter DNA by extended protein-protein and protein-DNA contacts.	[Plaschka, C.; Hantsche, M.; Dienemann, C.; Burzinski, C.; Cramer, P.] Max Planck Inst Biophys Chem, Dept Mol Biol, Fassberg 11, D-37077 Gottingen, Germany; [Plitzko, J.] Max Planck Inst Biochem, Klopferspitz 18, D-82152 Martinsried, Germany	Max Planck Society; Max Planck Society	Cramer, P (corresponding author), Max Planck Inst Biophys Chem, Dept Mol Biol, Fassberg 11, D-37077 Gottingen, Germany.	patrick.cramer@mpibpc.mpg.de	Plitzko, Juergen M/H-9576-2014	Plitzko, Juergen M/0000-0002-6402-8315; Plaschka, Clemens/0000-0002-6020-9514; Hantsche-Grininger, Merle/0000-0002-5137-1616; Dienemann, Christian/0000-0002-2172-5110	Deutsche Forschungsgemeinschaft; European Research Council; Volkswagen Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Volkswagen Foundation(Volkswagen)	We thank C. Bernecky, W. Muhlbacher, S. Neyer, S. Sainsbury, and D. Tegunov for help and discussions; L. Lariviere and L. Wenzeck for cloning and initial purification of TFIIE; W. Muhlbacher for initial cloning of TFIIA; S. Bilakovic for the modified pET-DUET-1 vector; J. Mahamid for help with data collection for the CC; K. Maier for help with yeast growth assays; M. Raabe and H. Urlaub for protein identification; K. Kinkelin for initial Pol II-TFIIF co-crystallization; and S. Hahn for providing the TFA1 yeast strain and the shuffle plasmid pSH810. C.P. (SFB860), M. H. (GRK1721), and P.C. were supported by the Deutsche Forschungsgemeinschaft, the Advanced Grant TRANSIT of the European Research Council, and the Volkswagen Foundation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bae B, 2015, ELIFE, V4, DOI 10.7554/eLife.08504; Baumli S, 2005, J BIOL CHEM, V280, P18171, DOI 10.1074/jbc.M413466200; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Blombach F, 2015, ELIFE, V4, DOI 10.7554/eLife.08378; BURATOWSKI S, 1991, P NATL ACAD SCI USA, V88, P7509, DOI 10.1073/pnas.88.17.7509; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; Cabart P, 2012, J BIOL CHEM, V287, P961, DOI 10.1074/jbc.M111.297572; Cabart P, 2011, P NATL ACAD SCI USA, V108, P15786, DOI 10.1073/pnas.1104591108; Chakraborty A, 2012, SCIENCE, V337, P591, DOI 10.1126/science.1218716; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Deng WS, 2007, CHROMOSOMA, V116, P417, DOI 10.1007/s00412-007-0113-9; Eichner J, 2010, EMBO J, V29, P706, DOI 10.1038/emboj.2009.386; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esnault C, 2008, MOL CELL, V31, P337, DOI 10.1016/j.molcel.2008.06.021; Eswar N., CURRENT PROTOC BIOIN; Feklistov A, 2011, CELL, V147, P1257, DOI 10.1016/j.cell.2011.10.041; Fishburn J, 2012, MOL CELL BIOL, V32, P12, DOI 10.1128/MCB.06242-11; Forget D, 2004, MOL CELL BIOL, V24, P1122, DOI 10.1128/MCB.24.3.1122-1131.2004; Gaiser F, 2000, J MOL BIOL, V302, P1119, DOI 10.1006/jmbi.2000.4110; Geiger JH, 1996, SCIENCE, V272, P830, DOI 10.1126/science.272.5263.830; GIARDINA C, 1993, SCIENCE, V261, P759, DOI 10.1126/science.8342041; Grohmann D, 2011, MOL CELL, V43, P263, DOI 10.1016/j.molcel.2011.05.030; Grunberg S, 2013, TRENDS BIOCHEM SCI, V38, P603, DOI 10.1016/j.tibs.2013.09.002; Grunberg S, 2012, NAT STRUCT MOL BIOL, V19, P788, DOI 10.1038/nsmb.2334; HA I, 1993, GENE DEV, V7, P1021, DOI 10.1101/gad.7.6.1021; Harami GM, 2013, TRENDS BIOCHEM SCI, V38, P364, DOI 10.1016/j.tibs.2013.04.006; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Holstege FCP, 1996, EMBO J, V15, P1666, DOI 10.1002/j.1460-2075.1996.tb00512.x; HOLSTEGE FCP, 1995, EMBO J, V14, P810, DOI 10.1002/j.1460-2075.1995.tb07059.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kilpatrick AM, 2012, PROTEINS, V80, P519, DOI 10.1002/prot.23217; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; Kinkelin K, 2013, P NATL ACAD SCI USA, V110, P15277, DOI 10.1073/pnas.1311010110; Korinek A, 2011, J STRUCT BIOL, V175, P394, DOI 10.1016/j.jsb.2011.06.003; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Kouzine F, 2013, CELL, V153, P988, DOI 10.1016/j.cell.2013.04.033; Li XM, 2013, J STRUCT BIOL, V184, P251, DOI 10.1016/j.jsb.2013.08.005; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; Martinez-Rucobo FW, 2011, EMBO J, V30, P1302, DOI 10.1038/emboj.2011.64; MAXON ME, 1994, GENE DEV, V8, P515, DOI 10.1101/gad.8.5.515; Meinhart A, 2003, J BIOL CHEM, V278, P48267, DOI 10.1074/jbc.M307874200; Miller G, 2006, NAT STRUCT MOL BIOL, V13, P603, DOI 10.1038/nsmb1117; Muhlbacher W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5310; Murakami K, 2015, P NATL ACAD SCI USA, V112, P13543, DOI 10.1073/pnas.1518255112; Murakami K, 2013, SCIENCE, V342, P709, DOI 10.1126/science.1238724; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; OHKUMA Y, 1994, NATURE, V368, P160, DOI 10.1038/368160a0; Okamoto T, 1998, J BIOL CHEM, V273, P19866, DOI 10.1074/jbc.273.31.19866; Okuda M, 2004, J BIOL CHEM, V279, P51395, DOI 10.1074/jbc.M404722200; Okuda M, 2000, EMBO J, V19, P1346, DOI 10.1093/emboj/19.6.1346; Okuda M, 2008, EMBO J, V27, P1161, DOI 10.1038/emboj.2008.47; PAN GH, 1994, J BIOL CHEM, V269, P30101; PARVIN JD, 1992, CELL, V68, P1135, DOI 10.1016/0092-8674(92)90084-P; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plaschka C, 2015, NATURE, V518, P376, DOI 10.1038/nature14229; Robert F, 1996, J BIOL CHEM, V271, P8517, DOI 10.1074/jbc.271.15.8517; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Sainsbury S, 2015, NAT REV MOL CELL BIO, V16, P129, DOI 10.1038/nrm3952; Sainsbury S, 2013, NATURE, V493, P437, DOI 10.1038/nature11715; Scheres SHW, 2015, J STRUCT BIOL, V189, P114, DOI 10.1016/j.jsb.2014.11.010; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Seizl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027595; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Nguyen THD, 2015, NATURE, V523, P47, DOI 10.1038/nature14548; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang Y, 2015, SCIENCE, V349, P882, DOI 10.1126/science.aab1478; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786; Zuo YH, 2015, MOL CELL, V58, P534, DOI 10.1016/j.molcel.2015.03.010	79	143	144	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					353	+		10.1038/nature17990	http://dx.doi.org/10.1038/nature17990			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0AH	27193681				2022-12-28	WOS:000376004300040
J	Caulfield, T; Sipp, D; Murry, CE; Daley, GQ; Kimmelman, J				Caulfield, Timothy; Sipp, Douglas; Murry, Charles E.; Daley, George Q.; Kimmelman, Jonathan			Confronting stem cell hype	SCIENCE			English	Editorial Material							SCIENCE; MEDIA		[Caulfield, Timothy] Univ Alberta, Hlth Law Inst, Edmonton, AB T6G 2H5, Canada; [Sipp, Douglas] Riken Ctr Dev Biol, Kobe, Hyogo 6500047, Japan; [Sipp, Douglas] Keio Univ, Sch Med, Tokyo 1608582, Japan; [Murry, Charles E.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA; [Daley, George Q.] Harvard Univ, Boston Childrens Hosp, Sch Med, Boston, MA 02115 USA; [Kimmelman, Jonathan] McGill Univ, Biomed Eth Unit, STREAM Res Grp, Montreal, PQ H3A 1X1, Canada	University of Alberta; RIKEN; Keio University; University of Washington; University of Washington Seattle; Harvard University; Boston Children's Hospital; Harvard Medical School; McGill University	Caulfield, T (corresponding author), Univ Alberta, Hlth Law Inst, Edmonton, AB T6G 2H5, Canada.	caulfield@ualberta.ca	Sipp, Douglas/C-9218-2017	Sipp, Douglas/0000-0002-5979-0938				Abola MV, 2016, JAMA ONCOL, V2, P139, DOI 10.1001/jamaoncol.2015.3931; Bianco P, 2014, NATURE, V510, P336, DOI 10.1038/510336a; Bik HM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001535; Bubela T, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-133; Caplan A., 2011, SCI PROGR       0418; Caulfield T, 2012, PUBLIC HEALTH GENOM, V15, P209, DOI 10.1159/000336533; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; ISSCR, 2016, GUID STEM CELL SCI C; Kamenova K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010496; Kimmelman J, 2007, HASTINGS CENT REP, V37, P36, DOI 10.1353/hcr.2007.0092; London AJ, 2015, ELIFE, V4, DOI 10.7554/eLife.12844; Love B, 2013, AM J INFECT CONTROL, V41, P568, DOI 10.1016/j.ajic.2012.10.016; National Health Service, 2011, HOP HYP AN STEM CELL; Nisbet M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088473; Petersen A, 2015, J SOCIOL, V51, P28, DOI 10.1177/1440783314562314; Rinaldi A, 2012, EMBO REP, V13, P303, DOI 10.1038/embor.2012.39; Sharpe K, 2016, STEM CELL REV REP, V12, P1, DOI 10.1007/s12015-015-9627-3; Shineha R, 2016, E ASIAN SCI TECH SOC, V10, P229, DOI 10.1215/18752160-3326668; Thaler AD, 2015, OCEAN COAST MANAGE, V115, P88, DOI 10.1016/j.ocecoaman.2015.04.005; The Royal Society, 2000, SCI MED GUID SCI WOR; Vinkers CH, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6467; Woloshin S, 2009, ANN INTERN MED, V150, P613, DOI 10.7326/0003-4819-150-9-200905050-00007	22	86	87	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2016	352	6287					776	777		10.1126/science.aaf4620	http://dx.doi.org/10.1126/science.aaf4620			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5FP	27174977				2022-12-28	WOS:000375663000023
J	Pehrsson, EC; Tsukayama, P; Patel, S; Mejia-Bautista, M; Sosa-Soto, G; Navarrete, KM; Alderon, MC; Abrera, LC; Hoyos-Arango, W; Bertoli, MT; Berg, DE; Gilman, RH; Dantas, G				Pehrsson, Erica C.; Tsukayama, Pablo; Patel, Sanket; Mejia-Bautista, Melissa; Sosa-Soto, Giordano; Navarrete, Karla M.; Alderon, Maritza C.; Abrera, Lilia C.; Hoyos-Arango, William; Teresita Bertoli, M.; Berg, Douglas E.; Gilman, Robert H.; Dantas, Gautam			Interconnected microbiomes and resistomes in low-income human habitats	NATURE			English	Article							ANTIBIOTIC-RESISTANCE GENES; WATER; COMMUNITY; SANITATION; BACTERIA	Antibiotic-resistant infections annually claim hundreds of thousands of lives worldwide. This problem is exacerbated by exchange of resistance genes between pathogens and benign microbes from diverse habitats. Mapping resistance gene dissemination between humans and their environment is a public health priority. Here we characterized the bacterial community structure and resistance exchange networks of hundreds of interconnected human faecal and environmental samples from two low-income Latin American communities. We found that resistomes across habitats are generally structured by bacterial phylogeny along ecological gradients, but identified key resistance genes that cross habitat boundaries and determined their association with mobile genetic elements. We also assessed the effectiveness of widely used excreta management strategies in reducing faecal bacteria and resistance genes in these settings representative of low- and middle-income countries. Our results lay the foundation for quantitative risk assessment and surveillance of resistance gene dissemination across interconnected habitats in settings representing over two-thirds of the world's population.	[Pehrsson, Erica C.; Tsukayama, Pablo; Patel, Sanket; Mejia-Bautista, Melissa; Sosa-Soto, Giordano; Dantas, Gautam] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63110 USA; [Patel, Sanket; Dantas, Gautam] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Mejia-Bautista, Melissa; Sosa-Soto, Giordano; Navarrete, Karla M.; Hoyos-Arango, William; Teresita Bertoli, M.] Univ Dr Jose Matias Delgado, Fac Ciencias Salud Dr Luis Edmundo Vasquez, Antiguo Cuscatlan, El Salvador; [Alderon, Maritza C.; Gilman, Robert H.] Univ Peruana Cayetano Heredia, Labs Invest & Desarrollo, Lima 31, Peru; [Abrera, Lilia C.; Gilman, Robert H.] Asociac Benef PRISMA, Lima 32, Peru; [Berg, Douglas E.; Dantas, Gautam] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Berg, Douglas E.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Gilman, Robert H.] Johns Hopkins Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Dantas, Gautam] Washington Univ, Dept Biomed Engn, St Louis, MO 63105 USA	Washington University (WUSTL); Washington University (WUSTL); Universidad Peruana Cayetano Heredia; Washington University (WUSTL); University of California System; University of California San Diego; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Washington University (WUSTL)	Dantas, G (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63110 USA.; Dantas, G (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Dantas, G (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Dantas, G (corresponding author), Washington Univ, Dept Biomed Engn, St Louis, MO 63105 USA.	dantas@wustl.edu		Pehrsson, Erica/0000-0002-2968-6179; Dantas, Gautam/0000-0003-0455-8370; Tsukayama, Pablo/0000-0002-1669-2553; Calderon Sanchez, Maritza Mercedes/0000-0001-6582-7306	Edward Mallinckrodt, Jr. Foundation; Children's Discovery Institute [MD-II-2011-117]; National Institute of General Medical Sciences of the National Institutes of Health [R01-GM099538]; Department of Defense (DoD) through the National Defense Science and Engineering Graduate (NDSEG) Fellowship; MRC [MR/K007467/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099538] Funding Source: NIH RePORTER; Medical Research Council [MR/K007467/1] Funding Source: researchfish	Edward Mallinckrodt, Jr. Foundation; Children's Discovery Institute; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Defense (DoD) through the National Defense Science and Engineering Graduate (NDSEG) Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the residents of our study communities in El Salvador and Peru for their generosity and trust, without which this study would not have been possible; Epilogos Charities Inc. for on-site logistical support and community networking; the Fundacion Luis Edmundo Vasquez (FUNDALEV), Universidad Dr. Jose Matias Delgado, Asociacion Benefica Prisma, and Universidad Peruana Cayetano Heredia for logistical support in the collection and shipment of samples; S. del Pilar Basilio at SEDAPAL in Lima for facilitating access and sample collection at the 'PTAR San Juan' WWTP; J. Hoisington-Lopez at the Center for Genome Sciences and Systems Biology and staff at the Genome Technology Access Center at Washington University School of Medicine for generating Illumina sequencing data; S. Alvarez and staff at the Proteomics & Mass Spectrometry Facility at the Donald Danforth Plant Science Center for mass-spectrometry analyses of water samples; and members of the Dantas laboratory for discussions of the results and analyses. This work is supported in part by awards to G.D. through the Edward Mallinckrodt, Jr. Foundation (Scholar Award), the Children's Discovery Institute (MD-II-2011-117), and the National Institute of General Medical Sciences of the National Institutes of Health (R01-GM099538). Work at the DDPSC was supported by the National Science Foundation (DBI-0521250) for acquisition of the QTRAP LC-MS/MS instrument. E.C.P. is funded by the Department of Defense (DoD) through the National Defense Science and Engineering Graduate (NDSEG) Fellowship. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.	Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Allen HK, 2009, ISME J, V3, P243, DOI 10.1038/ismej.2008.86; [Anonymous], 2015, GLOB HLTH OBS IND ES; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Centers for Disease Control and Prevention, 2013, ANT RES THREATS US; Checkley W, 2004, LANCET, V363, P112, DOI 10.1016/S0140-6736(03)15261-0; Clemente JC, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500183; Cooper MA, 2010, J INFECT DIS, V202, P1713, DOI 10.1086/657142; Corrales LF, 2006, TROP MED INT HEALTH, V11, P1821, DOI 10.1111/j.1365-3156.2006.01737.x; Cullen TW, 2015, SCIENCE, V347, P170, DOI 10.1126/science.1260580; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Forsberg KJ, 2014, NATURE, V509, P612, DOI 10.1038/nature13377; Forsberg KJ, 2012, SCIENCE, V337, P1107, DOI 10.1126/science.1220761; Gibson MK, 2015, ISME J, V9, P207, DOI 10.1038/ismej.2014.106; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; Hu YF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3151; HUOVINEN P, 1995, ANTIMICROB AGENTS CH, V39, P279, DOI 10.1128/AAC.39.2.279; Kaminski J, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004557; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Li B, 2015, ISME J, V9, P2490, DOI 10.1038/ismej.2015.59; Li B, 2009, ANAL CHIM ACTA, V645, P64, DOI 10.1016/j.aca.2009.04.042; Lozupone CA, 2013, GENOME RES, V23, P1704, DOI 10.1101/gr.151803.112; Martinez JL, 2015, NAT REV MICROBIOL, V13, P116, DOI 10.1038/nrmicro3399; Martinez JL, 2009, P ROY SOC B-BIOL SCI, V276, P2521, DOI 10.1098/rspb.2009.0320; McArthur AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; Moore AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078822; Munck C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9452; Obregon-Tito AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7505; Okeke IN, 2005, LANCET INFECT DIS, V5, P481, DOI 10.1016/S1473-3099(05)70189-4; ONeill J, 2014, REV AMR ANTIMICROBIA; Oswald WE, 2007, AM J TROP MED HYG, V77, P699, DOI 10.4269/ajtmh.2007.77.699; Pallecchi L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001790; Patil KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038581; Pehrsson EC, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00145; Rampelli S, 2015, CURR BIOL, V25, P1682, DOI 10.1016/j.cub.2015.04.055; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Smillie CS, 2011, NATURE, V480, P241, DOI 10.1038/nature10571; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Stalder T, 2014, ISME J, V8, P768, DOI 10.1038/ismej.2013.189; The World Bank Group, 2015, DAT COUNTR HIGH INC; The World Bank Group, 2015, DAT TOP URB DEV; Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7; Walson JL, 2001, J INFECT DIS, V184, P1163, DOI 10.1086/323647; WHO / UNICEF Joint Monitoring Programme (JMP) for Water Supply and Sanitation, 2015, EL SALV EST US WAT S; World Health Organization, 2016, ANTIMICROBIAL RESIST; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	55	292	302	16	244	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					212	+		10.1038/nature17672	http://dx.doi.org/10.1038/nature17672			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0BJ	27172044	Green Accepted			2022-12-28	WOS:000376007200042
J	Sarewitz, D				Sarewitz, Daniel			The pressure to publish pushes down quality	NATURE			English	Editorial Material									[Sarewitz, Daniel] Arizona State Univ, Consortium Sci Policy & Outcomes, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Sarewitz, D (corresponding author), Arizona State Univ, Consortium Sci Policy & Outcomes, Tempe, AZ 85287 USA.	daniel.sarewitz@asu.edu							0	77	80	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					147	147		10.1038/533147a	http://dx.doi.org/10.1038/533147a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM0BJ	27172010	Bronze			2022-12-28	WOS:000376007200013
J	Afzal, S; Tybjaerg-Hansen, A; Jensen, GB; Nordestgaard, BG				Afzal, Shoaib; Tybjaerg-Hansen, Anne; Jensen, Gorm B.; Nordestgaard, Borge G.			Change in Body Mass Index Associated With Lowest Mortality in Denmark, 1976-2013	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALL-CAUSE MORTALITY; BLOOD-PRESSURE; OBESITY; RISK; OVERWEIGHT; DEATH; UNDERWEIGHT; CATEGORIES; ADIPOSITY; MEDIATORS	IMPORTANCE Research has shown a U-shaped pattern in the association of body mass index (BMI) with mortality. Although average BMI has increased over time in most countries, the prevalence of cardiovascular risk factors may also be decreasing among obese individuals over time. Thus, the BMI associated with lowest all-cause mortality may have changed. OBJECTIVE To determine whether the BMI value that is associated with the lowest all-cause mortality has increased in the general population over a period of 3 decades. DESIGN, SETTING, AND PARTICIPANTS Three cohorts from the same general population enrolled at different times: the Copenhagen City Heart Study in 1976-1978 (n = 13 704) and 1991-1994 (n = 9482) and the Copenhagen General Population Study in 2003-2013 (n = 97 362). All participants were followed up from inclusion in the studies to November 2014, emigration, or death, whichever came first. EXPOSURES For observational studies, BMI was modeled using splines and in categories defined by the World Health Organization. Body mass index was calculated as weight in kilograms divided by height in meters squared. MAIN OUTCOMES AND MEASURES Main outcome was all-cause mortality and secondary outcomes were cause-specific mortality. RESULTS The number of deaths during follow-up was 10 624 in the 1976-1978 cohort (78% cumulative mortality; mortality rate [MR], 30/1000 person-years [95% CI, 20-46]), 5025 in the 1991-1994 cohort (53%; MR, 16/1000 person-years [95% CI, 9-30]), and 5580 in the 2003-2013 cohort (6%; MR, 4/1000 person-years [95% CI, 1-10]). Except for cancer mortality, the association of BMI with all-cause, cardiovascular, and other mortality was curvilinear (U-shaped). The BMI associated with the lowest all-cause mortality increased by 3.3 from the 1976-1978 cohort compared with the 2003-2013 cohort. [GRAPHICS] The multivariable-adjusted hazard ratios for all-cause mortality for BMI of 30 or more vs BMI of 18.5 to 24.9 were 1.31 (95% CI, 1.23-1.39; MR, 46/1000 person-years [95% CI, 32-66] vs 28/1000 person-years [95% CI, 18-45]) in the 1976-1978 cohort, 1.13 (95% CI, 1.04-1.22; MR, 28/1000 person-years [95% CI, 17-47] vs 15/1000 person-years [95% CI, 7-31]) in the 1991-1994 cohort, and 0.99 (95% CI, 0.92-1.07; MR, 5/1000 person-years [95% CI, 2-12] vs 4/1000 person-years [95% CI, 1-11]) in the 2003-2013 cohort. CONCLUSIONS AND RELEVANCE Among 3 Danish cohorts, the BMI associated with the lowest all-cause mortality increased by 3.3 from cohorts enrolled from 1976-1978 through 2003-2013. Further investigation is needed to understand the reason for this change and its implications.	[Afzal, Shoaib; Tybjaerg-Hansen, Anne; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Clin Biochem, Herlev Ringvej 75, DK-2730 Herlev, Denmark; [Afzal, Shoaib; Tybjaerg-Hansen, Anne; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Copenhagen Gen Populat Study, Herlev, Denmark; [Afzal, Shoaib; Tybjaerg-Hansen, Anne; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Rigshosp, Dept Clin Biochem, Mol Genet Sect, Copenhagen, Denmark; [Afzal, Shoaib; Tybjaerg-Hansen, Anne] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Tybjaerg-Hansen, Anne; Jensen, Gorm B.; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Frederiksberg Hosp, Copenhagen City Heart Study, Frederiksberg, Denmark	University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen	Nordestgaard, BG (corresponding author), Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Clin Biochem, Herlev Ringvej 75, DK-2730 Herlev, Denmark.	boerge.nordestgaard@regionh.dk	Afzal, Shoaib/B-6763-2012; Nordestgaard, Borge Gronne/ABF-1310-2020	Afzal, Shoaib/0000-0002-1442-4694; Nordestgaard, Borge/0000-0002-1954-7220	Danish Heart Foundation; Danish Medical Research Council; Copenhagen County Foundation; Herlev and Gentofte Hospital, Copenhagen University Hospital	Danish Heart Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Copenhagen County Foundation; Herlev and Gentofte Hospital, Copenhagen University Hospital	The Copenhagen General Population Study and Copenhagen City Heart Study are supported by the Danish Heart Foundation, Danish Medical Research Council, Copenhagen County Foundation, and Herlev and Gentofte Hospital, Copenhagen University Hospital.	Afzal S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6330; Afzal S, 2013, CLIN CHEM, V59, P771, DOI 10.1373/clinchem.2012.201939; Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; [Anonymous], TECHN REP SER WHO; ASNAES S, 1980, FORENSIC SCI INT, V15, P191, DOI 10.1016/0379-0738(80)90133-4; Boggs DA, 2011, NEW ENGL J MED, V365, P901, DOI 10.1056/NEJMoa1104119; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DiCiccio TJ, 1996, STAT SCI, V11, P189; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Fall T, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001474; Flegal KM, 2007, AM J EPIDEMIOL, V166, P975, DOI 10.1093/aje/kwm152; Flegal KM, 2014, AM J EPIDEMIOL, V180, P288, DOI 10.1093/aje/kwu111; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Flegal KM, 2011, AM J EPIDEMIOL, V173, P1, DOI 10.1093/aje/kwq341; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Greenberg JA, 2006, OBESITY, V14, P2071, DOI 10.1038/oby.2006.242; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Mehta NK, 2011, POPUL DEV REV, V37, P435, DOI 10.1111/j.1728-4457.2011.00429.x; Mehta T, 2014, OBES REV, V15, P619, DOI 10.1111/obr.12191; Nordestgaard BG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001212; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Su DJ, 2005, AM J HUM BIOL, V17, P341, DOI 10.1002/ajhb.20124; Timpson NJ, 2009, HYPERTENSION, V54, P84, DOI 10.1161/HYPERTENSIONAHA.109.130005; Varbo A, 2015, CIRC RES, V116, P665, DOI 10.1161/CIRCRESAHA.116.304846; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Winter JE, 2014, AM J CLIN NUTR, V99, P875, DOI 10.3945/ajcn.113.068122; World Health Organization, GLOB STAT REP NONC D; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679	34	88	89	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 10	2016	315	18					1989	1996		10.1001/jama.2016.4666	http://dx.doi.org/10.1001/jama.2016.4666			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2JP	27163987	Bronze			2022-12-28	WOS:000375461100016
J	Yawar, A				Yawar, Athar			The art of medicine The medicine of Alex Higgins	LANCET			English	Editorial Material												athar.yawar@doctors.org.uk							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 30	2016	387	10030					1808	1809		10.1016/S0140-6736(16)30328-2	http://dx.doi.org/10.1016/S0140-6736(16)30328-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DK6SS	27203495				2022-12-28	WOS:000375056100014
J	Lee, BS; Walker, J; Delbanco, T; Elmore, JG				Lee, Bryan S.; Walker, Jan; Delbanco, Tom; Elmore, Joann G.			Transparent Electronic Health Records and Lagging Laws	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Washington, Sch Med, Seattle, WA USA; [Lee, Bryan S.] Altos Eye Phys, 762 Altos Oaks Dr 1, Los Altos, CA 94024 USA; [Walker, Jan; Delbanco, Tom] Harvard Med Sch, Beth Israel Deaconess Med Ctr, 330 Brookline Ave, Boston, MA 02215 USA; [Elmore, Joann G.] Univ Washington, Dept Internal Med, Harborview Med Ctr, Box 359780,325 Ninth Ave, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harborview Medical Center; University of Washington; University of Washington Seattle	Lee, BS (corresponding author), Altos Eye Phys, 762 Altos Oaks Dr 1, Los Altos, CA 94024 USA.	bryan@bryanlee.pro			NCI NIH HHS [K05 CA104699] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K05CA104699] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bell SK, 2015, JT COMM J QUAL PATIE, V41, P378, DOI 10.1016/S1553-7250(15)41049-9; Bourgeois FC, 2008, J AM MED INFORM ASSN, V15, P737, DOI 10.1197/jamia.M2865; Coleman DL, 2013, PEDIATRICS, V131, P786, DOI 10.1542/peds.2012-2470; Delbanco T, 2012, ANN INTERN MED, V157, P461, DOI 10.7326/0003-4819-157-7-201210020-00002; Hickey Kathryn, 2007, JONAS Healthc Law Ethics Regul, V9, P100; HICKSON GB, 1992, JAMA-J AM MED ASSOC, V267, P1359, DOI 10.1001/jama.267.10.1359; HUYCKE LI, 1994, ANN INTERN MED, V120, P792, DOI 10.7326/0003-4819-120-9-199405010-00011; Kahn MW, 2014, JAMA-J AM MED ASSOC, V311, P1291, DOI 10.1001/jama.2014.1824	8	18	18	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 2	2016	165	3					219	+		10.7326/M15-2827	http://dx.doi.org/10.7326/M15-2827			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS2HA	27214266	Green Accepted			2022-12-28	WOS:000380583300011
J	Amabile-Cuevas, C				Amabile-Cuevas, Carlos			Society must seize control of the antibiotics crisis	NATURE			English	Editorial Material									[Amabile-Cuevas, Carlos] Lusara Fdn, Mexico City, DF, Mexico		Amabile-Cuevas, C (corresponding author), Lusara Fdn, Mexico City, DF, Mexico.	carlos.amabile@lusara.org	Amábile-Cuevas, Carlos/HDO-1753-2022	Amábile-Cuevas, Carlos/0000-0001-6806-544X					0	17	17	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2016	533	7604					439	439		10.1038/533439a	http://dx.doi.org/10.1038/533439a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM6EJ	27225081	Bronze			2022-12-28	WOS:000376443100004
J	Rouse, DJ; Keimig, TW; Riley, LE; Letourneau, AR; Platt, MY				Rouse, Dwight J.; Keimig, Thomas W.; Riley, Laura E.; Letourneau, Alyssa R.; Platt, Mia Y.			Case 16-2016: A 31-Year-Old Pregnant Woman with Fever	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LISTERIOSIS; INFECTION; WOMEN		[Rouse, Dwight J.] Brown Univ, Women & Infants Hosp Rhode Isl, Dept Obstet & Gynecol, Providence, RI 02912 USA; [Rouse, Dwight J.] Brown Univ, Warren Alpert Med Sch, Dept Obstet & Gynecol, Providence, RI 02912 USA; [Keimig, Thomas W.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiol, Boston, MA USA; [Riley, Laura E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Obstet & Gynecol, Boston, MA USA; [Letourneau, Alyssa R.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA USA; [Platt, Mia Y.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Pathol, Boston, MA USA; [Keimig, Thomas W.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Riley, Laura E.] Harvard Univ, Sch Med, Dept Obstet & Gynecol, Boston, MA USA; [Letourneau, Alyssa R.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Platt, Mia Y.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Brown University; Women & Infants Hospital Rhode Island; Brown University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Rouse, DJ (corresponding author), Brown Univ, Women & Infants Hosp Rhode Isl, Dept Obstet & Gynecol, Providence, RI 02912 USA.; Rouse, DJ (corresponding author), Brown Univ, Warren Alpert Med Sch, Dept Obstet & Gynecol, Providence, RI 02912 USA.							Adams Deborah A, 2014, MMWR Morb Mortal Wkly Rep, V61, P1; Alsup D, 2015, CNN             0409; [Anonymous], 2012, N ENGL J MED, V366, P1039; Centers for Disease Control and Prevention, 2014, LIST LIST PREV; Lamont RF, 2011, J PERINAT MED, V39, P227, DOI [10.1515/JPM.2011.035, 10.1515/jpm.2011.035]; MASCOLA L, 1994, AM J OBSTET GYNECOL, V170, P1328; Mylonakis E, 2002, MEDICINE, V81, P260, DOI 10.1097/00005792-200207000-00002; Poulsen KP, 2013, ANIM HEALTH RES REV, V14, P30, DOI 10.1017/S1466252312000242; Sheffield JS, 2005, OBSTET GYNECOL, V106, P1085, DOI 10.1097/01.AOG.0000185257.52328.a2; Tita ATN, 2010, CLIN PERINATOL, V37, P339, DOI 10.1016/j.clp.2010.02.003; Varma JK, 2007, CLIN INFECT DIS, V44, P521, DOI 10.1086/509920; Williamson C, 2014, OBSTET GYNECOL, V124, P120, DOI 10.1097/AOG.0000000000000346	12	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 26	2016	374	21					2076	2083		10.1056/NEJMcpc1516451	http://dx.doi.org/10.1056/NEJMcpc1516451			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6EN	27223150				2022-12-28	WOS:000376443500012
J	Rubino, F				Rubino, Francesco			Time to think differently about diabetes	NATURE			English	Editorial Material							BARIATRIC SURGERY; TYPE-2; KG/M(2); DISEASE		[Rubino, Francesco] Kings Coll London, Metab & Bariatr Surg, London, England; [Rubino, Francesco] Kings Coll Hosp London, London, England; [Rubino, Francesco] Diabet Surg Summit, Rome, Italy	University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital	Rubino, F (corresponding author), Kings Coll London, Metab & Bariatr Surg, London, England.; Rubino, F (corresponding author), Kings Coll Hosp London, London, England.; Rubino, F (corresponding author), Diabet Surg Summit, Rome, Italy.	francesco.rubino@kcl.ac.uk						Cohen RV, 2007, SURG OBES RELAT DIS, V3, P195, DOI 10.1016/j.soard.2007.01.009; Dixon JB, 2015, MOL CELL ENDOCRINOL, V418, P143, DOI 10.1016/j.mce.2015.05.033; Klein S, 2011, OBESITY, V19, P581, DOI 10.1038/oby.2010.199; Leyton O., 1925, LANCET, V206, P1162, DOI 10.1016/S0140-6736(01)50045-8; Mingrone G, 2015, LANCET, V386, P964, DOI 10.1016/S0140-6736(15)00075-6; PORIES WJ, 1995, ANN SURG, V222, P339, DOI 10.1097/00000658-199509000-00011; Rubino FA, 2004, ANN SURG, V239, P1, DOI 10.1097/01.sla.0000102989.54824.fc; Rubino F, 2008, DIABETES CARE, V31, pS290, DOI 10.2337/dc08-s271; Rubino F, 2016, DIABETES CARE, V39, P861, DOI 10.2337/dc16-0236; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	10	18	30	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2016	533	7604					459	461		10.1038/533459a	http://dx.doi.org/10.1038/533459a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6EJ	27225102	Bronze			2022-12-28	WOS:000376443100014
J	Zhou, F; Li, XL; Wang, WL; Zhu, P; Zhou, J; He, WY; Ding, M; Xiong, FY; Zheng, XN; Li, Z; Ni, YL; Mu, XH; Wen, L; Cheng, T; Lan, Y; Yuan, WP; Tang, FC; Liu, B				Zhou, Fan; Li, Xianlong; Wang, Weili; Zhu, Ping; Zhou, Jie; He, Wenyan; Ding, Meng; Xiong, Fuyin; Zheng, Xiaona; Li, Zhuan; Ni, Yanli; Mu, Xiaohuan; Wen, Lu; Cheng, Tao; Lan, Yu; Yuan, Weiping; Tang, Fuchou; Liu, Bing			Tracing haematopoietic stem cell formation at single-cell resolution	NATURE			English	Article							RNA-SEQ; AGM REGION; DEFINITIVE HEMATOPOIESIS; HAEMOGENIC ENDOTHELIUM; TRANSCRIPTOME ANALYSIS; EMBRYONIC-DEVELOPMENT; PROGENITOR CELLS; FETAL LIVER; LINEAGE; DIFFERENTIATION	Haematopoietic stem cells (HSCs) are derived early from embryonic precursors, such as haemogenic endothelial cells and pre-haematopoietic stem cells (pre-HSCs), the molecular identity of which still remains elusive. Here we use potent surface markers to capture the nascent pre-HSCs at high purity, as rigorously validated by single-cell-initiated serial transplantation. Then we apply single-cell RNA sequencing to analyse endothelial cells, CD45(-) and CD45(+) pre-HSCs in the aorta-gonad-mesonephros region, and HSCs in fetal liver. Pre-HSCs show unique features in transcriptional machinery, arterial signature, metabolism state, signalling pathway, and transcription factor network. Functionally, activation of mechanistic targets of rapamycin (mTOR) is shown to be indispensable for the emergence of HSCs but not haematopoietic progenitors. Transcriptome data-based functional analysis reveals remarkable heterogeneity in cell-cycle status of pre-HSCs. Finally, the core molecular signature of pre-HSCs is identified. Collectively, our work paves the way for dissection of complex molecular mechanisms regulating stepwise generation of HSCs in vivo, informing future efforts to engineer HSCs for clinical applications.	[Zhou, Fan; Zhou, Jie; He, Wenyan; Ding, Meng; Xiong, Fuyin; Zheng, Xiaona; Li, Zhuan; Ni, Yanli; Liu, Bing] Acad Mil Med Sci, Translat Med Ctr Stem Cells, Ivy Translat Med Ctr 307, Affiliated Hosp,State Key Lab Prote,Lab Oncol, Beijing 100071, Peoples R China; [Li, Xianlong; Zhu, Ping; Wen, Lu; Tang, Fuchou] Peking Univ, Coll Life Sci, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China; [Wang, Weili; Mu, Xiaohuan; Cheng, Tao; Yuan, Weiping; Liu, Bing] Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China; [Wang, Weili; Mu, Xiaohuan; Cheng, Tao; Yuan, Weiping; Liu, Bing] Chinese Acad Med Sci, Blood Dis Hosp, State Key Lab Expt Hematol, Tianjin 300020, Peoples R China; [Zhu, Ping; Tang, Fuchou] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Wen, Lu; Tang, Fuchou] Minist Educ, Key Lab Cell Proliferat & Differentiat, Beijing 100871, Peoples R China; [Cheng, Tao] Collaborat Innovat Ctr Canc Med, Natl Inst Biol Sci, Tianjin 300020, Peoples R China; [Lan, Yu] Inst Biotechnol, Genet Lab Dev & Dis, State Key Lab Prote, Beijing 100071, Peoples R China; [Tang, Fuchou] CMTM, Beijing 100101, Peoples R China; [Liu, Bing] Med Coll Jinan Univ, Inst Hematol, Guangzhou 510632, Guangdong, Peoples R China	Academy of Military Medical Sciences - China; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Peking University; Jinan University	Liu, B (corresponding author), Acad Mil Med Sci, Translat Med Ctr Stem Cells, Ivy Translat Med Ctr 307, Affiliated Hosp,State Key Lab Prote,Lab Oncol, Beijing 100071, Peoples R China.; Tang, FC (corresponding author), Peking Univ, Coll Life Sci, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China.; Yuan, WP; Liu, B (corresponding author), Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China.; Yuan, WP; Liu, B (corresponding author), Chinese Acad Med Sci, Blood Dis Hosp, State Key Lab Expt Hematol, Tianjin 300020, Peoples R China.; Tang, FC (corresponding author), Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China.; Tang, FC (corresponding author), Minist Educ, Key Lab Cell Proliferat & Differentiat, Beijing 100871, Peoples R China.; Tang, FC (corresponding author), CMTM, Beijing 100101, Peoples R China.; Liu, B (corresponding author), Med Coll Jinan Univ, Inst Hematol, Guangzhou 510632, Guangdong, Peoples R China.	wpyuan@ihcams.ac.cn; tangfuchou@pku.edu.cn; bingliu17@yahoo.com	Liu, Bing/ABH-2370-2021; Lan, Yu/AAV-2236-2021	Liu, Bing/0000-0002-7313-6924; Lan, Yu/0000-0002-4731-5945; Zhu, Ping/0000-0002-4521-7524; Cheng, Tao/0000-0002-5925-2769; Li, Xianlong/0000-0001-7745-2695	Chinese National Key Program on Basic Research [2011CB964800, 2012CB966904, 2012CB966704, 2012CB966604]; National Natural Science Foundation of China [31425012, 31371185, 81400076, 31322037, 81561138005, 81421002, 81561138003, 81370596, 91439128]; National Key Program on Stem Cell and Translational Research [SQ2016ZY05002341]; SKLEH-Pilot Research Grant [ZK12-04, ZK13-04]	Chinese National Key Program on Basic Research; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Program on Stem Cell and Translational Research; SKLEH-Pilot Research Grant	We thank H. Wu, J. Zheng, and H. Guo for discussion, and S. Hou and L. Zhang for technique support. This work was supported by the Chinese National Key Program on Basic Research (2011CB964800, 2012CB966904, 2012CB966704, 2012CB966604), the National Natural Science Foundation of China (31425012, 31371185, 81400076, 31322037, 81561138005, 81421002, 81561138003, 81370596, 91439128), National Key Program on Stem Cell and Translational Research (SQ2016ZY05002341), and a SKLEH-Pilot Research Grant (ZK12-04 and ZK13-04).	Acar M, 2015, NATURE, V526, P126, DOI 10.1038/nature15250; Benz C, 2012, CELL STEM CELL, V10, P273, DOI 10.1016/j.stem.2012.02.007; Bowie MB, 2006, J CLIN INVEST, V116, P2808, DOI 10.1172/JCI28310; Cabezas-Wallscheid N, 2014, CELL STEM CELL, V15, P507, DOI 10.1016/j.stem.2014.07.005; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Chen MJ, 2011, CELL STEM CELL, V9, P541, DOI 10.1016/j.stem.2011.10.003; Cheng T, 1996, P NATL ACAD SCI USA, V93, P13158, DOI 10.1073/pnas.93.23.13158; Clements WK, 2013, NAT REV IMMUNOL, V13, P336, DOI 10.1038/nri3443; Ditadi A, 2015, NAT CELL BIOL, V17, P580, DOI 10.1038/ncb3161; Durruthy-Durruthy R, 2014, CELL, V157, P964, DOI 10.1016/j.cell.2014.03.036; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; Espin-Palazon R, 2014, CELL, V159, P1070, DOI 10.1016/j.cell.2014.10.031; Etzrodt M, 2014, CELL STEM CELL, V15, P546, DOI 10.1016/j.stem.2014.10.015; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; Gama-Norton L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9510; Gazit R, 2013, STEM CELL REP, V1, P266, DOI 10.1016/j.stemcr.2013.07.004; Godin I, 1999, J EXP MED, V190, P43, DOI 10.1084/jem.190.1.43; Guo GJ, 2013, CELL STEM CELL, V13, P492, DOI 10.1016/j.stem.2013.07.017; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iwasaki H, 2010, BLOOD, V116, P544, DOI 10.1182/blood-2009-08-240903; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kieusseian A, 2012, DEVELOPMENT, V139, P3521, DOI 10.1242/dev.079210; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee SH, 2009, J MOL CELL CARDIOL, V46, P596, DOI 10.1016/j.yjmcc.2008.12.021; Li Y, 2014, GENE DEV, V28, P2597, DOI 10.1101/gad.253302.114; Li Z, 2013, J GENET GENOMICS, V40, P557, DOI 10.1016/j.jgg.2013.09.001; Li ZA, 2012, CELL STEM CELL, V11, P663, DOI 10.1016/j.stem.2012.07.004; Magee JA, 2012, CELL STEM CELL, V11, P415, DOI 10.1016/j.stem.2012.05.026; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Riddell J, 2014, CELL, V157, P549, DOI 10.1016/j.cell.2014.04.006; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Robin C, 2006, DEV CELL, V11, P171, DOI 10.1016/j.devcel.2006.07.002; Rybtsov S, 2014, STEM CELL REP, V3, P489, DOI 10.1016/j.stemcr.2014.07.009; Rybtsov S, 2011, J EXP MED, V208, P1305, DOI 10.1084/jem.20102419; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sohr S, 2008, CELL CYCLE, V7, P3448, DOI 10.4161/cc.7.21.7014; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Taoudi S, 2008, CELL STEM CELL, V3, P99, DOI 10.1016/j.stem.2008.06.004; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Wang YH, 2014, CELL, V158, P1309, DOI 10.1016/j.cell.2014.07.048; Wang Y, 2015, MOL CELL, V58, P598, DOI 10.1016/j.molcel.2015.05.005; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yokomizo T, 2010, DEVELOPMENT, V137, P3651, DOI 10.1242/dev.051094; Zhang YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103970; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	56	201	217	7	169	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2016	533	7604					487	+		10.1038/nature17997	http://dx.doi.org/10.1038/nature17997			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6EJ	27225119				2022-12-28	WOS:000376443100031
J	Smith, JM				Smith, Jeanette M.			A Rock on the Lukenia Hills	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 24	2016	315	20					2150	2151		10.1001/jama.2015.14281	http://dx.doi.org/10.1001/jama.2015.14281			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM4US	27218614				2022-12-28	WOS:000376343000001
J	Hunt, ST; Milina, M; Alba-Rubio, AC; Hendon, CH; Dumesic, JA; Roman-Leshkov, Y				Hunt, Sean T.; Milina, Maria; Alba-Rubio, Ana C.; Hendon, Christopher H.; Dumesic, James A.; Roman-Leshkov, Yuriy			Self-assembly of noble metal monolayers on transition metal carbide nanoparticle catalysts	SCIENCE			English	Article							OXYGEN-REDUCTION ELECTROCATALYSTS; CORE-SHELL NANOPARTICLES; TUNGSTEN CARBIDE; ALLOY NANOPARTICLES; PLATINUM; SURFACES; HYDROGEN; BEHAVIOR; OXIDATION; METHANOL	We demonstrated the self-assembly of transition metal carbide nanoparticles coated with atomically thin noble metal monolayers by carburizing mixtures of noble metal salts and transition metal oxides encapsulated in removable silica templates. This approach allows for control of the final core-shell architecture, including particle size, monolayer coverage, and heterometallic composition. Carbon-supported Ti0.1W0.9C nanoparticles coated with Pt or bimetallic PtRu monolayers exhibited enhanced resistance to sintering and CO poisoning, achieving an order of magnitude increase in specific activity over commercial catalysts for methanol electrooxidation after 10,000 cycles. These core-shell materials provide a new direction to reduce the loading, enhance the activity, and increase the stability of noble metal catalysts.	[Hunt, Sean T.; Milina, Maria; Hendon, Christopher H.; Roman-Leshkov, Yuriy] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Alba-Rubio, Ana C.; Dumesic, James A.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA; [Alba-Rubio, Ana C.] Univ Toledo, Dept Chem & Environm Engn, 2801 W Bancroft St, Toledo, OH 43606 USA	Massachusetts Institute of Technology (MIT); University of Wisconsin System; University of Wisconsin Madison; University System of Ohio; University of Toledo	Roman-Leshkov, Y (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	yroman@mit.edu	Roman-Leshkov, Yuriy/E-1387-2014; Alba-Rubio, Ana C./G-4672-2011	Roman-Leshkov, Yuriy/0000-0002-0025-4233; Alba-Rubio, Ana C./0000-0002-1831-8338; Hendon, Christopher/0000-0002-7132-768X	U.S. Department of Energy, Office of Basic Energy Sciences [DE-FG02-12ER16352, DE-SC0014058]; National Science Foundation (NSF) [ACI-1053575]; University of Wisconsin Materials Research Science and Engineering Center [DMR-1121288]; NSF [1122374]; Swiss National Science Foundation [P2EZP2_159124]	U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Science Foundation (NSF)(National Science Foundation (NSF)); University of Wisconsin Materials Research Science and Engineering Center(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Work at MIT was supported by the U.S. Department of Energy, Office of Basic Energy Sciences (grant DE-FG02-12ER16352). This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by the National Science Foundation (NSF) (grant ACI-1053575). The authors acknowledge the use of facilities and instrumentation supported by the University of Wisconsin Materials Research Science and Engineering Center (grant DMR-1121288). S.T.H. thanks NSF for financial support through the NSF Graduate Research Fellowship under grant no. 1122374. M.M. thanks the Swiss National Science Foundation (project number P2EZP2_159124) for financial support. J.A.D. acknowledges funding by the U.S. Department of Energy, Office of Basic Energy Sciences (grant DE-SC0014058).	Alayoglu S, 2008, NAT MATER, V7, P333, DOI 10.1038/nmat2156; Bell AT, 2003, SCIENCE, V299, P1688, DOI 10.1126/science.1083671; BENNETT LH, 1974, SCIENCE, V184, P563, DOI 10.1126/science.184.4136.563; Bonifacio CS, 2015, CHEM MATER, V27, P6960, DOI 10.1021/acs.chemmater.5b01862; Chen C, 2014, SCIENCE, V343, P1339, DOI 10.1126/science.1249061; Cui CH, 2013, NAT MATER, V12, P765, DOI [10.1038/NMAT3668, 10.1038/nmat3668]; Deluga GA, 2004, SCIENCE, V303, P993, DOI 10.1126/science.1093045; Esposito DV, 2012, J AM CHEM SOC, V134, P3025, DOI 10.1021/ja208656v; Esposito DV, 2011, ENERG ENVIRON SCI, V4, P3900, DOI 10.1039/c1ee01851e; Greeley J, 2009, NAT CHEM, V1, P552, DOI [10.1038/NCHEM.367, 10.1038/nchem.367]; Hammer B, 1996, PHYS REV LETT, V76, P2141, DOI 10.1103/PhysRevLett.76.2141; Hunt ST, 2014, ANGEW CHEM INT EDIT, V53, P5131, DOI 10.1002/anie.201400294; Kelly TG, 2011, J PHYS CHEM C, V115, P6644, DOI 10.1021/jp112006v; Kimmel YC, 2014, ACS CATAL, V4, P1558, DOI 10.1021/cs500182h; LEVY RB, 1973, SCIENCE, V181, P547, DOI 10.1126/science.181.4099.547; Liu ZF, 2010, ANGEW CHEM INT EDIT, V49, P3173, DOI 10.1002/anie.200907019; Michalsky R, 2014, J PHYS CHEM C, V118, P13026, DOI 10.1021/jp503756g; Ono S, 2005, SOLID STATE COMMUN, V133, P55, DOI 10.1016/j.ssc.2004.09.048; Oyama S. T., 1996, CHEM TRANSITION META; Schaidle JA, 2012, J CATAL, V289, P210, DOI 10.1016/j.jcat.2012.02.012; Schmidt TJ, 1999, ELECTROCHEM COMMUN, V1, P1, DOI 10.1016/S1388-2481(98)00004-6; Schottky W, 1918, ANN PHYS-BERLIN, V57, P541; Singh AK, 2013, CHEMCATCHEM, V5, P652, DOI 10.1002/cctc.201200591; Stephens IEL, 2012, ENERG ENVIRON SCI, V5, P6744, DOI 10.1039/c2ee03590a; Strasser P, 2010, NAT CHEM, V2, P454, DOI [10.1038/NCHEM.623, 10.1038/nchem.623]; Tao F, 2008, SCIENCE, V322, P932, DOI 10.1126/science.1164170; Wang C, 2011, ADV FUNCT MATER, V21, P147, DOI 10.1002/adfm.201001138; Yang H, 2011, ANGEW CHEM INT EDIT, V50, P2674, DOI 10.1002/anie.201005868; Zhai YP, 2010, SCIENCE, V329, P1633, DOI 10.1126/science.1192449; Zhang J, 2007, SCIENCE, V315, P220, DOI 10.1126/science.1134569; Zhang L, 2015, SCIENCE, V349, P412, DOI 10.1126/science.aab0801	31	400	406	63	1125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2016	352	6288			SI		974	978		10.1126/science.aad8471	http://dx.doi.org/10.1126/science.aad8471			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM2AK	27199426	Green Submitted			2022-12-28	WOS:000376147800044
J	Traunmuller, L; Gomez, AM; Nguyen, TM; Scheiffele, P				Traunmuller, Lisa; Gomez, Andrea M.; Thi-Minh Nguyen; Scheiffele, Peter			Control of neuronal synapse specification by a highly dedicated alternative splicing program	SCIENCE			English	Article							PROTEINS; NEUREXIN; NEUROLIGIN-1; MECHANISMS; RECEPTORS; BINDING; DOMAIN; ROLES	Alternative RNA splicing represents a central mechanism for expanding the coding power of genomes. Individual RNA-binding proteins can control alternative splicing choices in hundreds of RNA transcripts, thereby tuning amounts and functions of large numbers of cellular proteins. We found that the RNA-binding protein SLM2 is essential for functional specification of glutamatergic synapses in the mouse hippocampus. Genome-wide mapping revealed a markedly selective SLM2-dependent splicing program primarily consisting of only a few target messenger RNAs that encode synaptic proteins. Genetic correction of a single SLM2-dependent target exon in the synaptic recognition molecule neurexin-1 was sufficient to rescue synaptic plasticity and behavioral defects in Slm2 knockout mice. These findings uncover a highly selective alternative splicing program that specifies synaptic properties in the central nervous system.	[Traunmuller, Lisa; Gomez, Andrea M.; Thi-Minh Nguyen; Scheiffele, Peter] Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland	University of Basel	Scheiffele, P (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	peter.scheiffele@unibas.ch		Scheiffele, Peter/0000-0002-9516-9399; Gomez, Andrea/0000-0002-2923-6362	Boehringer Ingelheim Fonds; European Molecular Biology Organization long-term fellowship; International PhD Program University of Basel; Swiss National Science Foundation; European Autism Interventions EU-AIMS; Innovative Medicines Initiative; Kanton Basel-Stadt	Boehringer Ingelheim Fonds(Boehringer Ingelheim); European Molecular Biology Organization long-term fellowship(European Molecular Biology Organization (EMBO)); International PhD Program University of Basel; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Autism Interventions EU-AIMS; Innovative Medicines Initiative; Kanton Basel-Stadt	We thank O. Mauger, D. Schreiner, and L. Xiao for insightful comments on the manuscript and Y. Hayashi and J. Bischofberger for expert advice. We thank C. Bornmann and P. Demougin, F. Lemoine, P. de la Grange, A. Schmidt, and M. Ruegg for suggestions and experimental support. L.T. was financially supported by the Boehringer Ingelheim Fonds. A.M.G. was supported by a European Molecular Biology Organization long-term fellowship. T.-M.N. was supported by the International PhD Program University of Basel. This work was supported by funds to P.S. from the Swiss National Science Foundation; European Autism Interventions EU-AIMS, which receives support from the Innovative Medicines Initiative; and the Kanton Basel-Stadt. Sequencing data were deposited at the functional genomics data repository Gene Expression Omnibus (accession number GSE79902).	Aoto J, 2013, CELL, V154, P75, DOI 10.1016/j.cell.2013.05.060; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Budreck EC, 2013, P NATL ACAD SCI USA, V110, P725, DOI 10.1073/pnas.1214718110; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Cohen SJ, 2015, BEHAV BRAIN RES, V285, P105, DOI 10.1016/j.bbr.2014.08.002; Ehrmann I, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003474; Iijima T, 2014, J CELL BIOL, V204, P331, DOI 10.1083/jcb.201310136; Iijima T, 2011, CELL, V147, P1601, DOI 10.1016/j.cell.2011.11.028; Li Q, 2014, ELIFE, V3, DOI 10.7554/eLife.01201; Matsuda K, 2011, EUR J NEUROSCI, V33, P1447, DOI 10.1111/j.1460-9568.2011.07638.x; Norris AD, 2014, MOL CELL, V54, P946, DOI 10.1016/j.molcel.2014.05.004; Quesnel-Vallieres M, 2015, GENE DEV, V29, P746, DOI 10.1101/gad.256115.114; Raj B, 2015, NEURON, V87, P14, DOI 10.1016/j.neuron.2015.05.004; Schreiner D, 2014, NEURON, V84, P386, DOI 10.1016/j.neuron.2014.09.011; Schreiner D, 2014, CURR OPIN NEUROBIOL, V27, P25, DOI 10.1016/j.conb.2014.02.009; Shipman SL, 2011, NAT NEUROSCI, V14, P718, DOI 10.1038/nn.2825; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Traunmuller L, 2014, J NEUROSCI, V34, P16755, DOI 10.1523/JNEUROSCI.3395-14.2014; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Zheng S, 2013, TRENDS GENET, V29, P442, DOI 10.1016/j.tig.2013.04.003	22	74	75	3	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2016	352	6288			SI		982	986		10.1126/science.aaf2397	http://dx.doi.org/10.1126/science.aaf2397			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM2AK	27174676				2022-12-28	WOS:000376147800046
J	Shih, HY; Sciume, G; Mikami, Y; Guo, LY; Sun, HW; Brooks, SR; Urban, JF; Davis, FP; Kanno, Y; O'Shea, JJ				Shih, Han-Yu; Sciume, Giuseppe; Mikami, Yohei; Guo, Liying; Sun, Hong-Wei; Brooks, Stephen R.; Urban, Joseph F., Jr.; Davis, Fred P.; Kanno, Yuka; O'Shea, John J.			Developmental Acquisition of Regulomes Underlies Innate Lymphoid Cell Functionality	CELL			English	Article							IMMUNOLOGICAL GENOME PROJECT; MURINE BONE-MARROW; TRANSCRIPTION FACTOR; NATURAL-KILLER; T-BET; ADAPTIVE IMMUNITY; ENHANCERS; FATE; IDENTIFICATION; MACROPHAGE	Innate lymphoid cells (ILCs) play key roles in host defense, barrier integrity, and homeostasis and mirror adaptive CD4(+) T helper (Th) cell subtypes in both usage of effector molecules and transcription factors. To better understand the relationship between ILC subsets and their Th cell counterparts, we measured genome-wide chromatin accessibility. We find that chromatin in proximity to effector genes is selectively accessible in ILCs prior to high-level transcription upon activation. Accessibility of these regions is acquired in a stepwise manner during development and changes little after in vitro or in vivo activation. Conversely, dramatic chromatin remodeling occurs in naive CD4(+) T cells during Th cell differentiation using a type-2-infection model. This alteration results in a substantial convergence of Th2 cells toward ILC2 regulomes. Our data indicate extensive sharing of regulatory circuitry across the innate and adaptive compartments of the immune system, in spite of their divergent developing pathways.	[Shih, Han-Yu; Sciume, Giuseppe; Mikami, Yohei; Davis, Fred P.; Kanno, Yuka; O'Shea, John J.] NIAMSD, Lymphocyte Cell Biol Sect, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Guo, Liying] NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA; [Sun, Hong-Wei; Brooks, Stephen R.] NIAMSD, Biodata Min & Discovery Sect, NIH, Bethesda, MD 20892 USA; [Urban, Joseph F., Jr.] ARS, Diet Genom & Immunol Lab, Beltsville Human Nutr Res Ctr, USDA, Beltsville, MD 20705 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); United States Department of Agriculture (USDA)	Shih, HY; O'Shea, JJ (corresponding author), NIAMSD, Lymphocyte Cell Biol Sect, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA.	han-yu.shih@nih.gov; john.oshea@nih.gov	Sciume, Giuseppe/K-8985-2016; Kanno, Yuka/B-5802-2013; MIKAMI, YOHEI/GRJ-8133-2022	Sciume, Giuseppe/0000-0003-0131-512X; Kanno, Yuka/0000-0001-5668-9319; MIKAMI, YOHEI/0000-0001-5104-4415; Davis, Fred/0000-0001-8294-1610; Shih, Han-Yu/0000-0002-7525-5433	NIAMS; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041106, ZIAAR041159, ZIHAR041173] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Drs. Y. Belkaid, K. Zhao, V. Sartorelli, J. Zhu, I. Fraser, and A. Poholek for critically reading this manuscript. We also thank G. Gutierrez-Cruz (Genome Analysis Core Facility, NIAMS) and J. Simone, J. Lay, and K. Tinsley (Flow Cytometry Section, NIAMS) for their technical support. This study utilized the high-performance computational capabilities of the Biowulf Linux cluster at the NIH. This work was supported by the Intramural Research Programs of the NIAMS.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2014, R LANG ENV STAT COMP; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balasubramani A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1003969; Balasubramani A, 2010, IMMUNOL REV, V238, P216, DOI 10.1111/j.1600-065X.2010.00961.x; Barton K, 1998, IMMUNITY, V9, P555, DOI 10.1016/S1074-7613(00)80638-X; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Bible PW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127285; Bornstein C, 2014, MOL CELL, V56, P749, DOI 10.1016/j.molcel.2014.10.014; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; De Obaldia ME, 2015, ANNU REV IMMUNOL, V33, P607, DOI 10.1146/annurev-immunol-032414-112032; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Ebihara T, 2015, NAT IMMUNOL, V16, P1124, DOI 10.1038/ni.3272; Factor DC, 2014, CELL STEM CELL, V14, P854, DOI 10.1016/j.stem.2014.05.005; Fathman JW, 2011, BLOOD, V118, P5439, DOI 10.1182/blood-2011-04-348912; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hirahara K, 2015, IMMUNITY, V42, P877, DOI 10.1016/j.immuni.2015.04.014; Hirano M, 2011, ADV IMMUNOL, V109, P125, DOI 10.1016/B978-0-12-387664-5.00004-2; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Kang J, 2015, ANNU REV IMMUNOL, V33, P505, DOI 10.1146/annurev-immunol-032414-112025; Kearley J, 2015, IMMUNITY, V42, P566, DOI 10.1016/j.immuni.2015.02.011; Kim CC, 2013, CURR OPIN IMMUNOL, V25, P593, DOI 10.1016/j.coi.2013.09.013; Klose CSN, 2014, CURR TOP MICROBIOL, V381, P215, DOI 10.1007/82_2014_381; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lohoff M, 2000, J EXP MED, V192, P325, DOI 10.1084/jem.192.3.325; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meylan F, 2014, MUCOSAL IMMUNOL, V7, P958, DOI 10.1038/mi.2013.114; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rankin LC, 2013, NAT IMMUNOL, V14, P389, DOI 10.1038/ni.2545; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Rosmaraki EE, 2001, EUR J IMMUNOL, V31, P1900, DOI 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M; Sciume G, 2012, J EXP MED, V209, P2331, DOI 10.1084/jem.20122097; Serafini N, 2015, NAT REV IMMUNOL, V15, P415, DOI 10.1038/nri3855; Shay T, 2013, TRENDS IMMUNOL, V34, P602, DOI 10.1016/j.it.2013.03.004; Shih HY, 2014, IMMUNOL REV, V261, P23, DOI 10.1111/imr.12208; Sonnenberg GF, 2015, NAT MED, V21, P698, DOI 10.1038/nm.3892; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Stergachis AB, 2014, NATURE, V515, P365, DOI 10.1038/nature13972; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Tindemans I, 2014, IMMUNITY, V41, P191, DOI 10.1016/j.immuni.2014.06.006; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Verykokakis M, 2014, IMMUNOL REV, V261, P177, DOI 10.1111/imr.12203; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Xu HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052249; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhong C, 2016, NAT IMMUNOL, V17, P169, DOI 10.1038/ni.3318	62	207	208	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2016	165	5					1120	1133		10.1016/j.cell.2016.04.029	http://dx.doi.org/10.1016/j.cell.2016.04.029			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DM6QT	27156451	Green Accepted, Bronze			2022-12-28	WOS:000376478200013
J	Denman, M				Denman, Michael			Prednisolone was equivalent to indomethacin for pain reduction in acute gout	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Denman, Michael] Univ London Imperial Coll Sci Technol & Med, London, England	Imperial College London	Denman, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, London, England.								0	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2016	164	10					JC51	JC51		10.7326/ACPJC-2016-164-10-051	http://dx.doi.org/10.7326/ACPJC-2016-164-10-051			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8GF	27182917				2022-12-28	WOS:000375878500002
J	Casey, K; Glennerster, R				Casey, Katherine; Glennerster, Rachel			Reconciliation in Sierra Leone	SCIENCE			English	Editorial Material							CIVIL-WAR		[Casey, Katherine] Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA; [Glennerster, Rachel] MIT, Abdul Latif Jameel Poverty Act Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Stanford University; Massachusetts Institute of Technology (MIT)	Casey, K (corresponding author), Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA.; Glennerster, R (corresponding author), MIT, Abdul Latif Jameel Poverty Act Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	kecasey@stanford.edu; rglenner@mit.edu						[Anonymous], 2015, WORKING PAPER; Asare Joe, 2005, BMJ, V331, P720, DOI 10.1136/bmj.331.7519.720-b; Bellows J, 2009, J PUBLIC ECON, V93, P1144, DOI 10.1016/j.jpubeco.2009.07.012; Blattman C., 2015, GENERATING EMPLOYMEN, DOI [10.2139/ssrn.2622220, DOI 10.2139/SSRN.2622220]; Blattman C., 2015, 7648 WORLD BANK; Casey K, 2012, Q J ECON, V127, P1755, DOI 10.1093/qje/qje027; Cilliers J, 2016, SCIENCE, V352, P787, DOI 10.1126/science.aad9682; Fearon JD, 2015, AM POLIT SCI REV, V109, P450, DOI 10.1017/S0003055415000283; Fearon JD, 2003, AM POLIT SCI REV, V97, P75, DOI 10.1017/S0003055403000534; Humphreys M, 2006, AM POLIT SCI REV, V100, P429, DOI 10.1017/S0003055406062289; International Monetary Fund, 2015, WORLD EC OUTL DAT; Pettersson T, 2015, J PEACE RES, V52, P536, DOI 10.1177/0022343315595927; PUTNAM RD, 1995, J DEMOCRACY, V0006; UNDP, 2006, EV UNDP SUPP CONFL A; WHO, 2012, PROMIND PROF MENT HL; WHO, 2014, MENT HLTH ATL	16	1	1	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2016	352	6287					766	767		10.1126/science.aaf7874	http://dx.doi.org/10.1126/science.aaf7874			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5FP	27174970				2022-12-28	WOS:000375663000016
J	Horitani, M; Shisler, K; Broderick, WE; Hutcheson, RU; Duschene, KS; Marts, AR; Hoffman, BM; Broderick, JB				Horitani, Masaki; Shisler, Krista; Broderick, William E.; Hutcheson, Rachel U.; Duschene, Kaitlin S.; Marts, Amy R.; Hoffman, Brian M.; Broderick, Joan B.			Radical SAM catalysis via an organometallic intermediate with an Fe-[5 '-C]-deoxyadenosyl bond	SCIENCE			English	Article							PYRUVATE FORMATE-LYASE; NUCLEAR DOUBLE-RESONANCE; PEROXIDASE COMPOUND-ES; LYSINE 2,3-AMINOMUTASE; S-ADENOSYLMETHIONINE; ACTIVATING ENZYME; SPECTROSCOPIC EVIDENCE; ALLYLIC ANALOG; WILD-TYPE; MECHANISM	Radical S-adenosylmethionine (SAM) enzymes use a [4Fe-4S] cluster to cleave SAM to initiate diverse radical reactions. These reactions are thought to involve the 5'-deoxyadenosyl radical intermediate, which has not yet been detected. We used rapid freeze-quenching to trap a catalytically competent intermediate in the reaction catalyzed by the radical SAM enzyme pyruvate formate-lyase activating enzyme. Characterization of the intermediate by electron paramagnetic resonance and C-13, Fe-57 electron nuclear double-resonance spectroscopies reveals that it contains an organometallic center in which the 5' carbon of a SAM-derived deoxyadenosyl moiety forms a bond with the unique iron site of the [4Fe-4S] cluster. Discovery of this intermediate extends the list of enzymatic bioorganometallic centers to the radical SAM enzymes, the largest enzyme superfamily known, and reveals intriguing parallels to B-12 radical enzymes.	[Horitani, Masaki; Marts, Amy R.; Hoffman, Brian M.] Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA; [Shisler, Krista; Broderick, William E.; Hutcheson, Rachel U.; Duschene, Kaitlin S.; Broderick, Joan B.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA	Northwestern University; Montana State University System; Montana State University Bozeman	Hoffman, BM (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.; Broderick, JB (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA.	bmh@northwestern.edu; jbroderick@chemistry.montana.edu	Horitani, Masaki/P-1090-2019; Horitani, Masaki/I-3158-2014	Horitani, Masaki/0000-0002-8881-0600; Horitani, Masaki/0000-0002-8881-0600	NIH [GM 111097, GM 54608]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054608, R55GM054608, R01GM111097, R29GM054608] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the NIH (grant GM 111097 to B.M.H. and grant GM 54608 to J.B.B.). We thank B.-H. Huynh and C. Krebs for contributions in the early stages of this study.	Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; Becker A, 1999, NAT STRUCT BIOL, V6, P969; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; Brown KL, 2005, CHEM REV, V105, P2075, DOI 10.1021/cr030720z; Chen DW, 2003, J AM CHEM SOC, V125, P11788, DOI 10.1021/ja036120z; COLE T, 1961, J CHEM PHYS, V34, P1085, DOI 10.1063/1.1731663; Cutsail GE, 2015, BBA-MOL CELL RES, V1853, P1370, DOI 10.1016/j.bbamcr.2015.01.025; Horitani M, 2015, J AM CHEM SOC, V137, P7111, DOI 10.1021/jacs.5b00498; HOUSEMAN ALP, 1993, BIOCHEMISTRY-US, V32, P4430, DOI 10.1021/bi00067a036; HUYETT JE, 1995, J AM CHEM SOC, V117, P9033, DOI 10.1021/ja00140a021; Lee HI, 2004, J AM CHEM SOC, V126, P9563, DOI 10.1021/ja048714n; Lepore BW, 2005, P NATL ACAD SCI USA, V102, P13819, DOI 10.1073/pnas.0505726102; Lubitz W, 2014, CHEM REV, V114, P4081, DOI 10.1021/cr4005814; Magnusson OT, 2001, BIOCHEMISTRY-US, V40, P7773, DOI 10.1021/bi0104569; Magnusson OT, 1999, J AM CHEM SOC, V121, P9764, DOI 10.1021/ja9925507; MCCONNELL HM, 1959, J CHEM PHYS, V31, P1688, DOI 10.1063/1.1730687; Peng Y, 2010, J BIOL CHEM, V285, P27224, DOI 10.1074/jbc.M109.096875; Shisler KA, 2014, ARCH BIOCHEM BIOPHYS, V546, P64, DOI 10.1016/j.abb.2014.01.020; Sicoli G, 2016, SCIENCE, V351, P1320, DOI 10.1126/science.aad8995; SIVARAJA M, 1989, SCIENCE, V245, P738, DOI 10.1126/science.2549632; Span I, 2014, J AM CHEM SOC, V136, P7926, DOI 10.1021/ja501127j; Vey JL, 2008, P NATL ACAD SCI USA, V105, P16137, DOI 10.1073/pnas.0806640105; WAGNER AFV, 1992, P NATL ACAD SCI USA, V89, P996, DOI 10.1073/pnas.89.3.996; Walsby CJ, 2002, J AM CHEM SOC, V124, P11270, DOI 10.1021/ja027078v; Walsby CJ, 2002, J AM CHEM SOC, V124, P3143, DOI 10.1021/ja012034s; Xu WY, 2012, BIOCHEMISTRY-US, V51, P4835, DOI 10.1021/bi3001215	26	80	80	4	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2016	352	6287					822	825		10.1126/science.aaf5327	http://dx.doi.org/10.1126/science.aaf5327			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5FP	27174986	Green Accepted			2022-12-28	WOS:000375663000040
J	Farvid, MS; Chen, WY; Michels, KB; Cho, E; Willett, WC; Eliassen, AH				Farvid, Maryam S.; Chen, Wendy Y.; Michels, Karin B.; Cho, Eunyoung; Willett, Walter C.; Eliassen, A. Heather			Fruit and vegetable consumption in adolescence and early adulthood and risk of breast cancer: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PROGESTERONE-RECEPTOR STATUS; ESTROGEN-RECEPTOR; DIETARY FIBER; POOLED ANALYSIS; BETA-CAROTENE; VITAMIN-C; METAANALYSIS; RETINOL; REPRODUCIBILITY; TOCOPHEROL	OBJECTIVE To evaluate the association between fruit and vegetable intake during adolescence and early adulthood and risk of breast cancer. DESIGN Prospective cohort study. SETTING Health professionals in the United States. PARTICIPANTS 90 476 premenopausal women aged 27-44 from the Nurses' Health Study II who completed a questionnaire on diet in 1991 as well as 44 223 of those women who completed a questionnaire about their diet during adolescence in 1998. MAIN OUTCOME MEASURE Incident cases of invasive breast cancer, identified through self report and confirmed by pathology report. RESULTS There were 3235 cases of invasive breast cancer during follow-up to 2013. Of these, 1347 cases were among women who completed a questionnaire about their diet during adolescence (ages 13-18). Total fruit consumption during adolescence was associated with a lower risk of breast cancer. The hazard ratio was 0.75 (95% confidence interval 0.62 to 0.90; P=0.01 for trend) for the highest (median intake 2.9 servings/day) versus the lowest (median intake 0.5 serving/day) fifth of intake. The association for fruit intake during adolescence was independent of adult fruit intake. There was no association between risk and total fruit intake in early adulthood and total vegetable intake in either adolescence or early adulthood. Higher early adulthood intake of fruits and vegetables rich in alpha carotene was associated with lower risk of premenopausal breast cancer. The hazard ratio was 0.82 (0.70 to 0.96) for the highest fifth (median intake 0.5 serving/day) versus the lowest fifth (median intake 0.03 serving/day) intake. The association with adolescent fruit intake was stronger for both estrogen and progesterone receptor negative cancers than estrogen and progesterone receptor positive cancers (P=0.02 for heterogeneity). For individual fruits and vegetables, greater consumption of apple, banana, and grapes during adolescence and oranges and kale during early adulthood was significantly associated with a reduced risk of breast cancer. Fruit juice intake in adolescence or early adulthood was not associated with risk. CONCLUSION There is an association between higher fruit intake and lower risk of breast cancer. Food choices during adolescence might be particularly important.	[Farvid, Maryam S.; Willett, Walter C.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Farvid, Maryam S.] Massachusetts Gen Hosp, Mongan Inst Hlth Policy, Harvard Massachusetts Gen Hosp Ctr Gen Vulnerable, Boston, MA 02114 USA; [Chen, Wendy Y.; Michels, Karin B.; Cho, Eunyoung; Willett, Walter C.; Eliassen, A. Heather] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Chen, Wendy Y.; Michels, Karin B.; Cho, Eunyoung; Willett, Walter C.; Eliassen, A. Heather] Harvard Univ, Sch Med, Boston, MA USA; [Chen, Wendy Y.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Michels, Karin B.; Willett, Walter C.; Eliassen, A. Heather] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Michels, Karin B.] Harvard Univ, Brigham & Womens Hosp, Obstet & Gynecol Epidemiol Ctr, Dept Obstet Gynecol & Reprod Biol,Sch Med, Boston, MA 02115 USA; [Cho, Eunyoung] Brown Univ, Warren Alpert Med Sch, Dept Dermatol, Providence, RI 02912 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Brown University	Farvid, MS (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.; Farvid, MS (corresponding author), Massachusetts Gen Hosp, Mongan Inst Hlth Policy, Harvard Massachusetts Gen Hosp Ctr Gen Vulnerable, Boston, MA 02114 USA.	mfarvid@hsph.harvard.edu	Cho, Eunyoung/AAV-4469-2020; f, m/AAM-2063-2021	Cho, Eunyoung/0000-0001-6594-2582; Farvid, Maryam/0000-0003-1783-4186; Eliassen, A Heather/0000-0002-3961-6609	National Institutes of Health [R01 CA050385, UM1 CA176726]; Breast Cancer Research Foundation; Japan Pharmaceutical Manufacturers Association; NATIONAL CANCER INSTITUTE [UM1CA176726, R01CA050385] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; Japan Pharmaceutical Manufacturers Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by the National Institutes of Health Grants (R01 CA050385, UM1 CA176726) and a grant from The Breast Cancer Research Foundation. MSF was supported by the Japan Pharmaceutical Manufacturers Association.	[Anonymous], 2001, NUTR DAT STAND REF R; Archer E, 2015, MAYO CLIN PROC, V90, P911, DOI 10.1016/j.mayocp.2015.04.009; Aune D, 2012, ANN ONCOL, V23, P1394, DOI 10.1093/annonc/mdr589; Bhupathiraju Shilpa N, 2013, Am J Clin Nutr, V98, P1514, DOI 10.3945/ajcn.113.066381; Blanchard CM, 2008, J CLIN ONCOL, V26, P2198, DOI 10.1200/JCO.2007.14.6217; Boggs DA, 2010, AM J EPIDEMIOL, V172, P1268, DOI 10.1093/aje/kwq293; Bradbury KE, 2014, AM J CLIN NUTR, V100, p394S, DOI 10.3945/ajcn.113.071357; Butler LM, 2010, AM J CLIN NUTR, V91, P1013, DOI 10.3945/ajcn.2009.28572; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Chlebowski RT, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv327; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; COLDITZ GA, 1987, AM J EPIDEMIOL, V126, P319, DOI 10.1093/aje/126.2.319; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Eliassen AH, 2012, JNCI-J NATL CANCER I, V104, P1905, DOI 10.1093/jnci/djs461; Farvid MS, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1226; Fung TT, 2006, J NUTR, V136, P466, DOI 10.1093/jn/136.2.466; George SM, 2009, AM J CLIN NUTR, V89, P347, DOI 10.3945/ajcn.2008.26722; Gram IT, 2015, AM J EPIDEMIOL, V182, P917, DOI 10.1093/aje/kwv092; Hefti MM, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3462; Hendrickson SJ, 2013, NUTRIENTS, V5, P4051, DOI 10.3390/nu5104051; Holland GWA, 1991, COMPOSITION FOODS; Hu FL, 2015, J CANCER RES CLIN, V141, P601, DOI 10.1007/s00432-014-1852-7; Joshipura KJ, 2001, ANN INTERN MED, V134, P1106, DOI 10.7326/0003-4819-134-12-200106190-00010; Jung S, 2013, JNCI-J NATL CANCER I, V105, P219, DOI 10.1093/jnci/djs635; Land CE, 2003, RADIAT RES, V160, P707, DOI 10.1667/RR3082; Lof M, 2011, CANCER CAUSE CONTROL, V22, P283, DOI 10.1007/s10552-010-9696-1; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; Maillard V, 2010, INT J CANCER, V127, P1188, DOI 10.1002/ijc.25138; Maruti SS, 2006, EPIDEMIOLOGY, V17, P226, DOI 10.1097/01.ede.0000198181.86685.49; Maruti SS, 2005, AM J EPIDEMIOL, V161, P89, DOI 10.1093/aje/kwi019; Muraki I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5001; Nagel G, 2010, BREAST CANCER RES TR, V119, P753, DOI 10.1007/s10549-009-0444-8; Olsen A, 2003, J NUTR, V133, P2342, DOI 10.1093/jn/133.7.2342; ROHAN TE, 1993, CANCER CAUSE CONTROL, V4, P29, DOI 10.1007/BF00051711; SHIBATA A, 1992, BRIT J CANCER, V66, P673, DOI 10.1038/bjc.1992.336; Sonestedt E, 2008, CARCINOGENESIS, V29, P2203, DOI 10.1093/carcin/bgn196; STEINMETZ KA, 1993, CANCER RES, V53, P536; Subar AF, 2015, J NUTR, V145, P2639, DOI 10.3945/jn.115.219634; Suzuki R, 2013, CANCER CAUSE CONTROL, V24, P2117, DOI 10.1007/s10552-013-0289-7; Swerdlow AJ, 2000, J CLIN ONCOL, V18, P498, DOI 10.1200/JCO.2000.18.3.498; van Gils CH, 2005, JAMA-J AM MED ASSOC, V293, P183, DOI 10.1001/jama.293.2.183; Verhoeven DTH, 1997, BRIT J CANCER, V75, P149, DOI 10.1038/bjc.1997.25; Wahner-Roedler DL, 2003, MAYO CLIN PROC, V78, P708, DOI 10.4065/78.6.708; Willett W, 2013, NUTR EPIDEMIOLOGY, P96; World Cancer Research Fund/American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Zhang SM, 1999, JNCI-J NATL CANCER I, V91, P547, DOI 10.1093/jnci/91.6.547; Zhang XH, 2012, AM J CLIN NUTR, V95, P713, DOI 10.3945/ajcn.111.014415	47	80	85	1	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 11	2016	353								i2343	10.1136/bmj.i2343	http://dx.doi.org/10.1136/bmj.i2343			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6FR	27170029	hybrid, Green Published			2022-12-28	WOS:000376446500006
J	Jayasekera, CR; Arora, S; Ahmed, A				Jayasekera, Channa R.; Arora, Sanjeev; Ahmed, Aijaz			Hepatitis C Treatment Delivery Mandates Optimizing Available Health Care Human Resources A Case for Task Shifting	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VIRUS-INFECTION		[Jayasekera, Channa R.] Calif Pacific Med Ctr, Dept Transplantat, 4th Flr,2340 Clay St, San Francisco, CA USA; [Jayasekera, Channa R.] Stanford Univ, Ctr Innovat Global Hlth, Stanford, CA 94305 USA; [Arora, Sanjeev] Univ New Mexico, Hlth Sci Ctr, Dept Internal Med, Albuquerque, NM 87131 USA; [Arora, Sanjeev] Univ New Mexico, Project ECHO, Albuquerque, NM 87131 USA; [Ahmed, Aijaz] Stanford Univ, Med Ctr, Div Gastroenterol & Hepatol, Liver Transplant Program, Stanford, CA 94305 USA	California Pacific Medical Center; Stanford University; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; Stanford University	Jayasekera, CR (corresponding author), Calif Pacific Med Ctr, Dept Transplantat, 4th Flr,2340 Clay St, San Francisco, CA USA.	jayasec@sutterhealth.org						Andrieux-Meyer I, 2015, LANCET GLOB HEALTH, V3, pE676, DOI 10.1016/S2214-109X(15)00156-4; Arora S, 2011, NEW ENGL J MED, V364, P2199, DOI 10.1056/NEJMoa1009370; Chirikov VV, 2015, HEPATOLOGY, V62, P68, DOI 10.1002/hep.27775; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Kredo T, 2013, COCHRANE DB SYST REV, V6, DOI DOI 10.102/14651858.CD009987; Kredo T, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007331.pub3; Reau Nancy, 2014, Clin Liver Dis (Hoboken), V4, P31, DOI 10.1002/cld.376; Thomas DL, 2013, NAT MED, V19, P850, DOI 10.1038/nm.3184	8	17	17	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 10	2016	315	18					1947	1948		10.1001/jama.2016.1993	http://dx.doi.org/10.1001/jama.2016.1993			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2JP	27163981				2022-12-28	WOS:000375461100009
J	Snyder, A				Snyder, Alison			Yvette Fay Francis-McBarnette Obituary	LANCET			English	Biographical-Item												amsnyder@alum.mit.edu							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2016	387	10031					1902	1902						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL1EE	27203644				2022-12-28	WOS:000375374200018
J	Sauermann, H; Roach, M				Sauermann, Henry; Roach, Michael			Why pursue the postdoc path?	SCIENCE			English	Editorial Material							BIOMEDICAL-RESEARCH		[Sauermann, Henry] Georgia Inst Technol, Scheller Coll Business, Atlanta, GA 30308 USA; [Sauermann, Henry] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Roach, Michael] Cornell Univ, Dyson Sch Appl Econ & Management, Ithaca, NY 14853 USA	University System of Georgia; Georgia Institute of Technology; National Bureau of Economic Research; Cornell University	Sauermann, H (corresponding author), Georgia Inst Technol, Scheller Coll Business, Atlanta, GA 30308 USA.; Sauermann, H (corresponding author), Natl Bur Econ Res, Cambridge, MA 02138 USA.	henry.sauermann@scheller.gatech.edu		Roach, Michael/0000-0002-9781-8567				Alberts B, 2014, P NATL ACAD SCI USA, V111, P5773, DOI 10.1073/pnas.1404402111; Biomedical Research Workforce Working Group, 2012, REP NIH ADV COMM DIR; Cyranoski D, 2011, NATURE, V472, P276, DOI 10.1038/472276a; Freeman R, 2001, SCIENCE, V294, P2293, DOI 10.1126/science.1067477; Gibbs KD, 2015, CBE-LIFE SCI EDUC, V14, DOI 10.1187/cbe.15-03-0075; Hermanowicz JC, 2006, SCI TECHNOL HUM VAL, V31, P135, DOI 10.1177/0162243905283637; Kaplan Karen, 2012, Nature, V483, P499; McDowell Gary S, 2014, F1000Res, V3, P291, DOI 10.12688/f1000research.5878.2; National Academies, 2014, POSTD EXP REV; National Research Council (NRC), 1998, TRENDS EARL CAR LIF; National Science Board, 2016, SCI ENG IND; Powell K, 2015, NATURE, V520, P144, DOI 10.1038/520144a; Sauermann H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036307; Stephan P, 2005, AM ECON REV, V95, P71, DOI 10.1257/000282805774669619; Stephan P, 2013, BIOSCIENCE, V63, P245, DOI 10.1525/bio.2013.63.4.2; Teitelbaum MS, 2008, SCIENCE, V321, P644, DOI 10.1126/science.1160272	16	60	60	3	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2016	352	6286					663	664		10.1126/science.aaf2061	http://dx.doi.org/10.1126/science.aaf2061			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL1UC	27151854				2022-12-28	WOS:000375417100019
J	Black, N				Black, Nick			Is hospital mortality higher at weekends? If so, why?	LANCET			English	Editorial Material							ASSOCIATION; DEATHS; COHORT		[Black, Nick] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1H 9SH, England	University of London; London School of Hygiene & Tropical Medicine	Black, N (corresponding author), London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1H 9SH, England.	nick.black@lshtm.ac.uk						Aldridge C, 2016, LANCET; Aylin P, 2010, QUAL SAF HEALTH CARE, V19, P213, DOI 10.1136/qshc.2008.028639; Bell CM, 2001, NEW ENGL J MED, V345, P663, DOI 10.1056/NEJMsa003376; Bray B, 2016, LANCET; Bray BD, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001705; Freemantle N, 2012, J ROY SOC MED, V105, P74, DOI 10.1258/jrsm.2012.120009; Hogan H, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3239; MANGOLD WD, 1981, AM J PUBLIC HEALTH, V71, P601, DOI 10.2105/AJPH.71.6.601; MATHERS CD, 1983, J EPIDEMIOL COMMUN H, V37, P57, DOI 10.1136/jech.37.1.57; McFarlane A, 1978, BMJ-BRIT MED J, V2, P1670; Meacock R, 2016, J HLTH SERV RES POLI; NHS England, 7 DAY HOSP SERV; Palmer WL, 2012, ARCH NEUROL-CHICAGO, V69, P1296, DOI 10.1001/archneurol.2012.1030; Royal College of Physicians, 2012, STAND ASS AC ILLN SE; Sacks GD, 2015, BMJ QUAL SAF, V24, P458, DOI 10.1136/bmjqs-2014-003764; Taylor N, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0879-z; Wunsch H, 2004, INTENS CARE MED, V30, P895, DOI 10.1007/s00134-004-2170-3	17	18	18	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2016	388	10040					108	111		10.1016/S0140-6736(16)30505-0	http://dx.doi.org/10.1016/S0140-6736(16)30505-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ5TZ	27178478	Green Submitted, hybrid			2022-12-28	WOS:000379269200010
J	Liu, S; Liu, QL; Tabuchi, M; Wu, MN				Liu, Sha; Liu, Qili; Tabuchi, Masashi; Wu, Mark N.			Sleep Drive Is Encoded by Neural Plastic Changes in a Dedicated Circuit	CELL			English	Article							MEMORY CONSOLIDATION; NMDA RECEPTORS; REMOTE-CONTROL; ACTIVE ZONE; DROSOPHILA; NEURONS; WAKEFULNESS; HOMEOSTASIS; EXPRESSION; RAT	Prolonged wakefulness leads to an increased pressure for sleep, but how this homeostatic drive is generated and subsequently persists is unclear. Here, from a neural circuit screen in Drosophila, we identify a subset of ellipsoid body (EB) neurons whose activation generates sleep drive. Patch-clamp analysis indicates these EB neurons are highly sensitive to sleep loss, switching from spiking to burst-firing modes. Functional imaging and translational profiling experiments reveal that elevated sleep need triggers reversible increases in cytosolic Ca2+ levels, NMDA receptor expression, and structural markers of synaptic strength, suggesting these EB neurons undergo "sleep-need"-dependent plasticity. Strikingly, the synaptic plasticity of these EB neurons is both necessary and sufficient for generating sleep drive, indicating that sleep pressure is encoded by plastic changes within this circuit. These studies define an integrator circuit for sleep homeostasis and provide a mechanism explaining the generation and persistence of sleep drive.	[Liu, Sha; Liu, Qili; Tabuchi, Masashi; Wu, Mark N.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21287 USA; [Wu, Mark N.] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University	Wu, MN (corresponding author), Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21287 USA.; Wu, MN (corresponding author), Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21287 USA.	marknwu@jhmi.edu		Tabuchi, Masashi/0000-0002-8734-6922; Liu, Sha/0000-0002-7168-330X	NIH [R01NS079584, R21NS088521]; NINDS Center Grant [NS05027]; Burroughs-Wellcome Fund Career Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS050274, R01NS079584, R21NS088521] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS Center Grant; Burroughs-Wellcome Fund Career Award(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Rubin, T. Littleton, J. Wang, C.-H. Lee, J.-R. Martin, R. Jackson, C.-L. Wu, and the Bloomington Stock Center for reagents. We thank C. Potter, T. Lloyd, D. O'Connor, J. Cohen, A. Kolodkin, and members of M.N.W.'s lab for comments on the manuscript. This work was supported by NIH grants R01NS079584 (M.N.W.) and R21NS088521 (M.N.W.), NINDS Center Grant NS05027 for machine shop work, and a Burroughs-Wellcome Fund Career Award for Medical Scientists (M.N.W.).	BENINGTON JH, 1995, PROG NEUROBIOL, V45, P347, DOI 10.1016/0301-0082(94)00057-O; Berridge KC, 2004, PHYSIOL BEHAV, V81, P179, DOI 10.1016/j.physbeh.2004.02.004; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Borbely A A, 1982, Hum Neurobiol, V1, P195; Borst A, 2015, NAT NEUROSCI, V18, P1067, DOI 10.1038/nn.4050; Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011; Cannon WB, 1929, PHYSIOL REV, V9, P399, DOI 10.1152/physrev.1929.9.3.399; Chen Y, 2014, NEURON, V81, P280, DOI 10.1016/j.neuron.2013.12.021; Cirelli C, 2009, NAT REV NEUROSCI, V10, P549, DOI 10.1038/nrn2683; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; DAAN S, 1984, AM J PHYSIOL, V246, pR161, DOI 10.1152/ajpregu.1984.246.2.R161; Donlea JM, 2014, NEURON, V81, P860, DOI 10.1016/j.neuron.2013.12.013; Donlea JM, 2011, SCIENCE, V332, P1571, DOI 10.1126/science.1202249; Enderle J., 2012, INTRO BIOMEDICAL ENG; Frank MG, 1997, AM J PHYSIOL-REG I, V272, pR1792, DOI 10.1152/ajpregu.1997.272.6.R1792; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Holderith N, 2012, NAT NEUROSCI, V15, P988, DOI 10.1038/nn.3137; Huang YM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001703; Huber R, 2000, BRAIN RES, V857, P8, DOI 10.1016/S0006-8993(99)02248-9; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; JONZON B, 1985, J NEUROCHEM, V44, P217, DOI 10.1111/j.1471-4159.1985.tb07133.x; Kayser MS, 2014, SCIENCE, V344, P269, DOI 10.1126/science.1250553; Kunst M, 2014, CURR BIOL, V24, P2652, DOI 10.1016/j.cub.2014.09.077; Lai SL, 2006, NAT NEUROSCI, V9, P703, DOI 10.1038/nn1681; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Liu QL, 2012, CURR BIOL, V22, P2114, DOI 10.1016/j.cub.2012.09.008; Liu S, 2014, NEURON, V82, P151, DOI 10.1016/j.neuron.2014.01.040; Luan HJ, 2006, NEURON, V52, P425, DOI 10.1016/j.neuron.2006.08.028; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Masuyama K, 2012, J NEUROGENET, V26, P89, DOI 10.3109/01677063.2011.642910; Melom JE, 2013, J NEUROSCI, V33, P1169, DOI 10.1523/JNEUROSCI.3920-12.2013; Methippara MM, 2005, AM J PHYSIOL-REG I, V289, pR1715, DOI 10.1152/ajpregu.00247.2005; Moore SJ, 2009, NEURON, V61, P287, DOI 10.1016/j.neuron.2008.12.013; Murmu MS, 2010, J EXP BIOL, V213, P4163, DOI 10.1242/jeb.046474; O'Leary T, 2014, NEURON, V82, P809, DOI 10.1016/j.neuron.2014.04.002; Pettipher R, 2007, NAT REV DRUG DISCOV, V6, P313, DOI 10.1038/nrd2266; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; ROFFWARG HP, 1966, SCIENCE, V152, P604, DOI 10.1126/science.152.3722.604; Saito YC, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00192; Sarantopoulos C, 2004, J NEUROSCI METH, V139, P61, DOI 10.1016/j.jneumeth.2004.04.015; Sehgal A, 2011, CELL, V146, P194, DOI 10.1016/j.cell.2011.07.004; Strausfeld NJ, 2013, SCIENCE, V340, P157, DOI 10.1126/science.1231828; Sugie A, 2015, NEURON, V86, P711, DOI 10.1016/j.neuron.2015.03.046; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Ueno T, 2012, NAT NEUROSCI, V15, P1516, DOI 10.1038/nn.3238; Wevhersmuller A., 2011, J NEUROSCI, V31, P6041; Wu CL, 2007, NAT NEUROSCI, V10, P1578, DOI 10.1038/nn2005; Xia SZ, 2005, CURR BIOL, V15, P603, DOI 10.1016/j.cub.2005.02.059	50	159	162	2	392	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2016	165	6					1347	1360		10.1016/j.cell.2016.04.013	http://dx.doi.org/10.1016/j.cell.2016.04.013			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DN4NV	27212237	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000377045400010
J	Makushok, T; Alves, P; Huisman, SM; Kijowski, AR; Brunner, D				Makushok, Tatyana; Alves, Paulo; Huisman, Stephen Michiel; Kijowski, Adam Rafal; Brunner, Damian			Sterol-Rich Membrane Domains Define Fission Yeast Cell Polarity	CELL			English	Article							DISRUPT MICROFILAMENT ORGANIZATION; FORMIN FOR3P; SCHIZOSACCHAROMYCES-POMBE; LIPID RAFTS; SACCHAROMYCES-CEREVISIAE; ACTIN CABLES; PROTEIN; GROWTH; MORPHOGENESIS; MICROTUBULES	Cell polarization is crucial for the functioning of all organisms. The cytoskeleton is central to the process but its role in symmetry breaking is poorly understood. We study cell polarization when fission yeast cells exit starvation. We show that the basis of polarity generation is de novo sterol biosynthesis, cell surface delivery of sterols, and their recruitment to the cell poles. This involves four phases occurring independent of the polarity factor cdc42p. Initially, multiple, randomly distributed sterol-rich membrane (SRM) domains form at the plasma membrane, independent of the cytoskeleton and cell growth. These domains provide platforms on which the growth and polarity machinery assembles. SRM domains are then polarized by the microtubule-dependent polarity factor tea1p, which prepares for monopolar growth initiation and later switching to bipolar growth. SRM polarization requires F-actin but not the F-actin organizing polarity factors for3p and bud6p. We conclude that SRMs are key to cell polarization.	[Makushok, Tatyana] Univ Calif San Francisco, 600 16th St, San Francisco, CA 94143 USA; [Alves, Paulo] IGBMC, 1 Rue Laurent Fries, F-67404 Illkirch Graffenstaden, France; [Huisman, Stephen Michiel; Kijowski, Adam Rafal; Brunner, Damian] Univ Zurich, Inst Mol Life Sci, Winterthurerstr 190, CH-8057 Zurich, Switzerland	University of California System; University of California San Francisco; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Zurich	Brunner, D (corresponding author), Univ Zurich, Inst Mol Life Sci, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	damian.brunner@imls.uzh.ch	Brunner, Damian/F-2024-2011	Brunner, Damian/0000-0001-5250-492X; Huisman, Stephen/0000-0002-1658-8350	Human Frontier Science Program (HFSP) research grant [RGP0011/2005-C]; Swiss National Science Foundation (SNSF) grant; University of Zurich	Human Frontier Science Program (HFSP) research grant(Human Frontier Science Program); Swiss National Science Foundation (SNSF) grant(Swiss National Science Foundation (SNSF)); University of Zurich	We thank R.W. Klemm, E. Brunner, and M. Daellenbach for critical reading of the manuscript and R.W. Klemm for technical help on thin-layer chromatography (TLC). This work was supported by a Human Frontier Science Program (HFSP) research grant (RGP0011/2005-C) and a Swiss National Science Foundation (SNSF) grant. We thank the Advanced Light Microscopy Facility (ALMF) at the European Molecular Biology Laboratory (EMBL) and the Center for Microscopy and Image Analysis of the University of Zurich (UZH) for valuable support. D.B. acknowledges financial support from the University of Zurich.	Abenza JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106959; Akhshi TK, 2014, CYTOSKELETON, V71, P1, DOI 10.1002/cm.21150; Bagnat M, 2002, BIOL CHEM, V383, P1475, DOI 10.1515/BC.2002.169; Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697; Beinhauer JD, 1997, J CELL BIOL, V139, P717, DOI 10.1083/jcb.139.3.717; Bendezu FO, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002097; Bendezu FO, 2011, MOL BIOL CELL, V22, P44, DOI 10.1091/mbc.E10-08-0720; Bonazzi D, 2014, DEV CELL, V28, P534, DOI 10.1016/j.devcel.2014.01.023; Castagnetti S, 2007, J CELL SCI, V120, P2205, DOI 10.1242/jcs.03464; Chang F, 2003, NAT CELL BIOL, V5, P294, DOI 10.1038/ncb0403-294; Das M, 2012, SCIENCE, V337, P239, DOI 10.1126/science.1218377; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Faty M, 2002, CURR GENET, V41, P123, DOI 10.1007/s00294-002-0304-0; Feierbach B, 2004, J CELL BIOL, V165, P697, DOI 10.1083/jcb.200403090; Feierbach B, 2001, CURR BIOL, V11, P1656, DOI 10.1016/S0960-9822(01)00525-5; Foethke D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.76; Fuchs E, 2001, GENE DEV, V15, P1, DOI 10.1101/gad.861501; Glynn JM, 2001, CURR BIOL, V11, P836, DOI 10.1016/S0960-9822(01)00235-4; Huber F, 2015, CURR OPIN CELL BIOL, V32, P39, DOI 10.1016/j.ceb.2014.10.005; Huisman SM, 2011, SEMIN CELL DEV BIOL, V22, P799, DOI 10.1016/j.semcdb.2011.07.013; Kelly FD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027977; Klose C, 2010, J BIOL CHEM, V285, P30224, DOI 10.1074/jbc.M110.123554; Kokkoris K., 2014, J CELL SCI, V125, P2007; LOWRY RR, 1968, J LIPID RES, V9, P397; Markgraf DF, 2014, CELL REP, V6, P44, DOI 10.1016/j.celrep.2013.11.046; Martin SG, 2005, DEV CELL, V8, P479, DOI 10.1016/j.devcel.2005.02.008; Martin SG, 2007, MOL BIOL CELL, V18, P4155, DOI 10.1091/mbc.E07-02-0094; Martin SG, 2006, CURR BIOL, V16, P1161, DOI 10.1016/j.cub.2006.04.040; Martin SG, 2014, FEMS MICROBIOL REV, V38, P228, DOI 10.1111/1574-6976.12055; Martin SG, 2009, TRENDS CELL BIOL, V19, P447, DOI 10.1016/j.tcb.2009.06.003; Mata J, 1997, CELL, V89, P939, DOI 10.1016/S0092-8674(00)80279-2; Meder D, 2005, J CELL BIOL, V168, P303, DOI 10.1083/jcb.200407072; Meinhardt H, 2000, BIOESSAYS, V22, P753, DOI 10.1002/1521-1878(200008)22:8<753::AID-BIES9>3.3.CO;2-Q; Minc N, 2009, CURR BIOL, V19, P83, DOI 10.1016/j.cub.2008.12.008; MITCHISON JM, 1985, J CELL SCI, V75, P357; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moseley JB, 2009, CURR OPIN CELL BIOL, V21, P82, DOI 10.1016/j.ceb.2008.12.005; Pelham RJ, 2001, NAT CELL BIOL, V3, P235, DOI 10.1038/35060020; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; PRINGLE JR, 1989, METHOD CELL BIOL, V31, P357; Ragkousi K, 2014, J CELL BIOL, V207, P181, DOI 10.1083/jcb.201408044; Redon M, 2009, EUR FOOD RES TECHNOL, V228, P833, DOI 10.1007/s00217-008-0996-6; Rincon SA, 2009, MOL BIOL CELL, V20, P4390, DOI 10.1091/mbc.E09-03-0207; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Sawin KE, 2004, J CELL SCI, V117, P689, DOI 10.1242/jcs.00925; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Siegrist SE, 2007, GENE DEV, V21, P483, DOI 10.1101/gad.1511207; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Sutterlin C, 1997, J CELL SCI, V110, P2703; Takeda T, 2005, CURR BIOL, V15, P1331, DOI 10.1016/j.cub.2005.07.009; Takeda T, 2004, NAT CELL BIOL, V6, P1142, DOI 10.1038/ncb1189; Tatebe H, 2008, CURR BIOL, V18, P322, DOI 10.1016/j.cub.2008.02.005; Toya M, 1999, MOL BIOL CELL, V10, P2745, DOI 10.1091/mbc.10.8.2745; VANDENBOSSCHE H, 1980, ANTIMICROB AGENTS CH, V17, P922, DOI 10.1128/AAC.17.6.922; Veen M, 2003, FEMS YEAST RES, V4, P87, DOI 10.1016/S1567-1356(03)00126-0; Wachtler V, 2006, TRENDS CELL BIOL, V16, P1, DOI 10.1016/j.tcb.2005.11.008; Wachtler V, 2003, J CELL SCI, V116, P867, DOI 10.1242/jcs.00299; Wedlich-Soldner R, 2008, SEMIN CELL DEV BIOL, V19, P224, DOI 10.1016/j.semcdb.2008.01.003; ZaitsevskayaCarter T, 1997, EMBO J, V16, P1318, DOI 10.1093/emboj/16.6.1318	64	26	26	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2016	165	5					1182	1196		10.1016/j.cell.2016.04.037	http://dx.doi.org/10.1016/j.cell.2016.04.037			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DM6QT	27180904	Bronze			2022-12-28	WOS:000376478200018
J	Vanaja, SK; Russo, AJ; Behl, B; Banerjee, I; Yankova, M; Deshmukh, SD; Rathinam, VAK				Vanaja, Sivapriya Kailasan; Russo, Ashley J.; Behl, Bharat; Banerjee, Ishita; Yankova, Maya; Deshmukh, Sachin D.; Rathinam, Vijay A. K.			Bacterial Outer Membrane Vesicles Mediate Cytosolic Localization of LPS and Caspase-11 Activation	CELL			English	Article							NONCANONICAL INFLAMMASOME ACTIVATION; LEGIONELLA-PNEUMOPHILA; ESCHERICHIA-COLI; ENVELOPE STRESS; HOST-DEFENSE; GASDERMIN D; RECOGNITION; MECHANISM; CELLS	Sensing of lipopolysaccharide (LPS) in the cytosol triggers caspase-11 activation and is central to host defense against Gram-negative bacterial infections and to the pathogenesis of sepsis. Most Gram-negative bacteria that activate caspase-11, however, are not cytosolic, and the mechanism by which LPS from these bacteria gains access to caspase-11 in the cytosol remains elusive. Here, we identify outer membrane vesicles (OMVs) produced by Gram-negative bacteria as a vehicle that delivers LPS into the cytosol triggering caspase-11-dependent effector responses in vitro and in vivo. OMVs are internalized via endocytosis, and LPS is released into the cytosol from early endosomes. The use of hypovesiculating bacterial mutants, compromised in their ability to generate OMVs, reveals the importance of OMVs in mediating the cytosolic localization of LPS. Collectively, these findings demonstrate a critical role for OMVs in enabling the cytosolic entry of LPS and, consequently, caspase-11 activation during Gram-negative bacterial infections.	[Vanaja, Sivapriya Kailasan; Russo, Ashley J.; Behl, Bharat; Banerjee, Ishita; Rathinam, Vijay A. K.] UConn Hlth Sch Med, Dept Immunol, 263 Farmington Ave, Farmington, CT 06030 USA; [Yankova, Maya] UConn Hlth Sch Med, Cent Electron Microscopy Facil, 263 Farmington Ave, Farmington, CT 06030 USA; [Deshmukh, Sachin D.] Jena Univ Hosp, Ctr Sepsis Control & Care, Erlanger Allee 101, D-07747 Jena, Germany	Friedrich Schiller University of Jena	Rathinam, VAK (corresponding author), UConn Hlth Sch Med, Dept Immunol, 263 Farmington Ave, Farmington, CT 06030 USA.	rathinam@uchc.edu	Rathinam, Vijay/ABE-7544-2020; BANERJEE, ISHITA/AAA-4580-2020	Rathinam, Vijay/0000-0002-8009-3977; BANERJEE, ISHITA/0000-0002-9710-6180	UConn Health; Charles Hood Child Health Research Award by the Charles H. Hood Foundation; NIH [AI119015]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI119015] Funding Source: NIH RePORTER	UConn Health; Charles Hood Child Health Research Award by the Charles H. Hood Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Kate Fitzgerald and Vishva Dixit for caspase-11<SUP>-/-</SUP> mice; the Central Electron Microscopy facility at UConn Health for TEM; Kate Fitzgerald, Kamal Khanna, and Anthony Vella for critical review of the manuscript; Meta Kuehn, Yale E. coli Genetic Stock Center, John Leong, and Egil Lien for bacterial strains; and Sanjay Ram, Dan Granoff, Serena Giuntini, Jonathan Kagan, Justin Radolf, Arvind Anand, and Jorge Cervantes for reagents or technical help. This work was supported by funds from UConn Health, the Charles Hood Child Health Research Award by the Charles H. Hood Foundation, and the NIH (AI119015 to V.R.).	Acevedo R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00121; Bonham KS, 2014, CELL HOST MICROBE, V15, P523, DOI 10.1016/j.chom.2014.05.001; Bossaller L, 2012, J IMMUNOL, V189, P5508, DOI 10.4049/jimmunol.1202121; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Chutkan Halima, 2013, Methods Mol Biol, V966, P259, DOI 10.1007/978-1-62703-245-2_16; Demuth DR, 2003, CELL MICROBIOL, V5, P111, DOI 10.1046/j.1462-5822.2003.00259.x; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Galka F, 2008, INFECT IMMUN, V76, P1825, DOI 10.1128/IAI.01396-07; Gurung P, 2012, J BIOL CHEM, V287, P34474, DOI 10.1074/jbc.M112.401406; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Hickey CA, 2015, CELL HOST MICROBE, V17, P672, DOI 10.1016/j.chom.2015.04.002; Jager J, 2015, CELL MICROBIOL, V17, P607, DOI 10.1111/cmi.12392; Kaparakis M, 2010, CELL MICROBIOL, V12, P372, DOI 10.1111/j.1462-5822.2009.01404.x; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kesty NC, 2004, EMBO J, V23, P4538, DOI 10.1038/sj.emboj.7600471; Kim JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059276; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Mallick EM, 2012, J CLIN INVEST, V122, P4012, DOI 10.1172/JCI62746; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; McBroom AJ, 2007, MOL MICROBIOL, V63, P545, DOI 10.1111/j.1365-2958.2006.05522.x; McBroom AJ, 2006, J BACTERIOL, V188, P5385, DOI 10.1128/JB.00498-06; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Meunier E, 2014, NATURE, V509, P366, DOI 10.1038/nature13157; Namork E, 2002, LANCET, V360, P1741, DOI 10.1016/S0140-6736(02)11721-1; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Park KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011334; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ramsby M., 2005, PROTEOMICS PROTOCOLS, P37; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Schwechheimer C, 2013, J BACTERIOL, V195, P4161, DOI 10.1128/JB.02192-12; Shen Y, 2012, CELL HOST MICROBE, V12, P509, DOI 10.1016/j.chom.2012.08.004; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; STEPHENS DS, 1982, J INFECT DIS, V146, P568, DOI 10.1093/infdis/146.4.568; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Vanaja SK, 2014, P NATL ACAD SCI USA, V111, P7765, DOI 10.1073/pnas.1400075111; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007	45	332	350	17	148	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2016	165	5					1106	1119		10.1016/j.cell.2016.04.015	http://dx.doi.org/10.1016/j.cell.2016.04.015			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DM6QT	27156449	Green Accepted, Bronze			2022-12-28	WOS:000376478200012
J	Lawson, JH; Glickman, MH; Ilzecki, M; Jakimowicz, T; Jaroszynski, A; Peden, EK; Pilgrim, AJ; Prichard, HL; Guziewicz, M; Przywara, S; Szmidt, J; Turek, J; Witkiewicz, W; Zapotoczny, N; Zubilewicz, T; Niklason, LE				Lawson, Jeffrey H.; Glickman, Marc H.; Ilzecki, Marek; Jakimowicz, Tomasz; Jaroszynski, Andrzej; Peden, Eric K.; Pilgrim, Alison J.; Prichard, Heather L.; Guziewicz, Malgorzata; Przywara, Stanislaw; Szmidt, Jacek; Turek, Jakub; Witkiewicz, Wojciech; Zapotoczny, Norbert; Zubilewicz, Tomasz; Niklason, Laura E.			Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials	LANCET			English	Article							ENGINEERED VASCULAR GRAFT; BOVINE CAROTID-ARTERY; HEMODIALYSIS ACCESS; ARTERIOVENOUS-FISTULA; POLYTETRAFLUOROETHYLENE; COMPLICATIONS; PATENCY	Background For patients with end-stage renal disease who are not candidates for fistula, dialysis access grafts are the best option for chronic haemodialysis. However, polytetrafluoroethylene arteriovenous grafts are prone to thrombosis, infection, and intimal hyperplasia at the venous anastomosis. We developed and tested a bioengineered human acellular vessel as a potential solution to these limitations in dialysis access. Methods We did two single-arm phase 2 trials at six centres in the USA and Poland. We enrolled adults with end-stage renal disease. A novel bioengineered human acellular vessel was implanted into the arms of patients for haemodialysis access. Primary endpoints were safety (freedom from immune response or infection, aneurysm, or mechanical failure, and incidence of adverse events), and efficacy as assessed by primary, primary assisted, and secondary patencies at 6 months. All patients were followed up for at least 1 year, or had a censoring event. These trials are registered with ClinicalTrials.gov, NCT01744418 and NCT01840956. Findings Human acellular vessels were implanted into 60 patients. Mean follow-up was 16 months (SD 7.6). One vessel became infected during 82 patient-years of follow-up. The vessels had no dilatation and rarely had post-cannulation bleeding. At 6 months, 63% (95% CI 47-72) of patients had primary patency, 73% (57-81) had primary assisted patency, and 97% (85-98) had secondary patency, with most loss of primary patency because of thrombosis. At 12 months, 28% (17-40) had primary patency, 38% (26-51) had primary assisted patency, and 89% (74-93) had secondary patency. Interpretation Bioengineered human acellular vessels seem to provide safe and functional haemodialysis access, and warrant further study in randomised controlled trials.	[Lawson, Jeffrey H.; Glickman, Marc H.; Pilgrim, Alison J.; Prichard, Heather L.] Humacyte, Durham, NC USA; [Lawson, Jeffrey H.] Duke Univ, Durham, NC USA; [Glickman, Marc H.] Sentara Heart Hosp, Norfolk, VA USA; [Ilzecki, Marek; Przywara, Stanislaw; Zubilewicz, Tomasz] Med Univ Lublin, Dept Vasc Surg & Angiol, Lublin, Poland; [Jaroszynski, Andrzej] Med Univ Lublin, Dept Family Med, Lublin, Poland; [Jakimowicz, Tomasz; Szmidt, Jacek] Med Univ Warsaw, Dept Gen Vasc & Transplant Surg, Warsaw, Poland; [Guziewicz, Malgorzata; Turek, Jakub; Witkiewicz, Wojciech; Zapotoczny, Norbert] Gen Hosp Wroclaw, Dept Vasc Surg, Ctr Res & Dev, Wroclaw, Poland; [Peden, Eric K.] Cardiovasc Surg Associates, Houston, TX USA; [Niklason, Laura E.] Yale Univ, Dept Anesthesia, Room 301D Amistad Bldg, New Haven, CT 06519 USA; [Niklason, Laura E.] Yale Univ, Dept Biomed Engn, Room 301D Amistad Bldg, New Haven, CT 06519 USA	Duke University; Sentara Healthcare; Medical University of Lublin; Medical University of Lublin; Medical University of Warsaw; Yale University; Yale University	Niklason, LE (corresponding author), Yale Univ, Dept Anesthesia, Room 301D Amistad Bldg, New Haven, CT 06519 USA.; Niklason, LE (corresponding author), Yale Univ, Dept Biomed Engn, Room 301D Amistad Bldg, New Haven, CT 06519 USA.	laura.niklason@yale.edu	Przywara, Stanislaw/GRO-7170-2022	Jakimowicz, Tomasz/0000-0002-3012-2215; Jaroszynski, Andrzej/0000-0001-8194-1723; Przywara, Stanislaw/0000-0002-8855-3974	Humacyte; US National Institutes of Health [R44 HL118736]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R44HL118736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R44DK085760] Funding Source: NIH RePORTER	Humacyte; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Humacyte and by the US National Institutes of Health (R44 HL118736). We thank Michael Perelman and Shannon Dahl for assistance with manuscript preparation. William Tente and Juliana Blum assisted with site recruitment and regulatory documents. Justin Strader and Stuart Irwin oversaw graft manufacture, Robert Schutte developed the manufacturing system, and Maribel Santiago did histological analysis. Sally Wade provided editorial assistance.	Akoh JA, 2010, J VASC ACCESS, V11, P155, DOI 10.1177/112972981001100213; Allahverdian S, 2014, CIRCULATION, V129, P1551, DOI 10.1161/CIRCULATIONAHA.113.005015; Augustine JJ, 2012, TRANSPLANTATION, V94, P738, DOI 10.1097/TP.0b013e3182612921; CDC, DIAL EV PROT; Chang CC, 2000, J MATER SCI-MATER M, V11, P337, DOI 10.1023/A:1008925722623; Dahl SLM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001426; Dahl SLM, 2003, CELL TRANSPLANT, V12, P659, DOI 10.3727/000000003108747136; Das N, 2011, CARDIOVASC INTER RAD, V34, P958, DOI 10.1007/s00270-011-0096-z; Dixon BS, 2009, NEW ENGL J MED, V360, P2191, DOI 10.1056/NEJMoa0805840; Fokou M, 2012, ANN VASC SURG, V26, P680, DOI 10.1016/j.avsg.2011.09.014; Frid MG, 2006, AM J PATHOL, V168, P659, DOI 10.2353/ajpath.2006.050599; Harlander-Locke M, 2014, VASC ENDOVASC SURG, V48, P497, DOI 10.1177/1538574414561231; Haskal ZJ, 2010, NEW ENGL J MED, V362, P494, DOI 10.1056/NEJMoa0902045; Hatzibaloglou A, 2004, J Vasc Access, V5, P16; Huber TS, 2003, J VASC SURG, V38, P1005, DOI 10.1016/S0741-5214(03)00426-9; Katzman HE, 2005, J AM COLL SURGEONS, V201, P223, DOI 10.1016/j.jamcollsurg.2005.03.040; Kennealey PT, 2011, J VASC SURG, V53, P1640, DOI 10.1016/j.jvs.2011.02.008; Kingston GT, 2009, HISTOPATHOLOGY, V55, P154, DOI 10.1111/j.1365-2559.2009.03360.x; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Lok CE, 2013, CLIN J AM SOC NEPHRO, V8, P810, DOI 10.2215/CJN.00730112; Madden R, 2002, AM J KIDNEY DIS, V40, P1240, DOI 10.1053/ajkd.2002.36892; Manduz S, 2008, INT J ANGIOL, V17, P37, DOI 10.1055/s-0031-1278278; McAllister TN, 2009, LANCET, V373, P1440, DOI 10.1016/S0140-6736(09)60248-8; Miller PE, 2000, AM J KIDNEY DIS, V36, P68, DOI 10.1053/ajkd.2000.8269; Nassar GM, 2014, SEMIN DIALYSIS, V27, P310, DOI 10.1111/sdi.12173; Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489; Niklason LE, 2001, J VASC SURG, V33, P628, DOI 10.1067/mva.2001.111747; Poh M, 2005, LANCET, V365, P2122, DOI 10.1016/S0140-6736(05)66735-9; Quint C, 2011, P NATL ACAD SCI USA, V108, P9214, DOI 10.1073/pnas.1019506108; Raya-Rivera AM, 2014, LANCET, V384, P329, DOI 10.1016/S0140-6736(14)60542-0; Roy-Chaudhury P, 2001, KIDNEY INT, V59, P2325, DOI 10.1046/j.1523-1755.2001.00750.x; Schild AF, 2008, J VASC ACCESS, V9, P231, DOI 10.1177/112972980800900402; Schmidli J, 2004, EUR J VASC ENDOVASC, V27, P251, DOI 10.1016/j.ejvs.2003.12.001; Schon D, 2007, CLIN J AM SOC NEPHRO, V2, P268, DOI 10.2215/CJN.01880606; Shinoka T, 1998, J THORAC CARDIOV SUR, V115, P536, DOI 10.1016/S0022-5223(98)70315-0; Sidawy AN, 2002, J VASC SURG, V35, P603, DOI 10.1067/mva.2002.122025; Smith MPW, 2009, HEMODIAL INT, V13, P3, DOI 10.1111/j.1542-4758.2009.00349.x; United States Renal Data System, 2015 ANN DAT REP; Valenti D, 2014, VASC ENDOVASC SURG, V48, P491, DOI 10.1177/1538574414561229; Wystrychowski W, 2014, J VASC SURG, V60, P1353, DOI 10.1016/j.jvs.2013.08.018; ZIBARI GB, 1988, SURGERY, V104, P681	41	202	209	3	63	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 14	2016	387	10032					2026	2034		10.1016/S0140-6736(16)00557-2	http://dx.doi.org/10.1016/S0140-6736(16)00557-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8HJ	27203778	Green Accepted			2022-12-28	WOS:000375881500031
J	van Gils, JA; Lisovski, S; Lok, T; Meissner, W; Ozarowska, A; de Fouw, J; Rakhimberdiev, E; Soloviev, MY; Piersma, T; Klaassen, M				van Gils, Jan A.; Lisovski, Simeon; Lok, Tamar; Meissner, Wlodzimierz; Ozarowska, Agnieszka; de Fouw, Jimmy; Rakhimberdiev, Eldar; Soloviev, Mikhail Y.; Piersma, Theunis; Klaassen, Marcel			Body shrinkage due to Arctic warming reduces red knot fitness in tropical wintering range	SCIENCE			English	Article							CLIMATE-CHANGE; BERGMANNS RULE; SEA-ICE; SIZE; ADVANCEMENT; SHOREBIRDS; PRESSURE; GROWTH	Reductions in body size are increasingly being identified as a response to climate warming. Here we present evidence for a case of such body shrinkage, potentially due to malnutrition in early life. We show that an avian long-distance migrant (red knot, Calidris canutus canutus), which is experiencing globally unrivaled warming rates at its high-Arctic breeding grounds, produces smaller offspring with shorter bills during summers with early snowmelt. This has consequences half a world away at their tropical wintering grounds, where shorter-billed individuals have reduced survival rates. This is associated with these molluscivores eating fewer deeply buried bivalve prey and more shallowly buried seagrass rhizomes. We suggest that seasonal migrants can experience reduced fitness at one end of their range as a result of a changing climate at the other end.	[van Gils, Jan A.; de Fouw, Jimmy; Rakhimberdiev, Eldar; Piersma, Theunis] NIOZ Royal Netherlands Inst Sea Res, Dept Coastal Syst, POB 59, NL-1790 AB Den Burg, Texel, Netherlands; [van Gils, Jan A.; de Fouw, Jimmy; Rakhimberdiev, Eldar; Piersma, Theunis] Univ Utrecht, POB 59, NL-1790 AB Den Burg, Texel, Netherlands; [Lisovski, Simeon; Klaassen, Marcel] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Waurn Ponds Campus, Geelong, Vic 3217, Australia; [Lok, Tamar; Piersma, Theunis] Univ Groningen, Groningen Inst Evolutionary Life Sci GELIFES, Conservat Ecol Grp, POB 11103, NL-9700 CC Groningen, Netherlands; [Lok, Tamar] Ctr Ecol Fonct & Evolut, Unite Mixte Rech 5175, Campus Ctr Natl Rech Sci,1919 Route Mende, F-34293 Montpellier 5, France; [Meissner, Wlodzimierz; Ozarowska, Agnieszka] Univ Gdansk, Dept Vertebrate Ecol & Zool, Avian Ecophysiol Unit, Wita Stwosza 59, PL-80308 Gdansk, Poland; [Rakhimberdiev, Eldar; Soloviev, Mikhail Y.] Moscow MV Lomonosov State Univ, Dept Vertebrate Zool, Moscow 119991, Russia	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University; Deakin University; University of Groningen; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Fahrenheit Universities; University of Gdansk; Lomonosov Moscow State University	van Gils, JA (corresponding author), NIOZ Royal Netherlands Inst Sea Res, Dept Coastal Syst, POB 59, NL-1790 AB Den Burg, Texel, Netherlands.; van Gils, JA (corresponding author), Univ Utrecht, POB 59, NL-1790 AB Den Burg, Texel, Netherlands.	jan.van.gils@nioz.nl	Soloviev, Mikhail Y/J-2991-2012; Ożarowska, Agnieszka/AAF-6348-2020; van Gils, Jan/B-5544-2008; Lisovski, Simeon/AAD-4201-2019; Klaassen, Marcel/B-4325-2008; Ożarowska, Agnieszka/AAL-5784-2020; Rakhimberdiev, Eldar/V-6325-2018; Meissner, Wlodzimierz/A-3657-2008; Lok, Tamar/D-8520-2012	Ożarowska, Agnieszka/0000-0002-6904-8016; van Gils, Jan/0000-0002-4132-8243; Klaassen, Marcel/0000-0003-3907-9599; Rakhimberdiev, Eldar/0000-0001-6357-6187; Meissner, Wlodzimierz/0000-0001-5995-9185; Lok, Tamar/0000-0003-3753-8501; Lisovski, Simeon/0000-0002-6399-0035; Soloviev, Mikhail/0000-0003-4040-1477; Piersma, Theunis/0000-0001-9668-466X	NWO (Netherlands Organisation for Scientific Research) [864.09.002]; NWO-Rubicon; Waddenfonds project Metawad [WF209925]; BirdLife Netherlands; World Wildlife Fund-Netherlands; Prins Bernhard Cultuurfondsprijs voor Natuurbehoud; NWO-WOTRO (Science for Global Development) Integrated Programme [W.01.65.221.00]; MAVA (Switzerland); Australian Research Council [DP130101935]	NWO (Netherlands Organisation for Scientific Research)(Netherlands Organization for Scientific Research (NWO)); NWO-Rubicon(Netherlands Organization for Scientific Research (NWO)); Waddenfonds project Metawad; BirdLife Netherlands; World Wildlife Fund-Netherlands; Prins Bernhard Cultuurfondsprijs voor Natuurbehoud; NWO-WOTRO (Science for Global Development) Integrated Programme; MAVA (Switzerland); Australian Research Council(Australian Research Council)	This paper was conceptualized during J.A.v.G.'s sabbatical at the Centre for Integrative Ecology at Deakin University and benefited greatly from discussions with Y. Aharon-Rotman and B. J. Hoye at Deakin University; discussions with A. I. Bijleveld, S. Duijns, E. M. A. Kok, and T. Oudman at NIOZ; and comments by three anonymous referees. We thank W. Bouma and F. Sanders for wordsmithing and D. Visser for graphical support. Field support was provided by Waterbird Research Group KULING in the Polish Baltic and the Banc d'Arguin teams led by B. Spaans, J. Leyrer, M. Brugge, A. Dekinga, and J. ten Horn; we were hosted at Iwik by Parc National du Banc d'Arguin (PNBA) staff (notably M. Camara). We thank the directors of the PNBA for access to the study area. Stable isotope analyses were conducted by T. Leerink, J. Ossebaar, and K. Donkers. Financial support was provided by a NWO (Netherlands Organisation for Scientific Research) Vidi grant (864.09.002) to J.A.v.G., NWO-Rubicon funding to T.L., a suite of grants to T.P. [Waddenfonds project Metawad (WF209925), BirdLife Netherlands, World Wildlife Fund-Netherlands, the Prins Bernhard Cultuurfondsprijs voor Natuurbehoud, NWO-WOTRO (Science for Global Development) Integrated Programme (W.01.65.221.00), and MAVA (Switzerland)], and a grant from the Australian Research Council (DP130101935) to M. K. Data and R codes are available at Dryad at http://dx.doi.org/10.5061/dryad.n1m8d.	Bale JS, 2010, J EXP BIOL, V213, P980, DOI 10.1242/jeb.037911; Baudron AR, 2014, GLOBAL CHANGE BIOL, V20, P1023, DOI 10.1111/gcb.12514; Bowden JJ, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0574; Danks HV, 1999, EUR J ENTOMOL, V96, P83; Gardner JL, 2011, TRENDS ECOL EVOL, V26, P285, DOI 10.1016/j.tree.2011.03.005; Grilli MP, 1997, B ENTOMOL RES, V87, P45, DOI 10.1017/S0007485300036348; Hoye TT, 2007, CURR BIOL, V17, pR449, DOI 10.1016/j.cub.2007.04.047; JONSSON PE, 1990, BIOL J LINN SOC, V41, P301, DOI 10.1111/j.1095-8312.1990.tb00838.x; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Leyrer Jutta, 2009, Wader Study Group Bulletin, V116, P145; Liebezeit JR, 2014, POLAR BIOL, V37, P1309, DOI 10.1007/s00300-014-1522-x; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Oudman T, 2014, AM NAT, V183, P650, DOI 10.1086/675759; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; PEREZLLORENS JL, 1991, BOT MAR, V34, P319, DOI 10.1515/botm.1991.34.4.319; Piersma T, 1997, OIKOS, V80, P623, DOI 10.2307/3546640; Piersma T, 1998, P ROY SOC B-BIOL SCI, V265, P1377, DOI 10.1098/rspb.1998.0445; Rode KD, 2010, ECOL APPL, V20, P768, DOI 10.1890/08-1036.1; Schekkerman H, 2003, OECOLOGIA, V134, P332, DOI 10.1007/s00442-002-1124-0; Screen JA, 2010, NATURE, V464, P1334, DOI 10.1038/nature09051; Sheridan JA, 2011, NAT CLIM CHANGE, V1, P401, DOI 10.1038/NCLIMATE1259; Stein RW, 2005, PHYSIOL BIOCHEM ZOOL, V78, P434, DOI 10.1086/430038; Teplitsky C, 2008, P NATL ACAD SCI USA, V105, P13492, DOI 10.1073/pnas.0800999105; Teplitsky C, 2014, EVOL APPL, V7, P156, DOI 10.1111/eva.12129; Tingley MP, 2013, NATURE, V496, P201, DOI 10.1038/nature11969; van Gils JA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0861; van Roomen M., 2015, STATUS COASTAL WATER; VANDIJK AJ, 1990, ARDEA, V78, P145	28	127	142	3	218	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2016	352	6287					819	821		10.1126/science.aad6351	http://dx.doi.org/10.1126/science.aad6351			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5FP	27174985	Green Published, Green Submitted			2022-12-28	WOS:000375663000039
J	Brooks, M				Brooks, Michael			ZIKA Mosquitoes and Zika: time to harness genetic modification?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DRIVE					mb@michaelbrooks.org						Adelman ZN, 2016, TRENDS PARASITOL, V32, P219, DOI 10.1016/j.pt.2015.12.003; Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864; Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; Isaacs AT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002017; Lafrance Adrienne, 2016, YOUR GRANDMOTHERS DR; Purdue Extension, 2016, US PUBL OV SUPP US G; Suresh A., 2016, ARE GENETICALLY ENG; WHO, 2016, MOSQ VECT CONTR EM R; Worth K., 2016, PBS NEWSHOUR    0307	11	4	4	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 9	2016	353								i2548	10.1136/bmj.i2548	http://dx.doi.org/10.1136/bmj.i2548			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6EX	27160110	Green Published, Bronze			2022-12-28	WOS:000376444500003
J	Sahakyan, A; Plath, K				Sahakyan, Anna; Plath, Kathrin			Transcriptome Encyclopedia of Early Human Development	CELL			English	Editorial Material							RNA	Our understanding of human pre-implantation development is limited by the availability of human embryos and cannot completely rely on mouse studies. Petropoulos et al. now provide an extensive transcriptome analysis of a large number of human pre-implantation embryos at single-cell resolution, revealing previously unrecognized features unique to early human development.	[Sahakyan, Anna; Plath, Kathrin] Univ Calif Los Angeles, David Geffen Sch Med,Bioinformat Interdept Progra, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Biol Chem,Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Plath, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med,Bioinformat Interdept Progra, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Biol Chem,Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA.	kplath@mednet.ucla.edu		Plath, Kathrin/0000-0001-7796-3372; Sahakyan, Anna/0000-0002-8840-9171	NIGMS NIH HHS [R01 GM115233] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115233] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blakeley P, 2015, DEVELOPMENT, V142, P3613, DOI 10.1242/dev.131235; Brown CJ, 2003, SEMIN CELL DEV BIOL, V14, P341, DOI 10.1016/j.semcdb.2003.09.013; Chazaud C, 2016, DEVELOPMENT, V143, P1063, DOI 10.1242/dev.128314; Crane E, 2015, NATURE, V523, P240, DOI 10.1038/nature14450; Gkountela S, 2015, CELL, V161, P1425, DOI 10.1016/j.cell.2015.05.012; Guo F, 2015, CELL, V161, P1437, DOI 10.1016/j.cell.2015.05.015; Okamoto I, 2011, NATURE, V472, P370, DOI 10.1038/nature09872; Petropoulos S, 2016, CELL, V167, P285, DOI [10.1016/j.cell.2016.08.009, 10.1016/j.cell.2016.03.023]; Theunissen TW, 2014, CELL STEM CELL, V14, P720, DOI 10.1016/j.stem.2014.05.002; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660	10	4	4	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2016	165	4					777	779		10.1016/j.cell.2016.04.042	http://dx.doi.org/10.1016/j.cell.2016.04.042			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DL7DN	27153491	Green Accepted, Bronze			2022-12-28	WOS:000375800300007
J	Xiao, CC; Calado, DP; Galler, G; Thai, TH; Patterson, HC; Wang, J; Rajewsky, N; Bender, TP; Rajewsky, K				Xiao, Changchun; Calado, Dinis Pedro; Galler, Gunther; Thai, To-Ha; Patterson, Heide Christine; Wang, Jing; Rajewsky, Nikolaus; Bender, Timothy P.; Rajewsky, Klaus			MiR-150 Controls B Cell Differentiation by Targeting the Transcription Factor c-Myb (vol 131, pg 146, 2007)	CELL			English	Correction												klaus.rajewsky@mdc-berlin.de		Rajewsky, Klaus/0000-0002-6633-6370; Rajewsky, Nikolaus/0000-0002-4785-4332; Galler, Gunther/0000-0003-4507-5957				Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021	1	16	17	1	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2016	165	4					1027	1027		10.1016/j.cell.2016.04.056	http://dx.doi.org/10.1016/j.cell.2016.04.056			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DL7DN	27153500	Bronze			2022-12-28	WOS:000375800300027
J	Efroni, I; Mello, A; Nawy, T; Ip, PL; Rahni, R; DelRose, N; Powers, A; Satija, R; Birnbaum, KD				Efroni, Idan; Mello, Alison; Nawy, Tal; Ip, Pui-Leng; Rahni, Ramin; DelRose, Nicholas; Powers, Ashley; Satija, Rahul; Birnbaum, Kenneth D.			Root Regeneration Triggers an Embryo-like Sequence Guided by Hormonal Interactions	CELL			English	Article							STEM-CELL NICHE; ARABIDOPSIS ROOT; GENE-EXPRESSION; AUXIN; CYTOKININ; FATE; MERISTEM; ORGANOGENESIS; SPECIFICATION; POSITION	Plant roots can regenerate after excision of their tip, including the stem cell niche. To determine which developmental program mediates such repair, we applied a combination of lineage tracing, single-cell RNA sequencing, and marker analysis to test different models of tissue reassembly. We show that multiple cell types can reconstitute stem cells, demonstrating the latent potential of untreated plant cells. The transcriptome of regenerating cells prior to stem cell activation resembles that of an embryonic root progenitor. Regeneration defects are more severe in embryonic than in adult root mutants. Furthermore, the signaling domains of the hormones auxin and cytokinin mirror their embryonic dynamics and manipulation of both hormones alters the position of new tissues and stem cell niche markers. Our findings suggest that plant root regeneration follows, on a larger scale, the developmental stages of embryonic patterning and is guided by spatial information provided by complementary hormone domains.	[Efroni, Idan; Mello, Alison; Nawy, Tal; Ip, Pui-Leng; Rahni, Ramin; DelRose, Nicholas; Satija, Rahul; Birnbaum, Kenneth D.] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Powers, Ashley; Satija, Rahul] New York Genome Ctr, New York, NY 10013 USA; [Efroni, Idan] Hebrew Univ Jerusalem, Robert H Smith Inst Plant Sci & Genet Agr, IL-76100 Rehovot, Israel	New York University; Hebrew University of Jerusalem	Birnbaum, KD (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA.	ken.birnbaum@nyu.edu	Satija, Rahul/AAF-9564-2019	Mello, Alison/0000-0003-0386-8078; Nawy, Tal/0000-0003-3720-3699	NIH [R01 GM078279]; EMBO grant [LTF185-2010]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078279] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO grant(European Molecular Biology Organization (EMBO)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Charles W. Melnyk and Bruno Muller for sharing materials; Claude Desplan, Esteban Mazzoni, Phillip Benfey, Kim Gallagher, and Wolfgang Lukowitz for critical reading of this manuscript; and the NYU GenCore for generating RNA-seq data. Funding was provided by NIH grant R01 GM078279 to K.D.B. and EMBO grant LTF185-2010 for I.E.	Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Alvarado AS, 2006, NAT REV GENET, V7, P873, DOI 10.1038/nrg1923; Atta R, 2009, PLANT J, V57, P626, DOI 10.1111/j.1365-313X.2008.03715.x; Bellini C, 2014, ANNU REV PLANT BIOL, V65, P639, DOI 10.1146/annurev-arplant-050213-035645; Bennett T, 2010, CURR TOP DEV BIOL, V91, P67, DOI 10.1016/S0070-2153(10)91003-X; BERLETH T, 1993, DEVELOPMENT, V118, P575; Bielach A, 2012, PLANT CELL, V24, P3967, DOI 10.1105/tpc.112.103044; Birnbaum KD, 2008, CELL, V132, P697, DOI 10.1016/j.cell.2008.01.040; Birnbaum KD, 2011, NUCLEIC ACIDS RES, V39, P9093, DOI 10.1093/nar/gkr591; Bishopp A, 2011, CURR BIOL, V21, P917, DOI 10.1016/j.cub.2011.04.017; Chang L, 2015, J EXP BOT, V66, P4759, DOI 10.1093/jxb/erv252; Chen YY, 2014, BIOCHEM SOC T, V42, P617, DOI 10.1042/BST20140061; Crawford BCW, 2015, SCIENCE, V347, P655, DOI 10.1126/science.aaa0196; De Rybel B, 2014, SCIENCE, V345, DOI 10.1126/science.1255215; De Smet I, 2010, P NATL ACAD SCI USA, V107, P2705, DOI 10.1073/pnas.0915001107; Dello Ioio R, 2012, CURR BIOL, V22, P1699, DOI 10.1016/j.cub.2012.07.005; Efroni I, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0580-x; FELDMAN LJ, 1976, PLANTA, V128, P207, DOI 10.1007/BF00393230; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Fukaki H, 2002, PLANT J, V29, P153, DOI 10.1046/j.0960-7412.2001.01201.x; Haecker A, 2004, DEVELOPMENT, V131, P657, DOI 10.1242/dev.00963; Hamann T, 1999, DEVELOPMENT, V126, P1387; Hamann T, 2002, GENE DEV, V16, P1610, DOI 10.1101/gad.229402; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Hassan H, 2010, DEVELOPMENT, V137, P1523, DOI 10.1242/dev.048777; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; Heyman J, 2013, SCIENCE, V342, P860, DOI 10.1126/science.1240667; Ikeuchi M, 2015, NAT PLANTS, V1, P1, DOI [10.1038/nplants.2015.89, 10.1038/NPLANTS.2015.89]; Kareem A, 2015, CURR BIOL, V25, P1017, DOI 10.1016/j.cub.2015.02.022; Kidner C, 2000, PLANTA, V211, P191, DOI 10.1007/s004250000284; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Kurakawa T, 2007, NATURE, V445, P652, DOI 10.1038/nature05504; Lavenus J, 2013, TRENDS PLANT SCI, V18, P455, DOI 10.1016/j.tplants.2013.04.006; Lee JY, 2006, P NATL ACAD SCI USA, V103, P6055, DOI 10.1073/pnas.0510607103; Lee MM, 1999, CELL, V99, P473, DOI 10.1016/S0092-8674(00)81536-6; Lin Y, 2001, DEVELOPMENT, V128, P3697; Liu JC, 2014, PLANT CELL, V26, P1081, DOI 10.1105/tpc.114.122887; Mahonen AP, 2000, GENE DEV, V14, P2938, DOI 10.1101/gad.189200; MAYER U, 1993, DEVELOPMENT, V117, P149; Moreno-Risueno MA, 2015, SCIENCE, V350, P426, DOI 10.1126/science.aad1171; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; Nawy T, 2005, PLANT CELL, V17, P1908, DOI 10.1105/tpc.105.031724; Nawy T, 2010, DEV CELL, V19, P103, DOI 10.1016/j.devcel.2010.06.004; Okushima Y, 2007, PLANT CELL, V19, P118, DOI 10.1105/tpc.106.047761; Oviedo NJ, 2003, DEV DYNAM, V226, P326, DOI 10.1002/dvdy.10228; Rademacher EH, 2012, DEV CELL, V22, P211, DOI 10.1016/j.devcel.2011.10.026; Roensch K, 2013, SCIENCE, V342, P1375, DOI 10.1126/science.1241796; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schaller GE, 2015, PLANT CELL, V27, P44, DOI 10.1105/tpc.114.133595; SCHERES B, 1994, DEVELOPMENT, V120, P2475; Schlereth A, 2010, NATURE, V464, P913, DOI 10.1038/nature08836; Sena G, 2009, NATURE, V457, P1150, DOI 10.1038/nature07597; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Sugimoto K, 2011, TRENDS CELL BIOL, V21, P212, DOI 10.1016/j.tcb.2010.12.004; Sugimoto K, 2010, DEV CELL, V18, P463, DOI 10.1016/j.devcel.2010.02.004; ten Hove CA, 2015, DEVELOPMENT, V142, P420, DOI 10.1242/dev.111500; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; Ueda M, 2011, DEV CELL, V20, P264, DOI 10.1016/j.devcel.2011.01.009; VANDENBERG C, 1995, NATURE, V378, P62, DOI 10.1038/378062a0; Welch D, 2007, GENE DEV, V21, P2196, DOI 10.1101/gad.440307; Wendrich JR, 2015, PLANT REPROD, V28, P153, DOI 10.1007/s00497-015-0266-2; Wysocka-Diller JW, 2000, DEVELOPMENT, V127, P595; Xu J, 2006, SCIENCE, V311, P385, DOI 10.1126/science.1121790; Zurcher E, 2013, PLANT PHYSIOL, V161, P1066, DOI 10.1104/pp.112.211763	67	136	145	6	101	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1721	1733		10.1016/j.cell.2016.04.046	http://dx.doi.org/10.1016/j.cell.2016.04.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27212234	Green Accepted, Bronze			2022-12-28	WOS:000378062000022
J	Ki-moon, B				Ki-moon, Ban			Sustainability-engaging future generations now	LANCET			English	Editorial Material							HEALTH		[Ki-moon, Ban] United Nations Headquarters, Execut Off UN Secretary Gen, New York, NY 10017 USA		Ki-moon, B (corresponding author), United Nations Headquarters, Execut Off UN Secretary Gen, New York, NY 10017 USA.	kuot@un.org						Every Woman Every Child, 2015, GLOBAL STRATEGY WOME; Laski L, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4119; Patton GC, 2016, LANCET; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; UN, 2015, SUSTAINABLE DEV GOAL; UN, 2015, 2030 AG SUST DEV; UNFPA, 2010, CAS INV YOUNG PEOPL; United Nations Department of Economic and Social Affairs, 2015, WORLD POPULATION PRO; WHO, 2014, HLTH WORLDS AD 2 CHA	9	21	21	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 11	2016	387	10036					2356	2358		10.1016/S0140-6736(16)30271-9	http://dx.doi.org/10.1016/S0140-6736(16)30271-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DO1ST	27174307				2022-12-28	WOS:000377560100007
J	Scherber, RM; Mesa, RA				Scherber, Robyn M.; Mesa, Ruben A.			Elevated Hemoglobin or Hematocrit Level	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							POLYCYTHEMIA-VERA; JAK2 V617F; MUTATIONS		[Scherber, Robyn M.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Scherber, Robyn M.; Mesa, Ruben A.] Mayo Clin, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA	Oregon Health & Science University; Mayo Clinic; Mayo Clinic Phoenix	Mesa, RA (corresponding author), Mayo Clin, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	mesa.ruben@mayo.edu						Barbui T, 2014, LEUKEMIA, V28, P1191, DOI 10.1038/leu.2013.380; Ma XM, 2008, AM J HEMATOL, V83, P359, DOI 10.1002/ajh.21129; Nielsen C, 2013, BRIT J HAEMATOL, V160, P70, DOI 10.1111/bjh.12099; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Scott LM, 2011, AM J HEMATOL, V86, P668, DOI 10.1002/ajh.22063; Steensma DP, 2006, J MOL DIAGN, V8, P397, DOI 10.2353/jmoldx.2006.060007; Tefferi A, 2013, LEUKEMIA, V27, P1874, DOI 10.1038/leu.2013.163; Tefferi A, 2015, JAMA ONCOL, V1, P97, DOI 10.1001/jamaoncol.2015.89; Thiele Juergen, 2009, Curr Hematol Malig Rep, V4, P33, DOI 10.1007/s11899-009-0005-6	9	2	2	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 24	2016	315	20					2225	2226		10.1001/jama.2016.2435	http://dx.doi.org/10.1001/jama.2016.2435			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM4US	27218633				2022-12-28	WOS:000376343000020
J	Gotts, JE; Matthay, MA				Gotts, Jeffrey E.; Matthay, Michael A.			Sepsis: pathophysiology and clinical management	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ACUTE KIDNEY INJURY; CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; ACUTE LUNG INJURY; SYSTEMIC INFLAMMATORY RESPONSE; GOAL-DIRECTED RESUSCITATION; TUMOR-NECROSIS-FACTOR; LONG-TERM MORTALITY; SEPTIC SHOCK; DOUBLE-BLIND	Sepsis, severe sepsis, and septic shock represent increasingly severe systemic inflammatory responses to infection. Sepsis is common in the aging population, and it disproportionately affects patients with cancer and underlying immunosuppression. In its most severe form, sepsis causes multiple organ dysfunction that can produce a state of chronic critical illness characterized by severe immune dysfunction and catabolism. Much has been learnt about the pathogenesis of sepsis at the molecular, cell, and intact organ level. Despite uncertainties in hemodynamic management and several treatments that have failed in clinical trials, investigational therapies increasingly target sepsis induced organ and immune dysfunction. Outcomes in sepsis have greatly improved overall, probably because of an enhanced focus on early diagnosis and fluid resuscitation, the rapid delivery of effective antibiotics, and other improvements in supportive care for critically ill patients. These improvements include lung protective ventilation, more judicious use of blood products, and strategies to reduce nosocomial infections.	[Matthay, Michael A.] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Cardiovasc Res Inst, Dept Anesthesia, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Matthay, MA (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94143 USA.	Michael.matthay@ucsf.edu						Abraham E, 2016, JAMA-J AM MED ASSOC, V315, P757, DOI 10.1001/jama.2016.0290; Adrie C, 2007, CHEST, V132, P1786, DOI 10.1378/chest.07-0420; Afshari A, 2007, BMJ-BRIT MED J, V335, P1248, DOI 10.1136/bmj.39398.682500.25; Agnese DM, 2002, J INFECT DIS, V186, P1522, DOI 10.1086/344893; Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Angele MK, 2014, VIRULENCE, V5, P12, DOI 10.4161/viru.26982; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2000, JAMA-J AM MED ASSOC, V283, P1723, DOI 10.1001/jama.283.13.1723; Annane D, 2003, AM J RESP CRIT CARE, V168, P165, DOI 10.1164/rccm.2201087; Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206; Asfar P, 2014, NEW ENGL J MED, V370, P1583, DOI 10.1056/NEJMoa1312173; Barnato AE, 2008, AM J RESP CRIT CARE, V177, P279, DOI 10.1164/rccm.200703-480OC; Beale R, 2009, INFECTION, V37, P222, DOI 10.1007/s15010-008-8203-z; Bello S, 2014, CHEST, V146, P1029, DOI 10.1378/chest.13-2853; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Bernik TR, 2002, J VASC SURG, V36, P1231, DOI 10.1067/mva.2002.129643; BJELAKOVIC G, 2014, COCHRANE DB SYST REV, P7469, DOI [10.1002/14651858.cd007470.pub3, DOI 10.1002/14651858.CD007470.PUB3]; Blair LJ, 2016, SURG ENDOSC, V30, P1287, DOI 10.1007/s00464-015-4349-9; Bochud PY, 2008, NEW ENGL J MED, V359, P1766, DOI 10.1056/NEJMoa0802629; BONE RC, 1992, CRIT CARE MED, V20, P724, DOI 10.1097/00003246-199206000-00002; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Borthwick EMJ, 2013, COCHRANE DB SYST REV, V1, DOI [10.1002/14651858.CD008075, DOI 10.1002/14651858.CD0080750.PUB2]; Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Brun-Buisson C, 2004, INTENS CARE MED, V30, P580, DOI 10.1007/s00134-003-2121-4; BRUNBUISSON C, 1995, JAMA-J AM MED ASSOC, V274, P968, DOI 10.1001/jama.274.12.968; Cabrera-Perez J, 2014, J LEUKOCYTE BIOL, V96, P767, DOI 10.1189/jlb.5MR0114-067R; Caironi P, 2014, NEW ENGL J MED, V370, P1412, DOI 10.1056/NEJMoa1305727; Calfee CS, 2015, CRIT CARE MED, V43, P1790, DOI 10.1097/CCM.0000000000001089; Calfee CS, 2014, LANCET RESP MED, V2, P611, DOI 10.1016/S2213-2600(14)70097-9; Calfee CS, 2011, AM J RESP CRIT CARE, V183, P1660, DOI 10.1164/rccm.201011-1802OC; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Casaer MP, 2011, NEW ENGL J MED, V365, P506, DOI 10.1056/NEJMoa1102662; Churpek MM, 2015, AM J RESP CRIT CARE, V192, P958, DOI 10.1164/rccm.201502-0275OC; Clark MF, 2006, INTENS CARE MED, V32, P1706, DOI 10.1007/s00134-006-0327-y; De Backer D, 2012, CRIT CARE MED, V40, P725, DOI 10.1097/CCM.0b013e31823778ee; De Backer D, 2010, CURR OPIN CRIT CARE, V16, P250, DOI 10.1097/MCC.0b013e3283383621; de Haan K, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0660-4; De Waele J, 2014, BMC INFECT DIS, V14, DOI [10.1186/1471-2334-14-420, 10.1186/1471-2334-14-193]; Dellinger RP, 2013, INTENS CARE MED, V39, P165, DOI [10.1007/s00134-012-2769-8, 10.1097/CCM.0b013e31827e83af]; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Deutschman CS, 2014, IMMUNITY, V40, P464, DOI 10.1016/j.immuni.2014.04.001; Doig CJ, 1998, AM J RESP CRIT CARE, V158, P444, DOI 10.1164/ajrccm.158.2.9710092; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P763, DOI 10.1097/01.CCM.0000256726.80998.BF; Drazen JM, 2012, NEW ENGL J MED, V367, P863, DOI 10.1056/NEJMe1209433; Drewry AM, 2014, SHOCK, V42, P383, DOI 10.1097/SHK.0000000000000234; DUNN DL, 1991, CHEST, V100, pS164, DOI 10.1378/chest.100.3_Supplement.164S; Efron PA, 2015, J LEUKOCYTE BIOL, V98, P945, DOI 10.1189/jlb.5MR0315-127R; Eichacker PQ, 2006, NEW ENGL J MED, V355, P1640, DOI 10.1056/NEJMp068197; Eisner MD, 2001, AM J RESP CRIT CARE, V164, P231, DOI 10.1164/ajrccm.164.2.2011093; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345; Esposito S, 2014, EUR J INTERN MED, V25, P203, DOI 10.1016/j.ejim.2013.12.004; Fernandez JF, 2012, CHEST, V142, P231, DOI 10.1378/chest.11-2420; Ferrer R, 2014, CRIT CARE MED, V42, P1749, DOI 10.1097/CCM.0000000000000330; Ferwerda B, 2007, P NATL ACAD SCI USA, V104, P16645, DOI 10.1073/pnas.0704828104; Ferwerda B, 2009, P NATL ACAD SCI USA, V106, P10272, DOI 10.1073/pnas.0811273106; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Fink MP, 2014, NAT REV DRUG DISCOV, V13, P741, DOI 10.1038/nrd4368; Fink Mitchell P, 2003, Curr Opin Crit Care, V9, P143, DOI 10.1097/00075198-200304000-00011; Fisher CJ, 1996, NEW ENGL J MED, V334, P1697, DOI 10.1056/NEJM199606273342603; FISHER CJ, 1994, JAMA-J AM MED ASSOC, V271, P1836, DOI 10.1001/jama.271.23.1836; Fraser GL, 2013, CRIT CARE MED, V41, pS30, DOI 10.1097/CCM.0b013e3182a16898; Fullerton JN, 2013, J PATHOL, V231, P8, DOI 10.1002/path.4232; Funk DJ, 2013, CRIT CARE MED, V41, P573, DOI 10.1097/CCM.0b013e31827bfc25; Galiczewski JM, 2016, INTENS CRIT CARE NUR, V32, P1, DOI 10.1016/j.iccn.2015.08.007; Garcia-Alvarez M, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0503-3; Garcia-Vidal C, 2010, THORAX, V65, P77, DOI 10.1136/thx.2009.123612; GATTINONI L, 1995, NEW ENGL J MED, V333, P1025, DOI 10.1056/NEJM199510193331601; Georges S, 2013, EPIDEMIOL INFECT, V141, P1787, DOI 10.1017/S0950268813000083; Greenfield Neal, 2012, Hosp Pract (1995), V40, P147, DOI 10.3810/hp.2012.04.980; Gustot T, 2014, LIVER INT, V34, P1496, DOI 10.1111/liv.12520; Hanberger H, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-513; Hanberger H, 2011, INT J ANTIMICROB AG, V38, P331, DOI 10.1016/j.ijantimicag.2011.05.013; Harrison DA, 2006, CRIT CARE, V10, DOI 10.1186/cc4854; Hartl WH, 2014, NUTRITION, V30, P261, DOI 10.1016/j.nut.2013.07.019; Hartman ME, 2013, PEDIATR CRIT CARE ME, V14, P686, DOI 10.1097/PCC.0b013e3182917fad; Hassoun HT, 2001, SHOCK, V15, P1, DOI 10.1097/00024382-200115010-00001; Havel C, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003709.pub3; HAYES MA, 1994, NEW ENGL J MED, V330, P1717, DOI 10.1056/NEJM199406163302404; Henckaerts L, 2009, CRIT CARE MED, V37, P192, DOI 10.1097/CCM.0b013e31819263d8; Henriksen DP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124838; Holst LB, 2014, NEW ENGL J MED, V371, P1381, DOI 10.1056/NEJMoa1406617; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Iacobone Emanuele, 2009, Crit Care Med, V37, pS331, DOI 10.1097/CCM.0b013e3181b6ed58; Ishikawa K, 2010, CONTRIB NEPHROL, V165, P18, DOI 10.1159/000313740; Jaimes F, 2009, CRIT CARE MED, V37, P1185, DOI 10.1097/CCM.0b013e31819c06bc; Jones AE, 2010, JAMA-J AM MED ASSOC, V303, P739, DOI 10.1001/jama.2010.158; Kamisoglu K, 2013, SHOCK, V40, P519, DOI 10.1097/SHK.0000000000000063; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Kett DH, 2011, CRIT CARE MED, V39, P665, DOI 10.1097/CCM.0b013e318206c1ca; KIMCHI A, 1984, J AM COLL CARDIOL, V4, P945, DOI 10.1016/S0735-1097(84)80055-8; Koh IHJ, 2010, SHOCK, V34, P27, DOI 10.1097/SHK.0b013e3181e7e80c; Kollef MH, 1998, CHEST, V114, P541, DOI 10.1378/chest.114.2.541; Koretz RL, 2007, AM J GASTROENTEROL, V102, P412, DOI 10.1111/j.1572-0241.2006.01024.x; Kraut JA, 2014, NEW ENGL J MED, V371, P2309, DOI 10.1056/NEJMra1309483; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lemay AC, 2014, AM J MED SCI, V347, P282, DOI 10.1097/MAJ.0b013e318295a147; Levi M, 2013, MINERVA ANESTESIOL, V79, P294; Levi M, 2001, J CRIT CARE, V16, P167, DOI 10.1053/jcrc.2001.30666; Levy BD, 2014, ANNU REV PHYSIOL, V76, P467, DOI 10.1146/annurev-physiol-021113-170408; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Liu KD, 2014, ANN INTENSIVE CARE, V4, DOI 10.1186/s13613-014-0022-z; Lombardo E, 2015, WORLD J STEM CELLS, V7, P368, DOI 10.4252/wjsc.v7.i2.368; Lorenz E, 2002, ARCH INTERN MED, V162, P1028, DOI 10.1001/archinte.162.9.1028; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Marshall JC, 2014, TRENDS MOL MED, V20, P195, DOI 10.1016/j.molmed.2014.01.007; Martin GS, 2006, CRIT CARE MED, V34, P15, DOI 10.1097/01.CCM.0000194535.82812.BA; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Martinod K, 2014, BLOOD, V123, P2768, DOI 10.1182/blood-2013-10-463646; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Mayr FB, 2010, JAMA-J AM MED ASSOC, V303, P2495, DOI 10.1001/jama.2010.851; MCCLOSKEY RV, 1994, ANN INTERN MED, V121, P1, DOI 10.7326/0003-4819-121-1-199407010-00001; Mehta D, 2014, AM J PHYSIOL-LUNG C, V307, pL924, DOI 10.1152/ajplung.00318.2014; Meisel C, 2009, AM J RESP CRIT CARE, V180, P640, DOI 10.1164/rccm.200903-0363OC; Meyer NJ, 2015, CRIT CARE MED, V43, P242, DOI 10.1097/CCM.0000000000000664; Meziani F, 2010, CRIT CARE, V14, DOI 10.1186/cc9231; Moine P, 2004, SHOCK, V22, P297, DOI 10.1097/01.shk.0000140663.80530.73; Morelli A, 2013, JAMA-J AM MED ASSOC, V310, P1683, DOI 10.1001/jama.2013.278477; Mouncey PR, 2015, NEW ENGL J MED, V372, P1301, DOI 10.1056/NEJMoa1500896; Munford RS, 2006, ANNU REV PATHOL-MECH, V1, P467, DOI 10.1146/annurev.pathol.1.110304.100200; Nakada TA, 2015, CRIT CARE MED, V43, P101, DOI 10.1097/CCM.0000000000000604; Nelson JE, 2010, AM J RESP CRIT CARE, V182, P446, DOI 10.1164/rccm.201002-0210CI; Netea MG, 2011, NEW ENGL J MED, V364, P60, DOI 10.1056/NEJMra1001976; O'Brien JM, 2007, CRIT CARE MED, V35, P345, DOI 10.1097/01.CCM.0000254340.91644.B2; Obaro SK, 1996, BMJ-BRIT MED J, V312, P1521, DOI 10.1136/bmj.312.7045.1521; Opal SM, 1997, CRIT CARE MED, V25, P1115, DOI 10.1097/00003246-199707000-00010; Opal SM, 2013, JAMA-J AM MED ASSOC, V309, P1154, DOI 10.1001/jama.2013.2194; Ortiz-Pomales YT, 2013, BURNS, V39, P68, DOI 10.1016/j.burns.2012.04.004; Osuchowski MF, 2014, SHOCK, V41, P463, DOI 10.1097/SHK.0000000000000153; Otto GP, 2011, CRIT CARE, V15, DOI 10.1186/cc10332; Panacek EA, 2004, CRIT CARE MED, V32, P2173, DOI 10.1097/01.CCM.0000145229.59014.6c; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; PARKER MM, 1984, ANN INTERN MED, V100, P483, DOI 10.7326/0003-4819-100-4-483; Patel A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4561; Patel GP, 2012, AM J RESP CRIT CARE, V185, P133, DOI 10.1164/rccm.201011-1897CI; Payen D, 2009, CRIT CARE MED, V37, P803, DOI 10.1097/CCM.0b013e3181962316; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Persichini R, 2012, CRIT CARE MED, V40, P3146, DOI 10.1097/CCM.0b013e318260c6c3; Plantinga TS, 2012, J INFECT DIS, V205, P934, DOI 10.1093/infdis/jir867; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Prowle JR, 2015, SEMIN NEPHROL, V35, P64, DOI 10.1016/j.semnephrol.2015.01.007; Puthucheary ZA, 2013, JAMA-J AM MED ASSOC, V310, P1591, DOI 10.1001/jama.2013.278481; Qiu P, 2013, CRIT CARE MED, V41, P2419, DOI 10.1097/CCM.0b013e3182982add; Rabuel C, 2006, INTENS CARE MED, V32, P799, DOI 10.1007/s00134-006-0142-5; Ranieri VM, 2012, NEW ENGL J MED, V366, P2055, DOI 10.1056/NEJMoa1202290; Rautanen A, 2015, LANCET RESP MED, V3, P53, DOI 10.1016/S2213-2600(14)70290-5; Reade MC, 2014, NEW ENGL J MED, V370, P444, DOI 10.1056/NEJMra1208705; Rice TW, 2012, JAMA-J AM MED ASSOC, V307, P795, DOI 10.1001/jama.2012.137; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Ronco JJ, 1996, CRIT CARE CLIN, V12, P645, DOI 10.1016/S0749-0704(05)70268-2; RONCO JJ, 1993, JAMA-J AM MED ASSOC, V270, P1724, DOI 10.1001/jama.270.14.1724; Root RK, 2003, CRIT CARE MED, V31, P367, DOI 10.1097/01.CCM.0000048629.32625.5D; Rosolem MM, 2012, J CRIT CARE, V27, P301, DOI 10.1016/j.jcrc.2011.06.014; Sakr Y, 2013, CRIT CARE, V17, DOI 10.1186/cc12570; Schmid-Schonbein GW, 2014, ANN BIOMED ENG, V42, P405, DOI 10.1007/s10439-013-0891-6; Schramm P, 2012, CRIT CARE, V16, DOI 10.1186/cc11665; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schulte W, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/165974; SCHUMER W, 1976, ANN SURG, V184, P333, DOI 10.1097/00000658-197609000-00011; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Serhan CN, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016311; Shapiro NI, 2005, ANN EMERG MED, V45, P524, DOI 10.1016/j.annemergmed.2004.12.006; Sharshar T, 2004, BRAIN PATHOL, V14, P21, DOI 10.1111/j.1750-3639.2004.tb00494.x; Sharshar T, 2007, INTENS CARE MED, V33, P798, DOI 10.1007/s00134-007-0598-y; Shehabi Y, 2012, AM J RESP CRIT CARE, V186, P724, DOI 10.1164/rccm.201203-0522OC; Shi ZD, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008367.pub2; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Singer M, 2014, VIRULENCE, V5, P66, DOI 10.4161/viru.26907; Sivapalan P, 2015, CRIT CARE MED, V43, P2030, DOI 10.1097/CCM.0000000000001179; Slutsky AS, 2013, NEW ENGL J MED, V369, P2126, DOI 10.1056/NEJMra1208707; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; Sterling SA, 2015, CRIT CARE MED, V43, P1907, DOI 10.1097/CCM.0000000000001142; Takasu O, 2013, AM J RESP CRIT CARE, V187, P509, DOI 10.1164/rccm.201211-1983OC; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; TALAN DA, 1989, ANN EMERG MED, V18, P856, DOI 10.1016/S0196-0644(89)80213-6; Tang BM, 2010, CRIT CARE, V14, DOI 10.1186/cc9392; Tolsma V, 2014, CHEST, V146, P1205, DOI 10.1378/chest.13-2618; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0; Turan A, 2011, ANESTHESIOLOGY, V114, P837, DOI 10.1097/ALN.0b013e318210f560; Ulloa L, 2005, TRENDS MOL MED, V11, P56, DOI 10.1016/j.molmed.2004.12.007; Van der Graaf CAA, 2006, EUR CYTOKINE NETW, V17, P29; van Gestel A, 2004, CRIT CARE, V8, pR153, DOI 10.1186/cc2858; Van Westerloo DJ, 2006, GASTROENTEROLOGY, V130, P1822, DOI 10.1053/j.gastro.2006.02.022; Veenstra DL, 1999, JAMA-J AM MED ASSOC, V281, P261, DOI 10.1001/jama.281.3.261; de Oliveira FSV, 2015, J CRIT CARE, V30, P97, DOI 10.1016/j.jcrc.2014.09.002; Vincent JL, 2013, LANCET, V381, P774, DOI 10.1016/S0140-6736(12)61815-7; Vincent JL, 2011, CRIT CARE NURS CLIN, V23, P29, DOI 10.1016/j.ccell.2010.12.002; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Waechter J, 2014, CRIT CARE MED, V42, P2158, DOI 10.1097/CCM.0000000000000520; Walley KR, 2015, AM J RESP CRIT CARE, V192, P1275, DOI 10.1164/rccm.201505-0876CI; Walton AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098819; Wan L, 2008, CRIT CARE MED, V36, pS198, DOI 10.1097/CCM.0b013e318168ccd5; Wang HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048307; Ward PA, 2009, J CELL MOL MED, V13, P4154, DOI 10.1111/j.1582-4934.2009.00893.x; Warren BL, 2001, JAMA-J AM MED ASSOC, V286, P1869, DOI 10.1001/jama.286.15.1869; Weiss SL, 2015, AM J RESP CRIT CARE, V191, P1147, DOI 10.1164/rccm.201412-2323OC; Wichmann MW, 2000, INTENS CARE MED, V26, P167, DOI 10.1007/s001340050041; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Williams MD, 2004, CRIT CARE, V8, pR291, DOI 10.1186/cc2893; WOLINSKY H, 1980, CIRC RES, V47, P301, DOI 10.1161/01.RES.47.3.301; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602; Young P, 2015, JAMA-J AM MED ASSOC, V314, P1701, DOI 10.1001/jama.2015.12334; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356; Ziaja M, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0383-y; Zuber B, 2012, CRIT CARE MED, V40, P55, DOI 10.1097/CCM.0b013e31822d74ba	217	460	502	10	207	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 23	2016	353								i1585	10.1136/bmj.i1585	http://dx.doi.org/10.1136/bmj.i1585			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3BM	27217054				2022-12-28	WOS:000376937200001
J	Aitken, ARA; Roberts, JL; van Ommen, TD; Young, DA; Golledge, NR; Greenbaum, JS; Blankenship, DD; Siegert, MJ				Aitken, A. R. A.; Roberts, J. L.; van Ommen, T. D.; Young, D. A.; Golledge, N. R.; Greenbaum, J. S.; Blankenship, D. D.; Siegert, M. J.			Repeated large-scale retreat and advance of Totten Glacier indicated by inland bed erosion	NATURE			English	Article							ANTARCTIC ICE-SHEET; EAST ANTARCTICA; SEA-LEVEL; TEMPERATURE VARIABILITY; PLIOCENE; STABILITY; GREENLAND; SURFACE; MODEL; OCEAN	Climate variations cause ice sheets to retreat and advance, raising or lowering sea level by metres to decametres. The basic relationship is unambiguous, but the timing, magnitude and sources of sea-level change remain unclear; in particular, the contribution of the East Antarctic Ice Sheet (EAIS) is ill defined, restricting our appreciation of potential future change. Several lines of evidence suggest possible collapse of the Totten Glacier into interior basins during past warm periods, most notably the Pliocene epoch(1-4), causing several metres of sea-level rise. However, the structure and long-term evolution of the ice sheet in this region have been understood insufficiently to constrain past ice-sheet extents. Here we show that deep ice-sheet erosion-enough to expose basement rocks-has occurred in two regions: the head of the Totten Glacier, within 150 kilometres of today's grounding line; and deep within the Sabrina Subglacial Basin, 350-550 kilometres from this grounding line. Our results, based on ICECAP aerogeophysical data, demarcate the marginal zones of two distinct quasi-stable EAIS configurations, corresponding to the 'modern-scale' ice sheet (with a marginal zone near the present ice-sheet margin) and the retreated ice sheet (with the marginal zone located far inland). The transitional region of 200-250 kilometres in width is less eroded, suggesting shorter-lived exposure to eroding conditions during repeated retreat-advance events, which are probably driven by ocean-forced instabilities. Representative ice-sheet models indicate that the global sea-level increase resulting from retreat in this sector can be up to 0.9 metres in the modern-scale configuration, and exceeds 2 metres in the retreated configuration.	[Aitken, A. R. A.] Univ Western Australia, Sch Earth & Environm, Perth, WA 6008, Australia; [Roberts, J. L.; van Ommen, T. D.] Australian Antarctic Div, Channel Highway, Kingston, Tas 7050, Australia; [Roberts, J. L.; van Ommen, T. D.] Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas 7005, Australia; [Young, D. A.; Greenbaum, J. S.; Blankenship, D. D.] Univ Texas Austin, Inst Geophys, Austin, TX 78758 USA; [Golledge, N. R.] Victoria Univ Wellington, Antarctic Res Ctr, Wellington 6140, New Zealand; [Golledge, N. R.] GNS Sci, Lower Hutt 5011, New Zealand; [Siegert, M. J.] Univ London Imperial Coll Sci Technol & Med, Grantham Inst, London SW7 2AZ, England; [Siegert, M. J.] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England	University of Western Australia; Australian Antarctic Division; Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); University of Tasmania; University of Texas System; University of Texas Austin; Victoria University Wellington; GNS Science - New Zealand; Imperial College London; Imperial College London	Aitken, ARA (corresponding author), Univ Western Australia, Sch Earth & Environm, Perth, WA 6008, Australia.	alan.aitken@uwa.edu.au	Roberts, Jason L/B-2235-2012; van Ommen, Tas D/B-5020-2012; Young, Duncan A./G-6256-2010; Siegert, Martin/M-9939-2019; Siegert, Martin J/A-3826-2008	Roberts, Jason L/0000-0002-3477-4069; van Ommen, Tas D/0000-0002-2463-1718; Young, Duncan A./0000-0002-6866-8176; Siegert, Martin/0000-0002-0090-4806; Siegert, Martin J/0000-0002-0090-4806; Golledge, Nicholas/0000-0001-7676-8970; Aitken, Alan/0000-0002-6375-2504	National Science Foundation [PLR-0733025]; National Aeronautics and Space Administration [NNX09AR52G, NNG10HPO6C, NNX11AD33G]; Australian Antarctic Division [3013, 4077]; National Environment and Research Council [NE/D003733/1]; Jackson School of Geosciences; G. Unger Vetlesen Foundation; Australian Government's Cooperative Research Centres Programme through the Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); Royal Society of New Zealand's Marsden Fund [VUW1203]; NERC [NE/F016646/1, NE/F016646/2] Funding Source: UKRI; Natural Environment Research Council [NE/F016646/2, NE/F016646/1] Funding Source: researchfish	National Science Foundation(National Science Foundation (NSF)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Australian Antarctic Division; National Environment and Research Council; Jackson School of Geosciences; G. Unger Vetlesen Foundation; Australian Government's Cooperative Research Centres Programme through the Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Royal Society of New Zealand's Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Collection of ICECAP data was supported by: National Science Foundation grant PLR-0733025; National Aeronautics and Space Administration grants NNX09AR52G, NNG10HPO6C and NNX11AD33G (Operation Ice Bridge and the American Recovery and Reinvestment Act); Australian Antarctic Division projects 3013 and 4077; National Environment and Research Council grant NE/D003733/1; the Jackson School of Geosciences; the G. Unger Vetlesen Foundation; and the Australian Government's Cooperative Research Centres Programme through the Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC). Ice-sheet modelling was funded under contract VUW1203 of the Royal Society of New Zealand's Marsden Fund. We thank S. Jamieson for comments and for supplying model images for comparison. This is the University of Texas Institute of Geophysics contribution 2950.	Aitken ARA, 2016, GONDWANA RES, V29, P136, DOI 10.1016/j.gr.2014.10.019; Aitken ARA, 2014, GEOPHYS RES LETT, V41, P2390, DOI 10.1002/2014GL059405; Aitken ARA, 2013, TECTONOPHYSICS, V609, P468, DOI 10.1016/j.tecto.2012.06.049; Albrecht T, 2012, J GLACIOL, V58, P165, DOI 10.3189/2012JoG11J191; Alley RB, 2010, QUATERNARY SCI REV, V29, P1728, DOI 10.1016/j.quascirev.2010.02.007; Blankenship D.D., 2012, ICEBRIDGE HICARS 2 L; Blankenship D.D., 2011, ICEBRIDGE BGM 3 GRAV; Blankenship D.D., 2014, ICEBRIDGE CMG GT 1A; Blankenship D.D., 2011, ICEBRIDGE GEOMETRICS; Blankenship DD, 2012, ICEBRIDGE RIEGL LASE; Cook CP, 2013, NAT GEOSCI, V6, P765, DOI [10.1038/ngeo1889, 10.1038/NGEO1889]; de Boer B, 2015, CRYOSPHERE, V9, P881, DOI 10.5194/tc-9-881-2015; Drewry D, 1986, GLACIAL GEOLOGIC PRO; Feldmann J, 2014, J GLACIOL, V60, P353, DOI 10.3189/2014JoG13J093; FLOWER BP, 1994, PALAEOGEOGR PALAEOCL, V108, P537, DOI 10.1016/0031-0182(94)90251-8; Fretwell P, 2013, CRYOSPHERE, V7, P375, DOI 10.5194/tc-7-375-2013; Gasson E, 2015, GEOPHYS RES LETT, V42, P5372, DOI 10.1002/2015GL064322; Golledge NR, 2015, NATURE, V526, P421, DOI 10.1038/nature15706; Greenbaum JS, 2015, NAT GEOSCI, V8, P294, DOI 10.1038/NGEO2388; Gudmundsson GH, 2013, CRYOSPHERE, V7, P647, DOI 10.5194/tc-7-647-2013; Gwyther DE, 2014, OCEAN SCI, V10, P267, DOI 10.5194/os-10-267-2014; Jamieson SSR, 2010, EARTH PLANET SC LETT, V293, P1, DOI 10.1016/j.epsl.2010.02.012; Joughin I, 2011, NAT GEOSCI, V4, P506, DOI [10.1038/ngeo1194, 10.1038/NGEO1194]; Khazendar A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3857; KU CC, 1983, GEOPHYSICS, V48, P754, DOI 10.1190/1.1441505; Levermann A, 2012, CRYOSPHERE, V6, P273, DOI 10.5194/tc-6-273-2012; Miller KG, 2012, GEOLOGY, V40, P407, DOI 10.1130/G32869.1; Patterson MO, 2014, NAT GEOSCI, V7, P841, DOI 10.1038/NGEO2273; Pierce EL, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2011PA002127; Pollard D, 2015, EARTH PLANET SC LETT, V412, P112, DOI 10.1016/j.epsl.2014.12.035; Pollard D, 2009, NATURE, V458, P329, DOI 10.1038/nature07809; Pritchard HD, 2009, NATURE, V461, P971, DOI 10.1038/nature08471; Rignot E, 2013, SCIENCE, V341, P266, DOI 10.1126/science.1235798; Rignot E, 2011, SCIENCE, V333, P1427, DOI 10.1126/science.1208336; Roberts JL, 2011, CRYOSPHERE, V5, P551, DOI 10.5194/tc-5-551-2011; Rogozhina I, 2014, CRYOSPHERE, V8, P575, DOI 10.5194/tc-8-575-2014; Rose KC, 2013, EARTH PLANET SC LETT, V375, P1, DOI 10.1016/j.epsl.2013.03.053; Seguinot J, 2013, J GLACIOL, V59, P1202, DOI 10.3189/2013JoG13J081; TALWANI M, 1965, GEOPHYSICS, V30, P797, DOI 10.1190/1.1439654; Webring M., 1985, 85122 US GEOL SURV; Williams T, 2010, EARTH PLANET SC LETT, V290, P351, DOI 10.1016/j.epsl.2009.12.031; Winkelmann R., 2015, CRYOSPHERE DISCUSS, V9, P1705, DOI DOI 10.5194/TCD-9-1705-2015; Winnick MJ, 2015, GEOLOGY, V43, P879, DOI 10.1130/G36999.1; Wright AP, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF002066; Young DA, 2011, NATURE, V474, P72, DOI 10.1038/nature10114	45	68	69	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					385	+		10.1038/nature17447	http://dx.doi.org/10.1038/nature17447			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0AH	27193684	Green Submitted			2022-12-28	WOS:000376004300046
J	Deweerdt, S				Deweerdt, Sarah			Food for thought	NATURE			English	Editorial Material							IRRITABLE-BOWEL-SYNDROME; SYMPTOMS											Biesiekierski JR, 2013, GASTROENTEROLOGY, V145, P320, DOI 10.1053/j.gastro.2013.04.051; Bohn L, 2015, GASTROENTEROLOGY, V149, P1399, DOI 10.1053/j.gastro.2015.07.054; Shepherd SJ, 2008, CLIN GASTROENTEROL H, V6, P765, DOI 10.1016/j.cgh.2008.02.058	3	0	0	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					S108	S109		10.1038/533S108a	http://dx.doi.org/10.1038/533S108a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0AH	27191488	Bronze			2022-12-28	WOS:000376004300004
J	Mpe, M; Schauer, C				Mpe, Matlawene; Schauer, Cameron			Splenosis Mimicking Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mpe, Matlawene; Schauer, Cameron] Whangarei Hosp, Whangarei, New Zealand		Schauer, C (corresponding author), Whangarei Hosp, Whangarei, New Zealand.	cameron.schauer@gmail.com							0	5	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 19	2016	374	20					1965	1965		10.1056/NEJMicm1512086	http://dx.doi.org/10.1056/NEJMicm1512086			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM1OX	27192674				2022-12-28	WOS:000376116600009
J	Sridhar, D; Kickbusch, I; Moon, S; Dzau, V; Heymann, D; Jha, AK; Saavendra, J; Stocking, B; Woskie, L; Piot, P				Sridhar, Devi; Kickbusch, Ilona; Moon, Suerie; Dzau, Victor; Heymann, David; Jha, Ashish K.; Saavendra, Jorge; Stocking, Barbara; Woskie, Liana; Piot, Peter			Facing forward after Ebola: questions for the next director general of the World Health Organization	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GLOBAL HEALTH		[Sridhar, Devi] Univ Edinburgh, Sch Med, Edinburgh EH8 9AG, Midlothian, Scotland; [Kickbusch, Ilona] Grad Inst Int Studies, Geneva, Switzerland; [Moon, Suerie; Jha, Ashish K.; Woskie, Liana] Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA; [Dzau, Victor] Natl Acad Med, Washington, DC USA; [Heymann, David] Ctr Global Hlth Secur, Chatham House, London, England; [Saavendra, Jorge] AIDS Healthcare Fdn, Mexico City, DF, Mexico; [Stocking, Barbara] Univ Cambridge, Murray Edwards Coll, Cambridge, England; [Piot, Peter] London Sch Hyg & Trop Med, London WC1, England	University of Edinburgh; Harvard University; Harvard T.H. Chan School of Public Health; National Academies of Sciences, Engineering & Medicine; University of Cambridge; University of London; London School of Hygiene & Tropical Medicine	Sridhar, D (corresponding author), Univ Edinburgh, Sch Med, Edinburgh EH8 9AG, Midlothian, Scotland.	devi.sridhar@ed.ac.uk		Moon, Suerie/0000-0001-8504-1212; Woskie, Liana/0000-0002-7451-6849				Checchi F, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i469; Heymann DL, 2015, LANCET, V385, P1884, DOI 10.1016/S0140-6736(15)60858-3; Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0; National Academy of Medicine Commission on a Global Health Risk Framework for the Future, 2016, FIN REP NEGL DIM GLO; Sridhar D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3841; UN, 2016, PROTECTING HUMANITY; WHO, 2015, REP EB INT ASS PAN; WHO, 2015, FOLL WORLD HLTH ASS	8	3	3	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 18	2016	353								i2666	10.1136/bmj.i2666	http://dx.doi.org/10.1136/bmj.i2666			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GC	27193334	Green Published			2022-12-28	WOS:000376447600003
J	Primack, BA				Primack, Brian A.			Varenicline, combination NRT, and nicotine patch did not differ for smoking cessation at 6 mo	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TRIAL		[Primack, Brian A.] Univ Pittsburgh, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Primack, BA (corresponding author), Univ Pittsburgh, Pittsburgh, PA USA.			Primack, Brian/0000-0002-5962-0939				Aubin HJ, 2008, THORAX, V63, P717, DOI 10.1136/thx.2007.090647; Hughes JR, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000031.pub4; Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P56, DOI 10.1001/jama.296.1.56	3	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2016	164	10					JC54	JC54		10.7326/ACPJC-2016-164-10-054	http://dx.doi.org/10.7326/ACPJC-2016-164-10-054			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8GF	27182920				2022-12-28	WOS:000375878500005
J	Smith, JM				Smith, Jeanette M.			Bror Julius Olsson Nordfeldt	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 17	2016	315	19					2048	2049		10.1001/jama.2015.14268	http://dx.doi.org/10.1001/jama.2015.14268			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL9PN	27187285				2022-12-28	WOS:000375975300001
J	MacDougall, J				MacDougall, Julia			My seismic career shift	SCIENCE			English	Editorial Material									[MacDougall, Julia] Reviewed Com, Somerville, NJ USA		MacDougall, J (corresponding author), Reviewed Com, Somerville, NJ USA.								0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2016	352	6287					862	862		10.1126/science.352.6287.862	http://dx.doi.org/10.1126/science.352.6287.862			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5FP	27174991				2022-12-28	WOS:000375663000048
J	Delichatsios, HK; Leonard, MM; Fasano, A; Nose, V				Delichatsios, Helen K.; Leonard, Maureen M.; Fasano, Alessio; Nose, Vania			Case 14-2016: A 37-Year-Old Woman with Adult-Onset Psychosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CELIAC-DISEASE; HYPOTHYROIDISM; GLUTEN; MANIFESTATIONS; ASSOCIATION; GUIDELINES; DEFICIENCY; MECHANISMS; SOCIETY; UPDATE		[Delichatsios, Helen K.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Leonard, Maureen M.; Fasano, Alessio] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Nose, Vania] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Delichatsios, Helen K.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Leonard, Maureen M.; Fasano, Alessio] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Nose, Vania] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Delichatsios, HK (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Delichatsios, HK (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA.		Fasano, Alessio/K-5486-2016	Fasano, Alessio/0000-0002-2134-0261	General Mills; Crestovo; Pfizer; Mead Johnson	General Mills; Crestovo; Pfizer(Pfizer); Mead Johnson	Dr. Fasano reports receiving consulting fees from General Mills, Crestovo, and Pfizer and lecture fees from Mead Johnson and holding stock in Alba Therapeutics. No other potential conflict of interest relevant to this article was reported.	Abdou E, 2015, NEUROCHEM RES, V40, P353, DOI 10.1007/s11064-014-1430-z; AURICCHIO S, 1988, PEDIATR CLIN N AM, V35, P157; Bushara KO, 2005, GASTROENTEROLOGY, V128, pS92, DOI 10.1053/j.gastro.2005.02.018; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Fasano A, 2012, NEW ENGL J MED, V367, P2419, DOI 10.1056/NEJMcp1113994; FISH LH, 1987, NEW ENGL J MED, V316, P764, DOI 10.1056/NEJM198703263161302; Galland L, 2014, J MED FOOD, V17, P1261, DOI 10.1089/jmf.2014.7000; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; Jackson JR, 2012, PSYCHIAT QUART, V83, P91, DOI 10.1007/s11126-011-9186-y; Jonklaas J, 2014, THYROID, V24, P1670, DOI 10.1089/thy.2014.0028; Leffler DA, 2015, NAT REV GASTRO HEPAT, V12, P561, DOI 10.1038/nrgastro.2015.131; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; McCowen KC, 1997, NEW ENGL J MED, V337, P1010; Mechanick JI, 2013, SURG OBES RELAT DIS, V9, P159, DOI 10.1016/j.soard.2012.12.010; Murri MB, 2013, SCHIZOPHR RES, V150, P235, DOI 10.1016/j.schres.2013.07.017; Pfeiffer Ronald F, 2014, Handb Clin Neurol, V120, P621, DOI 10.1016/B978-0-7020-4087-0.00042-5; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P35; Rostom A, 2005, GASTROENTEROLOGY, V128, pS38, DOI 10.1053/j.gastro.2005.02.028; Toh BH, 1997, NEW ENGL J MED, V337, P1441, DOI 10.1056/NEJM199711133372007	19	4	5	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2016	374	19					1875	1883		10.1056/NEJMcpc1514473	http://dx.doi.org/10.1056/NEJMcpc1514473			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6JS	27168437				2022-12-28	WOS:000375746100012
J	Dijkstra, KDB				Dijkstra, Klaas-Douwe B.			Restore our sense of species	NATURE			English	Editorial Material							TAXONOMY		[Dijkstra, Klaas-Douwe B.] Univ Stellenbosch, ZA-7600 Stellenbosch, South Africa; [Dijkstra, Klaas-Douwe B.] Naturalis Biodivers Ctr, Leiden, Netherlands	Stellenbosch University; Naturalis Biodiversity Center	Dijkstra, KDB (corresponding author), Univ Stellenbosch, ZA-7600 Stellenbosch, South Africa.; Dijkstra, KDB (corresponding author), Naturalis Biodivers Ctr, Leiden, Netherlands.	african.dragonflies@gmail.com	Dijkstra, Klaas-Douwe B./L-2407-2017	Dijkstra, Klaas-Douwe B./0000-0002-5232-2277				Dijkstra KDB, 2015, ODONATOLOGICA, V44, P447; Dijkstra KDB, 2014, ANNU REV ENTOMOL, V59, P143, DOI 10.1146/annurev-ento-011613-161958; Edward McCord, 2012, THE VALUE OF SPECIES; Godfray HCJ, 2002, NATURE, V417, P17, DOI 10.1038/417017a; Mens LP, 2016, ZOOTAXA, V4109, P153, DOI 10.11646/zootaxa.4109.2.3; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Pearson DL, 2011, BIOSCIENCE, V61, P58, DOI 10.1525/bio.2011.61.1.11; Tewksbury JJ, 2014, BIOSCIENCE, V64, P300, DOI 10.1093/biosci/biu032; Wheeler Q, 2010, SYST BIODIVERS, V8, P11, DOI 10.1080/14772001003628075; Winker K, 2013, NATURE, V493, P480, DOI 10.1038/493480b	10	15	17	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					172	174		10.1038/533172a	http://dx.doi.org/10.1038/533172a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0BJ	27172032	Bronze			2022-12-28	WOS:000376007200025
J	Spitzer, MH; Nolan, GP				Spitzer, Matthew H.; Nolan, Garry P.			Mass Cytometry: Single Cells, Many Features	CELL			English	Article							FLOW-CYTOMETRY; IMMUNE-SYSTEM; IDENTIFICATION; EXPRESSION; PROGRESSION; DIVERSITY; RESPONSES	Technology development in biological research often aims to either increase the number of cellular features that can be surveyed simultaneously or enhance the resolution at which such observations are possible. For decades, flow cytometry has balanced these goals to fill a critical need by enabling the measurement of multiple features in single cells, commonly to examine complex or hierarchical cellular systems. Recently, a format for flow cytometry has been developed that leverages the precision of mass spectrometry. This fusion of the two technologies, termed mass cytometry, provides measurement of over 40 simultaneous cellular parameters at single-cell resolution, significantly augmenting the ability of cytometry to evaluate complex cellular systems and processes. In this Primer, we review the current state of mass cytometry, providing an overview of the instrumentation, its present capabilities, and methods of data analysis, as well as thoughts on future developments and applications.	[Spitzer, Matthew H.; Nolan, Garry P.] Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA; [Spitzer, Matthew H.; Nolan, Garry P.] Stanford Univ, Program Immunol, Stanford, CA 94305 USA; [Spitzer, Matthew H.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Spitzer, Matthew H.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Stanford University; Stanford University; Stanford University; University of California System; University of California San Francisco	Spitzer, MH; Nolan, GP (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA.; Spitzer, MH; Nolan, GP (corresponding author), Stanford Univ, Program Immunol, Stanford, CA 94305 USA.; Spitzer, MH (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.; Spitzer, MH (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	matthew.spitzer@ucsf.edu; gnolan@stanford.edu	Nolan, Garry/AAE-7903-2019	Nolan, Garry/0000-0002-8862-9043; Spitzer, Matthew/0000-0002-5291-3819	company Fluidigm; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028183] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [F31CA189331] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229, P01AI036535] Funding Source: NIH RePORTER	company Fluidigm; DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	G.P.N. has a personal financial interest in the company Fluidigm, the manufacturer of the mass cytometer referenced in this study.	Aghaeepour N, 2013, NAT METHODS, V10, P228, DOI [10.1038/NMETH.2365, 10.1038/nmeth.2365]; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Angelo M, 2014, NAT MED, V20, P436, DOI 10.1038/nm.3488; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Baumgarth N, 2000, J IMMUNOL METHODS, V243, P77, DOI 10.1016/S0022-1759(00)00229-5; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Behbehani GK, 2014, CYTOM PART A, V85A, P1011, DOI 10.1002/cyto.a.22573; Behbehani GK, 2012, CYTOM PART A, V81A, P552, DOI 10.1002/cyto.a.22075; Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; Bendall SC, 2012, TRENDS IMMUNOL, V33, P323, DOI 10.1016/j.it.2012.02.010; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bjornson ZB, 2013, CURR OPIN IMMUNOL, V25, P484, DOI 10.1016/j.coi.2013.07.004; Bodenmiller B, 2012, NAT BIOTECHNOL, V30, P858, DOI 10.1038/nbt.2317; Bruggner RV, 2014, P NATL ACAD SCI USA, V111, pE2770, DOI 10.1073/pnas.1408792111; Chan C, 2008, CYTOM PART A, V73A, P693, DOI 10.1002/cyto.a.20583; Chen T.J., 2014, CYTOBANK PROVIDING A, P127; Chester C, 2015, J IMMUNOL, V195, P773, DOI 10.4049/jimmunol.1500633; Diggins KE, 2015, METHODS, V82, P55, DOI 10.1016/j.ymeth.2015.05.008; Dvinge H, 2014, P NATL ACAD SCI USA, V111, P16802, DOI 10.1073/pnas.1413374111; Eades P., 1984, C NUMERANTIUM, V42, P149; Edgar LJ, 2014, ANGEW CHEM INT EDIT, V53, P11473, DOI 10.1002/anie.201405233; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Frei AP, 2016, NAT METHODS, V13, P269, DOI [10.1038/NMETH.3742, 10.1038/nmeth.3742]; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Gaudilliere B, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009701; Giesen C, 2014, NAT METHODS, V11, P417, DOI [10.1038/NMETH.2869, 10.1038/nmeth.2869]; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Horowitz A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006702; Hotson AN, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaa9303; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/nmeth.2772, 10.1038/NMETH.2772]; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Lou XD, 2007, ANGEW CHEM INT EDIT, V46, P6111, DOI 10.1002/anie.200700796; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Mei H.E., 2015, CYTOMETRY, V89, P292; Mingueneau M, 2014, P NATL ACAD SCI USA, V111, P16466, DOI 10.1073/pnas.1419337111; Mingueneau M, 2013, NAT IMMUNOL, V14, P619, DOI 10.1038/ni.2590; Newell EW, 2013, NAT BIOTECHNOL, V31, P623, DOI 10.1038/nbt.2593; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Ornatsky OI, 2008, ANAL CHEM, V80, P2539, DOI 10.1021/ac702128m; Ornatsky O, 2010, J IMMUNOL METHODS, V361, P1, DOI 10.1016/j.jim.2010.07.002; Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108; Pyne S, 2009, P NATL ACAD SCI USA, V106, P8519, DOI 10.1073/pnas.0903028106; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Shekhar K, 2014, P NATL ACAD SCI USA, V111, P202, DOI 10.1073/pnas.1321405111; Spitzer MH, 2015, SCIENCE, V349, DOI 10.1126/science.1259425; Strauss-Albee DM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5722; Thomsen ER, 2016, NAT METHODS, V13, P87, DOI [10.1038/NMETH.3629, 10.1038/nmeth.3629]; Tricot S, 2015, CYTOM PART A, V87A, P357, DOI 10.1002/cyto.a.22648; Wong MT, 2015, CELL REP, V11, P1822, DOI 10.1016/j.celrep.2015.05.022; Zunder ER, 2015, CELL STEM CELL, V16, P323, DOI 10.1016/j.stem.2015.01.015; Zunder ER, 2015, NAT PROTOC, V10, P316, DOI 10.1038/nprot.2015.020	55	647	656	40	302	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2016	165	4					780	791		10.1016/j.cell.2016.04.019	http://dx.doi.org/10.1016/j.cell.2016.04.019			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DL7DN	27153492	Green Accepted, Bronze			2022-12-28	WOS:000375800300008
J	van Es, N; van der Hulle, T; van Es, J; den Exter, PL; Douma, RA; Goekoop, RJ; Mos, ICM; Galipienzo, J; Kamphuisen, PW; Huisman, MV; Klok, FA; Buller, HR; Bossuyt, PM				van Es, Nick; van der Hulle, Tom; van Es, Josien; den Exter, Paul L.; Douma, Renee A.; Goekoop, Robbert J.; Mos, Inge C. M.; Galipienzo, Javier; Kamphuisen, Pieter W.; Huisman, Menno V.; Klok, Frederikus A.; Buller, Harry R.; Bossuyt, Patrick M.			Wells Rule and D-Dimer Testing to Rule Out Pulmonary Embolism A Systematic Review and Individual-Patient Data Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							PREVIOUS VENOUS THROMBOEMBOLISM; CLINICAL DECISION RULES; DIAGNOSTIC-ACCURACY; COMPUTED-TOMOGRAPHY; OLDER PATIENTS; MANAGEMENT; EXCLUSION; CUTOFF; EMERGENCY; MODEL	Background: The performance of different diagnostic strategies for pulmonary embolism (PE) in patient subgroups is unclear. Purpose: To evaluate and compare the efficiency and safety of the Wells rule with fixed or age-adjusted D-dimer testing overall and in inpatients and persons with cancer, chronic obstructive pulmonary disease, previous venous thromboembolism, delayed presentation, and age 75 years or older. Data Sources: MEDLINE and EMBASE from 1 January 1988 to 13 February 2016. Study Selection: 6 prospective studies in which the diagnostic management of PE was guided by the dichotomized Wells rule and quantitative D-dimer testing. Data Extraction: Individual data of 7268 patients; risk of bias assessed by 2 investigators with the QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies 2) tool. Data Synthesis: The proportion of patients in whom imaging could be withheld based on a "PE-unlikely" Wells score and a negative D-dimer test result (efficiency) was estimated using fixed (<= 500 mu g/L) and age-adjusted (age x 10 mu g/L in patients aged >50 years) D-dimer thresholds; their 3-month incidence of symptomatic venous thromboembolism (failure rate) was also estimated. Overall, efficiency increased from 28% to 33% when the age-adjusted (instead of the fixed) D-dimer threshold was applied. This increase was more prominent in elderly patients (12%) but less so in inpatients (2.6%). The failure rate of age-adjusted D-dimer testing was less than 3% in all examined subgroups. Limitation: Post hoc analysis, between-study differences in patient characteristics, use of various D-dimer assays, and limited statistical power to assess failure rate. Conclusion: Age-adjusted D-dimer testing is associated with a 5% absolute increase in the proportion of patients with suspected PE in whom imaging can be safely withheld compared with fixed D-dimer testing. This strategy seems safe across different high-risk subgroups, but its efficiency varies.	Acad Med Ctr, Amsterdam, Netherlands; Leiden Univ, Med Ctr, Leiden, Netherlands; [Galipienzo, Javier] MD Anderson Canc Ctr, Serv Anestesiol & Reanimac, Calle Arturo Soria 270, Madrid 28033, Spain; [Kamphuisen, Pieter W.] Univ Groningen, Univ Med Ctr Groningen, Afdeling Interne Geneeskunde, Hanzepl 1, NL-9713 GZ Groningen, Netherlands; [van Es, Nick; Buller, Harry R.] Acad Med Ctr, Afdeling Vasc Geneeskunde, Room F4-136,Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [van der Hulle, Tom; den Exter, Paul L.; Mos, Inge C. M.; Huisman, Menno V.; Klok, Frederikus A.] Leids Univ, Med Ctr, Afdeling Trombose & Hemostase, Albinusdreef 2,POB 9600, NL-2300 RC Leiden, Netherlands; [van Es, Josien] Onze Lieve Vrouwe Gasthuis Cost, Afdeling Longziekten, Qosterpk 9, NL-1091 AC Amsterdam, Netherlands; [Douma, Renee A.] Acad Med Ctr, Afdeling Interne Geneeskunde, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Goekoop, Robbert J.] HagaZiekenhuis, Afdeling Interne Geneeskunde, Leyweg 275, NL-2545 CH The Hague, Netherlands; [Bossuyt, Patrick M.] Acad Med Ctr, Afdeling Klin Epidemiol Biostat & Bioinformat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Texas System; UTMD Anderson Cancer Center; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Haga Hospital; University of Amsterdam; Academic Medical Center Amsterdam	van Es, N (corresponding author), Acad Med Ctr, Afdeling Vasc Geneeskunde, Room F4-136,Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	n.vanes@amc.nl	Bossuyt, Patrick M/AAR-1183-2021; Klok, Erik/U-4870-2019; Bossuyt, Patrick M./B-4557-2016	Bossuyt, Patrick M/0000-0003-4427-0128; Klok, Erik/0000-0001-9961-0754; Bossuyt, Patrick M./0000-0003-4427-0128; den Exter, Paul/0000-0002-1543-5731; van Es, Nick/0000-0001-5256-6346; van der Hulle, Tom/0000-0002-2296-1828; Kamphuisen, Pieter/0000-0002-6263-0177				Anderson DR, 2007, JAMA-J AM MED ASSOC, V298, P2743, DOI 10.1001/jama.298.23.2743; Carrier M, 2010, J THROMB HAEMOST, V8, P1716, DOI 10.1111/j.1538-7836.2010.03938.x; Debray TPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060650; den Exter PL, 2013, AM J RESP CRIT CARE, V187, P1369, DOI 10.1164/rccm.201212-2219OC; Di Nisio M, 2007, J THROMB HAEMOST, V5, P296, DOI 10.1111/j.1538-7836.2007.02328.x; Douma RA, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-11-201106070-00002; Douma RA, 2010, THROMB HAEMOSTASIS, V104, P831, DOI 10.1160/TH10-02-0093; Douma RA, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1475; Galipienzo J, 2012, Rom J Intern Med, V50, P195; Geersing GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032844; Goekoop RJ, 2007, THROMB HAEMOSTASIS, V97, P146, DOI 10.1160/TH06-09-0529; Kline JA, 2006, CHEST, V129, P1417, DOI 10.1378/chest.129.6.1417; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283; Le Gal G, 2006, ARCH INTERN MED, V166, P176, DOI 10.1001/archinte.166.2.176; Lucassen W, 2011, ANN INTERN MED, V155, P448, DOI 10.7326/0003-4819-155-7-201110040-00007; Mos ICM, 2014, THROMB RES, V133, P1039, DOI 10.1016/j.thromres.2014.03.050; Nijkeuter M, 2007, THROMB HAEMOSTASIS, V97, P944, DOI 10.1160/TH06-11-0635; Penaloza A, 2012, J THROMB HAEMOST, V10, P1291, DOI 10.1111/j.1538-7836.2012.04769.x; Pollack CV, 2011, J AM COLL CARDIOL, V57, P700, DOI 10.1016/j.jacc.2010.05.071; Qaseem A, 2007, ANN FAM MED, V5, P57, DOI 10.1370/afm.667; Righini M, 2006, THROMB HAEMOSTASIS, V95, P56, DOI 10.1160/TH05-08-0588; Righini M, 2014, JAMA-J AM MED ASSOC, V311, P1117, DOI 10.1001/jama.2014.2135; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; Schouten HJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2492; Sohne M, 2006, J THROMB HAEMOST, V4, P1042, DOI 10.1111/j.1538-7836.2006.01918.x; Sohne M, 2005, THROMB HAEMOSTASIS, V94, P206, DOI 10.1160/TH04-11-0753; Stewart GB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046042; Stewart LA, 2015, JAMA-J AM MED ASSOC, V313, P1657, DOI 10.1001/jama.2015.3656; van Beek EJR, 2001, CLIN RADIOL, V56, P838, DOI 10.1053/crad.2001.0778; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172; van der Heijden GJMG, 2006, J CLIN EPIDEMIOL, V59, P1102, DOI 10.1016/j.jclinepi.2006.01.015; van der Hulle T, 2014, BRIT J HAEMATOL, V167, P681, DOI 10.1111/bjh.13090; Wells PS, 1998, ANN INTERN MED, V129, P997, DOI 10.7326/0003-4819-129-12-199812150-00002; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009	36	89	92	0	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2016	165	4					253	+		10.7326/M16-0031	http://dx.doi.org/10.7326/M16-0031			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT1UI	27182696				2022-12-28	WOS:000381267200014
J	Hunink, MGM; Fleischmann, KE				Hunink, M. G. Myriam; Fleischmann, Kirsten E.			The Role of Randomized and Nonrandomized Studies in Evaluating Diagnostic Strategies	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CARDIOVASCULAR MAGNETIC-RESONANCE; EMISSION COMPUTED-TOMOGRAPHY; CORONARY-HEART-DISEASE; COST-EFFECTIVENESS; CE-MARC; MEDIATION		[Hunink, M. G. Myriam] Erasmus Univ, Med Ctr, Rotterdam, Netherlands; [Fleischmann, Kirsten E.] Univ Calif San Francisco, San Francisco, CA 94143 USA	Erasmus University Rotterdam; Erasmus MC; University of California System; University of California San Francisco	Hunink, MGM (corresponding author), POB 2040, NL-3000 CA Rotterdam, Netherlands.	m.hunink@erasmusmc.nl						Boldt J, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-30; FRYBACK DG, 1991, MED DECIS MAKING, V11, P88, DOI 10.1177/0272989X9101100203; Genders TSS, 2015, ANN INTERN MED, V162, P474, DOI 10.7326/M14-0027; Greenwood JP, 2016, ANN INTERN MED, V165, P1, DOI 10.7326/M15-1801; Greenwood JP, 2012, LANCET, V379, P453, DOI 10.1016/S0140-6736(11)61335-4; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Iwata K, 2013, RADIOL PHYS TECHNOL, V6, P28, DOI 10.1007/s12194-012-0165-2; Richiardi L, 2013, INT J EPIDEMIOL, V42, P1511, DOI 10.1093/ije/dyt127; VanderWeele TJ, 2014, EPIDEMIOLOGY, V25, P749, DOI 10.1097/EDE.0000000000000121; Walker S, 2013, HEART, V99, P873, DOI 10.1136/heartjnl-2013-303624	10	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2016	165	1					61	+		10.7326/M16-0811	http://dx.doi.org/10.7326/M16-0811			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ5AD	27159031				2022-12-28	WOS:000379215800012
J	Wang, QC; Zheng, QX; Tan, HY; Zhang, B; Li, XL; Yang, YX; Yu, J; Liu, Y; Chai, H; Wang, X; Sun, ZS; Wang, JQ; Zhu, S; Wang, FL; Yang, MJ; Guo, CX; Wang, H; Zheng, QY; Li, Y; Chen, Q; Zhou, AM; Tang, TS				Wang, Qiao-Chu; Zheng, Qiaoxia; Tan, Haiyan; Zhang, Bing; Li, Xiaoling; Yang, Yuxiu; Yu, Jie; Liu, Yang; Chai, Hao; Wang, Xi; Sun, Zhongshuai; Wang, Jiu-Qiang; Zhu, Shu; Wang, Fengli; Yang, Maojun; Guo, Caixia; Wang, Heng; Zheng, Qingyin; Li, Yang; Chen, Quan; Zhou, Aimin; Tang, Tie-Shan			TMCO1 Is an ER Ca2+ Load-Activated Ca2+ Channel	CELL			English	Article							CRAC CHANNEL; INOSITOL TRISPHOSPHATE; CALCIUM-ENTRY; STORE; STIM1; ORAI1; OLIGOMERIZATION; SELECTIVITY; DEFICIENCY; DEPLETION	Maintaining homeostasis of Ca2+ stores in the endoplasmic reticulum (ER) is crucial for proper Ca2+ signaling and key cellular functions. The Ca2+-release-activated Ca2+ (CRAC) channel is responsible for Ca2+ influx and refilling after store depletion, but how cells cope with excess Ca2+ when ER stores are overloaded is unclear. We show that TMCO1 is an ER transmembrane protein that actively prevents Ca2+ stores from overfilling, acting as what we term a "Ca2+ load-activated Ca2+ channel" or "CLAC" channel. TMCO1 undergoes reversible homotetramerization in response to ER Ca2+ overloading and disassembly upon Ca2+ depletion and forms a Ca2+-selective ion channel on giant liposomes. TMCO1 knockout mice reproduce the main clinical features of human cerebrofaciothoracic (CFT) dysplasia spectrum, a developmental disorder linked to TMCO1 dysfunction, and exhibit severe mishandling of ER Ca2+ in cells. Our findings indicate that TMCO1 provides a protective mechanism to prevent overfilling of ER stores with Ca2+ ions.	[Wang, Qiao-Chu; Zheng, Qiaoxia; Li, Xiaoling; Wang, Xi; Wang, Jiu-Qiang; Zhu, Shu; Wang, Fengli; Chen, Quan; Tang, Tie-Shan] Chinese Acad Sci, Univ Chinese Acad Sci, Inst Zool, State Key Lab Membrane Biol, Beijing 100101, Peoples R China; [Tan, Haiyan; Zhou, Aimin] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA; [Tan, Haiyan; Zhou, Aimin] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA; [Zhang, Bing; Yang, Yuxiu; Chai, Hao; Li, Yang] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China; [Yu, Jie; Yang, Maojun] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Sch Life Sci, Ministry Educ,Key Lab Prot Sci,Tsinghua Peking Jo, Beijing 100084, Peoples R China; [Liu, Yang; Sun, Zhongshuai; Guo, Caixia] Chinese Acad Sci, Beijing Inst Genom, China Gastrointestinal Canc Res Ctr, Key Lab Genom & Precis Med, Beijing 100101, Peoples R China; [Wang, Heng] Ctr Special Needs Children, DDC Clin, Middlefield, OH 44062 USA; [Zheng, Qingyin] Case Western Reserve Univ, Dept Otolaryngol HNS, Cleveland, OH 44106 USA	Chinese Academy of Sciences; Institute of Zoology, CAS; University of Chinese Academy of Sciences, CAS; University System of Ohio; Cleveland State University; University System of Ohio; Cleveland State University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Tsinghua University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Case Western Reserve University	Tang, TS (corresponding author), Chinese Acad Sci, Univ Chinese Acad Sci, Inst Zool, State Key Lab Membrane Biol, Beijing 100101, Peoples R China.; Zhou, AM (corresponding author), Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA.; Zhou, AM (corresponding author), Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA.	a.zhou@csuohio.edu; tangtsh@ioz.ac.cn		wang, fengli/0000-0002-3461-6204; Yang, Maojun/0000-0002-6798-3094	National Basic Research Program of China [2012CB944702, NSFC 81371415, 91519324, 31570816, 31401151, 81300982]; Ohio Research Scholars Program; Faculty Research and Development Program of Cleveland State University;  [2013CB91060101];  [3137106601];  [3117101101];  [2012ZX09301];  [2011CB910502];  [2012CB911101];  [NSFC 31030020];  [31170679];  [2013CB945003];  [31471331];  [XDB14030302]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC015111] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); Ohio Research Scholars Program; Faculty Research and Development Program of Cleveland State University; ; ; ; ; ; ; ; ; ; ; ; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Yun Wang, Yang Zhang, and Wenjuan Xie for assistance in stable cell lines and constructs; Pingsheng Liu for help with cross-linking; Liangyi Chen for help with single-molecule bleaching; Junjie Hu for help with subcellular localization; Heping (Peace) Cheng for critical reading of the manuscript and helpful discussion; Paula L. Fischhaber for proofreading the manuscript; Roger Tsien for providing cameleon plasmids; Amy Palmer, Weiwei Shen, and Nicolas Demaurex for help with ER Ca<SUP>2+</SUP> measurements. This work was supported by grants to T.-S.T. (National Basic Research Program of China 2012CB944702; NSFC 81371415, 91519324, 31570816, 31401151, and 81300982), A.Z. (awards from the Ohio Research Scholars Program and the Faculty Research and Development Program of Cleveland State University), Y. Li (2013CB91060101, 3137106601, 3117101101, and 2012ZX09301), M.Y. (2011CB910502, 2012CB911101, NSFC 31030020, and 31170679), and C.G. (2013CB945003, 31471331, and XDB14030302).	Alanay Y, 2014, AM J MED GENET A, V164, P291, DOI 10.1002/ajmg.a.36248; ALMERS W, 1984, J PHYSIOL-LONDON, V353, P585, DOI 10.1113/jphysiol.1984.sp015352; Austin RC, 2009, ANTIOXID REDOX SIGN, V11, P2279, DOI [10.1089/ars.2009.2686, 10.1089/ARS.2009.2686]; Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BEZPROZVANNY I, 1994, J GEN PHYSIOL, V104, P821, DOI 10.1085/jgp.104.5.821; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Bultynck G, 2012, J BIOL CHEM, V287, P2544, DOI 10.1074/jbc.M111.275354; Caglayan AO, 2013, CLIN GENET, V84, P394, DOI 10.1111/cge.12088; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Chae HJ, 2004, MOL CELL, V15, P355, DOI 10.1016/j.molcel.2004.06.038; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Finn JT, 1997, NATURE, V385, P815, DOI 10.1038/385815a0; FRINGS S, 1995, NEURON, V15, P169, DOI 10.1016/0896-6273(95)90074-8; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Li Y, 2007, J GEN PHYSIOL, V129, P109, DOI 10.1085/jgp.200609655; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Oakes SA, 2005, P NATL ACAD SCI USA, V102, P105, DOI 10.1073/pnas.0408352102; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Palty R, 2012, CELL, V149, P425, DOI 10.1016/j.cell.2012.01.055; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Putney JW, 2009, IMMUNOL REV, V231, P10, DOI 10.1111/j.1600-065X.2009.00810.x; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Sammels E, 2010, CELL CALCIUM, V47, P297, DOI 10.1016/j.ceca.2010.02.001; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xin BZ, 2010, P NATL ACAD SCI USA, V107, P258, DOI 10.1073/pnas.0908457107; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	44	89	92	3	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2016	165	6					1454	1466		10.1016/j.cell.2016.04.051	http://dx.doi.org/10.1016/j.cell.2016.04.051			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DN4NV	27212239	Green Submitted, Bronze			2022-12-28	WOS:000377045400018
J	Maskarinec, SA; Fowler, VG				Maskarinec, Stacey A.; Fowler, Vance G., Jr.			Persistent Rash in a Patient Receiving Total Parenteral Nutrition	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACRODERMATITIS-ENTEROPATHICA; SHORTAGES		[Maskarinec, Stacey A.; Fowler, Vance G., Jr.] Duke Univ, Sch Med, Dept Med, Div Infect Dis & Int Hlth, POB 102359, Durham, NC 27710 USA; [Fowler, Vance G., Jr.] Duke Univ, Duke Clin Res Inst, Durham, NC USA	Duke University; Duke University	Fowler, VG (corresponding author), Duke Univ, Sch Med, Dept Med, Div Infect Dis & Int Hlth, POB 102359, Durham, NC 27710 USA.	vance.fowler@duke.edu	Fowler, Vance/AAW-2017-2021	Maskarinec, Stacey/0000-0002-1716-8374	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI093969, R01AI068804, T32AI052080] Funding Source: NIH RePORTER; NIAID NIH HHS [K24-AI093969, R01 AI068804, 5T32-AI052080-12, T32 AI052080, K24 AI093969, R01-AI068804] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cousins RJ, 2006, J BIOL CHEM, V281, P24085, DOI 10.1074/jbc.R600011200; Hanson C, 2012, NUTRIENTS, V4, P1977, DOI 10.3390/nu4121977; Jensen GL, 2002, JPEN-PARENTER ENTER, V26, pS29, DOI 10.1177/014860710202600509; Kury S, 2002, NAT GENET, V31, P239, DOI 10.1038/ng913; Lakdawala N, 2015, CLIN DERMATOL, V33, P414, DOI 10.1016/j.clindermatol.2015.04.002; Maverakis E, 2007, J AM ACAD DERMATOL, V56, P116, DOI 10.1016/j.jaad.2006.08.015; Mirtallo JM, 2012, NUTR CLIN PRACT, V27, P385, DOI 10.1177/0884533612444538; Sehgal VN, 2000, CLIN DERMATOL, V18, P745, DOI 10.1016/S0738-081X(00)00150-4; SUBRAMANIAN L, 1983, NUTR REV, V41, P217; World Health Organization, 2007, PREV CONTR MICR DEF	10	2	2	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 24	2016	315	20					2223	2224		10.1001/jama.2016.4154	http://dx.doi.org/10.1001/jama.2016.4154			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM4US	27218632	Green Accepted			2022-12-28	WOS:000376343000019
J	Wang, SV; Franklin, JM; Glynn, RJ; Schneeweiss, S; Eddings, W; Gagne, JJ				Wang, Shirley V.; Franklin, Jessica M.; Glynn, Robert J.; Schneeweiss, Sebastian; Eddings, Wesley; Gagne, Joshua J.			Prediction of rates of thromboembolic and major bleeding outcomes with dabigatran or warfarin among patients with atrial fibrillation: new initiator cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK STRATIFICATION; CLINICAL-TRIALS; STROKE; THERAPY; ANTICOAGULANTS; APIXABAN; EFFICACY; SAFETY	OBJECTIVES To compare stratified event rates from randomized controlled trials with predicted event rates from models developed in observational data, and assess their ability to accurately capture observed rates of thromboembolism and major bleeding for patients treated with dabigatran or warfarin as part of routine care. DESIGN New initiator cohort study. SETTING Data from United Health (October 2009 to June 2013), a commercial healthcare claims database in the United States. PARTICIPANTS 21 934 adults with atrial fibrillation initiating dabigatran (150 mg dose only) or warfarin treatment as part of routine care. MAIN OUTCOME MEASURES Predicted annual rates of thromboembolism or major bleeding, based on estimates from randomized controlled trials, models developed in routine care patients, and baseline risk scores (CHADS(2), CHA(2)DS(2)-VASc, and HAS-BLED). Thromboembolism was a composite outcome, including primary inpatient diagnosis codes for ischemic or ill defined stroke, transient ischemic attack, pulmonary embolism, deep vein thrombosis, and systemic embolism. Major bleeding was a composite outcome including codes occurring in an inpatient setting for hemorrhagic stroke; major upper, lower, or unspecified gastrointestinal bleed; and major urogenital or other bleed. RESULTS 6516 (30%) and 15 418 (70%) of patients initiated dabigatran and warfarin, respectively. Annual event rates per 100 patients were 1.7 for thromboembolism and 4.6 for major bleeding. For thromboembolism, calibration of estimates from randomized controlled trials was similar to calibration for model based predictions; however, trial estimates for major bleeding consistently underestimated the rate of bleeding among patients in routine care. Underestimation of bleeding rates was particularly pronounced in warfarin initiators with high HAS-LED scores, where event rates were underestimated by up to 4.0 per 100 patient years. Harrell's c indices for discrimination for thromboembolism or major bleeding in dabigatran and warfarin initiators ranged between 0.59 and 0.66 for randomized controlled trial predictions, and between 0.52 and 0.70 for cross validated model based predictions. CONCLUSION Estimated rates of thromboembolism under dabigatran or warfarin treatment in randomized controlled trials were close to observed rates in routine care patients. However, rates of major bleeding were underestimated. Models developed in routine care patients can provide accurate, tailored estimates of risk and benefit under alternative treatment to enhance patient centered care.	[Wang, Shirley V.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St, Boston, MA 02120 USA; Harvard Univ, Sch Med, 1620 Tremont St, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Wang, SV (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St, Boston, MA 02120 USA.	swang27@partners.org	Schneeweiss, Sebastian/C-2125-2013	Schneeweiss, Sebastian/0000-0003-2575-467X	Agency for Healthcare Research and Quality [R00HS022193]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R00HS022193] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	SVW was supported by grant number R00HS022193 from the Agency for Healthcare Research and Quality. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality.	[Anonymous], 2006, REGRESSION MODELING; Bungard TJ, 2000, ARCH INTERN MED, V160, P41, DOI 10.1001/archinte.160.1.41; Camm AJ, 2012, EUR HEART J, V33; Cohen D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4747; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Demler OV, 2015, STAT MED, V34, P1659, DOI 10.1002/sim.6428; Ezekowitz MD, 2009, AM HEART J, V157, P805, DOI 10.1016/j.ahj.2009.02.005; Gage BF, 2004, CIRCULATION, V110, P2287, DOI 10.1161/01.CIR.0000145172.55640.93; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Graham DJ, 2015, CIRCULATION, V131, P157, DOI 10.1161/CIRCULATIONAHA.114.012061; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Hylek EM, 2007, CIRCULATION, V115, P2689, DOI 10.1161/CIRCULATIONAHA.106.653048; Kent DM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-85; Larsen TB, 2013, J AM COLL CARDIOL, V61, P2264, DOI 10.1016/j.jacc.2013.03.020; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lopes RD, 2012, LANCET, V380, P1749, DOI 10.1016/S0140-6736(12)60986-6; Manning WJ, 2012, ANTITHROMBOTIC THERA; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; National Institute for Health and Care Excellence, 2014, NICE GUIDELINES CG18; Ogilvie IM, 2010, AM J MED, V123, P638, DOI 10.1016/j.amjmed.2009.11.025; Optum Life Science, 2016, CLAIMS DAT; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Steyerberg E.W., 2019, CLIN PREDICTION MODE, DOI [10.1007/978-3-030-16399-0, DOI 10.1007/978-3-030-16399-0]; Sturmer T, 2014, J INTERN MED, V275, P570, DOI 10.1111/joim.12197; Walker AM., 2013, COMP EFF RES, V2013, P3, DOI [DOI 10.2147/CER.S40357, 10.2147/CER.S40357]	28	30	30	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 24	2016	353								i2607	10.1136/bmj.i2607	http://dx.doi.org/10.1136/bmj.i2607			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3CB	27221664	Green Published, hybrid			2022-12-28	WOS:000376938800002
J	Zarbock, A; Kellum, JA; Schmidt, C; Van Aken, H; Wempe, C; Pavenstadt, H; Boanta, A; Gerss, J; Meersch, M				Zarbock, Alexander; Kellum, John A.; Schmidt, Christoph; Van Aken, Hugo; Wempe, Carola; Pavenstaedt, Hermann; Boanta, Andreea; Gerss, Joachim; Meersch, Melanie			Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury The ELAIN Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SURVIVAL; INTERLEUKIN-8; DIALYSIS; FAILURE; HEMOFILTRATION; BIOMARKERS; INTENSITY; PNEUMONIA; RECOVERY; OUTCOMES	IMPORTANCE Optimal timing of initiation of renal replacement therapy (RRT) for severe acute kidney injury (AKI) but without life-threatening indications is still unknown. OBJECTIVE To determine whether early initiation of RRT in patients who are critically ill with AKI reduces 90-day all-cause mortality. DESIGN, SETTING, AND PARTICIPANTS Single-center randomized clinical trial of 231 critically ill patients with AKI Kidney Disease: Improving Global Outcomes (KDIGO) stage 2 (>= 2 times baseline or urinary output <0.5 mL/kg/h for >= 12 hours) and plasma neutrophil gelatinase-associated lipocalin level higher than 150 ng/mL enrolled between August 2013 and June 2015 from a university hospital in Germany. INTERVENTIONS Early (within 8 hours of diagnosis of KDIGO stage 2; n = 112) or delayed (within 12 hours of stage 3 AKI or no initiation; n = 119) initiation of RRT. MAIN OUTCOMES AND MEASURES The primary end point was mortality at 90 days after randomization. Secondary end points included 28- and 60-day mortality, clinical evidence of organ dysfunction, recovery of renal function, requirement of RRT after day 90, duration of renal support, and intensive care unit (ICU) and hospital length of stay. RESULTS Among 231 patients (mean age, 67 years; men, 146 [63.2%]), all patients in the early group (n = 112) and 108 of 119 patients (90.8%) in the delayed group received RRT. All patients completed follow-up at 90 days. Median time (Q1, Q3) from meeting full eligibility criteria to RRT initiation was significantly shorter in the early group (6.0 hours [Q1, Q3: 4.0, 7.0]) than in the delayed group (25.5 h [Q1, Q3: 18.8, 40.3]; difference, -21.0 [95% CI, -24.0 to -18.0]; P < .001). Early initiation of RRT significantly reduced 90-day mortality (44 of 112 patients [39.3%]) compared with delayed initiation of RRT (65 of 119 patients [54.7%]; hazard ratio [HR], 0.66 [95% CI, 0.45 to 0.97]; difference, -15.4%[95% CI, -28.1% to -2.6%]; P = .03). More patients in the early group recovered renal function by day 90 (60 of 112 patients [53.6%] in the early group vs 46 of 119 patients [38.7%] in the delayed group; odds ratio [OR], 0.55 [95% CI, 0.32 to 0.93]; difference, 14.9% [95% CI, 2.2% to 27.6%]; P = .02). Duration of RRT and length of hospital stay were significantly shorter in the early group than in the delayed group (RRT: 9 days [Q1, Q3: 4, 44] in the early group vs 25 days [Q1, Q3: 7, >90] in the delayed group; P = .04; HR, 0.69 [95% CI, 0.48 to 1.00]; difference, -18 days [95% CI, -41 to 4]; hospital stay: 51 days [Q1, Q3: 31, 74] in the early group vs 82 days [Q1, Q3: 67, >90] in the delayed group; P < .001; HR, 0.34 [95% CI, 0.22 to 0.52]; difference, -37 days [95% CI, -infinity to -19.5]), but there was no significant effect on requirement of RRT after day 90, organ dysfunction, and length of ICU stay. CONCLUSIONS AND RELEVANCE Among critically ill patients with AKI, early RRT compared with delayed initiation of RRT reduced mortality over the first 90 days. Further multicenter trials of this intervention are warranted.	[Zarbock, Alexander; Schmidt, Christoph; Van Aken, Hugo; Wempe, Carola; Boanta, Andreea; Meersch, Melanie] Univ Hosp Munster, Dept Anaesthesiol Intens Care Med & Pain Med, Munster, Germany; [Kellum, John A.] Univ Pittsburgh, Dept Crit Care Med, Ctr Crit Care Nephrol, Pittsburgh, PA 15260 USA; [Pavenstaedt, Hermann] Univ Hosp Munster, Dept Internal Med D, Munster, Germany; [Gerss, Joachim] Univ Munster, Inst Biostat & Clin Res, D-48149 Munster, Germany	University of Munster; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Munster; University of Munster	Zarbock, A (corresponding author), Univ Hosp Munster, Dept Anesthesiol Crit Care Med & Pain Therapy, Albert Schweitzer Campus 1,Gebaude A1, D-48149 Munster, Germany.	zarbock@uni-muenster.de	Gerß, Joachim WO/B-5702-2013; Kellum, John A/HCH-2944-2022; Kellum, John/AAP-3072-2020	Kellum, John A/0000-0003-1995-2653; Kellum, John/0000-0003-1995-2653	Else-Kroner Fresenius Stiftung [2013_A46]	Else-Kroner Fresenius Stiftung	The study was funded by the Else-Kroner Fresenius Stiftung (2013_A46 to A.Z.).	Bacher M, 1996, P NATL ACAD SCI USA, V93, P7849, DOI 10.1073/pnas.93.15.7849; Bagshaw SM, 2009, J CRIT CARE, V24, P129, DOI 10.1016/j.jcrc.2007.12.017; Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413; Bouchard J, 2009, KIDNEY INT, V76, P422, DOI 10.1038/ki.2009.159; Bouman CSC, 2002, CRIT CARE MED, V30, P2205, DOI 10.1097/00003246-200210000-00005; Chawla LS, 2007, CLIN J AM SOC NEPHRO, V2, P22, DOI 10.2215/CJN.02510706; Chou YH, 2011, CRIT CARE, V15, DOI 10.1186/cc10252; Clark WR, 2006, BLOOD PURIFICAT, V24, P487, DOI 10.1159/000095929; Cruz DN, 2011, SEMIN DIALYSIS, V24, P124, DOI 10.1111/j.1525-139X.2011.00830.x; Cruz DN, 2010, INTENS CARE MED, V36, P444, DOI 10.1007/s00134-009-1711-1; Demirkilic U, 2004, J CARDIAC SURG, V19, P17, DOI 10.1111/j.0886-0440.2004.04004.x; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Elahi MM, 2004, EUR J CARDIO-THORAC, V26, P1027, DOI 10.1016/j.ejcts.2004.07.039; Gangemi S, 2002, AM J NEPHROL, V22, P417, DOI 10.1159/000065269; Gettings LG, 1999, INTENS CARE MED, V25, P805, DOI 10.1007/s001340050956; Gibney N, 2008, CLIN J AM SOC NEPHRO, V3, P876, DOI 10.2215/CJN.04871107; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; Hoste E, 2015, INTENS CARE MED, V41, P1411, DOI 10.1007/s00134-015-3934-7; Jamale TE, 2013, AM J KIDNEY DIS, V62, P1116, DOI 10.1053/j.ajkd.2013.06.012; Jun M, 2010, CLIN J AM SOC NEPHRO, V5, P956, DOI 10.2215/CJN.09111209; Karvellas CJ, 2011, CRIT CARE, V15, DOI 10.1186/cc10061; Kellum JA, 2008, CLIN J AM SOC NEPHRO, V3, P887, DOI 10.2215/CJN.04891107; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; Kwon O, 2003, AM J KIDNEY DIS, V41, P1074, DOI 10.1016/S0272-6386(03)00206-3; Lehmacher W, 1999, BIOMETRICS, V55, P1286, DOI 10.1111/j.0006-341X.1999.01286.x; Liangos O, 2009, NEPHRON CLIN PRACT, V113, pC148, DOI 10.1159/000232595; Liu KD, 2007, CRIT CARE MED, V35, P2755, DOI 10.1097/01.CCM.0000291649.72238.6D; Liu KD, 2006, CLIN J AM SOC NEPHRO, V1, P915, DOI 10.2215/CJN.01430406; Liu KD, 2009, CRIT CARE, V13, DOI 10.1186/cc7940; Matson J, 2004, Crit Care Resusc, V6, P209; Murugan R, 2014, NEPHROL DIAL TRANSPL, V29, P1854, DOI 10.1093/ndt/gfu051; Murugan R, 2010, KIDNEY INT, V77, P527, DOI 10.1038/ki.2009.502; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Ronco C, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0850-8; Shiao CC, 2009, CRIT CARE, V13, DOI 10.1186/cc8147; Simmons EM, 2004, KIDNEY INT, V65, P1357, DOI 10.1111/j.1523-1755.2004.00512.x; Sugahara Souichi, 2004, Hemodial Int, V8, P320, DOI 10.1111/j.1492-7535.2004.80404.x; Wald R, 2015, KIDNEY INT, V88, P897, DOI 10.1038/ki.2015.184; Wassmer G, 2006, BIOMETRICAL J, V48, P714, DOI 10.1002/bimj.200510190; Zarbock A, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1249-9	40	605	654	3	41	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 24	2016	315	20					2190	2199		10.1001/jama.2016.5828	http://dx.doi.org/10.1001/jama.2016.5828			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM4US	27209269	Bronze			2022-12-28	WOS:000376343000015
J	Marcus, HJ; Payne, CJ; Hughes-Hallett, A; Marcus, AP; Yang, GZ; Darzi, A; Nandi, D				Marcus, Hani J.; Payne, Christopher J.; Hughes-Hallett, Archie; Marcus, Adam P.; Yang, Guang-Zhong; Darzi, Ara; Nandi, Dipankar			Regulatory approval of new medical devices: cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IDEAL FRAMEWORK; TRANSLATIONAL RESEARCH; PREMARKET APPROVAL; LIFE-CYCLE; INNOVATION; RECALLS; TRIALS	OBJECTIVE To investigate the regulatory approval of new medical devices. DESIGN Cross sectional study of new medical devices reported in the biomedical literature. DATA SOURCES PubMed was searched between 1 January 2000 and 31 December 2004 to identify clinical studies of new medical devices. The search was carried out during this period to allow time for regulatory approval. ELIGIBILITY CRITERIA FOR STUDY SELECTION Articles were included if they reported a clinical study of a new medical device and there was no evidence of a previous clinical study in the literature. We defined a medical device according to the US Food and Drug Administration as an "instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article." MAIN OUTCOME MEASURES Type of device, target specialty, and involvement of academia or of industry for each clinical study. The FDA medical databases were then searched for clearance or approval relevant to the device. RESULTS 5574 titles and abstracts were screened, 493 full text articles assessed for eligibility, and 218 clinical studies of new medical devices included. In all, 99/218 (45%) of the devices described in clinical studies ultimately received regulatory clearance or approval. These included 510(k) clearance for devices determined to be "substantially equivalent" to another legally marketed device (78/99; 79%), premarket approval for high risk devices (17/99; 17%), and others (4/99; 4%). Of these, 43 devices (43/99; 43%) were actually cleared or approved before a clinical study was published. CONCLUSIONS We identified a multitude of new medical devices in clinical studies, almost half of which received regulatory clearance or approval. The 510(k) pathway was most commonly used, and clearance often preceded the first published clinical study.	[Marcus, Hani J.; Payne, Christopher J.; Hughes-Hallett, Archie; Yang, Guang-Zhong; Darzi, Ara] Univ London Imperial Coll Sci Technol & Med, Hamlyn Ctr, Inst Global Hlth Innovat, London W2 1NY, England; [Marcus, Hani J.; Nandi, Dipankar] Imperial Coll Healthcare NHS Trust, Dept Neurosurg, London, England; [Marcus, Adam P.] Univ London Imperial Coll Sci Technol & Med, London, England	Imperial College London; Imperial College London; Imperial College London	Marcus, HJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hamlyn Ctr, Inst Global Hlth Innovat, London W2 1NY, England.; Marcus, HJ (corresponding author), Imperial Coll Healthcare NHS Trust, Dept Neurosurg, London, England.	hani.marcus10@imperial.ac.uk	Nandi, Dipankar/AAN-7186-2020	Payne, Christopher/0000-0002-5741-8948	Imperial College Wellcome Trust; Wates Foundation	Imperial College Wellcome Trust; Wates Foundation	HJM was supported by an Imperial College Wellcome Trust clinical fellowship, and CJP was supported by a Wates Foundation fellowship.	Barkun JS, 2009, LANCET, V374, P1089, DOI 10.1016/S0140-6736(09)61083-7; Chang L, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2613; Contopoulos-Ioannidis DG, 2008, SCIENCE, V321, P1298, DOI 10.1126/science.1160622; Contopoulos-Ioannidis DG, 2003, AM J MED, V114, P477, DOI 10.1016/S0002-9343(03)00013-5; Cook JA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2820; Drolet BC, 2011, TRANSL RES, V157, P1, DOI 10.1016/j.trsl.2010.10.002; Ergina PL, 2009, LANCET, V374, P1097, DOI 10.1016/S0140-6736(09)61086-2; Ergina PL, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3011; Kesselheim AS, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5303; Marcus HJ, 2013, BMJ-BRIT MED J, V346, pf1573, DOI DOI 10.1097/SLA.0000000000001532.PAUL; McCulloch P, 2009, LANCET, V374, P1105, DOI 10.1016/S0140-6736(09)61116-8; McCulloch P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3012; McMurry-Heath M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3005269; Nieuwenhuijse MJ, 2014, BMJ-BRIT MED J, V349, pg5133, DOI [10.1136/bmj.g5133, DOI 10.1136/BMJ.G5133]; Normand SLT, 2012, BMJ, P345; Rathi VK, 2015, JAMA-J AM MED ASSOC, V314, P604, DOI 10.1001/jama.2015.8761; STEINER CA, 1994, NEW ENGL J MED, V330, P403, DOI 10.1056/NEJM199402103300607; Thompson M, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2973; Wilmshurst P, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2822; Zuckerman D, 2014, JAMA INTERN MED, V174, P1781, DOI 10.1001/jamainternmed.2014.4193; Zuckerman DM, 2011, ARCH INTERN MED, V171, P1006, DOI 10.1001/archinternmed.2011.30	21	22	22	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2016	353								i2587	10.1136/bmj.i2587	http://dx.doi.org/10.1136/bmj.i2587			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GI	27207165	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000376448200002
J	Owens, B				Owens, Brian			Access all areas	NATURE			English	Editorial Material																			0	10	10	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					S71	S72		10.1038/533S71a	http://dx.doi.org/10.1038/533S71a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0BJ	27167398	Bronze			2022-12-28	WOS:000376007200009
